data_6ocv_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6ocv _Structure_validation_residue.Date_analyzed 2020-05-01 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.4 mmm . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 120.822 0.344 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.492 ' HA ' HG23 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -78.09 -25.39 47.58 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -178.832 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.45 -39.4 50.6 Favored Glycine 0 C--N 1.351 1.392 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.0 tpp -69.78 -38.07 76.57 Favored 'General case' 0 C--N 1.357 0.914 0 O-C-N 121.911 -0.758 . . . . 0.0 111.081 -177.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.492 HG23 ' HA ' ' A' ' 2' ' ' MET . 26.8 m -69.26 -22.63 25.98 Favored 'Isoleucine or valine' 0 C--N 1.356 0.89 0 O-C-N 121.504 -0.748 . . . . 0.0 109.51 -179.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -70.22 -36.76 74.75 Favored 'General case' 0 C--N 1.359 0.989 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 87.8 m -66.56 -40.91 89.26 Favored 'General case' 0 C--N 1.357 0.911 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.64 -38.9 97.18 Favored Glycine 0 C--N 1.357 1.71 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.647 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -65.55 -40.31 92.72 Favored 'General case' 0 C--N 1.351 0.673 0 CA-C-N 117.207 0.503 . . . . 0.0 110.739 -178.205 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 20.7 mmt -63.75 -41.44 98.0 Favored 'General case' 0 C--N 1.355 0.819 0 O-C-N 121.419 -0.801 . . . . 0.0 111.207 -178.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -66.82 -40.36 88.02 Favored 'General case' 0 C--N 1.348 0.518 0 O-C-N 122.011 -0.431 . . . . 0.0 111.691 -177.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 55.7 tp -66.08 -43.29 87.77 Favored 'General case' 0 C--N 1.349 0.573 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -177.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.647 HG12 ' O ' ' A' ' 9' ' ' LEU . 1.7 mm -73.18 -36.57 50.34 Favored 'Isoleucine or valine' 0 C--N 1.36 1.029 0 O-C-N 121.076 -1.015 . . . . 0.0 111.14 -175.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.417 ' HG3' HD22 ' A' ' 22' ' ' LEU . 19.9 tt0 -70.66 -42.57 70.62 Favored 'General case' 0 C--N 1.35 0.612 0 O-C-N 121.505 -0.747 . . . . 0.0 111.746 -176.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -72.01 -38.33 69.62 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -175.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -102.75 -23.97 13.76 Favored 'General case' 0 CA--C 1.509 -0.612 0 C-N-CA 118.524 -1.27 . . . . 0.0 113.655 -174.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 13.8 m-30 -108.2 -37.43 6.03 Favored 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 117.994 -1.482 . . . . 0.0 111.531 -176.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 143.37 178.11 18.89 Favored Glycine 0 C--N 1.347 1.173 0 C-N-CA 118.842 -1.646 . . . . 0.0 109.214 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -102.19 -26.93 13.16 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 -177.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -70.48 -38.92 74.47 Favored 'General case' 0 C--N 1.36 1.061 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.6 m -67.31 -38.48 85.02 Favored 'General case' 0 C--N 1.359 0.995 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.442 HD12 ' HB ' ' A' ' 13' ' ' ILE . 35.2 tp -60.57 -38.81 85.81 Favored 'General case' 0 C--N 1.356 0.859 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -63.77 -37.91 89.15 Favored 'General case' 0 C--N 1.358 0.96 0 O-C-N 122.122 -0.361 . . . . 0.0 111.485 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 87.1 m -65.42 -38.86 91.19 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.575 HD11 ' HB3' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -62.34 -39.36 92.84 Favored 'General case' 0 C--N 1.354 0.768 0 CA-C-O 120.958 0.408 . . . . 0.0 109.988 -179.046 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 85.7 mt -73.09 -15.27 61.5 Favored 'General case' 0 C--N 1.359 0.987 0 O-C-N 121.7 -0.625 . . . . 0.0 110.518 -178.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -86.13 -27.89 24.35 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 119.2 -1.0 . . . . 0.0 109.429 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.6 t -67.0 -36.47 82.25 Favored 'General case' 0 C--N 1.354 0.804 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.638 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 1.7 p -93.65 -37.97 11.57 Favored 'General case' 0 C--N 1.357 0.931 0 C-N-CA 118.781 -1.168 . . . . 0.0 108.12 -179.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.638 ' HB2' ' O ' ' A' ' 29' ' ' CYS . 13.7 mt-10 84.65 133.18 0.05 OUTLIER 'General case' 0 C--N 1.36 1.026 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.501 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -86.08 -169.12 2.5 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.874 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.457 ' H ' ' HB2' ' A' ' 31' ' ' LEU . 63.2 tt0 -152.91 -28.21 0.15 Allowed 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.7 t -141.85 -71.21 0.34 Allowed 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -178.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -130.6 -45.71 1.07 Allowed 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 125.7 -32.65 3.8 Favored Glycine 0 C--N 1.352 1.452 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 84.8 mt -113.3 102.84 14.49 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.806 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -97.23 -2.3 43.05 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.9 m 79.42 174.68 0.14 Allowed 'General case' 0 C--N 1.362 1.135 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.495 ' C ' HG21 ' A' ' 40' ' ' VAL . 31.8 p -87.96 113.91 24.07 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 121.115 -0.99 . . . . 0.0 109.561 -178.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.495 HG21 ' C ' ' A' ' 39' ' ' SER . 0.0 OUTLIER -173.31 -9.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.362 1.146 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.946 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -115.25 166.17 12.17 Favored Glycine 0 C--N 1.356 1.671 0 N-CA-C 109.211 -1.555 . . . . 0.0 109.211 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.3 m -130.1 130.36 44.74 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -117.3 172.33 7.37 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -70.68 172.91 7.86 Favored 'General case' 0 C--N 1.356 0.879 0 CA-C-O 121.762 0.791 . . . . 0.0 109.58 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -81.4 -25.99 35.79 Favored 'General case' 0 C--N 1.356 0.85 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -64.52 -28.19 69.48 Favored 'General case' 0 C--N 1.354 0.779 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -61.79 -42.34 98.87 Favored 'General case' 0 C--N 1.353 0.725 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 62.6 tp -67.04 -40.0 87.06 Favored 'General case' 0 C--N 1.355 0.811 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.439 -179.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 59.0 tp -72.15 -33.51 67.79 Favored 'General case' 0 C--N 1.35 0.611 0 O-C-N 122.14 -0.35 . . . . 0.0 110.68 -177.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -64.73 -42.78 94.97 Favored 'General case' 0 N--CA 1.445 -0.688 0 O-C-N 121.66 -0.65 . . . . 0.0 109.852 -177.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.575 ' HB3' HD11 ' A' ' 25' ' ' LEU . 77.6 mt -72.76 -33.83 66.6 Favored 'General case' 0 C--N 1.361 1.08 0 C-N-CA 119.762 -0.775 . . . . 0.0 109.753 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.48 ' O ' HG13 ' A' ' 52' ' ' VAL . 35.8 t -63.03 -42.3 96.12 Favored 'Isoleucine or valine' 0 C--N 1.35 0.605 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.512 ' O ' HG11 ' A' ' 53' ' ' VAL . 55.7 t -66.1 -39.71 85.19 Favored 'Isoleucine or valine' 0 C--N 1.351 0.663 0 O-C-N 121.795 -0.565 . . . . 0.0 109.515 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.508 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 34.9 tptt -63.54 -28.64 70.08 Favored 'General case' 0 C--N 1.361 1.099 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.44 HD13 HD11 ' A' ' 66' ' ' LEU . 16.8 mt -66.51 -38.77 87.93 Favored 'General case' 0 C--N 1.355 0.847 0 O-C-N 121.996 -0.44 . . . . 0.0 110.459 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.7 p -72.13 -17.47 61.96 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.76 -178.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -101.57 -38.43 7.95 Favored 'General case' 0 C--N 1.354 0.769 0 C-N-CA 119.369 -0.932 . . . . 0.0 111.651 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.406 HG11 ' N ' ' A' ' 59' ' ' SER . 4.7 p -72.3 -38.27 61.09 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 O-C-N 121.616 -0.678 . . . . 0.0 111.24 -177.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.406 ' N ' HG11 ' A' ' 58' ' ' VAL . 1.9 t -113.21 -7.71 13.57 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 118.948 -1.101 . . . . 0.0 110.406 -178.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 64.86 49.56 2.15 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.437 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 58.7 t -113.07 133.39 22.04 Favored Pre-proline 0 N--CA 1.443 -0.79 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 61' ' ' VAL . 39.3 Cg_exo -58.14 147.36 83.84 Favored 'Trans proline' 0 CA--C 1.499 -1.259 0 C-N-CA 122.562 2.175 . . . . 0.0 112.631 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.454 ' HA ' HD21 ' A' ' 66' ' ' LEU . 3.7 m -75.65 -11.52 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.922 -178.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 68.3 p -95.88 -32.97 12.39 Favored 'General case' 0 C--N 1.358 0.96 0 C-N-CA 118.183 -1.407 . . . . 0.0 109.468 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -77.52 -22.72 50.73 Favored 'General case' 0 C--N 1.355 0.814 0 O-C-N 121.488 -0.758 . . . . 0.0 109.138 179.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.454 HD21 ' HA ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -79.76 -35.61 38.46 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -179.301 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -69.93 -28.4 36.46 Favored 'Isoleucine or valine' 0 C--N 1.357 0.9 0 C-N-CA 119.932 -0.707 . . . . 0.0 110.049 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 63.2 mtp180 -70.45 -50.12 41.55 Favored 'General case' 0 C--N 1.362 1.15 0 O-C-N 121.398 -0.814 . . . . 0.0 110.533 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.68 -35.96 81.36 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 122.246 -0.284 . . . . 0.0 110.91 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -61.1 -47.44 86.26 Favored 'General case' 0 C--N 1.348 0.512 0 O-C-N 122.229 -0.294 . . . . 0.0 110.498 -178.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.85 -39.59 97.06 Favored Glycine 0 C--N 1.355 1.616 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 -178.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.0 -48.97 76.53 Favored 'General case' 0 C--N 1.352 0.694 0 CA-C-N 118.363 1.081 . . . . 0.0 111.635 -177.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.716 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 10.0 mttm -63.17 -48.38 78.65 Favored 'General case' 0 C--N 1.359 0.987 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -177.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -68.77 -39.07 80.42 Favored 'General case' 0 C--N 1.348 0.533 0 O-C-N 121.198 -0.939 . . . . 0.0 111.777 -175.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -62.84 -45.96 90.13 Favored 'General case' 0 C--N 1.353 0.761 0 O-C-N 121.152 -0.968 . . . . 0.0 111.286 -178.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.476 ' O ' HG21 ' A' ' 76' ' ' VAL . 8.5 p -70.08 -15.08 18.89 Favored 'Isoleucine or valine' 0 C--N 1.359 0.993 0 O-C-N 121.377 -0.827 . . . . 0.0 109.392 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.716 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 75.2 mm-40 -71.07 -38.93 72.47 Favored 'General case' 0 C--N 1.352 0.702 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 81.7 mt -72.17 -33.12 67.45 Favored 'General case' 0 C--N 1.356 0.873 0 O-C-N 122.432 -0.168 . . . . 0.0 110.739 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 47.3 mm -64.48 -54.05 35.36 Favored 'Isoleucine or valine' 0 C--N 1.358 0.943 0 C-N-CA 120.126 -0.63 . . . . 0.0 110.396 -177.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -75.33 -14.37 60.48 Favored 'General case' 0 C--N 1.351 0.673 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.45 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.09 -36.78 64.11 Favored Glycine 0 C--N 1.347 1.192 0 N-CA-C 110.969 -0.853 . . . . 0.0 110.969 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -134.18 106.81 11.28 Favored Pre-proline 0 C--N 1.357 0.894 0 CA-C-O 122.68 1.229 . . . . 0.0 109.189 -176.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.541 ' O ' ' HB2' ' A' ' 87' ' ' ASN . 39.3 Cg_endo -68.97 -23.3 34.57 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.675 2.25 . . . . 0.0 114.239 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -90.55 -8.71 49.56 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 tp -90.31 -21.25 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 -178.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -104.11 -14.74 15.78 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.541 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 20.1 t30 -73.3 -41.02 64.06 Favored 'General case' 0 C--N 1.359 1.012 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -68.1 -28.4 67.3 Favored 'General case' 0 C--N 1.352 0.716 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.552 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 25.9 ttp -84.86 148.55 26.22 Favored 'General case' 0 C--N 1.351 0.636 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.13 -21.63 8.14 Favored 'General case' 0 C--N 1.364 1.216 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.984 -177.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -164.22 171.18 15.31 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -177.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.454 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 86.6 p -70.22 -34.0 72.37 Favored 'General case' 0 C--N 1.354 0.776 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.197 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -70.04 -38.46 75.84 Favored 'General case' 0 C--N 1.357 0.922 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -66.14 -24.67 66.71 Favored 'General case' 0 C--N 1.358 0.952 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.454 ' HB3' ' O ' ' A' ' 92' ' ' SER . 61.3 tp -62.63 -46.63 87.34 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.2 mp -62.76 -32.6 73.78 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 122.246 -0.284 . . . . 0.0 110.302 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 35.8 t -62.73 -45.58 92.07 Favored 'General case' 0 C--N 1.356 0.864 0 O-C-N 121.688 -0.632 . . . . 0.0 111.597 -178.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.08 25.87 10.99 Favored 'General case' 0 C--N 1.361 1.071 0 O-C-N 121.057 -1.027 . . . . 0.0 110.453 -178.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.65 HG21 ' N ' ' A' ' 100' ' ' ASP . 12.3 tt -64.26 -29.66 47.94 Favored 'Isoleucine or valine' 0 C--N 1.352 0.689 0 C-N-CA 120.341 -0.543 . . . . 0.0 110.507 -179.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.65 ' N ' HG21 ' A' ' 99' ' ' ILE . 36.5 t70 -120.19 -18.59 7.99 Favored 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 119.336 -0.946 . . . . 0.0 109.115 -179.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 35.5 t -66.06 -45.98 79.42 Favored 'General case' 0 N--CA 1.443 -0.785 0 O-C-N 121.841 -0.537 . . . . 0.0 110.85 -178.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.57 ' O ' HG13 ' A' ' 105' ' ' VAL . 30.8 t80 -124.97 -31.21 3.15 Favored 'General case' 0 C--N 1.359 0.99 0 C-N-CA 118.23 -1.388 . . . . 0.0 111.992 -177.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 96.3 mt -67.52 -47.27 81.09 Favored 'Isoleucine or valine' 0 C--N 1.352 0.704 0 O-C-N 121.034 -1.041 . . . . 0.0 110.687 -177.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 17.5 m170 -87.72 3.16 49.06 Favored 'General case' 0 N--CA 1.441 -0.913 0 O-C-N 121.252 -0.905 . . . . 0.0 110.15 -177.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.57 HG13 ' O ' ' A' ' 102' ' ' PHE . 1.8 p -87.39 -34.15 7.26 Favored 'Isoleucine or valine' 0 C--N 1.356 0.872 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 178.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -71.86 -40.26 69.1 Favored 'General case' 0 C--N 1.359 0.997 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 62.4 t -62.81 -47.37 93.19 Favored 'Isoleucine or valine' 0 C--N 1.356 0.87 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.517 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -60.55 -48.25 82.62 Favored 'General case' 0 C--N 1.359 0.979 0 O-C-N 122.115 -0.366 . . . . 0.0 111.364 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -61.96 -37.57 85.27 Favored 'General case' 0 C--N 1.354 0.786 0 O-C-N 121.533 -0.729 . . . . 0.0 110.708 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.8 mt -57.47 -74.96 0.05 OUTLIER 'General case' 0 C--N 1.356 0.851 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -114.54 135.52 22.3 Favored Pre-proline 0 N--CA 1.441 -0.921 0 C-N-CA 118.656 -1.218 . . . . 0.0 109.146 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -84.66 -5.91 9.87 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 123.133 2.555 . . . . 0.0 115.055 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -66.96 -36.58 82.53 Favored 'General case' 0 C--N 1.355 0.808 0 O-C-N 122.009 -0.432 . . . . 0.0 110.073 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.71 145.21 56.29 Favored 'General case' 0 C--N 1.355 0.807 0 CA-C-O 121.683 0.754 . . . . 0.0 110.139 -178.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -131.09 135.64 47.69 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.492 ' HB3' ' HD2' ' A' ' 117' ' ' PRO . 91.6 mt -127.9 155.73 77.11 Favored Pre-proline 0 N--CA 1.443 -0.791 0 CA-C-O 122.173 0.987 . . . . 0.0 109.246 -178.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.492 ' HD2' ' HB3' ' A' ' 116' ' ' LEU . 84.6 Cg_endo -81.89 -151.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.081 0 C-N-CA 123.736 2.957 . . . . 0.0 113.895 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.434 ' H ' ' HB2' ' A' ' 117' ' ' PRO . 99.3 mttt -115.52 146.42 41.72 Favored 'General case' 0 C--N 1.362 1.126 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -179.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.722 ' CE1' HD11 ' A' ' 131' ' ' LEU . 14.1 t80 -140.6 125.57 18.34 Favored 'General case' 0 C--N 1.362 1.144 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -177.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 93.3 m -125.83 134.06 51.78 Favored 'General case' 0 C--N 1.36 1.038 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 79.0 m -113.36 131.19 56.07 Favored 'General case' 0 C--N 1.356 0.872 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.772 -178.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -117.69 141.77 48.01 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 177.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.421 ' HG3' HD11 ' A' ' 129' ' ' ILE . 58.0 ttp180 -117.75 116.57 27.28 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.536 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 87.6 mt -84.49 -25.75 28.63 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 120.686 -0.406 . . . . 0.0 109.994 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 179.2 -144.26 6.11 Favored Glycine 0 C--N 1.349 1.251 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -94.68 -40.88 9.57 Favored 'General case' 0 N--CA 1.436 -1.137 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.567 -178.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -99.17 2.31 45.72 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.614 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.536 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 8.4 m-20 -121.72 131.63 54.18 Favored 'General case' 0 C--N 1.358 0.961 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.548 HG23 HD12 ' A' ' 129' ' ' ILE . 8.5 mm -140.91 137.43 34.7 Favored 'Isoleucine or valine' 0 C--N 1.354 0.797 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 179.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.451 ' N ' HG21 ' A' ' 129' ' ' ILE . 61.9 mtm180 -123.78 140.35 53.08 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.722 HD11 ' CE1' ' A' ' 119' ' ' PHE . 1.1 pp -127.79 129.43 47.01 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -99.49 133.96 43.06 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -129.67 120.32 24.99 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -178.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.57 ' HA ' ' O ' ' A' ' 171' ' ' THR . 74.2 mt-30 -114.25 115.08 26.85 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 18.1 t -161.69 152.01 17.32 Favored 'General case' 0 C--N 1.359 0.991 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.412 ' C ' ' HD3' ' A' ' 138' ' ' PRO . 58.2 mtmt -92.02 2.22 56.7 Favored 'General case' 0 C--N 1.358 0.939 0 C-N-CA 120.15 -0.62 . . . . 0.0 109.937 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -134.4 73.03 69.62 Favored Pre-proline 0 C--N 1.355 0.81 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.412 ' HD3' ' C ' ' A' ' 136' ' ' LYS . 67.0 Cg_endo -96.19 110.01 0.12 Allowed 'Trans proline' 0 N--CA 1.445 -1.368 0 C-N-CA 122.714 2.276 . . . . 0.0 116.079 -177.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -113.64 113.93 25.73 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 176.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.08 -38.7 92.0 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.264 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.3 m -62.41 -27.07 68.84 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 121.871 -0.518 . . . . 0.0 110.731 -178.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -76.02 -47.94 22.89 Favored 'General case' 0 C--N 1.351 0.64 0 C-N-CA 120.196 -0.602 . . . . 0.0 109.702 -178.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.68 -40.17 94.93 Favored 'General case' 0 C--N 1.358 0.949 0 O-C-N 122.17 -0.331 . . . . 0.0 111.269 -178.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -62.82 -36.54 83.52 Favored 'General case' 0 C--N 1.355 0.818 0 O-C-N 121.92 -0.487 . . . . 0.0 110.088 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.3 -42.81 98.94 Favored Glycine 0 C--N 1.347 1.171 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.0 mt -69.75 -40.93 75.86 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 96.0 mt -71.69 -42.34 67.55 Favored 'General case' 0 C--N 1.363 1.168 0 O-C-N 121.091 -1.006 . . . . 0.0 111.086 -176.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.527 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 37.2 t70 -69.3 -31.78 70.49 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 121.887 -0.508 . . . . 0.0 110.484 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . 0.471 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -62.66 -39.26 97.69 Favored Glycine 0 C--N 1.356 1.658 0 N-CA-C 108.62 -1.792 . . . . 0.0 108.62 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . 0.404 ' SG ' HD21 ' A' ' 95' ' ' LEU . 42.8 t -60.42 -42.55 96.27 Favored 'General case' 0 C--N 1.35 0.625 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -74.55 -1.6 22.14 Favored 'General case' 0 C--N 1.36 1.058 0 O-C-N 121.72 -0.612 . . . . 0.0 109.458 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.527 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 77.7 mm-40 -83.56 -46.9 11.89 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -65.87 -45.04 83.59 Favored 'General case' 0 C--N 1.36 1.036 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -68.96 -26.15 64.91 Favored 'General case' 0 C--N 1.362 1.126 0 O-C-N 121.75 -0.594 . . . . 0.0 110.796 -178.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 86.2 tttt 72.73 75.92 0.15 Allowed 'General case' 0 C--N 1.359 0.989 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.4 ' HG3' ' H ' ' A' ' 157' ' ' ASP . 3.2 tp10 -143.7 -168.28 2.8 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.4 ' H ' ' HG3' ' A' ' 156' ' ' GLU . 1.9 m-20 -152.24 92.99 1.76 Allowed 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 16.3 m-30 -112.38 161.93 16.13 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 93.7 m -118.5 125.95 50.97 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 119.293 -0.963 . . . . 0.0 109.234 -177.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 3.6 mp -104.61 122.33 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 178.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.6 m -120.52 -171.3 2.15 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-O 121.665 0.745 . . . . 0.0 109.241 -178.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.515 ' HD2' ' HG3' ' A' ' 167' ' ' GLN . 5.9 ptt85 -152.0 161.6 42.39 Favored 'General case' 0 C--N 1.357 0.897 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 56.8 p -107.95 143.9 28.28 Favored Pre-proline 0 C--N 1.36 1.049 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.835 ' HA ' ' HB2' ' A' ' 167' ' ' GLN . 56.7 Cg_endo -75.15 -7.86 19.4 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 123.204 2.603 . . . . 0.0 115.578 -178.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -71.6 -41.42 68.96 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 36.5 p -116.89 16.03 15.2 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.835 ' HB2' ' HA ' ' A' ' 164' ' ' PRO . 37.6 tt0 -58.38 -39.02 78.5 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.323 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -113.23 49.04 0.98 Allowed 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 20.7 t -139.11 142.24 38.09 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.61 ' O ' ' HB ' ' A' ' 171' ' ' THR . 61.8 mt-10 -96.52 163.7 12.93 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.61 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 18.6 m 84.12 -56.71 0.13 Allowed 'General case' 0 C--N 1.369 1.418 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.657 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -110.79 118.8 37.13 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.924 -178.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 99.6 t -132.01 133.4 60.83 Favored 'Isoleucine or valine' 0 C--N 1.358 0.963 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 49.2 mm -112.03 125.84 69.36 Favored 'Isoleucine or valine' 0 C--N 1.36 1.03 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.617 ' HB2' ' HG ' ' A' ' 131' ' ' LEU . 96.8 m-85 -116.07 148.75 39.91 Favored 'General case' 0 C--N 1.359 0.996 0 CA-C-O 121.901 0.857 . . . . 0.0 109.063 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -126.55 119.87 28.2 Favored 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.456 HD13 ' CD2' ' A' ' 131' ' ' LEU . 4.0 mp -115.42 121.58 67.52 Favored 'Isoleucine or valine' 0 C--N 1.354 0.795 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 38.0 p -126.11 159.55 32.55 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 121.429 0.633 . . . . 0.0 110.811 -178.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 77.3 mtm180 . . . . . 0 C--N 1.367 1.365 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 177.392 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.404 ' HG3' ' H2 ' ' A' ' 1' ' ' MET . 55.7 mtp . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.089 0.471 . . . . 0.0 110.228 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.39 -17.86 55.85 Favored 'General case' 0 C--N 1.355 0.839 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -178.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -76.33 -41.12 26.72 Favored Glycine 0 C--N 1.349 1.256 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 14.5 tpp -69.12 -38.68 79.02 Favored 'General case' 0 C--N 1.355 0.827 0 O-C-N 121.946 -0.738 . . . . 0.0 110.612 -177.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.5 m -68.25 -22.83 27.85 Favored 'Isoleucine or valine' 0 C--N 1.357 0.903 0 C-N-CA 120.27 -0.572 . . . . 0.0 109.617 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -70.57 -35.58 73.15 Favored 'General case' 0 C--N 1.356 0.876 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 85.5 m -67.15 -40.85 86.77 Favored 'General case' 0 C--N 1.355 0.814 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.43 -39.39 97.73 Favored Glycine 0 C--N 1.359 1.814 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.601 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -64.62 -39.6 93.99 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-N 117.131 0.465 . . . . 0.0 110.711 -178.481 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.424 ' SD ' HD11 ' A' ' 26' ' ' LEU . 25.8 mmt -63.43 -40.44 97.18 Favored 'General case' 0 C--N 1.352 0.684 0 O-C-N 121.679 -0.638 . . . . 0.0 110.984 -178.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -66.88 -40.22 87.75 Favored 'General case' 0 C--N 1.349 0.571 0 O-C-N 121.956 -0.465 . . . . 0.0 111.362 -177.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 53.7 tp -66.42 -42.83 87.2 Favored 'General case' 0 C--N 1.35 0.588 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -178.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.601 HG12 ' O ' ' A' ' 9' ' ' LEU . 1.4 mm -74.99 -36.76 39.52 Favored 'Isoleucine or valine' 0 C--N 1.359 1.008 0 O-C-N 120.988 -1.07 . . . . 0.0 111.002 -175.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -68.18 -43.66 77.65 Favored 'General case' 0 C--N 1.353 0.729 0 O-C-N 121.723 -0.611 . . . . 0.0 111.555 -176.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -71.22 -35.27 71.43 Favored 'General case' 0 N--CA 1.446 -0.634 0 O-C-N 121.974 -0.454 . . . . 0.0 111.909 -176.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -72.69 -48.56 38.02 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -175.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -126.41 -20.9 4.3 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 117.349 -1.741 . . . . 0.0 113.816 -176.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 141.36 179.6 18.7 Favored Glycine 0 CA--C 1.497 -1.078 0 C-N-CA 117.789 -2.148 . . . . 0.0 109.884 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -97.16 -12.26 23.29 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -177.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -70.64 -41.08 72.65 Favored 'General case' 0 C--N 1.36 1.05 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 94.5 m -69.51 -39.05 77.79 Favored 'General case' 0 C--N 1.357 0.932 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 59.1 tp -61.17 -37.99 84.87 Favored 'General case' 0 C--N 1.357 0.905 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -65.17 -35.71 81.94 Favored 'General case' 0 C--N 1.356 0.851 0 O-C-N 122.177 -0.327 . . . . 0.0 110.802 -178.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.5 m -63.71 -40.74 97.53 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.466 ' CD2' ' HB3' ' A' ' 54' ' ' LYS . 87.6 mt -64.87 -37.97 89.4 Favored 'General case' 0 C--N 1.356 0.874 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.458 ' HB3' HD21 ' A' ' 31' ' ' LEU . 6.7 mp -69.39 -14.8 63.1 Favored 'General case' 0 C--N 1.357 0.922 0 O-C-N 121.415 -0.803 . . . . 0.0 109.802 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -85.84 -28.38 24.47 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.224 178.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 55.0 p -68.18 -23.11 64.82 Favored 'General case' 0 C--N 1.361 1.066 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.3 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.0 p -106.96 -33.6 7.45 Favored 'General case' 0 C--N 1.357 0.912 0 C-N-CA 118.933 -1.107 . . . . 0.0 108.141 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 83.63 132.56 0.05 OUTLIER 'General case' 0 C--N 1.361 1.106 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.458 HD21 ' HB3' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -100.53 109.63 21.75 Favored 'General case' 0 C--N 1.357 0.896 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.737 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -72.23 -40.71 67.55 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 178.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.445 ' HB3' ' H ' ' A' ' 34' ' ' GLU . 0.9 OUTLIER -116.09 -86.22 0.62 Allowed 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -179.212 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.445 ' H ' ' HB3' ' A' ' 33' ' ' SER . 57.4 mt-10 -122.14 -40.88 2.46 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -178.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.62 -32.79 6.33 Favored Glycine 0 C--N 1.351 1.365 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 80.4 mt -109.89 104.15 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.005 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.487 ' HD1' ' HA ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -82.89 -143.44 0.06 Allowed 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.337 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 86.2 m -109.82 -56.89 2.26 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.5 p 166.03 16.57 0.0 OUTLIER 'General case' 0 C--N 1.363 1.161 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 23.3 m -109.79 6.48 8.97 Favored 'Isoleucine or valine' 0 C--N 1.353 0.738 0 C-N-CA 119.522 -0.871 . . . . 0.0 111.313 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -91.75 143.67 16.71 Favored Glycine 0 C--N 1.354 1.533 0 C-N-CA 119.223 -1.465 . . . . 0.0 109.505 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 57.0 m -126.61 130.19 50.0 Favored 'General case' 0 C--N 1.356 0.871 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -125.27 174.52 8.06 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -76.07 -179.0 4.69 Favored 'General case' 0 C--N 1.356 0.864 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -86.44 -19.87 28.98 Favored 'General case' 0 C--N 1.356 0.876 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.646 ' HA ' HD21 ' A' ' 49' ' ' LEU . 38.1 tt0 -63.98 -35.5 80.9 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.0 tp10 -61.59 -40.55 95.21 Favored 'General case' 0 C--N 1.349 0.572 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.407 ' O ' HG23 ' A' ' 52' ' ' VAL . 60.4 tp -65.38 -40.29 93.32 Favored 'General case' 0 C--N 1.357 0.896 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.691 -178.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.646 HD21 ' HA ' ' A' ' 46' ' ' GLN . 0.1 OUTLIER -83.45 -14.57 52.23 Favored 'General case' 0 C--N 1.352 0.71 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.131 -177.226 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -71.62 -43.57 65.95 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.457 ' HA ' HD22 ' A' ' 51' ' ' LEU . 82.8 mt -73.24 -34.93 66.14 Favored 'General case' 0 C--N 1.361 1.083 0 C-N-CA 120.17 -0.612 . . . . 0.0 109.704 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.664 HG12 HD23 ' A' ' 66' ' ' LEU . 50.3 t -63.91 -41.41 92.42 Favored 'Isoleucine or valine' 0 C--N 1.352 0.697 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 52.9 t -65.84 -40.74 88.46 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 O-C-N 121.761 -0.587 . . . . 0.0 109.962 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.466 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 24.6 tptt -67.65 -20.29 65.3 Favored 'General case' 0 C--N 1.36 1.054 0 O-C-N 120.939 -1.101 . . . . 0.0 108.863 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.575 HD12 HD12 ' A' ' 13' ' ' ILE . 0.6 OUTLIER -71.83 -37.47 70.3 Favored 'General case' 0 C--N 1.353 0.745 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.068 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' A' ' 60' ' ' SER . 81.2 p -73.04 -17.32 61.45 Favored 'General case' 0 C--N 1.356 0.852 0 O-C-N 121.766 -0.584 . . . . 0.0 110.285 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -99.51 -37.56 9.13 Favored 'General case' 0 C--N 1.355 0.805 0 O-C-N 121.305 -0.872 . . . . 0.0 111.325 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.565 HG12 ' N ' ' A' ' 59' ' ' SER . 5.1 p -71.85 -34.7 52.24 Favored 'Isoleucine or valine' 0 C--N 1.353 0.723 0 O-C-N 121.709 -0.619 . . . . 0.0 111.52 -177.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.571 ' HB3' HG23 ' A' ' 61' ' ' VAL . 4.3 t -119.99 -8.74 9.75 Favored 'General case' 0 CA--C 1.508 -0.671 0 C-N-CA 119.26 -0.976 . . . . 0.0 109.849 -178.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.477 ' HA ' ' O ' ' A' ' 56' ' ' SER . 0.6 OUTLIER 66.65 47.78 1.54 Allowed 'General case' 0 C--N 1.353 0.737 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 179.61 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.614 HG13 ' HD2' ' A' ' 62' ' ' PRO . 47.6 t -107.44 133.35 20.41 Favored Pre-proline 0 CA--C 1.505 -0.773 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.614 ' HD2' HG13 ' A' ' 61' ' ' VAL . 41.9 Cg_exo -57.38 147.21 78.89 Favored 'Trans proline' 0 CA--C 1.498 -1.3 0 C-N-CA 122.505 2.137 . . . . 0.0 112.794 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.4 m -75.9 -13.61 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.826 -178.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 69.0 p -97.54 -32.77 11.64 Favored 'General case' 0 C--N 1.36 1.055 0 C-N-CA 118.176 -1.41 . . . . 0.0 109.533 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -76.6 -21.47 55.52 Favored 'General case' 0 C--N 1.354 0.776 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.664 HD23 HG12 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -82.05 -35.57 28.6 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.139 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.575 HG12 ' N ' ' A' ' 68' ' ' ARG . 1.3 p -68.92 -26.43 32.52 Favored 'Isoleucine or valine' 0 C--N 1.354 0.795 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.914 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.575 ' N ' HG12 ' A' ' 67' ' ' VAL . 4.5 mmm-85 -73.04 -52.5 14.13 Favored 'General case' 0 C--N 1.36 1.055 0 O-C-N 121.596 -0.69 . . . . 0.0 110.124 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 86.1 mt -63.37 -35.93 82.04 Favored 'General case' 0 C--N 1.357 0.929 0 O-C-N 121.991 -0.443 . . . . 0.0 110.979 -178.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -60.92 -47.27 87.17 Favored 'General case' 0 C--N 1.349 0.555 0 O-C-N 122.258 -0.276 . . . . 0.0 110.494 -178.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.54 -37.94 94.13 Favored Glycine 0 C--N 1.356 1.641 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -62.47 -49.33 75.85 Favored 'General case' 0 C--N 1.35 0.622 0 CA-C-N 118.044 0.922 . . . . 0.0 111.485 -177.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.707 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 11.9 mttm -64.36 -47.72 78.25 Favored 'General case' 0 C--N 1.359 0.996 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -177.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -68.5 -38.84 81.31 Favored 'General case' 0 C--N 1.347 0.5 0 O-C-N 121.265 -0.897 . . . . 0.0 112.004 -175.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -64.84 -42.85 94.59 Favored 'General case' 0 C--N 1.352 0.703 0 O-C-N 121.116 -0.99 . . . . 0.0 111.077 -177.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 76' ' ' VAL . 9.9 p -71.7 -15.43 18.28 Favored 'Isoleucine or valine' 0 C--N 1.36 1.057 0 O-C-N 121.324 -0.86 . . . . 0.0 109.114 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.707 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 74.1 mm-40 -71.88 -38.71 69.97 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 84.5 mt -74.32 -29.69 61.72 Favored 'General case' 0 C--N 1.358 0.967 0 O-C-N 122.215 -0.303 . . . . 0.0 110.749 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.4 mm -66.41 -53.28 37.72 Favored 'Isoleucine or valine' 0 C--N 1.357 0.91 0 C-N-CA 119.973 -0.691 . . . . 0.0 109.973 -177.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -76.08 -14.71 60.19 Favored 'General case' 0 C--N 1.351 0.651 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.39 178.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.0 -36.93 64.47 Favored Glycine 0 C--N 1.349 1.267 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.476 ' HA ' ' HD2' ' A' ' 83' ' ' PRO . 98.6 m-70 -131.86 105.52 14.01 Favored Pre-proline 0 N--CA 1.44 -0.968 0 CA-C-O 122.604 1.192 . . . . 0.0 108.911 -177.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.476 ' HD2' ' HA ' ' A' ' 82' ' ' HIS . 41.4 Cg_endo -68.87 -23.29 35.24 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.637 2.225 . . . . 0.0 114.052 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -90.61 -9.64 46.24 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.3 tp -89.52 -21.75 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 -178.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -102.24 -17.4 15.96 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 51.3 t30 -70.84 -41.28 71.68 Favored 'General case' 0 C--N 1.359 0.999 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -66.13 -33.48 75.86 Favored 'General case' 0 C--N 1.352 0.699 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.318 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.566 ' HG2' ' N ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -80.87 149.97 29.28 Favored 'General case' 0 C--N 1.353 0.745 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 -179.029 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.566 ' N ' ' HG2' ' A' ' 89' ' ' MET . 1.4 mtpt -117.56 -24.69 7.2 Favored 'General case' 0 C--N 1.361 1.1 0 C-N-CA 120.07 -0.652 . . . . 0.0 111.183 -177.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -165.83 171.88 12.29 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -177.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.437 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 57.8 m -67.26 -39.44 86.1 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.486 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.668 ' HZ ' ' HG3' ' A' ' 179' ' ' ARG . 64.7 m-85 -67.77 -39.14 84.15 Favored 'General case' 0 C--N 1.358 0.94 0 O-C-N 121.216 -0.928 . . . . 0.0 108.681 -179.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -66.16 -22.79 66.38 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.437 ' HB3' ' O ' ' A' ' 92' ' ' SER . 62.0 tp -65.2 -45.13 85.99 Favored 'General case' 0 C--N 1.357 0.929 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.3 mp -61.44 -36.5 80.54 Favored 'General case' 0 C--N 1.358 0.956 0 O-C-N 122.001 -0.437 . . . . 0.0 110.239 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 34.7 t -67.77 -39.79 84.09 Favored 'General case' 0 C--N 1.349 0.549 0 O-C-N 121.829 -0.545 . . . . 0.0 110.021 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.2 tttp -93.78 8.1 42.38 Favored 'General case' 0 C--N 1.353 0.75 0 O-C-N 122.286 -0.259 . . . . 0.0 111.279 -176.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.474 HG22 ' N ' ' A' ' 100' ' ' ASP . 15.6 tt -64.29 -38.18 81.85 Favored 'Isoleucine or valine' 0 C--N 1.36 1.033 0 O-C-N 121.464 -0.773 . . . . 0.0 111.694 -176.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.474 ' N ' HG22 ' A' ' 99' ' ' ILE . 6.2 p-10 -107.87 -15.79 14.46 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 118.181 -1.408 . . . . 0.0 110.195 -178.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.462 ' O ' HG22 ' A' ' 105' ' ' VAL . 34.9 t -64.83 -46.6 81.25 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 121.76 -0.588 . . . . 0.0 111.272 -179.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -137.32 -15.12 1.47 Allowed 'General case' 0 C--N 1.36 1.058 0 C-N-CA 117.497 -1.681 . . . . 0.0 112.684 -177.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 31.0 mm -71.0 -51.74 32.99 Favored 'Isoleucine or valine' 0 C--N 1.352 0.682 0 CA-C-N 119.982 1.265 . . . . 0.0 110.715 -177.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -92.03 2.88 56.28 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 119.529 -0.869 . . . . 0.0 110.22 -177.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.462 HG22 ' O ' ' A' ' 101' ' ' SER . 49.5 t -85.79 -44.37 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.083 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 178.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 54.7 tp10 -68.1 -40.41 82.62 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 66.6 t -63.84 -46.28 94.75 Favored 'Isoleucine or valine' 0 C--N 1.356 0.889 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.074 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 92.4 t80 -60.94 -48.51 81.5 Favored 'General case' 0 C--N 1.359 1.019 0 O-C-N 122.06 -0.4 . . . . 0.0 111.322 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -61.28 -37.12 82.02 Favored 'General case' 0 C--N 1.357 0.896 0 O-C-N 121.567 -0.708 . . . . 0.0 110.596 -178.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 15.5 mt -56.68 -72.94 0.07 Allowed 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -121.9 135.16 25.05 Favored Pre-proline 0 N--CA 1.438 -1.061 0 C-N-CA 118.488 -1.285 . . . . 0.0 108.638 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -83.47 -2.56 10.55 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 123.197 2.598 . . . . 0.0 115.255 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 29.7 mm100 -66.07 -37.16 85.13 Favored 'General case' 0 C--N 1.354 0.778 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.61 145.8 55.2 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-O 121.614 0.721 . . . . 0.0 109.846 -178.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -127.54 134.07 49.76 Favored 'General case' 0 C--N 1.357 0.922 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.504 ' HB3' ' HD2' ' A' ' 117' ' ' PRO . 86.8 mt -128.25 156.43 76.67 Favored Pre-proline 0 C--N 1.354 0.769 0 CA-C-O 122.116 0.96 . . . . 0.0 109.21 -178.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.504 ' HD2' ' HB3' ' A' ' 116' ' ' LEU . 95.3 Cg_endo -84.05 -153.67 0.05 OUTLIER 'Trans proline' 0 C--N 1.318 -1.074 0 C-N-CA 123.763 2.975 . . . . 0.0 114.317 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.43 ' H ' ' HB2' ' A' ' 117' ' ' PRO . 74.7 mmtt -116.66 143.79 45.21 Favored 'General case' 0 C--N 1.364 1.233 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -126.3 130.78 51.51 Favored 'General case' 0 C--N 1.364 1.203 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -178.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.523 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 94.1 m -127.52 129.18 46.93 Favored 'General case' 0 C--N 1.358 0.951 0 N-CA-C 105.739 -1.949 . . . . 0.0 105.739 177.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 77.2 m -122.88 131.47 53.76 Favored 'General case' 0 CA--C 1.504 -0.794 0 C-N-CA 119.178 -1.009 . . . . 0.0 109.855 -178.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -120.03 132.43 55.46 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 106.325 -1.732 . . . . 0.0 106.325 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.616 ' HG3' HD11 ' A' ' 129' ' ' ILE . 58.0 ttp180 -105.28 117.27 33.59 Favored 'General case' 0 C--N 1.353 0.729 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.424 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 95.2 mt -88.42 -19.84 26.02 Favored 'General case' 0 C--N 1.354 0.781 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.464 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 176.75 -146.74 8.05 Favored Glycine 0 C--N 1.348 1.229 0 C-N-CA 118.905 -1.617 . . . . 0.0 109.06 -178.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -94.82 -39.31 10.32 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -178.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -101.27 0.69 37.78 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.24 -178.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.424 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 66.2 m-20 -118.49 130.74 56.11 Favored 'General case' 0 C--N 1.358 0.955 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.616 HD11 ' HG3' ' A' ' 123' ' ' ARG . 8.0 mm -141.9 136.79 30.65 Favored 'Isoleucine or valine' 0 C--N 1.355 0.829 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.572 ' N ' HG21 ' A' ' 129' ' ' ILE . 52.2 mtm180 -118.21 137.87 52.71 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 5.6 tp -125.0 119.14 27.86 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.523 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 13.7 m-70 -99.68 134.15 42.99 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.559 ' HE2' ' HG ' ' A' ' 135' ' ' SER . 32.0 t80 -129.22 121.58 27.94 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 -178.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.44 ' HA ' ' O ' ' A' ' 171' ' ' THR . 27.7 mt-30 -114.96 111.47 21.2 Favored 'General case' 0 C--N 1.357 0.916 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.559 ' HG ' ' HE2' ' A' ' 133' ' ' TYR . 87.6 p -160.72 161.99 32.39 Favored 'General case' 0 C--N 1.358 0.964 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.406 ' C ' ' HD3' ' A' ' 138' ' ' PRO . 99.4 mttt -98.8 3.59 47.47 Favored 'General case' 0 C--N 1.354 0.796 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 10.8 mtp180 -133.42 74.08 72.24 Favored Pre-proline 0 C--N 1.353 0.75 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.406 ' HD3' ' C ' ' A' ' 136' ' ' LYS . 84.6 Cg_endo -94.74 102.25 0.12 Allowed 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 122.799 2.332 . . . . 0.0 115.926 -177.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -110.11 109.11 19.53 Favored 'General case' 0 CA--C 1.502 -0.904 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 176.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.88 -39.31 93.9 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.679 -178.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 74.3 m -62.92 -27.24 69.24 Favored 'General case' 0 C--N 1.354 0.763 0 O-C-N 121.813 -0.554 . . . . 0.0 110.762 -178.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -76.03 -46.49 29.06 Favored 'General case' 0 N--CA 1.444 -0.757 0 O-C-N 121.719 -0.613 . . . . 0.0 109.65 -178.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.19 -39.93 95.03 Favored 'General case' 0 C--N 1.359 1.01 0 O-C-N 122.124 -0.36 . . . . 0.0 111.234 -178.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -62.79 -36.95 84.81 Favored 'General case' 0 C--N 1.356 0.864 0 O-C-N 121.904 -0.498 . . . . 0.0 109.919 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.07 -43.05 98.64 Favored Glycine 0 C--N 1.348 1.205 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.8 mt -70.54 -40.84 73.19 Favored 'General case' 0 C--N 1.352 0.681 0 CA-C-N 117.606 0.703 . . . . 0.0 112.887 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 97.8 mt -71.04 -42.69 69.17 Favored 'General case' 0 C--N 1.362 1.142 0 O-C-N 121.118 -0.989 . . . . 0.0 110.945 -176.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -70.43 -29.95 66.68 Favored 'General case' 0 N--CA 1.445 -0.675 0 O-C-N 122.015 -0.428 . . . . 0.0 110.486 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . 0.529 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -63.04 -39.69 98.35 Favored Glycine 0 C--N 1.357 1.735 0 N-CA-C 108.394 -1.882 . . . . 0.0 108.394 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 48.8 t -61.16 -42.56 98.78 Favored 'General case' 0 C--N 1.351 0.639 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -75.8 1.87 13.75 Favored 'General case' 0 C--N 1.361 1.071 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.529 ' HB2' ' O ' ' A' ' 149' ' ' GLY . 15.5 mm-40 -87.12 -45.56 10.58 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -66.45 -44.55 82.51 Favored 'General case' 0 C--N 1.359 0.984 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.453 ' O ' ' HB2' ' A' ' 155' ' ' LYS . 50.6 m-85 -70.15 -25.45 63.46 Favored 'General case' 0 C--N 1.361 1.108 0 O-C-N 121.84 -0.537 . . . . 0.0 111.119 -178.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 154' ' ' PHE . 97.3 mttt 71.6 66.07 0.15 Allowed 'General case' 0 C--N 1.363 1.168 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 -177.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -128.68 -177.44 4.19 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -140.98 95.18 2.8 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -117.27 154.29 31.46 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 93.5 m -119.63 126.47 51.25 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 3.5 mp -103.82 122.45 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 3.0 m -118.15 -174.84 2.73 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-O 121.797 0.808 . . . . 0.0 109.29 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.11 155.38 42.12 Favored 'General case' 0 C--N 1.356 0.874 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -178.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' THR . . . . . 0.408 ' O ' ' HB3' ' A' ' 167' ' ' GLN . 63.8 p -98.79 146.86 32.36 Favored Pre-proline 0 C--N 1.36 1.062 0 CA-C-O 122.502 1.144 . . . . 0.0 108.359 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.697 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 76.9 Cg_endo -76.9 -11.22 18.16 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 123.006 2.47 . . . . 0.0 114.971 -178.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -72.09 -41.79 66.91 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 120.193 -0.603 . . . . 0.0 109.583 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 39.0 p -116.06 14.57 16.06 Favored 'General case' 0 CA--C 1.505 -0.786 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.381 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.697 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.3 pp0? -68.38 -10.27 53.92 Favored 'General case' 0 C--N 1.351 0.665 0 O-C-N 121.525 -0.734 . . . . 0.0 110.083 178.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 55.6 p30 -121.57 35.16 4.96 Favored 'General case' 0 N--CA 1.435 -1.198 0 O-C-N 121.16 -0.962 . . . . 0.0 109.48 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 94.1 p -145.51 157.83 43.94 Favored 'General case' 0 C--N 1.353 0.736 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.61 ' O ' ' HB ' ' A' ' 171' ' ' THR . 60.0 mt-10 -106.96 170.2 8.09 Favored 'General case' 0 C--N 1.356 0.856 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -179.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.61 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 6.1 m 82.79 -53.96 0.19 Allowed 'General case' 0 C--N 1.37 1.489 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.62 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -115.64 117.59 30.73 Favored 'General case' 0 CA--C 1.505 -0.763 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.655 -178.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 94.9 t -130.38 132.8 64.62 Favored 'Isoleucine or valine' 0 C--N 1.357 0.917 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 49.8 mm -107.23 127.02 63.33 Favored 'Isoleucine or valine' 0 C--N 1.359 1.0 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -115.42 155.28 27.72 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 122.139 0.971 . . . . 0.0 108.688 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -138.21 119.11 14.24 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -178.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.0 mp -114.03 119.22 60.61 Favored 'Isoleucine or valine' 0 C--N 1.355 0.807 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 89.4 m -122.02 144.51 48.85 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -177.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.668 ' HG3' ' HZ ' ' A' ' 93' ' ' PHE . 3.8 mtm180 . . . . . 0 C--N 1.367 1.358 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.516 ' HE2' ' HE3' ' A' ' 4' ' ' MET . 81.4 mmm . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 120.821 0.343 . . . . 0.0 110.19 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.5 -22.68 47.06 Favored 'General case' 0 C--N 1.356 0.856 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -178.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.66 -40.56 45.82 Favored Glycine 0 C--N 1.35 1.348 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' MET . . . . . 0.516 ' HE3' ' HE2' ' A' ' 1' ' ' MET . 3.1 tpp -70.27 -37.0 74.78 Favored 'General case' 0 C--N 1.354 0.792 0 O-C-N 122.132 -0.628 . . . . 0.0 110.865 -177.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.0 m -71.17 -22.71 22.73 Favored 'Isoleucine or valine' 0 C--N 1.357 0.895 0 O-C-N 121.642 -0.661 . . . . 0.0 109.524 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.445 ' HZ ' ' CG ' ' A' ' 47' ' ' GLU . 2.2 m-85 -70.8 -35.23 72.43 Favored 'General case' 0 C--N 1.357 0.915 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 85.4 m -66.95 -40.63 87.59 Favored 'General case' 0 C--N 1.354 0.795 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.13 -38.76 97.06 Favored Glycine 0 C--N 1.358 1.785 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.608 HD12 HD11 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -65.94 -39.85 90.85 Favored 'General case' 0 C--N 1.352 0.686 0 CA-C-N 117.241 0.521 . . . . 0.0 110.608 -178.087 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.888 ' HE1' HD22 ' A' ' 26' ' ' LEU . 24.8 mmt -64.73 -40.12 94.79 Favored 'General case' 0 C--N 1.354 0.775 0 O-C-N 121.591 -0.693 . . . . 0.0 110.707 -178.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -65.86 -39.93 91.19 Favored 'General case' 0 C--N 1.349 0.569 0 O-C-N 122.107 -0.37 . . . . 0.0 111.303 -178.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 56.3 tp -65.81 -42.86 90.15 Favored 'General case' 0 C--N 1.349 0.572 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -178.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.736 HD13 HD12 ' A' ' 55' ' ' LEU . 1.9 mm -74.5 -35.38 38.45 Favored 'Isoleucine or valine' 0 C--N 1.361 1.073 0 O-C-N 121.031 -1.043 . . . . 0.0 110.746 -175.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -72.0 -42.54 66.3 Favored 'General case' 0 C--N 1.349 0.55 0 O-C-N 121.648 -0.657 . . . . 0.0 111.475 -176.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -70.95 -36.68 72.7 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -176.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -101.1 -25.06 14.17 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 118.725 -1.19 . . . . 0.0 113.628 -174.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -114.8 -36.43 4.5 Favored 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 117.606 -1.638 . . . . 0.0 112.288 -176.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 145.03 177.98 20.26 Favored Glycine 0 C--N 1.348 1.227 0 C-N-CA 118.176 -1.964 . . . . 0.0 110.314 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -99.33 -25.89 14.34 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 -177.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -70.14 -39.15 75.56 Favored 'General case' 0 C--N 1.358 0.937 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.1 m -67.64 -39.33 84.62 Favored 'General case' 0 C--N 1.357 0.919 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.723 HD22 HD11 ' A' ' 26' ' ' LEU . 2.7 tt -60.21 -38.66 84.02 Favored 'General case' 0 C--N 1.357 0.933 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -64.16 -36.82 85.28 Favored 'General case' 0 C--N 1.355 0.821 0 O-C-N 122.081 -0.387 . . . . 0.0 110.901 -178.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.445 HG21 ' O ' ' A' ' 24' ' ' THR . 88.2 m -65.0 -40.35 94.82 Favored 'General case' 0 C--N 1.354 0.775 0 O-C-N 121.638 -0.664 . . . . 0.0 109.55 -178.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.444 HD22 ' HA ' ' A' ' 25' ' ' LEU . 88.6 mt -63.74 -38.17 90.09 Favored 'General case' 0 C--N 1.355 0.847 0 O-C-N 122.023 -0.423 . . . . 0.0 109.941 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.888 HD22 ' HE1' ' A' ' 10' ' ' MET . 82.5 mt -70.53 -17.35 62.94 Favored 'General case' 0 C--N 1.36 1.028 0 O-C-N 121.532 -0.73 . . . . 0.0 110.373 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -85.56 -27.38 25.58 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.488 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.5 t -66.09 -36.71 83.91 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 99.5 m -96.5 -35.67 11.05 Favored 'General case' 0 C--N 1.357 0.902 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -178.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 83.31 136.12 0.06 Allowed 'General case' 0 C--N 1.358 0.969 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.525 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -84.8 -171.41 3.62 Favored 'General case' 0 C--N 1.356 0.876 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.535 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -151.2 -24.32 0.21 Allowed 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.1 t -147.07 -67.92 0.26 Allowed 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -128.5 -50.64 1.27 Allowed 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.81 -44.5 1.36 Allowed Glycine 0 C--N 1.351 1.377 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 82.3 mt -110.38 105.18 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.971 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.403 ' HD1' ' HA ' ' A' ' 37' ' ' TYR . 0.1 OUTLIER -82.75 -142.09 0.06 Allowed 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.664 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.404 ' O ' ' HB3' ' A' ' 39' ' ' SER . 87.8 m -112.17 -58.77 2.09 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 38' ' ' THR . 52.6 p 165.59 16.92 0.0 OUTLIER 'General case' 0 C--N 1.362 1.113 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.5 t -103.26 3.63 10.64 Favored 'Isoleucine or valine' 0 C--N 1.353 0.732 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.209 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -94.34 141.71 15.68 Favored Glycine 0 C--N 1.352 1.461 0 C-N-CA 119.25 -1.452 . . . . 0.0 109.631 -178.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 50.0 m -124.55 124.73 42.89 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 178.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -117.74 174.98 5.87 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -80.83 -173.06 4.0 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -91.97 -14.85 28.82 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -69.48 -28.87 66.45 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.445 ' CG ' ' HZ ' ' A' ' 6' ' ' PHE . 20.3 tp10 -63.71 -41.28 98.11 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.483 HD12 HG22 ' A' ' 52' ' ' VAL . 1.9 tm? -67.65 -38.74 84.23 Favored 'General case' 0 C--N 1.359 1.017 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 60.4 tp -70.05 -34.05 72.73 Favored 'General case' 0 CA--C 1.508 -0.639 0 O-C-N 122.134 -0.354 . . . . 0.0 110.141 -177.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 70.6 tp60 -65.2 -41.16 94.78 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -178.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.412 HD21 ' HB3' ' A' ' 25' ' ' LEU . 85.1 mt -81.51 -18.71 44.13 Favored 'General case' 0 C--N 1.362 1.121 0 O-C-N 121.558 -0.714 . . . . 0.0 110.846 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.483 HG22 HD12 ' A' ' 48' ' ' LEU . 1.6 t -80.6 -38.53 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 C-N-CA 119.706 -0.798 . . . . 0.0 109.124 -178.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.551 HG11 ' N ' ' A' ' 54' ' ' LYS . 5.7 p -74.22 -31.51 29.35 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 C-N-CA 119.756 -0.778 . . . . 0.0 109.417 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.551 ' N ' HG11 ' A' ' 53' ' ' VAL . 36.3 tptt -70.22 -26.94 64.1 Favored 'General case' 0 C--N 1.366 1.289 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.736 HD12 HD13 ' A' ' 13' ' ' ILE . 1.7 tt -67.98 -39.04 83.35 Favored 'General case' 0 C--N 1.353 0.735 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.511 ' O ' ' HA ' ' A' ' 60' ' ' SER . 59.9 p -72.8 -17.26 61.59 Favored 'General case' 0 C--N 1.357 0.933 0 O-C-N 121.729 -0.607 . . . . 0.0 110.916 -178.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -98.93 -37.15 9.51 Favored 'General case' 0 C--N 1.353 0.739 0 O-C-N 121.181 -0.949 . . . . 0.0 111.364 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.525 HG12 ' N ' ' A' ' 59' ' ' SER . 5.2 p -70.92 -35.02 57.98 Favored 'Isoleucine or valine' 0 C--N 1.351 0.672 0 O-C-N 121.712 -0.617 . . . . 0.0 111.399 -177.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.525 ' N ' HG12 ' A' ' 58' ' ' VAL . 3.9 t -120.49 -7.57 9.67 Favored 'General case' 0 C--N 1.352 0.708 0 C-N-CA 119.118 -1.033 . . . . 0.0 110.08 -178.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.511 ' HA ' ' O ' ' A' ' 56' ' ' SER . 1.0 OUTLIER 66.03 46.41 2.18 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.552 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.506 HG13 ' HD2' ' A' ' 62' ' ' PRO . 61.3 t -106.23 132.82 20.58 Favored Pre-proline 0 CA--C 1.506 -0.745 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.506 ' HD2' HG13 ' A' ' 61' ' ' VAL . 50.4 Cg_exo -56.62 146.02 78.32 Favored 'Trans proline' 0 CA--C 1.497 -1.341 0 C-N-CA 122.59 2.193 . . . . 0.0 113.071 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.462 ' HA ' HD22 ' A' ' 66' ' ' LEU . 4.8 m -75.25 -12.89 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.792 -178.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 72.2 p -96.36 -32.24 12.47 Favored 'General case' 0 C--N 1.358 0.944 0 C-N-CA 118.273 -1.371 . . . . 0.0 109.761 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -80.26 -20.67 43.98 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 121.394 -0.816 . . . . 0.0 108.912 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.462 HD22 ' HA ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -81.0 -36.49 30.57 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -179.901 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.597 HG12 ' N ' ' A' ' 68' ' ' ARG . 2.1 p -67.44 -29.86 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.678 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.597 ' N ' HG12 ' A' ' 67' ' ' VAL . 76.2 mtp180 -70.35 -48.81 54.7 Favored 'General case' 0 C--N 1.366 1.298 0 O-C-N 121.428 -0.795 . . . . 0.0 110.777 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.432 ' HA ' HD23 ' A' ' 69' ' ' LEU . 84.9 mt -64.14 -35.84 82.08 Favored 'General case' 0 C--N 1.355 0.84 0 O-C-N 122.033 -0.417 . . . . 0.0 110.961 -178.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -60.8 -47.37 86.64 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 122.132 -0.355 . . . . 0.0 110.427 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.19 -39.07 96.64 Favored Glycine 0 C--N 1.354 1.579 0 N-CA-C 111.729 -0.549 . . . . 0.0 111.729 -178.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.44 -47.55 81.43 Favored 'General case' 0 C--N 1.351 0.651 0 CA-C-N 118.227 1.013 . . . . 0.0 111.462 -177.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.748 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 10.6 mttm -63.98 -50.17 69.6 Favored 'General case' 0 C--N 1.357 0.921 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -177.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.411 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.4 tm? -68.67 -38.96 80.77 Favored 'General case' 0 C--N 1.349 0.552 0 O-C-N 121.339 -0.85 . . . . 0.0 111.868 -175.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -63.43 -45.09 92.57 Favored 'General case' 0 C--N 1.352 0.678 0 O-C-N 121.208 -0.932 . . . . 0.0 110.965 -177.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 8.6 p -70.59 -15.71 19.19 Favored 'Isoleucine or valine' 0 C--N 1.358 0.958 0 O-C-N 121.521 -0.737 . . . . 0.0 109.366 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.748 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 75.1 mm-40 -71.28 -38.73 71.81 Favored 'General case' 0 C--N 1.35 0.608 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.7 mt -73.04 -31.66 64.58 Favored 'General case' 0 C--N 1.356 0.865 0 O-C-N 122.426 -0.171 . . . . 0.0 110.685 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.9 mm -65.06 -53.72 37.81 Favored 'Isoleucine or valine' 0 C--N 1.359 0.984 0 C-N-CA 120.081 -0.648 . . . . 0.0 110.099 -177.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -74.99 -14.98 60.68 Favored 'General case' 0 C--N 1.351 0.634 0 C-N-CA 119.554 -0.859 . . . . 0.0 109.37 178.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.58 -37.66 68.26 Favored Glycine 0 C--N 1.349 1.278 0 N-CA-C 110.971 -0.851 . . . . 0.0 110.971 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -132.45 108.3 13.38 Favored Pre-proline 0 N--CA 1.441 -0.917 0 CA-C-O 122.776 1.274 . . . . 0.0 109.232 -177.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.8 -24.58 40.38 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.596 2.197 . . . . 0.0 114.301 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -93.7 -5.05 49.4 Favored 'General case' 0 CA--C 1.5 -0.966 0 C-N-CA 119.448 -0.901 . . . . 0.0 108.776 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -89.64 -19.97 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.444 ' HA ' ' HE2' ' A' ' 89' ' ' MET . . . -100.78 -25.18 14.21 Favored 'General case' 0 C--N 1.361 1.106 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -70.23 -35.23 73.71 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 120.207 -0.597 . . . . 0.0 109.443 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -65.42 -36.98 85.57 Favored 'General case' 0 C--N 1.355 0.837 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.415 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.583 ' HG2' ' N ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -81.52 155.05 25.96 Favored 'General case' 0 C--N 1.355 0.841 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -178.468 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.583 ' N ' ' HG2' ' A' ' 89' ' ' MET . 0.8 OUTLIER -120.36 -25.41 5.64 Favored 'General case' 0 C--N 1.364 1.199 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.031 -177.655 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -165.12 172.09 13.01 Favored 'General case' 0 C--N 1.354 0.78 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 -177.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.407 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 41.1 t -64.62 -43.16 94.61 Favored 'General case' 0 C--N 1.356 0.863 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.208 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -67.11 -39.72 86.72 Favored 'General case' 0 C--N 1.356 0.853 0 O-C-N 121.429 -0.794 . . . . 0.0 109.282 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -66.41 -23.17 66.26 Favored 'General case' 0 C--N 1.355 0.821 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.678 ' O ' HG13 ' A' ' 99' ' ' ILE . 61.2 tp -64.78 -46.28 82.78 Favored 'General case' 0 C--N 1.356 0.888 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.493 ' HA ' ' CD1' ' A' ' 99' ' ' ILE . 3.2 mp -59.94 -35.11 74.23 Favored 'General case' 0 C--N 1.36 1.035 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.5 t -69.61 -39.57 77.15 Favored 'General case' 0 C--N 1.349 0.549 0 O-C-N 121.994 -0.441 . . . . 0.0 109.934 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.1 tttp -87.32 1.37 53.47 Favored 'General case' 0 C--N 1.357 0.905 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -176.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.678 HG13 ' O ' ' A' ' 95' ' ' LEU . 81.4 mt -61.51 -47.06 95.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.868 0 CA-C-N 119.282 0.946 . . . . 0.0 111.408 -177.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -92.88 -25.67 17.98 Favored 'General case' 0 N--CA 1.442 -0.858 0 O-C-N 121.04 -1.037 . . . . 0.0 110.973 -177.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 35.0 t -63.21 -49.0 75.92 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 121.64 -0.662 . . . . 0.0 112.667 -177.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.643 ' HA ' HG13 ' A' ' 105' ' ' VAL . 16.9 t80 -139.42 -14.25 1.12 Allowed 'General case' 0 C--N 1.361 1.066 0 C-N-CA 117.274 -1.77 . . . . 0.0 113.529 -176.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 32.7 mm -71.77 -52.14 27.42 Favored 'Isoleucine or valine' 0 C--O 1.246 0.875 0 CA-C-N 120.659 1.572 . . . . 0.0 110.592 -177.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -91.82 2.3 56.6 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 119.659 -0.817 . . . . 0.0 110.299 -176.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.643 HG13 ' HA ' ' A' ' 102' ' ' PHE . 1.3 p -92.4 -32.47 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.597 ' N ' HG12 ' A' ' 105' ' ' VAL . 89.0 tt0 -72.93 -40.82 65.12 Favored 'General case' 0 C--N 1.357 0.924 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.6 p -74.99 -35.99 37.07 Favored 'Isoleucine or valine' 0 C--N 1.355 0.847 0 C-N-CA 119.231 -0.988 . . . . 0.0 109.684 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -61.23 -48.61 80.68 Favored 'General case' 0 C--N 1.365 1.245 0 O-C-N 121.727 -0.608 . . . . 0.0 110.428 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -60.35 -37.48 80.82 Favored 'General case' 0 C--N 1.358 0.961 0 O-C-N 121.694 -0.629 . . . . 0.0 110.096 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 13.4 mt -56.5 -75.07 0.04 OUTLIER 'General case' 0 C--N 1.356 0.869 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.425 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 92.6 m-85 -119.05 135.21 23.72 Favored Pre-proline 0 N--CA 1.439 -0.983 0 C-N-CA 118.855 -1.138 . . . . 0.0 108.821 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 111' ' ' TYR . 89.4 Cg_endo -84.16 -1.5 9.86 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 123.315 2.677 . . . . 0.0 115.318 -178.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -65.78 -37.24 85.76 Favored 'General case' 0 C--N 1.354 0.788 0 O-C-N 121.805 -0.56 . . . . 0.0 109.933 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.35 144.9 56.27 Favored 'General case' 0 C--N 1.353 0.734 0 CA-C-O 121.495 0.664 . . . . 0.0 109.742 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -131.45 135.96 47.57 Favored 'General case' 0 C--N 1.356 0.882 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.547 ' HB3' ' HD2' ' A' ' 117' ' ' PRO . 90.7 mt -128.45 157.17 75.61 Favored Pre-proline 0 N--CA 1.443 -0.794 0 CA-C-O 122.189 0.995 . . . . 0.0 109.286 -178.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.547 ' HD2' ' HB3' ' A' ' 116' ' ' LEU . 94.0 Cg_endo -80.29 -153.52 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.122 0 C-N-CA 123.644 2.896 . . . . 0.0 113.472 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.414 ' H ' ' HB2' ' A' ' 117' ' ' PRO . 99.4 mttt -118.21 144.14 45.97 Favored 'General case' 0 C--N 1.362 1.148 0 C-N-CA 119.172 -1.011 . . . . 0.0 108.458 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -129.59 134.36 47.68 Favored 'General case' 0 C--N 1.361 1.081 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.525 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 94.2 m -125.05 129.32 50.03 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 177.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 84.4 m -116.02 127.26 54.77 Favored 'General case' 0 CA--C 1.504 -0.802 0 C-N-CA 119.094 -1.042 . . . . 0.0 109.402 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -120.36 130.77 54.55 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.548 ' HG3' HD12 ' A' ' 129' ' ' ILE . 57.9 ttp180 -105.16 116.98 32.87 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -179.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.509 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 90.7 mt -85.81 -24.32 26.84 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 120.709 -0.397 . . . . 0.0 109.997 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -179.6 -146.0 6.61 Favored Glycine 0 C--N 1.349 1.294 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 -178.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -94.12 -40.16 10.2 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 120.007 -0.677 . . . . 0.0 109.274 -178.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -101.69 4.25 40.5 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 119.882 -0.727 . . . . 0.0 110.406 -178.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.509 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 8.4 m-20 -120.74 130.65 54.13 Favored 'General case' 0 C--N 1.36 1.035 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.567 HG22 ' N ' ' A' ' 130' ' ' ARG . 8.7 mm -141.49 137.71 32.51 Favored 'Isoleucine or valine' 0 C--N 1.356 0.871 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.567 ' N ' HG22 ' A' ' 129' ' ' ILE . 60.3 mtm180 -124.11 138.83 54.38 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.633 ' HG ' ' O ' ' A' ' 131' ' ' LEU . 0.1 OUTLIER -130.63 127.42 38.93 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.594 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.525 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 12.3 m170 -95.6 135.72 36.9 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 179.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -127.69 118.83 24.55 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 -178.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.526 ' HA ' ' O ' ' A' ' 171' ' ' THR . 29.1 tt0 -113.82 111.93 22.56 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 14.5 t -161.86 153.82 19.19 Favored 'General case' 0 C--N 1.359 0.99 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.403 ' C ' ' HD3' ' A' ' 138' ' ' PRO . 57.6 mtmt -91.47 3.36 55.16 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 120.26 -0.576 . . . . 0.0 109.893 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 93.2 mtm-85 -133.7 73.78 71.41 Favored Pre-proline 0 C--N 1.355 0.847 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 178.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.403 ' HD3' ' C ' ' A' ' 136' ' ' LYS . 87.2 Cg_endo -94.81 103.47 0.12 Allowed 'Trans proline' 0 N--CA 1.444 -1.426 0 C-N-CA 122.489 2.126 . . . . 0.0 115.67 -177.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -111.15 113.01 25.21 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 176.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.95 -38.75 92.23 Favored 'General case' 0 C--N 1.353 0.748 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.068 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.0 m -64.13 -26.28 68.46 Favored 'General case' 0 C--N 1.353 0.742 0 O-C-N 122.052 -0.405 . . . . 0.0 110.902 -178.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -76.47 -47.41 23.04 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 121.669 -0.645 . . . . 0.0 109.666 -178.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.88 -39.49 93.62 Favored 'General case' 0 C--N 1.357 0.919 0 O-C-N 122.071 -0.393 . . . . 0.0 110.8 -178.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.34 -36.83 85.01 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 122.029 -0.419 . . . . 0.0 109.901 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.44 -43.25 98.93 Favored Glycine 0 C--N 1.348 1.201 0 N-CA-C 109.901 -1.279 . . . . 0.0 109.901 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.0 mt -69.08 -41.08 77.98 Favored 'General case' 0 C--N 1.352 0.694 0 CA-C-N 117.612 0.706 . . . . 0.0 112.415 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 98.2 mt -71.5 -42.49 67.95 Favored 'General case' 0 C--N 1.36 1.042 0 O-C-N 121.3 -0.875 . . . . 0.0 110.714 -177.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.583 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 37.5 t70 -69.38 -32.52 71.61 Favored 'General case' 0 N--CA 1.445 -0.703 0 O-C-N 122.049 -0.407 . . . . 0.0 110.642 -179.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -62.85 -39.57 98.16 Favored Glycine 0 C--N 1.357 1.736 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 47.0 t -60.1 -41.73 93.18 Favored 'General case' 0 C--N 1.351 0.653 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -77.56 0.23 23.81 Favored 'General case' 0 C--N 1.359 0.982 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.583 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 76.8 mm-40 -83.65 -46.77 11.95 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -68.55 -41.46 79.76 Favored 'General case' 0 C--N 1.359 0.991 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.523 ' HZ ' ' SD ' ' A' ' 89' ' ' MET . 9.7 m-30 -69.66 -26.98 64.66 Favored 'General case' 0 C--N 1.36 1.055 0 O-C-N 121.821 -0.549 . . . . 0.0 110.628 -178.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 85.0 tttt 73.59 74.88 0.13 Allowed 'General case' 0 C--N 1.361 1.091 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -142.81 -170.34 3.21 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -148.57 94.37 2.28 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 15.7 m-30 -113.42 156.59 23.22 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 94.5 m -119.23 126.85 52.5 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 119.082 -1.047 . . . . 0.0 108.837 -178.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 3.9 mp -104.76 122.61 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 178.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.8 m -120.47 -171.95 2.27 Favored 'General case' 0 C--N 1.355 0.808 0 CA-C-O 121.812 0.815 . . . . 0.0 108.899 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.01 158.64 44.37 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -178.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 50.2 p -98.27 146.59 31.79 Favored Pre-proline 0 C--N 1.357 0.934 0 CA-C-O 122.368 1.08 . . . . 0.0 108.134 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.64 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 72.8 Cg_endo -75.95 -10.98 19.84 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.924 2.416 . . . . 0.0 115.031 -178.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -72.62 -41.17 65.84 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.388 -178.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 39.0 p -116.7 15.32 15.43 Favored 'General case' 0 C--N 1.354 0.795 0 C-N-CA 120.264 -0.575 . . . . 0.0 110.288 -178.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.64 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.2 pp0? -66.67 -12.76 59.67 Favored 'General case' 0 C--N 1.354 0.798 0 O-C-N 121.608 -0.683 . . . . 0.0 110.22 178.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -124.62 38.23 4.24 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 57.7 m -137.21 146.76 45.23 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.607 ' O ' ' HB ' ' A' ' 171' ' ' THR . 61.4 mt-10 -99.85 165.46 11.56 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.607 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 16.4 m 82.28 -59.39 0.19 Allowed 'General case' 0 C--N 1.369 1.453 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.799 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -107.73 117.1 33.24 Favored 'General case' 0 CA--C 1.505 -0.784 0 C-N-CA 119.884 -0.726 . . . . 0.0 109.868 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 88.2 t -131.8 133.66 61.0 Favored 'Isoleucine or valine' 0 C--N 1.358 0.943 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 178.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.433 HD13 HG21 ' A' ' 174' ' ' ILE . 49.5 mm -109.59 126.0 66.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.955 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -114.13 147.27 39.1 Favored 'General case' 0 C--N 1.359 0.988 0 CA-C-O 121.942 0.877 . . . . 0.0 108.767 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -128.26 118.19 22.84 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.0 mp -112.58 118.06 56.87 Favored 'Isoleucine or valine' 0 C--N 1.355 0.838 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 85.1 m -128.28 144.79 51.16 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 -177.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 81.1 mtm180 . . . . . 0 C--N 1.37 1.491 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 178.171 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.627 ' HG2' ' HG3' ' A' ' 4' ' ' MET . 54.0 tpp . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.026 0.441 . . . . 0.0 110.333 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.492 ' HA ' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -82.59 -19.14 39.03 Favored 'General case' 0 C--N 1.355 0.833 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.247 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.2 -38.98 58.78 Favored Glycine 0 C--N 1.351 1.382 0 N-CA-C 108.563 -1.815 . . . . 0.0 108.563 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' MET . . . . . 0.627 ' HG3' ' HG2' ' A' ' 1' ' ' MET . 3.2 mtt -70.04 -35.86 74.61 Favored 'General case' 0 C--N 1.356 0.867 0 O-C-N 122.205 -0.585 . . . . 0.0 111.542 -177.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.492 HG22 ' HA ' ' A' ' 2' ' ' MET . 27.2 m -69.34 -23.92 27.1 Favored 'Isoleucine or valine' 0 C--N 1.356 0.874 0 O-C-N 121.41 -0.806 . . . . 0.0 109.355 -178.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -71.79 -35.37 69.98 Favored 'General case' 0 C--N 1.357 0.908 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 87.9 m -67.33 -41.67 84.87 Favored 'General case' 0 C--N 1.355 0.84 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.48 -38.35 96.2 Favored Glycine 0 C--N 1.356 1.69 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.608 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -67.18 -38.56 85.61 Favored 'General case' 0 C--N 1.351 0.657 0 CA-C-N 117.311 0.556 . . . . 0.0 110.503 -177.927 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 21.3 mmt -64.26 -40.7 96.53 Favored 'General case' 0 C--N 1.354 0.798 0 O-C-N 121.616 -0.677 . . . . 0.0 110.767 -178.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -66.2 -40.4 90.35 Favored 'General case' 0 C--N 1.349 0.559 0 O-C-N 122.057 -0.402 . . . . 0.0 111.684 -178.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 57.8 tp -65.75 -42.73 90.59 Favored 'General case' 0 C--N 1.35 0.595 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -178.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.608 HG12 ' O ' ' A' ' 9' ' ' LEU . 1.7 mm -75.61 -36.32 34.02 Favored 'Isoleucine or valine' 0 C--N 1.357 0.917 0 O-C-N 121.049 -1.032 . . . . 0.0 110.955 -175.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -67.96 -42.57 80.7 Favored 'General case' 0 C--N 1.351 0.67 0 O-C-N 121.858 -0.526 . . . . 0.0 111.108 -176.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -73.48 -31.28 63.66 Favored 'General case' 0 N--CA 1.447 -0.617 0 O-C-N 122.014 -0.429 . . . . 0.0 111.499 -177.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -72.63 -49.08 34.35 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -175.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -128.56 -20.35 3.63 Favored 'General case' 0 C--N 1.355 0.812 0 C-N-CA 117.566 -1.654 . . . . 0.0 113.02 -176.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 140.8 179.08 17.89 Favored Glycine 0 CA--C 1.496 -1.094 0 C-N-CA 118.104 -1.998 . . . . 0.0 109.657 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -94.26 -11.09 30.89 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -177.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -70.88 -41.52 71.24 Favored 'General case' 0 C--N 1.36 1.046 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 92.8 m -69.91 -38.89 76.4 Favored 'General case' 0 C--N 1.359 0.98 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 56.6 tp -60.5 -37.66 81.81 Favored 'General case' 0 C--N 1.357 0.9 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -64.94 -35.43 81.13 Favored 'General case' 0 C--N 1.357 0.919 0 O-C-N 122.203 -0.311 . . . . 0.0 110.757 -178.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.425 ' O ' HG21 ' A' ' 24' ' ' THR . 91.2 m -64.44 -41.23 96.67 Favored 'General case' 0 C--N 1.354 0.771 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -178.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.427 ' CD2' ' HB3' ' A' ' 54' ' ' LYS . 93.0 mt -65.23 -37.43 87.23 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 80.3 mt -69.7 -14.38 62.77 Favored 'General case' 0 C--N 1.358 0.971 0 O-C-N 121.445 -0.784 . . . . 0.0 109.604 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -88.07 -25.74 22.9 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 119.621 -0.831 . . . . 0.0 109.287 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 55.9 p -70.27 -23.9 62.96 Favored 'General case' 0 C--N 1.359 1.017 0 C-N-CA 119.65 -0.82 . . . . 0.0 109.22 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.434 ' H ' ' HG ' ' A' ' 29' ' ' CYS . 1.8 p -105.8 -37.19 6.79 Favored 'General case' 0 C--N 1.358 0.967 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 86.09 132.15 0.04 OUTLIER 'General case' 0 C--N 1.36 1.031 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.551 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -90.88 -166.18 1.52 Allowed 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.451 ' H ' ' HB2' ' A' ' 31' ' ' LEU . 54.5 tt0 -153.35 -64.81 0.15 Allowed 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.6 t -97.92 -65.19 0.98 Allowed 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -138.11 -45.0 0.51 Allowed 'General case' 0 CA--C 1.503 -0.863 0 C-N-CA 119.567 -0.853 . . . . 0.0 108.752 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 125.88 -35.59 2.97 Favored Glycine 0 C--N 1.352 1.427 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 85.0 mt -107.91 100.26 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.788 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -97.13 -1.47 45.1 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.606 HG23 ' H ' ' A' ' 39' ' ' SER . 2.7 m 77.55 -179.63 0.13 Allowed 'General case' 0 C--N 1.361 1.107 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 -178.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.606 ' H ' HG23 ' A' ' 38' ' ' THR . 21.2 p -85.7 102.71 13.85 Favored 'General case' 0 C--N 1.353 0.729 0 O-C-N 121.116 -0.99 . . . . 0.0 109.261 -178.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.662 ' O ' HG13 ' A' ' 40' ' ' VAL . 97.3 t -153.19 -18.54 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.359 1.013 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -112.58 164.93 12.02 Favored Glycine 0 C--N 1.356 1.668 0 C-N-CA 119.311 -1.423 . . . . 0.0 110.156 -176.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.6 m -128.62 127.76 42.87 Favored 'General case' 0 C--N 1.355 0.816 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -116.42 176.42 5.12 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -79.34 -176.53 5.26 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -91.15 -16.03 28.42 Favored 'General case' 0 CA--C 1.503 -0.858 0 C-N-CA 120.105 -0.638 . . . . 0.0 109.406 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -70.23 -28.15 65.03 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -63.37 -40.85 98.37 Favored 'General case' 0 C--N 1.352 0.68 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 63.3 tp -66.82 -38.57 86.71 Favored 'General case' 0 C--N 1.357 0.899 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.308 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.478 ' O ' HG21 ' A' ' 53' ' ' VAL . 58.3 tp -77.31 -26.2 52.0 Favored 'General case' 0 C--N 1.349 0.567 0 O-C-N 122.071 -0.393 . . . . 0.0 110.134 -177.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -67.67 -43.9 79.08 Favored 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 121.724 -0.61 . . . . 0.0 110.048 -178.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 81.8 mt -71.93 -34.84 69.38 Favored 'General case' 0 C--N 1.36 1.022 0 C-N-CA 120.164 -0.614 . . . . 0.0 109.467 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.514 ' O ' HG13 ' A' ' 52' ' ' VAL . 40.0 t -63.11 -40.73 90.14 Favored 'Isoleucine or valine' 0 C--N 1.35 0.593 0 O-C-N 122.331 -0.231 . . . . 0.0 110.456 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.496 ' O ' HG11 ' A' ' 53' ' ' VAL . 54.9 t -68.13 -40.29 82.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.662 0 O-C-N 121.672 -0.642 . . . . 0.0 109.929 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.427 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 24.8 tptt -68.39 -23.02 64.61 Favored 'General case' 0 C--N 1.36 1.022 0 O-C-N 121.021 -1.05 . . . . 0.0 108.695 -179.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.472 HD12 HD12 ' A' ' 13' ' ' ILE . 1.9 mt -68.96 -37.48 78.86 Favored 'General case' 0 C--N 1.351 0.674 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.402 ' O ' ' HA ' ' A' ' 60' ' ' SER . 59.5 p -73.29 -17.11 61.35 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.382 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -100.3 -37.06 9.04 Favored 'General case' 0 C--N 1.354 0.78 0 C-N-CA 119.534 -0.867 . . . . 0.0 111.402 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.542 HG11 ' N ' ' A' ' 59' ' ' SER . 4.9 p -72.67 -36.86 54.38 Favored 'Isoleucine or valine' 0 C--N 1.353 0.725 0 O-C-N 121.56 -0.712 . . . . 0.0 111.525 -177.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.542 ' N ' HG11 ' A' ' 58' ' ' VAL . 5.3 t -117.89 -3.95 11.14 Favored 'General case' 0 C--N 1.352 0.691 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.143 -178.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 56' ' ' SER . 73.2 m 62.9 42.45 7.67 Favored 'General case' 0 C--N 1.355 0.839 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.637 HG11 ' HD2' ' A' ' 62' ' ' PRO . 55.1 t -102.37 131.45 22.5 Favored Pre-proline 0 CA--C 1.503 -0.855 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.637 ' HD2' HG11 ' A' ' 61' ' ' VAL . 42.2 Cg_exo -57.52 147.42 78.74 Favored 'Trans proline' 0 CA--C 1.498 -1.292 0 C-N-CA 122.55 2.167 . . . . 0.0 112.624 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.1 m -75.22 -12.83 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.671 -178.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 64.4 p -96.45 -34.07 11.65 Favored 'General case' 0 C--N 1.359 0.996 0 C-N-CA 118.393 -1.323 . . . . 0.0 109.488 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -75.59 -23.71 56.49 Favored 'General case' 0 C--N 1.354 0.795 0 O-C-N 121.5 -0.75 . . . . 0.0 109.087 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.501 HD23 HG12 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -79.96 -36.25 36.44 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.007 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.515 HG12 ' N ' ' A' ' 68' ' ' ARG . 1.9 p -69.41 -25.45 29.16 Favored 'Isoleucine or valine' 0 C--N 1.354 0.797 0 C-N-CA 120.206 -0.597 . . . . 0.0 110.046 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.515 ' N ' HG12 ' A' ' 67' ' ' VAL . 5.5 mmm-85 -73.15 -52.48 14.04 Favored 'General case' 0 C--N 1.363 1.162 0 O-C-N 121.548 -0.72 . . . . 0.0 110.12 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.7 mt -63.31 -35.43 80.36 Favored 'General case' 0 C--N 1.357 0.903 0 O-C-N 121.983 -0.448 . . . . 0.0 110.941 -178.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -61.1 -47.67 85.24 Favored 'General case' 0 C--N 1.351 0.638 0 O-C-N 122.117 -0.365 . . . . 0.0 110.624 -178.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.91 -38.51 95.52 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 111.738 -0.545 . . . . 0.0 111.738 -178.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.14 -47.87 80.9 Favored 'General case' 0 C--N 1.349 0.568 0 CA-C-N 118.067 0.934 . . . . 0.0 111.348 -177.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.735 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 9.9 mttm -64.51 -49.21 72.2 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 113.61 0.966 . . . . 0.0 113.61 -177.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -68.4 -39.81 81.55 Favored 'General case' 0 C--N 1.349 0.585 0 O-C-N 121.082 -1.012 . . . . 0.0 111.86 -175.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -63.41 -45.09 92.6 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 121.091 -1.006 . . . . 0.0 111.258 -177.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.404 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 9.8 p -71.09 -14.92 18.34 Favored 'Isoleucine or valine' 0 C--N 1.359 0.988 0 O-C-N 121.478 -0.763 . . . . 0.0 109.506 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.735 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 74.1 mm-40 -72.74 -38.79 67.3 Favored 'General case' 0 C--N 1.35 0.629 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 78.9 mt -69.09 -35.27 76.3 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 47.7 mm -62.5 -51.49 71.53 Favored 'Isoleucine or valine' 0 C--N 1.356 0.89 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.227 -177.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' A' ' 76' ' ' VAL . 10.2 mt-10 -75.64 -11.87 60.09 Favored 'General case' 0 C--N 1.353 0.73 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.98 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -94.01 -9.37 59.61 Favored Glycine 0 C--N 1.347 1.166 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.482 -178.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.5 ' HB2' HG22 ' A' ' 85' ' ' ILE . 87.5 m-70 -143.93 95.32 5.73 Favored Pre-proline 0 CA--C 1.503 -0.839 0 CA-C-N 118.91 1.355 . . . . 0.0 109.126 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.526 ' O ' ' HB2' ' A' ' 87' ' ' ASN . 38.3 Cg_endo -68.71 -23.8 35.66 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.393 2.062 . . . . 0.0 114.046 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -90.75 -9.11 47.81 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.5 HG22 ' HB2' ' A' ' 82' ' ' HIS . 0.6 OUTLIER -89.01 -21.99 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.971 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 -178.792 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -104.38 -14.81 15.61 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.526 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 20.1 t30 -72.88 -40.66 65.42 Favored 'General case' 0 C--N 1.36 1.048 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -67.35 -29.79 69.43 Favored 'General case' 0 C--N 1.353 0.735 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.156 -178.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 28.4 ttp -84.17 146.58 27.77 Favored 'General case' 0 C--N 1.351 0.655 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.75 -21.51 10.15 Favored 'General case' 0 C--N 1.361 1.104 0 O-C-N 121.58 -0.7 . . . . 0.0 110.937 -177.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -164.54 171.39 14.6 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 -177.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.423 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 88.4 p -71.01 -31.7 68.28 Favored 'General case' 0 C--N 1.352 0.682 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.014 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -70.4 -38.46 74.66 Favored 'General case' 0 C--N 1.358 0.942 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -66.67 -24.18 66.24 Favored 'General case' 0 C--N 1.358 0.977 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.423 ' HB3' ' O ' ' A' ' 92' ' ' SER . 61.4 tp -62.92 -46.36 88.16 Favored 'General case' 0 C--N 1.355 0.814 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.3 mp -62.61 -32.89 73.98 Favored 'General case' 0 C--N 1.354 0.765 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 36.3 t -62.41 -45.02 94.99 Favored 'General case' 0 C--N 1.355 0.81 0 O-C-N 121.84 -0.537 . . . . 0.0 111.347 -178.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.08 28.45 8.78 Favored 'General case' 0 C--N 1.361 1.085 0 O-C-N 121.103 -0.998 . . . . 0.0 110.539 -178.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.626 HG23 ' N ' ' A' ' 100' ' ' ASP . 10.6 tt -62.71 -29.91 48.12 Favored 'Isoleucine or valine' 0 C--N 1.354 0.794 0 O-C-N 121.827 -0.546 . . . . 0.0 110.314 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.626 ' N ' HG23 ' A' ' 99' ' ' ILE . 9.9 p-10 -127.4 -8.8 5.76 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 118.54 -1.264 . . . . 0.0 109.916 -179.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 58.4 m -90.88 -2.93 57.7 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 119.566 -0.854 . . . . 0.0 110.313 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.473 ' O ' HG13 ' A' ' 105' ' ' VAL . 11.9 t80 -146.51 -46.92 0.19 Allowed 'General case' 0 C--N 1.357 0.912 0 C-N-CA 118.264 -1.374 . . . . 0.0 109.754 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 96.1 mt -68.57 -48.41 72.18 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 O-C-N 121.788 -0.57 . . . . 0.0 110.948 -178.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 44.4 m170 -85.71 -1.52 57.27 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.329 -177.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.473 HG13 ' O ' ' A' ' 102' ' ' PHE . 2.0 p -89.11 -32.72 5.85 Favored 'Isoleucine or valine' 0 C--N 1.354 0.793 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -72.3 -40.14 67.76 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.641 HG13 ' N ' ' A' ' 108' ' ' TYR . 0.5 OUTLIER -73.17 -33.97 43.4 Favored 'Isoleucine or valine' 0 C--N 1.355 0.824 0 C-N-CA 119.518 -0.873 . . . . 0.0 109.576 -178.752 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.641 ' N ' HG13 ' A' ' 107' ' ' VAL . 92.3 t80 -60.67 -49.01 79.25 Favored 'General case' 0 C--N 1.363 1.164 0 O-C-N 121.8 -0.563 . . . . 0.0 110.441 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -60.44 -38.99 85.9 Favored 'General case' 0 C--N 1.358 0.96 0 O-C-N 121.579 -0.701 . . . . 0.0 110.096 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.0 mt -57.15 -76.92 0.03 OUTLIER 'General case' 0 C--N 1.354 0.798 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.427 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 92.7 m-85 -115.89 136.11 22.85 Favored Pre-proline 0 N--CA 1.442 -0.855 0 O-C-N 121.067 -1.021 . . . . 0.0 108.817 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 111' ' ' TYR . 68.8 Cg_endo -86.38 -1.72 8.45 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 123.32 2.68 . . . . 0.0 115.585 -178.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -66.73 -36.83 83.4 Favored 'General case' 0 C--N 1.356 0.855 0 O-C-N 121.652 -0.655 . . . . 0.0 110.2 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.46 145.76 54.67 Favored 'General case' 0 C--N 1.352 0.696 0 CA-C-O 121.61 0.719 . . . . 0.0 110.105 -178.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -130.8 134.43 46.84 Favored 'General case' 0 C--N 1.358 0.936 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.5 ' HB3' ' HD2' ' A' ' 117' ' ' PRO . 2.8 mm? -116.36 156.45 47.26 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-O 122.145 0.974 . . . . 0.0 108.855 -178.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.5 ' HD2' ' HB3' ' A' ' 116' ' ' LEU . 85.5 Cg_endo -83.88 -151.86 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.123 0 C-N-CA 123.517 2.812 . . . . 0.0 113.147 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.405 ' H ' ' HB2' ' A' ' 117' ' ' PRO . 74.7 mmtt -114.53 138.72 50.28 Favored 'General case' 0 C--N 1.362 1.152 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -125.2 126.38 45.12 Favored 'General case' 0 C--N 1.36 1.05 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -178.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.571 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 93.8 m -124.88 127.66 47.47 Favored 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 177.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 77.1 m -121.63 129.99 53.18 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 119.129 -1.029 . . . . 0.0 109.585 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -118.38 148.81 42.14 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 178.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.549 ' HG3' HD12 ' A' ' 129' ' ' ILE . 57.4 ttp180 -120.55 117.21 27.03 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -179.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.45 ' HA ' HD23 ' A' ' 124' ' ' LEU . 95.0 mt -90.55 -16.2 29.24 Favored 'General case' 0 CA--C 1.503 -0.853 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.52 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 175.37 -148.68 9.63 Favored Glycine 0 N--CA 1.437 -1.271 0 N-CA-C 108.891 -1.684 . . . . 0.0 108.891 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -94.35 -37.35 11.52 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -178.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -103.01 3.82 36.62 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.02 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.418 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 66.6 m-20 -119.83 130.81 55.08 Favored 'General case' 0 C--N 1.359 1.003 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.549 HD12 ' HG3' ' A' ' 123' ' ' ARG . 8.4 mm -142.27 136.07 28.49 Favored 'Isoleucine or valine' 0 C--N 1.355 0.819 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.478 ' N ' HG22 ' A' ' 129' ' ' ILE . 53.2 mtm180 -116.16 139.48 50.28 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 6.3 tp -126.7 118.81 25.5 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.571 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 12.4 m-70 -99.55 133.43 43.88 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -129.94 122.61 28.88 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 -178.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.498 ' HA ' ' O ' ' A' ' 171' ' ' THR . 32.2 tt0 -115.73 113.04 22.93 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.2 t -162.51 154.16 18.25 Favored 'General case' 0 C--N 1.359 1.002 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.42 ' C ' ' HD3' ' A' ' 138' ' ' PRO . 57.7 mtmt -91.41 3.94 53.69 Favored 'General case' 0 C--N 1.357 0.921 0 C-N-CA 120.186 -0.605 . . . . 0.0 109.865 -179.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 93.8 mtm-85 -133.01 74.11 74.29 Favored Pre-proline 0 C--N 1.356 0.882 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.42 ' HD3' ' C ' ' A' ' 136' ' ' LYS . 94.1 Cg_endo -96.23 102.7 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.657 2.238 . . . . 0.0 115.759 -177.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -111.47 113.42 25.84 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 176.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.01 -38.16 90.07 Favored 'General case' 0 C--N 1.354 0.778 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.026 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.7 m -63.48 -28.04 69.69 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 122.042 -0.411 . . . . 0.0 110.694 -178.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -75.59 -46.53 31.28 Favored 'General case' 0 C--N 1.352 0.687 0 C-N-CA 120.146 -0.622 . . . . 0.0 109.567 -178.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.68 -39.85 94.38 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 122.258 -0.276 . . . . 0.0 111.187 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.19 -37.2 86.31 Favored 'General case' 0 C--N 1.355 0.81 0 O-C-N 121.987 -0.446 . . . . 0.0 110.184 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.51 -42.88 99.27 Favored Glycine 0 C--N 1.348 1.248 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 -179.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 83.1 mt -70.07 -40.65 74.9 Favored 'General case' 0 C--N 1.351 0.667 0 CA-C-N 117.522 0.661 . . . . 0.0 112.627 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 97.1 mt -71.35 -42.38 68.58 Favored 'General case' 0 C--N 1.361 1.07 0 O-C-N 121.235 -0.916 . . . . 0.0 110.902 -176.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.52 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 36.4 t70 -70.06 -31.07 68.5 Favored 'General case' 0 N--CA 1.445 -0.695 0 O-C-N 121.934 -0.479 . . . . 0.0 110.407 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -63.12 -39.09 97.57 Favored Glycine 0 C--N 1.356 1.672 0 N-CA-C 108.461 -1.856 . . . . 0.0 108.461 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 46.3 t -60.75 -42.2 96.92 Favored 'General case' 0 C--N 1.35 0.622 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 178.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -74.97 -1.25 21.76 Favored 'General case' 0 C--N 1.36 1.046 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.52 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 76.9 mm-40 -83.46 -46.91 11.94 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -65.54 -45.6 82.8 Favored 'General case' 0 C--N 1.36 1.042 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.411 178.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -68.57 -25.95 65.16 Favored 'General case' 0 C--N 1.363 1.191 0 O-C-N 121.798 -0.564 . . . . 0.0 110.896 -178.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 85.1 tttt 73.16 76.43 0.14 Allowed 'General case' 0 C--N 1.36 1.031 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -144.9 -168.56 2.96 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -150.71 93.25 1.93 Allowed 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 14.1 m-30 -111.35 160.08 17.39 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 92.7 m -120.18 127.08 52.13 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 119.289 -0.964 . . . . 0.0 108.819 -178.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 3.5 mp -105.55 122.21 58.69 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 178.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.9 m -118.09 -173.01 2.36 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-O 121.851 0.834 . . . . 0.0 109.241 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.19 157.89 43.74 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -178.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 52.3 p -99.95 146.43 31.88 Favored Pre-proline 0 C--N 1.358 0.963 0 CA-C-O 122.344 1.069 . . . . 0.0 108.189 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.634 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 72.2 Cg_endo -76.35 -11.14 19.14 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.965 2.443 . . . . 0.0 115.052 -178.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -72.24 -41.29 66.97 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.474 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 36.2 p -117.54 15.82 14.62 Favored 'General case' 0 CA--C 1.505 -0.773 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.355 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.634 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.5 pp0? -65.59 -13.76 59.72 Favored 'General case' 0 C--N 1.355 0.807 0 O-C-N 121.657 -0.652 . . . . 0.0 110.341 178.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 46.6 p30 -125.43 39.76 3.89 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 19.8 t -139.72 144.93 37.75 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.611 ' O ' ' HB ' ' A' ' 171' ' ' THR . 61.9 mt-10 -98.71 164.43 12.23 Favored 'General case' 0 C--N 1.354 0.801 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.611 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 18.4 m 84.35 -60.76 0.1 Allowed 'General case' 0 C--N 1.369 1.44 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -107.2 117.74 34.88 Favored 'General case' 0 CA--C 1.503 -0.855 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.633 -178.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 97.9 t -131.26 132.96 62.9 Favored 'Isoleucine or valine' 0 C--N 1.357 0.923 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 178.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 49.9 mm -107.8 127.43 63.87 Favored 'Isoleucine or valine' 0 C--N 1.357 0.899 0 N-CA-C 107.877 -1.156 . . . . 0.0 107.877 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -115.66 156.14 26.43 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 122.073 0.94 . . . . 0.0 108.593 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -138.84 119.52 14.09 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.7 mp -114.56 118.86 59.88 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 106.395 -1.705 . . . . 0.0 106.395 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 86.1 m -128.2 143.55 51.05 Favored 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -177.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 70.3 mtm180 . . . . . 0 C--N 1.369 1.431 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.287 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.0 mtm . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.532 0.682 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.594 ' HA ' HG23 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -82.48 -9.34 59.47 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -178.998 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.33 -42.31 49.96 Favored Glycine 0 C--N 1.352 1.422 0 N-CA-C 108.734 -1.746 . . . . 0.0 108.734 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 61.5 mtt -66.68 -38.78 87.49 Favored 'General case' 0 C--N 1.357 0.893 0 O-C-N 122.13 -0.629 . . . . 0.0 111.21 -178.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.594 HG23 ' HA ' ' A' ' 2' ' ' MET . 34.7 m -69.23 -23.06 26.38 Favored 'Isoleucine or valine' 0 C--N 1.356 0.871 0 C-N-CA 120.178 -0.609 . . . . 0.0 109.91 -178.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -70.75 -37.25 73.42 Favored 'General case' 0 C--N 1.355 0.833 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.4 m -67.98 -41.07 82.92 Favored 'General case' 0 C--N 1.354 0.803 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.44 -38.97 97.19 Favored Glycine 0 C--N 1.357 1.702 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.649 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -65.5 -40.12 92.66 Favored 'General case' 0 C--N 1.351 0.652 0 O-C-N 122.384 -0.48 . . . . 0.0 110.733 -178.351 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.402 ' HE1' HD21 ' A' ' 26' ' ' LEU . 24.6 mmt -63.11 -40.42 97.56 Favored 'General case' 0 C--N 1.352 0.676 0 O-C-N 121.611 -0.681 . . . . 0.0 110.935 -178.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -67.33 -40.24 85.91 Favored 'General case' 0 C--N 1.348 0.526 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.438 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 53.7 tp -66.36 -43.07 87.04 Favored 'General case' 0 C--N 1.35 0.588 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -178.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.649 HG12 ' O ' ' A' ' 9' ' ' LEU . 1.1 mm -76.36 -36.05 28.48 Favored 'Isoleucine or valine' 0 C--N 1.36 1.04 0 O-C-N 120.924 -1.11 . . . . 0.0 111.113 -175.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -67.61 -43.18 81.07 Favored 'General case' 0 C--N 1.351 0.642 0 O-C-N 121.683 -0.636 . . . . 0.0 111.134 -176.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -72.32 -33.28 67.23 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 121.956 -0.465 . . . . 0.0 111.76 -177.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -72.49 -48.45 40.61 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -175.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -127.57 -21.12 3.85 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 117.5 -1.68 . . . . 0.0 113.49 -176.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 140.56 179.81 18.45 Favored Glycine 0 CA--C 1.497 -1.041 0 C-N-CA 118.007 -2.044 . . . . 0.0 109.489 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -96.33 -11.96 25.1 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -177.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -70.79 -41.4 71.69 Favored 'General case' 0 C--N 1.36 1.032 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.413 HG23 HG23 ' A' ' 58' ' ' VAL . 94.3 m -69.73 -38.89 77.04 Favored 'General case' 0 C--N 1.357 0.896 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 55.5 tp -60.48 -37.12 80.03 Favored 'General case' 0 C--N 1.356 0.873 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -65.09 -35.46 81.22 Favored 'General case' 0 C--N 1.357 0.899 0 O-C-N 122.255 -0.278 . . . . 0.0 110.725 -178.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.7 m -64.49 -40.25 95.32 Favored 'General case' 0 C--N 1.358 0.946 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -178.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.46 HD22 ' HA ' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -65.09 -36.71 85.17 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.581 ' HB3' HD23 ' A' ' 31' ' ' LEU . 83.7 mt -70.88 -14.88 62.55 Favored 'General case' 0 C--N 1.356 0.891 0 O-C-N 121.501 -0.749 . . . . 0.0 109.81 -179.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -87.82 -25.79 23.15 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.292 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.4 p -69.22 -24.33 64.01 Favored 'General case' 0 C--N 1.36 1.027 0 C-N-CA 119.7 -0.8 . . . . 0.0 109.085 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.64 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 1.9 p -107.42 -34.88 6.93 Favored 'General case' 0 C--N 1.359 0.992 0 C-N-CA 119.008 -1.077 . . . . 0.0 108.442 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.64 ' HB2' ' O ' ' A' ' 29' ' ' CYS . 12.2 mt-10 83.37 133.58 0.05 Allowed 'General case' 0 C--N 1.359 1.012 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.581 HD23 ' HB3' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -103.2 111.06 23.26 Favored 'General case' 0 C--N 1.359 1.001 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.577 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -73.07 -41.11 64.47 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.451 ' HB3' ' H ' ' A' ' 34' ' ' GLU . 0.6 OUTLIER -113.96 -88.68 0.55 Allowed 'General case' 0 C--N 1.355 0.828 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.074 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.451 ' H ' ' HB3' ' A' ' 33' ' ' SER . 60.5 mt-10 -120.55 -43.15 2.5 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -178.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.91 -34.64 5.11 Favored Glycine 0 C--N 1.351 1.393 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 78.9 mt -106.66 102.67 14.28 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.95 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.47 -136.9 0.06 Allowed 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.478 ' O ' ' HB3' ' A' ' 39' ' ' SER . 52.0 m -113.2 -59.65 1.99 Allowed 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -179.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.478 ' HB3' ' O ' ' A' ' 38' ' ' THR . 61.4 p 158.48 10.34 0.0 OUTLIER 'General case' 0 C--N 1.363 1.182 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -178.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.4 p -98.07 6.8 8.65 Favored 'Isoleucine or valine' 0 C--N 1.353 0.733 0 C-N-CA 120.251 -0.579 . . . . 0.0 110.902 -177.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -105.3 154.95 17.13 Favored Glycine 0 C--N 1.353 1.5 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.1 t -134.88 124.99 25.87 Favored 'General case' 0 C--N 1.357 0.901 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -109.46 175.75 5.33 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -72.18 175.33 6.13 Favored 'General case' 0 C--N 1.356 0.879 0 CA-C-O 121.638 0.733 . . . . 0.0 109.443 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 10.7 t60 -82.77 -24.86 33.27 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -178.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -65.81 -28.17 68.8 Favored 'General case' 0 C--N 1.356 0.875 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.2 tp10 -62.58 -39.74 94.68 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -68.15 -38.63 82.35 Favored 'General case' 0 C--N 1.357 0.915 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.462 ' O ' HG21 ' A' ' 53' ' ' VAL . 59.2 tp -71.28 -32.38 68.62 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -177.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -66.76 -40.96 88.44 Favored 'General case' 0 N--CA 1.441 -0.878 0 O-C-N 122.02 -0.425 . . . . 0.0 110.027 -178.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.45 ' HA ' HD22 ' A' ' 51' ' ' LEU . 80.3 mt -82.47 -17.81 43.93 Favored 'General case' 0 C--N 1.357 0.898 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.191 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.489 ' O ' HG13 ' A' ' 52' ' ' VAL . 1.0 OUTLIER -81.56 -36.65 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -179.428 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.489 ' O ' HG11 ' A' ' 53' ' ' VAL . 54.3 t -68.34 -41.49 83.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.6 tptt -69.17 -26.03 64.65 Favored 'General case' 0 C--N 1.365 1.245 0 C-N-CA 119.485 -0.886 . . . . 0.0 109.337 -179.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.624 HD12 HD13 ' A' ' 13' ' ' ILE . 3.4 tt -67.04 -37.09 83.46 Favored 'General case' 0 C--N 1.353 0.748 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.619 ' HG ' HG12 ' A' ' 63' ' ' VAL . 68.2 m -76.67 -16.99 59.39 Favored 'General case' 0 C--N 1.352 0.691 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.341 -178.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -97.95 -38.39 9.42 Favored 'General case' 0 C--N 1.353 0.717 0 O-C-N 121.314 -0.867 . . . . 0.0 111.278 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.701 HG11 ' N ' ' A' ' 59' ' ' SER . 5.2 p -73.18 -35.85 48.5 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 O-C-N 121.668 -0.645 . . . . 0.0 111.186 -177.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.701 ' N ' HG11 ' A' ' 58' ' ' VAL . 61.2 m -111.71 -7.87 14.21 Favored 'General case' 0 CA--C 1.504 -0.821 0 C-N-CA 119.389 -0.924 . . . . 0.0 109.99 -177.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 64.72 52.71 1.63 Allowed 'General case' 0 C--N 1.355 0.831 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.507 HG13 ' HD2' ' A' ' 62' ' ' PRO . 48.6 t -112.75 135.76 21.59 Favored Pre-proline 0 CA--C 1.504 -0.81 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.507 ' HD2' HG13 ' A' ' 61' ' ' VAL . 31.2 Cg_exo -59.93 146.08 96.73 Favored 'Trans proline' 0 C--N 1.316 -1.178 0 C-N-CA 122.144 1.896 . . . . 0.0 112.464 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.619 HG12 ' HG ' ' A' ' 56' ' ' SER . 4.2 m -73.55 -16.09 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.91 -178.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 67.5 p -96.24 -32.0 12.66 Favored 'General case' 0 C--N 1.359 0.981 0 C-N-CA 118.129 -1.429 . . . . 0.0 110.318 -178.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -80.19 -19.16 47.69 Favored 'General case' 0 C--N 1.353 0.724 0 O-C-N 121.162 -0.961 . . . . 0.0 108.864 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.417 ' HB3' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -80.17 -37.85 32.51 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.845 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.607 HG12 ' N ' ' A' ' 68' ' ' ARG . 1.3 p -67.35 -28.38 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 C-N-CA 120.236 -0.586 . . . . 0.0 109.833 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.607 ' N ' HG12 ' A' ' 67' ' ' VAL . 71.3 mtp180 -71.47 -50.51 30.92 Favored 'General case' 0 C--N 1.364 1.234 0 O-C-N 121.444 -0.785 . . . . 0.0 110.831 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.43 -36.01 82.79 Favored 'General case' 0 C--N 1.357 0.91 0 O-C-N 121.929 -0.482 . . . . 0.0 111.159 -178.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -61.02 -47.31 87.01 Favored 'General case' 0 C--N 1.349 0.577 0 O-C-N 122.154 -0.341 . . . . 0.0 110.388 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.74 -38.45 95.2 Favored Glycine 0 C--N 1.356 1.643 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 -178.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.08 -48.59 77.97 Favored 'General case' 0 C--N 1.35 0.609 0 CA-C-N 118.104 0.952 . . . . 0.0 111.45 -177.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.534 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 10.9 mttm -64.29 -48.0 77.33 Favored 'General case' 0 C--N 1.358 0.947 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -177.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.429 ' O ' ' HB2' ' A' ' 77' ' ' GLU . 2.1 tm? -68.44 -39.28 81.57 Favored 'General case' 0 C--N 1.349 0.584 0 O-C-N 121.259 -0.9 . . . . 0.0 111.869 -175.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -63.97 -44.38 92.92 Favored 'General case' 0 C--N 1.352 0.69 0 O-C-N 121.248 -0.907 . . . . 0.0 111.06 -177.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.33 -15.27 18.44 Favored 'Isoleucine or valine' 0 C--N 1.359 1.009 0 O-C-N 121.486 -0.759 . . . . 0.0 108.953 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.534 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 14.7 mm-40 -71.67 -39.06 70.52 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 81.8 mt -73.32 -31.22 63.88 Favored 'General case' 0 C--N 1.359 0.984 0 O-C-N 122.301 -0.249 . . . . 0.0 110.505 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.9 mm -64.95 -53.56 40.01 Favored 'Isoleucine or valine' 0 C--N 1.359 1.013 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.956 -177.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -74.69 -15.0 60.81 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 119.693 -0.803 . . . . 0.0 109.36 178.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.65 -36.86 67.62 Favored Glycine 0 C--N 1.35 1.339 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.445 ' HB2' HG22 ' A' ' 85' ' ' ILE . 59.5 m80 -132.44 104.97 13.27 Favored Pre-proline 0 N--CA 1.44 -0.941 0 CA-C-N 118.534 1.167 . . . . 0.0 109.499 -177.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.462 ' O ' ' HB2' ' A' ' 87' ' ' ASN . 34.8 Cg_exo -62.07 -29.58 81.53 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 123.018 2.479 . . . . 0.0 113.872 178.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -91.53 -8.37 47.72 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.445 HG22 ' HB2' ' A' ' 82' ' ' HIS . 0.9 OUTLIER -86.71 -22.27 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 -178.765 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -104.57 -14.55 15.61 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 49.1 t30 -71.71 -40.85 69.21 Favored 'General case' 0 C--N 1.359 1.001 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -66.92 -30.95 71.23 Favored 'General case' 0 C--N 1.351 0.662 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.284 -178.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 17.5 ttp -83.93 150.16 25.86 Favored 'General case' 0 C--N 1.35 0.63 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.71 -22.31 7.49 Favored 'General case' 0 C--N 1.364 1.21 0 O-C-N 121.608 -0.683 . . . . 0.0 111.436 -177.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -165.28 172.03 12.86 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 119.083 -1.047 . . . . 0.0 108.277 -177.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.438 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 40.0 t -64.79 -43.3 93.66 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.056 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -66.13 -39.61 90.01 Favored 'General case' 0 C--N 1.355 0.847 0 O-C-N 121.414 -0.804 . . . . 0.0 109.138 -178.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -65.93 -24.35 66.8 Favored 'General case' 0 C--N 1.355 0.807 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.676 ' O ' HG12 ' A' ' 99' ' ' ILE . 61.7 tp -63.89 -47.16 81.73 Favored 'General case' 0 C--N 1.354 0.777 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.5 mp -60.58 -35.56 76.38 Favored 'General case' 0 C--N 1.36 1.054 0 O-C-N 122.215 -0.303 . . . . 0.0 110.345 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.8 t -68.49 -39.55 81.28 Favored 'General case' 0 C--N 1.348 0.526 0 O-C-N 122.03 -0.419 . . . . 0.0 109.967 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.06 1.26 54.67 Favored 'General case' 0 C--N 1.356 0.855 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -176.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.676 HG12 ' O ' ' A' ' 95' ' ' LEU . 23.4 mm -60.96 -47.16 94.79 Favored 'Isoleucine or valine' 0 C--N 1.359 0.989 0 CA-C-N 118.955 0.798 . . . . 0.0 112.089 -177.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -98.77 -20.63 16.79 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 118.273 -1.371 . . . . 0.0 111.282 -177.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.5 t -64.75 -48.48 74.4 Favored 'General case' 0 N--CA 1.445 -0.707 0 O-C-N 121.555 -0.716 . . . . 0.0 112.36 -178.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -136.51 -17.34 1.51 Allowed 'General case' 0 C--N 1.361 1.093 0 C-N-CA 117.174 -1.811 . . . . 0.0 113.536 -176.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 96.4 mt -71.56 -50.78 37.42 Favored 'Isoleucine or valine' 0 C--O 1.244 0.771 0 CA-C-N 120.574 1.534 . . . . 0.0 111.215 -177.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 28.8 m170 -89.83 1.5 56.08 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 119.628 -0.829 . . . . 0.0 110.107 -177.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 55.7 t -90.19 -41.73 13.74 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.053 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 54.7 tp10 -68.33 -40.02 81.73 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.5 p -74.05 -35.6 42.07 Favored 'Isoleucine or valine' 0 C--N 1.356 0.867 0 C-N-CA 119.18 -1.008 . . . . 0.0 109.708 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 94.2 t80 -61.26 -48.61 80.63 Favored 'General case' 0 C--N 1.364 1.203 0 O-C-N 121.775 -0.578 . . . . 0.0 110.526 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -61.48 -37.13 82.5 Favored 'General case' 0 C--N 1.358 0.948 0 O-C-N 121.742 -0.599 . . . . 0.0 110.162 -178.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 13.6 mt -56.21 -74.47 0.05 OUTLIER 'General case' 0 C--N 1.357 0.922 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.406 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 87.3 m-85 -118.41 133.74 23.49 Favored Pre-proline 0 N--CA 1.439 -0.98 0 C-N-CA 118.978 -1.089 . . . . 0.0 108.538 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 111' ' ' TYR . 96.2 Cg_endo -83.54 -1.48 10.17 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 123.31 2.674 . . . . 0.0 115.52 -178.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -65.73 -37.85 87.55 Favored 'General case' 0 C--N 1.355 0.835 0 O-C-N 121.746 -0.597 . . . . 0.0 110.092 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.38 145.11 56.58 Favored 'General case' 0 C--N 1.354 0.769 0 CA-C-O 121.513 0.673 . . . . 0.0 110.149 -178.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -131.93 135.66 46.79 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.554 ' HB3' ' HD2' ' A' ' 117' ' ' PRO . 93.1 mt -128.96 157.62 75.17 Favored Pre-proline 0 C--N 1.354 0.795 0 CA-C-O 122.098 0.952 . . . . 0.0 109.224 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.554 ' HD2' ' HB3' ' A' ' 116' ' ' LEU . 87.4 Cg_endo -81.35 -150.91 0.04 OUTLIER 'Trans proline' 0 C--N 1.318 -1.059 0 C-N-CA 123.685 2.923 . . . . 0.0 113.933 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.456 ' H ' ' HB2' ' A' ' 117' ' ' PRO . 74.6 mmtt -116.7 141.86 47.65 Favored 'General case' 0 C--N 1.364 1.238 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -130.34 133.14 46.2 Favored 'General case' 0 C--N 1.362 1.125 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.422 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 94.2 m -127.31 129.16 47.15 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 177.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 77.6 m -119.26 129.29 54.84 Favored 'General case' 0 C--N 1.355 0.808 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.382 -178.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -119.63 133.83 55.48 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.477 ' HG3' HD11 ' A' ' 129' ' ' ILE . 58.8 ttp180 -106.63 116.81 32.58 Favored 'General case' 0 C--N 1.352 0.716 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.487 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 94.6 mt -85.54 -23.73 27.56 Favored 'General case' 0 C--N 1.354 0.763 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.203 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -179.59 -144.72 6.0 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -94.02 -40.25 10.19 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 119.993 -0.683 . . . . 0.0 109.254 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -102.51 3.83 37.95 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.985 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.487 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 66.3 m-20 -118.13 129.02 55.28 Favored 'General case' 0 C--N 1.356 0.866 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.477 HD11 ' HG3' ' A' ' 123' ' ' ARG . 10.0 mm -141.25 133.53 29.37 Favored 'Isoleucine or valine' 0 C--N 1.356 0.854 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.459 ' N ' HG21 ' A' ' 129' ' ' ILE . 58.8 mtm180 -116.57 139.75 50.15 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.408 ' O ' ' HG ' ' A' ' 131' ' ' LEU . 0.9 OUTLIER -127.68 118.11 23.22 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -179.429 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.422 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 12.4 m-70 -97.15 132.63 42.74 Favored 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -128.7 120.18 26.0 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -178.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.573 ' HA ' ' O ' ' A' ' 171' ' ' THR . 74.4 mt-30 -115.0 111.77 21.64 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 107.599 -1.259 . . . . 0.0 107.599 178.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.4 t -162.16 153.86 18.61 Favored 'General case' 0 C--N 1.359 0.981 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -90.6 3.08 55.09 Favored 'General case' 0 C--N 1.354 0.782 0 C-N-CA 120.267 -0.573 . . . . 0.0 109.743 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -133.47 74.73 70.83 Favored Pre-proline 0 C--N 1.355 0.806 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -95.36 104.44 0.11 Allowed 'Trans proline' 0 N--CA 1.444 -1.407 0 C-N-CA 122.756 2.304 . . . . 0.0 115.746 -177.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -111.71 110.56 21.0 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 176.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.37 -38.88 92.57 Favored 'General case' 0 C--N 1.354 0.773 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.288 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.1 m -63.28 -26.63 68.86 Favored 'General case' 0 C--N 1.355 0.826 0 O-C-N 121.96 -0.463 . . . . 0.0 110.597 -178.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -75.58 -47.02 28.49 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.554 -178.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.78 -40.08 94.66 Favored 'General case' 0 C--N 1.358 0.96 0 O-C-N 122.154 -0.342 . . . . 0.0 111.226 -178.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.24 -36.91 85.22 Favored 'General case' 0 C--N 1.355 0.812 0 O-C-N 121.852 -0.53 . . . . 0.0 109.985 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.56 -43.71 98.59 Favored Glycine 0 C--N 1.346 1.096 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.3 mt -70.23 -40.34 74.56 Favored 'General case' 0 C--N 1.351 0.671 0 O-C-N 122.126 -0.632 . . . . 0.0 112.639 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 98.2 mt -71.2 -43.24 67.76 Favored 'General case' 0 C--N 1.361 1.068 0 O-C-N 121.21 -0.931 . . . . 0.0 111.115 -176.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.554 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 37.1 t70 -70.54 -29.54 66.03 Favored 'General case' 0 N--CA 1.443 -0.778 0 O-C-N 121.839 -0.538 . . . . 0.0 110.392 -179.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -63.17 -39.47 97.98 Favored Glycine 0 C--N 1.357 1.73 0 N-CA-C 108.464 -1.854 . . . . 0.0 108.464 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 47.9 t -60.38 -41.93 94.81 Favored 'General case' 0 C--N 1.351 0.632 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -75.83 0.17 19.05 Favored 'General case' 0 C--N 1.36 1.029 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.554 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 76.8 mm-40 -85.51 -46.39 10.9 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -66.36 -44.67 82.54 Favored 'General case' 0 C--N 1.36 1.033 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.422 ' O ' ' HB2' ' A' ' 155' ' ' LYS . 52.5 m-85 -69.96 -26.49 64.14 Favored 'General case' 0 C--N 1.36 1.028 0 O-C-N 121.872 -0.517 . . . . 0.0 111.137 -178.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 154' ' ' PHE . 44.1 mttt 71.43 71.78 0.17 Allowed 'General case' 0 C--N 1.363 1.154 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 -178.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.456 ' HB3' ' CE1' ' A' ' 158' ' ' PHE . 3.0 tp10 -141.26 -168.69 2.69 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -140.33 116.34 10.42 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.456 ' CE1' ' HB3' ' A' ' 156' ' ' GLU . 91.2 m-85 -133.65 149.86 51.57 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 92.1 m -120.94 127.59 51.97 Favored 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 3.6 mp -103.8 120.89 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 3.1 m -114.5 -177.6 3.17 Favored 'General case' 0 C--N 1.36 1.034 0 CA-C-O 121.708 0.766 . . . . 0.0 109.193 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -146.93 154.6 41.46 Favored 'General case' 0 C--N 1.355 0.847 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -178.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 54.2 p -97.4 146.5 31.48 Favored Pre-proline 0 C--N 1.358 0.961 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.678 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 72.3 Cg_endo -76.19 -11.2 19.4 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.941 2.427 . . . . 0.0 114.918 -178.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -72.63 -41.14 65.83 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.714 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 35.7 p -118.42 15.52 13.84 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.704 -178.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.678 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.1 pp0? -67.06 -13.57 62.06 Favored 'General case' 0 C--N 1.354 0.765 0 O-C-N 121.546 -0.721 . . . . 0.0 110.263 178.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 53.8 p-10 -121.09 35.1 4.99 Favored 'General case' 0 N--CA 1.438 -1.028 0 O-C-N 121.188 -0.945 . . . . 0.0 108.706 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 58.2 m -136.12 148.63 48.32 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.626 ' O ' ' HB ' ' A' ' 171' ' ' THR . 61.4 mt-10 -101.74 166.29 10.75 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.626 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 3.4 m 81.65 -59.04 0.23 Allowed 'General case' 0 C--N 1.37 1.469 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -107.8 117.77 34.98 Favored 'General case' 0 CA--C 1.507 -0.706 0 C-N-CA 119.916 -0.713 . . . . 0.0 109.565 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.483 HG13 ' CZ ' ' A' ' 175' ' ' PHE . 90.7 t -132.0 133.44 60.8 Favored 'Isoleucine or valine' 0 C--N 1.357 0.922 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 178.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.43 ' N ' HG12 ' A' ' 173' ' ' VAL . 50.1 mm -109.95 126.72 67.15 Favored 'Isoleucine or valine' 0 C--N 1.358 0.971 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.483 ' CZ ' HG13 ' A' ' 173' ' ' VAL . 92.7 m-85 -113.96 150.36 33.91 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -133.93 83.31 2.03 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.206 -178.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.6 mp -76.94 119.52 25.5 Favored 'Isoleucine or valine' 0 C--N 1.358 0.947 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 92.3 m -118.53 144.4 46.08 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 54.8 ttp180 . . . . . 0 C--N 1.36 1.027 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 -178.904 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.8 mmm . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.041 0.448 . . . . 0.0 110.018 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.561 ' HA ' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -77.18 -17.44 58.55 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 120.586 -0.446 . . . . 0.0 109.969 -178.498 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.76 -44.62 30.96 Favored Glycine 0 C--N 1.35 1.356 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 75.7 mtm -71.43 -33.79 69.7 Favored 'General case' 0 C--N 1.354 0.782 0 O-C-N 122.073 -0.663 . . . . 0.0 111.377 -177.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.561 HG22 ' HA ' ' A' ' 2' ' ' MET . 30.7 m -70.76 -22.89 23.53 Favored 'Isoleucine or valine' 0 C--N 1.357 0.9 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.064 -179.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.442 ' HZ ' ' CG ' ' A' ' 47' ' ' GLU . 1.7 m-30 -71.47 -35.31 70.79 Favored 'General case' 0 C--N 1.357 0.917 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 88.9 m -66.41 -39.67 89.13 Favored 'General case' 0 C--N 1.357 0.902 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.23 -37.88 95.28 Favored Glycine 0 C--N 1.357 1.71 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.638 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -66.89 -39.71 87.54 Favored 'General case' 0 C--N 1.354 0.773 0 CA-C-N 117.291 0.545 . . . . 0.0 110.526 -178.282 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 22.6 mmt -63.53 -41.42 98.46 Favored 'General case' 0 C--N 1.355 0.835 0 O-C-N 121.618 -0.676 . . . . 0.0 111.013 -178.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -66.34 -40.4 89.84 Favored 'General case' 0 C--N 1.347 0.493 0 O-C-N 122.148 -0.345 . . . . 0.0 111.702 -177.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 55.8 tp -66.03 -43.06 88.69 Favored 'General case' 0 C--N 1.349 0.583 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 -178.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.638 HG12 ' O ' ' A' ' 9' ' ' LEU . 1.7 mm -74.61 -36.45 40.96 Favored 'Isoleucine or valine' 0 C--N 1.358 0.935 0 O-C-N 121.003 -1.06 . . . . 0.0 111.155 -175.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -66.95 -42.53 85.06 Favored 'General case' 0 C--N 1.351 0.659 0 O-C-N 121.82 -0.55 . . . . 0.0 111.286 -176.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -75.04 -30.89 61.19 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 121.83 -0.544 . . . . 0.0 111.773 -177.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -72.96 -48.67 34.7 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.736 -175.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -127.72 -22.13 3.63 Favored 'General case' 0 CA--C 1.503 -0.849 0 C-N-CA 117.609 -1.636 . . . . 0.0 112.846 -176.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 146.34 178.69 21.94 Favored Glycine 0 N--CA 1.44 -1.077 0 C-N-CA 117.671 -2.204 . . . . 0.0 110.494 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -96.7 -17.5 20.28 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -70.3 -40.17 74.39 Favored 'General case' 0 C--N 1.361 1.089 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 94.5 m -68.28 -38.54 81.81 Favored 'General case' 0 C--N 1.357 0.918 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 178.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.515 HD11 ' HB ' ' A' ' 13' ' ' ILE . 27.1 tp -60.68 -36.49 78.9 Favored 'General case' 0 C--N 1.355 0.839 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -65.15 -37.12 86.39 Favored 'General case' 0 C--N 1.359 0.984 0 O-C-N 121.998 -0.439 . . . . 0.0 110.461 -178.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.434 ' O ' HG21 ' A' ' 24' ' ' THR . 89.7 m -65.67 -37.75 87.38 Favored 'General case' 0 C--N 1.355 0.811 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 23.4 tp -62.39 -40.73 97.44 Favored 'General case' 0 C--N 1.354 0.764 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.739 HD23 HD22 ' A' ' 31' ' ' LEU . 6.8 mp -74.94 -11.35 60.1 Favored 'General case' 0 C--N 1.36 1.031 0 O-C-N 121.693 -0.629 . . . . 0.0 110.483 -178.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -85.7 -29.21 24.14 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 119.254 -0.978 . . . . 0.0 108.925 178.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.7 t -67.13 -37.52 83.98 Favored 'General case' 0 C--N 1.357 0.92 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.663 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 1.8 p -89.81 -38.99 13.39 Favored 'General case' 0 C--N 1.359 1.011 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.663 ' HB2' ' O ' ' A' ' 29' ' ' CYS . 10.6 mt-10 85.61 132.39 0.04 OUTLIER 'General case' 0 C--N 1.362 1.119 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.739 HD22 HD23 ' A' ' 26' ' ' LEU . 0.4 OUTLIER -108.58 122.18 46.55 Favored 'General case' 0 C--N 1.357 0.898 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.433 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -94.25 -38.03 11.24 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -104.77 -78.16 0.57 Allowed 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.234 -178.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -137.24 -55.56 0.7 Allowed 'General case' 0 CA--C 1.502 -0.888 0 C-N-CA 119.609 -0.836 . . . . 0.0 108.853 -178.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 128.91 -52.11 0.84 Allowed Glycine 0 C--N 1.352 1.458 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 78.4 mt -97.67 95.29 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.755 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.647 ' CD2' HG23 ' A' ' 40' ' ' VAL . 1.2 t80 -65.38 -50.94 63.65 Favored 'General case' 0 C--N 1.36 1.059 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.441 ' CB ' ' O ' ' A' ' 37' ' ' TYR . 1.1 m 143.58 -64.32 0.0 OUTLIER 'General case' 0 C--N 1.368 1.406 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 178.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.431 ' C ' HG21 ' A' ' 40' ' ' VAL . 16.5 p 169.59 70.39 0.0 OUTLIER 'General case' 0 C--N 1.364 1.208 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.647 HG23 ' CD2' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -164.52 1.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.938 0 C-N-CA 119.853 -0.739 . . . . 0.0 109.695 -179.811 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.5 146.73 17.35 Favored Glycine 0 C--N 1.353 1.526 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 53.4 m -123.93 124.71 43.2 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -116.45 175.18 5.68 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -82.07 -172.62 4.05 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -92.42 -14.68 28.21 Favored 'General case' 0 N--CA 1.439 -0.975 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.365 -179.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -70.22 -28.44 65.27 Favored 'General case' 0 C--N 1.354 0.764 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.442 ' CG ' ' HZ ' ' A' ' 6' ' ' PHE . 26.0 tp10 -63.2 -40.3 97.09 Favored 'General case' 0 C--N 1.353 0.726 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.625 HD12 HG21 ' A' ' 52' ' ' VAL . 2.0 tm? -67.68 -38.29 83.52 Favored 'General case' 0 C--N 1.358 0.942 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.405 ' O ' HG22 ' A' ' 53' ' ' VAL . 58.5 tp -74.17 -29.35 61.73 Favored 'General case' 0 N--CA 1.447 -0.598 0 O-C-N 122.088 -0.382 . . . . 0.0 110.259 -176.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -68.28 -41.02 81.62 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 121.835 -0.54 . . . . 0.0 109.561 -178.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 63.2 mt -83.98 -15.92 45.94 Favored 'General case' 0 C--N 1.361 1.072 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.666 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.625 HG21 HD12 ' A' ' 48' ' ' LEU . 1.4 t -81.85 -35.76 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.494 ' O ' HG11 ' A' ' 53' ' ' VAL . 52.2 t -70.7 -39.84 76.23 Favored 'Isoleucine or valine' 0 C--N 1.354 0.791 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.0 tptt -67.19 -28.54 68.18 Favored 'General case' 0 C--N 1.36 1.048 0 O-C-N 121.266 -0.896 . . . . 0.0 108.622 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.592 HD13 HD11 ' A' ' 13' ' ' ILE . 2.5 tt -67.99 -37.79 81.91 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 60.0 p -72.32 -17.65 61.84 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.741 -178.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -101.44 -35.32 9.23 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 119.278 -0.969 . . . . 0.0 111.049 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.566 HG12 ' N ' ' A' ' 59' ' ' SER . 6.8 p -73.61 -36.86 48.44 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 O-C-N 121.797 -0.565 . . . . 0.0 111.081 -177.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.566 ' N ' HG12 ' A' ' 58' ' ' VAL . 73.0 m -113.17 -6.97 13.62 Favored 'General case' 0 CA--C 1.504 -0.825 0 C-N-CA 119.512 -0.875 . . . . 0.0 110.161 -177.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 64.35 48.63 2.74 Favored 'General case' 0 C--N 1.356 0.858 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.504 ' CG1' ' HD2' ' A' ' 62' ' ' PRO . 49.8 t -113.6 135.5 21.93 Favored Pre-proline 0 CA--C 1.505 -0.774 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.709 ' HG2' ' HB2' ' A' ' 65' ' ' GLU . 23.4 Cg_endo -62.57 149.12 92.12 Favored 'Trans proline' 0 CA--C 1.5 -1.203 0 C-N-CA 122.276 1.984 . . . . 0.0 112.518 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.422 ' HA ' HD22 ' A' ' 66' ' ' LEU . 4.2 m -75.98 -13.67 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.319 -177.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 72.1 p -95.22 -33.99 12.39 Favored 'General case' 0 C--N 1.356 0.878 0 C-N-CA 118.207 -1.397 . . . . 0.0 109.747 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.709 ' HB2' ' HG2' ' A' ' 62' ' ' PRO . 97.9 mt-10 -78.02 -21.84 50.15 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 121.336 -0.853 . . . . 0.0 108.978 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.422 HD22 ' HA ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -79.52 -37.48 36.54 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.541 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.584 HG11 ' N ' ' A' ' 68' ' ' ARG . 1.7 p -67.47 -26.9 36.84 Favored 'Isoleucine or valine' 0 C--N 1.355 0.812 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.902 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.584 ' N ' HG11 ' A' ' 67' ' ' VAL . 7.9 mmm-85 -71.98 -51.15 23.33 Favored 'General case' 0 C--N 1.363 1.184 0 O-C-N 121.549 -0.719 . . . . 0.0 110.451 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.409 ' HA ' HD23 ' A' ' 69' ' ' LEU . 85.2 mt -63.24 -36.06 82.41 Favored 'General case' 0 C--N 1.357 0.922 0 O-C-N 121.963 -0.461 . . . . 0.0 110.953 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -60.58 -46.83 88.77 Favored 'General case' 0 C--N 1.348 0.541 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -178.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.39 -38.42 94.71 Favored Glycine 0 C--N 1.352 1.455 0 N-CA-C 111.74 -0.544 . . . . 0.0 111.74 -178.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -63.16 -48.38 78.68 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-N 118.499 1.149 . . . . 0.0 111.547 -177.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.723 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 16.2 mttm -63.76 -49.41 73.08 Favored 'General case' 0 C--N 1.359 1.006 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -176.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -68.65 -39.71 80.58 Favored 'General case' 0 C--N 1.349 0.559 0 O-C-N 121.125 -0.985 . . . . 0.0 111.973 -175.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -63.86 -44.35 93.39 Favored 'General case' 0 C--N 1.352 0.702 0 O-C-N 121.196 -0.94 . . . . 0.0 111.187 -177.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.444 ' O ' HG22 ' A' ' 76' ' ' VAL . 9.9 p -70.33 -15.51 19.16 Favored 'Isoleucine or valine' 0 C--N 1.359 0.986 0 O-C-N 121.41 -0.806 . . . . 0.0 109.261 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.723 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 74.5 mm-40 -72.17 -38.33 69.16 Favored 'General case' 0 C--N 1.351 0.651 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 81.4 mt -74.25 -29.11 61.54 Favored 'General case' 0 C--N 1.357 0.9 0 O-C-N 122.311 -0.243 . . . . 0.0 110.543 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.8 mm -67.06 -54.16 27.12 Favored 'Isoleucine or valine' 0 C--N 1.359 1.007 0 C-N-CA 119.993 -0.683 . . . . 0.0 109.897 -177.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -74.63 -14.66 60.79 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 119.686 -0.806 . . . . 0.0 109.285 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.55 -37.25 62.23 Favored Glycine 0 C--N 1.348 1.228 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -134.01 104.16 11.67 Favored Pre-proline 0 N--CA 1.441 -0.88 0 CA-C-O 122.494 1.14 . . . . 0.0 109.026 -177.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.495 ' O ' ' HB2' ' A' ' 87' ' ' ASN . 37.6 Cg_endo -67.98 -23.2 40.85 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.556 2.171 . . . . 0.0 114.004 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -90.01 -8.38 51.72 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.4 tp -89.63 -22.81 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -178.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -102.51 -15.95 16.28 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.495 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 49.1 t30 -71.74 -40.92 69.07 Favored 'General case' 0 C--N 1.36 1.061 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -67.1 -29.21 68.9 Favored 'General case' 0 C--N 1.353 0.756 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.209 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 23.7 ttp -84.4 148.1 26.78 Favored 'General case' 0 C--N 1.351 0.652 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.5 -21.96 8.37 Favored 'General case' 0 C--N 1.363 1.193 0 C-N-CA 119.934 -0.707 . . . . 0.0 111.025 -177.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -165.3 171.66 13.28 Favored 'General case' 0 C--N 1.354 0.778 0 C-N-CA 119.045 -1.062 . . . . 0.0 108.338 -177.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 39.6 t -64.62 -42.13 95.71 Favored 'General case' 0 C--N 1.356 0.884 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.864 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -66.46 -39.11 88.63 Favored 'General case' 0 C--N 1.356 0.884 0 O-C-N 121.528 -0.733 . . . . 0.0 109.292 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -65.61 -25.72 67.51 Favored 'General case' 0 C--N 1.357 0.912 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 64.5 tp -62.94 -46.22 88.77 Favored 'General case' 0 C--N 1.355 0.826 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.7 mp -62.5 -32.5 73.43 Favored 'General case' 0 C--N 1.353 0.752 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 37.1 t -62.4 -45.37 93.44 Favored 'General case' 0 C--N 1.356 0.857 0 O-C-N 121.719 -0.613 . . . . 0.0 111.22 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.97 28.88 8.42 Favored 'General case' 0 C--N 1.36 1.049 0 C-N-CA 119.304 -0.958 . . . . 0.0 110.462 -178.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.645 HG23 ' N ' ' A' ' 100' ' ' ASP . 10.4 tt -62.3 -29.17 46.07 Favored 'Isoleucine or valine' 0 C--N 1.356 0.868 0 O-C-N 122.152 -0.343 . . . . 0.0 110.537 -178.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.645 ' N ' HG23 ' A' ' 99' ' ' ILE . 8.7 p-10 -127.15 -11.43 5.85 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 118.696 -1.202 . . . . 0.0 109.097 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.4 t -68.31 -45.55 72.67 Favored 'General case' 0 N--CA 1.439 -0.977 0 O-C-N 121.879 -0.513 . . . . 0.0 109.901 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.493 ' HA ' HG12 ' A' ' 105' ' ' VAL . 19.3 t80 -123.83 -29.53 3.67 Favored 'General case' 0 C--N 1.36 1.049 0 C-N-CA 118.38 -1.328 . . . . 0.0 111.549 -178.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 96.2 mt -69.75 -48.4 64.94 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 O-C-N 121.076 -1.015 . . . . 0.0 110.487 -177.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -89.03 3.65 50.97 Favored 'General case' 0 N--CA 1.44 -0.954 0 O-C-N 121.105 -0.997 . . . . 0.0 109.916 -177.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.544 HG11 ' N ' ' A' ' 106' ' ' GLU . 1.9 p -87.68 -33.98 7.04 Favored 'Isoleucine or valine' 0 C--N 1.357 0.899 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 178.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.544 ' N ' HG11 ' A' ' 105' ' ' VAL . 43.9 tt0 -71.64 -40.12 69.91 Favored 'General case' 0 C--N 1.36 1.049 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 62.2 t -62.82 -47.06 94.63 Favored 'Isoleucine or valine' 0 C--N 1.357 0.909 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.276 -179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -60.2 -48.61 81.02 Favored 'General case' 0 C--N 1.357 0.931 0 O-C-N 122.115 -0.366 . . . . 0.0 111.466 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -60.61 -38.93 86.33 Favored 'General case' 0 C--N 1.355 0.833 0 O-C-N 121.547 -0.721 . . . . 0.0 110.609 -178.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 19.6 mt -58.26 -75.64 0.05 OUTLIER 'General case' 0 C--N 1.354 0.804 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -115.29 132.97 22.8 Favored Pre-proline 0 N--CA 1.442 -0.874 0 C-N-CA 118.906 -1.117 . . . . 0.0 108.9 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -84.54 -3.4 10.0 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 123.176 2.584 . . . . 0.0 115.056 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -66.42 -36.6 83.21 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 122.001 -0.437 . . . . 0.0 109.948 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.4 146.34 54.13 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 121.714 0.769 . . . . 0.0 110.219 -178.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -130.54 135.18 47.67 Favored 'General case' 0 C--N 1.358 0.949 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.555 ' HB3' ' HD2' ' A' ' 117' ' ' PRO . 87.5 mt -127.03 157.0 73.44 Favored Pre-proline 0 N--CA 1.444 -0.756 0 CA-C-O 122.193 0.997 . . . . 0.0 109.394 -178.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.555 ' HD2' ' HB3' ' A' ' 116' ' ' LEU . 89.6 Cg_endo -80.37 -157.44 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -0.987 0 C-N-CA 123.914 3.076 . . . . 0.0 114.163 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -114.23 142.47 46.23 Favored 'General case' 0 C--N 1.367 1.332 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -124.0 127.85 48.51 Favored 'General case' 0 C--N 1.361 1.067 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -178.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.562 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 94.7 m -124.7 128.51 48.91 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 177.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 78.4 m -122.63 131.17 53.69 Favored 'General case' 0 CA--C 1.504 -0.825 0 C-N-CA 119.061 -1.055 . . . . 0.0 109.929 -177.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -118.15 149.52 40.92 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 177.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.565 ' HG3' HD11 ' A' ' 129' ' ' ILE . 57.8 ttp180 -121.2 117.74 27.85 Favored 'General case' 0 C--N 1.353 0.748 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.474 ' HA ' HD23 ' A' ' 124' ' ' LEU . 97.2 mt -93.37 -13.93 27.46 Favored 'General case' 0 C--N 1.356 0.856 0 C-N-CA 120.431 -0.507 . . . . 0.0 110.603 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 173.29 -149.16 10.88 Favored Glycine 0 C--N 1.348 1.226 0 C-N-CA 118.761 -1.685 . . . . 0.0 109.171 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -94.15 -37.91 11.34 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -103.6 5.79 36.79 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 120.166 -0.614 . . . . 0.0 109.39 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -121.49 127.85 51.48 Favored 'General case' 0 C--N 1.359 0.979 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.565 HD11 ' HG3' ' A' ' 123' ' ' ARG . 8.3 mm -141.71 135.95 30.59 Favored 'Isoleucine or valine' 0 C--N 1.354 0.787 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.498 ' N ' HG21 ' A' ' 129' ' ' ILE . 53.2 mtm180 -115.94 140.11 49.57 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 7.5 tp -126.79 118.64 25.07 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.654 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.562 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 12.6 m-70 -99.15 133.11 43.9 Favored 'General case' 0 CA--C 1.497 -1.087 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -127.46 120.54 28.61 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.461 ' HA ' ' O ' ' A' ' 171' ' ' THR . 36.2 tt0 -114.78 111.7 21.65 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 15.9 t -161.7 152.53 17.91 Favored 'General case' 0 C--N 1.359 0.986 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -90.82 1.49 56.89 Favored 'General case' 0 C--N 1.357 0.93 0 C-N-CA 120.245 -0.582 . . . . 0.0 109.95 -178.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -135.35 74.28 61.43 Favored Pre-proline 0 C--N 1.355 0.821 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -96.72 110.51 0.11 Allowed 'Trans proline' 0 N--CA 1.444 -1.429 0 C-N-CA 122.752 2.301 . . . . 0.0 116.03 -177.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -112.85 112.59 24.18 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 176.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.88 -38.59 91.64 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.116 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 74.0 m -63.21 -28.81 70.3 Favored 'General case' 0 C--N 1.354 0.783 0 O-C-N 121.927 -0.483 . . . . 0.0 110.689 -178.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -74.16 -46.82 39.91 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 120.236 -0.586 . . . . 0.0 109.719 -177.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.95 -39.67 93.85 Favored 'General case' 0 C--N 1.357 0.908 0 O-C-N 122.176 -0.327 . . . . 0.0 111.351 -177.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -63.09 -37.47 87.33 Favored 'General case' 0 C--N 1.355 0.83 0 O-C-N 121.872 -0.517 . . . . 0.0 110.164 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.54 -43.26 99.07 Favored Glycine 0 C--N 1.347 1.162 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 82.7 mt -70.07 -40.51 74.99 Favored 'General case' 0 C--N 1.351 0.657 0 CA-C-N 117.521 0.66 . . . . 0.0 112.724 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 98.0 mt -70.89 -42.39 70.04 Favored 'General case' 0 C--N 1.361 1.103 0 O-C-N 121.146 -0.971 . . . . 0.0 110.829 -176.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -70.4 -30.01 66.79 Favored 'General case' 0 N--CA 1.444 -0.735 0 O-C-N 121.953 -0.467 . . . . 0.0 110.677 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . 0.542 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -63.55 -39.59 97.79 Favored Glycine 0 C--N 1.356 1.688 0 N-CA-C 108.622 -1.791 . . . . 0.0 108.622 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 43.5 t -60.36 -42.99 96.91 Favored 'General case' 0 C--N 1.351 0.64 0 N-CA-C 109.146 -0.686 . . . . 0.0 109.146 178.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -78.83 2.66 19.2 Favored 'General case' 0 C--N 1.359 0.981 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.542 ' HB2' ' O ' ' A' ' 149' ' ' GLY . 24.3 mm-40 -84.56 -48.25 9.73 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -68.67 -40.65 80.05 Favored 'General case' 0 C--N 1.357 0.925 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.519 ' O ' ' HB2' ' A' ' 155' ' ' LYS . 9.1 m-30 -70.46 -26.73 63.77 Favored 'General case' 0 C--N 1.36 1.059 0 O-C-N 121.741 -0.599 . . . . 0.0 111.154 -178.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 154' ' ' PHE . 56.8 mtpt 73.2 64.85 0.1 Allowed 'General case' 0 C--N 1.361 1.103 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -178.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -127.16 -179.33 4.81 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -142.3 89.22 2.14 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 17.3 m-30 -115.14 156.7 24.79 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 93.7 m -118.79 127.73 53.8 Favored 'General case' 0 C--N 1.356 0.867 0 C-N-CA 119.462 -0.895 . . . . 0.0 108.831 -178.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 3.6 mp -102.88 121.84 54.53 Favored 'Isoleucine or valine' 0 C--N 1.352 0.698 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 178.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -118.05 -173.29 2.42 Favored 'General case' 0 C--N 1.356 0.884 0 CA-C-O 121.801 0.81 . . . . 0.0 109.524 -178.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 26.5 ptt180 -147.54 156.45 42.85 Favored 'General case' 0 C--N 1.357 0.894 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' THR . . . . . 0.404 ' O ' ' HB3' ' A' ' 167' ' ' GLN . 48.2 p -100.1 146.26 31.62 Favored Pre-proline 0 C--N 1.358 0.967 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.695 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 74.7 Cg_endo -76.83 -11.09 18.32 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.819 2.346 . . . . 0.0 115.234 -178.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -72.66 -41.5 65.33 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.589 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 35.5 p -117.83 16.27 14.36 Favored 'General case' 0 C--N 1.354 0.771 0 C-N-CA 120.069 -0.652 . . . . 0.0 110.443 -178.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.695 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.2 pp0? -66.6 -11.34 52.99 Favored 'General case' 0 C--N 1.353 0.743 0 O-C-N 121.595 -0.69 . . . . 0.0 110.457 178.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -126.56 38.54 4.1 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 58.9 m -137.6 147.11 44.76 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.613 ' O ' ' HB ' ' A' ' 171' ' ' THR . 60.5 mt-10 -101.27 165.23 11.39 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.613 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 19.9 m 84.75 -60.37 0.09 Allowed 'General case' 0 C--N 1.367 1.355 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -109.24 117.38 33.95 Favored 'General case' 0 CA--C 1.502 -0.878 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.43 -178.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 90.8 t -130.73 133.08 63.82 Favored 'Isoleucine or valine' 0 C--N 1.356 0.883 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 49.9 mm -108.53 126.89 65.31 Favored 'Isoleucine or valine' 0 C--N 1.358 0.958 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -115.93 156.62 25.89 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -137.94 118.94 14.33 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.2 mp -114.15 120.16 63.19 Favored 'Isoleucine or valine' 0 C--N 1.352 0.696 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 43.1 p -121.17 159.49 25.75 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-O 121.763 0.792 . . . . 0.0 110.662 -177.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.361 1.07 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 177.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.81 ' HG2' ' HG3' ' A' ' 4' ' ' MET . 51.9 tpp . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.038 0.447 . . . . 0.0 110.475 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.587 ' HA ' HG23 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -82.14 -14.98 54.9 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.383 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -71.93 -41.5 54.99 Favored Glycine 0 C--N 1.351 1.405 0 N-CA-C 108.558 -1.817 . . . . 0.0 108.558 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' MET . . . . . 0.81 ' HG3' ' HG2' ' A' ' 1' ' ' MET . 67.8 mtt -66.35 -38.22 87.13 Favored 'General case' 0 C--N 1.356 0.849 0 O-C-N 122.316 -0.52 . . . . 0.0 111.555 -178.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.587 HG23 ' HA ' ' A' ' 2' ' ' MET . 28.4 m -69.38 -23.93 27.05 Favored 'Isoleucine or valine' 0 C--N 1.357 0.914 0 C-N-CA 119.996 -0.682 . . . . 0.0 109.847 -177.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.558 ' HZ ' ' HG2' ' A' ' 47' ' ' GLU . 4.6 m-85 -71.36 -35.8 71.25 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 85.3 m -67.77 -41.31 83.47 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.38 -38.98 97.18 Favored Glycine 0 C--N 1.357 1.727 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.631 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -66.05 -39.87 90.49 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-N 117.338 0.569 . . . . 0.0 110.704 -178.336 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 25.6 mmt -64.14 -39.81 94.82 Favored 'General case' 0 C--N 1.351 0.662 0 O-C-N 121.802 -0.561 . . . . 0.0 110.847 -178.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.6 -39.83 88.57 Favored 'General case' 0 C--N 1.35 0.604 0 O-C-N 121.974 -0.454 . . . . 0.0 111.148 -178.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 56.0 tp -66.86 -42.83 85.02 Favored 'General case' 0 C--N 1.35 0.593 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.631 HG12 ' O ' ' A' ' 9' ' ' LEU . 2.2 mm -75.32 -36.42 36.23 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 O-C-N 121.053 -1.029 . . . . 0.0 111.074 -175.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -70.01 -42.6 72.81 Favored 'General case' 0 C--N 1.353 0.725 0 O-C-N 121.725 -0.609 . . . . 0.0 111.181 -176.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -71.3 -32.83 69.11 Favored 'General case' 0 N--CA 1.444 -0.735 0 O-C-N 122.002 -0.436 . . . . 0.0 111.219 -177.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -72.61 -50.51 24.82 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -175.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -128.91 -19.32 3.64 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 117.365 -1.734 . . . . 0.0 113.721 -176.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 142.08 179.66 19.25 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 117.594 -2.241 . . . . 0.0 110.134 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -96.06 -11.38 26.45 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -177.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -70.31 -40.23 74.34 Favored 'General case' 0 C--N 1.36 1.062 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 92.6 m -68.74 -39.03 80.54 Favored 'General case' 0 C--N 1.357 0.908 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.473 HD21 HD12 ' A' ' 26' ' ' LEU . 4.0 tt -60.36 -38.73 84.76 Favored 'General case' 0 C--N 1.359 0.99 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -63.98 -37.51 87.66 Favored 'General case' 0 C--N 1.355 0.828 0 O-C-N 122.085 -0.385 . . . . 0.0 111.053 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.44 HG21 ' O ' ' A' ' 24' ' ' THR . 90.1 m -65.36 -40.94 94.22 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 121.701 -0.624 . . . . 0.0 109.528 -178.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.471 ' CD2' ' HB3' ' A' ' 54' ' ' LYS . 87.8 mt -64.52 -38.0 89.49 Favored 'General case' 0 C--N 1.354 0.767 0 O-C-N 122.037 -0.414 . . . . 0.0 110.069 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.473 HD12 HD21 ' A' ' 22' ' ' LEU . 3.9 mp -72.7 -12.8 61.17 Favored 'General case' 0 C--N 1.361 1.072 0 O-C-N 121.51 -0.744 . . . . 0.0 110.145 -178.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -86.99 -28.49 22.62 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 119.298 -0.961 . . . . 0.0 109.047 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.9 t -67.14 -37.67 84.21 Favored 'General case' 0 C--N 1.354 0.801 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.9 p -89.8 -40.88 12.19 Favored 'General case' 0 C--N 1.359 0.996 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 86.18 132.89 0.04 OUTLIER 'General case' 0 C--N 1.36 1.051 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.5 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -83.62 -171.61 3.69 Favored 'General case' 0 C--N 1.357 0.916 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.996 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.4 ' H ' ' HB2' ' A' ' 31' ' ' LEU . 53.5 tt0 -151.2 -27.26 0.2 Allowed 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.3 t -144.26 -68.38 0.32 Allowed 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -129.74 -49.3 1.14 Allowed 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.32 -42.88 1.68 Allowed Glycine 0 C--N 1.352 1.427 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 82.9 mt -110.12 105.48 18.89 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.006 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -87.6 -137.7 0.1 Allowed 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 89.8 m -118.06 -59.0 1.95 Allowed 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.1 p 167.21 25.6 0.0 OUTLIER 'General case' 0 C--N 1.362 1.131 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.0 t -109.49 1.81 9.38 Favored 'Isoleucine or valine' 0 C--N 1.353 0.731 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.476 -178.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -96.78 143.47 16.76 Favored Glycine 0 C--N 1.353 1.502 0 C-N-CA 119.111 -1.518 . . . . 0.0 109.9 -178.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 51.5 m -123.11 127.43 48.7 Favored 'General case' 0 C--N 1.356 0.889 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -120.37 173.4 7.17 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -77.19 -176.63 4.16 Favored 'General case' 0 C--N 1.357 0.924 0 CA-C-O 121.568 0.699 . . . . 0.0 109.287 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 15.3 t60 -88.93 -22.16 23.22 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -66.23 -27.68 68.15 Favored 'General case' 0 C--N 1.356 0.881 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.558 ' HG2' ' HZ ' ' A' ' 6' ' ' PHE . 35.2 tp10 -62.19 -40.8 97.27 Favored 'General case' 0 C--N 1.352 0.704 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.584 HD12 HG22 ' A' ' 52' ' ' VAL . 1.9 tm? -67.05 -38.64 86.19 Favored 'General case' 0 C--N 1.357 0.899 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 59.0 tp -70.64 -34.25 71.86 Favored 'General case' 0 CA--C 1.51 -0.585 0 O-C-N 122.118 -0.364 . . . . 0.0 110.261 -176.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 71.7 tp60 -66.26 -40.54 90.24 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 121.89 -0.506 . . . . 0.0 109.774 -178.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 85.2 mt -81.99 -17.35 47.19 Favored 'General case' 0 C--N 1.361 1.066 0 C-N-CA 120.086 -0.645 . . . . 0.0 110.593 -178.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.584 HG22 HD12 ' A' ' 48' ' ' LEU . 1.3 t -81.38 -36.65 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.5 ' O ' HG12 ' A' ' 53' ' ' VAL . 54.7 t -70.05 -39.68 77.56 Favored 'Isoleucine or valine' 0 C--N 1.352 0.682 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.471 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 34.6 tptt -64.81 -28.33 69.49 Favored 'General case' 0 C--N 1.363 1.195 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.424 HD12 HD13 ' A' ' 13' ' ' ILE . 4.5 mt -67.13 -38.48 85.63 Favored 'General case' 0 C--N 1.356 0.866 0 C-N-CA 120.684 -0.407 . . . . 0.0 110.254 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 70.4 p -72.2 -17.65 61.91 Favored 'General case' 0 C--N 1.354 0.789 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.851 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -101.55 -37.4 8.41 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 121.173 -0.954 . . . . 0.0 111.643 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.4 p -72.07 -37.16 59.26 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 121.62 -0.675 . . . . 0.0 111.492 -177.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.4 t -115.64 -6.68 12.18 Favored 'General case' 0 C--N 1.351 0.668 0 C-N-CA 119.126 -1.03 . . . . 0.0 110.216 -177.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 65.0 46.91 2.67 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.642 HG13 ' HD2' ' A' ' 62' ' ' PRO . 46.5 t -107.49 135.44 19.71 Favored Pre-proline 0 CA--C 1.504 -0.801 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.642 ' HD2' HG13 ' A' ' 61' ' ' VAL . 23.9 Cg_endo -62.41 147.84 94.25 Favored 'Trans proline' 0 CA--C 1.5 -1.177 0 C-N-CA 122.078 1.852 . . . . 0.0 112.311 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.4 m -76.68 -12.51 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.545 -177.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 70.7 p -95.56 -33.27 12.47 Favored 'General case' 0 C--N 1.356 0.865 0 C-N-CA 118.166 -1.413 . . . . 0.0 109.956 -178.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.586 ' HB2' ' HG2' ' A' ' 62' ' ' PRO . 99.1 mt-10 -81.07 -20.08 42.35 Favored 'General case' 0 C--N 1.354 0.787 0 O-C-N 121.245 -0.909 . . . . 0.0 108.575 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.463 ' HB3' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -78.36 -37.32 44.56 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 179.572 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.595 HG12 ' N ' ' A' ' 68' ' ' ARG . 1.8 p -68.84 -29.35 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.278 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.595 ' N ' HG12 ' A' ' 67' ' ' VAL . 80.4 mtp180 -70.81 -48.55 53.54 Favored 'General case' 0 C--N 1.365 1.267 0 O-C-N 121.222 -0.923 . . . . 0.0 110.829 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 83.8 mt -63.76 -36.52 84.16 Favored 'General case' 0 C--N 1.355 0.812 0 O-C-N 122.049 -0.407 . . . . 0.0 110.751 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -61.21 -47.49 85.89 Favored 'General case' 0 C--N 1.348 0.512 0 O-C-N 122.307 -0.246 . . . . 0.0 110.587 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.61 -38.86 96.55 Favored Glycine 0 C--N 1.354 1.542 0 CA-C-O 119.812 -0.438 . . . . 0.0 112.204 -177.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -65.26 -46.05 82.08 Favored 'General case' 0 C--N 1.352 0.693 0 CA-C-N 118.554 1.177 . . . . 0.0 111.318 -176.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.758 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 10.7 mttm -63.74 -49.41 73.13 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -177.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.479 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.2 tm? -68.18 -40.18 82.32 Favored 'General case' 0 C--N 1.35 0.617 0 O-C-N 121.195 -0.941 . . . . 0.0 112.149 -175.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -62.94 -45.57 91.86 Favored 'General case' 0 C--N 1.353 0.743 0 O-C-N 121.179 -0.951 . . . . 0.0 111.238 -178.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.2 p -71.26 -14.79 18.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.888 0 O-C-N 121.523 -0.736 . . . . 0.0 109.588 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.758 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 76.6 mm-40 -73.77 -39.18 64.37 Favored 'General case' 0 C--N 1.35 0.617 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 80.1 mt -69.91 -36.71 75.58 Favored 'General case' 0 C--N 1.358 0.977 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.8 mm -62.55 -50.19 80.8 Favored 'Isoleucine or valine' 0 C--N 1.354 0.779 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -178.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -66.17 -24.4 66.63 Favored 'General case' 0 C--N 1.352 0.702 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.345 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.04 -1.18 63.16 Favored Glycine 0 C--N 1.349 1.253 0 C-N-CA 119.793 -1.194 . . . . 0.0 110.656 -177.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.7 ' HB3' ' HB ' ' A' ' 85' ' ' ILE . 84.2 m-70 -138.04 89.87 14.32 Favored Pre-proline 0 CA--C 1.5 -0.95 0 CA-C-N 119.003 1.402 . . . . 0.0 109.201 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 82' ' ' HIS . 34.8 Cg_endo -66.98 -28.52 41.8 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 C-N-CA 122.464 2.109 . . . . 0.0 114.34 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -92.95 -5.11 51.48 Favored 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 119.422 -0.911 . . . . 0.0 108.927 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.7 ' HB ' ' HB3' ' A' ' 82' ' ' HIS . 0.9 OUTLIER -90.04 -19.56 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 -179.973 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.5 -25.85 14.05 Favored 'General case' 0 C--N 1.362 1.127 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -69.84 -35.81 75.05 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -65.53 -36.74 84.69 Favored 'General case' 0 C--N 1.355 0.837 0 O-C-N 122.072 -0.393 . . . . 0.0 110.084 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.644 ' HG2' ' N ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -80.55 156.08 26.65 Favored 'General case' 0 C--N 1.356 0.859 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -178.576 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.644 ' N ' ' HG2' ' A' ' 89' ' ' MET . 4.0 mtpt -119.78 -25.46 5.89 Favored 'General case' 0 C--N 1.363 1.182 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.631 -177.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -166.22 173.75 9.86 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -177.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 61.7 m -66.29 -39.65 89.51 Favored 'General case' 0 C--N 1.354 0.777 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.284 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -67.53 -39.31 85.07 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 119.739 -0.784 . . . . 0.0 109.059 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -65.33 -24.5 67.28 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 57.0 tp -64.76 -44.33 90.4 Favored 'General case' 0 C--N 1.353 0.735 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.9 mp -61.66 -33.92 74.81 Favored 'General case' 0 C--N 1.356 0.879 0 O-C-N 122.139 -0.351 . . . . 0.0 111.025 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 86.3 p -86.56 -7.28 58.5 Favored 'General case' 0 C--N 1.354 0.767 0 C-N-CA 119.294 -0.962 . . . . 0.0 110.805 -178.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.7 tttp -111.36 0.68 16.71 Favored 'General case' 0 C--N 1.356 0.857 0 O-C-N 121.533 -0.729 . . . . 0.0 109.798 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.5 tp -65.66 -39.9 86.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.808 0 O-C-N 121.867 -0.52 . . . . 0.0 111.818 -177.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -95.51 -27.28 15.45 Favored 'General case' 0 N--CA 1.44 -0.959 0 O-C-N 120.827 -1.171 . . . . 0.0 111.657 -177.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 90.0 p -70.01 -39.87 75.58 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 119.412 -0.915 . . . . 0.0 112.984 -176.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.574 ' HA ' HG13 ' A' ' 105' ' ' VAL . 8.7 t80 -138.47 -19.61 1.07 Allowed 'General case' 0 C--N 1.361 1.08 0 C-N-CA 116.971 -1.891 . . . . 0.0 113.511 -177.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 24.1 mm -68.39 -51.0 51.76 Favored 'Isoleucine or valine' 0 C--O 1.244 0.783 0 CA-C-N 120.424 1.466 . . . . 0.0 110.379 -177.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 54.9 m80 -92.9 4.2 54.35 Favored 'General case' 0 N--CA 1.437 -1.076 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.551 -176.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.574 HG13 ' HA ' ' A' ' 102' ' ' PHE . 3.3 p -87.73 -35.67 8.57 Favored 'Isoleucine or valine' 0 C--N 1.353 0.749 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 178.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -72.65 -41.9 64.96 Favored 'General case' 0 C--N 1.358 0.938 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 67.0 t -65.3 -48.39 83.54 Favored 'Isoleucine or valine' 0 C--N 1.358 0.974 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.527 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -60.75 -47.87 84.35 Favored 'General case' 0 C--N 1.359 0.987 0 O-C-N 122.079 -0.388 . . . . 0.0 111.389 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . 0.495 ' HG2' ' O ' ' A' ' 105' ' ' VAL . 38.3 mmtt -61.14 -39.39 89.88 Favored 'General case' 0 N--CA 1.445 -0.703 0 O-C-N 121.685 -0.634 . . . . 0.0 110.696 -177.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 19.4 mt -56.46 -72.11 0.08 Allowed 'General case' 0 CA--C 1.505 -0.786 0 C-N-CA 120.541 -0.463 . . . . 0.0 109.762 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.442 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 87.7 m-85 -123.42 141.33 35.98 Favored Pre-proline 0 N--CA 1.439 -1.005 0 C-N-CA 118.538 -1.265 . . . . 0.0 109.207 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 111' ' ' TYR . 75.5 Cg_endo -86.29 -2.15 8.56 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 123.308 2.672 . . . . 0.0 115.402 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -66.31 -37.42 85.36 Favored 'General case' 0 C--N 1.355 0.839 0 O-C-N 121.757 -0.59 . . . . 0.0 109.908 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.34 144.92 56.79 Favored 'General case' 0 C--N 1.353 0.73 0 CA-C-O 121.548 0.69 . . . . 0.0 110.174 -178.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -112.05 143.51 42.94 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.455 HD23 ' N ' ' A' ' 116' ' ' LEU . 2.6 mm? -128.37 149.41 71.41 Favored Pre-proline 0 C--N 1.353 0.759 0 CA-C-O 122.164 0.983 . . . . 0.0 108.981 -178.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 116' ' ' LEU . 64.8 Cg_endo -91.85 -160.72 0.09 OUTLIER 'Trans proline' 0 C--N 1.316 -1.156 0 C-N-CA 123.857 3.038 . . . . 0.0 112.959 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -121.33 140.68 51.78 Favored 'General case' 0 C--N 1.363 1.18 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.441 ' HE2' ' CD1' ' A' ' 133' ' ' TYR . 65.7 m-85 -127.53 135.2 50.02 Favored 'General case' 0 C--N 1.36 1.06 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.164 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.511 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 93.3 m -124.09 126.31 46.0 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 176.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 80.3 m -117.92 126.96 53.35 Favored 'General case' 0 CA--C 1.502 -0.896 0 C-N-CA 119.17 -1.012 . . . . 0.0 109.372 -177.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -120.47 127.49 52.27 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 178.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -100.05 116.53 32.29 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.453 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 85.9 mt -82.35 -26.86 32.56 Favored 'General case' 0 C--N 1.355 0.836 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -178.74 -144.46 5.69 Favored Glycine 0 N--CA 1.437 -1.244 0 N-CA-C 108.78 -1.728 . . . . 0.0 108.78 -178.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -94.99 -39.62 10.09 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.297 -178.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -98.84 -1.47 40.17 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.758 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.453 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 66.8 m-20 -118.82 133.45 55.83 Favored 'General case' 0 C--N 1.357 0.913 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.536 HG23 ' N ' ' A' ' 130' ' ' ARG . 9.5 mm -140.78 136.79 35.13 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 179.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.536 ' N ' HG23 ' A' ' 129' ' ' ILE . 52.7 mtm180 -117.39 136.77 52.93 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 5.7 tp -125.95 118.9 26.36 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.511 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 12.3 m170 -98.53 130.58 45.1 Favored 'General case' 0 CA--C 1.496 -1.133 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.441 ' CD1' ' HE2' ' A' ' 119' ' ' PHE . 51.6 t80 -122.59 120.73 34.65 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 -178.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.463 ' HA ' ' O ' ' A' ' 171' ' ' THR . 36.1 tt0 -115.55 109.86 18.41 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.507 ' O ' ' HA ' ' A' ' 171' ' ' THR . 8.8 t -165.07 158.16 16.51 Favored 'General case' 0 C--N 1.359 0.979 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.509 ' C ' ' HD3' ' A' ' 138' ' ' PRO . 63.0 mtpt -91.0 5.85 47.17 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -129.58 72.32 81.97 Favored Pre-proline 0 C--N 1.354 0.804 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.509 ' HD3' ' C ' ' A' ' 136' ' ' LYS . 96.6 Cg_endo -95.21 88.03 0.11 Allowed 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 122.319 2.012 . . . . 0.0 115.446 -178.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -106.51 115.5 30.31 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 177.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.41 -38.27 90.5 Favored 'General case' 0 C--N 1.352 0.687 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.019 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 73.3 m -62.36 -33.57 74.99 Favored 'General case' 0 C--N 1.352 0.713 0 O-C-N 122.115 -0.366 . . . . 0.0 110.784 -178.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -73.15 -47.81 40.82 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.445 -177.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.25 -39.69 93.01 Favored 'General case' 0 C--N 1.355 0.839 0 O-C-N 122.105 -0.372 . . . . 0.0 111.419 -177.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.11 -36.58 84.07 Favored 'General case' 0 C--N 1.354 0.794 0 O-C-N 121.848 -0.532 . . . . 0.0 109.719 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.2 -43.23 98.64 Favored Glycine 0 C--N 1.346 1.091 0 N-CA-C 109.829 -1.309 . . . . 0.0 109.829 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 83.0 mt -70.45 -41.03 73.36 Favored 'General case' 0 C--N 1.353 0.728 0 O-C-N 122.049 -0.677 . . . . 0.0 112.733 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 98.6 mt -71.35 -42.33 68.64 Favored 'General case' 0 C--N 1.36 1.022 0 O-C-N 121.273 -0.892 . . . . 0.0 110.515 -177.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.509 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 21.3 t70 -69.43 -29.81 67.61 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 122.141 -0.349 . . . . 0.0 110.245 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . 0.475 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -63.09 -39.46 98.04 Favored Glycine 0 C--N 1.356 1.648 0 N-CA-C 108.276 -1.93 . . . . 0.0 108.276 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 48.7 t -60.43 -41.95 95.05 Favored 'General case' 0 C--N 1.35 0.598 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -74.42 -1.9 23.11 Favored 'General case' 0 C--N 1.362 1.121 0 O-C-N 121.82 -0.55 . . . . 0.0 109.544 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.509 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 76.4 mm-40 -83.74 -46.49 12.19 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -66.06 -44.11 85.48 Favored 'General case' 0 C--N 1.356 0.889 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.484 ' O ' ' HB2' ' A' ' 155' ' ' LYS . 38.0 m-85 -69.09 -25.96 64.69 Favored 'General case' 0 C--N 1.36 1.041 0 O-C-N 121.831 -0.543 . . . . 0.0 111.065 -178.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 154' ' ' PHE . 44.6 mttt 73.88 67.64 0.1 Allowed 'General case' 0 C--N 1.361 1.099 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -138.88 -168.11 2.35 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -148.32 96.64 2.65 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 13.2 m-30 -112.97 156.76 22.45 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 92.2 m -120.1 128.24 53.28 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 3.8 mp -107.1 123.14 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.0 m -117.99 -174.66 2.69 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-O 121.835 0.826 . . . . 0.0 109.347 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -146.29 156.12 43.13 Favored 'General case' 0 C--N 1.356 0.865 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 -178.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' THR . . . . . 0.451 ' HG1' ' HB ' ' A' ' 174' ' ' ILE . 51.2 p -98.72 145.94 30.78 Favored Pre-proline 0 C--N 1.359 0.983 0 CA-C-O 122.443 1.116 . . . . 0.0 108.0 178.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.649 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 72.1 Cg_endo -75.84 -10.93 20.01 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.91 2.407 . . . . 0.0 115.076 -178.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -73.38 -41.26 63.59 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.819 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 38.2 p -117.95 16.15 14.25 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.659 -178.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.649 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.3 pp0? -67.31 -11.47 57.67 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 121.571 -0.706 . . . . 0.0 110.129 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 54.3 p30 -118.51 34.66 5.09 Favored 'General case' 0 N--CA 1.439 -0.996 0 O-C-N 121.199 -0.938 . . . . 0.0 108.893 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 58.5 m -136.15 148.79 48.36 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.744 ' O ' ' HB ' ' A' ' 171' ' ' THR . 97.8 mt-10 -114.51 137.2 52.15 Favored 'General case' 0 C--N 1.354 0.794 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.744 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 1.1 m 115.03 -53.26 0.0 OUTLIER 'General case' 0 C--N 1.377 1.803 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -116.9 111.12 19.21 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 80.1 t -128.5 135.26 62.94 Favored 'Isoleucine or valine' 0 C--N 1.359 1.009 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.451 ' HB ' ' HG1' ' A' ' 163' ' ' THR . 50.4 mm -106.74 127.82 61.95 Favored 'Isoleucine or valine' 0 C--N 1.36 1.052 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -116.26 154.98 29.16 Favored 'General case' 0 C--N 1.356 0.875 0 CA-C-O 122.123 0.963 . . . . 0.0 108.849 -178.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -137.14 120.17 16.55 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -178.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.8 mp -115.47 119.84 62.98 Favored 'Isoleucine or valine' 0 C--N 1.354 0.804 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 90.0 m -120.8 141.55 50.42 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -178.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 . . . . . 0 C--N 1.367 1.36 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -179.944 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.7 mtp . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.185 0.517 . . . . 0.0 110.005 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.696 ' HA ' HG23 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -78.63 -16.27 57.54 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.63 -177.908 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.57 -42.27 48.35 Favored Glycine 0 C--N 1.352 1.433 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 62.3 mtt -68.27 -38.19 81.49 Favored 'General case' 0 C--N 1.358 0.942 0 O-C-N 121.893 -0.769 . . . . 0.0 111.464 -178.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.696 HG23 ' HA ' ' A' ' 2' ' ' MET . 27.6 m -68.23 -23.0 28.05 Favored 'Isoleucine or valine' 0 C--N 1.356 0.851 0 C-N-CA 120.031 -0.668 . . . . 0.0 109.749 -178.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -71.08 -37.54 72.46 Favored 'General case' 0 C--N 1.356 0.863 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 89.5 m -68.2 -41.66 81.05 Favored 'General case' 0 C--N 1.357 0.908 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.69 -39.17 97.59 Favored Glycine 0 C--N 1.358 1.757 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.709 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -65.93 -39.84 90.88 Favored 'General case' 0 C--N 1.35 0.614 0 CA-C-N 117.199 0.5 . . . . 0.0 110.618 -178.351 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.3 mmt -63.35 -40.82 98.33 Favored 'General case' 0 C--N 1.352 0.703 0 O-C-N 121.619 -0.675 . . . . 0.0 111.025 -178.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -67.59 -40.14 84.82 Favored 'General case' 0 C--N 1.349 0.563 0 O-C-N 121.896 -0.503 . . . . 0.0 111.504 -177.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 54.8 tp -66.77 -41.93 86.92 Favored 'General case' 0 C--N 1.349 0.558 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -178.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.709 HG12 ' O ' ' A' ' 9' ' ' LEU . 3.7 mm -73.68 -38.22 51.04 Favored 'Isoleucine or valine' 0 C--N 1.357 0.916 0 O-C-N 121.196 -0.94 . . . . 0.0 111.081 -175.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -67.12 -43.32 82.72 Favored 'General case' 0 C--N 1.351 0.646 0 O-C-N 121.914 -0.491 . . . . 0.0 111.573 -176.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -72.11 -33.88 68.17 Favored 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 121.842 -0.536 . . . . 0.0 111.733 -177.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -72.01 -48.5 44.27 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -175.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -127.8 -20.85 3.81 Favored 'General case' 0 C--N 1.354 0.797 0 C-N-CA 117.398 -1.721 . . . . 0.0 113.383 -176.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 141.88 179.72 19.15 Favored Glycine 0 CA--C 1.497 -1.038 0 C-N-CA 117.982 -2.056 . . . . 0.0 109.597 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -97.21 -12.43 23.02 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -177.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -71.44 -40.63 70.26 Favored 'General case' 0 C--N 1.359 1.01 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.44 HG23 HG22 ' A' ' 58' ' ' VAL . 93.7 m -69.21 -38.49 78.61 Favored 'General case' 0 C--N 1.356 0.885 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 59.3 tp -60.32 -38.54 84.06 Favored 'General case' 0 C--N 1.357 0.914 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -64.17 -35.72 81.73 Favored 'General case' 0 C--N 1.357 0.903 0 O-C-N 122.182 -0.324 . . . . 0.0 111.309 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 90.2 m -63.99 -41.39 97.52 Favored 'General case' 0 C--N 1.356 0.89 0 O-C-N 121.566 -0.709 . . . . 0.0 109.189 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.498 ' CD2' ' HB3' ' A' ' 54' ' ' LYS . 89.1 mt -65.02 -38.4 90.78 Favored 'General case' 0 C--N 1.355 0.839 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.27 -11.74 61.11 Favored 'General case' 0 C--N 1.358 0.97 0 O-C-N 121.363 -0.835 . . . . 0.0 109.734 -179.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -89.0 -27.25 20.99 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 119.527 -0.869 . . . . 0.0 108.916 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 55.9 p -69.58 -22.7 63.5 Favored 'General case' 0 C--N 1.362 1.109 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.164 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.0 p -106.98 -36.86 6.49 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 119.046 -1.062 . . . . 0.0 108.325 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 86.1 132.37 0.04 OUTLIER 'General case' 0 C--N 1.361 1.067 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.536 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -84.48 -168.04 2.02 Favored 'General case' 0 C--N 1.357 0.902 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.402 ' H ' ' HB2' ' A' ' 31' ' ' LEU . 63.3 tt0 -152.13 -32.57 0.14 Allowed 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.7 t -139.18 -73.37 0.38 Allowed 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -128.32 -33.97 2.1 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.96 -25.75 11.25 Favored Glycine 0 C--N 1.353 1.482 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 84.7 mt -113.71 102.93 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.792 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.4 ' CD2' HG23 ' A' ' 40' ' ' VAL . 53.8 t80 -99.68 -0.32 40.41 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.7 m 77.62 -179.99 0.13 Allowed 'General case' 0 C--N 1.361 1.096 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 -178.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.533 ' C ' HG21 ' A' ' 40' ' ' VAL . 24.9 p -90.9 114.26 26.67 Favored 'General case' 0 N--CA 1.443 -0.779 0 O-C-N 121.214 -0.929 . . . . 0.0 109.44 -178.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.533 HG21 ' C ' ' A' ' 39' ' ' SER . 0.0 OUTLIER -173.48 -8.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.189 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.15 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -117.42 167.56 12.73 Favored Glycine 0 C--N 1.355 1.63 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -178.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 68.6 m -132.24 136.84 47.26 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -124.02 172.57 8.87 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -71.27 174.8 5.96 Favored 'General case' 0 C--N 1.355 0.832 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.495 ' CD2' HH22 ' A' ' 137' ' ' ARG . 70.4 m80 -86.53 -17.04 35.1 Favored 'General case' 0 CA--C 1.502 -0.884 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.234 -178.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -69.06 -29.33 67.43 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.0 tp10 -63.13 -42.22 99.46 Favored 'General case' 0 C--N 1.351 0.647 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 55.0 tp -66.88 -39.4 87.49 Favored 'General case' 0 C--N 1.359 0.985 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.416 ' O ' HG22 ' A' ' 53' ' ' VAL . 59.0 tp -72.94 -28.98 62.75 Favored 'General case' 0 C--N 1.349 0.569 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -177.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -66.47 -43.22 86.08 Favored 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 121.917 -0.489 . . . . 0.0 110.108 -178.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.452 ' HA ' HD22 ' A' ' 51' ' ' LEU . 80.4 mt -72.36 -34.5 68.04 Favored 'General case' 0 C--N 1.36 1.052 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.278 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.503 HG13 HD21 ' A' ' 66' ' ' LEU . 39.3 t -63.24 -42.1 95.19 Favored 'Isoleucine or valine' 0 C--N 1.35 0.626 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.503 HG12 ' O ' ' A' ' 53' ' ' VAL . 54.6 t -66.58 -40.65 86.81 Favored 'Isoleucine or valine' 0 C--N 1.351 0.648 0 O-C-N 121.733 -0.604 . . . . 0.0 109.855 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.498 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 25.9 tptt -66.77 -22.97 66.02 Favored 'General case' 0 C--N 1.361 1.095 0 O-C-N 121.022 -1.049 . . . . 0.0 109.019 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.2 mt -69.78 -38.05 76.56 Favored 'General case' 0 C--N 1.355 0.826 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 57.6 p -71.38 -18.01 62.38 Favored 'General case' 0 C--N 1.353 0.752 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.357 -179.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -100.46 -35.75 9.45 Favored 'General case' 0 C--N 1.355 0.805 0 C-N-CA 119.648 -0.821 . . . . 0.0 111.408 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.44 HG22 HG23 ' A' ' 21' ' ' THR . 5.6 p -72.27 -40.22 65.01 Favored 'Isoleucine or valine' 0 C--N 1.354 0.766 0 O-C-N 121.664 -0.648 . . . . 0.0 111.507 -177.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.505 ' HG ' ' CG2' ' A' ' 61' ' ' VAL . 79.7 p -116.02 -2.49 12.26 Favored 'General case' 0 C--N 1.354 0.78 0 C-N-CA 118.89 -1.124 . . . . 0.0 110.914 -178.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 73.6 m 63.74 49.48 2.93 Favored 'General case' 0 C--N 1.357 0.916 0 CA-C-O 120.932 0.396 . . . . 0.0 110.033 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.505 ' CG2' ' HG ' ' A' ' 59' ' ' SER . 96.6 t -113.98 134.04 22.22 Favored Pre-proline 0 CA--C 1.504 -0.799 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.474 ' N ' HG11 ' A' ' 61' ' ' VAL . 41.3 Cg_exo -58.02 149.5 70.65 Favored 'Trans proline' 0 CA--C 1.499 -1.27 0 C-N-CA 122.778 2.319 . . . . 0.0 112.738 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.417 ' HA ' HD23 ' A' ' 66' ' ' LEU . 3.7 m -76.2 -11.64 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.679 -177.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 73.0 p -96.51 -33.36 11.87 Favored 'General case' 0 C--N 1.358 0.971 0 C-N-CA 118.433 -1.307 . . . . 0.0 109.504 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -77.65 -21.0 52.85 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 121.474 -0.766 . . . . 0.0 108.968 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.503 HD21 HG13 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -81.19 -34.23 32.46 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 -179.483 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.574 HG12 ' N ' ' A' ' 68' ' ' ARG . 1.5 p -70.98 -26.23 27.21 Favored 'Isoleucine or valine' 0 C--N 1.356 0.855 0 C-N-CA 120.169 -0.613 . . . . 0.0 109.799 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.574 ' N ' HG12 ' A' ' 67' ' ' VAL . 40.7 mtp180 -72.53 -52.87 13.81 Favored 'General case' 0 C--N 1.363 1.181 0 O-C-N 121.477 -0.765 . . . . 0.0 110.427 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.9 mt -63.41 -34.76 78.44 Favored 'General case' 0 C--N 1.357 0.913 0 O-C-N 121.959 -0.463 . . . . 0.0 110.905 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -61.1 -47.23 87.24 Favored 'General case' 0 C--N 1.348 0.502 0 O-C-N 122.248 -0.283 . . . . 0.0 110.239 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.06 -38.8 96.16 Favored Glycine 0 C--N 1.356 1.651 0 N-CA-C 111.729 -0.548 . . . . 0.0 111.729 -178.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -62.6 -49.35 75.58 Favored 'General case' 0 C--N 1.351 0.638 0 CA-C-N 118.31 1.055 . . . . 0.0 111.556 -177.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 12.2 mttm -65.09 -45.93 83.18 Favored 'General case' 0 C--N 1.357 0.926 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -177.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -69.78 -39.04 76.88 Favored 'General case' 0 C--N 1.348 0.52 0 O-C-N 121.161 -0.962 . . . . 0.0 111.841 -175.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -64.61 -44.05 91.8 Favored 'General case' 0 C--N 1.353 0.746 0 O-C-N 121.098 -1.001 . . . . 0.0 110.951 -178.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.429 ' O ' HG22 ' A' ' 76' ' ' VAL . 9.9 p -71.83 -13.86 17.08 Favored 'Isoleucine or valine' 0 C--N 1.359 0.985 0 O-C-N 121.45 -0.781 . . . . 0.0 109.0 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -74.37 -37.61 63.42 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.3 mt -74.67 -29.48 61.25 Favored 'General case' 0 C--N 1.357 0.927 0 O-C-N 122.285 -0.259 . . . . 0.0 110.369 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.6 mm -65.86 -52.84 44.77 Favored 'Isoleucine or valine' 0 C--N 1.357 0.895 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.682 -177.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -75.5 -15.35 60.41 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.279 178.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.25 -37.45 63.34 Favored Glycine 0 C--N 1.349 1.276 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -131.75 105.23 14.16 Favored Pre-proline 0 N--CA 1.441 -0.903 0 CA-C-O 122.615 1.198 . . . . 0.0 108.961 -177.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.54 ' O ' ' HB2' ' A' ' 87' ' ' ASN . 37.1 Cg_endo -67.47 -23.08 44.16 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.571 2.181 . . . . 0.0 114.356 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -95.39 -5.19 43.81 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 tp -89.75 -20.1 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -105.7 -18.06 14.19 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.54 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 1.5 t-20 -73.97 -38.0 64.31 Favored 'General case' 0 C--N 1.357 0.931 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -65.49 -33.84 76.86 Favored 'General case' 0 C--N 1.353 0.735 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -178.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 15.8 ttp -83.12 150.37 26.31 Favored 'General case' 0 C--N 1.351 0.654 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.02 -22.59 9.47 Favored 'General case' 0 C--N 1.364 1.199 0 O-C-N 121.691 -0.63 . . . . 0.0 111.14 -177.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -165.55 171.49 13.13 Favored 'General case' 0 C--N 1.354 0.761 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 -177.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.487 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 66.8 m -66.65 -39.54 88.28 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.448 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -68.44 -38.9 81.57 Favored 'General case' 0 C--N 1.355 0.836 0 O-C-N 121.296 -0.877 . . . . 0.0 108.991 -179.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -65.93 -24.09 66.75 Favored 'General case' 0 C--N 1.355 0.823 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.685 ' O ' HG12 ' A' ' 99' ' ' ILE . 59.7 tp -63.64 -47.38 81.54 Favored 'General case' 0 C--N 1.355 0.846 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.4 mp -60.07 -35.7 75.74 Favored 'General case' 0 C--N 1.359 1.013 0 O-C-N 122.256 -0.277 . . . . 0.0 110.521 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 34.0 t -70.14 -39.64 75.28 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.188 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.427 ' HZ2' ' HG3' ' A' ' 98' ' ' LYS . 2.5 tttp -86.99 0.35 55.31 Favored 'General case' 0 C--N 1.356 0.856 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -176.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.685 HG12 ' O ' ' A' ' 95' ' ' LEU . 22.8 mm -61.01 -46.7 96.15 Favored 'Isoleucine or valine' 0 C--N 1.357 0.896 0 CA-C-N 119.082 0.856 . . . . 0.0 112.014 -177.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -95.64 -22.63 17.46 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 118.402 -1.319 . . . . 0.0 111.329 -177.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 35.2 t -64.29 -48.65 74.87 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 121.565 -0.709 . . . . 0.0 112.491 -177.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -138.08 -16.49 1.25 Allowed 'General case' 0 C--N 1.36 1.06 0 C-N-CA 117.372 -1.731 . . . . 0.0 113.521 -176.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.448 HD12 ' HA ' ' A' ' 99' ' ' ILE . 96.3 mt -71.83 -50.27 39.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 CA-C-N 120.359 1.436 . . . . 0.0 111.182 -177.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -89.98 4.36 50.36 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 119.388 -0.925 . . . . 0.0 109.811 -177.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 57.7 t -86.44 -43.7 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.059 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 54.7 tp10 -67.53 -40.1 85.04 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 65.6 t -62.77 -46.92 95.16 Favored 'Isoleucine or valine' 0 C--N 1.356 0.88 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -60.74 -48.21 82.81 Favored 'General case' 0 C--N 1.36 1.038 0 O-C-N 122.198 -0.314 . . . . 0.0 111.541 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -61.25 -36.59 80.41 Favored 'General case' 0 C--N 1.355 0.821 0 O-C-N 121.534 -0.729 . . . . 0.0 110.503 -178.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 18.0 mt -58.6 -75.5 0.05 Allowed 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -115.58 132.14 23.29 Favored Pre-proline 0 N--CA 1.439 -0.975 0 C-N-CA 118.65 -1.22 . . . . 0.0 108.641 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -83.26 -3.53 10.91 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 123.175 2.583 . . . . 0.0 115.172 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -66.97 -36.36 82.02 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 121.879 -0.513 . . . . 0.0 110.009 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.32 144.86 56.31 Favored 'General case' 0 C--N 1.352 0.683 0 CA-C-O 121.74 0.781 . . . . 0.0 110.142 -178.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -128.86 133.76 48.07 Favored 'General case' 0 C--N 1.357 0.925 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.545 ' HB3' ' HD2' ' A' ' 117' ' ' PRO . 87.8 mt -127.76 156.44 75.71 Favored Pre-proline 0 N--CA 1.443 -0.787 0 CA-C-O 122.262 1.03 . . . . 0.0 109.243 -178.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.644 ' HG3' ' HH ' ' A' ' 133' ' ' TYR . 83.0 Cg_endo -80.46 -158.42 0.09 OUTLIER 'Trans proline' 0 C--N 1.318 -1.074 0 C-N-CA 123.826 3.017 . . . . 0.0 113.922 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -118.86 143.28 47.06 Favored 'General case' 0 C--N 1.364 1.209 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -129.65 135.7 48.84 Favored 'General case' 0 C--N 1.362 1.123 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -178.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 93.8 m -127.64 130.71 49.43 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 177.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -120.6 132.39 55.11 Favored 'General case' 0 CA--C 1.504 -0.804 0 C-N-CA 119.215 -0.994 . . . . 0.0 109.989 -178.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -119.71 138.5 53.26 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 178.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -109.32 117.84 35.13 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 -179.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.585 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 96.5 mt -91.77 -16.02 27.46 Favored 'General case' 0 C--N 1.356 0.856 0 C-N-CA 120.496 -0.481 . . . . 0.0 110.436 -179.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 174.04 -148.23 9.87 Favored Glycine 0 C--N 1.349 1.252 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -94.35 -37.55 11.42 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -102.05 4.17 39.48 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.031 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.585 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 8.7 m-20 -121.93 132.09 54.37 Favored 'General case' 0 C--N 1.359 0.984 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -179.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.589 HG21 ' N ' ' A' ' 130' ' ' ARG . 8.2 mm -143.64 137.8 25.19 Favored 'Isoleucine or valine' 0 C--N 1.356 0.863 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.589 ' N ' HG21 ' A' ' 129' ' ' ILE . 53.5 mtm180 -118.49 139.11 51.93 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 5.8 tp -125.53 116.91 22.51 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.52 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -98.29 134.39 41.38 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 107.327 -1.361 . . . . 0.0 107.327 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.644 ' HH ' ' HG3' ' A' ' 117' ' ' PRO . 67.7 t80 -129.51 119.55 23.89 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 -178.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.537 ' HA ' ' O ' ' A' ' 171' ' ' THR . 57.9 mt-30 -115.53 112.17 21.81 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 11.1 t -165.93 155.12 11.75 Favored 'General case' 0 C--N 1.357 0.921 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.448 ' C ' ' HD3' ' A' ' 138' ' ' PRO . 99.6 mttt -90.99 5.49 48.57 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.495 HH22 ' CD2' ' A' ' 45' ' ' HIS . 77.0 mtp180 -132.62 73.25 76.75 Favored Pre-proline 0 C--N 1.354 0.767 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.448 ' HD3' ' C ' ' A' ' 136' ' ' LYS . 92.7 Cg_endo -96.87 99.64 0.08 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.515 0 C-N-CA 122.737 2.291 . . . . 0.0 115.453 -178.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -109.4 111.13 22.5 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 177.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.71 -38.05 89.64 Favored 'General case' 0 C--N 1.354 0.787 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.02 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 74.1 m -63.03 -29.33 70.73 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 121.998 -0.439 . . . . 0.0 110.755 -178.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -75.01 -47.1 30.79 Favored 'General case' 0 C--N 1.35 0.612 0 O-C-N 121.698 -0.626 . . . . 0.0 109.763 -177.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.53 -40.06 94.91 Favored 'General case' 0 C--N 1.358 0.976 0 O-C-N 122.095 -0.378 . . . . 0.0 111.212 -178.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.1 -37.0 85.46 Favored 'General case' 0 C--N 1.355 0.809 0 O-C-N 121.938 -0.476 . . . . 0.0 110.212 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.84 -43.15 99.58 Favored Glycine 0 C--N 1.347 1.182 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 -178.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 83.8 mt -70.01 -40.42 75.27 Favored 'General case' 0 C--N 1.351 0.647 0 N-CA-C 112.673 0.619 . . . . 0.0 112.673 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 99.1 mt -71.34 -42.9 67.95 Favored 'General case' 0 C--N 1.361 1.082 0 O-C-N 121.198 -0.939 . . . . 0.0 110.993 -176.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.504 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 21.0 t70 -69.0 -31.72 70.75 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 122.028 -0.42 . . . . 0.0 110.418 -179.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . 0.476 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -62.96 -39.19 97.76 Favored Glycine 0 C--N 1.356 1.659 0 N-CA-C 108.656 -1.778 . . . . 0.0 108.656 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 49.4 t -60.84 -42.0 96.91 Favored 'General case' 0 C--N 1.351 0.674 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -74.59 -2.19 24.89 Favored 'General case' 0 C--N 1.361 1.082 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.504 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 77.0 mm-40 -83.29 -45.44 13.79 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -68.84 -42.56 76.98 Favored 'General case' 0 C--N 1.358 0.959 0 C-N-CA 120.011 -0.675 . . . . 0.0 109.681 179.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -69.75 -25.68 63.95 Favored 'General case' 0 C--N 1.362 1.132 0 O-C-N 121.659 -0.651 . . . . 0.0 110.619 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 21.2 tttm 73.16 73.39 0.13 Allowed 'General case' 0 C--N 1.36 1.05 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -143.61 -169.44 3.08 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -146.25 96.99 2.87 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 13.3 m-30 -114.9 155.38 26.96 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.402 HG21 ' N ' ' A' ' 160' ' ' ILE . 93.3 m -120.86 129.12 53.4 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 119.668 -0.813 . . . . 0.0 108.809 -178.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.402 ' N ' HG21 ' A' ' 159' ' ' THR . 3.7 mp -106.45 122.34 60.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.6 m -119.53 -172.12 2.26 Favored 'General case' 0 C--N 1.357 0.93 0 CA-C-O 121.792 0.806 . . . . 0.0 109.338 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 28.2 ptt-85 -148.42 157.91 43.77 Favored 'General case' 0 C--N 1.356 0.854 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -178.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 56.2 p -98.37 146.77 32.12 Favored Pre-proline 0 C--N 1.359 0.995 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 178.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.677 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 72.7 Cg_endo -75.35 -12.54 20.85 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.903 2.402 . . . . 0.0 115.238 -178.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -72.53 -41.31 66.0 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 120.009 -0.676 . . . . 0.0 109.956 -178.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 35.6 p -118.11 16.06 14.11 Favored 'General case' 0 C--N 1.354 0.797 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.734 -178.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.677 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.4 pp0? -66.97 -12.75 60.68 Favored 'General case' 0 C--N 1.353 0.749 0 O-C-N 121.605 -0.685 . . . . 0.0 110.346 178.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 54.1 p-10 -123.67 38.72 4.13 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 14.6 t -141.65 147.44 37.55 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.621 ' O ' ' HB ' ' A' ' 171' ' ' THR . 46.3 mp0 -101.67 167.4 10.13 Favored 'General case' 0 C--N 1.355 0.847 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.621 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 5.8 m 82.99 -60.01 0.15 Allowed 'General case' 0 C--N 1.37 1.465 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -108.05 116.11 31.37 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 96.1 t -131.64 133.21 61.82 Favored 'Isoleucine or valine' 0 C--N 1.358 0.966 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 50.9 mm -108.16 126.2 64.78 Favored 'Isoleucine or valine' 0 C--N 1.359 1.0 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -114.55 154.53 28.12 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -137.58 118.94 14.68 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 -178.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.7 mp -113.59 120.37 63.29 Favored 'Isoleucine or valine' 0 C--N 1.353 0.742 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 90.6 m -119.91 143.5 47.93 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -177.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 . . . . . 0 C--N 1.363 1.192 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 179.995 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.448 ' CB ' ' HE1' ' A' ' 4' ' ' MET . 87.7 mmm . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 121.09 0.471 . . . . 0.0 110.031 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.429 ' O ' ' HD1' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -82.04 -15.2 54.4 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 120.516 -0.474 . . . . 0.0 109.963 -178.338 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -71.65 -40.99 57.99 Favored Glycine 0 C--N 1.353 1.482 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' MET . . . . . 0.501 ' HG2' ' HB3' ' A' ' 39' ' ' SER . 76.5 mtm -70.15 -35.69 74.22 Favored 'General case' 0 C--N 1.356 0.873 0 O-C-N 121.958 -0.731 . . . . 0.0 111.499 -178.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.423 HG23 ' HA ' ' A' ' 2' ' ' MET . 32.8 m -68.45 -23.77 28.61 Favored 'Isoleucine or valine' 0 C--N 1.357 0.91 0 O-C-N 121.467 -0.77 . . . . 0.0 109.594 -179.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.506 ' HZ ' ' CG ' ' A' ' 47' ' ' GLU . 4.5 m-85 -71.38 -36.2 71.33 Favored 'General case' 0 C--N 1.358 0.949 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 90.1 m -66.7 -40.87 88.64 Favored 'General case' 0 C--N 1.357 0.913 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.75 -39.23 97.7 Favored Glycine 0 C--N 1.358 1.753 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.715 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -64.07 -41.47 97.33 Favored 'General case' 0 C--N 1.352 0.679 0 CA-C-N 117.163 0.482 . . . . 0.0 110.835 -178.515 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.639 ' HE3' HD22 ' A' ' 26' ' ' LEU . 17.6 mmt -63.58 -41.02 98.4 Favored 'General case' 0 C--N 1.353 0.746 0 O-C-N 121.438 -0.789 . . . . 0.0 111.079 -178.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -68.34 -40.5 81.55 Favored 'General case' 0 C--N 1.349 0.573 0 O-C-N 121.881 -0.512 . . . . 0.0 111.773 -177.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 56.3 tp -66.3 -43.65 85.69 Favored 'General case' 0 C--N 1.349 0.577 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -177.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.715 HG12 ' O ' ' A' ' 9' ' ' LEU . 1.1 mm -74.3 -34.6 37.5 Favored 'Isoleucine or valine' 0 C--N 1.358 0.956 0 O-C-N 121.127 -0.983 . . . . 0.0 110.96 -175.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.474 ' HB2' HD13 ' A' ' 22' ' ' LEU . 31.2 tt0 -72.73 -42.32 64.25 Favored 'General case' 0 C--N 1.35 0.59 0 O-C-N 121.642 -0.661 . . . . 0.0 111.538 -176.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -71.1 -37.9 72.38 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -175.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -99.42 -25.83 14.33 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 118.924 -1.11 . . . . 0.0 113.659 -174.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -113.62 -35.72 5.12 Favored 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 117.541 -1.664 . . . . 0.0 112.549 -176.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 145.31 177.78 20.35 Favored Glycine 0 C--N 1.349 1.266 0 C-N-CA 118.052 -2.023 . . . . 0.0 110.467 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -99.43 -27.16 13.87 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 -177.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -69.29 -39.22 78.45 Favored 'General case' 0 C--N 1.359 0.992 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 92.7 m -66.75 -39.1 87.78 Favored 'General case' 0 C--N 1.357 0.902 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.474 HD13 ' HB2' ' A' ' 14' ' ' GLU . 1.3 tt -61.62 -38.44 87.64 Favored 'General case' 0 C--N 1.358 0.938 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -63.74 -37.71 88.38 Favored 'General case' 0 C--N 1.356 0.875 0 O-C-N 122.026 -0.421 . . . . 0.0 110.765 -178.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.9 m -65.73 -38.96 90.58 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -178.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.596 HD12 ' HB3' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -63.67 -37.41 87.24 Favored 'General case' 0 C--N 1.354 0.765 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -179.043 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.639 HD22 ' HE3' ' A' ' 10' ' ' MET . 87.3 mt -74.02 -14.11 60.96 Favored 'General case' 0 C--N 1.359 0.998 0 O-C-N 121.722 -0.612 . . . . 0.0 110.337 -178.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -86.77 -28.23 23.13 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 119.218 -0.993 . . . . 0.0 109.203 179.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.1 t -67.39 -36.58 81.59 Favored 'General case' 0 C--N 1.354 0.761 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.679 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 2.0 p -92.12 -39.65 11.48 Favored 'General case' 0 C--N 1.358 0.963 0 C-N-CA 118.942 -1.103 . . . . 0.0 108.199 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.679 ' HB2' ' O ' ' A' ' 29' ' ' CYS . 14.5 mt-10 86.27 131.53 0.04 OUTLIER 'General case' 0 C--N 1.362 1.109 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.52 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -86.18 -169.45 2.64 Favored 'General case' 0 C--N 1.357 0.897 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.841 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.435 ' H ' ' HB2' ' A' ' 31' ' ' LEU . 53.6 tt0 -152.85 -28.23 0.15 Allowed 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 107.707 -1.219 . . . . 0.0 107.707 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.8 t -141.49 -71.13 0.35 Allowed 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -131.96 -42.97 0.99 Allowed 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.4 -32.71 4.22 Favored Glycine 0 C--N 1.353 1.479 0 N-CA-C 109.261 -1.535 . . . . 0.0 109.261 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 85.1 mt -111.63 101.33 12.38 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -96.41 -1.81 46.8 Favored 'General case' 0 C--N 1.354 0.803 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.571 HG22 ' H ' ' A' ' 39' ' ' SER . 4.0 m 80.1 174.9 0.13 Allowed 'General case' 0 C--N 1.362 1.13 0 N-CA-C 105.952 -1.869 . . . . 0.0 105.952 -178.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.571 ' H ' HG22 ' A' ' 38' ' ' THR . 26.0 p -89.16 113.84 25.07 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 121.033 -1.042 . . . . 0.0 109.78 -178.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -172.71 -8.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.362 1.143 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -113.55 164.75 12.02 Favored Glycine 0 C--N 1.357 1.698 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -178.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 53.5 m -129.11 132.78 47.44 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -117.98 170.62 8.68 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -77.64 -178.13 5.17 Favored 'General case' 0 C--N 1.356 0.866 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -88.32 -15.08 36.66 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -68.18 -29.8 68.75 Favored 'General case' 0 C--N 1.353 0.753 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 178.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.506 ' CG ' ' HZ ' ' A' ' 6' ' ' PHE . 24.1 tp10 -63.07 -41.6 99.47 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.467 HD22 ' O ' ' A' ' 48' ' ' LEU . 1.8 tm? -67.83 -39.99 83.83 Favored 'General case' 0 C--N 1.358 0.965 0 CA-C-O 120.647 0.26 . . . . 0.0 110.531 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 64.6 tp -71.01 -34.71 71.6 Favored 'General case' 0 CA--C 1.509 -0.62 0 O-C-N 122.132 -0.355 . . . . 0.0 110.661 -177.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 73.2 tp60 -65.81 -40.79 92.22 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 121.659 -0.651 . . . . 0.0 110.005 -178.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.596 ' HB3' HD12 ' A' ' 25' ' ' LEU . 73.4 mt -82.48 -19.22 39.25 Favored 'General case' 0 C--N 1.361 1.091 0 C-N-CA 119.622 -0.831 . . . . 0.0 110.574 -178.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.463 ' O ' HG13 ' A' ' 52' ' ' VAL . 1.4 t -79.35 -37.66 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.503 ' O ' HG11 ' A' ' 53' ' ' VAL . 54.2 t -69.05 -39.99 80.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.73 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 178.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.436 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 32.3 tptt -65.7 -27.86 68.64 Favored 'General case' 0 C--N 1.363 1.191 0 O-C-N 121.214 -0.929 . . . . 0.0 108.754 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.439 HD12 HD12 ' A' ' 13' ' ' ILE . 1.8 tt -67.44 -39.33 85.39 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 60' ' ' SER . 81.1 p -72.42 -17.33 61.81 Favored 'General case' 0 C--N 1.358 0.949 0 O-C-N 121.694 -0.628 . . . . 0.0 111.019 -178.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -99.96 -36.78 9.27 Favored 'General case' 0 C--N 1.353 0.736 0 O-C-N 121.153 -0.967 . . . . 0.0 111.346 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.545 HG11 ' N ' ' A' ' 59' ' ' SER . 5.2 p -70.38 -34.35 57.76 Favored 'Isoleucine or valine' 0 C--N 1.352 0.687 0 O-C-N 121.74 -0.6 . . . . 0.0 111.338 -177.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.545 ' N ' HG11 ' A' ' 58' ' ' VAL . 2.0 t -120.81 -7.15 9.57 Favored 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 119.128 -1.029 . . . . 0.0 109.924 -178.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 56' ' ' SER . 0.5 OUTLIER 65.67 47.6 2.12 Favored 'General case' 0 C--N 1.353 0.753 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.792 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.418 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 52.9 t -106.56 132.44 20.9 Favored Pre-proline 0 N--CA 1.443 -0.785 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 61' ' ' VAL . 46.4 Cg_exo -57.2 146.89 79.42 Favored 'Trans proline' 0 CA--C 1.498 -1.301 0 C-N-CA 122.504 2.136 . . . . 0.0 112.845 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.406 ' HA ' HD22 ' A' ' 66' ' ' LEU . 3.5 m -75.49 -12.12 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.605 -178.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 70.2 p -97.65 -32.71 11.63 Favored 'General case' 0 C--N 1.359 0.994 0 C-N-CA 118.258 -1.377 . . . . 0.0 109.26 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -75.43 -23.26 56.94 Favored 'General case' 0 C--N 1.355 0.841 0 O-C-N 121.42 -0.8 . . . . 0.0 109.106 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.406 HD22 ' HA ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -82.2 -34.86 28.79 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -179.007 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.586 HG12 ' N ' ' A' ' 68' ' ' ARG . 1.6 p -68.21 -27.15 36.0 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.688 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.586 ' N ' HG12 ' A' ' 67' ' ' VAL . 4.8 mmm-85 -73.28 -52.12 15.13 Favored 'General case' 0 C--N 1.364 1.198 0 O-C-N 121.609 -0.682 . . . . 0.0 110.284 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.66 -35.6 80.16 Favored 'General case' 0 C--N 1.357 0.92 0 O-C-N 121.973 -0.454 . . . . 0.0 110.954 -178.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -60.95 -47.74 85.05 Favored 'General case' 0 C--N 1.349 0.581 0 O-C-N 122.083 -0.385 . . . . 0.0 110.54 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.99 -38.95 96.35 Favored Glycine 0 C--N 1.355 1.587 0 N-CA-C 111.997 -0.441 . . . . 0.0 111.997 -178.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -63.38 -48.54 77.5 Favored 'General case' 0 C--N 1.35 0.626 0 CA-C-N 118.303 1.052 . . . . 0.0 111.55 -177.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.688 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 11.9 mttm -63.89 -48.6 76.03 Favored 'General case' 0 C--N 1.358 0.961 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -177.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.463 ' O ' HD23 ' A' ' 74' ' ' LEU . 2.3 tm? -68.54 -39.12 81.26 Favored 'General case' 0 C--N 1.35 0.588 0 O-C-N 121.197 -0.94 . . . . 0.0 111.699 -175.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 43.8 t80 -62.95 -45.07 94.21 Favored 'General case' 0 C--N 1.352 0.715 0 O-C-N 121.241 -0.912 . . . . 0.0 111.165 -178.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 76' ' ' VAL . 9.8 p -71.09 -14.66 18.11 Favored 'Isoleucine or valine' 0 C--N 1.359 1.006 0 O-C-N 121.396 -0.815 . . . . 0.0 109.5 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.688 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 73.6 mm-40 -71.43 -39.81 70.8 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 82.9 mt -70.94 -34.96 71.99 Favored 'General case' 0 C--N 1.357 0.911 0 O-C-N 122.188 -0.32 . . . . 0.0 110.599 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.6 mm -63.79 -53.33 45.82 Favored 'Isoleucine or valine' 0 C--N 1.357 0.916 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.615 -176.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -75.15 -10.98 59.96 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.938 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.23 -11.16 60.15 Favored Glycine 0 C--N 1.35 1.345 0 C-N-CA 119.734 -1.222 . . . . 0.0 110.696 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.494 ' HB2' HG22 ' A' ' 85' ' ' ILE . 96.3 m-70 -138.34 96.27 9.99 Favored Pre-proline 0 CA--C 1.503 -0.865 0 CA-C-N 118.991 1.396 . . . . 0.0 108.836 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.473 ' O ' ' HB2' ' A' ' 87' ' ' ASN . 37.7 Cg_endo -67.87 -25.74 38.74 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.428 2.085 . . . . 0.0 114.293 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -91.11 -8.39 48.96 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.494 HG22 ' HB2' ' A' ' 82' ' ' HIS . 1.5 tp -89.35 -21.73 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 -178.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.81 -16.94 15.26 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 47.1 t30 -70.84 -41.62 71.25 Favored 'General case' 0 C--N 1.36 1.046 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -68.5 -30.36 69.17 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.387 -178.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 29.5 ttp -84.0 148.07 27.08 Favored 'General case' 0 C--N 1.35 0.623 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.04 -21.62 8.2 Favored 'General case' 0 C--N 1.362 1.119 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.865 -177.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -164.83 170.64 15.18 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 119.172 -1.011 . . . . 0.0 108.337 -177.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.418 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 41.1 t -64.43 -41.96 96.28 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.806 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -66.17 -38.93 89.24 Favored 'General case' 0 C--N 1.355 0.821 0 O-C-N 121.568 -0.708 . . . . 0.0 109.251 -178.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -65.59 -25.84 67.58 Favored 'General case' 0 C--N 1.357 0.906 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.418 ' HB3' ' O ' ' A' ' 92' ' ' SER . 59.9 tp -62.74 -46.52 87.69 Favored 'General case' 0 C--N 1.355 0.823 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.3 mp -62.71 -32.59 73.73 Favored 'General case' 0 C--N 1.353 0.76 0 O-C-N 122.221 -0.299 . . . . 0.0 110.502 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 37.2 t -62.57 -45.22 93.9 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 121.774 -0.579 . . . . 0.0 111.351 -178.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.3 26.28 10.84 Favored 'General case' 0 C--N 1.363 1.185 0 O-C-N 121.07 -1.019 . . . . 0.0 110.491 -178.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.464 HG22 ' N ' ' A' ' 100' ' ' ASP . 10.1 tt -60.6 -29.53 44.97 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.575 -179.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.464 ' N ' HG22 ' A' ' 99' ' ' ILE . 10.6 p-10 -129.3 -7.12 4.78 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 118.444 -1.302 . . . . 0.0 110.039 -179.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 64.5 m -90.75 -3.21 57.61 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.295 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -147.68 -48.7 0.17 Allowed 'General case' 0 C--N 1.357 0.911 0 C-N-CA 118.221 -1.392 . . . . 0.0 109.724 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 96.1 mt -65.75 -47.39 86.07 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 O-C-N 122.038 -0.414 . . . . 0.0 110.922 -177.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 22.7 m170 -83.77 -3.79 58.11 Favored 'General case' 0 C--N 1.354 0.799 0 O-C-N 121.461 -0.774 . . . . 0.0 109.78 -177.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 56.4 t -75.13 -45.24 42.51 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.907 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -70.0 -38.94 76.13 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -178.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 56.7 t -61.65 -46.31 96.82 Favored 'Isoleucine or valine' 0 C--N 1.355 0.822 0 O-C-N 122.196 -0.315 . . . . 0.0 110.48 -178.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -60.04 -47.76 84.5 Favored 'General case' 0 C--N 1.357 0.898 0 O-C-N 122.127 -0.358 . . . . 0.0 111.089 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -61.77 -36.07 79.97 Favored 'General case' 0 C--N 1.355 0.839 0 O-C-N 121.552 -0.718 . . . . 0.0 110.11 -178.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 15.3 mt -59.66 -79.66 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -111.97 140.59 23.59 Favored Pre-proline 0 N--CA 1.442 -0.848 0 C-N-CA 118.877 -1.129 . . . . 0.0 109.242 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -88.84 -6.1 5.82 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 123.286 2.657 . . . . 0.0 114.919 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -69.02 -33.7 74.06 Favored 'General case' 0 C--N 1.353 0.722 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.66 145.08 56.72 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 121.697 0.761 . . . . 0.0 110.13 -178.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.457 ' O ' HD12 ' A' ' 116' ' ' LEU . 46.5 mt-10 -118.55 143.32 46.84 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 179.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.457 HD12 ' O ' ' A' ' 115' ' ' GLU . 2.6 mm? -126.77 149.7 69.31 Favored Pre-proline 0 N--CA 1.445 -0.702 0 CA-C-O 122.074 0.94 . . . . 0.0 108.597 -178.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 116' ' ' LEU . 87.7 Cg_endo -91.28 -155.51 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.265 0 C-N-CA 123.743 2.962 . . . . 0.0 113.197 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -115.98 138.32 51.31 Favored 'General case' 0 C--N 1.362 1.113 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -127.16 129.54 48.08 Favored 'General case' 0 C--N 1.361 1.104 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.576 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 93.2 m -128.58 131.44 48.18 Favored 'General case' 0 C--N 1.356 0.864 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 177.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -125.01 132.44 53.24 Favored 'General case' 0 CA--C 1.503 -0.853 0 C-N-CA 119.316 -0.954 . . . . 0.0 109.769 -178.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -121.28 140.81 51.57 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 178.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.466 ' HG3' HD11 ' A' ' 129' ' ' ILE . 57.7 ttp180 -111.88 117.75 33.62 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.439 ' HA ' HD22 ' A' ' 124' ' ' LEU . 94.9 mt -92.91 -16.64 24.95 Favored 'General case' 0 C--N 1.354 0.781 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.193 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 178.19 -150.48 9.83 Favored Glycine 0 C--N 1.347 1.186 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -91.33 -39.69 11.9 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.43 ' HB2' ' HB2' ' A' ' 179' ' ' ARG . 8.2 p30 -104.87 9.3 34.8 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 119.759 -0.777 . . . . 0.0 109.177 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -119.64 124.62 46.76 Favored 'General case' 0 C--N 1.358 0.961 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.53 HG22 ' N ' ' A' ' 130' ' ' ARG . 9.8 mm -140.13 137.25 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.53 ' N ' HG22 ' A' ' 129' ' ' ILE . 50.9 mtm180 -116.95 137.65 52.08 Favored 'General case' 0 CA--C 1.492 -1.266 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 6.7 tp -123.23 117.86 26.27 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.023 -0.989 . . . . 0.0 108.486 -178.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.576 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 12.6 m-70 -99.6 131.32 45.68 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -127.95 121.37 29.73 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.542 ' HA ' ' O ' ' A' ' 171' ' ' THR . 75.3 mt-30 -114.5 115.02 26.57 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 179.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.2 t -162.86 152.22 15.31 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -90.81 1.14 57.18 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 120.17 -0.612 . . . . 0.0 109.794 -178.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -136.22 74.26 55.79 Favored Pre-proline 0 C--N 1.354 0.789 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -95.42 110.64 0.14 Allowed 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.54 2.16 . . . . 0.0 115.935 -177.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -110.99 112.1 23.69 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 176.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.12 -39.27 93.68 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.424 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.3 m -63.7 -26.96 68.9 Favored 'General case' 0 C--N 1.353 0.758 0 O-C-N 121.894 -0.504 . . . . 0.0 110.729 -178.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -75.78 -47.03 27.5 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 121.731 -0.606 . . . . 0.0 109.692 -177.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.28 -39.83 93.07 Favored 'General case' 0 C--N 1.358 0.94 0 O-C-N 122.074 -0.391 . . . . 0.0 111.323 -178.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -62.97 -36.85 84.87 Favored 'General case' 0 C--N 1.357 0.909 0 O-C-N 121.827 -0.546 . . . . 0.0 109.972 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.6 -43.01 99.42 Favored Glycine 0 C--N 1.346 1.114 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 83.9 mt -70.49 -40.64 73.47 Favored 'General case' 0 C--N 1.351 0.672 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -179.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 98.2 mt -70.92 -42.55 69.75 Favored 'General case' 0 C--N 1.361 1.09 0 O-C-N 121.154 -0.966 . . . . 0.0 110.907 -176.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.572 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 37.2 t70 -70.12 -29.43 66.36 Favored 'General case' 0 N--CA 1.444 -0.737 0 O-C-N 121.995 -0.44 . . . . 0.0 110.373 -179.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -63.1 -39.57 98.16 Favored Glycine 0 C--N 1.357 1.701 0 N-CA-C 108.474 -1.85 . . . . 0.0 108.474 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 45.1 t -61.01 -42.22 98.03 Favored 'General case' 0 C--N 1.351 0.672 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -75.92 0.73 17.29 Favored 'General case' 0 C--N 1.36 1.027 0 O-C-N 121.803 -0.561 . . . . 0.0 109.489 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.572 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 76.8 mm-40 -85.78 -45.96 11.12 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -66.67 -44.63 81.29 Favored 'General case' 0 C--N 1.358 0.949 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.463 ' O ' ' HB2' ' A' ' 155' ' ' LYS . 51.6 m-85 -70.12 -26.08 63.79 Favored 'General case' 0 C--N 1.361 1.077 0 O-C-N 121.783 -0.573 . . . . 0.0 111.126 -178.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 154' ' ' PHE . 41.1 mttt 73.39 71.32 0.12 Allowed 'General case' 0 C--N 1.361 1.102 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -178.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -137.02 -172.48 3.2 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -148.72 94.0 2.21 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 19.3 m-30 -114.89 158.79 21.49 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 94.0 m -118.32 125.03 49.23 Favored 'General case' 0 C--N 1.356 0.868 0 C-N-CA 119.368 -0.933 . . . . 0.0 108.848 -178.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 3.6 mp -101.57 121.8 52.94 Favored 'Isoleucine or valine' 0 C--N 1.353 0.736 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 178.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.2 m -119.2 -173.53 2.53 Favored 'General case' 0 C--N 1.357 0.907 0 CA-C-O 121.787 0.803 . . . . 0.0 109.55 -178.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -147.52 155.95 42.37 Favored 'General case' 0 C--N 1.357 0.918 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -178.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 57.4 p -99.07 146.83 32.36 Favored Pre-proline 0 C--N 1.358 0.966 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.696 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 73.7 Cg_endo -76.02 -10.99 19.72 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.786 2.324 . . . . 0.0 115.082 -178.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -73.17 -41.45 63.85 Favored 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.795 -178.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 37.3 p -117.27 14.96 14.88 Favored 'General case' 0 C--N 1.356 0.872 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.734 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.696 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.1 pp0? -66.52 -12.75 59.08 Favored 'General case' 0 C--N 1.353 0.748 0 O-C-N 121.62 -0.675 . . . . 0.0 110.521 178.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 53.8 p-10 -121.89 34.71 5.09 Favored 'General case' 0 N--CA 1.439 -1.015 0 O-C-N 121.068 -1.02 . . . . 0.0 108.447 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 57.2 m -136.11 148.45 48.26 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.65 ' O ' ' HB ' ' A' ' 171' ' ' THR . 61.1 mt-10 -101.85 166.37 10.69 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.65 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 2.5 m 83.2 -56.94 0.16 Allowed 'General case' 0 C--N 1.368 1.374 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -112.23 117.62 33.05 Favored 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 119.861 -0.735 . . . . 0.0 109.609 -178.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.434 HG13 ' CE1' ' A' ' 175' ' ' PHE . 88.5 t -130.73 132.83 63.99 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 49.8 mm -107.35 125.86 63.58 Favored 'Isoleucine or valine' 0 C--N 1.359 0.982 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.434 ' CE1' HG13 ' A' ' 173' ' ' VAL . 93.9 m-85 -114.92 155.89 26.04 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 122.061 0.934 . . . . 0.0 108.652 -179.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -138.16 119.31 14.52 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -178.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.8 mp -115.09 121.37 66.95 Favored 'Isoleucine or valine' 0 C--N 1.353 0.735 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 42.8 p -126.02 159.86 31.61 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 121.698 0.761 . . . . 0.0 110.854 -177.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.43 ' HB2' ' HB2' ' A' ' 127' ' ' ASN . 0.1 OUTLIER . . . . . 0 C--N 1.366 1.287 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 177.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.5 mmm . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.068 0.461 . . . . 0.0 110.147 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.594 ' HA ' HG23 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -79.27 -19.55 50.29 Favored 'General case' 0 C--N 1.356 0.877 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -178.945 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.06 -41.13 40.91 Favored Glycine 0 C--N 1.348 1.224 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.92 -34.95 69.49 Favored 'General case' 0 C--N 1.354 0.779 0 O-C-N 122.119 -0.636 . . . . 0.0 111.3 -177.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.594 HG23 ' HA ' ' A' ' 2' ' ' MET . 34.9 m -71.04 -23.5 23.56 Favored 'Isoleucine or valine' 0 C--N 1.352 0.714 0 C-N-CA 119.915 -0.714 . . . . 0.0 109.122 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.434 ' N ' HG22 ' A' ' 5' ' ' VAL . 7.4 m-30 -71.75 -33.44 68.66 Favored 'General case' 0 C--N 1.358 0.969 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 85.0 m -66.98 -40.06 87.32 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.24 -37.79 95.13 Favored Glycine 0 C--N 1.357 1.72 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.63 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -67.77 -38.47 83.46 Favored 'General case' 0 C--N 1.353 0.719 0 CA-C-N 117.346 0.573 . . . . 0.0 110.297 -178.006 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.934 ' HE3' HD23 ' A' ' 26' ' ' LEU . 22.0 mmt -64.01 -41.22 97.54 Favored 'General case' 0 C--N 1.356 0.868 0 O-C-N 121.644 -0.66 . . . . 0.0 111.002 -178.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -66.09 -40.33 90.73 Favored 'General case' 0 C--N 1.348 0.504 0 O-C-N 122.17 -0.331 . . . . 0.0 111.554 -177.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 55.5 tp -65.78 -42.74 90.41 Favored 'General case' 0 C--N 1.349 0.575 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -178.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.63 HG12 ' O ' ' A' ' 9' ' ' LEU . 2.4 mm -73.83 -36.96 47.37 Favored 'Isoleucine or valine' 0 C--N 1.358 0.949 0 O-C-N 121.067 -1.021 . . . . 0.0 111.167 -175.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -67.42 -44.43 78.79 Favored 'General case' 0 C--N 1.353 0.733 0 O-C-N 121.815 -0.553 . . . . 0.0 111.432 -176.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -72.85 -31.14 64.54 Favored 'General case' 0 N--CA 1.447 -0.579 0 O-C-N 122.013 -0.429 . . . . 0.0 111.626 -177.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -72.74 -50.02 27.24 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -175.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -128.47 -20.25 3.68 Favored 'General case' 0 C--N 1.354 0.797 0 C-N-CA 117.328 -1.749 . . . . 0.0 113.328 -176.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 144.44 179.79 21.13 Favored Glycine 0 N--CA 1.44 -1.061 0 C-N-CA 117.575 -2.25 . . . . 0.0 110.537 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.412 ' HD1' HD22 ' A' ' 22' ' ' LEU . 79.2 t80 -96.55 -16.37 21.11 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 -177.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -70.08 -41.18 74.45 Favored 'General case' 0 C--N 1.36 1.051 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.6 m -69.76 -38.42 76.76 Favored 'General case' 0 C--N 1.358 0.944 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.412 HD22 ' HD1' ' A' ' 19' ' ' TYR . 39.6 tp -59.64 -37.94 80.03 Favored 'General case' 0 C--N 1.356 0.867 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -65.76 -35.61 81.21 Favored 'General case' 0 C--N 1.356 0.89 0 O-C-N 122.068 -0.395 . . . . 0.0 110.847 -178.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.439 ' O ' HG23 ' A' ' 24' ' ' THR . 85.8 m -65.33 -39.42 92.38 Favored 'General case' 0 C--N 1.355 0.815 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 -178.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.489 HD12 HD21 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -63.33 -37.96 89.29 Favored 'General case' 0 C--N 1.355 0.807 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.522 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.934 HD23 ' HE3' ' A' ' 10' ' ' MET . 84.5 mt -75.28 -11.85 60.15 Favored 'General case' 0 C--N 1.361 1.079 0 O-C-N 121.652 -0.655 . . . . 0.0 110.457 -178.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -88.48 -27.22 21.63 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 119.115 -1.034 . . . . 0.0 108.982 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.7 t -68.26 -37.64 80.94 Favored 'General case' 0 C--N 1.356 0.883 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.8 p -90.54 -41.07 11.6 Favored 'General case' 0 C--N 1.358 0.935 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 85.02 134.09 0.05 OUTLIER 'General case' 0 C--N 1.36 1.047 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.469 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -84.9 -171.75 3.81 Favored 'General case' 0 C--N 1.356 0.88 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.89 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.416 ' H ' ' HB2' ' A' ' 31' ' ' LEU . 63.1 tt0 -151.27 -23.69 0.21 Allowed 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.9 t -148.34 -64.53 0.25 Allowed 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -131.13 -55.97 1.04 Allowed 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 130.76 -44.61 1.2 Allowed Glycine 0 C--N 1.353 1.498 0 N-CA-C 108.749 -1.74 . . . . 0.0 108.749 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 80.3 mt -107.08 100.45 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.758 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.563 ' O ' ' HB ' ' A' ' 38' ' ' THR . 0.9 OUTLIER -71.79 -28.7 63.79 Favored 'General case' 0 C--N 1.357 0.924 0 O-C-N 121.962 -0.461 . . . . 0.0 109.912 -179.844 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.563 ' HB ' ' O ' ' A' ' 37' ' ' TYR . 12.3 m 113.3 -67.36 0.0 OUTLIER 'General case' 0 C--N 1.37 1.47 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.679 ' C ' HG21 ' A' ' 40' ' ' VAL . 14.1 p 175.01 64.25 0.0 OUTLIER 'General case' 0 C--N 1.359 0.993 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.679 HG21 ' C ' ' A' ' 39' ' ' SER . 2.1 t -148.59 -5.97 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.836 0 C-N-CA 119.573 -0.851 . . . . 0.0 109.725 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -98.56 144.32 17.15 Favored Glycine 0 C--N 1.352 1.444 0 C-N-CA 119.162 -1.494 . . . . 0.0 110.23 -177.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.2 m -124.53 122.5 37.75 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -117.63 179.4 4.07 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -83.02 -171.33 3.5 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 73.3 m80 -93.67 -15.13 25.61 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.418 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -70.6 -28.7 65.05 Favored 'General case' 0 C--N 1.354 0.767 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 27.5 tp10 -63.27 -41.12 98.99 Favored 'General case' 0 C--N 1.352 0.688 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 60.9 tp -67.7 -37.99 83.04 Favored 'General case' 0 C--N 1.355 0.823 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.295 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.451 ' O ' HG22 ' A' ' 53' ' ' VAL . 59.8 tp -77.37 -27.74 52.69 Favored 'General case' 0 C--N 1.351 0.633 0 O-C-N 121.983 -0.448 . . . . 0.0 110.496 -176.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 72.7 tp60 -68.48 -42.38 78.78 Favored 'General case' 0 C--N 1.351 0.672 0 O-C-N 121.546 -0.721 . . . . 0.0 109.526 -178.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.489 HD21 HD12 ' A' ' 25' ' ' LEU . 82.4 mt -71.9 -35.16 69.62 Favored 'General case' 0 C--N 1.362 1.14 0 C-N-CA 119.963 -0.695 . . . . 0.0 109.355 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.574 HG12 HD21 ' A' ' 66' ' ' LEU . 33.6 t -62.02 -40.21 86.51 Favored 'Isoleucine or valine' 0 C--N 1.351 0.632 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.504 ' O ' HG11 ' A' ' 53' ' ' VAL . 55.9 t -67.57 -39.33 82.16 Favored 'Isoleucine or valine' 0 C--N 1.351 0.631 0 O-C-N 121.723 -0.611 . . . . 0.0 109.392 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.466 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 33.7 tptt -65.39 -29.17 69.85 Favored 'General case' 0 C--N 1.361 1.07 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -179.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.486 HD13 HD11 ' A' ' 66' ' ' LEU . 19.7 mt -66.17 -37.94 86.86 Favored 'General case' 0 C--N 1.355 0.815 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.303 179.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 56.3 p -72.16 -17.68 61.93 Favored 'General case' 0 C--N 1.354 0.796 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.704 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -101.8 -37.56 8.24 Favored 'General case' 0 C--N 1.353 0.754 0 O-C-N 121.244 -0.91 . . . . 0.0 111.473 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.1 p -74.22 -38.38 47.88 Favored 'Isoleucine or valine' 0 C--N 1.354 0.779 0 O-C-N 121.599 -0.688 . . . . 0.0 111.143 -177.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.4 t -112.21 -7.62 14.02 Favored 'General case' 0 C--N 1.353 0.756 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.309 -177.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 64.25 47.73 3.09 Favored 'General case' 0 C--N 1.354 0.781 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.638 HG13 ' HD2' ' A' ' 62' ' ' PRO . 62.0 t -111.5 133.8 21.37 Favored Pre-proline 0 N--CA 1.443 -0.813 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.638 ' HD2' HG13 ' A' ' 61' ' ' VAL . 34.1 Cg_exo -58.44 148.35 80.91 Favored 'Trans proline' 0 CA--C 1.498 -1.294 0 C-N-CA 122.565 2.177 . . . . 0.0 112.771 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.462 HG22 HG22 ' A' ' 64' ' ' THR . 3.9 m -72.73 -15.02 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.687 -178.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.462 HG22 HG22 ' A' ' 63' ' ' VAL . 70.6 p -96.42 -31.61 12.75 Favored 'General case' 0 C--N 1.359 0.987 0 C-N-CA 118.608 -1.237 . . . . 0.0 109.075 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -71.06 -33.01 69.86 Favored 'General case' 0 C--N 1.353 0.728 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.574 HD21 HG12 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -77.23 -34.88 55.91 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -177.889 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.585 HG12 ' N ' ' A' ' 68' ' ' ARG . 1.5 p -70.64 -26.03 27.64 Favored 'Isoleucine or valine' 0 C--N 1.354 0.776 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.523 -178.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.585 ' N ' HG12 ' A' ' 67' ' ' VAL . 5.3 mmm-85 -74.58 -51.44 14.55 Favored 'General case' 0 C--N 1.36 1.039 0 O-C-N 121.438 -0.789 . . . . 0.0 110.105 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.0 mt -63.2 -35.33 79.97 Favored 'General case' 0 C--N 1.357 0.896 0 O-C-N 122.046 -0.409 . . . . 0.0 110.606 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -60.94 -47.16 87.72 Favored 'General case' 0 C--N 1.35 0.623 0 O-C-N 122.301 -0.25 . . . . 0.0 110.333 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.6 -38.58 95.23 Favored Glycine 0 C--N 1.354 1.547 0 N-CA-C 111.848 -0.501 . . . . 0.0 111.848 -178.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -63.86 -47.65 79.84 Favored 'General case' 0 C--N 1.353 0.726 0 CA-C-N 118.411 1.105 . . . . 0.0 111.457 -177.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.749 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 12.9 mttm -64.15 -49.46 72.02 Favored 'General case' 0 C--N 1.358 0.97 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -176.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.422 HD21 ' HB2' ' A' ' 77' ' ' GLU . 2.2 tm? -69.18 -39.38 78.75 Favored 'General case' 0 C--N 1.35 0.609 0 O-C-N 121.214 -0.929 . . . . 0.0 111.882 -175.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -63.47 -44.29 94.86 Favored 'General case' 0 C--N 1.353 0.748 0 O-C-N 121.122 -0.987 . . . . 0.0 110.988 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.29 -14.89 18.19 Favored 'Isoleucine or valine' 0 C--N 1.358 0.954 0 O-C-N 121.496 -0.752 . . . . 0.0 109.194 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.749 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 74.3 mm-40 -71.43 -38.98 71.34 Favored 'General case' 0 C--N 1.352 0.674 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 82.5 mt -72.99 -31.36 64.45 Favored 'General case' 0 C--N 1.356 0.855 0 O-C-N 122.426 -0.171 . . . . 0.0 110.545 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 49.1 mm -65.58 -54.25 30.19 Favored 'Isoleucine or valine' 0 C--N 1.359 0.993 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.286 -177.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -75.38 -14.57 60.48 Favored 'General case' 0 CA--C 1.51 -0.571 0 C-N-CA 119.516 -0.874 . . . . 0.0 109.381 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.35 -37.21 63.01 Favored Glycine 0 C--N 1.349 1.259 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.417 ' HB2' HG23 ' A' ' 85' ' ' ILE . 98.7 m-70 -131.38 106.24 14.61 Favored Pre-proline 0 N--CA 1.441 -0.885 0 CA-C-O 122.664 1.221 . . . . 0.0 109.046 -177.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.33 -24.87 42.88 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.52 2.147 . . . . 0.0 114.113 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.433 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 44.6 mt-10 -93.11 -4.95 51.39 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.417 HG23 ' HB2' ' A' ' 82' ' ' HIS . 1.0 OUTLIER -90.32 -20.08 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.224 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 -179.629 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -101.72 -24.66 14.05 Favored 'General case' 0 C--N 1.36 1.038 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -70.26 -35.65 73.92 Favored 'General case' 0 C--N 1.358 0.955 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 84' ' ' GLU . 78.6 mm-40 -65.01 -36.1 83.31 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 122.058 -0.401 . . . . 0.0 110.058 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.458 ' HE1' ' HB3' ' A' ' 89' ' ' MET . 21.8 ttp -83.56 149.87 26.31 Favored 'General case' 0 C--N 1.352 0.698 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -178.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.53 -21.95 8.36 Favored 'General case' 0 C--N 1.364 1.222 0 C-N-CA 120.074 -0.651 . . . . 0.0 111.032 -177.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -164.55 170.93 15.19 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 -177.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.425 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 41.0 t -64.4 -42.69 95.97 Favored 'General case' 0 C--N 1.356 0.873 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.955 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -66.86 -38.82 87.09 Favored 'General case' 0 C--N 1.355 0.833 0 O-C-N 121.492 -0.755 . . . . 0.0 109.328 -178.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -65.91 -24.61 66.87 Favored 'General case' 0 C--N 1.357 0.912 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.425 ' HB3' ' O ' ' A' ' 92' ' ' SER . 62.5 tp -63.09 -46.41 87.53 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.7 mp -63.03 -32.35 73.7 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 122.185 -0.322 . . . . 0.0 110.405 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 36.5 t -62.15 -45.08 95.04 Favored 'General case' 0 C--N 1.355 0.847 0 O-C-N 121.783 -0.573 . . . . 0.0 111.304 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.66 26.42 10.39 Favored 'General case' 0 C--N 1.362 1.11 0 O-C-N 121.015 -1.053 . . . . 0.0 110.515 -178.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.484 HG22 ' N ' ' A' ' 100' ' ' ASP . 13.0 tt -64.09 -29.57 47.69 Favored 'Isoleucine or valine' 0 C--N 1.352 0.691 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.151 -179.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.484 ' N ' HG22 ' A' ' 99' ' ' ILE . 4.0 p-10 -126.21 -9.46 6.44 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 118.564 -1.254 . . . . 0.0 109.762 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 58.8 m -90.92 -2.54 57.72 Favored 'General case' 0 N--CA 1.441 -0.884 0 O-C-N 121.406 -0.809 . . . . 0.0 110.345 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -147.03 -47.69 0.18 Allowed 'General case' 0 C--N 1.358 0.968 0 C-N-CA 118.28 -1.368 . . . . 0.0 109.913 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 96.2 mt -67.53 -47.84 79.07 Favored 'Isoleucine or valine' 0 C--N 1.354 0.779 0 O-C-N 121.931 -0.481 . . . . 0.0 111.161 -178.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 22.4 m170 -83.55 -1.14 53.09 Favored 'General case' 0 C--N 1.356 0.875 0 O-C-N 121.403 -0.811 . . . . 0.0 110.056 -177.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 70.5 t -83.96 -43.13 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.952 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -67.3 -39.88 85.99 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.323 -178.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.1 p -71.97 -36.5 57.74 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 C-N-CA 119.596 -0.842 . . . . 0.0 110.106 -178.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 93.3 t80 -60.86 -48.6 81.07 Favored 'General case' 0 C--N 1.363 1.171 0 O-C-N 121.744 -0.597 . . . . 0.0 110.71 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -60.25 -38.1 82.45 Favored 'General case' 0 C--N 1.358 0.941 0 O-C-N 121.665 -0.647 . . . . 0.0 110.069 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 16.9 mt -58.05 -76.56 0.04 OUTLIER 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.423 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 91.3 m-85 -115.72 134.3 22.7 Favored Pre-proline 0 N--CA 1.44 -0.954 0 C-N-CA 118.986 -1.086 . . . . 0.0 108.83 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 111' ' ' TYR . 74.3 Cg_endo -86.21 -2.08 8.62 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 123.222 2.615 . . . . 0.0 115.403 -179.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -67.39 -36.18 80.8 Favored 'General case' 0 C--N 1.355 0.814 0 O-C-N 121.773 -0.579 . . . . 0.0 109.997 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.73 143.99 55.36 Favored 'General case' 0 C--N 1.354 0.775 0 CA-C-O 121.651 0.738 . . . . 0.0 110.018 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.417 ' O ' HD13 ' A' ' 116' ' ' LEU . 46.2 mt-10 -114.26 145.58 41.55 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 117' ' ' PRO . 5.6 mp -127.48 145.78 55.91 Favored Pre-proline 0 N--CA 1.445 -0.716 0 CA-C-O 122.198 0.999 . . . . 0.0 108.98 -178.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 116' ' ' LEU . 73.7 Cg_endo -91.31 -152.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.197 0 C-N-CA 123.909 3.073 . . . . 0.0 113.178 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.421 ' H ' ' HB2' ' A' ' 117' ' ' PRO . 75.0 mmtt -115.03 142.46 46.61 Favored 'General case' 0 C--N 1.362 1.125 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.598 ' CE2' ' HD1' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -137.71 125.42 22.37 Favored 'General case' 0 C--N 1.361 1.09 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -177.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.433 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 94.1 m -124.23 129.99 51.74 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 177.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 74.8 m -118.01 131.35 56.48 Favored 'General case' 0 CA--C 1.504 -0.8 0 C-N-CA 119.277 -0.969 . . . . 0.0 109.852 -177.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -121.02 148.37 44.22 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 58.1 ttp180 -123.32 117.39 25.13 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.487 ' HA ' HD22 ' A' ' 124' ' ' LEU . 95.3 mt -92.07 -15.09 28.27 Favored 'General case' 0 C--N 1.354 0.797 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.709 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 178.59 -150.37 9.61 Favored Glycine 0 N--CA 1.439 -1.154 0 N-CA-C 108.886 -1.686 . . . . 0.0 108.886 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -90.4 -38.23 13.45 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -105.99 9.5 32.55 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 119.762 -0.775 . . . . 0.0 109.524 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.471 ' CB ' ' HB2' ' A' ' 124' ' ' LEU . 61.9 m-20 -118.3 123.21 44.8 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 17.8 mm -137.9 133.26 44.57 Favored 'Isoleucine or valine' 0 C--N 1.353 0.729 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 59.9 mtm180 -120.49 139.43 52.9 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' A' ' 131' ' ' LEU . 0.7 OUTLIER -130.04 127.0 39.05 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.917 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.433 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 11.9 m170 -97.34 130.7 44.47 Favored 'General case' 0 CA--C 1.494 -1.188 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 178.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.598 ' HD1' ' CE2' ' A' ' 119' ' ' PHE . 52.5 t80 -124.86 121.43 34.51 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 -178.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.482 ' HA ' ' O ' ' A' ' 171' ' ' THR . 28.2 tt0 -114.42 112.44 23.03 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.8 t -162.28 153.39 17.8 Favored 'General case' 0 C--N 1.358 0.974 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -90.43 5.99 45.2 Favored 'General case' 0 C--N 1.357 0.903 0 C-N-CA 120.199 -0.6 . . . . 0.0 109.912 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 94.7 mtm-85 -131.94 77.35 72.05 Favored Pre-proline 0 C--N 1.356 0.856 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 178.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -91.48 93.07 0.22 Allowed 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.748 2.298 . . . . 0.0 115.709 -177.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -107.43 106.36 16.73 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 177.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.3 -38.88 92.63 Favored 'General case' 0 C--N 1.355 0.835 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.367 -178.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 74.2 m -63.05 -27.1 69.17 Favored 'General case' 0 C--N 1.353 0.755 0 O-C-N 121.981 -0.449 . . . . 0.0 110.554 -178.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -75.58 -47.18 27.78 Favored 'General case' 0 N--CA 1.445 -0.721 0 O-C-N 121.735 -0.603 . . . . 0.0 109.553 -178.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.28 -39.4 92.53 Favored 'General case' 0 C--N 1.358 0.944 0 O-C-N 122.108 -0.37 . . . . 0.0 111.331 -178.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -62.19 -36.94 83.42 Favored 'General case' 0 C--N 1.358 0.947 0 O-C-N 121.777 -0.577 . . . . 0.0 109.764 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.53 -42.2 99.03 Favored Glycine 0 C--N 1.347 1.157 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 83.2 mt -70.19 -41.35 73.82 Favored 'General case' 0 C--N 1.352 0.692 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 96.6 mt -71.27 -42.08 69.22 Favored 'General case' 0 C--N 1.364 1.212 0 O-C-N 121.066 -1.021 . . . . 0.0 110.654 -177.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -70.35 -30.84 67.88 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 121.866 -0.521 . . . . 0.0 110.635 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -63.55 -39.75 97.97 Favored Glycine 0 C--N 1.356 1.654 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 42.7 t -60.43 -43.11 97.12 Favored 'General case' 0 C--N 1.35 0.615 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 178.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -78.91 2.38 20.35 Favored 'General case' 0 C--N 1.355 0.847 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -83.73 -49.09 9.45 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -66.69 -42.93 85.67 Favored 'General case' 0 C--N 1.36 1.061 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.412 ' HZ ' ' HE3' ' A' ' 89' ' ' MET . 9.6 m-30 -69.01 -27.38 65.62 Favored 'General case' 0 C--N 1.361 1.068 0 O-C-N 121.831 -0.543 . . . . 0.0 110.797 -178.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 85.2 tttt 73.01 75.06 0.14 Allowed 'General case' 0 C--N 1.36 1.058 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -137.65 -177.73 4.92 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -140.27 90.06 2.34 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 16.8 m-30 -116.3 155.11 28.98 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 178.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 93.5 m -119.66 128.83 54.2 Favored 'General case' 0 C--N 1.355 0.808 0 C-N-CA 119.551 -0.859 . . . . 0.0 108.828 -178.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.414 HG13 HG12 ' A' ' 177' ' ' ILE . 3.5 mp -106.24 123.22 60.83 Favored 'Isoleucine or valine' 0 C--N 1.352 0.704 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.1 m -119.43 -170.77 2.0 Allowed 'General case' 0 C--N 1.356 0.869 0 CA-C-O 121.685 0.755 . . . . 0.0 109.197 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 11.3 ptt85 -147.76 157.0 43.33 Favored 'General case' 0 C--N 1.357 0.931 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -178.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' THR . . . . . 0.498 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 32.5 p -97.5 146.37 31.28 Favored Pre-proline 0 C--N 1.36 1.043 0 CA-C-O 122.415 1.103 . . . . 0.0 108.447 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.498 ' HD3' ' HA ' ' A' ' 163' ' ' THR . 16.0 Cg_exo -70.42 -16.7 34.82 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 123.641 2.894 . . . . 0.0 114.486 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -71.95 -40.71 68.49 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.933 -177.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 39.6 p -119.27 15.75 13.09 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.876 -178.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.485 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 12.7 pt20 -67.55 -12.15 59.71 Favored 'General case' 0 C--N 1.352 0.69 0 C-N-CA 119.974 -0.691 . . . . 0.0 110.155 178.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -126.51 37.79 4.24 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 18.2 t -138.94 144.65 39.13 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.614 ' O ' ' HB ' ' A' ' 171' ' ' THR . 61.4 mt-10 -97.87 163.99 12.56 Favored 'General case' 0 C--N 1.354 0.769 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.614 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 18.0 m 83.95 -59.91 0.12 Allowed 'General case' 0 C--N 1.372 1.555 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -105.71 118.0 35.47 Favored 'General case' 0 CA--C 1.503 -0.827 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.596 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 92.8 t -131.48 133.78 61.5 Favored 'Isoleucine or valine' 0 C--N 1.358 0.952 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 178.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 48.4 mm -113.52 126.98 71.06 Favored 'Isoleucine or valine' 0 C--N 1.359 1.021 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.482 ' HB2' ' HG ' ' A' ' 131' ' ' LEU . 97.2 m-85 -116.74 147.2 42.25 Favored 'General case' 0 C--N 1.36 1.054 0 CA-C-O 121.947 0.88 . . . . 0.0 109.105 -179.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -125.2 120.16 30.52 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.498 HD11 HD22 ' A' ' 131' ' ' LEU . 51.8 mt -116.22 124.79 72.86 Favored 'Isoleucine or valine' 0 C--N 1.353 0.752 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 -178.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 54.9 p -118.55 157.97 26.31 Favored 'General case' 0 CA--C 1.501 -0.92 0 CA-C-O 121.764 0.792 . . . . 0.0 109.581 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 . . . . . 0 C--N 1.356 0.858 0 N-CA-C 106.325 -1.732 . . . . 0.0 106.325 178.838 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.556 ' HE3' ' HE1' ' A' ' 4' ' ' MET . 3.8 mtm . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 121.287 0.565 . . . . 0.0 110.887 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.459 ' O ' HG23 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -83.93 -12.71 54.98 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.172 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.62 -40.2 54.15 Favored Glycine 0 C--N 1.351 1.397 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' MET . . . . . 0.556 ' HE1' ' HE3' ' A' ' 1' ' ' MET . 7.8 mtm -71.08 -35.4 71.84 Favored 'General case' 0 C--N 1.359 1.0 0 O-C-N 121.875 -0.779 . . . . 0.0 111.299 -177.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 2' ' ' MET . 34.1 m -68.48 -23.98 28.81 Favored 'Isoleucine or valine' 0 C--N 1.356 0.854 0 C-N-CA 119.674 -0.81 . . . . 0.0 109.22 -179.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.472 ' HE2' HD11 ' A' ' 51' ' ' LEU . 5.4 m-85 -71.31 -35.87 71.42 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 178.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 88.6 m -67.35 -41.63 84.85 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.73 -38.95 97.31 Favored Glycine 0 C--N 1.357 1.743 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.653 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -66.73 -39.98 88.2 Favored 'General case' 0 C--N 1.352 0.685 0 O-C-N 122.301 -0.529 . . . . 0.0 110.76 -178.107 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.741 ' HE2' HD21 ' A' ' 26' ' ' LEU . 22.4 mmt -64.25 -41.04 97.15 Favored 'General case' 0 C--N 1.354 0.791 0 O-C-N 121.523 -0.735 . . . . 0.0 111.137 -178.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -67.26 -40.0 86.17 Favored 'General case' 0 C--N 1.35 0.598 0 O-C-N 121.96 -0.463 . . . . 0.0 111.623 -177.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 54.7 tp -66.33 -42.09 88.68 Favored 'General case' 0 C--N 1.348 0.503 0 N-CA-C 112.694 0.628 . . . . 0.0 112.694 -178.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.679 HD12 HD12 ' A' ' 55' ' ' LEU . 2.1 mm -75.17 -35.77 35.3 Favored 'Isoleucine or valine' 0 C--N 1.36 1.048 0 O-C-N 121.11 -0.994 . . . . 0.0 110.86 -175.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -71.13 -41.89 69.91 Favored 'General case' 0 C--N 1.35 0.587 0 O-C-N 121.558 -0.714 . . . . 0.0 111.405 -176.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -72.04 -38.21 69.56 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -175.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -102.57 -23.22 13.89 Favored 'General case' 0 C--N 1.349 0.584 0 C-N-CA 118.794 -1.162 . . . . 0.0 113.466 -174.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 14.6 m-30 -109.07 -37.76 5.73 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 118.191 -1.404 . . . . 0.0 111.399 -176.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 140.63 178.76 17.48 Favored Glycine 0 N--CA 1.439 -1.144 0 N-CA-C 108.732 -1.747 . . . . 0.0 108.732 -179.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -101.6 -25.61 13.82 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -177.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -70.3 -39.61 74.72 Favored 'General case' 0 C--N 1.361 1.098 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.551 HG23 HG21 ' A' ' 58' ' ' VAL . 95.0 m -67.69 -38.38 83.59 Favored 'General case' 0 C--N 1.358 0.96 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.5 HD13 ' HB ' ' A' ' 13' ' ' ILE . 39.1 tp -59.59 -38.54 81.49 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -66.12 -36.13 82.33 Favored 'General case' 0 C--N 1.356 0.858 0 O-C-N 122.09 -0.381 . . . . 0.0 111.07 -178.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.6 m -64.13 -41.19 97.3 Favored 'General case' 0 C--N 1.355 0.846 0 O-C-N 121.606 -0.684 . . . . 0.0 109.352 -178.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.3 mt -64.28 -36.84 85.42 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.741 HD21 ' HE2' ' A' ' 10' ' ' MET . 84.3 mt -70.19 -16.2 63.04 Favored 'General case' 0 C--N 1.359 0.982 0 O-C-N 121.782 -0.574 . . . . 0.0 110.105 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -84.89 -28.79 25.72 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 119.524 -0.87 . . . . 0.0 109.167 178.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.4 t -66.52 -36.89 83.82 Favored 'General case' 0 C--N 1.355 0.838 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.8 p -93.07 -37.19 12.29 Favored 'General case' 0 C--N 1.359 1.004 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -179.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 83.66 133.39 0.05 Allowed 'General case' 0 C--N 1.36 1.04 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.522 HD23 ' HB3' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -111.97 132.05 55.02 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 179.246 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -107.88 -21.46 12.83 Favored 'General case' 0 CA--C 1.497 -1.083 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.121 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -114.24 -80.15 0.59 Allowed 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 118.874 -1.131 . . . . 0.0 109.098 -178.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -137.16 -53.17 0.68 Allowed 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 131.4 -44.6 1.19 Allowed Glycine 0 C--N 1.352 1.437 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 82.8 mt -107.87 100.05 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.795 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -98.21 0.07 45.11 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.4 m 78.75 174.22 0.16 Allowed 'General case' 0 C--N 1.362 1.127 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 -178.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 41.7 p -86.81 119.25 26.84 Favored 'General case' 0 N--CA 1.443 -0.778 0 O-C-N 121.131 -0.981 . . . . 0.0 109.531 -178.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -176.21 -12.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.362 1.117 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -114.25 168.05 12.47 Favored Glycine 0 C--N 1.358 1.793 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 -178.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 48.9 m -130.95 132.21 44.92 Favored 'General case' 0 C--N 1.355 0.838 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -119.14 173.64 6.8 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -70.19 172.49 8.0 Favored 'General case' 0 C--N 1.357 0.9 0 CA-C-O 121.671 0.748 . . . . 0.0 109.478 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -83.77 -24.05 31.25 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -178.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -65.79 -27.41 68.25 Favored 'General case' 0 C--N 1.355 0.832 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -61.48 -42.11 98.28 Favored 'General case' 0 C--N 1.353 0.734 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 61.8 tp -67.4 -38.89 85.34 Favored 'General case' 0 C--N 1.355 0.816 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.296 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 57.9 tp -73.5 -28.05 61.7 Favored 'General case' 0 C--N 1.352 0.697 0 O-C-N 122.081 -0.387 . . . . 0.0 110.278 -177.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 71.7 tp60 -67.42 -42.42 83.22 Favored 'General case' 0 N--CA 1.445 -0.695 0 O-C-N 121.702 -0.624 . . . . 0.0 109.481 -178.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.485 ' HA ' HD23 ' A' ' 51' ' ' LEU . 88.1 mt -76.9 -25.09 52.61 Favored 'General case' 0 C--N 1.36 1.031 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.843 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.489 ' O ' HG13 ' A' ' 52' ' ' VAL . 32.2 t -70.78 -41.7 77.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.616 HG12 ' N ' ' A' ' 54' ' ' LYS . 5.1 p -71.82 -30.88 39.25 Favored 'Isoleucine or valine' 0 C--N 1.354 0.797 0 O-C-N 121.514 -0.741 . . . . 0.0 109.766 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.616 ' N ' HG12 ' A' ' 53' ' ' VAL . 31.1 tptt -71.83 -27.16 62.71 Favored 'General case' 0 C--N 1.364 1.204 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.679 HD12 HD12 ' A' ' 13' ' ' ILE . 2.0 tt -66.58 -41.25 88.81 Favored 'General case' 0 C--N 1.354 0.768 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.507 ' O ' ' HA ' ' A' ' 60' ' ' SER . 46.8 t -65.24 -39.4 92.64 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 121.88 -0.512 . . . . 0.0 110.313 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -76.95 -39.12 51.81 Favored 'General case' 0 C--N 1.352 0.717 0 O-C-N 120.974 -1.078 . . . . 0.0 112.975 -178.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.551 HG21 HG23 ' A' ' 21' ' ' THR . 5.4 p -70.74 -38.02 71.3 Favored 'Isoleucine or valine' 0 C--N 1.354 0.794 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -175.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.0 t -118.12 -4.44 11.0 Favored 'General case' 0 CA--C 1.505 -0.779 0 C-N-CA 118.975 -1.09 . . . . 0.0 110.085 -177.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.507 ' HA ' ' O ' ' A' ' 56' ' ' SER . 0.3 OUTLIER 69.36 41.23 1.35 Allowed 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.078 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.434 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 61.6 t -110.8 123.86 34.45 Favored Pre-proline 0 CA--C 1.502 -0.891 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 178.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 61' ' ' VAL . 32.5 Cg_exo -57.73 155.03 34.03 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 122.85 2.367 . . . . 0.0 113.689 -178.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.607 ' HA ' ' CD2' ' A' ' 66' ' ' LEU . 11.4 m -75.3 -9.34 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.457 -177.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 80.6 p -96.39 -36.13 10.95 Favored 'General case' 0 C--N 1.356 0.882 0 C-N-CA 118.221 -1.392 . . . . 0.0 109.431 -179.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -75.2 -22.3 58.08 Favored 'General case' 0 C--N 1.353 0.733 0 O-C-N 121.407 -0.808 . . . . 0.0 109.337 179.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.607 ' CD2' ' HA ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -82.58 -32.67 28.37 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -178.997 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.588 HG12 ' N ' ' A' ' 68' ' ' ARG . 2.3 p -70.98 -25.39 25.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.844 0 C-N-CA 120.077 -0.649 . . . . 0.0 109.864 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.588 ' N ' HG12 ' A' ' 67' ' ' VAL . 4.7 mmm-85 -73.29 -53.15 11.55 Favored 'General case' 0 C--N 1.363 1.153 0 O-C-N 121.519 -0.738 . . . . 0.0 109.841 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.54 -34.34 77.58 Favored 'General case' 0 C--N 1.356 0.889 0 O-C-N 122.112 -0.368 . . . . 0.0 110.806 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -61.23 -47.2 87.18 Favored 'General case' 0 C--N 1.35 0.613 0 O-C-N 122.083 -0.385 . . . . 0.0 110.369 -178.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.65 -38.6 95.33 Favored Glycine 0 C--N 1.356 1.663 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 -178.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -63.29 -47.98 80.04 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-N 118.115 0.957 . . . . 0.0 111.644 -177.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 12.8 mttm -65.42 -47.04 77.63 Favored 'General case' 0 C--N 1.359 1.018 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -177.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -70.3 -39.24 74.95 Favored 'General case' 0 C--N 1.349 0.571 0 O-C-N 121.158 -0.964 . . . . 0.0 111.712 -175.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -63.89 -45.55 88.88 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 121.114 -0.991 . . . . 0.0 111.047 -178.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 76' ' ' VAL . 9.8 p -71.44 -14.01 17.37 Favored 'Isoleucine or valine' 0 C--N 1.359 0.988 0 O-C-N 121.545 -0.722 . . . . 0.0 109.073 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -71.36 -40.65 70.49 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 79.5 mt -70.32 -34.02 72.2 Favored 'General case' 0 C--N 1.356 0.887 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.337 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 46.4 mm -63.16 -52.95 52.42 Favored 'Isoleucine or valine' 0 C--N 1.358 0.964 0 O-C-N 121.723 -0.611 . . . . 0.0 110.105 -177.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -75.0 -10.7 59.72 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 120.1 -0.64 . . . . 0.0 111.289 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.76 -8.68 58.06 Favored Glycine 0 C--N 1.351 1.401 0 C-N-CA 119.617 -1.277 . . . . 0.0 110.825 -178.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.626 ' HB2' HG21 ' A' ' 85' ' ' ILE . 93.3 m-70 -137.22 91.35 14.65 Favored Pre-proline 0 C--N 1.353 0.721 0 CA-C-N 118.994 1.397 . . . . 0.0 108.982 -179.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -59.82 -32.96 96.2 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 123.027 2.484 . . . . 0.0 114.408 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -93.24 -2.71 54.82 Favored 'General case' 0 CA--C 1.504 -0.82 0 C-N-CA 119.74 -0.784 . . . . 0.0 109.616 -178.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.626 HG21 ' HB2' ' A' ' 82' ' ' HIS . 0.4 OUTLIER -89.07 -19.87 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 -179.832 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -101.64 -23.42 14.26 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -70.27 -36.66 74.57 Favored 'General case' 0 C--N 1.359 0.995 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -65.77 -35.91 82.06 Favored 'General case' 0 C--N 1.355 0.82 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.013 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 23.8 ttp -83.26 149.61 26.69 Favored 'General case' 0 C--N 1.353 0.732 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -178.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.6 -21.91 8.91 Favored 'General case' 0 C--N 1.364 1.233 0 O-C-N 121.698 -0.626 . . . . 0.0 110.556 -177.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -163.91 170.75 16.3 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -177.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.454 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 89.3 p -70.86 -32.32 69.28 Favored 'General case' 0 C--N 1.353 0.736 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.965 -179.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -70.3 -38.94 75.09 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -67.06 -23.73 65.9 Favored 'General case' 0 C--N 1.358 0.937 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.454 ' HB3' ' O ' ' A' ' 92' ' ' SER . 61.0 tp -62.67 -46.53 87.73 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.9 mp -63.13 -31.22 72.32 Favored 'General case' 0 C--N 1.355 0.812 0 O-C-N 122.257 -0.277 . . . . 0.0 110.289 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 36.1 t -62.2 -45.98 90.93 Favored 'General case' 0 C--N 1.356 0.868 0 O-C-N 121.69 -0.631 . . . . 0.0 111.237 -178.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.467 ' HZ3' ' HG2' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -114.89 28.92 8.39 Favored 'General case' 0 C--N 1.36 1.055 0 O-C-N 121.068 -1.02 . . . . 0.0 110.232 -178.338 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.571 HG22 ' N ' ' A' ' 100' ' ' ASP . 12.9 tt -63.45 -27.64 43.41 Favored 'Isoleucine or valine' 0 C--N 1.354 0.79 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.5 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.571 ' N ' HG22 ' A' ' 99' ' ' ILE . 3.0 p-10 -125.98 -12.29 6.45 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 118.825 -1.15 . . . . 0.0 109.044 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.3 t -69.11 -45.53 69.98 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.057 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -123.85 -28.73 3.77 Favored 'General case' 0 C--N 1.358 0.943 0 C-N-CA 118.636 -1.226 . . . . 0.0 111.47 -177.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 96.2 mt -70.17 -47.8 65.46 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 O-C-N 121.147 -0.971 . . . . 0.0 110.922 -178.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 39.3 m170 -87.96 1.71 53.46 Favored 'General case' 0 C--N 1.355 0.834 0 O-C-N 121.224 -0.923 . . . . 0.0 110.028 -177.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.6 p -92.37 -31.71 4.85 Favored 'Isoleucine or valine' 0 C--N 1.354 0.799 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -71.99 -39.8 69.02 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.695 HG13 ' N ' ' A' ' 108' ' ' TYR . 0.5 OUTLIER -72.98 -36.6 51.68 Favored 'Isoleucine or valine' 0 C--N 1.354 0.795 0 C-N-CA 119.605 -0.838 . . . . 0.0 109.704 -178.866 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.695 ' N ' HG13 ' A' ' 107' ' ' VAL . 91.6 t80 -61.06 -48.7 80.52 Favored 'General case' 0 C--N 1.364 1.21 0 O-C-N 121.808 -0.557 . . . . 0.0 110.651 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -60.91 -37.9 83.87 Favored 'General case' 0 C--N 1.357 0.903 0 O-C-N 121.709 -0.619 . . . . 0.0 110.226 -179.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.8 mt -57.9 -76.46 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.404 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 79.5 m-85 -116.37 135.04 22.78 Favored Pre-proline 0 N--CA 1.441 -0.899 0 C-N-CA 118.926 -1.109 . . . . 0.0 108.756 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 111' ' ' TYR . 81.2 Cg_endo -85.29 -2.41 9.35 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 123.215 2.61 . . . . 0.0 115.41 -178.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 30.4 mm100 -66.72 -36.42 82.42 Favored 'General case' 0 C--N 1.354 0.79 0 O-C-N 121.779 -0.575 . . . . 0.0 110.029 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.97 146.12 53.82 Favored 'General case' 0 C--N 1.354 0.778 0 CA-C-O 121.695 0.76 . . . . 0.0 110.092 -178.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -117.43 156.77 27.38 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 178.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.844 ' HG ' ' HD2' ' A' ' 117' ' ' PRO . 4.3 tp -142.3 143.47 27.39 Favored Pre-proline 0 N--CA 1.441 -0.893 0 CA-C-O 122.009 0.909 . . . . 0.0 108.646 -178.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.844 ' HD2' ' HG ' ' A' ' 116' ' ' LEU . 97.5 Cg_endo -85.73 -152.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.128 0 C-N-CA 123.602 2.868 . . . . 0.0 113.534 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -114.25 145.94 41.08 Favored 'General case' 0 C--N 1.363 1.19 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.412 ' CE1' HD11 ' A' ' 131' ' ' LEU . 9.4 t80 -145.39 125.28 13.49 Favored 'General case' 0 C--N 1.36 1.052 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -177.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 93.5 m -124.84 132.49 53.32 Favored 'General case' 0 C--N 1.359 0.995 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 179.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 75.2 m -113.68 130.25 56.44 Favored 'General case' 0 C--N 1.356 0.883 0 C-N-CA 119.735 -0.786 . . . . 0.0 109.576 -178.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -121.04 126.7 50.55 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 178.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.622 ' HG3' HD11 ' A' ' 129' ' ' ILE . 58.4 ttp180 -102.53 117.4 34.62 Favored 'General case' 0 C--N 1.353 0.755 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.57 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 85.7 mt -83.3 -27.03 30.08 Favored 'General case' 0 CA--C 1.504 -0.818 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.112 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -177.18 -144.96 5.55 Favored Glycine 0 C--N 1.35 1.319 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 -178.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -94.11 -39.06 10.79 Favored 'General case' 0 N--CA 1.438 -1.07 0 O-C-N 121.993 -0.71 . . . . 0.0 109.312 -178.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -101.94 1.89 37.3 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.614 -178.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.57 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 6.6 m-20 -118.97 130.77 55.87 Favored 'General case' 0 C--N 1.359 0.993 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.622 HD11 ' HG3' ' A' ' 123' ' ' ARG . 14.2 mm -139.37 135.81 40.83 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 179.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 58.3 mtm180 -122.0 141.01 51.78 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.617 ' HG ' ' HB2' ' A' ' 175' ' ' PHE . 0.9 OUTLIER -131.39 127.01 36.65 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.676 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -97.47 130.77 44.53 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 178.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -125.15 121.04 33.07 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 -178.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.527 ' HA ' ' O ' ' A' ' 171' ' ' THR . 28.7 tt0 -114.9 112.05 22.13 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 14.5 t -161.73 152.65 18.02 Favored 'General case' 0 C--N 1.358 0.976 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.432 ' C ' ' HD3' ' A' ' 138' ' ' PRO . 57.9 mtmt -90.7 3.56 53.92 Favored 'General case' 0 C--N 1.357 0.891 0 C-N-CA 120.269 -0.572 . . . . 0.0 109.576 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -133.49 73.48 72.99 Favored Pre-proline 0 CA--C 1.506 -0.736 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.432 ' HD3' ' C ' ' A' ' 136' ' ' LYS . 89.6 Cg_endo -96.36 104.14 0.09 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.541 0 C-N-CA 122.662 2.241 . . . . 0.0 115.678 -177.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -111.87 113.44 25.77 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 176.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.93 -38.12 89.93 Favored 'General case' 0 C--N 1.353 0.75 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.968 -179.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 74.6 m -63.02 -26.17 68.73 Favored 'General case' 0 C--N 1.353 0.741 0 O-C-N 121.971 -0.456 . . . . 0.0 110.55 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -76.57 -46.72 25.1 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 120.13 -0.628 . . . . 0.0 109.375 -178.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.59 -40.24 95.16 Favored 'General case' 0 C--N 1.357 0.915 0 O-C-N 122.187 -0.321 . . . . 0.0 111.087 -178.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.19 -36.79 84.81 Favored 'General case' 0 C--N 1.355 0.834 0 O-C-N 121.961 -0.462 . . . . 0.0 110.112 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.37 -42.94 99.09 Favored Glycine 0 C--N 1.347 1.157 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.5 mt -70.06 -40.92 74.8 Favored 'General case' 0 C--N 1.353 0.719 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 96.7 mt -71.84 -42.2 67.24 Favored 'General case' 0 C--N 1.364 1.2 0 O-C-N 121.059 -1.026 . . . . 0.0 110.801 -176.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.538 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 20.9 t70 -69.15 -33.15 72.97 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 122.097 -0.377 . . . . 0.0 110.57 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -62.75 -39.28 97.76 Favored Glycine 0 C--N 1.357 1.713 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 45.9 t -60.51 -42.24 95.99 Favored 'General case' 0 C--N 1.35 0.598 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -75.99 -0.13 20.51 Favored 'General case' 0 C--N 1.36 1.043 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.538 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 76.8 mm-40 -84.56 -46.41 11.59 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -66.16 -44.59 83.64 Favored 'General case' 0 C--N 1.359 1.002 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 8.8 m-30 -69.5 -26.28 64.46 Favored 'General case' 0 C--N 1.361 1.086 0 O-C-N 121.87 -0.518 . . . . 0.0 110.81 -178.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 85.0 tttt 73.16 75.95 0.14 Allowed 'General case' 0 C--N 1.36 1.024 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -178.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -141.42 -171.34 3.28 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -148.34 92.65 2.05 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -113.86 158.41 21.09 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 93.3 m -119.9 127.85 53.09 Favored 'General case' 0 C--N 1.355 0.82 0 C-N-CA 119.404 -0.919 . . . . 0.0 108.974 -178.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.438 ' N ' HD13 ' A' ' 160' ' ' ILE . 3.7 mp -105.86 122.82 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 178.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.4 m -116.67 -172.46 2.2 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 121.822 0.82 . . . . 0.0 109.116 -178.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -146.46 155.67 42.72 Favored 'General case' 0 C--N 1.354 0.792 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -178.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' THR . . . . . 0.414 ' O ' ' HB3' ' A' ' 167' ' ' GLN . 41.7 p -98.68 146.3 31.38 Favored Pre-proline 0 C--N 1.359 0.999 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.696 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 72.6 Cg_endo -76.35 -11.87 19.01 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 123.044 2.496 . . . . 0.0 115.148 -178.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -72.66 -41.07 65.82 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 120.056 -0.657 . . . . 0.0 109.551 -178.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 35.8 p -117.72 15.23 14.47 Favored 'General case' 0 C--N 1.354 0.802 0 C-N-CA 120.129 -0.628 . . . . 0.0 110.48 -178.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.696 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.3 pp0? -67.11 -11.85 58.36 Favored 'General case' 0 C--N 1.354 0.802 0 O-C-N 121.576 -0.703 . . . . 0.0 110.193 178.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -127.0 42.29 3.35 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 15.4 t -142.96 145.4 32.96 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.627 ' O ' ' HB ' ' A' ' 171' ' ' THR . 61.5 mt-10 -98.86 165.0 11.98 Favored 'General case' 0 C--N 1.353 0.751 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.627 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 11.9 m 83.71 -59.12 0.13 Allowed 'General case' 0 C--N 1.37 1.483 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -107.35 117.46 34.13 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 119.889 -0.724 . . . . 0.0 109.654 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 90.4 t -131.85 134.15 60.37 Favored 'Isoleucine or valine' 0 C--N 1.357 0.914 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 178.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 49.2 mm -113.4 126.97 70.92 Favored 'Isoleucine or valine' 0 C--N 1.359 0.987 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.617 ' HB2' ' HG ' ' A' ' 131' ' ' LEU . 97.1 m-85 -116.62 147.13 42.18 Favored 'General case' 0 C--N 1.361 1.081 0 CA-C-O 122.008 0.909 . . . . 0.0 108.778 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -125.68 119.37 27.82 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.524 HD11 ' CD2' ' A' ' 131' ' ' LEU . 51.0 mt -114.67 115.87 50.84 Favored 'Isoleucine or valine' 0 C--N 1.354 0.801 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 -179.177 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 88.4 m -127.55 140.5 52.08 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -178.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 . . . . . 0 C--N 1.366 1.307 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 179.231 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.9 mtp . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.096 0.474 . . . . 0.0 110.079 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.655 ' HA ' HG23 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -79.28 -17.28 54.98 Favored 'General case' 0 C--N 1.354 0.796 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.016 -178.365 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.83 -42.06 32.02 Favored Glycine 0 C--N 1.348 1.245 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.3 tpp -70.73 -37.92 73.52 Favored 'General case' 0 C--N 1.354 0.797 0 O-C-N 122.103 -0.645 . . . . 0.0 110.808 -177.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.655 HG23 ' HA ' ' A' ' 2' ' ' MET . 27.2 m -69.87 -23.16 25.33 Favored 'Isoleucine or valine' 0 C--N 1.357 0.914 0 O-C-N 121.614 -0.679 . . . . 0.0 109.723 -179.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.434 ' HZ ' ' CG ' ' A' ' 47' ' ' GLU . 1.5 m-85 -71.22 -34.78 71.13 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 88.3 m -67.03 -40.29 87.19 Favored 'General case' 0 C--N 1.354 0.795 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.04 -39.21 97.76 Favored Glycine 0 C--N 1.359 1.825 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.583 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -64.7 -40.02 94.66 Favored 'General case' 0 C--N 1.352 0.703 0 O-C-N 122.54 -0.388 . . . . 0.0 110.695 -178.333 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 24.6 mmt -64.18 -40.52 96.29 Favored 'General case' 0 C--N 1.353 0.739 0 O-C-N 121.672 -0.642 . . . . 0.0 111.046 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -65.53 -40.32 92.77 Favored 'General case' 0 C--N 1.349 0.552 0 O-C-N 121.991 -0.443 . . . . 0.0 111.516 -178.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 56.0 tp -66.14 -43.62 86.53 Favored 'General case' 0 C--N 1.348 0.542 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -178.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.583 HG12 ' O ' ' A' ' 9' ' ' LEU . 2.4 mm -72.84 -37.28 54.32 Favored 'Isoleucine or valine' 0 C--N 1.361 1.071 0 O-C-N 121.155 -0.966 . . . . 0.0 110.975 -175.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -71.13 -41.49 70.44 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.864 -0.522 . . . . 0.0 111.609 -175.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -72.59 -35.47 67.92 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -175.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -94.54 -30.27 14.47 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 118.901 -1.12 . . . . 0.0 113.966 -174.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -116.04 -30.97 5.87 Favored 'General case' 0 CA--C 1.506 -0.712 0 C-N-CA 117.538 -1.665 . . . . 0.0 112.728 -176.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 139.87 177.71 16.05 Favored Glycine 0 C--N 1.346 1.113 0 C-N-CA 118.346 -1.883 . . . . 0.0 109.523 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -99.11 -18.35 17.75 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -177.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -70.44 -39.59 74.26 Favored 'General case' 0 C--N 1.36 1.049 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 94.3 m -67.92 -39.19 83.55 Favored 'General case' 0 C--N 1.357 0.899 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.605 HD21 HD11 ' A' ' 26' ' ' LEU . 1.0 OUTLIER -60.71 -38.16 84.09 Favored 'General case' 0 C--N 1.355 0.847 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.518 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -63.78 -37.17 86.38 Favored 'General case' 0 C--N 1.357 0.916 0 O-C-N 122.154 -0.341 . . . . 0.0 110.787 -178.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.4 m -64.91 -40.49 95.15 Favored 'General case' 0 C--N 1.356 0.884 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -178.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.626 ' CD2' ' HB3' ' A' ' 54' ' ' LYS . 31.4 mt -63.84 -36.75 84.93 Favored 'General case' 0 C--N 1.359 0.982 0 O-C-N 121.946 -0.471 . . . . 0.0 109.957 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.605 HD11 HD21 ' A' ' 22' ' ' LEU . 87.5 mt -71.49 -16.03 62.34 Favored 'General case' 0 C--N 1.358 0.971 0 O-C-N 121.661 -0.65 . . . . 0.0 110.184 -178.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -86.46 -27.73 23.92 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 119.351 -0.939 . . . . 0.0 109.278 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 41.7 t -67.01 -37.1 83.57 Favored 'General case' 0 C--N 1.355 0.845 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.8 p -93.02 -39.0 11.34 Favored 'General case' 0 C--N 1.359 0.988 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -179.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 84.12 133.25 0.05 OUTLIER 'General case' 0 C--N 1.361 1.104 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 179.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.514 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -91.44 -167.05 1.7 Allowed 'General case' 0 C--N 1.357 0.919 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.636 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.492 ' H ' ' HB2' ' A' ' 31' ' ' LEU . 63.3 tt0 -152.99 -66.76 0.16 Allowed 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.7 t -97.57 -66.55 0.89 Allowed 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -130.35 -44.76 1.12 Allowed 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -179.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.21 -33.72 5.42 Favored Glycine 0 C--N 1.353 1.474 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 179.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 83.8 mt -117.22 107.51 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.01 0 CA-C-N 118.413 1.107 . . . . 0.0 108.073 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.466 ' HD1' ' HA ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -84.08 -147.78 0.1 Allowed 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.185 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.754 HG21 ' H ' ' A' ' 39' ' ' SER . 5.0 t -119.46 -53.56 2.22 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.754 ' H ' HG21 ' A' ' 38' ' ' THR . 23.8 p 170.05 65.33 0.0 OUTLIER 'General case' 0 C--N 1.362 1.138 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.5 t -145.49 -11.24 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.957 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.149 -178.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -91.62 142.08 15.93 Favored Glycine 0 C--N 1.352 1.446 0 C-N-CA 119.275 -1.44 . . . . 0.0 110.538 -177.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.1 m -123.61 123.12 39.86 Favored 'General case' 0 C--N 1.354 0.767 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -117.5 175.4 5.65 Favored 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -81.86 -172.49 3.94 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 68.9 m80 -90.64 -15.09 31.07 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -68.74 -29.39 67.79 Favored 'General case' 0 C--N 1.352 0.678 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.434 ' CG ' ' HZ ' ' A' ' 6' ' ' PHE . 26.5 tp10 -64.38 -39.81 94.59 Favored 'General case' 0 C--N 1.353 0.722 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.495 HD13 HG22 ' A' ' 52' ' ' VAL . 1.8 tm? -66.66 -38.56 87.11 Favored 'General case' 0 C--N 1.36 1.03 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 61.9 tp -70.32 -35.06 73.4 Favored 'General case' 0 CA--C 1.508 -0.667 0 O-C-N 122.232 -0.292 . . . . 0.0 110.47 -177.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -64.67 -41.2 96.24 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 121.936 -0.478 . . . . 0.0 109.914 -177.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.426 ' HA ' HD22 ' A' ' 51' ' ' LEU . 80.7 mt -83.55 -18.1 39.53 Favored 'General case' 0 C--N 1.359 1.001 0 C-N-CA 119.625 -0.83 . . . . 0.0 110.601 -179.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.495 HG22 HD13 ' A' ' 48' ' ' LEU . 1.4 t -80.33 -38.84 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.585 HG12 ' N ' ' A' ' 54' ' ' LYS . 5.0 p -71.76 -30.55 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 O-C-N 121.597 -0.689 . . . . 0.0 109.406 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.626 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 33.5 tptt -70.97 -28.39 64.42 Favored 'General case' 0 C--N 1.368 1.373 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 mt -63.85 -42.02 97.66 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.446 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 46.7 t -66.21 -39.94 89.98 Favored 'General case' 0 C--N 1.352 0.707 0 O-C-N 121.736 -0.602 . . . . 0.0 110.648 -179.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -77.64 -40.31 42.21 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 121.123 -0.985 . . . . 0.0 112.876 -177.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.472 HG11 ' N ' ' A' ' 59' ' ' SER . 4.0 p -75.29 -39.88 42.62 Favored 'Isoleucine or valine' 0 C--N 1.354 0.771 0 O-C-N 121.531 -0.731 . . . . 0.0 112.348 -175.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.472 ' N ' HG11 ' A' ' 58' ' ' VAL . 63.4 m -105.69 -9.25 17.41 Favored 'General case' 0 CA--C 1.503 -0.845 0 O-C-N 121.173 -0.954 . . . . 0.0 110.316 -177.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.441 ' HA ' ' O ' ' A' ' 56' ' ' SER . 0.4 OUTLIER 68.03 38.16 2.8 Favored 'General case' 0 C--N 1.351 0.656 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.881 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.506 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 58.2 t -115.37 128.05 26.28 Favored Pre-proline 0 N--CA 1.443 -0.81 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.506 ' HD3' ' HA ' ' A' ' 61' ' ' VAL . 37.2 Cg_exo -59.86 154.02 52.9 Favored 'Trans proline' 0 CA--C 1.496 -1.376 0 C-N-CA 122.72 2.28 . . . . 0.0 113.519 -179.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.3 m -76.43 -7.71 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.66 -177.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 81.4 p -94.71 -36.4 11.75 Favored 'General case' 0 C--N 1.358 0.944 0 C-N-CA 118.315 -1.354 . . . . 0.0 110.113 -178.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -82.48 -23.42 34.72 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.522 ' HA ' HD22 ' A' ' 66' ' ' LEU . 0.5 OUTLIER -70.29 -43.36 70.57 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.609 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.61 HG11 ' N ' ' A' ' 68' ' ' ARG . 4.6 p -67.47 -28.89 43.67 Favored 'Isoleucine or valine' 0 C--N 1.354 0.803 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.678 -179.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.61 ' N ' HG11 ' A' ' 67' ' ' VAL . 82.7 mtp180 -65.96 -47.92 73.02 Favored 'General case' 0 C--N 1.366 1.286 0 O-C-N 121.067 -1.021 . . . . 0.0 110.242 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 69' ' ' LEU . 88.6 mt -64.53 -36.33 83.85 Favored 'General case' 0 C--N 1.353 0.739 0 O-C-N 122.353 -0.217 . . . . 0.0 111.191 -178.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -60.84 -47.4 86.53 Favored 'General case' 0 C--N 1.349 0.582 0 O-C-N 122.115 -0.365 . . . . 0.0 110.44 -178.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.03 -39.24 96.8 Favored Glycine 0 C--N 1.353 1.524 0 N-CA-C 111.882 -0.487 . . . . 0.0 111.882 -178.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.38 -47.86 80.28 Favored 'General case' 0 C--N 1.351 0.656 0 CA-C-N 118.127 0.963 . . . . 0.0 111.615 -177.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.4 mttm -64.38 -49.02 73.26 Favored 'General case' 0 C--N 1.357 0.925 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -177.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.432 ' O ' HD23 ' A' ' 74' ' ' LEU . 2.5 tm? -69.11 -39.8 78.74 Favored 'General case' 0 C--N 1.349 0.566 0 O-C-N 121.194 -0.941 . . . . 0.0 111.865 -175.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -64.16 -45.97 86.1 Favored 'General case' 0 C--N 1.353 0.744 0 O-C-N 121.269 -0.895 . . . . 0.0 111.123 -177.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.11 -12.38 15.79 Favored 'Isoleucine or valine' 0 C--N 1.358 0.941 0 O-C-N 121.586 -0.696 . . . . 0.0 109.463 -179.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -78.52 -36.79 44.39 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 80.2 mt -70.57 -34.61 72.39 Favored 'General case' 0 C--N 1.358 0.94 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.3 mm -62.77 -50.37 79.99 Favored 'Isoleucine or valine' 0 C--N 1.357 0.904 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -178.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -67.89 -22.3 65.1 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.414 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.83 -1.18 61.8 Favored Glycine 0 C--N 1.347 1.19 0 C-N-CA 119.609 -1.281 . . . . 0.0 110.684 -177.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.672 ' HB3' ' HB ' ' A' ' 85' ' ' ILE . 93.2 m-70 -141.21 88.6 10.0 Favored Pre-proline 0 CA--C 1.503 -0.859 0 CA-C-N 118.937 1.368 . . . . 0.0 108.962 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 82' ' ' HIS . 36.8 Cg_endo -67.52 -25.79 40.84 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.425 2.083 . . . . 0.0 114.194 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -92.75 -6.14 49.69 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.672 ' HB ' ' HB3' ' A' ' 82' ' ' HIS . 1.0 OUTLIER -90.44 -22.3 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 -178.81 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -102.05 -21.4 14.46 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -69.85 -39.15 76.56 Favored 'General case' 0 C--N 1.355 0.827 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -65.48 -33.75 76.67 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.666 ' HG2' ' N ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -80.28 155.43 27.29 Favored 'General case' 0 C--N 1.353 0.749 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 -178.908 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.666 ' N ' ' HG2' ' A' ' 89' ' ' MET . 3.4 mtpt -117.15 -27.71 6.41 Favored 'General case' 0 C--N 1.364 1.207 0 C-N-CA 120.058 -0.657 . . . . 0.0 111.319 -177.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -167.08 175.47 7.51 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 -177.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 65.1 m -66.62 -40.09 88.63 Favored 'General case' 0 C--N 1.354 0.763 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.415 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -68.03 -39.61 83.09 Favored 'General case' 0 C--N 1.356 0.882 0 C-N-CA 119.587 -0.845 . . . . 0.0 108.805 -178.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -66.57 -23.03 66.15 Favored 'General case' 0 C--N 1.354 0.779 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 60.1 tp -65.25 -45.52 84.26 Favored 'General case' 0 C--N 1.354 0.797 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.5 mp -61.83 -36.5 81.36 Favored 'General case' 0 C--N 1.357 0.901 0 O-C-N 121.993 -0.442 . . . . 0.0 110.165 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 34.0 t -67.49 -39.83 85.2 Favored 'General case' 0 C--N 1.349 0.561 0 O-C-N 121.927 -0.483 . . . . 0.0 110.211 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.4 tttp -93.01 6.37 48.18 Favored 'General case' 0 C--N 1.353 0.76 0 O-C-N 122.241 -0.287 . . . . 0.0 111.567 -176.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.9 tp -64.4 -38.74 83.36 Favored 'Isoleucine or valine' 0 C--N 1.356 0.859 0 O-C-N 121.391 -0.818 . . . . 0.0 111.671 -177.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -103.44 -21.69 13.76 Favored 'General case' 0 N--CA 1.437 -1.116 0 O-C-N 120.884 -1.135 . . . . 0.0 110.26 -178.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.455 ' O ' HG22 ' A' ' 105' ' ' VAL . 35.2 t -62.98 -47.0 85.04 Favored 'General case' 0 N--CA 1.445 -0.687 0 O-C-N 121.564 -0.71 . . . . 0.0 111.691 -178.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -137.5 -14.49 1.47 Allowed 'General case' 0 C--N 1.36 1.057 0 C-N-CA 117.369 -1.732 . . . . 0.0 113.036 -177.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 32.3 mm -70.41 -51.37 38.52 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 CA-C-N 120.099 1.318 . . . . 0.0 110.633 -177.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 35.5 m170 -91.9 2.32 56.61 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 119.485 -0.886 . . . . 0.0 110.301 -177.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.455 HG22 ' O ' ' A' ' 101' ' ' SER . 52.7 t -83.26 -44.22 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.032 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 177.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -68.34 -40.56 81.52 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 69.9 t -63.45 -46.77 94.35 Favored 'Isoleucine or valine' 0 C--N 1.357 0.901 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.363 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -60.75 -48.59 81.09 Favored 'General case' 0 C--N 1.357 0.926 0 O-C-N 122.064 -0.397 . . . . 0.0 111.409 -179.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -61.6 -37.21 83.07 Favored 'General case' 0 C--N 1.356 0.86 0 O-C-N 121.495 -0.753 . . . . 0.0 110.538 -178.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.5 mt -56.98 -73.9 0.06 Allowed 'General case' 0 C--N 1.357 0.9 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -119.13 135.47 23.9 Favored Pre-proline 0 N--CA 1.438 -1.047 0 C-N-CA 118.475 -1.29 . . . . 0.0 109.032 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -83.51 -4.61 10.87 Favored 'Trans proline' 0 C--N 1.313 -1.342 0 C-N-CA 123.174 2.583 . . . . 0.0 115.175 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -66.6 -36.84 83.58 Favored 'General case' 0 C--N 1.354 0.79 0 O-C-N 121.88 -0.512 . . . . 0.0 109.842 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.1 145.65 55.09 Favored 'General case' 0 C--N 1.354 0.764 0 CA-C-O 121.554 0.692 . . . . 0.0 109.787 -178.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -130.45 135.44 47.99 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.566 ' HB3' ' HD2' ' A' ' 117' ' ' PRO . 86.4 mt -127.68 157.18 74.09 Favored Pre-proline 0 N--CA 1.443 -0.823 0 CA-C-O 122.173 0.987 . . . . 0.0 109.196 -178.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.566 ' HD2' ' HB3' ' A' ' 116' ' ' LEU . 83.6 Cg_endo -81.02 -156.36 0.07 OUTLIER 'Trans proline' 0 C--N 1.316 -1.139 0 C-N-CA 123.797 2.998 . . . . 0.0 114.115 -179.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.405 ' H ' ' HB2' ' A' ' 117' ' ' PRO . 74.6 mmtt -113.38 140.26 48.2 Favored 'General case' 0 C--N 1.364 1.207 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -123.67 127.02 47.59 Favored 'General case' 0 C--N 1.362 1.144 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -179.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.516 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 94.2 m -126.26 128.98 48.01 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 177.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 81.0 m -119.83 130.73 55.03 Favored 'General case' 0 CA--C 1.503 -0.851 0 C-N-CA 119.105 -1.038 . . . . 0.0 109.677 -177.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -119.14 127.13 53.05 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 178.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 66.2 ttp85 -102.18 116.69 33.2 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.431 ' HA ' HD22 ' A' ' 124' ' ' LEU . 92.8 mt -87.42 -21.61 25.49 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.378 -179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 177.68 -146.59 7.69 Favored Glycine 0 N--CA 1.438 -1.226 0 C-N-CA 118.844 -1.645 . . . . 0.0 109.103 -178.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -94.72 -40.05 9.98 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 120.081 -0.648 . . . . 0.0 109.411 -178.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -101.53 1.45 38.02 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.24 -178.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -119.01 130.43 55.66 Favored 'General case' 0 C--N 1.358 0.968 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.466 HD13 HG22 ' A' ' 129' ' ' ILE . 7.6 mm -141.13 136.77 33.68 Favored 'Isoleucine or valine' 0 C--N 1.356 0.861 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 55.6 mtm180 -122.57 139.14 54.24 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.674 ' HG ' ' O ' ' A' ' 131' ' ' LEU . 0.1 OUTLIER -130.16 125.68 35.63 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.078 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.516 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 13.5 m-70 -96.77 134.56 39.89 Favored 'General case' 0 CA--C 1.495 -1.165 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -127.87 119.9 26.59 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 -178.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.535 ' HA ' ' O ' ' A' ' 171' ' ' THR . 76.6 mt-30 -113.51 114.74 26.94 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 179.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 12.7 t -162.73 152.55 15.92 Favored 'General case' 0 C--N 1.358 0.96 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -90.62 2.71 55.62 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 120.271 -0.572 . . . . 0.0 109.652 -179.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -136.11 74.54 55.86 Favored Pre-proline 0 CA--C 1.505 -0.752 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -95.88 107.78 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.771 2.314 . . . . 0.0 115.776 -177.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -111.94 113.6 26.02 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 176.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.98 -38.28 90.49 Favored 'General case' 0 C--N 1.353 0.73 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.007 -179.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.0 m -63.27 -27.34 69.27 Favored 'General case' 0 C--N 1.354 0.773 0 O-C-N 122.009 -0.432 . . . . 0.0 110.875 -178.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -76.63 -46.43 25.96 Favored 'General case' 0 C--N 1.351 0.652 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.639 -178.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.63 -40.11 94.9 Favored 'General case' 0 C--N 1.357 0.923 0 O-C-N 122.039 -0.413 . . . . 0.0 111.056 -178.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.64 -37.25 86.61 Favored 'General case' 0 C--N 1.355 0.83 0 O-C-N 121.907 -0.496 . . . . 0.0 110.081 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -59.88 -43.16 98.28 Favored Glycine 0 C--N 1.347 1.176 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 83.5 mt -69.78 -40.78 75.83 Favored 'General case' 0 C--N 1.352 0.694 0 CA-C-N 117.749 0.774 . . . . 0.0 112.503 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 98.0 mt -71.29 -42.41 68.73 Favored 'General case' 0 C--N 1.361 1.083 0 O-C-N 121.206 -0.934 . . . . 0.0 110.961 -176.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.52 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 37.0 t70 -69.93 -31.36 69.08 Favored 'General case' 0 N--CA 1.446 -0.652 0 O-C-N 121.956 -0.465 . . . . 0.0 110.514 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -62.84 -39.38 97.92 Favored Glycine 0 C--N 1.357 1.745 0 N-CA-C 108.46 -1.856 . . . . 0.0 108.46 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 49.9 t -60.71 -41.46 95.29 Favored 'General case' 0 C--N 1.35 0.6 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -74.8 -1.48 22.33 Favored 'General case' 0 C--N 1.361 1.077 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.52 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 77.7 mm-40 -84.4 -46.07 12.08 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 92.9 t80 -65.95 -45.06 83.16 Favored 'General case' 0 C--N 1.359 0.989 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.417 ' HZ ' ' SD ' ' A' ' 89' ' ' MET . 38.9 m-85 -69.01 -26.62 65.09 Favored 'General case' 0 C--N 1.36 1.053 0 O-C-N 121.874 -0.516 . . . . 0.0 110.802 -178.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 78.9 tttt 72.72 74.35 0.15 Allowed 'General case' 0 C--N 1.36 1.035 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -143.13 -168.12 2.72 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -148.67 94.45 2.28 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -111.88 156.11 22.56 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 178.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 93.9 m -119.47 127.1 52.74 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 119.208 -0.997 . . . . 0.0 108.716 -178.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 3.7 mp -103.89 122.2 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.5 m -115.64 -175.96 2.83 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-O 121.826 0.822 . . . . 0.0 109.134 -179.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 3.5 ptt180 -146.75 153.63 40.46 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 -178.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' THR . . . . . 0.406 ' O ' ' HB3' ' A' ' 167' ' ' GLN . 44.8 p -97.62 145.93 30.55 Favored Pre-proline 0 C--N 1.361 1.08 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.648 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 76.8 Cg_endo -77.13 -11.24 17.79 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.944 2.429 . . . . 0.0 115.127 -178.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -72.74 -41.29 65.32 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.573 -178.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 36.8 p -116.96 15.3 15.16 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.299 -178.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.648 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.5 pp0? -65.13 -13.65 58.63 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.408 178.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -126.89 43.18 3.17 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 16.8 t -142.57 145.13 33.27 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.637 ' O ' ' HB ' ' A' ' 171' ' ' THR . 61.1 mt-10 -98.98 165.49 11.73 Favored 'General case' 0 C--N 1.354 0.804 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.637 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 3.0 m 83.42 -57.13 0.15 Allowed 'General case' 0 C--N 1.369 1.423 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.637 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -110.93 117.44 33.38 Favored 'General case' 0 CA--C 1.506 -0.72 0 C-N-CA 119.814 -0.754 . . . . 0.0 109.603 -178.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 98.7 t -131.33 133.39 62.27 Favored 'Isoleucine or valine' 0 C--N 1.356 0.857 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 178.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 48.6 mm -109.36 125.99 66.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.964 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -179.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -115.08 148.38 39.0 Favored 'General case' 0 C--N 1.357 0.922 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -128.58 117.4 21.19 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 -179.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.8 mp -111.94 118.38 57.51 Favored 'Isoleucine or valine' 0 C--N 1.354 0.765 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 89.3 m -124.3 142.84 50.94 Favored 'General case' 0 CA--C 1.502 -0.893 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -177.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 12.2 ttt180 . . . . . 0 C--N 1.363 1.153 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 178.848 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.738 ' HG2' ' HB2' ' A' ' 4' ' ' MET . 27.2 tpp . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 120.881 0.372 . . . . 0.0 110.538 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.416 ' HA ' HG21 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -81.34 -20.14 41.29 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -179.695 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -77.86 -37.68 29.08 Favored Glycine 0 C--N 1.35 1.331 0 N-CA-C 109.101 -1.599 . . . . 0.0 109.101 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' MET . . . . . 0.738 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 3.0 tpp -70.84 -38.21 73.18 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 122.035 -0.685 . . . . 0.0 110.707 -177.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.416 HG21 ' HA ' ' A' ' 2' ' ' MET . 27.2 m -71.28 -23.14 22.82 Favored 'Isoleucine or valine' 0 C--N 1.357 0.93 0 O-C-N 121.651 -0.656 . . . . 0.0 109.415 -178.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.0 m-30 -71.06 -33.38 70.22 Favored 'General case' 0 C--N 1.357 0.893 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.1 m -67.14 -40.17 86.68 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.93 -38.82 97.22 Favored Glycine 0 C--N 1.36 1.893 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.525 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.1 OUTLIER -66.13 -39.11 89.62 Favored 'General case' 0 C--N 1.353 0.736 0 CA-C-N 117.274 0.537 . . . . 0.0 110.31 -177.952 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.911 ' HE2' HD23 ' A' ' 26' ' ' LEU . 25.5 mmt -64.02 -40.6 96.71 Favored 'General case' 0 C--N 1.355 0.822 0 O-C-N 121.635 -0.666 . . . . 0.0 110.753 -178.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -64.77 -40.07 94.66 Favored 'General case' 0 C--N 1.349 0.547 0 O-C-N 122.055 -0.403 . . . . 0.0 111.307 -178.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 58.2 tp -65.0 -42.68 94.26 Favored 'General case' 0 C--N 1.35 0.592 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.525 HG12 ' O ' ' A' ' 9' ' ' LEU . 3.3 mm -72.44 -37.58 57.99 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 O-C-N 121.169 -0.957 . . . . 0.0 111.179 -175.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -68.02 -43.75 78.05 Favored 'General case' 0 C--N 1.352 0.679 0 O-C-N 121.821 -0.549 . . . . 0.0 111.653 -175.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -71.9 -32.45 67.42 Favored 'General case' 0 N--CA 1.447 -0.579 0 O-C-N 122.001 -0.437 . . . . 0.0 111.487 -177.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -72.5 -49.96 29.32 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -175.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -127.98 -20.97 3.73 Favored 'General case' 0 C--N 1.357 0.917 0 C-N-CA 117.347 -1.741 . . . . 0.0 113.694 -176.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 143.42 178.88 19.61 Favored Glycine 0 CA--C 1.499 -0.947 0 C-N-CA 117.678 -2.201 . . . . 0.0 110.23 -179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -96.5 -11.34 25.65 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -177.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -74.64 -36.57 62.88 Favored 'General case' 0 C--N 1.359 0.986 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.2 m -70.11 -38.91 75.74 Favored 'General case' 0 C--N 1.358 0.952 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 178.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.505 HD23 ' CD1' ' A' ' 26' ' ' LEU . 1.7 tt -59.84 -38.09 81.09 Favored 'General case' 0 C--N 1.359 0.994 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -64.12 -37.09 86.19 Favored 'General case' 0 C--N 1.356 0.87 0 O-C-N 122.097 -0.377 . . . . 0.0 110.788 -178.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.5 m -65.25 -40.63 94.24 Favored 'General case' 0 C--N 1.355 0.836 0 O-C-N 121.698 -0.626 . . . . 0.0 109.62 -178.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.458 HD11 HG21 ' A' ' 13' ' ' ILE . 78.7 mt -64.9 -36.82 85.6 Favored 'General case' 0 C--N 1.356 0.868 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 -178.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.911 HD23 ' HE2' ' A' ' 10' ' ' MET . 81.1 mt -70.84 -16.5 62.72 Favored 'General case' 0 C--N 1.36 1.048 0 O-C-N 121.765 -0.584 . . . . 0.0 110.235 -179.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -85.07 -27.83 26.06 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.29 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.2 t -66.89 -37.54 84.59 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.8 p -91.61 -39.54 11.82 Favored 'General case' 0 C--N 1.359 0.995 0 C-N-CA 119.064 -1.054 . . . . 0.0 108.18 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 86.15 132.45 0.04 OUTLIER 'General case' 0 C--N 1.36 1.049 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.528 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -91.91 -167.07 1.69 Allowed 'General case' 0 C--N 1.356 0.885 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.841 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.494 ' H ' ' HB2' ' A' ' 31' ' ' LEU . 4.3 mt-30 -153.05 -66.3 0.15 Allowed 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 106.816 -1.549 . . . . 0.0 106.816 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.0 t -97.71 -67.12 0.86 Allowed 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -131.42 -46.53 0.98 Allowed 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.24 -37.37 3.51 Favored Glycine 0 C--N 1.354 1.566 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 179.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 81.9 mt -113.62 106.09 20.02 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.041 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.495 ' HD1' ' HA ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -82.57 -150.78 0.09 Allowed 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.496 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.469 ' H ' ' HB3' ' A' ' 37' ' ' TYR . 86.2 m -112.09 -57.84 2.21 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.426 ' C ' HG21 ' A' ' 40' ' ' VAL . 11.6 p 169.06 69.8 0.0 OUTLIER 'General case' 0 C--N 1.36 1.029 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.426 HG21 ' C ' ' A' ' 39' ' ' SER . 2.2 t -150.29 -6.69 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.361 1.081 0 C-N-CA 119.707 -0.797 . . . . 0.0 110.047 -178.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -95.26 143.08 16.42 Favored Glycine 0 C--N 1.352 1.447 0 C-N-CA 119.28 -1.438 . . . . 0.0 110.465 -177.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.0 m -123.94 116.77 23.42 Favored 'General case' 0 C--N 1.356 0.871 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 178.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -111.66 177.42 4.66 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -78.66 -175.14 4.23 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 65.4 m80 -94.38 -15.6 24.2 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 119.781 -0.767 . . . . 0.0 109.179 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -68.88 -29.22 67.47 Favored 'General case' 0 C--N 1.353 0.749 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.6 tp10 -62.72 -41.51 99.19 Favored 'General case' 0 C--N 1.353 0.719 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 59.9 tp -67.62 -38.74 84.36 Favored 'General case' 0 C--N 1.357 0.893 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.218 -179.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 60.5 tp -72.3 -34.69 68.32 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 122.259 -0.276 . . . . 0.0 110.689 -177.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 72.7 tp60 -64.18 -41.81 96.95 Favored 'General case' 0 C--N 1.353 0.721 0 O-C-N 121.589 -0.694 . . . . 0.0 110.004 -177.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 84.2 mt -71.79 -34.64 69.58 Favored 'General case' 0 C--N 1.362 1.113 0 C-N-CA 119.534 -0.867 . . . . 0.0 109.431 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.514 HG13 HD21 ' A' ' 66' ' ' LEU . 29.2 t -62.65 -42.12 94.82 Favored 'Isoleucine or valine' 0 C--N 1.351 0.645 0 CA-C-O 120.705 0.288 . . . . 0.0 110.309 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.495 ' O ' HG11 ' A' ' 53' ' ' VAL . 53.9 t -65.76 -40.21 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 32.1 tptt -65.22 -29.2 69.98 Favored 'General case' 0 C--N 1.361 1.107 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.538 HD12 HD13 ' A' ' 66' ' ' LEU . 16.0 mt -64.27 -40.26 95.6 Favored 'General case' 0 C--N 1.357 0.902 0 O-C-N 121.968 -0.457 . . . . 0.0 110.395 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.575 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 46.5 t -65.39 -37.44 87.0 Favored 'General case' 0 C--N 1.349 0.573 0 O-C-N 121.775 -0.578 . . . . 0.0 110.324 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -83.74 -38.25 21.61 Favored 'General case' 0 C--N 1.353 0.73 0 O-C-N 121.242 -0.911 . . . . 0.0 112.811 -177.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.729 HG12 ' N ' ' A' ' 59' ' ' SER . 4.6 p -76.03 -41.6 38.4 Favored 'Isoleucine or valine' 0 C--N 1.355 0.83 0 O-C-N 121.354 -0.841 . . . . 0.0 111.897 -176.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.729 ' N ' HG12 ' A' ' 58' ' ' VAL . 72.8 m -103.66 -5.66 22.38 Favored 'General case' 0 C--N 1.354 0.803 0 O-C-N 121.198 -0.939 . . . . 0.0 110.486 -177.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 74.6 m 65.05 38.95 5.9 Favored 'General case' 0 C--N 1.354 0.769 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.575 ' O ' ' HA ' ' A' ' 56' ' ' SER . 55.4 t -115.53 132.22 23.23 Favored Pre-proline 0 CA--C 1.505 -0.778 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.553 ' HD2' HG13 ' A' ' 61' ' ' VAL . 31.2 Cg_endo -63.99 157.16 54.47 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.258 1.972 . . . . 0.0 114.095 -178.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.61 ' HA ' ' CD2' ' A' ' 66' ' ' LEU . 15.5 m -75.98 -12.66 14.62 Favored 'Isoleucine or valine' 0 C--N 1.353 0.742 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.031 -177.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 81.1 p -94.13 -35.14 12.67 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 118.068 -1.453 . . . . 0.0 110.129 -178.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -80.9 -21.22 40.76 Favored 'General case' 0 C--N 1.353 0.737 0 O-C-N 121.167 -0.958 . . . . 0.0 108.892 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.61 ' CD2' ' HA ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -77.19 -36.67 54.78 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.732 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.614 HG11 ' N ' ' A' ' 68' ' ' ARG . 1.8 p -68.83 -28.9 41.59 Favored 'Isoleucine or valine' 0 C--N 1.359 0.981 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.055 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.614 ' N ' HG11 ' A' ' 67' ' ' VAL . 79.8 mtp180 -68.49 -49.1 62.24 Favored 'General case' 0 C--N 1.365 1.265 0 O-C-N 121.234 -0.916 . . . . 0.0 110.656 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.9 mt -63.83 -36.41 83.81 Favored 'General case' 0 C--N 1.357 0.893 0 O-C-N 122.069 -0.395 . . . . 0.0 111.027 -178.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -61.16 -47.07 87.88 Favored 'General case' 0 C--N 1.348 0.536 0 O-C-N 122.134 -0.354 . . . . 0.0 110.495 -178.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.25 -39.29 96.99 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-O 119.787 -0.452 . . . . 0.0 112.17 -177.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -65.7 -45.45 82.75 Favored 'General case' 0 C--N 1.352 0.674 0 CA-C-N 118.513 1.157 . . . . 0.0 111.638 -177.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 12.2 mttm -64.86 -48.24 75.0 Favored 'General case' 0 C--N 1.357 0.921 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -177.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -70.76 -39.31 73.33 Favored 'General case' 0 C--N 1.349 0.563 0 O-C-N 121.263 -0.898 . . . . 0.0 111.963 -176.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -63.56 -46.45 85.85 Favored 'General case' 0 C--N 1.353 0.755 0 O-C-N 121.103 -0.998 . . . . 0.0 111.239 -178.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.8 p -70.89 -14.72 18.26 Favored 'Isoleucine or valine' 0 C--N 1.357 0.931 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -71.11 -39.76 71.88 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 87.7 mt -75.78 -27.19 57.93 Favored 'General case' 0 C--N 1.359 0.986 0 O-C-N 122.258 -0.276 . . . . 0.0 110.569 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.1 mm -65.78 -53.59 36.78 Favored 'Isoleucine or valine' 0 C--N 1.36 1.059 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.432 -178.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -75.26 -14.6 60.52 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 119.611 -0.836 . . . . 0.0 109.259 178.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.7 -37.58 61.47 Favored Glycine 0 C--N 1.35 1.345 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -132.55 102.9 13.69 Favored Pre-proline 0 C--N 1.356 0.887 0 CA-C-O 122.611 1.196 . . . . 0.0 109.104 -177.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.503 ' O ' ' HB2' ' A' ' 87' ' ' ASN . 40.3 Cg_endo -68.74 -22.23 37.49 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.556 2.17 . . . . 0.0 114.039 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -90.69 -9.56 46.36 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -89.84 -21.89 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.967 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 -178.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.534 ' HA ' ' HE2' ' A' ' 89' ' ' MET . . . -102.66 -16.35 16.06 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.503 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 49.2 t30 -70.99 -40.64 71.75 Favored 'General case' 0 C--N 1.36 1.028 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -67.7 -28.38 67.63 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 120.746 -0.381 . . . . 0.0 110.418 -179.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.687 ' SD ' ' HZ ' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -81.59 152.24 27.29 Favored 'General case' 0 C--N 1.352 0.696 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -179.488 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.621 ' N ' ' HG2' ' A' ' 89' ' ' MET . 4.6 mtpt -117.14 -26.76 6.69 Favored 'General case' 0 C--N 1.365 1.246 0 C-N-CA 120.054 -0.659 . . . . 0.0 111.293 -177.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -167.74 175.6 6.85 Favored 'General case' 0 C--N 1.354 0.797 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -177.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.427 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 42.2 t -64.75 -43.95 91.67 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.383 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -68.08 -39.54 82.9 Favored 'General case' 0 C--N 1.355 0.836 0 O-C-N 121.365 -0.834 . . . . 0.0 109.418 -178.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -66.23 -22.45 66.33 Favored 'General case' 0 C--N 1.353 0.757 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.427 ' HB3' ' O ' ' A' ' 92' ' ' SER . 60.3 tp -65.08 -46.03 82.85 Favored 'General case' 0 C--N 1.354 0.767 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.9 mp -62.96 -36.13 82.45 Favored 'General case' 0 C--N 1.355 0.839 0 O-C-N 122.2 -0.313 . . . . 0.0 110.744 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 35.9 t -65.09 -41.69 94.74 Favored 'General case' 0 C--N 1.349 0.582 0 O-C-N 121.849 -0.532 . . . . 0.0 111.555 -178.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.807 ' HG2' ' O ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -102.37 9.85 39.5 Favored 'General case' 0 C--N 1.358 0.946 0 O-C-N 121.676 -0.64 . . . . 0.0 110.327 -176.126 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.69 HG21 ' N ' ' A' ' 100' ' ' ASP . 11.7 tt -63.1 -35.14 70.5 Favored 'Isoleucine or valine' 0 C--N 1.354 0.797 0 O-C-N 121.088 -1.008 . . . . 0.0 111.984 -176.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.69 ' N ' HG21 ' A' ' 99' ' ' ILE . 37.4 t70 -111.28 -18.52 12.91 Favored 'General case' 0 N--CA 1.438 -1.054 0 O-C-N 120.814 -1.179 . . . . 0.0 109.99 -178.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 37.7 t -64.38 -46.9 81.35 Favored 'General case' 0 N--CA 1.443 -0.808 0 O-C-N 121.697 -0.627 . . . . 0.0 111.107 -178.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.429 ' O ' HG13 ' A' ' 105' ' ' VAL . 35.2 t80 -130.15 -21.1 2.98 Favored 'General case' 0 C--N 1.359 0.986 0 C-N-CA 118.002 -1.479 . . . . 0.0 112.565 -177.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 96.1 mt -71.15 -49.5 48.25 Favored 'Isoleucine or valine' 0 C--O 1.242 0.693 0 O-C-N 120.771 -1.205 . . . . 0.0 110.976 -177.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 29.8 m170 -89.41 3.49 52.1 Favored 'General case' 0 N--CA 1.439 -0.982 0 O-C-N 121.111 -0.993 . . . . 0.0 109.996 -177.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.429 HG13 ' O ' ' A' ' 102' ' ' PHE . 2.5 p -88.82 -34.26 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 178.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -72.11 -40.92 67.8 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 76.5 t -63.81 -46.54 94.1 Favored 'Isoleucine or valine' 0 C--N 1.356 0.861 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -60.6 -48.62 80.96 Favored 'General case' 0 C--N 1.359 1.015 0 O-C-N 122.226 -0.296 . . . . 0.0 111.447 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -60.97 -38.11 84.77 Favored 'General case' 0 C--N 1.356 0.857 0 O-C-N 121.567 -0.708 . . . . 0.0 110.651 -178.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 18.5 mt -57.66 -75.66 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -116.22 132.7 23.14 Favored Pre-proline 0 N--CA 1.438 -1.054 0 C-N-CA 118.708 -1.197 . . . . 0.0 108.857 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -83.04 -4.87 11.28 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 123.136 2.557 . . . . 0.0 115.003 -179.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -66.9 -36.76 83.01 Favored 'General case' 0 C--N 1.355 0.806 0 O-C-N 121.964 -0.46 . . . . 0.0 109.826 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.5 147.25 52.27 Favored 'General case' 0 C--N 1.352 0.69 0 CA-C-O 121.585 0.707 . . . . 0.0 109.849 -178.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -132.47 135.56 46.12 Favored 'General case' 0 C--N 1.357 0.898 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 179.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.536 ' HB3' ' HD2' ' A' ' 117' ' ' PRO . 2.7 mm? -124.12 156.45 66.28 Favored Pre-proline 0 C--N 1.354 0.789 0 CA-C-O 122.023 0.916 . . . . 0.0 108.649 -178.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.536 ' HD2' ' HB3' ' A' ' 116' ' ' LEU . 95.0 Cg_endo -79.23 -160.17 0.12 Allowed 'Trans proline' 0 C--N 1.318 -1.047 0 C-N-CA 123.554 2.836 . . . . 0.0 113.22 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -120.73 144.11 48.42 Favored 'General case' 0 C--N 1.364 1.201 0 C-N-CA 118.997 -1.081 . . . . 0.0 108.24 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.56 ' HE2' ' CD1' ' A' ' 133' ' ' TYR . 22.4 m-85 -129.13 137.77 51.4 Favored 'General case' 0 C--N 1.362 1.109 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.35 -178.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.434 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 93.8 m -123.87 129.49 51.08 Favored 'General case' 0 C--N 1.356 0.85 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 177.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 82.5 m -113.49 127.55 56.14 Favored 'General case' 0 CA--C 1.503 -0.846 0 C-N-CA 119.069 -1.052 . . . . 0.0 109.717 -177.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -120.24 118.9 31.68 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 178.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.436 ' HG3' HD11 ' A' ' 129' ' ' ILE . 58.7 ttp180 -96.23 117.85 31.6 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -178.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.404 ' HA ' HD22 ' A' ' 124' ' ' LEU . 92.8 mt -88.98 -20.07 24.91 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.303 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -179.88 -150.08 8.93 Favored Glycine 0 C--N 1.349 1.303 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 -178.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -94.69 -36.06 11.9 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -178.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -103.34 0.12 30.93 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 120.176 -0.61 . . . . 0.0 109.969 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -116.69 134.03 55.3 Favored 'General case' 0 C--N 1.358 0.954 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.645 HG23 ' N ' ' A' ' 130' ' ' ARG . 8.1 mm -144.85 137.95 22.1 Favored 'Isoleucine or valine' 0 C--N 1.357 0.923 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.645 ' N ' HG23 ' A' ' 129' ' ' ILE . 26.1 mtm180 -125.42 135.83 52.78 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.626 ' HG ' ' O ' ' A' ' 131' ' ' LEU . 0.2 OUTLIER -129.05 128.03 42.76 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.708 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.434 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 18.5 m170 -95.78 138.29 33.64 Favored 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.56 ' CD1' ' HE2' ' A' ' 119' ' ' PHE . 65.3 t80 -126.3 118.97 26.19 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 -178.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.486 ' HA ' ' O ' ' A' ' 171' ' ' THR . 27.5 tt0 -113.36 114.15 26.23 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 12.7 t -165.11 151.32 10.07 Favored 'General case' 0 C--N 1.358 0.962 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -91.12 4.31 52.51 Favored 'General case' 0 C--N 1.355 0.846 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.638 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.452 HH11 ' HD2' ' A' ' 137' ' ' ARG . 1.0 OUTLIER -135.68 72.69 62.75 Favored Pre-proline 0 C--N 1.355 0.847 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 179.053 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -96.47 108.23 0.1 Allowed 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 122.749 2.299 . . . . 0.0 115.924 -177.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -111.91 113.27 25.49 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 176.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.21 -38.6 91.8 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.101 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.1 m -63.43 -28.18 69.8 Favored 'General case' 0 C--N 1.353 0.726 0 O-C-N 121.967 -0.458 . . . . 0.0 110.903 -178.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -75.33 -45.94 36.39 Favored 'General case' 0 C--N 1.351 0.641 0 C-N-CA 120.156 -0.617 . . . . 0.0 109.552 -177.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.67 -39.79 91.71 Favored 'General case' 0 C--N 1.356 0.887 0 O-C-N 122.047 -0.408 . . . . 0.0 111.356 -177.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -62.99 -37.26 86.46 Favored 'General case' 0 C--N 1.355 0.843 0 O-C-N 121.78 -0.575 . . . . 0.0 110.057 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.59 -42.94 99.4 Favored Glycine 0 C--N 1.348 1.214 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 82.8 mt -69.54 -41.14 76.34 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 117.437 0.619 . . . . 0.0 112.596 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 97.0 mt -71.29 -42.04 69.18 Favored 'General case' 0 C--N 1.36 1.06 0 O-C-N 121.252 -0.905 . . . . 0.0 110.999 -177.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -69.88 -31.83 69.86 Favored 'General case' 0 C--N 1.349 0.555 0 O-C-N 121.994 -0.441 . . . . 0.0 110.597 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . 0.553 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -62.59 -40.03 98.62 Favored Glycine 0 C--N 1.355 1.632 0 N-CA-C 108.674 -1.771 . . . . 0.0 108.674 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 45.1 t -61.05 -42.67 98.91 Favored 'General case' 0 C--N 1.35 0.621 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.475 ' HB2' ' O ' ' A' ' 156' ' ' GLU . . . -76.05 1.79 14.54 Favored 'General case' 0 C--N 1.357 0.931 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.553 ' HB2' ' O ' ' A' ' 149' ' ' GLY . 7.6 mm-40 -86.57 -47.7 9.0 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -65.11 -45.19 86.14 Favored 'General case' 0 C--N 1.359 0.993 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.687 ' HZ ' ' SD ' ' A' ' 89' ' ' MET . 51.9 m-85 -69.25 -27.99 65.92 Favored 'General case' 0 C--N 1.362 1.132 0 O-C-N 121.897 -0.502 . . . . 0.0 111.013 -178.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 85.2 tttt 72.3 73.59 0.16 Allowed 'General case' 0 C--N 1.359 0.998 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -178.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.475 ' O ' ' HB2' ' A' ' 151' ' ' ALA . 2.4 tp10 -156.34 119.21 4.14 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -82.39 106.84 14.6 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 120.086 -0.646 . . . . 0.0 111.069 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 11.9 m-30 -112.38 160.31 17.83 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 176.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 92.3 m -120.47 127.84 52.59 Favored 'General case' 0 CA--C 1.505 -0.772 0 C-N-CA 118.938 -1.105 . . . . 0.0 109.073 -178.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 3.9 mp -105.65 122.63 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.7 m -118.87 -171.93 2.19 Favored 'General case' 0 C--N 1.358 0.936 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -178.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -145.36 154.57 42.44 Favored 'General case' 0 C--N 1.356 0.851 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -178.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' THR . . . . . 0.42 ' O ' ' HB3' ' A' ' 167' ' ' GLN . 28.7 p -96.27 144.84 28.53 Favored Pre-proline 0 C--N 1.36 1.054 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 178.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.723 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 72.9 Cg_endo -75.63 -12.83 20.29 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.79 2.326 . . . . 0.0 115.203 -178.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -72.91 -41.77 64.25 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.664 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 41.9 p -115.84 15.14 16.36 Favored 'General case' 0 C--N 1.355 0.807 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.391 -178.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.723 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.3 pp0? -66.6 -12.64 58.9 Favored 'General case' 0 C--N 1.355 0.834 0 O-C-N 121.59 -0.694 . . . . 0.0 110.454 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -128.08 42.53 3.3 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 19.1 t -143.17 145.03 32.44 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.626 ' O ' ' HB ' ' A' ' 171' ' ' THR . 61.7 mt-10 -97.44 165.45 12.0 Favored 'General case' 0 C--N 1.355 0.818 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.626 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 16.9 m 84.81 -58.62 0.1 Allowed 'General case' 0 C--N 1.369 1.451 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -109.9 114.74 28.53 Favored 'General case' 0 CA--C 1.504 -0.803 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.45 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 95.2 t -133.26 133.09 58.28 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 63.3 mt -117.57 128.48 74.79 Favored 'Isoleucine or valine' 0 C--N 1.358 0.968 0 CA-C-O 122.14 0.971 . . . . 0.0 109.456 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -110.52 145.23 38.1 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 114.838 -1.074 . . . . 0.0 108.336 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -119.61 118.3 30.63 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.7 mp -112.4 119.0 59.23 Favored 'Isoleucine or valine' 0 C--N 1.354 0.793 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 -178.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 90.3 m -124.6 142.05 51.65 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -177.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 13.6 ttt180 . . . . . 0 C--N 1.36 1.038 0 N-CA-C 106.835 -1.542 . . . . 0.0 106.835 179.127 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.502 ' HE2' ' HE3' ' A' ' 4' ' ' MET . 76.5 mtm . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.298 0.57 . . . . 0.0 110.828 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.74 -14.11 58.4 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -178.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.22 -41.99 44.62 Favored Glycine 0 C--N 1.351 1.369 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' MET . . . . . 0.502 ' HE3' ' HE2' ' A' ' 1' ' ' MET . 17.6 ttp -68.15 -39.37 82.67 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 122.119 -0.636 . . . . 0.0 111.564 -177.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.0 m -68.25 -23.5 28.65 Favored 'Isoleucine or valine' 0 C--N 1.356 0.871 0 O-C-N 121.462 -0.773 . . . . 0.0 109.534 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.411 ' HZ ' ' CG ' ' A' ' 47' ' ' GLU . 2.6 m-85 -71.53 -34.05 69.71 Favored 'General case' 0 C--N 1.359 0.994 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 179.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.8 m -66.1 -40.37 90.69 Favored 'General case' 0 C--N 1.355 0.826 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -61.83 -38.68 96.38 Favored Glycine 0 C--N 1.358 1.8 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.693 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -64.54 -41.78 96.13 Favored 'General case' 0 C--N 1.352 0.705 0 CA-C-N 117.072 0.436 . . . . 0.0 111.068 -178.552 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.608 ' HE1' HD22 ' A' ' 26' ' ' LEU . 18.5 mmt -63.0 -41.29 99.55 Favored 'General case' 0 C--N 1.353 0.733 0 O-C-N 121.519 -0.738 . . . . 0.0 111.247 -178.113 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -67.91 -40.27 83.47 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.762 -177.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 55.3 tp -66.7 -43.34 84.63 Favored 'General case' 0 C--N 1.349 0.549 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -177.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.693 HG12 ' O ' ' A' ' 9' ' ' LEU . 1.6 mm -73.84 -37.95 49.44 Favored 'Isoleucine or valine' 0 C--N 1.359 0.979 0 O-C-N 121.06 -1.025 . . . . 0.0 111.057 -175.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -70.19 -42.01 72.96 Favored 'General case' 0 C--N 1.349 0.554 0 O-C-N 121.699 -0.626 . . . . 0.0 111.546 -176.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -71.48 -37.3 71.3 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -175.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -93.37 -32.39 14.28 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -174.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -115.51 -32.22 5.64 Favored 'General case' 0 CA--C 1.506 -0.723 0 C-N-CA 117.424 -1.71 . . . . 0.0 112.828 -176.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 146.58 178.19 21.77 Favored Glycine 0 C--N 1.346 1.085 0 C-N-CA 117.954 -2.069 . . . . 0.0 110.379 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -101.5 -23.75 14.26 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -177.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -69.52 -39.83 77.28 Favored 'General case' 0 C--N 1.36 1.047 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.413 HG21 HG22 ' A' ' 58' ' ' VAL . 94.9 m -67.96 -38.33 82.64 Favored 'General case' 0 C--N 1.357 0.915 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.468 HD13 ' HB ' ' A' ' 13' ' ' ILE . 42.8 tp -59.93 -38.1 81.41 Favored 'General case' 0 C--N 1.355 0.838 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 179.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -65.5 -36.57 84.24 Favored 'General case' 0 C--N 1.358 0.958 0 O-C-N 122.081 -0.387 . . . . 0.0 110.805 -178.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.4 m -65.33 -38.84 91.37 Favored 'General case' 0 C--N 1.354 0.797 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.572 HD11 ' HB3' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -63.06 -38.23 90.37 Favored 'General case' 0 C--N 1.353 0.732 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -179.13 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.608 HD22 ' HE1' ' A' ' 10' ' ' MET . 85.0 mt -73.84 -14.11 61.03 Favored 'General case' 0 C--N 1.359 1.009 0 O-C-N 121.749 -0.594 . . . . 0.0 110.415 -178.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -86.61 -28.59 23.16 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 119.185 -1.006 . . . . 0.0 109.374 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.7 t -67.03 -37.04 83.41 Favored 'General case' 0 C--N 1.355 0.827 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.0 p -91.51 -39.89 11.68 Favored 'General case' 0 C--N 1.359 1.015 0 C-N-CA 118.849 -1.14 . . . . 0.0 108.153 -179.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 85.97 131.45 0.04 OUTLIER 'General case' 0 C--N 1.361 1.091 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.502 ' HB2' ' H ' ' A' ' 32' ' ' GLN . 0.2 OUTLIER -90.52 -166.83 1.68 Allowed 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.888 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.502 ' H ' ' HB2' ' A' ' 31' ' ' LEU . 60.6 tt0 -154.2 -61.78 0.13 Allowed 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 -179.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.8 t -101.53 -68.39 0.82 Allowed 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -137.0 -42.67 0.58 Allowed 'General case' 0 CA--C 1.502 -0.899 0 C-N-CA 119.583 -0.847 . . . . 0.0 108.881 -178.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.16 -33.92 3.86 Favored Glycine 0 C--N 1.352 1.442 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 84.8 mt -112.44 102.03 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.728 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -104.28 11.73 34.5 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.721 HG23 ' H ' ' A' ' 39' ' ' SER . 1.9 m 76.31 -170.53 0.08 Allowed 'General case' 0 C--N 1.358 0.974 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.721 ' H ' HG23 ' A' ' 38' ' ' THR . 21.6 p -97.65 51.45 1.07 Allowed 'General case' 0 C--N 1.354 0.769 0 O-C-N 121.151 -0.968 . . . . 0.0 110.26 -178.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.9 t -107.95 -10.78 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.685 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -107.09 159.18 14.76 Favored Glycine 0 C--N 1.357 1.743 0 C-N-CA 119.338 -1.411 . . . . 0.0 109.92 -178.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 36.2 m -129.28 134.26 47.87 Favored 'General case' 0 C--N 1.361 1.097 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -122.35 174.37 7.05 Favored 'General case' 0 C--N 1.355 0.815 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -77.31 -176.49 4.16 Favored 'General case' 0 C--N 1.357 0.899 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.496 ' CD2' HH22 ' A' ' 137' ' ' ARG . 74.8 m80 -92.16 -15.95 26.94 Favored 'General case' 0 C--N 1.356 0.887 0 C-N-CA 120.131 -0.628 . . . . 0.0 109.417 -178.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -67.6 -28.29 67.63 Favored 'General case' 0 C--N 1.351 0.64 0 N-CA-C 107.605 -1.258 . . . . 0.0 107.605 177.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.411 ' CG ' ' HZ ' ' A' ' 6' ' ' PHE . 29.8 tp10 -63.11 -41.52 99.36 Favored 'General case' 0 C--N 1.352 0.687 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.431 HD13 ' C ' ' A' ' 48' ' ' LEU . 2.4 tm? -67.88 -39.46 83.7 Favored 'General case' 0 C--N 1.359 1.001 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -179.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 60.8 tp -69.64 -36.42 76.1 Favored 'General case' 0 CA--C 1.508 -0.664 0 O-C-N 122.167 -0.333 . . . . 0.0 110.498 -177.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -65.02 -40.22 94.54 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 121.686 -0.634 . . . . 0.0 109.986 -178.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.572 ' HB3' HD11 ' A' ' 25' ' ' LEU . 77.0 mt -81.37 -19.16 43.28 Favored 'General case' 0 C--N 1.36 1.028 0 C-N-CA 119.644 -0.823 . . . . 0.0 110.661 -178.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.462 ' O ' HG11 ' A' ' 52' ' ' VAL . 1.2 t -78.96 -37.22 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.501 ' O ' HG12 ' A' ' 53' ' ' VAL . 55.6 t -68.79 -40.41 81.35 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.448 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 32.2 tptt -65.1 -27.15 68.56 Favored 'General case' 0 C--N 1.364 1.235 0 O-C-N 121.126 -0.984 . . . . 0.0 108.827 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.512 HD12 HD13 ' A' ' 13' ' ' ILE . 1.5 tt -68.26 -38.0 81.33 Favored 'General case' 0 C--N 1.354 0.764 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.1 p -72.75 -18.23 61.53 Favored 'General case' 0 C--N 1.357 0.894 0 O-C-N 121.54 -0.725 . . . . 0.0 110.948 -179.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -100.05 -37.7 8.87 Favored 'General case' 0 C--N 1.351 0.674 0 O-C-N 121.168 -0.957 . . . . 0.0 111.668 -179.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.413 HG22 HG21 ' A' ' 21' ' ' THR . 4.3 p -72.96 -35.96 50.14 Favored 'Isoleucine or valine' 0 C--N 1.351 0.642 0 O-C-N 121.713 -0.617 . . . . 0.0 111.36 -177.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.6 m -111.99 -7.99 14.09 Favored 'General case' 0 CA--C 1.505 -0.754 0 C-N-CA 119.372 -0.931 . . . . 0.0 110.116 -177.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 64.22 49.12 2.69 Favored 'General case' 0 C--N 1.354 0.784 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.511 ' CG1' ' HD2' ' A' ' 62' ' ' PRO . 52.3 t -113.62 135.51 21.94 Favored Pre-proline 0 CA--C 1.504 -0.802 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.693 ' HG2' ' HB2' ' A' ' 65' ' ' GLU . 20.8 Cg_endo -61.68 149.61 89.18 Favored 'Trans proline' 0 CA--C 1.5 -1.192 0 C-N-CA 122.339 2.026 . . . . 0.0 112.684 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.435 ' HA ' HD22 ' A' ' 66' ' ' LEU . 3.0 m -76.67 -11.78 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.39 -177.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 72.0 p -96.62 -34.68 11.32 Favored 'General case' 0 C--N 1.357 0.93 0 C-N-CA 118.194 -1.402 . . . . 0.0 109.525 -179.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.693 ' HB2' ' HG2' ' A' ' 62' ' ' PRO . 69.1 mt-10 -76.85 -22.3 53.74 Favored 'General case' 0 C--N 1.354 0.792 0 O-C-N 121.437 -0.789 . . . . 0.0 108.893 179.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.435 HD22 ' HA ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -79.19 -36.75 39.73 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.408 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.6 HG12 ' N ' ' A' ' 68' ' ' ARG . 1.7 p -68.12 -26.82 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 C-N-CA 120.123 -0.631 . . . . 0.0 109.9 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.6 ' N ' HG12 ' A' ' 67' ' ' VAL . 6.6 mmm-85 -72.1 -51.66 20.46 Favored 'General case' 0 C--N 1.364 1.216 0 O-C-N 121.549 -0.719 . . . . 0.0 110.453 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.3 mt -62.49 -36.27 81.96 Favored 'General case' 0 C--N 1.357 0.905 0 O-C-N 122.012 -0.43 . . . . 0.0 111.038 -178.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -61.02 -47.5 86.12 Favored 'General case' 0 C--N 1.349 0.556 0 O-C-N 122.23 -0.294 . . . . 0.0 110.639 -178.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.83 -39.21 96.51 Favored Glycine 0 C--N 1.356 1.69 0 N-CA-C 111.888 -0.485 . . . . 0.0 111.888 -177.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -62.76 -49.16 76.11 Favored 'General case' 0 C--N 1.352 0.688 0 CA-C-N 118.303 1.051 . . . . 0.0 111.693 -177.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 10.2 mttm -63.3 -47.67 81.28 Favored 'General case' 0 C--N 1.359 0.985 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -177.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.401 ' O ' ' HB2' ' A' ' 77' ' ' GLU . 2.4 tm? -69.41 -38.69 78.02 Favored 'General case' 0 C--N 1.348 0.526 0 O-C-N 121.104 -0.997 . . . . 0.0 111.807 -175.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -63.71 -46.8 83.8 Favored 'General case' 0 C--N 1.355 0.834 0 O-C-N 121.037 -1.04 . . . . 0.0 111.443 -177.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -70.58 -13.83 17.5 Favored 'Isoleucine or valine' 0 C--N 1.36 1.024 0 O-C-N 121.517 -0.739 . . . . 0.0 109.371 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 74' ' ' LEU . 7.7 mm-40 -73.08 -38.34 66.44 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 85.4 mt -73.97 -30.67 62.62 Favored 'General case' 0 C--N 1.357 0.922 0 O-C-N 122.3 -0.25 . . . . 0.0 110.519 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 47.9 mm -65.1 -53.53 39.96 Favored 'Isoleucine or valine' 0 C--N 1.357 0.921 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.957 -177.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -74.61 -15.52 60.83 Favored 'General case' 0 C--N 1.351 0.634 0 C-N-CA 119.573 -0.851 . . . . 0.0 109.526 178.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.45 -36.43 62.87 Favored Glycine 0 C--N 1.349 1.26 0 N-CA-C 111.001 -0.839 . . . . 0.0 111.001 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.489 ' HA ' ' HD2' ' A' ' 83' ' ' PRO . 99.3 m-70 -130.65 105.57 15.67 Favored Pre-proline 0 N--CA 1.441 -0.88 0 CA-C-O 122.686 1.231 . . . . 0.0 109.263 -176.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.489 ' HD2' ' HA ' ' A' ' 82' ' ' HIS . 37.8 Cg_endo -67.69 -26.0 39.66 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.647 2.231 . . . . 0.0 114.085 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -89.86 -7.66 53.74 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 tp -90.36 -20.97 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 -178.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -101.52 -23.63 14.27 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -70.16 -37.33 75.17 Favored 'General case' 0 C--N 1.359 1.001 0 O-C-N 121.867 -0.521 . . . . 0.0 109.855 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -64.89 -34.98 79.67 Favored 'General case' 0 C--N 1.358 0.975 0 O-C-N 121.836 -0.54 . . . . 0.0 110.545 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 18.4 ttp -82.9 152.51 25.52 Favored 'General case' 0 C--N 1.352 0.704 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 -178.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.43 -21.89 7.84 Favored 'General case' 0 C--N 1.364 1.225 0 O-C-N 121.641 -0.662 . . . . 0.0 111.356 -177.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -165.8 171.42 12.83 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -177.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.466 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 62.8 m -66.65 -40.81 88.84 Favored 'General case' 0 C--N 1.355 0.82 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.584 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.492 ' CE1' ' HE2' ' A' ' 158' ' ' PHE . 60.4 m-85 -66.67 -39.65 88.24 Favored 'General case' 0 C--N 1.357 0.915 0 O-C-N 121.188 -0.945 . . . . 0.0 108.836 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -65.79 -23.31 66.68 Favored 'General case' 0 C--N 1.356 0.884 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.713 ' O ' HG13 ' A' ' 99' ' ' ILE . 57.9 tp -63.58 -46.86 83.92 Favored 'General case' 0 C--N 1.355 0.843 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.48 ' HA ' ' CD1' ' A' ' 99' ' ' ILE . 4.2 mp -60.59 -37.34 81.04 Favored 'General case' 0 C--N 1.359 1.016 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.416 -179.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 34.3 t -67.88 -39.71 83.66 Favored 'General case' 0 C--N 1.349 0.566 0 O-C-N 121.918 -0.489 . . . . 0.0 110.242 -179.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.414 ' HG3' ' HZ3' ' A' ' 98' ' ' LYS . 0.2 OUTLIER -85.72 -0.89 56.44 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -176.558 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.713 HG13 ' O ' ' A' ' 95' ' ' LEU . 78.8 mt -60.81 -47.09 94.78 Favored 'Isoleucine or valine' 0 C--N 1.357 0.906 0 CA-C-N 118.919 0.782 . . . . 0.0 112.331 -177.223 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -94.44 -23.92 17.54 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 118.55 -1.26 . . . . 0.0 111.522 -176.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.561 ' O ' HG22 ' A' ' 105' ' ' VAL . 34.5 t -63.86 -48.07 78.21 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.607 -0.683 . . . . 0.0 112.717 -177.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -137.92 -15.86 1.32 Allowed 'General case' 0 C--N 1.359 0.992 0 C-N-CA 116.946 -1.901 . . . . 0.0 113.763 -176.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.546 HG21 ' HD2' ' A' ' 104' ' ' HIS . 96.4 mt -70.81 -49.7 48.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 CA-C-N 120.54 1.518 . . . . 0.0 111.164 -177.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.546 ' HD2' HG21 ' A' ' 103' ' ' ILE . 17.8 m170 -89.04 0.67 56.49 Favored 'General case' 0 N--CA 1.442 -0.858 0 O-C-N 121.176 -0.953 . . . . 0.0 110.171 -177.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.561 HG22 ' O ' ' A' ' 101' ' ' SER . 72.7 t -83.71 -44.18 18.22 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.996 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 178.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -67.68 -40.55 84.4 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 71.9 t -63.06 -45.22 99.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.826 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.256 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -60.33 -48.38 82.01 Favored 'General case' 0 C--N 1.36 1.055 0 O-C-N 122.016 -0.428 . . . . 0.0 111.34 -178.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -63.5 -35.41 80.37 Favored 'General case' 0 C--N 1.354 0.795 0 O-C-N 121.544 -0.722 . . . . 0.0 110.615 -178.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 16.4 mt -57.33 -72.1 0.09 Allowed 'General case' 0 C--N 1.357 0.919 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.104 -179.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.452 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 94.4 m-85 -122.31 143.7 40.0 Favored Pre-proline 0 N--CA 1.441 -0.899 0 C-N-CA 118.038 -1.465 . . . . 0.0 109.292 -179.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 111' ' ' TYR . 61.9 Cg_endo -87.25 -2.46 7.83 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 C-N-CA 123.505 2.803 . . . . 0.0 116.265 -178.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -83.42 -8.11 59.44 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 121.272 -0.892 . . . . 0.0 109.486 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -83.06 144.33 29.98 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.505 ' O ' HD12 ' A' ' 116' ' ' LEU . 46.0 mt-10 -120.33 144.11 48.02 Favored 'General case' 0 C--N 1.359 1.021 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.505 HD12 ' O ' ' A' ' 115' ' ' GLU . 2.6 mm? -129.88 152.52 80.04 Favored Pre-proline 0 C--N 1.358 0.946 0 CA-C-O 121.951 0.882 . . . . 0.0 109.27 -178.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 116' ' ' LEU . 87.7 Cg_endo -92.73 -155.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.32 -0.946 0 C-N-CA 123.929 3.086 . . . . 0.0 113.036 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -122.5 141.84 51.22 Favored 'General case' 0 C--N 1.368 1.399 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -132.61 137.04 46.9 Favored 'General case' 0 C--N 1.362 1.132 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.629 -178.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.47 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 93.7 m -127.32 128.52 46.06 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 176.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 78.2 m -118.69 128.89 54.94 Favored 'General case' 0 CA--C 1.503 -0.862 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.436 -178.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -120.85 130.89 54.12 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -103.55 117.23 33.95 Favored 'General case' 0 C--N 1.353 0.738 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -179.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.471 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 88.7 mt -83.27 -27.48 29.83 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 120.668 -0.413 . . . . 0.0 109.968 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 179.49 -143.24 5.59 Favored Glycine 0 C--N 1.351 1.378 0 C-N-CA 118.771 -1.681 . . . . 0.0 109.648 -178.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -91.37 -45.98 8.27 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -178.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -98.67 3.25 47.75 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.699 -177.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.471 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 66.7 m-20 -119.91 133.38 55.59 Favored 'General case' 0 C--N 1.357 0.917 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.572 HG21 ' N ' ' A' ' 130' ' ' ARG . 8.1 mm -142.57 138.45 28.69 Favored 'Isoleucine or valine' 0 C--N 1.357 0.91 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 179.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.572 ' N ' HG21 ' A' ' 129' ' ' ILE . 52.3 mtm180 -119.79 137.75 53.77 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 6.6 tp -125.5 119.45 28.25 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.76 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.47 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 11.8 m170 -99.92 135.2 41.71 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -128.06 121.97 30.99 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -178.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.466 ' HA ' ' O ' ' A' ' 171' ' ' THR . 10.2 tt0 -115.55 112.88 22.86 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 178.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.402 ' O ' ' HA ' ' A' ' 171' ' ' THR . 8.8 t -167.25 156.63 10.45 Favored 'General case' 0 C--N 1.357 0.908 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.449 ' C ' ' HD3' ' A' ' 138' ' ' PRO . 99.5 mttt -91.3 6.86 43.61 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.496 HH22 ' CD2' ' A' ' 45' ' ' HIS . 75.0 mtp180 -130.82 74.04 80.44 Favored Pre-proline 0 C--N 1.355 0.816 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.449 ' HD3' ' C ' ' A' ' 136' ' ' LYS . 80.1 Cg_endo -95.57 89.27 0.1 Allowed 'Trans proline' 0 N--CA 1.445 -1.373 0 C-N-CA 122.821 2.347 . . . . 0.0 115.559 -178.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -106.57 112.42 25.41 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 177.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.89 -37.74 88.51 Favored 'General case' 0 C--N 1.353 0.735 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.132 -178.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 71.5 m -61.77 -32.46 72.73 Favored 'General case' 0 C--N 1.353 0.741 0 O-C-N 121.967 -0.458 . . . . 0.0 110.693 -178.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -73.11 -46.48 51.04 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 120.25 -0.58 . . . . 0.0 109.988 -177.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.35 -40.17 95.33 Favored 'General case' 0 C--N 1.356 0.88 0 O-C-N 122.127 -0.358 . . . . 0.0 111.461 -177.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -63.27 -36.89 85.16 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 121.85 -0.531 . . . . 0.0 110.273 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.14 -43.52 98.28 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 -178.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 82.7 mt -69.82 -40.57 75.84 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 96.2 mt -71.63 -42.43 67.63 Favored 'General case' 0 C--N 1.362 1.152 0 O-C-N 121.152 -0.968 . . . . 0.0 111.186 -176.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.497 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 36.2 t70 -69.84 -30.55 68.06 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 121.834 -0.541 . . . . 0.0 110.535 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . 0.487 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -62.85 -39.1 97.58 Favored Glycine 0 C--N 1.357 1.708 0 N-CA-C 108.303 -1.919 . . . . 0.0 108.303 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 48.9 t -60.55 -42.02 95.71 Favored 'General case' 0 C--N 1.351 0.659 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -74.96 -1.24 21.69 Favored 'General case' 0 C--N 1.361 1.093 0 O-C-N 121.739 -0.601 . . . . 0.0 109.476 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.497 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 76.5 mm-40 -84.38 -46.33 11.83 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -68.06 -43.19 79.19 Favored 'General case' 0 C--N 1.359 1.017 0 C-N-CA 120.002 -0.679 . . . . 0.0 109.553 179.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -69.19 -27.67 65.71 Favored 'General case' 0 C--N 1.361 1.076 0 O-C-N 121.739 -0.601 . . . . 0.0 110.701 -178.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 86.1 tttt 70.42 72.31 0.21 Allowed 'General case' 0 C--N 1.361 1.07 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -178.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -143.45 -167.26 2.52 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -142.18 116.6 9.61 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . 0.492 ' HE2' ' CE1' ' A' ' 93' ' ' PHE . 94.9 m-85 -135.09 150.47 50.24 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 178.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 92.4 m -120.63 127.82 52.44 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 3.4 mp -105.9 122.88 60.04 Favored 'Isoleucine or valine' 0 C--N 1.351 0.672 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.9 m -120.12 -173.61 2.59 Favored 'General case' 0 C--N 1.357 0.911 0 CA-C-O 121.86 0.838 . . . . 0.0 109.341 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -147.74 156.96 43.29 Favored 'General case' 0 C--N 1.357 0.932 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -178.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 64.6 p -100.79 146.2 31.68 Favored Pre-proline 0 C--N 1.359 0.988 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.894 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 62.7 Cg_endo -75.75 -9.6 19.77 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.754 2.303 . . . . 0.0 115.424 -178.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -71.97 -41.11 68.1 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 119.771 -0.772 . . . . 0.0 109.101 -179.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 39.2 p -118.05 14.53 14.08 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 120.071 -0.651 . . . . 0.0 110.538 -178.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.894 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 11.6 pt20 -67.03 -10.34 48.73 Favored 'General case' 0 C--N 1.355 0.828 0 O-C-N 121.455 -0.778 . . . . 0.0 110.335 178.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -126.54 38.28 4.15 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.9 m -137.38 146.9 45.02 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.63 ' O ' ' HB ' ' A' ' 171' ' ' THR . 60.5 mt-10 -98.77 164.4 12.23 Favored 'General case' 0 C--N 1.353 0.759 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.63 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 1.7 m 82.05 -56.65 0.23 Allowed 'General case' 0 C--N 1.371 1.532 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.004 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -110.19 117.65 34.26 Favored 'General case' 0 CA--C 1.503 -0.83 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.802 -178.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 67.4 t -131.22 134.0 61.75 Favored 'Isoleucine or valine' 0 C--N 1.357 0.912 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 50.4 mm -108.53 125.44 65.38 Favored 'Isoleucine or valine' 0 C--N 1.357 0.914 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -113.25 153.16 28.84 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 122.136 0.969 . . . . 0.0 108.541 -179.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -136.69 117.56 14.16 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -178.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.3 mp -113.04 118.6 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 -179.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.49 HG21 ' N ' ' A' ' 179' ' ' ARG . 89.4 m -120.28 144.24 47.9 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -177.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.49 ' N ' HG21 ' A' ' 178' ' ' THR . 5.2 ttt180 . . . . . 0 C--N 1.363 1.185 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.6 mtp . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.212 0.53 . . . . 0.0 109.862 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.855 ' HA ' HG23 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -82.17 -5.46 58.49 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.046 -177.873 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.52 -46.16 26.47 Favored Glycine 0 C--N 1.35 1.34 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 76.9 mtm -72.15 -34.53 68.57 Favored 'General case' 0 C--N 1.354 0.791 0 O-C-N 121.92 -0.753 . . . . 0.0 111.271 -177.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.855 HG23 ' HA ' ' A' ' 2' ' ' MET . 36.0 m -69.78 -23.44 25.8 Favored 'Isoleucine or valine' 0 C--N 1.356 0.868 0 C-N-CA 119.926 -0.709 . . . . 0.0 109.346 -179.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.425 ' HZ ' ' CG ' ' A' ' 47' ' ' GLU . 1.6 m-85 -71.79 -34.45 69.42 Favored 'General case' 0 C--N 1.357 0.908 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.6 m -66.7 -39.65 88.16 Favored 'General case' 0 C--N 1.354 0.798 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -61.29 -38.81 96.28 Favored Glycine 0 C--N 1.359 1.809 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.636 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -65.33 -40.08 93.24 Favored 'General case' 0 C--N 1.353 0.741 0 O-C-N 122.354 -0.498 . . . . 0.0 110.761 -178.83 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.2 mmt -63.02 -41.02 99.43 Favored 'General case' 0 C--N 1.351 0.665 0 O-C-N 121.632 -0.667 . . . . 0.0 111.099 -178.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -66.81 -40.65 88.14 Favored 'General case' 0 C--N 1.35 0.613 0 O-C-N 121.869 -0.519 . . . . 0.0 111.688 -177.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 53.9 tp -65.8 -42.78 90.25 Favored 'General case' 0 C--N 1.349 0.585 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.636 HG12 ' O ' ' A' ' 9' ' ' LEU . 1.5 mm -75.67 -37.44 36.19 Favored 'Isoleucine or valine' 0 C--N 1.357 0.896 0 O-C-N 121.083 -1.011 . . . . 0.0 111.134 -175.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -68.53 -43.16 77.35 Favored 'General case' 0 C--N 1.352 0.703 0 O-C-N 121.911 -0.493 . . . . 0.0 111.315 -176.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -71.42 -34.36 70.25 Favored 'General case' 0 N--CA 1.446 -0.634 0 O-C-N 122.06 -0.4 . . . . 0.0 111.717 -177.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -71.83 -48.71 44.33 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -175.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -128.22 -19.29 3.93 Favored 'General case' 0 C--N 1.356 0.854 0 C-N-CA 117.352 -1.739 . . . . 0.0 113.747 -176.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 140.56 179.48 18.15 Favored Glycine 0 CA--C 1.497 -1.066 0 C-N-CA 117.773 -2.156 . . . . 0.0 109.97 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -96.42 -12.09 24.75 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -177.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -70.49 -41.41 72.71 Favored 'General case' 0 C--N 1.361 1.073 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.2 m -69.91 -39.08 76.41 Favored 'General case' 0 C--N 1.356 0.859 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 58.3 tp -60.6 -37.93 83.03 Favored 'General case' 0 C--N 1.357 0.918 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -64.59 -36.26 83.66 Favored 'General case' 0 C--N 1.357 0.893 0 O-C-N 122.132 -0.355 . . . . 0.0 110.84 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 93.6 m -63.52 -41.19 98.51 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -178.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.546 HD11 HG21 ' A' ' 13' ' ' ILE . 88.7 mt -64.17 -37.72 88.47 Favored 'General case' 0 C--N 1.352 0.711 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.09 -13.62 61.63 Favored 'General case' 0 C--N 1.36 1.053 0 O-C-N 121.606 -0.684 . . . . 0.0 110.085 -178.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -86.74 -28.94 22.74 Favored 'General case' 0 CA--C 1.506 -0.712 0 O-C-N 121.262 -0.899 . . . . 0.0 109.12 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.8 t -66.81 -36.29 82.03 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.662 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 2.2 p -92.15 -38.16 12.31 Favored 'General case' 0 C--N 1.359 0.996 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.662 ' HB2' ' O ' ' A' ' 29' ' ' CYS . 15.9 mt-10 85.96 131.73 0.04 OUTLIER 'General case' 0 C--N 1.36 1.041 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.551 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -89.96 -167.49 1.86 Allowed 'General case' 0 C--N 1.356 0.871 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.791 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.469 ' H ' ' HB2' ' A' ' 31' ' ' LEU . 63.7 tt0 -153.39 -66.59 0.15 Allowed 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.2 m -96.47 -62.06 1.33 Allowed 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -141.1 -43.2 0.38 Allowed 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -179.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.43 -39.02 2.47 Favored Glycine 0 C--N 1.351 1.398 0 N-CA-C 108.69 -1.764 . . . . 0.0 108.69 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 84.9 mt -109.8 104.68 17.46 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.878 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.466 ' HB3' ' H ' ' A' ' 38' ' ' THR . 4.0 t80 -74.03 -92.31 0.02 OUTLIER 'General case' 0 C--N 1.355 0.833 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.466 ' H ' ' HB3' ' A' ' 37' ' ' TYR . 1.2 m -166.37 -64.52 0.03 OUTLIER 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 -178.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.3 p 161.87 80.9 0.0 OUTLIER 'General case' 0 C--N 1.362 1.122 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -172.05 -4.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.972 0 C-N-CA 119.459 -0.896 . . . . 0.0 109.735 -179.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -96.3 150.61 19.67 Favored Glycine 0 C--N 1.355 1.6 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 -178.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 59.2 m -125.41 131.5 52.91 Favored 'General case' 0 C--N 1.354 0.77 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -121.05 171.11 8.9 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -76.24 -178.67 4.62 Favored 'General case' 0 C--N 1.355 0.842 0 CA-C-O 121.642 0.734 . . . . 0.0 109.573 -178.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -86.36 -19.65 29.45 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -179.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.582 ' HA ' HD21 ' A' ' 49' ' ' LEU . 0.5 OUTLIER -65.55 -30.65 71.42 Favored 'General case' 0 C--N 1.354 0.764 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 179.08 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.425 ' CG ' ' HZ ' ' A' ' 6' ' ' PHE . 23.6 tp10 -63.97 -40.25 95.97 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.401 ' C ' HD13 ' A' ' 48' ' ' LEU . 2.3 tm? -65.52 -39.41 91.79 Favored 'General case' 0 C--N 1.358 0.972 0 O-C-N 122.305 -0.247 . . . . 0.0 111.266 -178.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.582 HD21 ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -81.37 -15.02 56.52 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 119.078 -1.049 . . . . 0.0 110.402 -176.339 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 71.5 tp60 -73.09 -41.44 64.06 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.459 ' HA ' HD22 ' A' ' 51' ' ' LEU . 84.3 mt -84.51 -17.96 37.33 Favored 'General case' 0 C--N 1.362 1.111 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.723 -178.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.503 ' O ' HG11 ' A' ' 52' ' ' VAL . 1.6 t -80.52 -37.45 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.499 ' O ' HG11 ' A' ' 53' ' ' VAL . 48.9 t -69.73 -39.68 78.3 Favored 'Isoleucine or valine' 0 C--N 1.354 0.78 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.459 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 32.9 tptt -66.15 -27.16 67.81 Favored 'General case' 0 C--N 1.363 1.171 0 O-C-N 121.235 -0.915 . . . . 0.0 108.6 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.573 HD12 HD13 ' A' ' 13' ' ' ILE . 0.3 OUTLIER -68.38 -37.64 80.59 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.704 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 60' ' ' SER . 77.0 p -73.9 -16.93 61.09 Favored 'General case' 0 C--N 1.355 0.847 0 O-C-N 121.693 -0.629 . . . . 0.0 110.885 -178.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -100.46 -36.38 9.23 Favored 'General case' 0 C--N 1.353 0.752 0 C-N-CA 119.377 -0.929 . . . . 0.0 111.434 -179.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.5 p -72.66 -34.44 47.54 Favored 'Isoleucine or valine' 0 C--N 1.351 0.651 0 O-C-N 121.683 -0.636 . . . . 0.0 111.455 -177.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.2 t -119.99 -5.58 10.05 Favored 'General case' 0 C--N 1.353 0.725 0 C-N-CA 119.143 -1.023 . . . . 0.0 110.069 -178.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 56' ' ' SER . 73.3 m 64.3 43.25 4.86 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.532 HG13 ' HD2' ' A' ' 62' ' ' PRO . 50.0 t -103.37 132.89 20.65 Favored Pre-proline 0 N--CA 1.443 -0.799 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 179.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.532 ' HD2' HG13 ' A' ' 61' ' ' VAL . 45.5 Cg_exo -57.31 146.68 81.24 Favored 'Trans proline' 0 CA--C 1.497 -1.345 0 C-N-CA 122.397 2.065 . . . . 0.0 112.959 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.1 m -75.15 -14.1 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.788 -178.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 52.6 p -96.07 -31.88 12.81 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 118.139 -1.425 . . . . 0.0 109.611 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -78.01 -21.49 50.73 Favored 'General case' 0 C--N 1.356 0.856 0 O-C-N 121.385 -0.822 . . . . 0.0 108.894 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.443 HD13 HD13 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -81.82 -35.73 29.14 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.4 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.59 HG12 ' N ' ' A' ' 68' ' ' ARG . 1.4 p -68.79 -27.17 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 C-N-CA 120.138 -0.625 . . . . 0.0 109.95 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.59 ' N ' HG12 ' A' ' 67' ' ' VAL . 6.5 mmm-85 -73.21 -51.2 18.6 Favored 'General case' 0 C--N 1.362 1.131 0 O-C-N 121.521 -0.737 . . . . 0.0 110.435 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.414 ' HA ' HD23 ' A' ' 69' ' ' LEU . 84.7 mt -63.69 -36.08 82.68 Favored 'General case' 0 C--N 1.357 0.934 0 O-C-N 121.976 -0.452 . . . . 0.0 110.85 -178.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -60.65 -47.36 86.58 Favored 'General case' 0 C--N 1.349 0.577 0 O-C-N 122.208 -0.307 . . . . 0.0 110.297 -178.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.57 -37.87 94.06 Favored Glycine 0 C--N 1.354 1.552 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 -178.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -63.02 -48.64 77.91 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-N 118.261 1.031 . . . . 0.0 111.397 -177.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.716 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 16.0 mttm -64.39 -48.96 73.47 Favored 'General case' 0 C--N 1.359 0.983 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -176.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.441 HD21 ' O ' ' A' ' 74' ' ' LEU . 2.3 tm? -68.29 -39.68 82.03 Favored 'General case' 0 C--N 1.348 0.534 0 O-C-N 121.207 -0.933 . . . . 0.0 112.047 -175.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -63.88 -42.83 97.39 Favored 'General case' 0 C--N 1.353 0.719 0 O-C-N 121.115 -0.991 . . . . 0.0 111.22 -177.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.7 p -71.97 -15.48 18.11 Favored 'Isoleucine or valine' 0 C--N 1.36 1.026 0 O-C-N 121.232 -0.917 . . . . 0.0 109.217 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.716 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 74.1 mm-40 -71.52 -38.89 71.07 Favored 'General case' 0 C--N 1.349 0.552 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 80.7 mt -72.45 -33.3 66.97 Favored 'General case' 0 C--N 1.358 0.967 0 O-C-N 122.334 -0.229 . . . . 0.0 110.754 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 43.5 mm -64.43 -52.97 48.57 Favored 'Isoleucine or valine' 0 C--N 1.357 0.912 0 O-C-N 121.733 -0.604 . . . . 0.0 110.509 -177.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -76.67 -14.75 59.94 Favored 'General case' 0 C--N 1.35 0.591 0 C-N-CA 119.423 -0.911 . . . . 0.0 109.501 178.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.85 -36.32 61.43 Favored Glycine 0 C--N 1.349 1.27 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -179.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.493 ' HB2' HG22 ' A' ' 85' ' ' ILE . 99.4 m-70 -128.46 104.45 19.58 Favored Pre-proline 0 N--CA 1.44 -0.938 0 CA-C-O 122.564 1.173 . . . . 0.0 109.596 -176.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.406 ' O ' ' HB2' ' A' ' 87' ' ' ASN . 32.0 Cg_exo -61.08 -33.23 91.8 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 123.366 2.711 . . . . 0.0 114.29 179.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -91.34 -5.67 54.23 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 120.14 -0.624 . . . . 0.0 109.834 -178.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.493 HG22 ' HB2' ' A' ' 82' ' ' HIS . 0.5 OUTLIER -87.89 -23.15 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -178.727 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.6 -18.03 14.91 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . 0.406 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 54.2 t30 -72.39 -38.36 68.49 Favored 'General case' 0 C--N 1.358 0.94 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -65.17 -33.51 76.18 Favored 'General case' 0 C--N 1.355 0.816 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.504 ' SD ' ' HB2' ' A' ' 95' ' ' LEU . 17.8 ttp -84.53 152.08 24.15 Favored 'General case' 0 C--N 1.351 0.651 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -178.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.64 -21.4 8.54 Favored 'General case' 0 C--N 1.364 1.21 0 C-N-CA 120.051 -0.659 . . . . 0.0 111.19 -177.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -165.96 171.28 12.77 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -177.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 67.3 m -66.63 -39.89 88.49 Favored 'General case' 0 C--N 1.355 0.842 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.68 -179.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -67.48 -39.21 85.25 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 119.616 -0.834 . . . . 0.0 108.83 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -66.26 -23.36 66.39 Favored 'General case' 0 C--N 1.355 0.832 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.698 ' O ' HG13 ' A' ' 99' ' ' ILE . 66.1 tp -65.25 -45.17 85.67 Favored 'General case' 0 C--N 1.357 0.926 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.43 ' HA ' HD13 ' A' ' 99' ' ' ILE . 3.3 mp -60.08 -35.94 76.29 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.1 t -70.49 -39.62 74.06 Favored 'General case' 0 C--N 1.35 0.599 0 O-C-N 121.881 -0.512 . . . . 0.0 109.935 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.3 -0.33 52.06 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -176.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.698 HG13 ' O ' ' A' ' 95' ' ' LEU . 81.1 mt -61.6 -47.18 94.56 Favored 'Isoleucine or valine' 0 C--N 1.357 0.894 0 CA-C-N 119.197 0.908 . . . . 0.0 111.704 -177.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -93.06 -23.41 18.66 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 118.642 -1.223 . . . . 0.0 111.349 -177.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.525 ' O ' HG22 ' A' ' 105' ' ' VAL . 33.6 t -63.71 -48.57 76.56 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 121.645 -0.659 . . . . 0.0 112.592 -177.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -139.99 -12.87 1.09 Allowed 'General case' 0 C--N 1.359 0.982 0 C-N-CA 117.083 -1.847 . . . . 0.0 113.685 -177.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 24.9 mm -70.12 -51.23 41.05 Favored 'Isoleucine or valine' 0 C--O 1.242 0.706 0 CA-C-N 120.352 1.433 . . . . 0.0 110.564 -177.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 65.5 m170 -91.72 1.15 57.35 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.209 -177.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.525 HG22 ' O ' ' A' ' 101' ' ' SER . 79.5 t -81.39 -44.54 20.6 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.009 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 178.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 54.8 tp10 -68.09 -40.44 82.65 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 53.8 t -62.13 -46.95 95.29 Favored 'Isoleucine or valine' 0 C--N 1.355 0.824 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.685 -179.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -60.45 -48.13 83.11 Favored 'General case' 0 C--N 1.361 1.078 0 O-C-N 121.998 -0.438 . . . . 0.0 111.546 -179.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -60.66 -36.84 79.7 Favored 'General case' 0 C--N 1.355 0.821 0 O-C-N 121.503 -0.748 . . . . 0.0 110.383 -178.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 18.5 mt -59.49 -77.08 0.04 OUTLIER 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.428 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 79.8 m-85 -119.14 140.32 28.69 Favored Pre-proline 0 N--CA 1.44 -0.958 0 C-N-CA 118.574 -1.251 . . . . 0.0 108.973 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 111' ' ' TYR . 67.3 Cg_endo -87.18 -2.1 7.87 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 123.077 2.518 . . . . 0.0 115.124 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 29.7 mm100 -66.9 -36.51 82.45 Favored 'General case' 0 C--N 1.355 0.824 0 O-C-N 121.819 -0.551 . . . . 0.0 109.888 -179.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.24 144.63 57.04 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 121.56 0.695 . . . . 0.0 110.067 -178.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -115.91 142.78 46.33 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.446 ' HA ' ' HD3' ' A' ' 117' ' ' PRO . 2.6 mm? -127.16 148.8 67.49 Favored Pre-proline 0 N--CA 1.444 -0.737 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -178.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 116' ' ' LEU . 92.1 Cg_endo -91.07 -157.36 0.06 OUTLIER 'Trans proline' 0 C--N 1.315 -1.21 0 C-N-CA 123.797 2.998 . . . . 0.0 113.263 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -118.41 140.4 49.92 Favored 'General case' 0 C--N 1.363 1.186 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.423 ' CZ ' ' HG2' ' A' ' 117' ' ' PRO . 94.2 m-85 -131.51 135.03 46.74 Favored 'General case' 0 C--N 1.359 1.013 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.526 -178.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.487 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 93.6 m -124.05 127.57 48.06 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 176.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 75.2 m -118.06 128.02 54.36 Favored 'General case' 0 CA--C 1.504 -0.794 0 C-N-CA 119.215 -0.994 . . . . 0.0 109.545 -177.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -118.77 151.36 38.18 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 178.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.604 ' HG3' HD11 ' A' ' 129' ' ' ILE . 58.0 ttp180 -122.56 117.16 25.23 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.491 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 94.7 mt -86.9 -22.54 25.63 Favored 'General case' 0 C--N 1.354 0.782 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.219 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 177.8 -145.64 7.17 Favored Glycine 0 C--N 1.348 1.248 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 -178.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -94.7 -39.35 10.36 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -178.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -99.46 1.97 44.57 Favored 'General case' 0 C--N 1.353 0.756 0 C-N-CA 120.292 -0.563 . . . . 0.0 109.95 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.491 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 66.1 m-20 -121.12 133.42 55.21 Favored 'General case' 0 C--N 1.357 0.935 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.167 -179.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.604 HD11 ' HG3' ' A' ' 123' ' ' ARG . 8.0 mm -142.86 136.42 26.49 Favored 'Isoleucine or valine' 0 C--N 1.356 0.878 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.443 ' N ' HG21 ' A' ' 129' ' ' ILE . 52.9 mtm180 -116.94 139.06 51.09 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.0 tp -128.02 118.6 23.8 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.487 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 12.0 m170 -97.35 132.92 42.61 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -126.42 121.38 32.27 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -178.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.492 ' HA ' ' O ' ' A' ' 171' ' ' THR . 29.9 tt0 -115.24 112.2 22.09 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.3 t -162.02 151.39 15.96 Favored 'General case' 0 C--N 1.36 1.038 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -90.47 2.31 55.82 Favored 'General case' 0 C--N 1.356 0.867 0 C-N-CA 120.316 -0.554 . . . . 0.0 109.777 -179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -134.17 74.65 67.24 Favored Pre-proline 0 C--N 1.354 0.786 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -94.82 106.24 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.659 2.239 . . . . 0.0 115.968 -177.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -111.18 109.61 19.74 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 176.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.82 -39.14 93.51 Favored 'General case' 0 C--N 1.354 0.797 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.66 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 73.8 m -62.81 -27.6 69.42 Favored 'General case' 0 C--N 1.354 0.797 0 O-C-N 121.876 -0.515 . . . . 0.0 110.715 -178.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -76.53 -46.49 26.28 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.862 -177.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.83 -39.81 94.17 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 122.05 -0.406 . . . . 0.0 111.176 -177.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -63.17 -36.83 84.92 Favored 'General case' 0 C--N 1.356 0.86 0 O-C-N 121.902 -0.499 . . . . 0.0 109.85 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.01 -42.94 98.58 Favored Glycine 0 C--N 1.348 1.202 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 86.3 mt -70.57 -41.0 73.0 Favored 'General case' 0 C--N 1.354 0.761 0 CA-C-N 117.552 0.676 . . . . 0.0 112.775 -179.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.408 HD21 ' HA ' ' A' ' 147' ' ' LEU . 97.1 mt -71.37 -41.82 69.22 Favored 'General case' 0 C--N 1.361 1.092 0 O-C-N 121.155 -0.966 . . . . 0.0 110.832 -176.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.495 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 36.8 t70 -69.97 -28.61 65.68 Favored 'General case' 0 N--CA 1.442 -0.865 0 O-C-N 121.258 -0.901 . . . . 0.0 109.987 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -63.72 -40.61 98.7 Favored Glycine 0 C--N 1.355 1.601 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 14.1 p -65.6 -31.49 72.56 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 119.341 -0.943 . . . . 0.0 109.451 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -78.75 -1.16 33.32 Favored 'General case' 0 C--N 1.363 1.184 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 177.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.495 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 76.8 mm-40 -85.33 -45.55 11.81 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -66.71 -45.72 77.86 Favored 'General case' 0 C--N 1.36 1.062 0 C-N-CA 120.152 -0.619 . . . . 0.0 109.545 178.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -68.98 -26.83 65.24 Favored 'General case' 0 C--N 1.361 1.078 0 O-C-N 121.843 -0.536 . . . . 0.0 110.664 -178.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 84.6 tttt 73.51 71.85 0.12 Allowed 'General case' 0 C--N 1.362 1.109 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -139.38 -171.62 3.17 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -147.28 94.69 2.43 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 16.3 m-30 -114.78 157.17 23.6 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 178.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 93.4 m -120.2 128.8 53.71 Favored 'General case' 0 C--N 1.354 0.791 0 C-N-CA 119.655 -0.818 . . . . 0.0 108.857 -178.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 3.5 mp -104.49 122.04 56.98 Favored 'Isoleucine or valine' 0 C--N 1.351 0.66 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 179.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.3 m -117.86 -174.05 2.56 Favored 'General case' 0 C--N 1.358 0.948 0 CA-C-O 121.942 0.877 . . . . 0.0 109.462 -178.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 26.6 ptt180 -146.2 155.69 42.88 Favored 'General case' 0 C--N 1.357 0.918 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -178.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' THR . . . . . 0.507 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 34.8 p -96.98 145.67 29.98 Favored Pre-proline 0 C--N 1.358 0.971 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.611 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 15.3 Cg_exo -70.82 -16.19 33.09 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 123.439 2.759 . . . . 0.0 114.445 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -71.63 -40.78 69.53 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 120.436 -0.506 . . . . 0.0 110.708 -177.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 40.8 p -119.28 16.38 13.11 Favored 'General case' 0 C--N 1.353 0.739 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.852 -178.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.611 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 9.9 pt20 -66.89 -12.86 60.73 Favored 'General case' 0 C--N 1.353 0.741 0 O-C-N 121.517 -0.739 . . . . 0.0 110.212 178.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 54.0 p30 -124.74 38.23 4.24 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 19.9 t -139.42 144.95 38.32 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.59 ' O ' ' HB ' ' A' ' 171' ' ' THR . 62.0 mt-10 -97.9 165.07 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -179.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.59 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 18.7 m 82.52 -58.98 0.18 Allowed 'General case' 0 C--N 1.37 1.49 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.771 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -107.75 116.83 32.66 Favored 'General case' 0 CA--C 1.503 -0.829 0 C-N-CA 119.952 -0.699 . . . . 0.0 109.538 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.493 HG13 ' CZ ' ' A' ' 175' ' ' PHE . 85.1 t -130.69 132.45 64.24 Favored 'Isoleucine or valine' 0 C--N 1.357 0.904 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 178.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.413 ' HA ' HD12 ' A' ' 174' ' ' ILE . 50.8 mm -107.74 126.31 64.15 Favored 'Isoleucine or valine' 0 C--N 1.356 0.878 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.493 ' CZ ' HG13 ' A' ' 173' ' ' VAL . 90.0 m-85 -114.8 154.44 28.57 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-O 122.173 0.987 . . . . 0.0 108.588 -178.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -136.82 119.24 15.79 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.8 mp -113.85 119.83 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 N-CA-C 106.525 -1.658 . . . . 0.0 106.525 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 89.6 m -120.39 143.06 48.64 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -177.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 10.2 ttm180 . . . . . 0 C--N 1.363 1.184 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -179.964 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.2 mmm . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.065 0.459 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.467 ' O ' HG23 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -80.18 -19.05 47.98 Favored 'General case' 0 C--N 1.356 0.856 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -178.989 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.73 -40.44 45.6 Favored Glycine 0 C--N 1.35 1.323 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.22 -34.81 68.62 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 121.853 -0.792 . . . . 0.0 111.164 -177.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 2' ' ' MET . 28.1 m -69.03 -23.99 27.76 Favored 'Isoleucine or valine' 0 C--N 1.356 0.85 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.452 ' HZ ' ' CG ' ' A' ' 47' ' ' GLU . 2.0 m-85 -70.6 -35.03 72.77 Favored 'General case' 0 C--N 1.356 0.86 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 89.6 m -67.4 -39.71 85.57 Favored 'General case' 0 C--N 1.356 0.883 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -61.81 -38.45 95.99 Favored Glycine 0 C--N 1.36 1.874 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.696 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -64.72 -41.35 96.05 Favored 'General case' 0 C--N 1.352 0.685 0 O-C-N 122.511 -0.405 . . . . 0.0 110.791 -178.768 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.744 ' HE3' HD22 ' A' ' 26' ' ' LEU . 20.7 mmt -62.71 -40.92 98.68 Favored 'General case' 0 C--N 1.352 0.692 0 O-C-N 121.693 -0.629 . . . . 0.0 110.891 -178.165 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -68.06 -40.66 82.71 Favored 'General case' 0 C--N 1.347 0.481 0 O-C-N 121.952 -0.467 . . . . 0.0 111.738 -177.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 54.0 tp -66.65 -43.79 83.67 Favored 'General case' 0 C--N 1.35 0.599 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -178.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.696 HG12 ' O ' ' A' ' 9' ' ' LEU . 2.0 mm -72.71 -37.36 55.4 Favored 'Isoleucine or valine' 0 C--N 1.36 1.032 0 O-C-N 121.164 -0.96 . . . . 0.0 111.054 -175.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -71.65 -42.85 67.03 Favored 'General case' 0 C--N 1.35 0.619 0 O-C-N 121.662 -0.649 . . . . 0.0 111.835 -176.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -71.26 -37.03 71.95 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -175.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -98.31 -27.95 13.89 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 118.627 -1.229 . . . . 0.0 114.085 -174.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -115.28 -30.55 6.25 Favored 'General case' 0 CA--C 1.506 -0.743 0 C-N-CA 117.162 -1.815 . . . . 0.0 112.7 -176.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 143.17 177.83 18.48 Favored Glycine 0 C--N 1.347 1.155 0 C-N-CA 118.122 -1.99 . . . . 0.0 110.068 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -101.46 -24.4 14.18 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 -177.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -68.98 -39.86 79.16 Favored 'General case' 0 C--N 1.361 1.106 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 96.3 m -68.54 -38.63 81.0 Favored 'General case' 0 C--N 1.357 0.923 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 178.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.491 HD11 ' HB ' ' A' ' 13' ' ' ILE . 41.9 tp -59.4 -39.16 82.53 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -65.31 -37.21 86.44 Favored 'General case' 0 C--N 1.355 0.828 0 O-C-N 122.144 -0.347 . . . . 0.0 111.241 -178.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.451 HG21 ' O ' ' A' ' 24' ' ' THR . 88.6 m -64.61 -40.72 96.0 Favored 'General case' 0 C--N 1.354 0.787 0 O-C-N 121.679 -0.638 . . . . 0.0 109.708 -178.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.413 HD21 ' HA ' ' A' ' 25' ' ' LEU . 10.2 mt -64.81 -37.47 87.71 Favored 'General case' 0 C--N 1.353 0.757 0 C-N-CA 120.566 -0.454 . . . . 0.0 109.777 -178.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.744 HD22 ' HE3' ' A' ' 10' ' ' MET . 83.6 mt -70.0 -17.24 63.27 Favored 'General case' 0 C--N 1.359 0.996 0 O-C-N 121.739 -0.6 . . . . 0.0 110.192 -179.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -84.66 -28.27 26.53 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 119.51 -0.876 . . . . 0.0 109.493 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 45.7 t -66.76 -36.89 83.47 Favored 'General case' 0 C--N 1.354 0.781 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.64 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 2.2 p -92.91 -37.98 11.96 Favored 'General case' 0 C--N 1.358 0.957 0 C-N-CA 118.936 -1.106 . . . . 0.0 108.031 -178.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.64 ' HB2' ' O ' ' A' ' 29' ' ' CYS . 14.9 mt-10 84.73 132.61 0.05 OUTLIER 'General case' 0 C--N 1.359 1.005 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.514 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -90.25 -167.67 1.9 Allowed 'General case' 0 C--N 1.356 0.85 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.286 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.471 ' H ' ' HB2' ' A' ' 31' ' ' LEU . 63.7 tt0 -154.25 -64.63 0.14 Allowed 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.5 t -97.26 -64.92 1.0 Allowed 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -139.21 -44.02 0.46 Allowed 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 -178.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.74 -35.97 3.0 Favored Glycine 0 C--N 1.352 1.448 0 N-CA-C 109.151 -1.579 . . . . 0.0 109.151 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 82.5 mt -110.84 101.92 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.782 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.587 ' CD2' HG23 ' A' ' 40' ' ' VAL . 0.4 OUTLIER -66.65 -57.27 7.53 Favored 'General case' 0 C--N 1.358 0.964 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 178.947 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.417 ' CB ' ' O ' ' A' ' 37' ' ' TYR . 1.0 OUTLIER 148.65 -64.04 0.0 OUTLIER 'General case' 0 C--N 1.367 1.355 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 178.422 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.7 p 168.73 70.69 0.0 OUTLIER 'General case' 0 C--N 1.362 1.135 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.587 HG23 ' CD2' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -159.21 4.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.869 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.797 -179.438 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.78 -158.11 21.14 Favored Glycine 0 C--N 1.355 1.597 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 -179.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 171.17 85.34 0.0 OUTLIER 'General case' 0 CA--C 1.5 -0.963 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 -178.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -95.47 177.08 5.94 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -83.63 -170.82 3.25 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -91.93 -14.95 28.73 Favored 'General case' 0 CA--C 1.499 -0.992 0 C-N-CA 119.994 -0.682 . . . . 0.0 109.3 -179.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -69.85 -30.5 67.99 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.452 ' CG ' ' HZ ' ' A' ' 6' ' ' PHE . 33.0 tp10 -64.02 -40.82 97.18 Favored 'General case' 0 C--N 1.351 0.654 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.695 HD21 ' O ' ' A' ' 48' ' ' LEU . 4.6 tt -71.78 -35.52 70.05 Favored 'General case' 0 C--N 1.357 0.896 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -179.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 61.5 tp -69.99 -36.7 75.36 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -177.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 72.9 tp60 -65.0 -41.72 95.14 Favored 'General case' 0 N--CA 1.441 -0.881 0 O-C-N 121.87 -0.519 . . . . 0.0 109.707 -178.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.507 ' HA ' HD22 ' A' ' 51' ' ' LEU . 81.7 mt -73.94 -35.82 64.61 Favored 'General case' 0 C--N 1.364 1.2 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.28 -179.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.482 ' O ' HG13 ' A' ' 52' ' ' VAL . 1.4 t -64.03 -39.05 84.07 Favored 'Isoleucine or valine' 0 C--N 1.353 0.76 0 O-C-N 121.904 -0.497 . . . . 0.0 109.759 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.51 HG12 ' O ' ' A' ' 53' ' ' VAL . 55.8 t -67.66 -39.6 82.5 Favored 'Isoleucine or valine' 0 C--N 1.352 0.699 0 O-C-N 121.675 -0.641 . . . . 0.0 109.474 179.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 35.1 tptt -63.51 -28.7 70.13 Favored 'General case' 0 C--N 1.363 1.175 0 O-C-N 121.234 -0.916 . . . . 0.0 108.711 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.48 HD13 HD12 ' A' ' 66' ' ' LEU . 14.1 mt -66.65 -38.3 86.6 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.439 179.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.6 p -72.54 -17.79 61.69 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.879 -178.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -101.72 -38.68 7.78 Favored 'General case' 0 C--N 1.353 0.729 0 C-N-CA 119.358 -0.937 . . . . 0.0 111.813 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.42 HG11 ' N ' ' A' ' 59' ' ' SER . 3.6 p -74.38 -37.48 45.05 Favored 'Isoleucine or valine' 0 C--N 1.352 0.704 0 O-C-N 121.515 -0.741 . . . . 0.0 111.255 -176.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.42 ' N ' HG11 ' A' ' 58' ' ' VAL . 1.9 t -110.57 -9.44 14.55 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 119.249 -0.981 . . . . 0.0 110.281 -178.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 65.29 49.26 1.97 Allowed 'General case' 0 C--N 1.354 0.792 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.424 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 58.2 t -113.92 133.49 22.3 Favored Pre-proline 0 CA--C 1.504 -0.822 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 61' ' ' VAL . 43.2 Cg_exo -57.88 147.44 81.42 Favored 'Trans proline' 0 CA--C 1.499 -1.229 0 C-N-CA 122.581 2.187 . . . . 0.0 112.825 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.2 m -74.51 -13.03 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.912 -178.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 68.2 p -95.95 -32.03 12.8 Favored 'General case' 0 C--N 1.357 0.922 0 C-N-CA 118.151 -1.42 . . . . 0.0 109.509 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -76.44 -24.43 53.93 Favored 'General case' 0 C--N 1.355 0.819 0 O-C-N 121.452 -0.78 . . . . 0.0 109.201 179.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.48 HD12 HD13 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -80.15 -36.92 34.48 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -179.029 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.543 HG12 ' N ' ' A' ' 68' ' ' ARG . 1.5 p -67.97 -26.87 35.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.737 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.036 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.543 ' N ' HG12 ' A' ' 67' ' ' VAL . 5.2 mmm-85 -73.14 -51.17 18.92 Favored 'General case' 0 C--N 1.362 1.151 0 O-C-N 121.549 -0.719 . . . . 0.0 110.283 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.1 mt -63.64 -36.24 83.16 Favored 'General case' 0 C--N 1.357 0.929 0 O-C-N 121.959 -0.463 . . . . 0.0 111.003 -178.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -60.85 -47.83 84.57 Favored 'General case' 0 C--N 1.349 0.575 0 O-C-N 122.155 -0.341 . . . . 0.0 110.596 -178.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.76 -38.09 94.65 Favored Glycine 0 C--N 1.355 1.592 0 N-CA-C 111.854 -0.498 . . . . 0.0 111.854 -178.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -63.64 -47.94 79.27 Favored 'General case' 0 C--N 1.35 0.588 0 CA-C-N 117.976 0.888 . . . . 0.0 111.508 -177.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.657 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 12.6 mttm -64.65 -48.51 74.55 Favored 'General case' 0 C--N 1.358 0.973 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -177.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -68.71 -39.2 80.56 Favored 'General case' 0 C--N 1.348 0.507 0 O-C-N 121.3 -0.875 . . . . 0.0 111.926 -175.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -63.22 -44.33 95.56 Favored 'General case' 0 C--N 1.354 0.766 0 O-C-N 121.068 -1.02 . . . . 0.0 111.044 -178.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.12 -15.23 18.55 Favored 'Isoleucine or valine' 0 C--N 1.359 0.982 0 O-C-N 121.509 -0.744 . . . . 0.0 109.184 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.657 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 69.5 mm-40 -71.8 -38.83 70.18 Favored 'General case' 0 C--N 1.349 0.574 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.2 mt -72.98 -32.37 65.15 Favored 'General case' 0 C--N 1.358 0.946 0 O-C-N 122.309 -0.244 . . . . 0.0 110.471 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.8 mm -64.58 -53.43 42.53 Favored 'Isoleucine or valine' 0 C--N 1.357 0.922 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.372 -177.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -75.39 -15.49 60.45 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 119.624 -0.831 . . . . 0.0 109.337 178.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.11 -37.06 64.0 Favored Glycine 0 C--N 1.35 1.348 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.485 ' HA ' ' HD2' ' A' ' 83' ' ' PRO . 99.1 m-70 -131.33 105.73 14.69 Favored Pre-proline 0 N--CA 1.441 -0.922 0 CA-C-O 122.643 1.211 . . . . 0.0 109.321 -176.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.485 ' HD2' ' HA ' ' A' ' 82' ' ' HIS . 37.8 Cg_endo -67.99 -25.88 37.91 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.614 2.209 . . . . 0.0 114.146 179.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -89.0 -8.26 54.41 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.2 tp -90.26 -20.56 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -178.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.41 -23.57 14.71 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -70.06 -37.42 75.51 Favored 'General case' 0 C--N 1.358 0.949 0 C-N-CA 120.264 -0.575 . . . . 0.0 109.527 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -64.9 -36.21 83.63 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.333 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.424 ' HE2' ' HB3' ' A' ' 89' ' ' MET . 25.9 ttp -82.75 149.31 27.34 Favored 'General case' 0 C--N 1.351 0.646 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 -178.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.59 -22.27 8.17 Favored 'General case' 0 C--N 1.361 1.093 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.831 -177.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -165.25 171.76 13.23 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -177.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.428 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 41.0 t -64.3 -42.07 96.54 Favored 'General case' 0 C--N 1.357 0.921 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.08 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -66.54 -38.55 87.37 Favored 'General case' 0 C--N 1.355 0.81 0 O-C-N 121.437 -0.789 . . . . 0.0 109.493 -178.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -65.65 -25.31 67.3 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.544 HD21 ' HG ' ' A' ' 150' ' ' CYS . 57.6 tp -63.21 -46.62 86.16 Favored 'General case' 0 C--N 1.357 0.928 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.1 mp -61.78 -32.64 72.93 Favored 'General case' 0 C--N 1.356 0.862 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 36.0 t -62.87 -44.74 95.29 Favored 'General case' 0 C--N 1.354 0.762 0 O-C-N 121.931 -0.481 . . . . 0.0 111.584 -178.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.97 26.88 10.1 Favored 'General case' 0 C--N 1.364 1.225 0 O-C-N 120.939 -1.101 . . . . 0.0 111.132 -177.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 8.9 tp -61.31 -30.33 47.72 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 C-N-CA 120.431 -0.507 . . . . 0.0 110.539 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -126.95 -7.78 6.05 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 118.484 -1.287 . . . . 0.0 110.005 -179.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 57.5 m -90.43 -3.36 57.73 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.442 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -149.0 -47.39 0.14 Allowed 'General case' 0 C--N 1.358 0.956 0 C-N-CA 118.132 -1.427 . . . . 0.0 110.043 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 96.2 mt -67.41 -47.29 81.35 Favored 'Isoleucine or valine' 0 C--N 1.354 0.802 0 O-C-N 121.926 -0.484 . . . . 0.0 110.979 -177.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -84.65 0.33 50.69 Favored 'General case' 0 C--N 1.353 0.754 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.933 -177.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 77.3 t -80.78 -45.01 21.53 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.975 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -67.45 -40.0 85.39 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.959 -179.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 64.8 t -62.96 -46.71 95.61 Favored 'Isoleucine or valine' 0 C--N 1.354 0.782 0 O-C-N 122.155 -0.341 . . . . 0.0 110.742 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -60.21 -47.85 84.2 Favored 'General case' 0 C--N 1.358 0.945 0 O-C-N 122.112 -0.367 . . . . 0.0 111.361 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -62.91 -36.18 82.53 Favored 'General case' 0 C--N 1.353 0.753 0 O-C-N 121.545 -0.722 . . . . 0.0 110.502 -178.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.5 mt -59.08 -77.22 0.04 OUTLIER 'General case' 0 C--N 1.357 0.931 0 C-N-CA 120.444 -0.503 . . . . 0.0 109.809 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -111.13 141.76 24.95 Favored Pre-proline 0 N--CA 1.442 -0.863 0 C-N-CA 118.583 -1.247 . . . . 0.0 109.553 -179.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -90.73 0.63 5.06 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 123.781 2.988 . . . . 0.0 115.216 -179.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -86.1 4.42 38.29 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 121.63 -0.668 . . . . 0.0 109.851 -178.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -96.1 143.81 26.91 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 119.798 -0.761 . . . . 0.0 109.7 -178.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -119.51 141.43 49.21 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 178.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.41 HD21 ' HA ' ' A' ' 116' ' ' LEU . 95.6 mt -136.53 152.97 75.71 Favored Pre-proline 0 C--N 1.355 0.831 0 CA-C-O 122.198 0.999 . . . . 0.0 109.518 -178.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -87.19 -158.15 0.08 OUTLIER 'Trans proline' 0 C--N 1.32 -0.925 0 C-N-CA 123.96 3.106 . . . . 0.0 113.894 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -114.84 139.2 49.95 Favored 'General case' 0 C--N 1.368 1.38 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -125.32 127.31 46.45 Favored 'General case' 0 C--N 1.362 1.13 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -178.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.549 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 93.9 m -125.47 128.79 48.6 Favored 'General case' 0 C--N 1.357 0.912 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 177.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 73.7 m -119.76 128.12 53.45 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 119.323 -0.951 . . . . 0.0 109.506 -178.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -122.18 145.44 48.19 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 178.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.748 ' HG3' HD11 ' A' ' 129' ' ' ILE . 35.4 ttp180 -100.33 -169.02 1.66 Allowed 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.676 ' H ' ' HG2' ' A' ' 123' ' ' ARG . 21.9 mt -165.12 -36.91 0.03 OUTLIER 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 -178.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -171.03 -150.89 7.27 Favored Glycine 0 C--N 1.353 1.503 0 N-CA-C 108.241 -1.944 . . . . 0.0 108.241 -178.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -94.29 -40.1 10.16 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.331 -179.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -97.64 3.84 50.27 Favored 'General case' 0 C--N 1.352 0.683 0 C-N-CA 120.216 -0.593 . . . . 0.0 110.276 -178.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -122.31 135.22 54.69 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 119.552 -0.859 . . . . 0.0 109.405 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.748 HD11 ' HG3' ' A' ' 123' ' ' ARG . 6.4 mm -142.11 136.9 29.94 Favored 'Isoleucine or valine' 0 C--N 1.356 0.87 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 178.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.552 ' N ' HG21 ' A' ' 129' ' ' ILE . 52.3 mtm180 -114.88 138.47 50.76 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 8.3 tp -126.28 118.35 24.93 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.549 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 15.7 m-70 -98.27 134.43 41.32 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 179.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -130.3 121.43 26.05 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.545 ' HA ' ' O ' ' A' ' 171' ' ' THR . 75.1 mt-30 -114.15 114.69 26.39 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 19.4 t -161.52 150.41 15.95 Favored 'General case' 0 C--N 1.357 0.916 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -90.5 1.69 56.44 Favored 'General case' 0 C--N 1.355 0.805 0 C-N-CA 120.306 -0.557 . . . . 0.0 109.879 -178.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -136.78 74.57 51.37 Favored Pre-proline 0 CA--C 1.506 -0.742 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -94.11 110.6 0.18 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.657 2.238 . . . . 0.0 116.157 -177.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -111.56 109.7 19.74 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 176.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.4 -39.65 95.09 Favored 'General case' 0 C--N 1.355 0.811 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.518 -178.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 74.8 m -64.29 -24.93 67.83 Favored 'General case' 0 C--N 1.353 0.738 0 O-C-N 121.849 -0.532 . . . . 0.0 110.831 -178.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -76.51 -47.69 21.95 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 120.192 -0.603 . . . . 0.0 109.611 -178.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.1 -39.21 92.83 Favored 'General case' 0 C--N 1.357 0.93 0 O-C-N 122.115 -0.365 . . . . 0.0 111.123 -178.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -62.65 -37.29 85.77 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 121.801 -0.562 . . . . 0.0 109.77 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.27 -42.53 98.78 Favored Glycine 0 C--N 1.347 1.162 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.2 mt -70.46 -40.72 73.52 Favored 'General case' 0 C--N 1.352 0.687 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 96.3 mt -70.91 -41.97 70.54 Favored 'General case' 0 C--N 1.361 1.096 0 O-C-N 121.32 -0.862 . . . . 0.0 110.891 -177.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.574 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 36.8 t70 -70.33 -29.73 66.52 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 121.893 -0.504 . . . . 0.0 110.295 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -63.3 -39.43 97.83 Favored Glycine 0 C--N 1.356 1.656 0 N-CA-C 108.489 -1.844 . . . . 0.0 108.489 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . 0.544 ' HG ' HD21 ' A' ' 95' ' ' LEU . 47.6 t -60.68 -42.25 96.73 Favored 'General case' 0 C--N 1.351 0.635 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -75.99 0.08 19.78 Favored 'General case' 0 C--N 1.36 1.025 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.574 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 76.5 mm-40 -84.6 -46.03 11.95 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -67.65 -43.77 79.51 Favored 'General case' 0 C--N 1.359 0.999 0 C-N-CA 120.109 -0.636 . . . . 0.0 109.559 179.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.482 ' O ' ' HB2' ' A' ' 155' ' ' LYS . 54.3 m-85 -70.42 -24.94 63.01 Favored 'General case' 0 C--N 1.361 1.087 0 O-C-N 121.734 -0.604 . . . . 0.0 111.311 -178.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 154' ' ' PHE . 47.9 mttt 73.62 67.82 0.1 Allowed 'General case' 0 C--N 1.362 1.116 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -178.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -134.16 -176.04 4.06 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -146.76 91.88 2.08 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 16.3 m-30 -113.54 157.73 21.66 Favored 'General case' 0 C--N 1.352 0.678 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 179.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 92.6 m -119.27 127.77 53.54 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 119.548 -0.861 . . . . 0.0 108.832 -178.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 3.2 mp -103.97 121.9 56.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.661 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.9 m -118.38 -173.69 2.52 Favored 'General case' 0 C--N 1.358 0.935 0 CA-C-O 121.661 0.743 . . . . 0.0 109.412 -178.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -146.97 157.0 43.5 Favored 'General case' 0 C--N 1.356 0.858 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 -178.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 49.6 p -99.64 146.37 31.7 Favored Pre-proline 0 C--N 1.358 0.974 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.689 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 73.9 Cg_endo -75.04 -12.0 21.42 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.941 2.427 . . . . 0.0 114.966 -178.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -72.63 -41.67 65.28 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.84 -178.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 37.8 p -117.21 15.5 14.92 Favored 'General case' 0 C--N 1.354 0.789 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.717 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.689 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.1 pp0? -67.59 -11.62 58.52 Favored 'General case' 0 C--N 1.354 0.796 0 O-C-N 121.569 -0.707 . . . . 0.0 110.245 178.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 54.4 p-10 -122.41 33.33 5.48 Favored 'General case' 0 N--CA 1.438 -1.038 0 O-C-N 121.148 -0.97 . . . . 0.0 108.707 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 57.8 m -135.67 148.37 48.9 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.625 ' O ' ' HB ' ' A' ' 171' ' ' THR . 60.8 mt-10 -100.77 166.12 11.03 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.625 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 6.9 m 83.26 -59.66 0.14 Allowed 'General case' 0 C--N 1.369 1.434 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -108.42 118.05 35.76 Favored 'General case' 0 CA--C 1.505 -0.77 0 C-N-CA 119.901 -0.72 . . . . 0.0 109.567 -178.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.534 HG13 ' CZ ' ' A' ' 175' ' ' PHE . 97.2 t -131.01 132.78 63.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.916 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 178.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.419 ' N ' HG12 ' A' ' 173' ' ' VAL . 49.5 mm -106.54 126.06 62.33 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.534 ' CZ ' HG13 ' A' ' 173' ' ' VAL . 89.0 m-85 -115.44 156.46 25.57 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 122.141 0.972 . . . . 0.0 108.562 -179.12 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -138.79 120.77 15.55 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -178.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.8 mp -115.06 121.12 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 89.1 m -117.96 143.26 46.52 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -177.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 30.4 ttm180 . . . . . 0 C--N 1.364 1.221 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 179.725 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.3 mmm . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 120.876 0.37 . . . . 0.0 110.17 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.5 ' HA ' HG23 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -79.52 -22.14 44.32 Favored 'General case' 0 C--N 1.356 0.854 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.059 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -76.16 -39.36 32.22 Favored Glycine 0 C--N 1.348 1.238 0 N-CA-C 109.084 -1.607 . . . . 0.0 109.084 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.4 tpp -70.63 -37.03 73.75 Favored 'General case' 0 C--N 1.353 0.725 0 O-C-N 122.297 -0.531 . . . . 0.0 110.593 -177.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.5 HG23 ' HA ' ' A' ' 2' ' ' MET . 26.9 m -70.77 -22.46 23.24 Favored 'Isoleucine or valine' 0 C--N 1.358 0.939 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -179.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.516 ' HZ ' ' HG2' ' A' ' 47' ' ' GLU . 2.2 m-30 -69.92 -35.32 74.47 Favored 'General case' 0 C--N 1.357 0.912 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 84.9 m -67.06 -40.05 87.01 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.44 -37.86 95.35 Favored Glycine 0 C--N 1.358 1.753 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.657 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -66.96 -39.76 87.31 Favored 'General case' 0 C--N 1.352 0.681 0 CA-C-N 117.29 0.545 . . . . 0.0 110.544 -178.224 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.686 ' HE1' HD22 ' A' ' 26' ' ' LEU . 22.7 mmt -63.71 -41.16 98.14 Favored 'General case' 0 C--N 1.354 0.786 0 O-C-N 121.753 -0.592 . . . . 0.0 110.905 -178.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -66.38 -40.14 89.5 Favored 'General case' 0 C--N 1.349 0.572 0 O-C-N 121.989 -0.444 . . . . 0.0 111.381 -178.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 57.7 tp -66.43 -41.95 88.43 Favored 'General case' 0 C--N 1.35 0.608 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.682 HD11 HD23 ' A' ' 55' ' ' LEU . 3.8 mm -73.78 -37.9 49.69 Favored 'Isoleucine or valine' 0 C--N 1.358 0.941 0 O-C-N 121.186 -0.947 . . . . 0.0 111.187 -176.082 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -69.05 -42.8 75.81 Favored 'General case' 0 C--N 1.352 0.714 0 O-C-N 121.7 -0.625 . . . . 0.0 111.236 -176.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -72.22 -33.24 67.43 Favored 'General case' 0 N--CA 1.446 -0.646 0 O-C-N 121.953 -0.467 . . . . 0.0 111.771 -177.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -73.02 -48.65 34.35 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -175.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -126.61 -20.33 4.36 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 117.718 -1.593 . . . . 0.0 112.367 -176.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 130.25 164.11 11.24 Favored Glycine 0 N--CA 1.437 -1.271 0 C-N-CA 118.102 -1.999 . . . . 0.0 110.809 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -67.08 -24.54 65.97 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 113.828 -1.186 . . . . 0.0 111.266 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -64.06 -44.27 92.95 Favored 'General case' 0 C--N 1.359 1.014 0 O-C-N 121.0 -1.062 . . . . 0.0 109.882 -179.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 94.2 m -67.24 -37.58 83.79 Favored 'General case' 0 C--N 1.352 0.717 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.532 HD11 ' HB ' ' A' ' 13' ' ' ILE . 33.3 tp -60.06 -37.59 80.32 Favored 'General case' 0 C--N 1.352 0.685 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.585 -179.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -66.14 -36.73 83.9 Favored 'General case' 0 C--N 1.356 0.87 0 O-C-N 122.105 -0.372 . . . . 0.0 110.704 -178.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.428 HG21 ' O ' ' A' ' 24' ' ' THR . 86.5 m -65.02 -40.43 94.87 Favored 'General case' 0 C--N 1.355 0.808 0 O-C-N 121.707 -0.621 . . . . 0.0 109.368 -178.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.907 HD23 HG13 ' A' ' 58' ' ' VAL . 83.2 mt -66.33 -36.32 82.63 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -179.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.686 HD22 ' HE1' ' A' ' 10' ' ' MET . 81.9 mt -72.41 -12.91 61.31 Favored 'General case' 0 C--N 1.36 1.042 0 O-C-N 121.819 -0.55 . . . . 0.0 110.106 -178.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -89.11 -26.23 21.45 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 119.098 -1.041 . . . . 0.0 108.971 178.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.9 t -67.76 -36.64 80.87 Favored 'General case' 0 C--N 1.358 0.936 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 178.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.65 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 1.8 p -92.92 -40.72 10.44 Favored 'General case' 0 C--N 1.359 0.985 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -179.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.65 ' HB2' ' O ' ' A' ' 29' ' ' CYS . 13.6 mt-10 84.94 134.71 0.05 Allowed 'General case' 0 C--N 1.361 1.089 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.474 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -85.79 -170.46 3.11 Favored 'General case' 0 C--N 1.358 0.936 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.49 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.438 ' H ' ' HB2' ' A' ' 31' ' ' LEU . 63.0 tt0 -150.99 -24.27 0.21 Allowed 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.3 t -148.84 -65.13 0.23 Allowed 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -178.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -130.73 -55.49 1.07 Allowed 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 -179.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 131.43 -41.21 1.54 Allowed Glycine 0 C--N 1.351 1.407 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 79.7 mt -106.84 101.67 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.555 ' O ' ' HB ' ' A' ' 38' ' ' THR . 0.8 OUTLIER -72.23 -30.05 64.53 Favored 'General case' 0 C--N 1.357 0.906 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.685 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.555 ' HB ' ' O ' ' A' ' 37' ' ' TYR . 8.0 m 114.71 -67.12 0.0 OUTLIER 'General case' 0 C--N 1.37 1.489 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.415 ' C ' HG21 ' A' ' 40' ' ' VAL . 13.2 p 174.13 63.71 0.0 OUTLIER 'General case' 0 C--N 1.36 1.043 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -179.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.415 HG21 ' C ' ' A' ' 39' ' ' SER . 1.1 t -148.43 -5.03 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.831 0 C-N-CA 119.411 -0.916 . . . . 0.0 109.692 -178.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -98.12 143.92 16.96 Favored Glycine 0 C--N 1.352 1.428 0 C-N-CA 119.186 -1.483 . . . . 0.0 110.071 -178.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.0 m -124.07 122.61 38.33 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 178.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -117.14 175.86 5.4 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 -178.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -82.59 -172.04 3.83 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -90.97 -13.81 32.7 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 120.014 -0.674 . . . . 0.0 109.305 -179.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -70.12 -29.32 66.23 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.516 ' HG2' ' HZ ' ' A' ' 6' ' ' PHE . 25.9 tp10 -63.28 -40.33 97.08 Favored 'General case' 0 C--N 1.352 0.693 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.478 ' O ' HD23 ' A' ' 48' ' ' LEU . 1.8 tm? -67.63 -38.08 83.37 Favored 'General case' 0 C--N 1.357 0.9 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 58.6 tp -73.9 -29.66 62.18 Favored 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 122.063 -0.398 . . . . 0.0 110.336 -176.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 71.6 tp60 -69.0 -40.09 78.95 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -178.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.481 ' HA ' HD22 ' A' ' 51' ' ' LEU . 81.3 mt -83.31 -17.17 43.42 Favored 'General case' 0 C--N 1.36 1.039 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.699 -178.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.49 ' O ' HG13 ' A' ' 52' ' ' VAL . 1.1 t -82.25 -35.25 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.51 ' O ' HG11 ' A' ' 53' ' ' VAL . 55.1 t -69.07 -39.38 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 34.0 tptt -66.79 -32.09 73.15 Favored 'General case' 0 C--N 1.364 1.209 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.682 HD23 HD11 ' A' ' 13' ' ' ILE . 18.1 mt -62.78 -39.58 94.65 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.32 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.506 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 39.3 t -65.95 -36.61 83.8 Favored 'General case' 0 C--N 1.35 0.605 0 O-C-N 121.942 -0.474 . . . . 0.0 110.647 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -86.42 -37.65 18.15 Favored 'General case' 0 C--N 1.355 0.834 0 O-C-N 120.961 -1.087 . . . . 0.0 112.766 -177.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.907 HG13 HD23 ' A' ' 25' ' ' LEU . 4.9 p -75.47 -40.01 41.38 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 O-C-N 121.37 -0.831 . . . . 0.0 111.482 -176.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.4 t -106.5 -5.84 18.55 Favored 'General case' 0 C--N 1.352 0.69 0 C-N-CA 119.304 -0.958 . . . . 0.0 110.331 -177.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 56' ' ' SER . 72.3 m 65.29 39.91 5.11 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 56' ' ' SER . 59.4 t -114.72 124.77 29.97 Favored Pre-proline 0 CA--C 1.503 -0.831 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 61' ' ' VAL . 32.1 Cg_exo -57.93 155.33 33.73 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 122.803 2.335 . . . . 0.0 113.562 -179.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.468 ' HA ' ' CD2' ' A' ' 66' ' ' LEU . 13.7 m -74.45 -12.09 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.89 -177.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 72.9 p -94.2 -34.2 12.99 Favored 'General case' 0 C--N 1.357 0.905 0 C-N-CA 118.067 -1.453 . . . . 0.0 110.154 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -80.21 -20.83 43.77 Favored 'General case' 0 C--N 1.354 0.803 0 O-C-N 121.202 -0.936 . . . . 0.0 109.13 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.636 HD13 HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -79.88 -34.43 39.19 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -179.757 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.63 HG12 ' N ' ' A' ' 68' ' ' ARG . 2.4 p -69.82 -29.54 41.12 Favored 'Isoleucine or valine' 0 C--N 1.357 0.912 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.023 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.63 ' N ' HG12 ' A' ' 67' ' ' VAL . 79.6 mtp180 -69.93 -48.1 59.78 Favored 'General case' 0 C--N 1.364 1.232 0 O-C-N 121.373 -0.83 . . . . 0.0 110.71 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.4 mt -64.36 -36.24 83.48 Favored 'General case' 0 C--N 1.355 0.828 0 O-C-N 121.949 -0.469 . . . . 0.0 110.796 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -61.08 -47.73 85.01 Favored 'General case' 0 C--N 1.35 0.593 0 O-C-N 122.212 -0.305 . . . . 0.0 110.715 -178.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.61 -38.95 96.69 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 119.817 -0.435 . . . . 0.0 112.227 -177.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -66.19 -45.35 81.1 Favored 'General case' 0 C--N 1.352 0.675 0 CA-C-N 118.441 1.121 . . . . 0.0 111.453 -176.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.744 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 6.6 mttm -64.16 -49.52 71.79 Favored 'General case' 0 C--N 1.356 0.886 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -177.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -68.12 -40.74 82.45 Favored 'General case' 0 C--N 1.349 0.568 0 O-C-N 121.358 -0.839 . . . . 0.0 112.219 -175.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -64.12 -44.55 91.89 Favored 'General case' 0 C--N 1.354 0.784 0 O-C-N 121.066 -1.021 . . . . 0.0 111.485 -177.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.65 -14.54 17.69 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 O-C-N 121.48 -0.762 . . . . 0.0 109.664 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.744 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 77.1 mm-40 -74.75 -37.82 62.38 Favored 'General case' 0 C--N 1.351 0.636 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 178.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 73.9 mt -67.41 -37.41 83.03 Favored 'General case' 0 C--N 1.36 1.063 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.0 mm -63.1 -50.63 78.57 Favored 'Isoleucine or valine' 0 C--N 1.356 0.857 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 -178.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -68.12 -20.94 64.95 Favored 'General case' 0 C--N 1.35 0.595 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.494 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -99.2 -0.97 56.99 Favored Glycine 0 N--CA 1.437 -1.256 0 C-N-CA 119.509 -1.329 . . . . 0.0 110.713 -177.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.697 ' HB3' ' HB ' ' A' ' 85' ' ' ILE . 93.4 m-70 -139.14 88.88 12.83 Favored Pre-proline 0 CA--C 1.502 -0.892 0 CA-C-N 119.113 1.456 . . . . 0.0 109.044 -179.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 82' ' ' HIS . 31.9 Cg_endo -65.85 -27.78 51.26 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.504 2.136 . . . . 0.0 114.556 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -95.1 -4.2 46.69 Favored 'General case' 0 CA--C 1.502 -0.895 0 C-N-CA 119.388 -0.925 . . . . 0.0 108.978 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.697 ' HB ' ' HB3' ' A' ' 82' ' ' HIS . 0.1 OUTLIER -89.0 -19.68 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 -179.575 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -104.4 -23.39 13.19 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -68.55 -36.96 79.52 Favored 'General case' 0 C--N 1.362 1.129 0 O-C-N 121.656 -0.652 . . . . 0.0 109.372 178.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -65.42 -35.12 79.99 Favored 'General case' 0 C--N 1.356 0.883 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.416 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.479 ' SD ' ' HB2' ' A' ' 95' ' ' LEU . 18.1 ttp -83.69 151.14 25.42 Favored 'General case' 0 C--N 1.352 0.715 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -178.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.79 -22.8 9.49 Favored 'General case' 0 C--N 1.365 1.261 0 O-C-N 121.632 -0.667 . . . . 0.0 111.258 -177.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -166.0 172.26 11.65 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -177.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.435 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 63.4 m -66.42 -39.73 89.15 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.506 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -67.82 -39.33 83.92 Favored 'General case' 0 C--N 1.356 0.865 0 O-C-N 121.375 -0.828 . . . . 0.0 109.093 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -65.53 -24.61 67.16 Favored 'General case' 0 C--N 1.355 0.83 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.745 ' O ' HG13 ' A' ' 99' ' ' ILE . 64.9 tp -63.65 -46.92 83.41 Favored 'General case' 0 C--N 1.353 0.732 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.56 ' HA ' HD12 ' A' ' 99' ' ' ILE . 2.0 mp -59.81 -36.65 77.2 Favored 'General case' 0 C--N 1.361 1.081 0 O-C-N 122.143 -0.348 . . . . 0.0 110.28 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.7 t -70.2 -39.81 74.96 Favored 'General case' 0 C--N 1.348 0.519 0 O-C-N 122.003 -0.436 . . . . 0.0 110.238 -179.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.485 ' HG3' ' HZ3' ' A' ' 98' ' ' LYS . 1.8 tttp -87.43 2.7 49.75 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 122.136 -0.353 . . . . 0.0 111.934 -176.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.745 HG13 ' O ' ' A' ' 95' ' ' LEU . 77.3 mt -61.18 -46.9 95.72 Favored 'Isoleucine or valine' 0 C--N 1.355 0.822 0 CA-C-N 119.156 0.889 . . . . 0.0 111.967 -177.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -94.66 -23.56 17.54 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 118.52 -1.272 . . . . 0.0 111.176 -177.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.0 t -63.63 -50.09 70.72 Favored 'General case' 0 N--CA 1.445 -0.718 0 O-C-N 121.644 -0.66 . . . . 0.0 112.527 -177.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.646 ' HA ' HG12 ' A' ' 105' ' ' VAL . 17.5 t80 -134.68 -15.89 2.06 Favored 'General case' 0 C--N 1.361 1.071 0 C-N-CA 117.352 -1.739 . . . . 0.0 113.578 -176.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 29.3 mm -71.15 -51.58 33.6 Favored 'Isoleucine or valine' 0 C--O 1.245 0.847 0 CA-C-N 120.493 1.497 . . . . 0.0 110.683 -177.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.435 ' HB3' HD22 ' A' ' 116' ' ' LEU . 64.7 m170 -91.58 1.49 57.1 Favored 'General case' 0 N--CA 1.439 -1.021 0 O-C-N 121.284 -0.885 . . . . 0.0 110.348 -177.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.646 HG12 ' HA ' ' A' ' 102' ' ' PHE . 1.2 p -88.8 -33.45 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 178.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.641 ' N ' HG11 ' A' ' 105' ' ' VAL . 0.6 OUTLIER -72.38 -40.36 67.31 Favored 'General case' 0 CA--C 1.5 -0.957 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.362 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.636 HG12 ' N ' ' A' ' 108' ' ' TYR . 0.5 OUTLIER -72.33 -37.05 57.15 Favored 'Isoleucine or valine' 0 C--N 1.355 0.809 0 C-N-CA 119.592 -0.843 . . . . 0.0 109.89 -178.815 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . 0.636 ' N ' HG12 ' A' ' 107' ' ' VAL . 91.5 t80 -61.24 -49.0 78.87 Favored 'General case' 0 C--N 1.362 1.115 0 O-C-N 121.786 -0.571 . . . . 0.0 110.828 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -60.0 -37.43 79.65 Favored 'General case' 0 C--N 1.357 0.908 0 O-C-N 121.639 -0.663 . . . . 0.0 110.057 -179.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 14.7 mt -57.15 -75.47 0.04 OUTLIER 'General case' 0 C--N 1.356 0.866 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.411 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 90.3 m-85 -119.82 136.8 25.08 Favored Pre-proline 0 N--CA 1.441 -0.915 0 C-N-CA 119.026 -1.069 . . . . 0.0 108.733 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 111' ' ' TYR . 76.6 Cg_endo -85.28 -1.96 9.3 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 123.205 2.603 . . . . 0.0 115.345 -178.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -67.52 -36.26 80.69 Favored 'General case' 0 C--N 1.354 0.784 0 O-C-N 121.712 -0.617 . . . . 0.0 110.229 -179.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.34 144.42 56.97 Favored 'General case' 0 C--N 1.354 0.792 0 CA-C-O 121.647 0.737 . . . . 0.0 109.995 -178.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -114.54 148.08 38.49 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.462 ' HA ' ' HD3' ' A' ' 117' ' ' PRO . 1.2 mp -128.6 144.11 50.93 Favored Pre-proline 0 N--CA 1.442 -0.841 0 CA-C-O 122.143 0.973 . . . . 0.0 109.099 -178.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 116' ' ' LEU . 97.6 Cg_endo -87.68 -155.46 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.215 0 C-N-CA 123.738 2.959 . . . . 0.0 112.959 179.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -120.21 140.26 51.42 Favored 'General case' 0 C--N 1.363 1.165 0 C-N-CA 119.142 -1.023 . . . . 0.0 108.316 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -133.03 133.4 43.03 Favored 'General case' 0 C--N 1.362 1.114 0 C-N-CA 120.069 -0.653 . . . . 0.0 109.835 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.462 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 93.6 m -124.22 128.03 48.58 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 176.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 74.7 m -118.78 127.68 53.76 Favored 'General case' 0 CA--C 1.503 -0.848 0 C-N-CA 119.162 -1.015 . . . . 0.0 109.52 -177.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -116.9 153.14 33.09 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 178.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.542 ' HG3' HD12 ' A' ' 129' ' ' ILE . 57.4 ttp180 -123.72 117.17 24.34 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 -179.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.433 HD21 ' HA ' ' A' ' 124' ' ' LEU . 95.9 mt -90.28 -16.69 28.82 Favored 'General case' 0 C--N 1.355 0.831 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.55 -179.301 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 174.77 -148.9 10.0 Favored Glycine 0 N--CA 1.437 -1.236 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -94.1 -37.18 11.74 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . 0.479 ' HB2' ' HG2' ' A' ' 179' ' ' ARG . 41.3 p-10 -102.45 1.22 34.96 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 119.886 -0.725 . . . . 0.0 110.315 -178.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -119.8 131.57 55.36 Favored 'General case' 0 C--N 1.358 0.977 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.549 HG21 ' N ' ' A' ' 130' ' ' ARG . 7.9 mm -141.29 136.25 32.58 Favored 'Isoleucine or valine' 0 C--N 1.354 0.778 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.549 ' N ' HG21 ' A' ' 129' ' ' ILE . 53.5 mtm180 -116.04 139.18 50.54 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.3 tp -127.93 117.42 21.72 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.462 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 12.0 m170 -96.78 133.98 40.65 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 179.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -129.77 122.44 28.83 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -178.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.546 ' HA ' ' O ' ' A' ' 171' ' ' THR . 76.2 mt-30 -116.21 115.7 26.47 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 12.8 t -163.22 155.19 17.84 Favored 'General case' 0 C--N 1.36 1.023 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -91.66 2.33 56.55 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 121.821 -0.55 . . . . 0.0 109.873 -178.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 93.6 mtm-85 -135.08 74.32 63.09 Favored Pre-proline 0 CA--C 1.505 -0.771 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -95.39 105.64 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.736 2.291 . . . . 0.0 115.7 -177.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -112.41 114.1 26.63 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 176.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.89 -38.82 92.52 Favored 'General case' 0 C--N 1.355 0.805 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.242 -179.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.3 m -63.63 -27.03 68.95 Favored 'General case' 0 C--N 1.354 0.782 0 O-C-N 121.926 -0.484 . . . . 0.0 110.827 -178.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -76.58 -47.87 21.1 Favored 'General case' 0 N--CA 1.446 -0.642 0 O-C-N 121.763 -0.586 . . . . 0.0 109.856 -177.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.49 -39.6 94.1 Favored 'General case' 0 C--N 1.357 0.895 0 O-C-N 122.183 -0.323 . . . . 0.0 111.149 -177.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -63.27 -37.64 88.04 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 121.907 -0.495 . . . . 0.0 109.927 -179.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.03 -42.91 98.6 Favored Glycine 0 C--N 1.348 1.217 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 -179.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 83.6 mt -70.06 -40.84 74.85 Favored 'General case' 0 C--N 1.353 0.747 0 CA-C-N 117.774 0.787 . . . . 0.0 112.549 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 97.7 mt -71.03 -42.07 70.01 Favored 'General case' 0 C--N 1.36 1.061 0 O-C-N 121.271 -0.893 . . . . 0.0 110.551 -176.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.505 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 21.5 t70 -69.17 -32.09 71.17 Favored 'General case' 0 N--CA 1.445 -0.723 0 O-C-N 122.211 -0.306 . . . . 0.0 110.505 -179.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . 0.475 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -63.04 -39.85 98.55 Favored Glycine 0 C--N 1.357 1.707 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 49.5 t -61.14 -42.11 97.95 Favored 'General case' 0 C--N 1.35 0.594 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' A' ' 156' ' ' GLU . . . -73.84 -2.39 23.48 Favored 'General case' 0 C--N 1.359 1.001 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.505 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 74.5 mm-40 -83.17 -45.96 13.29 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.052 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 92.9 t80 -65.89 -45.06 83.4 Favored 'General case' 0 C--N 1.359 1.008 0 C-N-CA 120.154 -0.619 . . . . 0.0 109.609 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -68.88 -26.4 65.1 Favored 'General case' 0 C--N 1.363 1.158 0 O-C-N 121.716 -0.615 . . . . 0.0 111.023 -178.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 78.2 tttt 74.39 71.95 0.11 Allowed 'General case' 0 C--N 1.361 1.072 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.431 ' O ' ' HB2' ' A' ' 151' ' ' ALA . 5.4 tp10 -161.34 125.24 3.35 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 178.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -87.25 108.35 18.9 Favored 'General case' 0 C--N 1.354 0.788 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.339 -179.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 9.3 m-30 -107.37 163.89 12.65 Favored 'General case' 0 C--N 1.353 0.734 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 177.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 95.5 m -121.37 129.21 52.92 Favored 'General case' 0 C--N 1.354 0.802 0 C-N-CA 118.972 -1.091 . . . . 0.0 109.41 -178.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 3.6 mp -110.5 122.12 64.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 178.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.7 m -119.12 -171.87 2.19 Favored 'General case' 0 C--N 1.357 0.916 0 CA-C-O 121.674 0.75 . . . . 0.0 109.245 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.11 159.29 44.53 Favored 'General case' 0 C--N 1.357 0.913 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 -178.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 64.6 p -100.72 146.83 32.76 Favored Pre-proline 0 C--N 1.359 1.012 0 CA-C-O 122.471 1.129 . . . . 0.0 108.298 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.662 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 73.5 Cg_endo -76.22 -11.49 19.32 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.957 2.438 . . . . 0.0 115.193 -178.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -72.11 -41.44 67.24 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 119.936 -0.705 . . . . 0.0 109.42 -178.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 31.4 p -116.73 16.5 15.34 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 120.159 -0.616 . . . . 0.0 110.323 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.662 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.2 pp0? -66.73 -10.29 45.49 Favored 'General case' 0 C--N 1.354 0.796 0 O-C-N 121.642 -0.661 . . . . 0.0 110.45 178.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -128.02 38.69 3.97 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 74.8 m -136.54 146.34 46.07 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.665 ' O ' ' HB ' ' A' ' 171' ' ' THR . 59.2 mp0 -99.61 162.55 12.95 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.665 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 1.5 m 84.53 -57.72 0.11 Allowed 'General case' 0 C--N 1.369 1.455 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.566 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -109.67 118.38 36.4 Favored 'General case' 0 CA--C 1.505 -0.75 0 C-N-CA 119.798 -0.761 . . . . 0.0 109.789 -178.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.579 HG11 ' CZ ' ' A' ' 175' ' ' PHE . 97.5 t -132.4 132.32 60.42 Favored 'Isoleucine or valine' 0 C--N 1.36 1.065 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 178.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.429 ' N ' HG13 ' A' ' 173' ' ' VAL . 50.3 mm -105.31 127.46 60.03 Favored 'Isoleucine or valine' 0 C--N 1.356 0.89 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.579 ' CZ ' HG11 ' A' ' 173' ' ' VAL . 93.9 m-85 -116.31 153.82 31.29 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -136.73 119.36 16.02 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -178.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.0 mp -114.21 119.06 60.29 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 -179.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 88.4 m -126.62 140.76 52.18 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -177.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.479 ' HG2' ' HB2' ' A' ' 127' ' ' ASN . 39.7 ptt180 . . . . . 0 C--N 1.366 1.285 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 179.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.456 ' HB2' ' HB2' ' A' ' 4' ' ' MET . 2.3 mmm . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 120.943 0.401 . . . . 0.0 110.07 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.659 ' HA ' HG23 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -80.63 -18.72 47.25 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 120.161 -0.616 . . . . 0.0 109.353 -179.043 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.11 -40.92 49.35 Favored Glycine 0 C--N 1.353 1.497 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' MET . . . . . 0.456 ' HB2' ' HB2' ' A' ' 1' ' ' MET . 4.9 mtm -70.39 -36.33 74.04 Favored 'General case' 0 C--N 1.36 1.044 0 O-C-N 121.836 -0.802 . . . . 0.0 111.335 -178.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.659 HG23 ' HA ' ' A' ' 2' ' ' MET . 34.6 m -69.4 -22.95 25.97 Favored 'Isoleucine or valine' 0 C--N 1.356 0.872 0 O-C-N 121.555 -0.715 . . . . 0.0 109.366 -178.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -71.05 -35.85 72.1 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 85.4 m -67.07 -41.37 86.51 Favored 'General case' 0 C--N 1.356 0.881 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.62 -39.01 97.36 Favored Glycine 0 C--N 1.359 1.81 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.733 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -64.99 -40.37 94.86 Favored 'General case' 0 C--N 1.351 0.658 0 CA-C-N 117.3 0.55 . . . . 0.0 110.731 -178.471 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.996 ' HE1' HD22 ' A' ' 26' ' ' LEU . 21.1 mmt -63.47 -40.68 97.76 Favored 'General case' 0 C--N 1.351 0.665 0 O-C-N 121.606 -0.684 . . . . 0.0 110.981 -178.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -67.23 -41.71 85.21 Favored 'General case' 0 C--N 1.35 0.611 0 O-C-N 121.859 -0.526 . . . . 0.0 111.691 -178.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 59.6 tp -65.61 -43.39 89.77 Favored 'General case' 0 C--N 1.35 0.598 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -178.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.733 HG12 ' O ' ' A' ' 9' ' ' LEU . 2.4 mm -72.92 -36.9 52.83 Favored 'Isoleucine or valine' 0 C--N 1.356 0.883 0 O-C-N 121.167 -0.958 . . . . 0.0 111.091 -175.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -65.99 -43.31 88.14 Favored 'General case' 0 C--N 1.352 0.688 0 O-C-N 121.746 -0.596 . . . . 0.0 111.663 -176.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -73.67 -37.27 65.31 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 121.773 -0.579 . . . . 0.0 112.279 -176.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -71.9 -41.64 67.72 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -175.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -129.9 -27.1 2.34 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 117.43 -1.708 . . . . 0.0 113.358 -177.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 148.19 -179.94 24.65 Favored Glycine 0 C--N 1.346 1.115 0 C-N-CA 117.499 -2.286 . . . . 0.0 110.664 -179.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 93.4 t80 -98.05 -20.41 17.39 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -177.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -70.27 -40.16 74.51 Favored 'General case' 0 C--N 1.361 1.085 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.58 HG22 HG21 ' A' ' 58' ' ' VAL . 93.3 m -68.35 -38.15 81.19 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.423 HD12 ' HB ' ' A' ' 13' ' ' ILE . 31.6 tp -59.97 -37.6 80.1 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -66.22 -35.18 79.77 Favored 'General case' 0 C--N 1.359 0.989 0 O-C-N 121.989 -0.444 . . . . 0.0 110.81 -178.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.8 m -64.86 -39.26 93.27 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -178.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.691 HD12 ' HB3' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -62.83 -38.12 89.48 Favored 'General case' 0 C--N 1.352 0.696 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 -179.266 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.996 HD22 ' HE1' ' A' ' 10' ' ' MET . 80.4 mt -74.52 -12.89 60.59 Favored 'General case' 0 C--N 1.358 0.947 0 O-C-N 121.768 -0.582 . . . . 0.0 110.746 -178.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -87.71 -27.11 22.6 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 119.1 -1.04 . . . . 0.0 108.929 178.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.9 t -67.15 -37.36 83.66 Favored 'General case' 0 C--N 1.357 0.905 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.639 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 2.0 p -93.25 -37.72 11.91 Favored 'General case' 0 C--N 1.358 0.935 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.639 ' HB2' ' O ' ' A' ' 29' ' ' CYS . 9.9 mt-10 85.37 133.57 0.05 OUTLIER 'General case' 0 C--N 1.359 0.979 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.507 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -85.37 -169.9 2.87 Favored 'General case' 0 C--N 1.358 0.954 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.431 ' H ' ' HB2' ' A' ' 31' ' ' LEU . 54.8 tt0 -150.84 -26.49 0.22 Allowed 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.7 t -146.65 -66.97 0.28 Allowed 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -178.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -130.33 -50.65 1.09 Allowed 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -178.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 127.86 -40.08 1.8 Allowed Glycine 0 C--N 1.351 1.382 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 86.4 mt -110.01 101.71 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.86 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.404 ' CE2' ' HB ' ' A' ' 40' ' ' VAL . 57.0 t80 -100.33 1.63 41.74 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.7 m 74.46 -176.56 0.15 Allowed 'General case' 0 C--N 1.362 1.144 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 -178.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.583 ' C ' HG23 ' A' ' 40' ' ' VAL . 28.1 p -87.99 104.69 16.87 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 121.184 -0.948 . . . . 0.0 108.788 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.596 ' O ' HG13 ' A' ' 40' ' ' VAL . 61.4 t -152.99 -21.29 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.361 1.1 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.76 171.59 13.86 Favored Glycine 0 C--N 1.357 1.696 0 C-N-CA 119.049 -1.548 . . . . 0.0 110.162 -176.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 59.2 m -131.29 136.05 47.83 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -121.31 175.42 6.15 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -78.48 -176.17 4.65 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . 0.407 ' CD2' HH22 ' A' ' 137' ' ' ARG . 73.5 m80 -94.15 -15.13 24.94 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.441 -178.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -68.86 -27.78 66.13 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 177.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.2 tp10 -62.62 -40.32 96.59 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -68.93 -38.65 79.65 Favored 'General case' 0 C--N 1.357 0.933 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.418 ' O ' HG22 ' A' ' 53' ' ' VAL . 59.2 tp -70.39 -35.05 73.24 Favored 'General case' 0 CA--C 1.506 -0.712 0 O-C-N 122.099 -0.376 . . . . 0.0 110.14 -176.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 71.7 tp60 -66.6 -39.94 88.63 Favored 'General case' 0 N--CA 1.443 -0.781 0 O-C-N 121.873 -0.517 . . . . 0.0 109.779 -178.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.691 ' HB3' HD12 ' A' ' 25' ' ' LEU . 68.3 mt -80.68 -18.01 49.32 Favored 'General case' 0 C--N 1.363 1.171 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.301 -179.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.471 ' O ' HG13 ' A' ' 52' ' ' VAL . 0.9 OUTLIER -80.35 -34.81 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.809 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.496 ' O ' HG11 ' A' ' 53' ' ' VAL . 54.3 t -70.17 -40.48 78.22 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.443 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 33.5 tptt -65.75 -27.6 68.42 Favored 'General case' 0 C--N 1.364 1.226 0 O-C-N 121.231 -0.918 . . . . 0.0 108.737 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.588 HD11 HD12 ' A' ' 13' ' ' ILE . 1.5 tt -68.5 -37.37 80.01 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.7 p -72.07 -18.72 61.91 Favored 'General case' 0 C--N 1.359 0.992 0 O-C-N 121.439 -0.788 . . . . 0.0 110.704 -178.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -99.89 -36.4 9.43 Favored 'General case' 0 C--N 1.353 0.738 0 O-C-N 121.3 -0.875 . . . . 0.0 111.424 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.58 HG21 HG22 ' A' ' 21' ' ' THR . 5.7 p -72.94 -36.52 51.76 Favored 'Isoleucine or valine' 0 C--N 1.35 0.62 0 O-C-N 121.717 -0.614 . . . . 0.0 111.294 -177.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.574 ' N ' HG13 ' A' ' 58' ' ' VAL . 74.7 m -114.09 -6.68 13.09 Favored 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 119.35 -0.94 . . . . 0.0 109.936 -178.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 64.31 50.31 2.35 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.631 HG13 ' HD2' ' A' ' 62' ' ' PRO . 56.1 t -113.81 136.14 22.05 Favored Pre-proline 0 CA--C 1.505 -0.778 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.727 ' HG2' ' HB2' ' A' ' 65' ' ' GLU . 23.3 Cg_endo -62.36 149.22 91.58 Favored 'Trans proline' 0 CA--C 1.5 -1.192 0 C-N-CA 122.226 1.95 . . . . 0.0 112.391 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.5 m -75.83 -14.16 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.344 -177.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 68.7 p -94.71 -34.65 12.47 Favored 'General case' 0 C--N 1.358 0.939 0 C-N-CA 118.347 -1.341 . . . . 0.0 109.722 -178.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.727 ' HB2' ' HG2' ' A' ' 62' ' ' PRO . 97.7 mt-10 -78.32 -20.48 51.34 Favored 'General case' 0 C--N 1.354 0.768 0 O-C-N 121.31 -0.869 . . . . 0.0 109.075 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.423 ' HB3' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -79.7 -37.67 35.19 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -179.624 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.8 p -67.92 -25.82 33.25 Favored 'Isoleucine or valine' 0 C--N 1.354 0.8 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.812 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 9.3 mtp180 -72.61 -53.17 12.61 Favored 'General case' 0 C--N 1.364 1.216 0 O-C-N 121.467 -0.771 . . . . 0.0 110.532 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 92.3 mt -63.07 -34.81 78.39 Favored 'General case' 0 C--N 1.357 0.927 0 O-C-N 121.933 -0.479 . . . . 0.0 111.031 -178.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -60.69 -47.34 86.72 Favored 'General case' 0 C--N 1.348 0.519 0 O-C-N 122.138 -0.351 . . . . 0.0 110.244 -178.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.44 -38.31 94.6 Favored Glycine 0 C--N 1.357 1.696 0 N-CA-C 111.766 -0.534 . . . . 0.0 111.766 -178.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.19 -49.04 75.81 Favored 'General case' 0 C--N 1.352 0.696 0 CA-C-N 118.264 1.032 . . . . 0.0 111.821 -177.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.559 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 8.4 mttm -64.26 -47.86 77.96 Favored 'General case' 0 C--N 1.358 0.948 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -177.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -68.66 -39.06 80.84 Favored 'General case' 0 C--N 1.35 0.624 0 O-C-N 121.055 -1.028 . . . . 0.0 111.92 -175.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -65.36 -43.23 91.45 Favored 'General case' 0 C--N 1.356 0.855 0 O-C-N 121.126 -0.984 . . . . 0.0 111.46 -177.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -72.16 -12.68 16.05 Favored 'Isoleucine or valine' 0 C--N 1.359 1.004 0 O-C-N 121.149 -0.969 . . . . 0.0 109.266 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.559 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 70.1 mm-40 -81.33 -29.78 34.06 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 73.3 mt -72.9 -34.69 66.81 Favored 'General case' 0 C--N 1.358 0.946 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.7 mm -64.63 -50.75 74.27 Favored 'Isoleucine or valine' 0 C--N 1.357 0.91 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -178.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -69.42 -28.29 66.01 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -66.68 -34.15 86.56 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -178.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.427 ' HA ' ' HD2' ' A' ' 83' ' ' PRO . 96.7 m-70 -135.7 101.34 10.76 Favored Pre-proline 0 CA--C 1.501 -0.91 0 CA-C-N 118.511 1.155 . . . . 0.0 109.372 -176.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 82' ' ' HIS . 34.7 Cg_endo -66.85 -22.52 49.03 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.416 2.077 . . . . 0.0 113.607 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 42.5 mt-10 -91.87 -6.14 52.05 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.6 tp -90.32 -19.65 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.23 -26.09 14.04 Favored 'General case' 0 C--N 1.361 1.084 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -70.75 -34.73 72.15 Favored 'General case' 0 C--N 1.356 0.875 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 84' ' ' GLU . 78.2 mm-40 -65.49 -36.25 83.28 Favored 'General case' 0 C--N 1.357 0.919 0 O-C-N 122.023 -0.423 . . . . 0.0 110.254 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.45 ' SD ' ' HB2' ' A' ' 95' ' ' LEU . 16.6 ttp -83.12 153.04 25.03 Favored 'General case' 0 C--N 1.353 0.743 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -178.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.96 -24.13 7.2 Favored 'General case' 0 C--N 1.365 1.253 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.352 -176.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -164.63 170.57 15.54 Favored 'General case' 0 C--N 1.354 0.802 0 C-N-CA 119.098 -1.041 . . . . 0.0 108.344 -177.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.404 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 39.7 t -64.01 -43.4 95.76 Favored 'General case' 0 C--N 1.357 0.899 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.489 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -66.33 -39.61 89.36 Favored 'General case' 0 C--N 1.355 0.816 0 O-C-N 121.366 -0.834 . . . . 0.0 109.255 -178.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -65.09 -25.73 67.92 Favored 'General case' 0 C--N 1.353 0.76 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.618 ' O ' HG13 ' A' ' 99' ' ' ILE . 61.8 tp -63.37 -46.46 86.39 Favored 'General case' 0 C--N 1.356 0.867 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.2 mp -59.54 -34.79 73.1 Favored 'General case' 0 C--N 1.357 0.917 0 O-C-N 122.177 -0.327 . . . . 0.0 110.591 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.4 t -69.88 -39.28 76.4 Favored 'General case' 0 C--N 1.348 0.538 0 O-C-N 121.917 -0.49 . . . . 0.0 109.944 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.405 ' HZ3' ' HG3' ' A' ' 98' ' ' LYS . 1.4 tttp -90.97 4.11 52.88 Favored 'General case' 0 C--N 1.352 0.712 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -176.064 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.618 HG13 ' O ' ' A' ' 95' ' ' LEU . 77.6 mt -61.62 -47.29 94.01 Favored 'Isoleucine or valine' 0 C--N 1.358 0.977 0 CA-C-N 119.657 1.117 . . . . 0.0 111.9 -177.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -98.49 -22.46 16.0 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 118.408 -1.317 . . . . 0.0 111.285 -176.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 33.4 t -65.69 -47.01 76.9 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 121.684 -0.635 . . . . 0.0 111.951 -177.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.414 ' HA ' HG12 ' A' ' 105' ' ' VAL . 11.5 t80 -132.26 -23.04 2.19 Favored 'General case' 0 C--N 1.361 1.079 0 C-N-CA 117.763 -1.575 . . . . 0.0 113.056 -176.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 31.1 mm -69.21 -50.03 56.23 Favored 'Isoleucine or valine' 0 C--N 1.354 0.785 0 CA-C-N 120.001 1.273 . . . . 0.0 110.57 -177.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 54.8 m170 -90.12 3.8 52.29 Favored 'General case' 0 N--CA 1.439 -0.976 0 O-C-N 121.311 -0.868 . . . . 0.0 110.444 -177.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.535 HG11 ' N ' ' A' ' 106' ' ' GLU . 1.3 p -89.35 -34.01 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 178.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . 0.535 ' N ' HG11 ' A' ' 105' ' ' VAL . 44.1 tt0 -72.54 -40.03 67.06 Favored 'General case' 0 C--N 1.36 1.065 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 73.4 t -63.09 -46.35 96.32 Favored 'Isoleucine or valine' 0 C--N 1.355 0.846 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 93.2 t80 -60.6 -48.76 80.34 Favored 'General case' 0 C--N 1.361 1.089 0 O-C-N 122.064 -0.397 . . . . 0.0 111.428 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -60.9 -37.1 81.07 Favored 'General case' 0 C--N 1.356 0.864 0 O-C-N 121.556 -0.715 . . . . 0.0 110.604 -178.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.9 mt -58.17 -73.83 0.07 Allowed 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -121.67 134.75 24.71 Favored Pre-proline 0 N--CA 1.439 -1.023 0 C-N-CA 118.37 -1.332 . . . . 0.0 108.773 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -84.51 -1.12 9.59 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 123.25 2.634 . . . . 0.0 115.052 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -66.75 -36.03 81.48 Favored 'General case' 0 C--N 1.354 0.795 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.13 145.39 56.35 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 121.649 0.738 . . . . 0.0 110.146 -178.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -126.95 134.31 50.44 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 179.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.47 ' HB3' ' HD2' ' A' ' 117' ' ' PRO . 84.4 mt -126.81 155.33 75.48 Favored Pre-proline 0 N--CA 1.442 -0.833 0 CA-C-O 122.184 0.992 . . . . 0.0 109.087 -178.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.47 ' HD2' ' HB3' ' A' ' 116' ' ' LEU . 87.7 Cg_endo -85.1 -152.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.125 0 C-N-CA 123.887 3.058 . . . . 0.0 114.543 -178.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.44 ' H ' ' HB2' ' A' ' 117' ' ' PRO . 74.7 mmtt -112.64 148.67 34.13 Favored 'General case' 0 C--N 1.368 1.38 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -179.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.528 ' CZ ' HD11 ' A' ' 131' ' ' LEU . 8.3 t80 -142.5 125.06 15.76 Favored 'General case' 0 C--N 1.361 1.066 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -177.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 95.8 m -126.44 133.62 51.19 Favored 'General case' 0 C--N 1.361 1.068 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 85.0 m -117.63 132.16 56.54 Favored 'General case' 0 C--N 1.358 0.946 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.732 -178.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -120.43 125.05 46.97 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 177.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.442 ' HG3' HD11 ' A' ' 129' ' ' ILE . 58.7 ttp180 -101.61 117.3 34.61 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 -179.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.501 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 94.5 mt -84.98 -25.64 27.63 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.502 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -179.1 -142.6 4.98 Favored Glycine 0 C--N 1.349 1.257 0 C-N-CA 118.898 -1.62 . . . . 0.0 109.082 -178.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -94.1 -41.1 9.7 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 119.928 -0.709 . . . . 0.0 109.616 -178.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -102.18 3.49 38.46 Favored 'General case' 0 C--N 1.352 0.712 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.446 -178.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.501 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 67.4 m-20 -118.01 128.95 55.28 Favored 'General case' 0 C--N 1.356 0.885 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.517 HG21 ' N ' ' A' ' 130' ' ' ARG . 10.6 mm -140.88 133.79 31.33 Favored 'Isoleucine or valine' 0 C--N 1.357 0.935 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.517 ' N ' HG21 ' A' ' 129' ' ' ILE . 62.3 mtm180 -121.34 140.84 51.58 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' A' ' 131' ' ' LEU . 0.3 OUTLIER -129.79 128.03 41.55 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.679 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -99.08 131.28 45.24 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -126.24 120.99 31.43 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -178.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.468 ' HA ' ' O ' ' A' ' 171' ' ' THR . 27.5 tt0 -114.88 110.23 19.35 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.486 ' O ' ' HA ' ' A' ' 171' ' ' THR . 11.6 t -162.95 154.37 17.53 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -87.93 9.2 22.94 Favored 'General case' 0 C--N 1.355 0.836 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . 0.407 HH22 ' CD2' ' A' ' 45' ' ' HIS . 78.3 mtp180 -129.46 78.28 75.92 Favored Pre-proline 0 N--CA 1.443 -0.777 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -91.98 86.61 0.24 Allowed 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.663 2.242 . . . . 0.0 115.556 -178.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -111.7 109.71 19.71 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 177.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -70.4 -30.73 67.69 Favored 'General case' 0 C--N 1.354 0.792 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.3 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.4 m -62.88 -34.22 76.93 Favored 'General case' 0 C--N 1.352 0.697 0 O-C-N 122.001 -0.437 . . . . 0.0 109.95 -179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -74.35 -44.59 51.7 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 120.434 -0.506 . . . . 0.0 109.732 -177.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.55 -40.39 95.49 Favored 'General case' 0 C--N 1.357 0.902 0 O-C-N 122.067 -0.395 . . . . 0.0 111.254 -177.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.87 -37.02 85.84 Favored 'General case' 0 CA--C 1.506 -0.736 0 O-C-N 122.012 -0.43 . . . . 0.0 110.187 -179.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.49 -43.71 98.5 Favored Glycine 0 C--N 1.347 1.161 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -178.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 82.8 mt -69.9 -40.49 75.58 Favored 'General case' 0 C--N 1.35 0.612 0 O-C-N 122.108 -0.642 . . . . 0.0 112.507 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 96.7 mt -71.75 -43.16 66.28 Favored 'General case' 0 C--N 1.361 1.103 0 O-C-N 121.215 -0.928 . . . . 0.0 111.032 -176.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.609 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 37.3 t70 -71.01 -31.46 67.98 Favored 'General case' 0 N--CA 1.447 -0.604 0 O-C-N 122.1 -0.375 . . . . 0.0 110.634 -178.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -62.77 -39.89 98.52 Favored Glycine 0 C--N 1.358 1.76 0 N-CA-C 108.512 -1.835 . . . . 0.0 108.512 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 48.8 t -60.71 -41.61 95.57 Favored 'General case' 0 C--N 1.35 0.591 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -76.83 2.05 15.64 Favored 'General case' 0 C--N 1.361 1.079 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.609 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 77.3 mm-40 -86.0 -46.16 10.78 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -66.16 -45.18 81.82 Favored 'General case' 0 C--N 1.361 1.102 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -69.54 -26.61 64.58 Favored 'General case' 0 C--N 1.362 1.124 0 O-C-N 121.842 -0.536 . . . . 0.0 110.793 -178.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 84.7 tttt 71.65 77.7 0.17 Allowed 'General case' 0 C--N 1.358 0.95 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -141.38 -170.66 3.13 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 179.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -145.96 93.5 2.34 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 13.5 m-30 -113.52 155.93 24.49 Favored 'General case' 0 CA--C 1.504 -0.802 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 178.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 95.5 m -120.2 127.54 52.54 Favored 'General case' 0 C--N 1.356 0.856 0 C-N-CA 119.392 -0.923 . . . . 0.0 108.979 -178.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 3.7 mp -100.99 121.3 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 178.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.12 -176.44 2.9 Favored 'General case' 0 C--N 1.365 1.245 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 28.8 ptt180 -146.95 154.46 41.29 Favored 'General case' 0 C--N 1.359 0.98 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -179.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 35.1 p -97.69 146.56 31.64 Favored Pre-proline 0 C--N 1.36 1.06 0 CA-C-O 122.448 1.118 . . . . 0.0 108.046 178.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.656 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 72.1 Cg_endo -75.03 -12.49 21.45 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 123.055 2.504 . . . . 0.0 114.923 -178.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -72.21 -41.21 67.15 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.84 -178.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 26.8 p -118.6 16.45 13.69 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 119.824 -0.75 . . . . 0.0 110.829 -178.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.656 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.2 pp0? -67.15 -14.37 62.84 Favored 'General case' 0 C--N 1.352 0.707 0 O-C-N 121.563 -0.71 . . . . 0.0 110.121 178.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -124.28 38.81 4.11 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 22.0 t -138.49 143.37 39.55 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 107.165 -1.421 . . . . 0.0 107.165 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.633 ' O ' ' HB ' ' A' ' 171' ' ' THR . 60.5 mt-10 -96.77 163.63 12.91 Favored 'General case' 0 C--N 1.354 0.776 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.633 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 2.7 m 81.91 -57.49 0.23 Allowed 'General case' 0 C--N 1.374 1.645 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.906 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -105.63 117.76 34.85 Favored 'General case' 0 CA--C 1.504 -0.813 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.567 -178.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.659 HG11 ' CE1' ' A' ' 175' ' ' PHE . 89.0 t -132.57 134.21 58.98 Favored 'Isoleucine or valine' 0 C--N 1.357 0.928 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . 0.435 ' N ' HG13 ' A' ' 173' ' ' VAL . 48.5 mm -115.22 127.73 72.68 Favored 'Isoleucine or valine' 0 C--N 1.361 1.07 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.659 ' CE1' HG11 ' A' ' 173' ' ' VAL . 97.6 m-85 -116.2 146.33 42.4 Favored 'General case' 0 C--N 1.359 1.021 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -125.53 84.05 2.23 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.193 -178.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . 0.413 HD13 ' CD2' ' A' ' 131' ' ' LEU . 3.6 mp -77.1 117.99 22.98 Favored 'Isoleucine or valine' 0 C--N 1.363 1.167 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 90.1 m -128.35 144.41 51.13 Favored 'General case' 0 C--N 1.356 0.885 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -178.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 59.3 mtm180 . . . . . 0 C--N 1.371 1.539 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.499 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.4 mtm . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 121.252 0.548 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.99 -13.5 53.14 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.0 -39.32 38.18 Favored Glycine 0 C--N 1.353 1.49 0 N-CA-C 108.641 -1.783 . . . . 0.0 108.641 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.7 tpp -71.6 -36.69 70.9 Favored 'General case' 0 C--N 1.359 0.982 0 O-C-N 121.92 -0.753 . . . . 0.0 110.767 -177.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.5 m -69.81 -22.76 25.12 Favored 'Isoleucine or valine' 0 C--N 1.357 0.908 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -179.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.432 ' HZ ' ' HG2' ' A' ' 47' ' ' GLU . 1.8 m-30 -70.4 -35.57 73.54 Favored 'General case' 0 C--N 1.357 0.922 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 85.3 m -67.38 -40.61 85.71 Favored 'General case' 0 C--N 1.355 0.847 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.34 -38.81 96.87 Favored Glycine 0 C--N 1.358 1.75 0 N-CA-C 110.541 -1.023 . . . . 0.0 110.541 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.668 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -66.96 -39.42 87.24 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 122.297 -0.531 . . . . 0.0 110.674 -178.198 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.677 ' HE2' HD22 ' A' ' 26' ' ' LEU . 20.9 mmt -63.91 -41.01 97.78 Favored 'General case' 0 C--N 1.354 0.78 0 O-C-N 121.602 -0.686 . . . . 0.0 110.979 -178.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -67.43 -40.76 85.5 Favored 'General case' 0 C--N 1.349 0.554 0 O-C-N 121.929 -0.482 . . . . 0.0 111.857 -177.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 54.7 tp -65.52 -42.83 91.58 Favored 'General case' 0 C--N 1.349 0.571 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -178.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.668 HG12 ' O ' ' A' ' 9' ' ' LEU . 1.2 mm -76.42 -35.74 27.4 Favored 'Isoleucine or valine' 0 C--N 1.358 0.951 0 O-C-N 120.957 -1.09 . . . . 0.0 111.041 -175.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -67.98 -43.38 79.1 Favored 'General case' 0 C--N 1.352 0.677 0 O-C-N 121.766 -0.584 . . . . 0.0 111.173 -176.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -72.64 -33.71 66.81 Favored 'General case' 0 N--CA 1.448 -0.566 0 O-C-N 121.98 -0.45 . . . . 0.0 111.658 -177.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -71.57 -47.88 52.02 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -175.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -127.89 -19.18 4.09 Favored 'General case' 0 C--N 1.355 0.834 0 C-N-CA 117.417 -1.713 . . . . 0.0 113.496 -176.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 139.99 178.92 17.32 Favored Glycine 0 N--CA 1.44 -1.053 0 C-N-CA 117.923 -2.084 . . . . 0.0 109.862 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -95.99 -12.4 25.05 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -177.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -70.69 -40.48 72.87 Favored 'General case' 0 C--N 1.359 0.997 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.8 m -69.09 -39.25 79.13 Favored 'General case' 0 C--N 1.357 0.907 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 53.4 tp -62.59 -37.83 87.76 Favored 'General case' 0 C--N 1.357 0.934 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -62.97 -37.42 87.06 Favored 'General case' 0 C--N 1.358 0.955 0 O-C-N 121.968 -0.458 . . . . 0.0 110.997 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.6 m -65.6 -38.22 88.86 Favored 'General case' 0 C--N 1.353 0.735 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 21.8 tp -62.53 -39.49 93.74 Favored 'General case' 0 C--N 1.353 0.735 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.677 HD22 ' HE2' ' A' ' 10' ' ' MET . 85.6 mt -72.95 -13.85 61.33 Favored 'General case' 0 C--N 1.359 0.997 0 O-C-N 121.92 -0.488 . . . . 0.0 110.579 -178.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -86.93 -28.77 22.55 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 119.312 -0.955 . . . . 0.0 109.368 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.0 t -67.25 -37.01 82.82 Favored 'General case' 0 C--N 1.355 0.839 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.1 p -91.63 -39.5 11.84 Favored 'General case' 0 C--N 1.357 0.924 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -179.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 86.06 132.85 0.04 OUTLIER 'General case' 0 C--N 1.36 1.052 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.494 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -86.91 -169.55 2.68 Favored 'General case' 0 C--N 1.357 0.9 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -179.884 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.443 ' H ' ' HB2' ' A' ' 31' ' ' LEU . 62.5 tt0 -152.26 -24.92 0.17 Allowed 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.8 t -145.22 -69.51 0.28 Allowed 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -179.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -131.05 -50.24 1.02 Allowed 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -178.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 130.41 -37.31 2.15 Favored Glycine 0 C--N 1.353 1.475 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 83.0 mt -110.0 100.75 11.41 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.438 ' CE2' HG22 ' A' ' 40' ' ' VAL . 70.4 t80 -95.65 -4.78 43.77 Favored 'General case' 0 C--N 1.354 0.801 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.741 HG22 ' H ' ' A' ' 39' ' ' SER . 5.2 m 82.43 174.84 0.09 Allowed 'General case' 0 C--N 1.362 1.118 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 -178.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.741 ' H ' HG22 ' A' ' 38' ' ' THR . 41.1 p -89.38 114.89 26.38 Favored 'General case' 0 N--CA 1.443 -0.791 0 O-C-N 121.041 -1.037 . . . . 0.0 109.855 -178.042 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.54 HG23 ' C ' ' A' ' 39' ' ' SER . 0.0 OUTLIER -172.92 -3.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.218 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.795 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -98.26 -136.74 9.38 Favored Glycine 0 C--N 1.357 1.735 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -178.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 164.47 98.97 0.0 OUTLIER 'General case' 0 C--N 1.362 1.132 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 -178.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -98.11 176.87 5.59 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.71 -174.61 4.42 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -91.1 -15.89 28.72 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 120.011 -0.676 . . . . 0.0 109.29 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -70.31 -29.32 66.03 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.432 ' HG2' ' HZ ' ' A' ' 6' ' ' PHE . 33.1 tp10 -63.69 -41.64 98.1 Favored 'General case' 0 C--N 1.354 0.769 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 54.5 tp -67.24 -38.36 85.06 Favored 'General case' 0 C--N 1.354 0.782 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.197 -179.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 60.6 tp -76.49 -28.04 56.3 Favored 'General case' 0 C--N 1.349 0.583 0 O-C-N 122.029 -0.419 . . . . 0.0 110.647 -177.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 71.5 tp60 -68.2 -42.6 79.64 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 121.509 -0.745 . . . . 0.0 109.615 -178.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.511 ' HA ' HD22 ' A' ' 51' ' ' LEU . 57.5 mt -72.8 -33.8 66.47 Favored 'General case' 0 C--N 1.363 1.18 0 C-N-CA 119.679 -0.809 . . . . 0.0 109.48 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.479 ' O ' HG11 ' A' ' 52' ' ' VAL . 38.7 t -62.61 -41.47 92.26 Favored 'Isoleucine or valine' 0 C--N 1.35 0.59 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 51.3 t -68.1 -40.61 83.3 Favored 'Isoleucine or valine' 0 C--N 1.351 0.668 0 O-C-N 121.716 -0.615 . . . . 0.0 109.809 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 31.7 tptt -66.84 -26.08 66.74 Favored 'General case' 0 C--N 1.359 1.007 0 O-C-N 121.131 -0.98 . . . . 0.0 108.768 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.59 HD12 HD13 ' A' ' 13' ' ' ILE . 2.2 tt -69.09 -37.5 78.46 Favored 'General case' 0 C--N 1.353 0.744 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' A' ' 60' ' ' SER . 71.5 p -72.05 -18.05 61.97 Favored 'General case' 0 C--N 1.356 0.868 0 O-C-N 121.722 -0.611 . . . . 0.0 110.624 -178.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -100.5 -35.04 9.68 Favored 'General case' 0 C--N 1.353 0.743 0 O-C-N 121.143 -0.973 . . . . 0.0 111.389 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.408 HG11 ' N ' ' A' ' 59' ' ' SER . 5.5 p -72.29 -34.8 50.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.719 0 O-C-N 121.755 -0.591 . . . . 0.0 111.375 -177.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.408 ' N ' HG11 ' A' ' 58' ' ' VAL . 2.5 t -120.29 -7.4 9.79 Favored 'General case' 0 C--N 1.353 0.718 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.094 -177.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 56' ' ' SER . 0.6 OUTLIER 65.71 47.26 2.17 Favored 'General case' 0 C--N 1.353 0.76 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.796 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.417 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 52.3 t -108.71 131.92 21.48 Favored Pre-proline 0 CA--C 1.503 -0.839 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 179.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 61' ' ' VAL . 42.7 Cg_exo -57.46 147.24 79.41 Favored 'Trans proline' 0 CA--C 1.497 -1.355 0 C-N-CA 122.439 2.093 . . . . 0.0 112.82 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.489 ' HA ' HD22 ' A' ' 66' ' ' LEU . 3.9 m -75.51 -12.97 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.685 -178.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 71.5 p -96.09 -33.04 12.23 Favored 'General case' 0 C--N 1.358 0.961 0 C-N-CA 118.291 -1.364 . . . . 0.0 109.534 -179.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -76.55 -22.58 54.14 Favored 'General case' 0 C--N 1.354 0.799 0 O-C-N 121.449 -0.782 . . . . 0.0 109.033 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.489 HD22 ' HA ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -81.7 -34.89 30.37 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.093 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.576 HG11 ' N ' ' A' ' 68' ' ' ARG . 1.5 p -69.4 -26.33 31.13 Favored 'Isoleucine or valine' 0 C--N 1.354 0.795 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.916 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.576 ' N ' HG11 ' A' ' 67' ' ' VAL . 7.5 mmm-85 -72.96 -51.5 18.13 Favored 'General case' 0 C--N 1.363 1.157 0 O-C-N 121.53 -0.731 . . . . 0.0 110.269 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.403 ' HA ' HD23 ' A' ' 69' ' ' LEU . 83.7 mt -63.76 -36.17 83.01 Favored 'General case' 0 C--N 1.357 0.923 0 O-C-N 122.064 -0.398 . . . . 0.0 110.939 -179.042 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -60.94 -46.9 88.82 Favored 'General case' 0 C--N 1.35 0.609 0 O-C-N 122.233 -0.292 . . . . 0.0 110.238 -178.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.56 -37.97 94.21 Favored Glycine 0 C--N 1.355 1.598 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 -178.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -63.64 -47.84 79.69 Favored 'General case' 0 C--N 1.354 0.782 0 CA-C-N 118.419 1.109 . . . . 0.0 111.486 -177.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.9 mttm -64.38 -47.72 78.2 Favored 'General case' 0 C--N 1.36 1.027 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -176.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.434 HD21 ' O ' ' A' ' 74' ' ' LEU . 2.5 tm? -69.64 -40.21 76.64 Favored 'General case' 0 C--N 1.349 0.581 0 O-C-N 121.051 -1.031 . . . . 0.0 111.828 -175.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -63.76 -45.45 89.74 Favored 'General case' 0 C--N 1.354 0.768 0 O-C-N 121.19 -0.944 . . . . 0.0 111.27 -178.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 8.5 p -71.72 -12.83 16.31 Favored 'Isoleucine or valine' 0 C--N 1.357 0.911 0 O-C-N 121.543 -0.723 . . . . 0.0 109.294 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.33 -37.39 60.74 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 82.4 mt -72.53 -32.84 66.44 Favored 'General case' 0 C--N 1.358 0.949 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.7 mm -64.07 -52.99 49.34 Favored 'Isoleucine or valine' 0 C--N 1.36 1.043 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.196 -177.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -75.36 -14.87 60.5 Favored 'General case' 0 CA--C 1.51 -0.593 0 C-N-CA 119.693 -0.803 . . . . 0.0 109.529 178.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.32 -37.05 63.17 Favored Glycine 0 C--N 1.349 1.267 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -179.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -133.45 105.78 12.06 Favored Pre-proline 0 N--CA 1.44 -0.97 0 CA-C-O 122.555 1.169 . . . . 0.0 109.199 -176.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.8 -25.03 39.81 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.381 2.054 . . . . 0.0 113.806 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -88.78 -7.69 55.76 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.8 tp -89.31 -22.7 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 -178.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -98.7 -22.12 16.06 Favored 'General case' 0 C--N 1.362 1.113 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -70.03 -37.22 75.54 Favored 'General case' 0 C--N 1.358 0.976 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -64.78 -36.73 85.27 Favored 'General case' 0 C--N 1.358 0.956 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.261 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.577 ' HG2' ' N ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -82.17 151.07 27.08 Favored 'General case' 0 C--N 1.352 0.704 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -178.837 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.577 ' N ' ' HG2' ' A' ' 89' ' ' MET . 0.7 OUTLIER -118.27 -22.63 7.61 Favored 'General case' 0 C--N 1.363 1.18 0 C-N-CA 119.852 -0.739 . . . . 0.0 111.298 -177.472 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -166.71 172.77 10.22 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.435 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 65.1 m -67.12 -40.06 86.76 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.478 -179.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -68.68 -39.09 80.75 Favored 'General case' 0 C--N 1.356 0.859 0 O-C-N 121.322 -0.862 . . . . 0.0 109.011 -178.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -66.29 -23.16 66.34 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.612 HD21 ' HG ' ' A' ' 150' ' ' CYS . 58.3 tp -63.99 -46.1 86.07 Favored 'General case' 0 C--N 1.355 0.829 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.2 mp -63.14 -33.13 74.79 Favored 'General case' 0 C--N 1.354 0.797 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 35.6 t -62.34 -44.4 96.58 Favored 'General case' 0 C--N 1.353 0.747 0 O-C-N 121.897 -0.502 . . . . 0.0 110.954 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.63 26.73 10.37 Favored 'General case' 0 C--N 1.359 0.99 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.376 -177.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.614 HG22 ' N ' ' A' ' 100' ' ' ASP . 14.1 tt -62.36 -31.55 52.08 Favored 'Isoleucine or valine' 0 C--N 1.356 0.88 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.625 -179.088 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.614 ' N ' HG22 ' A' ' 99' ' ' ILE . 21.8 t70 -119.43 -18.29 8.55 Favored 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 119.218 -0.993 . . . . 0.0 109.113 -178.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 35.6 t -64.25 -46.61 82.99 Favored 'General case' 0 N--CA 1.444 -0.747 0 O-C-N 121.82 -0.55 . . . . 0.0 110.869 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.408 ' HA ' HG13 ' A' ' 105' ' ' VAL . 14.4 t80 -127.59 -26.34 3.01 Favored 'General case' 0 C--N 1.36 1.028 0 C-N-CA 118.103 -1.439 . . . . 0.0 111.828 -177.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 19.0 mm -67.05 -50.23 65.97 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 O-C-N 121.097 -1.002 . . . . 0.0 110.236 -177.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 49.4 m170 -91.08 3.43 54.77 Favored 'General case' 0 N--CA 1.439 -0.985 0 O-C-N 121.462 -0.774 . . . . 0.0 110.408 -177.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.408 HG13 ' HA ' ' A' ' 102' ' ' PHE . 2.4 p -87.64 -35.4 8.26 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -72.88 -39.95 66.01 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 74.4 t -63.48 -46.06 96.17 Favored 'Isoleucine or valine' 0 C--N 1.357 0.909 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.255 -179.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -60.3 -48.13 83.06 Favored 'General case' 0 C--N 1.36 1.026 0 O-C-N 122.117 -0.364 . . . . 0.0 111.484 -178.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -61.98 -36.55 81.81 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 121.412 -0.805 . . . . 0.0 110.506 -178.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.9 mt -58.28 -76.33 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 120.665 -0.414 . . . . 0.0 109.951 -179.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.456 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 90.5 m-85 -110.9 141.0 23.26 Favored Pre-proline 0 N--CA 1.443 -0.807 0 C-N-CA 118.745 -1.182 . . . . 0.0 109.169 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 111' ' ' TYR . 54.2 Cg_endo -88.39 -7.53 5.79 Favored 'Trans proline' 0 C--N 1.315 -1.198 0 C-N-CA 123.219 2.613 . . . . 0.0 115.877 -178.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -77.96 -23.87 48.31 Favored 'General case' 0 C--N 1.354 0.789 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.22 -178.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.2 142.53 58.29 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 121.512 0.672 . . . . 0.0 109.656 -178.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -118.72 143.63 46.75 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.431 ' HA ' HD23 ' A' ' 116' ' ' LEU . 96.3 mt -136.93 152.22 73.66 Favored Pre-proline 0 C--N 1.354 0.802 0 CA-C-O 122.138 0.971 . . . . 0.0 109.604 -178.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 116' ' ' LEU . 75.0 Cg_endo -89.85 -155.24 0.05 OUTLIER 'Trans proline' 0 C--N 1.318 -1.03 0 C-N-CA 123.934 3.089 . . . . 0.0 113.484 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -119.63 142.34 48.51 Favored 'General case' 0 C--N 1.367 1.327 0 C-N-CA 119.328 -0.949 . . . . 0.0 108.711 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -126.26 128.66 47.53 Favored 'General case' 0 C--N 1.363 1.157 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -178.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.553 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 93.6 m -124.17 128.26 48.98 Favored 'General case' 0 C--N 1.357 0.893 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 176.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 78.1 m -121.77 130.97 53.81 Favored 'General case' 0 CA--C 1.504 -0.827 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.175 -177.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -118.76 149.81 40.85 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 177.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.558 ' HG3' HD11 ' A' ' 129' ' ' ILE . 58.0 ttp180 -121.62 117.61 27.15 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -179.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.458 ' HA ' HD22 ' A' ' 124' ' ' LEU . 96.0 mt -91.34 -16.27 27.74 Favored 'General case' 0 C--N 1.354 0.796 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.57 -179.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 175.41 -149.5 10.21 Favored Glycine 0 C--N 1.348 1.214 0 C-N-CA 118.859 -1.639 . . . . 0.0 109.076 -179.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -93.87 -37.64 11.63 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -178.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -102.83 4.38 37.73 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.81 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.41 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 67.1 m-20 -120.8 129.62 53.65 Favored 'General case' 0 C--N 1.357 0.934 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -179.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.558 HD11 ' HG3' ' A' ' 123' ' ' ARG . 8.3 mm -141.89 136.57 30.47 Favored 'Isoleucine or valine' 0 C--N 1.355 0.834 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.497 ' N ' HG23 ' A' ' 129' ' ' ILE . 51.7 mtm180 -116.63 139.67 50.26 Favored 'General case' 0 CA--C 1.495 -1.16 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 8.0 tp -127.61 119.57 26.22 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-N 115.172 -0.922 . . . . 0.0 108.856 -178.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.553 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 12.1 m170 -99.2 134.28 42.27 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 178.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -130.21 122.26 27.77 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -178.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.491 ' HA ' ' O ' ' A' ' 171' ' ' THR . 30.0 tt0 -114.35 113.74 24.96 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 15.6 t -161.88 153.34 18.55 Favored 'General case' 0 C--N 1.358 0.954 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -91.55 3.89 53.91 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.866 -179.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 94.3 mtm-85 -133.42 74.98 70.65 Favored Pre-proline 0 C--N 1.355 0.847 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 178.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -94.88 100.89 0.11 Allowed 'Trans proline' 0 N--CA 1.442 -1.506 0 C-N-CA 122.621 2.214 . . . . 0.0 115.63 -177.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -110.67 113.54 26.22 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 176.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.63 -38.59 91.7 Favored 'General case' 0 C--N 1.354 0.771 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.166 -179.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 73.4 m -63.83 -26.98 68.87 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 121.886 -0.509 . . . . 0.0 110.808 -178.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -76.11 -47.37 24.74 Favored 'General case' 0 C--N 1.352 0.695 0 C-N-CA 120.038 -0.665 . . . . 0.0 109.593 -177.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.46 -39.8 94.5 Favored 'General case' 0 C--N 1.356 0.864 0 O-C-N 122.215 -0.303 . . . . 0.0 111.185 -178.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -63.31 -37.37 86.98 Favored 'General case' 0 C--N 1.354 0.797 0 O-C-N 121.879 -0.513 . . . . 0.0 109.908 -179.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.04 -42.94 98.63 Favored Glycine 0 C--N 1.348 1.232 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 -179.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.0 mt -70.82 -41.0 72.14 Favored 'General case' 0 C--N 1.354 0.762 0 CA-C-N 117.586 0.693 . . . . 0.0 112.704 -179.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 98.5 mt -71.08 -42.15 69.74 Favored 'General case' 0 C--N 1.36 1.057 0 O-C-N 121.28 -0.888 . . . . 0.0 110.833 -176.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.473 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 36.3 t70 -70.53 -28.9 65.29 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 121.935 -0.478 . . . . 0.0 110.385 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . 0.447 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -63.08 -39.01 97.51 Favored Glycine 0 C--N 1.358 1.793 0 N-CA-C 108.049 -2.02 . . . . 0.0 108.049 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . 0.612 ' HG ' HD21 ' A' ' 95' ' ' LEU . 48.1 t -60.95 -42.13 97.66 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -74.71 -0.36 17.85 Favored 'General case' 0 C--N 1.361 1.095 0 O-C-N 121.789 -0.57 . . . . 0.0 109.603 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 75.7 mm-40 -85.79 -45.8 11.26 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.013 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -65.61 -46.06 80.74 Favored 'General case' 0 C--N 1.361 1.082 0 C-N-CA 120.158 -0.617 . . . . 0.0 109.363 178.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . 0.566 ' HZ ' ' SD ' ' A' ' 89' ' ' MET . 37.5 m-85 -68.44 -27.85 66.54 Favored 'General case' 0 C--N 1.363 1.189 0 O-C-N 121.859 -0.525 . . . . 0.0 110.917 -178.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 85.4 tttt 74.44 73.94 0.11 Allowed 'General case' 0 C--N 1.36 1.041 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -178.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -142.84 -169.28 2.97 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -148.15 96.18 2.59 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 13.1 m-30 -113.24 155.55 24.88 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 178.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 92.2 m -119.32 128.16 53.87 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -178.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 3.7 mp -105.47 122.04 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 179.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.7 m -117.06 -174.41 2.58 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-O 121.913 0.863 . . . . 0.0 109.352 -178.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -146.08 155.48 42.8 Favored 'General case' 0 C--N 1.356 0.862 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 -177.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 47.3 p -100.28 146.6 32.25 Favored Pre-proline 0 C--N 1.359 0.997 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.668 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 75.0 Cg_endo -76.4 -11.46 19.0 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 123.056 2.504 . . . . 0.0 115.022 -178.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -72.34 -41.51 66.4 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 119.932 -0.707 . . . . 0.0 109.591 -178.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 37.9 p -116.76 15.59 15.36 Favored 'General case' 0 CA--C 1.505 -0.785 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.527 -178.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.668 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.3 pp0? -67.03 -12.18 59.15 Favored 'General case' 0 C--N 1.353 0.744 0 O-C-N 121.595 -0.691 . . . . 0.0 110.52 178.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -122.97 34.36 5.15 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 65.4 m -134.91 147.27 49.77 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.6 ' O ' ' HB ' ' A' ' 171' ' ' THR . 37.3 mt-10 -101.12 165.67 11.18 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.6 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 18.6 m 83.15 -60.52 0.14 Allowed 'General case' 0 C--N 1.37 1.467 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -107.37 117.31 33.75 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.623 -178.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 90.1 t -130.69 133.02 63.98 Favored 'Isoleucine or valine' 0 C--N 1.357 0.899 0 N-CA-C 106.924 -1.509 . . . . 0.0 106.924 178.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 49.6 mm -107.25 127.27 63.17 Favored 'Isoleucine or valine' 0 C--N 1.358 0.976 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -115.85 156.8 25.47 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 122.156 0.979 . . . . 0.0 108.513 -179.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -138.54 119.42 14.28 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -178.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.8 mp -113.55 118.54 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 -179.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' THR . . . . . 0.554 HG23 ' N ' ' A' ' 179' ' ' ARG . 91.4 m -122.84 142.38 50.82 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -177.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.554 ' N ' HG23 ' A' ' 178' ' ' THR . 72.0 ttt180 . . . . . 0 C--N 1.362 1.147 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 179.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.684 ' HG2' ' HG3' ' A' ' 4' ' ' MET . 27.7 tpp . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 120.986 0.422 . . . . 0.0 110.402 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' MET . . . . . 0.706 ' HA ' HG23 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -81.1 -14.49 57.7 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 -179.471 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.5 -42.96 38.99 Favored Glycine 0 C--N 1.35 1.333 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' MET . . . . . 0.684 ' HG3' ' HG2' ' A' ' 1' ' ' MET . 76.0 mtm -70.38 -34.78 72.98 Favored 'General case' 0 C--N 1.355 0.808 0 O-C-N 122.149 -0.618 . . . . 0.0 111.206 -178.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.706 HG23 ' HA ' ' A' ' 2' ' ' MET . 35.7 m -68.95 -23.34 27.19 Favored 'Isoleucine or valine' 0 C--N 1.358 0.946 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.314 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.462 ' HZ ' ' CG ' ' A' ' 47' ' ' GLU . 2.6 m-85 -72.22 -33.07 67.3 Favored 'General case' 0 C--N 1.357 0.922 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.1 m -67.01 -40.09 87.21 Favored 'General case' 0 C--N 1.355 0.846 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.54 -39.32 97.7 Favored Glycine 0 C--N 1.359 1.83 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.662 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -64.22 -40.66 96.51 Favored 'General case' 0 C--N 1.351 0.671 0 O-C-N 122.522 -0.399 . . . . 0.0 110.698 -178.795 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' MET . . . . . 0.523 ' HE3' HD22 ' A' ' 26' ' ' LEU . 20.5 mmt -63.43 -40.63 97.7 Favored 'General case' 0 C--N 1.352 0.708 0 O-C-N 121.72 -0.612 . . . . 0.0 110.832 -178.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -67.29 -40.5 86.09 Favored 'General case' 0 C--N 1.349 0.563 0 O-C-N 122.012 -0.43 . . . . 0.0 111.692 -178.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 54.9 tp -66.31 -42.93 87.57 Favored 'General case' 0 C--N 1.35 0.606 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -178.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.662 HG12 ' O ' ' A' ' 9' ' ' LEU . 2.6 mm -73.51 -37.1 49.63 Favored 'Isoleucine or valine' 0 C--N 1.36 1.032 0 O-C-N 121.142 -0.974 . . . . 0.0 110.861 -175.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -71.02 -42.35 69.68 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 121.659 -0.65 . . . . 0.0 111.73 -176.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -71.31 -37.57 71.79 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -175.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -100.66 -27.0 13.62 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 118.678 -1.209 . . . . 0.0 113.791 -174.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -111.56 -34.23 6.14 Favored 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 117.579 -1.648 . . . . 0.0 112.146 -176.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 142.11 178.41 18.15 Favored Glycine 0 C--N 1.348 1.216 0 C-N-CA 118.431 -1.842 . . . . 0.0 109.774 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 93.3 t80 -101.08 -26.19 13.78 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 -177.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -69.11 -39.72 78.77 Favored 'General case' 0 C--N 1.36 1.054 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.533 HG23 HG23 ' A' ' 58' ' ' VAL . 93.5 m -67.96 -38.54 82.89 Favored 'General case' 0 C--N 1.357 0.898 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 178.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.547 HD11 ' HB ' ' A' ' 13' ' ' ILE . 34.7 tp -59.53 -38.34 80.74 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -65.14 -37.11 86.38 Favored 'General case' 0 C--N 1.357 0.933 0 O-C-N 122.214 -0.304 . . . . 0.0 111.081 -178.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.45 HG22 ' O ' ' A' ' 24' ' ' THR . 89.3 m -64.45 -40.96 96.71 Favored 'General case' 0 C--N 1.355 0.834 0 O-C-N 121.636 -0.665 . . . . 0.0 109.774 -178.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.492 ' CD2' ' HB3' ' A' ' 54' ' ' LYS . 84.8 mt -64.48 -37.49 87.73 Favored 'General case' 0 C--N 1.356 0.861 0 O-C-N 121.892 -0.505 . . . . 0.0 109.744 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.523 HD22 ' HE3' ' A' ' 10' ' ' MET . 82.5 mt -67.68 -18.77 65.04 Favored 'General case' 0 C--N 1.357 0.922 0 O-C-N 121.426 -0.796 . . . . 0.0 109.629 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -85.74 -25.85 26.19 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.712 179.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.9 p -69.28 -24.45 63.96 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 119.856 -0.738 . . . . 0.0 109.304 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.4 p -106.96 -34.38 7.21 Favored 'General case' 0 C--N 1.357 0.898 0 C-N-CA 119.041 -1.064 . . . . 0.0 108.17 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 82.55 134.0 0.06 Allowed 'General case' 0 C--N 1.359 0.98 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.553 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -84.59 -169.82 2.81 Favored 'General case' 0 C--N 1.357 0.898 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.655 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -151.68 -25.25 0.19 Allowed 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.5 t -146.12 -73.18 0.23 Allowed 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -126.83 -38.73 2.02 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -179.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.35 -31.74 5.68 Favored Glycine 0 C--N 1.353 1.502 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 82.7 mt -112.5 99.98 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.52 ' CE2' ' HB ' ' A' ' 40' ' ' VAL . 3.0 t80 -70.84 -33.24 70.47 Favored 'General case' 0 C--N 1.357 0.916 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.501 ' HB ' ' O ' ' A' ' 37' ' ' TYR . 6.0 m 119.45 -70.07 0.0 OUTLIER 'General case' 0 C--N 1.369 1.456 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.633 ' C ' HG21 ' A' ' 40' ' ' VAL . 15.6 p 174.4 66.62 0.0 OUTLIER 'General case' 0 C--N 1.359 0.998 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.633 HG21 ' C ' ' A' ' 39' ' ' SER . 19.0 t -147.53 -11.52 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.878 0 C-N-CA 119.772 -0.771 . . . . 0.0 109.463 -178.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.53 146.01 18.07 Favored Glycine 0 C--N 1.352 1.461 0 C-N-CA 119.314 -1.422 . . . . 0.0 110.53 -177.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 52.7 m -122.25 125.74 46.69 Favored 'General case' 0 C--N 1.354 0.775 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 178.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -117.05 172.04 7.53 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 121.644 0.735 . . . . 0.0 109.058 -178.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -78.3 -176.15 4.54 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-O 121.662 0.744 . . . . 0.0 109.249 -179.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -85.56 -23.25 27.72 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -179.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -65.89 -28.88 69.28 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.462 ' CG ' ' HZ ' ' A' ' 6' ' ' PHE . 24.4 tp10 -62.95 -39.55 94.98 Favored 'General case' 0 C--N 1.352 0.717 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.678 HD13 HG22 ' A' ' 52' ' ' VAL . 1.9 tm? -67.67 -38.81 84.25 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.433 ' O ' HG21 ' A' ' 53' ' ' VAL . 61.8 tp -70.44 -34.31 72.31 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -177.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -65.15 -41.36 94.83 Favored 'General case' 0 N--CA 1.443 -0.799 0 O-C-N 122.041 -0.412 . . . . 0.0 110.227 -178.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.45 ' HA ' HD22 ' A' ' 51' ' ' LEU . 78.5 mt -81.86 -19.4 41.04 Favored 'General case' 0 C--N 1.357 0.934 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.384 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.678 HG22 HD13 ' A' ' 48' ' ' LEU . 1.3 t -80.18 -37.23 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -179.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.498 ' O ' HG11 ' A' ' 53' ' ' VAL . 52.5 t -67.78 -40.85 84.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.492 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 25.0 tptt -66.66 -25.81 66.75 Favored 'General case' 0 C--N 1.364 1.219 0 O-C-N 121.07 -1.019 . . . . 0.0 108.895 -179.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.432 HD13 ' CD1' ' A' ' 66' ' ' LEU . 6.4 mt -67.11 -37.99 84.86 Favored 'General case' 0 C--N 1.355 0.807 0 C-N-CA 120.431 -0.507 . . . . 0.0 109.904 178.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.451 ' O ' ' HA ' ' A' ' 60' ' ' SER . 57.4 p -72.86 -17.81 61.5 Favored 'General case' 0 C--N 1.354 0.791 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.477 -179.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -99.3 -38.04 9.02 Favored 'General case' 0 C--N 1.354 0.777 0 O-C-N 121.321 -0.862 . . . . 0.0 111.497 -179.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.533 HG23 HG23 ' A' ' 21' ' ' THR . 4.8 p -72.91 -37.88 55.27 Favored 'Isoleucine or valine' 0 C--N 1.353 0.722 0 O-C-N 121.656 -0.653 . . . . 0.0 111.327 -177.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.0 t -115.4 -6.72 12.32 Favored 'General case' 0 C--N 1.352 0.717 0 C-N-CA 119.033 -1.067 . . . . 0.0 110.265 -178.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 56' ' ' SER . 74.5 m 64.78 44.16 3.82 Favored 'General case' 0 C--N 1.355 0.829 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.417 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 53.5 t -105.95 133.59 20.14 Favored Pre-proline 0 N--CA 1.444 -0.764 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 61' ' ' VAL . 45.0 Cg_exo -57.59 147.08 81.29 Favored 'Trans proline' 0 CA--C 1.498 -1.28 0 C-N-CA 122.538 2.159 . . . . 0.0 112.815 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.5 m -75.47 -12.13 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.919 -178.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 67.3 p -96.48 -32.42 12.31 Favored 'General case' 0 C--N 1.358 0.969 0 C-N-CA 118.289 -1.364 . . . . 0.0 109.489 -179.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -77.82 -22.89 49.34 Favored 'General case' 0 C--N 1.355 0.819 0 O-C-N 121.341 -0.849 . . . . 0.0 108.868 179.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.507 HD23 HG21 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -79.97 -37.36 34.52 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.196 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.564 HG12 ' N ' ' A' ' 68' ' ' ARG . 1.9 p -67.97 -26.66 35.15 Favored 'Isoleucine or valine' 0 C--N 1.355 0.828 0 C-N-CA 120.089 -0.644 . . . . 0.0 110.002 -179.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.564 ' N ' HG12 ' A' ' 67' ' ' VAL . 7.2 mmm-85 -72.16 -50.86 24.39 Favored 'General case' 0 C--N 1.363 1.159 0 O-C-N 121.519 -0.738 . . . . 0.0 110.354 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.416 ' HA ' HD23 ' A' ' 69' ' ' LEU . 83.9 mt -63.57 -36.0 82.35 Favored 'General case' 0 C--N 1.357 0.932 0 O-C-N 122.061 -0.399 . . . . 0.0 110.966 -178.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -60.8 -47.69 85.18 Favored 'General case' 0 C--N 1.35 0.608 0 O-C-N 122.221 -0.299 . . . . 0.0 110.64 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.54 95.75 Favored Glycine 0 C--N 1.354 1.554 0 N-CA-C 111.834 -0.506 . . . . 0.0 111.834 -178.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.65 -47.65 80.45 Favored 'General case' 0 C--N 1.349 0.568 0 CA-C-N 118.13 0.965 . . . . 0.0 111.548 -177.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 10.2 mttm -65.39 -48.39 73.02 Favored 'General case' 0 C--N 1.359 1.006 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -177.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . 0.441 HD21 ' O ' ' A' ' 74' ' ' LEU . 2.4 tm? -68.93 -39.37 79.63 Favored 'General case' 0 C--N 1.348 0.529 0 O-C-N 121.156 -0.965 . . . . 0.0 111.788 -175.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -63.81 -44.96 91.73 Favored 'General case' 0 C--N 1.354 0.779 0 O-C-N 121.084 -1.01 . . . . 0.0 111.032 -178.003 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.83 -13.86 17.08 Favored 'Isoleucine or valine' 0 C--N 1.359 0.98 0 O-C-N 121.548 -0.72 . . . . 0.0 109.084 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.412 ' HB2' ' O ' ' A' ' 74' ' ' LEU . 6.7 mm-40 -73.52 -38.06 65.44 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.6 mt -74.47 -29.78 61.59 Favored 'General case' 0 C--N 1.357 0.928 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 46.5 mm -65.25 -52.94 46.29 Favored 'Isoleucine or valine' 0 C--N 1.358 0.977 0 C-N-CA 120.059 -0.656 . . . . 0.0 109.883 -177.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -75.36 -15.89 60.44 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.425 178.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.85 -37.26 65.72 Favored Glycine 0 C--N 1.349 1.27 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -131.88 106.21 13.97 Favored Pre-proline 0 N--CA 1.441 -0.923 0 CA-C-O 122.58 1.181 . . . . 0.0 109.37 -177.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -68.36 -25.35 36.14 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.581 2.187 . . . . 0.0 113.848 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -88.5 -9.1 53.55 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -89.51 -21.92 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 -178.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.26 -23.25 14.85 Favored 'General case' 0 C--N 1.36 1.049 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -70.2 -37.24 75.04 Favored 'General case' 0 C--N 1.358 0.959 0 O-C-N 121.845 -0.535 . . . . 0.0 109.845 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -64.28 -36.24 83.47 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.322 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.476 ' SD ' ' HB2' ' A' ' 95' ' ' LEU . 17.4 ttp -83.32 153.54 24.56 Favored 'General case' 0 C--N 1.351 0.67 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -178.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.46 -22.65 8.08 Favored 'General case' 0 C--N 1.365 1.276 0 O-C-N 121.627 -0.671 . . . . 0.0 111.138 -177.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -164.21 170.14 16.7 Favored 'General case' 0 CA--C 1.504 -0.802 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -177.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.499 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 64.9 m -66.05 -40.56 91.04 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.469 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 1.6 m-30 -68.42 -37.9 80.74 Favored 'General case' 0 C--N 1.354 0.788 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.135 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -66.22 -22.5 66.34 Favored 'General case' 0 C--N 1.357 0.935 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LEU . . . . . 0.499 ' HB3' ' O ' ' A' ' 92' ' ' SER . 62.0 tp -64.42 -45.16 88.77 Favored 'General case' 0 C--N 1.357 0.919 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.049 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.5 mp -60.89 -35.76 77.47 Favored 'General case' 0 C--N 1.356 0.874 0 O-C-N 122.139 -0.351 . . . . 0.0 110.17 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.6 t -69.09 -39.9 78.72 Favored 'General case' 0 C--N 1.35 0.613 0 O-C-N 121.871 -0.518 . . . . 0.0 110.067 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.528 ' HZ3' ' HG3' ' A' ' 98' ' ' LYS . 0.2 OUTLIER -92.77 8.15 40.62 Favored 'General case' 0 C--N 1.354 0.766 0 O-C-N 122.163 -0.336 . . . . 0.0 111.359 -176.803 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.597 HG21 ' N ' ' A' ' 100' ' ' ASP . 19.3 tt -63.32 -38.81 83.13 Favored 'Isoleucine or valine' 0 C--N 1.36 1.024 0 O-C-N 121.44 -0.787 . . . . 0.0 111.876 -176.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.597 ' N ' HG21 ' A' ' 99' ' ' ILE . 3.1 p-10 -108.51 -14.75 14.59 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 118.103 -1.439 . . . . 0.0 110.156 -178.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' SER . . . . . 0.573 ' O ' HG22 ' A' ' 105' ' ' VAL . 34.9 t -64.42 -46.09 84.73 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 120.253 -0.579 . . . . 0.0 111.07 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -137.37 -15.09 1.46 Allowed 'General case' 0 C--N 1.359 1.016 0 C-N-CA 117.343 -1.743 . . . . 0.0 112.512 -177.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.403 ' HB ' ' O ' ' A' ' 99' ' ' ILE . 26.5 mm -70.56 -51.74 34.83 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 CA-C-N 119.875 1.216 . . . . 0.0 110.468 -177.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 51.8 m170 -92.09 -1.05 57.41 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.203 -177.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.573 HG22 ' O ' ' A' ' 101' ' ' SER . 65.6 t -80.04 -44.6 22.71 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.026 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 178.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 54.8 tp10 -68.31 -40.76 81.59 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.1 t -62.66 -46.69 95.75 Favored 'Isoleucine or valine' 0 C--N 1.356 0.856 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.598 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -60.38 -48.24 82.61 Favored 'General case' 0 C--N 1.359 0.993 0 O-C-N 121.967 -0.458 . . . . 0.0 111.472 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -60.61 -36.55 78.87 Favored 'General case' 0 C--N 1.356 0.857 0 O-C-N 121.544 -0.722 . . . . 0.0 110.293 -178.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.4 mt -59.27 -77.16 0.04 OUTLIER 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' TYR . . . . . 0.438 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 82.7 m-85 -118.9 140.73 29.01 Favored Pre-proline 0 N--CA 1.438 -1.027 0 C-N-CA 118.663 -1.215 . . . . 0.0 109.053 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 111' ' ' TYR . 73.7 Cg_endo -87.0 -2.5 8.05 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 C-N-CA 123.129 2.553 . . . . 0.0 114.904 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -66.97 -36.52 82.38 Favored 'General case' 0 C--N 1.355 0.825 0 O-C-N 121.921 -0.487 . . . . 0.0 110.06 -179.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.82 147.11 53.68 Favored 'General case' 0 C--N 1.352 0.704 0 CA-C-O 121.525 0.679 . . . . 0.0 109.81 -178.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.427 ' O ' HD12 ' A' ' 116' ' ' LEU . 46.5 mt-10 -117.51 142.66 46.9 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 179.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.427 HD12 ' O ' ' A' ' 115' ' ' GLU . 2.7 mm? -127.12 149.29 69.06 Favored Pre-proline 0 C--N 1.352 0.695 0 CA-C-O 122.178 0.99 . . . . 0.0 108.73 -178.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 116' ' ' LEU . 75.1 Cg_endo -89.65 -158.86 0.08 OUTLIER 'Trans proline' 0 C--N 1.316 -1.18 0 C-N-CA 123.75 2.967 . . . . 0.0 113.029 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -118.33 140.56 49.65 Favored 'General case' 0 C--N 1.362 1.128 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -126.55 129.36 48.44 Favored 'General case' 0 C--N 1.361 1.081 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -178.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' THR . . . . . 0.506 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 95.3 m -125.42 127.53 46.69 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 176.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 80.9 m -120.12 129.51 54.2 Favored 'General case' 0 CA--C 1.503 -0.855 0 C-N-CA 119.087 -1.045 . . . . 0.0 109.693 -177.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -120.74 117.48 27.59 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 178.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.607 ' HG3' ' CD1' ' A' ' 129' ' ' ILE . 12.9 ttm180 -92.8 113.81 26.19 Favored 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -179.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.573 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 87.1 mt -75.96 -38.99 56.93 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.074 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -166.21 -139.65 2.7 Favored Glycine 0 C--N 1.351 1.387 0 N-CA-C 109.231 -1.547 . . . . 0.0 109.231 -178.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -94.75 -41.09 9.43 Favored 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 120.134 -0.626 . . . . 0.0 109.452 -178.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 51.3 p-10 -101.28 4.48 41.76 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 120.049 -0.661 . . . . 0.0 109.956 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.573 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 67.3 m-20 -118.2 128.36 54.63 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.607 ' CD1' ' HG3' ' A' ' 123' ' ' ARG . 3.4 mm -139.42 132.33 36.92 Favored 'Isoleucine or valine' 0 C--N 1.355 0.823 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.457 ' N ' HG23 ' A' ' 129' ' ' ILE . 52.9 mtm180 -116.08 137.8 51.8 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 179.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.9 tp -127.5 118.83 24.76 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 115.328 -0.851 . . . . 0.0 108.829 -178.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' HIS . . . . . 0.506 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 11.9 m170 -97.56 131.54 44.06 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 178.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -127.37 121.14 30.16 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 -178.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.522 ' HA ' ' O ' ' A' ' 171' ' ' THR . 28.6 tt0 -113.75 113.9 25.61 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.7 t -161.06 151.82 18.3 Favored 'General case' 0 C--N 1.359 0.982 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.417 ' C ' ' HD3' ' A' ' 138' ' ' PRO . 99.4 mttt -90.72 2.08 56.29 Favored 'General case' 0 C--N 1.355 0.838 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -179.155 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -132.99 74.54 73.69 Favored Pre-proline 0 CA--C 1.505 -0.787 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' PRO . . . . . 0.417 ' HD3' ' C ' ' A' ' 136' ' ' LYS . 90.2 Cg_endo -96.47 102.2 0.09 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.533 0 C-N-CA 122.743 2.296 . . . . 0.0 115.818 -177.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -110.76 114.07 27.15 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 105.971 -1.862 . . . . 0.0 105.971 176.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.88 -38.41 90.98 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.311 -178.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 74.5 m -64.01 -27.1 68.89 Favored 'General case' 0 C--N 1.354 0.777 0 O-C-N 121.864 -0.522 . . . . 0.0 110.7 -178.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -76.33 -47.08 24.77 Favored 'General case' 0 C--N 1.351 0.646 0 O-C-N 121.743 -0.598 . . . . 0.0 109.765 -177.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.67 -39.77 94.27 Favored 'General case' 0 C--N 1.356 0.885 0 O-C-N 122.183 -0.323 . . . . 0.0 111.256 -178.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.61 -37.71 88.38 Favored 'General case' 0 C--N 1.355 0.836 0 O-C-N 121.867 -0.521 . . . . 0.0 110.024 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.15 -43.17 98.63 Favored Glycine 0 C--N 1.347 1.188 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -179.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' LEU . . . . . 0.402 ' HA ' HD23 ' A' ' 146' ' ' LEU . 83.6 mt -70.44 -40.38 73.81 Favored 'General case' 0 C--N 1.352 0.682 0 CA-C-N 117.559 0.68 . . . . 0.0 112.649 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.434 ' HA ' HD23 ' A' ' 147' ' ' LEU . 98.4 mt -70.91 -42.47 69.89 Favored 'General case' 0 C--N 1.362 1.11 0 O-C-N 121.215 -0.928 . . . . 0.0 110.86 -176.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.577 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 37.2 t70 -71.5 -28.85 64.19 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 121.894 -0.504 . . . . 0.0 110.336 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -63.03 -39.64 98.31 Favored Glycine 0 C--N 1.357 1.719 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' CYS . . . . . 0.484 ' HG ' HD22 ' A' ' 95' ' ' LEU . 44.1 t -61.03 -41.06 95.86 Favored 'General case' 0 C--N 1.352 0.681 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -76.22 0.86 17.63 Favored 'General case' 0 C--N 1.361 1.071 0 CA-C-O 121.406 0.622 . . . . 0.0 109.403 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.577 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 76.8 mm-40 -86.37 -45.8 10.86 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -68.34 -43.67 76.99 Favored 'General case' 0 C--N 1.357 0.912 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.503 179.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -69.73 -27.9 65.35 Favored 'General case' 0 C--N 1.361 1.078 0 O-C-N 121.815 -0.553 . . . . 0.0 110.932 -178.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 85.1 tttt 71.56 69.22 0.16 Allowed 'General case' 0 C--N 1.362 1.114 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -177.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -134.57 -176.71 4.31 Favored 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -135.95 110.45 8.54 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -132.9 150.34 52.17 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 95.2 m -120.39 126.57 50.8 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 3.5 mp -101.86 121.31 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 179.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.7 m -116.32 -176.69 3.01 Favored 'General case' 0 C--N 1.361 1.082 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.746 ' HD2' ' HG3' ' A' ' 167' ' ' GLN . 8.8 ptt180 -148.95 158.17 43.97 Favored 'General case' 0 C--N 1.356 0.858 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 -179.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 65.5 p -104.75 145.01 29.89 Favored Pre-proline 0 C--N 1.359 1.017 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 179.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' PRO . . . . . 0.811 ' HA ' ' HB2' ' A' ' 167' ' ' GLN . 57.7 Cg_endo -75.36 -8.24 19.49 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 123.094 2.529 . . . . 0.0 115.521 -178.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -71.19 -41.31 70.45 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 34.1 p -117.77 16.12 14.41 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.811 ' HB2' ' HA ' ' A' ' 164' ' ' PRO . 45.1 tt0 -58.96 -38.67 79.6 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.87 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -111.71 48.69 0.94 Allowed 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 19.0 t -139.64 142.95 36.98 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.602 ' O ' ' HB ' ' A' ' 171' ' ' THR . 61.0 mt-10 -97.15 164.77 12.36 Favored 'General case' 0 C--N 1.356 0.86 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' THR . . . . . 0.602 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 3.1 m 80.81 -57.73 0.3 Allowed 'General case' 0 C--N 1.371 1.542 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -107.96 116.76 32.55 Favored 'General case' 0 CA--C 1.503 -0.83 0 C-N-CA 119.843 -0.743 . . . . 0.0 109.732 -178.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 86.3 t -130.26 131.86 65.35 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 178.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 50.5 mm -108.1 125.75 64.71 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -112.51 151.15 30.31 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-O 122.138 0.97 . . . . 0.0 108.551 -179.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -133.9 82.84 2.0 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.804 -178.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.1 mp -78.23 116.49 21.98 Favored 'Isoleucine or valine' 0 C--N 1.359 1.007 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 90.7 m -118.3 144.2 46.02 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -178.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 . . . . . 0 C--N 1.36 1.035 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 -179.669 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 1.078 ' HG2' HMDA ' A' ' 202' ' ' HEM . 93.4 mmm . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 120.822 0.344 . . . . 0.0 110.197 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.492 ' HA ' HG23 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -78.09 -25.39 47.58 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -178.832 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.45 -39.4 50.6 Favored Glycine 0 C--N 1.351 1.392 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.0 tpp -69.78 -38.07 76.57 Favored 'General case' 0 C--N 1.357 0.914 0 O-C-N 121.911 -0.758 . . . . 0.0 111.081 -177.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.492 HG23 ' HA ' ' A' ' 2' ' ' MET . 26.8 m -69.26 -22.63 25.98 Favored 'Isoleucine or valine' 0 C--N 1.356 0.89 0 O-C-N 121.504 -0.748 . . . . 0.0 109.51 -179.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -70.22 -36.76 74.75 Favored 'General case' 0 C--N 1.359 0.989 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 87.8 m -66.56 -40.91 89.26 Favored 'General case' 0 C--N 1.357 0.911 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.64 -38.9 97.18 Favored Glycine 0 C--N 1.357 1.71 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.647 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -65.55 -40.31 92.72 Favored 'General case' 0 C--N 1.351 0.673 0 CA-C-N 117.207 0.503 . . . . 0.0 110.739 -178.205 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 20.7 mmt -63.75 -41.44 98.0 Favored 'General case' 0 C--N 1.355 0.819 0 O-C-N 121.419 -0.801 . . . . 0.0 111.207 -178.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -66.82 -40.36 88.02 Favored 'General case' 0 C--N 1.348 0.518 0 O-C-N 122.011 -0.431 . . . . 0.0 111.691 -177.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 55.7 tp -66.08 -43.29 87.77 Favored 'General case' 0 C--N 1.349 0.573 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -177.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.647 HG12 ' O ' ' A' ' 9' ' ' LEU . 1.7 mm -73.18 -36.57 50.34 Favored 'Isoleucine or valine' 0 C--N 1.36 1.029 0 O-C-N 121.076 -1.015 . . . . 0.0 111.14 -175.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.417 ' HG3' HD22 ' A' ' 22' ' ' LEU . 19.9 tt0 -70.66 -42.57 70.62 Favored 'General case' 0 C--N 1.35 0.612 0 O-C-N 121.505 -0.747 . . . . 0.0 111.746 -176.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -72.01 -38.33 69.62 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -175.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -102.75 -23.97 13.76 Favored 'General case' 0 CA--C 1.509 -0.612 0 C-N-CA 118.524 -1.27 . . . . 0.0 113.655 -174.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 13.8 m-30 -108.2 -37.43 6.03 Favored 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 117.994 -1.482 . . . . 0.0 111.531 -176.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 143.37 178.11 18.89 Favored Glycine 0 C--N 1.347 1.173 0 C-N-CA 118.842 -1.646 . . . . 0.0 109.214 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -102.19 -26.93 13.16 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 -177.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -70.48 -38.92 74.47 Favored 'General case' 0 C--N 1.36 1.061 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.6 m -67.31 -38.48 85.02 Favored 'General case' 0 C--N 1.359 0.995 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.442 HD12 ' HB ' ' A' ' 13' ' ' ILE . 35.2 tp -60.57 -38.81 85.81 Favored 'General case' 0 C--N 1.356 0.859 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -63.77 -37.91 89.15 Favored 'General case' 0 C--N 1.358 0.96 0 O-C-N 122.122 -0.361 . . . . 0.0 111.485 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 87.1 m -65.42 -38.86 91.19 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.575 HD11 ' HB3' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -62.34 -39.36 92.84 Favored 'General case' 0 C--N 1.354 0.768 0 CA-C-O 120.958 0.408 . . . . 0.0 109.988 -179.046 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 85.7 mt -73.09 -15.27 61.5 Favored 'General case' 0 C--N 1.359 0.987 0 O-C-N 121.7 -0.625 . . . . 0.0 110.518 -178.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -86.13 -27.89 24.35 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 119.2 -1.0 . . . . 0.0 109.429 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.6 t -67.0 -36.47 82.25 Favored 'General case' 0 C--N 1.354 0.804 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.638 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 1.7 p -93.65 -37.97 11.57 Favored 'General case' 0 C--N 1.357 0.931 0 C-N-CA 118.781 -1.168 . . . . 0.0 108.12 -179.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.638 ' HB2' ' O ' ' A' ' 29' ' ' CYS . 13.7 mt-10 84.65 133.18 0.05 OUTLIER 'General case' 0 C--N 1.36 1.026 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.501 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -86.08 -169.12 2.5 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.874 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.457 ' H ' ' HB2' ' A' ' 31' ' ' LEU . 63.2 tt0 -152.91 -28.21 0.15 Allowed 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.7 t -141.85 -71.21 0.34 Allowed 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -178.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -130.6 -45.71 1.07 Allowed 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 125.7 -32.65 3.8 Favored Glycine 0 C--N 1.352 1.452 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 84.8 mt -113.3 102.84 14.49 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.806 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -97.23 -2.3 43.05 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.9 m 79.42 174.68 0.14 Allowed 'General case' 0 C--N 1.362 1.135 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 -178.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.495 ' C ' HG21 ' A' ' 40' ' ' VAL . 31.8 p -87.96 113.91 24.07 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 121.115 -0.99 . . . . 0.0 109.561 -178.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.495 HG21 ' C ' ' A' ' 39' ' ' SER . 0.0 OUTLIER -173.31 -9.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.362 1.146 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.946 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -115.25 166.17 12.17 Favored Glycine 0 C--N 1.356 1.671 0 N-CA-C 109.211 -1.555 . . . . 0.0 109.211 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.3 m -130.1 130.36 44.74 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -117.3 172.33 7.37 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -70.68 172.91 7.86 Favored 'General case' 0 C--N 1.356 0.879 0 CA-C-O 121.762 0.791 . . . . 0.0 109.58 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -81.4 -25.99 35.79 Favored 'General case' 0 C--N 1.356 0.85 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -64.52 -28.19 69.48 Favored 'General case' 0 C--N 1.354 0.779 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -61.79 -42.34 98.87 Favored 'General case' 0 C--N 1.353 0.725 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 62.6 tp -67.04 -40.0 87.06 Favored 'General case' 0 C--N 1.355 0.811 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.439 -179.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 59.0 tp -72.15 -33.51 67.79 Favored 'General case' 0 C--N 1.35 0.611 0 O-C-N 122.14 -0.35 . . . . 0.0 110.68 -177.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -64.73 -42.78 94.97 Favored 'General case' 0 N--CA 1.445 -0.688 0 O-C-N 121.66 -0.65 . . . . 0.0 109.852 -177.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.575 ' HB3' HD11 ' A' ' 25' ' ' LEU . 77.6 mt -72.76 -33.83 66.6 Favored 'General case' 0 C--N 1.361 1.08 0 C-N-CA 119.762 -0.775 . . . . 0.0 109.753 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.48 ' O ' HG13 ' A' ' 52' ' ' VAL . 35.8 t -63.03 -42.3 96.12 Favored 'Isoleucine or valine' 0 C--N 1.35 0.605 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.512 ' O ' HG11 ' A' ' 53' ' ' VAL . 55.7 t -66.1 -39.71 85.19 Favored 'Isoleucine or valine' 0 C--N 1.351 0.663 0 O-C-N 121.795 -0.565 . . . . 0.0 109.515 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.508 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 34.9 tptt -63.54 -28.64 70.08 Favored 'General case' 0 C--N 1.361 1.099 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.44 HD13 HD11 ' A' ' 66' ' ' LEU . 16.8 mt -66.51 -38.77 87.93 Favored 'General case' 0 C--N 1.355 0.847 0 O-C-N 121.996 -0.44 . . . . 0.0 110.459 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.7 p -72.13 -17.47 61.96 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.76 -178.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -101.57 -38.43 7.95 Favored 'General case' 0 C--N 1.354 0.769 0 C-N-CA 119.369 -0.932 . . . . 0.0 111.651 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.406 HG11 ' N ' ' A' ' 59' ' ' SER . 4.7 p -72.3 -38.27 61.09 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 O-C-N 121.616 -0.678 . . . . 0.0 111.24 -177.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.406 ' N ' HG11 ' A' ' 58' ' ' VAL . 1.9 t -113.21 -7.71 13.57 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 118.948 -1.101 . . . . 0.0 110.406 -178.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 64.86 49.56 2.15 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.437 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 58.7 t -113.07 133.39 22.04 Favored Pre-proline 0 N--CA 1.443 -0.79 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 61' ' ' VAL . 39.3 Cg_exo -58.14 147.36 83.84 Favored 'Trans proline' 0 CA--C 1.499 -1.259 0 C-N-CA 122.562 2.175 . . . . 0.0 112.631 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.454 ' HA ' HD21 ' A' ' 66' ' ' LEU . 3.7 m -75.65 -11.52 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.922 -178.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 68.3 p -95.88 -32.97 12.39 Favored 'General case' 0 C--N 1.358 0.96 0 C-N-CA 118.183 -1.407 . . . . 0.0 109.468 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -77.52 -22.72 50.73 Favored 'General case' 0 C--N 1.355 0.814 0 O-C-N 121.488 -0.758 . . . . 0.0 109.138 179.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.454 HD21 ' HA ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -79.76 -35.61 38.46 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -179.301 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -69.93 -28.4 36.46 Favored 'Isoleucine or valine' 0 C--N 1.357 0.9 0 C-N-CA 119.932 -0.707 . . . . 0.0 110.049 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 63.2 mtp180 -70.45 -50.12 41.55 Favored 'General case' 0 C--N 1.362 1.15 0 O-C-N 121.398 -0.814 . . . . 0.0 110.533 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.68 -35.96 81.36 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 122.246 -0.284 . . . . 0.0 110.91 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -61.1 -47.44 86.26 Favored 'General case' 0 C--N 1.348 0.512 0 O-C-N 122.229 -0.294 . . . . 0.0 110.498 -178.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.85 -39.59 97.06 Favored Glycine 0 C--N 1.355 1.616 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 -178.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.0 -48.97 76.53 Favored 'General case' 0 C--N 1.352 0.694 0 CA-C-N 118.363 1.081 . . . . 0.0 111.635 -177.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.716 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 10.0 mttm -63.17 -48.38 78.65 Favored 'General case' 0 C--N 1.359 0.987 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -177.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -68.77 -39.07 80.42 Favored 'General case' 0 C--N 1.348 0.533 0 O-C-N 121.198 -0.939 . . . . 0.0 111.777 -175.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.582 ' CE1' HBBA ' A' ' 202' ' ' HEM . 48.0 t80 -62.84 -45.96 90.13 Favored 'General case' 0 C--N 1.353 0.761 0 O-C-N 121.152 -0.968 . . . . 0.0 111.286 -178.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.476 ' O ' HG21 ' A' ' 76' ' ' VAL . 8.5 p -70.08 -15.08 18.89 Favored 'Isoleucine or valine' 0 C--N 1.359 0.993 0 O-C-N 121.377 -0.827 . . . . 0.0 109.392 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.716 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 75.2 mm-40 -71.07 -38.93 72.47 Favored 'General case' 0 C--N 1.352 0.702 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 81.7 mt -72.17 -33.12 67.45 Favored 'General case' 0 C--N 1.356 0.873 0 O-C-N 122.432 -0.168 . . . . 0.0 110.739 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 47.3 mm -64.48 -54.05 35.36 Favored 'Isoleucine or valine' 0 C--N 1.358 0.943 0 C-N-CA 120.126 -0.63 . . . . 0.0 110.396 -177.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -75.33 -14.37 60.48 Favored 'General case' 0 C--N 1.351 0.673 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.45 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.09 -36.78 64.11 Favored Glycine 0 C--N 1.347 1.192 0 N-CA-C 110.969 -0.853 . . . . 0.0 110.969 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -134.18 106.81 11.28 Favored Pre-proline 0 C--N 1.357 0.894 0 CA-C-O 122.68 1.229 . . . . 0.0 109.189 -176.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.541 ' O ' ' HB2' ' A' ' 87' ' ' ASN . 39.3 Cg_endo -68.97 -23.3 34.57 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.675 2.25 . . . . 0.0 114.239 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -90.55 -8.71 49.56 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 tp -90.31 -21.25 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 -178.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -104.11 -14.74 15.78 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.541 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 20.1 t30 -73.3 -41.02 64.06 Favored 'General case' 0 C--N 1.359 1.012 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -68.1 -28.4 67.3 Favored 'General case' 0 C--N 1.352 0.716 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.552 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 25.9 ttp -84.86 148.55 26.22 Favored 'General case' 0 C--N 1.351 0.636 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.13 -21.63 8.14 Favored 'General case' 0 C--N 1.364 1.216 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.984 -177.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -164.22 171.18 15.31 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -177.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.454 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 86.6 p -70.22 -34.0 72.37 Favored 'General case' 0 C--N 1.354 0.776 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.197 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -70.04 -38.46 75.84 Favored 'General case' 0 C--N 1.357 0.922 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -66.14 -24.67 66.71 Favored 'General case' 0 C--N 1.358 0.952 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.454 ' HB3' ' O ' ' A' ' 92' ' ' SER . 61.3 tp -62.63 -46.63 87.34 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.2 mp -62.76 -32.6 73.78 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 122.246 -0.284 . . . . 0.0 110.302 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 35.8 t -62.73 -45.58 92.07 Favored 'General case' 0 C--N 1.356 0.864 0 O-C-N 121.688 -0.632 . . . . 0.0 111.597 -178.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.08 25.87 10.99 Favored 'General case' 0 C--N 1.361 1.071 0 O-C-N 121.057 -1.027 . . . . 0.0 110.453 -178.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 1.017 HD12 ' C3B' ' A' ' 202' ' ' HEM . 12.3 tt -64.26 -29.66 47.94 Favored 'Isoleucine or valine' 0 C--N 1.352 0.689 0 C-N-CA 120.341 -0.543 . . . . 0.0 110.507 -179.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.65 ' N ' HG21 ' A' ' 99' ' ' ILE . 36.5 t70 -120.19 -18.59 7.99 Favored 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 119.336 -0.946 . . . . 0.0 109.115 -179.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 35.5 t -66.06 -45.98 79.42 Favored 'General case' 0 N--CA 1.443 -0.785 0 O-C-N 121.841 -0.537 . . . . 0.0 110.85 -178.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.57 ' O ' HG13 ' A' ' 105' ' ' VAL . 30.8 t80 -124.97 -31.21 3.15 Favored 'General case' 0 C--N 1.359 0.99 0 C-N-CA 118.23 -1.388 . . . . 0.0 111.992 -177.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 96.3 mt -67.52 -47.27 81.09 Favored 'Isoleucine or valine' 0 C--N 1.352 0.704 0 O-C-N 121.034 -1.041 . . . . 0.0 110.687 -177.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 17.5 m170 -87.72 3.16 49.06 Favored 'General case' 0 N--CA 1.441 -0.913 0 O-C-N 121.252 -0.905 . . . . 0.0 110.15 -177.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.57 HG13 ' O ' ' A' ' 102' ' ' PHE . 1.8 p -87.39 -34.15 7.26 Favored 'Isoleucine or valine' 0 C--N 1.356 0.872 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 178.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -71.86 -40.26 69.1 Favored 'General case' 0 C--N 1.359 0.997 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.534 HG12 ' CMD' ' A' ' 202' ' ' HEM . 62.4 t -62.81 -47.37 93.19 Favored 'Isoleucine or valine' 0 C--N 1.356 0.87 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.517 -179.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -60.55 -48.25 82.62 Favored 'General case' 0 C--N 1.359 0.979 0 O-C-N 122.115 -0.366 . . . . 0.0 111.364 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -61.96 -37.57 85.27 Favored 'General case' 0 C--N 1.354 0.786 0 O-C-N 121.533 -0.729 . . . . 0.0 110.708 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.8 mt -57.47 -74.96 0.05 OUTLIER 'General case' 0 C--N 1.356 0.851 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -114.54 135.52 22.3 Favored Pre-proline 0 N--CA 1.441 -0.921 0 C-N-CA 118.656 -1.218 . . . . 0.0 109.146 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -84.66 -5.91 9.87 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 123.133 2.555 . . . . 0.0 115.055 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -66.96 -36.58 82.53 Favored 'General case' 0 C--N 1.355 0.808 0 O-C-N 122.009 -0.432 . . . . 0.0 110.073 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.71 145.21 56.29 Favored 'General case' 0 C--N 1.355 0.807 0 CA-C-O 121.683 0.754 . . . . 0.0 110.139 -178.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -131.09 135.64 47.69 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.492 ' HB3' ' HD2' ' A' ' 117' ' ' PRO . 91.6 mt -127.9 155.73 77.11 Favored Pre-proline 0 N--CA 1.443 -0.791 0 CA-C-O 122.173 0.987 . . . . 0.0 109.246 -178.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.492 ' HD2' ' HB3' ' A' ' 116' ' ' LEU . 84.6 Cg_endo -81.89 -151.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.081 0 C-N-CA 123.736 2.957 . . . . 0.0 113.895 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.434 ' H ' ' HB2' ' A' ' 117' ' ' PRO . 99.3 mttt -115.52 146.42 41.72 Favored 'General case' 0 C--N 1.362 1.126 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -179.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.722 ' CE1' HD11 ' A' ' 131' ' ' LEU . 14.1 t80 -140.6 125.57 18.34 Favored 'General case' 0 C--N 1.362 1.144 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -177.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 93.3 m -125.83 134.06 51.78 Favored 'General case' 0 C--N 1.36 1.038 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 79.0 m -113.36 131.19 56.07 Favored 'General case' 0 C--N 1.356 0.872 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.772 -178.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -117.69 141.77 48.01 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 177.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.421 ' HG3' HD11 ' A' ' 129' ' ' ILE . 58.0 ttp180 -117.75 116.57 27.28 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.536 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 87.6 mt -84.49 -25.75 28.63 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 120.686 -0.406 . . . . 0.0 109.994 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 179.2 -144.26 6.11 Favored Glycine 0 C--N 1.349 1.251 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -94.68 -40.88 9.57 Favored 'General case' 0 N--CA 1.436 -1.137 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.567 -178.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -99.17 2.31 45.72 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.614 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.536 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 8.4 m-20 -121.72 131.63 54.18 Favored 'General case' 0 C--N 1.358 0.961 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.548 HG23 HD12 ' A' ' 129' ' ' ILE . 8.5 mm -140.91 137.43 34.7 Favored 'Isoleucine or valine' 0 C--N 1.354 0.797 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 179.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.451 ' N ' HG21 ' A' ' 129' ' ' ILE . 61.9 mtm180 -123.78 140.35 53.08 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.722 HD11 ' CE1' ' A' ' 119' ' ' PHE . 1.1 pp -127.79 129.43 47.01 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -99.49 133.96 43.06 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -129.67 120.32 24.99 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -178.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.57 ' HA ' ' O ' ' A' ' 171' ' ' THR . 74.2 mt-30 -114.25 115.08 26.85 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 18.1 t -161.69 152.01 17.32 Favored 'General case' 0 C--N 1.359 0.991 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.412 ' C ' ' HD3' ' A' ' 138' ' ' PRO . 58.2 mtmt -92.02 2.22 56.7 Favored 'General case' 0 C--N 1.358 0.939 0 C-N-CA 120.15 -0.62 . . . . 0.0 109.937 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -134.4 73.03 69.62 Favored Pre-proline 0 C--N 1.355 0.81 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.412 ' HD3' ' C ' ' A' ' 136' ' ' LYS . 67.0 Cg_endo -96.19 110.01 0.12 Allowed 'Trans proline' 0 N--CA 1.445 -1.368 0 C-N-CA 122.714 2.276 . . . . 0.0 116.079 -177.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -113.64 113.93 25.73 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 176.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.08 -38.7 92.0 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.264 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.3 m -62.41 -27.07 68.84 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 121.871 -0.518 . . . . 0.0 110.731 -178.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -76.02 -47.94 22.89 Favored 'General case' 0 C--N 1.351 0.64 0 C-N-CA 120.196 -0.602 . . . . 0.0 109.702 -178.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.68 -40.17 94.93 Favored 'General case' 0 C--N 1.358 0.949 0 O-C-N 122.17 -0.331 . . . . 0.0 111.269 -178.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -62.82 -36.54 83.52 Favored 'General case' 0 C--N 1.355 0.818 0 O-C-N 121.92 -0.487 . . . . 0.0 110.088 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.3 -42.81 98.94 Favored Glycine 0 C--N 1.347 1.171 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.0 mt -69.75 -40.93 75.86 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 96.0 mt -71.69 -42.34 67.55 Favored 'General case' 0 C--N 1.363 1.168 0 O-C-N 121.091 -1.006 . . . . 0.0 111.086 -176.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.527 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 37.2 t70 -69.3 -31.78 70.49 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 121.887 -0.508 . . . . 0.0 110.484 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.471 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -62.66 -39.26 97.69 Favored Glycine 0 C--N 1.356 1.658 0 N-CA-C 108.62 -1.792 . . . . 0.0 108.62 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . 0.404 ' SG ' HD21 ' A' ' 95' ' ' LEU . 42.8 t -60.42 -42.55 96.27 Favored 'General case' 0 C--N 1.35 0.625 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -74.55 -1.6 22.14 Favored 'General case' 0 C--N 1.36 1.058 0 O-C-N 121.72 -0.612 . . . . 0.0 109.458 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.527 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 77.7 mm-40 -83.56 -46.9 11.89 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -65.87 -45.04 83.59 Favored 'General case' 0 C--N 1.36 1.036 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -68.96 -26.15 64.91 Favored 'General case' 0 C--N 1.362 1.126 0 O-C-N 121.75 -0.594 . . . . 0.0 110.796 -178.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 86.2 tttt 72.73 75.92 0.15 Allowed 'General case' 0 C--N 1.359 0.989 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.4 ' HG3' ' H ' ' A' ' 157' ' ' ASP . 3.2 tp10 -143.7 -168.28 2.8 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.4 ' H ' ' HG3' ' A' ' 156' ' ' GLU . 1.9 m-20 -152.24 92.99 1.76 Allowed 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 16.3 m-30 -112.38 161.93 16.13 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 93.7 m -118.5 125.95 50.97 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 119.293 -0.963 . . . . 0.0 109.234 -177.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 3.6 mp -104.61 122.33 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 178.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.6 m -120.52 -171.3 2.15 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-O 121.665 0.745 . . . . 0.0 109.241 -178.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.515 ' HD2' ' HG3' ' A' ' 167' ' ' GLN . 5.9 ptt85 -152.0 161.6 42.39 Favored 'General case' 0 C--N 1.357 0.897 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 56.8 p -107.95 143.9 28.28 Favored Pre-proline 0 C--N 1.36 1.049 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.835 ' HA ' ' HB2' ' A' ' 167' ' ' GLN . 56.7 Cg_endo -75.15 -7.86 19.4 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 123.204 2.603 . . . . 0.0 115.578 -178.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -71.6 -41.42 68.96 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 36.5 p -116.89 16.03 15.2 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.835 ' HB2' ' HA ' ' A' ' 164' ' ' PRO . 37.6 tt0 -58.38 -39.02 78.5 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.323 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -113.23 49.04 0.98 Allowed 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 20.7 t -139.11 142.24 38.09 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.61 ' O ' ' HB ' ' A' ' 171' ' ' THR . 61.8 mt-10 -96.52 163.7 12.93 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.61 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 18.6 m 84.12 -56.71 0.13 Allowed 'General case' 0 C--N 1.369 1.418 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.657 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -110.79 118.8 37.13 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.924 -178.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 99.6 t -132.01 133.4 60.83 Favored 'Isoleucine or valine' 0 C--N 1.358 0.963 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 49.2 mm -112.03 125.84 69.36 Favored 'Isoleucine or valine' 0 C--N 1.36 1.03 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.617 ' HB2' ' HG ' ' A' ' 131' ' ' LEU . 96.8 m-85 -116.07 148.75 39.91 Favored 'General case' 0 C--N 1.359 0.996 0 CA-C-O 121.901 0.857 . . . . 0.0 109.063 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -126.55 119.87 28.2 Favored 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.456 HD13 ' CD2' ' A' ' 131' ' ' LEU . 4.0 mp -115.42 121.58 67.52 Favored 'Isoleucine or valine' 0 C--N 1.354 0.795 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 38.0 p -126.11 159.55 32.55 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 121.429 0.633 . . . . 0.0 110.811 -178.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 77.3 mtm180 -95.45 115.41 27.39 Favored 'General case' 0 C--N 1.367 1.365 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 177.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.444 ' HA ' ' HD3' ' A' ' 181' ' ' PRO . . . -67.44 146.56 98.74 Favored Pre-proline 0 C--N 1.357 0.912 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 177.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 180' ' ' ALA . 50.1 Cg_exo -55.85 125.54 19.46 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.521 2.148 . . . . 0.0 113.756 -179.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 6.8 ppt_? -151.18 170.68 18.86 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.625 ' O ' ' HB2' ' A' ' 184' ' ' ALA . . . 92.76 82.23 1.49 Allowed Glycine 0 C--N 1.351 1.394 0 N-CA-C 107.898 -2.081 . . . . 0.0 107.898 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.69 ' O ' ' HB2' ' A' ' 185' ' ' GLU . . . 81.62 -93.56 0.01 OUTLIER 'General case' 0 C--N 1.358 0.958 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.69 ' HB2' ' O ' ' A' ' 184' ' ' ALA . 35.1 tt0 150.85 84.21 0.0 OUTLIER 'General case' 0 C--N 1.365 1.263 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -112.71 112.28 23.67 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 178.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 59.4 tp -74.29 -47.11 36.87 Favored 'General case' 0 C--N 1.356 0.858 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -161.71 -80.76 0.04 OUTLIER 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -127.42 -69.24 0.75 Allowed 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 . . . . . 0 C--O 1.264 1.852 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 179.897 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' HEM . . . . . 1.078 HMDA ' HG2' ' A' ' 1' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.918 ' H2 ' HMDB ' A' ' 202' ' ' HEM . 55.7 mtp . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.089 0.471 . . . . 0.0 110.228 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.39 -17.86 55.85 Favored 'General case' 0 C--N 1.355 0.839 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -178.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -76.33 -41.12 26.72 Favored Glycine 0 C--N 1.349 1.256 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 14.5 tpp -69.12 -38.68 79.02 Favored 'General case' 0 C--N 1.355 0.827 0 O-C-N 121.946 -0.738 . . . . 0.0 110.612 -177.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.5 m -68.25 -22.83 27.85 Favored 'Isoleucine or valine' 0 C--N 1.357 0.903 0 C-N-CA 120.27 -0.572 . . . . 0.0 109.617 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -70.57 -35.58 73.15 Favored 'General case' 0 C--N 1.356 0.876 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 85.5 m -67.15 -40.85 86.77 Favored 'General case' 0 C--N 1.355 0.814 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.43 -39.39 97.73 Favored Glycine 0 C--N 1.359 1.814 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.601 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -64.62 -39.6 93.99 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-N 117.131 0.465 . . . . 0.0 110.711 -178.481 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.424 ' SD ' HD11 ' A' ' 26' ' ' LEU . 25.8 mmt -63.43 -40.44 97.18 Favored 'General case' 0 C--N 1.352 0.684 0 O-C-N 121.679 -0.638 . . . . 0.0 110.984 -178.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -66.88 -40.22 87.75 Favored 'General case' 0 C--N 1.349 0.571 0 O-C-N 121.956 -0.465 . . . . 0.0 111.362 -177.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 53.7 tp -66.42 -42.83 87.2 Favored 'General case' 0 C--N 1.35 0.588 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -178.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.601 HG12 ' O ' ' A' ' 9' ' ' LEU . 1.4 mm -74.99 -36.76 39.52 Favored 'Isoleucine or valine' 0 C--N 1.359 1.008 0 O-C-N 120.988 -1.07 . . . . 0.0 111.002 -175.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -68.18 -43.66 77.65 Favored 'General case' 0 C--N 1.353 0.729 0 O-C-N 121.723 -0.611 . . . . 0.0 111.555 -176.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -71.22 -35.27 71.43 Favored 'General case' 0 N--CA 1.446 -0.634 0 O-C-N 121.974 -0.454 . . . . 0.0 111.909 -176.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -72.69 -48.56 38.02 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -175.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -126.41 -20.9 4.3 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 117.349 -1.741 . . . . 0.0 113.816 -176.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 141.36 179.6 18.7 Favored Glycine 0 CA--C 1.497 -1.078 0 C-N-CA 117.789 -2.148 . . . . 0.0 109.884 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -97.16 -12.26 23.29 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -177.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -70.64 -41.08 72.65 Favored 'General case' 0 C--N 1.36 1.05 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 94.5 m -69.51 -39.05 77.79 Favored 'General case' 0 C--N 1.357 0.932 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 59.1 tp -61.17 -37.99 84.87 Favored 'General case' 0 C--N 1.357 0.905 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -65.17 -35.71 81.94 Favored 'General case' 0 C--N 1.356 0.851 0 O-C-N 122.177 -0.327 . . . . 0.0 110.802 -178.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.5 m -63.71 -40.74 97.53 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.466 ' CD2' ' HB3' ' A' ' 54' ' ' LYS . 87.6 mt -64.87 -37.97 89.4 Favored 'General case' 0 C--N 1.356 0.874 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.458 ' HB3' HD21 ' A' ' 31' ' ' LEU . 6.7 mp -69.39 -14.8 63.1 Favored 'General case' 0 C--N 1.357 0.922 0 O-C-N 121.415 -0.803 . . . . 0.0 109.802 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -85.84 -28.38 24.47 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.224 178.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 55.0 p -68.18 -23.11 64.82 Favored 'General case' 0 C--N 1.361 1.066 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.3 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.0 p -106.96 -33.6 7.45 Favored 'General case' 0 C--N 1.357 0.912 0 C-N-CA 118.933 -1.107 . . . . 0.0 108.141 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 83.63 132.56 0.05 OUTLIER 'General case' 0 C--N 1.361 1.106 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.458 HD21 ' HB3' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -100.53 109.63 21.75 Favored 'General case' 0 C--N 1.357 0.896 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.737 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -72.23 -40.71 67.55 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 178.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.445 ' HB3' ' H ' ' A' ' 34' ' ' GLU . 0.9 OUTLIER -116.09 -86.22 0.62 Allowed 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -179.212 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.445 ' H ' ' HB3' ' A' ' 33' ' ' SER . 57.4 mt-10 -122.14 -40.88 2.46 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -178.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.62 -32.79 6.33 Favored Glycine 0 C--N 1.351 1.365 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 80.4 mt -109.89 104.15 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.005 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.487 ' HD1' ' HA ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -82.89 -143.44 0.06 Allowed 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.337 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 86.2 m -109.82 -56.89 2.26 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.5 p 166.03 16.57 0.0 OUTLIER 'General case' 0 C--N 1.363 1.161 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 23.3 m -109.79 6.48 8.97 Favored 'Isoleucine or valine' 0 C--N 1.353 0.738 0 C-N-CA 119.522 -0.871 . . . . 0.0 111.313 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -91.75 143.67 16.71 Favored Glycine 0 C--N 1.354 1.533 0 C-N-CA 119.223 -1.465 . . . . 0.0 109.505 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 57.0 m -126.61 130.19 50.0 Favored 'General case' 0 C--N 1.356 0.871 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -125.27 174.52 8.06 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -76.07 -179.0 4.69 Favored 'General case' 0 C--N 1.356 0.864 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -86.44 -19.87 28.98 Favored 'General case' 0 C--N 1.356 0.876 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.646 ' HA ' HD21 ' A' ' 49' ' ' LEU . 38.1 tt0 -63.98 -35.5 80.9 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.0 tp10 -61.59 -40.55 95.21 Favored 'General case' 0 C--N 1.349 0.572 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.407 ' O ' HG23 ' A' ' 52' ' ' VAL . 60.4 tp -65.38 -40.29 93.32 Favored 'General case' 0 C--N 1.357 0.896 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.691 -178.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.646 HD21 ' HA ' ' A' ' 46' ' ' GLN . 0.1 OUTLIER -83.45 -14.57 52.23 Favored 'General case' 0 C--N 1.352 0.71 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.131 -177.226 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -71.62 -43.57 65.95 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.457 ' HA ' HD22 ' A' ' 51' ' ' LEU . 82.8 mt -73.24 -34.93 66.14 Favored 'General case' 0 C--N 1.361 1.083 0 C-N-CA 120.17 -0.612 . . . . 0.0 109.704 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.664 HG12 HD23 ' A' ' 66' ' ' LEU . 50.3 t -63.91 -41.41 92.42 Favored 'Isoleucine or valine' 0 C--N 1.352 0.697 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -179.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 52.9 t -65.84 -40.74 88.46 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 O-C-N 121.761 -0.587 . . . . 0.0 109.962 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.466 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 24.6 tptt -67.65 -20.29 65.3 Favored 'General case' 0 C--N 1.36 1.054 0 O-C-N 120.939 -1.101 . . . . 0.0 108.863 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.575 HD12 HD12 ' A' ' 13' ' ' ILE . 0.6 OUTLIER -71.83 -37.47 70.3 Favored 'General case' 0 C--N 1.353 0.745 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.068 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.477 ' O ' ' HA ' ' A' ' 60' ' ' SER . 81.2 p -73.04 -17.32 61.45 Favored 'General case' 0 C--N 1.356 0.852 0 O-C-N 121.766 -0.584 . . . . 0.0 110.285 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -99.51 -37.56 9.13 Favored 'General case' 0 C--N 1.355 0.805 0 O-C-N 121.305 -0.872 . . . . 0.0 111.325 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.565 HG12 ' N ' ' A' ' 59' ' ' SER . 5.1 p -71.85 -34.7 52.24 Favored 'Isoleucine or valine' 0 C--N 1.353 0.723 0 O-C-N 121.709 -0.619 . . . . 0.0 111.52 -177.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.571 ' HB3' HG23 ' A' ' 61' ' ' VAL . 4.3 t -119.99 -8.74 9.75 Favored 'General case' 0 CA--C 1.508 -0.671 0 C-N-CA 119.26 -0.976 . . . . 0.0 109.849 -178.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.477 ' HA ' ' O ' ' A' ' 56' ' ' SER . 0.6 OUTLIER 66.65 47.78 1.54 Allowed 'General case' 0 C--N 1.353 0.737 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 179.61 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.614 HG13 ' HD2' ' A' ' 62' ' ' PRO . 47.6 t -107.44 133.35 20.41 Favored Pre-proline 0 CA--C 1.505 -0.773 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.614 ' HD2' HG13 ' A' ' 61' ' ' VAL . 41.9 Cg_exo -57.38 147.21 78.89 Favored 'Trans proline' 0 CA--C 1.498 -1.3 0 C-N-CA 122.505 2.137 . . . . 0.0 112.794 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.4 m -75.9 -13.61 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.826 -178.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 69.0 p -97.54 -32.77 11.64 Favored 'General case' 0 C--N 1.36 1.055 0 C-N-CA 118.176 -1.41 . . . . 0.0 109.533 -178.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -76.6 -21.47 55.52 Favored 'General case' 0 C--N 1.354 0.776 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.664 HD23 HG12 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -82.05 -35.57 28.6 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.139 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.575 HG12 ' N ' ' A' ' 68' ' ' ARG . 1.3 p -68.92 -26.43 32.52 Favored 'Isoleucine or valine' 0 C--N 1.354 0.795 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.914 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.575 ' N ' HG12 ' A' ' 67' ' ' VAL . 4.5 mmm-85 -73.04 -52.5 14.13 Favored 'General case' 0 C--N 1.36 1.055 0 O-C-N 121.596 -0.69 . . . . 0.0 110.124 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 86.1 mt -63.37 -35.93 82.04 Favored 'General case' 0 C--N 1.357 0.929 0 O-C-N 121.991 -0.443 . . . . 0.0 110.979 -178.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -60.92 -47.27 87.17 Favored 'General case' 0 C--N 1.349 0.555 0 O-C-N 122.258 -0.276 . . . . 0.0 110.494 -178.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.54 -37.94 94.13 Favored Glycine 0 C--N 1.356 1.641 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -62.47 -49.33 75.85 Favored 'General case' 0 C--N 1.35 0.622 0 CA-C-N 118.044 0.922 . . . . 0.0 111.485 -177.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.707 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 11.9 mttm -64.36 -47.72 78.25 Favored 'General case' 0 C--N 1.359 0.996 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -177.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -68.5 -38.84 81.31 Favored 'General case' 0 C--N 1.347 0.5 0 O-C-N 121.265 -0.897 . . . . 0.0 112.004 -175.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -64.84 -42.85 94.59 Favored 'General case' 0 C--N 1.352 0.703 0 O-C-N 121.116 -0.99 . . . . 0.0 111.077 -177.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 76' ' ' VAL . 9.9 p -71.7 -15.43 18.28 Favored 'Isoleucine or valine' 0 C--N 1.36 1.057 0 O-C-N 121.324 -0.86 . . . . 0.0 109.114 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.707 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 74.1 mm-40 -71.88 -38.71 69.97 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 84.5 mt -74.32 -29.69 61.72 Favored 'General case' 0 C--N 1.358 0.967 0 O-C-N 122.215 -0.303 . . . . 0.0 110.749 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.4 mm -66.41 -53.28 37.72 Favored 'Isoleucine or valine' 0 C--N 1.357 0.91 0 C-N-CA 119.973 -0.691 . . . . 0.0 109.973 -177.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -76.08 -14.71 60.19 Favored 'General case' 0 C--N 1.351 0.651 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.39 178.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.0 -36.93 64.47 Favored Glycine 0 C--N 1.349 1.267 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.476 ' HA ' ' HD2' ' A' ' 83' ' ' PRO . 98.6 m-70 -131.86 105.52 14.01 Favored Pre-proline 0 N--CA 1.44 -0.968 0 CA-C-O 122.604 1.192 . . . . 0.0 108.911 -177.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.476 ' HD2' ' HA ' ' A' ' 82' ' ' HIS . 41.4 Cg_endo -68.87 -23.29 35.24 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.637 2.225 . . . . 0.0 114.052 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -90.61 -9.64 46.24 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.3 tp -89.52 -21.75 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 -178.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -102.24 -17.4 15.96 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 51.3 t30 -70.84 -41.28 71.68 Favored 'General case' 0 C--N 1.359 0.999 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -66.13 -33.48 75.86 Favored 'General case' 0 C--N 1.352 0.699 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.318 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.566 ' HG2' ' N ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -80.87 149.97 29.28 Favored 'General case' 0 C--N 1.353 0.745 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 -179.029 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.566 ' N ' ' HG2' ' A' ' 89' ' ' MET . 1.4 mtpt -117.56 -24.69 7.2 Favored 'General case' 0 C--N 1.361 1.1 0 C-N-CA 120.07 -0.652 . . . . 0.0 111.183 -177.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -165.83 171.88 12.29 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -177.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.437 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 57.8 m -67.26 -39.44 86.1 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.486 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.668 ' HZ ' ' HG3' ' A' ' 179' ' ' ARG . 64.7 m-85 -67.77 -39.14 84.15 Favored 'General case' 0 C--N 1.358 0.94 0 O-C-N 121.216 -0.928 . . . . 0.0 108.681 -179.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -66.16 -22.79 66.38 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.437 ' HB3' ' O ' ' A' ' 92' ' ' SER . 62.0 tp -65.2 -45.13 85.99 Favored 'General case' 0 C--N 1.357 0.929 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.3 mp -61.44 -36.5 80.54 Favored 'General case' 0 C--N 1.358 0.956 0 O-C-N 122.001 -0.437 . . . . 0.0 110.239 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 34.7 t -67.77 -39.79 84.09 Favored 'General case' 0 C--N 1.349 0.549 0 O-C-N 121.829 -0.545 . . . . 0.0 110.021 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.2 tttp -93.78 8.1 42.38 Favored 'General case' 0 C--N 1.353 0.75 0 O-C-N 122.286 -0.259 . . . . 0.0 111.279 -176.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 1.04 HD13 ' C2B' ' A' ' 202' ' ' HEM . 15.6 tt -64.29 -38.18 81.85 Favored 'Isoleucine or valine' 0 C--N 1.36 1.033 0 O-C-N 121.464 -0.773 . . . . 0.0 111.694 -176.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.474 ' N ' HG22 ' A' ' 99' ' ' ILE . 6.2 p-10 -107.87 -15.79 14.46 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 118.181 -1.408 . . . . 0.0 110.195 -178.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.462 ' O ' HG22 ' A' ' 105' ' ' VAL . 34.9 t -64.83 -46.6 81.25 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 121.76 -0.588 . . . . 0.0 111.272 -179.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -137.32 -15.12 1.47 Allowed 'General case' 0 C--N 1.36 1.058 0 C-N-CA 117.497 -1.681 . . . . 0.0 112.684 -177.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.553 HG22 ' C1C' ' A' ' 202' ' ' HEM . 31.0 mm -71.0 -51.74 32.99 Favored 'Isoleucine or valine' 0 C--N 1.352 0.682 0 CA-C-N 119.982 1.265 . . . . 0.0 110.715 -177.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -92.03 2.88 56.28 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 119.529 -0.869 . . . . 0.0 110.22 -177.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.462 HG22 ' O ' ' A' ' 101' ' ' SER . 49.5 t -85.79 -44.37 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.083 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 178.265 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 54.7 tp10 -68.1 -40.41 82.62 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.446 HG13 ' HMD' ' A' ' 202' ' ' HEM . 66.6 t -63.84 -46.28 94.75 Favored 'Isoleucine or valine' 0 C--N 1.356 0.889 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.074 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 92.4 t80 -60.94 -48.51 81.5 Favored 'General case' 0 C--N 1.359 1.019 0 O-C-N 122.06 -0.4 . . . . 0.0 111.322 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -61.28 -37.12 82.02 Favored 'General case' 0 C--N 1.357 0.896 0 O-C-N 121.567 -0.708 . . . . 0.0 110.596 -178.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 15.5 mt -56.68 -72.94 0.07 Allowed 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 88.3 m-85 -121.9 135.16 25.05 Favored Pre-proline 0 N--CA 1.438 -1.061 0 C-N-CA 118.488 -1.285 . . . . 0.0 108.638 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -83.47 -2.56 10.55 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 123.197 2.598 . . . . 0.0 115.255 -178.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 29.7 mm100 -66.07 -37.16 85.13 Favored 'General case' 0 C--N 1.354 0.778 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.61 145.8 55.2 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-O 121.614 0.721 . . . . 0.0 109.846 -178.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -127.54 134.07 49.76 Favored 'General case' 0 C--N 1.357 0.922 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.504 ' HB3' ' HD2' ' A' ' 117' ' ' PRO . 86.8 mt -128.25 156.43 76.67 Favored Pre-proline 0 C--N 1.354 0.769 0 CA-C-O 122.116 0.96 . . . . 0.0 109.21 -178.596 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.504 ' HD2' ' HB3' ' A' ' 116' ' ' LEU . 95.3 Cg_endo -84.05 -153.67 0.05 OUTLIER 'Trans proline' 0 C--N 1.318 -1.074 0 C-N-CA 123.763 2.975 . . . . 0.0 114.317 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.43 ' H ' ' HB2' ' A' ' 117' ' ' PRO . 74.7 mmtt -116.66 143.79 45.21 Favored 'General case' 0 C--N 1.364 1.233 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -178.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -126.3 130.78 51.51 Favored 'General case' 0 C--N 1.364 1.203 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -178.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.523 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 94.1 m -127.52 129.18 46.93 Favored 'General case' 0 C--N 1.358 0.951 0 N-CA-C 105.739 -1.949 . . . . 0.0 105.739 177.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 77.2 m -122.88 131.47 53.76 Favored 'General case' 0 CA--C 1.504 -0.794 0 C-N-CA 119.178 -1.009 . . . . 0.0 109.855 -178.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -120.03 132.43 55.46 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 106.325 -1.732 . . . . 0.0 106.325 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.616 ' HG3' HD11 ' A' ' 129' ' ' ILE . 58.0 ttp180 -105.28 117.27 33.59 Favored 'General case' 0 C--N 1.353 0.729 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.424 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 95.2 mt -88.42 -19.84 26.02 Favored 'General case' 0 C--N 1.354 0.781 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.464 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 176.75 -146.74 8.05 Favored Glycine 0 C--N 1.348 1.229 0 C-N-CA 118.905 -1.617 . . . . 0.0 109.06 -178.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -94.82 -39.31 10.32 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -178.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -101.27 0.69 37.78 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.24 -178.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.424 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 66.2 m-20 -118.49 130.74 56.11 Favored 'General case' 0 C--N 1.358 0.955 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.616 HD11 ' HG3' ' A' ' 123' ' ' ARG . 8.0 mm -141.9 136.79 30.65 Favored 'Isoleucine or valine' 0 C--N 1.355 0.829 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.572 ' N ' HG21 ' A' ' 129' ' ' ILE . 52.2 mtm180 -118.21 137.87 52.71 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.058 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 5.6 tp -125.0 119.14 27.86 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.523 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 13.7 m-70 -99.68 134.15 42.99 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.917 ' HH ' HMAA ' A' ' 202' ' ' HEM . 32.0 t80 -129.22 121.58 27.94 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 -178.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.44 ' HA ' ' O ' ' A' ' 171' ' ' THR . 27.7 mt-30 -114.96 111.47 21.2 Favored 'General case' 0 C--N 1.357 0.916 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.559 ' HG ' ' HE2' ' A' ' 133' ' ' TYR . 87.6 p -160.72 161.99 32.39 Favored 'General case' 0 C--N 1.358 0.964 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.406 ' C ' ' HD3' ' A' ' 138' ' ' PRO . 99.4 mttt -98.8 3.59 47.47 Favored 'General case' 0 C--N 1.354 0.796 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 10.8 mtp180 -133.42 74.08 72.24 Favored Pre-proline 0 C--N 1.353 0.75 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.406 ' HD3' ' C ' ' A' ' 136' ' ' LYS . 84.6 Cg_endo -94.74 102.25 0.12 Allowed 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 122.799 2.332 . . . . 0.0 115.926 -177.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -110.11 109.11 19.53 Favored 'General case' 0 CA--C 1.502 -0.904 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 176.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.88 -39.31 93.9 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.679 -178.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 74.3 m -62.92 -27.24 69.24 Favored 'General case' 0 C--N 1.354 0.763 0 O-C-N 121.813 -0.554 . . . . 0.0 110.762 -178.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -76.03 -46.49 29.06 Favored 'General case' 0 N--CA 1.444 -0.757 0 O-C-N 121.719 -0.613 . . . . 0.0 109.65 -178.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.19 -39.93 95.03 Favored 'General case' 0 C--N 1.359 1.01 0 O-C-N 122.124 -0.36 . . . . 0.0 111.234 -178.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -62.79 -36.95 84.81 Favored 'General case' 0 C--N 1.356 0.864 0 O-C-N 121.904 -0.498 . . . . 0.0 109.919 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.07 -43.05 98.64 Favored Glycine 0 C--N 1.348 1.205 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.8 mt -70.54 -40.84 73.19 Favored 'General case' 0 C--N 1.352 0.681 0 CA-C-N 117.606 0.703 . . . . 0.0 112.887 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 97.8 mt -71.04 -42.69 69.17 Favored 'General case' 0 C--N 1.362 1.142 0 O-C-N 121.118 -0.989 . . . . 0.0 110.945 -176.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -70.43 -29.95 66.68 Favored 'General case' 0 N--CA 1.445 -0.675 0 O-C-N 122.015 -0.428 . . . . 0.0 110.486 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.529 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -63.04 -39.69 98.35 Favored Glycine 0 C--N 1.357 1.735 0 N-CA-C 108.394 -1.882 . . . . 0.0 108.394 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 48.8 t -61.16 -42.56 98.78 Favored 'General case' 0 C--N 1.351 0.639 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -75.8 1.87 13.75 Favored 'General case' 0 C--N 1.361 1.071 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.529 ' HB2' ' O ' ' A' ' 149' ' ' GLY . 15.5 mm-40 -87.12 -45.56 10.58 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -66.45 -44.55 82.51 Favored 'General case' 0 C--N 1.359 0.984 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.453 ' O ' ' HB2' ' A' ' 155' ' ' LYS . 50.6 m-85 -70.15 -25.45 63.46 Favored 'General case' 0 C--N 1.361 1.108 0 O-C-N 121.84 -0.537 . . . . 0.0 111.119 -178.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 154' ' ' PHE . 97.3 mttt 71.6 66.07 0.15 Allowed 'General case' 0 C--N 1.363 1.168 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 -177.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -128.68 -177.44 4.19 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -140.98 95.18 2.8 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -117.27 154.29 31.46 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 93.5 m -119.63 126.47 51.25 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 3.5 mp -103.82 122.45 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 3.0 m -118.15 -174.84 2.73 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-O 121.797 0.808 . . . . 0.0 109.29 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.11 155.38 42.12 Favored 'General case' 0 C--N 1.356 0.874 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -178.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' THR . . . . . 0.408 ' O ' ' HB3' ' A' ' 167' ' ' GLN . 63.8 p -98.79 146.86 32.36 Favored Pre-proline 0 C--N 1.36 1.062 0 CA-C-O 122.502 1.144 . . . . 0.0 108.359 179.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.697 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 76.9 Cg_endo -76.9 -11.22 18.16 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 123.006 2.47 . . . . 0.0 114.971 -178.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -72.09 -41.79 66.91 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 120.193 -0.603 . . . . 0.0 109.583 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 39.0 p -116.06 14.57 16.06 Favored 'General case' 0 CA--C 1.505 -0.786 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.381 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.697 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.3 pp0? -68.38 -10.27 53.92 Favored 'General case' 0 C--N 1.351 0.665 0 O-C-N 121.525 -0.734 . . . . 0.0 110.083 178.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 55.6 p30 -121.57 35.16 4.96 Favored 'General case' 0 N--CA 1.435 -1.198 0 O-C-N 121.16 -0.962 . . . . 0.0 109.48 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 94.1 p -145.51 157.83 43.94 Favored 'General case' 0 C--N 1.353 0.736 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.61 ' O ' ' HB ' ' A' ' 171' ' ' THR . 60.0 mt-10 -106.96 170.2 8.09 Favored 'General case' 0 C--N 1.356 0.856 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -179.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.61 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 6.1 m 82.79 -53.96 0.19 Allowed 'General case' 0 C--N 1.37 1.489 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.62 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -115.64 117.59 30.73 Favored 'General case' 0 CA--C 1.505 -0.763 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.655 -178.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 94.9 t -130.38 132.8 64.62 Favored 'Isoleucine or valine' 0 C--N 1.357 0.917 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 49.8 mm -107.23 127.02 63.33 Favored 'Isoleucine or valine' 0 C--N 1.359 1.0 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -115.42 155.28 27.72 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 122.139 0.971 . . . . 0.0 108.688 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -138.21 119.11 14.24 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -178.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.0 mp -114.03 119.22 60.61 Favored 'Isoleucine or valine' 0 C--N 1.355 0.807 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 89.4 m -122.02 144.51 48.85 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -177.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.668 ' HG3' ' HZ ' ' A' ' 93' ' ' PHE . 3.8 mtm180 -86.8 115.48 24.26 Favored 'General case' 0 C--N 1.367 1.358 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -65.9 150.54 96.38 Favored Pre-proline 0 C--N 1.358 0.945 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 178.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.51 132.06 26.24 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 121.995 1.797 . . . . 0.0 114.173 -178.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.511 HH11 ' HD2' ' A' ' 182' ' ' ARG . 4.9 mtm105 -126.45 66.56 1.23 Allowed 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 179.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 77.0 58.41 3.44 Favored Glycine 0 N--CA 1.441 -0.993 0 N-CA-C 108.019 -2.032 . . . . 0.0 108.019 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 170.13 71.83 0.0 OUTLIER 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -114.76 99.8 7.77 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -116.02 121.85 43.45 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 81.4 mt -98.26 -50.33 4.38 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . 0.502 ' HB3' ' H ' ' A' ' 189' ' ' PHE . 2.7 t80 -160.75 -85.84 0.03 OUTLIER 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . 0.502 ' H ' ' HB3' ' A' ' 188' ' ' TYR . 89.7 t80 -138.79 130.7 27.92 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 . . . . . 0 C--O 1.264 1.852 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.974 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' HEM . . . . . 1.04 ' C2B' HD13 ' A' ' 99' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 1.003 ' HG2' HMDB ' A' ' 202' ' ' HEM . 81.4 mmm . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 120.821 0.343 . . . . 0.0 110.19 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.5 -22.68 47.06 Favored 'General case' 0 C--N 1.356 0.856 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -178.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.66 -40.56 45.82 Favored Glycine 0 C--N 1.35 1.348 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.516 ' HE3' ' HE2' ' A' ' 1' ' ' MET . 3.1 tpp -70.27 -37.0 74.78 Favored 'General case' 0 C--N 1.354 0.792 0 O-C-N 122.132 -0.628 . . . . 0.0 110.865 -177.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.0 m -71.17 -22.71 22.73 Favored 'Isoleucine or valine' 0 C--N 1.357 0.895 0 O-C-N 121.642 -0.661 . . . . 0.0 109.524 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.445 ' HZ ' ' CG ' ' A' ' 47' ' ' GLU . 2.2 m-85 -70.8 -35.23 72.43 Favored 'General case' 0 C--N 1.357 0.915 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 85.4 m -66.95 -40.63 87.59 Favored 'General case' 0 C--N 1.354 0.795 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.13 -38.76 97.06 Favored Glycine 0 C--N 1.358 1.785 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.608 HD12 HD11 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -65.94 -39.85 90.85 Favored 'General case' 0 C--N 1.352 0.686 0 CA-C-N 117.241 0.521 . . . . 0.0 110.608 -178.087 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.888 ' HE1' HD22 ' A' ' 26' ' ' LEU . 24.8 mmt -64.73 -40.12 94.79 Favored 'General case' 0 C--N 1.354 0.775 0 O-C-N 121.591 -0.693 . . . . 0.0 110.707 -178.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -65.86 -39.93 91.19 Favored 'General case' 0 C--N 1.349 0.569 0 O-C-N 122.107 -0.37 . . . . 0.0 111.303 -178.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 56.3 tp -65.81 -42.86 90.15 Favored 'General case' 0 C--N 1.349 0.572 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -178.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.736 HD13 HD12 ' A' ' 55' ' ' LEU . 1.9 mm -74.5 -35.38 38.45 Favored 'Isoleucine or valine' 0 C--N 1.361 1.073 0 O-C-N 121.031 -1.043 . . . . 0.0 110.746 -175.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -72.0 -42.54 66.3 Favored 'General case' 0 C--N 1.349 0.55 0 O-C-N 121.648 -0.657 . . . . 0.0 111.475 -176.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -70.95 -36.68 72.7 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -176.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -101.1 -25.06 14.17 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 118.725 -1.19 . . . . 0.0 113.628 -174.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -114.8 -36.43 4.5 Favored 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 117.606 -1.638 . . . . 0.0 112.288 -176.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 145.03 177.98 20.26 Favored Glycine 0 C--N 1.348 1.227 0 C-N-CA 118.176 -1.964 . . . . 0.0 110.314 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -99.33 -25.89 14.34 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 -177.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -70.14 -39.15 75.56 Favored 'General case' 0 C--N 1.358 0.937 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.1 m -67.64 -39.33 84.62 Favored 'General case' 0 C--N 1.357 0.919 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.723 HD22 HD11 ' A' ' 26' ' ' LEU . 2.7 tt -60.21 -38.66 84.02 Favored 'General case' 0 C--N 1.357 0.933 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -64.16 -36.82 85.28 Favored 'General case' 0 C--N 1.355 0.821 0 O-C-N 122.081 -0.387 . . . . 0.0 110.901 -178.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.445 HG21 ' O ' ' A' ' 24' ' ' THR . 88.2 m -65.0 -40.35 94.82 Favored 'General case' 0 C--N 1.354 0.775 0 O-C-N 121.638 -0.664 . . . . 0.0 109.55 -178.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.444 HD22 ' HA ' ' A' ' 25' ' ' LEU . 88.6 mt -63.74 -38.17 90.09 Favored 'General case' 0 C--N 1.355 0.847 0 O-C-N 122.023 -0.423 . . . . 0.0 109.941 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.888 HD22 ' HE1' ' A' ' 10' ' ' MET . 82.5 mt -70.53 -17.35 62.94 Favored 'General case' 0 C--N 1.36 1.028 0 O-C-N 121.532 -0.73 . . . . 0.0 110.373 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -85.56 -27.38 25.58 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.488 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.5 t -66.09 -36.71 83.91 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 99.5 m -96.5 -35.67 11.05 Favored 'General case' 0 C--N 1.357 0.902 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -178.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 83.31 136.12 0.06 Allowed 'General case' 0 C--N 1.358 0.969 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.525 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -84.8 -171.41 3.62 Favored 'General case' 0 C--N 1.356 0.876 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.535 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -151.2 -24.32 0.21 Allowed 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.1 t -147.07 -67.92 0.26 Allowed 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -128.5 -50.64 1.27 Allowed 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.81 -44.5 1.36 Allowed Glycine 0 C--N 1.351 1.377 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 82.3 mt -110.38 105.18 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.971 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.403 ' HD1' ' HA ' ' A' ' 37' ' ' TYR . 0.1 OUTLIER -82.75 -142.09 0.06 Allowed 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.664 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.404 ' O ' ' HB3' ' A' ' 39' ' ' SER . 87.8 m -112.17 -58.77 2.09 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.404 ' HB3' ' O ' ' A' ' 38' ' ' THR . 52.6 p 165.59 16.92 0.0 OUTLIER 'General case' 0 C--N 1.362 1.113 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.5 t -103.26 3.63 10.64 Favored 'Isoleucine or valine' 0 C--N 1.353 0.732 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.209 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -94.34 141.71 15.68 Favored Glycine 0 C--N 1.352 1.461 0 C-N-CA 119.25 -1.452 . . . . 0.0 109.631 -178.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 50.0 m -124.55 124.73 42.89 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 178.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -117.74 174.98 5.87 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -80.83 -173.06 4.0 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -91.97 -14.85 28.82 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -69.48 -28.87 66.45 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.445 ' CG ' ' HZ ' ' A' ' 6' ' ' PHE . 20.3 tp10 -63.71 -41.28 98.11 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.483 HD12 HG22 ' A' ' 52' ' ' VAL . 1.9 tm? -67.65 -38.74 84.23 Favored 'General case' 0 C--N 1.359 1.017 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 60.4 tp -70.05 -34.05 72.73 Favored 'General case' 0 CA--C 1.508 -0.639 0 O-C-N 122.134 -0.354 . . . . 0.0 110.141 -177.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 70.6 tp60 -65.2 -41.16 94.78 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -178.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.412 HD21 ' HB3' ' A' ' 25' ' ' LEU . 85.1 mt -81.51 -18.71 44.13 Favored 'General case' 0 C--N 1.362 1.121 0 O-C-N 121.558 -0.714 . . . . 0.0 110.846 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.483 HG22 HD12 ' A' ' 48' ' ' LEU . 1.6 t -80.6 -38.53 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 C-N-CA 119.706 -0.798 . . . . 0.0 109.124 -178.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.551 HG11 ' N ' ' A' ' 54' ' ' LYS . 5.7 p -74.22 -31.51 29.35 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 C-N-CA 119.756 -0.778 . . . . 0.0 109.417 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.551 ' N ' HG11 ' A' ' 53' ' ' VAL . 36.3 tptt -70.22 -26.94 64.1 Favored 'General case' 0 C--N 1.366 1.289 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.736 HD12 HD13 ' A' ' 13' ' ' ILE . 1.7 tt -67.98 -39.04 83.35 Favored 'General case' 0 C--N 1.353 0.735 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.511 ' O ' ' HA ' ' A' ' 60' ' ' SER . 59.9 p -72.8 -17.26 61.59 Favored 'General case' 0 C--N 1.357 0.933 0 O-C-N 121.729 -0.607 . . . . 0.0 110.916 -178.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -98.93 -37.15 9.51 Favored 'General case' 0 C--N 1.353 0.739 0 O-C-N 121.181 -0.949 . . . . 0.0 111.364 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.525 HG12 ' N ' ' A' ' 59' ' ' SER . 5.2 p -70.92 -35.02 57.98 Favored 'Isoleucine or valine' 0 C--N 1.351 0.672 0 O-C-N 121.712 -0.617 . . . . 0.0 111.399 -177.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.525 ' N ' HG12 ' A' ' 58' ' ' VAL . 3.9 t -120.49 -7.57 9.67 Favored 'General case' 0 C--N 1.352 0.708 0 C-N-CA 119.118 -1.033 . . . . 0.0 110.08 -178.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.511 ' HA ' ' O ' ' A' ' 56' ' ' SER . 1.0 OUTLIER 66.03 46.41 2.18 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.552 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.506 HG13 ' HD2' ' A' ' 62' ' ' PRO . 61.3 t -106.23 132.82 20.58 Favored Pre-proline 0 CA--C 1.506 -0.745 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.506 ' HD2' HG13 ' A' ' 61' ' ' VAL . 50.4 Cg_exo -56.62 146.02 78.32 Favored 'Trans proline' 0 CA--C 1.497 -1.341 0 C-N-CA 122.59 2.193 . . . . 0.0 113.071 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.462 ' HA ' HD22 ' A' ' 66' ' ' LEU . 4.8 m -75.25 -12.89 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.792 -178.29 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 72.2 p -96.36 -32.24 12.47 Favored 'General case' 0 C--N 1.358 0.944 0 C-N-CA 118.273 -1.371 . . . . 0.0 109.761 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -80.26 -20.67 43.98 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 121.394 -0.816 . . . . 0.0 108.912 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.462 HD22 ' HA ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -81.0 -36.49 30.57 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -179.901 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.597 HG12 ' N ' ' A' ' 68' ' ' ARG . 2.1 p -67.44 -29.86 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.678 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.597 ' N ' HG12 ' A' ' 67' ' ' VAL . 76.2 mtp180 -70.35 -48.81 54.7 Favored 'General case' 0 C--N 1.366 1.298 0 O-C-N 121.428 -0.795 . . . . 0.0 110.777 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.432 ' HA ' HD23 ' A' ' 69' ' ' LEU . 84.9 mt -64.14 -35.84 82.08 Favored 'General case' 0 C--N 1.355 0.84 0 O-C-N 122.033 -0.417 . . . . 0.0 110.961 -178.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -60.8 -47.37 86.64 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 122.132 -0.355 . . . . 0.0 110.427 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.19 -39.07 96.64 Favored Glycine 0 C--N 1.354 1.579 0 N-CA-C 111.729 -0.549 . . . . 0.0 111.729 -178.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.44 -47.55 81.43 Favored 'General case' 0 C--N 1.351 0.651 0 CA-C-N 118.227 1.013 . . . . 0.0 111.462 -177.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.748 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 10.6 mttm -63.98 -50.17 69.6 Favored 'General case' 0 C--N 1.357 0.921 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -177.121 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.411 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.4 tm? -68.67 -38.96 80.77 Favored 'General case' 0 C--N 1.349 0.552 0 O-C-N 121.339 -0.85 . . . . 0.0 111.868 -175.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -63.43 -45.09 92.57 Favored 'General case' 0 C--N 1.352 0.678 0 O-C-N 121.208 -0.932 . . . . 0.0 110.965 -177.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 8.6 p -70.59 -15.71 19.19 Favored 'Isoleucine or valine' 0 C--N 1.358 0.958 0 O-C-N 121.521 -0.737 . . . . 0.0 109.366 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.748 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 75.1 mm-40 -71.28 -38.73 71.81 Favored 'General case' 0 C--N 1.35 0.608 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.7 mt -73.04 -31.66 64.58 Favored 'General case' 0 C--N 1.356 0.865 0 O-C-N 122.426 -0.171 . . . . 0.0 110.685 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.9 mm -65.06 -53.72 37.81 Favored 'Isoleucine or valine' 0 C--N 1.359 0.984 0 C-N-CA 120.081 -0.648 . . . . 0.0 110.099 -177.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -74.99 -14.98 60.68 Favored 'General case' 0 C--N 1.351 0.634 0 C-N-CA 119.554 -0.859 . . . . 0.0 109.37 178.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.58 -37.66 68.26 Favored Glycine 0 C--N 1.349 1.278 0 N-CA-C 110.971 -0.851 . . . . 0.0 110.971 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -132.45 108.3 13.38 Favored Pre-proline 0 N--CA 1.441 -0.917 0 CA-C-O 122.776 1.274 . . . . 0.0 109.232 -177.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.8 -24.58 40.38 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.596 2.197 . . . . 0.0 114.301 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -93.7 -5.05 49.4 Favored 'General case' 0 CA--C 1.5 -0.966 0 C-N-CA 119.448 -0.901 . . . . 0.0 108.776 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -89.64 -19.97 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.444 ' HA ' ' HE2' ' A' ' 89' ' ' MET . . . -100.78 -25.18 14.21 Favored 'General case' 0 C--N 1.361 1.106 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -70.23 -35.23 73.71 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 120.207 -0.597 . . . . 0.0 109.443 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -65.42 -36.98 85.57 Favored 'General case' 0 C--N 1.355 0.837 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.415 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.583 ' HG2' ' N ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -81.52 155.05 25.96 Favored 'General case' 0 C--N 1.355 0.841 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -178.468 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.583 ' N ' ' HG2' ' A' ' 89' ' ' MET . 0.8 OUTLIER -120.36 -25.41 5.64 Favored 'General case' 0 C--N 1.364 1.199 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.031 -177.655 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -165.12 172.09 13.01 Favored 'General case' 0 C--N 1.354 0.78 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 -177.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.407 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 41.1 t -64.62 -43.16 94.61 Favored 'General case' 0 C--N 1.356 0.863 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.208 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -67.11 -39.72 86.72 Favored 'General case' 0 C--N 1.356 0.853 0 O-C-N 121.429 -0.794 . . . . 0.0 109.282 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -66.41 -23.17 66.26 Favored 'General case' 0 C--N 1.355 0.821 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.678 ' O ' HG13 ' A' ' 99' ' ' ILE . 61.2 tp -64.78 -46.28 82.78 Favored 'General case' 0 C--N 1.356 0.888 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.493 ' HA ' ' CD1' ' A' ' 99' ' ' ILE . 3.2 mp -59.94 -35.11 74.23 Favored 'General case' 0 C--N 1.36 1.035 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.5 t -69.61 -39.57 77.15 Favored 'General case' 0 C--N 1.349 0.549 0 O-C-N 121.994 -0.441 . . . . 0.0 109.934 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.1 tttp -87.32 1.37 53.47 Favored 'General case' 0 C--N 1.357 0.905 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -176.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.678 HG13 ' O ' ' A' ' 95' ' ' LEU . 81.4 mt -61.51 -47.06 95.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.868 0 CA-C-N 119.282 0.946 . . . . 0.0 111.408 -177.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -92.88 -25.67 17.98 Favored 'General case' 0 N--CA 1.442 -0.858 0 O-C-N 121.04 -1.037 . . . . 0.0 110.973 -177.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 35.0 t -63.21 -49.0 75.92 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 121.64 -0.662 . . . . 0.0 112.667 -177.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.643 ' HA ' HG13 ' A' ' 105' ' ' VAL . 16.9 t80 -139.42 -14.25 1.12 Allowed 'General case' 0 C--N 1.361 1.066 0 C-N-CA 117.274 -1.77 . . . . 0.0 113.529 -176.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.758 HG21 ' C2C' ' A' ' 202' ' ' HEM . 32.7 mm -71.77 -52.14 27.42 Favored 'Isoleucine or valine' 0 C--O 1.246 0.875 0 CA-C-N 120.659 1.572 . . . . 0.0 110.592 -177.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -91.82 2.3 56.6 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 119.659 -0.817 . . . . 0.0 110.299 -176.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.643 HG13 ' HA ' ' A' ' 102' ' ' PHE . 1.3 p -92.4 -32.47 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.597 ' N ' HG12 ' A' ' 105' ' ' VAL . 89.0 tt0 -72.93 -40.82 65.12 Favored 'General case' 0 C--N 1.357 0.924 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.6 p -74.99 -35.99 37.07 Favored 'Isoleucine or valine' 0 C--N 1.355 0.847 0 C-N-CA 119.231 -0.988 . . . . 0.0 109.684 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -61.23 -48.61 80.68 Favored 'General case' 0 C--N 1.365 1.245 0 O-C-N 121.727 -0.608 . . . . 0.0 110.428 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -60.35 -37.48 80.82 Favored 'General case' 0 C--N 1.358 0.961 0 O-C-N 121.694 -0.629 . . . . 0.0 110.096 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 13.4 mt -56.5 -75.07 0.04 OUTLIER 'General case' 0 C--N 1.356 0.869 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.425 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 92.6 m-85 -119.05 135.21 23.72 Favored Pre-proline 0 N--CA 1.439 -0.983 0 C-N-CA 118.855 -1.138 . . . . 0.0 108.821 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 111' ' ' TYR . 89.4 Cg_endo -84.16 -1.5 9.86 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 123.315 2.677 . . . . 0.0 115.318 -178.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -65.78 -37.24 85.76 Favored 'General case' 0 C--N 1.354 0.788 0 O-C-N 121.805 -0.56 . . . . 0.0 109.933 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.35 144.9 56.27 Favored 'General case' 0 C--N 1.353 0.734 0 CA-C-O 121.495 0.664 . . . . 0.0 109.742 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -131.45 135.96 47.57 Favored 'General case' 0 C--N 1.356 0.882 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.547 ' HB3' ' HD2' ' A' ' 117' ' ' PRO . 90.7 mt -128.45 157.17 75.61 Favored Pre-proline 0 N--CA 1.443 -0.794 0 CA-C-O 122.189 0.995 . . . . 0.0 109.286 -178.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.547 ' HD2' ' HB3' ' A' ' 116' ' ' LEU . 94.0 Cg_endo -80.29 -153.52 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.122 0 C-N-CA 123.644 2.896 . . . . 0.0 113.472 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.414 ' H ' ' HB2' ' A' ' 117' ' ' PRO . 99.4 mttt -118.21 144.14 45.97 Favored 'General case' 0 C--N 1.362 1.148 0 C-N-CA 119.172 -1.011 . . . . 0.0 108.458 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -129.59 134.36 47.68 Favored 'General case' 0 C--N 1.361 1.081 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.525 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 94.2 m -125.05 129.32 50.03 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 177.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 84.4 m -116.02 127.26 54.77 Favored 'General case' 0 CA--C 1.504 -0.802 0 C-N-CA 119.094 -1.042 . . . . 0.0 109.402 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -120.36 130.77 54.55 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.548 ' HG3' HD12 ' A' ' 129' ' ' ILE . 57.9 ttp180 -105.16 116.98 32.87 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -179.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.509 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 90.7 mt -85.81 -24.32 26.84 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 120.709 -0.397 . . . . 0.0 109.997 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -179.6 -146.0 6.61 Favored Glycine 0 C--N 1.349 1.294 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 -178.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -94.12 -40.16 10.2 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 120.007 -0.677 . . . . 0.0 109.274 -178.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -101.69 4.25 40.5 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 119.882 -0.727 . . . . 0.0 110.406 -178.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.509 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 8.4 m-20 -120.74 130.65 54.13 Favored 'General case' 0 C--N 1.36 1.035 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.567 HG22 ' N ' ' A' ' 130' ' ' ARG . 8.7 mm -141.49 137.71 32.51 Favored 'Isoleucine or valine' 0 C--N 1.356 0.871 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.567 ' N ' HG22 ' A' ' 129' ' ' ILE . 60.3 mtm180 -124.11 138.83 54.38 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.633 ' HG ' ' O ' ' A' ' 131' ' ' LEU . 0.1 OUTLIER -130.63 127.42 38.93 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.594 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.525 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 12.3 m170 -95.6 135.72 36.9 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 179.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -127.69 118.83 24.55 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 -178.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.526 ' HA ' ' O ' ' A' ' 171' ' ' THR . 29.1 tt0 -113.82 111.93 22.56 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 14.5 t -161.86 153.82 19.19 Favored 'General case' 0 C--N 1.359 0.99 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.403 ' C ' ' HD3' ' A' ' 138' ' ' PRO . 57.6 mtmt -91.47 3.36 55.16 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 120.26 -0.576 . . . . 0.0 109.893 -179.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 93.2 mtm-85 -133.7 73.78 71.41 Favored Pre-proline 0 C--N 1.355 0.847 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 178.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.403 ' HD3' ' C ' ' A' ' 136' ' ' LYS . 87.2 Cg_endo -94.81 103.47 0.12 Allowed 'Trans proline' 0 N--CA 1.444 -1.426 0 C-N-CA 122.489 2.126 . . . . 0.0 115.67 -177.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -111.15 113.01 25.21 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 176.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.95 -38.75 92.23 Favored 'General case' 0 C--N 1.353 0.748 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.068 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.0 m -64.13 -26.28 68.46 Favored 'General case' 0 C--N 1.353 0.742 0 O-C-N 122.052 -0.405 . . . . 0.0 110.902 -178.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.525 ' HE2' HAAA ' A' ' 202' ' ' HEM . 85.5 t80 -76.47 -47.41 23.04 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 121.669 -0.645 . . . . 0.0 109.666 -178.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.88 -39.49 93.62 Favored 'General case' 0 C--N 1.357 0.919 0 O-C-N 122.071 -0.393 . . . . 0.0 110.8 -178.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.34 -36.83 85.01 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 122.029 -0.419 . . . . 0.0 109.901 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.44 -43.25 98.93 Favored Glycine 0 C--N 1.348 1.201 0 N-CA-C 109.901 -1.279 . . . . 0.0 109.901 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.0 mt -69.08 -41.08 77.98 Favored 'General case' 0 C--N 1.352 0.694 0 CA-C-N 117.612 0.706 . . . . 0.0 112.415 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 98.2 mt -71.5 -42.49 67.95 Favored 'General case' 0 C--N 1.36 1.042 0 O-C-N 121.3 -0.875 . . . . 0.0 110.714 -177.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.583 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 37.5 t70 -69.38 -32.52 71.61 Favored 'General case' 0 N--CA 1.445 -0.703 0 O-C-N 122.049 -0.407 . . . . 0.0 110.642 -179.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -62.85 -39.57 98.16 Favored Glycine 0 C--N 1.357 1.736 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 47.0 t -60.1 -41.73 93.18 Favored 'General case' 0 C--N 1.351 0.653 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -77.56 0.23 23.81 Favored 'General case' 0 C--N 1.359 0.982 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.583 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 76.8 mm-40 -83.65 -46.77 11.95 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -68.55 -41.46 79.76 Favored 'General case' 0 C--N 1.359 0.991 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.523 ' HZ ' ' SD ' ' A' ' 89' ' ' MET . 9.7 m-30 -69.66 -26.98 64.66 Favored 'General case' 0 C--N 1.36 1.055 0 O-C-N 121.821 -0.549 . . . . 0.0 110.628 -178.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 85.0 tttt 73.59 74.88 0.13 Allowed 'General case' 0 C--N 1.361 1.091 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -142.81 -170.34 3.21 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -148.57 94.37 2.28 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 15.7 m-30 -113.42 156.59 23.22 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 94.5 m -119.23 126.85 52.5 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 119.082 -1.047 . . . . 0.0 108.837 -178.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 3.9 mp -104.76 122.61 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 178.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.8 m -120.47 -171.95 2.27 Favored 'General case' 0 C--N 1.355 0.808 0 CA-C-O 121.812 0.815 . . . . 0.0 108.899 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.01 158.64 44.37 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -178.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 50.2 p -98.27 146.59 31.79 Favored Pre-proline 0 C--N 1.357 0.934 0 CA-C-O 122.368 1.08 . . . . 0.0 108.134 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.64 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 72.8 Cg_endo -75.95 -10.98 19.84 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.924 2.416 . . . . 0.0 115.031 -178.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -72.62 -41.17 65.84 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.388 -178.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 39.0 p -116.7 15.32 15.43 Favored 'General case' 0 C--N 1.354 0.795 0 C-N-CA 120.264 -0.575 . . . . 0.0 110.288 -178.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.64 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.2 pp0? -66.67 -12.76 59.67 Favored 'General case' 0 C--N 1.354 0.798 0 O-C-N 121.608 -0.683 . . . . 0.0 110.22 178.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -124.62 38.23 4.24 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 57.7 m -137.21 146.76 45.23 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.607 ' O ' ' HB ' ' A' ' 171' ' ' THR . 61.4 mt-10 -99.85 165.46 11.56 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.607 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 16.4 m 82.28 -59.39 0.19 Allowed 'General case' 0 C--N 1.369 1.453 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.799 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -107.73 117.1 33.24 Favored 'General case' 0 CA--C 1.505 -0.784 0 C-N-CA 119.884 -0.726 . . . . 0.0 109.868 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 88.2 t -131.8 133.66 61.0 Favored 'Isoleucine or valine' 0 C--N 1.358 0.943 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 178.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.433 HD13 HG21 ' A' ' 174' ' ' ILE . 49.5 mm -109.59 126.0 66.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.955 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -114.13 147.27 39.1 Favored 'General case' 0 C--N 1.359 0.988 0 CA-C-O 121.942 0.877 . . . . 0.0 108.767 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -128.26 118.19 22.84 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.0 mp -112.58 118.06 56.87 Favored 'Isoleucine or valine' 0 C--N 1.355 0.838 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 -179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 85.1 m -128.28 144.79 51.16 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 -177.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 81.1 mtm180 -80.82 113.72 19.22 Favored 'General case' 0 C--N 1.37 1.491 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 178.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -71.87 156.65 90.78 Favored Pre-proline 0 CA--C 1.501 -0.923 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -55.98 111.5 0.79 Allowed 'Trans proline' 0 CA--C 1.497 -1.356 0 C-N-CA 122.136 1.891 . . . . 0.0 112.217 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -61.49 -46.14 91.26 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.483 -178.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 174.63 131.99 1.5 Allowed Glycine 0 N--CA 1.434 -1.44 0 N-CA-C 106.215 -2.754 . . . . 0.0 106.215 177.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.669 ' O ' ' HB2' ' A' ' 185' ' ' GLU . . . 64.73 -119.66 0.43 Allowed 'General case' 0 C--N 1.356 0.888 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.669 ' HB2' ' O ' ' A' ' 184' ' ' ALA . 36.8 tt0 151.19 82.17 0.0 OUTLIER 'General case' 0 C--N 1.363 1.179 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -113.48 125.84 54.66 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 15.1 mt -107.67 -78.83 0.58 Allowed 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -139.53 -97.05 0.16 Allowed 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -127.36 147.37 50.26 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 . . . . . 0 C--O 1.265 1.869 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.966 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' HEM . . . . . 1.088 HBDA ' HHA' ' A' ' 202' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.827 ' H3 ' ' CMD' ' A' ' 202' ' ' HEM . 54.0 tpp . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.026 0.441 . . . . 0.0 110.333 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.492 ' HA ' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -82.59 -19.14 39.03 Favored 'General case' 0 C--N 1.355 0.833 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.247 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.2 -38.98 58.78 Favored Glycine 0 C--N 1.351 1.382 0 N-CA-C 108.563 -1.815 . . . . 0.0 108.563 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.627 ' HG3' ' HG2' ' A' ' 1' ' ' MET . 3.2 mtt -70.04 -35.86 74.61 Favored 'General case' 0 C--N 1.356 0.867 0 O-C-N 122.205 -0.585 . . . . 0.0 111.542 -177.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.492 HG22 ' HA ' ' A' ' 2' ' ' MET . 27.2 m -69.34 -23.92 27.1 Favored 'Isoleucine or valine' 0 C--N 1.356 0.874 0 O-C-N 121.41 -0.806 . . . . 0.0 109.355 -178.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -71.79 -35.37 69.98 Favored 'General case' 0 C--N 1.357 0.908 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 87.9 m -67.33 -41.67 84.87 Favored 'General case' 0 C--N 1.355 0.84 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.48 -38.35 96.2 Favored Glycine 0 C--N 1.356 1.69 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.608 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -67.18 -38.56 85.61 Favored 'General case' 0 C--N 1.351 0.657 0 CA-C-N 117.311 0.556 . . . . 0.0 110.503 -177.927 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 21.3 mmt -64.26 -40.7 96.53 Favored 'General case' 0 C--N 1.354 0.798 0 O-C-N 121.616 -0.677 . . . . 0.0 110.767 -178.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -66.2 -40.4 90.35 Favored 'General case' 0 C--N 1.349 0.559 0 O-C-N 122.057 -0.402 . . . . 0.0 111.684 -178.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 57.8 tp -65.75 -42.73 90.59 Favored 'General case' 0 C--N 1.35 0.595 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -178.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.608 HG12 ' O ' ' A' ' 9' ' ' LEU . 1.7 mm -75.61 -36.32 34.02 Favored 'Isoleucine or valine' 0 C--N 1.357 0.917 0 O-C-N 121.049 -1.032 . . . . 0.0 110.955 -175.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -67.96 -42.57 80.7 Favored 'General case' 0 C--N 1.351 0.67 0 O-C-N 121.858 -0.526 . . . . 0.0 111.108 -176.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -73.48 -31.28 63.66 Favored 'General case' 0 N--CA 1.447 -0.617 0 O-C-N 122.014 -0.429 . . . . 0.0 111.499 -177.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -72.63 -49.08 34.35 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -175.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -128.56 -20.35 3.63 Favored 'General case' 0 C--N 1.355 0.812 0 C-N-CA 117.566 -1.654 . . . . 0.0 113.02 -176.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 140.8 179.08 17.89 Favored Glycine 0 CA--C 1.496 -1.094 0 C-N-CA 118.104 -1.998 . . . . 0.0 109.657 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -94.26 -11.09 30.89 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -177.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -70.88 -41.52 71.24 Favored 'General case' 0 C--N 1.36 1.046 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 92.8 m -69.91 -38.89 76.4 Favored 'General case' 0 C--N 1.359 0.98 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 56.6 tp -60.5 -37.66 81.81 Favored 'General case' 0 C--N 1.357 0.9 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -64.94 -35.43 81.13 Favored 'General case' 0 C--N 1.357 0.919 0 O-C-N 122.203 -0.311 . . . . 0.0 110.757 -178.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.425 ' O ' HG21 ' A' ' 24' ' ' THR . 91.2 m -64.44 -41.23 96.67 Favored 'General case' 0 C--N 1.354 0.771 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -178.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.427 ' CD2' ' HB3' ' A' ' 54' ' ' LYS . 93.0 mt -65.23 -37.43 87.23 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 80.3 mt -69.7 -14.38 62.77 Favored 'General case' 0 C--N 1.358 0.971 0 O-C-N 121.445 -0.784 . . . . 0.0 109.604 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -88.07 -25.74 22.9 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 119.621 -0.831 . . . . 0.0 109.287 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 55.9 p -70.27 -23.9 62.96 Favored 'General case' 0 C--N 1.359 1.017 0 C-N-CA 119.65 -0.82 . . . . 0.0 109.22 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.434 ' H ' ' HG ' ' A' ' 29' ' ' CYS . 1.8 p -105.8 -37.19 6.79 Favored 'General case' 0 C--N 1.358 0.967 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 86.09 132.15 0.04 OUTLIER 'General case' 0 C--N 1.36 1.031 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.551 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -90.88 -166.18 1.52 Allowed 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.451 ' H ' ' HB2' ' A' ' 31' ' ' LEU . 54.5 tt0 -153.35 -64.81 0.15 Allowed 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.6 t -97.92 -65.19 0.98 Allowed 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -138.11 -45.0 0.51 Allowed 'General case' 0 CA--C 1.503 -0.863 0 C-N-CA 119.567 -0.853 . . . . 0.0 108.752 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 125.88 -35.59 2.97 Favored Glycine 0 C--N 1.352 1.427 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 85.0 mt -107.91 100.26 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.788 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -97.13 -1.47 45.1 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.606 HG23 ' H ' ' A' ' 39' ' ' SER . 2.7 m 77.55 -179.63 0.13 Allowed 'General case' 0 C--N 1.361 1.107 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 -178.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.606 ' H ' HG23 ' A' ' 38' ' ' THR . 21.2 p -85.7 102.71 13.85 Favored 'General case' 0 C--N 1.353 0.729 0 O-C-N 121.116 -0.99 . . . . 0.0 109.261 -178.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.662 ' O ' HG13 ' A' ' 40' ' ' VAL . 97.3 t -153.19 -18.54 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.359 1.013 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -112.58 164.93 12.02 Favored Glycine 0 C--N 1.356 1.668 0 C-N-CA 119.311 -1.423 . . . . 0.0 110.156 -176.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.6 m -128.62 127.76 42.87 Favored 'General case' 0 C--N 1.355 0.816 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -116.42 176.42 5.12 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -79.34 -176.53 5.26 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -91.15 -16.03 28.42 Favored 'General case' 0 CA--C 1.503 -0.858 0 C-N-CA 120.105 -0.638 . . . . 0.0 109.406 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -70.23 -28.15 65.03 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -63.37 -40.85 98.37 Favored 'General case' 0 C--N 1.352 0.68 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 63.3 tp -66.82 -38.57 86.71 Favored 'General case' 0 C--N 1.357 0.899 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.308 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.478 ' O ' HG21 ' A' ' 53' ' ' VAL . 58.3 tp -77.31 -26.2 52.0 Favored 'General case' 0 C--N 1.349 0.567 0 O-C-N 122.071 -0.393 . . . . 0.0 110.134 -177.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -67.67 -43.9 79.08 Favored 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 121.724 -0.61 . . . . 0.0 110.048 -178.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 81.8 mt -71.93 -34.84 69.38 Favored 'General case' 0 C--N 1.36 1.022 0 C-N-CA 120.164 -0.614 . . . . 0.0 109.467 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.514 ' O ' HG13 ' A' ' 52' ' ' VAL . 40.0 t -63.11 -40.73 90.14 Favored 'Isoleucine or valine' 0 C--N 1.35 0.593 0 O-C-N 122.331 -0.231 . . . . 0.0 110.456 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.496 ' O ' HG11 ' A' ' 53' ' ' VAL . 54.9 t -68.13 -40.29 82.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.662 0 O-C-N 121.672 -0.642 . . . . 0.0 109.929 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.427 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 24.8 tptt -68.39 -23.02 64.61 Favored 'General case' 0 C--N 1.36 1.022 0 O-C-N 121.021 -1.05 . . . . 0.0 108.695 -179.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.472 HD12 HD12 ' A' ' 13' ' ' ILE . 1.9 mt -68.96 -37.48 78.86 Favored 'General case' 0 C--N 1.351 0.674 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.402 ' O ' ' HA ' ' A' ' 60' ' ' SER . 59.5 p -73.29 -17.11 61.35 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.382 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -100.3 -37.06 9.04 Favored 'General case' 0 C--N 1.354 0.78 0 C-N-CA 119.534 -0.867 . . . . 0.0 111.402 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.542 HG11 ' N ' ' A' ' 59' ' ' SER . 4.9 p -72.67 -36.86 54.38 Favored 'Isoleucine or valine' 0 C--N 1.353 0.725 0 O-C-N 121.56 -0.712 . . . . 0.0 111.525 -177.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.542 ' N ' HG11 ' A' ' 58' ' ' VAL . 5.3 t -117.89 -3.95 11.14 Favored 'General case' 0 C--N 1.352 0.691 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.143 -178.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 56' ' ' SER . 73.2 m 62.9 42.45 7.67 Favored 'General case' 0 C--N 1.355 0.839 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.637 HG11 ' HD2' ' A' ' 62' ' ' PRO . 55.1 t -102.37 131.45 22.5 Favored Pre-proline 0 CA--C 1.503 -0.855 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.637 ' HD2' HG11 ' A' ' 61' ' ' VAL . 42.2 Cg_exo -57.52 147.42 78.74 Favored 'Trans proline' 0 CA--C 1.498 -1.292 0 C-N-CA 122.55 2.167 . . . . 0.0 112.624 179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.1 m -75.22 -12.83 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.671 -178.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 64.4 p -96.45 -34.07 11.65 Favored 'General case' 0 C--N 1.359 0.996 0 C-N-CA 118.393 -1.323 . . . . 0.0 109.488 -179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -75.59 -23.71 56.49 Favored 'General case' 0 C--N 1.354 0.795 0 O-C-N 121.5 -0.75 . . . . 0.0 109.087 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.501 HD23 HG12 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -79.96 -36.25 36.44 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.007 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.515 HG12 ' N ' ' A' ' 68' ' ' ARG . 1.9 p -69.41 -25.45 29.16 Favored 'Isoleucine or valine' 0 C--N 1.354 0.797 0 C-N-CA 120.206 -0.597 . . . . 0.0 110.046 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.515 ' N ' HG12 ' A' ' 67' ' ' VAL . 5.5 mmm-85 -73.15 -52.48 14.04 Favored 'General case' 0 C--N 1.363 1.162 0 O-C-N 121.548 -0.72 . . . . 0.0 110.12 -179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.7 mt -63.31 -35.43 80.36 Favored 'General case' 0 C--N 1.357 0.903 0 O-C-N 121.983 -0.448 . . . . 0.0 110.941 -178.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -61.1 -47.67 85.24 Favored 'General case' 0 C--N 1.351 0.638 0 O-C-N 122.117 -0.365 . . . . 0.0 110.624 -178.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.91 -38.51 95.52 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 111.738 -0.545 . . . . 0.0 111.738 -178.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.14 -47.87 80.9 Favored 'General case' 0 C--N 1.349 0.568 0 CA-C-N 118.067 0.934 . . . . 0.0 111.348 -177.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.735 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 9.9 mttm -64.51 -49.21 72.2 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 113.61 0.966 . . . . 0.0 113.61 -177.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -68.4 -39.81 81.55 Favored 'General case' 0 C--N 1.349 0.585 0 O-C-N 121.082 -1.012 . . . . 0.0 111.86 -175.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -63.41 -45.09 92.6 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 121.091 -1.006 . . . . 0.0 111.258 -177.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.404 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 9.8 p -71.09 -14.92 18.34 Favored 'Isoleucine or valine' 0 C--N 1.359 0.988 0 O-C-N 121.478 -0.763 . . . . 0.0 109.506 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.735 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 74.1 mm-40 -72.74 -38.79 67.3 Favored 'General case' 0 C--N 1.35 0.629 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.401 HD12 HBCA ' A' ' 202' ' ' HEM . 78.9 mt -69.09 -35.27 76.3 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 47.7 mm -62.5 -51.49 71.53 Favored 'Isoleucine or valine' 0 C--N 1.356 0.89 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.227 -177.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.404 ' HG3' ' O ' ' A' ' 76' ' ' VAL . 10.2 mt-10 -75.64 -11.87 60.09 Favored 'General case' 0 C--N 1.353 0.73 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.98 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -94.01 -9.37 59.61 Favored Glycine 0 C--N 1.347 1.166 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.482 -178.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.5 ' HB2' HG22 ' A' ' 85' ' ' ILE . 87.5 m-70 -143.93 95.32 5.73 Favored Pre-proline 0 CA--C 1.503 -0.839 0 CA-C-N 118.91 1.355 . . . . 0.0 109.126 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.526 ' O ' ' HB2' ' A' ' 87' ' ' ASN . 38.3 Cg_endo -68.71 -23.8 35.66 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.393 2.062 . . . . 0.0 114.046 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -90.75 -9.11 47.81 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.5 HG22 ' HB2' ' A' ' 82' ' ' HIS . 0.6 OUTLIER -89.01 -21.99 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.971 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 -178.792 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -104.38 -14.81 15.61 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.526 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 20.1 t30 -72.88 -40.66 65.42 Favored 'General case' 0 C--N 1.36 1.048 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -67.35 -29.79 69.43 Favored 'General case' 0 C--N 1.353 0.735 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.156 -178.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 28.4 ttp -84.17 146.58 27.77 Favored 'General case' 0 C--N 1.351 0.655 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.75 -21.51 10.15 Favored 'General case' 0 C--N 1.361 1.104 0 O-C-N 121.58 -0.7 . . . . 0.0 110.937 -177.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -164.54 171.39 14.6 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 -177.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.423 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 88.4 p -71.01 -31.7 68.28 Favored 'General case' 0 C--N 1.352 0.682 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.014 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -70.4 -38.46 74.66 Favored 'General case' 0 C--N 1.358 0.942 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -66.67 -24.18 66.24 Favored 'General case' 0 C--N 1.358 0.977 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.423 ' HB3' ' O ' ' A' ' 92' ' ' SER . 61.4 tp -62.92 -46.36 88.16 Favored 'General case' 0 C--N 1.355 0.814 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.3 mp -62.61 -32.89 73.98 Favored 'General case' 0 C--N 1.354 0.765 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 36.3 t -62.41 -45.02 94.99 Favored 'General case' 0 C--N 1.355 0.81 0 O-C-N 121.84 -0.537 . . . . 0.0 111.347 -178.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.08 28.45 8.78 Favored 'General case' 0 C--N 1.361 1.085 0 O-C-N 121.103 -0.998 . . . . 0.0 110.539 -178.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 1.099 HD13 ' C2B' ' A' ' 202' ' ' HEM . 10.6 tt -62.71 -29.91 48.12 Favored 'Isoleucine or valine' 0 C--N 1.354 0.794 0 O-C-N 121.827 -0.546 . . . . 0.0 110.314 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.626 ' N ' HG23 ' A' ' 99' ' ' ILE . 9.9 p-10 -127.4 -8.8 5.76 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 118.54 -1.264 . . . . 0.0 109.916 -179.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 58.4 m -90.88 -2.93 57.7 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 119.566 -0.854 . . . . 0.0 110.313 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.473 ' O ' HG13 ' A' ' 105' ' ' VAL . 11.9 t80 -146.51 -46.92 0.19 Allowed 'General case' 0 C--N 1.357 0.912 0 C-N-CA 118.264 -1.374 . . . . 0.0 109.754 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.418 ' CG2' ' HAC' ' A' ' 202' ' ' HEM . 96.1 mt -68.57 -48.41 72.18 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 O-C-N 121.788 -0.57 . . . . 0.0 110.948 -178.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 44.4 m170 -85.71 -1.52 57.27 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.329 -177.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.473 HG13 ' O ' ' A' ' 102' ' ' PHE . 2.0 p -89.11 -32.72 5.85 Favored 'Isoleucine or valine' 0 C--N 1.354 0.793 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -72.3 -40.14 67.76 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.641 HG13 ' N ' ' A' ' 108' ' ' TYR . 0.5 OUTLIER -73.17 -33.97 43.4 Favored 'Isoleucine or valine' 0 C--N 1.355 0.824 0 C-N-CA 119.518 -0.873 . . . . 0.0 109.576 -178.752 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.641 ' N ' HG13 ' A' ' 107' ' ' VAL . 92.3 t80 -60.67 -49.01 79.25 Favored 'General case' 0 C--N 1.363 1.164 0 O-C-N 121.8 -0.563 . . . . 0.0 110.441 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -60.44 -38.99 85.9 Favored 'General case' 0 C--N 1.358 0.96 0 O-C-N 121.579 -0.701 . . . . 0.0 110.096 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.0 mt -57.15 -76.92 0.03 OUTLIER 'General case' 0 C--N 1.354 0.798 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.427 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 92.7 m-85 -115.89 136.11 22.85 Favored Pre-proline 0 N--CA 1.442 -0.855 0 O-C-N 121.067 -1.021 . . . . 0.0 108.817 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 111' ' ' TYR . 68.8 Cg_endo -86.38 -1.72 8.45 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 123.32 2.68 . . . . 0.0 115.585 -178.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -66.73 -36.83 83.4 Favored 'General case' 0 C--N 1.356 0.855 0 O-C-N 121.652 -0.655 . . . . 0.0 110.2 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.46 145.76 54.67 Favored 'General case' 0 C--N 1.352 0.696 0 CA-C-O 121.61 0.719 . . . . 0.0 110.105 -178.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -130.8 134.43 46.84 Favored 'General case' 0 C--N 1.358 0.936 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.5 ' HB3' ' HD2' ' A' ' 117' ' ' PRO . 2.8 mm? -116.36 156.45 47.26 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-O 122.145 0.974 . . . . 0.0 108.855 -178.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.5 ' HD2' ' HB3' ' A' ' 116' ' ' LEU . 85.5 Cg_endo -83.88 -151.86 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.123 0 C-N-CA 123.517 2.812 . . . . 0.0 113.147 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.405 ' H ' ' HB2' ' A' ' 117' ' ' PRO . 74.7 mmtt -114.53 138.72 50.28 Favored 'General case' 0 C--N 1.362 1.152 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -125.2 126.38 45.12 Favored 'General case' 0 C--N 1.36 1.05 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -178.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.571 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 93.8 m -124.88 127.66 47.47 Favored 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 177.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 77.1 m -121.63 129.99 53.18 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 119.129 -1.029 . . . . 0.0 109.585 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -118.38 148.81 42.14 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 178.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.549 ' HG3' HD12 ' A' ' 129' ' ' ILE . 57.4 ttp180 -120.55 117.21 27.03 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -179.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.45 ' HA ' HD23 ' A' ' 124' ' ' LEU . 95.0 mt -90.55 -16.2 29.24 Favored 'General case' 0 CA--C 1.503 -0.853 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.52 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 175.37 -148.68 9.63 Favored Glycine 0 N--CA 1.437 -1.271 0 N-CA-C 108.891 -1.684 . . . . 0.0 108.891 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -94.35 -37.35 11.52 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -178.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -103.01 3.82 36.62 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.02 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.418 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 66.6 m-20 -119.83 130.81 55.08 Favored 'General case' 0 C--N 1.359 1.003 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.549 HD12 ' HG3' ' A' ' 123' ' ' ARG . 8.4 mm -142.27 136.07 28.49 Favored 'Isoleucine or valine' 0 C--N 1.355 0.819 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.478 ' N ' HG22 ' A' ' 129' ' ' ILE . 53.2 mtm180 -116.16 139.48 50.28 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.105 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 6.3 tp -126.7 118.81 25.5 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.571 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 12.4 m-70 -99.55 133.43 43.88 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -129.94 122.61 28.88 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 -178.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.498 ' HA ' ' O ' ' A' ' 171' ' ' THR . 32.2 tt0 -115.73 113.04 22.93 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.2 t -162.51 154.16 18.25 Favored 'General case' 0 C--N 1.359 1.002 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.42 ' C ' ' HD3' ' A' ' 138' ' ' PRO . 57.7 mtmt -91.41 3.94 53.69 Favored 'General case' 0 C--N 1.357 0.921 0 C-N-CA 120.186 -0.605 . . . . 0.0 109.865 -179.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 93.8 mtm-85 -133.01 74.11 74.29 Favored Pre-proline 0 C--N 1.356 0.882 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.42 ' HD3' ' C ' ' A' ' 136' ' ' LYS . 94.1 Cg_endo -96.23 102.7 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.657 2.238 . . . . 0.0 115.759 -177.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -111.47 113.42 25.84 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 176.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.01 -38.16 90.07 Favored 'General case' 0 C--N 1.354 0.778 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.026 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.7 m -63.48 -28.04 69.69 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 122.042 -0.411 . . . . 0.0 110.694 -178.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -75.59 -46.53 31.28 Favored 'General case' 0 C--N 1.352 0.687 0 C-N-CA 120.146 -0.622 . . . . 0.0 109.567 -178.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.68 -39.85 94.38 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 122.258 -0.276 . . . . 0.0 111.187 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.19 -37.2 86.31 Favored 'General case' 0 C--N 1.355 0.81 0 O-C-N 121.987 -0.446 . . . . 0.0 110.184 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.51 -42.88 99.27 Favored Glycine 0 C--N 1.348 1.248 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 -179.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 83.1 mt -70.07 -40.65 74.9 Favored 'General case' 0 C--N 1.351 0.667 0 CA-C-N 117.522 0.661 . . . . 0.0 112.627 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 97.1 mt -71.35 -42.38 68.58 Favored 'General case' 0 C--N 1.361 1.07 0 O-C-N 121.235 -0.916 . . . . 0.0 110.902 -176.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.52 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 36.4 t70 -70.06 -31.07 68.5 Favored 'General case' 0 N--CA 1.445 -0.695 0 O-C-N 121.934 -0.479 . . . . 0.0 110.407 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -63.12 -39.09 97.57 Favored Glycine 0 C--N 1.356 1.672 0 N-CA-C 108.461 -1.856 . . . . 0.0 108.461 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 46.3 t -60.75 -42.2 96.92 Favored 'General case' 0 C--N 1.35 0.622 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 178.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -74.97 -1.25 21.76 Favored 'General case' 0 C--N 1.36 1.046 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.52 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 76.9 mm-40 -83.46 -46.91 11.94 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -65.54 -45.6 82.8 Favored 'General case' 0 C--N 1.36 1.042 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.411 178.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -68.57 -25.95 65.16 Favored 'General case' 0 C--N 1.363 1.191 0 O-C-N 121.798 -0.564 . . . . 0.0 110.896 -178.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 85.1 tttt 73.16 76.43 0.14 Allowed 'General case' 0 C--N 1.36 1.031 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -144.9 -168.56 2.96 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -150.71 93.25 1.93 Allowed 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 14.1 m-30 -111.35 160.08 17.39 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 92.7 m -120.18 127.08 52.13 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 119.289 -0.964 . . . . 0.0 108.819 -178.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 3.5 mp -105.55 122.21 58.69 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 178.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.9 m -118.09 -173.01 2.36 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-O 121.851 0.834 . . . . 0.0 109.241 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.19 157.89 43.74 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -178.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 52.3 p -99.95 146.43 31.88 Favored Pre-proline 0 C--N 1.358 0.963 0 CA-C-O 122.344 1.069 . . . . 0.0 108.189 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.634 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 72.2 Cg_endo -76.35 -11.14 19.14 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.965 2.443 . . . . 0.0 115.052 -178.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -72.24 -41.29 66.97 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.474 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 36.2 p -117.54 15.82 14.62 Favored 'General case' 0 CA--C 1.505 -0.773 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.355 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.634 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.5 pp0? -65.59 -13.76 59.72 Favored 'General case' 0 C--N 1.355 0.807 0 O-C-N 121.657 -0.652 . . . . 0.0 110.341 178.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 46.6 p30 -125.43 39.76 3.89 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 19.8 t -139.72 144.93 37.75 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.611 ' O ' ' HB ' ' A' ' 171' ' ' THR . 61.9 mt-10 -98.71 164.43 12.23 Favored 'General case' 0 C--N 1.354 0.801 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.611 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 18.4 m 84.35 -60.76 0.1 Allowed 'General case' 0 C--N 1.369 1.44 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -107.2 117.74 34.88 Favored 'General case' 0 CA--C 1.503 -0.855 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.633 -178.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 97.9 t -131.26 132.96 62.9 Favored 'Isoleucine or valine' 0 C--N 1.357 0.923 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 178.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 49.9 mm -107.8 127.43 63.87 Favored 'Isoleucine or valine' 0 C--N 1.357 0.899 0 N-CA-C 107.877 -1.156 . . . . 0.0 107.877 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -115.66 156.14 26.43 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 122.073 0.94 . . . . 0.0 108.593 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -138.84 119.52 14.09 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.7 mp -114.56 118.86 59.88 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 106.395 -1.705 . . . . 0.0 106.395 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 86.1 m -128.2 143.55 51.05 Favored 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -177.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 70.3 mtm180 -85.36 119.26 25.53 Favored 'General case' 0 C--N 1.369 1.431 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.432 ' HA ' ' HD3' ' A' ' 181' ' ' PRO . . . -68.79 148.39 97.98 Favored Pre-proline 0 C--N 1.356 0.861 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 180' ' ' ALA . 52.4 Cg_exo -55.08 126.86 23.98 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.622 2.215 . . . . 0.0 113.915 -178.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.473 HH11 ' HD2' ' A' ' 182' ' ' ARG . 5.2 mtm105 -113.94 -141.45 0.38 Allowed 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -95.77 58.13 1.55 Allowed Glycine 0 C--N 1.355 1.593 0 N-CA-C 107.477 -2.249 . . . . 0.0 107.477 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -153.6 164.71 37.8 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -154.23 152.31 30.18 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -173.01 67.63 0.03 OUTLIER 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 27.4 tp -97.48 -71.97 0.66 Allowed 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . 0.535 ' HB3' ' H ' ' A' ' 189' ' ' PHE . 0.2 OUTLIER -149.78 -124.39 0.05 OUTLIER 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -179.785 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . 0.535 ' H ' ' HB3' ' A' ' 188' ' ' TYR . 98.4 m-85 -127.72 148.17 50.41 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 . . . . . 0 C--O 1.264 1.85 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 179.957 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' HEM . . . . . 1.099 ' C2B' HD13 ' A' ' 99' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.559 ' H1 ' ' HAD' ' A' ' 202' ' ' HEM . 76.0 mtm . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.532 0.682 . . . . 0.0 111.095 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.594 ' HA ' HG23 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -82.48 -9.34 59.47 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -178.998 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.33 -42.31 49.96 Favored Glycine 0 C--N 1.352 1.422 0 N-CA-C 108.734 -1.746 . . . . 0.0 108.734 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 61.5 mtt -66.68 -38.78 87.49 Favored 'General case' 0 C--N 1.357 0.893 0 O-C-N 122.13 -0.629 . . . . 0.0 111.21 -178.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.594 HG23 ' HA ' ' A' ' 2' ' ' MET . 34.7 m -69.23 -23.06 26.38 Favored 'Isoleucine or valine' 0 C--N 1.356 0.871 0 C-N-CA 120.178 -0.609 . . . . 0.0 109.91 -178.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -70.75 -37.25 73.42 Favored 'General case' 0 C--N 1.355 0.833 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.4 m -67.98 -41.07 82.92 Favored 'General case' 0 C--N 1.354 0.803 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.44 -38.97 97.19 Favored Glycine 0 C--N 1.357 1.702 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.649 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -65.5 -40.12 92.66 Favored 'General case' 0 C--N 1.351 0.652 0 O-C-N 122.384 -0.48 . . . . 0.0 110.733 -178.351 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.402 ' HE1' HD21 ' A' ' 26' ' ' LEU . 24.6 mmt -63.11 -40.42 97.56 Favored 'General case' 0 C--N 1.352 0.676 0 O-C-N 121.611 -0.681 . . . . 0.0 110.935 -178.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -67.33 -40.24 85.91 Favored 'General case' 0 C--N 1.348 0.526 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.438 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 53.7 tp -66.36 -43.07 87.04 Favored 'General case' 0 C--N 1.35 0.588 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -178.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.649 HG12 ' O ' ' A' ' 9' ' ' LEU . 1.1 mm -76.36 -36.05 28.48 Favored 'Isoleucine or valine' 0 C--N 1.36 1.04 0 O-C-N 120.924 -1.11 . . . . 0.0 111.113 -175.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -67.61 -43.18 81.07 Favored 'General case' 0 C--N 1.351 0.642 0 O-C-N 121.683 -0.636 . . . . 0.0 111.134 -176.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -72.32 -33.28 67.23 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 121.956 -0.465 . . . . 0.0 111.76 -177.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -72.49 -48.45 40.61 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -175.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -127.57 -21.12 3.85 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 117.5 -1.68 . . . . 0.0 113.49 -176.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 140.56 179.81 18.45 Favored Glycine 0 CA--C 1.497 -1.041 0 C-N-CA 118.007 -2.044 . . . . 0.0 109.489 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -96.33 -11.96 25.1 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -177.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -70.79 -41.4 71.69 Favored 'General case' 0 C--N 1.36 1.032 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.413 HG23 HG23 ' A' ' 58' ' ' VAL . 94.3 m -69.73 -38.89 77.04 Favored 'General case' 0 C--N 1.357 0.896 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 55.5 tp -60.48 -37.12 80.03 Favored 'General case' 0 C--N 1.356 0.873 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -65.09 -35.46 81.22 Favored 'General case' 0 C--N 1.357 0.899 0 O-C-N 122.255 -0.278 . . . . 0.0 110.725 -178.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.7 m -64.49 -40.25 95.32 Favored 'General case' 0 C--N 1.358 0.946 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -178.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.46 HD22 ' HA ' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -65.09 -36.71 85.17 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.581 ' HB3' HD23 ' A' ' 31' ' ' LEU . 83.7 mt -70.88 -14.88 62.55 Favored 'General case' 0 C--N 1.356 0.891 0 O-C-N 121.501 -0.749 . . . . 0.0 109.81 -179.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -87.82 -25.79 23.15 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.292 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.4 p -69.22 -24.33 64.01 Favored 'General case' 0 C--N 1.36 1.027 0 C-N-CA 119.7 -0.8 . . . . 0.0 109.085 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.64 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 1.9 p -107.42 -34.88 6.93 Favored 'General case' 0 C--N 1.359 0.992 0 C-N-CA 119.008 -1.077 . . . . 0.0 108.442 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.64 ' HB2' ' O ' ' A' ' 29' ' ' CYS . 12.2 mt-10 83.37 133.58 0.05 Allowed 'General case' 0 C--N 1.359 1.012 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.581 HD23 ' HB3' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -103.2 111.06 23.26 Favored 'General case' 0 C--N 1.359 1.001 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.577 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -73.07 -41.11 64.47 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.451 ' HB3' ' H ' ' A' ' 34' ' ' GLU . 0.6 OUTLIER -113.96 -88.68 0.55 Allowed 'General case' 0 C--N 1.355 0.828 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.074 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.451 ' H ' ' HB3' ' A' ' 33' ' ' SER . 60.5 mt-10 -120.55 -43.15 2.5 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -178.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.91 -34.64 5.11 Favored Glycine 0 C--N 1.351 1.393 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 78.9 mt -106.66 102.67 14.28 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.95 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.47 -136.9 0.06 Allowed 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.478 ' O ' ' HB3' ' A' ' 39' ' ' SER . 52.0 m -113.2 -59.65 1.99 Allowed 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -179.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.478 ' HB3' ' O ' ' A' ' 38' ' ' THR . 61.4 p 158.48 10.34 0.0 OUTLIER 'General case' 0 C--N 1.363 1.182 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -178.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.4 p -98.07 6.8 8.65 Favored 'Isoleucine or valine' 0 C--N 1.353 0.733 0 C-N-CA 120.251 -0.579 . . . . 0.0 110.902 -177.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -105.3 154.95 17.13 Favored Glycine 0 C--N 1.353 1.5 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.1 t -134.88 124.99 25.87 Favored 'General case' 0 C--N 1.357 0.901 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -109.46 175.75 5.33 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -72.18 175.33 6.13 Favored 'General case' 0 C--N 1.356 0.879 0 CA-C-O 121.638 0.733 . . . . 0.0 109.443 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 10.7 t60 -82.77 -24.86 33.27 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -178.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -65.81 -28.17 68.8 Favored 'General case' 0 C--N 1.356 0.875 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.2 tp10 -62.58 -39.74 94.68 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -68.15 -38.63 82.35 Favored 'General case' 0 C--N 1.357 0.915 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.462 ' O ' HG21 ' A' ' 53' ' ' VAL . 59.2 tp -71.28 -32.38 68.62 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -177.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -66.76 -40.96 88.44 Favored 'General case' 0 N--CA 1.441 -0.878 0 O-C-N 122.02 -0.425 . . . . 0.0 110.027 -178.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.45 ' HA ' HD22 ' A' ' 51' ' ' LEU . 80.3 mt -82.47 -17.81 43.93 Favored 'General case' 0 C--N 1.357 0.898 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.191 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.489 ' O ' HG13 ' A' ' 52' ' ' VAL . 1.0 OUTLIER -81.56 -36.65 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -179.428 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.489 ' O ' HG11 ' A' ' 53' ' ' VAL . 54.3 t -68.34 -41.49 83.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.6 tptt -69.17 -26.03 64.65 Favored 'General case' 0 C--N 1.365 1.245 0 C-N-CA 119.485 -0.886 . . . . 0.0 109.337 -179.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.624 HD12 HD13 ' A' ' 13' ' ' ILE . 3.4 tt -67.04 -37.09 83.46 Favored 'General case' 0 C--N 1.353 0.748 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.619 ' HG ' HG12 ' A' ' 63' ' ' VAL . 68.2 m -76.67 -16.99 59.39 Favored 'General case' 0 C--N 1.352 0.691 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.341 -178.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -97.95 -38.39 9.42 Favored 'General case' 0 C--N 1.353 0.717 0 O-C-N 121.314 -0.867 . . . . 0.0 111.278 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.701 HG11 ' N ' ' A' ' 59' ' ' SER . 5.2 p -73.18 -35.85 48.5 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 O-C-N 121.668 -0.645 . . . . 0.0 111.186 -177.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.701 ' N ' HG11 ' A' ' 58' ' ' VAL . 61.2 m -111.71 -7.87 14.21 Favored 'General case' 0 CA--C 1.504 -0.821 0 C-N-CA 119.389 -0.924 . . . . 0.0 109.99 -177.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 64.72 52.71 1.63 Allowed 'General case' 0 C--N 1.355 0.831 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.507 HG13 ' HD2' ' A' ' 62' ' ' PRO . 48.6 t -112.75 135.76 21.59 Favored Pre-proline 0 CA--C 1.504 -0.81 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.507 ' HD2' HG13 ' A' ' 61' ' ' VAL . 31.2 Cg_exo -59.93 146.08 96.73 Favored 'Trans proline' 0 C--N 1.316 -1.178 0 C-N-CA 122.144 1.896 . . . . 0.0 112.464 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.619 HG12 ' HG ' ' A' ' 56' ' ' SER . 4.2 m -73.55 -16.09 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.91 -178.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 67.5 p -96.24 -32.0 12.66 Favored 'General case' 0 C--N 1.359 0.981 0 C-N-CA 118.129 -1.429 . . . . 0.0 110.318 -178.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -80.19 -19.16 47.69 Favored 'General case' 0 C--N 1.353 0.724 0 O-C-N 121.162 -0.961 . . . . 0.0 108.864 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.417 ' HB3' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -80.17 -37.85 32.51 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.845 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.607 HG12 ' N ' ' A' ' 68' ' ' ARG . 1.3 p -67.35 -28.38 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 C-N-CA 120.236 -0.586 . . . . 0.0 109.833 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.607 ' N ' HG12 ' A' ' 67' ' ' VAL . 71.3 mtp180 -71.47 -50.51 30.92 Favored 'General case' 0 C--N 1.364 1.234 0 O-C-N 121.444 -0.785 . . . . 0.0 110.831 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.43 -36.01 82.79 Favored 'General case' 0 C--N 1.357 0.91 0 O-C-N 121.929 -0.482 . . . . 0.0 111.159 -178.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -61.02 -47.31 87.01 Favored 'General case' 0 C--N 1.349 0.577 0 O-C-N 122.154 -0.341 . . . . 0.0 110.388 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.74 -38.45 95.2 Favored Glycine 0 C--N 1.356 1.643 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 -178.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.08 -48.59 77.97 Favored 'General case' 0 C--N 1.35 0.609 0 CA-C-N 118.104 0.952 . . . . 0.0 111.45 -177.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.534 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 10.9 mttm -64.29 -48.0 77.33 Favored 'General case' 0 C--N 1.358 0.947 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -177.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.429 ' O ' ' HB2' ' A' ' 77' ' ' GLU . 2.1 tm? -68.44 -39.28 81.57 Favored 'General case' 0 C--N 1.349 0.584 0 O-C-N 121.259 -0.9 . . . . 0.0 111.869 -175.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -63.97 -44.38 92.92 Favored 'General case' 0 C--N 1.352 0.69 0 O-C-N 121.248 -0.907 . . . . 0.0 111.06 -177.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.33 -15.27 18.44 Favored 'Isoleucine or valine' 0 C--N 1.359 1.009 0 O-C-N 121.486 -0.759 . . . . 0.0 108.953 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.534 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 14.7 mm-40 -71.67 -39.06 70.52 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 81.8 mt -73.32 -31.22 63.88 Favored 'General case' 0 C--N 1.359 0.984 0 O-C-N 122.301 -0.249 . . . . 0.0 110.505 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.9 mm -64.95 -53.56 40.01 Favored 'Isoleucine or valine' 0 C--N 1.359 1.013 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.956 -177.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -74.69 -15.0 60.81 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 119.693 -0.803 . . . . 0.0 109.36 178.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.65 -36.86 67.62 Favored Glycine 0 C--N 1.35 1.339 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.445 ' HB2' HG22 ' A' ' 85' ' ' ILE . 59.5 m80 -132.44 104.97 13.27 Favored Pre-proline 0 N--CA 1.44 -0.941 0 CA-C-N 118.534 1.167 . . . . 0.0 109.499 -177.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.462 ' O ' ' HB2' ' A' ' 87' ' ' ASN . 34.8 Cg_exo -62.07 -29.58 81.53 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 123.018 2.479 . . . . 0.0 113.872 178.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -91.53 -8.37 47.72 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.445 HG22 ' HB2' ' A' ' 82' ' ' HIS . 0.9 OUTLIER -86.71 -22.27 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 -178.765 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -104.57 -14.55 15.61 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 49.1 t30 -71.71 -40.85 69.21 Favored 'General case' 0 C--N 1.359 1.001 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -66.92 -30.95 71.23 Favored 'General case' 0 C--N 1.351 0.662 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.284 -178.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 17.5 ttp -83.93 150.16 25.86 Favored 'General case' 0 C--N 1.35 0.63 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.71 -22.31 7.49 Favored 'General case' 0 C--N 1.364 1.21 0 O-C-N 121.608 -0.683 . . . . 0.0 111.436 -177.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -165.28 172.03 12.86 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 119.083 -1.047 . . . . 0.0 108.277 -177.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.438 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 40.0 t -64.79 -43.3 93.66 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.056 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -66.13 -39.61 90.01 Favored 'General case' 0 C--N 1.355 0.847 0 O-C-N 121.414 -0.804 . . . . 0.0 109.138 -178.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -65.93 -24.35 66.8 Favored 'General case' 0 C--N 1.355 0.807 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.676 ' O ' HG12 ' A' ' 99' ' ' ILE . 61.7 tp -63.89 -47.16 81.73 Favored 'General case' 0 C--N 1.354 0.777 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.5 mp -60.58 -35.56 76.38 Favored 'General case' 0 C--N 1.36 1.054 0 O-C-N 122.215 -0.303 . . . . 0.0 110.345 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.8 t -68.49 -39.55 81.28 Favored 'General case' 0 C--N 1.348 0.526 0 O-C-N 122.03 -0.419 . . . . 0.0 109.967 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.06 1.26 54.67 Favored 'General case' 0 C--N 1.356 0.855 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -176.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.761 HD12 ' C3B' ' A' ' 202' ' ' HEM . 23.4 mm -60.96 -47.16 94.79 Favored 'Isoleucine or valine' 0 C--N 1.359 0.989 0 CA-C-N 118.955 0.798 . . . . 0.0 112.089 -177.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -98.77 -20.63 16.79 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 118.273 -1.371 . . . . 0.0 111.282 -177.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.5 t -64.75 -48.48 74.4 Favored 'General case' 0 N--CA 1.445 -0.707 0 O-C-N 121.555 -0.716 . . . . 0.0 112.36 -178.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -136.51 -17.34 1.51 Allowed 'General case' 0 C--N 1.361 1.093 0 C-N-CA 117.174 -1.811 . . . . 0.0 113.536 -176.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.492 HG22 ' C2C' ' A' ' 202' ' ' HEM . 96.4 mt -71.56 -50.78 37.42 Favored 'Isoleucine or valine' 0 C--O 1.244 0.771 0 CA-C-N 120.574 1.534 . . . . 0.0 111.215 -177.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 28.8 m170 -89.83 1.5 56.08 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 119.628 -0.829 . . . . 0.0 110.107 -177.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 55.7 t -90.19 -41.73 13.74 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.053 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 54.7 tp10 -68.33 -40.02 81.73 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.5 p -74.05 -35.6 42.07 Favored 'Isoleucine or valine' 0 C--N 1.356 0.867 0 C-N-CA 119.18 -1.008 . . . . 0.0 109.708 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 94.2 t80 -61.26 -48.61 80.63 Favored 'General case' 0 C--N 1.364 1.203 0 O-C-N 121.775 -0.578 . . . . 0.0 110.526 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -61.48 -37.13 82.5 Favored 'General case' 0 C--N 1.358 0.948 0 O-C-N 121.742 -0.599 . . . . 0.0 110.162 -178.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 13.6 mt -56.21 -74.47 0.05 OUTLIER 'General case' 0 C--N 1.357 0.922 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.406 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 87.3 m-85 -118.41 133.74 23.49 Favored Pre-proline 0 N--CA 1.439 -0.98 0 C-N-CA 118.978 -1.089 . . . . 0.0 108.538 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 111' ' ' TYR . 96.2 Cg_endo -83.54 -1.48 10.17 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 123.31 2.674 . . . . 0.0 115.52 -178.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -65.73 -37.85 87.55 Favored 'General case' 0 C--N 1.355 0.835 0 O-C-N 121.746 -0.597 . . . . 0.0 110.092 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.38 145.11 56.58 Favored 'General case' 0 C--N 1.354 0.769 0 CA-C-O 121.513 0.673 . . . . 0.0 110.149 -178.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -131.93 135.66 46.79 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.554 ' HB3' ' HD2' ' A' ' 117' ' ' PRO . 93.1 mt -128.96 157.62 75.17 Favored Pre-proline 0 C--N 1.354 0.795 0 CA-C-O 122.098 0.952 . . . . 0.0 109.224 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.554 ' HD2' ' HB3' ' A' ' 116' ' ' LEU . 87.4 Cg_endo -81.35 -150.91 0.04 OUTLIER 'Trans proline' 0 C--N 1.318 -1.059 0 C-N-CA 123.685 2.923 . . . . 0.0 113.933 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.456 ' H ' ' HB2' ' A' ' 117' ' ' PRO . 74.6 mmtt -116.7 141.86 47.65 Favored 'General case' 0 C--N 1.364 1.238 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -178.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -130.34 133.14 46.2 Favored 'General case' 0 C--N 1.362 1.125 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.422 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 94.2 m -127.31 129.16 47.15 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 177.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 77.6 m -119.26 129.29 54.84 Favored 'General case' 0 C--N 1.355 0.808 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.382 -178.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -119.63 133.83 55.48 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.477 ' HG3' HD11 ' A' ' 129' ' ' ILE . 58.8 ttp180 -106.63 116.81 32.58 Favored 'General case' 0 C--N 1.352 0.716 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.487 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 94.6 mt -85.54 -23.73 27.56 Favored 'General case' 0 C--N 1.354 0.763 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.203 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -179.59 -144.72 6.0 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -94.02 -40.25 10.19 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 119.993 -0.683 . . . . 0.0 109.254 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -102.51 3.83 37.95 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.985 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.487 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 66.3 m-20 -118.13 129.02 55.28 Favored 'General case' 0 C--N 1.356 0.866 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.477 HD11 ' HG3' ' A' ' 123' ' ' ARG . 10.0 mm -141.25 133.53 29.37 Favored 'Isoleucine or valine' 0 C--N 1.356 0.854 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.459 ' N ' HG21 ' A' ' 129' ' ' ILE . 58.8 mtm180 -116.57 139.75 50.15 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.408 ' O ' ' HG ' ' A' ' 131' ' ' LEU . 0.9 OUTLIER -127.68 118.11 23.22 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -179.429 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.422 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 12.4 m-70 -97.15 132.63 42.74 Favored 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -128.7 120.18 26.0 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -178.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.573 ' HA ' ' O ' ' A' ' 171' ' ' THR . 74.4 mt-30 -115.0 111.77 21.64 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 107.599 -1.259 . . . . 0.0 107.599 178.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.4 t -162.16 153.86 18.61 Favored 'General case' 0 C--N 1.359 0.981 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -90.6 3.08 55.09 Favored 'General case' 0 C--N 1.354 0.782 0 C-N-CA 120.267 -0.573 . . . . 0.0 109.743 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -133.47 74.73 70.83 Favored Pre-proline 0 C--N 1.355 0.806 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -95.36 104.44 0.11 Allowed 'Trans proline' 0 N--CA 1.444 -1.407 0 C-N-CA 122.756 2.304 . . . . 0.0 115.746 -177.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -111.71 110.56 21.0 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 176.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.37 -38.88 92.57 Favored 'General case' 0 C--N 1.354 0.773 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.288 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.1 m -63.28 -26.63 68.86 Favored 'General case' 0 C--N 1.355 0.826 0 O-C-N 121.96 -0.463 . . . . 0.0 110.597 -178.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -75.58 -47.02 28.49 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.554 -178.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.78 -40.08 94.66 Favored 'General case' 0 C--N 1.358 0.96 0 O-C-N 122.154 -0.342 . . . . 0.0 111.226 -178.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.24 -36.91 85.22 Favored 'General case' 0 C--N 1.355 0.812 0 O-C-N 121.852 -0.53 . . . . 0.0 109.985 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.56 -43.71 98.59 Favored Glycine 0 C--N 1.346 1.096 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.3 mt -70.23 -40.34 74.56 Favored 'General case' 0 C--N 1.351 0.671 0 O-C-N 122.126 -0.632 . . . . 0.0 112.639 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.48 HD21 ' HBB' ' A' ' 202' ' ' HEM . 98.2 mt -71.2 -43.24 67.76 Favored 'General case' 0 C--N 1.361 1.068 0 O-C-N 121.21 -0.931 . . . . 0.0 111.115 -176.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.554 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 37.1 t70 -70.54 -29.54 66.03 Favored 'General case' 0 N--CA 1.443 -0.778 0 O-C-N 121.839 -0.538 . . . . 0.0 110.392 -179.172 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -63.17 -39.47 97.98 Favored Glycine 0 C--N 1.357 1.73 0 N-CA-C 108.464 -1.854 . . . . 0.0 108.464 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 47.9 t -60.38 -41.93 94.81 Favored 'General case' 0 C--N 1.351 0.632 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -75.83 0.17 19.05 Favored 'General case' 0 C--N 1.36 1.029 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.554 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 76.8 mm-40 -85.51 -46.39 10.9 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -66.36 -44.67 82.54 Favored 'General case' 0 C--N 1.36 1.033 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.422 ' O ' ' HB2' ' A' ' 155' ' ' LYS . 52.5 m-85 -69.96 -26.49 64.14 Favored 'General case' 0 C--N 1.36 1.028 0 O-C-N 121.872 -0.517 . . . . 0.0 111.137 -178.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 154' ' ' PHE . 44.1 mttt 71.43 71.78 0.17 Allowed 'General case' 0 C--N 1.363 1.154 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 -178.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.456 ' HB3' ' CE1' ' A' ' 158' ' ' PHE . 3.0 tp10 -141.26 -168.69 2.69 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -140.33 116.34 10.42 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.456 ' CE1' ' HB3' ' A' ' 156' ' ' GLU . 91.2 m-85 -133.65 149.86 51.57 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 92.1 m -120.94 127.59 51.97 Favored 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 3.6 mp -103.8 120.89 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 179.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 3.1 m -114.5 -177.6 3.17 Favored 'General case' 0 C--N 1.36 1.034 0 CA-C-O 121.708 0.766 . . . . 0.0 109.193 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -146.93 154.6 41.46 Favored 'General case' 0 C--N 1.355 0.847 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -178.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 54.2 p -97.4 146.5 31.48 Favored Pre-proline 0 C--N 1.358 0.961 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.678 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 72.3 Cg_endo -76.19 -11.2 19.4 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.941 2.427 . . . . 0.0 114.918 -178.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -72.63 -41.14 65.83 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.714 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 35.7 p -118.42 15.52 13.84 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.704 -178.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.678 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.1 pp0? -67.06 -13.57 62.06 Favored 'General case' 0 C--N 1.354 0.765 0 O-C-N 121.546 -0.721 . . . . 0.0 110.263 178.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 53.8 p-10 -121.09 35.1 4.99 Favored 'General case' 0 N--CA 1.438 -1.028 0 O-C-N 121.188 -0.945 . . . . 0.0 108.706 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 58.2 m -136.12 148.63 48.32 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.626 ' O ' ' HB ' ' A' ' 171' ' ' THR . 61.4 mt-10 -101.74 166.29 10.75 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.626 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 3.4 m 81.65 -59.04 0.23 Allowed 'General case' 0 C--N 1.37 1.469 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -107.8 117.77 34.98 Favored 'General case' 0 CA--C 1.507 -0.706 0 C-N-CA 119.916 -0.713 . . . . 0.0 109.565 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.483 HG13 ' CZ ' ' A' ' 175' ' ' PHE . 90.7 t -132.0 133.44 60.8 Favored 'Isoleucine or valine' 0 C--N 1.357 0.922 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 178.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.43 ' N ' HG12 ' A' ' 173' ' ' VAL . 50.1 mm -109.95 126.72 67.15 Favored 'Isoleucine or valine' 0 C--N 1.358 0.971 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.483 ' CZ ' HG13 ' A' ' 173' ' ' VAL . 92.7 m-85 -113.96 150.36 33.91 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -179.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -133.93 83.31 2.03 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.206 -178.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.6 mp -76.94 119.52 25.5 Favored 'Isoleucine or valine' 0 C--N 1.358 0.947 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 92.3 m -118.53 144.4 46.08 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 54.8 ttp180 -87.41 117.77 26.41 Favored 'General case' 0 C--N 1.36 1.027 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 -178.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -67.18 156.61 87.62 Favored Pre-proline 0 C--N 1.357 0.911 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -61.68 128.74 25.43 Favored 'Trans proline' 0 CA--C 1.495 -1.439 0 C-N-CA 122.122 1.881 . . . . 0.0 113.709 -178.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.48 31.43 3.45 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 114.688 -1.142 . . . . 0.0 108.672 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 116.89 97.51 1.99 Allowed Glycine 0 N--CA 1.437 -1.247 0 N-CA-C 107.995 -2.042 . . . . 0.0 107.995 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 78.16 149.5 0.1 Allowed 'General case' 0 C--N 1.359 1.005 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -148.84 151.73 35.24 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -114.37 118.51 34.08 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 85.3 mt -89.35 -45.07 9.75 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . 0.479 ' HB3' ' H ' ' A' ' 189' ' ' PHE . 3.5 t80 -165.98 -86.52 0.02 OUTLIER 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . 0.479 ' H ' ' HB3' ' A' ' 188' ' ' TYR . 87.9 t80 -139.59 129.96 25.47 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 . . . . . 0 C--O 1.264 1.825 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -179.958 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' HEM . . . . . 0.965 ' HHA' ' CBD' ' A' ' 202' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.901 ' HG2' ' CMD' ' A' ' 202' ' ' HEM . 88.8 mmm . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.041 0.448 . . . . 0.0 110.018 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.561 ' HA ' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -77.18 -17.44 58.55 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 120.586 -0.446 . . . . 0.0 109.969 -178.498 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.76 -44.62 30.96 Favored Glycine 0 C--N 1.35 1.356 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 75.7 mtm -71.43 -33.79 69.7 Favored 'General case' 0 C--N 1.354 0.782 0 O-C-N 122.073 -0.663 . . . . 0.0 111.377 -177.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.561 HG22 ' HA ' ' A' ' 2' ' ' MET . 30.7 m -70.76 -22.89 23.53 Favored 'Isoleucine or valine' 0 C--N 1.357 0.9 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.064 -179.211 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.442 ' HZ ' ' CG ' ' A' ' 47' ' ' GLU . 1.7 m-30 -71.47 -35.31 70.79 Favored 'General case' 0 C--N 1.357 0.917 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 88.9 m -66.41 -39.67 89.13 Favored 'General case' 0 C--N 1.357 0.902 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.23 -37.88 95.28 Favored Glycine 0 C--N 1.357 1.71 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.638 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -66.89 -39.71 87.54 Favored 'General case' 0 C--N 1.354 0.773 0 CA-C-N 117.291 0.545 . . . . 0.0 110.526 -178.282 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 22.6 mmt -63.53 -41.42 98.46 Favored 'General case' 0 C--N 1.355 0.835 0 O-C-N 121.618 -0.676 . . . . 0.0 111.013 -178.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -66.34 -40.4 89.84 Favored 'General case' 0 C--N 1.347 0.493 0 O-C-N 122.148 -0.345 . . . . 0.0 111.702 -177.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 55.8 tp -66.03 -43.06 88.69 Favored 'General case' 0 C--N 1.349 0.583 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 -178.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.638 HG12 ' O ' ' A' ' 9' ' ' LEU . 1.7 mm -74.61 -36.45 40.96 Favored 'Isoleucine or valine' 0 C--N 1.358 0.935 0 O-C-N 121.003 -1.06 . . . . 0.0 111.155 -175.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -66.95 -42.53 85.06 Favored 'General case' 0 C--N 1.351 0.659 0 O-C-N 121.82 -0.55 . . . . 0.0 111.286 -176.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -75.04 -30.89 61.19 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 121.83 -0.544 . . . . 0.0 111.773 -177.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -72.96 -48.67 34.7 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.736 -175.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -127.72 -22.13 3.63 Favored 'General case' 0 CA--C 1.503 -0.849 0 C-N-CA 117.609 -1.636 . . . . 0.0 112.846 -176.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 146.34 178.69 21.94 Favored Glycine 0 N--CA 1.44 -1.077 0 C-N-CA 117.671 -2.204 . . . . 0.0 110.494 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -96.7 -17.5 20.28 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -70.3 -40.17 74.39 Favored 'General case' 0 C--N 1.361 1.089 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 94.5 m -68.28 -38.54 81.81 Favored 'General case' 0 C--N 1.357 0.918 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 178.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.515 HD11 ' HB ' ' A' ' 13' ' ' ILE . 27.1 tp -60.68 -36.49 78.9 Favored 'General case' 0 C--N 1.355 0.839 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -65.15 -37.12 86.39 Favored 'General case' 0 C--N 1.359 0.984 0 O-C-N 121.998 -0.439 . . . . 0.0 110.461 -178.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.434 ' O ' HG21 ' A' ' 24' ' ' THR . 89.7 m -65.67 -37.75 87.38 Favored 'General case' 0 C--N 1.355 0.811 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 23.4 tp -62.39 -40.73 97.44 Favored 'General case' 0 C--N 1.354 0.764 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.739 HD23 HD22 ' A' ' 31' ' ' LEU . 6.8 mp -74.94 -11.35 60.1 Favored 'General case' 0 C--N 1.36 1.031 0 O-C-N 121.693 -0.629 . . . . 0.0 110.483 -178.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -85.7 -29.21 24.14 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 119.254 -0.978 . . . . 0.0 108.925 178.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.7 t -67.13 -37.52 83.98 Favored 'General case' 0 C--N 1.357 0.92 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.663 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 1.8 p -89.81 -38.99 13.39 Favored 'General case' 0 C--N 1.359 1.011 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.663 ' HB2' ' O ' ' A' ' 29' ' ' CYS . 10.6 mt-10 85.61 132.39 0.04 OUTLIER 'General case' 0 C--N 1.362 1.119 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.739 HD22 HD23 ' A' ' 26' ' ' LEU . 0.4 OUTLIER -108.58 122.18 46.55 Favored 'General case' 0 C--N 1.357 0.898 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.433 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -94.25 -38.03 11.24 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -104.77 -78.16 0.57 Allowed 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.234 -178.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -137.24 -55.56 0.7 Allowed 'General case' 0 CA--C 1.502 -0.888 0 C-N-CA 119.609 -0.836 . . . . 0.0 108.853 -178.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 128.91 -52.11 0.84 Allowed Glycine 0 C--N 1.352 1.458 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 78.4 mt -97.67 95.29 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.755 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.647 ' CD2' HG23 ' A' ' 40' ' ' VAL . 1.2 t80 -65.38 -50.94 63.65 Favored 'General case' 0 C--N 1.36 1.059 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.441 ' CB ' ' O ' ' A' ' 37' ' ' TYR . 1.1 m 143.58 -64.32 0.0 OUTLIER 'General case' 0 C--N 1.368 1.406 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 178.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.431 ' C ' HG21 ' A' ' 40' ' ' VAL . 16.5 p 169.59 70.39 0.0 OUTLIER 'General case' 0 C--N 1.364 1.208 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.647 HG23 ' CD2' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -164.52 1.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.938 0 C-N-CA 119.853 -0.739 . . . . 0.0 109.695 -179.811 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.5 146.73 17.35 Favored Glycine 0 C--N 1.353 1.526 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 53.4 m -123.93 124.71 43.2 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -116.45 175.18 5.68 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -82.07 -172.62 4.05 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -92.42 -14.68 28.21 Favored 'General case' 0 N--CA 1.439 -0.975 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.365 -179.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -70.22 -28.44 65.27 Favored 'General case' 0 C--N 1.354 0.764 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.442 ' CG ' ' HZ ' ' A' ' 6' ' ' PHE . 26.0 tp10 -63.2 -40.3 97.09 Favored 'General case' 0 C--N 1.353 0.726 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.625 HD12 HG21 ' A' ' 52' ' ' VAL . 2.0 tm? -67.68 -38.29 83.52 Favored 'General case' 0 C--N 1.358 0.942 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.405 ' O ' HG22 ' A' ' 53' ' ' VAL . 58.5 tp -74.17 -29.35 61.73 Favored 'General case' 0 N--CA 1.447 -0.598 0 O-C-N 122.088 -0.382 . . . . 0.0 110.259 -176.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -68.28 -41.02 81.62 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 121.835 -0.54 . . . . 0.0 109.561 -178.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 63.2 mt -83.98 -15.92 45.94 Favored 'General case' 0 C--N 1.361 1.072 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.666 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.625 HG21 HD12 ' A' ' 48' ' ' LEU . 1.4 t -81.85 -35.76 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.494 ' O ' HG11 ' A' ' 53' ' ' VAL . 52.2 t -70.7 -39.84 76.23 Favored 'Isoleucine or valine' 0 C--N 1.354 0.791 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.0 tptt -67.19 -28.54 68.18 Favored 'General case' 0 C--N 1.36 1.048 0 O-C-N 121.266 -0.896 . . . . 0.0 108.622 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.592 HD13 HD11 ' A' ' 13' ' ' ILE . 2.5 tt -67.99 -37.79 81.91 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 60.0 p -72.32 -17.65 61.84 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.741 -178.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -101.44 -35.32 9.23 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 119.278 -0.969 . . . . 0.0 111.049 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.566 HG12 ' N ' ' A' ' 59' ' ' SER . 6.8 p -73.61 -36.86 48.44 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 O-C-N 121.797 -0.565 . . . . 0.0 111.081 -177.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.566 ' N ' HG12 ' A' ' 58' ' ' VAL . 73.0 m -113.17 -6.97 13.62 Favored 'General case' 0 CA--C 1.504 -0.825 0 C-N-CA 119.512 -0.875 . . . . 0.0 110.161 -177.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 64.35 48.63 2.74 Favored 'General case' 0 C--N 1.356 0.858 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.504 ' CG1' ' HD2' ' A' ' 62' ' ' PRO . 49.8 t -113.6 135.5 21.93 Favored Pre-proline 0 CA--C 1.505 -0.774 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.709 ' HG2' ' HB2' ' A' ' 65' ' ' GLU . 23.4 Cg_endo -62.57 149.12 92.12 Favored 'Trans proline' 0 CA--C 1.5 -1.203 0 C-N-CA 122.276 1.984 . . . . 0.0 112.518 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.422 ' HA ' HD22 ' A' ' 66' ' ' LEU . 4.2 m -75.98 -13.67 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.319 -177.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 72.1 p -95.22 -33.99 12.39 Favored 'General case' 0 C--N 1.356 0.878 0 C-N-CA 118.207 -1.397 . . . . 0.0 109.747 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.709 ' HB2' ' HG2' ' A' ' 62' ' ' PRO . 97.9 mt-10 -78.02 -21.84 50.15 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 121.336 -0.853 . . . . 0.0 108.978 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.422 HD22 ' HA ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -79.52 -37.48 36.54 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.541 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.584 HG11 ' N ' ' A' ' 68' ' ' ARG . 1.7 p -67.47 -26.9 36.84 Favored 'Isoleucine or valine' 0 C--N 1.355 0.812 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.902 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.584 ' N ' HG11 ' A' ' 67' ' ' VAL . 7.9 mmm-85 -71.98 -51.15 23.33 Favored 'General case' 0 C--N 1.363 1.184 0 O-C-N 121.549 -0.719 . . . . 0.0 110.451 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.409 ' HA ' HD23 ' A' ' 69' ' ' LEU . 85.2 mt -63.24 -36.06 82.41 Favored 'General case' 0 C--N 1.357 0.922 0 O-C-N 121.963 -0.461 . . . . 0.0 110.953 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -60.58 -46.83 88.77 Favored 'General case' 0 C--N 1.348 0.541 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -178.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.39 -38.42 94.71 Favored Glycine 0 C--N 1.352 1.455 0 N-CA-C 111.74 -0.544 . . . . 0.0 111.74 -178.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -63.16 -48.38 78.68 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-N 118.499 1.149 . . . . 0.0 111.547 -177.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.723 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 16.2 mttm -63.76 -49.41 73.08 Favored 'General case' 0 C--N 1.359 1.006 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -176.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -68.65 -39.71 80.58 Favored 'General case' 0 C--N 1.349 0.559 0 O-C-N 121.125 -0.985 . . . . 0.0 111.973 -175.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 1.006 ' CE1' HBBA ' A' ' 202' ' ' HEM . 35.9 t80 -63.86 -44.35 93.39 Favored 'General case' 0 C--N 1.352 0.702 0 O-C-N 121.196 -0.94 . . . . 0.0 111.187 -177.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.444 ' O ' HG22 ' A' ' 76' ' ' VAL . 9.9 p -70.33 -15.51 19.16 Favored 'Isoleucine or valine' 0 C--N 1.359 0.986 0 O-C-N 121.41 -0.806 . . . . 0.0 109.261 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.723 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 74.5 mm-40 -72.17 -38.33 69.16 Favored 'General case' 0 C--N 1.351 0.651 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 81.4 mt -74.25 -29.11 61.54 Favored 'General case' 0 C--N 1.357 0.9 0 O-C-N 122.311 -0.243 . . . . 0.0 110.543 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.8 mm -67.06 -54.16 27.12 Favored 'Isoleucine or valine' 0 C--N 1.359 1.007 0 C-N-CA 119.993 -0.683 . . . . 0.0 109.897 -177.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -74.63 -14.66 60.79 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 119.686 -0.806 . . . . 0.0 109.285 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.55 -37.25 62.23 Favored Glycine 0 C--N 1.348 1.228 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -134.01 104.16 11.67 Favored Pre-proline 0 N--CA 1.441 -0.88 0 CA-C-O 122.494 1.14 . . . . 0.0 109.026 -177.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.495 ' O ' ' HB2' ' A' ' 87' ' ' ASN . 37.6 Cg_endo -67.98 -23.2 40.85 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.556 2.171 . . . . 0.0 114.004 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -90.01 -8.38 51.72 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.4 tp -89.63 -22.81 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -178.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -102.51 -15.95 16.28 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.495 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 49.1 t30 -71.74 -40.92 69.07 Favored 'General case' 0 C--N 1.36 1.061 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -67.1 -29.21 68.9 Favored 'General case' 0 C--N 1.353 0.756 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.209 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 23.7 ttp -84.4 148.1 26.78 Favored 'General case' 0 C--N 1.351 0.652 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.5 -21.96 8.37 Favored 'General case' 0 C--N 1.363 1.193 0 C-N-CA 119.934 -0.707 . . . . 0.0 111.025 -177.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -165.3 171.66 13.28 Favored 'General case' 0 C--N 1.354 0.778 0 C-N-CA 119.045 -1.062 . . . . 0.0 108.338 -177.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 39.6 t -64.62 -42.13 95.71 Favored 'General case' 0 C--N 1.356 0.884 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.864 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -66.46 -39.11 88.63 Favored 'General case' 0 C--N 1.356 0.884 0 O-C-N 121.528 -0.733 . . . . 0.0 109.292 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -65.61 -25.72 67.51 Favored 'General case' 0 C--N 1.357 0.912 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 64.5 tp -62.94 -46.22 88.77 Favored 'General case' 0 C--N 1.355 0.826 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.7 mp -62.5 -32.5 73.43 Favored 'General case' 0 C--N 1.353 0.752 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 37.1 t -62.4 -45.37 93.44 Favored 'General case' 0 C--N 1.356 0.857 0 O-C-N 121.719 -0.613 . . . . 0.0 111.22 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.97 28.88 8.42 Favored 'General case' 0 C--N 1.36 1.049 0 C-N-CA 119.304 -0.958 . . . . 0.0 110.462 -178.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.676 HD11 HMBA ' A' ' 202' ' ' HEM . 10.4 tt -62.3 -29.17 46.07 Favored 'Isoleucine or valine' 0 C--N 1.356 0.868 0 O-C-N 122.152 -0.343 . . . . 0.0 110.537 -178.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.645 ' N ' HG23 ' A' ' 99' ' ' ILE . 8.7 p-10 -127.15 -11.43 5.85 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 118.696 -1.202 . . . . 0.0 109.097 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.4 t -68.31 -45.55 72.67 Favored 'General case' 0 N--CA 1.439 -0.977 0 O-C-N 121.879 -0.513 . . . . 0.0 109.901 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.493 ' HA ' HG12 ' A' ' 105' ' ' VAL . 19.3 t80 -123.83 -29.53 3.67 Favored 'General case' 0 C--N 1.36 1.049 0 C-N-CA 118.38 -1.328 . . . . 0.0 111.549 -178.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 96.2 mt -69.75 -48.4 64.94 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 O-C-N 121.076 -1.015 . . . . 0.0 110.487 -177.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -89.03 3.65 50.97 Favored 'General case' 0 N--CA 1.44 -0.954 0 O-C-N 121.105 -0.997 . . . . 0.0 109.916 -177.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.544 HG11 ' N ' ' A' ' 106' ' ' GLU . 1.9 p -87.68 -33.98 7.04 Favored 'Isoleucine or valine' 0 C--N 1.357 0.899 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 178.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.544 ' N ' HG11 ' A' ' 105' ' ' VAL . 43.9 tt0 -71.64 -40.12 69.91 Favored 'General case' 0 C--N 1.36 1.049 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.418 HG13 ' CMD' ' A' ' 202' ' ' HEM . 62.2 t -62.82 -47.06 94.63 Favored 'Isoleucine or valine' 0 C--N 1.357 0.909 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.276 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -60.2 -48.61 81.02 Favored 'General case' 0 C--N 1.357 0.931 0 O-C-N 122.115 -0.366 . . . . 0.0 111.466 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -60.61 -38.93 86.33 Favored 'General case' 0 C--N 1.355 0.833 0 O-C-N 121.547 -0.721 . . . . 0.0 110.609 -178.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 19.6 mt -58.26 -75.64 0.05 OUTLIER 'General case' 0 C--N 1.354 0.804 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -115.29 132.97 22.8 Favored Pre-proline 0 N--CA 1.442 -0.874 0 C-N-CA 118.906 -1.117 . . . . 0.0 108.9 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -84.54 -3.4 10.0 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 123.176 2.584 . . . . 0.0 115.056 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -66.42 -36.6 83.21 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 122.001 -0.437 . . . . 0.0 109.948 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.4 146.34 54.13 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 121.714 0.769 . . . . 0.0 110.219 -178.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -130.54 135.18 47.67 Favored 'General case' 0 C--N 1.358 0.949 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.555 ' HB3' ' HD2' ' A' ' 117' ' ' PRO . 87.5 mt -127.03 157.0 73.44 Favored Pre-proline 0 N--CA 1.444 -0.756 0 CA-C-O 122.193 0.997 . . . . 0.0 109.394 -178.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.555 ' HD2' ' HB3' ' A' ' 116' ' ' LEU . 89.6 Cg_endo -80.37 -157.44 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -0.987 0 C-N-CA 123.914 3.076 . . . . 0.0 114.163 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -114.23 142.47 46.23 Favored 'General case' 0 C--N 1.367 1.332 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -124.0 127.85 48.51 Favored 'General case' 0 C--N 1.361 1.067 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -178.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.562 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 94.7 m -124.7 128.51 48.91 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 177.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 78.4 m -122.63 131.17 53.69 Favored 'General case' 0 CA--C 1.504 -0.825 0 C-N-CA 119.061 -1.055 . . . . 0.0 109.929 -177.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -118.15 149.52 40.92 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 177.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.565 ' HG3' HD11 ' A' ' 129' ' ' ILE . 57.8 ttp180 -121.2 117.74 27.85 Favored 'General case' 0 C--N 1.353 0.748 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.474 ' HA ' HD23 ' A' ' 124' ' ' LEU . 97.2 mt -93.37 -13.93 27.46 Favored 'General case' 0 C--N 1.356 0.856 0 C-N-CA 120.431 -0.507 . . . . 0.0 110.603 -179.243 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 173.29 -149.16 10.88 Favored Glycine 0 C--N 1.348 1.226 0 C-N-CA 118.761 -1.685 . . . . 0.0 109.171 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -94.15 -37.91 11.34 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -103.6 5.79 36.79 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 120.166 -0.614 . . . . 0.0 109.39 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -121.49 127.85 51.48 Favored 'General case' 0 C--N 1.359 0.979 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.565 HD11 ' HG3' ' A' ' 123' ' ' ARG . 8.3 mm -141.71 135.95 30.59 Favored 'Isoleucine or valine' 0 C--N 1.354 0.787 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.498 ' N ' HG21 ' A' ' 129' ' ' ILE . 53.2 mtm180 -115.94 140.11 49.57 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 7.5 tp -126.79 118.64 25.07 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.654 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.562 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 12.6 m-70 -99.15 133.11 43.9 Favored 'General case' 0 CA--C 1.497 -1.087 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -127.46 120.54 28.61 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.461 ' HA ' ' O ' ' A' ' 171' ' ' THR . 36.2 tt0 -114.78 111.7 21.65 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 15.9 t -161.7 152.53 17.91 Favored 'General case' 0 C--N 1.359 0.986 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -90.82 1.49 56.89 Favored 'General case' 0 C--N 1.357 0.93 0 C-N-CA 120.245 -0.582 . . . . 0.0 109.95 -178.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -135.35 74.28 61.43 Favored Pre-proline 0 C--N 1.355 0.821 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -96.72 110.51 0.11 Allowed 'Trans proline' 0 N--CA 1.444 -1.429 0 C-N-CA 122.752 2.301 . . . . 0.0 116.03 -177.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -112.85 112.59 24.18 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 176.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.88 -38.59 91.64 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.116 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 74.0 m -63.21 -28.81 70.3 Favored 'General case' 0 C--N 1.354 0.783 0 O-C-N 121.927 -0.483 . . . . 0.0 110.689 -178.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -74.16 -46.82 39.91 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 120.236 -0.586 . . . . 0.0 109.719 -177.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.95 -39.67 93.85 Favored 'General case' 0 C--N 1.357 0.908 0 O-C-N 122.176 -0.327 . . . . 0.0 111.351 -177.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -63.09 -37.47 87.33 Favored 'General case' 0 C--N 1.355 0.83 0 O-C-N 121.872 -0.517 . . . . 0.0 110.164 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.54 -43.26 99.07 Favored Glycine 0 C--N 1.347 1.162 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 82.7 mt -70.07 -40.51 74.99 Favored 'General case' 0 C--N 1.351 0.657 0 CA-C-N 117.521 0.66 . . . . 0.0 112.724 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 98.0 mt -70.89 -42.39 70.04 Favored 'General case' 0 C--N 1.361 1.103 0 O-C-N 121.146 -0.971 . . . . 0.0 110.829 -176.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -70.4 -30.01 66.79 Favored 'General case' 0 N--CA 1.444 -0.735 0 O-C-N 121.953 -0.467 . . . . 0.0 110.677 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.542 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -63.55 -39.59 97.79 Favored Glycine 0 C--N 1.356 1.688 0 N-CA-C 108.622 -1.791 . . . . 0.0 108.622 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 43.5 t -60.36 -42.99 96.91 Favored 'General case' 0 C--N 1.351 0.64 0 N-CA-C 109.146 -0.686 . . . . 0.0 109.146 178.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -78.83 2.66 19.2 Favored 'General case' 0 C--N 1.359 0.981 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.542 ' HB2' ' O ' ' A' ' 149' ' ' GLY . 24.3 mm-40 -84.56 -48.25 9.73 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -68.67 -40.65 80.05 Favored 'General case' 0 C--N 1.357 0.925 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.519 ' O ' ' HB2' ' A' ' 155' ' ' LYS . 9.1 m-30 -70.46 -26.73 63.77 Favored 'General case' 0 C--N 1.36 1.059 0 O-C-N 121.741 -0.599 . . . . 0.0 111.154 -178.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 154' ' ' PHE . 56.8 mtpt 73.2 64.85 0.1 Allowed 'General case' 0 C--N 1.361 1.103 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -178.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -127.16 -179.33 4.81 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -142.3 89.22 2.14 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 17.3 m-30 -115.14 156.7 24.79 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 93.7 m -118.79 127.73 53.8 Favored 'General case' 0 C--N 1.356 0.867 0 C-N-CA 119.462 -0.895 . . . . 0.0 108.831 -178.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 3.6 mp -102.88 121.84 54.53 Favored 'Isoleucine or valine' 0 C--N 1.352 0.698 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 178.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -118.05 -173.29 2.42 Favored 'General case' 0 C--N 1.356 0.884 0 CA-C-O 121.801 0.81 . . . . 0.0 109.524 -178.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 26.5 ptt180 -147.54 156.45 42.85 Favored 'General case' 0 C--N 1.357 0.894 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' THR . . . . . 0.404 ' O ' ' HB3' ' A' ' 167' ' ' GLN . 48.2 p -100.1 146.26 31.62 Favored Pre-proline 0 C--N 1.358 0.967 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.695 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 74.7 Cg_endo -76.83 -11.09 18.32 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.819 2.346 . . . . 0.0 115.234 -178.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -72.66 -41.5 65.33 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.589 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 35.5 p -117.83 16.27 14.36 Favored 'General case' 0 C--N 1.354 0.771 0 C-N-CA 120.069 -0.652 . . . . 0.0 110.443 -178.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.695 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.2 pp0? -66.6 -11.34 52.99 Favored 'General case' 0 C--N 1.353 0.743 0 O-C-N 121.595 -0.69 . . . . 0.0 110.457 178.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -126.56 38.54 4.1 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 58.9 m -137.6 147.11 44.76 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.613 ' O ' ' HB ' ' A' ' 171' ' ' THR . 60.5 mt-10 -101.27 165.23 11.39 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.613 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 19.9 m 84.75 -60.37 0.09 Allowed 'General case' 0 C--N 1.367 1.355 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -109.24 117.38 33.95 Favored 'General case' 0 CA--C 1.502 -0.878 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.43 -178.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 90.8 t -130.73 133.08 63.82 Favored 'Isoleucine or valine' 0 C--N 1.356 0.883 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 49.9 mm -108.53 126.89 65.31 Favored 'Isoleucine or valine' 0 C--N 1.358 0.958 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -115.93 156.62 25.89 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -137.94 118.94 14.33 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.2 mp -114.15 120.16 63.19 Favored 'Isoleucine or valine' 0 C--N 1.352 0.696 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 43.1 p -121.17 159.49 25.75 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-O 121.763 0.792 . . . . 0.0 110.662 -177.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -109.39 110.65 21.85 Favored 'General case' 0 C--N 1.361 1.07 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 177.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.439 ' HA ' ' HD3' ' A' ' 181' ' ' PRO . . . -65.35 144.1 98.9 Favored Pre-proline 0 CA--C 1.503 -0.859 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 180' ' ' ALA . 50.2 Cg_exo -56.66 128.79 31.48 Favored 'Trans proline' 0 CA--C 1.493 -1.563 0 C-N-CA 122.665 2.243 . . . . 0.0 112.627 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -139.47 143.53 37.57 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-O 121.877 0.846 . . . . 0.0 109.164 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.491 ' O ' ' HB2' ' A' ' 184' ' ' ALA . . . 55.25 46.84 77.86 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.491 ' HB2' ' O ' ' A' ' 183' ' ' GLY . . . 153.7 99.45 0.0 OUTLIER 'General case' 0 C--N 1.359 1.006 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 -177.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -115.81 104.64 11.85 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -124.1 126.76 46.76 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 78.0 mt -109.07 -53.98 2.58 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -154.58 -87.87 0.05 OUTLIER 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -124.64 -60.06 1.41 Allowed 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 . . . . . 0 C--O 1.264 1.819 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 179.891 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' HEM . . . . . 1.006 HBBA ' CE1' ' A' ' 75' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 1.015 ' N ' HMDA ' A' ' 202' ' ' HEM . 51.9 tpp . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.038 0.447 . . . . 0.0 110.475 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.587 ' HA ' HG23 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -82.14 -14.98 54.9 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.383 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -71.93 -41.5 54.99 Favored Glycine 0 C--N 1.351 1.405 0 N-CA-C 108.558 -1.817 . . . . 0.0 108.558 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.81 ' HG3' ' HG2' ' A' ' 1' ' ' MET . 67.8 mtt -66.35 -38.22 87.13 Favored 'General case' 0 C--N 1.356 0.849 0 O-C-N 122.316 -0.52 . . . . 0.0 111.555 -178.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.587 HG23 ' HA ' ' A' ' 2' ' ' MET . 28.4 m -69.38 -23.93 27.05 Favored 'Isoleucine or valine' 0 C--N 1.357 0.914 0 C-N-CA 119.996 -0.682 . . . . 0.0 109.847 -177.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.558 ' HZ ' ' HG2' ' A' ' 47' ' ' GLU . 4.6 m-85 -71.36 -35.8 71.25 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 85.3 m -67.77 -41.31 83.47 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.38 -38.98 97.18 Favored Glycine 0 C--N 1.357 1.727 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.631 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -66.05 -39.87 90.49 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-N 117.338 0.569 . . . . 0.0 110.704 -178.336 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 25.6 mmt -64.14 -39.81 94.82 Favored 'General case' 0 C--N 1.351 0.662 0 O-C-N 121.802 -0.561 . . . . 0.0 110.847 -178.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.6 -39.83 88.57 Favored 'General case' 0 C--N 1.35 0.604 0 O-C-N 121.974 -0.454 . . . . 0.0 111.148 -178.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 56.0 tp -66.86 -42.83 85.02 Favored 'General case' 0 C--N 1.35 0.593 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.631 HG12 ' O ' ' A' ' 9' ' ' LEU . 2.2 mm -75.32 -36.42 36.23 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 O-C-N 121.053 -1.029 . . . . 0.0 111.074 -175.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -70.01 -42.6 72.81 Favored 'General case' 0 C--N 1.353 0.725 0 O-C-N 121.725 -0.609 . . . . 0.0 111.181 -176.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -71.3 -32.83 69.11 Favored 'General case' 0 N--CA 1.444 -0.735 0 O-C-N 122.002 -0.436 . . . . 0.0 111.219 -177.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -72.61 -50.51 24.82 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -175.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -128.91 -19.32 3.64 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 117.365 -1.734 . . . . 0.0 113.721 -176.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 142.08 179.66 19.25 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 117.594 -2.241 . . . . 0.0 110.134 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -96.06 -11.38 26.45 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -177.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -70.31 -40.23 74.34 Favored 'General case' 0 C--N 1.36 1.062 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 92.6 m -68.74 -39.03 80.54 Favored 'General case' 0 C--N 1.357 0.908 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.473 HD21 HD12 ' A' ' 26' ' ' LEU . 4.0 tt -60.36 -38.73 84.76 Favored 'General case' 0 C--N 1.359 0.99 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -63.98 -37.51 87.66 Favored 'General case' 0 C--N 1.355 0.828 0 O-C-N 122.085 -0.385 . . . . 0.0 111.053 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.44 HG21 ' O ' ' A' ' 24' ' ' THR . 90.1 m -65.36 -40.94 94.22 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 121.701 -0.624 . . . . 0.0 109.528 -178.204 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.471 ' CD2' ' HB3' ' A' ' 54' ' ' LYS . 87.8 mt -64.52 -38.0 89.49 Favored 'General case' 0 C--N 1.354 0.767 0 O-C-N 122.037 -0.414 . . . . 0.0 110.069 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.473 HD12 HD21 ' A' ' 22' ' ' LEU . 3.9 mp -72.7 -12.8 61.17 Favored 'General case' 0 C--N 1.361 1.072 0 O-C-N 121.51 -0.744 . . . . 0.0 110.145 -178.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -86.99 -28.49 22.62 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 119.298 -0.961 . . . . 0.0 109.047 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.9 t -67.14 -37.67 84.21 Favored 'General case' 0 C--N 1.354 0.801 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.9 p -89.8 -40.88 12.19 Favored 'General case' 0 C--N 1.359 0.996 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 86.18 132.89 0.04 OUTLIER 'General case' 0 C--N 1.36 1.051 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.5 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -83.62 -171.61 3.69 Favored 'General case' 0 C--N 1.357 0.916 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.996 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.4 ' H ' ' HB2' ' A' ' 31' ' ' LEU . 53.5 tt0 -151.2 -27.26 0.2 Allowed 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.3 t -144.26 -68.38 0.32 Allowed 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -129.74 -49.3 1.14 Allowed 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.32 -42.88 1.68 Allowed Glycine 0 C--N 1.352 1.427 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 82.9 mt -110.12 105.48 18.89 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.006 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -87.6 -137.7 0.1 Allowed 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 89.8 m -118.06 -59.0 1.95 Allowed 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.1 p 167.21 25.6 0.0 OUTLIER 'General case' 0 C--N 1.362 1.131 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.0 t -109.49 1.81 9.38 Favored 'Isoleucine or valine' 0 C--N 1.353 0.731 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.476 -178.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -96.78 143.47 16.76 Favored Glycine 0 C--N 1.353 1.502 0 C-N-CA 119.111 -1.518 . . . . 0.0 109.9 -178.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 51.5 m -123.11 127.43 48.7 Favored 'General case' 0 C--N 1.356 0.889 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -120.37 173.4 7.17 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -77.19 -176.63 4.16 Favored 'General case' 0 C--N 1.357 0.924 0 CA-C-O 121.568 0.699 . . . . 0.0 109.287 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 15.3 t60 -88.93 -22.16 23.22 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -66.23 -27.68 68.15 Favored 'General case' 0 C--N 1.356 0.881 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.558 ' HG2' ' HZ ' ' A' ' 6' ' ' PHE . 35.2 tp10 -62.19 -40.8 97.27 Favored 'General case' 0 C--N 1.352 0.704 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.584 HD12 HG22 ' A' ' 52' ' ' VAL . 1.9 tm? -67.05 -38.64 86.19 Favored 'General case' 0 C--N 1.357 0.899 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 59.0 tp -70.64 -34.25 71.86 Favored 'General case' 0 CA--C 1.51 -0.585 0 O-C-N 122.118 -0.364 . . . . 0.0 110.261 -176.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 71.7 tp60 -66.26 -40.54 90.24 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 121.89 -0.506 . . . . 0.0 109.774 -178.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 85.2 mt -81.99 -17.35 47.19 Favored 'General case' 0 C--N 1.361 1.066 0 C-N-CA 120.086 -0.645 . . . . 0.0 110.593 -178.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.584 HG22 HD12 ' A' ' 48' ' ' LEU . 1.3 t -81.38 -36.65 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.5 ' O ' HG12 ' A' ' 53' ' ' VAL . 54.7 t -70.05 -39.68 77.56 Favored 'Isoleucine or valine' 0 C--N 1.352 0.682 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.471 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 34.6 tptt -64.81 -28.33 69.49 Favored 'General case' 0 C--N 1.363 1.195 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.424 HD12 HD13 ' A' ' 13' ' ' ILE . 4.5 mt -67.13 -38.48 85.63 Favored 'General case' 0 C--N 1.356 0.866 0 C-N-CA 120.684 -0.407 . . . . 0.0 110.254 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 70.4 p -72.2 -17.65 61.91 Favored 'General case' 0 C--N 1.354 0.789 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.851 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -101.55 -37.4 8.41 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 121.173 -0.954 . . . . 0.0 111.643 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.4 p -72.07 -37.16 59.26 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 121.62 -0.675 . . . . 0.0 111.492 -177.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.4 t -115.64 -6.68 12.18 Favored 'General case' 0 C--N 1.351 0.668 0 C-N-CA 119.126 -1.03 . . . . 0.0 110.216 -177.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 65.0 46.91 2.67 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.642 HG13 ' HD2' ' A' ' 62' ' ' PRO . 46.5 t -107.49 135.44 19.71 Favored Pre-proline 0 CA--C 1.504 -0.801 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.642 ' HD2' HG13 ' A' ' 61' ' ' VAL . 23.9 Cg_endo -62.41 147.84 94.25 Favored 'Trans proline' 0 CA--C 1.5 -1.177 0 C-N-CA 122.078 1.852 . . . . 0.0 112.311 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.4 m -76.68 -12.51 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.545 -177.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 70.7 p -95.56 -33.27 12.47 Favored 'General case' 0 C--N 1.356 0.865 0 C-N-CA 118.166 -1.413 . . . . 0.0 109.956 -178.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.586 ' HB2' ' HG2' ' A' ' 62' ' ' PRO . 99.1 mt-10 -81.07 -20.08 42.35 Favored 'General case' 0 C--N 1.354 0.787 0 O-C-N 121.245 -0.909 . . . . 0.0 108.575 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.463 ' HB3' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -78.36 -37.32 44.56 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 179.572 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.595 HG12 ' N ' ' A' ' 68' ' ' ARG . 1.8 p -68.84 -29.35 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.278 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.595 ' N ' HG12 ' A' ' 67' ' ' VAL . 80.4 mtp180 -70.81 -48.55 53.54 Favored 'General case' 0 C--N 1.365 1.267 0 O-C-N 121.222 -0.923 . . . . 0.0 110.829 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 83.8 mt -63.76 -36.52 84.16 Favored 'General case' 0 C--N 1.355 0.812 0 O-C-N 122.049 -0.407 . . . . 0.0 110.751 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -61.21 -47.49 85.89 Favored 'General case' 0 C--N 1.348 0.512 0 O-C-N 122.307 -0.246 . . . . 0.0 110.587 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.61 -38.86 96.55 Favored Glycine 0 C--N 1.354 1.542 0 CA-C-O 119.812 -0.438 . . . . 0.0 112.204 -177.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -65.26 -46.05 82.08 Favored 'General case' 0 C--N 1.352 0.693 0 CA-C-N 118.554 1.177 . . . . 0.0 111.318 -176.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.758 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 10.7 mttm -63.74 -49.41 73.13 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -177.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.479 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.2 tm? -68.18 -40.18 82.32 Favored 'General case' 0 C--N 1.35 0.617 0 O-C-N 121.195 -0.941 . . . . 0.0 112.149 -175.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 49.3 t80 -62.94 -45.57 91.86 Favored 'General case' 0 C--N 1.353 0.743 0 O-C-N 121.179 -0.951 . . . . 0.0 111.238 -178.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.2 p -71.26 -14.79 18.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.888 0 O-C-N 121.523 -0.736 . . . . 0.0 109.588 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.758 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 76.6 mm-40 -73.77 -39.18 64.37 Favored 'General case' 0 C--N 1.35 0.617 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 80.1 mt -69.91 -36.71 75.58 Favored 'General case' 0 C--N 1.358 0.977 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.8 mm -62.55 -50.19 80.8 Favored 'Isoleucine or valine' 0 C--N 1.354 0.779 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -178.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -66.17 -24.4 66.63 Favored 'General case' 0 C--N 1.352 0.702 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.345 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.04 -1.18 63.16 Favored Glycine 0 C--N 1.349 1.253 0 C-N-CA 119.793 -1.194 . . . . 0.0 110.656 -177.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.7 ' HB3' ' HB ' ' A' ' 85' ' ' ILE . 84.2 m-70 -138.04 89.87 14.32 Favored Pre-proline 0 CA--C 1.5 -0.95 0 CA-C-N 119.003 1.402 . . . . 0.0 109.201 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 82' ' ' HIS . 34.8 Cg_endo -66.98 -28.52 41.8 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 C-N-CA 122.464 2.109 . . . . 0.0 114.34 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -92.95 -5.11 51.48 Favored 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 119.422 -0.911 . . . . 0.0 108.927 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.7 ' HB ' ' HB3' ' A' ' 82' ' ' HIS . 0.9 OUTLIER -90.04 -19.56 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 -179.973 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.5 -25.85 14.05 Favored 'General case' 0 C--N 1.362 1.127 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -69.84 -35.81 75.05 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -65.53 -36.74 84.69 Favored 'General case' 0 C--N 1.355 0.837 0 O-C-N 122.072 -0.393 . . . . 0.0 110.084 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.644 ' HG2' ' N ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -80.55 156.08 26.65 Favored 'General case' 0 C--N 1.356 0.859 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -178.576 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.644 ' N ' ' HG2' ' A' ' 89' ' ' MET . 4.0 mtpt -119.78 -25.46 5.89 Favored 'General case' 0 C--N 1.363 1.182 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.631 -177.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -166.22 173.75 9.86 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -177.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 61.7 m -66.29 -39.65 89.51 Favored 'General case' 0 C--N 1.354 0.777 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.284 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -67.53 -39.31 85.07 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 119.739 -0.784 . . . . 0.0 109.059 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -65.33 -24.5 67.28 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 57.0 tp -64.76 -44.33 90.4 Favored 'General case' 0 C--N 1.353 0.735 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.9 mp -61.66 -33.92 74.81 Favored 'General case' 0 C--N 1.356 0.879 0 O-C-N 122.139 -0.351 . . . . 0.0 111.025 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 86.3 p -86.56 -7.28 58.5 Favored 'General case' 0 C--N 1.354 0.767 0 C-N-CA 119.294 -0.962 . . . . 0.0 110.805 -178.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.7 tttp -111.36 0.68 16.71 Favored 'General case' 0 C--N 1.356 0.857 0 O-C-N 121.533 -0.729 . . . . 0.0 109.798 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 1.196 HD13 ' C3B' ' A' ' 202' ' ' HEM . 9.5 tp -65.66 -39.9 86.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.808 0 O-C-N 121.867 -0.52 . . . . 0.0 111.818 -177.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -95.51 -27.28 15.45 Favored 'General case' 0 N--CA 1.44 -0.959 0 O-C-N 120.827 -1.171 . . . . 0.0 111.657 -177.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 90.0 p -70.01 -39.87 75.58 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 119.412 -0.915 . . . . 0.0 112.984 -176.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.574 ' HA ' HG13 ' A' ' 105' ' ' VAL . 8.7 t80 -138.47 -19.61 1.07 Allowed 'General case' 0 C--N 1.361 1.08 0 C-N-CA 116.971 -1.891 . . . . 0.0 113.511 -177.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.405 HG22 ' C2C' ' A' ' 202' ' ' HEM . 24.1 mm -68.39 -51.0 51.76 Favored 'Isoleucine or valine' 0 C--O 1.244 0.783 0 CA-C-N 120.424 1.466 . . . . 0.0 110.379 -177.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 54.9 m80 -92.9 4.2 54.35 Favored 'General case' 0 N--CA 1.437 -1.076 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.551 -176.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.574 HG13 ' HA ' ' A' ' 102' ' ' PHE . 3.3 p -87.73 -35.67 8.57 Favored 'Isoleucine or valine' 0 C--N 1.353 0.749 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 178.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -72.65 -41.9 64.96 Favored 'General case' 0 C--N 1.358 0.938 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 67.0 t -65.3 -48.39 83.54 Favored 'Isoleucine or valine' 0 C--N 1.358 0.974 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.527 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -60.75 -47.87 84.35 Favored 'General case' 0 C--N 1.359 0.987 0 O-C-N 122.079 -0.388 . . . . 0.0 111.389 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . 0.495 ' HG2' ' O ' ' A' ' 105' ' ' VAL . 38.3 mmtt -61.14 -39.39 89.88 Favored 'General case' 0 N--CA 1.445 -0.703 0 O-C-N 121.685 -0.634 . . . . 0.0 110.696 -177.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 19.4 mt -56.46 -72.11 0.08 Allowed 'General case' 0 CA--C 1.505 -0.786 0 C-N-CA 120.541 -0.463 . . . . 0.0 109.762 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.442 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 87.7 m-85 -123.42 141.33 35.98 Favored Pre-proline 0 N--CA 1.439 -1.005 0 C-N-CA 118.538 -1.265 . . . . 0.0 109.207 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 111' ' ' TYR . 75.5 Cg_endo -86.29 -2.15 8.56 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 123.308 2.672 . . . . 0.0 115.402 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -66.31 -37.42 85.36 Favored 'General case' 0 C--N 1.355 0.839 0 O-C-N 121.757 -0.59 . . . . 0.0 109.908 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 1.131 ' HB3' ' HBD' ' A' ' 202' ' ' HEM . . . -65.34 144.92 56.79 Favored 'General case' 0 C--N 1.353 0.73 0 CA-C-O 121.548 0.69 . . . . 0.0 110.174 -178.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -112.05 143.51 42.94 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.455 HD23 ' N ' ' A' ' 116' ' ' LEU . 2.6 mm? -128.37 149.41 71.41 Favored Pre-proline 0 C--N 1.353 0.759 0 CA-C-O 122.164 0.983 . . . . 0.0 108.981 -178.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 116' ' ' LEU . 64.8 Cg_endo -91.85 -160.72 0.09 OUTLIER 'Trans proline' 0 C--N 1.316 -1.156 0 C-N-CA 123.857 3.038 . . . . 0.0 112.959 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -121.33 140.68 51.78 Favored 'General case' 0 C--N 1.363 1.18 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.441 ' HE2' ' CD1' ' A' ' 133' ' ' TYR . 65.7 m-85 -127.53 135.2 50.02 Favored 'General case' 0 C--N 1.36 1.06 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.164 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.511 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 93.3 m -124.09 126.31 46.0 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 176.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 80.3 m -117.92 126.96 53.35 Favored 'General case' 0 CA--C 1.502 -0.896 0 C-N-CA 119.17 -1.012 . . . . 0.0 109.372 -177.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -120.47 127.49 52.27 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 178.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -100.05 116.53 32.29 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.453 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 85.9 mt -82.35 -26.86 32.56 Favored 'General case' 0 C--N 1.355 0.836 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -178.74 -144.46 5.69 Favored Glycine 0 N--CA 1.437 -1.244 0 N-CA-C 108.78 -1.728 . . . . 0.0 108.78 -178.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -94.99 -39.62 10.09 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.297 -178.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -98.84 -1.47 40.17 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.758 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.453 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 66.8 m-20 -118.82 133.45 55.83 Favored 'General case' 0 C--N 1.357 0.913 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.536 HG23 ' N ' ' A' ' 130' ' ' ARG . 9.5 mm -140.78 136.79 35.13 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 179.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.536 ' N ' HG23 ' A' ' 129' ' ' ILE . 52.7 mtm180 -117.39 136.77 52.93 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 5.7 tp -125.95 118.9 26.36 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.511 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 12.3 m170 -98.53 130.58 45.1 Favored 'General case' 0 CA--C 1.496 -1.133 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.559 ' OH ' HBAA ' A' ' 202' ' ' HEM . 51.6 t80 -122.59 120.73 34.65 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 -178.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.463 ' HA ' ' O ' ' A' ' 171' ' ' THR . 36.1 tt0 -115.55 109.86 18.41 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.507 ' O ' ' HA ' ' A' ' 171' ' ' THR . 8.8 t -165.07 158.16 16.51 Favored 'General case' 0 C--N 1.359 0.979 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.509 ' C ' ' HD3' ' A' ' 138' ' ' PRO . 63.0 mtpt -91.0 5.85 47.17 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -129.58 72.32 81.97 Favored Pre-proline 0 C--N 1.354 0.804 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.509 ' HD3' ' C ' ' A' ' 136' ' ' LYS . 96.6 Cg_endo -95.21 88.03 0.11 Allowed 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 122.319 2.012 . . . . 0.0 115.446 -178.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -106.51 115.5 30.31 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 177.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.41 -38.27 90.5 Favored 'General case' 0 C--N 1.352 0.687 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.019 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 73.3 m -62.36 -33.57 74.99 Favored 'General case' 0 C--N 1.352 0.713 0 O-C-N 122.115 -0.366 . . . . 0.0 110.784 -178.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -73.15 -47.81 40.82 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.445 -177.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.25 -39.69 93.01 Favored 'General case' 0 C--N 1.355 0.839 0 O-C-N 122.105 -0.372 . . . . 0.0 111.419 -177.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.11 -36.58 84.07 Favored 'General case' 0 C--N 1.354 0.794 0 O-C-N 121.848 -0.532 . . . . 0.0 109.719 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.2 -43.23 98.64 Favored Glycine 0 C--N 1.346 1.091 0 N-CA-C 109.829 -1.309 . . . . 0.0 109.829 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 83.0 mt -70.45 -41.03 73.36 Favored 'General case' 0 C--N 1.353 0.728 0 O-C-N 122.049 -0.677 . . . . 0.0 112.733 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 98.6 mt -71.35 -42.33 68.64 Favored 'General case' 0 C--N 1.36 1.022 0 O-C-N 121.273 -0.892 . . . . 0.0 110.515 -177.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.509 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 21.3 t70 -69.43 -29.81 67.61 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 122.141 -0.349 . . . . 0.0 110.245 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.475 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -63.09 -39.46 98.04 Favored Glycine 0 C--N 1.356 1.648 0 N-CA-C 108.276 -1.93 . . . . 0.0 108.276 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 48.7 t -60.43 -41.95 95.05 Favored 'General case' 0 C--N 1.35 0.598 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -74.42 -1.9 23.11 Favored 'General case' 0 C--N 1.362 1.121 0 O-C-N 121.82 -0.55 . . . . 0.0 109.544 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.509 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 76.4 mm-40 -83.74 -46.49 12.19 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -66.06 -44.11 85.48 Favored 'General case' 0 C--N 1.356 0.889 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.484 ' O ' ' HB2' ' A' ' 155' ' ' LYS . 38.0 m-85 -69.09 -25.96 64.69 Favored 'General case' 0 C--N 1.36 1.041 0 O-C-N 121.831 -0.543 . . . . 0.0 111.065 -178.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 154' ' ' PHE . 44.6 mttt 73.88 67.64 0.1 Allowed 'General case' 0 C--N 1.361 1.099 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -138.88 -168.11 2.35 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -148.32 96.64 2.65 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 13.2 m-30 -112.97 156.76 22.45 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 92.2 m -120.1 128.24 53.28 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 3.8 mp -107.1 123.14 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 179.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.0 m -117.99 -174.66 2.69 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-O 121.835 0.826 . . . . 0.0 109.347 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -146.29 156.12 43.13 Favored 'General case' 0 C--N 1.356 0.865 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 -178.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' THR . . . . . 0.451 ' HG1' ' HB ' ' A' ' 174' ' ' ILE . 51.2 p -98.72 145.94 30.78 Favored Pre-proline 0 C--N 1.359 0.983 0 CA-C-O 122.443 1.116 . . . . 0.0 108.0 178.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.649 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 72.1 Cg_endo -75.84 -10.93 20.01 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.91 2.407 . . . . 0.0 115.076 -178.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -73.38 -41.26 63.59 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.819 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 38.2 p -117.95 16.15 14.25 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.659 -178.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.649 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.3 pp0? -67.31 -11.47 57.67 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 121.571 -0.706 . . . . 0.0 110.129 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 54.3 p30 -118.51 34.66 5.09 Favored 'General case' 0 N--CA 1.439 -0.996 0 O-C-N 121.199 -0.938 . . . . 0.0 108.893 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 58.5 m -136.15 148.79 48.36 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.744 ' O ' ' HB ' ' A' ' 171' ' ' THR . 97.8 mt-10 -114.51 137.2 52.15 Favored 'General case' 0 C--N 1.354 0.794 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.744 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 1.1 m 115.03 -53.26 0.0 OUTLIER 'General case' 0 C--N 1.377 1.803 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -116.9 111.12 19.21 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 80.1 t -128.5 135.26 62.94 Favored 'Isoleucine or valine' 0 C--N 1.359 1.009 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.451 ' HB ' ' HG1' ' A' ' 163' ' ' THR . 50.4 mm -106.74 127.82 61.95 Favored 'Isoleucine or valine' 0 C--N 1.36 1.052 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -116.26 154.98 29.16 Favored 'General case' 0 C--N 1.356 0.875 0 CA-C-O 122.123 0.963 . . . . 0.0 108.849 -178.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -137.14 120.17 16.55 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -178.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.8 mp -115.47 119.84 62.98 Favored 'Isoleucine or valine' 0 C--N 1.354 0.804 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 90.0 m -120.8 141.55 50.42 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -178.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -82.5 124.27 29.94 Favored 'General case' 0 C--N 1.367 1.36 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -67.66 157.32 86.58 Favored Pre-proline 0 C--N 1.357 0.912 0 N-CA-C 108.156 -1.054 . . . . 0.0 108.156 178.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -51.44 127.01 20.97 Favored 'Trans proline' 0 CA--C 1.499 -1.253 0 C-N-CA 122.678 2.252 . . . . 0.0 113.819 -178.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 182' ' ' ARG . 0.3 OUTLIER -96.91 23.31 7.29 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.223 -0.898 . . . . 0.0 108.625 -179.838 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 116.67 -19.58 12.46 Favored Glycine 0 C--N 1.351 1.403 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -123.45 122.25 37.78 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -126.45 118.73 25.57 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -120.11 123.48 43.47 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 82.9 mt -101.15 -51.71 3.45 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . 0.498 ' HB3' ' H ' ' A' ' 189' ' ' PHE . 3.4 t80 -161.07 -88.87 0.03 OUTLIER 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . 0.498 ' H ' ' HB3' ' A' ' 188' ' ' TYR . 89.0 t80 -139.2 129.59 25.6 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 . . . . . 0 C--O 1.265 1.899 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -179.972 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' HEM . . . . . 1.196 ' C3B' HD13 ' A' ' 99' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.889 ' HG3' ' CMD' ' A' ' 202' ' ' HEM . 90.7 mtp . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.185 0.517 . . . . 0.0 110.005 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.696 ' HA ' HG23 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -78.63 -16.27 57.54 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.63 -177.908 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.57 -42.27 48.35 Favored Glycine 0 C--N 1.352 1.433 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 62.3 mtt -68.27 -38.19 81.49 Favored 'General case' 0 C--N 1.358 0.942 0 O-C-N 121.893 -0.769 . . . . 0.0 111.464 -178.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.696 HG23 ' HA ' ' A' ' 2' ' ' MET . 27.6 m -68.23 -23.0 28.05 Favored 'Isoleucine or valine' 0 C--N 1.356 0.851 0 C-N-CA 120.031 -0.668 . . . . 0.0 109.749 -178.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -71.08 -37.54 72.46 Favored 'General case' 0 C--N 1.356 0.863 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 89.5 m -68.2 -41.66 81.05 Favored 'General case' 0 C--N 1.357 0.908 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.69 -39.17 97.59 Favored Glycine 0 C--N 1.358 1.757 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.709 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -65.93 -39.84 90.88 Favored 'General case' 0 C--N 1.35 0.614 0 CA-C-N 117.199 0.5 . . . . 0.0 110.618 -178.351 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.3 mmt -63.35 -40.82 98.33 Favored 'General case' 0 C--N 1.352 0.703 0 O-C-N 121.619 -0.675 . . . . 0.0 111.025 -178.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -67.59 -40.14 84.82 Favored 'General case' 0 C--N 1.349 0.563 0 O-C-N 121.896 -0.503 . . . . 0.0 111.504 -177.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 54.8 tp -66.77 -41.93 86.92 Favored 'General case' 0 C--N 1.349 0.558 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -178.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.709 HG12 ' O ' ' A' ' 9' ' ' LEU . 3.7 mm -73.68 -38.22 51.04 Favored 'Isoleucine or valine' 0 C--N 1.357 0.916 0 O-C-N 121.196 -0.94 . . . . 0.0 111.081 -175.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -67.12 -43.32 82.72 Favored 'General case' 0 C--N 1.351 0.646 0 O-C-N 121.914 -0.491 . . . . 0.0 111.573 -176.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -72.11 -33.88 68.17 Favored 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 121.842 -0.536 . . . . 0.0 111.733 -177.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -72.01 -48.5 44.27 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -175.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -127.8 -20.85 3.81 Favored 'General case' 0 C--N 1.354 0.797 0 C-N-CA 117.398 -1.721 . . . . 0.0 113.383 -176.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 141.88 179.72 19.15 Favored Glycine 0 CA--C 1.497 -1.038 0 C-N-CA 117.982 -2.056 . . . . 0.0 109.597 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -97.21 -12.43 23.02 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -177.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -71.44 -40.63 70.26 Favored 'General case' 0 C--N 1.359 1.01 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.44 HG23 HG22 ' A' ' 58' ' ' VAL . 93.7 m -69.21 -38.49 78.61 Favored 'General case' 0 C--N 1.356 0.885 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 59.3 tp -60.32 -38.54 84.06 Favored 'General case' 0 C--N 1.357 0.914 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -64.17 -35.72 81.73 Favored 'General case' 0 C--N 1.357 0.903 0 O-C-N 122.182 -0.324 . . . . 0.0 111.309 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 90.2 m -63.99 -41.39 97.52 Favored 'General case' 0 C--N 1.356 0.89 0 O-C-N 121.566 -0.709 . . . . 0.0 109.189 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.498 ' CD2' ' HB3' ' A' ' 54' ' ' LYS . 89.1 mt -65.02 -38.4 90.78 Favored 'General case' 0 C--N 1.355 0.839 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.27 -11.74 61.11 Favored 'General case' 0 C--N 1.358 0.97 0 O-C-N 121.363 -0.835 . . . . 0.0 109.734 -179.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -89.0 -27.25 20.99 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 119.527 -0.869 . . . . 0.0 108.916 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 55.9 p -69.58 -22.7 63.5 Favored 'General case' 0 C--N 1.362 1.109 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.164 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.0 p -106.98 -36.86 6.49 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 119.046 -1.062 . . . . 0.0 108.325 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 86.1 132.37 0.04 OUTLIER 'General case' 0 C--N 1.361 1.067 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.536 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -84.48 -168.04 2.02 Favored 'General case' 0 C--N 1.357 0.902 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.402 ' H ' ' HB2' ' A' ' 31' ' ' LEU . 63.3 tt0 -152.13 -32.57 0.14 Allowed 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.7 t -139.18 -73.37 0.38 Allowed 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -128.32 -33.97 2.1 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.96 -25.75 11.25 Favored Glycine 0 C--N 1.353 1.482 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 84.7 mt -113.71 102.93 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.792 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.4 ' CD2' HG23 ' A' ' 40' ' ' VAL . 53.8 t80 -99.68 -0.32 40.41 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.7 m 77.62 -179.99 0.13 Allowed 'General case' 0 C--N 1.361 1.096 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 -178.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.533 ' C ' HG21 ' A' ' 40' ' ' VAL . 24.9 p -90.9 114.26 26.67 Favored 'General case' 0 N--CA 1.443 -0.779 0 O-C-N 121.214 -0.929 . . . . 0.0 109.44 -178.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.533 HG21 ' C ' ' A' ' 39' ' ' SER . 0.0 OUTLIER -173.48 -8.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.189 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.15 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -117.42 167.56 12.73 Favored Glycine 0 C--N 1.355 1.63 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -178.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 68.6 m -132.24 136.84 47.26 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -124.02 172.57 8.87 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -71.27 174.8 5.96 Favored 'General case' 0 C--N 1.355 0.832 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.495 ' CD2' HH22 ' A' ' 137' ' ' ARG . 70.4 m80 -86.53 -17.04 35.1 Favored 'General case' 0 CA--C 1.502 -0.884 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.234 -178.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -69.06 -29.33 67.43 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.0 tp10 -63.13 -42.22 99.46 Favored 'General case' 0 C--N 1.351 0.647 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 55.0 tp -66.88 -39.4 87.49 Favored 'General case' 0 C--N 1.359 0.985 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.416 ' O ' HG22 ' A' ' 53' ' ' VAL . 59.0 tp -72.94 -28.98 62.75 Favored 'General case' 0 C--N 1.349 0.569 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -177.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -66.47 -43.22 86.08 Favored 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 121.917 -0.489 . . . . 0.0 110.108 -178.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.452 ' HA ' HD22 ' A' ' 51' ' ' LEU . 80.4 mt -72.36 -34.5 68.04 Favored 'General case' 0 C--N 1.36 1.052 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.278 179.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.503 HG13 HD21 ' A' ' 66' ' ' LEU . 39.3 t -63.24 -42.1 95.19 Favored 'Isoleucine or valine' 0 C--N 1.35 0.626 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.503 HG12 ' O ' ' A' ' 53' ' ' VAL . 54.6 t -66.58 -40.65 86.81 Favored 'Isoleucine or valine' 0 C--N 1.351 0.648 0 O-C-N 121.733 -0.604 . . . . 0.0 109.855 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.498 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 25.9 tptt -66.77 -22.97 66.02 Favored 'General case' 0 C--N 1.361 1.095 0 O-C-N 121.022 -1.049 . . . . 0.0 109.019 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.2 mt -69.78 -38.05 76.56 Favored 'General case' 0 C--N 1.355 0.826 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 57.6 p -71.38 -18.01 62.38 Favored 'General case' 0 C--N 1.353 0.752 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.357 -179.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -100.46 -35.75 9.45 Favored 'General case' 0 C--N 1.355 0.805 0 C-N-CA 119.648 -0.821 . . . . 0.0 111.408 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.44 HG22 HG23 ' A' ' 21' ' ' THR . 5.6 p -72.27 -40.22 65.01 Favored 'Isoleucine or valine' 0 C--N 1.354 0.766 0 O-C-N 121.664 -0.648 . . . . 0.0 111.507 -177.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.505 ' HG ' ' CG2' ' A' ' 61' ' ' VAL . 79.7 p -116.02 -2.49 12.26 Favored 'General case' 0 C--N 1.354 0.78 0 C-N-CA 118.89 -1.124 . . . . 0.0 110.914 -178.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 73.6 m 63.74 49.48 2.93 Favored 'General case' 0 C--N 1.357 0.916 0 CA-C-O 120.932 0.396 . . . . 0.0 110.033 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.505 ' CG2' ' HG ' ' A' ' 59' ' ' SER . 96.6 t -113.98 134.04 22.22 Favored Pre-proline 0 CA--C 1.504 -0.799 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.474 ' N ' HG11 ' A' ' 61' ' ' VAL . 41.3 Cg_exo -58.02 149.5 70.65 Favored 'Trans proline' 0 CA--C 1.499 -1.27 0 C-N-CA 122.778 2.319 . . . . 0.0 112.738 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.417 ' HA ' HD23 ' A' ' 66' ' ' LEU . 3.7 m -76.2 -11.64 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.679 -177.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 73.0 p -96.51 -33.36 11.87 Favored 'General case' 0 C--N 1.358 0.971 0 C-N-CA 118.433 -1.307 . . . . 0.0 109.504 -179.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -77.65 -21.0 52.85 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 121.474 -0.766 . . . . 0.0 108.968 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.503 HD21 HG13 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -81.19 -34.23 32.46 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 -179.483 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.574 HG12 ' N ' ' A' ' 68' ' ' ARG . 1.5 p -70.98 -26.23 27.21 Favored 'Isoleucine or valine' 0 C--N 1.356 0.855 0 C-N-CA 120.169 -0.613 . . . . 0.0 109.799 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.574 ' N ' HG12 ' A' ' 67' ' ' VAL . 40.7 mtp180 -72.53 -52.87 13.81 Favored 'General case' 0 C--N 1.363 1.181 0 O-C-N 121.477 -0.765 . . . . 0.0 110.427 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.9 mt -63.41 -34.76 78.44 Favored 'General case' 0 C--N 1.357 0.913 0 O-C-N 121.959 -0.463 . . . . 0.0 110.905 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -61.1 -47.23 87.24 Favored 'General case' 0 C--N 1.348 0.502 0 O-C-N 122.248 -0.283 . . . . 0.0 110.239 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.06 -38.8 96.16 Favored Glycine 0 C--N 1.356 1.651 0 N-CA-C 111.729 -0.548 . . . . 0.0 111.729 -178.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -62.6 -49.35 75.58 Favored 'General case' 0 C--N 1.351 0.638 0 CA-C-N 118.31 1.055 . . . . 0.0 111.556 -177.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 12.2 mttm -65.09 -45.93 83.18 Favored 'General case' 0 C--N 1.357 0.926 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -177.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -69.78 -39.04 76.88 Favored 'General case' 0 C--N 1.348 0.52 0 O-C-N 121.161 -0.962 . . . . 0.0 111.841 -175.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -64.61 -44.05 91.8 Favored 'General case' 0 C--N 1.353 0.746 0 O-C-N 121.098 -1.001 . . . . 0.0 110.951 -178.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.429 ' O ' HG22 ' A' ' 76' ' ' VAL . 9.9 p -71.83 -13.86 17.08 Favored 'Isoleucine or valine' 0 C--N 1.359 0.985 0 O-C-N 121.45 -0.781 . . . . 0.0 109.0 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -74.37 -37.61 63.42 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.3 mt -74.67 -29.48 61.25 Favored 'General case' 0 C--N 1.357 0.927 0 O-C-N 122.285 -0.259 . . . . 0.0 110.369 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.6 mm -65.86 -52.84 44.77 Favored 'Isoleucine or valine' 0 C--N 1.357 0.895 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.682 -177.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -75.5 -15.35 60.41 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.279 178.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.25 -37.45 63.34 Favored Glycine 0 C--N 1.349 1.276 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -131.75 105.23 14.16 Favored Pre-proline 0 N--CA 1.441 -0.903 0 CA-C-O 122.615 1.198 . . . . 0.0 108.961 -177.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.54 ' O ' ' HB2' ' A' ' 87' ' ' ASN . 37.1 Cg_endo -67.47 -23.08 44.16 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.571 2.181 . . . . 0.0 114.356 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -95.39 -5.19 43.81 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 tp -89.75 -20.1 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -105.7 -18.06 14.19 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.54 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 1.5 t-20 -73.97 -38.0 64.31 Favored 'General case' 0 C--N 1.357 0.931 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -65.49 -33.84 76.86 Favored 'General case' 0 C--N 1.353 0.735 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -178.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 15.8 ttp -83.12 150.37 26.31 Favored 'General case' 0 C--N 1.351 0.654 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.02 -22.59 9.47 Favored 'General case' 0 C--N 1.364 1.199 0 O-C-N 121.691 -0.63 . . . . 0.0 111.14 -177.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -165.55 171.49 13.13 Favored 'General case' 0 C--N 1.354 0.761 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 -177.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.487 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 66.8 m -66.65 -39.54 88.28 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.448 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -68.44 -38.9 81.57 Favored 'General case' 0 C--N 1.355 0.836 0 O-C-N 121.296 -0.877 . . . . 0.0 108.991 -179.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -65.93 -24.09 66.75 Favored 'General case' 0 C--N 1.355 0.823 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.685 ' O ' HG12 ' A' ' 99' ' ' ILE . 59.7 tp -63.64 -47.38 81.54 Favored 'General case' 0 C--N 1.355 0.846 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.4 mp -60.07 -35.7 75.74 Favored 'General case' 0 C--N 1.359 1.013 0 O-C-N 122.256 -0.277 . . . . 0.0 110.521 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 34.0 t -70.14 -39.64 75.28 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.188 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.427 ' HZ2' ' HG3' ' A' ' 98' ' ' LYS . 2.5 tttp -86.99 0.35 55.31 Favored 'General case' 0 C--N 1.356 0.856 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -176.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.685 HG12 ' O ' ' A' ' 95' ' ' LEU . 22.8 mm -61.01 -46.7 96.15 Favored 'Isoleucine or valine' 0 C--N 1.357 0.896 0 CA-C-N 119.082 0.856 . . . . 0.0 112.014 -177.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -95.64 -22.63 17.46 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 118.402 -1.319 . . . . 0.0 111.329 -177.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 35.2 t -64.29 -48.65 74.87 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 121.565 -0.709 . . . . 0.0 112.491 -177.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -138.08 -16.49 1.25 Allowed 'General case' 0 C--N 1.36 1.06 0 C-N-CA 117.372 -1.731 . . . . 0.0 113.521 -176.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.448 HD12 ' HA ' ' A' ' 99' ' ' ILE . 96.3 mt -71.83 -50.27 39.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 CA-C-N 120.359 1.436 . . . . 0.0 111.182 -177.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -89.98 4.36 50.36 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 119.388 -0.925 . . . . 0.0 109.811 -177.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 57.7 t -86.44 -43.7 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.059 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 54.7 tp10 -67.53 -40.1 85.04 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.524 HG11 ' HMD' ' A' ' 202' ' ' HEM . 65.6 t -62.77 -46.92 95.16 Favored 'Isoleucine or valine' 0 C--N 1.356 0.88 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 -179.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -60.74 -48.21 82.81 Favored 'General case' 0 C--N 1.36 1.038 0 O-C-N 122.198 -0.314 . . . . 0.0 111.541 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -61.25 -36.59 80.41 Favored 'General case' 0 C--N 1.355 0.821 0 O-C-N 121.534 -0.729 . . . . 0.0 110.503 -178.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 18.0 mt -58.6 -75.5 0.05 Allowed 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -115.58 132.14 23.29 Favored Pre-proline 0 N--CA 1.439 -0.975 0 C-N-CA 118.65 -1.22 . . . . 0.0 108.641 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -83.26 -3.53 10.91 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 123.175 2.583 . . . . 0.0 115.172 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -66.97 -36.36 82.02 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 121.879 -0.513 . . . . 0.0 110.009 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.32 144.86 56.31 Favored 'General case' 0 C--N 1.352 0.683 0 CA-C-O 121.74 0.781 . . . . 0.0 110.142 -178.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -128.86 133.76 48.07 Favored 'General case' 0 C--N 1.357 0.925 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.545 ' HB3' ' HD2' ' A' ' 117' ' ' PRO . 87.8 mt -127.76 156.44 75.71 Favored Pre-proline 0 N--CA 1.443 -0.787 0 CA-C-O 122.262 1.03 . . . . 0.0 109.243 -178.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.644 ' HG3' ' HH ' ' A' ' 133' ' ' TYR . 83.0 Cg_endo -80.46 -158.42 0.09 OUTLIER 'Trans proline' 0 C--N 1.318 -1.074 0 C-N-CA 123.826 3.017 . . . . 0.0 113.922 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -118.86 143.28 47.06 Favored 'General case' 0 C--N 1.364 1.209 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -129.65 135.7 48.84 Favored 'General case' 0 C--N 1.362 1.123 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -178.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 93.8 m -127.64 130.71 49.43 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 177.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -120.6 132.39 55.11 Favored 'General case' 0 CA--C 1.504 -0.804 0 C-N-CA 119.215 -0.994 . . . . 0.0 109.989 -178.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -119.71 138.5 53.26 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 178.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -109.32 117.84 35.13 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 -179.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.585 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 96.5 mt -91.77 -16.02 27.46 Favored 'General case' 0 C--N 1.356 0.856 0 C-N-CA 120.496 -0.481 . . . . 0.0 110.436 -179.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 174.04 -148.23 9.87 Favored Glycine 0 C--N 1.349 1.252 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -94.35 -37.55 11.42 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -102.05 4.17 39.48 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.031 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.585 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 8.7 m-20 -121.93 132.09 54.37 Favored 'General case' 0 C--N 1.359 0.984 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -179.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.589 HG21 ' N ' ' A' ' 130' ' ' ARG . 8.2 mm -143.64 137.8 25.19 Favored 'Isoleucine or valine' 0 C--N 1.356 0.863 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.589 ' N ' HG21 ' A' ' 129' ' ' ILE . 53.5 mtm180 -118.49 139.11 51.93 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 5.8 tp -125.53 116.91 22.51 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.52 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -98.29 134.39 41.38 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 107.327 -1.361 . . . . 0.0 107.327 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.644 ' HH ' ' HG3' ' A' ' 117' ' ' PRO . 67.7 t80 -129.51 119.55 23.89 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 -178.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.537 ' HA ' ' O ' ' A' ' 171' ' ' THR . 57.9 mt-30 -115.53 112.17 21.81 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 11.1 t -165.93 155.12 11.75 Favored 'General case' 0 C--N 1.357 0.921 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.448 ' C ' ' HD3' ' A' ' 138' ' ' PRO . 99.6 mttt -90.99 5.49 48.57 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.495 HH22 ' CD2' ' A' ' 45' ' ' HIS . 77.0 mtp180 -132.62 73.25 76.75 Favored Pre-proline 0 C--N 1.354 0.767 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.448 ' HD3' ' C ' ' A' ' 136' ' ' LYS . 92.7 Cg_endo -96.87 99.64 0.08 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.515 0 C-N-CA 122.737 2.291 . . . . 0.0 115.453 -178.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -109.4 111.13 22.5 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 177.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.71 -38.05 89.64 Favored 'General case' 0 C--N 1.354 0.787 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.02 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 74.1 m -63.03 -29.33 70.73 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 121.998 -0.439 . . . . 0.0 110.755 -178.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -75.01 -47.1 30.79 Favored 'General case' 0 C--N 1.35 0.612 0 O-C-N 121.698 -0.626 . . . . 0.0 109.763 -177.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.53 -40.06 94.91 Favored 'General case' 0 C--N 1.358 0.976 0 O-C-N 122.095 -0.378 . . . . 0.0 111.212 -178.027 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.1 -37.0 85.46 Favored 'General case' 0 C--N 1.355 0.809 0 O-C-N 121.938 -0.476 . . . . 0.0 110.212 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.84 -43.15 99.58 Favored Glycine 0 C--N 1.347 1.182 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 -178.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.44 HD12 ' O ' ' A' ' 201' ' ' CMO . 83.8 mt -70.01 -40.42 75.27 Favored 'General case' 0 C--N 1.351 0.647 0 N-CA-C 112.673 0.619 . . . . 0.0 112.673 -179.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 99.1 mt -71.34 -42.9 67.95 Favored 'General case' 0 C--N 1.361 1.082 0 O-C-N 121.198 -0.939 . . . . 0.0 110.993 -176.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.504 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 21.0 t70 -69.0 -31.72 70.75 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 122.028 -0.42 . . . . 0.0 110.418 -179.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.476 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -62.96 -39.19 97.76 Favored Glycine 0 C--N 1.356 1.659 0 N-CA-C 108.656 -1.778 . . . . 0.0 108.656 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 49.4 t -60.84 -42.0 96.91 Favored 'General case' 0 C--N 1.351 0.674 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -74.59 -2.19 24.89 Favored 'General case' 0 C--N 1.361 1.082 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.504 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 77.0 mm-40 -83.29 -45.44 13.79 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -68.84 -42.56 76.98 Favored 'General case' 0 C--N 1.358 0.959 0 C-N-CA 120.011 -0.675 . . . . 0.0 109.681 179.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -69.75 -25.68 63.95 Favored 'General case' 0 C--N 1.362 1.132 0 O-C-N 121.659 -0.651 . . . . 0.0 110.619 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 21.2 tttm 73.16 73.39 0.13 Allowed 'General case' 0 C--N 1.36 1.05 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -143.61 -169.44 3.08 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -146.25 96.99 2.87 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 13.3 m-30 -114.9 155.38 26.96 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.402 HG21 ' N ' ' A' ' 160' ' ' ILE . 93.3 m -120.86 129.12 53.4 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 119.668 -0.813 . . . . 0.0 108.809 -178.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.402 ' N ' HG21 ' A' ' 159' ' ' THR . 3.7 mp -106.45 122.34 60.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.6 m -119.53 -172.12 2.26 Favored 'General case' 0 C--N 1.357 0.93 0 CA-C-O 121.792 0.806 . . . . 0.0 109.338 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 28.2 ptt-85 -148.42 157.91 43.77 Favored 'General case' 0 C--N 1.356 0.854 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -178.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 56.2 p -98.37 146.77 32.12 Favored Pre-proline 0 C--N 1.359 0.995 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 178.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.677 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 72.7 Cg_endo -75.35 -12.54 20.85 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.903 2.402 . . . . 0.0 115.238 -178.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -72.53 -41.31 66.0 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 120.009 -0.676 . . . . 0.0 109.956 -178.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 35.6 p -118.11 16.06 14.11 Favored 'General case' 0 C--N 1.354 0.797 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.734 -178.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.677 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.4 pp0? -66.97 -12.75 60.68 Favored 'General case' 0 C--N 1.353 0.749 0 O-C-N 121.605 -0.685 . . . . 0.0 110.346 178.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 54.1 p-10 -123.67 38.72 4.13 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 14.6 t -141.65 147.44 37.55 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.621 ' O ' ' HB ' ' A' ' 171' ' ' THR . 46.3 mp0 -101.67 167.4 10.13 Favored 'General case' 0 C--N 1.355 0.847 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.621 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 5.8 m 82.99 -60.01 0.15 Allowed 'General case' 0 C--N 1.37 1.465 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -108.05 116.11 31.37 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 96.1 t -131.64 133.21 61.82 Favored 'Isoleucine or valine' 0 C--N 1.358 0.966 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 50.9 mm -108.16 126.2 64.78 Favored 'Isoleucine or valine' 0 C--N 1.359 1.0 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -114.55 154.53 28.12 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -137.58 118.94 14.68 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 -178.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.7 mp -113.59 120.37 63.29 Favored 'Isoleucine or valine' 0 C--N 1.353 0.742 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 90.6 m -119.91 143.5 47.93 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -177.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.574 ' HD3' ' HE ' ' A' ' 182' ' ' ARG . 37.2 ttm180 -79.59 114.3 18.41 Favored 'General case' 0 C--N 1.363 1.192 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.427 ' HA ' ' HD3' ' A' ' 181' ' ' PRO . . . -67.63 154.33 93.48 Favored Pre-proline 0 C--N 1.358 0.939 0 CA-C-O 121.993 0.901 . . . . 0.0 109.278 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 180' ' ' ALA . 52.9 Cg_exo -56.28 119.77 7.18 Favored 'Trans proline' 0 CA--C 1.499 -1.256 0 C-N-CA 122.865 2.377 . . . . 0.0 113.665 -179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.574 ' HE ' ' HD3' ' A' ' 179' ' ' ARG . 8.8 mtm180 -94.87 28.44 2.72 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.025 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 99.96 108.55 2.98 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 178.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 67.14 74.59 0.32 Allowed 'General case' 0 C--N 1.357 0.933 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 177.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -74.45 152.24 39.48 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -100.57 119.53 38.67 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 60.6 mt -116.03 -69.45 0.85 Allowed 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 179.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -139.65 -89.75 0.19 Allowed 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -129.26 149.15 51.18 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 . . . . . 0 C--O 1.264 1.82 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.887 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' CMO . . . . . 0.44 ' O ' HD12 ' A' ' 146' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' HEM . . . . . 1.072 ' HBD' ' HHA' ' A' ' 202' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.865 ' H2 ' HMDB ' A' ' 202' ' ' HEM . 87.7 mmm . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 121.09 0.471 . . . . 0.0 110.031 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.429 ' O ' ' HD1' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -82.04 -15.2 54.4 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 120.516 -0.474 . . . . 0.0 109.963 -178.338 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -71.65 -40.99 57.99 Favored Glycine 0 C--N 1.353 1.482 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.501 ' HG2' ' HB3' ' A' ' 39' ' ' SER . 76.5 mtm -70.15 -35.69 74.22 Favored 'General case' 0 C--N 1.356 0.873 0 O-C-N 121.958 -0.731 . . . . 0.0 111.499 -178.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.423 HG23 ' HA ' ' A' ' 2' ' ' MET . 32.8 m -68.45 -23.77 28.61 Favored 'Isoleucine or valine' 0 C--N 1.357 0.91 0 O-C-N 121.467 -0.77 . . . . 0.0 109.594 -179.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.506 ' HZ ' ' CG ' ' A' ' 47' ' ' GLU . 4.5 m-85 -71.38 -36.2 71.33 Favored 'General case' 0 C--N 1.358 0.949 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 90.1 m -66.7 -40.87 88.64 Favored 'General case' 0 C--N 1.357 0.913 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.75 -39.23 97.7 Favored Glycine 0 C--N 1.358 1.753 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.715 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -64.07 -41.47 97.33 Favored 'General case' 0 C--N 1.352 0.679 0 CA-C-N 117.163 0.482 . . . . 0.0 110.835 -178.515 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.639 ' HE3' HD22 ' A' ' 26' ' ' LEU . 17.6 mmt -63.58 -41.02 98.4 Favored 'General case' 0 C--N 1.353 0.746 0 O-C-N 121.438 -0.789 . . . . 0.0 111.079 -178.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -68.34 -40.5 81.55 Favored 'General case' 0 C--N 1.349 0.573 0 O-C-N 121.881 -0.512 . . . . 0.0 111.773 -177.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 56.3 tp -66.3 -43.65 85.69 Favored 'General case' 0 C--N 1.349 0.577 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -177.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.715 HG12 ' O ' ' A' ' 9' ' ' LEU . 1.1 mm -74.3 -34.6 37.5 Favored 'Isoleucine or valine' 0 C--N 1.358 0.956 0 O-C-N 121.127 -0.983 . . . . 0.0 110.96 -175.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.474 ' HB2' HD13 ' A' ' 22' ' ' LEU . 31.2 tt0 -72.73 -42.32 64.25 Favored 'General case' 0 C--N 1.35 0.59 0 O-C-N 121.642 -0.661 . . . . 0.0 111.538 -176.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -71.1 -37.9 72.38 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -175.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -99.42 -25.83 14.33 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 118.924 -1.11 . . . . 0.0 113.659 -174.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -113.62 -35.72 5.12 Favored 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 117.541 -1.664 . . . . 0.0 112.549 -176.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 145.31 177.78 20.35 Favored Glycine 0 C--N 1.349 1.266 0 C-N-CA 118.052 -2.023 . . . . 0.0 110.467 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -99.43 -27.16 13.87 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 -177.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -69.29 -39.22 78.45 Favored 'General case' 0 C--N 1.359 0.992 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 92.7 m -66.75 -39.1 87.78 Favored 'General case' 0 C--N 1.357 0.902 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.474 HD13 ' HB2' ' A' ' 14' ' ' GLU . 1.3 tt -61.62 -38.44 87.64 Favored 'General case' 0 C--N 1.358 0.938 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -63.74 -37.71 88.38 Favored 'General case' 0 C--N 1.356 0.875 0 O-C-N 122.026 -0.421 . . . . 0.0 110.765 -178.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.9 m -65.73 -38.96 90.58 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -178.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.596 HD12 ' HB3' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -63.67 -37.41 87.24 Favored 'General case' 0 C--N 1.354 0.765 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -179.043 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.639 HD22 ' HE3' ' A' ' 10' ' ' MET . 87.3 mt -74.02 -14.11 60.96 Favored 'General case' 0 C--N 1.359 0.998 0 O-C-N 121.722 -0.612 . . . . 0.0 110.337 -178.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -86.77 -28.23 23.13 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 119.218 -0.993 . . . . 0.0 109.203 179.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.1 t -67.39 -36.58 81.59 Favored 'General case' 0 C--N 1.354 0.761 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.679 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 2.0 p -92.12 -39.65 11.48 Favored 'General case' 0 C--N 1.358 0.963 0 C-N-CA 118.942 -1.103 . . . . 0.0 108.199 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.679 ' HB2' ' O ' ' A' ' 29' ' ' CYS . 14.5 mt-10 86.27 131.53 0.04 OUTLIER 'General case' 0 C--N 1.362 1.109 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.52 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -86.18 -169.45 2.64 Favored 'General case' 0 C--N 1.357 0.897 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.841 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.435 ' H ' ' HB2' ' A' ' 31' ' ' LEU . 53.6 tt0 -152.85 -28.23 0.15 Allowed 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 107.707 -1.219 . . . . 0.0 107.707 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.8 t -141.49 -71.13 0.35 Allowed 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -131.96 -42.97 0.99 Allowed 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.4 -32.71 4.22 Favored Glycine 0 C--N 1.353 1.479 0 N-CA-C 109.261 -1.535 . . . . 0.0 109.261 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 85.1 mt -111.63 101.33 12.38 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -96.41 -1.81 46.8 Favored 'General case' 0 C--N 1.354 0.803 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.571 HG22 ' H ' ' A' ' 39' ' ' SER . 4.0 m 80.1 174.9 0.13 Allowed 'General case' 0 C--N 1.362 1.13 0 N-CA-C 105.952 -1.869 . . . . 0.0 105.952 -178.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.571 ' H ' HG22 ' A' ' 38' ' ' THR . 26.0 p -89.16 113.84 25.07 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 121.033 -1.042 . . . . 0.0 109.78 -178.491 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -172.71 -8.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.362 1.143 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -113.55 164.75 12.02 Favored Glycine 0 C--N 1.357 1.698 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -178.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 53.5 m -129.11 132.78 47.44 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -117.98 170.62 8.68 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -77.64 -178.13 5.17 Favored 'General case' 0 C--N 1.356 0.866 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -88.32 -15.08 36.66 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -68.18 -29.8 68.75 Favored 'General case' 0 C--N 1.353 0.753 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 178.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.506 ' CG ' ' HZ ' ' A' ' 6' ' ' PHE . 24.1 tp10 -63.07 -41.6 99.47 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.467 HD22 ' O ' ' A' ' 48' ' ' LEU . 1.8 tm? -67.83 -39.99 83.83 Favored 'General case' 0 C--N 1.358 0.965 0 CA-C-O 120.647 0.26 . . . . 0.0 110.531 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 64.6 tp -71.01 -34.71 71.6 Favored 'General case' 0 CA--C 1.509 -0.62 0 O-C-N 122.132 -0.355 . . . . 0.0 110.661 -177.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 73.2 tp60 -65.81 -40.79 92.22 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 121.659 -0.651 . . . . 0.0 110.005 -178.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.596 ' HB3' HD12 ' A' ' 25' ' ' LEU . 73.4 mt -82.48 -19.22 39.25 Favored 'General case' 0 C--N 1.361 1.091 0 C-N-CA 119.622 -0.831 . . . . 0.0 110.574 -178.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.463 ' O ' HG13 ' A' ' 52' ' ' VAL . 1.4 t -79.35 -37.66 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.503 ' O ' HG11 ' A' ' 53' ' ' VAL . 54.2 t -69.05 -39.99 80.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.73 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 178.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.436 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 32.3 tptt -65.7 -27.86 68.64 Favored 'General case' 0 C--N 1.363 1.191 0 O-C-N 121.214 -0.929 . . . . 0.0 108.754 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.439 HD12 HD12 ' A' ' 13' ' ' ILE . 1.8 tt -67.44 -39.33 85.39 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 60' ' ' SER . 81.1 p -72.42 -17.33 61.81 Favored 'General case' 0 C--N 1.358 0.949 0 O-C-N 121.694 -0.628 . . . . 0.0 111.019 -178.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -99.96 -36.78 9.27 Favored 'General case' 0 C--N 1.353 0.736 0 O-C-N 121.153 -0.967 . . . . 0.0 111.346 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.545 HG11 ' N ' ' A' ' 59' ' ' SER . 5.2 p -70.38 -34.35 57.76 Favored 'Isoleucine or valine' 0 C--N 1.352 0.687 0 O-C-N 121.74 -0.6 . . . . 0.0 111.338 -177.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.545 ' N ' HG11 ' A' ' 58' ' ' VAL . 2.0 t -120.81 -7.15 9.57 Favored 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 119.128 -1.029 . . . . 0.0 109.924 -178.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 56' ' ' SER . 0.5 OUTLIER 65.67 47.6 2.12 Favored 'General case' 0 C--N 1.353 0.753 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.792 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.418 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 52.9 t -106.56 132.44 20.9 Favored Pre-proline 0 N--CA 1.443 -0.785 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 61' ' ' VAL . 46.4 Cg_exo -57.2 146.89 79.42 Favored 'Trans proline' 0 CA--C 1.498 -1.301 0 C-N-CA 122.504 2.136 . . . . 0.0 112.845 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.406 ' HA ' HD22 ' A' ' 66' ' ' LEU . 3.5 m -75.49 -12.12 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.605 -178.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 70.2 p -97.65 -32.71 11.63 Favored 'General case' 0 C--N 1.359 0.994 0 C-N-CA 118.258 -1.377 . . . . 0.0 109.26 -179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -75.43 -23.26 56.94 Favored 'General case' 0 C--N 1.355 0.841 0 O-C-N 121.42 -0.8 . . . . 0.0 109.106 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.406 HD22 ' HA ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -82.2 -34.86 28.79 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -179.007 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.586 HG12 ' N ' ' A' ' 68' ' ' ARG . 1.6 p -68.21 -27.15 36.0 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.688 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.586 ' N ' HG12 ' A' ' 67' ' ' VAL . 4.8 mmm-85 -73.28 -52.12 15.13 Favored 'General case' 0 C--N 1.364 1.198 0 O-C-N 121.609 -0.682 . . . . 0.0 110.284 -179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.66 -35.6 80.16 Favored 'General case' 0 C--N 1.357 0.92 0 O-C-N 121.973 -0.454 . . . . 0.0 110.954 -178.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -60.95 -47.74 85.05 Favored 'General case' 0 C--N 1.349 0.581 0 O-C-N 122.083 -0.385 . . . . 0.0 110.54 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.99 -38.95 96.35 Favored Glycine 0 C--N 1.355 1.587 0 N-CA-C 111.997 -0.441 . . . . 0.0 111.997 -178.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -63.38 -48.54 77.5 Favored 'General case' 0 C--N 1.35 0.626 0 CA-C-N 118.303 1.052 . . . . 0.0 111.55 -177.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.688 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 11.9 mttm -63.89 -48.6 76.03 Favored 'General case' 0 C--N 1.358 0.961 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -177.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.463 ' O ' HD23 ' A' ' 74' ' ' LEU . 2.3 tm? -68.54 -39.12 81.26 Favored 'General case' 0 C--N 1.35 0.588 0 O-C-N 121.197 -0.94 . . . . 0.0 111.699 -175.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.82 ' CE1' ' HBB' ' A' ' 202' ' ' HEM . 43.8 t80 -62.95 -45.07 94.21 Favored 'General case' 0 C--N 1.352 0.715 0 O-C-N 121.241 -0.912 . . . . 0.0 111.165 -178.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 76' ' ' VAL . 9.8 p -71.09 -14.66 18.11 Favored 'Isoleucine or valine' 0 C--N 1.359 1.006 0 O-C-N 121.396 -0.815 . . . . 0.0 109.5 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.688 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 73.6 mm-40 -71.43 -39.81 70.8 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 82.9 mt -70.94 -34.96 71.99 Favored 'General case' 0 C--N 1.357 0.911 0 O-C-N 122.188 -0.32 . . . . 0.0 110.599 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.6 mm -63.79 -53.33 45.82 Favored 'Isoleucine or valine' 0 C--N 1.357 0.916 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.615 -176.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -75.15 -10.98 59.96 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.938 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.23 -11.16 60.15 Favored Glycine 0 C--N 1.35 1.345 0 C-N-CA 119.734 -1.222 . . . . 0.0 110.696 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.494 ' HB2' HG22 ' A' ' 85' ' ' ILE . 96.3 m-70 -138.34 96.27 9.99 Favored Pre-proline 0 CA--C 1.503 -0.865 0 CA-C-N 118.991 1.396 . . . . 0.0 108.836 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.473 ' O ' ' HB2' ' A' ' 87' ' ' ASN . 37.7 Cg_endo -67.87 -25.74 38.74 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.428 2.085 . . . . 0.0 114.293 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -91.11 -8.39 48.96 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.494 HG22 ' HB2' ' A' ' 82' ' ' HIS . 1.5 tp -89.35 -21.73 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 -178.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.81 -16.94 15.26 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.473 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 47.1 t30 -70.84 -41.62 71.25 Favored 'General case' 0 C--N 1.36 1.046 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -68.5 -30.36 69.17 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.387 -178.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 29.5 ttp -84.0 148.07 27.08 Favored 'General case' 0 C--N 1.35 0.623 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.04 -21.62 8.2 Favored 'General case' 0 C--N 1.362 1.119 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.865 -177.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -164.83 170.64 15.18 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 119.172 -1.011 . . . . 0.0 108.337 -177.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.418 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 41.1 t -64.43 -41.96 96.28 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.806 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -66.17 -38.93 89.24 Favored 'General case' 0 C--N 1.355 0.821 0 O-C-N 121.568 -0.708 . . . . 0.0 109.251 -178.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -65.59 -25.84 67.58 Favored 'General case' 0 C--N 1.357 0.906 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.418 ' HB3' ' O ' ' A' ' 92' ' ' SER . 59.9 tp -62.74 -46.52 87.69 Favored 'General case' 0 C--N 1.355 0.823 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.3 mp -62.71 -32.59 73.73 Favored 'General case' 0 C--N 1.353 0.76 0 O-C-N 122.221 -0.299 . . . . 0.0 110.502 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 37.2 t -62.57 -45.22 93.9 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 121.774 -0.579 . . . . 0.0 111.351 -178.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.3 26.28 10.84 Favored 'General case' 0 C--N 1.363 1.185 0 O-C-N 121.07 -1.019 . . . . 0.0 110.491 -178.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.675 ' CD1' HMBA ' A' ' 202' ' ' HEM . 10.1 tt -60.6 -29.53 44.97 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.575 -179.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.464 ' N ' HG22 ' A' ' 99' ' ' ILE . 10.6 p-10 -129.3 -7.12 4.78 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 118.444 -1.302 . . . . 0.0 110.039 -179.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 64.5 m -90.75 -3.21 57.61 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.295 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -147.68 -48.7 0.17 Allowed 'General case' 0 C--N 1.357 0.911 0 C-N-CA 118.221 -1.392 . . . . 0.0 109.724 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 96.1 mt -65.75 -47.39 86.07 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 O-C-N 122.038 -0.414 . . . . 0.0 110.922 -177.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 22.7 m170 -83.77 -3.79 58.11 Favored 'General case' 0 C--N 1.354 0.799 0 O-C-N 121.461 -0.774 . . . . 0.0 109.78 -177.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 56.4 t -75.13 -45.24 42.51 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.907 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -70.0 -38.94 76.13 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -178.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 56.7 t -61.65 -46.31 96.82 Favored 'Isoleucine or valine' 0 C--N 1.355 0.822 0 O-C-N 122.196 -0.315 . . . . 0.0 110.48 -178.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -60.04 -47.76 84.5 Favored 'General case' 0 C--N 1.357 0.898 0 O-C-N 122.127 -0.358 . . . . 0.0 111.089 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -61.77 -36.07 79.97 Favored 'General case' 0 C--N 1.355 0.839 0 O-C-N 121.552 -0.718 . . . . 0.0 110.11 -178.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 15.3 mt -59.66 -79.66 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -111.97 140.59 23.59 Favored Pre-proline 0 N--CA 1.442 -0.848 0 C-N-CA 118.877 -1.129 . . . . 0.0 109.242 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -88.84 -6.1 5.82 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 123.286 2.657 . . . . 0.0 114.919 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -69.02 -33.7 74.06 Favored 'General case' 0 C--N 1.353 0.722 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.66 145.08 56.72 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 121.697 0.761 . . . . 0.0 110.13 -178.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.457 ' O ' HD12 ' A' ' 116' ' ' LEU . 46.5 mt-10 -118.55 143.32 46.84 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 179.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.457 HD12 ' O ' ' A' ' 115' ' ' GLU . 2.6 mm? -126.77 149.7 69.31 Favored Pre-proline 0 N--CA 1.445 -0.702 0 CA-C-O 122.074 0.94 . . . . 0.0 108.597 -178.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 116' ' ' LEU . 87.7 Cg_endo -91.28 -155.51 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.265 0 C-N-CA 123.743 2.962 . . . . 0.0 113.197 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -115.98 138.32 51.31 Favored 'General case' 0 C--N 1.362 1.113 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -127.16 129.54 48.08 Favored 'General case' 0 C--N 1.361 1.104 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.576 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 93.2 m -128.58 131.44 48.18 Favored 'General case' 0 C--N 1.356 0.864 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 177.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -125.01 132.44 53.24 Favored 'General case' 0 CA--C 1.503 -0.853 0 C-N-CA 119.316 -0.954 . . . . 0.0 109.769 -178.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -121.28 140.81 51.57 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 178.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.466 ' HG3' HD11 ' A' ' 129' ' ' ILE . 57.7 ttp180 -111.88 117.75 33.62 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.439 ' HA ' HD22 ' A' ' 124' ' ' LEU . 94.9 mt -92.91 -16.64 24.95 Favored 'General case' 0 C--N 1.354 0.781 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.193 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 178.19 -150.48 9.83 Favored Glycine 0 C--N 1.347 1.186 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -91.33 -39.69 11.9 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.43 ' HB2' ' HB2' ' A' ' 179' ' ' ARG . 8.2 p30 -104.87 9.3 34.8 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 119.759 -0.777 . . . . 0.0 109.177 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -119.64 124.62 46.76 Favored 'General case' 0 C--N 1.358 0.961 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.53 HG22 ' N ' ' A' ' 130' ' ' ARG . 9.8 mm -140.13 137.25 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.53 ' N ' HG22 ' A' ' 129' ' ' ILE . 50.9 mtm180 -116.95 137.65 52.08 Favored 'General case' 0 CA--C 1.492 -1.266 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 6.7 tp -123.23 117.86 26.27 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.023 -0.989 . . . . 0.0 108.486 -178.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.576 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 12.6 m-70 -99.6 131.32 45.68 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -127.95 121.37 29.73 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.542 ' HA ' ' O ' ' A' ' 171' ' ' THR . 75.3 mt-30 -114.5 115.02 26.57 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 179.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.2 t -162.86 152.22 15.31 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -90.81 1.14 57.18 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 120.17 -0.612 . . . . 0.0 109.794 -178.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -136.22 74.26 55.79 Favored Pre-proline 0 C--N 1.354 0.789 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -95.42 110.64 0.14 Allowed 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.54 2.16 . . . . 0.0 115.935 -177.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -110.99 112.1 23.69 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 176.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.12 -39.27 93.68 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.424 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.3 m -63.7 -26.96 68.9 Favored 'General case' 0 C--N 1.353 0.758 0 O-C-N 121.894 -0.504 . . . . 0.0 110.729 -178.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -75.78 -47.03 27.5 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 121.731 -0.606 . . . . 0.0 109.692 -177.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.28 -39.83 93.07 Favored 'General case' 0 C--N 1.358 0.94 0 O-C-N 122.074 -0.391 . . . . 0.0 111.323 -178.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -62.97 -36.85 84.87 Favored 'General case' 0 C--N 1.357 0.909 0 O-C-N 121.827 -0.546 . . . . 0.0 109.972 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.6 -43.01 99.42 Favored Glycine 0 C--N 1.346 1.114 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 83.9 mt -70.49 -40.64 73.47 Favored 'General case' 0 C--N 1.351 0.672 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -179.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 98.2 mt -70.92 -42.55 69.75 Favored 'General case' 0 C--N 1.361 1.09 0 O-C-N 121.154 -0.966 . . . . 0.0 110.907 -176.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.572 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 37.2 t70 -70.12 -29.43 66.36 Favored 'General case' 0 N--CA 1.444 -0.737 0 O-C-N 121.995 -0.44 . . . . 0.0 110.373 -179.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -63.1 -39.57 98.16 Favored Glycine 0 C--N 1.357 1.701 0 N-CA-C 108.474 -1.85 . . . . 0.0 108.474 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 45.1 t -61.01 -42.22 98.03 Favored 'General case' 0 C--N 1.351 0.672 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -75.92 0.73 17.29 Favored 'General case' 0 C--N 1.36 1.027 0 O-C-N 121.803 -0.561 . . . . 0.0 109.489 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.572 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 76.8 mm-40 -85.78 -45.96 11.12 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.016 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -66.67 -44.63 81.29 Favored 'General case' 0 C--N 1.358 0.949 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.463 ' O ' ' HB2' ' A' ' 155' ' ' LYS . 51.6 m-85 -70.12 -26.08 63.79 Favored 'General case' 0 C--N 1.361 1.077 0 O-C-N 121.783 -0.573 . . . . 0.0 111.126 -178.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 154' ' ' PHE . 41.1 mttt 73.39 71.32 0.12 Allowed 'General case' 0 C--N 1.361 1.102 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -178.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -137.02 -172.48 3.2 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -148.72 94.0 2.21 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 19.3 m-30 -114.89 158.79 21.49 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 94.0 m -118.32 125.03 49.23 Favored 'General case' 0 C--N 1.356 0.868 0 C-N-CA 119.368 -0.933 . . . . 0.0 108.848 -178.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 3.6 mp -101.57 121.8 52.94 Favored 'Isoleucine or valine' 0 C--N 1.353 0.736 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 178.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.2 m -119.2 -173.53 2.53 Favored 'General case' 0 C--N 1.357 0.907 0 CA-C-O 121.787 0.803 . . . . 0.0 109.55 -178.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -147.52 155.95 42.37 Favored 'General case' 0 C--N 1.357 0.918 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -178.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 57.4 p -99.07 146.83 32.36 Favored Pre-proline 0 C--N 1.358 0.966 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.696 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 73.7 Cg_endo -76.02 -10.99 19.72 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.786 2.324 . . . . 0.0 115.082 -178.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -73.17 -41.45 63.85 Favored 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.795 -178.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 37.3 p -117.27 14.96 14.88 Favored 'General case' 0 C--N 1.356 0.872 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.734 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.696 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.1 pp0? -66.52 -12.75 59.08 Favored 'General case' 0 C--N 1.353 0.748 0 O-C-N 121.62 -0.675 . . . . 0.0 110.521 178.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 53.8 p-10 -121.89 34.71 5.09 Favored 'General case' 0 N--CA 1.439 -1.015 0 O-C-N 121.068 -1.02 . . . . 0.0 108.447 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 57.2 m -136.11 148.45 48.26 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.65 ' O ' ' HB ' ' A' ' 171' ' ' THR . 61.1 mt-10 -101.85 166.37 10.69 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.65 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 2.5 m 83.2 -56.94 0.16 Allowed 'General case' 0 C--N 1.368 1.374 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -112.23 117.62 33.05 Favored 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 119.861 -0.735 . . . . 0.0 109.609 -178.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.434 HG13 ' CE1' ' A' ' 175' ' ' PHE . 88.5 t -130.73 132.83 63.99 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 49.8 mm -107.35 125.86 63.58 Favored 'Isoleucine or valine' 0 C--N 1.359 0.982 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.434 ' CE1' HG13 ' A' ' 173' ' ' VAL . 93.9 m-85 -114.92 155.89 26.04 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 122.061 0.934 . . . . 0.0 108.652 -179.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -138.16 119.31 14.52 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -178.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.8 mp -115.09 121.37 66.95 Favored 'Isoleucine or valine' 0 C--N 1.353 0.735 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 42.8 p -126.02 159.86 31.61 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 121.698 0.761 . . . . 0.0 110.854 -177.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.43 ' HB2' ' HB2' ' A' ' 127' ' ' ASN . 0.1 OUTLIER -99.35 113.4 25.7 Favored 'General case' 0 C--N 1.366 1.287 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 177.358 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -60.34 148.86 78.65 Favored Pre-proline 0 C--N 1.358 0.972 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.12 132.05 28.73 Favored 'Trans proline' 0 CA--C 1.495 -1.457 0 C-N-CA 122.225 1.95 . . . . 0.0 113.984 -178.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.47 HH11 ' HD2' ' A' ' 182' ' ' ARG . 7.0 mtm105 -137.79 -79.99 0.36 Allowed 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -135.02 160.26 24.26 Favored Glycine 0 C--N 1.348 1.237 0 N-CA-C 107.66 -2.176 . . . . 0.0 107.66 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 67.97 63.42 0.39 Allowed 'General case' 0 C--N 1.36 1.024 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -120.08 109.55 15.6 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -117.55 122.5 43.83 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 84.6 mt -117.47 -69.67 0.84 Allowed 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -140.0 -104.36 0.16 Allowed 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -117.47 146.31 43.59 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 . . . . . 0 C--O 1.263 1.812 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 179.966 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' HEM . . . . . 0.865 HMDB ' H2 ' ' A' ' 1' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.916 ' HG2' ' CMD' ' A' ' 202' ' ' HEM . 81.5 mmm . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.068 0.461 . . . . 0.0 110.147 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.594 ' HA ' HG23 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -79.27 -19.55 50.29 Favored 'General case' 0 C--N 1.356 0.877 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -178.945 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.06 -41.13 40.91 Favored Glycine 0 C--N 1.348 1.224 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.92 -34.95 69.49 Favored 'General case' 0 C--N 1.354 0.779 0 O-C-N 122.119 -0.636 . . . . 0.0 111.3 -177.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.594 HG23 ' HA ' ' A' ' 2' ' ' MET . 34.9 m -71.04 -23.5 23.56 Favored 'Isoleucine or valine' 0 C--N 1.352 0.714 0 C-N-CA 119.915 -0.714 . . . . 0.0 109.122 -179.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.434 ' N ' HG22 ' A' ' 5' ' ' VAL . 7.4 m-30 -71.75 -33.44 68.66 Favored 'General case' 0 C--N 1.358 0.969 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 85.0 m -66.98 -40.06 87.32 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.24 -37.79 95.13 Favored Glycine 0 C--N 1.357 1.72 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.63 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -67.77 -38.47 83.46 Favored 'General case' 0 C--N 1.353 0.719 0 CA-C-N 117.346 0.573 . . . . 0.0 110.297 -178.006 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.934 ' HE3' HD23 ' A' ' 26' ' ' LEU . 22.0 mmt -64.01 -41.22 97.54 Favored 'General case' 0 C--N 1.356 0.868 0 O-C-N 121.644 -0.66 . . . . 0.0 111.002 -178.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -66.09 -40.33 90.73 Favored 'General case' 0 C--N 1.348 0.504 0 O-C-N 122.17 -0.331 . . . . 0.0 111.554 -177.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 55.5 tp -65.78 -42.74 90.41 Favored 'General case' 0 C--N 1.349 0.575 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -178.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.63 HG12 ' O ' ' A' ' 9' ' ' LEU . 2.4 mm -73.83 -36.96 47.37 Favored 'Isoleucine or valine' 0 C--N 1.358 0.949 0 O-C-N 121.067 -1.021 . . . . 0.0 111.167 -175.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -67.42 -44.43 78.79 Favored 'General case' 0 C--N 1.353 0.733 0 O-C-N 121.815 -0.553 . . . . 0.0 111.432 -176.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -72.85 -31.14 64.54 Favored 'General case' 0 N--CA 1.447 -0.579 0 O-C-N 122.013 -0.429 . . . . 0.0 111.626 -177.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -72.74 -50.02 27.24 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -175.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -128.47 -20.25 3.68 Favored 'General case' 0 C--N 1.354 0.797 0 C-N-CA 117.328 -1.749 . . . . 0.0 113.328 -176.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 144.44 179.79 21.13 Favored Glycine 0 N--CA 1.44 -1.061 0 C-N-CA 117.575 -2.25 . . . . 0.0 110.537 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.412 ' HD1' HD22 ' A' ' 22' ' ' LEU . 79.2 t80 -96.55 -16.37 21.11 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 -177.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -70.08 -41.18 74.45 Favored 'General case' 0 C--N 1.36 1.051 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.6 m -69.76 -38.42 76.76 Favored 'General case' 0 C--N 1.358 0.944 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.412 HD22 ' HD1' ' A' ' 19' ' ' TYR . 39.6 tp -59.64 -37.94 80.03 Favored 'General case' 0 C--N 1.356 0.867 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -65.76 -35.61 81.21 Favored 'General case' 0 C--N 1.356 0.89 0 O-C-N 122.068 -0.395 . . . . 0.0 110.847 -178.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.439 ' O ' HG23 ' A' ' 24' ' ' THR . 85.8 m -65.33 -39.42 92.38 Favored 'General case' 0 C--N 1.355 0.815 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 -178.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.489 HD12 HD21 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -63.33 -37.96 89.29 Favored 'General case' 0 C--N 1.355 0.807 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.522 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.934 HD23 ' HE3' ' A' ' 10' ' ' MET . 84.5 mt -75.28 -11.85 60.15 Favored 'General case' 0 C--N 1.361 1.079 0 O-C-N 121.652 -0.655 . . . . 0.0 110.457 -178.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -88.48 -27.22 21.63 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 119.115 -1.034 . . . . 0.0 108.982 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.7 t -68.26 -37.64 80.94 Favored 'General case' 0 C--N 1.356 0.883 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.8 p -90.54 -41.07 11.6 Favored 'General case' 0 C--N 1.358 0.935 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 85.02 134.09 0.05 OUTLIER 'General case' 0 C--N 1.36 1.047 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.469 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -84.9 -171.75 3.81 Favored 'General case' 0 C--N 1.356 0.88 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.89 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.416 ' H ' ' HB2' ' A' ' 31' ' ' LEU . 63.1 tt0 -151.27 -23.69 0.21 Allowed 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.9 t -148.34 -64.53 0.25 Allowed 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -131.13 -55.97 1.04 Allowed 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 130.76 -44.61 1.2 Allowed Glycine 0 C--N 1.353 1.498 0 N-CA-C 108.749 -1.74 . . . . 0.0 108.749 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 80.3 mt -107.08 100.45 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.758 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.563 ' O ' ' HB ' ' A' ' 38' ' ' THR . 0.9 OUTLIER -71.79 -28.7 63.79 Favored 'General case' 0 C--N 1.357 0.924 0 O-C-N 121.962 -0.461 . . . . 0.0 109.912 -179.844 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.563 ' HB ' ' O ' ' A' ' 37' ' ' TYR . 12.3 m 113.3 -67.36 0.0 OUTLIER 'General case' 0 C--N 1.37 1.47 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.679 ' C ' HG21 ' A' ' 40' ' ' VAL . 14.1 p 175.01 64.25 0.0 OUTLIER 'General case' 0 C--N 1.359 0.993 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.679 HG21 ' C ' ' A' ' 39' ' ' SER . 2.1 t -148.59 -5.97 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.836 0 C-N-CA 119.573 -0.851 . . . . 0.0 109.725 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -98.56 144.32 17.15 Favored Glycine 0 C--N 1.352 1.444 0 C-N-CA 119.162 -1.494 . . . . 0.0 110.23 -177.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.2 m -124.53 122.5 37.75 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -117.63 179.4 4.07 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -83.02 -171.33 3.5 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 73.3 m80 -93.67 -15.13 25.61 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.418 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -70.6 -28.7 65.05 Favored 'General case' 0 C--N 1.354 0.767 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 27.5 tp10 -63.27 -41.12 98.99 Favored 'General case' 0 C--N 1.352 0.688 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 60.9 tp -67.7 -37.99 83.04 Favored 'General case' 0 C--N 1.355 0.823 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.295 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.451 ' O ' HG22 ' A' ' 53' ' ' VAL . 59.8 tp -77.37 -27.74 52.69 Favored 'General case' 0 C--N 1.351 0.633 0 O-C-N 121.983 -0.448 . . . . 0.0 110.496 -176.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 72.7 tp60 -68.48 -42.38 78.78 Favored 'General case' 0 C--N 1.351 0.672 0 O-C-N 121.546 -0.721 . . . . 0.0 109.526 -178.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.489 HD21 HD12 ' A' ' 25' ' ' LEU . 82.4 mt -71.9 -35.16 69.62 Favored 'General case' 0 C--N 1.362 1.14 0 C-N-CA 119.963 -0.695 . . . . 0.0 109.355 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.574 HG12 HD21 ' A' ' 66' ' ' LEU . 33.6 t -62.02 -40.21 86.51 Favored 'Isoleucine or valine' 0 C--N 1.351 0.632 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.504 ' O ' HG11 ' A' ' 53' ' ' VAL . 55.9 t -67.57 -39.33 82.16 Favored 'Isoleucine or valine' 0 C--N 1.351 0.631 0 O-C-N 121.723 -0.611 . . . . 0.0 109.392 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.466 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 33.7 tptt -65.39 -29.17 69.85 Favored 'General case' 0 C--N 1.361 1.07 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -179.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.486 HD13 HD11 ' A' ' 66' ' ' LEU . 19.7 mt -66.17 -37.94 86.86 Favored 'General case' 0 C--N 1.355 0.815 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.303 179.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 56.3 p -72.16 -17.68 61.93 Favored 'General case' 0 C--N 1.354 0.796 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.704 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -101.8 -37.56 8.24 Favored 'General case' 0 C--N 1.353 0.754 0 O-C-N 121.244 -0.91 . . . . 0.0 111.473 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.1 p -74.22 -38.38 47.88 Favored 'Isoleucine or valine' 0 C--N 1.354 0.779 0 O-C-N 121.599 -0.688 . . . . 0.0 111.143 -177.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 3.4 t -112.21 -7.62 14.02 Favored 'General case' 0 C--N 1.353 0.756 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.309 -177.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 64.25 47.73 3.09 Favored 'General case' 0 C--N 1.354 0.781 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.638 HG13 ' HD2' ' A' ' 62' ' ' PRO . 62.0 t -111.5 133.8 21.37 Favored Pre-proline 0 N--CA 1.443 -0.813 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.638 ' HD2' HG13 ' A' ' 61' ' ' VAL . 34.1 Cg_exo -58.44 148.35 80.91 Favored 'Trans proline' 0 CA--C 1.498 -1.294 0 C-N-CA 122.565 2.177 . . . . 0.0 112.771 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.462 HG22 HG22 ' A' ' 64' ' ' THR . 3.9 m -72.73 -15.02 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.687 -178.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.462 HG22 HG22 ' A' ' 63' ' ' VAL . 70.6 p -96.42 -31.61 12.75 Favored 'General case' 0 C--N 1.359 0.987 0 C-N-CA 118.608 -1.237 . . . . 0.0 109.075 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -71.06 -33.01 69.86 Favored 'General case' 0 C--N 1.353 0.728 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.574 HD21 HG12 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -77.23 -34.88 55.91 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -177.889 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.585 HG12 ' N ' ' A' ' 68' ' ' ARG . 1.5 p -70.64 -26.03 27.64 Favored 'Isoleucine or valine' 0 C--N 1.354 0.776 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.523 -178.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.585 ' N ' HG12 ' A' ' 67' ' ' VAL . 5.3 mmm-85 -74.58 -51.44 14.55 Favored 'General case' 0 C--N 1.36 1.039 0 O-C-N 121.438 -0.789 . . . . 0.0 110.105 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.0 mt -63.2 -35.33 79.97 Favored 'General case' 0 C--N 1.357 0.896 0 O-C-N 122.046 -0.409 . . . . 0.0 110.606 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -60.94 -47.16 87.72 Favored 'General case' 0 C--N 1.35 0.623 0 O-C-N 122.301 -0.25 . . . . 0.0 110.333 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.6 -38.58 95.23 Favored Glycine 0 C--N 1.354 1.547 0 N-CA-C 111.848 -0.501 . . . . 0.0 111.848 -178.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -63.86 -47.65 79.84 Favored 'General case' 0 C--N 1.353 0.726 0 CA-C-N 118.411 1.105 . . . . 0.0 111.457 -177.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.749 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 12.9 mttm -64.15 -49.46 72.02 Favored 'General case' 0 C--N 1.358 0.97 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -176.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.422 HD21 ' HB2' ' A' ' 77' ' ' GLU . 2.2 tm? -69.18 -39.38 78.75 Favored 'General case' 0 C--N 1.35 0.609 0 O-C-N 121.214 -0.929 . . . . 0.0 111.882 -175.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -63.47 -44.29 94.86 Favored 'General case' 0 C--N 1.353 0.748 0 O-C-N 121.122 -0.987 . . . . 0.0 110.988 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.29 -14.89 18.19 Favored 'Isoleucine or valine' 0 C--N 1.358 0.954 0 O-C-N 121.496 -0.752 . . . . 0.0 109.194 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.749 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 74.3 mm-40 -71.43 -38.98 71.34 Favored 'General case' 0 C--N 1.352 0.674 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 82.5 mt -72.99 -31.36 64.45 Favored 'General case' 0 C--N 1.356 0.855 0 O-C-N 122.426 -0.171 . . . . 0.0 110.545 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 49.1 mm -65.58 -54.25 30.19 Favored 'Isoleucine or valine' 0 C--N 1.359 0.993 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.286 -177.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -75.38 -14.57 60.48 Favored 'General case' 0 CA--C 1.51 -0.571 0 C-N-CA 119.516 -0.874 . . . . 0.0 109.381 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.35 -37.21 63.01 Favored Glycine 0 C--N 1.349 1.259 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.417 ' HB2' HG23 ' A' ' 85' ' ' ILE . 98.7 m-70 -131.38 106.24 14.61 Favored Pre-proline 0 N--CA 1.441 -0.885 0 CA-C-O 122.664 1.221 . . . . 0.0 109.046 -177.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.33 -24.87 42.88 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.52 2.147 . . . . 0.0 114.113 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.433 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 44.6 mt-10 -93.11 -4.95 51.39 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.417 HG23 ' HB2' ' A' ' 82' ' ' HIS . 1.0 OUTLIER -90.32 -20.08 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.224 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 -179.629 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -101.72 -24.66 14.05 Favored 'General case' 0 C--N 1.36 1.038 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -70.26 -35.65 73.92 Favored 'General case' 0 C--N 1.358 0.955 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 84' ' ' GLU . 78.6 mm-40 -65.01 -36.1 83.31 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 122.058 -0.401 . . . . 0.0 110.058 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.458 ' HE1' ' HB3' ' A' ' 89' ' ' MET . 21.8 ttp -83.56 149.87 26.31 Favored 'General case' 0 C--N 1.352 0.698 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -178.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.53 -21.95 8.36 Favored 'General case' 0 C--N 1.364 1.222 0 C-N-CA 120.074 -0.651 . . . . 0.0 111.032 -177.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -164.55 170.93 15.19 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 -177.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.425 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 41.0 t -64.4 -42.69 95.97 Favored 'General case' 0 C--N 1.356 0.873 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.955 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -66.86 -38.82 87.09 Favored 'General case' 0 C--N 1.355 0.833 0 O-C-N 121.492 -0.755 . . . . 0.0 109.328 -178.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -65.91 -24.61 66.87 Favored 'General case' 0 C--N 1.357 0.912 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.425 ' HB3' ' O ' ' A' ' 92' ' ' SER . 62.5 tp -63.09 -46.41 87.53 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.7 mp -63.03 -32.35 73.7 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 122.185 -0.322 . . . . 0.0 110.405 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 36.5 t -62.15 -45.08 95.04 Favored 'General case' 0 C--N 1.355 0.847 0 O-C-N 121.783 -0.573 . . . . 0.0 111.304 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.66 26.42 10.39 Favored 'General case' 0 C--N 1.362 1.11 0 O-C-N 121.015 -1.053 . . . . 0.0 110.515 -178.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 1.046 HD12 ' C3B' ' A' ' 202' ' ' HEM . 13.0 tt -64.09 -29.57 47.69 Favored 'Isoleucine or valine' 0 C--N 1.352 0.691 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.151 -179.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.484 ' N ' HG22 ' A' ' 99' ' ' ILE . 4.0 p-10 -126.21 -9.46 6.44 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 118.564 -1.254 . . . . 0.0 109.762 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 58.8 m -90.92 -2.54 57.72 Favored 'General case' 0 N--CA 1.441 -0.884 0 O-C-N 121.406 -0.809 . . . . 0.0 110.345 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -147.03 -47.69 0.18 Allowed 'General case' 0 C--N 1.358 0.968 0 C-N-CA 118.28 -1.368 . . . . 0.0 109.913 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 96.2 mt -67.53 -47.84 79.07 Favored 'Isoleucine or valine' 0 C--N 1.354 0.779 0 O-C-N 121.931 -0.481 . . . . 0.0 111.161 -178.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 22.4 m170 -83.55 -1.14 53.09 Favored 'General case' 0 C--N 1.356 0.875 0 O-C-N 121.403 -0.811 . . . . 0.0 110.056 -177.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 70.5 t -83.96 -43.13 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.952 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -67.3 -39.88 85.99 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.323 -178.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.1 p -71.97 -36.5 57.74 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 C-N-CA 119.596 -0.842 . . . . 0.0 110.106 -178.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 93.3 t80 -60.86 -48.6 81.07 Favored 'General case' 0 C--N 1.363 1.171 0 O-C-N 121.744 -0.597 . . . . 0.0 110.71 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -60.25 -38.1 82.45 Favored 'General case' 0 C--N 1.358 0.941 0 O-C-N 121.665 -0.647 . . . . 0.0 110.069 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 16.9 mt -58.05 -76.56 0.04 OUTLIER 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.423 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 91.3 m-85 -115.72 134.3 22.7 Favored Pre-proline 0 N--CA 1.44 -0.954 0 C-N-CA 118.986 -1.086 . . . . 0.0 108.83 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 111' ' ' TYR . 74.3 Cg_endo -86.21 -2.08 8.62 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 123.222 2.615 . . . . 0.0 115.403 -179.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -67.39 -36.18 80.8 Favored 'General case' 0 C--N 1.355 0.814 0 O-C-N 121.773 -0.579 . . . . 0.0 109.997 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.73 143.99 55.36 Favored 'General case' 0 C--N 1.354 0.775 0 CA-C-O 121.651 0.738 . . . . 0.0 110.018 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.417 ' O ' HD13 ' A' ' 116' ' ' LEU . 46.2 mt-10 -114.26 145.58 41.55 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 117' ' ' PRO . 5.6 mp -127.48 145.78 55.91 Favored Pre-proline 0 N--CA 1.445 -0.716 0 CA-C-O 122.198 0.999 . . . . 0.0 108.98 -178.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.548 ' HD3' HBAA ' A' ' 202' ' ' HEM . 73.7 Cg_endo -91.31 -152.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.197 0 C-N-CA 123.909 3.073 . . . . 0.0 113.178 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.421 ' H ' ' HB2' ' A' ' 117' ' ' PRO . 75.0 mmtt -115.03 142.46 46.61 Favored 'General case' 0 C--N 1.362 1.125 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 179.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.598 ' CE2' ' HD1' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -137.71 125.42 22.37 Favored 'General case' 0 C--N 1.361 1.09 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -177.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.433 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 94.1 m -124.23 129.99 51.74 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 177.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 74.8 m -118.01 131.35 56.48 Favored 'General case' 0 CA--C 1.504 -0.8 0 C-N-CA 119.277 -0.969 . . . . 0.0 109.852 -177.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -121.02 148.37 44.22 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 58.1 ttp180 -123.32 117.39 25.13 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.487 ' HA ' HD22 ' A' ' 124' ' ' LEU . 95.3 mt -92.07 -15.09 28.27 Favored 'General case' 0 C--N 1.354 0.797 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.709 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 178.59 -150.37 9.61 Favored Glycine 0 N--CA 1.439 -1.154 0 N-CA-C 108.886 -1.686 . . . . 0.0 108.886 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -90.4 -38.23 13.45 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -105.99 9.5 32.55 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 119.762 -0.775 . . . . 0.0 109.524 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.471 ' CB ' ' HB2' ' A' ' 124' ' ' LEU . 61.9 m-20 -118.3 123.21 44.8 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 17.8 mm -137.9 133.26 44.57 Favored 'Isoleucine or valine' 0 C--N 1.353 0.729 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 59.9 mtm180 -120.49 139.43 52.9 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.561 ' HG ' ' O ' ' A' ' 131' ' ' LEU . 0.7 OUTLIER -130.04 127.0 39.05 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.917 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.433 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 11.9 m170 -97.34 130.7 44.47 Favored 'General case' 0 CA--C 1.494 -1.188 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 178.82 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.598 ' HD1' ' CE2' ' A' ' 119' ' ' PHE . 52.5 t80 -124.86 121.43 34.51 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 -178.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.482 ' HA ' ' O ' ' A' ' 171' ' ' THR . 28.2 tt0 -114.42 112.44 23.03 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.8 t -162.28 153.39 17.8 Favored 'General case' 0 C--N 1.358 0.974 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -90.43 5.99 45.2 Favored 'General case' 0 C--N 1.357 0.903 0 C-N-CA 120.199 -0.6 . . . . 0.0 109.912 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 94.7 mtm-85 -131.94 77.35 72.05 Favored Pre-proline 0 C--N 1.356 0.856 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 178.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -91.48 93.07 0.22 Allowed 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.748 2.298 . . . . 0.0 115.709 -177.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -107.43 106.36 16.73 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 177.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.3 -38.88 92.63 Favored 'General case' 0 C--N 1.355 0.835 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.367 -178.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 74.2 m -63.05 -27.1 69.17 Favored 'General case' 0 C--N 1.353 0.755 0 O-C-N 121.981 -0.449 . . . . 0.0 110.554 -178.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -75.58 -47.18 27.78 Favored 'General case' 0 N--CA 1.445 -0.721 0 O-C-N 121.735 -0.603 . . . . 0.0 109.553 -178.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.28 -39.4 92.53 Favored 'General case' 0 C--N 1.358 0.944 0 O-C-N 122.108 -0.37 . . . . 0.0 111.331 -178.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -62.19 -36.94 83.42 Favored 'General case' 0 C--N 1.358 0.947 0 O-C-N 121.777 -0.577 . . . . 0.0 109.764 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.53 -42.2 99.03 Favored Glycine 0 C--N 1.347 1.157 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.409 ' HB3' ' HBB' ' A' ' 202' ' ' HEM . 83.2 mt -70.19 -41.35 73.82 Favored 'General case' 0 C--N 1.352 0.692 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 96.6 mt -71.27 -42.08 69.22 Favored 'General case' 0 C--N 1.364 1.212 0 O-C-N 121.066 -1.021 . . . . 0.0 110.654 -177.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -70.35 -30.84 67.88 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 121.866 -0.521 . . . . 0.0 110.635 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -63.55 -39.75 97.97 Favored Glycine 0 C--N 1.356 1.654 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 42.7 t -60.43 -43.11 97.12 Favored 'General case' 0 C--N 1.35 0.615 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 178.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -78.91 2.38 20.35 Favored 'General case' 0 C--N 1.355 0.847 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -83.73 -49.09 9.45 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -66.69 -42.93 85.67 Favored 'General case' 0 C--N 1.36 1.061 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.412 ' HZ ' ' HE3' ' A' ' 89' ' ' MET . 9.6 m-30 -69.01 -27.38 65.62 Favored 'General case' 0 C--N 1.361 1.068 0 O-C-N 121.831 -0.543 . . . . 0.0 110.797 -178.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 85.2 tttt 73.01 75.06 0.14 Allowed 'General case' 0 C--N 1.36 1.058 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -137.65 -177.73 4.92 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -140.27 90.06 2.34 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 16.8 m-30 -116.3 155.11 28.98 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 178.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 93.5 m -119.66 128.83 54.2 Favored 'General case' 0 C--N 1.355 0.808 0 C-N-CA 119.551 -0.859 . . . . 0.0 108.828 -178.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.414 HG13 HG12 ' A' ' 177' ' ' ILE . 3.5 mp -106.24 123.22 60.83 Favored 'Isoleucine or valine' 0 C--N 1.352 0.704 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.1 m -119.43 -170.77 2.0 Allowed 'General case' 0 C--N 1.356 0.869 0 CA-C-O 121.685 0.755 . . . . 0.0 109.197 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 11.3 ptt85 -147.76 157.0 43.33 Favored 'General case' 0 C--N 1.357 0.931 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -178.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' THR . . . . . 0.498 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 32.5 p -97.5 146.37 31.28 Favored Pre-proline 0 C--N 1.36 1.043 0 CA-C-O 122.415 1.103 . . . . 0.0 108.447 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.498 ' HD3' ' HA ' ' A' ' 163' ' ' THR . 16.0 Cg_exo -70.42 -16.7 34.82 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 123.641 2.894 . . . . 0.0 114.486 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -71.95 -40.71 68.49 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.933 -177.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 39.6 p -119.27 15.75 13.09 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.876 -178.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.485 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 12.7 pt20 -67.55 -12.15 59.71 Favored 'General case' 0 C--N 1.352 0.69 0 C-N-CA 119.974 -0.691 . . . . 0.0 110.155 178.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -126.51 37.79 4.24 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 18.2 t -138.94 144.65 39.13 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.614 ' O ' ' HB ' ' A' ' 171' ' ' THR . 61.4 mt-10 -97.87 163.99 12.56 Favored 'General case' 0 C--N 1.354 0.769 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.614 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 18.0 m 83.95 -59.91 0.12 Allowed 'General case' 0 C--N 1.372 1.555 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -105.71 118.0 35.47 Favored 'General case' 0 CA--C 1.503 -0.827 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.596 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 92.8 t -131.48 133.78 61.5 Favored 'Isoleucine or valine' 0 C--N 1.358 0.952 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 178.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 48.4 mm -113.52 126.98 71.06 Favored 'Isoleucine or valine' 0 C--N 1.359 1.021 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.482 ' HB2' ' HG ' ' A' ' 131' ' ' LEU . 97.2 m-85 -116.74 147.2 42.25 Favored 'General case' 0 C--N 1.36 1.054 0 CA-C-O 121.947 0.88 . . . . 0.0 109.105 -179.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -125.2 120.16 30.52 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.498 HD11 HD22 ' A' ' 131' ' ' LEU . 51.8 mt -116.22 124.79 72.86 Favored 'Isoleucine or valine' 0 C--N 1.353 0.752 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 -178.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 54.9 p -118.55 157.97 26.31 Favored 'General case' 0 CA--C 1.501 -0.92 0 CA-C-O 121.764 0.792 . . . . 0.0 109.581 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -102.87 119.03 38.12 Favored 'General case' 0 C--N 1.356 0.858 0 N-CA-C 106.325 -1.732 . . . . 0.0 106.325 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.41 ' HB2' ' HD2' ' A' ' 181' ' ' PRO . . . -60.6 149.65 77.78 Favored Pre-proline 0 C--N 1.357 0.897 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.41 ' HD2' ' HB2' ' A' ' 180' ' ' ALA . 18.4 Cg_endo -59.2 138.11 83.01 Favored 'Trans proline' 0 CA--C 1.494 -1.522 0 C-N-CA 122.167 1.911 . . . . 0.0 113.646 -178.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.505 HH11 ' HD2' ' A' ' 182' ' ' ARG . 6.1 mtm105 -127.47 148.74 50.31 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 -179.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 63.17 -136.58 43.03 Favored Glycine 0 C--N 1.348 1.249 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -95.42 -179.97 4.96 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -128.51 126.81 41.17 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -112.31 123.14 49.62 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 52.6 tp -112.46 -66.95 1.03 Allowed 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -133.3 -82.48 0.47 Allowed 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -131.54 -67.82 0.67 Allowed 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 . . . . . 0 C--O 1.264 1.857 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 179.767 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' HEM . . . . . 1.046 ' C3B' HD12 ' A' ' 99' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.556 ' HE3' ' HE1' ' A' ' 4' ' ' MET . 3.8 mtm . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 121.287 0.565 . . . . 0.0 110.887 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.459 ' O ' HG23 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -83.93 -12.71 54.98 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.172 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.62 -40.2 54.15 Favored Glycine 0 C--N 1.351 1.397 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.556 ' HE1' ' HE3' ' A' ' 1' ' ' MET . 7.8 mtm -71.08 -35.4 71.84 Favored 'General case' 0 C--N 1.359 1.0 0 O-C-N 121.875 -0.779 . . . . 0.0 111.299 -177.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.459 HG23 ' O ' ' A' ' 2' ' ' MET . 34.1 m -68.48 -23.98 28.81 Favored 'Isoleucine or valine' 0 C--N 1.356 0.854 0 C-N-CA 119.674 -0.81 . . . . 0.0 109.22 -179.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.472 ' HE2' HD11 ' A' ' 51' ' ' LEU . 5.4 m-85 -71.31 -35.87 71.42 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 178.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 88.6 m -67.35 -41.63 84.85 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.73 -38.95 97.31 Favored Glycine 0 C--N 1.357 1.743 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.653 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -66.73 -39.98 88.2 Favored 'General case' 0 C--N 1.352 0.685 0 O-C-N 122.301 -0.529 . . . . 0.0 110.76 -178.107 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.741 ' HE2' HD21 ' A' ' 26' ' ' LEU . 22.4 mmt -64.25 -41.04 97.15 Favored 'General case' 0 C--N 1.354 0.791 0 O-C-N 121.523 -0.735 . . . . 0.0 111.137 -178.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -67.26 -40.0 86.17 Favored 'General case' 0 C--N 1.35 0.598 0 O-C-N 121.96 -0.463 . . . . 0.0 111.623 -177.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 54.7 tp -66.33 -42.09 88.68 Favored 'General case' 0 C--N 1.348 0.503 0 N-CA-C 112.694 0.628 . . . . 0.0 112.694 -178.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.679 HD12 HD12 ' A' ' 55' ' ' LEU . 2.1 mm -75.17 -35.77 35.3 Favored 'Isoleucine or valine' 0 C--N 1.36 1.048 0 O-C-N 121.11 -0.994 . . . . 0.0 110.86 -175.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -71.13 -41.89 69.91 Favored 'General case' 0 C--N 1.35 0.587 0 O-C-N 121.558 -0.714 . . . . 0.0 111.405 -176.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -72.04 -38.21 69.56 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -175.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -102.57 -23.22 13.89 Favored 'General case' 0 C--N 1.349 0.584 0 C-N-CA 118.794 -1.162 . . . . 0.0 113.466 -174.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 14.6 m-30 -109.07 -37.76 5.73 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 118.191 -1.404 . . . . 0.0 111.399 -176.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 140.63 178.76 17.48 Favored Glycine 0 N--CA 1.439 -1.144 0 N-CA-C 108.732 -1.747 . . . . 0.0 108.732 -179.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -101.6 -25.61 13.82 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -177.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -70.3 -39.61 74.72 Favored 'General case' 0 C--N 1.361 1.098 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.551 HG23 HG21 ' A' ' 58' ' ' VAL . 95.0 m -67.69 -38.38 83.59 Favored 'General case' 0 C--N 1.358 0.96 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.5 HD13 ' HB ' ' A' ' 13' ' ' ILE . 39.1 tp -59.59 -38.54 81.49 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -66.12 -36.13 82.33 Favored 'General case' 0 C--N 1.356 0.858 0 O-C-N 122.09 -0.381 . . . . 0.0 111.07 -178.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.6 m -64.13 -41.19 97.3 Favored 'General case' 0 C--N 1.355 0.846 0 O-C-N 121.606 -0.684 . . . . 0.0 109.352 -178.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.3 mt -64.28 -36.84 85.42 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.741 HD21 ' HE2' ' A' ' 10' ' ' MET . 84.3 mt -70.19 -16.2 63.04 Favored 'General case' 0 C--N 1.359 0.982 0 O-C-N 121.782 -0.574 . . . . 0.0 110.105 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -84.89 -28.79 25.72 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 119.524 -0.87 . . . . 0.0 109.167 178.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.4 t -66.52 -36.89 83.82 Favored 'General case' 0 C--N 1.355 0.838 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.8 p -93.07 -37.19 12.29 Favored 'General case' 0 C--N 1.359 1.004 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -179.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 83.66 133.39 0.05 Allowed 'General case' 0 C--N 1.36 1.04 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.522 HD23 ' HB3' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -111.97 132.05 55.02 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 179.246 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -107.88 -21.46 12.83 Favored 'General case' 0 CA--C 1.497 -1.083 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.121 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -114.24 -80.15 0.59 Allowed 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 118.874 -1.131 . . . . 0.0 109.098 -178.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -137.16 -53.17 0.68 Allowed 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 131.4 -44.6 1.19 Allowed Glycine 0 C--N 1.352 1.437 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 82.8 mt -107.87 100.05 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.795 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -98.21 0.07 45.11 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 3.4 m 78.75 174.22 0.16 Allowed 'General case' 0 C--N 1.362 1.127 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 -178.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 41.7 p -86.81 119.25 26.84 Favored 'General case' 0 N--CA 1.443 -0.778 0 O-C-N 121.131 -0.981 . . . . 0.0 109.531 -178.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -176.21 -12.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.362 1.117 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -114.25 168.05 12.47 Favored Glycine 0 C--N 1.358 1.793 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 -178.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 48.9 m -130.95 132.21 44.92 Favored 'General case' 0 C--N 1.355 0.838 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -119.14 173.64 6.8 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -70.19 172.49 8.0 Favored 'General case' 0 C--N 1.357 0.9 0 CA-C-O 121.671 0.748 . . . . 0.0 109.478 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -83.77 -24.05 31.25 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -178.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -65.79 -27.41 68.25 Favored 'General case' 0 C--N 1.355 0.832 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -61.48 -42.11 98.28 Favored 'General case' 0 C--N 1.353 0.734 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 61.8 tp -67.4 -38.89 85.34 Favored 'General case' 0 C--N 1.355 0.816 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.296 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 57.9 tp -73.5 -28.05 61.7 Favored 'General case' 0 C--N 1.352 0.697 0 O-C-N 122.081 -0.387 . . . . 0.0 110.278 -177.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 71.7 tp60 -67.42 -42.42 83.22 Favored 'General case' 0 N--CA 1.445 -0.695 0 O-C-N 121.702 -0.624 . . . . 0.0 109.481 -178.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.485 ' HA ' HD23 ' A' ' 51' ' ' LEU . 88.1 mt -76.9 -25.09 52.61 Favored 'General case' 0 C--N 1.36 1.031 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.843 -179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.489 ' O ' HG13 ' A' ' 52' ' ' VAL . 32.2 t -70.78 -41.7 77.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.616 HG12 ' N ' ' A' ' 54' ' ' LYS . 5.1 p -71.82 -30.88 39.25 Favored 'Isoleucine or valine' 0 C--N 1.354 0.797 0 O-C-N 121.514 -0.741 . . . . 0.0 109.766 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.616 ' N ' HG12 ' A' ' 53' ' ' VAL . 31.1 tptt -71.83 -27.16 62.71 Favored 'General case' 0 C--N 1.364 1.204 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.679 HD12 HD12 ' A' ' 13' ' ' ILE . 2.0 tt -66.58 -41.25 88.81 Favored 'General case' 0 C--N 1.354 0.768 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.507 ' O ' ' HA ' ' A' ' 60' ' ' SER . 46.8 t -65.24 -39.4 92.64 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 121.88 -0.512 . . . . 0.0 110.313 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -76.95 -39.12 51.81 Favored 'General case' 0 C--N 1.352 0.717 0 O-C-N 120.974 -1.078 . . . . 0.0 112.975 -178.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.551 HG21 HG23 ' A' ' 21' ' ' THR . 5.4 p -70.74 -38.02 71.3 Favored 'Isoleucine or valine' 0 C--N 1.354 0.794 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -175.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.0 t -118.12 -4.44 11.0 Favored 'General case' 0 CA--C 1.505 -0.779 0 C-N-CA 118.975 -1.09 . . . . 0.0 110.085 -177.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.507 ' HA ' ' O ' ' A' ' 56' ' ' SER . 0.3 OUTLIER 69.36 41.23 1.35 Allowed 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.078 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.434 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 61.6 t -110.8 123.86 34.45 Favored Pre-proline 0 CA--C 1.502 -0.891 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 178.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 61' ' ' VAL . 32.5 Cg_exo -57.73 155.03 34.03 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 122.85 2.367 . . . . 0.0 113.689 -178.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.607 ' HA ' ' CD2' ' A' ' 66' ' ' LEU . 11.4 m -75.3 -9.34 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.457 -177.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 80.6 p -96.39 -36.13 10.95 Favored 'General case' 0 C--N 1.356 0.882 0 C-N-CA 118.221 -1.392 . . . . 0.0 109.431 -179.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -75.2 -22.3 58.08 Favored 'General case' 0 C--N 1.353 0.733 0 O-C-N 121.407 -0.808 . . . . 0.0 109.337 179.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.607 ' CD2' ' HA ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -82.58 -32.67 28.37 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -178.997 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.588 HG12 ' N ' ' A' ' 68' ' ' ARG . 2.3 p -70.98 -25.39 25.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.844 0 C-N-CA 120.077 -0.649 . . . . 0.0 109.864 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.588 ' N ' HG12 ' A' ' 67' ' ' VAL . 4.7 mmm-85 -73.29 -53.15 11.55 Favored 'General case' 0 C--N 1.363 1.153 0 O-C-N 121.519 -0.738 . . . . 0.0 109.841 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.54 -34.34 77.58 Favored 'General case' 0 C--N 1.356 0.889 0 O-C-N 122.112 -0.368 . . . . 0.0 110.806 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -61.23 -47.2 87.18 Favored 'General case' 0 C--N 1.35 0.613 0 O-C-N 122.083 -0.385 . . . . 0.0 110.369 -178.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.65 -38.6 95.33 Favored Glycine 0 C--N 1.356 1.663 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 -178.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -63.29 -47.98 80.04 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-N 118.115 0.957 . . . . 0.0 111.644 -177.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 12.8 mttm -65.42 -47.04 77.63 Favored 'General case' 0 C--N 1.359 1.018 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -177.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -70.3 -39.24 74.95 Favored 'General case' 0 C--N 1.349 0.571 0 O-C-N 121.158 -0.964 . . . . 0.0 111.712 -175.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -63.89 -45.55 88.88 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 121.114 -0.991 . . . . 0.0 111.047 -178.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 76' ' ' VAL . 9.8 p -71.44 -14.01 17.37 Favored 'Isoleucine or valine' 0 C--N 1.359 0.988 0 O-C-N 121.545 -0.722 . . . . 0.0 109.073 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -71.36 -40.65 70.49 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.572 HD11 HBCA ' A' ' 202' ' ' HEM . 79.5 mt -70.32 -34.02 72.2 Favored 'General case' 0 C--N 1.356 0.887 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.337 -179.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 46.4 mm -63.16 -52.95 52.42 Favored 'Isoleucine or valine' 0 C--N 1.358 0.964 0 O-C-N 121.723 -0.611 . . . . 0.0 110.105 -177.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -75.0 -10.7 59.72 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 120.1 -0.64 . . . . 0.0 111.289 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.76 -8.68 58.06 Favored Glycine 0 C--N 1.351 1.401 0 C-N-CA 119.617 -1.277 . . . . 0.0 110.825 -178.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.626 ' HB2' HG21 ' A' ' 85' ' ' ILE . 93.3 m-70 -137.22 91.35 14.65 Favored Pre-proline 0 C--N 1.353 0.721 0 CA-C-N 118.994 1.397 . . . . 0.0 108.982 -179.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -59.82 -32.96 96.2 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 123.027 2.484 . . . . 0.0 114.408 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -93.24 -2.71 54.82 Favored 'General case' 0 CA--C 1.504 -0.82 0 C-N-CA 119.74 -0.784 . . . . 0.0 109.616 -178.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.626 HG21 ' HB2' ' A' ' 82' ' ' HIS . 0.4 OUTLIER -89.07 -19.87 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 -179.832 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -101.64 -23.42 14.26 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -70.27 -36.66 74.57 Favored 'General case' 0 C--N 1.359 0.995 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -65.77 -35.91 82.06 Favored 'General case' 0 C--N 1.355 0.82 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.013 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 23.8 ttp -83.26 149.61 26.69 Favored 'General case' 0 C--N 1.353 0.732 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -178.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.6 -21.91 8.91 Favored 'General case' 0 C--N 1.364 1.233 0 O-C-N 121.698 -0.626 . . . . 0.0 110.556 -177.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -163.91 170.75 16.3 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -177.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.454 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 89.3 p -70.86 -32.32 69.28 Favored 'General case' 0 C--N 1.353 0.736 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.965 -179.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -70.3 -38.94 75.09 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -67.06 -23.73 65.9 Favored 'General case' 0 C--N 1.358 0.937 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.454 ' HB3' ' O ' ' A' ' 92' ' ' SER . 61.0 tp -62.67 -46.53 87.73 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.9 mp -63.13 -31.22 72.32 Favored 'General case' 0 C--N 1.355 0.812 0 O-C-N 122.257 -0.277 . . . . 0.0 110.289 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 36.1 t -62.2 -45.98 90.93 Favored 'General case' 0 C--N 1.356 0.868 0 O-C-N 121.69 -0.631 . . . . 0.0 111.237 -178.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.467 ' HZ3' ' HG2' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -114.89 28.92 8.39 Favored 'General case' 0 C--N 1.36 1.055 0 O-C-N 121.068 -1.02 . . . . 0.0 110.232 -178.338 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 1.396 HD11 ' C3B' ' A' ' 202' ' ' HEM . 12.9 tt -63.45 -27.64 43.41 Favored 'Isoleucine or valine' 0 C--N 1.354 0.79 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.5 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.571 ' N ' HG22 ' A' ' 99' ' ' ILE . 3.0 p-10 -125.98 -12.29 6.45 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 118.825 -1.15 . . . . 0.0 109.044 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.3 t -69.11 -45.53 69.98 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.057 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -123.85 -28.73 3.77 Favored 'General case' 0 C--N 1.358 0.943 0 C-N-CA 118.636 -1.226 . . . . 0.0 111.47 -177.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 96.2 mt -70.17 -47.8 65.46 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 O-C-N 121.147 -0.971 . . . . 0.0 110.922 -178.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 39.3 m170 -87.96 1.71 53.46 Favored 'General case' 0 C--N 1.355 0.834 0 O-C-N 121.224 -0.923 . . . . 0.0 110.028 -177.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.6 p -92.37 -31.71 4.85 Favored 'Isoleucine or valine' 0 C--N 1.354 0.799 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -71.99 -39.8 69.02 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.695 HG13 ' N ' ' A' ' 108' ' ' TYR . 0.5 OUTLIER -72.98 -36.6 51.68 Favored 'Isoleucine or valine' 0 C--N 1.354 0.795 0 C-N-CA 119.605 -0.838 . . . . 0.0 109.704 -178.866 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.695 ' N ' HG13 ' A' ' 107' ' ' VAL . 91.6 t80 -61.06 -48.7 80.52 Favored 'General case' 0 C--N 1.364 1.21 0 O-C-N 121.808 -0.557 . . . . 0.0 110.651 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -60.91 -37.9 83.87 Favored 'General case' 0 C--N 1.357 0.903 0 O-C-N 121.709 -0.619 . . . . 0.0 110.226 -179.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.8 mt -57.9 -76.46 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.404 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 79.5 m-85 -116.37 135.04 22.78 Favored Pre-proline 0 N--CA 1.441 -0.899 0 C-N-CA 118.926 -1.109 . . . . 0.0 108.756 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 111' ' ' TYR . 81.2 Cg_endo -85.29 -2.41 9.35 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 123.215 2.61 . . . . 0.0 115.41 -178.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 30.4 mm100 -66.72 -36.42 82.42 Favored 'General case' 0 C--N 1.354 0.79 0 O-C-N 121.779 -0.575 . . . . 0.0 110.029 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.97 146.12 53.82 Favored 'General case' 0 C--N 1.354 0.778 0 CA-C-O 121.695 0.76 . . . . 0.0 110.092 -178.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -117.43 156.77 27.38 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 178.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.844 ' HG ' ' HD2' ' A' ' 117' ' ' PRO . 4.3 tp -142.3 143.47 27.39 Favored Pre-proline 0 N--CA 1.441 -0.893 0 CA-C-O 122.009 0.909 . . . . 0.0 108.646 -178.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.844 ' HD2' ' HG ' ' A' ' 116' ' ' LEU . 97.5 Cg_endo -85.73 -152.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.128 0 C-N-CA 123.602 2.868 . . . . 0.0 113.534 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -114.25 145.94 41.08 Favored 'General case' 0 C--N 1.363 1.19 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.412 ' CE1' HD11 ' A' ' 131' ' ' LEU . 9.4 t80 -145.39 125.28 13.49 Favored 'General case' 0 C--N 1.36 1.052 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -177.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 93.5 m -124.84 132.49 53.32 Favored 'General case' 0 C--N 1.359 0.995 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 179.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 75.2 m -113.68 130.25 56.44 Favored 'General case' 0 C--N 1.356 0.883 0 C-N-CA 119.735 -0.786 . . . . 0.0 109.576 -178.372 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -121.04 126.7 50.55 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 178.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.622 ' HG3' HD11 ' A' ' 129' ' ' ILE . 58.4 ttp180 -102.53 117.4 34.62 Favored 'General case' 0 C--N 1.353 0.755 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.57 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 85.7 mt -83.3 -27.03 30.08 Favored 'General case' 0 CA--C 1.504 -0.818 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.112 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -177.18 -144.96 5.55 Favored Glycine 0 C--N 1.35 1.319 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 -178.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -94.11 -39.06 10.79 Favored 'General case' 0 N--CA 1.438 -1.07 0 O-C-N 121.993 -0.71 . . . . 0.0 109.312 -178.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -101.94 1.89 37.3 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.614 -178.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.57 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 6.6 m-20 -118.97 130.77 55.87 Favored 'General case' 0 C--N 1.359 0.993 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.622 HD11 ' HG3' ' A' ' 123' ' ' ARG . 14.2 mm -139.37 135.81 40.83 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 179.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 58.3 mtm180 -122.0 141.01 51.78 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.617 ' HG ' ' HB2' ' A' ' 175' ' ' PHE . 0.9 OUTLIER -131.39 127.01 36.65 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.676 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -97.47 130.77 44.53 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 178.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -125.15 121.04 33.07 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 -178.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.527 ' HA ' ' O ' ' A' ' 171' ' ' THR . 28.7 tt0 -114.9 112.05 22.13 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 14.5 t -161.73 152.65 18.02 Favored 'General case' 0 C--N 1.358 0.976 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.432 ' C ' ' HD3' ' A' ' 138' ' ' PRO . 57.9 mtmt -90.7 3.56 53.92 Favored 'General case' 0 C--N 1.357 0.891 0 C-N-CA 120.269 -0.572 . . . . 0.0 109.576 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -133.49 73.48 72.99 Favored Pre-proline 0 CA--C 1.506 -0.736 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.432 ' HD3' ' C ' ' A' ' 136' ' ' LYS . 89.6 Cg_endo -96.36 104.14 0.09 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.541 0 C-N-CA 122.662 2.241 . . . . 0.0 115.678 -177.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -111.87 113.44 25.77 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 176.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.93 -38.12 89.93 Favored 'General case' 0 C--N 1.353 0.75 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.968 -179.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 74.6 m -63.02 -26.17 68.73 Favored 'General case' 0 C--N 1.353 0.741 0 O-C-N 121.971 -0.456 . . . . 0.0 110.55 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -76.57 -46.72 25.1 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 120.13 -0.628 . . . . 0.0 109.375 -178.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.59 -40.24 95.16 Favored 'General case' 0 C--N 1.357 0.915 0 O-C-N 122.187 -0.321 . . . . 0.0 111.087 -178.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.19 -36.79 84.81 Favored 'General case' 0 C--N 1.355 0.834 0 O-C-N 121.961 -0.462 . . . . 0.0 110.112 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.37 -42.94 99.09 Favored Glycine 0 C--N 1.347 1.157 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.401 HD11 ' O ' ' A' ' 201' ' ' CMO . 84.5 mt -70.06 -40.92 74.8 Favored 'General case' 0 C--N 1.353 0.719 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.498 HD22 ' HBB' ' A' ' 202' ' ' HEM . 96.7 mt -71.84 -42.2 67.24 Favored 'General case' 0 C--N 1.364 1.2 0 O-C-N 121.059 -1.026 . . . . 0.0 110.801 -176.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.538 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 20.9 t70 -69.15 -33.15 72.97 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 122.097 -0.377 . . . . 0.0 110.57 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -62.75 -39.28 97.76 Favored Glycine 0 C--N 1.357 1.713 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 45.9 t -60.51 -42.24 95.99 Favored 'General case' 0 C--N 1.35 0.598 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -75.99 -0.13 20.51 Favored 'General case' 0 C--N 1.36 1.043 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.538 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 76.8 mm-40 -84.56 -46.41 11.59 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -66.16 -44.59 83.64 Favored 'General case' 0 C--N 1.359 1.002 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 8.8 m-30 -69.5 -26.28 64.46 Favored 'General case' 0 C--N 1.361 1.086 0 O-C-N 121.87 -0.518 . . . . 0.0 110.81 -178.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 85.0 tttt 73.16 75.95 0.14 Allowed 'General case' 0 C--N 1.36 1.024 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -178.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -141.42 -171.34 3.28 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -148.34 92.65 2.05 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -113.86 158.41 21.09 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 93.3 m -119.9 127.85 53.09 Favored 'General case' 0 C--N 1.355 0.82 0 C-N-CA 119.404 -0.919 . . . . 0.0 108.974 -178.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.438 ' N ' HD13 ' A' ' 160' ' ' ILE . 3.7 mp -105.86 122.82 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 178.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.4 m -116.67 -172.46 2.2 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 121.822 0.82 . . . . 0.0 109.116 -178.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -146.46 155.67 42.72 Favored 'General case' 0 C--N 1.354 0.792 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -178.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' THR . . . . . 0.414 ' O ' ' HB3' ' A' ' 167' ' ' GLN . 41.7 p -98.68 146.3 31.38 Favored Pre-proline 0 C--N 1.359 0.999 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.696 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 72.6 Cg_endo -76.35 -11.87 19.01 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 123.044 2.496 . . . . 0.0 115.148 -178.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -72.66 -41.07 65.82 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 120.056 -0.657 . . . . 0.0 109.551 -178.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 35.8 p -117.72 15.23 14.47 Favored 'General case' 0 C--N 1.354 0.802 0 C-N-CA 120.129 -0.628 . . . . 0.0 110.48 -178.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.696 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.3 pp0? -67.11 -11.85 58.36 Favored 'General case' 0 C--N 1.354 0.802 0 O-C-N 121.576 -0.703 . . . . 0.0 110.193 178.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -127.0 42.29 3.35 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 15.4 t -142.96 145.4 32.96 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.627 ' O ' ' HB ' ' A' ' 171' ' ' THR . 61.5 mt-10 -98.86 165.0 11.98 Favored 'General case' 0 C--N 1.353 0.751 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.627 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 11.9 m 83.71 -59.12 0.13 Allowed 'General case' 0 C--N 1.37 1.483 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -107.35 117.46 34.13 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 119.889 -0.724 . . . . 0.0 109.654 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 90.4 t -131.85 134.15 60.37 Favored 'Isoleucine or valine' 0 C--N 1.357 0.914 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 178.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 49.2 mm -113.4 126.97 70.92 Favored 'Isoleucine or valine' 0 C--N 1.359 0.987 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.617 ' HB2' ' HG ' ' A' ' 131' ' ' LEU . 97.1 m-85 -116.62 147.13 42.18 Favored 'General case' 0 C--N 1.361 1.081 0 CA-C-O 122.008 0.909 . . . . 0.0 108.778 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -125.68 119.37 27.82 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.524 HD11 ' CD2' ' A' ' 131' ' ' LEU . 51.0 mt -114.67 115.87 50.84 Favored 'Isoleucine or valine' 0 C--N 1.354 0.801 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 -179.177 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 88.4 m -127.55 140.5 52.08 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -178.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -84.3 127.58 34.06 Favored 'General case' 0 C--N 1.366 1.307 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.401 ' HA ' ' HD3' ' A' ' 181' ' ' PRO . . . -63.19 152.52 84.24 Favored Pre-proline 0 C--N 1.358 0.974 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 178.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 180' ' ' ALA . 84.2 Cg_exo -50.49 131.12 31.63 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 122.88 2.386 . . . . 0.0 114.023 -178.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -125.02 161.94 25.62 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 101.48 -146.43 17.24 Favored Glycine 0 N--CA 1.437 -1.269 0 N-CA-C 108.439 -1.864 . . . . 0.0 108.439 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -116.82 24.75 11.03 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 68.01 57.14 0.51 Allowed 'General case' 0 C--N 1.36 1.028 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -98.08 119.8 37.36 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 71.6 mt -111.93 -68.45 0.93 Allowed 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -145.13 -87.92 0.11 Allowed 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -127.98 147.81 50.5 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 . . . . . 0 C--O 1.265 1.886 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -179.99 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' CMO . . . . . 0.401 ' O ' HD11 ' A' ' 146' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' HEM . . . . . 1.396 ' C3B' HD11 ' A' ' 99' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.796 ' HG3' ' CMD' ' A' ' 202' ' ' HEM . 44.9 mtp . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.096 0.474 . . . . 0.0 110.079 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.655 ' HA ' HG23 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -79.28 -17.28 54.98 Favored 'General case' 0 C--N 1.354 0.796 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.016 -178.365 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.83 -42.06 32.02 Favored Glycine 0 C--N 1.348 1.245 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.3 tpp -70.73 -37.92 73.52 Favored 'General case' 0 C--N 1.354 0.797 0 O-C-N 122.103 -0.645 . . . . 0.0 110.808 -177.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.655 HG23 ' HA ' ' A' ' 2' ' ' MET . 27.2 m -69.87 -23.16 25.33 Favored 'Isoleucine or valine' 0 C--N 1.357 0.914 0 O-C-N 121.614 -0.679 . . . . 0.0 109.723 -179.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.434 ' HZ ' ' CG ' ' A' ' 47' ' ' GLU . 1.5 m-85 -71.22 -34.78 71.13 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 88.3 m -67.03 -40.29 87.19 Favored 'General case' 0 C--N 1.354 0.795 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.04 -39.21 97.76 Favored Glycine 0 C--N 1.359 1.825 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.583 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -64.7 -40.02 94.66 Favored 'General case' 0 C--N 1.352 0.703 0 O-C-N 122.54 -0.388 . . . . 0.0 110.695 -178.333 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 24.6 mmt -64.18 -40.52 96.29 Favored 'General case' 0 C--N 1.353 0.739 0 O-C-N 121.672 -0.642 . . . . 0.0 111.046 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -65.53 -40.32 92.77 Favored 'General case' 0 C--N 1.349 0.552 0 O-C-N 121.991 -0.443 . . . . 0.0 111.516 -178.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 56.0 tp -66.14 -43.62 86.53 Favored 'General case' 0 C--N 1.348 0.542 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -178.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.583 HG12 ' O ' ' A' ' 9' ' ' LEU . 2.4 mm -72.84 -37.28 54.32 Favored 'Isoleucine or valine' 0 C--N 1.361 1.071 0 O-C-N 121.155 -0.966 . . . . 0.0 110.975 -175.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 71.2 tt0 -71.13 -41.49 70.44 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.864 -0.522 . . . . 0.0 111.609 -175.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -72.59 -35.47 67.92 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -175.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -94.54 -30.27 14.47 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 118.901 -1.12 . . . . 0.0 113.966 -174.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -116.04 -30.97 5.87 Favored 'General case' 0 CA--C 1.506 -0.712 0 C-N-CA 117.538 -1.665 . . . . 0.0 112.728 -176.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 139.87 177.71 16.05 Favored Glycine 0 C--N 1.346 1.113 0 C-N-CA 118.346 -1.883 . . . . 0.0 109.523 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -99.11 -18.35 17.75 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -177.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -70.44 -39.59 74.26 Favored 'General case' 0 C--N 1.36 1.049 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 94.3 m -67.92 -39.19 83.55 Favored 'General case' 0 C--N 1.357 0.899 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.605 HD21 HD11 ' A' ' 26' ' ' LEU . 1.0 OUTLIER -60.71 -38.16 84.09 Favored 'General case' 0 C--N 1.355 0.847 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.518 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -63.78 -37.17 86.38 Favored 'General case' 0 C--N 1.357 0.916 0 O-C-N 122.154 -0.341 . . . . 0.0 110.787 -178.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.4 m -64.91 -40.49 95.15 Favored 'General case' 0 C--N 1.356 0.884 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -178.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.626 ' CD2' ' HB3' ' A' ' 54' ' ' LYS . 31.4 mt -63.84 -36.75 84.93 Favored 'General case' 0 C--N 1.359 0.982 0 O-C-N 121.946 -0.471 . . . . 0.0 109.957 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.605 HD11 HD21 ' A' ' 22' ' ' LEU . 87.5 mt -71.49 -16.03 62.34 Favored 'General case' 0 C--N 1.358 0.971 0 O-C-N 121.661 -0.65 . . . . 0.0 110.184 -178.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -86.46 -27.73 23.92 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 119.351 -0.939 . . . . 0.0 109.278 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 41.7 t -67.01 -37.1 83.57 Favored 'General case' 0 C--N 1.355 0.845 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.8 p -93.02 -39.0 11.34 Favored 'General case' 0 C--N 1.359 0.988 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -179.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 84.12 133.25 0.05 OUTLIER 'General case' 0 C--N 1.361 1.104 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 179.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.514 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -91.44 -167.05 1.7 Allowed 'General case' 0 C--N 1.357 0.919 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.636 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.492 ' H ' ' HB2' ' A' ' 31' ' ' LEU . 63.3 tt0 -152.99 -66.76 0.16 Allowed 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.7 t -97.57 -66.55 0.89 Allowed 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -130.35 -44.76 1.12 Allowed 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -179.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.21 -33.72 5.42 Favored Glycine 0 C--N 1.353 1.474 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 179.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 83.8 mt -117.22 107.51 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.01 0 CA-C-N 118.413 1.107 . . . . 0.0 108.073 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.466 ' HD1' ' HA ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -84.08 -147.78 0.1 Allowed 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.185 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.754 HG21 ' H ' ' A' ' 39' ' ' SER . 5.0 t -119.46 -53.56 2.22 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.754 ' H ' HG21 ' A' ' 38' ' ' THR . 23.8 p 170.05 65.33 0.0 OUTLIER 'General case' 0 C--N 1.362 1.138 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.5 t -145.49 -11.24 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.957 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.149 -178.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -91.62 142.08 15.93 Favored Glycine 0 C--N 1.352 1.446 0 C-N-CA 119.275 -1.44 . . . . 0.0 110.538 -177.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.1 m -123.61 123.12 39.86 Favored 'General case' 0 C--N 1.354 0.767 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -117.5 175.4 5.65 Favored 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -81.86 -172.49 3.94 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 68.9 m80 -90.64 -15.09 31.07 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.102 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -68.74 -29.39 67.79 Favored 'General case' 0 C--N 1.352 0.678 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.434 ' CG ' ' HZ ' ' A' ' 6' ' ' PHE . 26.5 tp10 -64.38 -39.81 94.59 Favored 'General case' 0 C--N 1.353 0.722 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.495 HD13 HG22 ' A' ' 52' ' ' VAL . 1.8 tm? -66.66 -38.56 87.11 Favored 'General case' 0 C--N 1.36 1.03 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 61.9 tp -70.32 -35.06 73.4 Favored 'General case' 0 CA--C 1.508 -0.667 0 O-C-N 122.232 -0.292 . . . . 0.0 110.47 -177.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -64.67 -41.2 96.24 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 121.936 -0.478 . . . . 0.0 109.914 -177.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.426 ' HA ' HD22 ' A' ' 51' ' ' LEU . 80.7 mt -83.55 -18.1 39.53 Favored 'General case' 0 C--N 1.359 1.001 0 C-N-CA 119.625 -0.83 . . . . 0.0 110.601 -179.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.495 HG22 HD13 ' A' ' 48' ' ' LEU . 1.4 t -80.33 -38.84 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.585 HG12 ' N ' ' A' ' 54' ' ' LYS . 5.0 p -71.76 -30.55 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 O-C-N 121.597 -0.689 . . . . 0.0 109.406 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.626 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 33.5 tptt -70.97 -28.39 64.42 Favored 'General case' 0 C--N 1.368 1.373 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.1 mt -63.85 -42.02 97.66 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.446 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 46.7 t -66.21 -39.94 89.98 Favored 'General case' 0 C--N 1.352 0.707 0 O-C-N 121.736 -0.602 . . . . 0.0 110.648 -179.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -77.64 -40.31 42.21 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 121.123 -0.985 . . . . 0.0 112.876 -177.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.472 HG11 ' N ' ' A' ' 59' ' ' SER . 4.0 p -75.29 -39.88 42.62 Favored 'Isoleucine or valine' 0 C--N 1.354 0.771 0 O-C-N 121.531 -0.731 . . . . 0.0 112.348 -175.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.472 ' N ' HG11 ' A' ' 58' ' ' VAL . 63.4 m -105.69 -9.25 17.41 Favored 'General case' 0 CA--C 1.503 -0.845 0 O-C-N 121.173 -0.954 . . . . 0.0 110.316 -177.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.441 ' HA ' ' O ' ' A' ' 56' ' ' SER . 0.4 OUTLIER 68.03 38.16 2.8 Favored 'General case' 0 C--N 1.351 0.656 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.881 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.506 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 58.2 t -115.37 128.05 26.28 Favored Pre-proline 0 N--CA 1.443 -0.81 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.506 ' HD3' ' HA ' ' A' ' 61' ' ' VAL . 37.2 Cg_exo -59.86 154.02 52.9 Favored 'Trans proline' 0 CA--C 1.496 -1.376 0 C-N-CA 122.72 2.28 . . . . 0.0 113.519 -179.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.3 m -76.43 -7.71 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.66 -177.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 81.4 p -94.71 -36.4 11.75 Favored 'General case' 0 C--N 1.358 0.944 0 C-N-CA 118.315 -1.354 . . . . 0.0 110.113 -178.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -82.48 -23.42 34.72 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.522 ' HA ' HD22 ' A' ' 66' ' ' LEU . 0.5 OUTLIER -70.29 -43.36 70.57 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.609 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.61 HG11 ' N ' ' A' ' 68' ' ' ARG . 4.6 p -67.47 -28.89 43.67 Favored 'Isoleucine or valine' 0 C--N 1.354 0.803 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.678 -179.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.61 ' N ' HG11 ' A' ' 67' ' ' VAL . 82.7 mtp180 -65.96 -47.92 73.02 Favored 'General case' 0 C--N 1.366 1.286 0 O-C-N 121.067 -1.021 . . . . 0.0 110.242 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.438 ' HA ' HD23 ' A' ' 69' ' ' LEU . 88.6 mt -64.53 -36.33 83.85 Favored 'General case' 0 C--N 1.353 0.739 0 O-C-N 122.353 -0.217 . . . . 0.0 111.191 -178.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -60.84 -47.4 86.53 Favored 'General case' 0 C--N 1.349 0.582 0 O-C-N 122.115 -0.365 . . . . 0.0 110.44 -178.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.03 -39.24 96.8 Favored Glycine 0 C--N 1.353 1.524 0 N-CA-C 111.882 -0.487 . . . . 0.0 111.882 -178.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.38 -47.86 80.28 Favored 'General case' 0 C--N 1.351 0.656 0 CA-C-N 118.127 0.963 . . . . 0.0 111.615 -177.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.4 mttm -64.38 -49.02 73.26 Favored 'General case' 0 C--N 1.357 0.925 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -177.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.432 ' O ' HD23 ' A' ' 74' ' ' LEU . 2.5 tm? -69.11 -39.8 78.74 Favored 'General case' 0 C--N 1.349 0.566 0 O-C-N 121.194 -0.941 . . . . 0.0 111.865 -175.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.842 ' CE1' ' HBB' ' A' ' 202' ' ' HEM . 41.0 t80 -64.16 -45.97 86.1 Favored 'General case' 0 C--N 1.353 0.744 0 O-C-N 121.269 -0.895 . . . . 0.0 111.123 -177.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.11 -12.38 15.79 Favored 'Isoleucine or valine' 0 C--N 1.358 0.941 0 O-C-N 121.586 -0.696 . . . . 0.0 109.463 -179.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -78.52 -36.79 44.39 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 80.2 mt -70.57 -34.61 72.39 Favored 'General case' 0 C--N 1.358 0.94 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.3 mm -62.77 -50.37 79.99 Favored 'Isoleucine or valine' 0 C--N 1.357 0.904 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -178.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -67.89 -22.3 65.1 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.414 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.83 -1.18 61.8 Favored Glycine 0 C--N 1.347 1.19 0 C-N-CA 119.609 -1.281 . . . . 0.0 110.684 -177.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.672 ' HB3' ' HB ' ' A' ' 85' ' ' ILE . 93.2 m-70 -141.21 88.6 10.0 Favored Pre-proline 0 CA--C 1.503 -0.859 0 CA-C-N 118.937 1.368 . . . . 0.0 108.962 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 82' ' ' HIS . 36.8 Cg_endo -67.52 -25.79 40.84 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.425 2.083 . . . . 0.0 114.194 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -92.75 -6.14 49.69 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.672 ' HB ' ' HB3' ' A' ' 82' ' ' HIS . 1.0 OUTLIER -90.44 -22.3 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 -178.81 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -102.05 -21.4 14.46 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -69.85 -39.15 76.56 Favored 'General case' 0 C--N 1.355 0.827 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -65.48 -33.75 76.67 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.666 ' HG2' ' N ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -80.28 155.43 27.29 Favored 'General case' 0 C--N 1.353 0.749 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 -178.908 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.666 ' N ' ' HG2' ' A' ' 89' ' ' MET . 3.4 mtpt -117.15 -27.71 6.41 Favored 'General case' 0 C--N 1.364 1.207 0 C-N-CA 120.058 -0.657 . . . . 0.0 111.319 -177.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -167.08 175.47 7.51 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 -177.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 65.1 m -66.62 -40.09 88.63 Favored 'General case' 0 C--N 1.354 0.763 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.415 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -68.03 -39.61 83.09 Favored 'General case' 0 C--N 1.356 0.882 0 C-N-CA 119.587 -0.845 . . . . 0.0 108.805 -178.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -66.57 -23.03 66.15 Favored 'General case' 0 C--N 1.354 0.779 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 60.1 tp -65.25 -45.52 84.26 Favored 'General case' 0 C--N 1.354 0.797 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.5 mp -61.83 -36.5 81.36 Favored 'General case' 0 C--N 1.357 0.901 0 O-C-N 121.993 -0.442 . . . . 0.0 110.165 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 34.0 t -67.49 -39.83 85.2 Favored 'General case' 0 C--N 1.349 0.561 0 O-C-N 121.927 -0.483 . . . . 0.0 110.211 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.4 tttp -93.01 6.37 48.18 Favored 'General case' 0 C--N 1.353 0.76 0 O-C-N 122.241 -0.287 . . . . 0.0 111.567 -176.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 1.52 HD13 ' C3B' ' A' ' 202' ' ' HEM . 9.9 tp -64.4 -38.74 83.36 Favored 'Isoleucine or valine' 0 C--N 1.356 0.859 0 O-C-N 121.391 -0.818 . . . . 0.0 111.671 -177.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -103.44 -21.69 13.76 Favored 'General case' 0 N--CA 1.437 -1.116 0 O-C-N 120.884 -1.135 . . . . 0.0 110.26 -178.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.455 ' O ' HG22 ' A' ' 105' ' ' VAL . 35.2 t -62.98 -47.0 85.04 Favored 'General case' 0 N--CA 1.445 -0.687 0 O-C-N 121.564 -0.71 . . . . 0.0 111.691 -178.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -137.5 -14.49 1.47 Allowed 'General case' 0 C--N 1.36 1.057 0 C-N-CA 117.369 -1.732 . . . . 0.0 113.036 -177.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.612 HG23 ' C2C' ' A' ' 202' ' ' HEM . 32.3 mm -70.41 -51.37 38.52 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 CA-C-N 120.099 1.318 . . . . 0.0 110.633 -177.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 35.5 m170 -91.9 2.32 56.61 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 119.485 -0.886 . . . . 0.0 110.301 -177.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.455 HG22 ' O ' ' A' ' 101' ' ' SER . 52.7 t -83.26 -44.22 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.032 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 177.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -68.34 -40.56 81.52 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 69.9 t -63.45 -46.77 94.35 Favored 'Isoleucine or valine' 0 C--N 1.357 0.901 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.363 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -60.75 -48.59 81.09 Favored 'General case' 0 C--N 1.357 0.926 0 O-C-N 122.064 -0.397 . . . . 0.0 111.409 -179.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -61.6 -37.21 83.07 Favored 'General case' 0 C--N 1.356 0.86 0 O-C-N 121.495 -0.753 . . . . 0.0 110.538 -178.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.5 mt -56.98 -73.9 0.06 Allowed 'General case' 0 C--N 1.357 0.9 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -119.13 135.47 23.9 Favored Pre-proline 0 N--CA 1.438 -1.047 0 C-N-CA 118.475 -1.29 . . . . 0.0 109.032 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -83.51 -4.61 10.87 Favored 'Trans proline' 0 C--N 1.313 -1.342 0 C-N-CA 123.174 2.583 . . . . 0.0 115.175 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -66.6 -36.84 83.58 Favored 'General case' 0 C--N 1.354 0.79 0 O-C-N 121.88 -0.512 . . . . 0.0 109.842 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.1 145.65 55.09 Favored 'General case' 0 C--N 1.354 0.764 0 CA-C-O 121.554 0.692 . . . . 0.0 109.787 -178.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -130.45 135.44 47.99 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.566 ' HB3' ' HD2' ' A' ' 117' ' ' PRO . 86.4 mt -127.68 157.18 74.09 Favored Pre-proline 0 N--CA 1.443 -0.823 0 CA-C-O 122.173 0.987 . . . . 0.0 109.196 -178.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.566 ' HD2' ' HB3' ' A' ' 116' ' ' LEU . 83.6 Cg_endo -81.02 -156.36 0.07 OUTLIER 'Trans proline' 0 C--N 1.316 -1.139 0 C-N-CA 123.797 2.998 . . . . 0.0 114.115 -179.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.405 ' H ' ' HB2' ' A' ' 117' ' ' PRO . 74.6 mmtt -113.38 140.26 48.2 Favored 'General case' 0 C--N 1.364 1.207 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -179.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -123.67 127.02 47.59 Favored 'General case' 0 C--N 1.362 1.144 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -179.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.516 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 94.2 m -126.26 128.98 48.01 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 177.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 81.0 m -119.83 130.73 55.03 Favored 'General case' 0 CA--C 1.503 -0.851 0 C-N-CA 119.105 -1.038 . . . . 0.0 109.677 -177.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -119.14 127.13 53.05 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 178.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 66.2 ttp85 -102.18 116.69 33.2 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.431 ' HA ' HD22 ' A' ' 124' ' ' LEU . 92.8 mt -87.42 -21.61 25.49 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.378 -179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 177.68 -146.59 7.69 Favored Glycine 0 N--CA 1.438 -1.226 0 C-N-CA 118.844 -1.645 . . . . 0.0 109.103 -178.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -94.72 -40.05 9.98 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 120.081 -0.648 . . . . 0.0 109.411 -178.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -101.53 1.45 38.02 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.24 -178.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -119.01 130.43 55.66 Favored 'General case' 0 C--N 1.358 0.968 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.466 HD13 HG22 ' A' ' 129' ' ' ILE . 7.6 mm -141.13 136.77 33.68 Favored 'Isoleucine or valine' 0 C--N 1.356 0.861 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 55.6 mtm180 -122.57 139.14 54.24 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.674 ' HG ' ' O ' ' A' ' 131' ' ' LEU . 0.1 OUTLIER -130.16 125.68 35.63 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.078 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.516 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 13.5 m-70 -96.77 134.56 39.89 Favored 'General case' 0 CA--C 1.495 -1.165 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.746 ' HH ' HBAA ' A' ' 202' ' ' HEM . 60.8 t80 -127.87 119.9 26.59 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 -178.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.535 ' HA ' ' O ' ' A' ' 171' ' ' THR . 76.6 mt-30 -113.51 114.74 26.94 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 179.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 12.7 t -162.73 152.55 15.92 Favored 'General case' 0 C--N 1.358 0.96 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -90.62 2.71 55.62 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 120.271 -0.572 . . . . 0.0 109.652 -179.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -136.11 74.54 55.86 Favored Pre-proline 0 CA--C 1.505 -0.752 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -95.88 107.78 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.771 2.314 . . . . 0.0 115.776 -177.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -111.94 113.6 26.02 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 176.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.98 -38.28 90.49 Favored 'General case' 0 C--N 1.353 0.73 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.007 -179.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.0 m -63.27 -27.34 69.27 Favored 'General case' 0 C--N 1.354 0.773 0 O-C-N 122.009 -0.432 . . . . 0.0 110.875 -178.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -76.63 -46.43 25.96 Favored 'General case' 0 C--N 1.351 0.652 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.639 -178.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.63 -40.11 94.9 Favored 'General case' 0 C--N 1.357 0.923 0 O-C-N 122.039 -0.413 . . . . 0.0 111.056 -178.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.64 -37.25 86.61 Favored 'General case' 0 C--N 1.355 0.83 0 O-C-N 121.907 -0.496 . . . . 0.0 110.081 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -59.88 -43.16 98.28 Favored Glycine 0 C--N 1.347 1.176 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 83.5 mt -69.78 -40.78 75.83 Favored 'General case' 0 C--N 1.352 0.694 0 CA-C-N 117.749 0.774 . . . . 0.0 112.503 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 98.0 mt -71.29 -42.41 68.73 Favored 'General case' 0 C--N 1.361 1.083 0 O-C-N 121.206 -0.934 . . . . 0.0 110.961 -176.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.52 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 37.0 t70 -69.93 -31.36 69.08 Favored 'General case' 0 N--CA 1.446 -0.652 0 O-C-N 121.956 -0.465 . . . . 0.0 110.514 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -62.84 -39.38 97.92 Favored Glycine 0 C--N 1.357 1.745 0 N-CA-C 108.46 -1.856 . . . . 0.0 108.46 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 49.9 t -60.71 -41.46 95.29 Favored 'General case' 0 C--N 1.35 0.6 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -74.8 -1.48 22.33 Favored 'General case' 0 C--N 1.361 1.077 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.52 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 77.7 mm-40 -84.4 -46.07 12.08 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 92.9 t80 -65.95 -45.06 83.16 Favored 'General case' 0 C--N 1.359 0.989 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.417 ' HZ ' ' SD ' ' A' ' 89' ' ' MET . 38.9 m-85 -69.01 -26.62 65.09 Favored 'General case' 0 C--N 1.36 1.053 0 O-C-N 121.874 -0.516 . . . . 0.0 110.802 -178.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 78.9 tttt 72.72 74.35 0.15 Allowed 'General case' 0 C--N 1.36 1.035 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -143.13 -168.12 2.72 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -148.67 94.45 2.28 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -111.88 156.11 22.56 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 178.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 93.9 m -119.47 127.1 52.74 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 119.208 -0.997 . . . . 0.0 108.716 -178.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 3.7 mp -103.89 122.2 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.5 m -115.64 -175.96 2.83 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-O 121.826 0.822 . . . . 0.0 109.134 -179.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 3.5 ptt180 -146.75 153.63 40.46 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 -178.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' THR . . . . . 0.406 ' O ' ' HB3' ' A' ' 167' ' ' GLN . 44.8 p -97.62 145.93 30.55 Favored Pre-proline 0 C--N 1.361 1.08 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.648 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 76.8 Cg_endo -77.13 -11.24 17.79 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.944 2.429 . . . . 0.0 115.127 -178.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -72.74 -41.29 65.32 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.573 -178.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 36.8 p -116.96 15.3 15.16 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.299 -178.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.648 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.5 pp0? -65.13 -13.65 58.63 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.408 178.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -126.89 43.18 3.17 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 16.8 t -142.57 145.13 33.27 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.637 ' O ' ' HB ' ' A' ' 171' ' ' THR . 61.1 mt-10 -98.98 165.49 11.73 Favored 'General case' 0 C--N 1.354 0.804 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.637 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 3.0 m 83.42 -57.13 0.15 Allowed 'General case' 0 C--N 1.369 1.423 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.637 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -110.93 117.44 33.38 Favored 'General case' 0 CA--C 1.506 -0.72 0 C-N-CA 119.814 -0.754 . . . . 0.0 109.603 -178.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 98.7 t -131.33 133.39 62.27 Favored 'Isoleucine or valine' 0 C--N 1.356 0.857 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 178.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 48.6 mm -109.36 125.99 66.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.964 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -179.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -115.08 148.38 39.0 Favored 'General case' 0 C--N 1.357 0.922 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -128.58 117.4 21.19 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 -179.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.8 mp -111.94 118.38 57.51 Favored 'Isoleucine or valine' 0 C--N 1.354 0.765 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 89.3 m -124.3 142.84 50.94 Favored 'General case' 0 CA--C 1.502 -0.893 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -177.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 12.2 ttt180 -91.01 113.48 25.75 Favored 'General case' 0 C--N 1.363 1.153 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 178.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.453 ' HA ' ' HD3' ' A' ' 181' ' ' PRO . . . -71.55 150.6 93.7 Favored Pre-proline 0 CA--C 1.498 -1.029 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 180' ' ' ALA . 50.0 Cg_exo -54.79 120.96 8.98 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.227 1.951 . . . . 0.0 112.861 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 3.9 ppt_? -135.99 146.48 47.25 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' A' ' 184' ' ' ALA . . . 91.48 78.25 1.37 Allowed Glycine 0 C--N 1.352 1.428 0 N-CA-C 107.839 -2.104 . . . . 0.0 107.839 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.469 ' HB2' ' O ' ' A' ' 183' ' ' GLY . . . 70.77 73.29 0.2 Allowed 'General case' 0 C--N 1.36 1.025 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -58.62 140.94 53.69 Favored 'General case' 0 C--N 1.357 0.922 0 CA-C-O 121.75 0.786 . . . . 0.0 110.076 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -126.39 131.43 51.76 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 50.1 tp -92.26 -65.71 0.98 Allowed 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -156.13 -85.25 0.05 Allowed 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -126.65 146.35 50.22 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 . . . . . 0 C--O 1.263 1.815 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -179.855 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' HEM . . . . . 1.52 ' C3B' HD13 ' A' ' 99' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.738 ' HG2' ' HB2' ' A' ' 4' ' ' MET . 27.2 tpp . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 120.881 0.372 . . . . 0.0 110.538 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.416 ' HA ' HG21 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -81.34 -20.14 41.29 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -179.695 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -77.86 -37.68 29.08 Favored Glycine 0 C--N 1.35 1.331 0 N-CA-C 109.101 -1.599 . . . . 0.0 109.101 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.738 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 3.0 tpp -70.84 -38.21 73.18 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 122.035 -0.685 . . . . 0.0 110.707 -177.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.416 HG21 ' HA ' ' A' ' 2' ' ' MET . 27.2 m -71.28 -23.14 22.82 Favored 'Isoleucine or valine' 0 C--N 1.357 0.93 0 O-C-N 121.651 -0.656 . . . . 0.0 109.415 -178.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.0 m-30 -71.06 -33.38 70.22 Favored 'General case' 0 C--N 1.357 0.893 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.1 m -67.14 -40.17 86.68 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.93 -38.82 97.22 Favored Glycine 0 C--N 1.36 1.893 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.525 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.1 OUTLIER -66.13 -39.11 89.62 Favored 'General case' 0 C--N 1.353 0.736 0 CA-C-N 117.274 0.537 . . . . 0.0 110.31 -177.952 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.911 ' HE2' HD23 ' A' ' 26' ' ' LEU . 25.5 mmt -64.02 -40.6 96.71 Favored 'General case' 0 C--N 1.355 0.822 0 O-C-N 121.635 -0.666 . . . . 0.0 110.753 -178.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -64.77 -40.07 94.66 Favored 'General case' 0 C--N 1.349 0.547 0 O-C-N 122.055 -0.403 . . . . 0.0 111.307 -178.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 58.2 tp -65.0 -42.68 94.26 Favored 'General case' 0 C--N 1.35 0.592 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.525 HG12 ' O ' ' A' ' 9' ' ' LEU . 3.3 mm -72.44 -37.58 57.99 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 O-C-N 121.169 -0.957 . . . . 0.0 111.179 -175.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -68.02 -43.75 78.05 Favored 'General case' 0 C--N 1.352 0.679 0 O-C-N 121.821 -0.549 . . . . 0.0 111.653 -175.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -71.9 -32.45 67.42 Favored 'General case' 0 N--CA 1.447 -0.579 0 O-C-N 122.001 -0.437 . . . . 0.0 111.487 -177.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -72.5 -49.96 29.32 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -175.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -127.98 -20.97 3.73 Favored 'General case' 0 C--N 1.357 0.917 0 C-N-CA 117.347 -1.741 . . . . 0.0 113.694 -176.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 143.42 178.88 19.61 Favored Glycine 0 CA--C 1.499 -0.947 0 C-N-CA 117.678 -2.201 . . . . 0.0 110.23 -179.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -96.5 -11.34 25.65 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -177.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -74.64 -36.57 62.88 Favored 'General case' 0 C--N 1.359 0.986 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.2 m -70.11 -38.91 75.74 Favored 'General case' 0 C--N 1.358 0.952 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 178.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.505 HD23 ' CD1' ' A' ' 26' ' ' LEU . 1.7 tt -59.84 -38.09 81.09 Favored 'General case' 0 C--N 1.359 0.994 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -64.12 -37.09 86.19 Favored 'General case' 0 C--N 1.356 0.87 0 O-C-N 122.097 -0.377 . . . . 0.0 110.788 -178.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.5 m -65.25 -40.63 94.24 Favored 'General case' 0 C--N 1.355 0.836 0 O-C-N 121.698 -0.626 . . . . 0.0 109.62 -178.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.458 HD11 HG21 ' A' ' 13' ' ' ILE . 78.7 mt -64.9 -36.82 85.6 Favored 'General case' 0 C--N 1.356 0.868 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 -178.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.911 HD23 ' HE2' ' A' ' 10' ' ' MET . 81.1 mt -70.84 -16.5 62.72 Favored 'General case' 0 C--N 1.36 1.048 0 O-C-N 121.765 -0.584 . . . . 0.0 110.235 -179.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -85.07 -27.83 26.06 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.29 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.2 t -66.89 -37.54 84.59 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.8 p -91.61 -39.54 11.82 Favored 'General case' 0 C--N 1.359 0.995 0 C-N-CA 119.064 -1.054 . . . . 0.0 108.18 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 86.15 132.45 0.04 OUTLIER 'General case' 0 C--N 1.36 1.049 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.528 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -91.91 -167.07 1.69 Allowed 'General case' 0 C--N 1.356 0.885 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.841 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.494 ' H ' ' HB2' ' A' ' 31' ' ' LEU . 4.3 mt-30 -153.05 -66.3 0.15 Allowed 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 106.816 -1.549 . . . . 0.0 106.816 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.0 t -97.71 -67.12 0.86 Allowed 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -131.42 -46.53 0.98 Allowed 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.24 -37.37 3.51 Favored Glycine 0 C--N 1.354 1.566 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 179.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 81.9 mt -113.62 106.09 20.02 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.041 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.495 ' HD1' ' HA ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -82.57 -150.78 0.09 Allowed 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.496 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.469 ' H ' ' HB3' ' A' ' 37' ' ' TYR . 86.2 m -112.09 -57.84 2.21 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.426 ' C ' HG21 ' A' ' 40' ' ' VAL . 11.6 p 169.06 69.8 0.0 OUTLIER 'General case' 0 C--N 1.36 1.029 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 -179.441 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.426 HG21 ' C ' ' A' ' 39' ' ' SER . 2.2 t -150.29 -6.69 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.361 1.081 0 C-N-CA 119.707 -0.797 . . . . 0.0 110.047 -178.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -95.26 143.08 16.42 Favored Glycine 0 C--N 1.352 1.447 0 C-N-CA 119.28 -1.438 . . . . 0.0 110.465 -177.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.0 m -123.94 116.77 23.42 Favored 'General case' 0 C--N 1.356 0.871 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 178.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -111.66 177.42 4.66 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -78.66 -175.14 4.23 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 65.4 m80 -94.38 -15.6 24.2 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 119.781 -0.767 . . . . 0.0 109.179 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -68.88 -29.22 67.47 Favored 'General case' 0 C--N 1.353 0.749 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.6 tp10 -62.72 -41.51 99.19 Favored 'General case' 0 C--N 1.353 0.719 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 59.9 tp -67.62 -38.74 84.36 Favored 'General case' 0 C--N 1.357 0.893 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.218 -179.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 60.5 tp -72.3 -34.69 68.32 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 122.259 -0.276 . . . . 0.0 110.689 -177.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 72.7 tp60 -64.18 -41.81 96.95 Favored 'General case' 0 C--N 1.353 0.721 0 O-C-N 121.589 -0.694 . . . . 0.0 110.004 -177.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 84.2 mt -71.79 -34.64 69.58 Favored 'General case' 0 C--N 1.362 1.113 0 C-N-CA 119.534 -0.867 . . . . 0.0 109.431 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.514 HG13 HD21 ' A' ' 66' ' ' LEU . 29.2 t -62.65 -42.12 94.82 Favored 'Isoleucine or valine' 0 C--N 1.351 0.645 0 CA-C-O 120.705 0.288 . . . . 0.0 110.309 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.495 ' O ' HG11 ' A' ' 53' ' ' VAL . 53.9 t -65.76 -40.21 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 -179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 32.1 tptt -65.22 -29.2 69.98 Favored 'General case' 0 C--N 1.361 1.107 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.538 HD12 HD13 ' A' ' 66' ' ' LEU . 16.0 mt -64.27 -40.26 95.6 Favored 'General case' 0 C--N 1.357 0.902 0 O-C-N 121.968 -0.457 . . . . 0.0 110.395 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.575 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 46.5 t -65.39 -37.44 87.0 Favored 'General case' 0 C--N 1.349 0.573 0 O-C-N 121.775 -0.578 . . . . 0.0 110.324 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -83.74 -38.25 21.61 Favored 'General case' 0 C--N 1.353 0.73 0 O-C-N 121.242 -0.911 . . . . 0.0 112.811 -177.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.729 HG12 ' N ' ' A' ' 59' ' ' SER . 4.6 p -76.03 -41.6 38.4 Favored 'Isoleucine or valine' 0 C--N 1.355 0.83 0 O-C-N 121.354 -0.841 . . . . 0.0 111.897 -176.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.729 ' N ' HG12 ' A' ' 58' ' ' VAL . 72.8 m -103.66 -5.66 22.38 Favored 'General case' 0 C--N 1.354 0.803 0 O-C-N 121.198 -0.939 . . . . 0.0 110.486 -177.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 74.6 m 65.05 38.95 5.9 Favored 'General case' 0 C--N 1.354 0.769 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.575 ' O ' ' HA ' ' A' ' 56' ' ' SER . 55.4 t -115.53 132.22 23.23 Favored Pre-proline 0 CA--C 1.505 -0.778 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.553 ' HD2' HG13 ' A' ' 61' ' ' VAL . 31.2 Cg_endo -63.99 157.16 54.47 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.258 1.972 . . . . 0.0 114.095 -178.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.61 ' HA ' ' CD2' ' A' ' 66' ' ' LEU . 15.5 m -75.98 -12.66 14.62 Favored 'Isoleucine or valine' 0 C--N 1.353 0.742 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.031 -177.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 81.1 p -94.13 -35.14 12.67 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 118.068 -1.453 . . . . 0.0 110.129 -178.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -80.9 -21.22 40.76 Favored 'General case' 0 C--N 1.353 0.737 0 O-C-N 121.167 -0.958 . . . . 0.0 108.892 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.61 ' CD2' ' HA ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -77.19 -36.67 54.78 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.732 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.614 HG11 ' N ' ' A' ' 68' ' ' ARG . 1.8 p -68.83 -28.9 41.59 Favored 'Isoleucine or valine' 0 C--N 1.359 0.981 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.055 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.614 ' N ' HG11 ' A' ' 67' ' ' VAL . 79.8 mtp180 -68.49 -49.1 62.24 Favored 'General case' 0 C--N 1.365 1.265 0 O-C-N 121.234 -0.916 . . . . 0.0 110.656 179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.9 mt -63.83 -36.41 83.81 Favored 'General case' 0 C--N 1.357 0.893 0 O-C-N 122.069 -0.395 . . . . 0.0 111.027 -178.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -61.16 -47.07 87.88 Favored 'General case' 0 C--N 1.348 0.536 0 O-C-N 122.134 -0.354 . . . . 0.0 110.495 -178.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.25 -39.29 96.99 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-O 119.787 -0.452 . . . . 0.0 112.17 -177.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -65.7 -45.45 82.75 Favored 'General case' 0 C--N 1.352 0.674 0 CA-C-N 118.513 1.157 . . . . 0.0 111.638 -177.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 12.2 mttm -64.86 -48.24 75.0 Favored 'General case' 0 C--N 1.357 0.921 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -177.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -70.76 -39.31 73.33 Favored 'General case' 0 C--N 1.349 0.563 0 O-C-N 121.263 -0.898 . . . . 0.0 111.963 -176.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -63.56 -46.45 85.85 Favored 'General case' 0 C--N 1.353 0.755 0 O-C-N 121.103 -0.998 . . . . 0.0 111.239 -178.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.8 p -70.89 -14.72 18.26 Favored 'Isoleucine or valine' 0 C--N 1.357 0.931 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -71.11 -39.76 71.88 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 87.7 mt -75.78 -27.19 57.93 Favored 'General case' 0 C--N 1.359 0.986 0 O-C-N 122.258 -0.276 . . . . 0.0 110.569 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.1 mm -65.78 -53.59 36.78 Favored 'Isoleucine or valine' 0 C--N 1.36 1.059 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.432 -178.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -75.26 -14.6 60.52 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 119.611 -0.836 . . . . 0.0 109.259 178.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.7 -37.58 61.47 Favored Glycine 0 C--N 1.35 1.345 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -132.55 102.9 13.69 Favored Pre-proline 0 C--N 1.356 0.887 0 CA-C-O 122.611 1.196 . . . . 0.0 109.104 -177.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.503 ' O ' ' HB2' ' A' ' 87' ' ' ASN . 40.3 Cg_endo -68.74 -22.23 37.49 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.556 2.17 . . . . 0.0 114.039 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -90.69 -9.56 46.36 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -89.84 -21.89 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.967 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 -178.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.534 ' HA ' ' HE2' ' A' ' 89' ' ' MET . . . -102.66 -16.35 16.06 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.503 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 49.2 t30 -70.99 -40.64 71.75 Favored 'General case' 0 C--N 1.36 1.028 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -67.7 -28.38 67.63 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 120.746 -0.381 . . . . 0.0 110.418 -179.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.687 ' SD ' ' HZ ' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -81.59 152.24 27.29 Favored 'General case' 0 C--N 1.352 0.696 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -179.488 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.621 ' N ' ' HG2' ' A' ' 89' ' ' MET . 4.6 mtpt -117.14 -26.76 6.69 Favored 'General case' 0 C--N 1.365 1.246 0 C-N-CA 120.054 -0.659 . . . . 0.0 111.293 -177.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -167.74 175.6 6.85 Favored 'General case' 0 C--N 1.354 0.797 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -177.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.427 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 42.2 t -64.75 -43.95 91.67 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.383 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -68.08 -39.54 82.9 Favored 'General case' 0 C--N 1.355 0.836 0 O-C-N 121.365 -0.834 . . . . 0.0 109.418 -178.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -66.23 -22.45 66.33 Favored 'General case' 0 C--N 1.353 0.757 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.427 ' HB3' ' O ' ' A' ' 92' ' ' SER . 60.3 tp -65.08 -46.03 82.85 Favored 'General case' 0 C--N 1.354 0.767 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.9 mp -62.96 -36.13 82.45 Favored 'General case' 0 C--N 1.355 0.839 0 O-C-N 122.2 -0.313 . . . . 0.0 110.744 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 35.9 t -65.09 -41.69 94.74 Favored 'General case' 0 C--N 1.349 0.582 0 O-C-N 121.849 -0.532 . . . . 0.0 111.555 -178.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.807 ' HG2' ' O ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -102.37 9.85 39.5 Favored 'General case' 0 C--N 1.358 0.946 0 O-C-N 121.676 -0.64 . . . . 0.0 110.327 -176.126 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 1.269 HD11 ' C3B' ' A' ' 202' ' ' HEM . 11.7 tt -63.1 -35.14 70.5 Favored 'Isoleucine or valine' 0 C--N 1.354 0.797 0 O-C-N 121.088 -1.008 . . . . 0.0 111.984 -176.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.69 ' N ' HG21 ' A' ' 99' ' ' ILE . 37.4 t70 -111.28 -18.52 12.91 Favored 'General case' 0 N--CA 1.438 -1.054 0 O-C-N 120.814 -1.179 . . . . 0.0 109.99 -178.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 37.7 t -64.38 -46.9 81.35 Favored 'General case' 0 N--CA 1.443 -0.808 0 O-C-N 121.697 -0.627 . . . . 0.0 111.107 -178.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.429 ' O ' HG13 ' A' ' 105' ' ' VAL . 35.2 t80 -130.15 -21.1 2.98 Favored 'General case' 0 C--N 1.359 0.986 0 C-N-CA 118.002 -1.479 . . . . 0.0 112.565 -177.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 96.1 mt -71.15 -49.5 48.25 Favored 'Isoleucine or valine' 0 C--O 1.242 0.693 0 O-C-N 120.771 -1.205 . . . . 0.0 110.976 -177.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 29.8 m170 -89.41 3.49 52.1 Favored 'General case' 0 N--CA 1.439 -0.982 0 O-C-N 121.111 -0.993 . . . . 0.0 109.996 -177.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.429 HG13 ' O ' ' A' ' 102' ' ' PHE . 2.5 p -88.82 -34.26 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 178.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -72.11 -40.92 67.8 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.473 HG12 HMDB ' A' ' 202' ' ' HEM . 76.5 t -63.81 -46.54 94.1 Favored 'Isoleucine or valine' 0 C--N 1.356 0.861 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -179.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -60.6 -48.62 80.96 Favored 'General case' 0 C--N 1.359 1.015 0 O-C-N 122.226 -0.296 . . . . 0.0 111.447 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -60.97 -38.11 84.77 Favored 'General case' 0 C--N 1.356 0.857 0 O-C-N 121.567 -0.708 . . . . 0.0 110.651 -178.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 18.5 mt -57.66 -75.66 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -116.22 132.7 23.14 Favored Pre-proline 0 N--CA 1.438 -1.054 0 C-N-CA 118.708 -1.197 . . . . 0.0 108.857 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -83.04 -4.87 11.28 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 123.136 2.557 . . . . 0.0 115.003 -179.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -66.9 -36.76 83.01 Favored 'General case' 0 C--N 1.355 0.806 0 O-C-N 121.964 -0.46 . . . . 0.0 109.826 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.5 147.25 52.27 Favored 'General case' 0 C--N 1.352 0.69 0 CA-C-O 121.585 0.707 . . . . 0.0 109.849 -178.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -132.47 135.56 46.12 Favored 'General case' 0 C--N 1.357 0.898 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 179.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.536 ' HB3' ' HD2' ' A' ' 117' ' ' PRO . 2.7 mm? -124.12 156.45 66.28 Favored Pre-proline 0 C--N 1.354 0.789 0 CA-C-O 122.023 0.916 . . . . 0.0 108.649 -178.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.793 ' HD3' ' CBA' ' A' ' 202' ' ' HEM . 95.0 Cg_endo -79.23 -160.17 0.12 Allowed 'Trans proline' 0 C--N 1.318 -1.047 0 C-N-CA 123.554 2.836 . . . . 0.0 113.22 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -120.73 144.11 48.42 Favored 'General case' 0 C--N 1.364 1.201 0 C-N-CA 118.997 -1.081 . . . . 0.0 108.24 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.56 ' HE2' ' CD1' ' A' ' 133' ' ' TYR . 22.4 m-85 -129.13 137.77 51.4 Favored 'General case' 0 C--N 1.362 1.109 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.35 -178.739 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.434 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 93.8 m -123.87 129.49 51.08 Favored 'General case' 0 C--N 1.356 0.85 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 177.199 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 82.5 m -113.49 127.55 56.14 Favored 'General case' 0 CA--C 1.503 -0.846 0 C-N-CA 119.069 -1.052 . . . . 0.0 109.717 -177.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -120.24 118.9 31.68 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 178.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.436 ' HG3' HD11 ' A' ' 129' ' ' ILE . 58.7 ttp180 -96.23 117.85 31.6 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -178.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.404 ' HA ' HD22 ' A' ' 124' ' ' LEU . 92.8 mt -88.98 -20.07 24.91 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.303 -179.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -179.88 -150.08 8.93 Favored Glycine 0 C--N 1.349 1.303 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 -178.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -94.69 -36.06 11.9 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -178.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -103.34 0.12 30.93 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 120.176 -0.61 . . . . 0.0 109.969 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -116.69 134.03 55.3 Favored 'General case' 0 C--N 1.358 0.954 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.645 HG23 ' N ' ' A' ' 130' ' ' ARG . 8.1 mm -144.85 137.95 22.1 Favored 'Isoleucine or valine' 0 C--N 1.357 0.923 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.645 ' N ' HG23 ' A' ' 129' ' ' ILE . 26.1 mtm180 -125.42 135.83 52.78 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.626 ' HG ' ' O ' ' A' ' 131' ' ' LEU . 0.2 OUTLIER -129.05 128.03 42.76 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.708 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.434 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 18.5 m170 -95.78 138.29 33.64 Favored 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.56 ' CD1' ' HE2' ' A' ' 119' ' ' PHE . 65.3 t80 -126.3 118.97 26.19 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 -178.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.486 ' HA ' ' O ' ' A' ' 171' ' ' THR . 27.5 tt0 -113.36 114.15 26.23 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 12.7 t -165.11 151.32 10.07 Favored 'General case' 0 C--N 1.358 0.962 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -91.12 4.31 52.51 Favored 'General case' 0 C--N 1.355 0.846 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.638 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.452 HH11 ' HD2' ' A' ' 137' ' ' ARG . 1.0 OUTLIER -135.68 72.69 62.75 Favored Pre-proline 0 C--N 1.355 0.847 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 179.053 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -96.47 108.23 0.1 Allowed 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 122.749 2.299 . . . . 0.0 115.924 -177.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -111.91 113.27 25.49 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 176.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.21 -38.6 91.8 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.101 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.1 m -63.43 -28.18 69.8 Favored 'General case' 0 C--N 1.353 0.726 0 O-C-N 121.967 -0.458 . . . . 0.0 110.903 -178.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -75.33 -45.94 36.39 Favored 'General case' 0 C--N 1.351 0.641 0 C-N-CA 120.156 -0.617 . . . . 0.0 109.552 -177.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.67 -39.79 91.71 Favored 'General case' 0 C--N 1.356 0.887 0 O-C-N 122.047 -0.408 . . . . 0.0 111.356 -177.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -62.99 -37.26 86.46 Favored 'General case' 0 C--N 1.355 0.843 0 O-C-N 121.78 -0.575 . . . . 0.0 110.057 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.59 -42.94 99.4 Favored Glycine 0 C--N 1.348 1.214 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 82.8 mt -69.54 -41.14 76.34 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 117.437 0.619 . . . . 0.0 112.596 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 97.0 mt -71.29 -42.04 69.18 Favored 'General case' 0 C--N 1.36 1.06 0 O-C-N 121.252 -0.905 . . . . 0.0 110.999 -177.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -69.88 -31.83 69.86 Favored 'General case' 0 C--N 1.349 0.555 0 O-C-N 121.994 -0.441 . . . . 0.0 110.597 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.553 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -62.59 -40.03 98.62 Favored Glycine 0 C--N 1.355 1.632 0 N-CA-C 108.674 -1.771 . . . . 0.0 108.674 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 45.1 t -61.05 -42.67 98.91 Favored 'General case' 0 C--N 1.35 0.621 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.475 ' HB2' ' O ' ' A' ' 156' ' ' GLU . . . -76.05 1.79 14.54 Favored 'General case' 0 C--N 1.357 0.931 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.553 ' HB2' ' O ' ' A' ' 149' ' ' GLY . 7.6 mm-40 -86.57 -47.7 9.0 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -65.11 -45.19 86.14 Favored 'General case' 0 C--N 1.359 0.993 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.687 ' HZ ' ' SD ' ' A' ' 89' ' ' MET . 51.9 m-85 -69.25 -27.99 65.92 Favored 'General case' 0 C--N 1.362 1.132 0 O-C-N 121.897 -0.502 . . . . 0.0 111.013 -178.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 85.2 tttt 72.3 73.59 0.16 Allowed 'General case' 0 C--N 1.359 0.998 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -178.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.475 ' O ' ' HB2' ' A' ' 151' ' ' ALA . 2.4 tp10 -156.34 119.21 4.14 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -82.39 106.84 14.6 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 120.086 -0.646 . . . . 0.0 111.069 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 11.9 m-30 -112.38 160.31 17.83 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 176.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 92.3 m -120.47 127.84 52.59 Favored 'General case' 0 CA--C 1.505 -0.772 0 C-N-CA 118.938 -1.105 . . . . 0.0 109.073 -178.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 3.9 mp -105.65 122.63 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.7 m -118.87 -171.93 2.19 Favored 'General case' 0 C--N 1.358 0.936 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -178.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -145.36 154.57 42.44 Favored 'General case' 0 C--N 1.356 0.851 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -178.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' THR . . . . . 0.42 ' O ' ' HB3' ' A' ' 167' ' ' GLN . 28.7 p -96.27 144.84 28.53 Favored Pre-proline 0 C--N 1.36 1.054 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 178.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.723 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 72.9 Cg_endo -75.63 -12.83 20.29 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.79 2.326 . . . . 0.0 115.203 -178.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -72.91 -41.77 64.25 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.664 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 41.9 p -115.84 15.14 16.36 Favored 'General case' 0 C--N 1.355 0.807 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.391 -178.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.723 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.3 pp0? -66.6 -12.64 58.9 Favored 'General case' 0 C--N 1.355 0.834 0 O-C-N 121.59 -0.694 . . . . 0.0 110.454 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -128.08 42.53 3.3 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 19.1 t -143.17 145.03 32.44 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.626 ' O ' ' HB ' ' A' ' 171' ' ' THR . 61.7 mt-10 -97.44 165.45 12.0 Favored 'General case' 0 C--N 1.355 0.818 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.626 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 16.9 m 84.81 -58.62 0.1 Allowed 'General case' 0 C--N 1.369 1.451 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -109.9 114.74 28.53 Favored 'General case' 0 CA--C 1.504 -0.803 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.45 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 95.2 t -133.26 133.09 58.28 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 63.3 mt -117.57 128.48 74.79 Favored 'Isoleucine or valine' 0 C--N 1.358 0.968 0 CA-C-O 122.14 0.971 . . . . 0.0 109.456 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -110.52 145.23 38.1 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 114.838 -1.074 . . . . 0.0 108.336 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -119.61 118.3 30.63 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.7 mp -112.4 119.0 59.23 Favored 'Isoleucine or valine' 0 C--N 1.354 0.793 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 -178.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 90.3 m -124.6 142.05 51.65 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -177.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 13.6 ttt180 -91.68 116.5 28.94 Favored 'General case' 0 C--N 1.36 1.038 0 N-CA-C 106.835 -1.542 . . . . 0.0 106.835 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.504 ' HB1' ' HD2' ' A' ' 181' ' ' PRO . . . -73.41 157.97 87.23 Favored Pre-proline 0 C--N 1.359 0.99 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.504 ' HD2' ' HB1' ' A' ' 180' ' ' ALA . 19.6 Cg_endo -60.05 120.5 8.32 Favored 'Trans proline' 0 CA--C 1.494 -1.507 0 C-N-CA 122.028 1.818 . . . . 0.0 112.864 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 6.9 ppt_? -145.92 159.14 43.65 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 73.07 65.98 2.14 Favored Glycine 0 C--N 1.356 1.656 0 N-CA-C 108.569 -1.813 . . . . 0.0 108.569 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 76.33 165.35 0.26 Allowed 'General case' 0 C--N 1.361 1.073 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -179.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -94.29 -177.6 4.33 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -159.14 100.47 1.54 Allowed 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -178.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.05 -73.79 0.67 Allowed 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . 0.572 ' HD2' ' CD1' ' A' ' 189' ' ' PHE . 0.3 OUTLIER -151.92 -94.1 0.05 Allowed 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -179.717 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . 0.572 ' CD1' ' HD2' ' A' ' 188' ' ' TYR . 89.9 m-85 -117.03 143.52 45.65 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 . . . . . 0 C--O 1.264 1.817 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -179.607 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' HEM . . . . . 1.269 ' C3B' HD11 ' A' ' 99' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.502 ' HE2' ' HE3' ' A' ' 4' ' ' MET . 76.5 mtm . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.298 0.57 . . . . 0.0 110.828 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.74 -14.11 58.4 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -178.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.22 -41.99 44.62 Favored Glycine 0 C--N 1.351 1.369 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.502 ' HE3' ' HE2' ' A' ' 1' ' ' MET . 17.6 ttp -68.15 -39.37 82.67 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 122.119 -0.636 . . . . 0.0 111.564 -177.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.0 m -68.25 -23.5 28.65 Favored 'Isoleucine or valine' 0 C--N 1.356 0.871 0 O-C-N 121.462 -0.773 . . . . 0.0 109.534 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.411 ' HZ ' ' CG ' ' A' ' 47' ' ' GLU . 2.6 m-85 -71.53 -34.05 69.71 Favored 'General case' 0 C--N 1.359 0.994 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 179.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.8 m -66.1 -40.37 90.69 Favored 'General case' 0 C--N 1.355 0.826 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -61.83 -38.68 96.38 Favored Glycine 0 C--N 1.358 1.8 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.693 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -64.54 -41.78 96.13 Favored 'General case' 0 C--N 1.352 0.705 0 CA-C-N 117.072 0.436 . . . . 0.0 111.068 -178.552 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.608 ' HE1' HD22 ' A' ' 26' ' ' LEU . 18.5 mmt -63.0 -41.29 99.55 Favored 'General case' 0 C--N 1.353 0.733 0 O-C-N 121.519 -0.738 . . . . 0.0 111.247 -178.113 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -67.91 -40.27 83.47 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.762 -177.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 55.3 tp -66.7 -43.34 84.63 Favored 'General case' 0 C--N 1.349 0.549 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -177.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.693 HG12 ' O ' ' A' ' 9' ' ' LEU . 1.6 mm -73.84 -37.95 49.44 Favored 'Isoleucine or valine' 0 C--N 1.359 0.979 0 O-C-N 121.06 -1.025 . . . . 0.0 111.057 -175.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -70.19 -42.01 72.96 Favored 'General case' 0 C--N 1.349 0.554 0 O-C-N 121.699 -0.626 . . . . 0.0 111.546 -176.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -71.48 -37.3 71.3 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -175.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -93.37 -32.39 14.28 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -174.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -115.51 -32.22 5.64 Favored 'General case' 0 CA--C 1.506 -0.723 0 C-N-CA 117.424 -1.71 . . . . 0.0 112.828 -176.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 146.58 178.19 21.77 Favored Glycine 0 C--N 1.346 1.085 0 C-N-CA 117.954 -2.069 . . . . 0.0 110.379 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -101.5 -23.75 14.26 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -177.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -69.52 -39.83 77.28 Favored 'General case' 0 C--N 1.36 1.047 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.413 HG21 HG22 ' A' ' 58' ' ' VAL . 94.9 m -67.96 -38.33 82.64 Favored 'General case' 0 C--N 1.357 0.915 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.468 HD13 ' HB ' ' A' ' 13' ' ' ILE . 42.8 tp -59.93 -38.1 81.41 Favored 'General case' 0 C--N 1.355 0.838 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 179.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -65.5 -36.57 84.24 Favored 'General case' 0 C--N 1.358 0.958 0 O-C-N 122.081 -0.387 . . . . 0.0 110.805 -178.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.4 m -65.33 -38.84 91.37 Favored 'General case' 0 C--N 1.354 0.797 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.572 HD11 ' HB3' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -63.06 -38.23 90.37 Favored 'General case' 0 C--N 1.353 0.732 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -179.13 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.608 HD22 ' HE1' ' A' ' 10' ' ' MET . 85.0 mt -73.84 -14.11 61.03 Favored 'General case' 0 C--N 1.359 1.009 0 O-C-N 121.749 -0.594 . . . . 0.0 110.415 -178.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -86.61 -28.59 23.16 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 119.185 -1.006 . . . . 0.0 109.374 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.7 t -67.03 -37.04 83.41 Favored 'General case' 0 C--N 1.355 0.827 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.0 p -91.51 -39.89 11.68 Favored 'General case' 0 C--N 1.359 1.015 0 C-N-CA 118.849 -1.14 . . . . 0.0 108.153 -179.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 85.97 131.45 0.04 OUTLIER 'General case' 0 C--N 1.361 1.091 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.502 ' HB2' ' H ' ' A' ' 32' ' ' GLN . 0.2 OUTLIER -90.52 -166.83 1.68 Allowed 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.888 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.502 ' H ' ' HB2' ' A' ' 31' ' ' LEU . 60.6 tt0 -154.2 -61.78 0.13 Allowed 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 -179.621 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.8 t -101.53 -68.39 0.82 Allowed 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -137.0 -42.67 0.58 Allowed 'General case' 0 CA--C 1.502 -0.899 0 C-N-CA 119.583 -0.847 . . . . 0.0 108.881 -178.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.16 -33.92 3.86 Favored Glycine 0 C--N 1.352 1.442 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 84.8 mt -112.44 102.03 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.728 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -104.28 11.73 34.5 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.721 HG23 ' H ' ' A' ' 39' ' ' SER . 1.9 m 76.31 -170.53 0.08 Allowed 'General case' 0 C--N 1.358 0.974 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.721 ' H ' HG23 ' A' ' 38' ' ' THR . 21.6 p -97.65 51.45 1.07 Allowed 'General case' 0 C--N 1.354 0.769 0 O-C-N 121.151 -0.968 . . . . 0.0 110.26 -178.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 17.9 t -107.95 -10.78 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.685 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -107.09 159.18 14.76 Favored Glycine 0 C--N 1.357 1.743 0 C-N-CA 119.338 -1.411 . . . . 0.0 109.92 -178.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 36.2 m -129.28 134.26 47.87 Favored 'General case' 0 C--N 1.361 1.097 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -122.35 174.37 7.05 Favored 'General case' 0 C--N 1.355 0.815 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -77.31 -176.49 4.16 Favored 'General case' 0 C--N 1.357 0.899 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.496 ' CD2' HH22 ' A' ' 137' ' ' ARG . 74.8 m80 -92.16 -15.95 26.94 Favored 'General case' 0 C--N 1.356 0.887 0 C-N-CA 120.131 -0.628 . . . . 0.0 109.417 -178.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -67.6 -28.29 67.63 Favored 'General case' 0 C--N 1.351 0.64 0 N-CA-C 107.605 -1.258 . . . . 0.0 107.605 177.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.411 ' CG ' ' HZ ' ' A' ' 6' ' ' PHE . 29.8 tp10 -63.11 -41.52 99.36 Favored 'General case' 0 C--N 1.352 0.687 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.431 HD13 ' C ' ' A' ' 48' ' ' LEU . 2.4 tm? -67.88 -39.46 83.7 Favored 'General case' 0 C--N 1.359 1.001 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -179.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 60.8 tp -69.64 -36.42 76.1 Favored 'General case' 0 CA--C 1.508 -0.664 0 O-C-N 122.167 -0.333 . . . . 0.0 110.498 -177.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -65.02 -40.22 94.54 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 121.686 -0.634 . . . . 0.0 109.986 -178.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.572 ' HB3' HD11 ' A' ' 25' ' ' LEU . 77.0 mt -81.37 -19.16 43.28 Favored 'General case' 0 C--N 1.36 1.028 0 C-N-CA 119.644 -0.823 . . . . 0.0 110.661 -178.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.462 ' O ' HG11 ' A' ' 52' ' ' VAL . 1.2 t -78.96 -37.22 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.501 ' O ' HG12 ' A' ' 53' ' ' VAL . 55.6 t -68.79 -40.41 81.35 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.448 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 32.2 tptt -65.1 -27.15 68.56 Favored 'General case' 0 C--N 1.364 1.235 0 O-C-N 121.126 -0.984 . . . . 0.0 108.827 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.512 HD12 HD13 ' A' ' 13' ' ' ILE . 1.5 tt -68.26 -38.0 81.33 Favored 'General case' 0 C--N 1.354 0.764 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.1 p -72.75 -18.23 61.53 Favored 'General case' 0 C--N 1.357 0.894 0 O-C-N 121.54 -0.725 . . . . 0.0 110.948 -179.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -100.05 -37.7 8.87 Favored 'General case' 0 C--N 1.351 0.674 0 O-C-N 121.168 -0.957 . . . . 0.0 111.668 -179.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.413 HG22 HG21 ' A' ' 21' ' ' THR . 4.3 p -72.96 -35.96 50.14 Favored 'Isoleucine or valine' 0 C--N 1.351 0.642 0 O-C-N 121.713 -0.617 . . . . 0.0 111.36 -177.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.6 m -111.99 -7.99 14.09 Favored 'General case' 0 CA--C 1.505 -0.754 0 C-N-CA 119.372 -0.931 . . . . 0.0 110.116 -177.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 64.22 49.12 2.69 Favored 'General case' 0 C--N 1.354 0.784 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.511 ' CG1' ' HD2' ' A' ' 62' ' ' PRO . 52.3 t -113.62 135.51 21.94 Favored Pre-proline 0 CA--C 1.504 -0.802 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.693 ' HG2' ' HB2' ' A' ' 65' ' ' GLU . 20.8 Cg_endo -61.68 149.61 89.18 Favored 'Trans proline' 0 CA--C 1.5 -1.192 0 C-N-CA 122.339 2.026 . . . . 0.0 112.684 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.435 ' HA ' HD22 ' A' ' 66' ' ' LEU . 3.0 m -76.67 -11.78 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.39 -177.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 72.0 p -96.62 -34.68 11.32 Favored 'General case' 0 C--N 1.357 0.93 0 C-N-CA 118.194 -1.402 . . . . 0.0 109.525 -179.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.693 ' HB2' ' HG2' ' A' ' 62' ' ' PRO . 69.1 mt-10 -76.85 -22.3 53.74 Favored 'General case' 0 C--N 1.354 0.792 0 O-C-N 121.437 -0.789 . . . . 0.0 108.893 179.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.435 HD22 ' HA ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -79.19 -36.75 39.73 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.408 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.6 HG12 ' N ' ' A' ' 68' ' ' ARG . 1.7 p -68.12 -26.82 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 C-N-CA 120.123 -0.631 . . . . 0.0 109.9 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.6 ' N ' HG12 ' A' ' 67' ' ' VAL . 6.6 mmm-85 -72.1 -51.66 20.46 Favored 'General case' 0 C--N 1.364 1.216 0 O-C-N 121.549 -0.719 . . . . 0.0 110.453 -179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.3 mt -62.49 -36.27 81.96 Favored 'General case' 0 C--N 1.357 0.905 0 O-C-N 122.012 -0.43 . . . . 0.0 111.038 -178.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -61.02 -47.5 86.12 Favored 'General case' 0 C--N 1.349 0.556 0 O-C-N 122.23 -0.294 . . . . 0.0 110.639 -178.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.83 -39.21 96.51 Favored Glycine 0 C--N 1.356 1.69 0 N-CA-C 111.888 -0.485 . . . . 0.0 111.888 -177.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -62.76 -49.16 76.11 Favored 'General case' 0 C--N 1.352 0.688 0 CA-C-N 118.303 1.051 . . . . 0.0 111.693 -177.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 10.2 mttm -63.3 -47.67 81.28 Favored 'General case' 0 C--N 1.359 0.985 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -177.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.401 ' O ' ' HB2' ' A' ' 77' ' ' GLU . 2.4 tm? -69.41 -38.69 78.02 Favored 'General case' 0 C--N 1.348 0.526 0 O-C-N 121.104 -0.997 . . . . 0.0 111.807 -175.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -63.71 -46.8 83.8 Favored 'General case' 0 C--N 1.355 0.834 0 O-C-N 121.037 -1.04 . . . . 0.0 111.443 -177.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -70.58 -13.83 17.5 Favored 'Isoleucine or valine' 0 C--N 1.36 1.024 0 O-C-N 121.517 -0.739 . . . . 0.0 109.371 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 74' ' ' LEU . 7.7 mm-40 -73.08 -38.34 66.44 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 85.4 mt -73.97 -30.67 62.62 Favored 'General case' 0 C--N 1.357 0.922 0 O-C-N 122.3 -0.25 . . . . 0.0 110.519 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 47.9 mm -65.1 -53.53 39.96 Favored 'Isoleucine or valine' 0 C--N 1.357 0.921 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.957 -177.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -74.61 -15.52 60.83 Favored 'General case' 0 C--N 1.351 0.634 0 C-N-CA 119.573 -0.851 . . . . 0.0 109.526 178.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.45 -36.43 62.87 Favored Glycine 0 C--N 1.349 1.26 0 N-CA-C 111.001 -0.839 . . . . 0.0 111.001 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.489 ' HA ' ' HD2' ' A' ' 83' ' ' PRO . 99.3 m-70 -130.65 105.57 15.67 Favored Pre-proline 0 N--CA 1.441 -0.88 0 CA-C-O 122.686 1.231 . . . . 0.0 109.263 -176.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.489 ' HD2' ' HA ' ' A' ' 82' ' ' HIS . 37.8 Cg_endo -67.69 -26.0 39.66 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.647 2.231 . . . . 0.0 114.085 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -89.86 -7.66 53.74 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 tp -90.36 -20.97 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 -178.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -101.52 -23.63 14.27 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -70.16 -37.33 75.17 Favored 'General case' 0 C--N 1.359 1.001 0 O-C-N 121.867 -0.521 . . . . 0.0 109.855 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -64.89 -34.98 79.67 Favored 'General case' 0 C--N 1.358 0.975 0 O-C-N 121.836 -0.54 . . . . 0.0 110.545 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 18.4 ttp -82.9 152.51 25.52 Favored 'General case' 0 C--N 1.352 0.704 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 -178.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.43 -21.89 7.84 Favored 'General case' 0 C--N 1.364 1.225 0 O-C-N 121.641 -0.662 . . . . 0.0 111.356 -177.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -165.8 171.42 12.83 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -177.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.466 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 62.8 m -66.65 -40.81 88.84 Favored 'General case' 0 C--N 1.355 0.82 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.584 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.492 ' CE1' ' HE2' ' A' ' 158' ' ' PHE . 60.4 m-85 -66.67 -39.65 88.24 Favored 'General case' 0 C--N 1.357 0.915 0 O-C-N 121.188 -0.945 . . . . 0.0 108.836 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -65.79 -23.31 66.68 Favored 'General case' 0 C--N 1.356 0.884 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.713 ' O ' HG13 ' A' ' 99' ' ' ILE . 57.9 tp -63.58 -46.86 83.92 Favored 'General case' 0 C--N 1.355 0.843 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.48 ' HA ' ' CD1' ' A' ' 99' ' ' ILE . 4.2 mp -60.59 -37.34 81.04 Favored 'General case' 0 C--N 1.359 1.016 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.416 -179.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 34.3 t -67.88 -39.71 83.66 Favored 'General case' 0 C--N 1.349 0.566 0 O-C-N 121.918 -0.489 . . . . 0.0 110.242 -179.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.414 ' HG3' ' HZ3' ' A' ' 98' ' ' LYS . 0.2 OUTLIER -85.72 -0.89 56.44 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -176.558 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.713 HG13 ' O ' ' A' ' 95' ' ' LEU . 78.8 mt -60.81 -47.09 94.78 Favored 'Isoleucine or valine' 0 C--N 1.357 0.906 0 CA-C-N 118.919 0.782 . . . . 0.0 112.331 -177.223 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -94.44 -23.92 17.54 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 118.55 -1.26 . . . . 0.0 111.522 -176.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.561 ' O ' HG22 ' A' ' 105' ' ' VAL . 34.5 t -63.86 -48.07 78.21 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.607 -0.683 . . . . 0.0 112.717 -177.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -137.92 -15.86 1.32 Allowed 'General case' 0 C--N 1.359 0.992 0 C-N-CA 116.946 -1.901 . . . . 0.0 113.763 -176.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.546 HG21 ' HD2' ' A' ' 104' ' ' HIS . 96.4 mt -70.81 -49.7 48.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 CA-C-N 120.54 1.518 . . . . 0.0 111.164 -177.404 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.546 ' HD2' HG21 ' A' ' 103' ' ' ILE . 17.8 m170 -89.04 0.67 56.49 Favored 'General case' 0 N--CA 1.442 -0.858 0 O-C-N 121.176 -0.953 . . . . 0.0 110.171 -177.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.561 HG22 ' O ' ' A' ' 101' ' ' SER . 72.7 t -83.71 -44.18 18.22 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.996 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 178.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -67.68 -40.55 84.4 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 71.9 t -63.06 -45.22 99.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.826 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.256 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -60.33 -48.38 82.01 Favored 'General case' 0 C--N 1.36 1.055 0 O-C-N 122.016 -0.428 . . . . 0.0 111.34 -178.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -63.5 -35.41 80.37 Favored 'General case' 0 C--N 1.354 0.795 0 O-C-N 121.544 -0.722 . . . . 0.0 110.615 -178.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 16.4 mt -57.33 -72.1 0.09 Allowed 'General case' 0 C--N 1.357 0.919 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.104 -179.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.452 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 94.4 m-85 -122.31 143.7 40.0 Favored Pre-proline 0 N--CA 1.441 -0.899 0 C-N-CA 118.038 -1.465 . . . . 0.0 109.292 -179.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 111' ' ' TYR . 61.9 Cg_endo -87.25 -2.46 7.83 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 C-N-CA 123.505 2.803 . . . . 0.0 116.265 -178.252 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -83.42 -8.11 59.44 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 121.272 -0.892 . . . . 0.0 109.486 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -83.06 144.33 29.98 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.505 ' O ' HD12 ' A' ' 116' ' ' LEU . 46.0 mt-10 -120.33 144.11 48.02 Favored 'General case' 0 C--N 1.359 1.021 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.505 HD12 ' O ' ' A' ' 115' ' ' GLU . 2.6 mm? -129.88 152.52 80.04 Favored Pre-proline 0 C--N 1.358 0.946 0 CA-C-O 121.951 0.882 . . . . 0.0 109.27 -178.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 116' ' ' LEU . 87.7 Cg_endo -92.73 -155.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.32 -0.946 0 C-N-CA 123.929 3.086 . . . . 0.0 113.036 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -122.5 141.84 51.22 Favored 'General case' 0 C--N 1.368 1.399 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -132.61 137.04 46.9 Favored 'General case' 0 C--N 1.362 1.132 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.629 -178.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.47 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 93.7 m -127.32 128.52 46.06 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 176.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 78.2 m -118.69 128.89 54.94 Favored 'General case' 0 CA--C 1.503 -0.862 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.436 -178.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -120.85 130.89 54.12 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -103.55 117.23 33.95 Favored 'General case' 0 C--N 1.353 0.738 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -179.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.471 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 88.7 mt -83.27 -27.48 29.83 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 120.668 -0.413 . . . . 0.0 109.968 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 179.49 -143.24 5.59 Favored Glycine 0 C--N 1.351 1.378 0 C-N-CA 118.771 -1.681 . . . . 0.0 109.648 -178.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -91.37 -45.98 8.27 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -178.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -98.67 3.25 47.75 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.699 -177.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.471 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 66.7 m-20 -119.91 133.38 55.59 Favored 'General case' 0 C--N 1.357 0.917 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.572 HG21 ' N ' ' A' ' 130' ' ' ARG . 8.1 mm -142.57 138.45 28.69 Favored 'Isoleucine or valine' 0 C--N 1.357 0.91 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 179.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.572 ' N ' HG21 ' A' ' 129' ' ' ILE . 52.3 mtm180 -119.79 137.75 53.77 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 6.6 tp -125.5 119.45 28.25 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.76 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.47 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 11.8 m170 -99.92 135.2 41.71 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -128.06 121.97 30.99 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -178.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.466 ' HA ' ' O ' ' A' ' 171' ' ' THR . 10.2 tt0 -115.55 112.88 22.86 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 178.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.402 ' O ' ' HA ' ' A' ' 171' ' ' THR . 8.8 t -167.25 156.63 10.45 Favored 'General case' 0 C--N 1.357 0.908 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.449 ' C ' ' HD3' ' A' ' 138' ' ' PRO . 99.5 mttt -91.3 6.86 43.61 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.496 HH22 ' CD2' ' A' ' 45' ' ' HIS . 75.0 mtp180 -130.82 74.04 80.44 Favored Pre-proline 0 C--N 1.355 0.816 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.449 ' HD3' ' C ' ' A' ' 136' ' ' LYS . 80.1 Cg_endo -95.57 89.27 0.1 Allowed 'Trans proline' 0 N--CA 1.445 -1.373 0 C-N-CA 122.821 2.347 . . . . 0.0 115.559 -178.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -106.57 112.42 25.41 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 177.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.89 -37.74 88.51 Favored 'General case' 0 C--N 1.353 0.735 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.132 -178.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 71.5 m -61.77 -32.46 72.73 Favored 'General case' 0 C--N 1.353 0.741 0 O-C-N 121.967 -0.458 . . . . 0.0 110.693 -178.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -73.11 -46.48 51.04 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 120.25 -0.58 . . . . 0.0 109.988 -177.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.35 -40.17 95.33 Favored 'General case' 0 C--N 1.356 0.88 0 O-C-N 122.127 -0.358 . . . . 0.0 111.461 -177.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -63.27 -36.89 85.16 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 121.85 -0.531 . . . . 0.0 110.273 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.14 -43.52 98.28 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 -178.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 82.7 mt -69.82 -40.57 75.84 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 96.2 mt -71.63 -42.43 67.63 Favored 'General case' 0 C--N 1.362 1.152 0 O-C-N 121.152 -0.968 . . . . 0.0 111.186 -176.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.497 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 36.2 t70 -69.84 -30.55 68.06 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 121.834 -0.541 . . . . 0.0 110.535 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.487 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -62.85 -39.1 97.58 Favored Glycine 0 C--N 1.357 1.708 0 N-CA-C 108.303 -1.919 . . . . 0.0 108.303 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 48.9 t -60.55 -42.02 95.71 Favored 'General case' 0 C--N 1.351 0.659 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -74.96 -1.24 21.69 Favored 'General case' 0 C--N 1.361 1.093 0 O-C-N 121.739 -0.601 . . . . 0.0 109.476 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.497 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 76.5 mm-40 -84.38 -46.33 11.83 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -68.06 -43.19 79.19 Favored 'General case' 0 C--N 1.359 1.017 0 C-N-CA 120.002 -0.679 . . . . 0.0 109.553 179.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -69.19 -27.67 65.71 Favored 'General case' 0 C--N 1.361 1.076 0 O-C-N 121.739 -0.601 . . . . 0.0 110.701 -178.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 86.1 tttt 70.42 72.31 0.21 Allowed 'General case' 0 C--N 1.361 1.07 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -178.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -143.45 -167.26 2.52 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -142.18 116.6 9.61 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . 0.492 ' HE2' ' CE1' ' A' ' 93' ' ' PHE . 94.9 m-85 -135.09 150.47 50.24 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 178.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 92.4 m -120.63 127.82 52.44 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 3.4 mp -105.9 122.88 60.04 Favored 'Isoleucine or valine' 0 C--N 1.351 0.672 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.9 m -120.12 -173.61 2.59 Favored 'General case' 0 C--N 1.357 0.911 0 CA-C-O 121.86 0.838 . . . . 0.0 109.341 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -147.74 156.96 43.29 Favored 'General case' 0 C--N 1.357 0.932 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -178.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 64.6 p -100.79 146.2 31.68 Favored Pre-proline 0 C--N 1.359 0.988 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.894 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 62.7 Cg_endo -75.75 -9.6 19.77 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.754 2.303 . . . . 0.0 115.424 -178.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -71.97 -41.11 68.1 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 119.771 -0.772 . . . . 0.0 109.101 -179.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 39.2 p -118.05 14.53 14.08 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 120.071 -0.651 . . . . 0.0 110.538 -178.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.894 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 11.6 pt20 -67.03 -10.34 48.73 Favored 'General case' 0 C--N 1.355 0.828 0 O-C-N 121.455 -0.778 . . . . 0.0 110.335 178.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -126.54 38.28 4.15 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.9 m -137.38 146.9 45.02 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.63 ' O ' ' HB ' ' A' ' 171' ' ' THR . 60.5 mt-10 -98.77 164.4 12.23 Favored 'General case' 0 C--N 1.353 0.759 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.63 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 1.7 m 82.05 -56.65 0.23 Allowed 'General case' 0 C--N 1.371 1.532 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.004 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -110.19 117.65 34.26 Favored 'General case' 0 CA--C 1.503 -0.83 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.802 -178.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 67.4 t -131.22 134.0 61.75 Favored 'Isoleucine or valine' 0 C--N 1.357 0.912 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 50.4 mm -108.53 125.44 65.38 Favored 'Isoleucine or valine' 0 C--N 1.357 0.914 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -113.25 153.16 28.84 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 122.136 0.969 . . . . 0.0 108.541 -179.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -136.69 117.56 14.16 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -178.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.3 mp -113.04 118.6 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 -179.161 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.49 HG21 ' N ' ' A' ' 179' ' ' ARG . 89.4 m -120.28 144.24 47.9 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -177.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.574 ' NE ' ' HD2' ' A' ' 182' ' ' ARG . 5.2 ttt180 -89.08 114.59 25.85 Favored 'General case' 0 C--N 1.363 1.185 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.434 ' HA ' ' HD3' ' A' ' 181' ' ' PRO . . . -60.5 147.78 82.21 Favored Pre-proline 0 C--N 1.359 0.982 0 CA-C-O 121.93 0.872 . . . . 0.0 108.925 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 180' ' ' ALA . 74.3 Cg_exo -51.95 128.56 27.22 Favored 'Trans proline' 0 CA--C 1.494 -1.478 0 C-N-CA 122.932 2.422 . . . . 0.0 113.762 -178.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.574 ' HD2' ' NE ' ' A' ' 179' ' ' ARG . 0.1 OUTLIER -110.73 21.86 16.05 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 179.935 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 148.25 -138.5 7.08 Favored Glycine 0 N--CA 1.436 -1.305 0 N-CA-C 107.591 -2.204 . . . . 0.0 107.591 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -79.45 169.42 18.08 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -117.24 112.34 20.66 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 -179.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -113.41 122.72 48.19 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.91 -81.25 0.45 Allowed 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -141.38 -83.06 0.21 Allowed 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -126.7 147.12 49.98 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 . . . . . 0 C--O 1.263 1.771 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 179.939 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' HEM . . . . . 0.83 ' HBD' ' HHA' ' A' ' 202' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.497 ' HG3' ' CMD' ' A' ' 202' ' ' HEM . 43.6 mtp . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.212 0.53 . . . . 0.0 109.862 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.855 ' HA ' HG23 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -82.17 -5.46 58.49 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.046 -177.873 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.52 -46.16 26.47 Favored Glycine 0 C--N 1.35 1.34 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 76.9 mtm -72.15 -34.53 68.57 Favored 'General case' 0 C--N 1.354 0.791 0 O-C-N 121.92 -0.753 . . . . 0.0 111.271 -177.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.855 HG23 ' HA ' ' A' ' 2' ' ' MET . 36.0 m -69.78 -23.44 25.8 Favored 'Isoleucine or valine' 0 C--N 1.356 0.868 0 C-N-CA 119.926 -0.709 . . . . 0.0 109.346 -179.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.425 ' HZ ' ' CG ' ' A' ' 47' ' ' GLU . 1.6 m-85 -71.79 -34.45 69.42 Favored 'General case' 0 C--N 1.357 0.908 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.6 m -66.7 -39.65 88.16 Favored 'General case' 0 C--N 1.354 0.798 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -61.29 -38.81 96.28 Favored Glycine 0 C--N 1.359 1.809 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.636 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -65.33 -40.08 93.24 Favored 'General case' 0 C--N 1.353 0.741 0 O-C-N 122.354 -0.498 . . . . 0.0 110.761 -178.83 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.2 mmt -63.02 -41.02 99.43 Favored 'General case' 0 C--N 1.351 0.665 0 O-C-N 121.632 -0.667 . . . . 0.0 111.099 -178.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -66.81 -40.65 88.14 Favored 'General case' 0 C--N 1.35 0.613 0 O-C-N 121.869 -0.519 . . . . 0.0 111.688 -177.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 53.9 tp -65.8 -42.78 90.25 Favored 'General case' 0 C--N 1.349 0.585 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.636 HG12 ' O ' ' A' ' 9' ' ' LEU . 1.5 mm -75.67 -37.44 36.19 Favored 'Isoleucine or valine' 0 C--N 1.357 0.896 0 O-C-N 121.083 -1.011 . . . . 0.0 111.134 -175.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -68.53 -43.16 77.35 Favored 'General case' 0 C--N 1.352 0.703 0 O-C-N 121.911 -0.493 . . . . 0.0 111.315 -176.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -71.42 -34.36 70.25 Favored 'General case' 0 N--CA 1.446 -0.634 0 O-C-N 122.06 -0.4 . . . . 0.0 111.717 -177.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -71.83 -48.71 44.33 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -175.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -128.22 -19.29 3.93 Favored 'General case' 0 C--N 1.356 0.854 0 C-N-CA 117.352 -1.739 . . . . 0.0 113.747 -176.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 140.56 179.48 18.15 Favored Glycine 0 CA--C 1.497 -1.066 0 C-N-CA 117.773 -2.156 . . . . 0.0 109.97 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -96.42 -12.09 24.75 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -177.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -70.49 -41.41 72.71 Favored 'General case' 0 C--N 1.361 1.073 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.2 m -69.91 -39.08 76.41 Favored 'General case' 0 C--N 1.356 0.859 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 58.3 tp -60.6 -37.93 83.03 Favored 'General case' 0 C--N 1.357 0.918 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -64.59 -36.26 83.66 Favored 'General case' 0 C--N 1.357 0.893 0 O-C-N 122.132 -0.355 . . . . 0.0 110.84 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 93.6 m -63.52 -41.19 98.51 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -178.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.546 HD11 HG21 ' A' ' 13' ' ' ILE . 88.7 mt -64.17 -37.72 88.47 Favored 'General case' 0 C--N 1.352 0.711 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.09 -13.62 61.63 Favored 'General case' 0 C--N 1.36 1.053 0 O-C-N 121.606 -0.684 . . . . 0.0 110.085 -178.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -86.74 -28.94 22.74 Favored 'General case' 0 CA--C 1.506 -0.712 0 O-C-N 121.262 -0.899 . . . . 0.0 109.12 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.8 t -66.81 -36.29 82.03 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.662 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 2.2 p -92.15 -38.16 12.31 Favored 'General case' 0 C--N 1.359 0.996 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.662 ' HB2' ' O ' ' A' ' 29' ' ' CYS . 15.9 mt-10 85.96 131.73 0.04 OUTLIER 'General case' 0 C--N 1.36 1.041 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.551 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -89.96 -167.49 1.86 Allowed 'General case' 0 C--N 1.356 0.871 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.791 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.469 ' H ' ' HB2' ' A' ' 31' ' ' LEU . 63.7 tt0 -153.39 -66.59 0.15 Allowed 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 -179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.2 m -96.47 -62.06 1.33 Allowed 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -141.1 -43.2 0.38 Allowed 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -179.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.43 -39.02 2.47 Favored Glycine 0 C--N 1.351 1.398 0 N-CA-C 108.69 -1.764 . . . . 0.0 108.69 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 84.9 mt -109.8 104.68 17.46 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.878 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.466 ' HB3' ' H ' ' A' ' 38' ' ' THR . 4.0 t80 -74.03 -92.31 0.02 OUTLIER 'General case' 0 C--N 1.355 0.833 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.466 ' H ' ' HB3' ' A' ' 37' ' ' TYR . 1.2 m -166.37 -64.52 0.03 OUTLIER 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 -178.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 12.3 p 161.87 80.9 0.0 OUTLIER 'General case' 0 C--N 1.362 1.122 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 -179.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -172.05 -4.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.972 0 C-N-CA 119.459 -0.896 . . . . 0.0 109.735 -179.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -96.3 150.61 19.67 Favored Glycine 0 C--N 1.355 1.6 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 -178.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 59.2 m -125.41 131.5 52.91 Favored 'General case' 0 C--N 1.354 0.77 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -121.05 171.11 8.9 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -76.24 -178.67 4.62 Favored 'General case' 0 C--N 1.355 0.842 0 CA-C-O 121.642 0.734 . . . . 0.0 109.573 -178.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -86.36 -19.65 29.45 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -179.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.582 ' HA ' HD21 ' A' ' 49' ' ' LEU . 0.5 OUTLIER -65.55 -30.65 71.42 Favored 'General case' 0 C--N 1.354 0.764 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 179.08 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.425 ' CG ' ' HZ ' ' A' ' 6' ' ' PHE . 23.6 tp10 -63.97 -40.25 95.97 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.401 ' C ' HD13 ' A' ' 48' ' ' LEU . 2.3 tm? -65.52 -39.41 91.79 Favored 'General case' 0 C--N 1.358 0.972 0 O-C-N 122.305 -0.247 . . . . 0.0 111.266 -178.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.582 HD21 ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -81.37 -15.02 56.52 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 119.078 -1.049 . . . . 0.0 110.402 -176.339 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 71.5 tp60 -73.09 -41.44 64.06 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.459 ' HA ' HD22 ' A' ' 51' ' ' LEU . 84.3 mt -84.51 -17.96 37.33 Favored 'General case' 0 C--N 1.362 1.111 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.723 -178.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.503 ' O ' HG11 ' A' ' 52' ' ' VAL . 1.6 t -80.52 -37.45 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.499 ' O ' HG11 ' A' ' 53' ' ' VAL . 48.9 t -69.73 -39.68 78.3 Favored 'Isoleucine or valine' 0 C--N 1.354 0.78 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.459 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 32.9 tptt -66.15 -27.16 67.81 Favored 'General case' 0 C--N 1.363 1.171 0 O-C-N 121.235 -0.915 . . . . 0.0 108.6 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.573 HD12 HD13 ' A' ' 13' ' ' ILE . 0.3 OUTLIER -68.38 -37.64 80.59 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.704 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 60' ' ' SER . 77.0 p -73.9 -16.93 61.09 Favored 'General case' 0 C--N 1.355 0.847 0 O-C-N 121.693 -0.629 . . . . 0.0 110.885 -178.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -100.46 -36.38 9.23 Favored 'General case' 0 C--N 1.353 0.752 0 C-N-CA 119.377 -0.929 . . . . 0.0 111.434 -179.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.5 p -72.66 -34.44 47.54 Favored 'Isoleucine or valine' 0 C--N 1.351 0.651 0 O-C-N 121.683 -0.636 . . . . 0.0 111.455 -177.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.2 t -119.99 -5.58 10.05 Favored 'General case' 0 C--N 1.353 0.725 0 C-N-CA 119.143 -1.023 . . . . 0.0 110.069 -178.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 56' ' ' SER . 73.3 m 64.3 43.25 4.86 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.532 HG13 ' HD2' ' A' ' 62' ' ' PRO . 50.0 t -103.37 132.89 20.65 Favored Pre-proline 0 N--CA 1.443 -0.799 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 179.489 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.532 ' HD2' HG13 ' A' ' 61' ' ' VAL . 45.5 Cg_exo -57.31 146.68 81.24 Favored 'Trans proline' 0 CA--C 1.497 -1.345 0 C-N-CA 122.397 2.065 . . . . 0.0 112.959 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.1 m -75.15 -14.1 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.788 -178.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 52.6 p -96.07 -31.88 12.81 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 118.139 -1.425 . . . . 0.0 109.611 -178.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -78.01 -21.49 50.73 Favored 'General case' 0 C--N 1.356 0.856 0 O-C-N 121.385 -0.822 . . . . 0.0 108.894 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.443 HD13 HD13 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -81.82 -35.73 29.14 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.4 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.59 HG12 ' N ' ' A' ' 68' ' ' ARG . 1.4 p -68.79 -27.17 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 C-N-CA 120.138 -0.625 . . . . 0.0 109.95 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.59 ' N ' HG12 ' A' ' 67' ' ' VAL . 6.5 mmm-85 -73.21 -51.2 18.6 Favored 'General case' 0 C--N 1.362 1.131 0 O-C-N 121.521 -0.737 . . . . 0.0 110.435 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.414 ' HA ' HD23 ' A' ' 69' ' ' LEU . 84.7 mt -63.69 -36.08 82.68 Favored 'General case' 0 C--N 1.357 0.934 0 O-C-N 121.976 -0.452 . . . . 0.0 110.85 -178.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -60.65 -47.36 86.58 Favored 'General case' 0 C--N 1.349 0.577 0 O-C-N 122.208 -0.307 . . . . 0.0 110.297 -178.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.57 -37.87 94.06 Favored Glycine 0 C--N 1.354 1.552 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 -178.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -63.02 -48.64 77.91 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-N 118.261 1.031 . . . . 0.0 111.397 -177.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.716 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 16.0 mttm -64.39 -48.96 73.47 Favored 'General case' 0 C--N 1.359 0.983 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -176.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.441 HD21 ' O ' ' A' ' 74' ' ' LEU . 2.3 tm? -68.29 -39.68 82.03 Favored 'General case' 0 C--N 1.348 0.534 0 O-C-N 121.207 -0.933 . . . . 0.0 112.047 -175.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -63.88 -42.83 97.39 Favored 'General case' 0 C--N 1.353 0.719 0 O-C-N 121.115 -0.991 . . . . 0.0 111.22 -177.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.7 p -71.97 -15.48 18.11 Favored 'Isoleucine or valine' 0 C--N 1.36 1.026 0 O-C-N 121.232 -0.917 . . . . 0.0 109.217 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.716 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 74.1 mm-40 -71.52 -38.89 71.07 Favored 'General case' 0 C--N 1.349 0.552 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 80.7 mt -72.45 -33.3 66.97 Favored 'General case' 0 C--N 1.358 0.967 0 O-C-N 122.334 -0.229 . . . . 0.0 110.754 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 43.5 mm -64.43 -52.97 48.57 Favored 'Isoleucine or valine' 0 C--N 1.357 0.912 0 O-C-N 121.733 -0.604 . . . . 0.0 110.509 -177.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -76.67 -14.75 59.94 Favored 'General case' 0 C--N 1.35 0.591 0 C-N-CA 119.423 -0.911 . . . . 0.0 109.501 178.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.85 -36.32 61.43 Favored Glycine 0 C--N 1.349 1.27 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -179.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.493 ' HB2' HG22 ' A' ' 85' ' ' ILE . 99.4 m-70 -128.46 104.45 19.58 Favored Pre-proline 0 N--CA 1.44 -0.938 0 CA-C-O 122.564 1.173 . . . . 0.0 109.596 -176.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.406 ' O ' ' HB2' ' A' ' 87' ' ' ASN . 32.0 Cg_exo -61.08 -33.23 91.8 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 123.366 2.711 . . . . 0.0 114.29 179.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -91.34 -5.67 54.23 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 120.14 -0.624 . . . . 0.0 109.834 -178.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.493 HG22 ' HB2' ' A' ' 82' ' ' HIS . 0.5 OUTLIER -87.89 -23.15 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -178.727 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.6 -18.03 14.91 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . 0.406 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 54.2 t30 -72.39 -38.36 68.49 Favored 'General case' 0 C--N 1.358 0.94 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -65.17 -33.51 76.18 Favored 'General case' 0 C--N 1.355 0.816 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.504 ' SD ' ' HB2' ' A' ' 95' ' ' LEU . 17.8 ttp -84.53 152.08 24.15 Favored 'General case' 0 C--N 1.351 0.651 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -178.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.64 -21.4 8.54 Favored 'General case' 0 C--N 1.364 1.21 0 C-N-CA 120.051 -0.659 . . . . 0.0 111.19 -177.405 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -165.96 171.28 12.77 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -177.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 67.3 m -66.63 -39.89 88.49 Favored 'General case' 0 C--N 1.355 0.842 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.68 -179.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -67.48 -39.21 85.25 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 119.616 -0.834 . . . . 0.0 108.83 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -66.26 -23.36 66.39 Favored 'General case' 0 C--N 1.355 0.832 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.698 ' O ' HG13 ' A' ' 99' ' ' ILE . 66.1 tp -65.25 -45.17 85.67 Favored 'General case' 0 C--N 1.357 0.926 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.43 ' HA ' HD13 ' A' ' 99' ' ' ILE . 3.3 mp -60.08 -35.94 76.29 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.1 t -70.49 -39.62 74.06 Favored 'General case' 0 C--N 1.35 0.599 0 O-C-N 121.881 -0.512 . . . . 0.0 109.935 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.3 -0.33 52.06 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -176.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.698 HG13 ' O ' ' A' ' 95' ' ' LEU . 81.1 mt -61.6 -47.18 94.56 Favored 'Isoleucine or valine' 0 C--N 1.357 0.894 0 CA-C-N 119.197 0.908 . . . . 0.0 111.704 -177.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -93.06 -23.41 18.66 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 118.642 -1.223 . . . . 0.0 111.349 -177.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.525 ' O ' HG22 ' A' ' 105' ' ' VAL . 33.6 t -63.71 -48.57 76.56 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 121.645 -0.659 . . . . 0.0 112.592 -177.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -139.99 -12.87 1.09 Allowed 'General case' 0 C--N 1.359 0.982 0 C-N-CA 117.083 -1.847 . . . . 0.0 113.685 -177.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.706 HG21 ' C1C' ' A' ' 202' ' ' HEM . 24.9 mm -70.12 -51.23 41.05 Favored 'Isoleucine or valine' 0 C--O 1.242 0.706 0 CA-C-N 120.352 1.433 . . . . 0.0 110.564 -177.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 65.5 m170 -91.72 1.15 57.35 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.209 -177.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.525 HG22 ' O ' ' A' ' 101' ' ' SER . 79.5 t -81.39 -44.54 20.6 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.009 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 178.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 54.8 tp10 -68.09 -40.44 82.65 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 53.8 t -62.13 -46.95 95.29 Favored 'Isoleucine or valine' 0 C--N 1.355 0.824 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.685 -179.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -60.45 -48.13 83.11 Favored 'General case' 0 C--N 1.361 1.078 0 O-C-N 121.998 -0.438 . . . . 0.0 111.546 -179.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -60.66 -36.84 79.7 Favored 'General case' 0 C--N 1.355 0.821 0 O-C-N 121.503 -0.748 . . . . 0.0 110.383 -178.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 18.5 mt -59.49 -77.08 0.04 OUTLIER 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.428 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 79.8 m-85 -119.14 140.32 28.69 Favored Pre-proline 0 N--CA 1.44 -0.958 0 C-N-CA 118.574 -1.251 . . . . 0.0 108.973 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 111' ' ' TYR . 67.3 Cg_endo -87.18 -2.1 7.87 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 123.077 2.518 . . . . 0.0 115.124 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 29.7 mm100 -66.9 -36.51 82.45 Favored 'General case' 0 C--N 1.355 0.824 0 O-C-N 121.819 -0.551 . . . . 0.0 109.888 -179.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.24 144.63 57.04 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 121.56 0.695 . . . . 0.0 110.067 -178.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -115.91 142.78 46.33 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 179.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.446 ' HA ' ' HD3' ' A' ' 117' ' ' PRO . 2.6 mm? -127.16 148.8 67.49 Favored Pre-proline 0 N--CA 1.444 -0.737 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -178.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 116' ' ' LEU . 92.1 Cg_endo -91.07 -157.36 0.06 OUTLIER 'Trans proline' 0 C--N 1.315 -1.21 0 C-N-CA 123.797 2.998 . . . . 0.0 113.263 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -118.41 140.4 49.92 Favored 'General case' 0 C--N 1.363 1.186 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.423 ' CZ ' ' HG2' ' A' ' 117' ' ' PRO . 94.2 m-85 -131.51 135.03 46.74 Favored 'General case' 0 C--N 1.359 1.013 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.526 -178.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.487 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 93.6 m -124.05 127.57 48.06 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 176.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 75.2 m -118.06 128.02 54.36 Favored 'General case' 0 CA--C 1.504 -0.794 0 C-N-CA 119.215 -0.994 . . . . 0.0 109.545 -177.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -118.77 151.36 38.18 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 178.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.604 ' HG3' HD11 ' A' ' 129' ' ' ILE . 58.0 ttp180 -122.56 117.16 25.23 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -179.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.491 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 94.7 mt -86.9 -22.54 25.63 Favored 'General case' 0 C--N 1.354 0.782 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.219 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 177.8 -145.64 7.17 Favored Glycine 0 C--N 1.348 1.248 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 -178.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -94.7 -39.35 10.36 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -178.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -99.46 1.97 44.57 Favored 'General case' 0 C--N 1.353 0.756 0 C-N-CA 120.292 -0.563 . . . . 0.0 109.95 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.491 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 66.1 m-20 -121.12 133.42 55.21 Favored 'General case' 0 C--N 1.357 0.935 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.167 -179.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.604 HD11 ' HG3' ' A' ' 123' ' ' ARG . 8.0 mm -142.86 136.42 26.49 Favored 'Isoleucine or valine' 0 C--N 1.356 0.878 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.443 ' N ' HG21 ' A' ' 129' ' ' ILE . 52.9 mtm180 -116.94 139.06 51.09 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.0 tp -128.02 118.6 23.8 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.487 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 12.0 m170 -97.35 132.92 42.61 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -126.42 121.38 32.27 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -178.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.492 ' HA ' ' O ' ' A' ' 171' ' ' THR . 29.9 tt0 -115.24 112.2 22.09 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.3 t -162.02 151.39 15.96 Favored 'General case' 0 C--N 1.36 1.038 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -90.47 2.31 55.82 Favored 'General case' 0 C--N 1.356 0.867 0 C-N-CA 120.316 -0.554 . . . . 0.0 109.777 -179.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -134.17 74.65 67.24 Favored Pre-proline 0 C--N 1.354 0.786 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -94.82 106.24 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.659 2.239 . . . . 0.0 115.968 -177.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -111.18 109.61 19.74 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 176.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.82 -39.14 93.51 Favored 'General case' 0 C--N 1.354 0.797 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.66 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 73.8 m -62.81 -27.6 69.42 Favored 'General case' 0 C--N 1.354 0.797 0 O-C-N 121.876 -0.515 . . . . 0.0 110.715 -178.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -76.53 -46.49 26.28 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.862 -177.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.83 -39.81 94.17 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 122.05 -0.406 . . . . 0.0 111.176 -177.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -63.17 -36.83 84.92 Favored 'General case' 0 C--N 1.356 0.86 0 O-C-N 121.902 -0.499 . . . . 0.0 109.85 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.01 -42.94 98.58 Favored Glycine 0 C--N 1.348 1.202 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 86.3 mt -70.57 -41.0 73.0 Favored 'General case' 0 C--N 1.354 0.761 0 CA-C-N 117.552 0.676 . . . . 0.0 112.775 -179.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.408 HD21 ' HA ' ' A' ' 147' ' ' LEU . 97.1 mt -71.37 -41.82 69.22 Favored 'General case' 0 C--N 1.361 1.092 0 O-C-N 121.155 -0.966 . . . . 0.0 110.832 -176.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.495 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 36.8 t70 -69.97 -28.61 65.68 Favored 'General case' 0 N--CA 1.442 -0.865 0 O-C-N 121.258 -0.901 . . . . 0.0 109.987 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -63.72 -40.61 98.7 Favored Glycine 0 C--N 1.355 1.601 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 14.1 p -65.6 -31.49 72.56 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 119.341 -0.943 . . . . 0.0 109.451 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -78.75 -1.16 33.32 Favored 'General case' 0 C--N 1.363 1.184 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 177.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.495 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 76.8 mm-40 -85.33 -45.55 11.81 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -66.71 -45.72 77.86 Favored 'General case' 0 C--N 1.36 1.062 0 C-N-CA 120.152 -0.619 . . . . 0.0 109.545 178.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -68.98 -26.83 65.24 Favored 'General case' 0 C--N 1.361 1.078 0 O-C-N 121.843 -0.536 . . . . 0.0 110.664 -178.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 84.6 tttt 73.51 71.85 0.12 Allowed 'General case' 0 C--N 1.362 1.109 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -139.38 -171.62 3.17 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -147.28 94.69 2.43 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 16.3 m-30 -114.78 157.17 23.6 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 178.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 93.4 m -120.2 128.8 53.71 Favored 'General case' 0 C--N 1.354 0.791 0 C-N-CA 119.655 -0.818 . . . . 0.0 108.857 -178.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 3.5 mp -104.49 122.04 56.98 Favored 'Isoleucine or valine' 0 C--N 1.351 0.66 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 179.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.3 m -117.86 -174.05 2.56 Favored 'General case' 0 C--N 1.358 0.948 0 CA-C-O 121.942 0.877 . . . . 0.0 109.462 -178.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 26.6 ptt180 -146.2 155.69 42.88 Favored 'General case' 0 C--N 1.357 0.918 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -178.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' THR . . . . . 0.507 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 34.8 p -96.98 145.67 29.98 Favored Pre-proline 0 C--N 1.358 0.971 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.611 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 15.3 Cg_exo -70.82 -16.19 33.09 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 123.439 2.759 . . . . 0.0 114.445 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -71.63 -40.78 69.53 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 120.436 -0.506 . . . . 0.0 110.708 -177.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 40.8 p -119.28 16.38 13.11 Favored 'General case' 0 C--N 1.353 0.739 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.852 -178.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.611 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 9.9 pt20 -66.89 -12.86 60.73 Favored 'General case' 0 C--N 1.353 0.741 0 O-C-N 121.517 -0.739 . . . . 0.0 110.212 178.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 54.0 p30 -124.74 38.23 4.24 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 19.9 t -139.42 144.95 38.32 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.59 ' O ' ' HB ' ' A' ' 171' ' ' THR . 62.0 mt-10 -97.9 165.07 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -179.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.59 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 18.7 m 82.52 -58.98 0.18 Allowed 'General case' 0 C--N 1.37 1.49 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.771 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -107.75 116.83 32.66 Favored 'General case' 0 CA--C 1.503 -0.829 0 C-N-CA 119.952 -0.699 . . . . 0.0 109.538 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.493 HG13 ' CZ ' ' A' ' 175' ' ' PHE . 85.1 t -130.69 132.45 64.24 Favored 'Isoleucine or valine' 0 C--N 1.357 0.904 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 178.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.413 ' HA ' HD12 ' A' ' 174' ' ' ILE . 50.8 mm -107.74 126.31 64.15 Favored 'Isoleucine or valine' 0 C--N 1.356 0.878 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.493 ' CZ ' HG13 ' A' ' 173' ' ' VAL . 90.0 m-85 -114.8 154.44 28.57 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-O 122.173 0.987 . . . . 0.0 108.588 -178.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -136.82 119.24 15.79 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.8 mp -113.85 119.83 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 N-CA-C 106.525 -1.658 . . . . 0.0 106.525 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 89.6 m -120.39 143.06 48.64 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -177.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 10.2 ttm180 -83.67 118.58 23.95 Favored 'General case' 0 C--N 1.363 1.184 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -64.33 157.16 72.9 Favored Pre-proline 0 C--N 1.359 1.004 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -50.0 126.07 16.11 Favored 'Trans proline' 0 CA--C 1.498 -1.313 0 C-N-CA 122.737 2.291 . . . . 0.0 114.055 -178.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -92.64 12.09 24.42 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 103.25 113.46 3.81 Favored Glycine 0 N--CA 1.439 -1.123 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 67.28 69.66 0.38 Allowed 'General case' 0 C--N 1.359 0.981 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -72.79 150.06 43.11 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -109.21 120.9 43.93 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 89.8 mt -106.25 -59.6 1.76 Allowed 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . 0.537 ' HB3' ' H ' ' A' ' 189' ' ' PHE . 0.2 OUTLIER -152.12 -101.81 0.05 Allowed 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 179.897 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . 0.537 ' H ' ' HB3' ' A' ' 188' ' ' TYR . 71.9 m-85 -114.03 144.47 43.05 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 . . . . . 0 C--O 1.265 1.873 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -179.85 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' HEM . . . . . 1.112 ' HBD' ' HHA' ' A' ' 202' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.993 ' H3 ' ' HMD' ' A' ' 202' ' ' HEM . 78.2 mmm . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.065 0.459 . . . . 0.0 110.202 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.629 ' HE3' ' O1D' ' A' ' 202' ' ' HEM . 0.0 OUTLIER -80.18 -19.05 47.98 Favored 'General case' 0 C--N 1.356 0.856 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -178.989 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.73 -40.44 45.6 Favored Glycine 0 C--N 1.35 1.323 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.22 -34.81 68.62 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 121.853 -0.792 . . . . 0.0 111.164 -177.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 2' ' ' MET . 28.1 m -69.03 -23.99 27.76 Favored 'Isoleucine or valine' 0 C--N 1.356 0.85 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.452 ' HZ ' ' CG ' ' A' ' 47' ' ' GLU . 2.0 m-85 -70.6 -35.03 72.77 Favored 'General case' 0 C--N 1.356 0.86 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 89.6 m -67.4 -39.71 85.57 Favored 'General case' 0 C--N 1.356 0.883 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -61.81 -38.45 95.99 Favored Glycine 0 C--N 1.36 1.874 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.696 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -64.72 -41.35 96.05 Favored 'General case' 0 C--N 1.352 0.685 0 O-C-N 122.511 -0.405 . . . . 0.0 110.791 -178.768 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.744 ' HE3' HD22 ' A' ' 26' ' ' LEU . 20.7 mmt -62.71 -40.92 98.68 Favored 'General case' 0 C--N 1.352 0.692 0 O-C-N 121.693 -0.629 . . . . 0.0 110.891 -178.165 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -68.06 -40.66 82.71 Favored 'General case' 0 C--N 1.347 0.481 0 O-C-N 121.952 -0.467 . . . . 0.0 111.738 -177.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 54.0 tp -66.65 -43.79 83.67 Favored 'General case' 0 C--N 1.35 0.599 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -178.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.696 HG12 ' O ' ' A' ' 9' ' ' LEU . 2.0 mm -72.71 -37.36 55.4 Favored 'Isoleucine or valine' 0 C--N 1.36 1.032 0 O-C-N 121.164 -0.96 . . . . 0.0 111.054 -175.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -71.65 -42.85 67.03 Favored 'General case' 0 C--N 1.35 0.619 0 O-C-N 121.662 -0.649 . . . . 0.0 111.835 -176.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -71.26 -37.03 71.95 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -175.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -98.31 -27.95 13.89 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 118.627 -1.229 . . . . 0.0 114.085 -174.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -115.28 -30.55 6.25 Favored 'General case' 0 CA--C 1.506 -0.743 0 C-N-CA 117.162 -1.815 . . . . 0.0 112.7 -176.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 143.17 177.83 18.48 Favored Glycine 0 C--N 1.347 1.155 0 C-N-CA 118.122 -1.99 . . . . 0.0 110.068 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -101.46 -24.4 14.18 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 -177.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -68.98 -39.86 79.16 Favored 'General case' 0 C--N 1.361 1.106 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 96.3 m -68.54 -38.63 81.0 Favored 'General case' 0 C--N 1.357 0.923 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 178.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.491 HD11 ' HB ' ' A' ' 13' ' ' ILE . 41.9 tp -59.4 -39.16 82.53 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -65.31 -37.21 86.44 Favored 'General case' 0 C--N 1.355 0.828 0 O-C-N 122.144 -0.347 . . . . 0.0 111.241 -178.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.451 HG21 ' O ' ' A' ' 24' ' ' THR . 88.6 m -64.61 -40.72 96.0 Favored 'General case' 0 C--N 1.354 0.787 0 O-C-N 121.679 -0.638 . . . . 0.0 109.708 -178.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.413 HD21 ' HA ' ' A' ' 25' ' ' LEU . 10.2 mt -64.81 -37.47 87.71 Favored 'General case' 0 C--N 1.353 0.757 0 C-N-CA 120.566 -0.454 . . . . 0.0 109.777 -178.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.744 HD22 ' HE3' ' A' ' 10' ' ' MET . 83.6 mt -70.0 -17.24 63.27 Favored 'General case' 0 C--N 1.359 0.996 0 O-C-N 121.739 -0.6 . . . . 0.0 110.192 -179.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -84.66 -28.27 26.53 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 119.51 -0.876 . . . . 0.0 109.493 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 45.7 t -66.76 -36.89 83.47 Favored 'General case' 0 C--N 1.354 0.781 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.64 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 2.2 p -92.91 -37.98 11.96 Favored 'General case' 0 C--N 1.358 0.957 0 C-N-CA 118.936 -1.106 . . . . 0.0 108.031 -178.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.64 ' HB2' ' O ' ' A' ' 29' ' ' CYS . 14.9 mt-10 84.73 132.61 0.05 OUTLIER 'General case' 0 C--N 1.359 1.005 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.514 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -90.25 -167.67 1.9 Allowed 'General case' 0 C--N 1.356 0.85 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.286 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.471 ' H ' ' HB2' ' A' ' 31' ' ' LEU . 63.7 tt0 -154.25 -64.63 0.14 Allowed 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.5 t -97.26 -64.92 1.0 Allowed 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -139.21 -44.02 0.46 Allowed 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 -178.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.74 -35.97 3.0 Favored Glycine 0 C--N 1.352 1.448 0 N-CA-C 109.151 -1.579 . . . . 0.0 109.151 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 82.5 mt -110.84 101.92 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.782 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.587 ' CD2' HG23 ' A' ' 40' ' ' VAL . 0.4 OUTLIER -66.65 -57.27 7.53 Favored 'General case' 0 C--N 1.358 0.964 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 178.947 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.417 ' CB ' ' O ' ' A' ' 37' ' ' TYR . 1.0 OUTLIER 148.65 -64.04 0.0 OUTLIER 'General case' 0 C--N 1.367 1.355 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 178.422 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 17.7 p 168.73 70.69 0.0 OUTLIER 'General case' 0 C--N 1.362 1.135 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 -179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.587 HG23 ' CD2' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -159.21 4.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.869 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.797 -179.438 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.78 -158.11 21.14 Favored Glycine 0 C--N 1.355 1.597 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 -179.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 171.17 85.34 0.0 OUTLIER 'General case' 0 CA--C 1.5 -0.963 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 -178.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -95.47 177.08 5.94 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -83.63 -170.82 3.25 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -91.93 -14.95 28.73 Favored 'General case' 0 CA--C 1.499 -0.992 0 C-N-CA 119.994 -0.682 . . . . 0.0 109.3 -179.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -69.85 -30.5 67.99 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.452 ' CG ' ' HZ ' ' A' ' 6' ' ' PHE . 33.0 tp10 -64.02 -40.82 97.18 Favored 'General case' 0 C--N 1.351 0.654 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.695 HD21 ' O ' ' A' ' 48' ' ' LEU . 4.6 tt -71.78 -35.52 70.05 Favored 'General case' 0 C--N 1.357 0.896 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -179.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 61.5 tp -69.99 -36.7 75.36 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -177.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 72.9 tp60 -65.0 -41.72 95.14 Favored 'General case' 0 N--CA 1.441 -0.881 0 O-C-N 121.87 -0.519 . . . . 0.0 109.707 -178.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.507 ' HA ' HD22 ' A' ' 51' ' ' LEU . 81.7 mt -73.94 -35.82 64.61 Favored 'General case' 0 C--N 1.364 1.2 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.28 -179.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.482 ' O ' HG13 ' A' ' 52' ' ' VAL . 1.4 t -64.03 -39.05 84.07 Favored 'Isoleucine or valine' 0 C--N 1.353 0.76 0 O-C-N 121.904 -0.497 . . . . 0.0 109.759 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.51 HG12 ' O ' ' A' ' 53' ' ' VAL . 55.8 t -67.66 -39.6 82.5 Favored 'Isoleucine or valine' 0 C--N 1.352 0.699 0 O-C-N 121.675 -0.641 . . . . 0.0 109.474 179.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 35.1 tptt -63.51 -28.7 70.13 Favored 'General case' 0 C--N 1.363 1.175 0 O-C-N 121.234 -0.916 . . . . 0.0 108.711 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.48 HD13 HD12 ' A' ' 66' ' ' LEU . 14.1 mt -66.65 -38.3 86.6 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.439 179.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.6 p -72.54 -17.79 61.69 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.879 -178.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -101.72 -38.68 7.78 Favored 'General case' 0 C--N 1.353 0.729 0 C-N-CA 119.358 -0.937 . . . . 0.0 111.813 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.42 HG11 ' N ' ' A' ' 59' ' ' SER . 3.6 p -74.38 -37.48 45.05 Favored 'Isoleucine or valine' 0 C--N 1.352 0.704 0 O-C-N 121.515 -0.741 . . . . 0.0 111.255 -176.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.42 ' N ' HG11 ' A' ' 58' ' ' VAL . 1.9 t -110.57 -9.44 14.55 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 119.249 -0.981 . . . . 0.0 110.281 -178.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 65.29 49.26 1.97 Allowed 'General case' 0 C--N 1.354 0.792 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.424 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 58.2 t -113.92 133.49 22.3 Favored Pre-proline 0 CA--C 1.504 -0.822 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 61' ' ' VAL . 43.2 Cg_exo -57.88 147.44 81.42 Favored 'Trans proline' 0 CA--C 1.499 -1.229 0 C-N-CA 122.581 2.187 . . . . 0.0 112.825 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.2 m -74.51 -13.03 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.912 -178.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 68.2 p -95.95 -32.03 12.8 Favored 'General case' 0 C--N 1.357 0.922 0 C-N-CA 118.151 -1.42 . . . . 0.0 109.509 -179.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -76.44 -24.43 53.93 Favored 'General case' 0 C--N 1.355 0.819 0 O-C-N 121.452 -0.78 . . . . 0.0 109.201 179.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.48 HD12 HD13 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -80.15 -36.92 34.48 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -179.029 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.543 HG12 ' N ' ' A' ' 68' ' ' ARG . 1.5 p -67.97 -26.87 35.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.737 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.036 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.543 ' N ' HG12 ' A' ' 67' ' ' VAL . 5.2 mmm-85 -73.14 -51.17 18.92 Favored 'General case' 0 C--N 1.362 1.151 0 O-C-N 121.549 -0.719 . . . . 0.0 110.283 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.1 mt -63.64 -36.24 83.16 Favored 'General case' 0 C--N 1.357 0.929 0 O-C-N 121.959 -0.463 . . . . 0.0 111.003 -178.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -60.85 -47.83 84.57 Favored 'General case' 0 C--N 1.349 0.575 0 O-C-N 122.155 -0.341 . . . . 0.0 110.596 -178.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.76 -38.09 94.65 Favored Glycine 0 C--N 1.355 1.592 0 N-CA-C 111.854 -0.498 . . . . 0.0 111.854 -178.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -63.64 -47.94 79.27 Favored 'General case' 0 C--N 1.35 0.588 0 CA-C-N 117.976 0.888 . . . . 0.0 111.508 -177.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.657 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 12.6 mttm -64.65 -48.51 74.55 Favored 'General case' 0 C--N 1.358 0.973 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -177.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -68.71 -39.2 80.56 Favored 'General case' 0 C--N 1.348 0.507 0 O-C-N 121.3 -0.875 . . . . 0.0 111.926 -175.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 1.006 ' CE1' ' HBB' ' A' ' 202' ' ' HEM . 40.7 t80 -63.22 -44.33 95.56 Favored 'General case' 0 C--N 1.354 0.766 0 O-C-N 121.068 -1.02 . . . . 0.0 111.044 -178.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.12 -15.23 18.55 Favored 'Isoleucine or valine' 0 C--N 1.359 0.982 0 O-C-N 121.509 -0.744 . . . . 0.0 109.184 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.657 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 69.5 mm-40 -71.8 -38.83 70.18 Favored 'General case' 0 C--N 1.349 0.574 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.2 mt -72.98 -32.37 65.15 Favored 'General case' 0 C--N 1.358 0.946 0 O-C-N 122.309 -0.244 . . . . 0.0 110.471 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.8 mm -64.58 -53.43 42.53 Favored 'Isoleucine or valine' 0 C--N 1.357 0.922 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.372 -177.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -75.39 -15.49 60.45 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 119.624 -0.831 . . . . 0.0 109.337 178.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.11 -37.06 64.0 Favored Glycine 0 C--N 1.35 1.348 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.485 ' HA ' ' HD2' ' A' ' 83' ' ' PRO . 99.1 m-70 -131.33 105.73 14.69 Favored Pre-proline 0 N--CA 1.441 -0.922 0 CA-C-O 122.643 1.211 . . . . 0.0 109.321 -176.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.485 ' HD2' ' HA ' ' A' ' 82' ' ' HIS . 37.8 Cg_endo -67.99 -25.88 37.91 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.614 2.209 . . . . 0.0 114.146 179.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -89.0 -8.26 54.41 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.2 tp -90.26 -20.56 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -178.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.41 -23.57 14.71 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -70.06 -37.42 75.51 Favored 'General case' 0 C--N 1.358 0.949 0 C-N-CA 120.264 -0.575 . . . . 0.0 109.527 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -64.9 -36.21 83.63 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.333 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.424 ' HE2' ' HB3' ' A' ' 89' ' ' MET . 25.9 ttp -82.75 149.31 27.34 Favored 'General case' 0 C--N 1.351 0.646 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 -178.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.59 -22.27 8.17 Favored 'General case' 0 C--N 1.361 1.093 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.831 -177.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -165.25 171.76 13.23 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -177.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.428 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 41.0 t -64.3 -42.07 96.54 Favored 'General case' 0 C--N 1.357 0.921 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.08 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -66.54 -38.55 87.37 Favored 'General case' 0 C--N 1.355 0.81 0 O-C-N 121.437 -0.789 . . . . 0.0 109.493 -178.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -65.65 -25.31 67.3 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.544 HD21 ' HG ' ' A' ' 150' ' ' CYS . 57.6 tp -63.21 -46.62 86.16 Favored 'General case' 0 C--N 1.357 0.928 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.1 mp -61.78 -32.64 72.93 Favored 'General case' 0 C--N 1.356 0.862 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 36.0 t -62.87 -44.74 95.29 Favored 'General case' 0 C--N 1.354 0.762 0 O-C-N 121.931 -0.481 . . . . 0.0 111.584 -178.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.97 26.88 10.1 Favored 'General case' 0 C--N 1.364 1.225 0 O-C-N 120.939 -1.101 . . . . 0.0 111.132 -177.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 1.035 HD11 ' C3B' ' A' ' 202' ' ' HEM . 8.9 tp -61.31 -30.33 47.72 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 C-N-CA 120.431 -0.507 . . . . 0.0 110.539 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -126.95 -7.78 6.05 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 118.484 -1.287 . . . . 0.0 110.005 -179.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 57.5 m -90.43 -3.36 57.73 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.442 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -149.0 -47.39 0.14 Allowed 'General case' 0 C--N 1.358 0.956 0 C-N-CA 118.132 -1.427 . . . . 0.0 110.043 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 96.2 mt -67.41 -47.29 81.35 Favored 'Isoleucine or valine' 0 C--N 1.354 0.802 0 O-C-N 121.926 -0.484 . . . . 0.0 110.979 -177.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -84.65 0.33 50.69 Favored 'General case' 0 C--N 1.353 0.754 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.933 -177.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 77.3 t -80.78 -45.01 21.53 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.975 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -67.45 -40.0 85.39 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.959 -179.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.442 HG13 ' CMD' ' A' ' 202' ' ' HEM . 64.8 t -62.96 -46.71 95.61 Favored 'Isoleucine or valine' 0 C--N 1.354 0.782 0 O-C-N 122.155 -0.341 . . . . 0.0 110.742 -178.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -60.21 -47.85 84.2 Favored 'General case' 0 C--N 1.358 0.945 0 O-C-N 122.112 -0.367 . . . . 0.0 111.361 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -62.91 -36.18 82.53 Favored 'General case' 0 C--N 1.353 0.753 0 O-C-N 121.545 -0.722 . . . . 0.0 110.502 -178.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.5 mt -59.08 -77.22 0.04 OUTLIER 'General case' 0 C--N 1.357 0.931 0 C-N-CA 120.444 -0.503 . . . . 0.0 109.809 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -111.13 141.76 24.95 Favored Pre-proline 0 N--CA 1.442 -0.863 0 C-N-CA 118.583 -1.247 . . . . 0.0 109.553 -179.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -90.73 0.63 5.06 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 123.781 2.988 . . . . 0.0 115.216 -179.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -86.1 4.42 38.29 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 121.63 -0.668 . . . . 0.0 109.851 -178.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -96.1 143.81 26.91 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 119.798 -0.761 . . . . 0.0 109.7 -178.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -119.51 141.43 49.21 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 178.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.41 HD21 ' HA ' ' A' ' 116' ' ' LEU . 95.6 mt -136.53 152.97 75.71 Favored Pre-proline 0 C--N 1.355 0.831 0 CA-C-O 122.198 0.999 . . . . 0.0 109.518 -178.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.451 ' HG3' HBAA ' A' ' 202' ' ' HEM . 78.3 Cg_endo -87.19 -158.15 0.08 OUTLIER 'Trans proline' 0 C--N 1.32 -0.925 0 C-N-CA 123.96 3.106 . . . . 0.0 113.894 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -114.84 139.2 49.95 Favored 'General case' 0 C--N 1.368 1.38 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -125.32 127.31 46.45 Favored 'General case' 0 C--N 1.362 1.13 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -178.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.549 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 93.9 m -125.47 128.79 48.6 Favored 'General case' 0 C--N 1.357 0.912 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 177.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 73.7 m -119.76 128.12 53.45 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 119.323 -0.951 . . . . 0.0 109.506 -178.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -122.18 145.44 48.19 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 178.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.748 ' HG3' HD11 ' A' ' 129' ' ' ILE . 35.4 ttp180 -100.33 -169.02 1.66 Allowed 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.676 ' H ' ' HG2' ' A' ' 123' ' ' ARG . 21.9 mt -165.12 -36.91 0.03 OUTLIER 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 -178.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -171.03 -150.89 7.27 Favored Glycine 0 C--N 1.353 1.503 0 N-CA-C 108.241 -1.944 . . . . 0.0 108.241 -178.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -94.29 -40.1 10.16 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.331 -179.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -97.64 3.84 50.27 Favored 'General case' 0 C--N 1.352 0.683 0 C-N-CA 120.216 -0.593 . . . . 0.0 110.276 -178.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -122.31 135.22 54.69 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 119.552 -0.859 . . . . 0.0 109.405 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.748 HD11 ' HG3' ' A' ' 123' ' ' ARG . 6.4 mm -142.11 136.9 29.94 Favored 'Isoleucine or valine' 0 C--N 1.356 0.87 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 178.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.552 ' N ' HG21 ' A' ' 129' ' ' ILE . 52.3 mtm180 -114.88 138.47 50.76 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 8.3 tp -126.28 118.35 24.93 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.549 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 15.7 m-70 -98.27 134.43 41.32 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 179.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -130.3 121.43 26.05 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.545 ' HA ' ' O ' ' A' ' 171' ' ' THR . 75.1 mt-30 -114.15 114.69 26.39 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 19.4 t -161.52 150.41 15.95 Favored 'General case' 0 C--N 1.357 0.916 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -90.5 1.69 56.44 Favored 'General case' 0 C--N 1.355 0.805 0 C-N-CA 120.306 -0.557 . . . . 0.0 109.879 -178.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -136.78 74.57 51.37 Favored Pre-proline 0 CA--C 1.506 -0.742 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -94.11 110.6 0.18 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.657 2.238 . . . . 0.0 116.157 -177.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -111.56 109.7 19.74 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 176.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.4 -39.65 95.09 Favored 'General case' 0 C--N 1.355 0.811 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.518 -178.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 74.8 m -64.29 -24.93 67.83 Favored 'General case' 0 C--N 1.353 0.738 0 O-C-N 121.849 -0.532 . . . . 0.0 110.831 -178.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -76.51 -47.69 21.95 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 120.192 -0.603 . . . . 0.0 109.611 -178.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.1 -39.21 92.83 Favored 'General case' 0 C--N 1.357 0.93 0 O-C-N 122.115 -0.365 . . . . 0.0 111.123 -178.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -62.65 -37.29 85.77 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 121.801 -0.562 . . . . 0.0 109.77 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.27 -42.53 98.78 Favored Glycine 0 C--N 1.347 1.162 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.2 mt -70.46 -40.72 73.52 Favored 'General case' 0 C--N 1.352 0.687 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 96.3 mt -70.91 -41.97 70.54 Favored 'General case' 0 C--N 1.361 1.096 0 O-C-N 121.32 -0.862 . . . . 0.0 110.891 -177.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.574 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 36.8 t70 -70.33 -29.73 66.52 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 121.893 -0.504 . . . . 0.0 110.295 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.463 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -63.3 -39.43 97.83 Favored Glycine 0 C--N 1.356 1.656 0 N-CA-C 108.489 -1.844 . . . . 0.0 108.489 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . 0.544 ' HG ' HD21 ' A' ' 95' ' ' LEU . 47.6 t -60.68 -42.25 96.73 Favored 'General case' 0 C--N 1.351 0.635 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -75.99 0.08 19.78 Favored 'General case' 0 C--N 1.36 1.025 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.574 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 76.5 mm-40 -84.6 -46.03 11.95 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -67.65 -43.77 79.51 Favored 'General case' 0 C--N 1.359 0.999 0 C-N-CA 120.109 -0.636 . . . . 0.0 109.559 179.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.482 ' O ' ' HB2' ' A' ' 155' ' ' LYS . 54.3 m-85 -70.42 -24.94 63.01 Favored 'General case' 0 C--N 1.361 1.087 0 O-C-N 121.734 -0.604 . . . . 0.0 111.311 -178.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 154' ' ' PHE . 47.9 mttt 73.62 67.82 0.1 Allowed 'General case' 0 C--N 1.362 1.116 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -178.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -134.16 -176.04 4.06 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -146.76 91.88 2.08 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 16.3 m-30 -113.54 157.73 21.66 Favored 'General case' 0 C--N 1.352 0.678 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 179.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 92.6 m -119.27 127.77 53.54 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 119.548 -0.861 . . . . 0.0 108.832 -178.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 3.2 mp -103.97 121.9 56.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.661 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 178.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.9 m -118.38 -173.69 2.52 Favored 'General case' 0 C--N 1.358 0.935 0 CA-C-O 121.661 0.743 . . . . 0.0 109.412 -178.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -146.97 157.0 43.5 Favored 'General case' 0 C--N 1.356 0.858 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 -178.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 49.6 p -99.64 146.37 31.7 Favored Pre-proline 0 C--N 1.358 0.974 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.689 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 73.9 Cg_endo -75.04 -12.0 21.42 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.941 2.427 . . . . 0.0 114.966 -178.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -72.63 -41.67 65.28 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.84 -178.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 37.8 p -117.21 15.5 14.92 Favored 'General case' 0 C--N 1.354 0.789 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.717 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.689 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.1 pp0? -67.59 -11.62 58.52 Favored 'General case' 0 C--N 1.354 0.796 0 O-C-N 121.569 -0.707 . . . . 0.0 110.245 178.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 54.4 p-10 -122.41 33.33 5.48 Favored 'General case' 0 N--CA 1.438 -1.038 0 O-C-N 121.148 -0.97 . . . . 0.0 108.707 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 57.8 m -135.67 148.37 48.9 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.625 ' O ' ' HB ' ' A' ' 171' ' ' THR . 60.8 mt-10 -100.77 166.12 11.03 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.625 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 6.9 m 83.26 -59.66 0.14 Allowed 'General case' 0 C--N 1.369 1.434 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -108.42 118.05 35.76 Favored 'General case' 0 CA--C 1.505 -0.77 0 C-N-CA 119.901 -0.72 . . . . 0.0 109.567 -178.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.534 HG13 ' CZ ' ' A' ' 175' ' ' PHE . 97.2 t -131.01 132.78 63.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.916 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 178.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.419 ' N ' HG12 ' A' ' 173' ' ' VAL . 49.5 mm -106.54 126.06 62.33 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.534 ' CZ ' HG13 ' A' ' 173' ' ' VAL . 89.0 m-85 -115.44 156.46 25.57 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 122.141 0.972 . . . . 0.0 108.562 -179.12 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -138.79 120.77 15.55 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -178.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.8 mp -115.06 121.12 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 89.1 m -117.96 143.26 46.52 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -177.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 30.4 ttm180 -90.85 118.77 30.52 Favored 'General case' 0 C--N 1.364 1.221 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.47 149.41 92.02 Favored Pre-proline 0 C--N 1.356 0.872 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.24 136.86 57.89 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.096 1.864 . . . . 0.0 113.672 -178.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . 0.507 HH11 ' HD2' ' A' ' 182' ' ' ARG . 1.7 mtm105 -136.71 153.51 50.86 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -179.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 92.18 -44.71 2.64 Favored Glycine 0 C--N 1.347 1.182 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 179.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -160.74 158.07 28.0 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 -179.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -118.82 115.05 23.61 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -122.81 124.45 43.34 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . 0.403 ' HA ' HD22 ' A' ' 187' ' ' LEU . 75.4 mt -104.69 -66.81 0.94 Allowed 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.489 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -150.55 -91.5 0.06 Allowed 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -126.84 147.57 50.03 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 . . . . . 0 C--O 1.263 1.799 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 179.941 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' HEM . . . . . 1.035 ' C3B' HD11 ' A' ' 99' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.881 ' HG2' ' CMD' ' A' ' 202' ' ' HEM . 76.3 mmm . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 120.876 0.37 . . . . 0.0 110.17 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.5 ' HA ' HG23 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -79.52 -22.14 44.32 Favored 'General case' 0 C--N 1.356 0.854 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.059 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -76.16 -39.36 32.22 Favored Glycine 0 C--N 1.348 1.238 0 N-CA-C 109.084 -1.607 . . . . 0.0 109.084 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.4 tpp -70.63 -37.03 73.75 Favored 'General case' 0 C--N 1.353 0.725 0 O-C-N 122.297 -0.531 . . . . 0.0 110.593 -177.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.5 HG23 ' HA ' ' A' ' 2' ' ' MET . 26.9 m -70.77 -22.46 23.24 Favored 'Isoleucine or valine' 0 C--N 1.358 0.939 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -179.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.516 ' HZ ' ' HG2' ' A' ' 47' ' ' GLU . 2.2 m-30 -69.92 -35.32 74.47 Favored 'General case' 0 C--N 1.357 0.912 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 84.9 m -67.06 -40.05 87.01 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.44 -37.86 95.35 Favored Glycine 0 C--N 1.358 1.753 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.657 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -66.96 -39.76 87.31 Favored 'General case' 0 C--N 1.352 0.681 0 CA-C-N 117.29 0.545 . . . . 0.0 110.544 -178.224 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.686 ' HE1' HD22 ' A' ' 26' ' ' LEU . 22.7 mmt -63.71 -41.16 98.14 Favored 'General case' 0 C--N 1.354 0.786 0 O-C-N 121.753 -0.592 . . . . 0.0 110.905 -178.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -66.38 -40.14 89.5 Favored 'General case' 0 C--N 1.349 0.572 0 O-C-N 121.989 -0.444 . . . . 0.0 111.381 -178.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 57.7 tp -66.43 -41.95 88.43 Favored 'General case' 0 C--N 1.35 0.608 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.682 HD11 HD23 ' A' ' 55' ' ' LEU . 3.8 mm -73.78 -37.9 49.69 Favored 'Isoleucine or valine' 0 C--N 1.358 0.941 0 O-C-N 121.186 -0.947 . . . . 0.0 111.187 -176.082 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -69.05 -42.8 75.81 Favored 'General case' 0 C--N 1.352 0.714 0 O-C-N 121.7 -0.625 . . . . 0.0 111.236 -176.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -72.22 -33.24 67.43 Favored 'General case' 0 N--CA 1.446 -0.646 0 O-C-N 121.953 -0.467 . . . . 0.0 111.771 -177.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -73.02 -48.65 34.35 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -175.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -126.61 -20.33 4.36 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 117.718 -1.593 . . . . 0.0 112.367 -176.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 130.25 164.11 11.24 Favored Glycine 0 N--CA 1.437 -1.271 0 C-N-CA 118.102 -1.999 . . . . 0.0 110.809 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -67.08 -24.54 65.97 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 113.828 -1.186 . . . . 0.0 111.266 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -64.06 -44.27 92.95 Favored 'General case' 0 C--N 1.359 1.014 0 O-C-N 121.0 -1.062 . . . . 0.0 109.882 -179.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 94.2 m -67.24 -37.58 83.79 Favored 'General case' 0 C--N 1.352 0.717 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.532 HD11 ' HB ' ' A' ' 13' ' ' ILE . 33.3 tp -60.06 -37.59 80.32 Favored 'General case' 0 C--N 1.352 0.685 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.585 -179.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -66.14 -36.73 83.9 Favored 'General case' 0 C--N 1.356 0.87 0 O-C-N 122.105 -0.372 . . . . 0.0 110.704 -178.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.428 HG21 ' O ' ' A' ' 24' ' ' THR . 86.5 m -65.02 -40.43 94.87 Favored 'General case' 0 C--N 1.355 0.808 0 O-C-N 121.707 -0.621 . . . . 0.0 109.368 -178.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.907 HD23 HG13 ' A' ' 58' ' ' VAL . 83.2 mt -66.33 -36.32 82.63 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -179.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.686 HD22 ' HE1' ' A' ' 10' ' ' MET . 81.9 mt -72.41 -12.91 61.31 Favored 'General case' 0 C--N 1.36 1.042 0 O-C-N 121.819 -0.55 . . . . 0.0 110.106 -178.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -89.11 -26.23 21.45 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 119.098 -1.041 . . . . 0.0 108.971 178.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.9 t -67.76 -36.64 80.87 Favored 'General case' 0 C--N 1.358 0.936 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 178.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.65 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 1.8 p -92.92 -40.72 10.44 Favored 'General case' 0 C--N 1.359 0.985 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -179.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.65 ' HB2' ' O ' ' A' ' 29' ' ' CYS . 13.6 mt-10 84.94 134.71 0.05 Allowed 'General case' 0 C--N 1.361 1.089 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.474 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -85.79 -170.46 3.11 Favored 'General case' 0 C--N 1.358 0.936 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.49 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.438 ' H ' ' HB2' ' A' ' 31' ' ' LEU . 63.0 tt0 -150.99 -24.27 0.21 Allowed 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.3 t -148.84 -65.13 0.23 Allowed 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -178.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -130.73 -55.49 1.07 Allowed 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 -179.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 131.43 -41.21 1.54 Allowed Glycine 0 C--N 1.351 1.407 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 79.7 mt -106.84 101.67 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.555 ' O ' ' HB ' ' A' ' 38' ' ' THR . 0.8 OUTLIER -72.23 -30.05 64.53 Favored 'General case' 0 C--N 1.357 0.906 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.685 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.555 ' HB ' ' O ' ' A' ' 37' ' ' TYR . 8.0 m 114.71 -67.12 0.0 OUTLIER 'General case' 0 C--N 1.37 1.489 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.415 ' C ' HG21 ' A' ' 40' ' ' VAL . 13.2 p 174.13 63.71 0.0 OUTLIER 'General case' 0 C--N 1.36 1.043 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -179.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.415 HG21 ' C ' ' A' ' 39' ' ' SER . 1.1 t -148.43 -5.03 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.831 0 C-N-CA 119.411 -0.916 . . . . 0.0 109.692 -178.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -98.12 143.92 16.96 Favored Glycine 0 C--N 1.352 1.428 0 C-N-CA 119.186 -1.483 . . . . 0.0 110.071 -178.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.0 m -124.07 122.61 38.33 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 178.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -117.14 175.86 5.4 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 -178.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -82.59 -172.04 3.83 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -90.97 -13.81 32.7 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 120.014 -0.674 . . . . 0.0 109.305 -179.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -70.12 -29.32 66.23 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.516 ' HG2' ' HZ ' ' A' ' 6' ' ' PHE . 25.9 tp10 -63.28 -40.33 97.08 Favored 'General case' 0 C--N 1.352 0.693 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.478 ' O ' HD23 ' A' ' 48' ' ' LEU . 1.8 tm? -67.63 -38.08 83.37 Favored 'General case' 0 C--N 1.357 0.9 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 58.6 tp -73.9 -29.66 62.18 Favored 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 122.063 -0.398 . . . . 0.0 110.336 -176.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 71.6 tp60 -69.0 -40.09 78.95 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -178.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.481 ' HA ' HD22 ' A' ' 51' ' ' LEU . 81.3 mt -83.31 -17.17 43.42 Favored 'General case' 0 C--N 1.36 1.039 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.699 -178.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.49 ' O ' HG13 ' A' ' 52' ' ' VAL . 1.1 t -82.25 -35.25 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.51 ' O ' HG11 ' A' ' 53' ' ' VAL . 55.1 t -69.07 -39.38 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 34.0 tptt -66.79 -32.09 73.15 Favored 'General case' 0 C--N 1.364 1.209 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.682 HD23 HD11 ' A' ' 13' ' ' ILE . 18.1 mt -62.78 -39.58 94.65 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.32 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.506 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 39.3 t -65.95 -36.61 83.8 Favored 'General case' 0 C--N 1.35 0.605 0 O-C-N 121.942 -0.474 . . . . 0.0 110.647 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -86.42 -37.65 18.15 Favored 'General case' 0 C--N 1.355 0.834 0 O-C-N 120.961 -1.087 . . . . 0.0 112.766 -177.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.907 HG13 HD23 ' A' ' 25' ' ' LEU . 4.9 p -75.47 -40.01 41.38 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 O-C-N 121.37 -0.831 . . . . 0.0 111.482 -176.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.4 t -106.5 -5.84 18.55 Favored 'General case' 0 C--N 1.352 0.69 0 C-N-CA 119.304 -0.958 . . . . 0.0 110.331 -177.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 56' ' ' SER . 72.3 m 65.29 39.91 5.11 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 56' ' ' SER . 59.4 t -114.72 124.77 29.97 Favored Pre-proline 0 CA--C 1.503 -0.831 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 61' ' ' VAL . 32.1 Cg_exo -57.93 155.33 33.73 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 122.803 2.335 . . . . 0.0 113.562 -179.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.468 ' HA ' ' CD2' ' A' ' 66' ' ' LEU . 13.7 m -74.45 -12.09 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.89 -177.097 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 72.9 p -94.2 -34.2 12.99 Favored 'General case' 0 C--N 1.357 0.905 0 C-N-CA 118.067 -1.453 . . . . 0.0 110.154 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -80.21 -20.83 43.77 Favored 'General case' 0 C--N 1.354 0.803 0 O-C-N 121.202 -0.936 . . . . 0.0 109.13 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.636 HD13 HD12 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -79.88 -34.43 39.19 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -179.757 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.63 HG12 ' N ' ' A' ' 68' ' ' ARG . 2.4 p -69.82 -29.54 41.12 Favored 'Isoleucine or valine' 0 C--N 1.357 0.912 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.023 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.63 ' N ' HG12 ' A' ' 67' ' ' VAL . 79.6 mtp180 -69.93 -48.1 59.78 Favored 'General case' 0 C--N 1.364 1.232 0 O-C-N 121.373 -0.83 . . . . 0.0 110.71 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.4 mt -64.36 -36.24 83.48 Favored 'General case' 0 C--N 1.355 0.828 0 O-C-N 121.949 -0.469 . . . . 0.0 110.796 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -61.08 -47.73 85.01 Favored 'General case' 0 C--N 1.35 0.593 0 O-C-N 122.212 -0.305 . . . . 0.0 110.715 -178.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.61 -38.95 96.69 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 119.817 -0.435 . . . . 0.0 112.227 -177.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -66.19 -45.35 81.1 Favored 'General case' 0 C--N 1.352 0.675 0 CA-C-N 118.441 1.121 . . . . 0.0 111.453 -176.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.744 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 6.6 mttm -64.16 -49.52 71.79 Favored 'General case' 0 C--N 1.356 0.886 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -177.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -68.12 -40.74 82.45 Favored 'General case' 0 C--N 1.349 0.568 0 O-C-N 121.358 -0.839 . . . . 0.0 112.219 -175.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -64.12 -44.55 91.89 Favored 'General case' 0 C--N 1.354 0.784 0 O-C-N 121.066 -1.021 . . . . 0.0 111.485 -177.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.65 -14.54 17.69 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 O-C-N 121.48 -0.762 . . . . 0.0 109.664 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.744 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 77.1 mm-40 -74.75 -37.82 62.38 Favored 'General case' 0 C--N 1.351 0.636 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 178.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.444 HD13 HBCA ' A' ' 202' ' ' HEM . 73.9 mt -67.41 -37.41 83.03 Favored 'General case' 0 C--N 1.36 1.063 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.0 mm -63.1 -50.63 78.57 Favored 'Isoleucine or valine' 0 C--N 1.356 0.857 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 -178.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -68.12 -20.94 64.95 Favored 'General case' 0 C--N 1.35 0.595 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.494 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -99.2 -0.97 56.99 Favored Glycine 0 N--CA 1.437 -1.256 0 C-N-CA 119.509 -1.329 . . . . 0.0 110.713 -177.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.697 ' HB3' ' HB ' ' A' ' 85' ' ' ILE . 93.4 m-70 -139.14 88.88 12.83 Favored Pre-proline 0 CA--C 1.502 -0.892 0 CA-C-N 119.113 1.456 . . . . 0.0 109.044 -179.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 82' ' ' HIS . 31.9 Cg_endo -65.85 -27.78 51.26 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.504 2.136 . . . . 0.0 114.556 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -95.1 -4.2 46.69 Favored 'General case' 0 CA--C 1.502 -0.895 0 C-N-CA 119.388 -0.925 . . . . 0.0 108.978 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.697 ' HB ' ' HB3' ' A' ' 82' ' ' HIS . 0.1 OUTLIER -89.0 -19.68 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 -179.575 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -104.4 -23.39 13.19 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -68.55 -36.96 79.52 Favored 'General case' 0 C--N 1.362 1.129 0 O-C-N 121.656 -0.652 . . . . 0.0 109.372 178.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -65.42 -35.12 79.99 Favored 'General case' 0 C--N 1.356 0.883 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.416 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.479 ' SD ' ' HB2' ' A' ' 95' ' ' LEU . 18.1 ttp -83.69 151.14 25.42 Favored 'General case' 0 C--N 1.352 0.715 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -178.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.79 -22.8 9.49 Favored 'General case' 0 C--N 1.365 1.261 0 O-C-N 121.632 -0.667 . . . . 0.0 111.258 -177.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -166.0 172.26 11.65 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -177.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.435 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 63.4 m -66.42 -39.73 89.15 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.506 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -67.82 -39.33 83.92 Favored 'General case' 0 C--N 1.356 0.865 0 O-C-N 121.375 -0.828 . . . . 0.0 109.093 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -65.53 -24.61 67.16 Favored 'General case' 0 C--N 1.355 0.83 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.745 ' O ' HG13 ' A' ' 99' ' ' ILE . 64.9 tp -63.65 -46.92 83.41 Favored 'General case' 0 C--N 1.353 0.732 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.56 ' HA ' HD12 ' A' ' 99' ' ' ILE . 2.0 mp -59.81 -36.65 77.2 Favored 'General case' 0 C--N 1.361 1.081 0 O-C-N 122.143 -0.348 . . . . 0.0 110.28 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.7 t -70.2 -39.81 74.96 Favored 'General case' 0 C--N 1.348 0.519 0 O-C-N 122.003 -0.436 . . . . 0.0 110.238 -179.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.485 ' HG3' ' HZ3' ' A' ' 98' ' ' LYS . 1.8 tttp -87.43 2.7 49.75 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 122.136 -0.353 . . . . 0.0 111.934 -176.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.745 HG13 ' O ' ' A' ' 95' ' ' LEU . 77.3 mt -61.18 -46.9 95.72 Favored 'Isoleucine or valine' 0 C--N 1.355 0.822 0 CA-C-N 119.156 0.889 . . . . 0.0 111.967 -177.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -94.66 -23.56 17.54 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 118.52 -1.272 . . . . 0.0 111.176 -177.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.0 t -63.63 -50.09 70.72 Favored 'General case' 0 N--CA 1.445 -0.718 0 O-C-N 121.644 -0.66 . . . . 0.0 112.527 -177.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.646 ' HA ' HG12 ' A' ' 105' ' ' VAL . 17.5 t80 -134.68 -15.89 2.06 Favored 'General case' 0 C--N 1.361 1.071 0 C-N-CA 117.352 -1.739 . . . . 0.0 113.578 -176.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.65 HG23 ' C2C' ' A' ' 202' ' ' HEM . 29.3 mm -71.15 -51.58 33.6 Favored 'Isoleucine or valine' 0 C--O 1.245 0.847 0 CA-C-N 120.493 1.497 . . . . 0.0 110.683 -177.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.435 ' HB3' HD22 ' A' ' 116' ' ' LEU . 64.7 m170 -91.58 1.49 57.1 Favored 'General case' 0 N--CA 1.439 -1.021 0 O-C-N 121.284 -0.885 . . . . 0.0 110.348 -177.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.646 HG12 ' HA ' ' A' ' 102' ' ' PHE . 1.2 p -88.8 -33.45 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 178.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.641 ' N ' HG11 ' A' ' 105' ' ' VAL . 0.6 OUTLIER -72.38 -40.36 67.31 Favored 'General case' 0 CA--C 1.5 -0.957 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.362 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.636 HG12 ' N ' ' A' ' 108' ' ' TYR . 0.5 OUTLIER -72.33 -37.05 57.15 Favored 'Isoleucine or valine' 0 C--N 1.355 0.809 0 C-N-CA 119.592 -0.843 . . . . 0.0 109.89 -178.815 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.636 ' N ' HG12 ' A' ' 107' ' ' VAL . 91.5 t80 -61.24 -49.0 78.87 Favored 'General case' 0 C--N 1.362 1.115 0 O-C-N 121.786 -0.571 . . . . 0.0 110.828 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -60.0 -37.43 79.65 Favored 'General case' 0 C--N 1.357 0.908 0 O-C-N 121.639 -0.663 . . . . 0.0 110.057 -179.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 14.7 mt -57.15 -75.47 0.04 OUTLIER 'General case' 0 C--N 1.356 0.866 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.411 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 90.3 m-85 -119.82 136.8 25.08 Favored Pre-proline 0 N--CA 1.441 -0.915 0 C-N-CA 119.026 -1.069 . . . . 0.0 108.733 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 111' ' ' TYR . 76.6 Cg_endo -85.28 -1.96 9.3 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 123.205 2.603 . . . . 0.0 115.345 -178.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -67.52 -36.26 80.69 Favored 'General case' 0 C--N 1.354 0.784 0 O-C-N 121.712 -0.617 . . . . 0.0 110.229 -179.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.34 144.42 56.97 Favored 'General case' 0 C--N 1.354 0.792 0 CA-C-O 121.647 0.737 . . . . 0.0 109.995 -178.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -114.54 148.08 38.49 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.462 ' HA ' ' HD3' ' A' ' 117' ' ' PRO . 1.2 mp -128.6 144.11 50.93 Favored Pre-proline 0 N--CA 1.442 -0.841 0 CA-C-O 122.143 0.973 . . . . 0.0 109.099 -178.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 116' ' ' LEU . 97.6 Cg_endo -87.68 -155.46 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.215 0 C-N-CA 123.738 2.959 . . . . 0.0 112.959 179.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -120.21 140.26 51.42 Favored 'General case' 0 C--N 1.363 1.165 0 C-N-CA 119.142 -1.023 . . . . 0.0 108.316 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -133.03 133.4 43.03 Favored 'General case' 0 C--N 1.362 1.114 0 C-N-CA 120.069 -0.653 . . . . 0.0 109.835 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.462 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 93.6 m -124.22 128.03 48.58 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 176.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 74.7 m -118.78 127.68 53.76 Favored 'General case' 0 CA--C 1.503 -0.848 0 C-N-CA 119.162 -1.015 . . . . 0.0 109.52 -177.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -116.9 153.14 33.09 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 178.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.542 ' HG3' HD12 ' A' ' 129' ' ' ILE . 57.4 ttp180 -123.72 117.17 24.34 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 -179.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.433 HD21 ' HA ' ' A' ' 124' ' ' LEU . 95.9 mt -90.28 -16.69 28.82 Favored 'General case' 0 C--N 1.355 0.831 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.55 -179.301 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 174.77 -148.9 10.0 Favored Glycine 0 N--CA 1.437 -1.236 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -94.1 -37.18 11.74 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . 0.479 ' HB2' ' HG2' ' A' ' 179' ' ' ARG . 41.3 p-10 -102.45 1.22 34.96 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 119.886 -0.725 . . . . 0.0 110.315 -178.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -119.8 131.57 55.36 Favored 'General case' 0 C--N 1.358 0.977 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.549 HG21 ' N ' ' A' ' 130' ' ' ARG . 7.9 mm -141.29 136.25 32.58 Favored 'Isoleucine or valine' 0 C--N 1.354 0.778 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 179.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.549 ' N ' HG21 ' A' ' 129' ' ' ILE . 53.5 mtm180 -116.04 139.18 50.54 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.3 tp -127.93 117.42 21.72 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.462 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 12.0 m170 -96.78 133.98 40.65 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 179.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.641 ' HH ' HBAA ' A' ' 202' ' ' HEM . 72.8 t80 -129.77 122.44 28.83 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -178.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.546 ' HA ' ' O ' ' A' ' 171' ' ' THR . 76.2 mt-30 -116.21 115.7 26.47 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 12.8 t -163.22 155.19 17.84 Favored 'General case' 0 C--N 1.36 1.023 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -91.66 2.33 56.55 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 121.821 -0.55 . . . . 0.0 109.873 -178.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 93.6 mtm-85 -135.08 74.32 63.09 Favored Pre-proline 0 CA--C 1.505 -0.771 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -95.39 105.64 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.736 2.291 . . . . 0.0 115.7 -177.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -112.41 114.1 26.63 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 176.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.89 -38.82 92.52 Favored 'General case' 0 C--N 1.355 0.805 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.242 -179.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.3 m -63.63 -27.03 68.95 Favored 'General case' 0 C--N 1.354 0.782 0 O-C-N 121.926 -0.484 . . . . 0.0 110.827 -178.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -76.58 -47.87 21.1 Favored 'General case' 0 N--CA 1.446 -0.642 0 O-C-N 121.763 -0.586 . . . . 0.0 109.856 -177.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.49 -39.6 94.1 Favored 'General case' 0 C--N 1.357 0.895 0 O-C-N 122.183 -0.323 . . . . 0.0 111.149 -177.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -63.27 -37.64 88.04 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 121.907 -0.495 . . . . 0.0 109.927 -179.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.03 -42.91 98.6 Favored Glycine 0 C--N 1.348 1.217 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 -179.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 83.6 mt -70.06 -40.84 74.85 Favored 'General case' 0 C--N 1.353 0.747 0 CA-C-N 117.774 0.787 . . . . 0.0 112.549 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 97.7 mt -71.03 -42.07 70.01 Favored 'General case' 0 C--N 1.36 1.061 0 O-C-N 121.271 -0.893 . . . . 0.0 110.551 -176.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.505 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 21.5 t70 -69.17 -32.09 71.17 Favored 'General case' 0 N--CA 1.445 -0.723 0 O-C-N 122.211 -0.306 . . . . 0.0 110.505 -179.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.475 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -63.04 -39.85 98.55 Favored Glycine 0 C--N 1.357 1.707 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 49.5 t -61.14 -42.11 97.95 Favored 'General case' 0 C--N 1.35 0.594 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.431 ' HB2' ' O ' ' A' ' 156' ' ' GLU . . . -73.84 -2.39 23.48 Favored 'General case' 0 C--N 1.359 1.001 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.505 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 74.5 mm-40 -83.17 -45.96 13.29 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.052 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 92.9 t80 -65.89 -45.06 83.4 Favored 'General case' 0 C--N 1.359 1.008 0 C-N-CA 120.154 -0.619 . . . . 0.0 109.609 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -68.88 -26.4 65.1 Favored 'General case' 0 C--N 1.363 1.158 0 O-C-N 121.716 -0.615 . . . . 0.0 111.023 -178.182 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 78.2 tttt 74.39 71.95 0.11 Allowed 'General case' 0 C--N 1.361 1.072 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.431 ' O ' ' HB2' ' A' ' 151' ' ' ALA . 5.4 tp10 -161.34 125.24 3.35 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 178.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -87.25 108.35 18.9 Favored 'General case' 0 C--N 1.354 0.788 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.339 -179.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 9.3 m-30 -107.37 163.89 12.65 Favored 'General case' 0 C--N 1.353 0.734 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 177.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 95.5 m -121.37 129.21 52.92 Favored 'General case' 0 C--N 1.354 0.802 0 C-N-CA 118.972 -1.091 . . . . 0.0 109.41 -178.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 3.6 mp -110.5 122.12 64.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 178.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.7 m -119.12 -171.87 2.19 Favored 'General case' 0 C--N 1.357 0.916 0 CA-C-O 121.674 0.75 . . . . 0.0 109.245 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.11 159.29 44.53 Favored 'General case' 0 C--N 1.357 0.913 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 -178.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 64.6 p -100.72 146.83 32.76 Favored Pre-proline 0 C--N 1.359 1.012 0 CA-C-O 122.471 1.129 . . . . 0.0 108.298 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.662 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 73.5 Cg_endo -76.22 -11.49 19.32 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.957 2.438 . . . . 0.0 115.193 -178.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -72.11 -41.44 67.24 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 119.936 -0.705 . . . . 0.0 109.42 -178.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 31.4 p -116.73 16.5 15.34 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 120.159 -0.616 . . . . 0.0 110.323 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.662 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.2 pp0? -66.73 -10.29 45.49 Favored 'General case' 0 C--N 1.354 0.796 0 O-C-N 121.642 -0.661 . . . . 0.0 110.45 178.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -128.02 38.69 3.97 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 74.8 m -136.54 146.34 46.07 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.665 ' O ' ' HB ' ' A' ' 171' ' ' THR . 59.2 mp0 -99.61 162.55 12.95 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.665 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 1.5 m 84.53 -57.72 0.11 Allowed 'General case' 0 C--N 1.369 1.455 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.566 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -109.67 118.38 36.4 Favored 'General case' 0 CA--C 1.505 -0.75 0 C-N-CA 119.798 -0.761 . . . . 0.0 109.789 -178.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.579 HG11 ' CZ ' ' A' ' 175' ' ' PHE . 97.5 t -132.4 132.32 60.42 Favored 'Isoleucine or valine' 0 C--N 1.36 1.065 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 178.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.429 ' N ' HG13 ' A' ' 173' ' ' VAL . 50.3 mm -105.31 127.46 60.03 Favored 'Isoleucine or valine' 0 C--N 1.356 0.89 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.579 ' CZ ' HG11 ' A' ' 173' ' ' VAL . 93.9 m-85 -116.31 153.82 31.29 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -136.73 119.36 16.02 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -178.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.0 mp -114.21 119.06 60.29 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 -179.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 88.4 m -126.62 140.76 52.18 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -177.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.479 ' HG2' ' HB2' ' A' ' 127' ' ' ASN . 39.7 ptt180 -80.48 121.4 25.71 Favored 'General case' 0 C--N 1.366 1.285 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 179.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.401 ' HA ' ' HD3' ' A' ' 181' ' ' PRO . . . -66.07 149.17 97.97 Favored Pre-proline 0 CA--C 1.499 -1.008 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 180' ' ' ALA . 52.6 Cg_exo -54.19 122.63 11.8 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.44 2.093 . . . . 0.0 113.204 -179.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -138.78 148.57 44.0 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 72.51 62.0 3.41 Favored Glycine 0 C--N 1.353 1.504 0 N-CA-C 108.155 -1.978 . . . . 0.0 108.155 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 78.24 167.55 0.22 Allowed 'General case' 0 C--N 1.362 1.131 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -131.4 121.27 24.33 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -123.67 128.88 50.27 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.09 -76.98 0.6 Allowed 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -131.59 -87.82 0.47 Allowed 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -127.89 147.31 50.45 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 . . . . . 0 C--O 1.265 1.874 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -179.964 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' HEM . . . . . 0.881 ' CMD' ' HG2' ' A' ' 1' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.456 ' HB2' ' HB2' ' A' ' 4' ' ' MET . 2.3 mmm . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 120.943 0.401 . . . . 0.0 110.07 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.659 ' HA ' HG23 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -80.63 -18.72 47.25 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 120.161 -0.616 . . . . 0.0 109.353 -179.043 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.11 -40.92 49.35 Favored Glycine 0 C--N 1.353 1.497 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.456 ' HB2' ' HB2' ' A' ' 1' ' ' MET . 4.9 mtm -70.39 -36.33 74.04 Favored 'General case' 0 C--N 1.36 1.044 0 O-C-N 121.836 -0.802 . . . . 0.0 111.335 -178.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.659 HG23 ' HA ' ' A' ' 2' ' ' MET . 34.6 m -69.4 -22.95 25.97 Favored 'Isoleucine or valine' 0 C--N 1.356 0.872 0 O-C-N 121.555 -0.715 . . . . 0.0 109.366 -178.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -71.05 -35.85 72.1 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 85.4 m -67.07 -41.37 86.51 Favored 'General case' 0 C--N 1.356 0.881 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.62 -39.01 97.36 Favored Glycine 0 C--N 1.359 1.81 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.733 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -64.99 -40.37 94.86 Favored 'General case' 0 C--N 1.351 0.658 0 CA-C-N 117.3 0.55 . . . . 0.0 110.731 -178.471 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.996 ' HE1' HD22 ' A' ' 26' ' ' LEU . 21.1 mmt -63.47 -40.68 97.76 Favored 'General case' 0 C--N 1.351 0.665 0 O-C-N 121.606 -0.684 . . . . 0.0 110.981 -178.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -67.23 -41.71 85.21 Favored 'General case' 0 C--N 1.35 0.611 0 O-C-N 121.859 -0.526 . . . . 0.0 111.691 -178.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 59.6 tp -65.61 -43.39 89.77 Favored 'General case' 0 C--N 1.35 0.598 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -178.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.733 HG12 ' O ' ' A' ' 9' ' ' LEU . 2.4 mm -72.92 -36.9 52.83 Favored 'Isoleucine or valine' 0 C--N 1.356 0.883 0 O-C-N 121.167 -0.958 . . . . 0.0 111.091 -175.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -65.99 -43.31 88.14 Favored 'General case' 0 C--N 1.352 0.688 0 O-C-N 121.746 -0.596 . . . . 0.0 111.663 -176.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -73.67 -37.27 65.31 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 121.773 -0.579 . . . . 0.0 112.279 -176.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -71.9 -41.64 67.72 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -175.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -129.9 -27.1 2.34 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 117.43 -1.708 . . . . 0.0 113.358 -177.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 148.19 -179.94 24.65 Favored Glycine 0 C--N 1.346 1.115 0 C-N-CA 117.499 -2.286 . . . . 0.0 110.664 -179.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 93.4 t80 -98.05 -20.41 17.39 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -177.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -70.27 -40.16 74.51 Favored 'General case' 0 C--N 1.361 1.085 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.58 HG22 HG21 ' A' ' 58' ' ' VAL . 93.3 m -68.35 -38.15 81.19 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.423 HD12 ' HB ' ' A' ' 13' ' ' ILE . 31.6 tp -59.97 -37.6 80.1 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -66.22 -35.18 79.77 Favored 'General case' 0 C--N 1.359 0.989 0 O-C-N 121.989 -0.444 . . . . 0.0 110.81 -178.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.8 m -64.86 -39.26 93.27 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -178.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.691 HD12 ' HB3' ' A' ' 51' ' ' LEU . 0.2 OUTLIER -62.83 -38.12 89.48 Favored 'General case' 0 C--N 1.352 0.696 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 -179.266 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.996 HD22 ' HE1' ' A' ' 10' ' ' MET . 80.4 mt -74.52 -12.89 60.59 Favored 'General case' 0 C--N 1.358 0.947 0 O-C-N 121.768 -0.582 . . . . 0.0 110.746 -178.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -87.71 -27.11 22.6 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 119.1 -1.04 . . . . 0.0 108.929 178.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.9 t -67.15 -37.36 83.66 Favored 'General case' 0 C--N 1.357 0.905 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.639 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 2.0 p -93.25 -37.72 11.91 Favored 'General case' 0 C--N 1.358 0.935 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.639 ' HB2' ' O ' ' A' ' 29' ' ' CYS . 9.9 mt-10 85.37 133.57 0.05 OUTLIER 'General case' 0 C--N 1.359 0.979 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.507 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -85.37 -169.9 2.87 Favored 'General case' 0 C--N 1.358 0.954 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.431 ' H ' ' HB2' ' A' ' 31' ' ' LEU . 54.8 tt0 -150.84 -26.49 0.22 Allowed 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -179.355 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.7 t -146.65 -66.97 0.28 Allowed 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -178.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -130.33 -50.65 1.09 Allowed 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -178.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 127.86 -40.08 1.8 Allowed Glycine 0 C--N 1.351 1.382 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 86.4 mt -110.01 101.71 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.86 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.404 ' CE2' ' HB ' ' A' ' 40' ' ' VAL . 57.0 t80 -100.33 1.63 41.74 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.7 m 74.46 -176.56 0.15 Allowed 'General case' 0 C--N 1.362 1.144 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 -178.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.583 ' C ' HG23 ' A' ' 40' ' ' VAL . 28.1 p -87.99 104.69 16.87 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 121.184 -0.948 . . . . 0.0 108.788 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.596 ' O ' HG13 ' A' ' 40' ' ' VAL . 61.4 t -152.99 -21.29 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.361 1.1 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.76 171.59 13.86 Favored Glycine 0 C--N 1.357 1.696 0 C-N-CA 119.049 -1.548 . . . . 0.0 110.162 -176.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 59.2 m -131.29 136.05 47.83 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -121.31 175.42 6.15 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -78.48 -176.17 4.65 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . 0.407 ' CD2' HH22 ' A' ' 137' ' ' ARG . 73.5 m80 -94.15 -15.13 24.94 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.441 -178.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -68.86 -27.78 66.13 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 177.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.2 tp10 -62.62 -40.32 96.59 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -68.93 -38.65 79.65 Favored 'General case' 0 C--N 1.357 0.933 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.418 ' O ' HG22 ' A' ' 53' ' ' VAL . 59.2 tp -70.39 -35.05 73.24 Favored 'General case' 0 CA--C 1.506 -0.712 0 O-C-N 122.099 -0.376 . . . . 0.0 110.14 -176.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 71.7 tp60 -66.6 -39.94 88.63 Favored 'General case' 0 N--CA 1.443 -0.781 0 O-C-N 121.873 -0.517 . . . . 0.0 109.779 -178.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.691 ' HB3' HD12 ' A' ' 25' ' ' LEU . 68.3 mt -80.68 -18.01 49.32 Favored 'General case' 0 C--N 1.363 1.171 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.301 -179.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.471 ' O ' HG13 ' A' ' 52' ' ' VAL . 0.9 OUTLIER -80.35 -34.81 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.809 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.496 ' O ' HG11 ' A' ' 53' ' ' VAL . 54.3 t -70.17 -40.48 78.22 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.443 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 33.5 tptt -65.75 -27.6 68.42 Favored 'General case' 0 C--N 1.364 1.226 0 O-C-N 121.231 -0.918 . . . . 0.0 108.737 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.588 HD11 HD12 ' A' ' 13' ' ' ILE . 1.5 tt -68.5 -37.37 80.01 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.7 p -72.07 -18.72 61.91 Favored 'General case' 0 C--N 1.359 0.992 0 O-C-N 121.439 -0.788 . . . . 0.0 110.704 -178.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -99.89 -36.4 9.43 Favored 'General case' 0 C--N 1.353 0.738 0 O-C-N 121.3 -0.875 . . . . 0.0 111.424 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.58 HG21 HG22 ' A' ' 21' ' ' THR . 5.7 p -72.94 -36.52 51.76 Favored 'Isoleucine or valine' 0 C--N 1.35 0.62 0 O-C-N 121.717 -0.614 . . . . 0.0 111.294 -177.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.574 ' N ' HG13 ' A' ' 58' ' ' VAL . 74.7 m -114.09 -6.68 13.09 Favored 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 119.35 -0.94 . . . . 0.0 109.936 -178.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 64.31 50.31 2.35 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.631 HG13 ' HD2' ' A' ' 62' ' ' PRO . 56.1 t -113.81 136.14 22.05 Favored Pre-proline 0 CA--C 1.505 -0.778 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.727 ' HG2' ' HB2' ' A' ' 65' ' ' GLU . 23.3 Cg_endo -62.36 149.22 91.58 Favored 'Trans proline' 0 CA--C 1.5 -1.192 0 C-N-CA 122.226 1.95 . . . . 0.0 112.391 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.5 m -75.83 -14.16 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.344 -177.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 68.7 p -94.71 -34.65 12.47 Favored 'General case' 0 C--N 1.358 0.939 0 C-N-CA 118.347 -1.341 . . . . 0.0 109.722 -178.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.727 ' HB2' ' HG2' ' A' ' 62' ' ' PRO . 97.7 mt-10 -78.32 -20.48 51.34 Favored 'General case' 0 C--N 1.354 0.768 0 O-C-N 121.31 -0.869 . . . . 0.0 109.075 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.423 ' HB3' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -79.7 -37.67 35.19 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -179.624 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.8 p -67.92 -25.82 33.25 Favored 'Isoleucine or valine' 0 C--N 1.354 0.8 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.812 -179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 9.3 mtp180 -72.61 -53.17 12.61 Favored 'General case' 0 C--N 1.364 1.216 0 O-C-N 121.467 -0.771 . . . . 0.0 110.532 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 92.3 mt -63.07 -34.81 78.39 Favored 'General case' 0 C--N 1.357 0.927 0 O-C-N 121.933 -0.479 . . . . 0.0 111.031 -178.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -60.69 -47.34 86.72 Favored 'General case' 0 C--N 1.348 0.519 0 O-C-N 122.138 -0.351 . . . . 0.0 110.244 -178.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.44 -38.31 94.6 Favored Glycine 0 C--N 1.357 1.696 0 N-CA-C 111.766 -0.534 . . . . 0.0 111.766 -178.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.19 -49.04 75.81 Favored 'General case' 0 C--N 1.352 0.696 0 CA-C-N 118.264 1.032 . . . . 0.0 111.821 -177.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.559 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 8.4 mttm -64.26 -47.86 77.96 Favored 'General case' 0 C--N 1.358 0.948 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -177.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -68.66 -39.06 80.84 Favored 'General case' 0 C--N 1.35 0.624 0 O-C-N 121.055 -1.028 . . . . 0.0 111.92 -175.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -65.36 -43.23 91.45 Favored 'General case' 0 C--N 1.356 0.855 0 O-C-N 121.126 -0.984 . . . . 0.0 111.46 -177.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -72.16 -12.68 16.05 Favored 'Isoleucine or valine' 0 C--N 1.359 1.004 0 O-C-N 121.149 -0.969 . . . . 0.0 109.266 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.559 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 70.1 mm-40 -81.33 -29.78 34.06 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 73.3 mt -72.9 -34.69 66.81 Favored 'General case' 0 C--N 1.358 0.946 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.7 mm -64.63 -50.75 74.27 Favored 'Isoleucine or valine' 0 C--N 1.357 0.91 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -178.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -69.42 -28.29 66.01 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -66.68 -34.15 86.56 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -178.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.427 ' HA ' ' HD2' ' A' ' 83' ' ' PRO . 96.7 m-70 -135.7 101.34 10.76 Favored Pre-proline 0 CA--C 1.501 -0.91 0 CA-C-N 118.511 1.155 . . . . 0.0 109.372 -176.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 82' ' ' HIS . 34.7 Cg_endo -66.85 -22.52 49.03 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.416 2.077 . . . . 0.0 113.607 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.438 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 42.5 mt-10 -91.87 -6.14 52.05 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.6 tp -90.32 -19.65 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 -179.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.23 -26.09 14.04 Favored 'General case' 0 C--N 1.361 1.084 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -70.75 -34.73 72.15 Favored 'General case' 0 C--N 1.356 0.875 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 84' ' ' GLU . 78.2 mm-40 -65.49 -36.25 83.28 Favored 'General case' 0 C--N 1.357 0.919 0 O-C-N 122.023 -0.423 . . . . 0.0 110.254 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.45 ' SD ' ' HB2' ' A' ' 95' ' ' LEU . 16.6 ttp -83.12 153.04 25.03 Favored 'General case' 0 C--N 1.353 0.743 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -178.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.96 -24.13 7.2 Favored 'General case' 0 C--N 1.365 1.253 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.352 -176.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -164.63 170.57 15.54 Favored 'General case' 0 C--N 1.354 0.802 0 C-N-CA 119.098 -1.041 . . . . 0.0 108.344 -177.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.404 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 39.7 t -64.01 -43.4 95.76 Favored 'General case' 0 C--N 1.357 0.899 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.489 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -66.33 -39.61 89.36 Favored 'General case' 0 C--N 1.355 0.816 0 O-C-N 121.366 -0.834 . . . . 0.0 109.255 -178.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -65.09 -25.73 67.92 Favored 'General case' 0 C--N 1.353 0.76 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.618 ' O ' HG13 ' A' ' 99' ' ' ILE . 61.8 tp -63.37 -46.46 86.39 Favored 'General case' 0 C--N 1.356 0.867 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.2 mp -59.54 -34.79 73.1 Favored 'General case' 0 C--N 1.357 0.917 0 O-C-N 122.177 -0.327 . . . . 0.0 110.591 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.4 t -69.88 -39.28 76.4 Favored 'General case' 0 C--N 1.348 0.538 0 O-C-N 121.917 -0.49 . . . . 0.0 109.944 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.405 ' HZ3' ' HG3' ' A' ' 98' ' ' LYS . 1.4 tttp -90.97 4.11 52.88 Favored 'General case' 0 C--N 1.352 0.712 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -176.064 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.674 HD13 HMBA ' A' ' 202' ' ' HEM . 77.6 mt -61.62 -47.29 94.01 Favored 'Isoleucine or valine' 0 C--N 1.358 0.977 0 CA-C-N 119.657 1.117 . . . . 0.0 111.9 -177.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -98.49 -22.46 16.0 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 118.408 -1.317 . . . . 0.0 111.285 -176.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 33.4 t -65.69 -47.01 76.9 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 121.684 -0.635 . . . . 0.0 111.951 -177.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.414 ' HA ' HG12 ' A' ' 105' ' ' VAL . 11.5 t80 -132.26 -23.04 2.19 Favored 'General case' 0 C--N 1.361 1.079 0 C-N-CA 117.763 -1.575 . . . . 0.0 113.056 -176.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.567 HG23 ' C2C' ' A' ' 202' ' ' HEM . 31.1 mm -69.21 -50.03 56.23 Favored 'Isoleucine or valine' 0 C--N 1.354 0.785 0 CA-C-N 120.001 1.273 . . . . 0.0 110.57 -177.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 54.8 m170 -90.12 3.8 52.29 Favored 'General case' 0 N--CA 1.439 -0.976 0 O-C-N 121.311 -0.868 . . . . 0.0 110.444 -177.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.535 HG11 ' N ' ' A' ' 106' ' ' GLU . 1.3 p -89.35 -34.01 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 178.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.535 ' N ' HG11 ' A' ' 105' ' ' VAL . 44.1 tt0 -72.54 -40.03 67.06 Favored 'General case' 0 C--N 1.36 1.065 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.491 HG12 HMDA ' A' ' 202' ' ' HEM . 73.4 t -63.09 -46.35 96.32 Favored 'Isoleucine or valine' 0 C--N 1.355 0.846 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 93.2 t80 -60.6 -48.76 80.34 Favored 'General case' 0 C--N 1.361 1.089 0 O-C-N 122.064 -0.397 . . . . 0.0 111.428 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -60.9 -37.1 81.07 Favored 'General case' 0 C--N 1.356 0.864 0 O-C-N 121.556 -0.715 . . . . 0.0 110.604 -178.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.9 mt -58.17 -73.83 0.07 Allowed 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -121.67 134.75 24.71 Favored Pre-proline 0 N--CA 1.439 -1.023 0 C-N-CA 118.37 -1.332 . . . . 0.0 108.773 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -84.51 -1.12 9.59 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 123.25 2.634 . . . . 0.0 115.052 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -66.75 -36.03 81.48 Favored 'General case' 0 C--N 1.354 0.795 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.13 145.39 56.35 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 121.649 0.738 . . . . 0.0 110.146 -178.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -126.95 134.31 50.44 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 179.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.47 ' HB3' ' HD2' ' A' ' 117' ' ' PRO . 84.4 mt -126.81 155.33 75.48 Favored Pre-proline 0 N--CA 1.442 -0.833 0 CA-C-O 122.184 0.992 . . . . 0.0 109.087 -178.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.47 ' HD2' ' HB3' ' A' ' 116' ' ' LEU . 87.7 Cg_endo -85.1 -152.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.125 0 C-N-CA 123.887 3.058 . . . . 0.0 114.543 -178.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.44 ' H ' ' HB2' ' A' ' 117' ' ' PRO . 74.7 mmtt -112.64 148.67 34.13 Favored 'General case' 0 C--N 1.368 1.38 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -179.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.528 ' CZ ' HD11 ' A' ' 131' ' ' LEU . 8.3 t80 -142.5 125.06 15.76 Favored 'General case' 0 C--N 1.361 1.066 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -177.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 95.8 m -126.44 133.62 51.19 Favored 'General case' 0 C--N 1.361 1.068 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 85.0 m -117.63 132.16 56.54 Favored 'General case' 0 C--N 1.358 0.946 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.732 -178.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -120.43 125.05 46.97 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 177.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.442 ' HG3' HD11 ' A' ' 129' ' ' ILE . 58.7 ttp180 -101.61 117.3 34.61 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 -179.218 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.501 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 94.5 mt -84.98 -25.64 27.63 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.502 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -179.1 -142.6 4.98 Favored Glycine 0 C--N 1.349 1.257 0 C-N-CA 118.898 -1.62 . . . . 0.0 109.082 -178.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -94.1 -41.1 9.7 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 119.928 -0.709 . . . . 0.0 109.616 -178.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -102.18 3.49 38.46 Favored 'General case' 0 C--N 1.352 0.712 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.446 -178.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.501 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 67.4 m-20 -118.01 128.95 55.28 Favored 'General case' 0 C--N 1.356 0.885 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.517 HG21 ' N ' ' A' ' 130' ' ' ARG . 10.6 mm -140.88 133.79 31.33 Favored 'Isoleucine or valine' 0 C--N 1.357 0.935 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.517 ' N ' HG21 ' A' ' 129' ' ' ILE . 62.3 mtm180 -121.34 140.84 51.58 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.619 ' HG ' ' O ' ' A' ' 131' ' ' LEU . 0.3 OUTLIER -129.79 128.03 41.55 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.679 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -99.08 131.28 45.24 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -126.24 120.99 31.43 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -178.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.468 ' HA ' ' O ' ' A' ' 171' ' ' THR . 27.5 tt0 -114.88 110.23 19.35 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.486 ' O ' ' HA ' ' A' ' 171' ' ' THR . 11.6 t -162.95 154.37 17.53 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -87.93 9.2 22.94 Favored 'General case' 0 C--N 1.355 0.836 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . 0.407 HH22 ' CD2' ' A' ' 45' ' ' HIS . 78.3 mtp180 -129.46 78.28 75.92 Favored Pre-proline 0 N--CA 1.443 -0.777 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -91.98 86.61 0.24 Allowed 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.663 2.242 . . . . 0.0 115.556 -178.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -111.7 109.71 19.71 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 177.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -70.4 -30.73 67.69 Favored 'General case' 0 C--N 1.354 0.792 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.3 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.4 m -62.88 -34.22 76.93 Favored 'General case' 0 C--N 1.352 0.697 0 O-C-N 122.001 -0.437 . . . . 0.0 109.95 -179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -74.35 -44.59 51.7 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 120.434 -0.506 . . . . 0.0 109.732 -177.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.55 -40.39 95.49 Favored 'General case' 0 C--N 1.357 0.902 0 O-C-N 122.067 -0.395 . . . . 0.0 111.254 -177.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.87 -37.02 85.84 Favored 'General case' 0 CA--C 1.506 -0.736 0 O-C-N 122.012 -0.43 . . . . 0.0 110.187 -179.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.49 -43.71 98.5 Favored Glycine 0 C--N 1.347 1.161 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -178.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 82.8 mt -69.9 -40.49 75.58 Favored 'General case' 0 C--N 1.35 0.612 0 O-C-N 122.108 -0.642 . . . . 0.0 112.507 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 96.7 mt -71.75 -43.16 66.28 Favored 'General case' 0 C--N 1.361 1.103 0 O-C-N 121.215 -0.928 . . . . 0.0 111.032 -176.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.609 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 37.3 t70 -71.01 -31.46 67.98 Favored 'General case' 0 N--CA 1.447 -0.604 0 O-C-N 122.1 -0.375 . . . . 0.0 110.634 -178.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -62.77 -39.89 98.52 Favored Glycine 0 C--N 1.358 1.76 0 N-CA-C 108.512 -1.835 . . . . 0.0 108.512 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 48.8 t -60.71 -41.61 95.57 Favored 'General case' 0 C--N 1.35 0.591 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -76.83 2.05 15.64 Favored 'General case' 0 C--N 1.361 1.079 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.609 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 77.3 mm-40 -86.0 -46.16 10.78 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -66.16 -45.18 81.82 Favored 'General case' 0 C--N 1.361 1.102 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -69.54 -26.61 64.58 Favored 'General case' 0 C--N 1.362 1.124 0 O-C-N 121.842 -0.536 . . . . 0.0 110.793 -178.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 84.7 tttt 71.65 77.7 0.17 Allowed 'General case' 0 C--N 1.358 0.95 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.28 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -141.38 -170.66 3.13 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 179.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -145.96 93.5 2.34 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 13.5 m-30 -113.52 155.93 24.49 Favored 'General case' 0 CA--C 1.504 -0.802 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 178.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 95.5 m -120.2 127.54 52.54 Favored 'General case' 0 C--N 1.356 0.856 0 C-N-CA 119.392 -0.923 . . . . 0.0 108.979 -178.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 3.7 mp -100.99 121.3 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 178.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.12 -176.44 2.9 Favored 'General case' 0 C--N 1.365 1.245 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 28.8 ptt180 -146.95 154.46 41.29 Favored 'General case' 0 C--N 1.359 0.98 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -179.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 35.1 p -97.69 146.56 31.64 Favored Pre-proline 0 C--N 1.36 1.06 0 CA-C-O 122.448 1.118 . . . . 0.0 108.046 178.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.656 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 72.1 Cg_endo -75.03 -12.49 21.45 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 123.055 2.504 . . . . 0.0 114.923 -178.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -72.21 -41.21 67.15 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.84 -178.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 26.8 p -118.6 16.45 13.69 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 119.824 -0.75 . . . . 0.0 110.829 -178.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.656 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.2 pp0? -67.15 -14.37 62.84 Favored 'General case' 0 C--N 1.352 0.707 0 O-C-N 121.563 -0.71 . . . . 0.0 110.121 178.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -124.28 38.81 4.11 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 22.0 t -138.49 143.37 39.55 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 107.165 -1.421 . . . . 0.0 107.165 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.633 ' O ' ' HB ' ' A' ' 171' ' ' THR . 60.5 mt-10 -96.77 163.63 12.91 Favored 'General case' 0 C--N 1.354 0.776 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.633 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 2.7 m 81.91 -57.49 0.23 Allowed 'General case' 0 C--N 1.374 1.645 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.906 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -105.63 117.76 34.85 Favored 'General case' 0 CA--C 1.504 -0.813 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.567 -178.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.659 HG11 ' CE1' ' A' ' 175' ' ' PHE . 89.0 t -132.57 134.21 58.98 Favored 'Isoleucine or valine' 0 C--N 1.357 0.928 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . 0.435 ' N ' HG13 ' A' ' 173' ' ' VAL . 48.5 mm -115.22 127.73 72.68 Favored 'Isoleucine or valine' 0 C--N 1.361 1.07 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.659 ' CE1' HG11 ' A' ' 173' ' ' VAL . 97.6 m-85 -116.2 146.33 42.4 Favored 'General case' 0 C--N 1.359 1.021 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -125.53 84.05 2.23 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.193 -178.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . 0.413 HD13 ' CD2' ' A' ' 131' ' ' LEU . 3.6 mp -77.1 117.99 22.98 Favored 'Isoleucine or valine' 0 C--N 1.363 1.167 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 90.1 m -128.35 144.41 51.13 Favored 'General case' 0 C--N 1.356 0.885 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -178.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 59.3 mtm180 -79.7 116.59 19.96 Favored 'General case' 0 C--N 1.371 1.539 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -65.9 149.85 97.11 Favored Pre-proline 0 C--N 1.358 0.959 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.9 124.74 12.66 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 121.775 1.65 . . . . 0.0 113.51 -178.666 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 2.9 ppt_? -137.03 152.88 50.6 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 75.82 62.92 2.54 Favored Glycine 0 C--N 1.351 1.373 0 N-CA-C 107.489 -2.244 . . . . 0.0 107.489 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 80.1 163.83 0.18 Allowed 'General case' 0 C--N 1.361 1.088 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -178.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -146.99 148.84 32.11 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -123.79 126.68 46.9 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 78.5 mt -99.23 -61.39 1.37 Allowed 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . 0.439 ' HB3' ' H ' ' A' ' 189' ' ' PHE . 0.2 OUTLIER -151.19 -94.57 0.06 Allowed 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 179.672 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . 0.439 ' H ' ' HB3' ' A' ' 188' ' ' TYR . 99.0 m-85 -128.83 147.76 50.83 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 . . . . . 0 C--O 1.264 1.816 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -179.937 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' HEM . . . . . 0.739 HBBA HMBB ' A' ' 202' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.4 mtm . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 121.252 0.548 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.99 -13.5 53.14 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -179.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.0 -39.32 38.18 Favored Glycine 0 C--N 1.353 1.49 0 N-CA-C 108.641 -1.783 . . . . 0.0 108.641 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.7 tpp -71.6 -36.69 70.9 Favored 'General case' 0 C--N 1.359 0.982 0 O-C-N 121.92 -0.753 . . . . 0.0 110.767 -177.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 35.5 m -69.81 -22.76 25.12 Favored 'Isoleucine or valine' 0 C--N 1.357 0.908 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -179.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.432 ' HZ ' ' HG2' ' A' ' 47' ' ' GLU . 1.8 m-30 -70.4 -35.57 73.54 Favored 'General case' 0 C--N 1.357 0.922 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 85.3 m -67.38 -40.61 85.71 Favored 'General case' 0 C--N 1.355 0.847 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.34 -38.81 96.87 Favored Glycine 0 C--N 1.358 1.75 0 N-CA-C 110.541 -1.023 . . . . 0.0 110.541 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.668 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -66.96 -39.42 87.24 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 122.297 -0.531 . . . . 0.0 110.674 -178.198 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.677 ' HE2' HD22 ' A' ' 26' ' ' LEU . 20.9 mmt -63.91 -41.01 97.78 Favored 'General case' 0 C--N 1.354 0.78 0 O-C-N 121.602 -0.686 . . . . 0.0 110.979 -178.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -67.43 -40.76 85.5 Favored 'General case' 0 C--N 1.349 0.554 0 O-C-N 121.929 -0.482 . . . . 0.0 111.857 -177.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 54.7 tp -65.52 -42.83 91.58 Favored 'General case' 0 C--N 1.349 0.571 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -178.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.668 HG12 ' O ' ' A' ' 9' ' ' LEU . 1.2 mm -76.42 -35.74 27.4 Favored 'Isoleucine or valine' 0 C--N 1.358 0.951 0 O-C-N 120.957 -1.09 . . . . 0.0 111.041 -175.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -67.98 -43.38 79.1 Favored 'General case' 0 C--N 1.352 0.677 0 O-C-N 121.766 -0.584 . . . . 0.0 111.173 -176.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -72.64 -33.71 66.81 Favored 'General case' 0 N--CA 1.448 -0.566 0 O-C-N 121.98 -0.45 . . . . 0.0 111.658 -177.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -71.57 -47.88 52.02 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -175.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -127.89 -19.18 4.09 Favored 'General case' 0 C--N 1.355 0.834 0 C-N-CA 117.417 -1.713 . . . . 0.0 113.496 -176.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 139.99 178.92 17.32 Favored Glycine 0 N--CA 1.44 -1.053 0 C-N-CA 117.923 -2.084 . . . . 0.0 109.862 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -95.99 -12.4 25.05 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -177.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -70.69 -40.48 72.87 Favored 'General case' 0 C--N 1.359 0.997 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.8 m -69.09 -39.25 79.13 Favored 'General case' 0 C--N 1.357 0.907 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 53.4 tp -62.59 -37.83 87.76 Favored 'General case' 0 C--N 1.357 0.934 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -62.97 -37.42 87.06 Favored 'General case' 0 C--N 1.358 0.955 0 O-C-N 121.968 -0.458 . . . . 0.0 110.997 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.6 m -65.6 -38.22 88.86 Favored 'General case' 0 C--N 1.353 0.735 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 21.8 tp -62.53 -39.49 93.74 Favored 'General case' 0 C--N 1.353 0.735 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.677 HD22 ' HE2' ' A' ' 10' ' ' MET . 85.6 mt -72.95 -13.85 61.33 Favored 'General case' 0 C--N 1.359 0.997 0 O-C-N 121.92 -0.488 . . . . 0.0 110.579 -178.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -86.93 -28.77 22.55 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 119.312 -0.955 . . . . 0.0 109.368 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.0 t -67.25 -37.01 82.82 Favored 'General case' 0 C--N 1.355 0.839 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.1 p -91.63 -39.5 11.84 Favored 'General case' 0 C--N 1.357 0.924 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -179.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 86.06 132.85 0.04 OUTLIER 'General case' 0 C--N 1.36 1.052 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.494 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -86.91 -169.55 2.68 Favored 'General case' 0 C--N 1.357 0.9 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -179.884 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.443 ' H ' ' HB2' ' A' ' 31' ' ' LEU . 62.5 tt0 -152.26 -24.92 0.17 Allowed 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.8 t -145.22 -69.51 0.28 Allowed 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -179.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -131.05 -50.24 1.02 Allowed 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -178.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 130.41 -37.31 2.15 Favored Glycine 0 C--N 1.353 1.475 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 83.0 mt -110.0 100.75 11.41 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.438 ' CE2' HG22 ' A' ' 40' ' ' VAL . 70.4 t80 -95.65 -4.78 43.77 Favored 'General case' 0 C--N 1.354 0.801 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.741 HG22 ' H ' ' A' ' 39' ' ' SER . 5.2 m 82.43 174.84 0.09 Allowed 'General case' 0 C--N 1.362 1.118 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 -178.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.741 ' H ' HG22 ' A' ' 38' ' ' THR . 41.1 p -89.38 114.89 26.38 Favored 'General case' 0 N--CA 1.443 -0.791 0 O-C-N 121.041 -1.037 . . . . 0.0 109.855 -178.042 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.54 HG23 ' C ' ' A' ' 39' ' ' SER . 0.0 OUTLIER -172.92 -3.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.218 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.795 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -98.26 -136.74 9.38 Favored Glycine 0 C--N 1.357 1.735 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -178.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 164.47 98.97 0.0 OUTLIER 'General case' 0 C--N 1.362 1.132 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 -178.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -98.11 176.87 5.59 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.71 -174.61 4.42 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -91.1 -15.89 28.72 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 120.011 -0.676 . . . . 0.0 109.29 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -70.31 -29.32 66.03 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.432 ' HG2' ' HZ ' ' A' ' 6' ' ' PHE . 33.1 tp10 -63.69 -41.64 98.1 Favored 'General case' 0 C--N 1.354 0.769 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 54.5 tp -67.24 -38.36 85.06 Favored 'General case' 0 C--N 1.354 0.782 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.197 -179.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 60.6 tp -76.49 -28.04 56.3 Favored 'General case' 0 C--N 1.349 0.583 0 O-C-N 122.029 -0.419 . . . . 0.0 110.647 -177.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 71.5 tp60 -68.2 -42.6 79.64 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 121.509 -0.745 . . . . 0.0 109.615 -178.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.511 ' HA ' HD22 ' A' ' 51' ' ' LEU . 57.5 mt -72.8 -33.8 66.47 Favored 'General case' 0 C--N 1.363 1.18 0 C-N-CA 119.679 -0.809 . . . . 0.0 109.48 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.479 ' O ' HG11 ' A' ' 52' ' ' VAL . 38.7 t -62.61 -41.47 92.26 Favored 'Isoleucine or valine' 0 C--N 1.35 0.59 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 51.3 t -68.1 -40.61 83.3 Favored 'Isoleucine or valine' 0 C--N 1.351 0.668 0 O-C-N 121.716 -0.615 . . . . 0.0 109.809 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 31.7 tptt -66.84 -26.08 66.74 Favored 'General case' 0 C--N 1.359 1.007 0 O-C-N 121.131 -0.98 . . . . 0.0 108.768 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.59 HD12 HD13 ' A' ' 13' ' ' ILE . 2.2 tt -69.09 -37.5 78.46 Favored 'General case' 0 C--N 1.353 0.744 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' A' ' 60' ' ' SER . 71.5 p -72.05 -18.05 61.97 Favored 'General case' 0 C--N 1.356 0.868 0 O-C-N 121.722 -0.611 . . . . 0.0 110.624 -178.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -100.5 -35.04 9.68 Favored 'General case' 0 C--N 1.353 0.743 0 O-C-N 121.143 -0.973 . . . . 0.0 111.389 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.408 HG11 ' N ' ' A' ' 59' ' ' SER . 5.5 p -72.29 -34.8 50.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.719 0 O-C-N 121.755 -0.591 . . . . 0.0 111.375 -177.33 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.408 ' N ' HG11 ' A' ' 58' ' ' VAL . 2.5 t -120.29 -7.4 9.79 Favored 'General case' 0 C--N 1.353 0.718 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.094 -177.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 56' ' ' SER . 0.6 OUTLIER 65.71 47.26 2.17 Favored 'General case' 0 C--N 1.353 0.76 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.796 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.417 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 52.3 t -108.71 131.92 21.48 Favored Pre-proline 0 CA--C 1.503 -0.839 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 179.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 61' ' ' VAL . 42.7 Cg_exo -57.46 147.24 79.41 Favored 'Trans proline' 0 CA--C 1.497 -1.355 0 C-N-CA 122.439 2.093 . . . . 0.0 112.82 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.489 ' HA ' HD22 ' A' ' 66' ' ' LEU . 3.9 m -75.51 -12.97 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.685 -178.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 71.5 p -96.09 -33.04 12.23 Favored 'General case' 0 C--N 1.358 0.961 0 C-N-CA 118.291 -1.364 . . . . 0.0 109.534 -179.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -76.55 -22.58 54.14 Favored 'General case' 0 C--N 1.354 0.799 0 O-C-N 121.449 -0.782 . . . . 0.0 109.033 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.489 HD22 ' HA ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -81.7 -34.89 30.37 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.093 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.576 HG11 ' N ' ' A' ' 68' ' ' ARG . 1.5 p -69.4 -26.33 31.13 Favored 'Isoleucine or valine' 0 C--N 1.354 0.795 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.916 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.576 ' N ' HG11 ' A' ' 67' ' ' VAL . 7.5 mmm-85 -72.96 -51.5 18.13 Favored 'General case' 0 C--N 1.363 1.157 0 O-C-N 121.53 -0.731 . . . . 0.0 110.269 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.403 ' HA ' HD23 ' A' ' 69' ' ' LEU . 83.7 mt -63.76 -36.17 83.01 Favored 'General case' 0 C--N 1.357 0.923 0 O-C-N 122.064 -0.398 . . . . 0.0 110.939 -179.042 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -60.94 -46.9 88.82 Favored 'General case' 0 C--N 1.35 0.609 0 O-C-N 122.233 -0.292 . . . . 0.0 110.238 -178.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.56 -37.97 94.21 Favored Glycine 0 C--N 1.355 1.598 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 -178.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -63.64 -47.84 79.69 Favored 'General case' 0 C--N 1.354 0.782 0 CA-C-N 118.419 1.109 . . . . 0.0 111.486 -177.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.9 mttm -64.38 -47.72 78.2 Favored 'General case' 0 C--N 1.36 1.027 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -176.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.434 HD21 ' O ' ' A' ' 74' ' ' LEU . 2.5 tm? -69.64 -40.21 76.64 Favored 'General case' 0 C--N 1.349 0.581 0 O-C-N 121.051 -1.031 . . . . 0.0 111.828 -175.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.762 ' CE1' HBBA ' A' ' 202' ' ' HEM . 41.7 t80 -63.76 -45.45 89.74 Favored 'General case' 0 C--N 1.354 0.768 0 O-C-N 121.19 -0.944 . . . . 0.0 111.27 -178.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 8.5 p -71.72 -12.83 16.31 Favored 'Isoleucine or valine' 0 C--N 1.357 0.911 0 O-C-N 121.543 -0.723 . . . . 0.0 109.294 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.33 -37.39 60.74 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 82.4 mt -72.53 -32.84 66.44 Favored 'General case' 0 C--N 1.358 0.949 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.7 mm -64.07 -52.99 49.34 Favored 'Isoleucine or valine' 0 C--N 1.36 1.043 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.196 -177.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -75.36 -14.87 60.5 Favored 'General case' 0 CA--C 1.51 -0.593 0 C-N-CA 119.693 -0.803 . . . . 0.0 109.529 178.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.32 -37.05 63.17 Favored Glycine 0 C--N 1.349 1.267 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -179.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -133.45 105.78 12.06 Favored Pre-proline 0 N--CA 1.44 -0.97 0 CA-C-O 122.555 1.169 . . . . 0.0 109.199 -176.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.8 -25.03 39.81 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.381 2.054 . . . . 0.0 113.806 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -88.78 -7.69 55.76 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.8 tp -89.31 -22.7 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 -178.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -98.7 -22.12 16.06 Favored 'General case' 0 C--N 1.362 1.113 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -70.03 -37.22 75.54 Favored 'General case' 0 C--N 1.358 0.976 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -64.78 -36.73 85.27 Favored 'General case' 0 C--N 1.358 0.956 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.261 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.577 ' HG2' ' N ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -82.17 151.07 27.08 Favored 'General case' 0 C--N 1.352 0.704 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -178.837 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.577 ' N ' ' HG2' ' A' ' 89' ' ' MET . 0.7 OUTLIER -118.27 -22.63 7.61 Favored 'General case' 0 C--N 1.363 1.18 0 C-N-CA 119.852 -0.739 . . . . 0.0 111.298 -177.472 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -166.71 172.77 10.22 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.435 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 65.1 m -67.12 -40.06 86.76 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.478 -179.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -68.68 -39.09 80.75 Favored 'General case' 0 C--N 1.356 0.859 0 O-C-N 121.322 -0.862 . . . . 0.0 109.011 -178.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -66.29 -23.16 66.34 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.612 HD21 ' HG ' ' A' ' 150' ' ' CYS . 58.3 tp -63.99 -46.1 86.07 Favored 'General case' 0 C--N 1.355 0.829 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.2 mp -63.14 -33.13 74.79 Favored 'General case' 0 C--N 1.354 0.797 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 35.6 t -62.34 -44.4 96.58 Favored 'General case' 0 C--N 1.353 0.747 0 O-C-N 121.897 -0.502 . . . . 0.0 110.954 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.63 26.73 10.37 Favored 'General case' 0 C--N 1.359 0.99 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.376 -177.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 1.296 HD12 ' C2B' ' A' ' 202' ' ' HEM . 14.1 tt -62.36 -31.55 52.08 Favored 'Isoleucine or valine' 0 C--N 1.356 0.88 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.625 -179.088 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.614 ' N ' HG22 ' A' ' 99' ' ' ILE . 21.8 t70 -119.43 -18.29 8.55 Favored 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 119.218 -0.993 . . . . 0.0 109.113 -178.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 35.6 t -64.25 -46.61 82.99 Favored 'General case' 0 N--CA 1.444 -0.747 0 O-C-N 121.82 -0.55 . . . . 0.0 110.869 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.408 ' HA ' HG13 ' A' ' 105' ' ' VAL . 14.4 t80 -127.59 -26.34 3.01 Favored 'General case' 0 C--N 1.36 1.028 0 C-N-CA 118.103 -1.439 . . . . 0.0 111.828 -177.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.472 HG21 HMCB ' A' ' 202' ' ' HEM . 19.0 mm -67.05 -50.23 65.97 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 O-C-N 121.097 -1.002 . . . . 0.0 110.236 -177.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 49.4 m170 -91.08 3.43 54.77 Favored 'General case' 0 N--CA 1.439 -0.985 0 O-C-N 121.462 -0.774 . . . . 0.0 110.408 -177.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.408 HG13 ' HA ' ' A' ' 102' ' ' PHE . 2.4 p -87.64 -35.4 8.26 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -72.88 -39.95 66.01 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.448 HG13 HMDA ' A' ' 202' ' ' HEM . 74.4 t -63.48 -46.06 96.17 Favored 'Isoleucine or valine' 0 C--N 1.357 0.909 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.255 -179.115 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -60.3 -48.13 83.06 Favored 'General case' 0 C--N 1.36 1.026 0 O-C-N 122.117 -0.364 . . . . 0.0 111.484 -178.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -61.98 -36.55 81.81 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 121.412 -0.805 . . . . 0.0 110.506 -178.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.9 mt -58.28 -76.33 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 120.665 -0.414 . . . . 0.0 109.951 -179.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.456 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 90.5 m-85 -110.9 141.0 23.26 Favored Pre-proline 0 N--CA 1.443 -0.807 0 C-N-CA 118.745 -1.182 . . . . 0.0 109.169 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 111' ' ' TYR . 54.2 Cg_endo -88.39 -7.53 5.79 Favored 'Trans proline' 0 C--N 1.315 -1.198 0 C-N-CA 123.219 2.613 . . . . 0.0 115.877 -178.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -77.96 -23.87 48.31 Favored 'General case' 0 C--N 1.354 0.789 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.22 -178.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.2 142.53 58.29 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 121.512 0.672 . . . . 0.0 109.656 -178.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -118.72 143.63 46.75 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.431 ' HA ' HD23 ' A' ' 116' ' ' LEU . 96.3 mt -136.93 152.22 73.66 Favored Pre-proline 0 C--N 1.354 0.802 0 CA-C-O 122.138 0.971 . . . . 0.0 109.604 -178.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 116' ' ' LEU . 75.0 Cg_endo -89.85 -155.24 0.05 OUTLIER 'Trans proline' 0 C--N 1.318 -1.03 0 C-N-CA 123.934 3.089 . . . . 0.0 113.484 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -119.63 142.34 48.51 Favored 'General case' 0 C--N 1.367 1.327 0 C-N-CA 119.328 -0.949 . . . . 0.0 108.711 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -126.26 128.66 47.53 Favored 'General case' 0 C--N 1.363 1.157 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -178.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.553 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 93.6 m -124.17 128.26 48.98 Favored 'General case' 0 C--N 1.357 0.893 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 176.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 78.1 m -121.77 130.97 53.81 Favored 'General case' 0 CA--C 1.504 -0.827 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.175 -177.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -118.76 149.81 40.85 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 177.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.558 ' HG3' HD11 ' A' ' 129' ' ' ILE . 58.0 ttp180 -121.62 117.61 27.15 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -179.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.458 ' HA ' HD22 ' A' ' 124' ' ' LEU . 96.0 mt -91.34 -16.27 27.74 Favored 'General case' 0 C--N 1.354 0.796 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.57 -179.481 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 175.41 -149.5 10.21 Favored Glycine 0 C--N 1.348 1.214 0 C-N-CA 118.859 -1.639 . . . . 0.0 109.076 -179.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -93.87 -37.64 11.63 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -178.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -102.83 4.38 37.73 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.81 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.41 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 67.1 m-20 -120.8 129.62 53.65 Favored 'General case' 0 C--N 1.357 0.934 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -179.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.558 HD11 ' HG3' ' A' ' 123' ' ' ARG . 8.3 mm -141.89 136.57 30.47 Favored 'Isoleucine or valine' 0 C--N 1.355 0.834 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.497 ' N ' HG23 ' A' ' 129' ' ' ILE . 51.7 mtm180 -116.63 139.67 50.26 Favored 'General case' 0 CA--C 1.495 -1.16 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 8.0 tp -127.61 119.57 26.22 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-N 115.172 -0.922 . . . . 0.0 108.856 -178.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.553 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 12.1 m170 -99.2 134.28 42.27 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 178.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.66 ' HH ' HMAA ' A' ' 202' ' ' HEM . 52.2 t80 -130.21 122.26 27.77 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -178.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.491 ' HA ' ' O ' ' A' ' 171' ' ' THR . 30.0 tt0 -114.35 113.74 24.96 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 15.6 t -161.88 153.34 18.55 Favored 'General case' 0 C--N 1.358 0.954 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -91.55 3.89 53.91 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.866 -179.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 94.3 mtm-85 -133.42 74.98 70.65 Favored Pre-proline 0 C--N 1.355 0.847 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 178.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -94.88 100.89 0.11 Allowed 'Trans proline' 0 N--CA 1.442 -1.506 0 C-N-CA 122.621 2.214 . . . . 0.0 115.63 -177.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -110.67 113.54 26.22 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 176.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.63 -38.59 91.7 Favored 'General case' 0 C--N 1.354 0.771 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.166 -179.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 73.4 m -63.83 -26.98 68.87 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 121.886 -0.509 . . . . 0.0 110.808 -178.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -76.11 -47.37 24.74 Favored 'General case' 0 C--N 1.352 0.695 0 C-N-CA 120.038 -0.665 . . . . 0.0 109.593 -177.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.46 -39.8 94.5 Favored 'General case' 0 C--N 1.356 0.864 0 O-C-N 122.215 -0.303 . . . . 0.0 111.185 -178.005 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -63.31 -37.37 86.98 Favored 'General case' 0 C--N 1.354 0.797 0 O-C-N 121.879 -0.513 . . . . 0.0 109.908 -179.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.04 -42.94 98.63 Favored Glycine 0 C--N 1.348 1.232 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 -179.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.0 mt -70.82 -41.0 72.14 Favored 'General case' 0 C--N 1.354 0.762 0 CA-C-N 117.586 0.693 . . . . 0.0 112.704 -179.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 98.5 mt -71.08 -42.15 69.74 Favored 'General case' 0 C--N 1.36 1.057 0 O-C-N 121.28 -0.888 . . . . 0.0 110.833 -176.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.473 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 36.3 t70 -70.53 -28.9 65.29 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 121.935 -0.478 . . . . 0.0 110.385 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.447 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -63.08 -39.01 97.51 Favored Glycine 0 C--N 1.358 1.793 0 N-CA-C 108.049 -2.02 . . . . 0.0 108.049 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . 0.612 ' HG ' HD21 ' A' ' 95' ' ' LEU . 48.1 t -60.95 -42.13 97.66 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -74.71 -0.36 17.85 Favored 'General case' 0 C--N 1.361 1.095 0 O-C-N 121.789 -0.57 . . . . 0.0 109.603 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 75.7 mm-40 -85.79 -45.8 11.26 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.013 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -65.61 -46.06 80.74 Favored 'General case' 0 C--N 1.361 1.082 0 C-N-CA 120.158 -0.617 . . . . 0.0 109.363 178.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . 0.566 ' HZ ' ' SD ' ' A' ' 89' ' ' MET . 37.5 m-85 -68.44 -27.85 66.54 Favored 'General case' 0 C--N 1.363 1.189 0 O-C-N 121.859 -0.525 . . . . 0.0 110.917 -178.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 85.4 tttt 74.44 73.94 0.11 Allowed 'General case' 0 C--N 1.36 1.041 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -178.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -142.84 -169.28 2.97 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -148.15 96.18 2.59 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 13.1 m-30 -113.24 155.55 24.88 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 178.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 92.2 m -119.32 128.16 53.87 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -178.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 3.7 mp -105.47 122.04 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 179.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.7 m -117.06 -174.41 2.58 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-O 121.913 0.863 . . . . 0.0 109.352 -178.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -146.08 155.48 42.8 Favored 'General case' 0 C--N 1.356 0.862 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 -177.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 47.3 p -100.28 146.6 32.25 Favored Pre-proline 0 C--N 1.359 0.997 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.668 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 75.0 Cg_endo -76.4 -11.46 19.0 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 123.056 2.504 . . . . 0.0 115.022 -178.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -72.34 -41.51 66.4 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 119.932 -0.707 . . . . 0.0 109.591 -178.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 37.9 p -116.76 15.59 15.36 Favored 'General case' 0 CA--C 1.505 -0.785 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.527 -178.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.668 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.3 pp0? -67.03 -12.18 59.15 Favored 'General case' 0 C--N 1.353 0.744 0 O-C-N 121.595 -0.691 . . . . 0.0 110.52 178.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -122.97 34.36 5.15 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 65.4 m -134.91 147.27 49.77 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.6 ' O ' ' HB ' ' A' ' 171' ' ' THR . 37.3 mt-10 -101.12 165.67 11.18 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.6 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 18.6 m 83.15 -60.52 0.14 Allowed 'General case' 0 C--N 1.37 1.467 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -107.37 117.31 33.75 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.623 -178.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 90.1 t -130.69 133.02 63.98 Favored 'Isoleucine or valine' 0 C--N 1.357 0.899 0 N-CA-C 106.924 -1.509 . . . . 0.0 106.924 178.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 49.6 mm -107.25 127.27 63.17 Favored 'Isoleucine or valine' 0 C--N 1.358 0.976 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -115.85 156.8 25.47 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 122.156 0.979 . . . . 0.0 108.513 -179.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -138.54 119.42 14.28 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -178.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.8 mp -113.55 118.54 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 -179.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.554 HG23 ' N ' ' A' ' 179' ' ' ARG . 91.4 m -122.84 142.38 50.82 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -177.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.554 ' N ' HG23 ' A' ' 178' ' ' THR . 72.0 ttt180 -101.03 118.94 37.99 Favored 'General case' 0 C--N 1.362 1.147 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 179.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -71.57 155.67 92.27 Favored Pre-proline 0 N--CA 1.442 -0.86 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 178.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -62.86 129.91 27.62 Favored 'Trans proline' 0 CA--C 1.49 -1.706 0 C-N-CA 121.552 1.502 . . . . 0.0 112.787 -179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -143.02 163.75 31.96 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -178.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 102.88 -25.57 26.98 Favored Glycine 0 C--N 1.349 1.286 0 N-CA-C 108.333 -1.907 . . . . 0.0 108.333 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -151.63 -100.86 0.06 Allowed 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 163.81 76.31 0.0 OUTLIER 'General case' 0 C--N 1.362 1.131 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -113.48 113.69 25.5 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 179.35 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.66 -65.97 0.97 Allowed 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . 0.42 ' HB3' ' H ' ' A' ' 189' ' ' PHE . 2.5 t80 -136.16 -83.48 0.38 Allowed 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . 0.42 ' H ' ' HB3' ' A' ' 188' ' ' TYR . 1.1 t80 -137.69 -69.64 0.45 Allowed 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 . . . . . 0 C--O 1.264 1.838 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.732 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' HEM . . . . . 1.296 ' C2B' HD12 ' A' ' 99' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.684 ' HG2' ' HG3' ' A' ' 4' ' ' MET . 27.7 tpp . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 120.986 0.422 . . . . 0.0 110.402 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' MET . . . . . 0.706 ' HA ' HG23 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -81.1 -14.49 57.7 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 -179.471 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.5 -42.96 38.99 Favored Glycine 0 C--N 1.35 1.333 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.684 ' HG3' ' HG2' ' A' ' 1' ' ' MET . 76.0 mtm -70.38 -34.78 72.98 Favored 'General case' 0 C--N 1.355 0.808 0 O-C-N 122.149 -0.618 . . . . 0.0 111.206 -178.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.706 HG23 ' HA ' ' A' ' 2' ' ' MET . 35.7 m -68.95 -23.34 27.19 Favored 'Isoleucine or valine' 0 C--N 1.358 0.946 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.314 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.462 ' HZ ' ' CG ' ' A' ' 47' ' ' GLU . 2.6 m-85 -72.22 -33.07 67.3 Favored 'General case' 0 C--N 1.357 0.922 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.1 m -67.01 -40.09 87.21 Favored 'General case' 0 C--N 1.355 0.846 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.54 -39.32 97.7 Favored Glycine 0 C--N 1.359 1.83 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.662 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -64.22 -40.66 96.51 Favored 'General case' 0 C--N 1.351 0.671 0 O-C-N 122.522 -0.399 . . . . 0.0 110.698 -178.795 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' MET . . . . . 0.523 ' HE3' HD22 ' A' ' 26' ' ' LEU . 20.5 mmt -63.43 -40.63 97.7 Favored 'General case' 0 C--N 1.352 0.708 0 O-C-N 121.72 -0.612 . . . . 0.0 110.832 -178.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -67.29 -40.5 86.09 Favored 'General case' 0 C--N 1.349 0.563 0 O-C-N 122.012 -0.43 . . . . 0.0 111.692 -178.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 54.9 tp -66.31 -42.93 87.57 Favored 'General case' 0 C--N 1.35 0.606 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -178.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.662 HG12 ' O ' ' A' ' 9' ' ' LEU . 2.6 mm -73.51 -37.1 49.63 Favored 'Isoleucine or valine' 0 C--N 1.36 1.032 0 O-C-N 121.142 -0.974 . . . . 0.0 110.861 -175.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -71.02 -42.35 69.68 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 121.659 -0.65 . . . . 0.0 111.73 -176.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -71.31 -37.57 71.79 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -175.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -100.66 -27.0 13.62 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 118.678 -1.209 . . . . 0.0 113.791 -174.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -111.56 -34.23 6.14 Favored 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 117.579 -1.648 . . . . 0.0 112.146 -176.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 142.11 178.41 18.15 Favored Glycine 0 C--N 1.348 1.216 0 C-N-CA 118.431 -1.842 . . . . 0.0 109.774 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 93.3 t80 -101.08 -26.19 13.78 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 -177.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -69.11 -39.72 78.77 Favored 'General case' 0 C--N 1.36 1.054 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.533 HG23 HG23 ' A' ' 58' ' ' VAL . 93.5 m -67.96 -38.54 82.89 Favored 'General case' 0 C--N 1.357 0.898 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 178.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.547 HD11 ' HB ' ' A' ' 13' ' ' ILE . 34.7 tp -59.53 -38.34 80.74 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -65.14 -37.11 86.38 Favored 'General case' 0 C--N 1.357 0.933 0 O-C-N 122.214 -0.304 . . . . 0.0 111.081 -178.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.45 HG22 ' O ' ' A' ' 24' ' ' THR . 89.3 m -64.45 -40.96 96.71 Favored 'General case' 0 C--N 1.355 0.834 0 O-C-N 121.636 -0.665 . . . . 0.0 109.774 -178.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.492 ' CD2' ' HB3' ' A' ' 54' ' ' LYS . 84.8 mt -64.48 -37.49 87.73 Favored 'General case' 0 C--N 1.356 0.861 0 O-C-N 121.892 -0.505 . . . . 0.0 109.744 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.523 HD22 ' HE3' ' A' ' 10' ' ' MET . 82.5 mt -67.68 -18.77 65.04 Favored 'General case' 0 C--N 1.357 0.922 0 O-C-N 121.426 -0.796 . . . . 0.0 109.629 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -85.74 -25.85 26.19 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.712 179.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.9 p -69.28 -24.45 63.96 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 119.856 -0.738 . . . . 0.0 109.304 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.4 p -106.96 -34.38 7.21 Favored 'General case' 0 C--N 1.357 0.898 0 C-N-CA 119.041 -1.064 . . . . 0.0 108.17 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 82.55 134.0 0.06 Allowed 'General case' 0 C--N 1.359 0.98 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.553 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -84.59 -169.82 2.81 Favored 'General case' 0 C--N 1.357 0.898 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.655 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -151.68 -25.25 0.19 Allowed 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.5 t -146.12 -73.18 0.23 Allowed 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -126.83 -38.73 2.02 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -179.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.35 -31.74 5.68 Favored Glycine 0 C--N 1.353 1.502 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 82.7 mt -112.5 99.98 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.52 ' CE2' ' HB ' ' A' ' 40' ' ' VAL . 3.0 t80 -70.84 -33.24 70.47 Favored 'General case' 0 C--N 1.357 0.916 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.501 ' HB ' ' O ' ' A' ' 37' ' ' TYR . 6.0 m 119.45 -70.07 0.0 OUTLIER 'General case' 0 C--N 1.369 1.456 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.633 ' C ' HG21 ' A' ' 40' ' ' VAL . 15.6 p 174.4 66.62 0.0 OUTLIER 'General case' 0 C--N 1.359 0.998 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.633 HG21 ' C ' ' A' ' 39' ' ' SER . 19.0 t -147.53 -11.52 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.878 0 C-N-CA 119.772 -0.771 . . . . 0.0 109.463 -178.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.53 146.01 18.07 Favored Glycine 0 C--N 1.352 1.461 0 C-N-CA 119.314 -1.422 . . . . 0.0 110.53 -177.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 52.7 m -122.25 125.74 46.69 Favored 'General case' 0 C--N 1.354 0.775 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 178.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -117.05 172.04 7.53 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 121.644 0.735 . . . . 0.0 109.058 -178.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -78.3 -176.15 4.54 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-O 121.662 0.744 . . . . 0.0 109.249 -179.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -85.56 -23.25 27.72 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -179.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -65.89 -28.88 69.28 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.462 ' CG ' ' HZ ' ' A' ' 6' ' ' PHE . 24.4 tp10 -62.95 -39.55 94.98 Favored 'General case' 0 C--N 1.352 0.717 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.678 HD13 HG22 ' A' ' 52' ' ' VAL . 1.9 tm? -67.67 -38.81 84.25 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.433 ' O ' HG21 ' A' ' 53' ' ' VAL . 61.8 tp -70.44 -34.31 72.31 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -177.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -65.15 -41.36 94.83 Favored 'General case' 0 N--CA 1.443 -0.799 0 O-C-N 122.041 -0.412 . . . . 0.0 110.227 -178.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.45 ' HA ' HD22 ' A' ' 51' ' ' LEU . 78.5 mt -81.86 -19.4 41.04 Favored 'General case' 0 C--N 1.357 0.934 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.384 -179.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.678 HG22 HD13 ' A' ' 48' ' ' LEU . 1.3 t -80.18 -37.23 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -179.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.498 ' O ' HG11 ' A' ' 53' ' ' VAL . 52.5 t -67.78 -40.85 84.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.492 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 25.0 tptt -66.66 -25.81 66.75 Favored 'General case' 0 C--N 1.364 1.219 0 O-C-N 121.07 -1.019 . . . . 0.0 108.895 -179.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.432 HD13 ' CD1' ' A' ' 66' ' ' LEU . 6.4 mt -67.11 -37.99 84.86 Favored 'General case' 0 C--N 1.355 0.807 0 C-N-CA 120.431 -0.507 . . . . 0.0 109.904 178.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.451 ' O ' ' HA ' ' A' ' 60' ' ' SER . 57.4 p -72.86 -17.81 61.5 Favored 'General case' 0 C--N 1.354 0.791 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.477 -179.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -99.3 -38.04 9.02 Favored 'General case' 0 C--N 1.354 0.777 0 O-C-N 121.321 -0.862 . . . . 0.0 111.497 -179.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.533 HG23 HG23 ' A' ' 21' ' ' THR . 4.8 p -72.91 -37.88 55.27 Favored 'Isoleucine or valine' 0 C--N 1.353 0.722 0 O-C-N 121.656 -0.653 . . . . 0.0 111.327 -177.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.0 t -115.4 -6.72 12.32 Favored 'General case' 0 C--N 1.352 0.717 0 C-N-CA 119.033 -1.067 . . . . 0.0 110.265 -178.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 56' ' ' SER . 74.5 m 64.78 44.16 3.82 Favored 'General case' 0 C--N 1.355 0.829 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.417 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 53.5 t -105.95 133.59 20.14 Favored Pre-proline 0 N--CA 1.444 -0.764 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 61' ' ' VAL . 45.0 Cg_exo -57.59 147.08 81.29 Favored 'Trans proline' 0 CA--C 1.498 -1.28 0 C-N-CA 122.538 2.159 . . . . 0.0 112.815 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.5 m -75.47 -12.13 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.919 -178.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 67.3 p -96.48 -32.42 12.31 Favored 'General case' 0 C--N 1.358 0.969 0 C-N-CA 118.289 -1.364 . . . . 0.0 109.489 -179.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -77.82 -22.89 49.34 Favored 'General case' 0 C--N 1.355 0.819 0 O-C-N 121.341 -0.849 . . . . 0.0 108.868 179.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.507 HD23 HG21 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -79.97 -37.36 34.52 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.196 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.564 HG12 ' N ' ' A' ' 68' ' ' ARG . 1.9 p -67.97 -26.66 35.15 Favored 'Isoleucine or valine' 0 C--N 1.355 0.828 0 C-N-CA 120.089 -0.644 . . . . 0.0 110.002 -179.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.564 ' N ' HG12 ' A' ' 67' ' ' VAL . 7.2 mmm-85 -72.16 -50.86 24.39 Favored 'General case' 0 C--N 1.363 1.159 0 O-C-N 121.519 -0.738 . . . . 0.0 110.354 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.416 ' HA ' HD23 ' A' ' 69' ' ' LEU . 83.9 mt -63.57 -36.0 82.35 Favored 'General case' 0 C--N 1.357 0.932 0 O-C-N 122.061 -0.399 . . . . 0.0 110.966 -178.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -60.8 -47.69 85.18 Favored 'General case' 0 C--N 1.35 0.608 0 O-C-N 122.221 -0.299 . . . . 0.0 110.64 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.54 95.75 Favored Glycine 0 C--N 1.354 1.554 0 N-CA-C 111.834 -0.506 . . . . 0.0 111.834 -178.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.65 -47.65 80.45 Favored 'General case' 0 C--N 1.349 0.568 0 CA-C-N 118.13 0.965 . . . . 0.0 111.548 -177.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 10.2 mttm -65.39 -48.39 73.02 Favored 'General case' 0 C--N 1.359 1.006 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -177.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . 0.441 HD21 ' O ' ' A' ' 74' ' ' LEU . 2.4 tm? -68.93 -39.37 79.63 Favored 'General case' 0 C--N 1.348 0.529 0 O-C-N 121.156 -0.965 . . . . 0.0 111.788 -175.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.863 ' CE1' ' HBB' ' A' ' 202' ' ' HEM . 38.3 t80 -63.81 -44.96 91.73 Favored 'General case' 0 C--N 1.354 0.779 0 O-C-N 121.084 -1.01 . . . . 0.0 111.032 -178.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.83 -13.86 17.08 Favored 'Isoleucine or valine' 0 C--N 1.359 0.98 0 O-C-N 121.548 -0.72 . . . . 0.0 109.084 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.412 ' HB2' ' O ' ' A' ' 74' ' ' LEU . 6.7 mm-40 -73.52 -38.06 65.44 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . 0.522 HD11 HBCA ' A' ' 202' ' ' HEM . 83.6 mt -74.47 -29.78 61.59 Favored 'General case' 0 C--N 1.357 0.928 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 46.5 mm -65.25 -52.94 46.29 Favored 'Isoleucine or valine' 0 C--N 1.358 0.977 0 C-N-CA 120.059 -0.656 . . . . 0.0 109.883 -177.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -75.36 -15.89 60.44 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.425 178.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.85 -37.26 65.72 Favored Glycine 0 C--N 1.349 1.27 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -131.88 106.21 13.97 Favored Pre-proline 0 N--CA 1.441 -0.923 0 CA-C-O 122.58 1.181 . . . . 0.0 109.37 -177.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -68.36 -25.35 36.14 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.581 2.187 . . . . 0.0 113.848 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -88.5 -9.1 53.55 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -89.51 -21.92 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 -178.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.26 -23.25 14.85 Favored 'General case' 0 C--N 1.36 1.049 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -70.2 -37.24 75.04 Favored 'General case' 0 C--N 1.358 0.959 0 O-C-N 121.845 -0.535 . . . . 0.0 109.845 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -64.28 -36.24 83.47 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.322 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.476 ' SD ' ' HB2' ' A' ' 95' ' ' LEU . 17.4 ttp -83.32 153.54 24.56 Favored 'General case' 0 C--N 1.351 0.67 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -178.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.46 -22.65 8.08 Favored 'General case' 0 C--N 1.365 1.276 0 O-C-N 121.627 -0.671 . . . . 0.0 111.138 -177.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -164.21 170.14 16.7 Favored 'General case' 0 CA--C 1.504 -0.802 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -177.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.499 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 64.9 m -66.05 -40.56 91.04 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.469 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 1.6 m-30 -68.42 -37.9 80.74 Favored 'General case' 0 C--N 1.354 0.788 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.135 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -66.22 -22.5 66.34 Favored 'General case' 0 C--N 1.357 0.935 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . 0.499 ' HB3' ' O ' ' A' ' 92' ' ' SER . 62.0 tp -64.42 -45.16 88.77 Favored 'General case' 0 C--N 1.357 0.919 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.049 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.5 mp -60.89 -35.76 77.47 Favored 'General case' 0 C--N 1.356 0.874 0 O-C-N 122.139 -0.351 . . . . 0.0 110.17 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.6 t -69.09 -39.9 78.72 Favored 'General case' 0 C--N 1.35 0.613 0 O-C-N 121.871 -0.518 . . . . 0.0 110.067 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.528 ' HZ3' ' HG3' ' A' ' 98' ' ' LYS . 0.2 OUTLIER -92.77 8.15 40.62 Favored 'General case' 0 C--N 1.354 0.766 0 O-C-N 122.163 -0.336 . . . . 0.0 111.359 -176.803 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.986 HD12 ' C2B' ' A' ' 202' ' ' HEM . 19.3 tt -63.32 -38.81 83.13 Favored 'Isoleucine or valine' 0 C--N 1.36 1.024 0 O-C-N 121.44 -0.787 . . . . 0.0 111.876 -176.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.597 ' N ' HG21 ' A' ' 99' ' ' ILE . 3.1 p-10 -108.51 -14.75 14.59 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 118.103 -1.439 . . . . 0.0 110.156 -178.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' SER . . . . . 0.573 ' O ' HG22 ' A' ' 105' ' ' VAL . 34.9 t -64.42 -46.09 84.73 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 120.253 -0.579 . . . . 0.0 111.07 -179.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -137.37 -15.09 1.46 Allowed 'General case' 0 C--N 1.359 1.016 0 C-N-CA 117.343 -1.743 . . . . 0.0 112.512 -177.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.593 HG21 ' C2C' ' A' ' 202' ' ' HEM . 26.5 mm -70.56 -51.74 34.83 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 CA-C-N 119.875 1.216 . . . . 0.0 110.468 -177.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 51.8 m170 -92.09 -1.05 57.41 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.203 -177.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.573 HG22 ' O ' ' A' ' 101' ' ' SER . 65.6 t -80.04 -44.6 22.71 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.026 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 178.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 54.8 tp10 -68.31 -40.76 81.59 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.1 t -62.66 -46.69 95.75 Favored 'Isoleucine or valine' 0 C--N 1.356 0.856 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.598 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -60.38 -48.24 82.61 Favored 'General case' 0 C--N 1.359 0.993 0 O-C-N 121.967 -0.458 . . . . 0.0 111.472 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -60.61 -36.55 78.87 Favored 'General case' 0 C--N 1.356 0.857 0 O-C-N 121.544 -0.722 . . . . 0.0 110.293 -178.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.4 mt -59.27 -77.16 0.04 OUTLIER 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' TYR . . . . . 0.438 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 82.7 m-85 -118.9 140.73 29.01 Favored Pre-proline 0 N--CA 1.438 -1.027 0 C-N-CA 118.663 -1.215 . . . . 0.0 109.053 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 111' ' ' TYR . 73.7 Cg_endo -87.0 -2.5 8.05 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 C-N-CA 123.129 2.553 . . . . 0.0 114.904 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -66.97 -36.52 82.38 Favored 'General case' 0 C--N 1.355 0.825 0 O-C-N 121.921 -0.487 . . . . 0.0 110.06 -179.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.959 ' HB1' ' HBD' ' A' ' 202' ' ' HEM . . . -66.82 147.11 53.68 Favored 'General case' 0 C--N 1.352 0.704 0 CA-C-O 121.525 0.679 . . . . 0.0 109.81 -178.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.427 ' O ' HD12 ' A' ' 116' ' ' LEU . 46.5 mt-10 -117.51 142.66 46.9 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 179.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.427 HD12 ' O ' ' A' ' 115' ' ' GLU . 2.7 mm? -127.12 149.29 69.06 Favored Pre-proline 0 C--N 1.352 0.695 0 CA-C-O 122.178 0.99 . . . . 0.0 108.73 -178.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.493 ' HD3' ' CGA' ' A' ' 202' ' ' HEM . 75.1 Cg_endo -89.65 -158.86 0.08 OUTLIER 'Trans proline' 0 C--N 1.316 -1.18 0 C-N-CA 123.75 2.967 . . . . 0.0 113.029 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -118.33 140.56 49.65 Favored 'General case' 0 C--N 1.362 1.128 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -126.55 129.36 48.44 Favored 'General case' 0 C--N 1.361 1.081 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -178.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' THR . . . . . 0.506 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 95.3 m -125.42 127.53 46.69 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 176.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 80.9 m -120.12 129.51 54.2 Favored 'General case' 0 CA--C 1.503 -0.855 0 C-N-CA 119.087 -1.045 . . . . 0.0 109.693 -177.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -120.74 117.48 27.59 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 178.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.607 ' HG3' ' CD1' ' A' ' 129' ' ' ILE . 12.9 ttm180 -92.8 113.81 26.19 Favored 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -179.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.573 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 87.1 mt -75.96 -38.99 56.93 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.074 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -166.21 -139.65 2.7 Favored Glycine 0 C--N 1.351 1.387 0 N-CA-C 109.231 -1.547 . . . . 0.0 109.231 -178.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -94.75 -41.09 9.43 Favored 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 120.134 -0.626 . . . . 0.0 109.452 -178.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 51.3 p-10 -101.28 4.48 41.76 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 120.049 -0.661 . . . . 0.0 109.956 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.573 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 67.3 m-20 -118.2 128.36 54.63 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.607 ' CD1' ' HG3' ' A' ' 123' ' ' ARG . 3.4 mm -139.42 132.33 36.92 Favored 'Isoleucine or valine' 0 C--N 1.355 0.823 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.457 ' N ' HG23 ' A' ' 129' ' ' ILE . 52.9 mtm180 -116.08 137.8 51.8 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 179.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.9 tp -127.5 118.83 24.76 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 115.328 -0.851 . . . . 0.0 108.829 -178.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.506 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 11.9 m170 -97.56 131.54 44.06 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 178.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -127.37 121.14 30.16 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 -178.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.522 ' HA ' ' O ' ' A' ' 171' ' ' THR . 28.6 tt0 -113.75 113.9 25.61 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.7 t -161.06 151.82 18.3 Favored 'General case' 0 C--N 1.359 0.982 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.417 ' C ' ' HD3' ' A' ' 138' ' ' PRO . 99.4 mttt -90.72 2.08 56.29 Favored 'General case' 0 C--N 1.355 0.838 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -179.155 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -132.99 74.54 73.69 Favored Pre-proline 0 CA--C 1.505 -0.787 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' PRO . . . . . 0.417 ' HD3' ' C ' ' A' ' 136' ' ' LYS . 90.2 Cg_endo -96.47 102.2 0.09 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.533 0 C-N-CA 122.743 2.296 . . . . 0.0 115.818 -177.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -110.76 114.07 27.15 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 105.971 -1.862 . . . . 0.0 105.971 176.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.88 -38.41 90.98 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.311 -178.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 74.5 m -64.01 -27.1 68.89 Favored 'General case' 0 C--N 1.354 0.777 0 O-C-N 121.864 -0.522 . . . . 0.0 110.7 -178.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -76.33 -47.08 24.77 Favored 'General case' 0 C--N 1.351 0.646 0 O-C-N 121.743 -0.598 . . . . 0.0 109.765 -177.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.67 -39.77 94.27 Favored 'General case' 0 C--N 1.356 0.885 0 O-C-N 122.183 -0.323 . . . . 0.0 111.256 -178.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.61 -37.71 88.38 Favored 'General case' 0 C--N 1.355 0.836 0 O-C-N 121.867 -0.521 . . . . 0.0 110.024 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.15 -43.17 98.63 Favored Glycine 0 C--N 1.347 1.188 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -179.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' LEU . . . . . 0.402 ' HA ' HD23 ' A' ' 146' ' ' LEU . 83.6 mt -70.44 -40.38 73.81 Favored 'General case' 0 C--N 1.352 0.682 0 CA-C-N 117.559 0.68 . . . . 0.0 112.649 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.434 ' HA ' HD23 ' A' ' 147' ' ' LEU . 98.4 mt -70.91 -42.47 69.89 Favored 'General case' 0 C--N 1.362 1.11 0 O-C-N 121.215 -0.928 . . . . 0.0 110.86 -176.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.577 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 37.2 t70 -71.5 -28.85 64.19 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 121.894 -0.504 . . . . 0.0 110.336 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -63.03 -39.64 98.31 Favored Glycine 0 C--N 1.357 1.719 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' CYS . . . . . 0.484 ' HG ' HD22 ' A' ' 95' ' ' LEU . 44.1 t -61.03 -41.06 95.86 Favored 'General case' 0 C--N 1.352 0.681 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -76.22 0.86 17.63 Favored 'General case' 0 C--N 1.361 1.071 0 CA-C-O 121.406 0.622 . . . . 0.0 109.403 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.577 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 76.8 mm-40 -86.37 -45.8 10.86 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -68.34 -43.67 76.99 Favored 'General case' 0 C--N 1.357 0.912 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.503 179.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -69.73 -27.9 65.35 Favored 'General case' 0 C--N 1.361 1.078 0 O-C-N 121.815 -0.553 . . . . 0.0 110.932 -178.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 85.1 tttt 71.56 69.22 0.16 Allowed 'General case' 0 C--N 1.362 1.114 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -177.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -134.57 -176.71 4.31 Favored 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -135.95 110.45 8.54 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -132.9 150.34 52.17 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 95.2 m -120.39 126.57 50.8 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 3.5 mp -101.86 121.31 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 179.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.7 m -116.32 -176.69 3.01 Favored 'General case' 0 C--N 1.361 1.082 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.746 ' HD2' ' HG3' ' A' ' 167' ' ' GLN . 8.8 ptt180 -148.95 158.17 43.97 Favored 'General case' 0 C--N 1.356 0.858 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 -179.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 65.5 p -104.75 145.01 29.89 Favored Pre-proline 0 C--N 1.359 1.017 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 179.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . 0.811 ' HA ' ' HB2' ' A' ' 167' ' ' GLN . 57.7 Cg_endo -75.36 -8.24 19.49 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 123.094 2.529 . . . . 0.0 115.521 -178.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -71.19 -41.31 70.45 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 34.1 p -117.77 16.12 14.41 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.811 ' HB2' ' HA ' ' A' ' 164' ' ' PRO . 45.1 tt0 -58.96 -38.67 79.6 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.87 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -111.71 48.69 0.94 Allowed 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 19.0 t -139.64 142.95 36.98 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.602 ' O ' ' HB ' ' A' ' 171' ' ' THR . 61.0 mt-10 -97.15 164.77 12.36 Favored 'General case' 0 C--N 1.356 0.86 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' THR . . . . . 0.602 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 3.1 m 80.81 -57.73 0.3 Allowed 'General case' 0 C--N 1.371 1.542 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -107.96 116.76 32.55 Favored 'General case' 0 CA--C 1.503 -0.83 0 C-N-CA 119.843 -0.743 . . . . 0.0 109.732 -178.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 86.3 t -130.26 131.86 65.35 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 178.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 50.5 mm -108.1 125.75 64.71 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -112.51 151.15 30.31 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-O 122.138 0.97 . . . . 0.0 108.551 -179.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -133.9 82.84 2.0 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.804 -178.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.1 mp -78.23 116.49 21.98 Favored 'Isoleucine or valine' 0 C--N 1.359 1.007 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 90.7 m -118.3 144.2 46.02 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -178.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -87.96 113.78 23.94 Favored 'General case' 0 C--N 1.36 1.035 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 -179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.444 ' HA ' ' HD3' ' A' ' 181' ' ' PRO . . . -62.81 143.86 96.83 Favored Pre-proline 0 CA--C 1.5 -0.979 0 CA-C-O 121.983 0.896 . . . . 0.0 108.85 -179.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 180' ' ' ALA . 53.2 Cg_exo -54.97 127.73 27.54 Favored 'Trans proline' 0 CA--C 1.497 -1.353 0 C-N-CA 122.85 2.367 . . . . 0.0 113.397 -179.381 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.37 148.13 51.82 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 73.46 -152.06 45.84 Favored Glycine 0 C--N 1.351 1.376 0 N-CA-C 107.102 -2.399 . . . . 0.0 107.102 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -86.89 -179.74 6.57 Favored 'General case' 0 N--CA 1.433 -1.275 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -75.51 176.65 7.37 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -150.58 161.65 42.16 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 -178.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -153.22 -86.88 0.06 Allowed 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -155.81 -80.1 0.08 Allowed 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -136.24 129.08 31.01 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 -179.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 . . . . . 0 C--O 1.264 1.855 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.968 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' HEM . . . . . 1.027 HMDB HBDA ' A' ' 202' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.4 mmm . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 120.822 0.344 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.09 -25.39 47.58 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -178.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.45 -39.4 50.6 Favored Glycine 0 C--N 1.351 1.392 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.0 tpp -69.78 -38.07 76.57 Favored 'General case' 0 C--N 1.357 0.914 0 O-C-N 121.911 -0.758 . . . . 0.0 111.081 -177.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.8 m -69.26 -22.63 25.98 Favored 'Isoleucine or valine' 0 C--N 1.356 0.89 0 O-C-N 121.504 -0.748 . . . . 0.0 109.51 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -70.22 -36.76 74.75 Favored 'General case' 0 C--N 1.359 0.989 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 87.8 m -66.56 -40.91 89.26 Favored 'General case' 0 C--N 1.357 0.911 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.64 -38.9 97.18 Favored Glycine 0 C--N 1.357 1.71 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.628 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -65.55 -40.31 92.72 Favored 'General case' 0 C--N 1.351 0.673 0 CA-C-N 117.207 0.503 . . . . 0.0 110.739 -178.205 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 20.7 mmt -63.75 -41.44 98.0 Favored 'General case' 0 C--N 1.355 0.819 0 O-C-N 121.419 -0.801 . . . . 0.0 111.207 -178.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -66.82 -40.36 88.02 Favored 'General case' 0 C--N 1.348 0.518 0 O-C-N 122.011 -0.431 . . . . 0.0 111.691 -177.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 55.7 tp -66.08 -43.29 87.77 Favored 'General case' 0 C--N 1.349 0.573 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -177.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.628 HG12 ' O ' ' A' ' 9' ' ' LEU . 1.7 mm -73.18 -36.57 50.34 Favored 'Isoleucine or valine' 0 C--N 1.36 1.029 0 O-C-N 121.076 -1.015 . . . . 0.0 111.14 -175.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -70.66 -42.57 70.62 Favored 'General case' 0 C--N 1.35 0.612 0 O-C-N 121.505 -0.747 . . . . 0.0 111.746 -176.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -72.01 -38.33 69.62 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -175.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -102.75 -23.97 13.76 Favored 'General case' 0 CA--C 1.509 -0.612 0 C-N-CA 118.524 -1.27 . . . . 0.0 113.655 -174.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 13.8 m-30 -108.2 -37.43 6.03 Favored 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 117.994 -1.482 . . . . 0.0 111.531 -176.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 143.37 178.11 18.89 Favored Glycine 0 C--N 1.347 1.173 0 C-N-CA 118.842 -1.646 . . . . 0.0 109.214 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -102.19 -26.93 13.16 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 -177.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -70.48 -38.92 74.47 Favored 'General case' 0 C--N 1.36 1.061 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.6 m -67.31 -38.48 85.02 Favored 'General case' 0 C--N 1.359 0.995 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 35.2 tp -60.57 -38.81 85.81 Favored 'General case' 0 C--N 1.356 0.859 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -63.77 -37.91 89.15 Favored 'General case' 0 C--N 1.358 0.96 0 O-C-N 122.122 -0.361 . . . . 0.0 111.485 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 87.1 m -65.42 -38.86 91.19 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.699 HD13 HD22 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -62.34 -39.36 92.84 Favored 'General case' 0 C--N 1.354 0.768 0 CA-C-O 120.958 0.408 . . . . 0.0 109.988 -179.046 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 85.7 mt -73.09 -15.27 61.5 Favored 'General case' 0 C--N 1.359 0.987 0 O-C-N 121.7 -0.625 . . . . 0.0 110.518 -178.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -86.13 -27.89 24.35 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 119.2 -1.0 . . . . 0.0 109.429 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.6 t -67.0 -36.47 82.25 Favored 'General case' 0 C--N 1.354 0.804 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.625 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 1.7 p -93.65 -37.97 11.57 Favored 'General case' 0 C--N 1.357 0.931 0 C-N-CA 118.781 -1.168 . . . . 0.0 108.12 -179.12 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.625 ' HB2' ' O ' ' A' ' 29' ' ' CYS . 13.7 mt-10 84.65 133.18 0.05 OUTLIER 'General case' 0 C--N 1.36 1.026 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.514 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -86.08 -169.12 2.5 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.874 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -152.91 -28.21 0.15 Allowed 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.7 t -141.85 -71.21 0.34 Allowed 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -178.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -130.6 -45.71 1.07 Allowed 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 125.7 -32.65 3.8 Favored Glycine 0 C--N 1.352 1.452 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 84.8 mt -113.3 102.84 14.49 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.806 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -97.23 -2.3 43.05 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.731 HG22 ' H ' ' A' ' 39' ' ' SER . 3.9 m 79.42 174.68 0.14 Allowed 'General case' 0 C--N 1.362 1.135 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 -178.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.731 ' H ' HG22 ' A' ' 38' ' ' THR . 31.8 p -87.96 113.91 24.07 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 121.115 -0.99 . . . . 0.0 109.561 -178.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.481 HG13 ' O ' ' A' ' 39' ' ' SER . 0.0 OUTLIER -173.31 -9.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.362 1.146 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.946 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -115.25 166.17 12.17 Favored Glycine 0 C--N 1.356 1.671 0 N-CA-C 109.211 -1.555 . . . . 0.0 109.211 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.3 m -130.1 130.36 44.74 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -117.3 172.33 7.37 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -70.68 172.91 7.86 Favored 'General case' 0 C--N 1.356 0.879 0 CA-C-O 121.762 0.791 . . . . 0.0 109.58 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -81.4 -25.99 35.79 Favored 'General case' 0 C--N 1.356 0.85 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -64.52 -28.19 69.48 Favored 'General case' 0 C--N 1.354 0.779 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -61.79 -42.34 98.87 Favored 'General case' 0 C--N 1.353 0.725 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.456 ' O ' HG23 ' A' ' 52' ' ' VAL . 62.6 tp -67.04 -40.0 87.06 Favored 'General case' 0 C--N 1.355 0.811 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.439 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 59.0 tp -72.15 -33.51 67.79 Favored 'General case' 0 C--N 1.35 0.611 0 O-C-N 122.14 -0.35 . . . . 0.0 110.68 -177.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -64.73 -42.78 94.97 Favored 'General case' 0 N--CA 1.445 -0.688 0 O-C-N 121.66 -0.65 . . . . 0.0 109.852 -177.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.699 HD22 HD13 ' A' ' 25' ' ' LEU . 77.6 mt -72.76 -33.83 66.6 Favored 'General case' 0 C--N 1.361 1.08 0 C-N-CA 119.762 -0.775 . . . . 0.0 109.753 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 48' ' ' LEU . 35.8 t -63.03 -42.3 96.12 Favored 'Isoleucine or valine' 0 C--N 1.35 0.605 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.7 t -66.1 -39.71 85.19 Favored 'Isoleucine or valine' 0 C--N 1.351 0.663 0 O-C-N 121.795 -0.565 . . . . 0.0 109.515 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.485 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 34.9 tptt -63.54 -28.64 70.08 Favored 'General case' 0 C--N 1.361 1.099 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.523 HD21 HD12 ' A' ' 13' ' ' ILE . 16.8 mt -66.51 -38.77 87.93 Favored 'General case' 0 C--N 1.355 0.847 0 O-C-N 121.996 -0.44 . . . . 0.0 110.459 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.7 p -72.13 -17.47 61.96 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.76 -178.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -101.57 -38.43 7.95 Favored 'General case' 0 C--N 1.354 0.769 0 C-N-CA 119.369 -0.932 . . . . 0.0 111.651 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.7 p -72.3 -38.27 61.09 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 O-C-N 121.616 -0.678 . . . . 0.0 111.24 -177.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.589 ' HB3' HG23 ' A' ' 61' ' ' VAL . 1.9 t -113.21 -7.71 13.57 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 118.948 -1.101 . . . . 0.0 110.406 -178.262 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 64.86 49.56 2.15 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.589 HG23 ' HB3' ' A' ' 59' ' ' SER . 58.7 t -113.07 133.39 22.04 Favored Pre-proline 0 N--CA 1.443 -0.79 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 61' ' ' VAL . 39.3 Cg_exo -58.14 147.36 83.84 Favored 'Trans proline' 0 CA--C 1.499 -1.259 0 C-N-CA 122.562 2.175 . . . . 0.0 112.631 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.7 m -75.65 -11.52 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.922 -178.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 68.3 p -95.88 -32.97 12.39 Favored 'General case' 0 C--N 1.358 0.96 0 C-N-CA 118.183 -1.407 . . . . 0.0 109.468 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -77.52 -22.72 50.73 Favored 'General case' 0 C--N 1.355 0.814 0 O-C-N 121.488 -0.758 . . . . 0.0 109.138 179.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.76 -35.61 38.46 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -69.93 -28.4 36.46 Favored 'Isoleucine or valine' 0 C--N 1.357 0.9 0 C-N-CA 119.932 -0.707 . . . . 0.0 110.049 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 63.2 mtp180 -70.45 -50.12 41.55 Favored 'General case' 0 C--N 1.362 1.15 0 O-C-N 121.398 -0.814 . . . . 0.0 110.533 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.68 -35.96 81.36 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 122.246 -0.284 . . . . 0.0 110.91 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -61.1 -47.44 86.26 Favored 'General case' 0 C--N 1.348 0.512 0 O-C-N 122.229 -0.294 . . . . 0.0 110.498 -178.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.85 -39.59 97.06 Favored Glycine 0 C--N 1.355 1.616 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 -178.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.0 -48.97 76.53 Favored 'General case' 0 C--N 1.352 0.694 0 CA-C-N 118.363 1.081 . . . . 0.0 111.635 -177.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.698 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 10.0 mttm -63.17 -48.38 78.65 Favored 'General case' 0 C--N 1.359 0.987 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -177.325 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.414 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.5 tm? -68.77 -39.07 80.42 Favored 'General case' 0 C--N 1.348 0.533 0 O-C-N 121.198 -0.939 . . . . 0.0 111.777 -175.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.413 ' CE2' ' HA ' ' A' ' 150' ' ' CYS . 48.0 t80 -62.84 -45.96 90.13 Favored 'General case' 0 C--N 1.353 0.761 0 O-C-N 121.152 -0.968 . . . . 0.0 111.286 -178.11 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 8.5 p -70.08 -15.08 18.89 Favored 'Isoleucine or valine' 0 C--N 1.359 0.993 0 O-C-N 121.377 -0.827 . . . . 0.0 109.392 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.698 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 75.2 mm-40 -71.07 -38.93 72.47 Favored 'General case' 0 C--N 1.352 0.702 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 81.7 mt -72.17 -33.12 67.45 Favored 'General case' 0 C--N 1.356 0.873 0 O-C-N 122.432 -0.168 . . . . 0.0 110.739 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 47.3 mm -64.48 -54.05 35.36 Favored 'Isoleucine or valine' 0 C--N 1.358 0.943 0 C-N-CA 120.126 -0.63 . . . . 0.0 110.396 -177.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -75.33 -14.37 60.48 Favored 'General case' 0 C--N 1.351 0.673 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.45 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.09 -36.78 64.11 Favored Glycine 0 C--N 1.347 1.192 0 N-CA-C 110.969 -0.853 . . . . 0.0 110.969 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -134.18 106.81 11.28 Favored Pre-proline 0 C--N 1.357 0.894 0 CA-C-O 122.68 1.229 . . . . 0.0 109.189 -176.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.526 ' O ' ' HB2' ' A' ' 87' ' ' ASN . 39.3 Cg_endo -68.97 -23.3 34.57 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.675 2.25 . . . . 0.0 114.239 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -90.55 -8.71 49.56 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 tp -90.31 -21.25 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 -178.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -104.11 -14.74 15.78 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.526 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 20.1 t30 -73.3 -41.02 64.06 Favored 'General case' 0 C--N 1.359 1.012 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -68.1 -28.4 67.3 Favored 'General case' 0 C--N 1.352 0.716 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.552 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 25.9 ttp -84.86 148.55 26.22 Favored 'General case' 0 C--N 1.351 0.636 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.13 -21.63 8.14 Favored 'General case' 0 C--N 1.364 1.216 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.984 -177.38 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -164.22 171.18 15.31 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -177.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.443 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 86.6 p -70.22 -34.0 72.37 Favored 'General case' 0 C--N 1.354 0.776 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.197 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -70.04 -38.46 75.84 Favored 'General case' 0 C--N 1.357 0.922 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -66.14 -24.67 66.71 Favored 'General case' 0 C--N 1.358 0.952 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.443 ' HB3' ' O ' ' A' ' 92' ' ' SER . 61.3 tp -62.63 -46.63 87.34 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.2 mp -62.76 -32.6 73.78 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 122.246 -0.284 . . . . 0.0 110.302 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 35.8 t -62.73 -45.58 92.07 Favored 'General case' 0 C--N 1.356 0.864 0 O-C-N 121.688 -0.632 . . . . 0.0 111.597 -178.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.08 25.87 10.99 Favored 'General case' 0 C--N 1.361 1.071 0 O-C-N 121.057 -1.027 . . . . 0.0 110.453 -178.015 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.3 tt -64.26 -29.66 47.94 Favored 'Isoleucine or valine' 0 C--N 1.352 0.689 0 C-N-CA 120.341 -0.543 . . . . 0.0 110.507 -179.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -120.19 -18.59 7.99 Favored 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 119.336 -0.946 . . . . 0.0 109.115 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 35.5 t -66.06 -45.98 79.42 Favored 'General case' 0 N--CA 1.443 -0.785 0 O-C-N 121.841 -0.537 . . . . 0.0 110.85 -178.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.552 ' O ' HG12 ' A' ' 105' ' ' VAL . 30.8 t80 -124.97 -31.21 3.15 Favored 'General case' 0 C--N 1.359 0.99 0 C-N-CA 118.23 -1.388 . . . . 0.0 111.992 -177.508 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 96.3 mt -67.52 -47.27 81.09 Favored 'Isoleucine or valine' 0 C--N 1.352 0.704 0 O-C-N 121.034 -1.041 . . . . 0.0 110.687 -177.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 17.5 m170 -87.72 3.16 49.06 Favored 'General case' 0 N--CA 1.441 -0.913 0 O-C-N 121.252 -0.905 . . . . 0.0 110.15 -177.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.552 HG12 ' O ' ' A' ' 102' ' ' PHE . 1.8 p -87.39 -34.15 7.26 Favored 'Isoleucine or valine' 0 C--N 1.356 0.872 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 178.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -71.86 -40.26 69.1 Favored 'General case' 0 C--N 1.359 0.997 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 62.4 t -62.81 -47.37 93.19 Favored 'Isoleucine or valine' 0 C--N 1.356 0.87 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.517 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -60.55 -48.25 82.62 Favored 'General case' 0 C--N 1.359 0.979 0 O-C-N 122.115 -0.366 . . . . 0.0 111.364 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -61.96 -37.57 85.27 Favored 'General case' 0 C--N 1.354 0.786 0 O-C-N 121.533 -0.729 . . . . 0.0 110.708 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.8 mt -57.47 -74.96 0.05 OUTLIER 'General case' 0 C--N 1.356 0.851 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -114.54 135.52 22.3 Favored Pre-proline 0 N--CA 1.441 -0.921 0 C-N-CA 118.656 -1.218 . . . . 0.0 109.146 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -84.66 -5.91 9.87 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 123.133 2.555 . . . . 0.0 115.055 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -66.96 -36.58 82.53 Favored 'General case' 0 C--N 1.355 0.808 0 O-C-N 122.009 -0.432 . . . . 0.0 110.073 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.71 145.21 56.29 Favored 'General case' 0 C--N 1.355 0.807 0 CA-C-O 121.683 0.754 . . . . 0.0 110.139 -178.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -131.09 135.64 47.69 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.467 ' HB3' ' HD2' ' A' ' 117' ' ' PRO . 91.6 mt -127.9 155.73 77.11 Favored Pre-proline 0 N--CA 1.443 -0.791 0 CA-C-O 122.173 0.987 . . . . 0.0 109.246 -178.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' A' ' 116' ' ' LEU . 84.6 Cg_endo -81.89 -151.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.081 0 C-N-CA 123.736 2.957 . . . . 0.0 113.895 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -115.52 146.42 41.72 Favored 'General case' 0 C--N 1.362 1.126 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.629 ' CE1' HD13 ' A' ' 131' ' ' LEU . 14.1 t80 -140.6 125.57 18.34 Favored 'General case' 0 C--N 1.362 1.144 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -177.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 93.3 m -125.83 134.06 51.78 Favored 'General case' 0 C--N 1.36 1.038 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 79.0 m -113.36 131.19 56.07 Favored 'General case' 0 C--N 1.356 0.872 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.772 -178.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -117.69 141.77 48.01 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 177.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -117.75 116.57 27.28 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.528 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 87.6 mt -84.49 -25.75 28.63 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 120.686 -0.406 . . . . 0.0 109.994 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 179.2 -144.26 6.11 Favored Glycine 0 C--N 1.349 1.251 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -94.68 -40.88 9.57 Favored 'General case' 0 N--CA 1.436 -1.137 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.567 -178.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -99.17 2.31 45.72 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.614 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.528 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 8.4 m-20 -121.72 131.63 54.18 Favored 'General case' 0 C--N 1.358 0.961 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.5 mm -140.91 137.43 34.7 Favored 'Isoleucine or valine' 0 C--N 1.354 0.797 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 61.9 mtm180 -123.78 140.35 53.08 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 1.038 HD23 HD11 ' A' ' 177' ' ' ILE . 1.1 pp -127.79 129.43 47.01 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -99.49 133.96 43.06 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -129.67 120.32 24.99 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -178.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.578 ' HA ' ' O ' ' A' ' 171' ' ' THR . 74.2 mt-30 -114.25 115.08 26.85 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 18.1 t -161.69 152.01 17.32 Favored 'General case' 0 C--N 1.359 0.991 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -92.02 2.22 56.7 Favored 'General case' 0 C--N 1.358 0.939 0 C-N-CA 120.15 -0.62 . . . . 0.0 109.937 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -134.4 73.03 69.62 Favored Pre-proline 0 C--N 1.355 0.81 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -96.19 110.01 0.12 Allowed 'Trans proline' 0 N--CA 1.445 -1.368 0 C-N-CA 122.714 2.276 . . . . 0.0 116.079 -177.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -113.64 113.93 25.73 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 176.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.08 -38.7 92.0 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.264 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.3 m -62.41 -27.07 68.84 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 121.871 -0.518 . . . . 0.0 110.731 -178.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -76.02 -47.94 22.89 Favored 'General case' 0 C--N 1.351 0.64 0 C-N-CA 120.196 -0.602 . . . . 0.0 109.702 -178.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.68 -40.17 94.93 Favored 'General case' 0 C--N 1.358 0.949 0 O-C-N 122.17 -0.331 . . . . 0.0 111.269 -178.115 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -62.82 -36.54 83.52 Favored 'General case' 0 C--N 1.355 0.818 0 O-C-N 121.92 -0.487 . . . . 0.0 110.088 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.3 -42.81 98.94 Favored Glycine 0 C--N 1.347 1.171 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.0 mt -69.75 -40.93 75.86 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 96.0 mt -71.69 -42.34 67.55 Favored 'General case' 0 C--N 1.363 1.168 0 O-C-N 121.091 -1.006 . . . . 0.0 111.086 -176.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.506 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 37.2 t70 -69.3 -31.78 70.49 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 121.887 -0.508 . . . . 0.0 110.484 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -62.66 -39.26 97.69 Favored Glycine 0 C--N 1.356 1.658 0 N-CA-C 108.62 -1.792 . . . . 0.0 108.62 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.413 ' HA ' ' CE2' ' A' ' 75' ' ' PHE . 42.8 t -60.42 -42.55 96.27 Favored 'General case' 0 C--N 1.35 0.625 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -74.55 -1.6 22.14 Favored 'General case' 0 C--N 1.36 1.058 0 O-C-N 121.72 -0.612 . . . . 0.0 109.458 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.506 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 77.7 mm-40 -83.56 -46.9 11.89 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.22 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -65.87 -45.04 83.59 Favored 'General case' 0 C--N 1.36 1.036 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -68.96 -26.15 64.91 Favored 'General case' 0 C--N 1.362 1.126 0 O-C-N 121.75 -0.594 . . . . 0.0 110.796 -178.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 86.2 tttt 72.73 75.92 0.15 Allowed 'General case' 0 C--N 1.359 0.989 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -143.7 -168.28 2.8 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -152.24 92.99 1.76 Allowed 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 16.3 m-30 -112.38 161.93 16.13 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 93.7 m -118.5 125.95 50.97 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 119.293 -0.963 . . . . 0.0 109.234 -177.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.5 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.6 mp -104.61 122.33 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 178.169 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.6 m -120.52 -171.3 2.15 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-O 121.665 0.745 . . . . 0.0 109.241 -178.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.49 ' HD2' ' HG3' ' A' ' 167' ' ' GLN . 5.9 ptt85 -152.0 161.6 42.39 Favored 'General case' 0 C--N 1.357 0.897 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 56.8 p -107.95 143.9 28.28 Favored Pre-proline 0 C--N 1.36 1.049 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.878 ' HA ' ' HB2' ' A' ' 167' ' ' GLN . 56.7 Cg_endo -75.15 -7.86 19.4 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 123.204 2.603 . . . . 0.0 115.578 -178.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -71.6 -41.42 68.96 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 36.5 p -116.89 16.03 15.2 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.878 ' HB2' ' HA ' ' A' ' 164' ' ' PRO . 37.6 tt0 -58.38 -39.02 78.5 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.323 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -113.23 49.04 0.98 Allowed 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 20.7 t -139.11 142.24 38.09 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.618 ' O ' ' HB ' ' A' ' 171' ' ' THR . 61.8 mt-10 -96.52 163.7 12.93 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.618 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 18.6 m 84.12 -56.71 0.13 Allowed 'General case' 0 C--N 1.369 1.418 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.657 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -110.79 118.8 37.13 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.924 -178.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 99.6 t -132.01 133.4 60.83 Favored 'Isoleucine or valine' 0 C--N 1.358 0.963 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 49.2 mm -112.03 125.84 69.36 Favored 'Isoleucine or valine' 0 C--N 1.36 1.03 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.576 ' HB2' ' HG ' ' A' ' 131' ' ' LEU . 96.8 m-85 -116.07 148.75 39.91 Favored 'General case' 0 C--N 1.359 0.996 0 CA-C-O 121.901 0.857 . . . . 0.0 109.063 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -126.55 119.87 28.2 Favored 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 1.038 HD11 HD23 ' A' ' 131' ' ' LEU . 4.0 mp -115.42 121.58 67.52 Favored 'Isoleucine or valine' 0 C--N 1.354 0.795 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 38.0 p -126.11 159.55 32.55 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 121.429 0.633 . . . . 0.0 110.811 -178.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 77.3 mtm180 . . . . . 0 C--N 1.367 1.365 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 177.392 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.7 mtp . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.089 0.471 . . . . 0.0 110.228 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.39 -17.86 55.85 Favored 'General case' 0 C--N 1.355 0.839 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -178.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -76.33 -41.12 26.72 Favored Glycine 0 C--N 1.349 1.256 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 14.5 tpp -69.12 -38.68 79.02 Favored 'General case' 0 C--N 1.355 0.827 0 O-C-N 121.946 -0.738 . . . . 0.0 110.612 -177.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.5 m -68.25 -22.83 27.85 Favored 'Isoleucine or valine' 0 C--N 1.357 0.903 0 C-N-CA 120.27 -0.572 . . . . 0.0 109.617 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -70.57 -35.58 73.15 Favored 'General case' 0 C--N 1.356 0.876 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 85.5 m -67.15 -40.85 86.77 Favored 'General case' 0 C--N 1.355 0.814 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.43 -39.39 97.73 Favored Glycine 0 C--N 1.359 1.814 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.583 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -64.62 -39.6 93.99 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-N 117.131 0.465 . . . . 0.0 110.711 -178.481 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.438 ' SD ' HD11 ' A' ' 26' ' ' LEU . 25.8 mmt -63.43 -40.44 97.18 Favored 'General case' 0 C--N 1.352 0.684 0 O-C-N 121.679 -0.638 . . . . 0.0 110.984 -178.361 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -66.88 -40.22 87.75 Favored 'General case' 0 C--N 1.349 0.571 0 O-C-N 121.956 -0.465 . . . . 0.0 111.362 -177.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 53.7 tp -66.42 -42.83 87.2 Favored 'General case' 0 C--N 1.35 0.588 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -178.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.583 HG12 ' O ' ' A' ' 9' ' ' LEU . 1.4 mm -74.99 -36.76 39.52 Favored 'Isoleucine or valine' 0 C--N 1.359 1.008 0 O-C-N 120.988 -1.07 . . . . 0.0 111.002 -175.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -68.18 -43.66 77.65 Favored 'General case' 0 C--N 1.353 0.729 0 O-C-N 121.723 -0.611 . . . . 0.0 111.555 -176.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -71.22 -35.27 71.43 Favored 'General case' 0 N--CA 1.446 -0.634 0 O-C-N 121.974 -0.454 . . . . 0.0 111.909 -176.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -72.69 -48.56 38.02 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -175.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -126.41 -20.9 4.3 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 117.349 -1.741 . . . . 0.0 113.816 -176.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 141.36 179.6 18.7 Favored Glycine 0 CA--C 1.497 -1.078 0 C-N-CA 117.789 -2.148 . . . . 0.0 109.884 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -97.16 -12.26 23.29 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -177.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -70.64 -41.08 72.65 Favored 'General case' 0 C--N 1.36 1.05 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 94.5 m -69.51 -39.05 77.79 Favored 'General case' 0 C--N 1.357 0.932 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.463 HD13 ' HB ' ' A' ' 13' ' ' ILE . 59.1 tp -61.17 -37.99 84.87 Favored 'General case' 0 C--N 1.357 0.905 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -65.17 -35.71 81.94 Favored 'General case' 0 C--N 1.356 0.851 0 O-C-N 122.177 -0.327 . . . . 0.0 110.802 -178.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.5 m -63.71 -40.74 97.53 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.435 ' CD2' ' HB3' ' A' ' 54' ' ' LYS . 87.6 mt -64.87 -37.97 89.4 Favored 'General case' 0 C--N 1.356 0.874 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.444 HD23 ' CD2' ' A' ' 31' ' ' LEU . 6.7 mp -69.39 -14.8 63.1 Favored 'General case' 0 C--N 1.357 0.922 0 O-C-N 121.415 -0.803 . . . . 0.0 109.802 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -85.84 -28.38 24.47 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.224 178.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 55.0 p -68.18 -23.11 64.82 Favored 'General case' 0 C--N 1.361 1.066 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.3 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.0 p -106.96 -33.6 7.45 Favored 'General case' 0 C--N 1.357 0.912 0 C-N-CA 118.933 -1.107 . . . . 0.0 108.141 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 83.63 132.56 0.05 OUTLIER 'General case' 0 C--N 1.361 1.106 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.457 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -100.53 109.63 21.75 Favored 'General case' 0 C--N 1.357 0.896 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.737 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -72.23 -40.71 67.55 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 178.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.43 ' HB3' ' H ' ' A' ' 34' ' ' GLU . 0.9 OUTLIER -116.09 -86.22 0.62 Allowed 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -179.212 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.43 ' H ' ' HB3' ' A' ' 33' ' ' SER . 57.4 mt-10 -122.14 -40.88 2.46 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -178.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.62 -32.79 6.33 Favored Glycine 0 C--N 1.351 1.365 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 80.4 mt -109.89 104.15 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.005 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.509 ' HD1' ' HA ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -82.89 -143.44 0.06 Allowed 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.337 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 86.2 m -109.82 -56.89 2.26 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.5 p 166.03 16.57 0.0 OUTLIER 'General case' 0 C--N 1.363 1.161 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 23.3 m -109.79 6.48 8.97 Favored 'Isoleucine or valine' 0 C--N 1.353 0.738 0 C-N-CA 119.522 -0.871 . . . . 0.0 111.313 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -91.75 143.67 16.71 Favored Glycine 0 C--N 1.354 1.533 0 C-N-CA 119.223 -1.465 . . . . 0.0 109.505 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 57.0 m -126.61 130.19 50.0 Favored 'General case' 0 C--N 1.356 0.871 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -125.27 174.52 8.06 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -76.07 -179.0 4.69 Favored 'General case' 0 C--N 1.356 0.864 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -86.44 -19.87 28.98 Favored 'General case' 0 C--N 1.356 0.876 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.744 ' HA ' HD23 ' A' ' 49' ' ' LEU . 38.1 tt0 -63.98 -35.5 80.9 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.0 tp10 -61.59 -40.55 95.21 Favored 'General case' 0 C--N 1.349 0.572 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 60.4 tp -65.38 -40.29 93.32 Favored 'General case' 0 C--N 1.357 0.896 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.691 -178.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.744 HD23 ' HA ' ' A' ' 46' ' ' GLN . 0.1 OUTLIER -83.45 -14.57 52.23 Favored 'General case' 0 C--N 1.352 0.71 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.131 -177.226 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -71.62 -43.57 65.95 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.8 mt -73.24 -34.93 66.14 Favored 'General case' 0 C--N 1.361 1.083 0 C-N-CA 120.17 -0.612 . . . . 0.0 109.704 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 50.3 t -63.91 -41.41 92.42 Favored 'Isoleucine or valine' 0 C--N 1.352 0.697 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 49' ' ' LEU . 52.9 t -65.84 -40.74 88.46 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 O-C-N 121.761 -0.587 . . . . 0.0 109.962 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.435 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 24.6 tptt -67.65 -20.29 65.3 Favored 'General case' 0 C--N 1.36 1.054 0 O-C-N 120.939 -1.101 . . . . 0.0 108.863 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.83 -37.47 70.3 Favored 'General case' 0 C--N 1.353 0.745 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.471 ' O ' ' HA ' ' A' ' 60' ' ' SER . 81.2 p -73.04 -17.32 61.45 Favored 'General case' 0 C--N 1.356 0.852 0 O-C-N 121.766 -0.584 . . . . 0.0 110.285 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -99.51 -37.56 9.13 Favored 'General case' 0 C--N 1.355 0.805 0 O-C-N 121.305 -0.872 . . . . 0.0 111.325 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.1 p -71.85 -34.7 52.24 Favored 'Isoleucine or valine' 0 C--N 1.353 0.723 0 O-C-N 121.709 -0.619 . . . . 0.0 111.52 -177.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.559 ' HB3' HG23 ' A' ' 61' ' ' VAL . 4.3 t -119.99 -8.74 9.75 Favored 'General case' 0 CA--C 1.508 -0.671 0 C-N-CA 119.26 -0.976 . . . . 0.0 109.849 -178.045 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.471 ' HA ' ' O ' ' A' ' 56' ' ' SER . 0.6 OUTLIER 66.65 47.78 1.54 Allowed 'General case' 0 C--N 1.353 0.737 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 179.61 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.559 HG23 ' HB3' ' A' ' 59' ' ' SER . 47.6 t -107.44 133.35 20.41 Favored Pre-proline 0 CA--C 1.505 -0.773 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.408 ' O ' ' HB3' ' A' ' 66' ' ' LEU . 41.9 Cg_exo -57.38 147.21 78.89 Favored 'Trans proline' 0 CA--C 1.498 -1.3 0 C-N-CA 122.505 2.137 . . . . 0.0 112.794 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.4 m -75.9 -13.61 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.826 -178.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.425 ' O ' HG12 ' A' ' 67' ' ' VAL . 69.0 p -97.54 -32.77 11.64 Favored 'General case' 0 C--N 1.36 1.055 0 C-N-CA 118.176 -1.41 . . . . 0.0 109.533 -178.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -76.6 -21.47 55.52 Favored 'General case' 0 C--N 1.354 0.776 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.408 ' HB3' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -82.05 -35.57 28.6 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.139 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.425 HG12 ' O ' ' A' ' 64' ' ' THR . 1.3 p -68.92 -26.43 32.52 Favored 'Isoleucine or valine' 0 C--N 1.354 0.795 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.914 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.5 mmm-85 -73.04 -52.5 14.13 Favored 'General case' 0 C--N 1.36 1.055 0 O-C-N 121.596 -0.69 . . . . 0.0 110.124 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 86.1 mt -63.37 -35.93 82.04 Favored 'General case' 0 C--N 1.357 0.929 0 O-C-N 121.991 -0.443 . . . . 0.0 110.979 -178.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -60.92 -47.27 87.17 Favored 'General case' 0 C--N 1.349 0.555 0 O-C-N 122.258 -0.276 . . . . 0.0 110.494 -178.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.54 -37.94 94.13 Favored Glycine 0 C--N 1.356 1.641 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -62.47 -49.33 75.85 Favored 'General case' 0 C--N 1.35 0.622 0 CA-C-N 118.044 0.922 . . . . 0.0 111.485 -177.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.689 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 11.9 mttm -64.36 -47.72 78.25 Favored 'General case' 0 C--N 1.359 0.996 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -177.13 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -68.5 -38.84 81.31 Favored 'General case' 0 C--N 1.347 0.5 0 O-C-N 121.265 -0.897 . . . . 0.0 112.004 -175.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -64.84 -42.85 94.59 Favored 'General case' 0 C--N 1.352 0.703 0 O-C-N 121.116 -0.99 . . . . 0.0 111.077 -177.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.7 -15.43 18.28 Favored 'Isoleucine or valine' 0 C--N 1.36 1.057 0 O-C-N 121.324 -0.86 . . . . 0.0 109.114 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.689 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 74.1 mm-40 -71.88 -38.71 69.97 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 84.5 mt -74.32 -29.69 61.72 Favored 'General case' 0 C--N 1.358 0.967 0 O-C-N 122.215 -0.303 . . . . 0.0 110.749 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.4 mm -66.41 -53.28 37.72 Favored 'Isoleucine or valine' 0 C--N 1.357 0.91 0 C-N-CA 119.973 -0.691 . . . . 0.0 109.973 -177.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -76.08 -14.71 60.19 Favored 'General case' 0 C--N 1.351 0.651 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.39 178.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.0 -36.93 64.47 Favored Glycine 0 C--N 1.349 1.267 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.483 ' HA ' ' HD2' ' A' ' 83' ' ' PRO . 98.6 m-70 -131.86 105.52 14.01 Favored Pre-proline 0 N--CA 1.44 -0.968 0 CA-C-O 122.604 1.192 . . . . 0.0 108.911 -177.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.483 ' HD2' ' HA ' ' A' ' 82' ' ' HIS . 41.4 Cg_endo -68.87 -23.29 35.24 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.637 2.225 . . . . 0.0 114.052 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -90.61 -9.64 46.24 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.3 tp -89.52 -21.75 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 -178.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -102.24 -17.4 15.96 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 51.3 t30 -70.84 -41.28 71.68 Favored 'General case' 0 C--N 1.359 0.999 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -66.13 -33.48 75.86 Favored 'General case' 0 C--N 1.352 0.699 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.318 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.538 ' HG2' ' N ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -80.87 149.97 29.28 Favored 'General case' 0 C--N 1.353 0.745 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 -179.029 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.538 ' N ' ' HG2' ' A' ' 89' ' ' MET . 1.4 mtpt -117.56 -24.69 7.2 Favored 'General case' 0 C--N 1.361 1.1 0 C-N-CA 120.07 -0.652 . . . . 0.0 111.183 -177.247 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -165.83 171.88 12.29 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -177.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.428 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 57.8 m -67.26 -39.44 86.1 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.486 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.648 ' HZ ' ' HG3' ' A' ' 179' ' ' ARG . 64.7 m-85 -67.77 -39.14 84.15 Favored 'General case' 0 C--N 1.358 0.94 0 O-C-N 121.216 -0.928 . . . . 0.0 108.681 -179.27 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -66.16 -22.79 66.38 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.428 ' HB3' ' O ' ' A' ' 92' ' ' SER . 62.0 tp -65.2 -45.13 85.99 Favored 'General case' 0 C--N 1.357 0.929 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.418 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.3 mp -61.44 -36.5 80.54 Favored 'General case' 0 C--N 1.358 0.956 0 O-C-N 122.001 -0.437 . . . . 0.0 110.239 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 34.7 t -67.77 -39.79 84.09 Favored 'General case' 0 C--N 1.349 0.549 0 O-C-N 121.829 -0.545 . . . . 0.0 110.021 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.2 tttp -93.78 8.1 42.38 Favored 'General case' 0 C--N 1.353 0.75 0 O-C-N 122.286 -0.259 . . . . 0.0 111.279 -176.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 15.6 tt -64.29 -38.18 81.85 Favored 'Isoleucine or valine' 0 C--N 1.36 1.033 0 O-C-N 121.464 -0.773 . . . . 0.0 111.694 -176.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -107.87 -15.79 14.46 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 118.181 -1.408 . . . . 0.0 110.195 -178.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.9 t -64.83 -46.6 81.25 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 121.76 -0.588 . . . . 0.0 111.272 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -137.32 -15.12 1.47 Allowed 'General case' 0 C--N 1.36 1.058 0 C-N-CA 117.497 -1.681 . . . . 0.0 112.684 -177.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 31.0 mm -71.0 -51.74 32.99 Favored 'Isoleucine or valine' 0 C--N 1.352 0.682 0 CA-C-N 119.982 1.265 . . . . 0.0 110.715 -177.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -92.03 2.88 56.28 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 119.529 -0.869 . . . . 0.0 110.22 -177.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 49.5 t -85.79 -44.37 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.083 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 178.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 54.7 tp10 -68.1 -40.41 82.62 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 66.6 t -63.84 -46.28 94.75 Favored 'Isoleucine or valine' 0 C--N 1.356 0.889 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.074 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 92.4 t80 -60.94 -48.51 81.5 Favored 'General case' 0 C--N 1.359 1.019 0 O-C-N 122.06 -0.4 . . . . 0.0 111.322 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -61.28 -37.12 82.02 Favored 'General case' 0 C--N 1.357 0.896 0 O-C-N 121.567 -0.708 . . . . 0.0 110.596 -178.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 15.5 mt -56.68 -72.94 0.07 Allowed 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.408 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 88.3 m-85 -121.9 135.16 25.05 Favored Pre-proline 0 N--CA 1.438 -1.061 0 C-N-CA 118.488 -1.285 . . . . 0.0 108.638 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 111' ' ' TYR . 97.7 Cg_endo -83.47 -2.56 10.55 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 123.197 2.598 . . . . 0.0 115.255 -178.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 29.7 mm100 -66.07 -37.16 85.13 Favored 'General case' 0 C--N 1.354 0.778 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.61 145.8 55.2 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-O 121.614 0.721 . . . . 0.0 109.846 -178.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -127.54 134.07 49.76 Favored 'General case' 0 C--N 1.357 0.922 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.485 ' HB3' ' HD2' ' A' ' 117' ' ' PRO . 86.8 mt -128.25 156.43 76.67 Favored Pre-proline 0 C--N 1.354 0.769 0 CA-C-O 122.116 0.96 . . . . 0.0 109.21 -178.596 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' A' ' 116' ' ' LEU . 95.3 Cg_endo -84.05 -153.67 0.05 OUTLIER 'Trans proline' 0 C--N 1.318 -1.074 0 C-N-CA 123.763 2.975 . . . . 0.0 114.317 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -116.66 143.79 45.21 Favored 'General case' 0 C--N 1.364 1.233 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -126.3 130.78 51.51 Favored 'General case' 0 C--N 1.364 1.203 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -178.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.494 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 94.1 m -127.52 129.18 46.93 Favored 'General case' 0 C--N 1.358 0.951 0 N-CA-C 105.739 -1.949 . . . . 0.0 105.739 177.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 77.2 m -122.88 131.47 53.76 Favored 'General case' 0 CA--C 1.504 -0.794 0 C-N-CA 119.178 -1.009 . . . . 0.0 109.855 -178.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -120.03 132.43 55.46 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 106.325 -1.732 . . . . 0.0 106.325 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -105.28 117.27 33.59 Favored 'General case' 0 C--N 1.353 0.729 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 95.2 mt -88.42 -19.84 26.02 Favored 'General case' 0 C--N 1.354 0.781 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.464 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 176.75 -146.74 8.05 Favored Glycine 0 C--N 1.348 1.229 0 C-N-CA 118.905 -1.617 . . . . 0.0 109.06 -178.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -94.82 -39.31 10.32 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -178.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -101.27 0.69 37.78 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.24 -178.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.412 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 66.2 m-20 -118.49 130.74 56.11 Favored 'General case' 0 C--N 1.358 0.955 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.0 mm -141.9 136.79 30.65 Favored 'Isoleucine or valine' 0 C--N 1.355 0.829 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 52.2 mtm180 -118.21 137.87 52.71 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 5.6 tp -125.0 119.14 27.86 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.494 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 13.7 m-70 -99.68 134.15 42.99 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.456 ' HE2' ' HG ' ' A' ' 135' ' ' SER . 32.0 t80 -129.22 121.58 27.94 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 -178.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.442 ' HA ' ' O ' ' A' ' 171' ' ' THR . 27.7 mt-30 -114.96 111.47 21.2 Favored 'General case' 0 C--N 1.357 0.916 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.54 ' O ' ' HA ' ' A' ' 171' ' ' THR . 87.6 p -160.72 161.99 32.39 Favored 'General case' 0 C--N 1.358 0.964 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -98.8 3.59 47.47 Favored 'General case' 0 C--N 1.354 0.796 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 10.8 mtp180 -133.42 74.08 72.24 Favored Pre-proline 0 C--N 1.353 0.75 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -94.74 102.25 0.12 Allowed 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 122.799 2.332 . . . . 0.0 115.926 -177.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -110.11 109.11 19.53 Favored 'General case' 0 CA--C 1.502 -0.904 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 176.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.88 -39.31 93.9 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.679 -178.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 74.3 m -62.92 -27.24 69.24 Favored 'General case' 0 C--N 1.354 0.763 0 O-C-N 121.813 -0.554 . . . . 0.0 110.762 -178.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -76.03 -46.49 29.06 Favored 'General case' 0 N--CA 1.444 -0.757 0 O-C-N 121.719 -0.613 . . . . 0.0 109.65 -178.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.19 -39.93 95.03 Favored 'General case' 0 C--N 1.359 1.01 0 O-C-N 122.124 -0.36 . . . . 0.0 111.234 -178.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -62.79 -36.95 84.81 Favored 'General case' 0 C--N 1.356 0.864 0 O-C-N 121.904 -0.498 . . . . 0.0 109.919 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.07 -43.05 98.64 Favored Glycine 0 C--N 1.348 1.205 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.8 mt -70.54 -40.84 73.19 Favored 'General case' 0 C--N 1.352 0.681 0 CA-C-N 117.606 0.703 . . . . 0.0 112.887 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 97.8 mt -71.04 -42.69 69.17 Favored 'General case' 0 C--N 1.362 1.142 0 O-C-N 121.118 -0.989 . . . . 0.0 110.945 -176.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -70.43 -29.95 66.68 Favored 'General case' 0 N--CA 1.445 -0.675 0 O-C-N 122.015 -0.428 . . . . 0.0 110.486 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.504 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -63.04 -39.69 98.35 Favored Glycine 0 C--N 1.357 1.735 0 N-CA-C 108.394 -1.882 . . . . 0.0 108.394 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 48.8 t -61.16 -42.56 98.78 Favored 'General case' 0 C--N 1.351 0.639 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -75.8 1.87 13.75 Favored 'General case' 0 C--N 1.361 1.071 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.504 ' HB2' ' O ' ' A' ' 149' ' ' GLY . 15.5 mm-40 -87.12 -45.56 10.58 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -66.45 -44.55 82.51 Favored 'General case' 0 C--N 1.359 0.984 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.439 ' O ' ' HB2' ' A' ' 155' ' ' LYS . 50.6 m-85 -70.15 -25.45 63.46 Favored 'General case' 0 C--N 1.361 1.108 0 O-C-N 121.84 -0.537 . . . . 0.0 111.119 -178.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 154' ' ' PHE . 97.3 mttt 71.6 66.07 0.15 Allowed 'General case' 0 C--N 1.363 1.168 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 -177.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -128.68 -177.44 4.19 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -140.98 95.18 2.8 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -117.27 154.29 31.46 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 93.5 m -119.63 126.47 51.25 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.526 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.5 mp -103.82 122.45 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 179.056 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 3.0 m -118.15 -174.84 2.73 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-O 121.797 0.808 . . . . 0.0 109.29 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.11 155.38 42.12 Favored 'General case' 0 C--N 1.356 0.874 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -178.125 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 63.8 p -98.79 146.86 32.36 Favored Pre-proline 0 C--N 1.36 1.062 0 CA-C-O 122.502 1.144 . . . . 0.0 108.359 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.668 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 76.9 Cg_endo -76.9 -11.22 18.16 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 123.006 2.47 . . . . 0.0 114.971 -178.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -72.09 -41.79 66.91 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 120.193 -0.603 . . . . 0.0 109.583 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 39.0 p -116.06 14.57 16.06 Favored 'General case' 0 CA--C 1.505 -0.786 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.381 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.668 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.3 pp0? -68.38 -10.27 53.92 Favored 'General case' 0 C--N 1.351 0.665 0 O-C-N 121.525 -0.734 . . . . 0.0 110.083 178.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 55.6 p30 -121.57 35.16 4.96 Favored 'General case' 0 N--CA 1.435 -1.198 0 O-C-N 121.16 -0.962 . . . . 0.0 109.48 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 94.1 p -145.51 157.83 43.94 Favored 'General case' 0 C--N 1.353 0.736 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.619 ' O ' ' HB ' ' A' ' 171' ' ' THR . 60.0 mt-10 -106.96 170.2 8.09 Favored 'General case' 0 C--N 1.356 0.856 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -179.262 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.619 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 6.1 m 82.79 -53.96 0.19 Allowed 'General case' 0 C--N 1.37 1.489 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.62 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -115.64 117.59 30.73 Favored 'General case' 0 CA--C 1.505 -0.763 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.655 -178.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 94.9 t -130.38 132.8 64.62 Favored 'Isoleucine or valine' 0 C--N 1.357 0.917 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 49.8 mm -107.23 127.02 63.33 Favored 'Isoleucine or valine' 0 C--N 1.359 1.0 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -115.42 155.28 27.72 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 122.139 0.971 . . . . 0.0 108.688 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -138.21 119.11 14.24 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -178.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.0 mp -114.03 119.22 60.61 Favored 'Isoleucine or valine' 0 C--N 1.355 0.807 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 89.4 m -122.02 144.51 48.85 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -177.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.648 ' HG3' ' HZ ' ' A' ' 93' ' ' PHE . 3.8 mtm180 . . . . . 0 C--N 1.367 1.358 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.4 mmm . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 120.821 0.343 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.409 ' HA ' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -78.5 -22.68 47.06 Favored 'General case' 0 C--N 1.356 0.856 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -178.943 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.66 -40.56 45.82 Favored Glycine 0 C--N 1.35 1.348 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.1 tpp -70.27 -37.0 74.78 Favored 'General case' 0 C--N 1.354 0.792 0 O-C-N 122.132 -0.628 . . . . 0.0 110.865 -177.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.409 HG22 ' HA ' ' A' ' 2' ' ' MET . 27.0 m -71.17 -22.71 22.73 Favored 'Isoleucine or valine' 0 C--N 1.357 0.895 0 O-C-N 121.642 -0.661 . . . . 0.0 109.524 -179.008 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.445 ' HZ ' ' CG ' ' A' ' 47' ' ' GLU . 2.2 m-85 -70.8 -35.23 72.43 Favored 'General case' 0 C--N 1.357 0.915 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 85.4 m -66.95 -40.63 87.59 Favored 'General case' 0 C--N 1.354 0.795 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.13 -38.76 97.06 Favored Glycine 0 C--N 1.358 1.785 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.518 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -65.94 -39.85 90.85 Favored 'General case' 0 C--N 1.352 0.686 0 CA-C-N 117.241 0.521 . . . . 0.0 110.608 -178.087 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.442 ' CE ' HD21 ' A' ' 26' ' ' LEU . 24.8 mmt -64.73 -40.12 94.79 Favored 'General case' 0 C--N 1.354 0.775 0 O-C-N 121.591 -0.693 . . . . 0.0 110.707 -178.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -65.86 -39.93 91.19 Favored 'General case' 0 C--N 1.349 0.569 0 O-C-N 122.107 -0.37 . . . . 0.0 111.303 -178.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 56.3 tp -65.81 -42.86 90.15 Favored 'General case' 0 C--N 1.349 0.572 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -178.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.518 HG12 ' O ' ' A' ' 9' ' ' LEU . 1.9 mm -74.5 -35.38 38.45 Favored 'Isoleucine or valine' 0 C--N 1.361 1.073 0 O-C-N 121.031 -1.043 . . . . 0.0 110.746 -175.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -72.0 -42.54 66.3 Favored 'General case' 0 C--N 1.349 0.55 0 O-C-N 121.648 -0.657 . . . . 0.0 111.475 -176.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -70.95 -36.68 72.7 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -176.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -101.1 -25.06 14.17 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 118.725 -1.19 . . . . 0.0 113.628 -174.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -114.8 -36.43 4.5 Favored 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 117.606 -1.638 . . . . 0.0 112.288 -176.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 145.03 177.98 20.26 Favored Glycine 0 C--N 1.348 1.227 0 C-N-CA 118.176 -1.964 . . . . 0.0 110.314 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -99.33 -25.89 14.34 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 -177.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -70.14 -39.15 75.56 Favored 'General case' 0 C--N 1.358 0.937 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.1 m -67.64 -39.33 84.62 Favored 'General case' 0 C--N 1.357 0.919 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.7 tt -60.21 -38.66 84.02 Favored 'General case' 0 C--N 1.357 0.933 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -64.16 -36.82 85.28 Favored 'General case' 0 C--N 1.355 0.821 0 O-C-N 122.081 -0.387 . . . . 0.0 110.901 -178.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 88.2 m -65.0 -40.35 94.82 Favored 'General case' 0 C--N 1.354 0.775 0 O-C-N 121.638 -0.664 . . . . 0.0 109.55 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 88.6 mt -63.74 -38.17 90.09 Favored 'General case' 0 C--N 1.355 0.847 0 O-C-N 122.023 -0.423 . . . . 0.0 109.941 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.442 HD21 ' CE ' ' A' ' 10' ' ' MET . 82.5 mt -70.53 -17.35 62.94 Favored 'General case' 0 C--N 1.36 1.028 0 O-C-N 121.532 -0.73 . . . . 0.0 110.373 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -85.56 -27.38 25.58 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.488 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.5 t -66.09 -36.71 83.91 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 99.5 m -96.5 -35.67 11.05 Favored 'General case' 0 C--N 1.357 0.902 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -178.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 83.31 136.12 0.06 Allowed 'General case' 0 C--N 1.358 0.969 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.538 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -84.8 -171.41 3.62 Favored 'General case' 0 C--N 1.356 0.876 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.535 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -151.2 -24.32 0.21 Allowed 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.1 t -147.07 -67.92 0.26 Allowed 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -128.5 -50.64 1.27 Allowed 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.81 -44.5 1.36 Allowed Glycine 0 C--N 1.351 1.377 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 82.3 mt -110.38 105.18 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.971 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.44 ' HD1' ' HA ' ' A' ' 37' ' ' TYR . 0.1 OUTLIER -82.75 -142.09 0.06 Allowed 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.664 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 87.8 m -112.17 -58.77 2.09 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 52.6 p 165.59 16.92 0.0 OUTLIER 'General case' 0 C--N 1.362 1.113 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.5 t -103.26 3.63 10.64 Favored 'Isoleucine or valine' 0 C--N 1.353 0.732 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.209 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -94.34 141.71 15.68 Favored Glycine 0 C--N 1.352 1.461 0 C-N-CA 119.25 -1.452 . . . . 0.0 109.631 -178.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 50.0 m -124.55 124.73 42.89 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 178.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -117.74 174.98 5.87 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -80.83 -173.06 4.0 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -91.97 -14.85 28.82 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -69.48 -28.87 66.45 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.445 ' CG ' ' HZ ' ' A' ' 6' ' ' PHE . 20.3 tp10 -63.71 -41.28 98.11 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.461 HD22 ' O ' ' A' ' 48' ' ' LEU . 1.9 tm? -67.65 -38.74 84.23 Favored 'General case' 0 C--N 1.359 1.017 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 60.4 tp -70.05 -34.05 72.73 Favored 'General case' 0 CA--C 1.508 -0.639 0 O-C-N 122.134 -0.354 . . . . 0.0 110.141 -177.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 70.6 tp60 -65.2 -41.16 94.78 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -178.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 85.1 mt -81.51 -18.71 44.13 Favored 'General case' 0 C--N 1.362 1.121 0 O-C-N 121.558 -0.714 . . . . 0.0 110.846 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.6 t -80.6 -38.53 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 C-N-CA 119.706 -0.798 . . . . 0.0 109.124 -178.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.7 p -74.22 -31.51 29.35 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 C-N-CA 119.756 -0.778 . . . . 0.0 109.417 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.3 tptt -70.22 -26.94 64.1 Favored 'General case' 0 C--N 1.366 1.289 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.7 tt -67.98 -39.04 83.35 Favored 'General case' 0 C--N 1.353 0.735 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.507 ' O ' ' HA ' ' A' ' 60' ' ' SER . 59.9 p -72.8 -17.26 61.59 Favored 'General case' 0 C--N 1.357 0.933 0 O-C-N 121.729 -0.607 . . . . 0.0 110.916 -178.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -98.93 -37.15 9.51 Favored 'General case' 0 C--N 1.353 0.739 0 O-C-N 121.181 -0.949 . . . . 0.0 111.364 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.2 p -70.92 -35.02 57.98 Favored 'Isoleucine or valine' 0 C--N 1.351 0.672 0 O-C-N 121.712 -0.617 . . . . 0.0 111.399 -177.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.505 ' HB3' HG23 ' A' ' 61' ' ' VAL . 3.9 t -120.49 -7.57 9.67 Favored 'General case' 0 C--N 1.352 0.708 0 C-N-CA 119.118 -1.033 . . . . 0.0 110.08 -178.218 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.507 ' HA ' ' O ' ' A' ' 56' ' ' SER . 1.0 OUTLIER 66.03 46.41 2.18 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.552 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.505 HG23 ' HB3' ' A' ' 59' ' ' SER . 61.3 t -106.23 132.82 20.58 Favored Pre-proline 0 CA--C 1.506 -0.745 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.62 146.02 78.32 Favored 'Trans proline' 0 CA--C 1.497 -1.341 0 C-N-CA 122.59 2.193 . . . . 0.0 113.071 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.404 ' HA ' ' CD2' ' A' ' 66' ' ' LEU . 4.8 m -75.25 -12.89 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.792 -178.29 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.47 ' O ' HG12 ' A' ' 67' ' ' VAL . 72.2 p -96.36 -32.24 12.47 Favored 'General case' 0 C--N 1.358 0.944 0 C-N-CA 118.273 -1.371 . . . . 0.0 109.761 -178.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -80.26 -20.67 43.98 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 121.394 -0.816 . . . . 0.0 108.912 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.404 ' CD2' ' HA ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -81.0 -36.49 30.57 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -179.901 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.47 HG12 ' O ' ' A' ' 64' ' ' THR . 2.1 p -67.44 -29.86 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.678 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 -70.35 -48.81 54.7 Favored 'General case' 0 C--N 1.366 1.298 0 O-C-N 121.428 -0.795 . . . . 0.0 110.777 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.9 mt -64.14 -35.84 82.08 Favored 'General case' 0 C--N 1.355 0.84 0 O-C-N 122.033 -0.417 . . . . 0.0 110.961 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -60.8 -47.37 86.64 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 122.132 -0.355 . . . . 0.0 110.427 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.19 -39.07 96.64 Favored Glycine 0 C--N 1.354 1.579 0 N-CA-C 111.729 -0.549 . . . . 0.0 111.729 -178.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.44 -47.55 81.43 Favored 'General case' 0 C--N 1.351 0.651 0 CA-C-N 118.227 1.013 . . . . 0.0 111.462 -177.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.73 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 10.6 mttm -63.98 -50.17 69.6 Favored 'General case' 0 C--N 1.357 0.921 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -177.121 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.417 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.4 tm? -68.67 -38.96 80.77 Favored 'General case' 0 C--N 1.349 0.552 0 O-C-N 121.339 -0.85 . . . . 0.0 111.868 -175.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -63.43 -45.09 92.57 Favored 'General case' 0 C--N 1.352 0.678 0 O-C-N 121.208 -0.932 . . . . 0.0 110.965 -177.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 8.6 p -70.59 -15.71 19.19 Favored 'Isoleucine or valine' 0 C--N 1.358 0.958 0 O-C-N 121.521 -0.737 . . . . 0.0 109.366 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.73 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 75.1 mm-40 -71.28 -38.73 71.81 Favored 'General case' 0 C--N 1.35 0.608 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.7 mt -73.04 -31.66 64.58 Favored 'General case' 0 C--N 1.356 0.865 0 O-C-N 122.426 -0.171 . . . . 0.0 110.685 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.9 mm -65.06 -53.72 37.81 Favored 'Isoleucine or valine' 0 C--N 1.359 0.984 0 C-N-CA 120.081 -0.648 . . . . 0.0 110.099 -177.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -74.99 -14.98 60.68 Favored 'General case' 0 C--N 1.351 0.634 0 C-N-CA 119.554 -0.859 . . . . 0.0 109.37 178.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.58 -37.66 68.26 Favored Glycine 0 C--N 1.349 1.278 0 N-CA-C 110.971 -0.851 . . . . 0.0 110.971 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -132.45 108.3 13.38 Favored Pre-proline 0 N--CA 1.441 -0.917 0 CA-C-O 122.776 1.274 . . . . 0.0 109.232 -177.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.8 -24.58 40.38 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.596 2.197 . . . . 0.0 114.301 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -93.7 -5.05 49.4 Favored 'General case' 0 CA--C 1.5 -0.966 0 C-N-CA 119.448 -0.901 . . . . 0.0 108.776 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -89.64 -19.97 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.78 -25.18 14.21 Favored 'General case' 0 C--N 1.361 1.106 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -70.23 -35.23 73.71 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 120.207 -0.597 . . . . 0.0 109.443 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -65.42 -36.98 85.57 Favored 'General case' 0 C--N 1.355 0.837 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.415 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.558 ' HG2' ' N ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -81.52 155.05 25.96 Favored 'General case' 0 C--N 1.355 0.841 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -178.468 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.558 ' N ' ' HG2' ' A' ' 89' ' ' MET . 0.8 OUTLIER -120.36 -25.41 5.64 Favored 'General case' 0 C--N 1.364 1.199 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.031 -177.655 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -165.12 172.09 13.01 Favored 'General case' 0 C--N 1.354 0.78 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 -177.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 41.1 t -64.62 -43.16 94.61 Favored 'General case' 0 C--N 1.356 0.863 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.208 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -67.11 -39.72 86.72 Favored 'General case' 0 C--N 1.356 0.853 0 O-C-N 121.429 -0.794 . . . . 0.0 109.282 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -66.41 -23.17 66.26 Favored 'General case' 0 C--N 1.355 0.821 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.661 ' O ' HG13 ' A' ' 99' ' ' ILE . 61.2 tp -64.78 -46.28 82.78 Favored 'General case' 0 C--N 1.356 0.888 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.496 ' HA ' ' CD1' ' A' ' 99' ' ' ILE . 3.2 mp -59.94 -35.11 74.23 Favored 'General case' 0 C--N 1.36 1.035 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.5 t -69.61 -39.57 77.15 Favored 'General case' 0 C--N 1.349 0.549 0 O-C-N 121.994 -0.441 . . . . 0.0 109.934 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.1 tttp -87.32 1.37 53.47 Favored 'General case' 0 C--N 1.357 0.905 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -176.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.661 HG13 ' O ' ' A' ' 95' ' ' LEU . 81.4 mt -61.51 -47.06 95.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.868 0 CA-C-N 119.282 0.946 . . . . 0.0 111.408 -177.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -92.88 -25.67 17.98 Favored 'General case' 0 N--CA 1.442 -0.858 0 O-C-N 121.04 -1.037 . . . . 0.0 110.973 -177.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 35.0 t -63.21 -49.0 75.92 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 121.64 -0.662 . . . . 0.0 112.667 -177.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.654 ' HA ' HG12 ' A' ' 105' ' ' VAL . 16.9 t80 -139.42 -14.25 1.12 Allowed 'General case' 0 C--N 1.361 1.066 0 C-N-CA 117.274 -1.77 . . . . 0.0 113.529 -176.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 32.7 mm -71.77 -52.14 27.42 Favored 'Isoleucine or valine' 0 C--O 1.246 0.875 0 CA-C-N 120.659 1.572 . . . . 0.0 110.592 -177.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -91.82 2.3 56.6 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 119.659 -0.817 . . . . 0.0 110.299 -176.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.654 HG12 ' HA ' ' A' ' 102' ' ' PHE . 1.3 p -92.4 -32.47 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -72.93 -40.82 65.12 Favored 'General case' 0 C--N 1.357 0.924 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.6 p -74.99 -35.99 37.07 Favored 'Isoleucine or valine' 0 C--N 1.355 0.847 0 C-N-CA 119.231 -0.988 . . . . 0.0 109.684 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -61.23 -48.61 80.68 Favored 'General case' 0 C--N 1.365 1.245 0 O-C-N 121.727 -0.608 . . . . 0.0 110.428 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -60.35 -37.48 80.82 Favored 'General case' 0 C--N 1.358 0.961 0 O-C-N 121.694 -0.629 . . . . 0.0 110.096 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 13.4 mt -56.5 -75.07 0.04 OUTLIER 'General case' 0 C--N 1.356 0.869 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.433 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 92.6 m-85 -119.05 135.21 23.72 Favored Pre-proline 0 N--CA 1.439 -0.983 0 C-N-CA 118.855 -1.138 . . . . 0.0 108.821 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 111' ' ' TYR . 89.4 Cg_endo -84.16 -1.5 9.86 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 123.315 2.677 . . . . 0.0 115.318 -178.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -65.78 -37.24 85.76 Favored 'General case' 0 C--N 1.354 0.788 0 O-C-N 121.805 -0.56 . . . . 0.0 109.933 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.35 144.9 56.27 Favored 'General case' 0 C--N 1.353 0.734 0 CA-C-O 121.495 0.664 . . . . 0.0 109.742 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -131.45 135.96 47.57 Favored 'General case' 0 C--N 1.356 0.882 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.522 ' HB3' ' HD2' ' A' ' 117' ' ' PRO . 90.7 mt -128.45 157.17 75.61 Favored Pre-proline 0 N--CA 1.443 -0.794 0 CA-C-O 122.189 0.995 . . . . 0.0 109.286 -178.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.522 ' HD2' ' HB3' ' A' ' 116' ' ' LEU . 94.0 Cg_endo -80.29 -153.52 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.122 0 C-N-CA 123.644 2.896 . . . . 0.0 113.472 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -118.21 144.14 45.97 Favored 'General case' 0 C--N 1.362 1.148 0 C-N-CA 119.172 -1.011 . . . . 0.0 108.458 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -129.59 134.36 47.68 Favored 'General case' 0 C--N 1.361 1.081 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.49 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 94.2 m -125.05 129.32 50.03 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 177.123 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 84.4 m -116.02 127.26 54.77 Favored 'General case' 0 CA--C 1.504 -0.802 0 C-N-CA 119.094 -1.042 . . . . 0.0 109.402 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -120.36 130.77 54.55 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 57.9 ttp180 -105.16 116.98 32.87 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.49 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 90.7 mt -85.81 -24.32 26.84 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 120.709 -0.397 . . . . 0.0 109.997 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -179.6 -146.0 6.61 Favored Glycine 0 C--N 1.349 1.294 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 -178.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -94.12 -40.16 10.2 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 120.007 -0.677 . . . . 0.0 109.274 -178.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -101.69 4.25 40.5 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 119.882 -0.727 . . . . 0.0 110.406 -178.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.49 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 8.4 m-20 -120.74 130.65 54.13 Favored 'General case' 0 C--N 1.36 1.035 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.404 HD13 ' HA ' ' A' ' 129' ' ' ILE . 8.7 mm -141.49 137.71 32.51 Favored 'Isoleucine or valine' 0 C--N 1.356 0.871 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 60.3 mtm180 -124.11 138.83 54.38 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' A' ' 131' ' ' LEU . 0.1 OUTLIER -130.63 127.42 38.93 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.594 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.49 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 12.3 m170 -95.6 135.72 36.9 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 179.167 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -127.69 118.83 24.55 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 -178.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.51 ' HA ' ' O ' ' A' ' 171' ' ' THR . 29.1 tt0 -113.82 111.93 22.56 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 14.5 t -161.86 153.82 19.19 Favored 'General case' 0 C--N 1.359 0.99 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -91.47 3.36 55.16 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 120.26 -0.576 . . . . 0.0 109.893 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 93.2 mtm-85 -133.7 73.78 71.41 Favored Pre-proline 0 C--N 1.355 0.847 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 178.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -94.81 103.47 0.12 Allowed 'Trans proline' 0 N--CA 1.444 -1.426 0 C-N-CA 122.489 2.126 . . . . 0.0 115.67 -177.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -111.15 113.01 25.21 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 176.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.95 -38.75 92.23 Favored 'General case' 0 C--N 1.353 0.748 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.068 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.0 m -64.13 -26.28 68.46 Favored 'General case' 0 C--N 1.353 0.742 0 O-C-N 122.052 -0.405 . . . . 0.0 110.902 -178.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -76.47 -47.41 23.04 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 121.669 -0.645 . . . . 0.0 109.666 -178.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.88 -39.49 93.62 Favored 'General case' 0 C--N 1.357 0.919 0 O-C-N 122.071 -0.393 . . . . 0.0 110.8 -178.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.34 -36.83 85.01 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 122.029 -0.419 . . . . 0.0 109.901 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.44 -43.25 98.93 Favored Glycine 0 C--N 1.348 1.201 0 N-CA-C 109.901 -1.279 . . . . 0.0 109.901 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.0 mt -69.08 -41.08 77.98 Favored 'General case' 0 C--N 1.352 0.694 0 CA-C-N 117.612 0.706 . . . . 0.0 112.415 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 98.2 mt -71.5 -42.49 67.95 Favored 'General case' 0 C--N 1.36 1.042 0 O-C-N 121.3 -0.875 . . . . 0.0 110.714 -177.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.559 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 37.5 t70 -69.38 -32.52 71.61 Favored 'General case' 0 N--CA 1.445 -0.703 0 O-C-N 122.049 -0.407 . . . . 0.0 110.642 -179.231 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.433 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -62.85 -39.57 98.16 Favored Glycine 0 C--N 1.357 1.736 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 47.0 t -60.1 -41.73 93.18 Favored 'General case' 0 C--N 1.351 0.653 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -77.56 0.23 23.81 Favored 'General case' 0 C--N 1.359 0.982 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.559 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 76.8 mm-40 -83.65 -46.77 11.95 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -68.55 -41.46 79.76 Favored 'General case' 0 C--N 1.359 0.991 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.52 ' HZ ' ' SD ' ' A' ' 89' ' ' MET . 9.7 m-30 -69.66 -26.98 64.66 Favored 'General case' 0 C--N 1.36 1.055 0 O-C-N 121.821 -0.549 . . . . 0.0 110.628 -178.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 85.0 tttt 73.59 74.88 0.13 Allowed 'General case' 0 C--N 1.361 1.091 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -142.81 -170.34 3.21 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -148.57 94.37 2.28 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 15.7 m-30 -113.42 156.59 23.22 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 94.5 m -119.23 126.85 52.5 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 119.082 -1.047 . . . . 0.0 108.837 -178.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.491 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.9 mp -104.76 122.61 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 178.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.8 m -120.47 -171.95 2.27 Favored 'General case' 0 C--N 1.355 0.808 0 CA-C-O 121.812 0.815 . . . . 0.0 108.899 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.01 158.64 44.37 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -178.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 50.2 p -98.27 146.59 31.79 Favored Pre-proline 0 C--N 1.357 0.934 0 CA-C-O 122.368 1.08 . . . . 0.0 108.134 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.623 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 72.8 Cg_endo -75.95 -10.98 19.84 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.924 2.416 . . . . 0.0 115.031 -178.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -72.62 -41.17 65.84 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.388 -178.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 39.0 p -116.7 15.32 15.43 Favored 'General case' 0 C--N 1.354 0.795 0 C-N-CA 120.264 -0.575 . . . . 0.0 110.288 -178.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.623 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.2 pp0? -66.67 -12.76 59.67 Favored 'General case' 0 C--N 1.354 0.798 0 O-C-N 121.608 -0.683 . . . . 0.0 110.22 178.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -124.62 38.23 4.24 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 57.7 m -137.21 146.76 45.23 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.617 ' O ' ' HB ' ' A' ' 171' ' ' THR . 61.4 mt-10 -99.85 165.46 11.56 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.617 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 16.4 m 82.28 -59.39 0.19 Allowed 'General case' 0 C--N 1.369 1.453 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.799 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -107.73 117.1 33.24 Favored 'General case' 0 CA--C 1.505 -0.784 0 C-N-CA 119.884 -0.726 . . . . 0.0 109.868 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 88.2 t -131.8 133.66 61.0 Favored 'Isoleucine or valine' 0 C--N 1.358 0.943 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 178.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 49.5 mm -109.59 126.0 66.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.955 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -114.13 147.27 39.1 Favored 'General case' 0 C--N 1.359 0.988 0 CA-C-O 121.942 0.877 . . . . 0.0 108.767 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -128.26 118.19 22.84 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.458 HD11 HD23 ' A' ' 131' ' ' LEU . 4.0 mp -112.58 118.06 56.87 Favored 'Isoleucine or valine' 0 C--N 1.355 0.838 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 -179.392 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 85.1 m -128.28 144.79 51.16 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 -177.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 81.1 mtm180 . . . . . 0 C--N 1.37 1.491 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 178.171 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.597 ' HG3' ' H ' ' A' ' 4' ' ' MET . 54.0 tpp . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.026 0.441 . . . . 0.0 110.333 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.59 -19.14 39.03 Favored 'General case' 0 C--N 1.355 0.833 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.2 -38.98 58.78 Favored Glycine 0 C--N 1.351 1.382 0 N-CA-C 108.563 -1.815 . . . . 0.0 108.563 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' MET . . . . . 0.597 ' H ' ' HG3' ' A' ' 1' ' ' MET . 3.2 mtt -70.04 -35.86 74.61 Favored 'General case' 0 C--N 1.356 0.867 0 O-C-N 122.205 -0.585 . . . . 0.0 111.542 -177.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.2 m -69.34 -23.92 27.1 Favored 'Isoleucine or valine' 0 C--N 1.356 0.874 0 O-C-N 121.41 -0.806 . . . . 0.0 109.355 -178.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -71.79 -35.37 69.98 Favored 'General case' 0 C--N 1.357 0.908 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 87.9 m -67.33 -41.67 84.87 Favored 'General case' 0 C--N 1.355 0.84 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.48 -38.35 96.2 Favored Glycine 0 C--N 1.356 1.69 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.589 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -67.18 -38.56 85.61 Favored 'General case' 0 C--N 1.351 0.657 0 CA-C-N 117.311 0.556 . . . . 0.0 110.503 -177.927 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 21.3 mmt -64.26 -40.7 96.53 Favored 'General case' 0 C--N 1.354 0.798 0 O-C-N 121.616 -0.677 . . . . 0.0 110.767 -178.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -66.2 -40.4 90.35 Favored 'General case' 0 C--N 1.349 0.559 0 O-C-N 122.057 -0.402 . . . . 0.0 111.684 -178.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 57.8 tp -65.75 -42.73 90.59 Favored 'General case' 0 C--N 1.35 0.595 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -178.137 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.589 HG12 ' O ' ' A' ' 9' ' ' LEU . 1.7 mm -75.61 -36.32 34.02 Favored 'Isoleucine or valine' 0 C--N 1.357 0.917 0 O-C-N 121.049 -1.032 . . . . 0.0 110.955 -175.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -67.96 -42.57 80.7 Favored 'General case' 0 C--N 1.351 0.67 0 O-C-N 121.858 -0.526 . . . . 0.0 111.108 -176.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -73.48 -31.28 63.66 Favored 'General case' 0 N--CA 1.447 -0.617 0 O-C-N 122.014 -0.429 . . . . 0.0 111.499 -177.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -72.63 -49.08 34.35 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -175.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -128.56 -20.35 3.63 Favored 'General case' 0 C--N 1.355 0.812 0 C-N-CA 117.566 -1.654 . . . . 0.0 113.02 -176.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 140.8 179.08 17.89 Favored Glycine 0 CA--C 1.496 -1.094 0 C-N-CA 118.104 -1.998 . . . . 0.0 109.657 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -94.26 -11.09 30.89 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -177.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -70.88 -41.52 71.24 Favored 'General case' 0 C--N 1.36 1.046 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 92.8 m -69.91 -38.89 76.4 Favored 'General case' 0 C--N 1.359 0.98 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.508 HD13 ' HB ' ' A' ' 13' ' ' ILE . 56.6 tp -60.5 -37.66 81.81 Favored 'General case' 0 C--N 1.357 0.9 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -64.94 -35.43 81.13 Favored 'General case' 0 C--N 1.357 0.919 0 O-C-N 122.203 -0.311 . . . . 0.0 110.757 -178.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.2 m -64.44 -41.23 96.67 Favored 'General case' 0 C--N 1.354 0.771 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -178.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 93.0 mt -65.23 -37.43 87.23 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 80.3 mt -69.7 -14.38 62.77 Favored 'General case' 0 C--N 1.358 0.971 0 O-C-N 121.445 -0.784 . . . . 0.0 109.604 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -88.07 -25.74 22.9 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 119.621 -0.831 . . . . 0.0 109.287 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 55.9 p -70.27 -23.9 62.96 Favored 'General case' 0 C--N 1.359 1.017 0 C-N-CA 119.65 -0.82 . . . . 0.0 109.22 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.8 p -105.8 -37.19 6.79 Favored 'General case' 0 C--N 1.358 0.967 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 86.09 132.15 0.04 OUTLIER 'General case' 0 C--N 1.36 1.031 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.466 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -90.88 -166.18 1.52 Allowed 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -153.35 -64.81 0.15 Allowed 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.6 t -97.92 -65.19 0.98 Allowed 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -138.11 -45.0 0.51 Allowed 'General case' 0 CA--C 1.503 -0.863 0 C-N-CA 119.567 -0.853 . . . . 0.0 108.752 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 125.88 -35.59 2.97 Favored Glycine 0 C--N 1.352 1.427 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 85.0 mt -107.91 100.26 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.788 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -97.13 -1.47 45.1 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.767 HG22 ' H ' ' A' ' 39' ' ' SER . 2.7 m 77.55 -179.63 0.13 Allowed 'General case' 0 C--N 1.361 1.107 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 -178.555 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.767 ' H ' HG22 ' A' ' 38' ' ' THR . 21.2 p -85.7 102.71 13.85 Favored 'General case' 0 C--N 1.353 0.729 0 O-C-N 121.116 -0.99 . . . . 0.0 109.261 -178.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.453 HG12 ' O ' ' A' ' 40' ' ' VAL . 97.3 t -153.19 -18.54 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.359 1.013 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -112.58 164.93 12.02 Favored Glycine 0 C--N 1.356 1.668 0 C-N-CA 119.311 -1.423 . . . . 0.0 110.156 -176.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.6 m -128.62 127.76 42.87 Favored 'General case' 0 C--N 1.355 0.816 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -116.42 176.42 5.12 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -79.34 -176.53 5.26 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -91.15 -16.03 28.42 Favored 'General case' 0 CA--C 1.503 -0.858 0 C-N-CA 120.105 -0.638 . . . . 0.0 109.406 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -70.23 -28.15 65.03 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -63.37 -40.85 98.37 Favored 'General case' 0 C--N 1.352 0.68 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.438 ' O ' HG23 ' A' ' 52' ' ' VAL . 63.3 tp -66.82 -38.57 86.71 Favored 'General case' 0 C--N 1.357 0.899 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.308 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.4 ' O ' HG23 ' A' ' 53' ' ' VAL . 58.3 tp -77.31 -26.2 52.0 Favored 'General case' 0 C--N 1.349 0.567 0 O-C-N 122.071 -0.393 . . . . 0.0 110.134 -177.275 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -67.67 -43.9 79.08 Favored 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 121.724 -0.61 . . . . 0.0 110.048 -178.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 81.8 mt -71.93 -34.84 69.38 Favored 'General case' 0 C--N 1.36 1.022 0 C-N-CA 120.164 -0.614 . . . . 0.0 109.467 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 48' ' ' LEU . 40.0 t -63.11 -40.73 90.14 Favored 'Isoleucine or valine' 0 C--N 1.35 0.593 0 O-C-N 122.331 -0.231 . . . . 0.0 110.456 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 49' ' ' LEU . 54.9 t -68.13 -40.29 82.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.662 0 O-C-N 121.672 -0.642 . . . . 0.0 109.929 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.8 tptt -68.39 -23.02 64.61 Favored 'General case' 0 C--N 1.36 1.022 0 O-C-N 121.021 -1.05 . . . . 0.0 108.695 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.406 HD13 HD13 ' A' ' 66' ' ' LEU . 1.9 mt -68.96 -37.48 78.86 Favored 'General case' 0 C--N 1.351 0.674 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.5 p -73.29 -17.11 61.35 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.382 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -100.3 -37.06 9.04 Favored 'General case' 0 C--N 1.354 0.78 0 C-N-CA 119.534 -0.867 . . . . 0.0 111.402 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.9 p -72.67 -36.86 54.38 Favored 'Isoleucine or valine' 0 C--N 1.353 0.725 0 O-C-N 121.56 -0.712 . . . . 0.0 111.525 -177.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.613 ' HB3' HG23 ' A' ' 61' ' ' VAL . 5.3 t -117.89 -3.95 11.14 Favored 'General case' 0 C--N 1.352 0.691 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.143 -178.119 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 73.2 m 62.9 42.45 7.67 Favored 'General case' 0 C--N 1.355 0.839 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.613 HG23 ' HB3' ' A' ' 59' ' ' SER . 55.1 t -102.37 131.45 22.5 Favored Pre-proline 0 CA--C 1.503 -0.855 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -57.52 147.42 78.74 Favored 'Trans proline' 0 CA--C 1.498 -1.292 0 C-N-CA 122.55 2.167 . . . . 0.0 112.624 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.1 m -75.22 -12.83 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.671 -178.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.451 ' O ' HG12 ' A' ' 67' ' ' VAL . 64.4 p -96.45 -34.07 11.65 Favored 'General case' 0 C--N 1.359 0.996 0 C-N-CA 118.393 -1.323 . . . . 0.0 109.488 -179.1 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -75.59 -23.71 56.49 Favored 'General case' 0 C--N 1.354 0.795 0 O-C-N 121.5 -0.75 . . . . 0.0 109.087 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.406 HD13 HD13 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -79.96 -36.25 36.44 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.007 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.451 HG12 ' O ' ' A' ' 64' ' ' THR . 1.9 p -69.41 -25.45 29.16 Favored 'Isoleucine or valine' 0 C--N 1.354 0.797 0 C-N-CA 120.206 -0.597 . . . . 0.0 110.046 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 5.5 mmm-85 -73.15 -52.48 14.04 Favored 'General case' 0 C--N 1.363 1.162 0 O-C-N 121.548 -0.72 . . . . 0.0 110.12 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.7 mt -63.31 -35.43 80.36 Favored 'General case' 0 C--N 1.357 0.903 0 O-C-N 121.983 -0.448 . . . . 0.0 110.941 -178.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -61.1 -47.67 85.24 Favored 'General case' 0 C--N 1.351 0.638 0 O-C-N 122.117 -0.365 . . . . 0.0 110.624 -178.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.91 -38.51 95.52 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 111.738 -0.545 . . . . 0.0 111.738 -178.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.14 -47.87 80.9 Favored 'General case' 0 C--N 1.349 0.568 0 CA-C-N 118.067 0.934 . . . . 0.0 111.348 -177.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.718 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 9.9 mttm -64.51 -49.21 72.2 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 113.61 0.966 . . . . 0.0 113.61 -177.125 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.418 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.4 tm? -68.4 -39.81 81.55 Favored 'General case' 0 C--N 1.349 0.585 0 O-C-N 121.082 -1.012 . . . . 0.0 111.86 -175.253 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -63.41 -45.09 92.6 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 121.091 -1.006 . . . . 0.0 111.258 -177.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.8 p -71.09 -14.92 18.34 Favored 'Isoleucine or valine' 0 C--N 1.359 0.988 0 O-C-N 121.478 -0.763 . . . . 0.0 109.506 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.718 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 74.1 mm-40 -72.74 -38.79 67.3 Favored 'General case' 0 C--N 1.35 0.629 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 78.9 mt -69.09 -35.27 76.3 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 47.7 mm -62.5 -51.49 71.53 Favored 'Isoleucine or valine' 0 C--N 1.356 0.89 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.227 -177.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -75.64 -11.87 60.09 Favored 'General case' 0 C--N 1.353 0.73 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.98 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -94.01 -9.37 59.61 Favored Glycine 0 C--N 1.347 1.166 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.482 -178.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.47 ' O ' HG22 ' A' ' 85' ' ' ILE . 87.5 m-70 -143.93 95.32 5.73 Favored Pre-proline 0 CA--C 1.503 -0.839 0 CA-C-N 118.91 1.355 . . . . 0.0 109.126 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.513 ' O ' ' HB2' ' A' ' 87' ' ' ASN . 38.3 Cg_endo -68.71 -23.8 35.66 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.393 2.062 . . . . 0.0 114.046 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -90.75 -9.11 47.81 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.47 HG22 ' O ' ' A' ' 82' ' ' HIS . 0.6 OUTLIER -89.01 -21.99 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.971 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 -178.792 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -104.38 -14.81 15.61 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.513 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 20.1 t30 -72.88 -40.66 65.42 Favored 'General case' 0 C--N 1.36 1.048 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -67.35 -29.79 69.43 Favored 'General case' 0 C--N 1.353 0.735 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.156 -178.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 28.4 ttp -84.17 146.58 27.77 Favored 'General case' 0 C--N 1.351 0.655 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.75 -21.51 10.15 Favored 'General case' 0 C--N 1.361 1.104 0 O-C-N 121.58 -0.7 . . . . 0.0 110.937 -177.483 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -164.54 171.39 14.6 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 -177.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.412 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 88.4 p -71.01 -31.7 68.28 Favored 'General case' 0 C--N 1.352 0.682 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.014 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -70.4 -38.46 74.66 Favored 'General case' 0 C--N 1.358 0.942 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -66.67 -24.18 66.24 Favored 'General case' 0 C--N 1.358 0.977 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.412 ' HB3' ' O ' ' A' ' 92' ' ' SER . 61.4 tp -62.92 -46.36 88.16 Favored 'General case' 0 C--N 1.355 0.814 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.3 mp -62.61 -32.89 73.98 Favored 'General case' 0 C--N 1.354 0.765 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 36.3 t -62.41 -45.02 94.99 Favored 'General case' 0 C--N 1.355 0.81 0 O-C-N 121.84 -0.537 . . . . 0.0 111.347 -178.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.08 28.45 8.78 Favored 'General case' 0 C--N 1.361 1.085 0 O-C-N 121.103 -0.998 . . . . 0.0 110.539 -178.02 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.6 tt -62.71 -29.91 48.12 Favored 'Isoleucine or valine' 0 C--N 1.354 0.794 0 O-C-N 121.827 -0.546 . . . . 0.0 110.314 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -127.4 -8.8 5.76 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 118.54 -1.264 . . . . 0.0 109.916 -179.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 58.4 m -90.88 -2.93 57.7 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 119.566 -0.854 . . . . 0.0 110.313 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.459 ' O ' HG12 ' A' ' 105' ' ' VAL . 11.9 t80 -146.51 -46.92 0.19 Allowed 'General case' 0 C--N 1.357 0.912 0 C-N-CA 118.264 -1.374 . . . . 0.0 109.754 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 96.1 mt -68.57 -48.41 72.18 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 O-C-N 121.788 -0.57 . . . . 0.0 110.948 -178.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 44.4 m170 -85.71 -1.52 57.27 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.329 -177.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.459 HG12 ' O ' ' A' ' 102' ' ' PHE . 2.0 p -89.11 -32.72 5.85 Favored 'Isoleucine or valine' 0 C--N 1.354 0.793 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -72.3 -40.14 67.76 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -73.17 -33.97 43.4 Favored 'Isoleucine or valine' 0 C--N 1.355 0.824 0 C-N-CA 119.518 -0.873 . . . . 0.0 109.576 -178.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -60.67 -49.01 79.25 Favored 'General case' 0 C--N 1.363 1.164 0 O-C-N 121.8 -0.563 . . . . 0.0 110.441 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -60.44 -38.99 85.9 Favored 'General case' 0 C--N 1.358 0.96 0 O-C-N 121.579 -0.701 . . . . 0.0 110.096 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.0 mt -57.15 -76.92 0.03 OUTLIER 'General case' 0 C--N 1.354 0.798 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.436 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 92.7 m-85 -115.89 136.11 22.85 Favored Pre-proline 0 N--CA 1.442 -0.855 0 O-C-N 121.067 -1.021 . . . . 0.0 108.817 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 111' ' ' TYR . 68.8 Cg_endo -86.38 -1.72 8.45 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 123.32 2.68 . . . . 0.0 115.585 -178.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -66.73 -36.83 83.4 Favored 'General case' 0 C--N 1.356 0.855 0 O-C-N 121.652 -0.655 . . . . 0.0 110.2 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.46 145.76 54.67 Favored 'General case' 0 C--N 1.352 0.696 0 CA-C-O 121.61 0.719 . . . . 0.0 110.105 -178.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -130.8 134.43 46.84 Favored 'General case' 0 C--N 1.358 0.936 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.478 ' HB3' ' HD2' ' A' ' 117' ' ' PRO . 2.8 mm? -116.36 156.45 47.26 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-O 122.145 0.974 . . . . 0.0 108.855 -178.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' A' ' 116' ' ' LEU . 85.5 Cg_endo -83.88 -151.86 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.123 0 C-N-CA 123.517 2.812 . . . . 0.0 113.147 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -114.53 138.72 50.28 Favored 'General case' 0 C--N 1.362 1.152 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -125.2 126.38 45.12 Favored 'General case' 0 C--N 1.36 1.05 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -178.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.534 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 93.8 m -124.88 127.66 47.47 Favored 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 177.229 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 77.1 m -121.63 129.99 53.18 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 119.129 -1.029 . . . . 0.0 109.585 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -118.38 148.81 42.14 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 178.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 57.4 ttp180 -120.55 117.21 27.03 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.403 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 95.0 mt -90.55 -16.2 29.24 Favored 'General case' 0 CA--C 1.503 -0.853 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.52 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 175.37 -148.68 9.63 Favored Glycine 0 N--CA 1.437 -1.271 0 N-CA-C 108.891 -1.684 . . . . 0.0 108.891 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -94.35 -37.35 11.52 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -178.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -103.01 3.82 36.62 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.02 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.403 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 66.6 m-20 -119.83 130.81 55.08 Favored 'General case' 0 C--N 1.359 1.003 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.403 HD13 ' HA ' ' A' ' 129' ' ' ILE . 8.4 mm -142.27 136.07 28.49 Favored 'Isoleucine or valine' 0 C--N 1.355 0.819 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 53.2 mtm180 -116.16 139.48 50.28 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 6.3 tp -126.7 118.81 25.5 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.534 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 12.4 m-70 -99.55 133.43 43.88 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -129.94 122.61 28.88 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 -178.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.496 ' HA ' ' O ' ' A' ' 171' ' ' THR . 32.2 tt0 -115.73 113.04 22.93 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.2 t -162.51 154.16 18.25 Favored 'General case' 0 C--N 1.359 1.002 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.406 ' C ' ' HD3' ' A' ' 138' ' ' PRO . 57.7 mtmt -91.41 3.94 53.69 Favored 'General case' 0 C--N 1.357 0.921 0 C-N-CA 120.186 -0.605 . . . . 0.0 109.865 -179.218 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 93.8 mtm-85 -133.01 74.11 74.29 Favored Pre-proline 0 C--N 1.356 0.882 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.406 ' HD3' ' C ' ' A' ' 136' ' ' LYS . 94.1 Cg_endo -96.23 102.7 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.657 2.238 . . . . 0.0 115.759 -177.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -111.47 113.42 25.84 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 176.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.01 -38.16 90.07 Favored 'General case' 0 C--N 1.354 0.778 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.026 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.7 m -63.48 -28.04 69.69 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 122.042 -0.411 . . . . 0.0 110.694 -178.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -75.59 -46.53 31.28 Favored 'General case' 0 C--N 1.352 0.687 0 C-N-CA 120.146 -0.622 . . . . 0.0 109.567 -178.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.68 -39.85 94.38 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 122.258 -0.276 . . . . 0.0 111.187 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.19 -37.2 86.31 Favored 'General case' 0 C--N 1.355 0.81 0 O-C-N 121.987 -0.446 . . . . 0.0 110.184 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.51 -42.88 99.27 Favored Glycine 0 C--N 1.348 1.248 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 -179.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 83.1 mt -70.07 -40.65 74.9 Favored 'General case' 0 C--N 1.351 0.667 0 CA-C-N 117.522 0.661 . . . . 0.0 112.627 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 97.1 mt -71.35 -42.38 68.58 Favored 'General case' 0 C--N 1.361 1.07 0 O-C-N 121.235 -0.916 . . . . 0.0 110.902 -176.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.497 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 36.4 t70 -70.06 -31.07 68.5 Favored 'General case' 0 N--CA 1.445 -0.695 0 O-C-N 121.934 -0.479 . . . . 0.0 110.407 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -63.12 -39.09 97.57 Favored Glycine 0 C--N 1.356 1.672 0 N-CA-C 108.461 -1.856 . . . . 0.0 108.461 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 46.3 t -60.75 -42.2 96.92 Favored 'General case' 0 C--N 1.35 0.622 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 178.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -74.97 -1.25 21.76 Favored 'General case' 0 C--N 1.36 1.046 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.497 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 76.9 mm-40 -83.46 -46.91 11.94 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -65.54 -45.6 82.8 Favored 'General case' 0 C--N 1.36 1.042 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.411 178.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -68.57 -25.95 65.16 Favored 'General case' 0 C--N 1.363 1.191 0 O-C-N 121.798 -0.564 . . . . 0.0 110.896 -178.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 85.1 tttt 73.16 76.43 0.14 Allowed 'General case' 0 C--N 1.36 1.031 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -144.9 -168.56 2.96 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -150.71 93.25 1.93 Allowed 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 14.1 m-30 -111.35 160.08 17.39 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 92.7 m -120.18 127.08 52.13 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 119.289 -0.964 . . . . 0.0 108.819 -178.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.527 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.5 mp -105.55 122.21 58.69 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 178.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.9 m -118.09 -173.01 2.36 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-O 121.851 0.834 . . . . 0.0 109.241 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.19 157.89 43.74 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -178.173 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 52.3 p -99.95 146.43 31.88 Favored Pre-proline 0 C--N 1.358 0.963 0 CA-C-O 122.344 1.069 . . . . 0.0 108.189 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.619 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 72.2 Cg_endo -76.35 -11.14 19.14 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.965 2.443 . . . . 0.0 115.052 -178.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -72.24 -41.29 66.97 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.474 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 36.2 p -117.54 15.82 14.62 Favored 'General case' 0 CA--C 1.505 -0.773 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.355 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.619 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.5 pp0? -65.59 -13.76 59.72 Favored 'General case' 0 C--N 1.355 0.807 0 O-C-N 121.657 -0.652 . . . . 0.0 110.341 178.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 46.6 p30 -125.43 39.76 3.89 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 19.8 t -139.72 144.93 37.75 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.617 ' O ' ' HB ' ' A' ' 171' ' ' THR . 61.9 mt-10 -98.71 164.43 12.23 Favored 'General case' 0 C--N 1.354 0.801 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.197 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.617 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 18.4 m 84.35 -60.76 0.1 Allowed 'General case' 0 C--N 1.369 1.44 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -107.2 117.74 34.88 Favored 'General case' 0 CA--C 1.503 -0.855 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.633 -178.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 97.9 t -131.26 132.96 62.9 Favored 'Isoleucine or valine' 0 C--N 1.357 0.923 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 178.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 49.9 mm -107.8 127.43 63.87 Favored 'Isoleucine or valine' 0 C--N 1.357 0.899 0 N-CA-C 107.877 -1.156 . . . . 0.0 107.877 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -115.66 156.14 26.43 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 122.073 0.94 . . . . 0.0 108.593 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -138.84 119.52 14.09 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.7 mp -114.56 118.86 59.88 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 106.395 -1.705 . . . . 0.0 106.395 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 86.1 m -128.2 143.55 51.05 Favored 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -177.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 70.3 mtm180 . . . . . 0 C--N 1.369 1.431 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.287 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.0 mtm . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.532 0.682 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.43 ' HA ' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -82.48 -9.34 59.47 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -178.998 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.33 -42.31 49.96 Favored Glycine 0 C--N 1.352 1.422 0 N-CA-C 108.734 -1.746 . . . . 0.0 108.734 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 61.5 mtt -66.68 -38.78 87.49 Favored 'General case' 0 C--N 1.357 0.893 0 O-C-N 122.13 -0.629 . . . . 0.0 111.21 -178.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.43 HG22 ' HA ' ' A' ' 2' ' ' MET . 34.7 m -69.23 -23.06 26.38 Favored 'Isoleucine or valine' 0 C--N 1.356 0.871 0 C-N-CA 120.178 -0.609 . . . . 0.0 109.91 -178.015 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -70.75 -37.25 73.42 Favored 'General case' 0 C--N 1.355 0.833 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.4 m -67.98 -41.07 82.92 Favored 'General case' 0 C--N 1.354 0.803 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.44 -38.97 97.19 Favored Glycine 0 C--N 1.357 1.702 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.63 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -65.5 -40.12 92.66 Favored 'General case' 0 C--N 1.351 0.652 0 O-C-N 122.384 -0.48 . . . . 0.0 110.733 -178.351 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.408 ' CE ' HD21 ' A' ' 26' ' ' LEU . 24.6 mmt -63.11 -40.42 97.56 Favored 'General case' 0 C--N 1.352 0.676 0 O-C-N 121.611 -0.681 . . . . 0.0 110.935 -178.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -67.33 -40.24 85.91 Favored 'General case' 0 C--N 1.348 0.526 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.438 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 53.7 tp -66.36 -43.07 87.04 Favored 'General case' 0 C--N 1.35 0.588 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -178.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.63 HG12 ' O ' ' A' ' 9' ' ' LEU . 1.1 mm -76.36 -36.05 28.48 Favored 'Isoleucine or valine' 0 C--N 1.36 1.04 0 O-C-N 120.924 -1.11 . . . . 0.0 111.113 -175.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -67.61 -43.18 81.07 Favored 'General case' 0 C--N 1.351 0.642 0 O-C-N 121.683 -0.636 . . . . 0.0 111.134 -176.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -72.32 -33.28 67.23 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 121.956 -0.465 . . . . 0.0 111.76 -177.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -72.49 -48.45 40.61 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -175.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -127.57 -21.12 3.85 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 117.5 -1.68 . . . . 0.0 113.49 -176.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 140.56 179.81 18.45 Favored Glycine 0 CA--C 1.497 -1.041 0 C-N-CA 118.007 -2.044 . . . . 0.0 109.489 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -96.33 -11.96 25.1 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -177.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -70.79 -41.4 71.69 Favored 'General case' 0 C--N 1.36 1.032 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 94.3 m -69.73 -38.89 77.04 Favored 'General case' 0 C--N 1.357 0.896 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.513 HD13 ' HB ' ' A' ' 13' ' ' ILE . 55.5 tp -60.48 -37.12 80.03 Favored 'General case' 0 C--N 1.356 0.873 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -65.09 -35.46 81.22 Favored 'General case' 0 C--N 1.357 0.899 0 O-C-N 122.255 -0.278 . . . . 0.0 110.725 -178.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.7 m -64.49 -40.25 95.32 Favored 'General case' 0 C--N 1.358 0.946 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -178.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.417 HD22 ' HB3' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -65.09 -36.71 85.17 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.563 ' HB3' HD23 ' A' ' 31' ' ' LEU . 83.7 mt -70.88 -14.88 62.55 Favored 'General case' 0 C--N 1.356 0.891 0 O-C-N 121.501 -0.749 . . . . 0.0 109.81 -179.039 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -87.82 -25.79 23.15 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.292 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.4 p -69.22 -24.33 64.01 Favored 'General case' 0 C--N 1.36 1.027 0 C-N-CA 119.7 -0.8 . . . . 0.0 109.085 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.621 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 1.9 p -107.42 -34.88 6.93 Favored 'General case' 0 C--N 1.359 0.992 0 C-N-CA 119.008 -1.077 . . . . 0.0 108.442 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.621 ' HB2' ' O ' ' A' ' 29' ' ' CYS . 12.2 mt-10 83.37 133.58 0.05 Allowed 'General case' 0 C--N 1.359 1.012 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.563 HD23 ' HB3' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -103.2 111.06 23.26 Favored 'General case' 0 C--N 1.359 1.001 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.577 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -73.07 -41.11 64.47 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.425 ' HB3' ' H ' ' A' ' 34' ' ' GLU . 0.6 OUTLIER -113.96 -88.68 0.55 Allowed 'General case' 0 C--N 1.355 0.828 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.074 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.425 ' H ' ' HB3' ' A' ' 33' ' ' SER . 60.5 mt-10 -120.55 -43.15 2.5 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -178.534 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.91 -34.64 5.11 Favored Glycine 0 C--N 1.351 1.393 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 78.9 mt -106.66 102.67 14.28 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.95 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.47 -136.9 0.06 Allowed 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.455 ' O ' ' HB3' ' A' ' 39' ' ' SER . 52.0 m -113.2 -59.65 1.99 Allowed 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -179.037 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.455 ' HB3' ' O ' ' A' ' 38' ' ' THR . 61.4 p 158.48 10.34 0.0 OUTLIER 'General case' 0 C--N 1.363 1.182 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -178.611 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.4 p -98.07 6.8 8.65 Favored 'Isoleucine or valine' 0 C--N 1.353 0.733 0 C-N-CA 120.251 -0.579 . . . . 0.0 110.902 -177.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -105.3 154.95 17.13 Favored Glycine 0 C--N 1.353 1.5 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.1 t -134.88 124.99 25.87 Favored 'General case' 0 C--N 1.357 0.901 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -109.46 175.75 5.33 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -72.18 175.33 6.13 Favored 'General case' 0 C--N 1.356 0.879 0 CA-C-O 121.638 0.733 . . . . 0.0 109.443 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 10.7 t60 -82.77 -24.86 33.27 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -178.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -65.81 -28.17 68.8 Favored 'General case' 0 C--N 1.356 0.875 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.2 tp10 -62.58 -39.74 94.68 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -68.15 -38.63 82.35 Favored 'General case' 0 C--N 1.357 0.915 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 59.2 tp -71.28 -32.38 68.62 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -177.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -66.76 -40.96 88.44 Favored 'General case' 0 N--CA 1.441 -0.878 0 O-C-N 122.02 -0.425 . . . . 0.0 110.027 -178.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 80.3 mt -82.47 -17.81 43.93 Favored 'General case' 0 C--N 1.357 0.898 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.191 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -81.56 -36.65 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 54.3 t -68.34 -41.49 83.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.417 ' HB3' HD22 ' A' ' 25' ' ' LEU . 22.6 tptt -69.17 -26.03 64.65 Favored 'General case' 0 C--N 1.365 1.245 0 C-N-CA 119.485 -0.886 . . . . 0.0 109.337 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.451 ' O ' HD23 ' A' ' 55' ' ' LEU . 3.4 tt -67.04 -37.09 83.46 Favored 'General case' 0 C--N 1.353 0.748 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.2 m -76.67 -16.99 59.39 Favored 'General case' 0 C--N 1.352 0.691 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.341 -178.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -97.95 -38.39 9.42 Favored 'General case' 0 C--N 1.353 0.717 0 O-C-N 121.314 -0.867 . . . . 0.0 111.278 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.2 p -73.18 -35.85 48.5 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 O-C-N 121.668 -0.645 . . . . 0.0 111.186 -177.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 61.2 m -111.71 -7.87 14.21 Favored 'General case' 0 CA--C 1.504 -0.821 0 C-N-CA 119.389 -0.924 . . . . 0.0 109.99 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 64.72 52.71 1.63 Allowed 'General case' 0 C--N 1.355 0.831 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.429 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 48.6 t -112.75 135.76 21.59 Favored Pre-proline 0 CA--C 1.504 -0.81 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 61' ' ' VAL . 31.2 Cg_exo -59.93 146.08 96.73 Favored 'Trans proline' 0 C--N 1.316 -1.178 0 C-N-CA 122.144 1.896 . . . . 0.0 112.464 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.2 m -73.55 -16.09 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.91 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.455 ' O ' HG12 ' A' ' 67' ' ' VAL . 67.5 p -96.24 -32.0 12.66 Favored 'General case' 0 C--N 1.359 0.981 0 C-N-CA 118.129 -1.429 . . . . 0.0 110.318 -178.236 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -80.19 -19.16 47.69 Favored 'General case' 0 C--N 1.353 0.724 0 O-C-N 121.162 -0.961 . . . . 0.0 108.864 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.401 ' HB3' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -80.17 -37.85 32.51 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.845 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.455 HG12 ' O ' ' A' ' 64' ' ' THR . 1.3 p -67.35 -28.38 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 C-N-CA 120.236 -0.586 . . . . 0.0 109.833 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 71.3 mtp180 -71.47 -50.51 30.92 Favored 'General case' 0 C--N 1.364 1.234 0 O-C-N 121.444 -0.785 . . . . 0.0 110.831 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.43 -36.01 82.79 Favored 'General case' 0 C--N 1.357 0.91 0 O-C-N 121.929 -0.482 . . . . 0.0 111.159 -178.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -61.02 -47.31 87.01 Favored 'General case' 0 C--N 1.349 0.577 0 O-C-N 122.154 -0.341 . . . . 0.0 110.388 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.74 -38.45 95.2 Favored Glycine 0 C--N 1.356 1.643 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 -178.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.08 -48.59 77.97 Favored 'General case' 0 C--N 1.35 0.609 0 CA-C-N 118.104 0.952 . . . . 0.0 111.45 -177.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.528 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 10.9 mttm -64.29 -48.0 77.33 Favored 'General case' 0 C--N 1.358 0.947 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -177.264 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.459 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.1 tm? -68.44 -39.28 81.57 Favored 'General case' 0 C--N 1.349 0.584 0 O-C-N 121.259 -0.9 . . . . 0.0 111.869 -175.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -63.97 -44.38 92.92 Favored 'General case' 0 C--N 1.352 0.69 0 O-C-N 121.248 -0.907 . . . . 0.0 111.06 -177.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.33 -15.27 18.44 Favored 'Isoleucine or valine' 0 C--N 1.359 1.009 0 O-C-N 121.486 -0.759 . . . . 0.0 108.953 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.528 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 14.7 mm-40 -71.67 -39.06 70.52 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 81.8 mt -73.32 -31.22 63.88 Favored 'General case' 0 C--N 1.359 0.984 0 O-C-N 122.301 -0.249 . . . . 0.0 110.505 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.9 mm -64.95 -53.56 40.01 Favored 'Isoleucine or valine' 0 C--N 1.359 1.013 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.956 -177.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -74.69 -15.0 60.81 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 119.693 -0.803 . . . . 0.0 109.36 178.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.65 -36.86 67.62 Favored Glycine 0 C--N 1.35 1.339 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.453 ' O ' HG22 ' A' ' 85' ' ' ILE . 59.5 m80 -132.44 104.97 13.27 Favored Pre-proline 0 N--CA 1.44 -0.941 0 CA-C-N 118.534 1.167 . . . . 0.0 109.499 -177.175 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.447 ' O ' ' HB2' ' A' ' 87' ' ' ASN . 34.8 Cg_exo -62.07 -29.58 81.53 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 123.018 2.479 . . . . 0.0 113.872 178.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -91.53 -8.37 47.72 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.453 HG22 ' O ' ' A' ' 82' ' ' HIS . 0.9 OUTLIER -86.71 -22.27 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 -178.765 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -104.57 -14.55 15.61 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 49.1 t30 -71.71 -40.85 69.21 Favored 'General case' 0 C--N 1.359 1.001 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -66.92 -30.95 71.23 Favored 'General case' 0 C--N 1.351 0.662 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.284 -178.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 17.5 ttp -83.93 150.16 25.86 Favored 'General case' 0 C--N 1.35 0.63 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.71 -22.31 7.49 Favored 'General case' 0 C--N 1.364 1.21 0 O-C-N 121.608 -0.683 . . . . 0.0 111.436 -177.056 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -165.28 172.03 12.86 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 119.083 -1.047 . . . . 0.0 108.277 -177.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.427 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 40.0 t -64.79 -43.3 93.66 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.056 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -66.13 -39.61 90.01 Favored 'General case' 0 C--N 1.355 0.847 0 O-C-N 121.414 -0.804 . . . . 0.0 109.138 -178.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -65.93 -24.35 66.8 Favored 'General case' 0 C--N 1.355 0.807 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.655 ' O ' HG12 ' A' ' 99' ' ' ILE . 61.7 tp -63.89 -47.16 81.73 Favored 'General case' 0 C--N 1.354 0.777 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.5 mp -60.58 -35.56 76.38 Favored 'General case' 0 C--N 1.36 1.054 0 O-C-N 122.215 -0.303 . . . . 0.0 110.345 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.8 t -68.49 -39.55 81.28 Favored 'General case' 0 C--N 1.348 0.526 0 O-C-N 122.03 -0.419 . . . . 0.0 109.967 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.06 1.26 54.67 Favored 'General case' 0 C--N 1.356 0.855 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -176.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.655 HG12 ' O ' ' A' ' 95' ' ' LEU . 23.4 mm -60.96 -47.16 94.79 Favored 'Isoleucine or valine' 0 C--N 1.359 0.989 0 CA-C-N 118.955 0.798 . . . . 0.0 112.089 -177.298 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -98.77 -20.63 16.79 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 118.273 -1.371 . . . . 0.0 111.282 -177.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.5 t -64.75 -48.48 74.4 Favored 'General case' 0 N--CA 1.445 -0.707 0 O-C-N 121.555 -0.716 . . . . 0.0 112.36 -178.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -136.51 -17.34 1.51 Allowed 'General case' 0 C--N 1.361 1.093 0 C-N-CA 117.174 -1.811 . . . . 0.0 113.536 -176.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.472 HD12 HD13 ' A' ' 99' ' ' ILE . 96.4 mt -71.56 -50.78 37.42 Favored 'Isoleucine or valine' 0 C--O 1.244 0.771 0 CA-C-N 120.574 1.534 . . . . 0.0 111.215 -177.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 28.8 m170 -89.83 1.5 56.08 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 119.628 -0.829 . . . . 0.0 110.107 -177.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 55.7 t -90.19 -41.73 13.74 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.053 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 54.7 tp10 -68.33 -40.02 81.73 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.5 p -74.05 -35.6 42.07 Favored 'Isoleucine or valine' 0 C--N 1.356 0.867 0 C-N-CA 119.18 -1.008 . . . . 0.0 109.708 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 94.2 t80 -61.26 -48.61 80.63 Favored 'General case' 0 C--N 1.364 1.203 0 O-C-N 121.775 -0.578 . . . . 0.0 110.526 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -61.48 -37.13 82.5 Favored 'General case' 0 C--N 1.358 0.948 0 O-C-N 121.742 -0.599 . . . . 0.0 110.162 -178.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 110' ' ' LEU . 13.6 mt -56.21 -74.47 0.05 OUTLIER 'General case' 0 C--N 1.357 0.922 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.412 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 87.3 m-85 -118.41 133.74 23.49 Favored Pre-proline 0 N--CA 1.439 -0.98 0 C-N-CA 118.978 -1.089 . . . . 0.0 108.538 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 111' ' ' TYR . 96.2 Cg_endo -83.54 -1.48 10.17 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 123.31 2.674 . . . . 0.0 115.52 -178.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -65.73 -37.85 87.55 Favored 'General case' 0 C--N 1.355 0.835 0 O-C-N 121.746 -0.597 . . . . 0.0 110.092 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.38 145.11 56.58 Favored 'General case' 0 C--N 1.354 0.769 0 CA-C-O 121.513 0.673 . . . . 0.0 110.149 -178.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -131.93 135.66 46.79 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.526 ' HB3' ' HD2' ' A' ' 117' ' ' PRO . 93.1 mt -128.96 157.62 75.17 Favored Pre-proline 0 C--N 1.354 0.795 0 CA-C-O 122.098 0.952 . . . . 0.0 109.224 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.526 ' HD2' ' HB3' ' A' ' 116' ' ' LEU . 87.4 Cg_endo -81.35 -150.91 0.04 OUTLIER 'Trans proline' 0 C--N 1.318 -1.059 0 C-N-CA 123.685 2.923 . . . . 0.0 113.933 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -116.7 141.86 47.65 Favored 'General case' 0 C--N 1.364 1.238 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -130.34 133.14 46.2 Favored 'General case' 0 C--N 1.362 1.125 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 94.2 m -127.31 129.16 47.15 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 177.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 77.6 m -119.26 129.29 54.84 Favored 'General case' 0 C--N 1.355 0.808 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.382 -178.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -119.63 133.83 55.48 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -106.63 116.81 32.58 Favored 'General case' 0 C--N 1.352 0.716 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.472 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 94.6 mt -85.54 -23.73 27.56 Favored 'General case' 0 C--N 1.354 0.763 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.203 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -179.59 -144.72 6.0 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -94.02 -40.25 10.19 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 119.993 -0.683 . . . . 0.0 109.254 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -102.51 3.83 37.95 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.985 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.472 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 66.3 m-20 -118.13 129.02 55.28 Favored 'General case' 0 C--N 1.356 0.866 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 10.0 mm -141.25 133.53 29.37 Favored 'Isoleucine or valine' 0 C--N 1.356 0.854 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 58.8 mtm180 -116.57 139.75 50.15 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -127.68 118.11 23.22 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -97.15 132.63 42.74 Favored 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -128.7 120.18 26.0 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -178.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.558 ' HA ' ' O ' ' A' ' 171' ' ' THR . 74.4 mt-30 -115.0 111.77 21.64 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 107.599 -1.259 . . . . 0.0 107.599 178.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.4 t -162.16 153.86 18.61 Favored 'General case' 0 C--N 1.359 0.981 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -90.6 3.08 55.09 Favored 'General case' 0 C--N 1.354 0.782 0 C-N-CA 120.267 -0.573 . . . . 0.0 109.743 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -133.47 74.73 70.83 Favored Pre-proline 0 C--N 1.355 0.806 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -95.36 104.44 0.11 Allowed 'Trans proline' 0 N--CA 1.444 -1.407 0 C-N-CA 122.756 2.304 . . . . 0.0 115.746 -177.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -111.71 110.56 21.0 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 176.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.37 -38.88 92.57 Favored 'General case' 0 C--N 1.354 0.773 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.288 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.1 m -63.28 -26.63 68.86 Favored 'General case' 0 C--N 1.355 0.826 0 O-C-N 121.96 -0.463 . . . . 0.0 110.597 -178.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -75.58 -47.02 28.49 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.554 -178.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.78 -40.08 94.66 Favored 'General case' 0 C--N 1.358 0.96 0 O-C-N 122.154 -0.342 . . . . 0.0 111.226 -178.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.24 -36.91 85.22 Favored 'General case' 0 C--N 1.355 0.812 0 O-C-N 121.852 -0.53 . . . . 0.0 109.985 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.56 -43.71 98.59 Favored Glycine 0 C--N 1.346 1.096 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.3 mt -70.23 -40.34 74.56 Favored 'General case' 0 C--N 1.351 0.671 0 O-C-N 122.126 -0.632 . . . . 0.0 112.639 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 98.2 mt -71.2 -43.24 67.76 Favored 'General case' 0 C--N 1.361 1.068 0 O-C-N 121.21 -0.931 . . . . 0.0 111.115 -176.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.531 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 37.1 t70 -70.54 -29.54 66.03 Favored 'General case' 0 N--CA 1.443 -0.778 0 O-C-N 121.839 -0.538 . . . . 0.0 110.392 -179.172 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.453 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -63.17 -39.47 97.98 Favored Glycine 0 C--N 1.357 1.73 0 N-CA-C 108.464 -1.854 . . . . 0.0 108.464 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 47.9 t -60.38 -41.93 94.81 Favored 'General case' 0 C--N 1.351 0.632 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -75.83 0.17 19.05 Favored 'General case' 0 C--N 1.36 1.029 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.531 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 76.8 mm-40 -85.51 -46.39 10.9 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -66.36 -44.67 82.54 Favored 'General case' 0 C--N 1.36 1.033 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.411 ' O ' ' HB2' ' A' ' 155' ' ' LYS . 52.5 m-85 -69.96 -26.49 64.14 Favored 'General case' 0 C--N 1.36 1.028 0 O-C-N 121.872 -0.517 . . . . 0.0 111.137 -178.24 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 154' ' ' PHE . 44.1 mttt 71.43 71.78 0.17 Allowed 'General case' 0 C--N 1.363 1.154 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 -178.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.443 ' HB3' ' CE1' ' A' ' 158' ' ' PHE . 3.0 tp10 -141.26 -168.69 2.69 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -140.33 116.34 10.42 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.443 ' CE1' ' HB3' ' A' ' 156' ' ' GLU . 91.2 m-85 -133.65 149.86 51.57 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 92.1 m -120.94 127.59 51.97 Favored 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.529 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.6 mp -103.8 120.89 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 3.1 m -114.5 -177.6 3.17 Favored 'General case' 0 C--N 1.36 1.034 0 CA-C-O 121.708 0.766 . . . . 0.0 109.193 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -146.93 154.6 41.46 Favored 'General case' 0 C--N 1.355 0.847 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -178.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 54.2 p -97.4 146.5 31.48 Favored Pre-proline 0 C--N 1.358 0.961 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.672 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 72.3 Cg_endo -76.19 -11.2 19.4 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.941 2.427 . . . . 0.0 114.918 -178.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -72.63 -41.14 65.83 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.714 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 35.7 p -118.42 15.52 13.84 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.704 -178.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.672 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.1 pp0? -67.06 -13.57 62.06 Favored 'General case' 0 C--N 1.354 0.765 0 O-C-N 121.546 -0.721 . . . . 0.0 110.263 178.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 53.8 p-10 -121.09 35.1 4.99 Favored 'General case' 0 N--CA 1.438 -1.028 0 O-C-N 121.188 -0.945 . . . . 0.0 108.706 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 58.2 m -136.12 148.63 48.32 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.625 ' O ' ' HB ' ' A' ' 171' ' ' THR . 61.4 mt-10 -101.74 166.29 10.75 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.625 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 3.4 m 81.65 -59.04 0.23 Allowed 'General case' 0 C--N 1.37 1.469 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -107.8 117.77 34.98 Favored 'General case' 0 CA--C 1.507 -0.706 0 C-N-CA 119.916 -0.713 . . . . 0.0 109.565 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 90.7 t -132.0 133.44 60.8 Favored 'Isoleucine or valine' 0 C--N 1.357 0.922 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 178.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 50.1 mm -109.95 126.72 67.15 Favored 'Isoleucine or valine' 0 C--N 1.358 0.971 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -113.96 150.36 33.91 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -133.93 83.31 2.03 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.206 -178.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.6 mp -76.94 119.52 25.5 Favored 'Isoleucine or valine' 0 C--N 1.358 0.947 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 92.3 m -118.53 144.4 46.08 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 54.8 ttp180 . . . . . 0 C--N 1.36 1.027 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 -178.904 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.8 mmm . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.041 0.448 . . . . 0.0 110.018 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.463 ' HA ' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -77.18 -17.44 58.55 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 120.586 -0.446 . . . . 0.0 109.969 -178.498 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.76 -44.62 30.96 Favored Glycine 0 C--N 1.35 1.356 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 75.7 mtm -71.43 -33.79 69.7 Favored 'General case' 0 C--N 1.354 0.782 0 O-C-N 122.073 -0.663 . . . . 0.0 111.377 -177.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.463 HG22 ' HA ' ' A' ' 2' ' ' MET . 30.7 m -70.76 -22.89 23.53 Favored 'Isoleucine or valine' 0 C--N 1.357 0.9 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.064 -179.211 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.442 ' HZ ' ' CG ' ' A' ' 47' ' ' GLU . 1.7 m-30 -71.47 -35.31 70.79 Favored 'General case' 0 C--N 1.357 0.917 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 88.9 m -66.41 -39.67 89.13 Favored 'General case' 0 C--N 1.357 0.902 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.23 -37.88 95.28 Favored Glycine 0 C--N 1.357 1.71 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.618 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -66.89 -39.71 87.54 Favored 'General case' 0 C--N 1.354 0.773 0 CA-C-N 117.291 0.545 . . . . 0.0 110.526 -178.282 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 22.6 mmt -63.53 -41.42 98.46 Favored 'General case' 0 C--N 1.355 0.835 0 O-C-N 121.618 -0.676 . . . . 0.0 111.013 -178.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -66.34 -40.4 89.84 Favored 'General case' 0 C--N 1.347 0.493 0 O-C-N 122.148 -0.345 . . . . 0.0 111.702 -177.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 55.8 tp -66.03 -43.06 88.69 Favored 'General case' 0 C--N 1.349 0.583 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 -178.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.618 HG12 ' O ' ' A' ' 9' ' ' LEU . 1.7 mm -74.61 -36.45 40.96 Favored 'Isoleucine or valine' 0 C--N 1.358 0.935 0 O-C-N 121.003 -1.06 . . . . 0.0 111.155 -175.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -66.95 -42.53 85.06 Favored 'General case' 0 C--N 1.351 0.659 0 O-C-N 121.82 -0.55 . . . . 0.0 111.286 -176.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -75.04 -30.89 61.19 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 121.83 -0.544 . . . . 0.0 111.773 -177.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -72.96 -48.67 34.7 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.736 -175.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -127.72 -22.13 3.63 Favored 'General case' 0 CA--C 1.503 -0.849 0 C-N-CA 117.609 -1.636 . . . . 0.0 112.846 -176.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 146.34 178.69 21.94 Favored Glycine 0 N--CA 1.44 -1.077 0 C-N-CA 117.671 -2.204 . . . . 0.0 110.494 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -96.7 -17.5 20.28 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -70.3 -40.17 74.39 Favored 'General case' 0 C--N 1.361 1.089 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 94.5 m -68.28 -38.54 81.81 Favored 'General case' 0 C--N 1.357 0.918 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 178.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 27.1 tp -60.68 -36.49 78.9 Favored 'General case' 0 C--N 1.355 0.839 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -65.15 -37.12 86.39 Favored 'General case' 0 C--N 1.359 0.984 0 O-C-N 121.998 -0.439 . . . . 0.0 110.461 -178.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.7 m -65.67 -37.75 87.38 Favored 'General case' 0 C--N 1.355 0.811 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 23.4 tp -62.39 -40.73 97.44 Favored 'General case' 0 C--N 1.354 0.764 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.484 ' HB3' HD23 ' A' ' 31' ' ' LEU . 6.8 mp -74.94 -11.35 60.1 Favored 'General case' 0 C--N 1.36 1.031 0 O-C-N 121.693 -0.629 . . . . 0.0 110.483 -178.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -85.7 -29.21 24.14 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 119.254 -0.978 . . . . 0.0 108.925 178.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.7 t -67.13 -37.52 83.98 Favored 'General case' 0 C--N 1.357 0.92 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.646 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 1.8 p -89.81 -38.99 13.39 Favored 'General case' 0 C--N 1.359 1.011 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.646 ' HB2' ' O ' ' A' ' 29' ' ' CYS . 10.6 mt-10 85.61 132.39 0.04 OUTLIER 'General case' 0 C--N 1.362 1.119 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.484 HD23 ' HB3' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -108.58 122.18 46.55 Favored 'General case' 0 C--N 1.357 0.898 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.433 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -94.25 -38.03 11.24 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -104.77 -78.16 0.57 Allowed 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.234 -178.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -137.24 -55.56 0.7 Allowed 'General case' 0 CA--C 1.502 -0.888 0 C-N-CA 119.609 -0.836 . . . . 0.0 108.853 -178.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 128.91 -52.11 0.84 Allowed Glycine 0 C--N 1.352 1.458 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 78.4 mt -97.67 95.29 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.755 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.608 ' CD2' HG23 ' A' ' 40' ' ' VAL . 1.2 t80 -65.38 -50.94 63.65 Favored 'General case' 0 C--N 1.36 1.059 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.461 HG22 ' N ' ' A' ' 39' ' ' SER . 1.1 m 143.58 -64.32 0.0 OUTLIER 'General case' 0 C--N 1.368 1.406 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 178.4 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.461 ' N ' HG22 ' A' ' 38' ' ' THR . 16.5 p 169.59 70.39 0.0 OUTLIER 'General case' 0 C--N 1.364 1.208 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.608 HG23 ' CD2' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -164.52 1.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.938 0 C-N-CA 119.853 -0.739 . . . . 0.0 109.695 -179.811 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.5 146.73 17.35 Favored Glycine 0 C--N 1.353 1.526 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 53.4 m -123.93 124.71 43.2 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -116.45 175.18 5.68 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -82.07 -172.62 4.05 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -92.42 -14.68 28.21 Favored 'General case' 0 N--CA 1.439 -0.975 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.365 -179.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -70.22 -28.44 65.27 Favored 'General case' 0 C--N 1.354 0.764 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.442 ' CG ' ' HZ ' ' A' ' 6' ' ' PHE . 26.0 tp10 -63.2 -40.3 97.09 Favored 'General case' 0 C--N 1.353 0.726 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.412 HD22 ' O ' ' A' ' 48' ' ' LEU . 2.0 tm? -67.68 -38.29 83.52 Favored 'General case' 0 C--N 1.358 0.942 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 58.5 tp -74.17 -29.35 61.73 Favored 'General case' 0 N--CA 1.447 -0.598 0 O-C-N 122.088 -0.382 . . . . 0.0 110.259 -176.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -68.28 -41.02 81.62 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 121.835 -0.54 . . . . 0.0 109.561 -178.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 63.2 mt -83.98 -15.92 45.94 Favored 'General case' 0 C--N 1.361 1.072 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.666 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.4 t -81.85 -35.76 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 52.2 t -70.7 -39.84 76.23 Favored 'Isoleucine or valine' 0 C--N 1.354 0.791 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.0 tptt -67.19 -28.54 68.18 Favored 'General case' 0 C--N 1.36 1.048 0 O-C-N 121.266 -0.896 . . . . 0.0 108.622 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.417 ' O ' HD23 ' A' ' 55' ' ' LEU . 2.5 tt -67.99 -37.79 81.91 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 60.0 p -72.32 -17.65 61.84 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.741 -178.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -101.44 -35.32 9.23 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 119.278 -0.969 . . . . 0.0 111.049 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.8 p -73.61 -36.86 48.44 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 O-C-N 121.797 -0.565 . . . . 0.0 111.081 -177.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 73.0 m -113.17 -6.97 13.62 Favored 'General case' 0 CA--C 1.504 -0.825 0 C-N-CA 119.512 -0.875 . . . . 0.0 110.161 -177.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 64.35 48.63 2.74 Favored 'General case' 0 C--N 1.356 0.858 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.562 HG13 ' HD2' ' A' ' 62' ' ' PRO . 49.8 t -113.6 135.5 21.93 Favored Pre-proline 0 CA--C 1.505 -0.774 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.67 ' HG2' ' HB2' ' A' ' 65' ' ' GLU . 23.4 Cg_endo -62.57 149.12 92.12 Favored 'Trans proline' 0 CA--C 1.5 -1.203 0 C-N-CA 122.276 1.984 . . . . 0.0 112.518 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.2 m -75.98 -13.67 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.319 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.45 ' O ' HG12 ' A' ' 67' ' ' VAL . 72.1 p -95.22 -33.99 12.39 Favored 'General case' 0 C--N 1.356 0.878 0 C-N-CA 118.207 -1.397 . . . . 0.0 109.747 -178.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.67 ' HB2' ' HG2' ' A' ' 62' ' ' PRO . 97.9 mt-10 -78.02 -21.84 50.15 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 121.336 -0.853 . . . . 0.0 108.978 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.52 -37.48 36.54 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 64' ' ' THR . 1.7 p -67.47 -26.9 36.84 Favored 'Isoleucine or valine' 0 C--N 1.355 0.812 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.902 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.9 mmm-85 -71.98 -51.15 23.33 Favored 'General case' 0 C--N 1.363 1.184 0 O-C-N 121.549 -0.719 . . . . 0.0 110.451 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.2 mt -63.24 -36.06 82.41 Favored 'General case' 0 C--N 1.357 0.922 0 O-C-N 121.963 -0.461 . . . . 0.0 110.953 -178.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -60.58 -46.83 88.77 Favored 'General case' 0 C--N 1.348 0.541 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -178.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.39 -38.42 94.71 Favored Glycine 0 C--N 1.352 1.455 0 N-CA-C 111.74 -0.544 . . . . 0.0 111.74 -178.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -63.16 -48.38 78.68 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-N 118.499 1.149 . . . . 0.0 111.547 -177.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.707 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 16.2 mttm -63.76 -49.41 73.08 Favored 'General case' 0 C--N 1.359 1.006 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -176.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.413 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.4 tm? -68.65 -39.71 80.58 Favored 'General case' 0 C--N 1.349 0.559 0 O-C-N 121.125 -0.985 . . . . 0.0 111.973 -175.329 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -63.86 -44.35 93.39 Favored 'General case' 0 C--N 1.352 0.702 0 O-C-N 121.196 -0.94 . . . . 0.0 111.187 -177.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -70.33 -15.51 19.16 Favored 'Isoleucine or valine' 0 C--N 1.359 0.986 0 O-C-N 121.41 -0.806 . . . . 0.0 109.261 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.707 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 74.5 mm-40 -72.17 -38.33 69.16 Favored 'General case' 0 C--N 1.351 0.651 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 81.4 mt -74.25 -29.11 61.54 Favored 'General case' 0 C--N 1.357 0.9 0 O-C-N 122.311 -0.243 . . . . 0.0 110.543 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.8 mm -67.06 -54.16 27.12 Favored 'Isoleucine or valine' 0 C--N 1.359 1.007 0 C-N-CA 119.993 -0.683 . . . . 0.0 109.897 -177.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -74.63 -14.66 60.79 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 119.686 -0.806 . . . . 0.0 109.285 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.55 -37.25 62.23 Favored Glycine 0 C--N 1.348 1.228 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -134.01 104.16 11.67 Favored Pre-proline 0 N--CA 1.441 -0.88 0 CA-C-O 122.494 1.14 . . . . 0.0 109.026 -177.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.48 ' O ' ' HB2' ' A' ' 87' ' ' ASN . 37.6 Cg_endo -67.98 -23.2 40.85 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.556 2.171 . . . . 0.0 114.004 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -90.01 -8.38 51.72 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.4 tp -89.63 -22.81 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -178.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -102.51 -15.95 16.28 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 49.1 t30 -71.74 -40.92 69.07 Favored 'General case' 0 C--N 1.36 1.061 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -67.1 -29.21 68.9 Favored 'General case' 0 C--N 1.353 0.756 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.209 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 23.7 ttp -84.4 148.1 26.78 Favored 'General case' 0 C--N 1.351 0.652 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.5 -21.96 8.37 Favored 'General case' 0 C--N 1.363 1.193 0 C-N-CA 119.934 -0.707 . . . . 0.0 111.025 -177.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -165.3 171.66 13.28 Favored 'General case' 0 C--N 1.354 0.778 0 C-N-CA 119.045 -1.062 . . . . 0.0 108.338 -177.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 39.6 t -64.62 -42.13 95.71 Favored 'General case' 0 C--N 1.356 0.884 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.864 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -66.46 -39.11 88.63 Favored 'General case' 0 C--N 1.356 0.884 0 O-C-N 121.528 -0.733 . . . . 0.0 109.292 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -65.61 -25.72 67.51 Favored 'General case' 0 C--N 1.357 0.912 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 64.5 tp -62.94 -46.22 88.77 Favored 'General case' 0 C--N 1.355 0.826 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.7 mp -62.5 -32.5 73.43 Favored 'General case' 0 C--N 1.353 0.752 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 37.1 t -62.4 -45.37 93.44 Favored 'General case' 0 C--N 1.356 0.857 0 O-C-N 121.719 -0.613 . . . . 0.0 111.22 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.97 28.88 8.42 Favored 'General case' 0 C--N 1.36 1.049 0 C-N-CA 119.304 -0.958 . . . . 0.0 110.462 -178.126 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.4 tt -62.3 -29.17 46.07 Favored 'Isoleucine or valine' 0 C--N 1.356 0.868 0 O-C-N 122.152 -0.343 . . . . 0.0 110.537 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -127.15 -11.43 5.85 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 118.696 -1.202 . . . . 0.0 109.097 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.4 t -68.31 -45.55 72.67 Favored 'General case' 0 N--CA 1.439 -0.977 0 O-C-N 121.879 -0.513 . . . . 0.0 109.901 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.479 ' O ' HG12 ' A' ' 105' ' ' VAL . 19.3 t80 -123.83 -29.53 3.67 Favored 'General case' 0 C--N 1.36 1.049 0 C-N-CA 118.38 -1.328 . . . . 0.0 111.549 -178.122 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 96.2 mt -69.75 -48.4 64.94 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 O-C-N 121.076 -1.015 . . . . 0.0 110.487 -177.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -89.03 3.65 50.97 Favored 'General case' 0 N--CA 1.44 -0.954 0 O-C-N 121.105 -0.997 . . . . 0.0 109.916 -177.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.479 HG12 ' O ' ' A' ' 102' ' ' PHE . 1.9 p -87.68 -33.98 7.04 Favored 'Isoleucine or valine' 0 C--N 1.357 0.899 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 178.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -71.64 -40.12 69.91 Favored 'General case' 0 C--N 1.36 1.049 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 62.2 t -62.82 -47.06 94.63 Favored 'Isoleucine or valine' 0 C--N 1.357 0.909 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.276 -179.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -60.2 -48.61 81.02 Favored 'General case' 0 C--N 1.357 0.931 0 O-C-N 122.115 -0.366 . . . . 0.0 111.466 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -60.61 -38.93 86.33 Favored 'General case' 0 C--N 1.355 0.833 0 O-C-N 121.547 -0.721 . . . . 0.0 110.609 -178.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 19.6 mt -58.26 -75.64 0.05 OUTLIER 'General case' 0 C--N 1.354 0.804 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -115.29 132.97 22.8 Favored Pre-proline 0 N--CA 1.442 -0.874 0 C-N-CA 118.906 -1.117 . . . . 0.0 108.9 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -84.54 -3.4 10.0 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 123.176 2.584 . . . . 0.0 115.056 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -66.42 -36.6 83.21 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 122.001 -0.437 . . . . 0.0 109.948 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.4 146.34 54.13 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 121.714 0.769 . . . . 0.0 110.219 -178.344 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -130.54 135.18 47.67 Favored 'General case' 0 C--N 1.358 0.949 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.529 ' HB3' ' HD2' ' A' ' 117' ' ' PRO . 87.5 mt -127.03 157.0 73.44 Favored Pre-proline 0 N--CA 1.444 -0.756 0 CA-C-O 122.193 0.997 . . . . 0.0 109.394 -178.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.529 ' HD2' ' HB3' ' A' ' 116' ' ' LEU . 89.6 Cg_endo -80.37 -157.44 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -0.987 0 C-N-CA 123.914 3.076 . . . . 0.0 114.163 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -114.23 142.47 46.23 Favored 'General case' 0 C--N 1.367 1.332 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -124.0 127.85 48.51 Favored 'General case' 0 C--N 1.361 1.067 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -178.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.537 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 94.7 m -124.7 128.51 48.91 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 177.403 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 78.4 m -122.63 131.17 53.69 Favored 'General case' 0 CA--C 1.504 -0.825 0 C-N-CA 119.061 -1.055 . . . . 0.0 109.929 -177.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -118.15 149.52 40.92 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 177.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -121.2 117.74 27.85 Favored 'General case' 0 C--N 1.353 0.748 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -179.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 97.2 mt -93.37 -13.93 27.46 Favored 'General case' 0 C--N 1.356 0.856 0 C-N-CA 120.431 -0.507 . . . . 0.0 110.603 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 173.29 -149.16 10.88 Favored Glycine 0 C--N 1.348 1.226 0 C-N-CA 118.761 -1.685 . . . . 0.0 109.171 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -94.15 -37.91 11.34 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -103.6 5.79 36.79 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 120.166 -0.614 . . . . 0.0 109.39 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -121.49 127.85 51.48 Favored 'General case' 0 C--N 1.359 0.979 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.3 mm -141.71 135.95 30.59 Favored 'Isoleucine or valine' 0 C--N 1.354 0.787 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 53.2 mtm180 -115.94 140.11 49.57 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 7.5 tp -126.79 118.64 25.07 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.654 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.537 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 12.6 m-70 -99.15 133.11 43.9 Favored 'General case' 0 CA--C 1.497 -1.087 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -127.46 120.54 28.61 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.466 ' HA ' ' O ' ' A' ' 171' ' ' THR . 36.2 tt0 -114.78 111.7 21.65 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 15.9 t -161.7 152.53 17.91 Favored 'General case' 0 C--N 1.359 0.986 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -90.82 1.49 56.89 Favored 'General case' 0 C--N 1.357 0.93 0 C-N-CA 120.245 -0.582 . . . . 0.0 109.95 -178.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -135.35 74.28 61.43 Favored Pre-proline 0 C--N 1.355 0.821 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -96.72 110.51 0.11 Allowed 'Trans proline' 0 N--CA 1.444 -1.429 0 C-N-CA 122.752 2.301 . . . . 0.0 116.03 -177.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -112.85 112.59 24.18 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 176.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.88 -38.59 91.64 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.116 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 74.0 m -63.21 -28.81 70.3 Favored 'General case' 0 C--N 1.354 0.783 0 O-C-N 121.927 -0.483 . . . . 0.0 110.689 -178.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -74.16 -46.82 39.91 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 120.236 -0.586 . . . . 0.0 109.719 -177.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.95 -39.67 93.85 Favored 'General case' 0 C--N 1.357 0.908 0 O-C-N 122.176 -0.327 . . . . 0.0 111.351 -177.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -63.09 -37.47 87.33 Favored 'General case' 0 C--N 1.355 0.83 0 O-C-N 121.872 -0.517 . . . . 0.0 110.164 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.54 -43.26 99.07 Favored Glycine 0 C--N 1.347 1.162 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 82.7 mt -70.07 -40.51 74.99 Favored 'General case' 0 C--N 1.351 0.657 0 CA-C-N 117.521 0.66 . . . . 0.0 112.724 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 98.0 mt -70.89 -42.39 70.04 Favored 'General case' 0 C--N 1.361 1.103 0 O-C-N 121.146 -0.971 . . . . 0.0 110.829 -176.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -70.4 -30.01 66.79 Favored 'General case' 0 N--CA 1.444 -0.735 0 O-C-N 121.953 -0.467 . . . . 0.0 110.677 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.524 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -63.55 -39.59 97.79 Favored Glycine 0 C--N 1.356 1.688 0 N-CA-C 108.622 -1.791 . . . . 0.0 108.622 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 43.5 t -60.36 -42.99 96.91 Favored 'General case' 0 C--N 1.351 0.64 0 N-CA-C 109.146 -0.686 . . . . 0.0 109.146 178.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -78.83 2.66 19.2 Favored 'General case' 0 C--N 1.359 0.981 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.524 ' HB2' ' O ' ' A' ' 149' ' ' GLY . 24.3 mm-40 -84.56 -48.25 9.73 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -68.67 -40.65 80.05 Favored 'General case' 0 C--N 1.357 0.925 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.504 ' O ' ' HB2' ' A' ' 155' ' ' LYS . 9.1 m-30 -70.46 -26.73 63.77 Favored 'General case' 0 C--N 1.36 1.059 0 O-C-N 121.741 -0.599 . . . . 0.0 111.154 -178.359 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.504 ' HB2' ' O ' ' A' ' 154' ' ' PHE . 56.8 mtpt 73.2 64.85 0.1 Allowed 'General case' 0 C--N 1.361 1.103 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -178.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -127.16 -179.33 4.81 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -142.3 89.22 2.14 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 17.3 m-30 -115.14 156.7 24.79 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 93.7 m -118.79 127.73 53.8 Favored 'General case' 0 C--N 1.356 0.867 0 C-N-CA 119.462 -0.895 . . . . 0.0 108.831 -178.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.517 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.6 mp -102.88 121.84 54.53 Favored 'Isoleucine or valine' 0 C--N 1.352 0.698 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 178.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -118.05 -173.29 2.42 Favored 'General case' 0 C--N 1.356 0.884 0 CA-C-O 121.801 0.81 . . . . 0.0 109.524 -178.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 26.5 ptt180 -147.54 156.45 42.85 Favored 'General case' 0 C--N 1.357 0.894 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 48.2 p -100.1 146.26 31.62 Favored Pre-proline 0 C--N 1.358 0.967 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.674 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 74.7 Cg_endo -76.83 -11.09 18.32 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.819 2.346 . . . . 0.0 115.234 -178.442 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -72.66 -41.5 65.33 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.589 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 35.5 p -117.83 16.27 14.36 Favored 'General case' 0 C--N 1.354 0.771 0 C-N-CA 120.069 -0.652 . . . . 0.0 110.443 -178.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.674 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.2 pp0? -66.6 -11.34 52.99 Favored 'General case' 0 C--N 1.353 0.743 0 O-C-N 121.595 -0.69 . . . . 0.0 110.457 178.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -126.56 38.54 4.1 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 58.9 m -137.6 147.11 44.76 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.624 ' O ' ' HB ' ' A' ' 171' ' ' THR . 60.5 mt-10 -101.27 165.23 11.39 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.624 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 19.9 m 84.75 -60.37 0.09 Allowed 'General case' 0 C--N 1.367 1.355 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -109.24 117.38 33.95 Favored 'General case' 0 CA--C 1.502 -0.878 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.43 -178.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 90.8 t -130.73 133.08 63.82 Favored 'Isoleucine or valine' 0 C--N 1.356 0.883 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 49.9 mm -108.53 126.89 65.31 Favored 'Isoleucine or valine' 0 C--N 1.358 0.958 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -115.93 156.62 25.89 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.414 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -137.94 118.94 14.33 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.2 mp -114.15 120.16 63.19 Favored 'Isoleucine or valine' 0 C--N 1.352 0.696 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 43.1 p -121.17 159.49 25.75 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-O 121.763 0.792 . . . . 0.0 110.662 -177.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.361 1.07 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 177.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.767 ' HG2' ' HG3' ' A' ' 4' ' ' MET . 51.9 tpp . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.038 0.447 . . . . 0.0 110.475 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.44 ' O ' ' HD1' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -82.14 -14.98 54.9 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.383 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -71.93 -41.5 54.99 Favored Glycine 0 C--N 1.351 1.405 0 N-CA-C 108.558 -1.817 . . . . 0.0 108.558 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' MET . . . . . 0.767 ' HG3' ' HG2' ' A' ' 1' ' ' MET . 67.8 mtt -66.35 -38.22 87.13 Favored 'General case' 0 C--N 1.356 0.849 0 O-C-N 122.316 -0.52 . . . . 0.0 111.555 -178.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.4 m -69.38 -23.93 27.05 Favored 'Isoleucine or valine' 0 C--N 1.357 0.914 0 C-N-CA 119.996 -0.682 . . . . 0.0 109.847 -177.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.577 ' HZ ' ' HG2' ' A' ' 47' ' ' GLU . 4.6 m-85 -71.36 -35.8 71.25 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 85.3 m -67.77 -41.31 83.47 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.38 -38.98 97.18 Favored Glycine 0 C--N 1.357 1.727 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.611 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -66.05 -39.87 90.49 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-N 117.338 0.569 . . . . 0.0 110.704 -178.336 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.418 ' CE ' HD11 ' A' ' 26' ' ' LEU . 25.6 mmt -64.14 -39.81 94.82 Favored 'General case' 0 C--N 1.351 0.662 0 O-C-N 121.802 -0.561 . . . . 0.0 110.847 -178.291 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.6 -39.83 88.57 Favored 'General case' 0 C--N 1.35 0.604 0 O-C-N 121.974 -0.454 . . . . 0.0 111.148 -178.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 56.0 tp -66.86 -42.83 85.02 Favored 'General case' 0 C--N 1.35 0.593 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.611 HG12 ' O ' ' A' ' 9' ' ' LEU . 2.2 mm -75.32 -36.42 36.23 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 O-C-N 121.053 -1.029 . . . . 0.0 111.074 -175.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -70.01 -42.6 72.81 Favored 'General case' 0 C--N 1.353 0.725 0 O-C-N 121.725 -0.609 . . . . 0.0 111.181 -176.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -71.3 -32.83 69.11 Favored 'General case' 0 N--CA 1.444 -0.735 0 O-C-N 122.002 -0.436 . . . . 0.0 111.219 -177.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -72.61 -50.51 24.82 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -175.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -128.91 -19.32 3.64 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 117.365 -1.734 . . . . 0.0 113.721 -176.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 142.08 179.66 19.25 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 117.594 -2.241 . . . . 0.0 110.134 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -96.06 -11.38 26.45 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -177.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -70.31 -40.23 74.34 Favored 'General case' 0 C--N 1.36 1.062 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 92.6 m -68.74 -39.03 80.54 Favored 'General case' 0 C--N 1.357 0.908 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.0 tt -60.36 -38.73 84.76 Favored 'General case' 0 C--N 1.359 0.99 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -63.98 -37.51 87.66 Favored 'General case' 0 C--N 1.355 0.828 0 O-C-N 122.085 -0.385 . . . . 0.0 111.053 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 90.1 m -65.36 -40.94 94.22 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 121.701 -0.624 . . . . 0.0 109.528 -178.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.442 ' CD2' ' HB3' ' A' ' 54' ' ' LYS . 87.8 mt -64.52 -38.0 89.49 Favored 'General case' 0 C--N 1.354 0.767 0 O-C-N 122.037 -0.414 . . . . 0.0 110.069 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.418 HD11 ' CE ' ' A' ' 10' ' ' MET . 3.9 mp -72.7 -12.8 61.17 Favored 'General case' 0 C--N 1.361 1.072 0 O-C-N 121.51 -0.744 . . . . 0.0 110.145 -178.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -86.99 -28.49 22.62 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 119.298 -0.961 . . . . 0.0 109.047 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.9 t -67.14 -37.67 84.21 Favored 'General case' 0 C--N 1.354 0.801 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.9 p -89.8 -40.88 12.19 Favored 'General case' 0 C--N 1.359 0.996 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 86.18 132.89 0.04 OUTLIER 'General case' 0 C--N 1.36 1.051 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.513 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -83.62 -171.61 3.69 Favored 'General case' 0 C--N 1.357 0.916 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.41 ' H ' ' H ' ' A' ' 33' ' ' SER . 53.5 tt0 -151.2 -27.26 0.2 Allowed 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.41 ' H ' ' H ' ' A' ' 32' ' ' GLN . 2.3 t -144.26 -68.38 0.32 Allowed 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -179.258 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -129.74 -49.3 1.14 Allowed 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.32 -42.88 1.68 Allowed Glycine 0 C--N 1.352 1.427 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 82.9 mt -110.12 105.48 18.89 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.006 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -87.6 -137.7 0.1 Allowed 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 89.8 m -118.06 -59.0 1.95 Allowed 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.1 p 167.21 25.6 0.0 OUTLIER 'General case' 0 C--N 1.362 1.131 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.0 t -109.49 1.81 9.38 Favored 'Isoleucine or valine' 0 C--N 1.353 0.731 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.476 -178.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -96.78 143.47 16.76 Favored Glycine 0 C--N 1.353 1.502 0 C-N-CA 119.111 -1.518 . . . . 0.0 109.9 -178.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 51.5 m -123.11 127.43 48.7 Favored 'General case' 0 C--N 1.356 0.889 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -120.37 173.4 7.17 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -77.19 -176.63 4.16 Favored 'General case' 0 C--N 1.357 0.924 0 CA-C-O 121.568 0.699 . . . . 0.0 109.287 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 15.3 t60 -88.93 -22.16 23.22 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -66.23 -27.68 68.15 Favored 'General case' 0 C--N 1.356 0.881 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.577 ' HG2' ' HZ ' ' A' ' 6' ' ' PHE . 35.2 tp10 -62.19 -40.8 97.27 Favored 'General case' 0 C--N 1.352 0.704 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.435 HD22 ' O ' ' A' ' 48' ' ' LEU . 1.9 tm? -67.05 -38.64 86.19 Favored 'General case' 0 C--N 1.357 0.899 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 59.0 tp -70.64 -34.25 71.86 Favored 'General case' 0 CA--C 1.51 -0.585 0 O-C-N 122.118 -0.364 . . . . 0.0 110.261 -176.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 71.7 tp60 -66.26 -40.54 90.24 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 121.89 -0.506 . . . . 0.0 109.774 -178.024 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 85.2 mt -81.99 -17.35 47.19 Favored 'General case' 0 C--N 1.361 1.066 0 C-N-CA 120.086 -0.645 . . . . 0.0 110.593 -178.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.3 t -81.38 -36.65 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 54.7 t -70.05 -39.68 77.56 Favored 'Isoleucine or valine' 0 C--N 1.352 0.682 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.442 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 34.6 tptt -64.81 -28.33 69.49 Favored 'General case' 0 C--N 1.363 1.195 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.498 HD21 HD12 ' A' ' 13' ' ' ILE . 4.5 mt -67.13 -38.48 85.63 Favored 'General case' 0 C--N 1.356 0.866 0 C-N-CA 120.684 -0.407 . . . . 0.0 110.254 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 70.4 p -72.2 -17.65 61.91 Favored 'General case' 0 C--N 1.354 0.789 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.851 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -101.55 -37.4 8.41 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 121.173 -0.954 . . . . 0.0 111.643 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.4 p -72.07 -37.16 59.26 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 121.62 -0.675 . . . . 0.0 111.492 -177.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.627 ' HB3' HG23 ' A' ' 61' ' ' VAL . 3.4 t -115.64 -6.68 12.18 Favored 'General case' 0 C--N 1.351 0.668 0 C-N-CA 119.126 -1.03 . . . . 0.0 110.216 -177.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 65.0 46.91 2.67 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.627 HG23 ' HB3' ' A' ' 59' ' ' SER . 46.5 t -107.49 135.44 19.71 Favored Pre-proline 0 CA--C 1.504 -0.801 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.545 ' HG2' ' HB2' ' A' ' 65' ' ' GLU . 23.9 Cg_endo -62.41 147.84 94.25 Favored 'Trans proline' 0 CA--C 1.5 -1.177 0 C-N-CA 122.078 1.852 . . . . 0.0 112.311 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.4 m -76.68 -12.51 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.545 -177.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.48 ' O ' HG12 ' A' ' 67' ' ' VAL . 70.7 p -95.56 -33.27 12.47 Favored 'General case' 0 C--N 1.356 0.865 0 C-N-CA 118.166 -1.413 . . . . 0.0 109.956 -178.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.545 ' HB2' ' HG2' ' A' ' 62' ' ' PRO . 99.1 mt-10 -81.07 -20.08 42.35 Favored 'General case' 0 C--N 1.354 0.787 0 O-C-N 121.245 -0.909 . . . . 0.0 108.575 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.447 ' HB3' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -78.36 -37.32 44.56 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 179.572 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 64' ' ' THR . 1.8 p -68.84 -29.35 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.278 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -70.81 -48.55 53.54 Favored 'General case' 0 C--N 1.365 1.267 0 O-C-N 121.222 -0.923 . . . . 0.0 110.829 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 83.8 mt -63.76 -36.52 84.16 Favored 'General case' 0 C--N 1.355 0.812 0 O-C-N 122.049 -0.407 . . . . 0.0 110.751 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -61.21 -47.49 85.89 Favored 'General case' 0 C--N 1.348 0.512 0 O-C-N 122.307 -0.246 . . . . 0.0 110.587 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.61 -38.86 96.55 Favored Glycine 0 C--N 1.354 1.542 0 CA-C-O 119.812 -0.438 . . . . 0.0 112.204 -177.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -65.26 -46.05 82.08 Favored 'General case' 0 C--N 1.352 0.693 0 CA-C-N 118.554 1.177 . . . . 0.0 111.318 -176.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.741 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 10.7 mttm -63.74 -49.41 73.13 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -177.482 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.481 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.2 tm? -68.18 -40.18 82.32 Favored 'General case' 0 C--N 1.35 0.617 0 O-C-N 121.195 -0.941 . . . . 0.0 112.149 -175.331 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.407 ' CE2' ' HA ' ' A' ' 150' ' ' CYS . 49.3 t80 -62.94 -45.57 91.86 Favored 'General case' 0 C--N 1.353 0.743 0 O-C-N 121.179 -0.951 . . . . 0.0 111.238 -178.043 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.2 p -71.26 -14.79 18.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.888 0 O-C-N 121.523 -0.736 . . . . 0.0 109.588 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.741 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 76.6 mm-40 -73.77 -39.18 64.37 Favored 'General case' 0 C--N 1.35 0.617 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 80.1 mt -69.91 -36.71 75.58 Favored 'General case' 0 C--N 1.358 0.977 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.8 mm -62.55 -50.19 80.8 Favored 'Isoleucine or valine' 0 C--N 1.354 0.779 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -178.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -66.17 -24.4 66.63 Favored 'General case' 0 C--N 1.352 0.702 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.345 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.04 -1.18 63.16 Favored Glycine 0 C--N 1.349 1.253 0 C-N-CA 119.793 -1.194 . . . . 0.0 110.656 -177.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.67 ' HB3' ' HB ' ' A' ' 85' ' ' ILE . 84.2 m-70 -138.04 89.87 14.32 Favored Pre-proline 0 CA--C 1.5 -0.95 0 CA-C-N 119.003 1.402 . . . . 0.0 109.201 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 82' ' ' HIS . 34.8 Cg_endo -66.98 -28.52 41.8 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 C-N-CA 122.464 2.109 . . . . 0.0 114.34 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -92.95 -5.11 51.48 Favored 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 119.422 -0.911 . . . . 0.0 108.927 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.67 ' HB ' ' HB3' ' A' ' 82' ' ' HIS . 0.9 OUTLIER -90.04 -19.56 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 -179.973 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.5 -25.85 14.05 Favored 'General case' 0 C--N 1.362 1.127 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -69.84 -35.81 75.05 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -65.53 -36.74 84.69 Favored 'General case' 0 C--N 1.355 0.837 0 O-C-N 122.072 -0.393 . . . . 0.0 110.084 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.615 ' HG2' ' N ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -80.55 156.08 26.65 Favored 'General case' 0 C--N 1.356 0.859 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -178.576 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.615 ' N ' ' HG2' ' A' ' 89' ' ' MET . 4.0 mtpt -119.78 -25.46 5.89 Favored 'General case' 0 C--N 1.363 1.182 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.631 -177.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -166.22 173.75 9.86 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -177.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 61.7 m -66.29 -39.65 89.51 Favored 'General case' 0 C--N 1.354 0.777 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.284 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -67.53 -39.31 85.07 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 119.739 -0.784 . . . . 0.0 109.059 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -65.33 -24.5 67.28 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 57.0 tp -64.76 -44.33 90.4 Favored 'General case' 0 C--N 1.353 0.735 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.9 mp -61.66 -33.92 74.81 Favored 'General case' 0 C--N 1.356 0.879 0 O-C-N 122.139 -0.351 . . . . 0.0 111.025 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 86.3 p -86.56 -7.28 58.5 Favored 'General case' 0 C--N 1.354 0.767 0 C-N-CA 119.294 -0.962 . . . . 0.0 110.805 -178.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.7 tttp -111.36 0.68 16.71 Favored 'General case' 0 C--N 1.356 0.857 0 O-C-N 121.533 -0.729 . . . . 0.0 109.798 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.412 HG23 ' N ' ' A' ' 100' ' ' ASP . 9.5 tp -65.66 -39.9 86.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.808 0 O-C-N 121.867 -0.52 . . . . 0.0 111.818 -177.135 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.412 ' N ' HG23 ' A' ' 99' ' ' ILE . 37.6 t70 -95.51 -27.28 15.45 Favored 'General case' 0 N--CA 1.44 -0.959 0 O-C-N 120.827 -1.171 . . . . 0.0 111.657 -177.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 90.0 p -70.01 -39.87 75.58 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 119.412 -0.915 . . . . 0.0 112.984 -176.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.555 ' HA ' HG12 ' A' ' 105' ' ' VAL . 8.7 t80 -138.47 -19.61 1.07 Allowed 'General case' 0 C--N 1.361 1.08 0 C-N-CA 116.971 -1.891 . . . . 0.0 113.511 -177.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 24.1 mm -68.39 -51.0 51.76 Favored 'Isoleucine or valine' 0 C--O 1.244 0.783 0 CA-C-N 120.424 1.466 . . . . 0.0 110.379 -177.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 54.9 m80 -92.9 4.2 54.35 Favored 'General case' 0 N--CA 1.437 -1.076 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.551 -176.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.555 HG12 ' HA ' ' A' ' 102' ' ' PHE . 3.3 p -87.73 -35.67 8.57 Favored 'Isoleucine or valine' 0 C--N 1.353 0.749 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 178.144 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -72.65 -41.9 64.96 Favored 'General case' 0 C--N 1.358 0.938 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 67.0 t -65.3 -48.39 83.54 Favored 'Isoleucine or valine' 0 C--N 1.358 0.974 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.527 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -60.75 -47.87 84.35 Favored 'General case' 0 C--N 1.359 0.987 0 O-C-N 122.079 -0.388 . . . . 0.0 111.389 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LYS . . . . . 0.477 ' HG2' ' O ' ' A' ' 105' ' ' VAL . 38.3 mmtt -61.14 -39.39 89.88 Favored 'General case' 0 N--CA 1.445 -0.703 0 O-C-N 121.685 -0.634 . . . . 0.0 110.696 -177.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 19.4 mt -56.46 -72.11 0.08 Allowed 'General case' 0 CA--C 1.505 -0.786 0 C-N-CA 120.541 -0.463 . . . . 0.0 109.762 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -123.42 141.33 35.98 Favored Pre-proline 0 N--CA 1.439 -1.005 0 C-N-CA 118.538 -1.265 . . . . 0.0 109.207 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -86.29 -2.15 8.56 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 123.308 2.672 . . . . 0.0 115.402 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -66.31 -37.42 85.36 Favored 'General case' 0 C--N 1.355 0.839 0 O-C-N 121.757 -0.59 . . . . 0.0 109.908 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.34 144.92 56.79 Favored 'General case' 0 C--N 1.353 0.73 0 CA-C-O 121.548 0.69 . . . . 0.0 110.174 -178.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.5 ' O ' HD13 ' A' ' 116' ' ' LEU . 47.3 mt-10 -112.05 143.51 42.94 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 179.047 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.5 HD13 ' O ' ' A' ' 115' ' ' GLU . 2.6 mm? -128.37 149.41 71.41 Favored Pre-proline 0 C--N 1.353 0.759 0 CA-C-O 122.164 0.983 . . . . 0.0 108.981 -178.297 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 116' ' ' LEU . 64.8 Cg_endo -91.85 -160.72 0.09 OUTLIER 'Trans proline' 0 C--N 1.316 -1.156 0 C-N-CA 123.857 3.038 . . . . 0.0 112.959 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -121.33 140.68 51.78 Favored 'General case' 0 C--N 1.363 1.18 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.443 ' HE2' ' CD1' ' A' ' 133' ' ' TYR . 65.7 m-85 -127.53 135.2 50.02 Favored 'General case' 0 C--N 1.36 1.06 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.164 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.476 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 93.3 m -124.09 126.31 46.0 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 176.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 80.3 m -117.92 126.96 53.35 Favored 'General case' 0 CA--C 1.502 -0.896 0 C-N-CA 119.17 -1.012 . . . . 0.0 109.372 -177.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -120.47 127.49 52.27 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 178.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -100.05 116.53 32.29 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.447 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 85.9 mt -82.35 -26.86 32.56 Favored 'General case' 0 C--N 1.355 0.836 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -178.74 -144.46 5.69 Favored Glycine 0 N--CA 1.437 -1.244 0 N-CA-C 108.78 -1.728 . . . . 0.0 108.78 -178.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -94.99 -39.62 10.09 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.297 -178.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -98.84 -1.47 40.17 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.758 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.447 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 66.8 m-20 -118.82 133.45 55.83 Favored 'General case' 0 C--N 1.357 0.913 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 9.5 mm -140.78 136.79 35.13 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 179.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 52.7 mtm180 -117.39 136.77 52.93 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 5.7 tp -125.95 118.9 26.36 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.476 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 12.3 m170 -98.53 130.58 45.1 Favored 'General case' 0 CA--C 1.496 -1.133 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.443 ' CD1' ' HE2' ' A' ' 119' ' ' PHE . 51.6 t80 -122.59 120.73 34.65 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 -178.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.463 ' HA ' ' O ' ' A' ' 171' ' ' THR . 36.1 tt0 -115.55 109.86 18.41 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.456 ' O ' ' HA ' ' A' ' 171' ' ' THR . 8.8 t -165.07 158.16 16.51 Favored 'General case' 0 C--N 1.359 0.979 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.493 ' C ' ' HD3' ' A' ' 138' ' ' PRO . 63.0 mtpt -91.0 5.85 47.17 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -129.58 72.32 81.97 Favored Pre-proline 0 C--N 1.354 0.804 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.493 ' HD3' ' C ' ' A' ' 136' ' ' LYS . 96.6 Cg_endo -95.21 88.03 0.11 Allowed 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 122.319 2.012 . . . . 0.0 115.446 -178.257 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -106.51 115.5 30.31 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 177.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.41 -38.27 90.5 Favored 'General case' 0 C--N 1.352 0.687 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.019 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 73.3 m -62.36 -33.57 74.99 Favored 'General case' 0 C--N 1.352 0.713 0 O-C-N 122.115 -0.366 . . . . 0.0 110.784 -178.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -73.15 -47.81 40.82 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.445 -177.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.25 -39.69 93.01 Favored 'General case' 0 C--N 1.355 0.839 0 O-C-N 122.105 -0.372 . . . . 0.0 111.419 -177.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.11 -36.58 84.07 Favored 'General case' 0 C--N 1.354 0.794 0 O-C-N 121.848 -0.532 . . . . 0.0 109.719 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.2 -43.23 98.64 Favored Glycine 0 C--N 1.346 1.091 0 N-CA-C 109.829 -1.309 . . . . 0.0 109.829 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 83.0 mt -70.45 -41.03 73.36 Favored 'General case' 0 C--N 1.353 0.728 0 O-C-N 122.049 -0.677 . . . . 0.0 112.733 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 98.6 mt -71.35 -42.33 68.64 Favored 'General case' 0 C--N 1.36 1.022 0 O-C-N 121.273 -0.892 . . . . 0.0 110.515 -177.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.487 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 21.3 t70 -69.43 -29.81 67.61 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 122.141 -0.349 . . . . 0.0 110.245 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -63.09 -39.46 98.04 Favored Glycine 0 C--N 1.356 1.648 0 N-CA-C 108.276 -1.93 . . . . 0.0 108.276 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.407 ' HA ' ' CE2' ' A' ' 75' ' ' PHE . 48.7 t -60.43 -41.95 95.05 Favored 'General case' 0 C--N 1.35 0.598 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -74.42 -1.9 23.11 Favored 'General case' 0 C--N 1.362 1.121 0 O-C-N 121.82 -0.55 . . . . 0.0 109.544 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 76.4 mm-40 -83.74 -46.49 12.19 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -66.06 -44.11 85.48 Favored 'General case' 0 C--N 1.356 0.889 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.472 ' O ' ' HB2' ' A' ' 155' ' ' LYS . 38.0 m-85 -69.09 -25.96 64.69 Favored 'General case' 0 C--N 1.36 1.041 0 O-C-N 121.831 -0.543 . . . . 0.0 111.065 -178.341 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 154' ' ' PHE . 44.6 mttt 73.88 67.64 0.1 Allowed 'General case' 0 C--N 1.361 1.099 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -138.88 -168.11 2.35 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -148.32 96.64 2.65 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 13.2 m-30 -112.97 156.76 22.45 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 92.2 m -120.1 128.24 53.28 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.505 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.8 mp -107.1 123.14 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.0 m -117.99 -174.66 2.69 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-O 121.835 0.826 . . . . 0.0 109.347 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -146.29 156.12 43.13 Favored 'General case' 0 C--N 1.356 0.865 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 -178.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.2 p -98.72 145.94 30.78 Favored Pre-proline 0 C--N 1.359 0.983 0 CA-C-O 122.443 1.116 . . . . 0.0 108.0 178.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.64 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 72.1 Cg_endo -75.84 -10.93 20.01 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.91 2.407 . . . . 0.0 115.076 -178.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -73.38 -41.26 63.59 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.819 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 38.2 p -117.95 16.15 14.25 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.659 -178.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.64 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.3 pp0? -67.31 -11.47 57.67 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 121.571 -0.706 . . . . 0.0 110.129 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 54.3 p30 -118.51 34.66 5.09 Favored 'General case' 0 N--CA 1.439 -0.996 0 O-C-N 121.199 -0.938 . . . . 0.0 108.893 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 58.5 m -136.15 148.79 48.36 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.752 ' O ' ' HB ' ' A' ' 171' ' ' THR . 97.8 mt-10 -114.51 137.2 52.15 Favored 'General case' 0 C--N 1.354 0.794 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.752 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 1.1 m 115.03 -53.26 0.0 OUTLIER 'General case' 0 C--N 1.377 1.803 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -116.9 111.12 19.21 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 80.1 t -128.5 135.26 62.94 Favored 'Isoleucine or valine' 0 C--N 1.359 1.009 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 50.4 mm -106.74 127.82 61.95 Favored 'Isoleucine or valine' 0 C--N 1.36 1.052 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -116.26 154.98 29.16 Favored 'General case' 0 C--N 1.356 0.875 0 CA-C-O 122.123 0.963 . . . . 0.0 108.849 -178.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -137.14 120.17 16.55 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -178.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.8 mp -115.47 119.84 62.98 Favored 'Isoleucine or valine' 0 C--N 1.354 0.804 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 90.0 m -120.8 141.55 50.42 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -178.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 . . . . . 0 C--N 1.367 1.36 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -179.944 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.7 mtp . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.185 0.517 . . . . 0.0 110.005 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.452 ' HA ' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -78.63 -16.27 57.54 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.63 -177.908 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.57 -42.27 48.35 Favored Glycine 0 C--N 1.352 1.433 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 62.3 mtt -68.27 -38.19 81.49 Favored 'General case' 0 C--N 1.358 0.942 0 O-C-N 121.893 -0.769 . . . . 0.0 111.464 -178.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.452 HG22 ' HA ' ' A' ' 2' ' ' MET . 27.6 m -68.23 -23.0 28.05 Favored 'Isoleucine or valine' 0 C--N 1.356 0.851 0 C-N-CA 120.031 -0.668 . . . . 0.0 109.749 -178.492 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -71.08 -37.54 72.46 Favored 'General case' 0 C--N 1.356 0.863 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 89.5 m -68.2 -41.66 81.05 Favored 'General case' 0 C--N 1.357 0.908 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.69 -39.17 97.59 Favored Glycine 0 C--N 1.358 1.757 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.687 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -65.93 -39.84 90.88 Favored 'General case' 0 C--N 1.35 0.614 0 CA-C-N 117.199 0.5 . . . . 0.0 110.618 -178.351 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.3 mmt -63.35 -40.82 98.33 Favored 'General case' 0 C--N 1.352 0.703 0 O-C-N 121.619 -0.675 . . . . 0.0 111.025 -178.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -67.59 -40.14 84.82 Favored 'General case' 0 C--N 1.349 0.563 0 O-C-N 121.896 -0.503 . . . . 0.0 111.504 -177.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 54.8 tp -66.77 -41.93 86.92 Favored 'General case' 0 C--N 1.349 0.558 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -178.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.687 HG12 ' O ' ' A' ' 9' ' ' LEU . 3.7 mm -73.68 -38.22 51.04 Favored 'Isoleucine or valine' 0 C--N 1.357 0.916 0 O-C-N 121.196 -0.94 . . . . 0.0 111.081 -175.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -67.12 -43.32 82.72 Favored 'General case' 0 C--N 1.351 0.646 0 O-C-N 121.914 -0.491 . . . . 0.0 111.573 -176.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -72.11 -33.88 68.17 Favored 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 121.842 -0.536 . . . . 0.0 111.733 -177.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -72.01 -48.5 44.27 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -175.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -127.8 -20.85 3.81 Favored 'General case' 0 C--N 1.354 0.797 0 C-N-CA 117.398 -1.721 . . . . 0.0 113.383 -176.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 141.88 179.72 19.15 Favored Glycine 0 CA--C 1.497 -1.038 0 C-N-CA 117.982 -2.056 . . . . 0.0 109.597 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -97.21 -12.43 23.02 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -177.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -71.44 -40.63 70.26 Favored 'General case' 0 C--N 1.359 1.01 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.7 m -69.21 -38.49 78.61 Favored 'General case' 0 C--N 1.356 0.885 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.578 HD13 ' HB ' ' A' ' 13' ' ' ILE . 59.3 tp -60.32 -38.54 84.06 Favored 'General case' 0 C--N 1.357 0.914 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -64.17 -35.72 81.73 Favored 'General case' 0 C--N 1.357 0.903 0 O-C-N 122.182 -0.324 . . . . 0.0 111.309 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 90.2 m -63.99 -41.39 97.52 Favored 'General case' 0 C--N 1.356 0.89 0 O-C-N 121.566 -0.709 . . . . 0.0 109.189 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.467 ' CD2' ' HB3' ' A' ' 54' ' ' LYS . 89.1 mt -65.02 -38.4 90.78 Favored 'General case' 0 C--N 1.355 0.839 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.27 -11.74 61.11 Favored 'General case' 0 C--N 1.358 0.97 0 O-C-N 121.363 -0.835 . . . . 0.0 109.734 -179.103 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -89.0 -27.25 20.99 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 119.527 -0.869 . . . . 0.0 108.916 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 55.9 p -69.58 -22.7 63.5 Favored 'General case' 0 C--N 1.362 1.109 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.164 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.0 p -106.98 -36.86 6.49 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 119.046 -1.062 . . . . 0.0 108.325 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 86.1 132.37 0.04 OUTLIER 'General case' 0 C--N 1.361 1.067 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.536 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -84.48 -168.04 2.02 Favored 'General case' 0 C--N 1.357 0.902 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.408 ' H ' ' HB2' ' A' ' 31' ' ' LEU . 63.3 tt0 -152.13 -32.57 0.14 Allowed 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.7 t -139.18 -73.37 0.38 Allowed 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -128.32 -33.97 2.1 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.96 -25.75 11.25 Favored Glycine 0 C--N 1.353 1.482 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 84.7 mt -113.71 102.93 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.792 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -99.68 -0.32 40.41 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.793 HG22 ' H ' ' A' ' 39' ' ' SER . 2.7 m 77.62 -179.99 0.13 Allowed 'General case' 0 C--N 1.361 1.096 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 -178.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.793 ' H ' HG22 ' A' ' 38' ' ' THR . 24.9 p -90.9 114.26 26.67 Favored 'General case' 0 N--CA 1.443 -0.779 0 O-C-N 121.214 -0.929 . . . . 0.0 109.44 -178.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.496 HG13 ' O ' ' A' ' 39' ' ' SER . 0.0 OUTLIER -173.48 -8.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.189 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.15 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -117.42 167.56 12.73 Favored Glycine 0 C--N 1.355 1.63 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -178.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 68.6 m -132.24 136.84 47.26 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -124.02 172.57 8.87 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -71.27 174.8 5.96 Favored 'General case' 0 C--N 1.355 0.832 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 76.8 m-70 -86.53 -17.04 35.1 Favored 'General case' 0 CA--C 1.502 -0.884 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.234 -178.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -69.06 -29.33 67.43 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.0 tp10 -63.13 -42.22 99.46 Favored 'General case' 0 C--N 1.351 0.647 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.407 ' O ' HG23 ' A' ' 52' ' ' VAL . 55.0 tp -66.88 -39.4 87.49 Favored 'General case' 0 C--N 1.359 0.985 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 59.0 tp -72.94 -28.98 62.75 Favored 'General case' 0 C--N 1.349 0.569 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -177.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -66.47 -43.22 86.08 Favored 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 121.917 -0.489 . . . . 0.0 110.108 -178.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 80.4 mt -72.36 -34.5 68.04 Favored 'General case' 0 C--N 1.36 1.052 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.278 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 48' ' ' LEU . 39.3 t -63.24 -42.1 95.19 Favored 'Isoleucine or valine' 0 C--N 1.35 0.626 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 54.6 t -66.58 -40.65 86.81 Favored 'Isoleucine or valine' 0 C--N 1.351 0.648 0 O-C-N 121.733 -0.604 . . . . 0.0 109.855 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.467 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 25.9 tptt -66.77 -22.97 66.02 Favored 'General case' 0 C--N 1.361 1.095 0 O-C-N 121.022 -1.049 . . . . 0.0 109.019 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.59 HD21 HD12 ' A' ' 13' ' ' ILE . 6.2 mt -69.78 -38.05 76.56 Favored 'General case' 0 C--N 1.355 0.826 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 57.6 p -71.38 -18.01 62.38 Favored 'General case' 0 C--N 1.353 0.752 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.357 -179.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -100.46 -35.75 9.45 Favored 'General case' 0 C--N 1.355 0.805 0 C-N-CA 119.648 -0.821 . . . . 0.0 111.408 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.6 p -72.27 -40.22 65.01 Favored 'Isoleucine or valine' 0 C--N 1.354 0.766 0 O-C-N 121.664 -0.648 . . . . 0.0 111.507 -177.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 79.7 p -116.02 -2.49 12.26 Favored 'General case' 0 C--N 1.354 0.78 0 C-N-CA 118.89 -1.124 . . . . 0.0 110.914 -178.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 73.6 m 63.74 49.48 2.93 Favored 'General case' 0 C--N 1.357 0.916 0 CA-C-O 120.932 0.396 . . . . 0.0 110.033 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.418 HG13 ' HD2' ' A' ' 62' ' ' PRO . 96.6 t -113.98 134.04 22.22 Favored Pre-proline 0 CA--C 1.504 -0.799 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.418 ' HD2' HG13 ' A' ' 61' ' ' VAL . 41.3 Cg_exo -58.02 149.5 70.65 Favored 'Trans proline' 0 CA--C 1.499 -1.27 0 C-N-CA 122.778 2.319 . . . . 0.0 112.738 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.421 ' HA ' HD23 ' A' ' 66' ' ' LEU . 3.7 m -76.2 -11.64 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.679 -177.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.494 ' O ' HG12 ' A' ' 67' ' ' VAL . 73.0 p -96.51 -33.36 11.87 Favored 'General case' 0 C--N 1.358 0.971 0 C-N-CA 118.433 -1.307 . . . . 0.0 109.504 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -77.65 -21.0 52.85 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 121.474 -0.766 . . . . 0.0 108.968 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -81.19 -34.23 32.46 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 -179.483 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.494 HG12 ' O ' ' A' ' 64' ' ' THR . 1.5 p -70.98 -26.23 27.21 Favored 'Isoleucine or valine' 0 C--N 1.356 0.855 0 C-N-CA 120.169 -0.613 . . . . 0.0 109.799 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 40.7 mtp180 -72.53 -52.87 13.81 Favored 'General case' 0 C--N 1.363 1.181 0 O-C-N 121.477 -0.765 . . . . 0.0 110.427 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.9 mt -63.41 -34.76 78.44 Favored 'General case' 0 C--N 1.357 0.913 0 O-C-N 121.959 -0.463 . . . . 0.0 110.905 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -61.1 -47.23 87.24 Favored 'General case' 0 C--N 1.348 0.502 0 O-C-N 122.248 -0.283 . . . . 0.0 110.239 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.06 -38.8 96.16 Favored Glycine 0 C--N 1.356 1.651 0 N-CA-C 111.729 -0.548 . . . . 0.0 111.729 -178.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -62.6 -49.35 75.58 Favored 'General case' 0 C--N 1.351 0.638 0 CA-C-N 118.31 1.055 . . . . 0.0 111.556 -177.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 12.2 mttm -65.09 -45.93 83.18 Favored 'General case' 0 C--N 1.357 0.926 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -177.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -69.78 -39.04 76.88 Favored 'General case' 0 C--N 1.348 0.52 0 O-C-N 121.161 -0.962 . . . . 0.0 111.841 -175.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -64.61 -44.05 91.8 Favored 'General case' 0 C--N 1.353 0.746 0 O-C-N 121.098 -1.001 . . . . 0.0 110.951 -178.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.83 -13.86 17.08 Favored 'Isoleucine or valine' 0 C--N 1.359 0.985 0 O-C-N 121.45 -0.781 . . . . 0.0 109.0 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -74.37 -37.61 63.42 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.3 mt -74.67 -29.48 61.25 Favored 'General case' 0 C--N 1.357 0.927 0 O-C-N 122.285 -0.259 . . . . 0.0 110.369 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.6 mm -65.86 -52.84 44.77 Favored 'Isoleucine or valine' 0 C--N 1.357 0.895 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.682 -177.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -75.5 -15.35 60.41 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.279 178.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.25 -37.45 63.34 Favored Glycine 0 C--N 1.349 1.276 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -131.75 105.23 14.16 Favored Pre-proline 0 N--CA 1.441 -0.903 0 CA-C-O 122.615 1.198 . . . . 0.0 108.961 -177.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.524 ' O ' ' HB2' ' A' ' 87' ' ' ASN . 37.1 Cg_endo -67.47 -23.08 44.16 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.571 2.181 . . . . 0.0 114.356 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -95.39 -5.19 43.81 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 tp -89.75 -20.1 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -105.7 -18.06 14.19 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.524 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 1.5 t-20 -73.97 -38.0 64.31 Favored 'General case' 0 C--N 1.357 0.931 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -65.49 -33.84 76.86 Favored 'General case' 0 C--N 1.353 0.735 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -178.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 15.8 ttp -83.12 150.37 26.31 Favored 'General case' 0 C--N 1.351 0.654 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.02 -22.59 9.47 Favored 'General case' 0 C--N 1.364 1.199 0 O-C-N 121.691 -0.63 . . . . 0.0 111.14 -177.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -165.55 171.49 13.13 Favored 'General case' 0 C--N 1.354 0.761 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 -177.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.476 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 66.8 m -66.65 -39.54 88.28 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.448 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -68.44 -38.9 81.57 Favored 'General case' 0 C--N 1.355 0.836 0 O-C-N 121.296 -0.877 . . . . 0.0 108.991 -179.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -65.93 -24.09 66.75 Favored 'General case' 0 C--N 1.355 0.823 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.664 ' O ' HG12 ' A' ' 99' ' ' ILE . 59.7 tp -63.64 -47.38 81.54 Favored 'General case' 0 C--N 1.355 0.846 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.4 mp -60.07 -35.7 75.74 Favored 'General case' 0 C--N 1.359 1.013 0 O-C-N 122.256 -0.277 . . . . 0.0 110.521 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 34.0 t -70.14 -39.64 75.28 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.188 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.5 tttp -86.99 0.35 55.31 Favored 'General case' 0 C--N 1.356 0.856 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -176.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.664 HG12 ' O ' ' A' ' 95' ' ' LEU . 22.8 mm -61.01 -46.7 96.15 Favored 'Isoleucine or valine' 0 C--N 1.357 0.896 0 CA-C-N 119.082 0.856 . . . . 0.0 112.014 -177.514 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -95.64 -22.63 17.46 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 118.402 -1.319 . . . . 0.0 111.329 -177.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 35.2 t -64.29 -48.65 74.87 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 121.565 -0.709 . . . . 0.0 112.491 -177.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -138.08 -16.49 1.25 Allowed 'General case' 0 C--N 1.36 1.06 0 C-N-CA 117.372 -1.731 . . . . 0.0 113.521 -176.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.645 HD12 HD13 ' A' ' 99' ' ' ILE . 96.3 mt -71.83 -50.27 39.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 CA-C-N 120.359 1.436 . . . . 0.0 111.182 -177.143 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -89.98 4.36 50.36 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 119.388 -0.925 . . . . 0.0 109.811 -177.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 57.7 t -86.44 -43.7 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.059 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 54.7 tp10 -67.53 -40.1 85.04 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 65.6 t -62.77 -46.92 95.16 Favored 'Isoleucine or valine' 0 C--N 1.356 0.88 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -60.74 -48.21 82.81 Favored 'General case' 0 C--N 1.36 1.038 0 O-C-N 122.198 -0.314 . . . . 0.0 111.541 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -61.25 -36.59 80.41 Favored 'General case' 0 C--N 1.355 0.821 0 O-C-N 121.534 -0.729 . . . . 0.0 110.503 -178.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 18.0 mt -58.6 -75.5 0.05 Allowed 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -115.58 132.14 23.29 Favored Pre-proline 0 N--CA 1.439 -0.975 0 C-N-CA 118.65 -1.22 . . . . 0.0 108.641 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -83.26 -3.53 10.91 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 123.175 2.583 . . . . 0.0 115.172 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -66.97 -36.36 82.02 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 121.879 -0.513 . . . . 0.0 110.009 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.32 144.86 56.31 Favored 'General case' 0 C--N 1.352 0.683 0 CA-C-O 121.74 0.781 . . . . 0.0 110.142 -178.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -128.86 133.76 48.07 Favored 'General case' 0 C--N 1.357 0.925 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.52 ' HB3' ' HD2' ' A' ' 117' ' ' PRO . 87.8 mt -127.76 156.44 75.71 Favored Pre-proline 0 N--CA 1.443 -0.787 0 CA-C-O 122.262 1.03 . . . . 0.0 109.243 -178.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.52 ' HD2' ' HB3' ' A' ' 116' ' ' LEU . 83.0 Cg_endo -80.46 -158.42 0.09 OUTLIER 'Trans proline' 0 C--N 1.318 -1.074 0 C-N-CA 123.826 3.017 . . . . 0.0 113.922 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -118.86 143.28 47.06 Favored 'General case' 0 C--N 1.364 1.209 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -129.65 135.7 48.84 Favored 'General case' 0 C--N 1.362 1.123 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -178.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 93.8 m -127.64 130.71 49.43 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 177.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -120.6 132.39 55.11 Favored 'General case' 0 CA--C 1.504 -0.804 0 C-N-CA 119.215 -0.994 . . . . 0.0 109.989 -178.272 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -119.71 138.5 53.26 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 178.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -109.32 117.84 35.13 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 -179.196 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.574 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 96.5 mt -91.77 -16.02 27.46 Favored 'General case' 0 C--N 1.356 0.856 0 C-N-CA 120.496 -0.481 . . . . 0.0 110.436 -179.336 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 174.04 -148.23 9.87 Favored Glycine 0 C--N 1.349 1.252 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -94.35 -37.55 11.42 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -102.05 4.17 39.48 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.031 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.574 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 8.7 m-20 -121.93 132.09 54.37 Favored 'General case' 0 C--N 1.359 0.984 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -179.336 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.2 mm -143.64 137.8 25.19 Favored 'Isoleucine or valine' 0 C--N 1.356 0.863 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 179.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 53.5 mtm180 -118.49 139.11 51.93 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 5.8 tp -125.53 116.91 22.51 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.52 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -98.29 134.39 41.38 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 107.327 -1.361 . . . . 0.0 107.327 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -129.51 119.55 23.89 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.524 ' HA ' ' O ' ' A' ' 171' ' ' THR . 57.9 mt-30 -115.53 112.17 21.81 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 11.1 t -165.93 155.12 11.75 Favored 'General case' 0 C--N 1.357 0.921 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.434 ' C ' ' HD3' ' A' ' 138' ' ' PRO . 99.6 mttt -90.99 5.49 48.57 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 77.0 mtp180 -132.62 73.25 76.75 Favored Pre-proline 0 C--N 1.354 0.767 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.434 ' HD3' ' C ' ' A' ' 136' ' ' LYS . 92.7 Cg_endo -96.87 99.64 0.08 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.515 0 C-N-CA 122.737 2.291 . . . . 0.0 115.453 -178.06 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -109.4 111.13 22.5 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 177.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.71 -38.05 89.64 Favored 'General case' 0 C--N 1.354 0.787 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.02 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 74.1 m -63.03 -29.33 70.73 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 121.998 -0.439 . . . . 0.0 110.755 -178.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -75.01 -47.1 30.79 Favored 'General case' 0 C--N 1.35 0.612 0 O-C-N 121.698 -0.626 . . . . 0.0 109.763 -177.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.53 -40.06 94.91 Favored 'General case' 0 C--N 1.358 0.976 0 O-C-N 122.095 -0.378 . . . . 0.0 111.212 -178.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.1 -37.0 85.46 Favored 'General case' 0 C--N 1.355 0.809 0 O-C-N 121.938 -0.476 . . . . 0.0 110.212 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.84 -43.15 99.58 Favored Glycine 0 C--N 1.347 1.182 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 -178.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 83.8 mt -70.01 -40.42 75.27 Favored 'General case' 0 C--N 1.351 0.647 0 N-CA-C 112.673 0.619 . . . . 0.0 112.673 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 99.1 mt -71.34 -42.9 67.95 Favored 'General case' 0 C--N 1.361 1.082 0 O-C-N 121.198 -0.939 . . . . 0.0 110.993 -176.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.483 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 21.0 t70 -69.0 -31.72 70.75 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 122.028 -0.42 . . . . 0.0 110.418 -179.324 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -62.96 -39.19 97.76 Favored Glycine 0 C--N 1.356 1.659 0 N-CA-C 108.656 -1.778 . . . . 0.0 108.656 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 49.4 t -60.84 -42.0 96.91 Favored 'General case' 0 C--N 1.351 0.674 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -74.59 -2.19 24.89 Favored 'General case' 0 C--N 1.361 1.082 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.483 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 77.0 mm-40 -83.29 -45.44 13.79 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -68.84 -42.56 76.98 Favored 'General case' 0 C--N 1.358 0.959 0 C-N-CA 120.011 -0.675 . . . . 0.0 109.681 179.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -69.75 -25.68 63.95 Favored 'General case' 0 C--N 1.362 1.132 0 O-C-N 121.659 -0.651 . . . . 0.0 110.619 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 21.2 tttm 73.16 73.39 0.13 Allowed 'General case' 0 C--N 1.36 1.05 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -143.61 -169.44 3.08 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -146.25 96.99 2.87 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 13.3 m-30 -114.9 155.38 26.96 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 93.3 m -120.86 129.12 53.4 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 119.668 -0.813 . . . . 0.0 108.809 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.515 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.7 mp -106.45 122.34 60.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.6 m -119.53 -172.12 2.26 Favored 'General case' 0 C--N 1.357 0.93 0 CA-C-O 121.792 0.806 . . . . 0.0 109.338 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 28.2 ptt-85 -148.42 157.91 43.77 Favored 'General case' 0 C--N 1.356 0.854 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -178.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 56.2 p -98.37 146.77 32.12 Favored Pre-proline 0 C--N 1.359 0.995 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 178.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.666 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 72.7 Cg_endo -75.35 -12.54 20.85 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.903 2.402 . . . . 0.0 115.238 -178.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -72.53 -41.31 66.0 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 120.009 -0.676 . . . . 0.0 109.956 -178.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 35.6 p -118.11 16.06 14.11 Favored 'General case' 0 C--N 1.354 0.797 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.734 -178.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.666 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.4 pp0? -66.97 -12.75 60.68 Favored 'General case' 0 C--N 1.353 0.749 0 O-C-N 121.605 -0.685 . . . . 0.0 110.346 178.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 54.1 p-10 -123.67 38.72 4.13 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 14.6 t -141.65 147.44 37.55 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.63 ' O ' ' HB ' ' A' ' 171' ' ' THR . 46.3 mp0 -101.67 167.4 10.13 Favored 'General case' 0 C--N 1.355 0.847 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.63 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 5.8 m 82.99 -60.01 0.15 Allowed 'General case' 0 C--N 1.37 1.465 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -108.05 116.11 31.37 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 96.1 t -131.64 133.21 61.82 Favored 'Isoleucine or valine' 0 C--N 1.358 0.966 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 50.9 mm -108.16 126.2 64.78 Favored 'Isoleucine or valine' 0 C--N 1.359 1.0 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -114.55 154.53 28.12 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -137.58 118.94 14.68 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 -178.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.7 mp -113.59 120.37 63.29 Favored 'Isoleucine or valine' 0 C--N 1.353 0.742 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 90.6 m -119.91 143.5 47.93 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -177.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 . . . . . 0 C--N 1.363 1.192 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 179.995 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.42 ' HG3' ' HE2' ' A' ' 4' ' ' MET . 87.7 mmm . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 121.09 0.471 . . . . 0.0 110.031 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.43 ' O ' ' HD1' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -82.04 -15.2 54.4 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 120.516 -0.474 . . . . 0.0 109.963 -178.338 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -71.65 -40.99 57.99 Favored Glycine 0 C--N 1.353 1.482 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' MET . . . . . 0.482 ' HG2' ' HB3' ' A' ' 39' ' ' SER . 76.5 mtm -70.15 -35.69 74.22 Favored 'General case' 0 C--N 1.356 0.873 0 O-C-N 121.958 -0.731 . . . . 0.0 111.499 -178.165 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.414 HG22 ' HA ' ' A' ' 2' ' ' MET . 32.8 m -68.45 -23.77 28.61 Favored 'Isoleucine or valine' 0 C--N 1.357 0.91 0 O-C-N 121.467 -0.77 . . . . 0.0 109.594 -179.101 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.505 ' HZ ' ' CG ' ' A' ' 47' ' ' GLU . 4.5 m-85 -71.38 -36.2 71.33 Favored 'General case' 0 C--N 1.358 0.949 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 90.1 m -66.7 -40.87 88.64 Favored 'General case' 0 C--N 1.357 0.913 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.75 -39.23 97.7 Favored Glycine 0 C--N 1.358 1.753 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.694 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -64.07 -41.47 97.33 Favored 'General case' 0 C--N 1.352 0.679 0 CA-C-N 117.163 0.482 . . . . 0.0 110.835 -178.515 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 17.6 mmt -63.58 -41.02 98.4 Favored 'General case' 0 C--N 1.353 0.746 0 O-C-N 121.438 -0.789 . . . . 0.0 111.079 -178.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -68.34 -40.5 81.55 Favored 'General case' 0 C--N 1.349 0.573 0 O-C-N 121.881 -0.512 . . . . 0.0 111.773 -177.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 56.3 tp -66.3 -43.65 85.69 Favored 'General case' 0 C--N 1.349 0.577 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -177.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.694 HG12 ' O ' ' A' ' 9' ' ' LEU . 1.1 mm -74.3 -34.6 37.5 Favored 'Isoleucine or valine' 0 C--N 1.358 0.956 0 O-C-N 121.127 -0.983 . . . . 0.0 110.96 -175.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -72.73 -42.32 64.25 Favored 'General case' 0 C--N 1.35 0.59 0 O-C-N 121.642 -0.661 . . . . 0.0 111.538 -176.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -71.1 -37.9 72.38 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -175.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -99.42 -25.83 14.33 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 118.924 -1.11 . . . . 0.0 113.659 -174.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -113.62 -35.72 5.12 Favored 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 117.541 -1.664 . . . . 0.0 112.549 -176.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 145.31 177.78 20.35 Favored Glycine 0 C--N 1.349 1.266 0 C-N-CA 118.052 -2.023 . . . . 0.0 110.467 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -99.43 -27.16 13.87 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 -177.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -69.29 -39.22 78.45 Favored 'General case' 0 C--N 1.359 0.992 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 92.7 m -66.75 -39.1 87.78 Favored 'General case' 0 C--N 1.357 0.902 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.3 tt -61.62 -38.44 87.64 Favored 'General case' 0 C--N 1.358 0.938 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -63.74 -37.71 88.38 Favored 'General case' 0 C--N 1.356 0.875 0 O-C-N 122.026 -0.421 . . . . 0.0 110.765 -178.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.9 m -65.73 -38.96 90.58 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -178.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.717 HD13 HD22 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -63.67 -37.41 87.24 Favored 'General case' 0 C--N 1.354 0.765 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -179.043 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.3 mt -74.02 -14.11 60.96 Favored 'General case' 0 C--N 1.359 0.998 0 O-C-N 121.722 -0.612 . . . . 0.0 110.337 -178.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -86.77 -28.23 23.13 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 119.218 -0.993 . . . . 0.0 109.203 179.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.1 t -67.39 -36.58 81.59 Favored 'General case' 0 C--N 1.354 0.761 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.661 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 2.0 p -92.12 -39.65 11.48 Favored 'General case' 0 C--N 1.358 0.963 0 C-N-CA 118.942 -1.103 . . . . 0.0 108.199 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.661 ' HB2' ' O ' ' A' ' 29' ' ' CYS . 14.5 mt-10 86.27 131.53 0.04 OUTLIER 'General case' 0 C--N 1.362 1.109 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.142 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.529 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -86.18 -169.45 2.64 Favored 'General case' 0 C--N 1.357 0.897 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.841 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -152.85 -28.23 0.15 Allowed 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 107.707 -1.219 . . . . 0.0 107.707 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.8 t -141.49 -71.13 0.35 Allowed 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -131.96 -42.97 0.99 Allowed 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.4 -32.71 4.22 Favored Glycine 0 C--N 1.353 1.479 0 N-CA-C 109.261 -1.535 . . . . 0.0 109.261 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 85.1 mt -111.63 101.33 12.38 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -96.41 -1.81 46.8 Favored 'General case' 0 C--N 1.354 0.803 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.747 HG22 ' H ' ' A' ' 39' ' ' SER . 4.0 m 80.1 174.9 0.13 Allowed 'General case' 0 C--N 1.362 1.13 0 N-CA-C 105.952 -1.869 . . . . 0.0 105.952 -178.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.747 ' H ' HG22 ' A' ' 38' ' ' THR . 26.0 p -89.16 113.84 25.07 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 121.033 -1.042 . . . . 0.0 109.78 -178.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 39' ' ' SER . 0.0 OUTLIER -172.71 -8.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.362 1.143 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.762 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.404 ' H ' ' H ' ' A' ' 40' ' ' VAL . . . -113.55 164.75 12.02 Favored Glycine 0 C--N 1.357 1.698 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -178.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 53.5 m -129.11 132.78 47.44 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -117.98 170.62 8.68 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -77.64 -178.13 5.17 Favored 'General case' 0 C--N 1.356 0.866 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -88.32 -15.08 36.66 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -68.18 -29.8 68.75 Favored 'General case' 0 C--N 1.353 0.753 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 178.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.505 ' CG ' ' HZ ' ' A' ' 6' ' ' PHE . 24.1 tp10 -63.07 -41.6 99.47 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.467 HD22 ' O ' ' A' ' 48' ' ' LEU . 1.8 tm? -67.83 -39.99 83.83 Favored 'General case' 0 C--N 1.358 0.965 0 CA-C-O 120.647 0.26 . . . . 0.0 110.531 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 64.6 tp -71.01 -34.71 71.6 Favored 'General case' 0 CA--C 1.509 -0.62 0 O-C-N 122.132 -0.355 . . . . 0.0 110.661 -177.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 73.2 tp60 -65.81 -40.79 92.22 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 121.659 -0.651 . . . . 0.0 110.005 -178.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.717 HD22 HD13 ' A' ' 25' ' ' LEU . 73.4 mt -82.48 -19.22 39.25 Favored 'General case' 0 C--N 1.361 1.091 0 C-N-CA 119.622 -0.831 . . . . 0.0 110.574 -178.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.4 t -79.35 -37.66 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 54.2 t -69.05 -39.99 80.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.73 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 178.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.414 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 32.3 tptt -65.7 -27.86 68.64 Favored 'General case' 0 C--N 1.363 1.191 0 O-C-N 121.214 -0.929 . . . . 0.0 108.754 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.8 tt -67.44 -39.33 85.39 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' A' ' 60' ' ' SER . 81.1 p -72.42 -17.33 61.81 Favored 'General case' 0 C--N 1.358 0.949 0 O-C-N 121.694 -0.628 . . . . 0.0 111.019 -178.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -99.96 -36.78 9.27 Favored 'General case' 0 C--N 1.353 0.736 0 O-C-N 121.153 -0.967 . . . . 0.0 111.346 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.2 p -70.38 -34.35 57.76 Favored 'Isoleucine or valine' 0 C--N 1.352 0.687 0 O-C-N 121.74 -0.6 . . . . 0.0 111.338 -177.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.645 ' HB3' HG23 ' A' ' 61' ' ' VAL . 2.0 t -120.81 -7.15 9.57 Favored 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 119.128 -1.029 . . . . 0.0 109.924 -178.351 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.473 ' HA ' ' O ' ' A' ' 56' ' ' SER . 0.5 OUTLIER 65.67 47.6 2.12 Favored 'General case' 0 C--N 1.353 0.753 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.792 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.645 HG23 ' HB3' ' A' ' 59' ' ' SER . 52.9 t -106.56 132.44 20.9 Favored Pre-proline 0 N--CA 1.443 -0.785 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -57.2 146.89 79.42 Favored 'Trans proline' 0 CA--C 1.498 -1.301 0 C-N-CA 122.504 2.136 . . . . 0.0 112.845 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.5 m -75.49 -12.12 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.605 -178.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.487 ' O ' HG12 ' A' ' 67' ' ' VAL . 70.2 p -97.65 -32.71 11.63 Favored 'General case' 0 C--N 1.359 0.994 0 C-N-CA 118.258 -1.377 . . . . 0.0 109.26 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -75.43 -23.26 56.94 Favored 'General case' 0 C--N 1.355 0.841 0 O-C-N 121.42 -0.8 . . . . 0.0 109.106 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -82.2 -34.86 28.79 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -179.007 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.487 HG12 ' O ' ' A' ' 64' ' ' THR . 1.6 p -68.21 -27.15 36.0 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.688 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.8 mmm-85 -73.28 -52.12 15.13 Favored 'General case' 0 C--N 1.364 1.198 0 O-C-N 121.609 -0.682 . . . . 0.0 110.284 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.66 -35.6 80.16 Favored 'General case' 0 C--N 1.357 0.92 0 O-C-N 121.973 -0.454 . . . . 0.0 110.954 -178.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -60.95 -47.74 85.05 Favored 'General case' 0 C--N 1.349 0.581 0 O-C-N 122.083 -0.385 . . . . 0.0 110.54 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.99 -38.95 96.35 Favored Glycine 0 C--N 1.355 1.587 0 N-CA-C 111.997 -0.441 . . . . 0.0 111.997 -178.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -63.38 -48.54 77.5 Favored 'General case' 0 C--N 1.35 0.626 0 CA-C-N 118.303 1.052 . . . . 0.0 111.55 -177.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.671 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 11.9 mttm -63.89 -48.6 76.03 Favored 'General case' 0 C--N 1.358 0.961 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -177.259 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.456 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.3 tm? -68.54 -39.12 81.26 Favored 'General case' 0 C--N 1.35 0.588 0 O-C-N 121.197 -0.94 . . . . 0.0 111.699 -175.54 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.4 ' CE2' ' HA ' ' A' ' 150' ' ' CYS . 43.8 t80 -62.95 -45.07 94.21 Favored 'General case' 0 C--N 1.352 0.715 0 O-C-N 121.241 -0.912 . . . . 0.0 111.165 -178.002 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.8 p -71.09 -14.66 18.11 Favored 'Isoleucine or valine' 0 C--N 1.359 1.006 0 O-C-N 121.396 -0.815 . . . . 0.0 109.5 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.671 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 73.6 mm-40 -71.43 -39.81 70.8 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 82.9 mt -70.94 -34.96 71.99 Favored 'General case' 0 C--N 1.357 0.911 0 O-C-N 122.188 -0.32 . . . . 0.0 110.599 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.6 mm -63.79 -53.33 45.82 Favored 'Isoleucine or valine' 0 C--N 1.357 0.916 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.615 -176.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -75.15 -10.98 59.96 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.938 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.23 -11.16 60.15 Favored Glycine 0 C--N 1.35 1.345 0 C-N-CA 119.734 -1.222 . . . . 0.0 110.696 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.465 ' HB3' ' HB ' ' A' ' 85' ' ' ILE . 96.3 m-70 -138.34 96.27 9.99 Favored Pre-proline 0 CA--C 1.503 -0.865 0 CA-C-N 118.991 1.396 . . . . 0.0 108.836 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.458 ' O ' ' HB2' ' A' ' 87' ' ' ASN . 37.7 Cg_endo -67.87 -25.74 38.74 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.428 2.085 . . . . 0.0 114.293 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -91.11 -8.39 48.96 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.465 ' HB ' ' HB3' ' A' ' 82' ' ' HIS . 1.5 tp -89.35 -21.73 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 -178.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.81 -16.94 15.26 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 47.1 t30 -70.84 -41.62 71.25 Favored 'General case' 0 C--N 1.36 1.046 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -68.5 -30.36 69.17 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.387 -178.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 29.5 ttp -84.0 148.07 27.08 Favored 'General case' 0 C--N 1.35 0.623 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.04 -21.62 8.2 Favored 'General case' 0 C--N 1.362 1.119 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.865 -177.453 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -164.83 170.64 15.18 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 119.172 -1.011 . . . . 0.0 108.337 -177.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.41 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 41.1 t -64.43 -41.96 96.28 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.806 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -66.17 -38.93 89.24 Favored 'General case' 0 C--N 1.355 0.821 0 O-C-N 121.568 -0.708 . . . . 0.0 109.251 -178.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -65.59 -25.84 67.58 Favored 'General case' 0 C--N 1.357 0.906 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.41 ' HB3' ' O ' ' A' ' 92' ' ' SER . 59.9 tp -62.74 -46.52 87.69 Favored 'General case' 0 C--N 1.355 0.823 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.3 mp -62.71 -32.59 73.73 Favored 'General case' 0 C--N 1.353 0.76 0 O-C-N 122.221 -0.299 . . . . 0.0 110.502 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 37.2 t -62.57 -45.22 93.9 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 121.774 -0.579 . . . . 0.0 111.351 -178.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.403 ' H ' ' HG3' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -111.3 26.28 10.84 Favored 'General case' 0 C--N 1.363 1.185 0 O-C-N 121.07 -1.019 . . . . 0.0 110.491 -178.171 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.1 tt -60.6 -29.53 44.97 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.575 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -129.3 -7.12 4.78 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 118.444 -1.302 . . . . 0.0 110.039 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 64.5 m -90.75 -3.21 57.61 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.295 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -147.68 -48.7 0.17 Allowed 'General case' 0 C--N 1.357 0.911 0 C-N-CA 118.221 -1.392 . . . . 0.0 109.724 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 96.1 mt -65.75 -47.39 86.07 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 O-C-N 122.038 -0.414 . . . . 0.0 110.922 -177.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 22.7 m170 -83.77 -3.79 58.11 Favored 'General case' 0 C--N 1.354 0.799 0 O-C-N 121.461 -0.774 . . . . 0.0 109.78 -177.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 56.4 t -75.13 -45.24 42.51 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.907 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -70.0 -38.94 76.13 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -178.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 56.7 t -61.65 -46.31 96.82 Favored 'Isoleucine or valine' 0 C--N 1.355 0.822 0 O-C-N 122.196 -0.315 . . . . 0.0 110.48 -178.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -60.04 -47.76 84.5 Favored 'General case' 0 C--N 1.357 0.898 0 O-C-N 122.127 -0.358 . . . . 0.0 111.089 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -61.77 -36.07 79.97 Favored 'General case' 0 C--N 1.355 0.839 0 O-C-N 121.552 -0.718 . . . . 0.0 110.11 -178.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 15.3 mt -59.66 -79.66 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -111.97 140.59 23.59 Favored Pre-proline 0 N--CA 1.442 -0.848 0 C-N-CA 118.877 -1.129 . . . . 0.0 109.242 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -88.84 -6.1 5.82 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 123.286 2.657 . . . . 0.0 114.919 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -69.02 -33.7 74.06 Favored 'General case' 0 C--N 1.353 0.722 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.66 145.08 56.72 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 121.697 0.761 . . . . 0.0 110.13 -178.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.469 ' O ' HD13 ' A' ' 116' ' ' LEU . 46.5 mt-10 -118.55 143.32 46.84 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 179.118 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.469 HD13 ' O ' ' A' ' 115' ' ' GLU . 2.6 mm? -126.77 149.7 69.31 Favored Pre-proline 0 N--CA 1.445 -0.702 0 CA-C-O 122.074 0.94 . . . . 0.0 108.597 -178.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 116' ' ' LEU . 87.7 Cg_endo -91.28 -155.51 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.265 0 C-N-CA 123.743 2.962 . . . . 0.0 113.197 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -115.98 138.32 51.31 Favored 'General case' 0 C--N 1.362 1.113 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -127.16 129.54 48.08 Favored 'General case' 0 C--N 1.361 1.104 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.548 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 93.2 m -128.58 131.44 48.18 Favored 'General case' 0 C--N 1.356 0.864 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 177.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -125.01 132.44 53.24 Favored 'General case' 0 CA--C 1.503 -0.853 0 C-N-CA 119.316 -0.954 . . . . 0.0 109.769 -178.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -121.28 140.81 51.57 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 178.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 57.7 ttp180 -111.88 117.75 33.62 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -179.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.9 mt -92.91 -16.64 24.95 Favored 'General case' 0 C--N 1.354 0.781 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.193 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 178.19 -150.48 9.83 Favored Glycine 0 C--N 1.347 1.186 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -91.33 -39.69 11.9 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.405 ' HB2' ' HB2' ' A' ' 179' ' ' ARG . 8.2 p30 -104.87 9.3 34.8 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 119.759 -0.777 . . . . 0.0 109.177 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -119.64 124.62 46.76 Favored 'General case' 0 C--N 1.358 0.961 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.403 HD13 ' HA ' ' A' ' 129' ' ' ILE . 9.8 mm -140.13 137.25 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 -116.95 137.65 52.08 Favored 'General case' 0 CA--C 1.492 -1.266 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 6.7 tp -123.23 117.86 26.27 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.023 -0.989 . . . . 0.0 108.486 -178.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.548 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 12.6 m-70 -99.6 131.32 45.68 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -127.95 121.37 29.73 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.541 ' HA ' ' O ' ' A' ' 171' ' ' THR . 75.3 mt-30 -114.5 115.02 26.57 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 179.034 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.2 t -162.86 152.22 15.31 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -90.81 1.14 57.18 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 120.17 -0.612 . . . . 0.0 109.794 -178.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -136.22 74.26 55.79 Favored Pre-proline 0 C--N 1.354 0.789 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -95.42 110.64 0.14 Allowed 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.54 2.16 . . . . 0.0 115.935 -177.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -110.99 112.1 23.69 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 176.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.12 -39.27 93.68 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.424 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.3 m -63.7 -26.96 68.9 Favored 'General case' 0 C--N 1.353 0.758 0 O-C-N 121.894 -0.504 . . . . 0.0 110.729 -178.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -75.78 -47.03 27.5 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 121.731 -0.606 . . . . 0.0 109.692 -177.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.28 -39.83 93.07 Favored 'General case' 0 C--N 1.358 0.94 0 O-C-N 122.074 -0.391 . . . . 0.0 111.323 -178.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -62.97 -36.85 84.87 Favored 'General case' 0 C--N 1.357 0.909 0 O-C-N 121.827 -0.546 . . . . 0.0 109.972 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.6 -43.01 99.42 Favored Glycine 0 C--N 1.346 1.114 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 83.9 mt -70.49 -40.64 73.47 Favored 'General case' 0 C--N 1.351 0.672 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -179.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 98.2 mt -70.92 -42.55 69.75 Favored 'General case' 0 C--N 1.361 1.09 0 O-C-N 121.154 -0.966 . . . . 0.0 110.907 -176.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.55 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 37.2 t70 -70.12 -29.43 66.36 Favored 'General case' 0 N--CA 1.444 -0.737 0 O-C-N 121.995 -0.44 . . . . 0.0 110.373 -179.358 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -63.1 -39.57 98.16 Favored Glycine 0 C--N 1.357 1.701 0 N-CA-C 108.474 -1.85 . . . . 0.0 108.474 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.4 ' HA ' ' CE2' ' A' ' 75' ' ' PHE . 45.1 t -61.01 -42.22 98.03 Favored 'General case' 0 C--N 1.351 0.672 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -75.92 0.73 17.29 Favored 'General case' 0 C--N 1.36 1.027 0 O-C-N 121.803 -0.561 . . . . 0.0 109.489 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.55 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 76.8 mm-40 -85.78 -45.96 11.12 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.016 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -66.67 -44.63 81.29 Favored 'General case' 0 C--N 1.358 0.949 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.45 ' O ' ' HB2' ' A' ' 155' ' ' LYS . 51.6 m-85 -70.12 -26.08 63.79 Favored 'General case' 0 C--N 1.361 1.077 0 O-C-N 121.783 -0.573 . . . . 0.0 111.126 -178.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 154' ' ' PHE . 41.1 mttt 73.39 71.32 0.12 Allowed 'General case' 0 C--N 1.361 1.102 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -178.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -137.02 -172.48 3.2 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -148.72 94.0 2.21 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 19.3 m-30 -114.89 158.79 21.49 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 94.0 m -118.32 125.03 49.23 Favored 'General case' 0 C--N 1.356 0.868 0 C-N-CA 119.368 -0.933 . . . . 0.0 108.848 -178.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.509 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.6 mp -101.57 121.8 52.94 Favored 'Isoleucine or valine' 0 C--N 1.353 0.736 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 178.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.2 m -119.2 -173.53 2.53 Favored 'General case' 0 C--N 1.357 0.907 0 CA-C-O 121.787 0.803 . . . . 0.0 109.55 -178.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -147.52 155.95 42.37 Favored 'General case' 0 C--N 1.357 0.918 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -178.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 57.4 p -99.07 146.83 32.36 Favored Pre-proline 0 C--N 1.358 0.966 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.686 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 73.7 Cg_endo -76.02 -10.99 19.72 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.786 2.324 . . . . 0.0 115.082 -178.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -73.17 -41.45 63.85 Favored 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.795 -178.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 37.3 p -117.27 14.96 14.88 Favored 'General case' 0 C--N 1.356 0.872 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.734 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.686 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.1 pp0? -66.52 -12.75 59.08 Favored 'General case' 0 C--N 1.353 0.748 0 O-C-N 121.62 -0.675 . . . . 0.0 110.521 178.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 53.8 p-10 -121.89 34.71 5.09 Favored 'General case' 0 N--CA 1.439 -1.015 0 O-C-N 121.068 -1.02 . . . . 0.0 108.447 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 57.2 m -136.11 148.45 48.26 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.639 ' O ' ' HB ' ' A' ' 171' ' ' THR . 61.1 mt-10 -101.85 166.37 10.69 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.639 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 2.5 m 83.2 -56.94 0.16 Allowed 'General case' 0 C--N 1.368 1.374 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -112.23 117.62 33.05 Favored 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 119.861 -0.735 . . . . 0.0 109.609 -178.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 88.5 t -130.73 132.83 63.99 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 49.8 mm -107.35 125.86 63.58 Favored 'Isoleucine or valine' 0 C--N 1.359 0.982 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -114.92 155.89 26.04 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 122.061 0.934 . . . . 0.0 108.652 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -138.16 119.31 14.52 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -178.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.8 mp -115.09 121.37 66.95 Favored 'Isoleucine or valine' 0 C--N 1.353 0.735 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 42.8 p -126.02 159.86 31.61 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 121.698 0.761 . . . . 0.0 110.854 -177.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.405 ' HB2' ' HB2' ' A' ' 127' ' ' ASN . 0.1 OUTLIER . . . . . 0 C--N 1.366 1.287 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 177.358 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.5 mmm . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.068 0.461 . . . . 0.0 110.147 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.27 -19.55 50.29 Favored 'General case' 0 C--N 1.356 0.877 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -178.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.06 -41.13 40.91 Favored Glycine 0 C--N 1.348 1.224 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.92 -34.95 69.49 Favored 'General case' 0 C--N 1.354 0.779 0 O-C-N 122.119 -0.636 . . . . 0.0 111.3 -177.501 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.9 m -71.04 -23.5 23.56 Favored 'Isoleucine or valine' 0 C--N 1.352 0.714 0 C-N-CA 119.915 -0.714 . . . . 0.0 109.122 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.4 m-30 -71.75 -33.44 68.66 Favored 'General case' 0 C--N 1.358 0.969 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 85.0 m -66.98 -40.06 87.32 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.24 -37.79 95.13 Favored Glycine 0 C--N 1.357 1.72 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.611 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -67.77 -38.47 83.46 Favored 'General case' 0 C--N 1.353 0.719 0 CA-C-N 117.346 0.573 . . . . 0.0 110.297 -178.006 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.469 ' CE ' HD21 ' A' ' 26' ' ' LEU . 22.0 mmt -64.01 -41.22 97.54 Favored 'General case' 0 C--N 1.356 0.868 0 O-C-N 121.644 -0.66 . . . . 0.0 111.002 -178.567 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -66.09 -40.33 90.73 Favored 'General case' 0 C--N 1.348 0.504 0 O-C-N 122.17 -0.331 . . . . 0.0 111.554 -177.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 55.5 tp -65.78 -42.74 90.41 Favored 'General case' 0 C--N 1.349 0.575 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -178.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.611 HG12 ' O ' ' A' ' 9' ' ' LEU . 2.4 mm -73.83 -36.96 47.37 Favored 'Isoleucine or valine' 0 C--N 1.358 0.949 0 O-C-N 121.067 -1.021 . . . . 0.0 111.167 -175.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -67.42 -44.43 78.79 Favored 'General case' 0 C--N 1.353 0.733 0 O-C-N 121.815 -0.553 . . . . 0.0 111.432 -176.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -72.85 -31.14 64.54 Favored 'General case' 0 N--CA 1.447 -0.579 0 O-C-N 122.013 -0.429 . . . . 0.0 111.626 -177.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -72.74 -50.02 27.24 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -175.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -128.47 -20.25 3.68 Favored 'General case' 0 C--N 1.354 0.797 0 C-N-CA 117.328 -1.749 . . . . 0.0 113.328 -176.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 144.44 179.79 21.13 Favored Glycine 0 N--CA 1.44 -1.061 0 C-N-CA 117.575 -2.25 . . . . 0.0 110.537 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -96.55 -16.37 21.11 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 -177.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -70.08 -41.18 74.45 Favored 'General case' 0 C--N 1.36 1.051 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.6 m -69.76 -38.42 76.76 Favored 'General case' 0 C--N 1.358 0.944 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.6 tp -59.64 -37.94 80.03 Favored 'General case' 0 C--N 1.356 0.867 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -65.76 -35.61 81.21 Favored 'General case' 0 C--N 1.356 0.89 0 O-C-N 122.068 -0.395 . . . . 0.0 110.847 -178.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.8 m -65.33 -39.42 92.38 Favored 'General case' 0 C--N 1.355 0.815 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 -178.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.515 HD22 ' HA ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -63.33 -37.96 89.29 Favored 'General case' 0 C--N 1.355 0.807 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.522 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.469 HD21 ' CE ' ' A' ' 10' ' ' MET . 84.5 mt -75.28 -11.85 60.15 Favored 'General case' 0 C--N 1.361 1.079 0 O-C-N 121.652 -0.655 . . . . 0.0 110.457 -178.455 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -88.48 -27.22 21.63 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 119.115 -1.034 . . . . 0.0 108.982 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.7 t -68.26 -37.64 80.94 Favored 'General case' 0 C--N 1.356 0.883 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.8 p -90.54 -41.07 11.6 Favored 'General case' 0 C--N 1.358 0.935 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 85.02 134.09 0.05 OUTLIER 'General case' 0 C--N 1.36 1.047 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.487 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -84.9 -171.75 3.81 Favored 'General case' 0 C--N 1.356 0.88 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.89 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -151.27 -23.69 0.21 Allowed 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.9 t -148.34 -64.53 0.25 Allowed 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -131.13 -55.97 1.04 Allowed 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 130.76 -44.61 1.2 Allowed Glycine 0 C--N 1.353 1.498 0 N-CA-C 108.749 -1.74 . . . . 0.0 108.749 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 80.3 mt -107.08 100.45 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.758 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.577 ' O ' ' HB ' ' A' ' 38' ' ' THR . 0.9 OUTLIER -71.79 -28.7 63.79 Favored 'General case' 0 C--N 1.357 0.924 0 O-C-N 121.962 -0.461 . . . . 0.0 109.912 -179.844 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.577 ' HB ' ' O ' ' A' ' 37' ' ' TYR . 12.3 m 113.3 -67.36 0.0 OUTLIER 'General case' 0 C--N 1.37 1.47 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.1 p 175.01 64.25 0.0 OUTLIER 'General case' 0 C--N 1.359 0.993 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.439 ' HB ' ' CE2' ' A' ' 37' ' ' TYR . 2.1 t -148.59 -5.97 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.836 0 C-N-CA 119.573 -0.851 . . . . 0.0 109.725 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -98.56 144.32 17.15 Favored Glycine 0 C--N 1.352 1.444 0 C-N-CA 119.162 -1.494 . . . . 0.0 110.23 -177.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.2 m -124.53 122.5 37.75 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -117.63 179.4 4.07 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -83.02 -171.33 3.5 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 73.3 m80 -93.67 -15.13 25.61 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.418 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -70.6 -28.7 65.05 Favored 'General case' 0 C--N 1.354 0.767 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 27.5 tp10 -63.27 -41.12 98.99 Favored 'General case' 0 C--N 1.352 0.688 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.444 ' O ' HG23 ' A' ' 52' ' ' VAL . 60.9 tp -67.7 -37.99 83.04 Favored 'General case' 0 C--N 1.355 0.823 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.295 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 59.8 tp -77.37 -27.74 52.69 Favored 'General case' 0 C--N 1.351 0.633 0 O-C-N 121.983 -0.448 . . . . 0.0 110.496 -176.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 72.7 tp60 -68.48 -42.38 78.78 Favored 'General case' 0 C--N 1.351 0.672 0 O-C-N 121.546 -0.721 . . . . 0.0 109.526 -178.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.423 HD22 HD13 ' A' ' 25' ' ' LEU . 82.4 mt -71.9 -35.16 69.62 Favored 'General case' 0 C--N 1.362 1.14 0 C-N-CA 119.963 -0.695 . . . . 0.0 109.355 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 48' ' ' LEU . 33.6 t -62.02 -40.21 86.51 Favored 'Isoleucine or valine' 0 C--N 1.351 0.632 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.9 t -67.57 -39.33 82.16 Favored 'Isoleucine or valine' 0 C--N 1.351 0.631 0 O-C-N 121.723 -0.611 . . . . 0.0 109.392 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.436 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 33.7 tptt -65.39 -29.17 69.85 Favored 'General case' 0 C--N 1.361 1.07 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -179.068 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.515 HD21 HD12 ' A' ' 13' ' ' ILE . 19.7 mt -66.17 -37.94 86.86 Favored 'General case' 0 C--N 1.355 0.815 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.303 179.178 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 56.3 p -72.16 -17.68 61.93 Favored 'General case' 0 C--N 1.354 0.796 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.704 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -101.8 -37.56 8.24 Favored 'General case' 0 C--N 1.353 0.754 0 O-C-N 121.244 -0.91 . . . . 0.0 111.473 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.1 p -74.22 -38.38 47.88 Favored 'Isoleucine or valine' 0 C--N 1.354 0.779 0 O-C-N 121.599 -0.688 . . . . 0.0 111.143 -177.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.549 ' HB3' HG23 ' A' ' 61' ' ' VAL . 3.4 t -112.21 -7.62 14.02 Favored 'General case' 0 C--N 1.353 0.756 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.309 -177.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 64.25 47.73 3.09 Favored 'General case' 0 C--N 1.354 0.781 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.549 HG23 ' HB3' ' A' ' 59' ' ' SER . 62.0 t -111.5 133.8 21.37 Favored Pre-proline 0 N--CA 1.443 -0.813 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 61' ' ' VAL . 34.1 Cg_exo -58.44 148.35 80.91 Favored 'Trans proline' 0 CA--C 1.498 -1.294 0 C-N-CA 122.565 2.177 . . . . 0.0 112.771 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.9 m -72.73 -15.02 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.687 -178.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.436 ' O ' HG12 ' A' ' 67' ' ' VAL . 70.6 p -96.42 -31.61 12.75 Favored 'General case' 0 C--N 1.359 0.987 0 C-N-CA 118.608 -1.237 . . . . 0.0 109.075 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -71.06 -33.01 69.86 Favored 'General case' 0 C--N 1.353 0.728 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.402 HD13 HD13 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -77.23 -34.88 55.91 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -177.889 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.436 HG12 ' O ' ' A' ' 64' ' ' THR . 1.5 p -70.64 -26.03 27.64 Favored 'Isoleucine or valine' 0 C--N 1.354 0.776 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.523 -178.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 5.3 mmm-85 -74.58 -51.44 14.55 Favored 'General case' 0 C--N 1.36 1.039 0 O-C-N 121.438 -0.789 . . . . 0.0 110.105 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.0 mt -63.2 -35.33 79.97 Favored 'General case' 0 C--N 1.357 0.896 0 O-C-N 122.046 -0.409 . . . . 0.0 110.606 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -60.94 -47.16 87.72 Favored 'General case' 0 C--N 1.35 0.623 0 O-C-N 122.301 -0.25 . . . . 0.0 110.333 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.6 -38.58 95.23 Favored Glycine 0 C--N 1.354 1.547 0 N-CA-C 111.848 -0.501 . . . . 0.0 111.848 -178.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -63.86 -47.65 79.84 Favored 'General case' 0 C--N 1.353 0.726 0 CA-C-N 118.411 1.105 . . . . 0.0 111.457 -177.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.729 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 12.9 mttm -64.15 -49.46 72.02 Favored 'General case' 0 C--N 1.358 0.97 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -176.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.418 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.2 tm? -69.18 -39.38 78.75 Favored 'General case' 0 C--N 1.35 0.609 0 O-C-N 121.214 -0.929 . . . . 0.0 111.882 -175.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -63.47 -44.29 94.86 Favored 'General case' 0 C--N 1.353 0.748 0 O-C-N 121.122 -0.987 . . . . 0.0 110.988 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.29 -14.89 18.19 Favored 'Isoleucine or valine' 0 C--N 1.358 0.954 0 O-C-N 121.496 -0.752 . . . . 0.0 109.194 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.729 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 74.3 mm-40 -71.43 -38.98 71.34 Favored 'General case' 0 C--N 1.352 0.674 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 82.5 mt -72.99 -31.36 64.45 Favored 'General case' 0 C--N 1.356 0.855 0 O-C-N 122.426 -0.171 . . . . 0.0 110.545 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 49.1 mm -65.58 -54.25 30.19 Favored 'Isoleucine or valine' 0 C--N 1.359 0.993 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.286 -177.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -75.38 -14.57 60.48 Favored 'General case' 0 CA--C 1.51 -0.571 0 C-N-CA 119.516 -0.874 . . . . 0.0 109.381 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.35 -37.21 63.01 Favored Glycine 0 C--N 1.349 1.259 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.427 ' O ' HG22 ' A' ' 85' ' ' ILE . 98.7 m-70 -131.38 106.24 14.61 Favored Pre-proline 0 N--CA 1.441 -0.885 0 CA-C-O 122.664 1.221 . . . . 0.0 109.046 -177.057 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.33 -24.87 42.88 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.52 2.147 . . . . 0.0 114.113 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.417 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 44.6 mt-10 -93.11 -4.95 51.39 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.427 HG22 ' O ' ' A' ' 82' ' ' HIS . 1.0 OUTLIER -90.32 -20.08 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.224 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 -179.629 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -101.72 -24.66 14.05 Favored 'General case' 0 C--N 1.36 1.038 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -70.26 -35.65 73.92 Favored 'General case' 0 C--N 1.358 0.955 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.417 ' HG2' ' O ' ' A' ' 84' ' ' GLU . 78.6 mm-40 -65.01 -36.1 83.31 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 122.058 -0.401 . . . . 0.0 110.058 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 21.8 ttp -83.56 149.87 26.31 Favored 'General case' 0 C--N 1.352 0.698 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -178.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.53 -21.95 8.36 Favored 'General case' 0 C--N 1.364 1.222 0 C-N-CA 120.074 -0.651 . . . . 0.0 111.032 -177.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -164.55 170.93 15.19 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 -177.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.415 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 41.0 t -64.4 -42.69 95.97 Favored 'General case' 0 C--N 1.356 0.873 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.955 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -66.86 -38.82 87.09 Favored 'General case' 0 C--N 1.355 0.833 0 O-C-N 121.492 -0.755 . . . . 0.0 109.328 -178.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -65.91 -24.61 66.87 Favored 'General case' 0 C--N 1.357 0.912 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.415 ' HB3' ' O ' ' A' ' 92' ' ' SER . 62.5 tp -63.09 -46.41 87.53 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.7 mp -63.03 -32.35 73.7 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 122.185 -0.322 . . . . 0.0 110.405 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 36.5 t -62.15 -45.08 95.04 Favored 'General case' 0 C--N 1.355 0.847 0 O-C-N 121.783 -0.573 . . . . 0.0 111.304 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.66 26.42 10.39 Favored 'General case' 0 C--N 1.362 1.11 0 O-C-N 121.015 -1.053 . . . . 0.0 110.515 -178.232 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.0 tt -64.09 -29.57 47.69 Favored 'Isoleucine or valine' 0 C--N 1.352 0.691 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.151 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -126.21 -9.46 6.44 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 118.564 -1.254 . . . . 0.0 109.762 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 58.8 m -90.92 -2.54 57.72 Favored 'General case' 0 N--CA 1.441 -0.884 0 O-C-N 121.406 -0.809 . . . . 0.0 110.345 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -147.03 -47.69 0.18 Allowed 'General case' 0 C--N 1.358 0.968 0 C-N-CA 118.28 -1.368 . . . . 0.0 109.913 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 96.2 mt -67.53 -47.84 79.07 Favored 'Isoleucine or valine' 0 C--N 1.354 0.779 0 O-C-N 121.931 -0.481 . . . . 0.0 111.161 -178.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.652 ' HB3' HD21 ' A' ' 116' ' ' LEU . 22.4 m170 -83.55 -1.14 53.09 Favored 'General case' 0 C--N 1.356 0.875 0 O-C-N 121.403 -0.811 . . . . 0.0 110.056 -177.541 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 70.5 t -83.96 -43.13 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.952 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -67.3 -39.88 85.99 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.323 -178.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.1 p -71.97 -36.5 57.74 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 C-N-CA 119.596 -0.842 . . . . 0.0 110.106 -178.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 93.3 t80 -60.86 -48.6 81.07 Favored 'General case' 0 C--N 1.363 1.171 0 O-C-N 121.744 -0.597 . . . . 0.0 110.71 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -60.25 -38.1 82.45 Favored 'General case' 0 C--N 1.358 0.941 0 O-C-N 121.665 -0.647 . . . . 0.0 110.069 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 16.9 mt -58.05 -76.56 0.04 OUTLIER 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.429 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 91.3 m-85 -115.72 134.3 22.7 Favored Pre-proline 0 N--CA 1.44 -0.954 0 C-N-CA 118.986 -1.086 . . . . 0.0 108.83 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 111' ' ' TYR . 74.3 Cg_endo -86.21 -2.08 8.62 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 123.222 2.615 . . . . 0.0 115.403 -179.012 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -67.39 -36.18 80.8 Favored 'General case' 0 C--N 1.355 0.814 0 O-C-N 121.773 -0.579 . . . . 0.0 109.997 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.73 143.99 55.36 Favored 'General case' 0 C--N 1.354 0.775 0 CA-C-O 121.651 0.738 . . . . 0.0 110.018 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -114.26 145.58 41.55 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.652 HD21 ' HB3' ' A' ' 104' ' ' HIS . 5.6 mp -127.48 145.78 55.91 Favored Pre-proline 0 N--CA 1.445 -0.716 0 CA-C-O 122.198 0.999 . . . . 0.0 108.98 -178.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 116' ' ' LEU . 73.7 Cg_endo -91.31 -152.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.197 0 C-N-CA 123.909 3.073 . . . . 0.0 113.178 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -115.03 142.46 46.61 Favored 'General case' 0 C--N 1.362 1.125 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.598 ' CE2' ' HD1' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -137.71 125.42 22.37 Favored 'General case' 0 C--N 1.361 1.09 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -177.999 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 94.1 m -124.23 129.99 51.74 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 177.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 74.8 m -118.01 131.35 56.48 Favored 'General case' 0 CA--C 1.504 -0.8 0 C-N-CA 119.277 -0.969 . . . . 0.0 109.852 -177.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -121.02 148.37 44.22 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 58.1 ttp180 -123.32 117.39 25.13 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.451 ' HB2' ' CB ' ' A' ' 128' ' ' ASP . 95.3 mt -92.07 -15.09 28.27 Favored 'General case' 0 C--N 1.354 0.797 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.709 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 178.59 -150.37 9.61 Favored Glycine 0 N--CA 1.439 -1.154 0 N-CA-C 108.886 -1.686 . . . . 0.0 108.886 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -90.4 -38.23 13.45 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -105.99 9.5 32.55 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 119.762 -0.775 . . . . 0.0 109.524 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.451 ' CB ' ' HB2' ' A' ' 124' ' ' LEU . 61.9 m-20 -118.3 123.21 44.8 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 17.8 mm -137.9 133.26 44.57 Favored 'Isoleucine or valine' 0 C--N 1.353 0.729 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 59.9 mtm180 -120.49 139.43 52.9 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.546 ' HG ' ' O ' ' A' ' 131' ' ' LEU . 0.7 OUTLIER -130.04 127.0 39.05 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.917 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -97.34 130.7 44.47 Favored 'General case' 0 CA--C 1.494 -1.188 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 178.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.598 ' HD1' ' CE2' ' A' ' 119' ' ' PHE . 52.5 t80 -124.86 121.43 34.51 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 -178.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.485 ' HA ' ' O ' ' A' ' 171' ' ' THR . 28.2 tt0 -114.42 112.44 23.03 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.8 t -162.28 153.39 17.8 Favored 'General case' 0 C--N 1.358 0.974 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -90.43 5.99 45.2 Favored 'General case' 0 C--N 1.357 0.903 0 C-N-CA 120.199 -0.6 . . . . 0.0 109.912 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 94.7 mtm-85 -131.94 77.35 72.05 Favored Pre-proline 0 C--N 1.356 0.856 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 178.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -91.48 93.07 0.22 Allowed 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.748 2.298 . . . . 0.0 115.709 -177.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -107.43 106.36 16.73 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 177.31 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.3 -38.88 92.63 Favored 'General case' 0 C--N 1.355 0.835 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.367 -178.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 74.2 m -63.05 -27.1 69.17 Favored 'General case' 0 C--N 1.353 0.755 0 O-C-N 121.981 -0.449 . . . . 0.0 110.554 -178.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -75.58 -47.18 27.78 Favored 'General case' 0 N--CA 1.445 -0.721 0 O-C-N 121.735 -0.603 . . . . 0.0 109.553 -178.089 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.28 -39.4 92.53 Favored 'General case' 0 C--N 1.358 0.944 0 O-C-N 122.108 -0.37 . . . . 0.0 111.331 -178.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -62.19 -36.94 83.42 Favored 'General case' 0 C--N 1.358 0.947 0 O-C-N 121.777 -0.577 . . . . 0.0 109.764 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.53 -42.2 99.03 Favored Glycine 0 C--N 1.347 1.157 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 83.2 mt -70.19 -41.35 73.82 Favored 'General case' 0 C--N 1.352 0.692 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 96.6 mt -71.27 -42.08 69.22 Favored 'General case' 0 C--N 1.364 1.212 0 O-C-N 121.066 -1.021 . . . . 0.0 110.654 -177.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -70.35 -30.84 67.88 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 121.866 -0.521 . . . . 0.0 110.635 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -63.55 -39.75 97.97 Favored Glycine 0 C--N 1.356 1.654 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 42.7 t -60.43 -43.11 97.12 Favored 'General case' 0 C--N 1.35 0.615 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 178.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -78.91 2.38 20.35 Favored 'General case' 0 C--N 1.355 0.847 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -83.73 -49.09 9.45 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -66.69 -42.93 85.67 Favored 'General case' 0 C--N 1.36 1.061 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 9.6 m-30 -69.01 -27.38 65.62 Favored 'General case' 0 C--N 1.361 1.068 0 O-C-N 121.831 -0.543 . . . . 0.0 110.797 -178.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 85.2 tttt 73.01 75.06 0.14 Allowed 'General case' 0 C--N 1.36 1.058 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -137.65 -177.73 4.92 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -140.27 90.06 2.34 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 16.8 m-30 -116.3 155.11 28.98 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 178.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 93.5 m -119.66 128.83 54.2 Favored 'General case' 0 C--N 1.355 0.808 0 C-N-CA 119.551 -0.859 . . . . 0.0 108.828 -178.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.507 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.5 mp -106.24 123.22 60.83 Favored 'Isoleucine or valine' 0 C--N 1.352 0.704 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.1 m -119.43 -170.77 2.0 Allowed 'General case' 0 C--N 1.356 0.869 0 CA-C-O 121.685 0.755 . . . . 0.0 109.197 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 11.3 ptt85 -147.76 157.0 43.33 Favored 'General case' 0 C--N 1.357 0.931 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -178.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' THR . . . . . 0.438 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 32.5 p -97.5 146.37 31.28 Favored Pre-proline 0 C--N 1.36 1.043 0 CA-C-O 122.415 1.103 . . . . 0.0 108.447 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.513 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 16.0 Cg_exo -70.42 -16.7 34.82 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 123.641 2.894 . . . . 0.0 114.486 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -71.95 -40.71 68.49 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.933 -177.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 39.6 p -119.27 15.75 13.09 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.876 -178.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.513 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 12.7 pt20 -67.55 -12.15 59.71 Favored 'General case' 0 C--N 1.352 0.69 0 C-N-CA 119.974 -0.691 . . . . 0.0 110.155 178.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -126.51 37.79 4.24 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 18.2 t -138.94 144.65 39.13 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.622 ' O ' ' HB ' ' A' ' 171' ' ' THR . 61.4 mt-10 -97.87 163.99 12.56 Favored 'General case' 0 C--N 1.354 0.769 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.35 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.622 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 18.0 m 83.95 -59.91 0.12 Allowed 'General case' 0 C--N 1.372 1.555 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -105.71 118.0 35.47 Favored 'General case' 0 CA--C 1.503 -0.827 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.596 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 92.8 t -131.48 133.78 61.5 Favored 'Isoleucine or valine' 0 C--N 1.358 0.952 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 178.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 48.4 mm -113.52 126.98 71.06 Favored 'Isoleucine or valine' 0 C--N 1.359 1.021 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.441 ' HB2' ' HG ' ' A' ' 131' ' ' LEU . 97.2 m-85 -116.74 147.2 42.25 Favored 'General case' 0 C--N 1.36 1.054 0 CA-C-O 121.947 0.88 . . . . 0.0 109.105 -179.162 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -125.2 120.16 30.52 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 51.8 mt -116.22 124.79 72.86 Favored 'Isoleucine or valine' 0 C--N 1.353 0.752 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 -178.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 54.9 p -118.55 157.97 26.31 Favored 'General case' 0 CA--C 1.501 -0.92 0 CA-C-O 121.764 0.792 . . . . 0.0 109.581 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 . . . . . 0 C--N 1.356 0.858 0 N-CA-C 106.325 -1.732 . . . . 0.0 106.325 178.838 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mtm . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 121.287 0.565 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.93 -12.71 54.98 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.172 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.62 -40.2 54.15 Favored Glycine 0 C--N 1.351 1.397 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 7.8 mtm -71.08 -35.4 71.84 Favored 'General case' 0 C--N 1.359 1.0 0 O-C-N 121.875 -0.779 . . . . 0.0 111.299 -177.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.1 m -68.48 -23.98 28.81 Favored 'Isoleucine or valine' 0 C--N 1.356 0.854 0 C-N-CA 119.674 -0.81 . . . . 0.0 109.22 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -71.31 -35.87 71.42 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 178.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 88.6 m -67.35 -41.63 84.85 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.73 -38.95 97.31 Favored Glycine 0 C--N 1.357 1.743 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.633 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -66.73 -39.98 88.2 Favored 'General case' 0 C--N 1.352 0.685 0 O-C-N 122.301 -0.529 . . . . 0.0 110.76 -178.107 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 22.4 mmt -64.25 -41.04 97.15 Favored 'General case' 0 C--N 1.354 0.791 0 O-C-N 121.523 -0.735 . . . . 0.0 111.137 -178.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -67.26 -40.0 86.17 Favored 'General case' 0 C--N 1.35 0.598 0 O-C-N 121.96 -0.463 . . . . 0.0 111.623 -177.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 54.7 tp -66.33 -42.09 88.68 Favored 'General case' 0 C--N 1.348 0.503 0 N-CA-C 112.694 0.628 . . . . 0.0 112.694 -178.037 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.633 HG12 ' O ' ' A' ' 9' ' ' LEU . 2.1 mm -75.17 -35.77 35.3 Favored 'Isoleucine or valine' 0 C--N 1.36 1.048 0 O-C-N 121.11 -0.994 . . . . 0.0 110.86 -175.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -71.13 -41.89 69.91 Favored 'General case' 0 C--N 1.35 0.587 0 O-C-N 121.558 -0.714 . . . . 0.0 111.405 -176.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -72.04 -38.21 69.56 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -175.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -102.57 -23.22 13.89 Favored 'General case' 0 C--N 1.349 0.584 0 C-N-CA 118.794 -1.162 . . . . 0.0 113.466 -174.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 14.6 m-30 -109.07 -37.76 5.73 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 118.191 -1.404 . . . . 0.0 111.399 -176.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 140.63 178.76 17.48 Favored Glycine 0 N--CA 1.439 -1.144 0 N-CA-C 108.732 -1.747 . . . . 0.0 108.732 -179.232 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -101.6 -25.61 13.82 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -177.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -70.3 -39.61 74.72 Favored 'General case' 0 C--N 1.361 1.098 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 95.0 m -67.69 -38.38 83.59 Favored 'General case' 0 C--N 1.358 0.96 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.1 tp -59.59 -38.54 81.49 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -66.12 -36.13 82.33 Favored 'General case' 0 C--N 1.356 0.858 0 O-C-N 122.09 -0.381 . . . . 0.0 111.07 -178.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.6 m -64.13 -41.19 97.3 Favored 'General case' 0 C--N 1.355 0.846 0 O-C-N 121.606 -0.684 . . . . 0.0 109.352 -178.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.3 mt -64.28 -36.84 85.42 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.568 ' HB3' HD23 ' A' ' 31' ' ' LEU . 84.3 mt -70.19 -16.2 63.04 Favored 'General case' 0 C--N 1.359 0.982 0 O-C-N 121.782 -0.574 . . . . 0.0 110.105 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -84.89 -28.79 25.72 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 119.524 -0.87 . . . . 0.0 109.167 178.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.4 t -66.52 -36.89 83.82 Favored 'General case' 0 C--N 1.355 0.838 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.8 p -93.07 -37.19 12.29 Favored 'General case' 0 C--N 1.359 1.004 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -179.279 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 83.66 133.39 0.05 Allowed 'General case' 0 C--N 1.36 1.04 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.568 HD23 ' HB3' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -111.97 132.05 55.02 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 179.246 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -107.88 -21.46 12.83 Favored 'General case' 0 CA--C 1.497 -1.083 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.121 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -114.24 -80.15 0.59 Allowed 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 118.874 -1.131 . . . . 0.0 109.098 -178.632 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -137.16 -53.17 0.68 Allowed 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 131.4 -44.6 1.19 Allowed Glycine 0 C--N 1.352 1.437 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 82.8 mt -107.87 100.05 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.795 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -98.21 0.07 45.11 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.706 HG22 ' H ' ' A' ' 39' ' ' SER . 3.4 m 78.75 174.22 0.16 Allowed 'General case' 0 C--N 1.362 1.127 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 -178.614 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.706 ' H ' HG22 ' A' ' 38' ' ' THR . 41.7 p -86.81 119.25 26.84 Favored 'General case' 0 N--CA 1.443 -0.778 0 O-C-N 121.131 -0.981 . . . . 0.0 109.531 -178.483 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.429 ' O ' HG13 ' A' ' 40' ' ' VAL . 0.5 OUTLIER -176.21 -12.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.362 1.117 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.721 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -114.25 168.05 12.47 Favored Glycine 0 C--N 1.358 1.793 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 -178.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 48.9 m -130.95 132.21 44.92 Favored 'General case' 0 C--N 1.355 0.838 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -119.14 173.64 6.8 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -70.19 172.49 8.0 Favored 'General case' 0 C--N 1.357 0.9 0 CA-C-O 121.671 0.748 . . . . 0.0 109.478 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -83.77 -24.05 31.25 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -178.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -65.79 -27.41 68.25 Favored 'General case' 0 C--N 1.355 0.832 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -61.48 -42.11 98.28 Favored 'General case' 0 C--N 1.353 0.734 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.512 ' O ' HG23 ' A' ' 52' ' ' VAL . 61.8 tp -67.4 -38.89 85.34 Favored 'General case' 0 C--N 1.355 0.816 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.296 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 57.9 tp -73.5 -28.05 61.7 Favored 'General case' 0 C--N 1.352 0.697 0 O-C-N 122.081 -0.387 . . . . 0.0 110.278 -177.199 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 71.7 tp60 -67.42 -42.42 83.22 Favored 'General case' 0 N--CA 1.445 -0.695 0 O-C-N 121.702 -0.624 . . . . 0.0 109.481 -178.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 88.1 mt -76.9 -25.09 52.61 Favored 'General case' 0 C--N 1.36 1.031 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.843 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 48' ' ' LEU . 32.2 t -70.78 -41.7 77.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.1 p -71.82 -30.88 39.25 Favored 'Isoleucine or valine' 0 C--N 1.354 0.797 0 O-C-N 121.514 -0.741 . . . . 0.0 109.766 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 31.1 tptt -71.83 -27.16 62.71 Favored 'General case' 0 C--N 1.364 1.204 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.0 tt -66.58 -41.25 88.81 Favored 'General case' 0 C--N 1.354 0.768 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.498 ' O ' ' HA ' ' A' ' 60' ' ' SER . 46.8 t -65.24 -39.4 92.64 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 121.88 -0.512 . . . . 0.0 110.313 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -76.95 -39.12 51.81 Favored 'General case' 0 C--N 1.352 0.717 0 O-C-N 120.974 -1.078 . . . . 0.0 112.975 -178.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.4 p -70.74 -38.02 71.3 Favored 'Isoleucine or valine' 0 C--N 1.354 0.794 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -175.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.0 t -118.12 -4.44 11.0 Favored 'General case' 0 CA--C 1.505 -0.779 0 C-N-CA 118.975 -1.09 . . . . 0.0 110.085 -177.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' A' ' 56' ' ' SER . 0.3 OUTLIER 69.36 41.23 1.35 Allowed 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.078 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 56' ' ' SER . 61.6 t -110.8 123.86 34.45 Favored Pre-proline 0 CA--C 1.502 -0.891 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 178.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 61' ' ' VAL . 32.5 Cg_exo -57.73 155.03 34.03 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 122.85 2.367 . . . . 0.0 113.689 -178.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.656 ' HA ' HD23 ' A' ' 66' ' ' LEU . 11.4 m -75.3 -9.34 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.457 -177.101 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.504 ' O ' HG12 ' A' ' 67' ' ' VAL . 80.6 p -96.39 -36.13 10.95 Favored 'General case' 0 C--N 1.356 0.882 0 C-N-CA 118.221 -1.392 . . . . 0.0 109.431 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -75.2 -22.3 58.08 Favored 'General case' 0 C--N 1.353 0.733 0 O-C-N 121.407 -0.808 . . . . 0.0 109.337 179.106 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.656 HD23 ' HA ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -82.58 -32.67 28.37 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -178.997 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.504 HG12 ' O ' ' A' ' 64' ' ' THR . 2.3 p -70.98 -25.39 25.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.844 0 C-N-CA 120.077 -0.649 . . . . 0.0 109.864 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.7 mmm-85 -73.29 -53.15 11.55 Favored 'General case' 0 C--N 1.363 1.153 0 O-C-N 121.519 -0.738 . . . . 0.0 109.841 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.54 -34.34 77.58 Favored 'General case' 0 C--N 1.356 0.889 0 O-C-N 122.112 -0.368 . . . . 0.0 110.806 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -61.23 -47.2 87.18 Favored 'General case' 0 C--N 1.35 0.613 0 O-C-N 122.083 -0.385 . . . . 0.0 110.369 -178.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.65 -38.6 95.33 Favored Glycine 0 C--N 1.356 1.663 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 -178.316 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -63.29 -47.98 80.04 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-N 118.115 0.957 . . . . 0.0 111.644 -177.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 12.8 mttm -65.42 -47.04 77.63 Favored 'General case' 0 C--N 1.359 1.018 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -177.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -70.3 -39.24 74.95 Favored 'General case' 0 C--N 1.349 0.571 0 O-C-N 121.158 -0.964 . . . . 0.0 111.712 -175.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -63.89 -45.55 88.88 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 121.114 -0.991 . . . . 0.0 111.047 -178.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.8 p -71.44 -14.01 17.37 Favored 'Isoleucine or valine' 0 C--N 1.359 0.988 0 O-C-N 121.545 -0.722 . . . . 0.0 109.073 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -71.36 -40.65 70.49 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 79.5 mt -70.32 -34.02 72.2 Favored 'General case' 0 C--N 1.356 0.887 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.337 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 46.4 mm -63.16 -52.95 52.42 Favored 'Isoleucine or valine' 0 C--N 1.358 0.964 0 O-C-N 121.723 -0.611 . . . . 0.0 110.105 -177.444 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -75.0 -10.7 59.72 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 120.1 -0.64 . . . . 0.0 111.289 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.76 -8.68 58.06 Favored Glycine 0 C--N 1.351 1.401 0 C-N-CA 119.617 -1.277 . . . . 0.0 110.825 -178.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.577 ' HB3' ' HB ' ' A' ' 85' ' ' ILE . 93.3 m-70 -137.22 91.35 14.65 Favored Pre-proline 0 C--N 1.353 0.721 0 CA-C-N 118.994 1.397 . . . . 0.0 108.982 -179.256 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -59.82 -32.96 96.2 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 123.027 2.484 . . . . 0.0 114.408 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -93.24 -2.71 54.82 Favored 'General case' 0 CA--C 1.504 -0.82 0 C-N-CA 119.74 -0.784 . . . . 0.0 109.616 -178.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.577 ' HB ' ' HB3' ' A' ' 82' ' ' HIS . 0.4 OUTLIER -89.07 -19.87 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 -179.832 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -101.64 -23.42 14.26 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -70.27 -36.66 74.57 Favored 'General case' 0 C--N 1.359 0.995 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -65.77 -35.91 82.06 Favored 'General case' 0 C--N 1.355 0.82 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.013 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 23.8 ttp -83.26 149.61 26.69 Favored 'General case' 0 C--N 1.353 0.732 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -178.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.6 -21.91 8.91 Favored 'General case' 0 C--N 1.364 1.233 0 O-C-N 121.698 -0.626 . . . . 0.0 110.556 -177.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -163.91 170.75 16.3 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -177.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.443 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 89.3 p -70.86 -32.32 69.28 Favored 'General case' 0 C--N 1.353 0.736 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.965 -179.238 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -70.3 -38.94 75.09 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -67.06 -23.73 65.9 Favored 'General case' 0 C--N 1.358 0.937 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.443 ' HB3' ' O ' ' A' ' 92' ' ' SER . 61.0 tp -62.67 -46.53 87.73 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.9 mp -63.13 -31.22 72.32 Favored 'General case' 0 C--N 1.355 0.812 0 O-C-N 122.257 -0.277 . . . . 0.0 110.289 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 36.1 t -62.2 -45.98 90.93 Favored 'General case' 0 C--N 1.356 0.868 0 O-C-N 121.69 -0.631 . . . . 0.0 111.237 -178.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.431 ' H ' ' HG3' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -114.89 28.92 8.39 Favored 'General case' 0 C--N 1.36 1.055 0 O-C-N 121.068 -1.02 . . . . 0.0 110.232 -178.338 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.467 ' HA ' HD12 ' A' ' 103' ' ' ILE . 12.9 tt -63.45 -27.64 43.41 Favored 'Isoleucine or valine' 0 C--N 1.354 0.79 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.5 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -125.98 -12.29 6.45 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 118.825 -1.15 . . . . 0.0 109.044 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.3 t -69.11 -45.53 69.98 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.057 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -123.85 -28.73 3.77 Favored 'General case' 0 C--N 1.358 0.943 0 C-N-CA 118.636 -1.226 . . . . 0.0 111.47 -177.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.467 HD12 ' HA ' ' A' ' 99' ' ' ILE . 96.2 mt -70.17 -47.8 65.46 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 O-C-N 121.147 -0.971 . . . . 0.0 110.922 -178.014 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 39.3 m170 -87.96 1.71 53.46 Favored 'General case' 0 C--N 1.355 0.834 0 O-C-N 121.224 -0.923 . . . . 0.0 110.028 -177.293 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.6 p -92.37 -31.71 4.85 Favored 'Isoleucine or valine' 0 C--N 1.354 0.799 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -71.99 -39.8 69.02 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -72.98 -36.6 51.68 Favored 'Isoleucine or valine' 0 C--N 1.354 0.795 0 C-N-CA 119.605 -0.838 . . . . 0.0 109.704 -178.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -61.06 -48.7 80.52 Favored 'General case' 0 C--N 1.364 1.21 0 O-C-N 121.808 -0.557 . . . . 0.0 110.651 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -60.91 -37.9 83.87 Favored 'General case' 0 C--N 1.357 0.903 0 O-C-N 121.709 -0.619 . . . . 0.0 110.226 -179.02 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.8 mt -57.9 -76.46 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.413 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 79.5 m-85 -116.37 135.04 22.78 Favored Pre-proline 0 N--CA 1.441 -0.899 0 C-N-CA 118.926 -1.109 . . . . 0.0 108.756 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 111' ' ' TYR . 81.2 Cg_endo -85.29 -2.41 9.35 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 123.215 2.61 . . . . 0.0 115.41 -178.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 30.4 mm100 -66.72 -36.42 82.42 Favored 'General case' 0 C--N 1.354 0.79 0 O-C-N 121.779 -0.575 . . . . 0.0 110.029 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.97 146.12 53.82 Favored 'General case' 0 C--N 1.354 0.778 0 CA-C-O 121.695 0.76 . . . . 0.0 110.092 -178.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -117.43 156.77 27.38 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 178.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.824 ' HG ' ' HD2' ' A' ' 117' ' ' PRO . 4.3 tp -142.3 143.47 27.39 Favored Pre-proline 0 N--CA 1.441 -0.893 0 CA-C-O 122.009 0.909 . . . . 0.0 108.646 -178.135 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.824 ' HD2' ' HG ' ' A' ' 116' ' ' LEU . 97.5 Cg_endo -85.73 -152.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.128 0 C-N-CA 123.602 2.868 . . . . 0.0 113.534 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -114.25 145.94 41.08 Favored 'General case' 0 C--N 1.363 1.19 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -145.39 125.28 13.49 Favored 'General case' 0 C--N 1.36 1.052 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -177.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 93.5 m -124.84 132.49 53.32 Favored 'General case' 0 C--N 1.359 0.995 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 179.121 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 75.2 m -113.68 130.25 56.44 Favored 'General case' 0 C--N 1.356 0.883 0 C-N-CA 119.735 -0.786 . . . . 0.0 109.576 -178.372 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -121.04 126.7 50.55 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 178.216 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 58.4 ttp180 -102.53 117.4 34.62 Favored 'General case' 0 C--N 1.353 0.755 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.549 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 85.7 mt -83.3 -27.03 30.08 Favored 'General case' 0 CA--C 1.504 -0.818 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.112 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -177.18 -144.96 5.55 Favored Glycine 0 C--N 1.35 1.319 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 -178.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -94.11 -39.06 10.79 Favored 'General case' 0 N--CA 1.438 -1.07 0 O-C-N 121.993 -0.71 . . . . 0.0 109.312 -178.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -101.94 1.89 37.3 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.614 -178.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.549 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 6.6 m-20 -118.97 130.77 55.87 Favored 'General case' 0 C--N 1.359 0.993 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 14.2 mm -139.37 135.81 40.83 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 58.3 mtm180 -122.0 141.01 51.78 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.57 ' HG ' ' HB2' ' A' ' 175' ' ' PHE . 0.9 OUTLIER -131.39 127.01 36.65 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.676 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -97.47 130.77 44.53 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 178.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -125.15 121.04 33.07 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 -178.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.513 ' HA ' ' O ' ' A' ' 171' ' ' THR . 28.7 tt0 -114.9 112.05 22.13 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 14.5 t -161.73 152.65 18.02 Favored 'General case' 0 C--N 1.358 0.976 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.418 ' C ' ' HD3' ' A' ' 138' ' ' PRO . 57.9 mtmt -90.7 3.56 53.92 Favored 'General case' 0 C--N 1.357 0.891 0 C-N-CA 120.269 -0.572 . . . . 0.0 109.576 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -133.49 73.48 72.99 Favored Pre-proline 0 CA--C 1.506 -0.736 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.418 ' HD3' ' C ' ' A' ' 136' ' ' LYS . 89.6 Cg_endo -96.36 104.14 0.09 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.541 0 C-N-CA 122.662 2.241 . . . . 0.0 115.678 -177.339 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -111.87 113.44 25.77 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 176.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.93 -38.12 89.93 Favored 'General case' 0 C--N 1.353 0.75 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.968 -179.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 74.6 m -63.02 -26.17 68.73 Favored 'General case' 0 C--N 1.353 0.741 0 O-C-N 121.971 -0.456 . . . . 0.0 110.55 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -76.57 -46.72 25.1 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 120.13 -0.628 . . . . 0.0 109.375 -178.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.59 -40.24 95.16 Favored 'General case' 0 C--N 1.357 0.915 0 O-C-N 122.187 -0.321 . . . . 0.0 111.087 -178.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.19 -36.79 84.81 Favored 'General case' 0 C--N 1.355 0.834 0 O-C-N 121.961 -0.462 . . . . 0.0 110.112 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.37 -42.94 99.09 Favored Glycine 0 C--N 1.347 1.157 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.5 mt -70.06 -40.92 74.8 Favored 'General case' 0 C--N 1.353 0.719 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 96.7 mt -71.84 -42.2 67.24 Favored 'General case' 0 C--N 1.364 1.2 0 O-C-N 121.059 -1.026 . . . . 0.0 110.801 -176.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.515 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 20.9 t70 -69.15 -33.15 72.97 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 122.097 -0.377 . . . . 0.0 110.57 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.433 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -62.75 -39.28 97.76 Favored Glycine 0 C--N 1.357 1.713 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 45.9 t -60.51 -42.24 95.99 Favored 'General case' 0 C--N 1.35 0.598 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -75.99 -0.13 20.51 Favored 'General case' 0 C--N 1.36 1.043 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.515 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 76.8 mm-40 -84.56 -46.41 11.59 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -66.16 -44.59 83.64 Favored 'General case' 0 C--N 1.359 1.002 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 8.8 m-30 -69.5 -26.28 64.46 Favored 'General case' 0 C--N 1.361 1.086 0 O-C-N 121.87 -0.518 . . . . 0.0 110.81 -178.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 85.0 tttt 73.16 75.95 0.14 Allowed 'General case' 0 C--N 1.36 1.024 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -178.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -141.42 -171.34 3.28 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -148.34 92.65 2.05 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -113.86 158.41 21.09 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 93.3 m -119.9 127.85 53.09 Favored 'General case' 0 C--N 1.355 0.82 0 C-N-CA 119.404 -0.919 . . . . 0.0 108.974 -178.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.498 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.7 mp -105.86 122.82 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 178.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.4 m -116.67 -172.46 2.2 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 121.822 0.82 . . . . 0.0 109.116 -178.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -146.46 155.67 42.72 Favored 'General case' 0 C--N 1.354 0.792 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -178.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 41.7 p -98.68 146.3 31.38 Favored Pre-proline 0 C--N 1.359 0.999 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.689 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 72.6 Cg_endo -76.35 -11.87 19.01 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 123.044 2.496 . . . . 0.0 115.148 -178.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -72.66 -41.07 65.82 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 120.056 -0.657 . . . . 0.0 109.551 -178.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 35.8 p -117.72 15.23 14.47 Favored 'General case' 0 C--N 1.354 0.802 0 C-N-CA 120.129 -0.628 . . . . 0.0 110.48 -178.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.689 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.3 pp0? -67.11 -11.85 58.36 Favored 'General case' 0 C--N 1.354 0.802 0 O-C-N 121.576 -0.703 . . . . 0.0 110.193 178.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -127.0 42.29 3.35 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 15.4 t -142.96 145.4 32.96 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.635 ' O ' ' HB ' ' A' ' 171' ' ' THR . 61.5 mt-10 -98.86 165.0 11.98 Favored 'General case' 0 C--N 1.353 0.751 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.635 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 11.9 m 83.71 -59.12 0.13 Allowed 'General case' 0 C--N 1.37 1.483 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -107.35 117.46 34.13 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 119.889 -0.724 . . . . 0.0 109.654 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 90.4 t -131.85 134.15 60.37 Favored 'Isoleucine or valine' 0 C--N 1.357 0.914 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 178.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 49.2 mm -113.4 126.97 70.92 Favored 'Isoleucine or valine' 0 C--N 1.359 0.987 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.57 ' HB2' ' HG ' ' A' ' 131' ' ' LEU . 97.1 m-85 -116.62 147.13 42.18 Favored 'General case' 0 C--N 1.361 1.081 0 CA-C-O 122.008 0.909 . . . . 0.0 108.778 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -125.68 119.37 27.82 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 51.0 mt -114.67 115.87 50.84 Favored 'Isoleucine or valine' 0 C--N 1.354 0.801 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 -179.177 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 88.4 m -127.55 140.5 52.08 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -178.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 . . . . . 0 C--N 1.366 1.307 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 179.231 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.9 mtp . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.096 0.474 . . . . 0.0 110.079 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.49 ' HA ' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -79.28 -17.28 54.98 Favored 'General case' 0 C--N 1.354 0.796 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.016 -178.365 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.83 -42.06 32.02 Favored Glycine 0 C--N 1.348 1.245 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.3 tpp -70.73 -37.92 73.52 Favored 'General case' 0 C--N 1.354 0.797 0 O-C-N 122.103 -0.645 . . . . 0.0 110.808 -177.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.49 HG22 ' HA ' ' A' ' 2' ' ' MET . 27.2 m -69.87 -23.16 25.33 Favored 'Isoleucine or valine' 0 C--N 1.357 0.914 0 O-C-N 121.614 -0.679 . . . . 0.0 109.723 -179.081 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.434 ' HZ ' ' CG ' ' A' ' 47' ' ' GLU . 1.5 m-85 -71.22 -34.78 71.13 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.474 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 88.3 m -67.03 -40.29 87.19 Favored 'General case' 0 C--N 1.354 0.795 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.04 -39.21 97.76 Favored Glycine 0 C--N 1.359 1.825 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.566 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -64.7 -40.02 94.66 Favored 'General case' 0 C--N 1.352 0.703 0 O-C-N 122.54 -0.388 . . . . 0.0 110.695 -178.333 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 24.6 mmt -64.18 -40.52 96.29 Favored 'General case' 0 C--N 1.353 0.739 0 O-C-N 121.672 -0.642 . . . . 0.0 111.046 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -65.53 -40.32 92.77 Favored 'General case' 0 C--N 1.349 0.552 0 O-C-N 121.991 -0.443 . . . . 0.0 111.516 -178.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 56.0 tp -66.14 -43.62 86.53 Favored 'General case' 0 C--N 1.348 0.542 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -178.09 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.566 HG12 ' O ' ' A' ' 9' ' ' LEU . 2.4 mm -72.84 -37.28 54.32 Favored 'Isoleucine or valine' 0 C--N 1.361 1.071 0 O-C-N 121.155 -0.966 . . . . 0.0 110.975 -175.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.423 ' HB2' HD13 ' A' ' 22' ' ' LEU . 71.2 tt0 -71.13 -41.49 70.44 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.864 -0.522 . . . . 0.0 111.609 -175.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -72.59 -35.47 67.92 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -175.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -94.54 -30.27 14.47 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 118.901 -1.12 . . . . 0.0 113.966 -174.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -116.04 -30.97 5.87 Favored 'General case' 0 CA--C 1.506 -0.712 0 C-N-CA 117.538 -1.665 . . . . 0.0 112.728 -176.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 139.87 177.71 16.05 Favored Glycine 0 C--N 1.346 1.113 0 C-N-CA 118.346 -1.883 . . . . 0.0 109.523 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -99.11 -18.35 17.75 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -177.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -70.44 -39.59 74.26 Favored 'General case' 0 C--N 1.36 1.049 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 94.3 m -67.92 -39.19 83.55 Favored 'General case' 0 C--N 1.357 0.899 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.171 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.423 HD13 ' HB2' ' A' ' 14' ' ' GLU . 1.0 OUTLIER -60.71 -38.16 84.09 Favored 'General case' 0 C--N 1.355 0.847 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.518 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -63.78 -37.17 86.38 Favored 'General case' 0 C--N 1.357 0.916 0 O-C-N 122.154 -0.341 . . . . 0.0 110.787 -178.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.4 m -64.91 -40.49 95.15 Favored 'General case' 0 C--N 1.356 0.884 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -178.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.596 ' CD2' ' HB3' ' A' ' 54' ' ' LYS . 31.4 mt -63.84 -36.75 84.93 Favored 'General case' 0 C--N 1.359 0.982 0 O-C-N 121.946 -0.471 . . . . 0.0 109.957 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.5 mt -71.49 -16.03 62.34 Favored 'General case' 0 C--N 1.358 0.971 0 O-C-N 121.661 -0.65 . . . . 0.0 110.184 -178.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -86.46 -27.73 23.92 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 119.351 -0.939 . . . . 0.0 109.278 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 41.7 t -67.01 -37.1 83.57 Favored 'General case' 0 C--N 1.355 0.845 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.8 p -93.02 -39.0 11.34 Favored 'General case' 0 C--N 1.359 0.988 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -179.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 84.12 133.25 0.05 OUTLIER 'General case' 0 C--N 1.361 1.104 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 179.009 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.524 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -91.44 -167.05 1.7 Allowed 'General case' 0 C--N 1.357 0.919 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.636 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.414 ' H ' ' HB2' ' A' ' 31' ' ' LEU . 63.3 tt0 -152.99 -66.76 0.16 Allowed 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.7 t -97.57 -66.55 0.89 Allowed 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -130.35 -44.76 1.12 Allowed 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -179.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.21 -33.72 5.42 Favored Glycine 0 C--N 1.353 1.474 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 179.008 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 83.8 mt -117.22 107.51 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.01 0 CA-C-N 118.413 1.107 . . . . 0.0 108.073 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.503 ' HD1' ' HA ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -84.08 -147.78 0.1 Allowed 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.185 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.524 HG23 ' N ' ' A' ' 39' ' ' SER . 5.0 t -119.46 -53.56 2.22 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.524 ' N ' HG23 ' A' ' 38' ' ' THR . 23.8 p 170.05 65.33 0.0 OUTLIER 'General case' 0 C--N 1.362 1.138 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.5 t -145.49 -11.24 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.957 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.149 -178.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -91.62 142.08 15.93 Favored Glycine 0 C--N 1.352 1.446 0 C-N-CA 119.275 -1.44 . . . . 0.0 110.538 -177.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.1 m -123.61 123.12 39.86 Favored 'General case' 0 C--N 1.354 0.767 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -117.5 175.4 5.65 Favored 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.146 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -81.86 -172.49 3.94 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 68.9 m80 -90.64 -15.09 31.07 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.102 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -68.74 -29.39 67.79 Favored 'General case' 0 C--N 1.352 0.678 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.434 ' CG ' ' HZ ' ' A' ' 6' ' ' PHE . 26.5 tp10 -64.38 -39.81 94.59 Favored 'General case' 0 C--N 1.353 0.722 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.419 HD22 ' O ' ' A' ' 48' ' ' LEU . 1.8 tm? -66.66 -38.56 87.11 Favored 'General case' 0 C--N 1.36 1.03 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 61.9 tp -70.32 -35.06 73.4 Favored 'General case' 0 CA--C 1.508 -0.667 0 O-C-N 122.232 -0.292 . . . . 0.0 110.47 -177.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -64.67 -41.2 96.24 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 121.936 -0.478 . . . . 0.0 109.914 -177.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 80.7 mt -83.55 -18.1 39.53 Favored 'General case' 0 C--N 1.359 1.001 0 C-N-CA 119.625 -0.83 . . . . 0.0 110.601 -179.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.4 t -80.33 -38.84 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.0 p -71.76 -30.55 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 O-C-N 121.597 -0.689 . . . . 0.0 109.406 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.596 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 33.5 tptt -70.97 -28.39 64.42 Favored 'General case' 0 C--N 1.368 1.373 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.539 HD13 HD11 ' A' ' 66' ' ' LEU . 1.1 mt -63.85 -42.02 97.66 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 46.7 t -66.21 -39.94 89.98 Favored 'General case' 0 C--N 1.352 0.707 0 O-C-N 121.736 -0.602 . . . . 0.0 110.648 -179.27 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -77.64 -40.31 42.21 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 121.123 -0.985 . . . . 0.0 112.876 -177.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.0 p -75.29 -39.88 42.62 Favored 'Isoleucine or valine' 0 C--N 1.354 0.771 0 O-C-N 121.531 -0.731 . . . . 0.0 112.348 -175.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 63.4 m -105.69 -9.25 17.41 Favored 'General case' 0 CA--C 1.503 -0.845 0 O-C-N 121.173 -0.954 . . . . 0.0 110.316 -177.32 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.417 ' HA ' ' O ' ' A' ' 56' ' ' SER . 0.4 OUTLIER 68.03 38.16 2.8 Favored 'General case' 0 C--N 1.351 0.656 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.881 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 56' ' ' SER . 58.2 t -115.37 128.05 26.28 Favored Pre-proline 0 N--CA 1.443 -0.81 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 61' ' ' VAL . 37.2 Cg_exo -59.86 154.02 52.9 Favored 'Trans proline' 0 CA--C 1.496 -1.376 0 C-N-CA 122.72 2.28 . . . . 0.0 113.519 -179.029 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.3 m -76.43 -7.71 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.66 -177.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.497 ' O ' HG12 ' A' ' 67' ' ' VAL . 81.4 p -94.71 -36.4 11.75 Favored 'General case' 0 C--N 1.358 0.944 0 C-N-CA 118.315 -1.354 . . . . 0.0 110.113 -178.492 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -82.48 -23.42 34.72 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.539 HD11 HD13 ' A' ' 55' ' ' LEU . 0.5 OUTLIER -70.29 -43.36 70.57 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.609 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.497 HG12 ' O ' ' A' ' 64' ' ' THR . 4.6 p -67.47 -28.89 43.67 Favored 'Isoleucine or valine' 0 C--N 1.354 0.803 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.678 -179.246 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -65.96 -47.92 73.02 Favored 'General case' 0 C--N 1.366 1.286 0 O-C-N 121.067 -1.021 . . . . 0.0 110.242 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 88.6 mt -64.53 -36.33 83.85 Favored 'General case' 0 C--N 1.353 0.739 0 O-C-N 122.353 -0.217 . . . . 0.0 111.191 -178.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -60.84 -47.4 86.53 Favored 'General case' 0 C--N 1.349 0.582 0 O-C-N 122.115 -0.365 . . . . 0.0 110.44 -178.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.03 -39.24 96.8 Favored Glycine 0 C--N 1.353 1.524 0 N-CA-C 111.882 -0.487 . . . . 0.0 111.882 -178.209 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.38 -47.86 80.28 Favored 'General case' 0 C--N 1.351 0.656 0 CA-C-N 118.127 0.963 . . . . 0.0 111.615 -177.332 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.4 mttm -64.38 -49.02 73.26 Favored 'General case' 0 C--N 1.357 0.925 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -177.132 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.418 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.5 tm? -69.11 -39.8 78.74 Favored 'General case' 0 C--N 1.349 0.566 0 O-C-N 121.194 -0.941 . . . . 0.0 111.865 -175.598 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -64.16 -45.97 86.1 Favored 'General case' 0 C--N 1.353 0.744 0 O-C-N 121.269 -0.895 . . . . 0.0 111.123 -177.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.11 -12.38 15.79 Favored 'Isoleucine or valine' 0 C--N 1.358 0.941 0 O-C-N 121.586 -0.696 . . . . 0.0 109.463 -179.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -78.52 -36.79 44.39 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 80.2 mt -70.57 -34.61 72.39 Favored 'General case' 0 C--N 1.358 0.94 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.3 mm -62.77 -50.37 79.99 Favored 'Isoleucine or valine' 0 C--N 1.357 0.904 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -178.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -67.89 -22.3 65.1 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.414 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.83 -1.18 61.8 Favored Glycine 0 C--N 1.347 1.19 0 C-N-CA 119.609 -1.281 . . . . 0.0 110.684 -177.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.637 ' HB3' ' HB ' ' A' ' 85' ' ' ILE . 93.2 m-70 -141.21 88.6 10.0 Favored Pre-proline 0 CA--C 1.503 -0.859 0 CA-C-N 118.937 1.368 . . . . 0.0 108.962 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 82' ' ' HIS . 36.8 Cg_endo -67.52 -25.79 40.84 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.425 2.083 . . . . 0.0 114.194 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -92.75 -6.14 49.69 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.637 ' HB ' ' HB3' ' A' ' 82' ' ' HIS . 1.0 OUTLIER -90.44 -22.3 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 -178.81 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -102.05 -21.4 14.46 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -69.85 -39.15 76.56 Favored 'General case' 0 C--N 1.355 0.827 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -65.48 -33.75 76.67 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.636 ' HG2' ' N ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -80.28 155.43 27.29 Favored 'General case' 0 C--N 1.353 0.749 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 -178.908 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.636 ' N ' ' HG2' ' A' ' 89' ' ' MET . 3.4 mtpt -117.15 -27.71 6.41 Favored 'General case' 0 C--N 1.364 1.207 0 C-N-CA 120.058 -0.657 . . . . 0.0 111.319 -177.248 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -167.08 175.47 7.51 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 -177.284 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 65.1 m -66.62 -40.09 88.63 Favored 'General case' 0 C--N 1.354 0.763 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.415 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -68.03 -39.61 83.09 Favored 'General case' 0 C--N 1.356 0.882 0 C-N-CA 119.587 -0.845 . . . . 0.0 108.805 -178.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -66.57 -23.03 66.15 Favored 'General case' 0 C--N 1.354 0.779 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.4 HD22 ' SG ' ' A' ' 150' ' ' CYS . 60.1 tp -65.25 -45.52 84.26 Favored 'General case' 0 C--N 1.354 0.797 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.5 mp -61.83 -36.5 81.36 Favored 'General case' 0 C--N 1.357 0.901 0 O-C-N 121.993 -0.442 . . . . 0.0 110.165 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 34.0 t -67.49 -39.83 85.2 Favored 'General case' 0 C--N 1.349 0.561 0 O-C-N 121.927 -0.483 . . . . 0.0 110.211 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.4 tttp -93.01 6.37 48.18 Favored 'General case' 0 C--N 1.353 0.76 0 O-C-N 122.241 -0.287 . . . . 0.0 111.567 -176.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.9 tp -64.4 -38.74 83.36 Favored 'Isoleucine or valine' 0 C--N 1.356 0.859 0 O-C-N 121.391 -0.818 . . . . 0.0 111.671 -177.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -103.44 -21.69 13.76 Favored 'General case' 0 N--CA 1.437 -1.116 0 O-C-N 120.884 -1.135 . . . . 0.0 110.26 -178.431 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 35.2 t -62.98 -47.0 85.04 Favored 'General case' 0 N--CA 1.445 -0.687 0 O-C-N 121.564 -0.71 . . . . 0.0 111.691 -178.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -137.5 -14.49 1.47 Allowed 'General case' 0 C--N 1.36 1.057 0 C-N-CA 117.369 -1.732 . . . . 0.0 113.036 -177.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 32.3 mm -70.41 -51.37 38.52 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 CA-C-N 120.099 1.318 . . . . 0.0 110.633 -177.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 35.5 m170 -91.9 2.32 56.61 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 119.485 -0.886 . . . . 0.0 110.301 -177.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 52.7 t -83.26 -44.22 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.032 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -68.34 -40.56 81.52 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 69.9 t -63.45 -46.77 94.35 Favored 'Isoleucine or valine' 0 C--N 1.357 0.901 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.363 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -60.75 -48.59 81.09 Favored 'General case' 0 C--N 1.357 0.926 0 O-C-N 122.064 -0.397 . . . . 0.0 111.409 -179.162 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -61.6 -37.21 83.07 Favored 'General case' 0 C--N 1.356 0.86 0 O-C-N 121.495 -0.753 . . . . 0.0 110.538 -178.274 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.5 mt -56.98 -73.9 0.06 Allowed 'General case' 0 C--N 1.357 0.9 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -119.13 135.47 23.9 Favored Pre-proline 0 N--CA 1.438 -1.047 0 C-N-CA 118.475 -1.29 . . . . 0.0 109.032 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -83.51 -4.61 10.87 Favored 'Trans proline' 0 C--N 1.313 -1.342 0 C-N-CA 123.174 2.583 . . . . 0.0 115.175 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -66.6 -36.84 83.58 Favored 'General case' 0 C--N 1.354 0.79 0 O-C-N 121.88 -0.512 . . . . 0.0 109.842 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.1 145.65 55.09 Favored 'General case' 0 C--N 1.354 0.764 0 CA-C-O 121.554 0.692 . . . . 0.0 109.787 -178.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -130.45 135.44 47.99 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.54 ' HB3' ' HD2' ' A' ' 117' ' ' PRO . 86.4 mt -127.68 157.18 74.09 Favored Pre-proline 0 N--CA 1.443 -0.823 0 CA-C-O 122.173 0.987 . . . . 0.0 109.196 -178.389 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.54 ' HD2' ' HB3' ' A' ' 116' ' ' LEU . 83.6 Cg_endo -81.02 -156.36 0.07 OUTLIER 'Trans proline' 0 C--N 1.316 -1.139 0 C-N-CA 123.797 2.998 . . . . 0.0 114.115 -179.265 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -113.38 140.26 48.2 Favored 'General case' 0 C--N 1.364 1.207 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -123.67 127.02 47.59 Favored 'General case' 0 C--N 1.362 1.144 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -179.108 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.479 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 94.2 m -126.26 128.98 48.01 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 177.226 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 81.0 m -119.83 130.73 55.03 Favored 'General case' 0 CA--C 1.503 -0.851 0 C-N-CA 119.105 -1.038 . . . . 0.0 109.677 -177.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -119.14 127.13 53.05 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 178.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 66.2 ttp85 -102.18 116.69 33.2 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 92.8 mt -87.42 -21.61 25.49 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.378 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 177.68 -146.59 7.69 Favored Glycine 0 N--CA 1.438 -1.226 0 C-N-CA 118.844 -1.645 . . . . 0.0 109.103 -178.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -94.72 -40.05 9.98 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 120.081 -0.648 . . . . 0.0 109.411 -178.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -101.53 1.45 38.02 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.24 -178.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -119.01 130.43 55.66 Favored 'General case' 0 C--N 1.358 0.968 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 7.6 mm -141.13 136.77 33.68 Favored 'Isoleucine or valine' 0 C--N 1.356 0.861 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 55.6 mtm180 -122.57 139.14 54.24 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.655 ' HG ' ' O ' ' A' ' 131' ' ' LEU . 0.1 OUTLIER -130.16 125.68 35.63 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.078 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.479 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 13.5 m-70 -96.77 134.56 39.89 Favored 'General case' 0 CA--C 1.495 -1.165 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -127.87 119.9 26.59 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 -178.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.534 ' HA ' ' O ' ' A' ' 171' ' ' THR . 76.6 mt-30 -113.51 114.74 26.94 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 179.07 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 12.7 t -162.73 152.55 15.92 Favored 'General case' 0 C--N 1.358 0.96 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -90.62 2.71 55.62 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 120.271 -0.572 . . . . 0.0 109.652 -179.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -136.11 74.54 55.86 Favored Pre-proline 0 CA--C 1.505 -0.752 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -95.88 107.78 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.771 2.314 . . . . 0.0 115.776 -177.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -111.94 113.6 26.02 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 176.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.98 -38.28 90.49 Favored 'General case' 0 C--N 1.353 0.73 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.007 -179.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.0 m -63.27 -27.34 69.27 Favored 'General case' 0 C--N 1.354 0.773 0 O-C-N 122.009 -0.432 . . . . 0.0 110.875 -178.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -76.63 -46.43 25.96 Favored 'General case' 0 C--N 1.351 0.652 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.639 -178.099 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.63 -40.11 94.9 Favored 'General case' 0 C--N 1.357 0.923 0 O-C-N 122.039 -0.413 . . . . 0.0 111.056 -178.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.64 -37.25 86.61 Favored 'General case' 0 C--N 1.355 0.83 0 O-C-N 121.907 -0.496 . . . . 0.0 110.081 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -59.88 -43.16 98.28 Favored Glycine 0 C--N 1.347 1.176 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 83.5 mt -69.78 -40.78 75.83 Favored 'General case' 0 C--N 1.352 0.694 0 CA-C-N 117.749 0.774 . . . . 0.0 112.503 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 98.0 mt -71.29 -42.41 68.73 Favored 'General case' 0 C--N 1.361 1.083 0 O-C-N 121.206 -0.934 . . . . 0.0 110.961 -176.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.496 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 37.0 t70 -69.93 -31.36 69.08 Favored 'General case' 0 N--CA 1.446 -0.652 0 O-C-N 121.956 -0.465 . . . . 0.0 110.514 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -62.84 -39.38 97.92 Favored Glycine 0 C--N 1.357 1.745 0 N-CA-C 108.46 -1.856 . . . . 0.0 108.46 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.4 ' SG ' HD22 ' A' ' 95' ' ' LEU . 49.9 t -60.71 -41.46 95.29 Favored 'General case' 0 C--N 1.35 0.6 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.563 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -74.8 -1.48 22.33 Favored 'General case' 0 C--N 1.361 1.077 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 77.7 mm-40 -84.4 -46.07 12.08 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.195 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 92.9 t80 -65.95 -45.06 83.16 Favored 'General case' 0 C--N 1.359 0.989 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.416 ' HZ ' ' SD ' ' A' ' 89' ' ' MET . 38.9 m-85 -69.01 -26.62 65.09 Favored 'General case' 0 C--N 1.36 1.053 0 O-C-N 121.874 -0.516 . . . . 0.0 110.802 -178.473 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 78.9 tttt 72.72 74.35 0.15 Allowed 'General case' 0 C--N 1.36 1.035 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -143.13 -168.12 2.72 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -148.67 94.45 2.28 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -111.88 156.11 22.56 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 178.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 93.9 m -119.47 127.1 52.74 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 119.208 -0.997 . . . . 0.0 108.716 -178.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.497 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.7 mp -103.89 122.2 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 178.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.5 m -115.64 -175.96 2.83 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-O 121.826 0.822 . . . . 0.0 109.134 -179.05 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 3.5 ptt180 -146.75 153.63 40.46 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 -178.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 44.8 p -97.62 145.93 30.55 Favored Pre-proline 0 C--N 1.361 1.08 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.623 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 76.8 Cg_endo -77.13 -11.24 17.79 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.944 2.429 . . . . 0.0 115.127 -178.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -72.74 -41.29 65.32 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.573 -178.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 36.8 p -116.96 15.3 15.16 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.299 -178.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.623 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.5 pp0? -65.13 -13.65 58.63 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.408 178.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -126.89 43.18 3.17 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 16.8 t -142.57 145.13 33.27 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.631 ' O ' ' HB ' ' A' ' 171' ' ' THR . 61.1 mt-10 -98.98 165.49 11.73 Favored 'General case' 0 C--N 1.354 0.804 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.152 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.631 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 3.0 m 83.42 -57.13 0.15 Allowed 'General case' 0 C--N 1.369 1.423 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.637 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -110.93 117.44 33.38 Favored 'General case' 0 CA--C 1.506 -0.72 0 C-N-CA 119.814 -0.754 . . . . 0.0 109.603 -178.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 98.7 t -131.33 133.39 62.27 Favored 'Isoleucine or valine' 0 C--N 1.356 0.857 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 178.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 48.6 mm -109.36 125.99 66.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.964 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -179.33 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -115.08 148.38 39.0 Favored 'General case' 0 C--N 1.357 0.922 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -128.58 117.4 21.19 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 -179.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.8 mp -111.94 118.38 57.51 Favored 'Isoleucine or valine' 0 C--N 1.354 0.765 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 89.3 m -124.3 142.84 50.94 Favored 'General case' 0 CA--C 1.502 -0.893 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -177.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 12.2 ttt180 . . . . . 0 C--N 1.363 1.153 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 178.848 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.692 ' HG2' ' HB2' ' A' ' 4' ' ' MET . 27.2 tpp . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 120.881 0.372 . . . . 0.0 110.538 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.34 -20.14 41.29 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -77.86 -37.68 29.08 Favored Glycine 0 C--N 1.35 1.331 0 N-CA-C 109.101 -1.599 . . . . 0.0 109.101 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' MET . . . . . 0.692 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 3.0 tpp -70.84 -38.21 73.18 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 122.035 -0.685 . . . . 0.0 110.707 -177.385 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.2 m -71.28 -23.14 22.82 Favored 'Isoleucine or valine' 0 C--N 1.357 0.93 0 O-C-N 121.651 -0.656 . . . . 0.0 109.415 -178.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.0 m-30 -71.06 -33.38 70.22 Favored 'General case' 0 C--N 1.357 0.893 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.358 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.1 m -67.14 -40.17 86.68 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.93 -38.82 97.22 Favored Glycine 0 C--N 1.36 1.893 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.506 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.1 OUTLIER -66.13 -39.11 89.62 Favored 'General case' 0 C--N 1.353 0.736 0 CA-C-N 117.274 0.537 . . . . 0.0 110.31 -177.952 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.443 ' CE ' HD21 ' A' ' 26' ' ' LEU . 25.5 mmt -64.02 -40.6 96.71 Favored 'General case' 0 C--N 1.355 0.822 0 O-C-N 121.635 -0.666 . . . . 0.0 110.753 -178.606 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -64.77 -40.07 94.66 Favored 'General case' 0 C--N 1.349 0.547 0 O-C-N 122.055 -0.403 . . . . 0.0 111.307 -178.115 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 58.2 tp -65.0 -42.68 94.26 Favored 'General case' 0 C--N 1.35 0.592 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.659 HD12 HD21 ' A' ' 55' ' ' LEU . 3.3 mm -72.44 -37.58 57.99 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 O-C-N 121.169 -0.957 . . . . 0.0 111.179 -175.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -68.02 -43.75 78.05 Favored 'General case' 0 C--N 1.352 0.679 0 O-C-N 121.821 -0.549 . . . . 0.0 111.653 -175.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -71.9 -32.45 67.42 Favored 'General case' 0 N--CA 1.447 -0.579 0 O-C-N 122.001 -0.437 . . . . 0.0 111.487 -177.296 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -72.5 -49.96 29.32 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -175.417 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -127.98 -20.97 3.73 Favored 'General case' 0 C--N 1.357 0.917 0 C-N-CA 117.347 -1.741 . . . . 0.0 113.694 -176.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 143.42 178.88 19.61 Favored Glycine 0 CA--C 1.499 -0.947 0 C-N-CA 117.678 -2.201 . . . . 0.0 110.23 -179.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -96.5 -11.34 25.65 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -177.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -74.64 -36.57 62.88 Favored 'General case' 0 C--N 1.359 0.986 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.2 m -70.11 -38.91 75.74 Favored 'General case' 0 C--N 1.358 0.952 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 178.25 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.7 tt -59.84 -38.09 81.09 Favored 'General case' 0 C--N 1.359 0.994 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -64.12 -37.09 86.19 Favored 'General case' 0 C--N 1.356 0.87 0 O-C-N 122.097 -0.377 . . . . 0.0 110.788 -178.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.5 m -65.25 -40.63 94.24 Favored 'General case' 0 C--N 1.355 0.836 0 O-C-N 121.698 -0.626 . . . . 0.0 109.62 -178.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.41 HD22 ' HB3' ' A' ' 54' ' ' LYS . 78.7 mt -64.9 -36.82 85.6 Favored 'General case' 0 C--N 1.356 0.868 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 -178.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.443 HD21 ' CE ' ' A' ' 10' ' ' MET . 81.1 mt -70.84 -16.5 62.72 Favored 'General case' 0 C--N 1.36 1.048 0 O-C-N 121.765 -0.584 . . . . 0.0 110.235 -179.22 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -85.07 -27.83 26.06 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.29 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.2 t -66.89 -37.54 84.59 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.8 p -91.61 -39.54 11.82 Favored 'General case' 0 C--N 1.359 0.995 0 C-N-CA 119.064 -1.054 . . . . 0.0 108.18 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 86.15 132.45 0.04 OUTLIER 'General case' 0 C--N 1.36 1.049 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.532 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -91.91 -167.07 1.69 Allowed 'General case' 0 C--N 1.356 0.885 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.841 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.416 ' H ' ' HB2' ' A' ' 31' ' ' LEU . 4.3 mt-30 -153.05 -66.3 0.15 Allowed 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 106.816 -1.549 . . . . 0.0 106.816 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.0 t -97.71 -67.12 0.86 Allowed 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -131.42 -46.53 0.98 Allowed 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.24 -37.37 3.51 Favored Glycine 0 C--N 1.354 1.566 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 179.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 81.9 mt -113.62 106.09 20.02 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.041 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.523 ' HD1' ' HA ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -82.57 -150.78 0.09 Allowed 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.496 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.409 ' H ' ' HB3' ' A' ' 37' ' ' TYR . 86.2 m -112.09 -57.84 2.21 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 11.6 p 169.06 69.8 0.0 OUTLIER 'General case' 0 C--N 1.36 1.029 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.2 t -150.29 -6.69 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.361 1.081 0 C-N-CA 119.707 -0.797 . . . . 0.0 110.047 -178.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -95.26 143.08 16.42 Favored Glycine 0 C--N 1.352 1.447 0 C-N-CA 119.28 -1.438 . . . . 0.0 110.465 -177.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.0 m -123.94 116.77 23.42 Favored 'General case' 0 C--N 1.356 0.871 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 178.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -111.66 177.42 4.66 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.064 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -78.66 -175.14 4.23 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 65.4 m80 -94.38 -15.6 24.2 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 119.781 -0.767 . . . . 0.0 109.179 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -68.88 -29.22 67.47 Favored 'General case' 0 C--N 1.353 0.749 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.02 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.6 tp10 -62.72 -41.51 99.19 Favored 'General case' 0 C--N 1.353 0.719 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.406 ' O ' HG23 ' A' ' 52' ' ' VAL . 59.9 tp -67.62 -38.74 84.36 Favored 'General case' 0 C--N 1.357 0.893 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.218 -179.181 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 60.5 tp -72.3 -34.69 68.32 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 122.259 -0.276 . . . . 0.0 110.689 -177.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 72.7 tp60 -64.18 -41.81 96.95 Favored 'General case' 0 C--N 1.353 0.721 0 O-C-N 121.589 -0.694 . . . . 0.0 110.004 -177.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 84.2 mt -71.79 -34.64 69.58 Favored 'General case' 0 C--N 1.362 1.113 0 C-N-CA 119.534 -0.867 . . . . 0.0 109.431 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.565 HG13 HD21 ' A' ' 66' ' ' LEU . 29.2 t -62.65 -42.12 94.82 Favored 'Isoleucine or valine' 0 C--N 1.351 0.645 0 CA-C-O 120.705 0.288 . . . . 0.0 110.309 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 53.9 t -65.76 -40.21 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.41 ' HB3' HD22 ' A' ' 25' ' ' LEU . 32.1 tptt -65.22 -29.2 69.98 Favored 'General case' 0 C--N 1.361 1.107 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.659 HD21 HD12 ' A' ' 13' ' ' ILE . 16.0 mt -64.27 -40.26 95.6 Favored 'General case' 0 C--N 1.357 0.902 0 O-C-N 121.968 -0.457 . . . . 0.0 110.395 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.611 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 46.5 t -65.39 -37.44 87.0 Favored 'General case' 0 C--N 1.349 0.573 0 O-C-N 121.775 -0.578 . . . . 0.0 110.324 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -83.74 -38.25 21.61 Favored 'General case' 0 C--N 1.353 0.73 0 O-C-N 121.242 -0.911 . . . . 0.0 112.811 -177.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.6 p -76.03 -41.6 38.4 Favored 'Isoleucine or valine' 0 C--N 1.355 0.83 0 O-C-N 121.354 -0.841 . . . . 0.0 111.897 -176.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 72.8 m -103.66 -5.66 22.38 Favored 'General case' 0 C--N 1.354 0.803 0 O-C-N 121.198 -0.939 . . . . 0.0 110.486 -177.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 74.6 m 65.05 38.95 5.9 Favored 'General case' 0 C--N 1.354 0.769 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.611 ' O ' ' HA ' ' A' ' 56' ' ' SER . 55.4 t -115.53 132.22 23.23 Favored Pre-proline 0 CA--C 1.505 -0.778 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.474 ' HD2' HG13 ' A' ' 61' ' ' VAL . 31.2 Cg_endo -63.99 157.16 54.47 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.258 1.972 . . . . 0.0 114.095 -178.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.839 ' HA ' HD23 ' A' ' 66' ' ' LEU . 15.5 m -75.98 -12.66 14.62 Favored 'Isoleucine or valine' 0 C--N 1.353 0.742 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.031 -177.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.475 ' O ' HG12 ' A' ' 67' ' ' VAL . 81.1 p -94.13 -35.14 12.67 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 118.068 -1.453 . . . . 0.0 110.129 -178.323 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -80.9 -21.22 40.76 Favored 'General case' 0 C--N 1.353 0.737 0 O-C-N 121.167 -0.958 . . . . 0.0 108.892 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.839 HD23 ' HA ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -77.19 -36.67 54.78 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.732 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.515 ' N ' ' HG ' ' A' ' 66' ' ' LEU . 1.8 p -68.83 -28.9 41.59 Favored 'Isoleucine or valine' 0 C--N 1.359 0.981 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.055 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -68.49 -49.1 62.24 Favored 'General case' 0 C--N 1.365 1.265 0 O-C-N 121.234 -0.916 . . . . 0.0 110.656 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.9 mt -63.83 -36.41 83.81 Favored 'General case' 0 C--N 1.357 0.893 0 O-C-N 122.069 -0.395 . . . . 0.0 111.027 -178.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -61.16 -47.07 87.88 Favored 'General case' 0 C--N 1.348 0.536 0 O-C-N 122.134 -0.354 . . . . 0.0 110.495 -178.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.25 -39.29 96.99 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-O 119.787 -0.452 . . . . 0.0 112.17 -177.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -65.7 -45.45 82.75 Favored 'General case' 0 C--N 1.352 0.674 0 CA-C-N 118.513 1.157 . . . . 0.0 111.638 -177.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 12.2 mttm -64.86 -48.24 75.0 Favored 'General case' 0 C--N 1.357 0.921 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -177.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.406 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.2 tm? -70.76 -39.31 73.33 Favored 'General case' 0 C--N 1.349 0.563 0 O-C-N 121.263 -0.898 . . . . 0.0 111.963 -176.024 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -63.56 -46.45 85.85 Favored 'General case' 0 C--N 1.353 0.755 0 O-C-N 121.103 -0.998 . . . . 0.0 111.239 -178.012 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.8 p -70.89 -14.72 18.26 Favored 'Isoleucine or valine' 0 C--N 1.357 0.931 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -71.11 -39.76 71.88 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 87.7 mt -75.78 -27.19 57.93 Favored 'General case' 0 C--N 1.359 0.986 0 O-C-N 122.258 -0.276 . . . . 0.0 110.569 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.1 mm -65.78 -53.59 36.78 Favored 'Isoleucine or valine' 0 C--N 1.36 1.059 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.432 -178.167 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -75.26 -14.6 60.52 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 119.611 -0.836 . . . . 0.0 109.259 178.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.7 -37.58 61.47 Favored Glycine 0 C--N 1.35 1.345 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -132.55 102.9 13.69 Favored Pre-proline 0 C--N 1.356 0.887 0 CA-C-O 122.611 1.196 . . . . 0.0 109.104 -177.063 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.488 ' O ' ' HB2' ' A' ' 87' ' ' ASN . 40.3 Cg_endo -68.74 -22.23 37.49 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.556 2.17 . . . . 0.0 114.039 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -90.69 -9.56 46.36 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -89.84 -21.89 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.967 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 -178.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -102.66 -16.35 16.06 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.18 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASN . . . . . 0.488 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 49.2 t30 -70.99 -40.64 71.75 Favored 'General case' 0 C--N 1.36 1.028 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -67.7 -28.38 67.63 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 120.746 -0.381 . . . . 0.0 110.418 -179.015 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.681 ' SD ' ' HZ ' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -81.59 152.24 27.29 Favored 'General case' 0 C--N 1.352 0.696 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -179.488 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.594 ' N ' ' HG2' ' A' ' 89' ' ' MET . 4.6 mtpt -117.14 -26.76 6.69 Favored 'General case' 0 C--N 1.365 1.246 0 C-N-CA 120.054 -0.659 . . . . 0.0 111.293 -177.094 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -167.74 175.6 6.85 Favored 'General case' 0 C--N 1.354 0.797 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -177.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.417 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 42.2 t -64.75 -43.95 91.67 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.383 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -68.08 -39.54 82.9 Favored 'General case' 0 C--N 1.355 0.836 0 O-C-N 121.365 -0.834 . . . . 0.0 109.418 -178.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -66.23 -22.45 66.33 Favored 'General case' 0 C--N 1.353 0.757 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.417 ' HB3' ' O ' ' A' ' 92' ' ' SER . 60.3 tp -65.08 -46.03 82.85 Favored 'General case' 0 C--N 1.354 0.767 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.9 mp -62.96 -36.13 82.45 Favored 'General case' 0 C--N 1.355 0.839 0 O-C-N 122.2 -0.313 . . . . 0.0 110.744 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 35.9 t -65.09 -41.69 94.74 Favored 'General case' 0 C--N 1.349 0.582 0 O-C-N 121.849 -0.532 . . . . 0.0 111.555 -178.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.786 ' HG2' ' O ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -102.37 9.85 39.5 Favored 'General case' 0 C--N 1.358 0.946 0 O-C-N 121.676 -0.64 . . . . 0.0 110.327 -176.126 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.661 ' HA ' HD12 ' A' ' 103' ' ' ILE . 11.7 tt -63.1 -35.14 70.5 Favored 'Isoleucine or valine' 0 C--N 1.354 0.797 0 O-C-N 121.088 -1.008 . . . . 0.0 111.984 -176.627 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -111.28 -18.52 12.91 Favored 'General case' 0 N--CA 1.438 -1.054 0 O-C-N 120.814 -1.179 . . . . 0.0 109.99 -178.234 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 37.7 t -64.38 -46.9 81.35 Favored 'General case' 0 N--CA 1.443 -0.808 0 O-C-N 121.697 -0.627 . . . . 0.0 111.107 -178.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -130.15 -21.1 2.98 Favored 'General case' 0 C--N 1.359 0.986 0 C-N-CA 118.002 -1.479 . . . . 0.0 112.565 -177.036 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.661 HD12 ' HA ' ' A' ' 99' ' ' ILE . 96.1 mt -71.15 -49.5 48.25 Favored 'Isoleucine or valine' 0 C--O 1.242 0.693 0 O-C-N 120.771 -1.205 . . . . 0.0 110.976 -177.283 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 29.8 m170 -89.41 3.49 52.1 Favored 'General case' 0 N--CA 1.439 -0.982 0 O-C-N 121.111 -0.993 . . . . 0.0 109.996 -177.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.5 p -88.82 -34.26 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 178.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -72.11 -40.92 67.8 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 76.5 t -63.81 -46.54 94.1 Favored 'Isoleucine or valine' 0 C--N 1.356 0.861 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -60.6 -48.62 80.96 Favored 'General case' 0 C--N 1.359 1.015 0 O-C-N 122.226 -0.296 . . . . 0.0 111.447 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -60.97 -38.11 84.77 Favored 'General case' 0 C--N 1.356 0.857 0 O-C-N 121.567 -0.708 . . . . 0.0 110.651 -178.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 18.5 mt -57.66 -75.66 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -116.22 132.7 23.14 Favored Pre-proline 0 N--CA 1.438 -1.054 0 C-N-CA 118.708 -1.197 . . . . 0.0 108.857 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -83.04 -4.87 11.28 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 123.136 2.557 . . . . 0.0 115.003 -179.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -66.9 -36.76 83.01 Favored 'General case' 0 C--N 1.355 0.806 0 O-C-N 121.964 -0.46 . . . . 0.0 109.826 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.5 147.25 52.27 Favored 'General case' 0 C--N 1.352 0.69 0 CA-C-O 121.585 0.707 . . . . 0.0 109.849 -178.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -132.47 135.56 46.12 Favored 'General case' 0 C--N 1.357 0.898 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 179.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.517 ' HB3' ' HD2' ' A' ' 117' ' ' PRO . 2.7 mm? -124.12 156.45 66.28 Favored Pre-proline 0 C--N 1.354 0.789 0 CA-C-O 122.023 0.916 . . . . 0.0 108.649 -178.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.517 ' HD2' ' HB3' ' A' ' 116' ' ' LEU . 95.0 Cg_endo -79.23 -160.17 0.12 Allowed 'Trans proline' 0 C--N 1.318 -1.047 0 C-N-CA 123.554 2.836 . . . . 0.0 113.22 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -120.73 144.11 48.42 Favored 'General case' 0 C--N 1.364 1.201 0 C-N-CA 118.997 -1.081 . . . . 0.0 108.24 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.56 ' HE2' ' CD1' ' A' ' 133' ' ' TYR . 22.4 m-85 -129.13 137.77 51.4 Favored 'General case' 0 C--N 1.362 1.109 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.35 -178.739 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.401 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 93.8 m -123.87 129.49 51.08 Favored 'General case' 0 C--N 1.356 0.85 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 177.199 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 82.5 m -113.49 127.55 56.14 Favored 'General case' 0 CA--C 1.503 -0.846 0 C-N-CA 119.069 -1.052 . . . . 0.0 109.717 -177.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -120.24 118.9 31.68 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 178.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -96.23 117.85 31.6 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -178.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 92.8 mt -88.98 -20.07 24.91 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.303 -179.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -179.88 -150.08 8.93 Favored Glycine 0 C--N 1.349 1.303 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 -178.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -94.69 -36.06 11.9 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -178.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -103.34 0.12 30.93 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 120.176 -0.61 . . . . 0.0 109.969 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -116.69 134.03 55.3 Favored 'General case' 0 C--N 1.358 0.954 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.411 HD13 ' HA ' ' A' ' 129' ' ' ILE . 8.1 mm -144.85 137.95 22.1 Favored 'Isoleucine or valine' 0 C--N 1.357 0.923 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 26.1 mtm180 -125.42 135.83 52.78 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.726 HD23 HD11 ' A' ' 177' ' ' ILE . 0.2 OUTLIER -129.05 128.03 42.76 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.708 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.401 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 18.5 m170 -95.78 138.29 33.64 Favored 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.56 ' CD1' ' HE2' ' A' ' 119' ' ' PHE . 65.3 t80 -126.3 118.97 26.19 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 -178.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.484 ' HA ' ' O ' ' A' ' 171' ' ' THR . 27.5 tt0 -113.36 114.15 26.23 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 12.7 t -165.11 151.32 10.07 Favored 'General case' 0 C--N 1.358 0.962 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -91.12 4.31 52.51 Favored 'General case' 0 C--N 1.355 0.846 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.638 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' A' ' 137' ' ' ARG . 1.0 OUTLIER -135.68 72.69 62.75 Favored Pre-proline 0 C--N 1.355 0.847 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 179.053 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -96.47 108.23 0.1 Allowed 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 122.749 2.299 . . . . 0.0 115.924 -177.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -111.91 113.27 25.49 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 176.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.21 -38.6 91.8 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.101 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.1 m -63.43 -28.18 69.8 Favored 'General case' 0 C--N 1.353 0.726 0 O-C-N 121.967 -0.458 . . . . 0.0 110.903 -178.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -75.33 -45.94 36.39 Favored 'General case' 0 C--N 1.351 0.641 0 C-N-CA 120.156 -0.617 . . . . 0.0 109.552 -177.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.67 -39.79 91.71 Favored 'General case' 0 C--N 1.356 0.887 0 O-C-N 122.047 -0.408 . . . . 0.0 111.356 -177.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -62.99 -37.26 86.46 Favored 'General case' 0 C--N 1.355 0.843 0 O-C-N 121.78 -0.575 . . . . 0.0 110.057 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.59 -42.94 99.4 Favored Glycine 0 C--N 1.348 1.214 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 82.8 mt -69.54 -41.14 76.34 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 117.437 0.619 . . . . 0.0 112.596 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 97.0 mt -71.29 -42.04 69.18 Favored 'General case' 0 C--N 1.36 1.06 0 O-C-N 121.252 -0.905 . . . . 0.0 110.999 -177.022 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -69.88 -31.83 69.86 Favored 'General case' 0 C--N 1.349 0.555 0 O-C-N 121.994 -0.441 . . . . 0.0 110.597 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.532 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -62.59 -40.03 98.62 Favored Glycine 0 C--N 1.355 1.632 0 N-CA-C 108.674 -1.771 . . . . 0.0 108.674 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.401 ' SG ' HD22 ' A' ' 95' ' ' LEU . 45.1 t -61.05 -42.67 98.91 Favored 'General case' 0 C--N 1.35 0.621 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.456 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.584 ' HB1' ' O ' ' A' ' 156' ' ' GLU . . . -76.05 1.79 14.54 Favored 'General case' 0 C--N 1.357 0.931 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.532 ' HB2' ' O ' ' A' ' 149' ' ' GLY . 7.6 mm-40 -86.57 -47.7 9.0 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -65.11 -45.19 86.14 Favored 'General case' 0 C--N 1.359 0.993 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.681 ' HZ ' ' SD ' ' A' ' 89' ' ' MET . 51.9 m-85 -69.25 -27.99 65.92 Favored 'General case' 0 C--N 1.362 1.132 0 O-C-N 121.897 -0.502 . . . . 0.0 111.013 -178.398 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 85.2 tttt 72.3 73.59 0.16 Allowed 'General case' 0 C--N 1.359 0.998 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -178.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.584 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 2.4 tp10 -156.34 119.21 4.14 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -82.39 106.84 14.6 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 120.086 -0.646 . . . . 0.0 111.069 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 11.9 m-30 -112.38 160.31 17.83 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 176.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 92.3 m -120.47 127.84 52.59 Favored 'General case' 0 CA--C 1.505 -0.772 0 C-N-CA 118.938 -1.105 . . . . 0.0 109.073 -178.145 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.48 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.9 mp -105.65 122.63 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 178.567 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.7 m -118.87 -171.93 2.19 Favored 'General case' 0 C--N 1.358 0.936 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -178.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -145.36 154.57 42.44 Favored 'General case' 0 C--N 1.356 0.851 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -178.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 28.7 p -96.27 144.84 28.53 Favored Pre-proline 0 C--N 1.36 1.054 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 178.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.702 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 72.9 Cg_endo -75.63 -12.83 20.29 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.79 2.326 . . . . 0.0 115.203 -178.512 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -72.91 -41.77 64.25 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.664 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 41.9 p -115.84 15.14 16.36 Favored 'General case' 0 C--N 1.355 0.807 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.391 -178.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.702 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.3 pp0? -66.6 -12.64 58.9 Favored 'General case' 0 C--N 1.355 0.834 0 O-C-N 121.59 -0.694 . . . . 0.0 110.454 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -128.08 42.53 3.3 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 19.1 t -143.17 145.03 32.44 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.633 ' O ' ' HB ' ' A' ' 171' ' ' THR . 61.7 mt-10 -97.44 165.45 12.0 Favored 'General case' 0 C--N 1.355 0.818 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.456 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.633 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 16.9 m 84.81 -58.62 0.1 Allowed 'General case' 0 C--N 1.369 1.451 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -109.9 114.74 28.53 Favored 'General case' 0 CA--C 1.504 -0.803 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.45 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 95.2 t -133.26 133.09 58.28 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 63.3 mt -117.57 128.48 74.79 Favored 'Isoleucine or valine' 0 C--N 1.358 0.968 0 CA-C-O 122.14 0.971 . . . . 0.0 109.456 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -110.52 145.23 38.1 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 114.838 -1.074 . . . . 0.0 108.336 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -119.61 118.3 30.63 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.726 HD11 HD23 ' A' ' 131' ' ' LEU . 3.7 mp -112.4 119.0 59.23 Favored 'Isoleucine or valine' 0 C--N 1.354 0.793 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 -178.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 90.3 m -124.6 142.05 51.65 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -177.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 13.6 ttt180 . . . . . 0 C--N 1.36 1.038 0 N-CA-C 106.835 -1.542 . . . . 0.0 106.835 179.127 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.5 mtm . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.298 0.57 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.74 -14.11 58.4 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -178.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.22 -41.99 44.62 Favored Glycine 0 C--N 1.351 1.369 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 17.6 ttp -68.15 -39.37 82.67 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 122.119 -0.636 . . . . 0.0 111.564 -177.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.0 m -68.25 -23.5 28.65 Favored 'Isoleucine or valine' 0 C--N 1.356 0.871 0 O-C-N 121.462 -0.773 . . . . 0.0 109.534 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.42 ' HZ ' ' HG3' ' A' ' 47' ' ' GLU . 2.6 m-85 -71.53 -34.05 69.71 Favored 'General case' 0 C--N 1.359 0.994 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 179.181 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.8 m -66.1 -40.37 90.69 Favored 'General case' 0 C--N 1.355 0.826 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -61.83 -38.68 96.38 Favored Glycine 0 C--N 1.358 1.8 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.673 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -64.54 -41.78 96.13 Favored 'General case' 0 C--N 1.352 0.705 0 CA-C-N 117.072 0.436 . . . . 0.0 111.068 -178.552 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 18.5 mmt -63.0 -41.29 99.55 Favored 'General case' 0 C--N 1.353 0.733 0 O-C-N 121.519 -0.738 . . . . 0.0 111.247 -178.113 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -67.91 -40.27 83.47 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.762 -177.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 55.3 tp -66.7 -43.34 84.63 Favored 'General case' 0 C--N 1.349 0.549 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -177.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.673 HG12 ' O ' ' A' ' 9' ' ' LEU . 1.6 mm -73.84 -37.95 49.44 Favored 'Isoleucine or valine' 0 C--N 1.359 0.979 0 O-C-N 121.06 -1.025 . . . . 0.0 111.057 -175.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -70.19 -42.01 72.96 Favored 'General case' 0 C--N 1.349 0.554 0 O-C-N 121.699 -0.626 . . . . 0.0 111.546 -176.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -71.48 -37.3 71.3 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -175.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -93.37 -32.39 14.28 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -174.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -115.51 -32.22 5.64 Favored 'General case' 0 CA--C 1.506 -0.723 0 C-N-CA 117.424 -1.71 . . . . 0.0 112.828 -176.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 146.58 178.19 21.77 Favored Glycine 0 C--N 1.346 1.085 0 C-N-CA 117.954 -2.069 . . . . 0.0 110.379 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -101.5 -23.75 14.26 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -177.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -69.52 -39.83 77.28 Favored 'General case' 0 C--N 1.36 1.047 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 94.9 m -67.96 -38.33 82.64 Favored 'General case' 0 C--N 1.357 0.915 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.8 tp -59.93 -38.1 81.41 Favored 'General case' 0 C--N 1.355 0.838 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 179.436 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -65.5 -36.57 84.24 Favored 'General case' 0 C--N 1.358 0.958 0 O-C-N 122.081 -0.387 . . . . 0.0 110.805 -178.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.4 m -65.33 -38.84 91.37 Favored 'General case' 0 C--N 1.354 0.797 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.639 HD13 HD22 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -63.06 -38.23 90.37 Favored 'General case' 0 C--N 1.353 0.732 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -179.13 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 85.0 mt -73.84 -14.11 61.03 Favored 'General case' 0 C--N 1.359 1.009 0 O-C-N 121.749 -0.594 . . . . 0.0 110.415 -178.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -86.61 -28.59 23.16 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 119.185 -1.006 . . . . 0.0 109.374 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.7 t -67.03 -37.04 83.41 Favored 'General case' 0 C--N 1.355 0.827 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.536 ' HB3' HD21 ' A' ' 51' ' ' LEU . 2.0 p -91.51 -39.89 11.68 Favored 'General case' 0 C--N 1.359 1.015 0 C-N-CA 118.849 -1.14 . . . . 0.0 108.153 -179.06 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 85.97 131.45 0.04 OUTLIER 'General case' 0 C--N 1.361 1.091 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.506 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -90.52 -166.83 1.68 Allowed 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.888 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.423 ' H ' ' HB2' ' A' ' 31' ' ' LEU . 60.6 tt0 -154.2 -61.78 0.13 Allowed 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 -179.621 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.8 t -101.53 -68.39 0.82 Allowed 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -137.0 -42.67 0.58 Allowed 'General case' 0 CA--C 1.502 -0.899 0 C-N-CA 119.583 -0.847 . . . . 0.0 108.881 -178.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.16 -33.92 3.86 Favored Glycine 0 C--N 1.352 1.442 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 84.8 mt -112.44 102.03 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.728 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -104.28 11.73 34.5 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.816 HG22 ' H ' ' A' ' 39' ' ' SER . 1.9 m 76.31 -170.53 0.08 Allowed 'General case' 0 C--N 1.358 0.974 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.816 ' H ' HG22 ' A' ' 38' ' ' THR . 21.6 p -97.65 51.45 1.07 Allowed 'General case' 0 C--N 1.354 0.769 0 O-C-N 121.151 -0.968 . . . . 0.0 110.26 -178.382 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.471 HG12 ' O ' ' A' ' 40' ' ' VAL . 17.9 t -107.95 -10.78 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.685 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -107.09 159.18 14.76 Favored Glycine 0 C--N 1.357 1.743 0 C-N-CA 119.338 -1.411 . . . . 0.0 109.92 -178.151 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 36.2 m -129.28 134.26 47.87 Favored 'General case' 0 C--N 1.361 1.097 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -122.35 174.37 7.05 Favored 'General case' 0 C--N 1.355 0.815 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -77.31 -176.49 4.16 Favored 'General case' 0 C--N 1.357 0.899 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -92.16 -15.95 26.94 Favored 'General case' 0 C--N 1.356 0.887 0 C-N-CA 120.131 -0.628 . . . . 0.0 109.417 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -67.6 -28.29 67.63 Favored 'General case' 0 C--N 1.351 0.64 0 N-CA-C 107.605 -1.258 . . . . 0.0 107.605 177.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.42 ' HG3' ' HZ ' ' A' ' 6' ' ' PHE . 29.8 tp10 -63.11 -41.52 99.36 Favored 'General case' 0 C--N 1.352 0.687 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -67.88 -39.46 83.7 Favored 'General case' 0 C--N 1.359 1.001 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 60.8 tp -69.64 -36.42 76.1 Favored 'General case' 0 CA--C 1.508 -0.664 0 O-C-N 122.167 -0.333 . . . . 0.0 110.498 -177.095 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -65.02 -40.22 94.54 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 121.686 -0.634 . . . . 0.0 109.986 -178.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.639 HD22 HD13 ' A' ' 25' ' ' LEU . 77.0 mt -81.37 -19.16 43.28 Favored 'General case' 0 C--N 1.36 1.028 0 C-N-CA 119.644 -0.823 . . . . 0.0 110.661 -178.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.2 t -78.96 -37.22 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.6 t -68.79 -40.41 81.35 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.421 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 32.2 tptt -65.1 -27.15 68.56 Favored 'General case' 0 C--N 1.364 1.235 0 O-C-N 121.126 -0.984 . . . . 0.0 108.827 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.5 tt -68.26 -38.0 81.33 Favored 'General case' 0 C--N 1.354 0.764 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.1 p -72.75 -18.23 61.53 Favored 'General case' 0 C--N 1.357 0.894 0 O-C-N 121.54 -0.725 . . . . 0.0 110.948 -179.011 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -100.05 -37.7 8.87 Favored 'General case' 0 C--N 1.351 0.674 0 O-C-N 121.168 -0.957 . . . . 0.0 111.668 -179.1 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.3 p -72.96 -35.96 50.14 Favored 'Isoleucine or valine' 0 C--N 1.351 0.642 0 O-C-N 121.713 -0.617 . . . . 0.0 111.36 -177.09 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.6 m -111.99 -7.99 14.09 Favored 'General case' 0 CA--C 1.505 -0.754 0 C-N-CA 119.372 -0.931 . . . . 0.0 110.116 -177.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 64.22 49.12 2.69 Favored 'General case' 0 C--N 1.354 0.784 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.583 HG13 ' HD2' ' A' ' 62' ' ' PRO . 52.3 t -113.62 135.51 21.94 Favored Pre-proline 0 CA--C 1.504 -0.802 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.652 ' HG2' ' HB2' ' A' ' 65' ' ' GLU . 20.8 Cg_endo -61.68 149.61 89.18 Favored 'Trans proline' 0 CA--C 1.5 -1.192 0 C-N-CA 122.339 2.026 . . . . 0.0 112.684 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.402 ' HA ' HD23 ' A' ' 66' ' ' LEU . 3.0 m -76.67 -11.78 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.39 -177.419 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.495 ' O ' HG12 ' A' ' 67' ' ' VAL . 72.0 p -96.62 -34.68 11.32 Favored 'General case' 0 C--N 1.357 0.93 0 C-N-CA 118.194 -1.402 . . . . 0.0 109.525 -179.05 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.652 ' HB2' ' HG2' ' A' ' 62' ' ' PRO . 69.1 mt-10 -76.85 -22.3 53.74 Favored 'General case' 0 C--N 1.354 0.792 0 O-C-N 121.437 -0.789 . . . . 0.0 108.893 179.092 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.408 ' HB3' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -79.19 -36.75 39.73 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.408 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.495 HG12 ' O ' ' A' ' 64' ' ' THR . 1.7 p -68.12 -26.82 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 C-N-CA 120.123 -0.631 . . . . 0.0 109.9 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.6 mmm-85 -72.1 -51.66 20.46 Favored 'General case' 0 C--N 1.364 1.216 0 O-C-N 121.549 -0.719 . . . . 0.0 110.453 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.3 mt -62.49 -36.27 81.96 Favored 'General case' 0 C--N 1.357 0.905 0 O-C-N 122.012 -0.43 . . . . 0.0 111.038 -178.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -61.02 -47.5 86.12 Favored 'General case' 0 C--N 1.349 0.556 0 O-C-N 122.23 -0.294 . . . . 0.0 110.639 -178.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.83 -39.21 96.51 Favored Glycine 0 C--N 1.356 1.69 0 N-CA-C 111.888 -0.485 . . . . 0.0 111.888 -177.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -62.76 -49.16 76.11 Favored 'General case' 0 C--N 1.352 0.688 0 CA-C-N 118.303 1.051 . . . . 0.0 111.693 -177.208 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 10.2 mttm -63.3 -47.67 81.28 Favored 'General case' 0 C--N 1.359 0.985 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -177.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.413 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.4 tm? -69.41 -38.69 78.02 Favored 'General case' 0 C--N 1.348 0.526 0 O-C-N 121.104 -0.997 . . . . 0.0 111.807 -175.682 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -63.71 -46.8 83.8 Favored 'General case' 0 C--N 1.355 0.834 0 O-C-N 121.037 -1.04 . . . . 0.0 111.443 -177.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -70.58 -13.83 17.5 Favored 'Isoleucine or valine' 0 C--N 1.36 1.024 0 O-C-N 121.517 -0.739 . . . . 0.0 109.371 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -73.08 -38.34 66.44 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 85.4 mt -73.97 -30.67 62.62 Favored 'General case' 0 C--N 1.357 0.922 0 O-C-N 122.3 -0.25 . . . . 0.0 110.519 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 47.9 mm -65.1 -53.53 39.96 Favored 'Isoleucine or valine' 0 C--N 1.357 0.921 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.957 -177.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -74.61 -15.52 60.83 Favored 'General case' 0 C--N 1.351 0.634 0 C-N-CA 119.573 -0.851 . . . . 0.0 109.526 178.426 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.45 -36.43 62.87 Favored Glycine 0 C--N 1.349 1.26 0 N-CA-C 111.001 -0.839 . . . . 0.0 111.001 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.486 ' HA ' ' HD2' ' A' ' 83' ' ' PRO . 99.3 m-70 -130.65 105.57 15.67 Favored Pre-proline 0 N--CA 1.441 -0.88 0 CA-C-O 122.686 1.231 . . . . 0.0 109.263 -176.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.486 ' HD2' ' HA ' ' A' ' 82' ' ' HIS . 37.8 Cg_endo -67.69 -26.0 39.66 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.647 2.231 . . . . 0.0 114.085 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -89.86 -7.66 53.74 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 tp -90.36 -20.97 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 -178.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -101.52 -23.63 14.27 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -70.16 -37.33 75.17 Favored 'General case' 0 C--N 1.359 1.001 0 O-C-N 121.867 -0.521 . . . . 0.0 109.855 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -64.89 -34.98 79.67 Favored 'General case' 0 C--N 1.358 0.975 0 O-C-N 121.836 -0.54 . . . . 0.0 110.545 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 18.4 ttp -82.9 152.51 25.52 Favored 'General case' 0 C--N 1.352 0.704 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 -178.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.43 -21.89 7.84 Favored 'General case' 0 C--N 1.364 1.225 0 O-C-N 121.641 -0.662 . . . . 0.0 111.356 -177.135 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -165.8 171.42 12.83 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -177.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.456 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 62.8 m -66.65 -40.81 88.84 Favored 'General case' 0 C--N 1.355 0.82 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.584 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.492 ' CE1' ' HE2' ' A' ' 158' ' ' PHE . 60.4 m-85 -66.67 -39.65 88.24 Favored 'General case' 0 C--N 1.357 0.915 0 O-C-N 121.188 -0.945 . . . . 0.0 108.836 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -65.79 -23.31 66.68 Favored 'General case' 0 C--N 1.356 0.884 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.694 ' O ' HG13 ' A' ' 99' ' ' ILE . 57.9 tp -63.58 -46.86 83.92 Favored 'General case' 0 C--N 1.355 0.843 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.477 ' HA ' ' CD1' ' A' ' 99' ' ' ILE . 4.2 mp -60.59 -37.34 81.04 Favored 'General case' 0 C--N 1.359 1.016 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.416 -179.539 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 34.3 t -67.88 -39.71 83.66 Favored 'General case' 0 C--N 1.349 0.566 0 O-C-N 121.918 -0.489 . . . . 0.0 110.242 -179.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.72 -0.89 56.44 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -176.558 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.694 HG13 ' O ' ' A' ' 95' ' ' LEU . 78.8 mt -60.81 -47.09 94.78 Favored 'Isoleucine or valine' 0 C--N 1.357 0.906 0 CA-C-N 118.919 0.782 . . . . 0.0 112.331 -177.223 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -94.44 -23.92 17.54 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 118.55 -1.26 . . . . 0.0 111.522 -176.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.5 t -63.86 -48.07 78.21 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.607 -0.683 . . . . 0.0 112.717 -177.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -137.92 -15.86 1.32 Allowed 'General case' 0 C--N 1.359 0.992 0 C-N-CA 116.946 -1.901 . . . . 0.0 113.763 -176.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.539 HD12 ' HA ' ' A' ' 99' ' ' ILE . 96.4 mt -70.81 -49.7 48.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 CA-C-N 120.54 1.518 . . . . 0.0 111.164 -177.404 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -89.04 0.67 56.49 Favored 'General case' 0 N--CA 1.442 -0.858 0 O-C-N 121.176 -0.953 . . . . 0.0 110.171 -177.158 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 72.7 t -83.71 -44.18 18.22 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.996 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 178.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -67.68 -40.55 84.4 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 71.9 t -63.06 -45.22 99.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.826 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.256 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -60.33 -48.38 82.01 Favored 'General case' 0 C--N 1.36 1.055 0 O-C-N 122.016 -0.428 . . . . 0.0 111.34 -178.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -63.5 -35.41 80.37 Favored 'General case' 0 C--N 1.354 0.795 0 O-C-N 121.544 -0.722 . . . . 0.0 110.615 -178.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 110' ' ' LEU . 16.4 mt -57.33 -72.1 0.09 Allowed 'General case' 0 C--N 1.357 0.919 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.104 -179.046 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -122.31 143.7 40.0 Favored Pre-proline 0 N--CA 1.441 -0.899 0 C-N-CA 118.038 -1.465 . . . . 0.0 109.292 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -87.25 -2.46 7.83 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 C-N-CA 123.505 2.803 . . . . 0.0 116.265 -178.252 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -83.42 -8.11 59.44 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 121.272 -0.892 . . . . 0.0 109.486 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -83.06 144.33 29.98 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.552 ' O ' HD13 ' A' ' 116' ' ' LEU . 46.0 mt-10 -120.33 144.11 48.02 Favored 'General case' 0 C--N 1.359 1.021 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.552 HD13 ' O ' ' A' ' 115' ' ' GLU . 2.6 mm? -129.88 152.52 80.04 Favored Pre-proline 0 C--N 1.358 0.946 0 CA-C-O 121.951 0.882 . . . . 0.0 109.27 -178.463 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 116' ' ' LEU . 87.7 Cg_endo -92.73 -155.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.32 -0.946 0 C-N-CA 123.929 3.086 . . . . 0.0 113.036 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -122.5 141.84 51.22 Favored 'General case' 0 C--N 1.368 1.399 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -132.61 137.04 46.9 Favored 'General case' 0 C--N 1.362 1.132 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.629 -178.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.437 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 93.7 m -127.32 128.52 46.06 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 176.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 78.2 m -118.69 128.89 54.94 Favored 'General case' 0 CA--C 1.503 -0.862 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.436 -178.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -120.85 130.89 54.12 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -103.55 117.23 33.95 Favored 'General case' 0 C--N 1.353 0.738 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -179.062 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.463 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 88.7 mt -83.27 -27.48 29.83 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 120.668 -0.413 . . . . 0.0 109.968 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 179.49 -143.24 5.59 Favored Glycine 0 C--N 1.351 1.378 0 C-N-CA 118.771 -1.681 . . . . 0.0 109.648 -178.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -91.37 -45.98 8.27 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -178.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -98.67 3.25 47.75 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.699 -177.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.463 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 66.7 m-20 -119.91 133.38 55.59 Favored 'General case' 0 C--N 1.357 0.917 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.533 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.1 mm -142.57 138.45 28.69 Favored 'Isoleucine or valine' 0 C--N 1.357 0.91 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 179.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 52.3 mtm180 -119.79 137.75 53.77 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 6.6 tp -125.5 119.45 28.25 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.76 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.437 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 11.8 m170 -99.92 135.2 41.71 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.325 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -128.06 121.97 30.99 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -178.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.448 ' HA ' ' O ' ' A' ' 171' ' ' THR . 10.2 tt0 -115.55 112.88 22.86 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 178.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.8 t -167.25 156.63 10.45 Favored 'General case' 0 C--N 1.357 0.908 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.439 ' C ' ' HD3' ' A' ' 138' ' ' PRO . 99.5 mttt -91.3 6.86 43.61 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 -130.82 74.04 80.44 Favored Pre-proline 0 C--N 1.355 0.816 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.439 ' HD3' ' C ' ' A' ' 136' ' ' LYS . 80.1 Cg_endo -95.57 89.27 0.1 Allowed 'Trans proline' 0 N--CA 1.445 -1.373 0 C-N-CA 122.821 2.347 . . . . 0.0 115.559 -178.308 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -106.57 112.42 25.41 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 177.333 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.89 -37.74 88.51 Favored 'General case' 0 C--N 1.353 0.735 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.132 -178.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 71.5 m -61.77 -32.46 72.73 Favored 'General case' 0 C--N 1.353 0.741 0 O-C-N 121.967 -0.458 . . . . 0.0 110.693 -178.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -73.11 -46.48 51.04 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 120.25 -0.58 . . . . 0.0 109.988 -177.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.35 -40.17 95.33 Favored 'General case' 0 C--N 1.356 0.88 0 O-C-N 122.127 -0.358 . . . . 0.0 111.461 -177.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -63.27 -36.89 85.16 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 121.85 -0.531 . . . . 0.0 110.273 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.14 -43.52 98.28 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 -178.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 82.7 mt -69.82 -40.57 75.84 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 96.2 mt -71.63 -42.43 67.63 Favored 'General case' 0 C--N 1.362 1.152 0 O-C-N 121.152 -0.968 . . . . 0.0 111.186 -176.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.472 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 36.2 t70 -69.84 -30.55 68.06 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 121.834 -0.541 . . . . 0.0 110.535 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -62.85 -39.1 97.58 Favored Glycine 0 C--N 1.357 1.708 0 N-CA-C 108.303 -1.919 . . . . 0.0 108.303 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 48.9 t -60.55 -42.02 95.71 Favored 'General case' 0 C--N 1.351 0.659 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -74.96 -1.24 21.69 Favored 'General case' 0 C--N 1.361 1.093 0 O-C-N 121.739 -0.601 . . . . 0.0 109.476 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.472 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 76.5 mm-40 -84.38 -46.33 11.83 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.238 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -68.06 -43.19 79.19 Favored 'General case' 0 C--N 1.359 1.017 0 C-N-CA 120.002 -0.679 . . . . 0.0 109.553 179.08 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -69.19 -27.67 65.71 Favored 'General case' 0 C--N 1.361 1.076 0 O-C-N 121.739 -0.601 . . . . 0.0 110.701 -178.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 86.1 tttt 70.42 72.31 0.21 Allowed 'General case' 0 C--N 1.361 1.07 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -178.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -143.45 -167.26 2.52 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -142.18 116.6 9.61 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' PHE . . . . . 0.492 ' HE2' ' CE1' ' A' ' 93' ' ' PHE . 94.9 m-85 -135.09 150.47 50.24 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 178.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 92.4 m -120.63 127.82 52.44 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.549 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.4 mp -105.9 122.88 60.04 Favored 'Isoleucine or valine' 0 C--N 1.351 0.672 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.9 m -120.12 -173.61 2.59 Favored 'General case' 0 C--N 1.357 0.911 0 CA-C-O 121.86 0.838 . . . . 0.0 109.341 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -147.74 156.96 43.29 Favored 'General case' 0 C--N 1.357 0.932 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -178.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 64.6 p -100.79 146.2 31.68 Favored Pre-proline 0 C--N 1.359 0.988 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.9 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 62.7 Cg_endo -75.75 -9.6 19.77 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.754 2.303 . . . . 0.0 115.424 -178.492 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -71.97 -41.11 68.1 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 119.771 -0.772 . . . . 0.0 109.101 -179.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 39.2 p -118.05 14.53 14.08 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 120.071 -0.651 . . . . 0.0 110.538 -178.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.9 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 11.6 pt20 -67.03 -10.34 48.73 Favored 'General case' 0 C--N 1.355 0.828 0 O-C-N 121.455 -0.778 . . . . 0.0 110.335 178.594 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -126.54 38.28 4.15 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.9 m -137.38 146.9 45.02 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.64 ' O ' ' HB ' ' A' ' 171' ' ' THR . 60.5 mt-10 -98.77 164.4 12.23 Favored 'General case' 0 C--N 1.353 0.759 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.64 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 1.7 m 82.05 -56.65 0.23 Allowed 'General case' 0 C--N 1.371 1.532 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.004 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -110.19 117.65 34.26 Favored 'General case' 0 CA--C 1.503 -0.83 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.802 -178.308 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 67.4 t -131.22 134.0 61.75 Favored 'Isoleucine or valine' 0 C--N 1.357 0.912 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.123 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 50.4 mm -108.53 125.44 65.38 Favored 'Isoleucine or valine' 0 C--N 1.357 0.914 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -113.25 153.16 28.84 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 122.136 0.969 . . . . 0.0 108.541 -179.098 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -136.69 117.56 14.16 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -178.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.3 mp -113.04 118.6 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 -179.161 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 89.4 m -120.28 144.24 47.9 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -177.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 . . . . . 0 C--N 1.363 1.185 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 179.476 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.6 mtp . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.212 0.53 . . . . 0.0 109.862 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.624 ' HA ' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -82.17 -5.46 58.49 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.046 -177.873 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.52 -46.16 26.47 Favored Glycine 0 C--N 1.35 1.34 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 76.9 mtm -72.15 -34.53 68.57 Favored 'General case' 0 C--N 1.354 0.791 0 O-C-N 121.92 -0.753 . . . . 0.0 111.271 -177.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.624 HG22 ' HA ' ' A' ' 2' ' ' MET . 36.0 m -69.78 -23.44 25.8 Favored 'Isoleucine or valine' 0 C--N 1.356 0.868 0 C-N-CA 119.926 -0.709 . . . . 0.0 109.346 -179.064 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.426 ' HZ ' ' CG ' ' A' ' 47' ' ' GLU . 1.6 m-85 -71.79 -34.45 69.42 Favored 'General case' 0 C--N 1.357 0.908 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.16 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.6 m -66.7 -39.65 88.16 Favored 'General case' 0 C--N 1.354 0.798 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -61.29 -38.81 96.28 Favored Glycine 0 C--N 1.359 1.809 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.617 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -65.33 -40.08 93.24 Favored 'General case' 0 C--N 1.353 0.741 0 O-C-N 122.354 -0.498 . . . . 0.0 110.761 -178.83 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.2 mmt -63.02 -41.02 99.43 Favored 'General case' 0 C--N 1.351 0.665 0 O-C-N 121.632 -0.667 . . . . 0.0 111.099 -178.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -66.81 -40.65 88.14 Favored 'General case' 0 C--N 1.35 0.613 0 O-C-N 121.869 -0.519 . . . . 0.0 111.688 -177.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 53.9 tp -65.8 -42.78 90.25 Favored 'General case' 0 C--N 1.349 0.585 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.617 HG12 ' O ' ' A' ' 9' ' ' LEU . 1.5 mm -75.67 -37.44 36.19 Favored 'Isoleucine or valine' 0 C--N 1.357 0.896 0 O-C-N 121.083 -1.011 . . . . 0.0 111.134 -175.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -68.53 -43.16 77.35 Favored 'General case' 0 C--N 1.352 0.703 0 O-C-N 121.911 -0.493 . . . . 0.0 111.315 -176.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -71.42 -34.36 70.25 Favored 'General case' 0 N--CA 1.446 -0.634 0 O-C-N 122.06 -0.4 . . . . 0.0 111.717 -177.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -71.83 -48.71 44.33 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -175.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -128.22 -19.29 3.93 Favored 'General case' 0 C--N 1.356 0.854 0 C-N-CA 117.352 -1.739 . . . . 0.0 113.747 -176.432 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 140.56 179.48 18.15 Favored Glycine 0 CA--C 1.497 -1.066 0 C-N-CA 117.773 -2.156 . . . . 0.0 109.97 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -96.42 -12.09 24.75 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -177.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -70.49 -41.41 72.71 Favored 'General case' 0 C--N 1.361 1.073 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.2 m -69.91 -39.08 76.41 Favored 'General case' 0 C--N 1.356 0.859 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.531 HD13 ' HB ' ' A' ' 13' ' ' ILE . 58.3 tp -60.6 -37.93 83.03 Favored 'General case' 0 C--N 1.357 0.918 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -64.59 -36.26 83.66 Favored 'General case' 0 C--N 1.357 0.893 0 O-C-N 122.132 -0.355 . . . . 0.0 110.84 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 93.6 m -63.52 -41.19 98.51 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -178.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.428 ' CD2' ' HB3' ' A' ' 54' ' ' LYS . 88.7 mt -64.17 -37.72 88.47 Favored 'General case' 0 C--N 1.352 0.711 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.09 -13.62 61.63 Favored 'General case' 0 C--N 1.36 1.053 0 O-C-N 121.606 -0.684 . . . . 0.0 110.085 -178.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -86.74 -28.94 22.74 Favored 'General case' 0 CA--C 1.506 -0.712 0 O-C-N 121.262 -0.899 . . . . 0.0 109.12 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.8 t -66.81 -36.29 82.03 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.647 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 2.2 p -92.15 -38.16 12.31 Favored 'General case' 0 C--N 1.359 0.996 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.647 ' HB2' ' O ' ' A' ' 29' ' ' CYS . 15.9 mt-10 85.96 131.73 0.04 OUTLIER 'General case' 0 C--N 1.36 1.041 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.511 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -89.96 -167.49 1.86 Allowed 'General case' 0 C--N 1.356 0.871 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.791 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -153.39 -66.59 0.15 Allowed 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.2 m -96.47 -62.06 1.33 Allowed 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -141.1 -43.2 0.38 Allowed 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -179.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.43 -39.02 2.47 Favored Glycine 0 C--N 1.351 1.398 0 N-CA-C 108.69 -1.764 . . . . 0.0 108.69 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 84.9 mt -109.8 104.68 17.46 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.878 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.425 ' HB3' ' H ' ' A' ' 38' ' ' THR . 4.0 t80 -74.03 -92.31 0.02 OUTLIER 'General case' 0 C--N 1.355 0.833 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.46 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.441 HG22 ' N ' ' A' ' 39' ' ' SER . 1.2 m -166.37 -64.52 0.03 OUTLIER 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 -178.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.441 ' N ' HG22 ' A' ' 38' ' ' THR . 12.3 p 161.87 80.9 0.0 OUTLIER 'General case' 0 C--N 1.362 1.122 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.513 ' O ' HG13 ' A' ' 40' ' ' VAL . 0.4 OUTLIER -172.05 -4.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.972 0 C-N-CA 119.459 -0.896 . . . . 0.0 109.735 -179.18 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -96.3 150.61 19.67 Favored Glycine 0 C--N 1.355 1.6 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 -178.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 59.2 m -125.41 131.5 52.91 Favored 'General case' 0 C--N 1.354 0.77 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -121.05 171.11 8.9 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -76.24 -178.67 4.62 Favored 'General case' 0 C--N 1.355 0.842 0 CA-C-O 121.642 0.734 . . . . 0.0 109.573 -178.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -86.36 -19.65 29.45 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -179.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.709 ' HA ' HD23 ' A' ' 49' ' ' LEU . 0.5 OUTLIER -65.55 -30.65 71.42 Favored 'General case' 0 C--N 1.354 0.764 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 179.08 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.426 ' CG ' ' HZ ' ' A' ' 6' ' ' PHE . 23.6 tp10 -63.97 -40.25 95.97 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -65.52 -39.41 91.79 Favored 'General case' 0 C--N 1.358 0.972 0 O-C-N 122.305 -0.247 . . . . 0.0 111.266 -178.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.709 HD23 ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -81.37 -15.02 56.52 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 119.078 -1.049 . . . . 0.0 110.402 -176.339 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 71.5 tp60 -73.09 -41.44 64.06 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 84.3 mt -84.51 -17.96 37.33 Favored 'General case' 0 C--N 1.362 1.111 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.723 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.6 t -80.52 -37.45 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.9 t -69.73 -39.68 78.3 Favored 'Isoleucine or valine' 0 C--N 1.354 0.78 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.428 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 32.9 tptt -66.15 -27.16 67.81 Favored 'General case' 0 C--N 1.363 1.171 0 O-C-N 121.235 -0.915 . . . . 0.0 108.6 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.496 HD13 HD13 ' A' ' 66' ' ' LEU . 0.3 OUTLIER -68.38 -37.64 80.59 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.704 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 60' ' ' SER . 77.0 p -73.9 -16.93 61.09 Favored 'General case' 0 C--N 1.355 0.847 0 O-C-N 121.693 -0.629 . . . . 0.0 110.885 -178.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -100.46 -36.38 9.23 Favored 'General case' 0 C--N 1.353 0.752 0 C-N-CA 119.377 -0.929 . . . . 0.0 111.434 -179.324 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.5 p -72.66 -34.44 47.54 Favored 'Isoleucine or valine' 0 C--N 1.351 0.651 0 O-C-N 121.683 -0.636 . . . . 0.0 111.455 -177.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.568 ' HB3' HG23 ' A' ' 61' ' ' VAL . 4.2 t -119.99 -5.58 10.05 Favored 'General case' 0 C--N 1.353 0.725 0 C-N-CA 119.143 -1.023 . . . . 0.0 110.069 -178.146 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.417 ' HA ' ' O ' ' A' ' 56' ' ' SER . 73.3 m 64.3 43.25 4.86 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.568 HG23 ' HB3' ' A' ' 59' ' ' SER . 50.0 t -103.37 132.89 20.65 Favored Pre-proline 0 N--CA 1.443 -0.799 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 179.489 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -57.31 146.68 81.24 Favored 'Trans proline' 0 CA--C 1.497 -1.345 0 C-N-CA 122.397 2.065 . . . . 0.0 112.959 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.1 m -75.15 -14.1 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.788 -178.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.412 ' O ' HG12 ' A' ' 67' ' ' VAL . 52.6 p -96.07 -31.88 12.81 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 118.139 -1.425 . . . . 0.0 109.611 -178.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -78.01 -21.49 50.73 Favored 'General case' 0 C--N 1.356 0.856 0 O-C-N 121.385 -0.822 . . . . 0.0 108.894 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.496 HD13 HD13 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -81.82 -35.73 29.14 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.4 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.421 HG11 ' HB3' ' A' ' 141' ' ' SER . 1.4 p -68.79 -27.17 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 C-N-CA 120.138 -0.625 . . . . 0.0 109.95 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.5 mmm-85 -73.21 -51.2 18.6 Favored 'General case' 0 C--N 1.362 1.131 0 O-C-N 121.521 -0.737 . . . . 0.0 110.435 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.7 mt -63.69 -36.08 82.68 Favored 'General case' 0 C--N 1.357 0.934 0 O-C-N 121.976 -0.452 . . . . 0.0 110.85 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -60.65 -47.36 86.58 Favored 'General case' 0 C--N 1.349 0.577 0 O-C-N 122.208 -0.307 . . . . 0.0 110.297 -178.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.57 -37.87 94.06 Favored Glycine 0 C--N 1.354 1.552 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 -178.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -63.02 -48.64 77.91 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-N 118.261 1.031 . . . . 0.0 111.397 -177.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.701 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 16.0 mttm -64.39 -48.96 73.47 Favored 'General case' 0 C--N 1.359 0.983 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -176.538 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.431 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.3 tm? -68.29 -39.68 82.03 Favored 'General case' 0 C--N 1.348 0.534 0 O-C-N 121.207 -0.933 . . . . 0.0 112.047 -175.363 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -63.88 -42.83 97.39 Favored 'General case' 0 C--N 1.353 0.719 0 O-C-N 121.115 -0.991 . . . . 0.0 111.22 -177.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.7 p -71.97 -15.48 18.11 Favored 'Isoleucine or valine' 0 C--N 1.36 1.026 0 O-C-N 121.232 -0.917 . . . . 0.0 109.217 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.701 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 74.1 mm-40 -71.52 -38.89 71.07 Favored 'General case' 0 C--N 1.349 0.552 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.219 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 80.7 mt -72.45 -33.3 66.97 Favored 'General case' 0 C--N 1.358 0.967 0 O-C-N 122.334 -0.229 . . . . 0.0 110.754 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 43.5 mm -64.43 -52.97 48.57 Favored 'Isoleucine or valine' 0 C--N 1.357 0.912 0 O-C-N 121.733 -0.604 . . . . 0.0 110.509 -177.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -76.67 -14.75 59.94 Favored 'General case' 0 C--N 1.35 0.591 0 C-N-CA 119.423 -0.911 . . . . 0.0 109.501 178.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.85 -36.32 61.43 Favored Glycine 0 C--N 1.349 1.27 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -179.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -128.46 104.45 19.58 Favored Pre-proline 0 N--CA 1.44 -0.938 0 CA-C-O 122.564 1.173 . . . . 0.0 109.596 -176.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.08 -33.23 91.8 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 123.366 2.711 . . . . 0.0 114.29 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -91.34 -5.67 54.23 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 120.14 -0.624 . . . . 0.0 109.834 -178.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -87.89 -23.15 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -178.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.6 -18.03 14.91 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -72.39 -38.36 68.49 Favored 'General case' 0 C--N 1.358 0.94 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -65.17 -33.51 76.18 Favored 'General case' 0 C--N 1.355 0.816 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.479 ' SD ' ' HB2' ' A' ' 95' ' ' LEU . 17.8 ttp -84.53 152.08 24.15 Favored 'General case' 0 C--N 1.351 0.651 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -178.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.64 -21.4 8.54 Favored 'General case' 0 C--N 1.364 1.21 0 C-N-CA 120.051 -0.659 . . . . 0.0 111.19 -177.405 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -165.96 171.28 12.77 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -177.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 67.3 m -66.63 -39.89 88.49 Favored 'General case' 0 C--N 1.355 0.842 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.68 -179.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -67.48 -39.21 85.25 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 119.616 -0.834 . . . . 0.0 108.83 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -66.26 -23.36 66.39 Favored 'General case' 0 C--N 1.355 0.832 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.681 ' O ' HG13 ' A' ' 99' ' ' ILE . 66.1 tp -65.25 -45.17 85.67 Favored 'General case' 0 C--N 1.357 0.926 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.425 ' HA ' ' CD1' ' A' ' 99' ' ' ILE . 3.3 mp -60.08 -35.94 76.29 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.1 t -70.49 -39.62 74.06 Favored 'General case' 0 C--N 1.35 0.599 0 O-C-N 121.881 -0.512 . . . . 0.0 109.935 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.3 -0.33 52.06 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -176.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.681 HG13 ' O ' ' A' ' 95' ' ' LEU . 81.1 mt -61.6 -47.18 94.56 Favored 'Isoleucine or valine' 0 C--N 1.357 0.894 0 CA-C-N 119.197 0.908 . . . . 0.0 111.704 -177.42 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -93.06 -23.41 18.66 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 118.642 -1.223 . . . . 0.0 111.349 -177.293 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 33.6 t -63.71 -48.57 76.56 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 121.645 -0.659 . . . . 0.0 112.592 -177.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -139.99 -12.87 1.09 Allowed 'General case' 0 C--N 1.359 0.982 0 C-N-CA 117.083 -1.847 . . . . 0.0 113.685 -177.034 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 24.9 mm -70.12 -51.23 41.05 Favored 'Isoleucine or valine' 0 C--O 1.242 0.706 0 CA-C-N 120.352 1.433 . . . . 0.0 110.564 -177.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -91.72 1.15 57.35 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.209 -177.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 79.5 t -81.39 -44.54 20.6 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.009 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 178.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 54.8 tp10 -68.09 -40.44 82.65 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 53.8 t -62.13 -46.95 95.29 Favored 'Isoleucine or valine' 0 C--N 1.355 0.824 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.685 -179.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -60.45 -48.13 83.11 Favored 'General case' 0 C--N 1.361 1.078 0 O-C-N 121.998 -0.438 . . . . 0.0 111.546 -179.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -60.66 -36.84 79.7 Favored 'General case' 0 C--N 1.355 0.821 0 O-C-N 121.503 -0.748 . . . . 0.0 110.383 -178.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 18.5 mt -59.49 -77.08 0.04 OUTLIER 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.438 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 79.8 m-85 -119.14 140.32 28.69 Favored Pre-proline 0 N--CA 1.44 -0.958 0 C-N-CA 118.574 -1.251 . . . . 0.0 108.973 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 111' ' ' TYR . 67.3 Cg_endo -87.18 -2.1 7.87 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 123.077 2.518 . . . . 0.0 115.124 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 29.7 mm100 -66.9 -36.51 82.45 Favored 'General case' 0 C--N 1.355 0.824 0 O-C-N 121.819 -0.551 . . . . 0.0 109.888 -179.272 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.24 144.63 57.04 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 121.56 0.695 . . . . 0.0 110.067 -178.326 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.453 ' O ' HD13 ' A' ' 116' ' ' LEU . 46.3 mt-10 -115.91 142.78 46.33 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 179.061 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.453 HD13 ' O ' ' A' ' 115' ' ' GLU . 2.6 mm? -127.16 148.8 67.49 Favored Pre-proline 0 N--CA 1.444 -0.737 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -178.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 116' ' ' LEU . 92.1 Cg_endo -91.07 -157.36 0.06 OUTLIER 'Trans proline' 0 C--N 1.315 -1.21 0 C-N-CA 123.797 2.998 . . . . 0.0 113.263 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -118.41 140.4 49.92 Favored 'General case' 0 C--N 1.363 1.186 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.414 ' CZ ' ' HG2' ' A' ' 117' ' ' PRO . 94.2 m-85 -131.51 135.03 46.74 Favored 'General case' 0 C--N 1.359 1.013 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.526 -178.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.453 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 93.6 m -124.05 127.57 48.06 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 176.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 75.2 m -118.06 128.02 54.36 Favored 'General case' 0 CA--C 1.504 -0.794 0 C-N-CA 119.215 -0.994 . . . . 0.0 109.545 -177.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -118.77 151.36 38.18 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 178.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -122.56 117.16 25.23 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.478 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 94.7 mt -86.9 -22.54 25.63 Favored 'General case' 0 C--N 1.354 0.782 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.219 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 177.8 -145.64 7.17 Favored Glycine 0 C--N 1.348 1.248 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 -178.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -94.7 -39.35 10.36 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -178.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -99.46 1.97 44.57 Favored 'General case' 0 C--N 1.353 0.756 0 C-N-CA 120.292 -0.563 . . . . 0.0 109.95 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.478 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 66.1 m-20 -121.12 133.42 55.21 Favored 'General case' 0 C--N 1.357 0.935 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.167 -179.181 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.413 HD13 ' HA ' ' A' ' 129' ' ' ILE . 8.0 mm -142.86 136.42 26.49 Favored 'Isoleucine or valine' 0 C--N 1.356 0.878 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 52.9 mtm180 -116.94 139.06 51.09 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.255 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.0 tp -128.02 118.6 23.8 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.453 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 12.0 m170 -97.35 132.92 42.61 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -126.42 121.38 32.27 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -178.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.485 ' HA ' ' O ' ' A' ' 171' ' ' THR . 29.9 tt0 -115.24 112.2 22.09 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.3 t -162.02 151.39 15.96 Favored 'General case' 0 C--N 1.36 1.038 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -90.47 2.31 55.82 Favored 'General case' 0 C--N 1.356 0.867 0 C-N-CA 120.316 -0.554 . . . . 0.0 109.777 -179.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -134.17 74.65 67.24 Favored Pre-proline 0 C--N 1.354 0.786 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -94.82 106.24 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.659 2.239 . . . . 0.0 115.968 -177.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -111.18 109.61 19.74 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 176.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.82 -39.14 93.51 Favored 'General case' 0 C--N 1.354 0.797 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.66 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.421 ' HB3' HG11 ' A' ' 67' ' ' VAL . 73.8 m -62.81 -27.6 69.42 Favored 'General case' 0 C--N 1.354 0.797 0 O-C-N 121.876 -0.515 . . . . 0.0 110.715 -178.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -76.53 -46.49 26.28 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.862 -177.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.83 -39.81 94.17 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 122.05 -0.406 . . . . 0.0 111.176 -177.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -63.17 -36.83 84.92 Favored 'General case' 0 C--N 1.356 0.86 0 O-C-N 121.902 -0.499 . . . . 0.0 109.85 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.01 -42.94 98.58 Favored Glycine 0 C--N 1.348 1.202 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 86.3 mt -70.57 -41.0 73.0 Favored 'General case' 0 C--N 1.354 0.761 0 CA-C-N 117.552 0.676 . . . . 0.0 112.775 -179.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 97.1 mt -71.37 -41.82 69.22 Favored 'General case' 0 C--N 1.361 1.092 0 O-C-N 121.155 -0.966 . . . . 0.0 110.832 -176.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.472 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 36.8 t70 -69.97 -28.61 65.68 Favored 'General case' 0 N--CA 1.442 -0.865 0 O-C-N 121.258 -0.901 . . . . 0.0 109.987 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.447 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -63.72 -40.61 98.7 Favored Glycine 0 C--N 1.355 1.601 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 14.1 p -65.6 -31.49 72.56 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 119.341 -0.943 . . . . 0.0 109.451 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -78.75 -1.16 33.32 Favored 'General case' 0 C--N 1.363 1.184 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 177.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.472 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 76.8 mm-40 -85.33 -45.55 11.81 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.052 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -66.71 -45.72 77.86 Favored 'General case' 0 C--N 1.36 1.062 0 C-N-CA 120.152 -0.619 . . . . 0.0 109.545 178.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -68.98 -26.83 65.24 Favored 'General case' 0 C--N 1.361 1.078 0 O-C-N 121.843 -0.536 . . . . 0.0 110.664 -178.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 84.6 tttt 73.51 71.85 0.12 Allowed 'General case' 0 C--N 1.362 1.109 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -139.38 -171.62 3.17 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -147.28 94.69 2.43 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 16.3 m-30 -114.78 157.17 23.6 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 178.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 93.4 m -120.2 128.8 53.71 Favored 'General case' 0 C--N 1.354 0.791 0 C-N-CA 119.655 -0.818 . . . . 0.0 108.857 -178.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.535 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.5 mp -104.49 122.04 56.98 Favored 'Isoleucine or valine' 0 C--N 1.351 0.66 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 179.024 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.3 m -117.86 -174.05 2.56 Favored 'General case' 0 C--N 1.358 0.948 0 CA-C-O 121.942 0.877 . . . . 0.0 109.462 -178.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 26.6 ptt180 -146.2 155.69 42.88 Favored 'General case' 0 C--N 1.357 0.918 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -178.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' THR . . . . . 0.446 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 34.8 p -96.98 145.67 29.98 Favored Pre-proline 0 C--N 1.358 0.971 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.623 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 15.3 Cg_exo -70.82 -16.19 33.09 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 123.439 2.759 . . . . 0.0 114.445 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -71.63 -40.78 69.53 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 120.436 -0.506 . . . . 0.0 110.708 -177.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 40.8 p -119.28 16.38 13.11 Favored 'General case' 0 C--N 1.353 0.739 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.852 -178.02 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.623 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 9.9 pt20 -66.89 -12.86 60.73 Favored 'General case' 0 C--N 1.353 0.741 0 O-C-N 121.517 -0.739 . . . . 0.0 110.212 178.463 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 54.0 p30 -124.74 38.23 4.24 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 19.9 t -139.42 144.95 38.32 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.599 ' O ' ' HB ' ' A' ' 171' ' ' THR . 62.0 mt-10 -97.9 165.07 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -179.357 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.599 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 18.7 m 82.52 -58.98 0.18 Allowed 'General case' 0 C--N 1.37 1.49 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.771 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -107.75 116.83 32.66 Favored 'General case' 0 CA--C 1.503 -0.829 0 C-N-CA 119.952 -0.699 . . . . 0.0 109.538 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 85.1 t -130.69 132.45 64.24 Favored 'Isoleucine or valine' 0 C--N 1.357 0.904 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 178.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 50.8 mm -107.74 126.31 64.15 Favored 'Isoleucine or valine' 0 C--N 1.356 0.878 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -114.8 154.44 28.57 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-O 122.173 0.987 . . . . 0.0 108.588 -178.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -136.82 119.24 15.79 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.8 mp -113.85 119.83 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 N-CA-C 106.525 -1.658 . . . . 0.0 106.525 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 89.6 m -120.39 143.06 48.64 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -177.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 10.2 ttm180 . . . . . 0 C--N 1.363 1.184 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -179.964 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.2 mmm . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.065 0.459 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.18 -19.05 47.98 Favored 'General case' 0 C--N 1.356 0.856 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -178.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.73 -40.44 45.6 Favored Glycine 0 C--N 1.35 1.323 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.22 -34.81 68.62 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 121.853 -0.792 . . . . 0.0 111.164 -177.379 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.1 m -69.03 -23.99 27.76 Favored 'Isoleucine or valine' 0 C--N 1.356 0.85 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.453 ' HZ ' ' CG ' ' A' ' 47' ' ' GLU . 2.0 m-85 -70.6 -35.03 72.77 Favored 'General case' 0 C--N 1.356 0.86 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.045 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 89.6 m -67.4 -39.71 85.57 Favored 'General case' 0 C--N 1.356 0.883 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -61.81 -38.45 95.99 Favored Glycine 0 C--N 1.36 1.874 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.675 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -64.72 -41.35 96.05 Favored 'General case' 0 C--N 1.352 0.685 0 O-C-N 122.511 -0.405 . . . . 0.0 110.791 -178.768 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.433 ' CE ' HD21 ' A' ' 26' ' ' LEU . 20.7 mmt -62.71 -40.92 98.68 Favored 'General case' 0 C--N 1.352 0.692 0 O-C-N 121.693 -0.629 . . . . 0.0 110.891 -178.165 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -68.06 -40.66 82.71 Favored 'General case' 0 C--N 1.347 0.481 0 O-C-N 121.952 -0.467 . . . . 0.0 111.738 -177.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 54.0 tp -66.65 -43.79 83.67 Favored 'General case' 0 C--N 1.35 0.599 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -178.107 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.675 HG12 ' O ' ' A' ' 9' ' ' LEU . 2.0 mm -72.71 -37.36 55.4 Favored 'Isoleucine or valine' 0 C--N 1.36 1.032 0 O-C-N 121.164 -0.96 . . . . 0.0 111.054 -175.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -71.65 -42.85 67.03 Favored 'General case' 0 C--N 1.35 0.619 0 O-C-N 121.662 -0.649 . . . . 0.0 111.835 -176.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -71.26 -37.03 71.95 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -175.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -98.31 -27.95 13.89 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 118.627 -1.229 . . . . 0.0 114.085 -174.061 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -115.28 -30.55 6.25 Favored 'General case' 0 CA--C 1.506 -0.743 0 C-N-CA 117.162 -1.815 . . . . 0.0 112.7 -176.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 143.17 177.83 18.48 Favored Glycine 0 C--N 1.347 1.155 0 C-N-CA 118.122 -1.99 . . . . 0.0 110.068 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -101.46 -24.4 14.18 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 -177.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -68.98 -39.86 79.16 Favored 'General case' 0 C--N 1.361 1.106 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 96.3 m -68.54 -38.63 81.0 Favored 'General case' 0 C--N 1.357 0.923 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 178.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.9 tp -59.4 -39.16 82.53 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -65.31 -37.21 86.44 Favored 'General case' 0 C--N 1.355 0.828 0 O-C-N 122.144 -0.347 . . . . 0.0 111.241 -178.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 88.6 m -64.61 -40.72 96.0 Favored 'General case' 0 C--N 1.354 0.787 0 O-C-N 121.679 -0.638 . . . . 0.0 109.708 -178.028 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.499 HD22 ' HB3' ' A' ' 54' ' ' LYS . 10.2 mt -64.81 -37.47 87.71 Favored 'General case' 0 C--N 1.353 0.757 0 C-N-CA 120.566 -0.454 . . . . 0.0 109.777 -178.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.433 HD21 ' CE ' ' A' ' 10' ' ' MET . 83.6 mt -70.0 -17.24 63.27 Favored 'General case' 0 C--N 1.359 0.996 0 O-C-N 121.739 -0.6 . . . . 0.0 110.192 -179.171 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -84.66 -28.27 26.53 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 119.51 -0.876 . . . . 0.0 109.493 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 45.7 t -66.76 -36.89 83.47 Favored 'General case' 0 C--N 1.354 0.781 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.625 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 2.2 p -92.91 -37.98 11.96 Favored 'General case' 0 C--N 1.358 0.957 0 C-N-CA 118.936 -1.106 . . . . 0.0 108.031 -178.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.625 ' HB2' ' O ' ' A' ' 29' ' ' CYS . 14.9 mt-10 84.73 132.61 0.05 OUTLIER 'General case' 0 C--N 1.359 1.005 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.528 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -90.25 -167.67 1.9 Allowed 'General case' 0 C--N 1.356 0.85 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.286 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -154.25 -64.63 0.14 Allowed 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.5 t -97.26 -64.92 1.0 Allowed 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -139.21 -44.02 0.46 Allowed 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 -178.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.74 -35.97 3.0 Favored Glycine 0 C--N 1.352 1.448 0 N-CA-C 109.151 -1.579 . . . . 0.0 109.151 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 82.5 mt -110.84 101.92 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.782 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.613 ' CD2' HG23 ' A' ' 40' ' ' VAL . 0.4 OUTLIER -66.65 -57.27 7.53 Favored 'General case' 0 C--N 1.358 0.964 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 178.947 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.478 HG22 ' N ' ' A' ' 39' ' ' SER . 1.0 OUTLIER 148.65 -64.04 0.0 OUTLIER 'General case' 0 C--N 1.367 1.355 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 178.422 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.478 ' N ' HG22 ' A' ' 38' ' ' THR . 17.7 p 168.73 70.69 0.0 OUTLIER 'General case' 0 C--N 1.362 1.135 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.613 HG23 ' CD2' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -159.21 4.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.869 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.797 -179.438 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.78 -158.11 21.14 Favored Glycine 0 C--N 1.355 1.597 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 -179.554 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 171.17 85.34 0.0 OUTLIER 'General case' 0 CA--C 1.5 -0.963 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 -178.554 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -95.47 177.08 5.94 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -83.63 -170.82 3.25 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -91.93 -14.95 28.73 Favored 'General case' 0 CA--C 1.499 -0.992 0 C-N-CA 119.994 -0.682 . . . . 0.0 109.3 -179.236 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -69.85 -30.5 67.99 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.453 ' CG ' ' HZ ' ' A' ' 6' ' ' PHE . 33.0 tp10 -64.02 -40.82 97.18 Favored 'General case' 0 C--N 1.351 0.654 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.655 ' O ' HD23 ' A' ' 48' ' ' LEU . 4.6 tt -71.78 -35.52 70.05 Favored 'General case' 0 C--N 1.357 0.896 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -179.149 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 61.5 tp -69.99 -36.7 75.36 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -177.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 72.9 tp60 -65.0 -41.72 95.14 Favored 'General case' 0 N--CA 1.441 -0.881 0 O-C-N 121.87 -0.519 . . . . 0.0 109.707 -178.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 81.7 mt -73.94 -35.82 64.61 Favored 'General case' 0 C--N 1.364 1.2 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.28 -179.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.4 t -64.03 -39.05 84.07 Favored 'Isoleucine or valine' 0 C--N 1.353 0.76 0 O-C-N 121.904 -0.497 . . . . 0.0 109.759 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.8 t -67.66 -39.6 82.5 Favored 'Isoleucine or valine' 0 C--N 1.352 0.699 0 O-C-N 121.675 -0.641 . . . . 0.0 109.474 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.499 ' HB3' HD22 ' A' ' 25' ' ' LEU . 35.1 tptt -63.51 -28.7 70.13 Favored 'General case' 0 C--N 1.363 1.175 0 O-C-N 121.234 -0.916 . . . . 0.0 108.711 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.583 HD21 HD12 ' A' ' 13' ' ' ILE . 14.1 mt -66.65 -38.3 86.6 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.439 179.097 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.6 p -72.54 -17.79 61.69 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.879 -178.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -101.72 -38.68 7.78 Favored 'General case' 0 C--N 1.353 0.729 0 C-N-CA 119.358 -0.937 . . . . 0.0 111.813 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.6 p -74.38 -37.48 45.05 Favored 'Isoleucine or valine' 0 C--N 1.352 0.704 0 O-C-N 121.515 -0.741 . . . . 0.0 111.255 -176.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.569 ' HB3' HG23 ' A' ' 61' ' ' VAL . 1.9 t -110.57 -9.44 14.55 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 119.249 -0.981 . . . . 0.0 110.281 -178.073 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 65.29 49.26 1.97 Allowed 'General case' 0 C--N 1.354 0.792 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.569 HG23 ' HB3' ' A' ' 59' ' ' SER . 58.2 t -113.92 133.49 22.3 Favored Pre-proline 0 CA--C 1.504 -0.822 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 61' ' ' VAL . 43.2 Cg_exo -57.88 147.44 81.42 Favored 'Trans proline' 0 CA--C 1.499 -1.229 0 C-N-CA 122.581 2.187 . . . . 0.0 112.825 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.2 m -74.51 -13.03 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.912 -178.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.411 ' O ' HG12 ' A' ' 67' ' ' VAL . 68.2 p -95.95 -32.03 12.8 Favored 'General case' 0 C--N 1.357 0.922 0 C-N-CA 118.151 -1.42 . . . . 0.0 109.509 -179.13 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -76.44 -24.43 53.93 Favored 'General case' 0 C--N 1.355 0.819 0 O-C-N 121.452 -0.78 . . . . 0.0 109.201 179.07 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.435 HD13 HD13 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -80.15 -36.92 34.48 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -179.029 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.411 HG12 ' O ' ' A' ' 64' ' ' THR . 1.5 p -67.97 -26.87 35.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.737 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.036 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 5.2 mmm-85 -73.14 -51.17 18.92 Favored 'General case' 0 C--N 1.362 1.151 0 O-C-N 121.549 -0.719 . . . . 0.0 110.283 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.1 mt -63.64 -36.24 83.16 Favored 'General case' 0 C--N 1.357 0.929 0 O-C-N 121.959 -0.463 . . . . 0.0 111.003 -178.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -60.85 -47.83 84.57 Favored 'General case' 0 C--N 1.349 0.575 0 O-C-N 122.155 -0.341 . . . . 0.0 110.596 -178.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.76 -38.09 94.65 Favored Glycine 0 C--N 1.355 1.592 0 N-CA-C 111.854 -0.498 . . . . 0.0 111.854 -178.188 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -63.64 -47.94 79.27 Favored 'General case' 0 C--N 1.35 0.588 0 CA-C-N 117.976 0.888 . . . . 0.0 111.508 -177.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.639 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 12.6 mttm -64.65 -48.51 74.55 Favored 'General case' 0 C--N 1.358 0.973 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -177.114 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.413 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.3 tm? -68.71 -39.2 80.56 Favored 'General case' 0 C--N 1.348 0.507 0 O-C-N 121.3 -0.875 . . . . 0.0 111.926 -175.553 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -63.22 -44.33 95.56 Favored 'General case' 0 C--N 1.354 0.766 0 O-C-N 121.068 -1.02 . . . . 0.0 111.044 -178.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.12 -15.23 18.55 Favored 'Isoleucine or valine' 0 C--N 1.359 0.982 0 O-C-N 121.509 -0.744 . . . . 0.0 109.184 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.639 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 69.5 mm-40 -71.8 -38.83 70.18 Favored 'General case' 0 C--N 1.349 0.574 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.2 mt -72.98 -32.37 65.15 Favored 'General case' 0 C--N 1.358 0.946 0 O-C-N 122.309 -0.244 . . . . 0.0 110.471 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.8 mm -64.58 -53.43 42.53 Favored 'Isoleucine or valine' 0 C--N 1.357 0.922 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.372 -177.217 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -75.39 -15.49 60.45 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 119.624 -0.831 . . . . 0.0 109.337 178.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.11 -37.06 64.0 Favored Glycine 0 C--N 1.35 1.348 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -131.33 105.73 14.69 Favored Pre-proline 0 N--CA 1.441 -0.922 0 CA-C-O 122.643 1.211 . . . . 0.0 109.321 -176.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.99 -25.88 37.91 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.614 2.209 . . . . 0.0 114.146 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -89.0 -8.26 54.41 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.2 tp -90.26 -20.56 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -178.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.41 -23.57 14.71 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -70.06 -37.42 75.51 Favored 'General case' 0 C--N 1.358 0.949 0 C-N-CA 120.264 -0.575 . . . . 0.0 109.527 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -64.9 -36.21 83.63 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.333 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 25.9 ttp -82.75 149.31 27.34 Favored 'General case' 0 C--N 1.351 0.646 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 -178.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.59 -22.27 8.17 Favored 'General case' 0 C--N 1.361 1.093 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.831 -177.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -165.25 171.76 13.23 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -177.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.418 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 41.0 t -64.3 -42.07 96.54 Favored 'General case' 0 C--N 1.357 0.921 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.08 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -66.54 -38.55 87.37 Favored 'General case' 0 C--N 1.355 0.81 0 O-C-N 121.437 -0.789 . . . . 0.0 109.493 -178.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -65.65 -25.31 67.3 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.418 ' HB3' ' O ' ' A' ' 92' ' ' SER . 57.6 tp -63.21 -46.62 86.16 Favored 'General case' 0 C--N 1.357 0.928 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.1 mp -61.78 -32.64 72.93 Favored 'General case' 0 C--N 1.356 0.862 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 36.0 t -62.87 -44.74 95.29 Favored 'General case' 0 C--N 1.354 0.762 0 O-C-N 121.931 -0.481 . . . . 0.0 111.584 -178.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.97 26.88 10.1 Favored 'General case' 0 C--N 1.364 1.225 0 O-C-N 120.939 -1.101 . . . . 0.0 111.132 -177.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 99' ' ' ILE . 8.9 tp -61.31 -30.33 47.72 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 C-N-CA 120.431 -0.507 . . . . 0.0 110.539 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -126.95 -7.78 6.05 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 118.484 -1.287 . . . . 0.0 110.005 -179.197 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 57.5 m -90.43 -3.36 57.73 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.442 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -149.0 -47.39 0.14 Allowed 'General case' 0 C--N 1.358 0.956 0 C-N-CA 118.132 -1.427 . . . . 0.0 110.043 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 96.2 mt -67.41 -47.29 81.35 Favored 'Isoleucine or valine' 0 C--N 1.354 0.802 0 O-C-N 121.926 -0.484 . . . . 0.0 110.979 -177.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -84.65 0.33 50.69 Favored 'General case' 0 C--N 1.353 0.754 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.933 -177.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 77.3 t -80.78 -45.01 21.53 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.975 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -67.45 -40.0 85.39 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.959 -179.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 64.8 t -62.96 -46.71 95.61 Favored 'Isoleucine or valine' 0 C--N 1.354 0.782 0 O-C-N 122.155 -0.341 . . . . 0.0 110.742 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -60.21 -47.85 84.2 Favored 'General case' 0 C--N 1.358 0.945 0 O-C-N 122.112 -0.367 . . . . 0.0 111.361 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -62.91 -36.18 82.53 Favored 'General case' 0 C--N 1.353 0.753 0 O-C-N 121.545 -0.722 . . . . 0.0 110.502 -178.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.5 mt -59.08 -77.22 0.04 OUTLIER 'General case' 0 C--N 1.357 0.931 0 C-N-CA 120.444 -0.503 . . . . 0.0 109.809 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.403 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 81.1 m-85 -111.13 141.76 24.95 Favored Pre-proline 0 N--CA 1.442 -0.863 0 C-N-CA 118.583 -1.247 . . . . 0.0 109.553 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 111' ' ' TYR . 51.3 Cg_endo -90.73 0.63 5.06 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 123.781 2.988 . . . . 0.0 115.216 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -86.1 4.42 38.29 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 121.63 -0.668 . . . . 0.0 109.851 -178.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -96.1 143.81 26.91 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 119.798 -0.761 . . . . 0.0 109.7 -178.017 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -119.51 141.43 49.21 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 178.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 95.6 mt -136.53 152.97 75.71 Favored Pre-proline 0 C--N 1.355 0.831 0 CA-C-O 122.198 0.999 . . . . 0.0 109.518 -178.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -87.19 -158.15 0.08 OUTLIER 'Trans proline' 0 C--N 1.32 -0.925 0 C-N-CA 123.96 3.106 . . . . 0.0 113.894 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -114.84 139.2 49.95 Favored 'General case' 0 C--N 1.368 1.38 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -125.32 127.31 46.45 Favored 'General case' 0 C--N 1.362 1.13 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -178.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.51 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 93.9 m -125.47 128.79 48.6 Favored 'General case' 0 C--N 1.357 0.912 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 177.309 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 73.7 m -119.76 128.12 53.45 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 119.323 -0.951 . . . . 0.0 109.506 -178.296 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -122.18 145.44 48.19 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 178.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.661 ' HG2' ' H ' ' A' ' 124' ' ' LEU . 35.4 ttp180 -100.33 -169.02 1.66 Allowed 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.661 ' H ' ' HG2' ' A' ' 123' ' ' ARG . 21.9 mt -165.12 -36.91 0.03 OUTLIER 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 -178.622 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -171.03 -150.89 7.27 Favored Glycine 0 C--N 1.353 1.503 0 N-CA-C 108.241 -1.944 . . . . 0.0 108.241 -178.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -94.29 -40.1 10.16 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.331 -179.059 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -97.64 3.84 50.27 Favored 'General case' 0 C--N 1.352 0.683 0 C-N-CA 120.216 -0.593 . . . . 0.0 110.276 -178.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -122.31 135.22 54.69 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 119.552 -0.859 . . . . 0.0 109.405 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.415 HD13 ' HA ' ' A' ' 129' ' ' ILE . 6.4 mm -142.11 136.9 29.94 Favored 'Isoleucine or valine' 0 C--N 1.356 0.87 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 178.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 52.3 mtm180 -114.88 138.47 50.76 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 8.3 tp -126.28 118.35 24.93 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.51 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 15.7 m-70 -98.27 134.43 41.32 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 179.212 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -130.3 121.43 26.05 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.544 ' HA ' ' O ' ' A' ' 171' ' ' THR . 75.1 mt-30 -114.15 114.69 26.39 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 19.4 t -161.52 150.41 15.95 Favored 'General case' 0 C--N 1.357 0.916 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -90.5 1.69 56.44 Favored 'General case' 0 C--N 1.355 0.805 0 C-N-CA 120.306 -0.557 . . . . 0.0 109.879 -178.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -136.78 74.57 51.37 Favored Pre-proline 0 CA--C 1.506 -0.742 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -94.11 110.6 0.18 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.657 2.238 . . . . 0.0 116.157 -177.272 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -111.56 109.7 19.74 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 176.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.4 -39.65 95.09 Favored 'General case' 0 C--N 1.355 0.811 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.518 -178.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 74.8 m -64.29 -24.93 67.83 Favored 'General case' 0 C--N 1.353 0.738 0 O-C-N 121.849 -0.532 . . . . 0.0 110.831 -178.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -76.51 -47.69 21.95 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 120.192 -0.603 . . . . 0.0 109.611 -178.015 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.1 -39.21 92.83 Favored 'General case' 0 C--N 1.357 0.93 0 O-C-N 122.115 -0.365 . . . . 0.0 111.123 -178.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -62.65 -37.29 85.77 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 121.801 -0.562 . . . . 0.0 109.77 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.27 -42.53 98.78 Favored Glycine 0 C--N 1.347 1.162 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.2 mt -70.46 -40.72 73.52 Favored 'General case' 0 C--N 1.352 0.687 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 96.3 mt -70.91 -41.97 70.54 Favored 'General case' 0 C--N 1.361 1.096 0 O-C-N 121.32 -0.862 . . . . 0.0 110.891 -177.016 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.551 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 36.8 t70 -70.33 -29.73 66.52 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 121.893 -0.504 . . . . 0.0 110.295 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -63.3 -39.43 97.83 Favored Glycine 0 C--N 1.356 1.656 0 N-CA-C 108.489 -1.844 . . . . 0.0 108.489 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 47.6 t -60.68 -42.25 96.73 Favored 'General case' 0 C--N 1.351 0.635 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -75.99 0.08 19.78 Favored 'General case' 0 C--N 1.36 1.025 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.551 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 76.5 mm-40 -84.6 -46.03 11.95 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.215 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -67.65 -43.77 79.51 Favored 'General case' 0 C--N 1.359 0.999 0 C-N-CA 120.109 -0.636 . . . . 0.0 109.559 179.02 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.467 ' O ' ' HB2' ' A' ' 155' ' ' LYS . 54.3 m-85 -70.42 -24.94 63.01 Favored 'General case' 0 C--N 1.361 1.087 0 O-C-N 121.734 -0.604 . . . . 0.0 111.311 -178.116 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 154' ' ' PHE . 47.9 mttt 73.62 67.82 0.1 Allowed 'General case' 0 C--N 1.362 1.116 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -178.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -134.16 -176.04 4.06 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -146.76 91.88 2.08 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 16.3 m-30 -113.54 157.73 21.66 Favored 'General case' 0 C--N 1.352 0.678 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 179.044 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 92.6 m -119.27 127.77 53.54 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 119.548 -0.861 . . . . 0.0 108.832 -178.32 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.554 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.2 mp -103.97 121.9 56.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.661 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 178.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.9 m -118.38 -173.69 2.52 Favored 'General case' 0 C--N 1.358 0.935 0 CA-C-O 121.661 0.743 . . . . 0.0 109.412 -178.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -146.97 157.0 43.5 Favored 'General case' 0 C--N 1.356 0.858 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 -178.43 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 49.6 p -99.64 146.37 31.7 Favored Pre-proline 0 C--N 1.358 0.974 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.685 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 73.9 Cg_endo -75.04 -12.0 21.42 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.941 2.427 . . . . 0.0 114.966 -178.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -72.63 -41.67 65.28 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.84 -178.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 37.8 p -117.21 15.5 14.92 Favored 'General case' 0 C--N 1.354 0.789 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.717 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.685 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.1 pp0? -67.59 -11.62 58.52 Favored 'General case' 0 C--N 1.354 0.796 0 O-C-N 121.569 -0.707 . . . . 0.0 110.245 178.609 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 54.4 p-10 -122.41 33.33 5.48 Favored 'General case' 0 N--CA 1.438 -1.038 0 O-C-N 121.148 -0.97 . . . . 0.0 108.707 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 57.8 m -135.67 148.37 48.9 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.634 ' O ' ' HB ' ' A' ' 171' ' ' THR . 60.8 mt-10 -100.77 166.12 11.03 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.634 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 6.9 m 83.26 -59.66 0.14 Allowed 'General case' 0 C--N 1.369 1.434 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -108.42 118.05 35.76 Favored 'General case' 0 CA--C 1.505 -0.77 0 C-N-CA 119.901 -0.72 . . . . 0.0 109.567 -178.356 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 97.2 t -131.01 132.78 63.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.916 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 178.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 49.5 mm -106.54 126.06 62.33 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -115.44 156.46 25.57 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 122.141 0.972 . . . . 0.0 108.562 -179.12 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -138.79 120.77 15.55 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -178.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.8 mp -115.06 121.12 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 89.1 m -117.96 143.26 46.52 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -177.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 30.4 ttm180 . . . . . 0 C--N 1.364 1.221 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 179.725 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.3 mmm . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 120.876 0.37 . . . . 0.0 110.17 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.52 -22.14 44.32 Favored 'General case' 0 C--N 1.356 0.854 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.059 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -76.16 -39.36 32.22 Favored Glycine 0 C--N 1.348 1.238 0 N-CA-C 109.084 -1.607 . . . . 0.0 109.084 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.4 tpp -70.63 -37.03 73.75 Favored 'General case' 0 C--N 1.353 0.725 0 O-C-N 122.297 -0.531 . . . . 0.0 110.593 -177.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.9 m -70.77 -22.46 23.24 Favored 'Isoleucine or valine' 0 C--N 1.358 0.939 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.527 ' HZ ' ' HG2' ' A' ' 47' ' ' GLU . 2.2 m-30 -69.92 -35.32 74.47 Favored 'General case' 0 C--N 1.357 0.912 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 84.9 m -67.06 -40.05 87.01 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.44 -37.86 95.35 Favored Glycine 0 C--N 1.358 1.753 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.637 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -66.96 -39.76 87.31 Favored 'General case' 0 C--N 1.352 0.681 0 CA-C-N 117.29 0.545 . . . . 0.0 110.544 -178.224 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.453 ' CE ' HD21 ' A' ' 26' ' ' LEU . 22.7 mmt -63.71 -41.16 98.14 Favored 'General case' 0 C--N 1.354 0.786 0 O-C-N 121.753 -0.592 . . . . 0.0 110.905 -178.33 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -66.38 -40.14 89.5 Favored 'General case' 0 C--N 1.349 0.572 0 O-C-N 121.989 -0.444 . . . . 0.0 111.381 -178.173 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 57.7 tp -66.43 -41.95 88.43 Favored 'General case' 0 C--N 1.35 0.608 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.637 HG12 ' O ' ' A' ' 9' ' ' LEU . 3.8 mm -73.78 -37.9 49.69 Favored 'Isoleucine or valine' 0 C--N 1.358 0.941 0 O-C-N 121.186 -0.947 . . . . 0.0 111.187 -176.082 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -69.05 -42.8 75.81 Favored 'General case' 0 C--N 1.352 0.714 0 O-C-N 121.7 -0.625 . . . . 0.0 111.236 -176.406 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -72.22 -33.24 67.43 Favored 'General case' 0 N--CA 1.446 -0.646 0 O-C-N 121.953 -0.467 . . . . 0.0 111.771 -177.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -73.02 -48.65 34.35 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -175.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -126.61 -20.33 4.36 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 117.718 -1.593 . . . . 0.0 112.367 -176.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 130.25 164.11 11.24 Favored Glycine 0 N--CA 1.437 -1.271 0 C-N-CA 118.102 -1.999 . . . . 0.0 110.809 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -67.08 -24.54 65.97 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 113.828 -1.186 . . . . 0.0 111.266 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -64.06 -44.27 92.95 Favored 'General case' 0 C--N 1.359 1.014 0 O-C-N 121.0 -1.062 . . . . 0.0 109.882 -179.098 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 94.2 m -67.24 -37.58 83.79 Favored 'General case' 0 C--N 1.352 0.717 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.454 HD13 ' HB ' ' A' ' 13' ' ' ILE . 33.3 tp -60.06 -37.59 80.32 Favored 'General case' 0 C--N 1.352 0.685 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.585 -179.267 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -66.14 -36.73 83.9 Favored 'General case' 0 C--N 1.356 0.87 0 O-C-N 122.105 -0.372 . . . . 0.0 110.704 -178.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.5 m -65.02 -40.43 94.87 Favored 'General case' 0 C--N 1.355 0.808 0 O-C-N 121.707 -0.621 . . . . 0.0 109.368 -178.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.443 HD21 HG11 ' A' ' 58' ' ' VAL . 83.2 mt -66.33 -36.32 82.63 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -179.036 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.453 HD21 ' CE ' ' A' ' 10' ' ' MET . 81.9 mt -72.41 -12.91 61.31 Favored 'General case' 0 C--N 1.36 1.042 0 O-C-N 121.819 -0.55 . . . . 0.0 110.106 -178.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -89.11 -26.23 21.45 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 119.098 -1.041 . . . . 0.0 108.971 178.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.9 t -67.76 -36.64 80.87 Favored 'General case' 0 C--N 1.358 0.936 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 178.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.636 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 1.8 p -92.92 -40.72 10.44 Favored 'General case' 0 C--N 1.359 0.985 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -179.107 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.636 ' HB2' ' O ' ' A' ' 29' ' ' CYS . 13.6 mt-10 84.94 134.71 0.05 Allowed 'General case' 0 C--N 1.361 1.089 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.007 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.493 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -85.79 -170.46 3.11 Favored 'General case' 0 C--N 1.358 0.936 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.49 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -150.99 -24.27 0.21 Allowed 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -179.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.3 t -148.84 -65.13 0.23 Allowed 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -178.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -130.73 -55.49 1.07 Allowed 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 -179.13 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 131.43 -41.21 1.54 Allowed Glycine 0 C--N 1.351 1.407 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 79.7 mt -106.84 101.67 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.57 ' O ' ' HB ' ' A' ' 38' ' ' THR . 0.8 OUTLIER -72.23 -30.05 64.53 Favored 'General case' 0 C--N 1.357 0.906 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.685 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.57 ' HB ' ' O ' ' A' ' 37' ' ' TYR . 8.0 m 114.71 -67.12 0.0 OUTLIER 'General case' 0 C--N 1.37 1.489 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.668 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.2 p 174.13 63.71 0.0 OUTLIER 'General case' 0 C--N 1.36 1.043 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -179.548 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.1 t -148.43 -5.03 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.831 0 C-N-CA 119.411 -0.916 . . . . 0.0 109.692 -178.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -98.12 143.92 16.96 Favored Glycine 0 C--N 1.352 1.428 0 C-N-CA 119.186 -1.483 . . . . 0.0 110.071 -178.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.0 m -124.07 122.61 38.33 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 178.476 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -117.14 175.86 5.4 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 -178.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -82.59 -172.04 3.83 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -90.97 -13.81 32.7 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 120.014 -0.674 . . . . 0.0 109.305 -179.049 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -70.12 -29.32 66.23 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.527 ' HG2' ' HZ ' ' A' ' 6' ' ' PHE . 25.9 tp10 -63.28 -40.33 97.08 Favored 'General case' 0 C--N 1.352 0.693 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.472 HD22 ' O ' ' A' ' 48' ' ' LEU . 1.8 tm? -67.63 -38.08 83.37 Favored 'General case' 0 C--N 1.357 0.9 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.44 ' O ' HG23 ' A' ' 53' ' ' VAL . 58.6 tp -73.9 -29.66 62.18 Favored 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 122.063 -0.398 . . . . 0.0 110.336 -176.704 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 71.6 tp60 -69.0 -40.09 78.95 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -178.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 81.3 mt -83.31 -17.17 43.42 Favored 'General case' 0 C--N 1.36 1.039 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.699 -178.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.1 t -82.25 -35.25 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 49' ' ' LEU . 55.1 t -69.07 -39.38 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.404 ' HB3' HD22 ' A' ' 25' ' ' LEU . 34.0 tptt -66.79 -32.09 73.15 Favored 'General case' 0 C--N 1.364 1.209 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -178.798 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.631 HD21 HD12 ' A' ' 13' ' ' ILE . 18.1 mt -62.78 -39.58 94.65 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.32 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.539 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 39.3 t -65.95 -36.61 83.8 Favored 'General case' 0 C--N 1.35 0.605 0 O-C-N 121.942 -0.474 . . . . 0.0 110.647 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -86.42 -37.65 18.15 Favored 'General case' 0 C--N 1.355 0.834 0 O-C-N 120.961 -1.087 . . . . 0.0 112.766 -177.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.443 HG11 HD21 ' A' ' 25' ' ' LEU . 4.9 p -75.47 -40.01 41.38 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 O-C-N 121.37 -0.831 . . . . 0.0 111.482 -176.414 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.4 t -106.5 -5.84 18.55 Favored 'General case' 0 C--N 1.352 0.69 0 C-N-CA 119.304 -0.958 . . . . 0.0 110.331 -177.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 56' ' ' SER . 72.3 m 65.29 39.91 5.11 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 56' ' ' SER . 59.4 t -114.72 124.77 29.97 Favored Pre-proline 0 CA--C 1.503 -0.831 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.93 155.33 33.73 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 122.803 2.335 . . . . 0.0 113.562 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.675 ' HA ' HD23 ' A' ' 66' ' ' LEU . 13.7 m -74.45 -12.09 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.89 -177.097 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.518 ' O ' HG12 ' A' ' 67' ' ' VAL . 72.9 p -94.2 -34.2 12.99 Favored 'General case' 0 C--N 1.357 0.905 0 C-N-CA 118.067 -1.453 . . . . 0.0 110.154 -178.537 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -80.21 -20.83 43.77 Favored 'General case' 0 C--N 1.354 0.803 0 O-C-N 121.202 -0.936 . . . . 0.0 109.13 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.675 HD23 ' HA ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -79.88 -34.43 39.19 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -179.757 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.518 HG12 ' O ' ' A' ' 64' ' ' THR . 2.4 p -69.82 -29.54 41.12 Favored 'Isoleucine or valine' 0 C--N 1.357 0.912 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.023 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -69.93 -48.1 59.78 Favored 'General case' 0 C--N 1.364 1.232 0 O-C-N 121.373 -0.83 . . . . 0.0 110.71 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.4 mt -64.36 -36.24 83.48 Favored 'General case' 0 C--N 1.355 0.828 0 O-C-N 121.949 -0.469 . . . . 0.0 110.796 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -61.08 -47.73 85.01 Favored 'General case' 0 C--N 1.35 0.593 0 O-C-N 122.212 -0.305 . . . . 0.0 110.715 -178.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.61 -38.95 96.69 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 119.817 -0.435 . . . . 0.0 112.227 -177.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -66.19 -45.35 81.1 Favored 'General case' 0 C--N 1.352 0.675 0 CA-C-N 118.441 1.121 . . . . 0.0 111.453 -176.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.731 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 6.6 mttm -64.16 -49.52 71.79 Favored 'General case' 0 C--N 1.356 0.886 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -177.284 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.47 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.5 tm? -68.12 -40.74 82.45 Favored 'General case' 0 C--N 1.349 0.568 0 O-C-N 121.358 -0.839 . . . . 0.0 112.219 -175.247 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -64.12 -44.55 91.89 Favored 'General case' 0 C--N 1.354 0.784 0 O-C-N 121.066 -1.021 . . . . 0.0 111.485 -177.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.65 -14.54 17.69 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 O-C-N 121.48 -0.762 . . . . 0.0 109.664 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.731 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 77.1 mm-40 -74.75 -37.82 62.38 Favored 'General case' 0 C--N 1.351 0.636 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 178.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 73.9 mt -67.41 -37.41 83.03 Favored 'General case' 0 C--N 1.36 1.063 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.0 mm -63.1 -50.63 78.57 Favored 'Isoleucine or valine' 0 C--N 1.356 0.857 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 -178.187 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -68.12 -20.94 64.95 Favored 'General case' 0 C--N 1.35 0.595 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.494 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -99.2 -0.97 56.99 Favored Glycine 0 N--CA 1.437 -1.256 0 C-N-CA 119.509 -1.329 . . . . 0.0 110.713 -177.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.669 ' HB3' ' HB ' ' A' ' 85' ' ' ILE . 93.4 m-70 -139.14 88.88 12.83 Favored Pre-proline 0 CA--C 1.502 -0.892 0 CA-C-N 119.113 1.456 . . . . 0.0 109.044 -179.354 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 82' ' ' HIS . 31.9 Cg_endo -65.85 -27.78 51.26 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.504 2.136 . . . . 0.0 114.556 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -95.1 -4.2 46.69 Favored 'General case' 0 CA--C 1.502 -0.895 0 C-N-CA 119.388 -0.925 . . . . 0.0 108.978 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.669 ' HB ' ' HB3' ' A' ' 82' ' ' HIS . 0.1 OUTLIER -89.0 -19.68 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 -179.575 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -104.4 -23.39 13.19 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -68.55 -36.96 79.52 Favored 'General case' 0 C--N 1.362 1.129 0 O-C-N 121.656 -0.652 . . . . 0.0 109.372 178.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -65.42 -35.12 79.99 Favored 'General case' 0 C--N 1.356 0.883 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.416 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.453 ' SD ' ' HB2' ' A' ' 95' ' ' LEU . 18.1 ttp -83.69 151.14 25.42 Favored 'General case' 0 C--N 1.352 0.715 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -178.33 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.79 -22.8 9.49 Favored 'General case' 0 C--N 1.365 1.261 0 O-C-N 121.632 -0.667 . . . . 0.0 111.258 -177.447 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -166.0 172.26 11.65 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -177.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.424 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 63.4 m -66.42 -39.73 89.15 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.506 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -67.82 -39.33 83.92 Favored 'General case' 0 C--N 1.356 0.865 0 O-C-N 121.375 -0.828 . . . . 0.0 109.093 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -65.53 -24.61 67.16 Favored 'General case' 0 C--N 1.355 0.83 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.726 ' O ' HG13 ' A' ' 99' ' ' ILE . 64.9 tp -63.65 -46.92 83.41 Favored 'General case' 0 C--N 1.353 0.732 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.365 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.468 ' HA ' ' CD1' ' A' ' 99' ' ' ILE . 2.0 mp -59.81 -36.65 77.2 Favored 'General case' 0 C--N 1.361 1.081 0 O-C-N 122.143 -0.348 . . . . 0.0 110.28 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.7 t -70.2 -39.81 74.96 Favored 'General case' 0 C--N 1.348 0.519 0 O-C-N 122.003 -0.436 . . . . 0.0 110.238 -179.079 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -87.43 2.7 49.75 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 122.136 -0.353 . . . . 0.0 111.934 -176.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.726 HG13 ' O ' ' A' ' 95' ' ' LEU . 77.3 mt -61.18 -46.9 95.72 Favored 'Isoleucine or valine' 0 C--N 1.355 0.822 0 CA-C-N 119.156 0.889 . . . . 0.0 111.967 -177.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -94.66 -23.56 17.54 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 118.52 -1.272 . . . . 0.0 111.176 -177.233 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.0 t -63.63 -50.09 70.72 Favored 'General case' 0 N--CA 1.445 -0.718 0 O-C-N 121.644 -0.66 . . . . 0.0 112.527 -177.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.51 ' HA ' HG12 ' A' ' 105' ' ' VAL . 17.5 t80 -134.68 -15.89 2.06 Favored 'General case' 0 C--N 1.361 1.071 0 C-N-CA 117.352 -1.739 . . . . 0.0 113.578 -176.66 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 29.3 mm -71.15 -51.58 33.6 Favored 'Isoleucine or valine' 0 C--O 1.245 0.847 0 CA-C-N 120.493 1.497 . . . . 0.0 110.683 -177.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.457 ' HB3' HD21 ' A' ' 116' ' ' LEU . 64.7 m170 -91.58 1.49 57.1 Favored 'General case' 0 N--CA 1.439 -1.021 0 O-C-N 121.284 -0.885 . . . . 0.0 110.348 -177.046 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.51 HG12 ' HA ' ' A' ' 102' ' ' PHE . 1.2 p -88.8 -33.45 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 178.76 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.38 -40.36 67.31 Favored 'General case' 0 CA--C 1.5 -0.957 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.362 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -72.33 -37.05 57.15 Favored 'Isoleucine or valine' 0 C--N 1.355 0.809 0 C-N-CA 119.592 -0.843 . . . . 0.0 109.89 -178.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -61.24 -49.0 78.87 Favored 'General case' 0 C--N 1.362 1.115 0 O-C-N 121.786 -0.571 . . . . 0.0 110.828 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -60.0 -37.43 79.65 Favored 'General case' 0 C--N 1.357 0.908 0 O-C-N 121.639 -0.663 . . . . 0.0 110.057 -179.176 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 14.7 mt -57.15 -75.47 0.04 OUTLIER 'General case' 0 C--N 1.356 0.866 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.417 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 90.3 m-85 -119.82 136.8 25.08 Favored Pre-proline 0 N--CA 1.441 -0.915 0 C-N-CA 119.026 -1.069 . . . . 0.0 108.733 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 111' ' ' TYR . 76.6 Cg_endo -85.28 -1.96 9.3 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 123.205 2.603 . . . . 0.0 115.345 -178.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -67.52 -36.26 80.69 Favored 'General case' 0 C--N 1.354 0.784 0 O-C-N 121.712 -0.617 . . . . 0.0 110.229 -179.075 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.34 144.42 56.97 Favored 'General case' 0 C--N 1.354 0.792 0 CA-C-O 121.647 0.737 . . . . 0.0 109.995 -178.218 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -114.54 148.08 38.49 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.462 ' HA ' ' HD3' ' A' ' 117' ' ' PRO . 1.2 mp -128.6 144.11 50.93 Favored Pre-proline 0 N--CA 1.442 -0.841 0 CA-C-O 122.143 0.973 . . . . 0.0 109.099 -178.399 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 116' ' ' LEU . 97.6 Cg_endo -87.68 -155.46 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.215 0 C-N-CA 123.738 2.959 . . . . 0.0 112.959 179.197 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -120.21 140.26 51.42 Favored 'General case' 0 C--N 1.363 1.165 0 C-N-CA 119.142 -1.023 . . . . 0.0 108.316 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -133.03 133.4 43.03 Favored 'General case' 0 C--N 1.362 1.114 0 C-N-CA 120.069 -0.653 . . . . 0.0 109.835 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.427 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 93.6 m -124.22 128.03 48.58 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 176.572 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 74.7 m -118.78 127.68 53.76 Favored 'General case' 0 CA--C 1.503 -0.848 0 C-N-CA 119.162 -1.015 . . . . 0.0 109.52 -177.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -116.9 153.14 33.09 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 178.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 57.4 ttp180 -123.72 117.17 24.34 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 95.9 mt -90.28 -16.69 28.82 Favored 'General case' 0 C--N 1.355 0.831 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.55 -179.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 174.77 -148.9 10.0 Favored Glycine 0 N--CA 1.437 -1.236 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -94.1 -37.18 11.74 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ASN . . . . . 0.455 ' HB2' ' HG2' ' A' ' 179' ' ' ARG . 41.3 p-10 -102.45 1.22 34.96 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 119.886 -0.725 . . . . 0.0 110.315 -178.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -119.8 131.57 55.36 Favored 'General case' 0 C--N 1.358 0.977 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.064 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 7.9 mm -141.29 136.25 32.58 Favored 'Isoleucine or valine' 0 C--N 1.354 0.778 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 179.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 53.5 mtm180 -116.04 139.18 50.54 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.3 tp -127.93 117.42 21.72 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.427 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 12.0 m170 -96.78 133.98 40.65 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 179.119 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -129.77 122.44 28.83 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -178.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.553 ' HA ' ' O ' ' A' ' 171' ' ' THR . 76.2 mt-30 -116.21 115.7 26.47 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.717 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 12.8 t -163.22 155.19 17.84 Favored 'General case' 0 C--N 1.36 1.023 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -91.66 2.33 56.55 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 121.821 -0.55 . . . . 0.0 109.873 -178.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 93.6 mtm-85 -135.08 74.32 63.09 Favored Pre-proline 0 CA--C 1.505 -0.771 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -95.39 105.64 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.736 2.291 . . . . 0.0 115.7 -177.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -112.41 114.1 26.63 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 176.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.89 -38.82 92.52 Favored 'General case' 0 C--N 1.355 0.805 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.242 -179.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.3 m -63.63 -27.03 68.95 Favored 'General case' 0 C--N 1.354 0.782 0 O-C-N 121.926 -0.484 . . . . 0.0 110.827 -178.315 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -76.58 -47.87 21.1 Favored 'General case' 0 N--CA 1.446 -0.642 0 O-C-N 121.763 -0.586 . . . . 0.0 109.856 -177.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.49 -39.6 94.1 Favored 'General case' 0 C--N 1.357 0.895 0 O-C-N 122.183 -0.323 . . . . 0.0 111.149 -177.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -63.27 -37.64 88.04 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 121.907 -0.495 . . . . 0.0 109.927 -179.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.03 -42.91 98.6 Favored Glycine 0 C--N 1.348 1.217 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 -179.199 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 83.6 mt -70.06 -40.84 74.85 Favored 'General case' 0 C--N 1.353 0.747 0 CA-C-N 117.774 0.787 . . . . 0.0 112.549 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 97.7 mt -71.03 -42.07 70.01 Favored 'General case' 0 C--N 1.36 1.061 0 O-C-N 121.271 -0.893 . . . . 0.0 110.551 -176.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.479 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 21.5 t70 -69.17 -32.09 71.17 Favored 'General case' 0 N--CA 1.445 -0.723 0 O-C-N 122.211 -0.306 . . . . 0.0 110.505 -179.213 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -63.04 -39.85 98.55 Favored Glycine 0 C--N 1.357 1.707 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' CYS . . . . . 0.42 ' SG ' HD22 ' A' ' 95' ' ' LEU . 49.5 t -61.14 -42.11 97.95 Favored 'General case' 0 C--N 1.35 0.594 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.665 ' HB1' ' O ' ' A' ' 156' ' ' GLU . . . -73.84 -2.39 23.48 Favored 'General case' 0 C--N 1.359 1.001 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.479 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 74.5 mm-40 -83.17 -45.96 13.29 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.052 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 92.9 t80 -65.89 -45.06 83.4 Favored 'General case' 0 C--N 1.359 1.008 0 C-N-CA 120.154 -0.619 . . . . 0.0 109.609 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -68.88 -26.4 65.1 Favored 'General case' 0 C--N 1.363 1.158 0 O-C-N 121.716 -0.615 . . . . 0.0 111.023 -178.182 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 78.2 tttt 74.39 71.95 0.11 Allowed 'General case' 0 C--N 1.361 1.072 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.665 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 5.4 tp10 -161.34 125.24 3.35 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 178.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -87.25 108.35 18.9 Favored 'General case' 0 C--N 1.354 0.788 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.339 -179.078 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 9.3 m-30 -107.37 163.89 12.65 Favored 'General case' 0 C--N 1.353 0.734 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 177.091 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 95.5 m -121.37 129.21 52.92 Favored 'General case' 0 C--N 1.354 0.802 0 C-N-CA 118.972 -1.091 . . . . 0.0 109.41 -178.116 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.509 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.6 mp -110.5 122.12 64.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 178.349 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.7 m -119.12 -171.87 2.19 Favored 'General case' 0 C--N 1.357 0.916 0 CA-C-O 121.674 0.75 . . . . 0.0 109.245 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.11 159.29 44.53 Favored 'General case' 0 C--N 1.357 0.913 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 -178.371 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 64.6 p -100.72 146.83 32.76 Favored Pre-proline 0 C--N 1.359 1.012 0 CA-C-O 122.471 1.129 . . . . 0.0 108.298 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.641 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 73.5 Cg_endo -76.22 -11.49 19.32 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.957 2.438 . . . . 0.0 115.193 -178.78 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -72.11 -41.44 67.24 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 119.936 -0.705 . . . . 0.0 109.42 -178.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 31.4 p -116.73 16.5 15.34 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 120.159 -0.616 . . . . 0.0 110.323 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.641 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.2 pp0? -66.73 -10.29 45.49 Favored 'General case' 0 C--N 1.354 0.796 0 O-C-N 121.642 -0.661 . . . . 0.0 110.45 178.75 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -128.02 38.69 3.97 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 74.8 m -136.54 146.34 46.07 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.675 ' O ' ' HB ' ' A' ' 171' ' ' THR . 59.2 mp0 -99.61 162.55 12.95 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.675 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 1.5 m 84.53 -57.72 0.11 Allowed 'General case' 0 C--N 1.369 1.455 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.566 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -109.67 118.38 36.4 Favored 'General case' 0 CA--C 1.505 -0.75 0 C-N-CA 119.798 -0.761 . . . . 0.0 109.789 -178.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 97.5 t -132.4 132.32 60.42 Favored 'Isoleucine or valine' 0 C--N 1.36 1.065 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 178.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 50.3 mm -105.31 127.46 60.03 Favored 'Isoleucine or valine' 0 C--N 1.356 0.89 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -116.31 153.82 31.29 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -136.73 119.36 16.02 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -178.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.0 mp -114.21 119.06 60.29 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 -179.148 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 88.4 m -126.62 140.76 52.18 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -177.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.455 ' HG2' ' HB2' ' A' ' 127' ' ' ASN . 39.7 ptt180 . . . . . 0 C--N 1.366 1.285 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 179.073 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.415 ' HB2' ' HB2' ' A' ' 4' ' ' MET . 2.3 mmm . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 120.943 0.401 . . . . 0.0 110.07 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.426 ' HA ' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -80.63 -18.72 47.25 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 120.161 -0.616 . . . . 0.0 109.353 -179.043 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.11 -40.92 49.35 Favored Glycine 0 C--N 1.353 1.497 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' MET . . . . . 0.415 ' HB2' ' HB2' ' A' ' 1' ' ' MET . 4.9 mtm -70.39 -36.33 74.04 Favored 'General case' 0 C--N 1.36 1.044 0 O-C-N 121.836 -0.802 . . . . 0.0 111.335 -178.147 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.426 HG22 ' HA ' ' A' ' 2' ' ' MET . 34.6 m -69.4 -22.95 25.97 Favored 'Isoleucine or valine' 0 C--N 1.356 0.872 0 O-C-N 121.555 -0.715 . . . . 0.0 109.366 -178.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -71.05 -35.85 72.1 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 85.4 m -67.07 -41.37 86.51 Favored 'General case' 0 C--N 1.356 0.881 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.62 -39.01 97.36 Favored Glycine 0 C--N 1.359 1.81 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.712 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -64.99 -40.37 94.86 Favored 'General case' 0 C--N 1.351 0.658 0 CA-C-N 117.3 0.55 . . . . 0.0 110.731 -178.471 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 10' ' ' MET . . . . . 0.46 ' CE ' HD21 ' A' ' 26' ' ' LEU . 21.1 mmt -63.47 -40.68 97.76 Favored 'General case' 0 C--N 1.351 0.665 0 O-C-N 121.606 -0.684 . . . . 0.0 110.981 -178.203 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -67.23 -41.71 85.21 Favored 'General case' 0 C--N 1.35 0.611 0 O-C-N 121.859 -0.526 . . . . 0.0 111.691 -178.13 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 59.6 tp -65.61 -43.39 89.77 Favored 'General case' 0 C--N 1.35 0.598 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -178.098 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.712 HG12 ' O ' ' A' ' 9' ' ' LEU . 2.4 mm -72.92 -36.9 52.83 Favored 'Isoleucine or valine' 0 C--N 1.356 0.883 0 O-C-N 121.167 -0.958 . . . . 0.0 111.091 -175.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -65.99 -43.31 88.14 Favored 'General case' 0 C--N 1.352 0.688 0 O-C-N 121.746 -0.596 . . . . 0.0 111.663 -176.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -73.67 -37.27 65.31 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 121.773 -0.579 . . . . 0.0 112.279 -176.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -71.9 -41.64 67.72 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -175.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -129.9 -27.1 2.34 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 117.43 -1.708 . . . . 0.0 113.358 -177.172 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 148.19 -179.94 24.65 Favored Glycine 0 C--N 1.346 1.115 0 C-N-CA 117.499 -2.286 . . . . 0.0 110.664 -179.116 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 93.4 t80 -98.05 -20.41 17.39 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -177.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -70.27 -40.16 74.51 Favored 'General case' 0 C--N 1.361 1.085 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.471 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.3 m -68.35 -38.15 81.19 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.404 HD13 ' HB ' ' A' ' 13' ' ' ILE . 31.6 tp -59.97 -37.6 80.1 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -66.22 -35.18 79.77 Favored 'General case' 0 C--N 1.359 0.989 0 O-C-N 121.989 -0.444 . . . . 0.0 110.81 -178.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.8 m -64.86 -39.26 93.27 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -178.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.662 HD13 HD22 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -62.83 -38.12 89.48 Favored 'General case' 0 C--N 1.352 0.696 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 -179.266 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.46 HD21 ' CE ' ' A' ' 10' ' ' MET . 80.4 mt -74.52 -12.89 60.59 Favored 'General case' 0 C--N 1.358 0.947 0 O-C-N 121.768 -0.582 . . . . 0.0 110.746 -178.554 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -87.71 -27.11 22.6 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 119.1 -1.04 . . . . 0.0 108.929 178.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.9 t -67.15 -37.36 83.66 Favored 'General case' 0 C--N 1.357 0.905 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.621 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 2.0 p -93.25 -37.72 11.91 Favored 'General case' 0 C--N 1.358 0.935 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.621 ' HB2' ' O ' ' A' ' 29' ' ' CYS . 9.9 mt-10 85.37 133.57 0.05 OUTLIER 'General case' 0 C--N 1.359 0.979 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.491 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -85.37 -169.9 2.87 Favored 'General case' 0 C--N 1.358 0.954 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -150.84 -26.49 0.22 Allowed 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -179.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.7 t -146.65 -66.97 0.28 Allowed 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -178.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -130.33 -50.65 1.09 Allowed 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -178.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 127.86 -40.08 1.8 Allowed Glycine 0 C--N 1.351 1.382 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 86.4 mt -110.01 101.71 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.86 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -100.33 1.63 41.74 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.786 HG22 ' H ' ' A' ' 39' ' ' SER . 1.7 m 74.46 -176.56 0.15 Allowed 'General case' 0 C--N 1.362 1.144 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 -178.447 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.786 ' H ' HG22 ' A' ' 38' ' ' THR . 28.1 p -87.99 104.69 16.87 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 121.184 -0.948 . . . . 0.0 108.788 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.426 HG12 ' O ' ' A' ' 40' ' ' VAL . 61.4 t -152.99 -21.29 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.361 1.1 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.402 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.76 171.59 13.86 Favored Glycine 0 C--N 1.357 1.696 0 C-N-CA 119.049 -1.548 . . . . 0.0 110.162 -176.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 59.2 m -131.29 136.05 47.83 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -121.31 175.42 6.15 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -78.48 -176.17 4.65 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.522 ' CE1' HH12 ' A' ' 137' ' ' ARG . 81.7 m-70 -94.15 -15.13 24.94 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.441 -178.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -68.86 -27.78 66.13 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 177.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.2 tp10 -62.62 -40.32 96.59 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.247 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -68.93 -38.65 79.65 Favored 'General case' 0 C--N 1.357 0.933 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 59.2 tp -70.39 -35.05 73.24 Favored 'General case' 0 CA--C 1.506 -0.712 0 O-C-N 122.099 -0.376 . . . . 0.0 110.14 -176.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 71.7 tp60 -66.6 -39.94 88.63 Favored 'General case' 0 N--CA 1.443 -0.781 0 O-C-N 121.873 -0.517 . . . . 0.0 109.779 -178.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.662 HD22 HD13 ' A' ' 25' ' ' LEU . 68.3 mt -80.68 -18.01 49.32 Favored 'General case' 0 C--N 1.363 1.171 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.301 -179.017 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -80.35 -34.81 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 54.3 t -70.17 -40.48 78.22 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.419 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 33.5 tptt -65.75 -27.6 68.42 Favored 'General case' 0 C--N 1.364 1.226 0 O-C-N 121.231 -0.918 . . . . 0.0 108.737 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.422 ' O ' HD23 ' A' ' 55' ' ' LEU . 1.5 tt -68.5 -37.37 80.01 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.7 p -72.07 -18.72 61.91 Favored 'General case' 0 C--N 1.359 0.992 0 O-C-N 121.439 -0.788 . . . . 0.0 110.704 -178.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -99.89 -36.4 9.43 Favored 'General case' 0 C--N 1.353 0.738 0 O-C-N 121.3 -0.875 . . . . 0.0 111.424 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.7 p -72.94 -36.52 51.76 Favored 'Isoleucine or valine' 0 C--N 1.35 0.62 0 O-C-N 121.717 -0.614 . . . . 0.0 111.294 -177.051 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 74.7 m -114.09 -6.68 13.09 Favored 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 119.35 -0.94 . . . . 0.0 109.936 -178.051 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 64.31 50.31 2.35 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.615 HG13 ' HD2' ' A' ' 62' ' ' PRO . 56.1 t -113.81 136.14 22.05 Favored Pre-proline 0 CA--C 1.505 -0.778 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.688 ' HG2' ' HB2' ' A' ' 65' ' ' GLU . 23.3 Cg_endo -62.36 149.22 91.58 Favored 'Trans proline' 0 CA--C 1.5 -1.192 0 C-N-CA 122.226 1.95 . . . . 0.0 112.391 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.5 m -75.83 -14.16 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.344 -177.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.467 ' O ' HG12 ' A' ' 67' ' ' VAL . 68.7 p -94.71 -34.65 12.47 Favored 'General case' 0 C--N 1.358 0.939 0 C-N-CA 118.347 -1.341 . . . . 0.0 109.722 -178.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.688 ' HB2' ' HG2' ' A' ' 62' ' ' PRO . 97.7 mt-10 -78.32 -20.48 51.34 Favored 'General case' 0 C--N 1.354 0.768 0 O-C-N 121.31 -0.869 . . . . 0.0 109.075 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.404 ' HB3' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -79.7 -37.67 35.19 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -179.624 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.467 HG12 ' O ' ' A' ' 64' ' ' THR . 1.8 p -67.92 -25.82 33.25 Favored 'Isoleucine or valine' 0 C--N 1.354 0.8 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.812 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 9.3 mtp180 -72.61 -53.17 12.61 Favored 'General case' 0 C--N 1.364 1.216 0 O-C-N 121.467 -0.771 . . . . 0.0 110.532 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 92.3 mt -63.07 -34.81 78.39 Favored 'General case' 0 C--N 1.357 0.927 0 O-C-N 121.933 -0.479 . . . . 0.0 111.031 -178.205 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -60.69 -47.34 86.72 Favored 'General case' 0 C--N 1.348 0.519 0 O-C-N 122.138 -0.351 . . . . 0.0 110.244 -178.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.44 -38.31 94.6 Favored Glycine 0 C--N 1.357 1.696 0 N-CA-C 111.766 -0.534 . . . . 0.0 111.766 -178.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.19 -49.04 75.81 Favored 'General case' 0 C--N 1.352 0.696 0 CA-C-N 118.264 1.032 . . . . 0.0 111.821 -177.237 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.542 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 8.4 mttm -64.26 -47.86 77.96 Favored 'General case' 0 C--N 1.358 0.948 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -177.159 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -68.66 -39.06 80.84 Favored 'General case' 0 C--N 1.35 0.624 0 O-C-N 121.055 -1.028 . . . . 0.0 111.92 -175.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -65.36 -43.23 91.45 Favored 'General case' 0 C--N 1.356 0.855 0 O-C-N 121.126 -0.984 . . . . 0.0 111.46 -177.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -72.16 -12.68 16.05 Favored 'Isoleucine or valine' 0 C--N 1.359 1.004 0 O-C-N 121.149 -0.969 . . . . 0.0 109.266 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.542 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 70.1 mm-40 -81.33 -29.78 34.06 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.183 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 73.3 mt -72.9 -34.69 66.81 Favored 'General case' 0 C--N 1.358 0.946 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.7 mm -64.63 -50.75 74.27 Favored 'Isoleucine or valine' 0 C--N 1.357 0.91 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -178.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -69.42 -28.29 66.01 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -66.68 -34.15 86.56 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -178.087 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.442 ' HA ' ' HD2' ' A' ' 83' ' ' PRO . 96.7 m-70 -135.7 101.34 10.76 Favored Pre-proline 0 CA--C 1.501 -0.91 0 CA-C-N 118.511 1.155 . . . . 0.0 109.372 -176.648 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' A' ' 82' ' ' HIS . 34.7 Cg_endo -66.85 -22.52 49.03 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.416 2.077 . . . . 0.0 113.607 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.425 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 42.5 mt-10 -91.87 -6.14 52.05 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.403 HG22 ' O ' ' A' ' 82' ' ' HIS . 1.6 tp -90.32 -19.65 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.23 -26.09 14.04 Favored 'General case' 0 C--N 1.361 1.084 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -70.75 -34.73 72.15 Favored 'General case' 0 C--N 1.356 0.875 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.425 ' HG2' ' O ' ' A' ' 84' ' ' GLU . 78.2 mm-40 -65.49 -36.25 83.28 Favored 'General case' 0 C--N 1.357 0.919 0 O-C-N 122.023 -0.423 . . . . 0.0 110.254 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.427 ' SD ' ' HB2' ' A' ' 95' ' ' LEU . 16.6 ttp -83.12 153.04 25.03 Favored 'General case' 0 C--N 1.353 0.743 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -178.509 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.96 -24.13 7.2 Favored 'General case' 0 C--N 1.365 1.253 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.352 -176.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -164.63 170.57 15.54 Favored 'General case' 0 C--N 1.354 0.802 0 C-N-CA 119.098 -1.041 . . . . 0.0 108.344 -177.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 39.7 t -64.01 -43.4 95.76 Favored 'General case' 0 C--N 1.357 0.899 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.489 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -66.33 -39.61 89.36 Favored 'General case' 0 C--N 1.355 0.816 0 O-C-N 121.366 -0.834 . . . . 0.0 109.255 -178.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -65.09 -25.73 67.92 Favored 'General case' 0 C--N 1.353 0.76 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.205 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.602 ' O ' HG13 ' A' ' 99' ' ' ILE . 61.8 tp -63.37 -46.46 86.39 Favored 'General case' 0 C--N 1.356 0.867 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.43 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.2 mp -59.54 -34.79 73.1 Favored 'General case' 0 C--N 1.357 0.917 0 O-C-N 122.177 -0.327 . . . . 0.0 110.591 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.4 t -69.88 -39.28 76.4 Favored 'General case' 0 C--N 1.348 0.538 0 O-C-N 121.917 -0.49 . . . . 0.0 109.944 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -90.97 4.11 52.88 Favored 'General case' 0 C--N 1.352 0.712 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -176.064 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.602 HG13 ' O ' ' A' ' 95' ' ' LEU . 77.6 mt -61.62 -47.29 94.01 Favored 'Isoleucine or valine' 0 C--N 1.358 0.977 0 CA-C-N 119.657 1.117 . . . . 0.0 111.9 -177.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -98.49 -22.46 16.0 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 118.408 -1.317 . . . . 0.0 111.285 -176.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 33.4 t -65.69 -47.01 76.9 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 121.684 -0.635 . . . . 0.0 111.951 -177.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -132.26 -23.04 2.19 Favored 'General case' 0 C--N 1.361 1.079 0 C-N-CA 117.763 -1.575 . . . . 0.0 113.056 -176.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 31.1 mm -69.21 -50.03 56.23 Favored 'Isoleucine or valine' 0 C--N 1.354 0.785 0 CA-C-N 120.001 1.273 . . . . 0.0 110.57 -177.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 54.8 m170 -90.12 3.8 52.29 Favored 'General case' 0 N--CA 1.439 -0.976 0 O-C-N 121.311 -0.868 . . . . 0.0 110.444 -177.018 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.3 p -89.35 -34.01 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 178.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -72.54 -40.03 67.06 Favored 'General case' 0 C--N 1.36 1.065 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 73.4 t -63.09 -46.35 96.32 Favored 'Isoleucine or valine' 0 C--N 1.355 0.846 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 93.2 t80 -60.6 -48.76 80.34 Favored 'General case' 0 C--N 1.361 1.089 0 O-C-N 122.064 -0.397 . . . . 0.0 111.428 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -60.9 -37.1 81.07 Favored 'General case' 0 C--N 1.356 0.864 0 O-C-N 121.556 -0.715 . . . . 0.0 110.604 -178.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 110' ' ' LEU . 17.9 mt -58.17 -73.83 0.07 Allowed 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -121.67 134.75 24.71 Favored Pre-proline 0 N--CA 1.439 -1.023 0 C-N-CA 118.37 -1.332 . . . . 0.0 108.773 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -84.51 -1.12 9.59 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 123.25 2.634 . . . . 0.0 115.052 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -66.75 -36.03 81.48 Favored 'General case' 0 C--N 1.354 0.795 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.13 145.39 56.35 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 121.649 0.738 . . . . 0.0 110.146 -178.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -126.95 134.31 50.44 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 179.232 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.453 ' HB3' ' HD2' ' A' ' 117' ' ' PRO . 84.4 mt -126.81 155.33 75.48 Favored Pre-proline 0 N--CA 1.442 -0.833 0 CA-C-O 122.184 0.992 . . . . 0.0 109.087 -178.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.453 ' HD2' ' HB3' ' A' ' 116' ' ' LEU . 87.7 Cg_endo -85.1 -152.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.125 0 C-N-CA 123.887 3.058 . . . . 0.0 114.543 -178.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -112.64 148.67 34.13 Favored 'General case' 0 C--N 1.368 1.38 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -179.175 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.642 ' CZ ' HD13 ' A' ' 131' ' ' LEU . 8.3 t80 -142.5 125.06 15.76 Favored 'General case' 0 C--N 1.361 1.066 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -177.742 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 95.8 m -126.44 133.62 51.19 Favored 'General case' 0 C--N 1.361 1.068 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 85.0 m -117.63 132.16 56.54 Favored 'General case' 0 C--N 1.358 0.946 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.732 -178.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -120.43 125.05 46.97 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 177.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -101.61 117.3 34.61 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.485 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 94.5 mt -84.98 -25.64 27.63 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.502 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -179.1 -142.6 4.98 Favored Glycine 0 C--N 1.349 1.257 0 C-N-CA 118.898 -1.62 . . . . 0.0 109.082 -178.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -94.1 -41.1 9.7 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 119.928 -0.709 . . . . 0.0 109.616 -178.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -102.18 3.49 38.46 Favored 'General case' 0 C--N 1.352 0.712 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.446 -178.192 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.485 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 67.4 m-20 -118.01 128.95 55.28 Favored 'General case' 0 C--N 1.356 0.885 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 10.6 mm -140.88 133.79 31.33 Favored 'Isoleucine or valine' 0 C--N 1.357 0.935 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 62.3 mtm180 -121.34 140.84 51.58 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.777 HD23 HD11 ' A' ' 177' ' ' ILE . 0.3 OUTLIER -129.79 128.03 41.55 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.679 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -99.08 131.28 45.24 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -126.24 120.99 31.43 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -178.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.468 ' HA ' ' O ' ' A' ' 171' ' ' THR . 27.5 tt0 -114.88 110.23 19.35 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 171' ' ' THR . 11.6 t -162.95 154.37 17.53 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -87.93 9.2 22.94 Favored 'General case' 0 C--N 1.355 0.836 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ARG . . . . . 0.522 HH12 ' CE1' ' A' ' 45' ' ' HIS . 78.3 mtp180 -129.46 78.28 75.92 Favored Pre-proline 0 N--CA 1.443 -0.777 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -91.98 86.61 0.24 Allowed 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.663 2.242 . . . . 0.0 115.556 -178.158 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -111.7 109.71 19.71 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 177.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -70.4 -30.73 67.69 Favored 'General case' 0 C--N 1.354 0.792 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.3 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.4 m -62.88 -34.22 76.93 Favored 'General case' 0 C--N 1.352 0.697 0 O-C-N 122.001 -0.437 . . . . 0.0 109.95 -179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -74.35 -44.59 51.7 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 120.434 -0.506 . . . . 0.0 109.732 -177.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.55 -40.39 95.49 Favored 'General case' 0 C--N 1.357 0.902 0 O-C-N 122.067 -0.395 . . . . 0.0 111.254 -177.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.87 -37.02 85.84 Favored 'General case' 0 CA--C 1.506 -0.736 0 O-C-N 122.012 -0.43 . . . . 0.0 110.187 -179.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.49 -43.71 98.5 Favored Glycine 0 C--N 1.347 1.161 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -178.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 82.8 mt -69.9 -40.49 75.58 Favored 'General case' 0 C--N 1.35 0.612 0 O-C-N 122.108 -0.642 . . . . 0.0 112.507 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 96.7 mt -71.75 -43.16 66.28 Favored 'General case' 0 C--N 1.361 1.103 0 O-C-N 121.215 -0.928 . . . . 0.0 111.032 -176.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.584 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 37.3 t70 -71.01 -31.46 67.98 Favored 'General case' 0 N--CA 1.447 -0.604 0 O-C-N 122.1 -0.375 . . . . 0.0 110.634 -178.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -62.77 -39.89 98.52 Favored Glycine 0 C--N 1.358 1.76 0 N-CA-C 108.512 -1.835 . . . . 0.0 108.512 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 48.8 t -60.71 -41.61 95.57 Favored 'General case' 0 C--N 1.35 0.591 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.425 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -76.83 2.05 15.64 Favored 'General case' 0 C--N 1.361 1.079 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.584 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 77.3 mm-40 -86.0 -46.16 10.78 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -66.16 -45.18 81.82 Favored 'General case' 0 C--N 1.361 1.102 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -69.54 -26.61 64.58 Favored 'General case' 0 C--N 1.362 1.124 0 O-C-N 121.842 -0.536 . . . . 0.0 110.793 -178.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 84.7 tttt 71.65 77.7 0.17 Allowed 'General case' 0 C--N 1.358 0.95 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.28 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -141.38 -170.66 3.13 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 179.201 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -145.96 93.5 2.34 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 13.5 m-30 -113.52 155.93 24.49 Favored 'General case' 0 CA--C 1.504 -0.802 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 178.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 95.5 m -120.2 127.54 52.54 Favored 'General case' 0 C--N 1.356 0.856 0 C-N-CA 119.392 -0.923 . . . . 0.0 108.979 -178.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.501 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.7 mp -100.99 121.3 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 178.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.12 -176.44 2.9 Favored 'General case' 0 C--N 1.365 1.245 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 28.8 ptt180 -146.95 154.46 41.29 Favored 'General case' 0 C--N 1.359 0.98 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -179.009 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 35.1 p -97.69 146.56 31.64 Favored Pre-proline 0 C--N 1.36 1.06 0 CA-C-O 122.448 1.118 . . . . 0.0 108.046 178.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.659 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 72.1 Cg_endo -75.03 -12.49 21.45 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 123.055 2.504 . . . . 0.0 114.923 -178.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -72.21 -41.21 67.15 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.84 -178.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 26.8 p -118.6 16.45 13.69 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 119.824 -0.75 . . . . 0.0 110.829 -178.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.659 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.2 pp0? -67.15 -14.37 62.84 Favored 'General case' 0 C--N 1.352 0.707 0 O-C-N 121.563 -0.71 . . . . 0.0 110.121 178.448 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -124.28 38.81 4.11 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 22.0 t -138.49 143.37 39.55 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 107.165 -1.421 . . . . 0.0 107.165 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.644 ' O ' ' HB ' ' A' ' 171' ' ' THR . 60.5 mt-10 -96.77 163.63 12.91 Favored 'General case' 0 C--N 1.354 0.776 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.199 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.644 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 2.7 m 81.91 -57.49 0.23 Allowed 'General case' 0 C--N 1.374 1.645 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.906 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -105.63 117.76 34.85 Favored 'General case' 0 CA--C 1.504 -0.813 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.567 -178.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 89.0 t -132.57 134.21 58.98 Favored 'Isoleucine or valine' 0 C--N 1.357 0.928 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.685 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 48.5 mm -115.22 127.73 72.68 Favored 'Isoleucine or valine' 0 C--N 1.361 1.07 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -116.2 146.33 42.4 Favored 'General case' 0 C--N 1.359 1.021 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.341 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -125.53 84.05 2.23 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.193 -178.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' ILE . . . . . 0.777 HD11 HD23 ' A' ' 131' ' ' LEU . 3.6 mp -77.1 117.99 22.98 Favored 'Isoleucine or valine' 0 C--N 1.363 1.167 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 90.1 m -128.35 144.41 51.13 Favored 'General case' 0 C--N 1.356 0.885 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -178.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 59.3 mtm180 . . . . . 0 C--N 1.371 1.539 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.499 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.4 mtm . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 121.252 0.548 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.401 ' HA ' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -83.99 -13.5 53.14 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -179.442 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.0 -39.32 38.18 Favored Glycine 0 C--N 1.353 1.49 0 N-CA-C 108.641 -1.783 . . . . 0.0 108.641 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.7 tpp -71.6 -36.69 70.9 Favored 'General case' 0 C--N 1.359 0.982 0 O-C-N 121.92 -0.753 . . . . 0.0 110.767 -177.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.401 HG22 ' HA ' ' A' ' 2' ' ' MET . 35.5 m -69.81 -22.76 25.12 Favored 'Isoleucine or valine' 0 C--N 1.357 0.908 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.446 ' HZ ' ' HG2' ' A' ' 47' ' ' GLU . 1.8 m-30 -70.4 -35.57 73.54 Favored 'General case' 0 C--N 1.357 0.922 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.244 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 85.3 m -67.38 -40.61 85.71 Favored 'General case' 0 C--N 1.355 0.847 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.34 -38.81 96.87 Favored Glycine 0 C--N 1.358 1.75 0 N-CA-C 110.541 -1.023 . . . . 0.0 110.541 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.648 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -66.96 -39.42 87.24 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 122.297 -0.531 . . . . 0.0 110.674 -178.198 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 20.9 mmt -63.91 -41.01 97.78 Favored 'General case' 0 C--N 1.354 0.78 0 O-C-N 121.602 -0.686 . . . . 0.0 110.979 -178.36 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -67.43 -40.76 85.5 Favored 'General case' 0 C--N 1.349 0.554 0 O-C-N 121.929 -0.482 . . . . 0.0 111.857 -177.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 54.7 tp -65.52 -42.83 91.58 Favored 'General case' 0 C--N 1.349 0.571 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -178.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.648 HG12 ' O ' ' A' ' 9' ' ' LEU . 1.2 mm -76.42 -35.74 27.4 Favored 'Isoleucine or valine' 0 C--N 1.358 0.951 0 O-C-N 120.957 -1.09 . . . . 0.0 111.041 -175.385 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -67.98 -43.38 79.1 Favored 'General case' 0 C--N 1.352 0.677 0 O-C-N 121.766 -0.584 . . . . 0.0 111.173 -176.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -72.64 -33.71 66.81 Favored 'General case' 0 N--CA 1.448 -0.566 0 O-C-N 121.98 -0.45 . . . . 0.0 111.658 -177.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -71.57 -47.88 52.02 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -175.13 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -127.89 -19.18 4.09 Favored 'General case' 0 C--N 1.355 0.834 0 C-N-CA 117.417 -1.713 . . . . 0.0 113.496 -176.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 139.99 178.92 17.32 Favored Glycine 0 N--CA 1.44 -1.053 0 C-N-CA 117.923 -2.084 . . . . 0.0 109.862 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -95.99 -12.4 25.05 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -177.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -70.69 -40.48 72.87 Favored 'General case' 0 C--N 1.359 0.997 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.8 m -69.09 -39.25 79.13 Favored 'General case' 0 C--N 1.357 0.907 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 53.4 tp -62.59 -37.83 87.76 Favored 'General case' 0 C--N 1.357 0.934 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -62.97 -37.42 87.06 Favored 'General case' 0 C--N 1.358 0.955 0 O-C-N 121.968 -0.458 . . . . 0.0 110.997 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.6 m -65.6 -38.22 88.86 Favored 'General case' 0 C--N 1.353 0.735 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.443 ' HG ' HD22 ' A' ' 51' ' ' LEU . 21.8 tp -62.53 -39.49 93.74 Favored 'General case' 0 C--N 1.353 0.735 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.281 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 85.6 mt -72.95 -13.85 61.33 Favored 'General case' 0 C--N 1.359 0.997 0 O-C-N 121.92 -0.488 . . . . 0.0 110.579 -178.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -86.93 -28.77 22.55 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 119.312 -0.955 . . . . 0.0 109.368 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.0 t -67.25 -37.01 82.82 Favored 'General case' 0 C--N 1.355 0.839 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.1 p -91.63 -39.5 11.84 Favored 'General case' 0 C--N 1.357 0.924 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -179.193 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 86.06 132.85 0.04 OUTLIER 'General case' 0 C--N 1.36 1.052 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.51 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -86.91 -169.55 2.68 Favored 'General case' 0 C--N 1.357 0.9 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -179.884 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.416 ' H ' ' H ' ' A' ' 33' ' ' SER . 62.5 tt0 -152.26 -24.92 0.17 Allowed 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.416 ' H ' ' H ' ' A' ' 32' ' ' GLN . 1.8 t -145.22 -69.51 0.28 Allowed 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -179.063 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -131.05 -50.24 1.02 Allowed 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -178.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 130.41 -37.31 2.15 Favored Glycine 0 C--N 1.353 1.475 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 83.0 mt -110.0 100.75 11.41 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -95.65 -4.78 43.77 Favored 'General case' 0 C--N 1.354 0.801 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.351 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.76 HG22 ' H ' ' A' ' 39' ' ' SER . 5.2 m 82.43 174.84 0.09 Allowed 'General case' 0 C--N 1.362 1.118 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 -178.534 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.76 ' H ' HG22 ' A' ' 38' ' ' THR . 41.1 p -89.38 114.89 26.38 Favored 'General case' 0 N--CA 1.443 -0.791 0 O-C-N 121.041 -1.037 . . . . 0.0 109.855 -178.042 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.46 HG13 ' O ' ' A' ' 39' ' ' SER . 0.0 OUTLIER -172.92 -3.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.218 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.795 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -98.26 -136.74 9.38 Favored Glycine 0 C--N 1.357 1.735 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -178.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 164.47 98.97 0.0 OUTLIER 'General case' 0 C--N 1.362 1.132 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 -178.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -98.11 176.87 5.59 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.71 -174.61 4.42 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.566 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -91.1 -15.89 28.72 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 120.011 -0.676 . . . . 0.0 109.29 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -70.31 -29.32 66.03 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.446 ' HG2' ' HZ ' ' A' ' 6' ' ' PHE . 33.1 tp10 -63.69 -41.64 98.1 Favored 'General case' 0 C--N 1.354 0.769 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.494 ' O ' HG23 ' A' ' 52' ' ' VAL . 54.5 tp -67.24 -38.36 85.06 Favored 'General case' 0 C--N 1.354 0.782 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.197 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 60.6 tp -76.49 -28.04 56.3 Favored 'General case' 0 C--N 1.349 0.583 0 O-C-N 122.029 -0.419 . . . . 0.0 110.647 -177.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 71.5 tp60 -68.2 -42.6 79.64 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 121.509 -0.745 . . . . 0.0 109.615 -178.122 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.443 HD22 ' HG ' ' A' ' 25' ' ' LEU . 57.5 mt -72.8 -33.8 66.47 Favored 'General case' 0 C--N 1.363 1.18 0 C-N-CA 119.679 -0.809 . . . . 0.0 109.48 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 48' ' ' LEU . 38.7 t -62.61 -41.47 92.26 Favored 'Isoleucine or valine' 0 C--N 1.35 0.59 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 51.3 t -68.1 -40.61 83.3 Favored 'Isoleucine or valine' 0 C--N 1.351 0.668 0 O-C-N 121.716 -0.615 . . . . 0.0 109.809 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 31.7 tptt -66.84 -26.08 66.74 Favored 'General case' 0 C--N 1.359 1.007 0 O-C-N 121.131 -0.98 . . . . 0.0 108.768 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.408 ' O ' HD23 ' A' ' 55' ' ' LEU . 2.2 tt -69.09 -37.5 78.46 Favored 'General case' 0 C--N 1.353 0.744 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.402 ' O ' ' HA ' ' A' ' 60' ' ' SER . 71.5 p -72.05 -18.05 61.97 Favored 'General case' 0 C--N 1.356 0.868 0 O-C-N 121.722 -0.611 . . . . 0.0 110.624 -178.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -100.5 -35.04 9.68 Favored 'General case' 0 C--N 1.353 0.743 0 O-C-N 121.143 -0.973 . . . . 0.0 111.389 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.5 p -72.29 -34.8 50.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.719 0 O-C-N 121.755 -0.591 . . . . 0.0 111.375 -177.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.562 ' HB3' HG23 ' A' ' 61' ' ' VAL . 2.5 t -120.29 -7.4 9.79 Favored 'General case' 0 C--N 1.353 0.718 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.094 -177.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 56' ' ' SER . 0.6 OUTLIER 65.71 47.26 2.17 Favored 'General case' 0 C--N 1.353 0.76 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.796 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.562 HG23 ' HB3' ' A' ' 59' ' ' SER . 52.3 t -108.71 131.92 21.48 Favored Pre-proline 0 CA--C 1.503 -0.839 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 179.334 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -57.46 147.24 79.41 Favored 'Trans proline' 0 CA--C 1.497 -1.355 0 C-N-CA 122.439 2.093 . . . . 0.0 112.82 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.9 m -75.51 -12.97 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.685 -178.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.433 ' O ' HG12 ' A' ' 67' ' ' VAL . 71.5 p -96.09 -33.04 12.23 Favored 'General case' 0 C--N 1.358 0.961 0 C-N-CA 118.291 -1.364 . . . . 0.0 109.534 -179.138 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -76.55 -22.58 54.14 Favored 'General case' 0 C--N 1.354 0.799 0 O-C-N 121.449 -0.782 . . . . 0.0 109.033 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -81.7 -34.89 30.37 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.093 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.433 HG12 ' O ' ' A' ' 64' ' ' THR . 1.5 p -69.4 -26.33 31.13 Favored 'Isoleucine or valine' 0 C--N 1.354 0.795 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.916 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.5 mmm-85 -72.96 -51.5 18.13 Favored 'General case' 0 C--N 1.363 1.157 0 O-C-N 121.53 -0.731 . . . . 0.0 110.269 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 83.7 mt -63.76 -36.17 83.01 Favored 'General case' 0 C--N 1.357 0.923 0 O-C-N 122.064 -0.398 . . . . 0.0 110.939 -179.042 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -60.94 -46.9 88.82 Favored 'General case' 0 C--N 1.35 0.609 0 O-C-N 122.233 -0.292 . . . . 0.0 110.238 -178.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.56 -37.97 94.21 Favored Glycine 0 C--N 1.355 1.598 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 -178.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -63.64 -47.84 79.69 Favored 'General case' 0 C--N 1.354 0.782 0 CA-C-N 118.419 1.109 . . . . 0.0 111.486 -177.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.9 mttm -64.38 -47.72 78.2 Favored 'General case' 0 C--N 1.36 1.027 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -176.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.427 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.5 tm? -69.64 -40.21 76.64 Favored 'General case' 0 C--N 1.349 0.581 0 O-C-N 121.051 -1.031 . . . . 0.0 111.828 -175.808 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -63.76 -45.45 89.74 Favored 'General case' 0 C--N 1.354 0.768 0 O-C-N 121.19 -0.944 . . . . 0.0 111.27 -178.126 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 8.5 p -71.72 -12.83 16.31 Favored 'Isoleucine or valine' 0 C--N 1.357 0.911 0 O-C-N 121.543 -0.723 . . . . 0.0 109.294 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.33 -37.39 60.74 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.48 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 82.4 mt -72.53 -32.84 66.44 Favored 'General case' 0 C--N 1.358 0.949 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.7 mm -64.07 -52.99 49.34 Favored 'Isoleucine or valine' 0 C--N 1.36 1.043 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.196 -177.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -75.36 -14.87 60.5 Favored 'General case' 0 CA--C 1.51 -0.593 0 C-N-CA 119.693 -0.803 . . . . 0.0 109.529 178.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.32 -37.05 63.17 Favored Glycine 0 C--N 1.349 1.267 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -179.121 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -133.45 105.78 12.06 Favored Pre-proline 0 N--CA 1.44 -0.97 0 CA-C-O 122.555 1.169 . . . . 0.0 109.199 -176.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.8 -25.03 39.81 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.381 2.054 . . . . 0.0 113.806 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -88.78 -7.69 55.76 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.8 tp -89.31 -22.7 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 -178.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -98.7 -22.12 16.06 Favored 'General case' 0 C--N 1.362 1.113 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.326 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -70.03 -37.22 75.54 Favored 'General case' 0 C--N 1.358 0.976 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -64.78 -36.73 85.27 Favored 'General case' 0 C--N 1.358 0.956 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.261 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.565 ' SD ' ' HZ ' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -82.17 151.07 27.08 Favored 'General case' 0 C--N 1.352 0.704 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -178.837 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.552 ' N ' ' HG2' ' A' ' 89' ' ' MET . 0.7 OUTLIER -118.27 -22.63 7.61 Favored 'General case' 0 C--N 1.363 1.18 0 C-N-CA 119.852 -0.739 . . . . 0.0 111.298 -177.472 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -166.71 172.77 10.22 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.425 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 65.1 m -67.12 -40.06 86.76 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.478 -179.38 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -68.68 -39.09 80.75 Favored 'General case' 0 C--N 1.356 0.859 0 O-C-N 121.322 -0.862 . . . . 0.0 109.011 -178.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -66.29 -23.16 66.34 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.425 ' HB3' ' O ' ' A' ' 92' ' ' SER . 58.3 tp -63.99 -46.1 86.07 Favored 'General case' 0 C--N 1.355 0.829 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.2 mp -63.14 -33.13 74.79 Favored 'General case' 0 C--N 1.354 0.797 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 35.6 t -62.34 -44.4 96.58 Favored 'General case' 0 C--N 1.353 0.747 0 O-C-N 121.897 -0.502 . . . . 0.0 110.954 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.63 26.73 10.37 Favored 'General case' 0 C--N 1.359 0.99 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.376 -177.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 14.1 tt -62.36 -31.55 52.08 Favored 'Isoleucine or valine' 0 C--N 1.356 0.88 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.625 -179.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -119.43 -18.29 8.55 Favored 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 119.218 -0.993 . . . . 0.0 109.113 -178.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 35.6 t -64.25 -46.61 82.99 Favored 'General case' 0 N--CA 1.444 -0.747 0 O-C-N 121.82 -0.55 . . . . 0.0 110.869 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.4 ' HA ' HG12 ' A' ' 105' ' ' VAL . 14.4 t80 -127.59 -26.34 3.01 Favored 'General case' 0 C--N 1.36 1.028 0 C-N-CA 118.103 -1.439 . . . . 0.0 111.828 -177.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 19.0 mm -67.05 -50.23 65.97 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 O-C-N 121.097 -1.002 . . . . 0.0 110.236 -177.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 49.4 m170 -91.08 3.43 54.77 Favored 'General case' 0 N--CA 1.439 -0.985 0 O-C-N 121.462 -0.774 . . . . 0.0 110.408 -177.171 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.4 HG12 ' HA ' ' A' ' 102' ' ' PHE . 2.4 p -87.64 -35.4 8.26 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.766 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -72.88 -39.95 66.01 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.028 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 74.4 t -63.48 -46.06 96.17 Favored 'Isoleucine or valine' 0 C--N 1.357 0.909 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.255 -179.115 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -60.3 -48.13 83.06 Favored 'General case' 0 C--N 1.36 1.026 0 O-C-N 122.117 -0.364 . . . . 0.0 111.484 -178.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -61.98 -36.55 81.81 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 121.412 -0.805 . . . . 0.0 110.506 -178.318 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.9 mt -58.28 -76.33 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 120.665 -0.414 . . . . 0.0 109.951 -179.318 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.468 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 90.5 m-85 -110.9 141.0 23.26 Favored Pre-proline 0 N--CA 1.443 -0.807 0 C-N-CA 118.745 -1.182 . . . . 0.0 109.169 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 111' ' ' TYR . 54.2 Cg_endo -88.39 -7.53 5.79 Favored 'Trans proline' 0 C--N 1.315 -1.198 0 C-N-CA 123.219 2.613 . . . . 0.0 115.877 -178.457 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -77.96 -23.87 48.31 Favored 'General case' 0 C--N 1.354 0.789 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.22 -178.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.2 142.53 58.29 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 121.512 0.672 . . . . 0.0 109.656 -178.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -118.72 143.63 46.75 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.434 ' HA ' ' HD3' ' A' ' 117' ' ' PRO . 96.3 mt -136.93 152.22 73.66 Favored Pre-proline 0 C--N 1.354 0.802 0 CA-C-O 122.138 0.971 . . . . 0.0 109.604 -178.292 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 116' ' ' LEU . 75.0 Cg_endo -89.85 -155.24 0.05 OUTLIER 'Trans proline' 0 C--N 1.318 -1.03 0 C-N-CA 123.934 3.089 . . . . 0.0 113.484 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -119.63 142.34 48.51 Favored 'General case' 0 C--N 1.367 1.327 0 C-N-CA 119.328 -0.949 . . . . 0.0 108.711 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -126.26 128.66 47.53 Favored 'General case' 0 C--N 1.363 1.157 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -178.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.526 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 93.6 m -124.17 128.26 48.98 Favored 'General case' 0 C--N 1.357 0.893 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 176.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 78.1 m -121.77 130.97 53.81 Favored 'General case' 0 CA--C 1.504 -0.827 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.175 -177.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -118.76 149.81 40.85 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 177.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -121.62 117.61 27.15 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -179.257 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.0 mt -91.34 -16.27 27.74 Favored 'General case' 0 C--N 1.354 0.796 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.57 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 175.41 -149.5 10.21 Favored Glycine 0 C--N 1.348 1.214 0 C-N-CA 118.859 -1.639 . . . . 0.0 109.076 -179.006 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -93.87 -37.64 11.63 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -178.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -102.83 4.38 37.73 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.81 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -120.8 129.62 53.65 Favored 'General case' 0 C--N 1.357 0.934 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -179.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.3 mm -141.89 136.57 30.47 Favored 'Isoleucine or valine' 0 C--N 1.355 0.834 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 51.7 mtm180 -116.63 139.67 50.26 Favored 'General case' 0 CA--C 1.495 -1.16 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 8.0 tp -127.61 119.57 26.22 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-N 115.172 -0.922 . . . . 0.0 108.856 -178.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.526 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 12.1 m170 -99.2 134.28 42.27 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 178.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -130.21 122.26 27.77 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -178.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.492 ' HA ' ' O ' ' A' ' 171' ' ' THR . 30.0 tt0 -114.35 113.74 24.96 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 15.6 t -161.88 153.34 18.55 Favored 'General case' 0 C--N 1.358 0.954 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -91.55 3.89 53.91 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.866 -179.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 94.3 mtm-85 -133.42 74.98 70.65 Favored Pre-proline 0 C--N 1.355 0.847 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 178.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -94.88 100.89 0.11 Allowed 'Trans proline' 0 N--CA 1.442 -1.506 0 C-N-CA 122.621 2.214 . . . . 0.0 115.63 -177.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -110.67 113.54 26.22 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 176.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.63 -38.59 91.7 Favored 'General case' 0 C--N 1.354 0.771 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.166 -179.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 73.4 m -63.83 -26.98 68.87 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 121.886 -0.509 . . . . 0.0 110.808 -178.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -76.11 -47.37 24.74 Favored 'General case' 0 C--N 1.352 0.695 0 C-N-CA 120.038 -0.665 . . . . 0.0 109.593 -177.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.46 -39.8 94.5 Favored 'General case' 0 C--N 1.356 0.864 0 O-C-N 122.215 -0.303 . . . . 0.0 111.185 -178.005 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -63.31 -37.37 86.98 Favored 'General case' 0 C--N 1.354 0.797 0 O-C-N 121.879 -0.513 . . . . 0.0 109.908 -179.278 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.04 -42.94 98.63 Favored Glycine 0 C--N 1.348 1.232 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 -179.239 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.0 mt -70.82 -41.0 72.14 Favored 'General case' 0 C--N 1.354 0.762 0 CA-C-N 117.586 0.693 . . . . 0.0 112.704 -179.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 98.5 mt -71.08 -42.15 69.74 Favored 'General case' 0 C--N 1.36 1.057 0 O-C-N 121.28 -0.888 . . . . 0.0 110.833 -176.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.447 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 36.3 t70 -70.53 -28.9 65.29 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 121.935 -0.478 . . . . 0.0 110.385 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.426 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -63.08 -39.01 97.51 Favored Glycine 0 C--N 1.358 1.793 0 N-CA-C 108.049 -2.02 . . . . 0.0 108.049 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 48.1 t -60.95 -42.13 97.66 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -74.71 -0.36 17.85 Favored 'General case' 0 C--N 1.361 1.095 0 O-C-N 121.789 -0.57 . . . . 0.0 109.603 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.447 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 75.7 mm-40 -85.79 -45.8 11.26 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.013 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -65.61 -46.06 80.74 Favored 'General case' 0 C--N 1.361 1.082 0 C-N-CA 120.158 -0.617 . . . . 0.0 109.363 178.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' PHE . . . . . 0.565 ' HZ ' ' SD ' ' A' ' 89' ' ' MET . 37.5 m-85 -68.44 -27.85 66.54 Favored 'General case' 0 C--N 1.363 1.189 0 O-C-N 121.859 -0.525 . . . . 0.0 110.917 -178.437 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 85.4 tttt 74.44 73.94 0.11 Allowed 'General case' 0 C--N 1.36 1.041 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -178.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -142.84 -169.28 2.97 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -148.15 96.18 2.59 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 13.1 m-30 -113.24 155.55 24.88 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 178.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 92.2 m -119.32 128.16 53.87 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -178.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.518 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.7 mp -105.47 122.04 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 179.213 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.7 m -117.06 -174.41 2.58 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-O 121.913 0.863 . . . . 0.0 109.352 -178.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -146.08 155.48 42.8 Favored 'General case' 0 C--N 1.356 0.862 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 -177.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 47.3 p -100.28 146.6 32.25 Favored Pre-proline 0 C--N 1.359 0.997 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.638 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 75.0 Cg_endo -76.4 -11.46 19.0 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 123.056 2.504 . . . . 0.0 115.022 -178.686 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -72.34 -41.51 66.4 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 119.932 -0.707 . . . . 0.0 109.591 -178.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 37.9 p -116.76 15.59 15.36 Favored 'General case' 0 CA--C 1.505 -0.785 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.527 -178.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.638 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.3 pp0? -67.03 -12.18 59.15 Favored 'General case' 0 C--N 1.353 0.744 0 O-C-N 121.595 -0.691 . . . . 0.0 110.52 178.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -122.97 34.36 5.15 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 65.4 m -134.91 147.27 49.77 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.61 ' O ' ' HB ' ' A' ' 171' ' ' THR . 37.3 mt-10 -101.12 165.67 11.18 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.61 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 18.6 m 83.15 -60.52 0.14 Allowed 'General case' 0 C--N 1.37 1.467 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -107.37 117.31 33.75 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.623 -178.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 90.1 t -130.69 133.02 63.98 Favored 'Isoleucine or valine' 0 C--N 1.357 0.899 0 N-CA-C 106.924 -1.509 . . . . 0.0 106.924 178.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 49.6 mm -107.25 127.27 63.17 Favored 'Isoleucine or valine' 0 C--N 1.358 0.976 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -115.85 156.8 25.47 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 122.156 0.979 . . . . 0.0 108.513 -179.027 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -138.54 119.42 14.28 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -178.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.8 mp -113.55 118.54 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 -179.323 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 91.4 m -122.84 142.38 50.82 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -177.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 . . . . . 0 C--N 1.362 1.147 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 179.394 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.636 ' HG2' ' HG3' ' A' ' 4' ' ' MET . 27.7 tpp . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 120.986 0.422 . . . . 0.0 110.402 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' MET . . . . . 0.425 ' HA ' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -81.1 -14.49 57.7 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 -179.471 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.5 -42.96 38.99 Favored Glycine 0 C--N 1.35 1.333 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' MET . . . . . 0.636 ' HG3' ' HG2' ' A' ' 1' ' ' MET . 76.0 mtm -70.38 -34.78 72.98 Favored 'General case' 0 C--N 1.355 0.808 0 O-C-N 122.149 -0.618 . . . . 0.0 111.206 -178.15 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.425 HG22 ' HA ' ' A' ' 2' ' ' MET . 35.7 m -68.95 -23.34 27.19 Favored 'Isoleucine or valine' 0 C--N 1.358 0.946 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.314 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.461 ' HZ ' ' CG ' ' A' ' 47' ' ' GLU . 2.6 m-85 -72.22 -33.07 67.3 Favored 'General case' 0 C--N 1.357 0.922 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.1 m -67.01 -40.09 87.21 Favored 'General case' 0 C--N 1.355 0.846 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.54 -39.32 97.7 Favored Glycine 0 C--N 1.359 1.83 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.644 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -64.22 -40.66 96.51 Favored 'General case' 0 C--N 1.351 0.671 0 O-C-N 122.522 -0.399 . . . . 0.0 110.698 -178.795 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 20.5 mmt -63.43 -40.63 97.7 Favored 'General case' 0 C--N 1.352 0.708 0 O-C-N 121.72 -0.612 . . . . 0.0 110.832 -178.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -67.29 -40.5 86.09 Favored 'General case' 0 C--N 1.349 0.563 0 O-C-N 122.012 -0.43 . . . . 0.0 111.692 -178.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 54.9 tp -66.31 -42.93 87.57 Favored 'General case' 0 C--N 1.35 0.606 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -178.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.644 HG12 ' O ' ' A' ' 9' ' ' LEU . 2.6 mm -73.51 -37.1 49.63 Favored 'Isoleucine or valine' 0 C--N 1.36 1.032 0 O-C-N 121.142 -0.974 . . . . 0.0 110.861 -175.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -71.02 -42.35 69.68 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 121.659 -0.65 . . . . 0.0 111.73 -176.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -71.31 -37.57 71.79 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -175.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -100.66 -27.0 13.62 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 118.678 -1.209 . . . . 0.0 113.791 -174.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -111.56 -34.23 6.14 Favored 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 117.579 -1.648 . . . . 0.0 112.146 -176.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 142.11 178.41 18.15 Favored Glycine 0 C--N 1.348 1.216 0 C-N-CA 118.431 -1.842 . . . . 0.0 109.774 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 93.3 t80 -101.08 -26.19 13.78 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 -177.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -69.11 -39.72 78.77 Favored 'General case' 0 C--N 1.36 1.054 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.443 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.5 m -67.96 -38.54 82.89 Favored 'General case' 0 C--N 1.357 0.898 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 34.7 tp -59.53 -38.34 80.74 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -65.14 -37.11 86.38 Favored 'General case' 0 C--N 1.357 0.933 0 O-C-N 122.214 -0.304 . . . . 0.0 111.081 -178.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.3 m -64.45 -40.96 96.71 Favored 'General case' 0 C--N 1.355 0.834 0 O-C-N 121.636 -0.665 . . . . 0.0 109.774 -178.197 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.461 ' CD2' ' HB3' ' A' ' 54' ' ' LYS . 84.8 mt -64.48 -37.49 87.73 Favored 'General case' 0 C--N 1.356 0.861 0 O-C-N 121.892 -0.505 . . . . 0.0 109.744 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 82.5 mt -67.68 -18.77 65.04 Favored 'General case' 0 C--N 1.357 0.922 0 O-C-N 121.426 -0.796 . . . . 0.0 109.629 -179.282 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -85.74 -25.85 26.19 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.712 179.06 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.9 p -69.28 -24.45 63.96 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 119.856 -0.738 . . . . 0.0 109.304 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.4 p -106.96 -34.38 7.21 Favored 'General case' 0 C--N 1.357 0.898 0 C-N-CA 119.041 -1.064 . . . . 0.0 108.17 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 82.55 134.0 0.06 Allowed 'General case' 0 C--N 1.359 0.98 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.23 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.428 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -84.59 -169.82 2.81 Favored 'General case' 0 C--N 1.357 0.898 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.655 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.421 ' H ' ' H ' ' A' ' 33' ' ' SER . 63.1 tt0 -151.68 -25.25 0.19 Allowed 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.421 ' H ' ' H ' ' A' ' 32' ' ' GLN . 1.5 t -146.12 -73.18 0.23 Allowed 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -179.167 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -126.83 -38.73 2.02 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -179.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.35 -31.74 5.68 Favored Glycine 0 C--N 1.353 1.502 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 82.7 mt -112.5 99.98 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.512 ' O ' ' HB ' ' A' ' 38' ' ' THR . 3.0 t80 -70.84 -33.24 70.47 Favored 'General case' 0 C--N 1.357 0.916 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.512 ' HB ' ' O ' ' A' ' 37' ' ' TYR . 6.0 m 119.45 -70.07 0.0 OUTLIER 'General case' 0 C--N 1.369 1.456 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.6 p 174.4 66.62 0.0 OUTLIER 'General case' 0 C--N 1.359 0.998 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.503 ' HB ' ' CE2' ' A' ' 37' ' ' TYR . 19.0 t -147.53 -11.52 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.878 0 C-N-CA 119.772 -0.771 . . . . 0.0 109.463 -178.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.53 146.01 18.07 Favored Glycine 0 C--N 1.352 1.461 0 C-N-CA 119.314 -1.422 . . . . 0.0 110.53 -177.063 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 52.7 m -122.25 125.74 46.69 Favored 'General case' 0 C--N 1.354 0.775 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 178.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -117.05 172.04 7.53 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 121.644 0.735 . . . . 0.0 109.058 -178.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -78.3 -176.15 4.54 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-O 121.662 0.744 . . . . 0.0 109.249 -179.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -85.56 -23.25 27.72 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -179.031 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -65.89 -28.88 69.28 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.461 ' CG ' ' HZ ' ' A' ' 6' ' ' PHE . 24.4 tp10 -62.95 -39.55 94.98 Favored 'General case' 0 C--N 1.352 0.717 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.639 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -67.67 -38.81 84.25 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 61.8 tp -70.44 -34.31 72.31 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -177.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -65.15 -41.36 94.83 Favored 'General case' 0 N--CA 1.443 -0.799 0 O-C-N 122.041 -0.412 . . . . 0.0 110.227 -178.266 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 78.5 mt -81.86 -19.4 41.04 Favored 'General case' 0 C--N 1.357 0.934 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.384 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.3 t -80.18 -37.23 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -179.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 52.5 t -67.78 -40.85 84.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.461 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 25.0 tptt -66.66 -25.81 66.75 Favored 'General case' 0 C--N 1.364 1.219 0 O-C-N 121.07 -1.019 . . . . 0.0 108.895 -179.421 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.534 HD21 HD12 ' A' ' 13' ' ' ILE . 6.4 mt -67.11 -37.99 84.86 Favored 'General case' 0 C--N 1.355 0.807 0 C-N-CA 120.431 -0.507 . . . . 0.0 109.904 178.614 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.448 ' O ' ' HA ' ' A' ' 60' ' ' SER . 57.4 p -72.86 -17.81 61.5 Favored 'General case' 0 C--N 1.354 0.791 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.477 -179.036 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -99.3 -38.04 9.02 Favored 'General case' 0 C--N 1.354 0.777 0 O-C-N 121.321 -0.862 . . . . 0.0 111.497 -179.292 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.8 p -72.91 -37.88 55.27 Favored 'Isoleucine or valine' 0 C--N 1.353 0.722 0 O-C-N 121.656 -0.653 . . . . 0.0 111.327 -177.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.552 ' HB3' HG23 ' A' ' 61' ' ' VAL . 5.0 t -115.4 -6.72 12.32 Favored 'General case' 0 C--N 1.352 0.717 0 C-N-CA 119.033 -1.067 . . . . 0.0 110.265 -178.383 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 56' ' ' SER . 74.5 m 64.78 44.16 3.82 Favored 'General case' 0 C--N 1.355 0.829 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.552 HG23 ' HB3' ' A' ' 59' ' ' SER . 53.5 t -105.95 133.59 20.14 Favored Pre-proline 0 N--CA 1.444 -0.764 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -57.59 147.08 81.29 Favored 'Trans proline' 0 CA--C 1.498 -1.28 0 C-N-CA 122.538 2.159 . . . . 0.0 112.815 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.5 m -75.47 -12.13 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.919 -178.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.435 ' O ' HG12 ' A' ' 67' ' ' VAL . 67.3 p -96.48 -32.42 12.31 Favored 'General case' 0 C--N 1.358 0.969 0 C-N-CA 118.289 -1.364 . . . . 0.0 109.489 -179.104 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -77.82 -22.89 49.34 Favored 'General case' 0 C--N 1.355 0.819 0 O-C-N 121.341 -0.849 . . . . 0.0 108.868 179.254 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.426 HD13 HD13 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -79.97 -37.36 34.52 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.196 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.435 HG12 ' O ' ' A' ' 64' ' ' THR . 1.9 p -67.97 -26.66 35.15 Favored 'Isoleucine or valine' 0 C--N 1.355 0.828 0 C-N-CA 120.089 -0.644 . . . . 0.0 110.002 -179.627 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.2 mmm-85 -72.16 -50.86 24.39 Favored 'General case' 0 C--N 1.363 1.159 0 O-C-N 121.519 -0.738 . . . . 0.0 110.354 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 83.9 mt -63.57 -36.0 82.35 Favored 'General case' 0 C--N 1.357 0.932 0 O-C-N 122.061 -0.399 . . . . 0.0 110.966 -178.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -60.8 -47.69 85.18 Favored 'General case' 0 C--N 1.35 0.608 0 O-C-N 122.221 -0.299 . . . . 0.0 110.64 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.54 95.75 Favored Glycine 0 C--N 1.354 1.554 0 N-CA-C 111.834 -0.506 . . . . 0.0 111.834 -178.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.65 -47.65 80.45 Favored 'General case' 0 C--N 1.349 0.568 0 CA-C-N 118.13 0.965 . . . . 0.0 111.548 -177.115 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 10.2 mttm -65.39 -48.39 73.02 Favored 'General case' 0 C--N 1.359 1.006 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -177.065 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LEU . . . . . 0.444 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.4 tm? -68.93 -39.37 79.63 Favored 'General case' 0 C--N 1.348 0.529 0 O-C-N 121.156 -0.965 . . . . 0.0 111.788 -175.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -63.81 -44.96 91.73 Favored 'General case' 0 C--N 1.354 0.779 0 O-C-N 121.084 -1.01 . . . . 0.0 111.032 -178.003 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.83 -13.86 17.08 Favored 'Isoleucine or valine' 0 C--N 1.359 0.98 0 O-C-N 121.548 -0.72 . . . . 0.0 109.084 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -73.52 -38.06 65.44 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.6 mt -74.47 -29.78 61.59 Favored 'General case' 0 C--N 1.357 0.928 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 46.5 mm -65.25 -52.94 46.29 Favored 'Isoleucine or valine' 0 C--N 1.358 0.977 0 C-N-CA 120.059 -0.656 . . . . 0.0 109.883 -177.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -75.36 -15.89 60.44 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.425 178.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.85 -37.26 65.72 Favored Glycine 0 C--N 1.349 1.27 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -131.88 106.21 13.97 Favored Pre-proline 0 N--CA 1.441 -0.923 0 CA-C-O 122.58 1.181 . . . . 0.0 109.37 -177.103 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -68.36 -25.35 36.14 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.581 2.187 . . . . 0.0 113.848 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -88.5 -9.1 53.55 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -89.51 -21.92 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 -178.624 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.26 -23.25 14.85 Favored 'General case' 0 C--N 1.36 1.049 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -70.2 -37.24 75.04 Favored 'General case' 0 C--N 1.358 0.959 0 O-C-N 121.845 -0.535 . . . . 0.0 109.845 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -64.28 -36.24 83.47 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.322 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.45 ' SD ' ' HB2' ' A' ' 95' ' ' LEU . 17.4 ttp -83.32 153.54 24.56 Favored 'General case' 0 C--N 1.351 0.67 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -178.593 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.46 -22.65 8.08 Favored 'General case' 0 C--N 1.365 1.276 0 O-C-N 121.627 -0.671 . . . . 0.0 111.138 -177.241 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -164.21 170.14 16.7 Favored 'General case' 0 CA--C 1.504 -0.802 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -177.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.489 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 64.9 m -66.05 -40.56 91.04 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.469 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 1.6 m-30 -68.42 -37.9 80.74 Favored 'General case' 0 C--N 1.354 0.788 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.135 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -66.22 -22.5 66.34 Favored 'General case' 0 C--N 1.357 0.935 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LEU . . . . . 0.489 ' HB3' ' O ' ' A' ' 92' ' ' SER . 62.0 tp -64.42 -45.16 88.77 Favored 'General case' 0 C--N 1.357 0.919 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.049 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.5 mp -60.89 -35.76 77.47 Favored 'General case' 0 C--N 1.356 0.874 0 O-C-N 122.139 -0.351 . . . . 0.0 110.17 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.6 t -69.09 -39.9 78.72 Favored 'General case' 0 C--N 1.35 0.613 0 O-C-N 121.871 -0.518 . . . . 0.0 110.067 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.77 8.15 40.62 Favored 'General case' 0 C--N 1.354 0.766 0 O-C-N 122.163 -0.336 . . . . 0.0 111.359 -176.803 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 19.3 tt -63.32 -38.81 83.13 Favored 'Isoleucine or valine' 0 C--N 1.36 1.024 0 O-C-N 121.44 -0.787 . . . . 0.0 111.876 -176.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -108.51 -14.75 14.59 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 118.103 -1.439 . . . . 0.0 110.156 -178.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.9 t -64.42 -46.09 84.73 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 120.253 -0.579 . . . . 0.0 111.07 -179.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -137.37 -15.09 1.46 Allowed 'General case' 0 C--N 1.359 1.016 0 C-N-CA 117.343 -1.743 . . . . 0.0 112.512 -177.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 26.5 mm -70.56 -51.74 34.83 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 CA-C-N 119.875 1.216 . . . . 0.0 110.468 -177.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 51.8 m170 -92.09 -1.05 57.41 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.203 -177.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 65.6 t -80.04 -44.6 22.71 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.026 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 178.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 54.8 tp10 -68.31 -40.76 81.59 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.1 t -62.66 -46.69 95.75 Favored 'Isoleucine or valine' 0 C--N 1.356 0.856 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.598 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -60.38 -48.24 82.61 Favored 'General case' 0 C--N 1.359 0.993 0 O-C-N 121.967 -0.458 . . . . 0.0 111.472 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -60.61 -36.55 78.87 Favored 'General case' 0 C--N 1.356 0.857 0 O-C-N 121.544 -0.722 . . . . 0.0 110.293 -178.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.4 mt -59.27 -77.16 0.04 OUTLIER 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' TYR . . . . . 0.444 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 82.7 m-85 -118.9 140.73 29.01 Favored Pre-proline 0 N--CA 1.438 -1.027 0 C-N-CA 118.663 -1.215 . . . . 0.0 109.053 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 111' ' ' TYR . 73.7 Cg_endo -87.0 -2.5 8.05 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 C-N-CA 123.129 2.553 . . . . 0.0 114.904 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -66.97 -36.52 82.38 Favored 'General case' 0 C--N 1.355 0.825 0 O-C-N 121.921 -0.487 . . . . 0.0 110.06 -179.456 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.82 147.11 53.68 Favored 'General case' 0 C--N 1.352 0.704 0 CA-C-O 121.525 0.679 . . . . 0.0 109.81 -178.441 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.462 ' O ' HD13 ' A' ' 116' ' ' LEU . 46.5 mt-10 -117.51 142.66 46.9 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 179.308 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.462 HD13 ' O ' ' A' ' 115' ' ' GLU . 2.7 mm? -127.12 149.29 69.06 Favored Pre-proline 0 C--N 1.352 0.695 0 CA-C-O 122.178 0.99 . . . . 0.0 108.73 -178.64 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -89.65 -158.86 0.08 OUTLIER 'Trans proline' 0 C--N 1.316 -1.18 0 C-N-CA 123.75 2.967 . . . . 0.0 113.029 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -118.33 140.56 49.65 Favored 'General case' 0 C--N 1.362 1.128 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -126.55 129.36 48.44 Favored 'General case' 0 C--N 1.361 1.081 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -178.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' THR . . . . . 0.478 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 95.3 m -125.42 127.53 46.69 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 176.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 80.9 m -120.12 129.51 54.2 Favored 'General case' 0 CA--C 1.503 -0.855 0 C-N-CA 119.087 -1.045 . . . . 0.0 109.693 -177.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -120.74 117.48 27.59 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 178.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.589 ' HG3' ' CD1' ' A' ' 129' ' ' ILE . 12.9 ttm180 -92.8 113.81 26.19 Favored 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -179.113 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.555 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 87.1 mt -75.96 -38.99 56.93 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.074 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -166.21 -139.65 2.7 Favored Glycine 0 C--N 1.351 1.387 0 N-CA-C 109.231 -1.547 . . . . 0.0 109.231 -178.173 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -94.75 -41.09 9.43 Favored 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 120.134 -0.626 . . . . 0.0 109.452 -178.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 51.3 p-10 -101.28 4.48 41.76 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 120.049 -0.661 . . . . 0.0 109.956 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.555 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 67.3 m-20 -118.2 128.36 54.63 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.589 ' CD1' ' HG3' ' A' ' 123' ' ' ARG . 3.4 mm -139.42 132.33 36.92 Favored 'Isoleucine or valine' 0 C--N 1.355 0.823 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.683 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 52.9 mtm180 -116.08 137.8 51.8 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 179.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.9 tp -127.5 118.83 24.76 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 115.328 -0.851 . . . . 0.0 108.829 -178.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' HIS . . . . . 0.478 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 11.9 m170 -97.56 131.54 44.06 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 178.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -127.37 121.14 30.16 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 -178.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.511 ' HA ' ' O ' ' A' ' 171' ' ' THR . 28.6 tt0 -113.75 113.9 25.61 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.7 t -161.06 151.82 18.3 Favored 'General case' 0 C--N 1.359 0.982 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.402 ' C ' ' HD3' ' A' ' 138' ' ' PRO . 99.4 mttt -90.72 2.08 56.29 Favored 'General case' 0 C--N 1.355 0.838 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -179.155 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -132.99 74.54 73.69 Favored Pre-proline 0 CA--C 1.505 -0.787 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' PRO . . . . . 0.402 ' HD3' ' C ' ' A' ' 136' ' ' LYS . 90.2 Cg_endo -96.47 102.2 0.09 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.533 0 C-N-CA 122.743 2.296 . . . . 0.0 115.818 -177.532 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -110.76 114.07 27.15 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 105.971 -1.862 . . . . 0.0 105.971 176.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.88 -38.41 90.98 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.311 -178.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 74.5 m -64.01 -27.1 68.89 Favored 'General case' 0 C--N 1.354 0.777 0 O-C-N 121.864 -0.522 . . . . 0.0 110.7 -178.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -76.33 -47.08 24.77 Favored 'General case' 0 C--N 1.351 0.646 0 O-C-N 121.743 -0.598 . . . . 0.0 109.765 -177.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.67 -39.77 94.27 Favored 'General case' 0 C--N 1.356 0.885 0 O-C-N 122.183 -0.323 . . . . 0.0 111.256 -178.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.61 -37.71 88.38 Favored 'General case' 0 C--N 1.355 0.836 0 O-C-N 121.867 -0.521 . . . . 0.0 110.024 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.15 -43.17 98.63 Favored Glycine 0 C--N 1.347 1.188 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -179.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 83.6 mt -70.44 -40.38 73.81 Favored 'General case' 0 C--N 1.352 0.682 0 CA-C-N 117.559 0.68 . . . . 0.0 112.649 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 98.4 mt -70.91 -42.47 69.89 Favored 'General case' 0 C--N 1.362 1.11 0 O-C-N 121.215 -0.928 . . . . 0.0 110.86 -176.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.555 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 37.2 t70 -71.5 -28.85 64.19 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 121.894 -0.504 . . . . 0.0 110.336 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -63.03 -39.64 98.31 Favored Glycine 0 C--N 1.357 1.719 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 44.1 t -61.03 -41.06 95.86 Favored 'General case' 0 C--N 1.352 0.681 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -76.22 0.86 17.63 Favored 'General case' 0 C--N 1.361 1.071 0 CA-C-O 121.406 0.622 . . . . 0.0 109.403 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.555 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 76.8 mm-40 -86.37 -45.8 10.86 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.304 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -68.34 -43.67 76.99 Favored 'General case' 0 C--N 1.357 0.912 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.503 179.086 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -69.73 -27.9 65.35 Favored 'General case' 0 C--N 1.361 1.078 0 O-C-N 121.815 -0.553 . . . . 0.0 110.932 -178.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 85.1 tttt 71.56 69.22 0.16 Allowed 'General case' 0 C--N 1.362 1.114 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -177.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -134.57 -176.71 4.31 Favored 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -135.95 110.45 8.54 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -132.9 150.34 52.17 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 95.2 m -120.39 126.57 50.8 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.531 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.5 mp -101.86 121.31 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.7 m -116.32 -176.69 3.01 Favored 'General case' 0 C--N 1.361 1.082 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.734 ' HD2' ' HG3' ' A' ' 167' ' ' GLN . 8.8 ptt180 -148.95 158.17 43.97 Favored 'General case' 0 C--N 1.356 0.858 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 -179.208 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 65.5 p -104.75 145.01 29.89 Favored Pre-proline 0 C--N 1.359 1.017 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 179.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' PRO . . . . . 0.868 ' HA ' ' HB2' ' A' ' 167' ' ' GLN . 57.7 Cg_endo -75.36 -8.24 19.49 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 123.094 2.529 . . . . 0.0 115.521 -178.64 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -71.19 -41.31 70.45 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 34.1 p -117.77 16.12 14.41 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.868 ' HB2' ' HA ' ' A' ' 164' ' ' PRO . 10.0 tt0 -58.96 -38.67 79.6 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.87 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -111.71 48.69 0.94 Allowed 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 19.0 t -139.64 142.95 36.98 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.613 ' O ' ' HB ' ' A' ' 171' ' ' THR . 61.0 mt-10 -97.15 164.77 12.36 Favored 'General case' 0 C--N 1.356 0.86 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.332 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' THR . . . . . 0.613 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 3.1 m 80.81 -57.73 0.3 Allowed 'General case' 0 C--N 1.371 1.542 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -107.96 116.76 32.55 Favored 'General case' 0 CA--C 1.503 -0.83 0 C-N-CA 119.843 -0.743 . . . . 0.0 109.732 -178.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 86.3 t -130.26 131.86 65.35 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 178.072 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 50.5 mm -108.1 125.75 64.71 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -112.51 151.15 30.31 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-O 122.138 0.97 . . . . 0.0 108.551 -179.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -133.9 82.84 2.0 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.804 -178.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.1 mp -78.23 116.49 21.98 Favored 'Isoleucine or valine' 0 C--N 1.359 1.007 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.259 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 90.7 m -118.3 144.2 46.02 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -178.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 . . . . . 0 C--N 1.36 1.035 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 -179.669 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 1.018 ' HG2' HMD3 ' A' ' 202' ' ' HEM . 93.4 mmm . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 120.822 0.344 . . . . 0.0 110.197 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.09 -25.39 47.58 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -178.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.45 -39.4 50.6 Favored Glycine 0 C--N 1.351 1.392 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.0 tpp -69.78 -38.07 76.57 Favored 'General case' 0 C--N 1.357 0.914 0 O-C-N 121.911 -0.758 . . . . 0.0 111.081 -177.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.8 m -69.26 -22.63 25.98 Favored 'Isoleucine or valine' 0 C--N 1.356 0.89 0 O-C-N 121.504 -0.748 . . . . 0.0 109.51 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -70.22 -36.76 74.75 Favored 'General case' 0 C--N 1.359 0.989 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 87.8 m -66.56 -40.91 89.26 Favored 'General case' 0 C--N 1.357 0.911 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.64 -38.9 97.18 Favored Glycine 0 C--N 1.357 1.71 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.628 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -65.55 -40.31 92.72 Favored 'General case' 0 C--N 1.351 0.673 0 CA-C-N 117.207 0.503 . . . . 0.0 110.739 -178.205 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 20.7 mmt -63.75 -41.44 98.0 Favored 'General case' 0 C--N 1.355 0.819 0 O-C-N 121.419 -0.801 . . . . 0.0 111.207 -178.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -66.82 -40.36 88.02 Favored 'General case' 0 C--N 1.348 0.518 0 O-C-N 122.011 -0.431 . . . . 0.0 111.691 -177.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 55.7 tp -66.08 -43.29 87.77 Favored 'General case' 0 C--N 1.349 0.573 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -177.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.628 HG12 ' O ' ' A' ' 9' ' ' LEU . 1.7 mm -73.18 -36.57 50.34 Favored 'Isoleucine or valine' 0 C--N 1.36 1.029 0 O-C-N 121.076 -1.015 . . . . 0.0 111.14 -175.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -70.66 -42.57 70.62 Favored 'General case' 0 C--N 1.35 0.612 0 O-C-N 121.505 -0.747 . . . . 0.0 111.746 -176.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -72.01 -38.33 69.62 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -175.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -102.75 -23.97 13.76 Favored 'General case' 0 CA--C 1.509 -0.612 0 C-N-CA 118.524 -1.27 . . . . 0.0 113.655 -174.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 13.8 m-30 -108.2 -37.43 6.03 Favored 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 117.994 -1.482 . . . . 0.0 111.531 -176.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 143.37 178.11 18.89 Favored Glycine 0 C--N 1.347 1.173 0 C-N-CA 118.842 -1.646 . . . . 0.0 109.214 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -102.19 -26.93 13.16 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 -177.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -70.48 -38.92 74.47 Favored 'General case' 0 C--N 1.36 1.061 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.6 m -67.31 -38.48 85.02 Favored 'General case' 0 C--N 1.359 0.995 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 35.2 tp -60.57 -38.81 85.81 Favored 'General case' 0 C--N 1.356 0.859 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -63.77 -37.91 89.15 Favored 'General case' 0 C--N 1.358 0.96 0 O-C-N 122.122 -0.361 . . . . 0.0 111.485 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 87.1 m -65.42 -38.86 91.19 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.699 HD13 HD22 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -62.34 -39.36 92.84 Favored 'General case' 0 C--N 1.354 0.768 0 CA-C-O 120.958 0.408 . . . . 0.0 109.988 -179.046 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 85.7 mt -73.09 -15.27 61.5 Favored 'General case' 0 C--N 1.359 0.987 0 O-C-N 121.7 -0.625 . . . . 0.0 110.518 -178.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -86.13 -27.89 24.35 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 119.2 -1.0 . . . . 0.0 109.429 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.6 t -67.0 -36.47 82.25 Favored 'General case' 0 C--N 1.354 0.804 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.625 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 1.7 p -93.65 -37.97 11.57 Favored 'General case' 0 C--N 1.357 0.931 0 C-N-CA 118.781 -1.168 . . . . 0.0 108.12 -179.12 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.625 ' HB2' ' O ' ' A' ' 29' ' ' CYS . 13.7 mt-10 84.65 133.18 0.05 OUTLIER 'General case' 0 C--N 1.36 1.026 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.514 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -86.08 -169.12 2.5 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.874 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -152.91 -28.21 0.15 Allowed 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.7 t -141.85 -71.21 0.34 Allowed 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -178.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -130.6 -45.71 1.07 Allowed 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 125.7 -32.65 3.8 Favored Glycine 0 C--N 1.352 1.452 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 84.8 mt -113.3 102.84 14.49 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.806 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -97.23 -2.3 43.05 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.731 HG22 ' H ' ' A' ' 39' ' ' SER . 3.9 m 79.42 174.68 0.14 Allowed 'General case' 0 C--N 1.362 1.135 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 -178.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.731 ' H ' HG22 ' A' ' 38' ' ' THR . 31.8 p -87.96 113.91 24.07 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 121.115 -0.99 . . . . 0.0 109.561 -178.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.481 HG13 ' O ' ' A' ' 39' ' ' SER . 0.0 OUTLIER -173.31 -9.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.362 1.146 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.946 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -115.25 166.17 12.17 Favored Glycine 0 C--N 1.356 1.671 0 N-CA-C 109.211 -1.555 . . . . 0.0 109.211 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.3 m -130.1 130.36 44.74 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -117.3 172.33 7.37 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -70.68 172.91 7.86 Favored 'General case' 0 C--N 1.356 0.879 0 CA-C-O 121.762 0.791 . . . . 0.0 109.58 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -81.4 -25.99 35.79 Favored 'General case' 0 C--N 1.356 0.85 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -64.52 -28.19 69.48 Favored 'General case' 0 C--N 1.354 0.779 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -61.79 -42.34 98.87 Favored 'General case' 0 C--N 1.353 0.725 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.456 ' O ' HG23 ' A' ' 52' ' ' VAL . 62.6 tp -67.04 -40.0 87.06 Favored 'General case' 0 C--N 1.355 0.811 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.439 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 59.0 tp -72.15 -33.51 67.79 Favored 'General case' 0 C--N 1.35 0.611 0 O-C-N 122.14 -0.35 . . . . 0.0 110.68 -177.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -64.73 -42.78 94.97 Favored 'General case' 0 N--CA 1.445 -0.688 0 O-C-N 121.66 -0.65 . . . . 0.0 109.852 -177.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.699 HD22 HD13 ' A' ' 25' ' ' LEU . 77.6 mt -72.76 -33.83 66.6 Favored 'General case' 0 C--N 1.361 1.08 0 C-N-CA 119.762 -0.775 . . . . 0.0 109.753 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 48' ' ' LEU . 35.8 t -63.03 -42.3 96.12 Favored 'Isoleucine or valine' 0 C--N 1.35 0.605 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.7 t -66.1 -39.71 85.19 Favored 'Isoleucine or valine' 0 C--N 1.351 0.663 0 O-C-N 121.795 -0.565 . . . . 0.0 109.515 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.485 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 34.9 tptt -63.54 -28.64 70.08 Favored 'General case' 0 C--N 1.361 1.099 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.523 HD21 HD12 ' A' ' 13' ' ' ILE . 16.8 mt -66.51 -38.77 87.93 Favored 'General case' 0 C--N 1.355 0.847 0 O-C-N 121.996 -0.44 . . . . 0.0 110.459 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.7 p -72.13 -17.47 61.96 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.76 -178.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -101.57 -38.43 7.95 Favored 'General case' 0 C--N 1.354 0.769 0 C-N-CA 119.369 -0.932 . . . . 0.0 111.651 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.7 p -72.3 -38.27 61.09 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 O-C-N 121.616 -0.678 . . . . 0.0 111.24 -177.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.589 ' HB3' HG23 ' A' ' 61' ' ' VAL . 1.9 t -113.21 -7.71 13.57 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 118.948 -1.101 . . . . 0.0 110.406 -178.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 64.86 49.56 2.15 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.589 HG23 ' HB3' ' A' ' 59' ' ' SER . 58.7 t -113.07 133.39 22.04 Favored Pre-proline 0 N--CA 1.443 -0.79 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 61' ' ' VAL . 39.3 Cg_exo -58.14 147.36 83.84 Favored 'Trans proline' 0 CA--C 1.499 -1.259 0 C-N-CA 122.562 2.175 . . . . 0.0 112.631 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.7 m -75.65 -11.52 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.922 -178.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 68.3 p -95.88 -32.97 12.39 Favored 'General case' 0 C--N 1.358 0.96 0 C-N-CA 118.183 -1.407 . . . . 0.0 109.468 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -77.52 -22.72 50.73 Favored 'General case' 0 C--N 1.355 0.814 0 O-C-N 121.488 -0.758 . . . . 0.0 109.138 179.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.76 -35.61 38.46 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -69.93 -28.4 36.46 Favored 'Isoleucine or valine' 0 C--N 1.357 0.9 0 C-N-CA 119.932 -0.707 . . . . 0.0 110.049 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 63.2 mtp180 -70.45 -50.12 41.55 Favored 'General case' 0 C--N 1.362 1.15 0 O-C-N 121.398 -0.814 . . . . 0.0 110.533 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.68 -35.96 81.36 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 122.246 -0.284 . . . . 0.0 110.91 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -61.1 -47.44 86.26 Favored 'General case' 0 C--N 1.348 0.512 0 O-C-N 122.229 -0.294 . . . . 0.0 110.498 -178.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.85 -39.59 97.06 Favored Glycine 0 C--N 1.355 1.616 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 -178.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.0 -48.97 76.53 Favored 'General case' 0 C--N 1.352 0.694 0 CA-C-N 118.363 1.081 . . . . 0.0 111.635 -177.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.698 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 10.0 mttm -63.17 -48.38 78.65 Favored 'General case' 0 C--N 1.359 0.987 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -177.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.414 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.5 tm? -68.77 -39.07 80.42 Favored 'General case' 0 C--N 1.348 0.533 0 O-C-N 121.198 -0.939 . . . . 0.0 111.777 -175.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.413 ' CE2' ' HA ' ' A' ' 150' ' ' CYS . 48.0 t80 -62.84 -45.96 90.13 Favored 'General case' 0 C--N 1.353 0.761 0 O-C-N 121.152 -0.968 . . . . 0.0 111.286 -178.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 8.5 p -70.08 -15.08 18.89 Favored 'Isoleucine or valine' 0 C--N 1.359 0.993 0 O-C-N 121.377 -0.827 . . . . 0.0 109.392 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.698 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 75.2 mm-40 -71.07 -38.93 72.47 Favored 'General case' 0 C--N 1.352 0.702 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 81.7 mt -72.17 -33.12 67.45 Favored 'General case' 0 C--N 1.356 0.873 0 O-C-N 122.432 -0.168 . . . . 0.0 110.739 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 47.3 mm -64.48 -54.05 35.36 Favored 'Isoleucine or valine' 0 C--N 1.358 0.943 0 C-N-CA 120.126 -0.63 . . . . 0.0 110.396 -177.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -75.33 -14.37 60.48 Favored 'General case' 0 C--N 1.351 0.673 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.45 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.09 -36.78 64.11 Favored Glycine 0 C--N 1.347 1.192 0 N-CA-C 110.969 -0.853 . . . . 0.0 110.969 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -134.18 106.81 11.28 Favored Pre-proline 0 C--N 1.357 0.894 0 CA-C-O 122.68 1.229 . . . . 0.0 109.189 -176.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.526 ' O ' ' HB2' ' A' ' 87' ' ' ASN . 39.3 Cg_endo -68.97 -23.3 34.57 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.675 2.25 . . . . 0.0 114.239 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -90.55 -8.71 49.56 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 tp -90.31 -21.25 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 -178.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -104.11 -14.74 15.78 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.526 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 20.1 t30 -73.3 -41.02 64.06 Favored 'General case' 0 C--N 1.359 1.012 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -68.1 -28.4 67.3 Favored 'General case' 0 C--N 1.352 0.716 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.552 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 25.9 ttp -84.86 148.55 26.22 Favored 'General case' 0 C--N 1.351 0.636 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.13 -21.63 8.14 Favored 'General case' 0 C--N 1.364 1.216 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.984 -177.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -164.22 171.18 15.31 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -177.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.443 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 86.6 p -70.22 -34.0 72.37 Favored 'General case' 0 C--N 1.354 0.776 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.197 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -70.04 -38.46 75.84 Favored 'General case' 0 C--N 1.357 0.922 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -66.14 -24.67 66.71 Favored 'General case' 0 C--N 1.358 0.952 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.443 ' HB3' ' O ' ' A' ' 92' ' ' SER . 61.3 tp -62.63 -46.63 87.34 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.2 mp -62.76 -32.6 73.78 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 122.246 -0.284 . . . . 0.0 110.302 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 35.8 t -62.73 -45.58 92.07 Favored 'General case' 0 C--N 1.356 0.864 0 O-C-N 121.688 -0.632 . . . . 0.0 111.597 -178.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.08 25.87 10.99 Favored 'General case' 0 C--N 1.361 1.071 0 O-C-N 121.057 -1.027 . . . . 0.0 110.453 -178.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 1.042 HD11 ' C3B' ' A' ' 202' ' ' HEM . 12.3 tt -64.26 -29.66 47.94 Favored 'Isoleucine or valine' 0 C--N 1.352 0.689 0 C-N-CA 120.341 -0.543 . . . . 0.0 110.507 -179.001 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -120.19 -18.59 7.99 Favored 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 119.336 -0.946 . . . . 0.0 109.115 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 35.5 t -66.06 -45.98 79.42 Favored 'General case' 0 N--CA 1.443 -0.785 0 O-C-N 121.841 -0.537 . . . . 0.0 110.85 -178.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.552 ' O ' HG12 ' A' ' 105' ' ' VAL . 30.8 t80 -124.97 -31.21 3.15 Favored 'General case' 0 C--N 1.359 0.99 0 C-N-CA 118.23 -1.388 . . . . 0.0 111.992 -177.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 96.3 mt -67.52 -47.27 81.09 Favored 'Isoleucine or valine' 0 C--N 1.352 0.704 0 O-C-N 121.034 -1.041 . . . . 0.0 110.687 -177.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 17.5 m170 -87.72 3.16 49.06 Favored 'General case' 0 N--CA 1.441 -0.913 0 O-C-N 121.252 -0.905 . . . . 0.0 110.15 -177.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.552 HG12 ' O ' ' A' ' 102' ' ' PHE . 1.8 p -87.39 -34.15 7.26 Favored 'Isoleucine or valine' 0 C--N 1.356 0.872 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 178.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -71.86 -40.26 69.1 Favored 'General case' 0 C--N 1.359 0.997 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.505 HG21 ' HHD' ' A' ' 202' ' ' HEM . 62.4 t -62.81 -47.37 93.19 Favored 'Isoleucine or valine' 0 C--N 1.356 0.87 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.517 -179.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -60.55 -48.25 82.62 Favored 'General case' 0 C--N 1.359 0.979 0 O-C-N 122.115 -0.366 . . . . 0.0 111.364 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -61.96 -37.57 85.27 Favored 'General case' 0 C--N 1.354 0.786 0 O-C-N 121.533 -0.729 . . . . 0.0 110.708 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.8 mt -57.47 -74.96 0.05 OUTLIER 'General case' 0 C--N 1.356 0.851 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -114.54 135.52 22.3 Favored Pre-proline 0 N--CA 1.441 -0.921 0 C-N-CA 118.656 -1.218 . . . . 0.0 109.146 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -84.66 -5.91 9.87 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 123.133 2.555 . . . . 0.0 115.055 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -66.96 -36.58 82.53 Favored 'General case' 0 C--N 1.355 0.808 0 O-C-N 122.009 -0.432 . . . . 0.0 110.073 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.71 145.21 56.29 Favored 'General case' 0 C--N 1.355 0.807 0 CA-C-O 121.683 0.754 . . . . 0.0 110.139 -178.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -131.09 135.64 47.69 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.467 ' HB3' ' HD2' ' A' ' 117' ' ' PRO . 91.6 mt -127.9 155.73 77.11 Favored Pre-proline 0 N--CA 1.443 -0.791 0 CA-C-O 122.173 0.987 . . . . 0.0 109.246 -178.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' A' ' 116' ' ' LEU . 84.6 Cg_endo -81.89 -151.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.081 0 C-N-CA 123.736 2.957 . . . . 0.0 113.895 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -115.52 146.42 41.72 Favored 'General case' 0 C--N 1.362 1.126 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.629 ' CE1' HD13 ' A' ' 131' ' ' LEU . 14.1 t80 -140.6 125.57 18.34 Favored 'General case' 0 C--N 1.362 1.144 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -177.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 93.3 m -125.83 134.06 51.78 Favored 'General case' 0 C--N 1.36 1.038 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 79.0 m -113.36 131.19 56.07 Favored 'General case' 0 C--N 1.356 0.872 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.772 -178.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -117.69 141.77 48.01 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 177.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -117.75 116.57 27.28 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.528 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 87.6 mt -84.49 -25.75 28.63 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 120.686 -0.406 . . . . 0.0 109.994 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 179.2 -144.26 6.11 Favored Glycine 0 C--N 1.349 1.251 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -94.68 -40.88 9.57 Favored 'General case' 0 N--CA 1.436 -1.137 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.567 -178.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -99.17 2.31 45.72 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.614 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.528 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 8.4 m-20 -121.72 131.63 54.18 Favored 'General case' 0 C--N 1.358 0.961 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.5 mm -140.91 137.43 34.7 Favored 'Isoleucine or valine' 0 C--N 1.354 0.797 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 61.9 mtm180 -123.78 140.35 53.08 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 1.038 HD23 HD11 ' A' ' 177' ' ' ILE . 1.1 pp -127.79 129.43 47.01 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -99.49 133.96 43.06 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -129.67 120.32 24.99 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -178.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.578 ' HA ' ' O ' ' A' ' 171' ' ' THR . 74.2 mt-30 -114.25 115.08 26.85 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 18.1 t -161.69 152.01 17.32 Favored 'General case' 0 C--N 1.359 0.991 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -92.02 2.22 56.7 Favored 'General case' 0 C--N 1.358 0.939 0 C-N-CA 120.15 -0.62 . . . . 0.0 109.937 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -134.4 73.03 69.62 Favored Pre-proline 0 C--N 1.355 0.81 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -96.19 110.01 0.12 Allowed 'Trans proline' 0 N--CA 1.445 -1.368 0 C-N-CA 122.714 2.276 . . . . 0.0 116.079 -177.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -113.64 113.93 25.73 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 176.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.08 -38.7 92.0 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.264 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.3 m -62.41 -27.07 68.84 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 121.871 -0.518 . . . . 0.0 110.731 -178.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -76.02 -47.94 22.89 Favored 'General case' 0 C--N 1.351 0.64 0 C-N-CA 120.196 -0.602 . . . . 0.0 109.702 -178.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.68 -40.17 94.93 Favored 'General case' 0 C--N 1.358 0.949 0 O-C-N 122.17 -0.331 . . . . 0.0 111.269 -178.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -62.82 -36.54 83.52 Favored 'General case' 0 C--N 1.355 0.818 0 O-C-N 121.92 -0.487 . . . . 0.0 110.088 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.3 -42.81 98.94 Favored Glycine 0 C--N 1.347 1.171 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.0 mt -69.75 -40.93 75.86 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 96.0 mt -71.69 -42.34 67.55 Favored 'General case' 0 C--N 1.363 1.168 0 O-C-N 121.091 -1.006 . . . . 0.0 111.086 -176.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.506 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 37.2 t70 -69.3 -31.78 70.49 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 121.887 -0.508 . . . . 0.0 110.484 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -62.66 -39.26 97.69 Favored Glycine 0 C--N 1.356 1.658 0 N-CA-C 108.62 -1.792 . . . . 0.0 108.62 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' CYS . . . . . 0.413 ' HA ' ' CE2' ' A' ' 75' ' ' PHE . 42.8 t -60.42 -42.55 96.27 Favored 'General case' 0 C--N 1.35 0.625 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -74.55 -1.6 22.14 Favored 'General case' 0 C--N 1.36 1.058 0 O-C-N 121.72 -0.612 . . . . 0.0 109.458 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.506 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 77.7 mm-40 -83.56 -46.9 11.89 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -65.87 -45.04 83.59 Favored 'General case' 0 C--N 1.36 1.036 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -68.96 -26.15 64.91 Favored 'General case' 0 C--N 1.362 1.126 0 O-C-N 121.75 -0.594 . . . . 0.0 110.796 -178.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 86.2 tttt 72.73 75.92 0.15 Allowed 'General case' 0 C--N 1.359 0.989 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -143.7 -168.28 2.8 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -152.24 92.99 1.76 Allowed 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 16.3 m-30 -112.38 161.93 16.13 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 93.7 m -118.5 125.95 50.97 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 119.293 -0.963 . . . . 0.0 109.234 -177.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.5 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.6 mp -104.61 122.33 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 178.169 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.6 m -120.52 -171.3 2.15 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-O 121.665 0.745 . . . . 0.0 109.241 -178.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.49 ' HD2' ' HG3' ' A' ' 167' ' ' GLN . 5.9 ptt85 -152.0 161.6 42.39 Favored 'General case' 0 C--N 1.357 0.897 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 56.8 p -107.95 143.9 28.28 Favored Pre-proline 0 C--N 1.36 1.049 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.878 ' HA ' ' HB2' ' A' ' 167' ' ' GLN . 56.7 Cg_endo -75.15 -7.86 19.4 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 123.204 2.603 . . . . 0.0 115.578 -178.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -71.6 -41.42 68.96 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 36.5 p -116.89 16.03 15.2 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.878 ' HB2' ' HA ' ' A' ' 164' ' ' PRO . 37.6 tt0 -58.38 -39.02 78.5 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.323 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -113.23 49.04 0.98 Allowed 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 20.7 t -139.11 142.24 38.09 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.618 ' O ' ' HB ' ' A' ' 171' ' ' THR . 61.8 mt-10 -96.52 163.7 12.93 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.618 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 18.6 m 84.12 -56.71 0.13 Allowed 'General case' 0 C--N 1.369 1.418 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.657 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -110.79 118.8 37.13 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.924 -178.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 99.6 t -132.01 133.4 60.83 Favored 'Isoleucine or valine' 0 C--N 1.358 0.963 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 49.2 mm -112.03 125.84 69.36 Favored 'Isoleucine or valine' 0 C--N 1.36 1.03 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.576 ' HB2' ' HG ' ' A' ' 131' ' ' LEU . 96.8 m-85 -116.07 148.75 39.91 Favored 'General case' 0 C--N 1.359 0.996 0 CA-C-O 121.901 0.857 . . . . 0.0 109.063 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -126.55 119.87 28.2 Favored 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 1.038 HD11 HD23 ' A' ' 131' ' ' LEU . 4.0 mp -115.42 121.58 67.52 Favored 'Isoleucine or valine' 0 C--N 1.354 0.795 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 38.0 p -126.11 159.55 32.55 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 121.429 0.633 . . . . 0.0 110.811 -178.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 77.3 mtm180 -95.45 115.41 27.39 Favored 'General case' 0 C--N 1.367 1.365 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 177.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.437 ' HA ' ' HD3' ' A' ' 181' ' ' PRO . . . -67.44 146.56 98.74 Favored Pre-proline 0 C--N 1.357 0.912 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 177.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 180' ' ' ALA . 50.1 Cg_exo -55.85 125.54 19.46 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.521 2.148 . . . . 0.0 113.756 -179.023 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 6.8 ppt_? -151.18 170.68 18.86 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.476 ' O ' ' HB3' ' A' ' 184' ' ' ALA . . . 92.76 82.23 1.49 Allowed Glycine 0 C--N 1.351 1.394 0 N-CA-C 107.898 -2.081 . . . . 0.0 107.898 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.672 ' O ' ' HB2' ' A' ' 185' ' ' GLU . . . 81.62 -93.56 0.01 OUTLIER 'General case' 0 C--N 1.358 0.958 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.672 ' HB2' ' O ' ' A' ' 184' ' ' ALA . 35.1 tt0 150.85 84.21 0.0 OUTLIER 'General case' 0 C--N 1.365 1.263 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -112.71 112.28 23.67 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 178.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 59.4 tp -74.29 -47.11 36.87 Favored 'General case' 0 C--N 1.356 0.858 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -161.71 -80.76 0.04 OUTLIER 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -127.42 -69.24 0.75 Allowed 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 . . . . . 0 C--O 1.264 1.852 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 179.897 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 201' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 202' ' ' HEM . . . . . 1.042 ' C3B' HD11 ' A' ' 99' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.894 ' HG3' ' CMD' ' A' ' 202' ' ' HEM . 55.7 mtp . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.089 0.471 . . . . 0.0 110.228 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.39 -17.86 55.85 Favored 'General case' 0 C--N 1.355 0.839 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -178.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -76.33 -41.12 26.72 Favored Glycine 0 C--N 1.349 1.256 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 14.5 tpp -69.12 -38.68 79.02 Favored 'General case' 0 C--N 1.355 0.827 0 O-C-N 121.946 -0.738 . . . . 0.0 110.612 -177.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.5 m -68.25 -22.83 27.85 Favored 'Isoleucine or valine' 0 C--N 1.357 0.903 0 C-N-CA 120.27 -0.572 . . . . 0.0 109.617 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -70.57 -35.58 73.15 Favored 'General case' 0 C--N 1.356 0.876 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 85.5 m -67.15 -40.85 86.77 Favored 'General case' 0 C--N 1.355 0.814 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.43 -39.39 97.73 Favored Glycine 0 C--N 1.359 1.814 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.583 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -64.62 -39.6 93.99 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-N 117.131 0.465 . . . . 0.0 110.711 -178.481 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.438 ' SD ' HD11 ' A' ' 26' ' ' LEU . 25.8 mmt -63.43 -40.44 97.18 Favored 'General case' 0 C--N 1.352 0.684 0 O-C-N 121.679 -0.638 . . . . 0.0 110.984 -178.361 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -66.88 -40.22 87.75 Favored 'General case' 0 C--N 1.349 0.571 0 O-C-N 121.956 -0.465 . . . . 0.0 111.362 -177.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 53.7 tp -66.42 -42.83 87.2 Favored 'General case' 0 C--N 1.35 0.588 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -178.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.583 HG12 ' O ' ' A' ' 9' ' ' LEU . 1.4 mm -74.99 -36.76 39.52 Favored 'Isoleucine or valine' 0 C--N 1.359 1.008 0 O-C-N 120.988 -1.07 . . . . 0.0 111.002 -175.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -68.18 -43.66 77.65 Favored 'General case' 0 C--N 1.353 0.729 0 O-C-N 121.723 -0.611 . . . . 0.0 111.555 -176.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -71.22 -35.27 71.43 Favored 'General case' 0 N--CA 1.446 -0.634 0 O-C-N 121.974 -0.454 . . . . 0.0 111.909 -176.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -72.69 -48.56 38.02 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -175.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -126.41 -20.9 4.3 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 117.349 -1.741 . . . . 0.0 113.816 -176.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 141.36 179.6 18.7 Favored Glycine 0 CA--C 1.497 -1.078 0 C-N-CA 117.789 -2.148 . . . . 0.0 109.884 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -97.16 -12.26 23.29 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -177.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -70.64 -41.08 72.65 Favored 'General case' 0 C--N 1.36 1.05 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 94.5 m -69.51 -39.05 77.79 Favored 'General case' 0 C--N 1.357 0.932 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.463 HD13 ' HB ' ' A' ' 13' ' ' ILE . 59.1 tp -61.17 -37.99 84.87 Favored 'General case' 0 C--N 1.357 0.905 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -65.17 -35.71 81.94 Favored 'General case' 0 C--N 1.356 0.851 0 O-C-N 122.177 -0.327 . . . . 0.0 110.802 -178.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.5 m -63.71 -40.74 97.53 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.435 ' CD2' ' HB3' ' A' ' 54' ' ' LYS . 87.6 mt -64.87 -37.97 89.4 Favored 'General case' 0 C--N 1.356 0.874 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.444 HD23 ' CD2' ' A' ' 31' ' ' LEU . 6.7 mp -69.39 -14.8 63.1 Favored 'General case' 0 C--N 1.357 0.922 0 O-C-N 121.415 -0.803 . . . . 0.0 109.802 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -85.84 -28.38 24.47 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.224 178.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 55.0 p -68.18 -23.11 64.82 Favored 'General case' 0 C--N 1.361 1.066 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.3 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.0 p -106.96 -33.6 7.45 Favored 'General case' 0 C--N 1.357 0.912 0 C-N-CA 118.933 -1.107 . . . . 0.0 108.141 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 83.63 132.56 0.05 OUTLIER 'General case' 0 C--N 1.361 1.106 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.457 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -100.53 109.63 21.75 Favored 'General case' 0 C--N 1.357 0.896 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.737 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -72.23 -40.71 67.55 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 178.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.43 ' HB3' ' H ' ' A' ' 34' ' ' GLU . 0.9 OUTLIER -116.09 -86.22 0.62 Allowed 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -179.212 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.43 ' H ' ' HB3' ' A' ' 33' ' ' SER . 57.4 mt-10 -122.14 -40.88 2.46 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -178.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.62 -32.79 6.33 Favored Glycine 0 C--N 1.351 1.365 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 80.4 mt -109.89 104.15 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.005 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.509 ' HD1' ' HA ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -82.89 -143.44 0.06 Allowed 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.337 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 86.2 m -109.82 -56.89 2.26 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.5 p 166.03 16.57 0.0 OUTLIER 'General case' 0 C--N 1.363 1.161 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 23.3 m -109.79 6.48 8.97 Favored 'Isoleucine or valine' 0 C--N 1.353 0.738 0 C-N-CA 119.522 -0.871 . . . . 0.0 111.313 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -91.75 143.67 16.71 Favored Glycine 0 C--N 1.354 1.533 0 C-N-CA 119.223 -1.465 . . . . 0.0 109.505 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 57.0 m -126.61 130.19 50.0 Favored 'General case' 0 C--N 1.356 0.871 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -125.27 174.52 8.06 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -76.07 -179.0 4.69 Favored 'General case' 0 C--N 1.356 0.864 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -86.44 -19.87 28.98 Favored 'General case' 0 C--N 1.356 0.876 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.744 ' HA ' HD23 ' A' ' 49' ' ' LEU . 38.1 tt0 -63.98 -35.5 80.9 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.0 tp10 -61.59 -40.55 95.21 Favored 'General case' 0 C--N 1.349 0.572 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 60.4 tp -65.38 -40.29 93.32 Favored 'General case' 0 C--N 1.357 0.896 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.691 -178.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.744 HD23 ' HA ' ' A' ' 46' ' ' GLN . 0.1 OUTLIER -83.45 -14.57 52.23 Favored 'General case' 0 C--N 1.352 0.71 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.131 -177.226 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -71.62 -43.57 65.95 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.8 mt -73.24 -34.93 66.14 Favored 'General case' 0 C--N 1.361 1.083 0 C-N-CA 120.17 -0.612 . . . . 0.0 109.704 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 50.3 t -63.91 -41.41 92.42 Favored 'Isoleucine or valine' 0 C--N 1.352 0.697 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 49' ' ' LEU . 52.9 t -65.84 -40.74 88.46 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 O-C-N 121.761 -0.587 . . . . 0.0 109.962 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.435 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 24.6 tptt -67.65 -20.29 65.3 Favored 'General case' 0 C--N 1.36 1.054 0 O-C-N 120.939 -1.101 . . . . 0.0 108.863 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.83 -37.47 70.3 Favored 'General case' 0 C--N 1.353 0.745 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.471 ' O ' ' HA ' ' A' ' 60' ' ' SER . 81.2 p -73.04 -17.32 61.45 Favored 'General case' 0 C--N 1.356 0.852 0 O-C-N 121.766 -0.584 . . . . 0.0 110.285 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -99.51 -37.56 9.13 Favored 'General case' 0 C--N 1.355 0.805 0 O-C-N 121.305 -0.872 . . . . 0.0 111.325 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.1 p -71.85 -34.7 52.24 Favored 'Isoleucine or valine' 0 C--N 1.353 0.723 0 O-C-N 121.709 -0.619 . . . . 0.0 111.52 -177.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.559 ' HB3' HG23 ' A' ' 61' ' ' VAL . 4.3 t -119.99 -8.74 9.75 Favored 'General case' 0 CA--C 1.508 -0.671 0 C-N-CA 119.26 -0.976 . . . . 0.0 109.849 -178.045 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.471 ' HA ' ' O ' ' A' ' 56' ' ' SER . 0.6 OUTLIER 66.65 47.78 1.54 Allowed 'General case' 0 C--N 1.353 0.737 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 179.61 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.559 HG23 ' HB3' ' A' ' 59' ' ' SER . 47.6 t -107.44 133.35 20.41 Favored Pre-proline 0 CA--C 1.505 -0.773 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.408 ' O ' ' HB3' ' A' ' 66' ' ' LEU . 41.9 Cg_exo -57.38 147.21 78.89 Favored 'Trans proline' 0 CA--C 1.498 -1.3 0 C-N-CA 122.505 2.137 . . . . 0.0 112.794 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.4 m -75.9 -13.61 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.826 -178.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.425 ' O ' HG12 ' A' ' 67' ' ' VAL . 69.0 p -97.54 -32.77 11.64 Favored 'General case' 0 C--N 1.36 1.055 0 C-N-CA 118.176 -1.41 . . . . 0.0 109.533 -178.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -76.6 -21.47 55.52 Favored 'General case' 0 C--N 1.354 0.776 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.408 ' HB3' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -82.05 -35.57 28.6 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.139 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.425 HG12 ' O ' ' A' ' 64' ' ' THR . 1.3 p -68.92 -26.43 32.52 Favored 'Isoleucine or valine' 0 C--N 1.354 0.795 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.914 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.5 mmm-85 -73.04 -52.5 14.13 Favored 'General case' 0 C--N 1.36 1.055 0 O-C-N 121.596 -0.69 . . . . 0.0 110.124 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 86.1 mt -63.37 -35.93 82.04 Favored 'General case' 0 C--N 1.357 0.929 0 O-C-N 121.991 -0.443 . . . . 0.0 110.979 -178.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -60.92 -47.27 87.17 Favored 'General case' 0 C--N 1.349 0.555 0 O-C-N 122.258 -0.276 . . . . 0.0 110.494 -178.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.54 -37.94 94.13 Favored Glycine 0 C--N 1.356 1.641 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -62.47 -49.33 75.85 Favored 'General case' 0 C--N 1.35 0.622 0 CA-C-N 118.044 0.922 . . . . 0.0 111.485 -177.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.689 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 11.9 mttm -64.36 -47.72 78.25 Favored 'General case' 0 C--N 1.359 0.996 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -177.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -68.5 -38.84 81.31 Favored 'General case' 0 C--N 1.347 0.5 0 O-C-N 121.265 -0.897 . . . . 0.0 112.004 -175.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -64.84 -42.85 94.59 Favored 'General case' 0 C--N 1.352 0.703 0 O-C-N 121.116 -0.99 . . . . 0.0 111.077 -177.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.7 -15.43 18.28 Favored 'Isoleucine or valine' 0 C--N 1.36 1.057 0 O-C-N 121.324 -0.86 . . . . 0.0 109.114 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.689 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 74.1 mm-40 -71.88 -38.71 69.97 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 84.5 mt -74.32 -29.69 61.72 Favored 'General case' 0 C--N 1.358 0.967 0 O-C-N 122.215 -0.303 . . . . 0.0 110.749 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.4 mm -66.41 -53.28 37.72 Favored 'Isoleucine or valine' 0 C--N 1.357 0.91 0 C-N-CA 119.973 -0.691 . . . . 0.0 109.973 -177.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -76.08 -14.71 60.19 Favored 'General case' 0 C--N 1.351 0.651 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.39 178.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.0 -36.93 64.47 Favored Glycine 0 C--N 1.349 1.267 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.483 ' HA ' ' HD2' ' A' ' 83' ' ' PRO . 98.6 m-70 -131.86 105.52 14.01 Favored Pre-proline 0 N--CA 1.44 -0.968 0 CA-C-O 122.604 1.192 . . . . 0.0 108.911 -177.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.483 ' HD2' ' HA ' ' A' ' 82' ' ' HIS . 41.4 Cg_endo -68.87 -23.29 35.24 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.637 2.225 . . . . 0.0 114.052 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -90.61 -9.64 46.24 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.3 tp -89.52 -21.75 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 -178.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -102.24 -17.4 15.96 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 51.3 t30 -70.84 -41.28 71.68 Favored 'General case' 0 C--N 1.359 0.999 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -66.13 -33.48 75.86 Favored 'General case' 0 C--N 1.352 0.699 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.318 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.538 ' HG2' ' N ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -80.87 149.97 29.28 Favored 'General case' 0 C--N 1.353 0.745 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 -179.029 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.538 ' N ' ' HG2' ' A' ' 89' ' ' MET . 1.4 mtpt -117.56 -24.69 7.2 Favored 'General case' 0 C--N 1.361 1.1 0 C-N-CA 120.07 -0.652 . . . . 0.0 111.183 -177.247 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -165.83 171.88 12.29 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -177.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.428 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 57.8 m -67.26 -39.44 86.1 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.486 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.648 ' HZ ' ' HG3' ' A' ' 179' ' ' ARG . 64.7 m-85 -67.77 -39.14 84.15 Favored 'General case' 0 C--N 1.358 0.94 0 O-C-N 121.216 -0.928 . . . . 0.0 108.681 -179.27 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -66.16 -22.79 66.38 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.428 ' HB3' ' O ' ' A' ' 92' ' ' SER . 62.0 tp -65.2 -45.13 85.99 Favored 'General case' 0 C--N 1.357 0.929 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.3 mp -61.44 -36.5 80.54 Favored 'General case' 0 C--N 1.358 0.956 0 O-C-N 122.001 -0.437 . . . . 0.0 110.239 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 34.7 t -67.77 -39.79 84.09 Favored 'General case' 0 C--N 1.349 0.549 0 O-C-N 121.829 -0.545 . . . . 0.0 110.021 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.2 tttp -93.78 8.1 42.38 Favored 'General case' 0 C--N 1.353 0.75 0 O-C-N 122.286 -0.259 . . . . 0.0 111.279 -176.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 1.053 HD11 ' C2B' ' A' ' 202' ' ' HEM . 15.6 tt -64.29 -38.18 81.85 Favored 'Isoleucine or valine' 0 C--N 1.36 1.033 0 O-C-N 121.464 -0.773 . . . . 0.0 111.694 -176.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -107.87 -15.79 14.46 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 118.181 -1.408 . . . . 0.0 110.195 -178.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.9 t -64.83 -46.6 81.25 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 121.76 -0.588 . . . . 0.0 111.272 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -137.32 -15.12 1.47 Allowed 'General case' 0 C--N 1.36 1.058 0 C-N-CA 117.497 -1.681 . . . . 0.0 112.684 -177.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.518 HG21 ' C1C' ' A' ' 202' ' ' HEM . 31.0 mm -71.0 -51.74 32.99 Favored 'Isoleucine or valine' 0 C--N 1.352 0.682 0 CA-C-N 119.982 1.265 . . . . 0.0 110.715 -177.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -92.03 2.88 56.28 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 119.529 -0.869 . . . . 0.0 110.22 -177.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 49.5 t -85.79 -44.37 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.083 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 178.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 54.7 tp10 -68.1 -40.41 82.62 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.502 HG11 HMD1 ' A' ' 202' ' ' HEM . 66.6 t -63.84 -46.28 94.75 Favored 'Isoleucine or valine' 0 C--N 1.356 0.889 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.074 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 92.4 t80 -60.94 -48.51 81.5 Favored 'General case' 0 C--N 1.359 1.019 0 O-C-N 122.06 -0.4 . . . . 0.0 111.322 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -61.28 -37.12 82.02 Favored 'General case' 0 C--N 1.357 0.896 0 O-C-N 121.567 -0.708 . . . . 0.0 110.596 -178.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 15.5 mt -56.68 -72.94 0.07 Allowed 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.408 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 88.3 m-85 -121.9 135.16 25.05 Favored Pre-proline 0 N--CA 1.438 -1.061 0 C-N-CA 118.488 -1.285 . . . . 0.0 108.638 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 111' ' ' TYR . 97.7 Cg_endo -83.47 -2.56 10.55 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 123.197 2.598 . . . . 0.0 115.255 -178.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 29.7 mm100 -66.07 -37.16 85.13 Favored 'General case' 0 C--N 1.354 0.778 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.61 145.8 55.2 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-O 121.614 0.721 . . . . 0.0 109.846 -178.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -127.54 134.07 49.76 Favored 'General case' 0 C--N 1.357 0.922 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.485 ' HB3' ' HD2' ' A' ' 117' ' ' PRO . 86.8 mt -128.25 156.43 76.67 Favored Pre-proline 0 C--N 1.354 0.769 0 CA-C-O 122.116 0.96 . . . . 0.0 109.21 -178.596 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' A' ' 116' ' ' LEU . 95.3 Cg_endo -84.05 -153.67 0.05 OUTLIER 'Trans proline' 0 C--N 1.318 -1.074 0 C-N-CA 123.763 2.975 . . . . 0.0 114.317 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -116.66 143.79 45.21 Favored 'General case' 0 C--N 1.364 1.233 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -126.3 130.78 51.51 Favored 'General case' 0 C--N 1.364 1.203 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -178.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.494 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 94.1 m -127.52 129.18 46.93 Favored 'General case' 0 C--N 1.358 0.951 0 N-CA-C 105.739 -1.949 . . . . 0.0 105.739 177.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 77.2 m -122.88 131.47 53.76 Favored 'General case' 0 CA--C 1.504 -0.794 0 C-N-CA 119.178 -1.009 . . . . 0.0 109.855 -178.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -120.03 132.43 55.46 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 106.325 -1.732 . . . . 0.0 106.325 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -105.28 117.27 33.59 Favored 'General case' 0 C--N 1.353 0.729 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 95.2 mt -88.42 -19.84 26.02 Favored 'General case' 0 C--N 1.354 0.781 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.464 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 176.75 -146.74 8.05 Favored Glycine 0 C--N 1.348 1.229 0 C-N-CA 118.905 -1.617 . . . . 0.0 109.06 -178.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -94.82 -39.31 10.32 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -178.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -101.27 0.69 37.78 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.24 -178.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.412 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 66.2 m-20 -118.49 130.74 56.11 Favored 'General case' 0 C--N 1.358 0.955 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.0 mm -141.9 136.79 30.65 Favored 'Isoleucine or valine' 0 C--N 1.355 0.829 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 52.2 mtm180 -118.21 137.87 52.71 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 5.6 tp -125.0 119.14 27.86 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.494 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 13.7 m-70 -99.68 134.15 42.99 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.456 ' HE2' ' HG ' ' A' ' 135' ' ' SER . 32.0 t80 -129.22 121.58 27.94 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 -178.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.442 ' HA ' ' O ' ' A' ' 171' ' ' THR . 27.7 mt-30 -114.96 111.47 21.2 Favored 'General case' 0 C--N 1.357 0.916 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.54 ' O ' ' HA ' ' A' ' 171' ' ' THR . 87.6 p -160.72 161.99 32.39 Favored 'General case' 0 C--N 1.358 0.964 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -98.8 3.59 47.47 Favored 'General case' 0 C--N 1.354 0.796 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 10.8 mtp180 -133.42 74.08 72.24 Favored Pre-proline 0 C--N 1.353 0.75 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -94.74 102.25 0.12 Allowed 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 122.799 2.332 . . . . 0.0 115.926 -177.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -110.11 109.11 19.53 Favored 'General case' 0 CA--C 1.502 -0.904 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 176.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.88 -39.31 93.9 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.679 -178.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 74.3 m -62.92 -27.24 69.24 Favored 'General case' 0 C--N 1.354 0.763 0 O-C-N 121.813 -0.554 . . . . 0.0 110.762 -178.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -76.03 -46.49 29.06 Favored 'General case' 0 N--CA 1.444 -0.757 0 O-C-N 121.719 -0.613 . . . . 0.0 109.65 -178.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.19 -39.93 95.03 Favored 'General case' 0 C--N 1.359 1.01 0 O-C-N 122.124 -0.36 . . . . 0.0 111.234 -178.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -62.79 -36.95 84.81 Favored 'General case' 0 C--N 1.356 0.864 0 O-C-N 121.904 -0.498 . . . . 0.0 109.919 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.07 -43.05 98.64 Favored Glycine 0 C--N 1.348 1.205 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.8 mt -70.54 -40.84 73.19 Favored 'General case' 0 C--N 1.352 0.681 0 CA-C-N 117.606 0.703 . . . . 0.0 112.887 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 97.8 mt -71.04 -42.69 69.17 Favored 'General case' 0 C--N 1.362 1.142 0 O-C-N 121.118 -0.989 . . . . 0.0 110.945 -176.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -70.43 -29.95 66.68 Favored 'General case' 0 N--CA 1.445 -0.675 0 O-C-N 122.015 -0.428 . . . . 0.0 110.486 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.504 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -63.04 -39.69 98.35 Favored Glycine 0 C--N 1.357 1.735 0 N-CA-C 108.394 -1.882 . . . . 0.0 108.394 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 48.8 t -61.16 -42.56 98.78 Favored 'General case' 0 C--N 1.351 0.639 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -75.8 1.87 13.75 Favored 'General case' 0 C--N 1.361 1.071 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.504 ' HB2' ' O ' ' A' ' 149' ' ' GLY . 15.5 mm-40 -87.12 -45.56 10.58 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -66.45 -44.55 82.51 Favored 'General case' 0 C--N 1.359 0.984 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.439 ' O ' ' HB2' ' A' ' 155' ' ' LYS . 50.6 m-85 -70.15 -25.45 63.46 Favored 'General case' 0 C--N 1.361 1.108 0 O-C-N 121.84 -0.537 . . . . 0.0 111.119 -178.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 154' ' ' PHE . 97.3 mttt 71.6 66.07 0.15 Allowed 'General case' 0 C--N 1.363 1.168 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 -177.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -128.68 -177.44 4.19 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -140.98 95.18 2.8 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -117.27 154.29 31.46 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 93.5 m -119.63 126.47 51.25 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.526 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.5 mp -103.82 122.45 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 179.056 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 3.0 m -118.15 -174.84 2.73 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-O 121.797 0.808 . . . . 0.0 109.29 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.11 155.38 42.12 Favored 'General case' 0 C--N 1.356 0.874 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -178.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 63.8 p -98.79 146.86 32.36 Favored Pre-proline 0 C--N 1.36 1.062 0 CA-C-O 122.502 1.144 . . . . 0.0 108.359 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.668 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 76.9 Cg_endo -76.9 -11.22 18.16 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 123.006 2.47 . . . . 0.0 114.971 -178.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -72.09 -41.79 66.91 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 120.193 -0.603 . . . . 0.0 109.583 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 39.0 p -116.06 14.57 16.06 Favored 'General case' 0 CA--C 1.505 -0.786 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.381 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.668 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.3 pp0? -68.38 -10.27 53.92 Favored 'General case' 0 C--N 1.351 0.665 0 O-C-N 121.525 -0.734 . . . . 0.0 110.083 178.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 55.6 p30 -121.57 35.16 4.96 Favored 'General case' 0 N--CA 1.435 -1.198 0 O-C-N 121.16 -0.962 . . . . 0.0 109.48 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 94.1 p -145.51 157.83 43.94 Favored 'General case' 0 C--N 1.353 0.736 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.619 ' O ' ' HB ' ' A' ' 171' ' ' THR . 60.0 mt-10 -106.96 170.2 8.09 Favored 'General case' 0 C--N 1.356 0.856 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -179.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.619 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 6.1 m 82.79 -53.96 0.19 Allowed 'General case' 0 C--N 1.37 1.489 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.62 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -115.64 117.59 30.73 Favored 'General case' 0 CA--C 1.505 -0.763 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.655 -178.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 94.9 t -130.38 132.8 64.62 Favored 'Isoleucine or valine' 0 C--N 1.357 0.917 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 49.8 mm -107.23 127.02 63.33 Favored 'Isoleucine or valine' 0 C--N 1.359 1.0 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -115.42 155.28 27.72 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 122.139 0.971 . . . . 0.0 108.688 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -138.21 119.11 14.24 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -178.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.0 mp -114.03 119.22 60.61 Favored 'Isoleucine or valine' 0 C--N 1.355 0.807 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 89.4 m -122.02 144.51 48.85 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -177.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.648 ' HG3' ' HZ ' ' A' ' 93' ' ' PHE . 3.8 mtm180 -86.8 115.48 24.26 Favored 'General case' 0 C--N 1.367 1.358 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -65.9 150.54 96.38 Favored Pre-proline 0 C--N 1.358 0.945 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 178.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.51 132.06 26.24 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 121.995 1.797 . . . . 0.0 114.173 -178.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.478 HH11 ' HD2' ' A' ' 182' ' ' ARG . 4.9 mtm105 -126.45 66.56 1.23 Allowed 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 179.295 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 77.0 58.41 3.44 Favored Glycine 0 N--CA 1.441 -0.993 0 N-CA-C 108.019 -2.032 . . . . 0.0 108.019 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 170.13 71.83 0.0 OUTLIER 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -114.76 99.8 7.77 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -116.02 121.85 43.45 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 81.4 mt -98.26 -50.33 4.38 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' TYR . . . . . 0.466 ' HB3' ' H ' ' A' ' 189' ' ' PHE . 2.7 t80 -160.75 -85.84 0.03 OUTLIER 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' PHE . . . . . 0.466 ' H ' ' HB3' ' A' ' 188' ' ' TYR . 89.7 t80 -138.79 130.7 27.92 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 . . . . . 0 C--O 1.264 1.852 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.974 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 201' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 202' ' ' HEM . . . . . 1.053 ' C2B' HD11 ' A' ' 99' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.927 ' HG2' HMD3 ' A' ' 202' ' ' HEM . 81.4 mmm . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 120.821 0.343 . . . . 0.0 110.19 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.409 ' HA ' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -78.5 -22.68 47.06 Favored 'General case' 0 C--N 1.356 0.856 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -178.943 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.66 -40.56 45.82 Favored Glycine 0 C--N 1.35 1.348 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.1 tpp -70.27 -37.0 74.78 Favored 'General case' 0 C--N 1.354 0.792 0 O-C-N 122.132 -0.628 . . . . 0.0 110.865 -177.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.409 HG22 ' HA ' ' A' ' 2' ' ' MET . 27.0 m -71.17 -22.71 22.73 Favored 'Isoleucine or valine' 0 C--N 1.357 0.895 0 O-C-N 121.642 -0.661 . . . . 0.0 109.524 -179.008 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.445 ' HZ ' ' CG ' ' A' ' 47' ' ' GLU . 2.2 m-85 -70.8 -35.23 72.43 Favored 'General case' 0 C--N 1.357 0.915 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 85.4 m -66.95 -40.63 87.59 Favored 'General case' 0 C--N 1.354 0.795 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.13 -38.76 97.06 Favored Glycine 0 C--N 1.358 1.785 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.518 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -65.94 -39.85 90.85 Favored 'General case' 0 C--N 1.352 0.686 0 CA-C-N 117.241 0.521 . . . . 0.0 110.608 -178.087 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.442 ' CE ' HD21 ' A' ' 26' ' ' LEU . 24.8 mmt -64.73 -40.12 94.79 Favored 'General case' 0 C--N 1.354 0.775 0 O-C-N 121.591 -0.693 . . . . 0.0 110.707 -178.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -65.86 -39.93 91.19 Favored 'General case' 0 C--N 1.349 0.569 0 O-C-N 122.107 -0.37 . . . . 0.0 111.303 -178.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 56.3 tp -65.81 -42.86 90.15 Favored 'General case' 0 C--N 1.349 0.572 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -178.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.518 HG12 ' O ' ' A' ' 9' ' ' LEU . 1.9 mm -74.5 -35.38 38.45 Favored 'Isoleucine or valine' 0 C--N 1.361 1.073 0 O-C-N 121.031 -1.043 . . . . 0.0 110.746 -175.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -72.0 -42.54 66.3 Favored 'General case' 0 C--N 1.349 0.55 0 O-C-N 121.648 -0.657 . . . . 0.0 111.475 -176.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -70.95 -36.68 72.7 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -176.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -101.1 -25.06 14.17 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 118.725 -1.19 . . . . 0.0 113.628 -174.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -114.8 -36.43 4.5 Favored 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 117.606 -1.638 . . . . 0.0 112.288 -176.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 145.03 177.98 20.26 Favored Glycine 0 C--N 1.348 1.227 0 C-N-CA 118.176 -1.964 . . . . 0.0 110.314 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -99.33 -25.89 14.34 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 -177.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -70.14 -39.15 75.56 Favored 'General case' 0 C--N 1.358 0.937 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.1 m -67.64 -39.33 84.62 Favored 'General case' 0 C--N 1.357 0.919 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.7 tt -60.21 -38.66 84.02 Favored 'General case' 0 C--N 1.357 0.933 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -64.16 -36.82 85.28 Favored 'General case' 0 C--N 1.355 0.821 0 O-C-N 122.081 -0.387 . . . . 0.0 110.901 -178.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 88.2 m -65.0 -40.35 94.82 Favored 'General case' 0 C--N 1.354 0.775 0 O-C-N 121.638 -0.664 . . . . 0.0 109.55 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 88.6 mt -63.74 -38.17 90.09 Favored 'General case' 0 C--N 1.355 0.847 0 O-C-N 122.023 -0.423 . . . . 0.0 109.941 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.442 HD21 ' CE ' ' A' ' 10' ' ' MET . 82.5 mt -70.53 -17.35 62.94 Favored 'General case' 0 C--N 1.36 1.028 0 O-C-N 121.532 -0.73 . . . . 0.0 110.373 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -85.56 -27.38 25.58 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.488 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.5 t -66.09 -36.71 83.91 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 99.5 m -96.5 -35.67 11.05 Favored 'General case' 0 C--N 1.357 0.902 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -178.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 83.31 136.12 0.06 Allowed 'General case' 0 C--N 1.358 0.969 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.538 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -84.8 -171.41 3.62 Favored 'General case' 0 C--N 1.356 0.876 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.535 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -151.2 -24.32 0.21 Allowed 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.1 t -147.07 -67.92 0.26 Allowed 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -128.5 -50.64 1.27 Allowed 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.81 -44.5 1.36 Allowed Glycine 0 C--N 1.351 1.377 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 82.3 mt -110.38 105.18 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.971 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.44 ' HD1' ' HA ' ' A' ' 37' ' ' TYR . 0.1 OUTLIER -82.75 -142.09 0.06 Allowed 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.664 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 87.8 m -112.17 -58.77 2.09 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 52.6 p 165.59 16.92 0.0 OUTLIER 'General case' 0 C--N 1.362 1.113 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.5 t -103.26 3.63 10.64 Favored 'Isoleucine or valine' 0 C--N 1.353 0.732 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.209 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -94.34 141.71 15.68 Favored Glycine 0 C--N 1.352 1.461 0 C-N-CA 119.25 -1.452 . . . . 0.0 109.631 -178.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 50.0 m -124.55 124.73 42.89 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 178.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -117.74 174.98 5.87 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -80.83 -173.06 4.0 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -91.97 -14.85 28.82 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -69.48 -28.87 66.45 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.445 ' CG ' ' HZ ' ' A' ' 6' ' ' PHE . 20.3 tp10 -63.71 -41.28 98.11 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.461 HD22 ' O ' ' A' ' 48' ' ' LEU . 1.9 tm? -67.65 -38.74 84.23 Favored 'General case' 0 C--N 1.359 1.017 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 60.4 tp -70.05 -34.05 72.73 Favored 'General case' 0 CA--C 1.508 -0.639 0 O-C-N 122.134 -0.354 . . . . 0.0 110.141 -177.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 70.6 tp60 -65.2 -41.16 94.78 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -178.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 85.1 mt -81.51 -18.71 44.13 Favored 'General case' 0 C--N 1.362 1.121 0 O-C-N 121.558 -0.714 . . . . 0.0 110.846 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.6 t -80.6 -38.53 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 C-N-CA 119.706 -0.798 . . . . 0.0 109.124 -178.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.7 p -74.22 -31.51 29.35 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 C-N-CA 119.756 -0.778 . . . . 0.0 109.417 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.3 tptt -70.22 -26.94 64.1 Favored 'General case' 0 C--N 1.366 1.289 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.7 tt -67.98 -39.04 83.35 Favored 'General case' 0 C--N 1.353 0.735 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.507 ' O ' ' HA ' ' A' ' 60' ' ' SER . 59.9 p -72.8 -17.26 61.59 Favored 'General case' 0 C--N 1.357 0.933 0 O-C-N 121.729 -0.607 . . . . 0.0 110.916 -178.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -98.93 -37.15 9.51 Favored 'General case' 0 C--N 1.353 0.739 0 O-C-N 121.181 -0.949 . . . . 0.0 111.364 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.2 p -70.92 -35.02 57.98 Favored 'Isoleucine or valine' 0 C--N 1.351 0.672 0 O-C-N 121.712 -0.617 . . . . 0.0 111.399 -177.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.505 ' HB3' HG23 ' A' ' 61' ' ' VAL . 3.9 t -120.49 -7.57 9.67 Favored 'General case' 0 C--N 1.352 0.708 0 C-N-CA 119.118 -1.033 . . . . 0.0 110.08 -178.218 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.507 ' HA ' ' O ' ' A' ' 56' ' ' SER . 1.0 OUTLIER 66.03 46.41 2.18 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.552 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.505 HG23 ' HB3' ' A' ' 59' ' ' SER . 61.3 t -106.23 132.82 20.58 Favored Pre-proline 0 CA--C 1.506 -0.745 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.62 146.02 78.32 Favored 'Trans proline' 0 CA--C 1.497 -1.341 0 C-N-CA 122.59 2.193 . . . . 0.0 113.071 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.404 ' HA ' ' CD2' ' A' ' 66' ' ' LEU . 4.8 m -75.25 -12.89 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.792 -178.29 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.47 ' O ' HG12 ' A' ' 67' ' ' VAL . 72.2 p -96.36 -32.24 12.47 Favored 'General case' 0 C--N 1.358 0.944 0 C-N-CA 118.273 -1.371 . . . . 0.0 109.761 -178.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -80.26 -20.67 43.98 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 121.394 -0.816 . . . . 0.0 108.912 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.404 ' CD2' ' HA ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -81.0 -36.49 30.57 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -179.901 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.47 HG12 ' O ' ' A' ' 64' ' ' THR . 2.1 p -67.44 -29.86 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.678 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 -70.35 -48.81 54.7 Favored 'General case' 0 C--N 1.366 1.298 0 O-C-N 121.428 -0.795 . . . . 0.0 110.777 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.9 mt -64.14 -35.84 82.08 Favored 'General case' 0 C--N 1.355 0.84 0 O-C-N 122.033 -0.417 . . . . 0.0 110.961 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -60.8 -47.37 86.64 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 122.132 -0.355 . . . . 0.0 110.427 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.19 -39.07 96.64 Favored Glycine 0 C--N 1.354 1.579 0 N-CA-C 111.729 -0.549 . . . . 0.0 111.729 -178.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.44 -47.55 81.43 Favored 'General case' 0 C--N 1.351 0.651 0 CA-C-N 118.227 1.013 . . . . 0.0 111.462 -177.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.73 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 10.6 mttm -63.98 -50.17 69.6 Favored 'General case' 0 C--N 1.357 0.921 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -177.121 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.417 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.4 tm? -68.67 -38.96 80.77 Favored 'General case' 0 C--N 1.349 0.552 0 O-C-N 121.339 -0.85 . . . . 0.0 111.868 -175.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -63.43 -45.09 92.57 Favored 'General case' 0 C--N 1.352 0.678 0 O-C-N 121.208 -0.932 . . . . 0.0 110.965 -177.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 8.6 p -70.59 -15.71 19.19 Favored 'Isoleucine or valine' 0 C--N 1.358 0.958 0 O-C-N 121.521 -0.737 . . . . 0.0 109.366 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.73 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 75.1 mm-40 -71.28 -38.73 71.81 Favored 'General case' 0 C--N 1.35 0.608 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.7 mt -73.04 -31.66 64.58 Favored 'General case' 0 C--N 1.356 0.865 0 O-C-N 122.426 -0.171 . . . . 0.0 110.685 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.9 mm -65.06 -53.72 37.81 Favored 'Isoleucine or valine' 0 C--N 1.359 0.984 0 C-N-CA 120.081 -0.648 . . . . 0.0 110.099 -177.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -74.99 -14.98 60.68 Favored 'General case' 0 C--N 1.351 0.634 0 C-N-CA 119.554 -0.859 . . . . 0.0 109.37 178.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.58 -37.66 68.26 Favored Glycine 0 C--N 1.349 1.278 0 N-CA-C 110.971 -0.851 . . . . 0.0 110.971 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -132.45 108.3 13.38 Favored Pre-proline 0 N--CA 1.441 -0.917 0 CA-C-O 122.776 1.274 . . . . 0.0 109.232 -177.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.8 -24.58 40.38 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.596 2.197 . . . . 0.0 114.301 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -93.7 -5.05 49.4 Favored 'General case' 0 CA--C 1.5 -0.966 0 C-N-CA 119.448 -0.901 . . . . 0.0 108.776 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -89.64 -19.97 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.78 -25.18 14.21 Favored 'General case' 0 C--N 1.361 1.106 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -70.23 -35.23 73.71 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 120.207 -0.597 . . . . 0.0 109.443 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -65.42 -36.98 85.57 Favored 'General case' 0 C--N 1.355 0.837 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.415 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.558 ' HG2' ' N ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -81.52 155.05 25.96 Favored 'General case' 0 C--N 1.355 0.841 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -178.468 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.558 ' N ' ' HG2' ' A' ' 89' ' ' MET . 0.8 OUTLIER -120.36 -25.41 5.64 Favored 'General case' 0 C--N 1.364 1.199 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.031 -177.655 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -165.12 172.09 13.01 Favored 'General case' 0 C--N 1.354 0.78 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 -177.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 41.1 t -64.62 -43.16 94.61 Favored 'General case' 0 C--N 1.356 0.863 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.208 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -67.11 -39.72 86.72 Favored 'General case' 0 C--N 1.356 0.853 0 O-C-N 121.429 -0.794 . . . . 0.0 109.282 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -66.41 -23.17 66.26 Favored 'General case' 0 C--N 1.355 0.821 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.661 ' O ' HG13 ' A' ' 99' ' ' ILE . 61.2 tp -64.78 -46.28 82.78 Favored 'General case' 0 C--N 1.356 0.888 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.496 ' HA ' ' CD1' ' A' ' 99' ' ' ILE . 3.2 mp -59.94 -35.11 74.23 Favored 'General case' 0 C--N 1.36 1.035 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.5 t -69.61 -39.57 77.15 Favored 'General case' 0 C--N 1.349 0.549 0 O-C-N 121.994 -0.441 . . . . 0.0 109.934 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.1 tttp -87.32 1.37 53.47 Favored 'General case' 0 C--N 1.357 0.905 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -176.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.661 HG13 ' O ' ' A' ' 95' ' ' LEU . 81.4 mt -61.51 -47.06 95.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.868 0 CA-C-N 119.282 0.946 . . . . 0.0 111.408 -177.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -92.88 -25.67 17.98 Favored 'General case' 0 N--CA 1.442 -0.858 0 O-C-N 121.04 -1.037 . . . . 0.0 110.973 -177.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 35.0 t -63.21 -49.0 75.92 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 121.64 -0.662 . . . . 0.0 112.667 -177.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.654 ' HA ' HG12 ' A' ' 105' ' ' VAL . 16.9 t80 -139.42 -14.25 1.12 Allowed 'General case' 0 C--N 1.361 1.066 0 C-N-CA 117.274 -1.77 . . . . 0.0 113.529 -176.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.662 HG21 ' C2C' ' A' ' 202' ' ' HEM . 32.7 mm -71.77 -52.14 27.42 Favored 'Isoleucine or valine' 0 C--O 1.246 0.875 0 CA-C-N 120.659 1.572 . . . . 0.0 110.592 -177.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -91.82 2.3 56.6 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 119.659 -0.817 . . . . 0.0 110.299 -176.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.654 HG12 ' HA ' ' A' ' 102' ' ' PHE . 1.3 p -92.4 -32.47 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -72.93 -40.82 65.12 Favored 'General case' 0 C--N 1.357 0.924 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.6 p -74.99 -35.99 37.07 Favored 'Isoleucine or valine' 0 C--N 1.355 0.847 0 C-N-CA 119.231 -0.988 . . . . 0.0 109.684 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -61.23 -48.61 80.68 Favored 'General case' 0 C--N 1.365 1.245 0 O-C-N 121.727 -0.608 . . . . 0.0 110.428 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -60.35 -37.48 80.82 Favored 'General case' 0 C--N 1.358 0.961 0 O-C-N 121.694 -0.629 . . . . 0.0 110.096 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 13.4 mt -56.5 -75.07 0.04 OUTLIER 'General case' 0 C--N 1.356 0.869 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.433 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 92.6 m-85 -119.05 135.21 23.72 Favored Pre-proline 0 N--CA 1.439 -0.983 0 C-N-CA 118.855 -1.138 . . . . 0.0 108.821 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 111' ' ' TYR . 89.4 Cg_endo -84.16 -1.5 9.86 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 123.315 2.677 . . . . 0.0 115.318 -178.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -65.78 -37.24 85.76 Favored 'General case' 0 C--N 1.354 0.788 0 O-C-N 121.805 -0.56 . . . . 0.0 109.933 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.35 144.9 56.27 Favored 'General case' 0 C--N 1.353 0.734 0 CA-C-O 121.495 0.664 . . . . 0.0 109.742 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -131.45 135.96 47.57 Favored 'General case' 0 C--N 1.356 0.882 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.522 ' HB3' ' HD2' ' A' ' 117' ' ' PRO . 90.7 mt -128.45 157.17 75.61 Favored Pre-proline 0 N--CA 1.443 -0.794 0 CA-C-O 122.189 0.995 . . . . 0.0 109.286 -178.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.522 ' HD2' ' HB3' ' A' ' 116' ' ' LEU . 94.0 Cg_endo -80.29 -153.52 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.122 0 C-N-CA 123.644 2.896 . . . . 0.0 113.472 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -118.21 144.14 45.97 Favored 'General case' 0 C--N 1.362 1.148 0 C-N-CA 119.172 -1.011 . . . . 0.0 108.458 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -129.59 134.36 47.68 Favored 'General case' 0 C--N 1.361 1.081 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.49 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 94.2 m -125.05 129.32 50.03 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 177.123 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 84.4 m -116.02 127.26 54.77 Favored 'General case' 0 CA--C 1.504 -0.802 0 C-N-CA 119.094 -1.042 . . . . 0.0 109.402 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -120.36 130.77 54.55 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 57.9 ttp180 -105.16 116.98 32.87 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.49 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 90.7 mt -85.81 -24.32 26.84 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 120.709 -0.397 . . . . 0.0 109.997 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -179.6 -146.0 6.61 Favored Glycine 0 C--N 1.349 1.294 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 -178.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -94.12 -40.16 10.2 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 120.007 -0.677 . . . . 0.0 109.274 -178.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -101.69 4.25 40.5 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 119.882 -0.727 . . . . 0.0 110.406 -178.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.49 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 8.4 m-20 -120.74 130.65 54.13 Favored 'General case' 0 C--N 1.36 1.035 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.404 HD13 ' HA ' ' A' ' 129' ' ' ILE . 8.7 mm -141.49 137.71 32.51 Favored 'Isoleucine or valine' 0 C--N 1.356 0.871 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 60.3 mtm180 -124.11 138.83 54.38 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' A' ' 131' ' ' LEU . 0.1 OUTLIER -130.63 127.42 38.93 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.594 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.49 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 12.3 m170 -95.6 135.72 36.9 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 179.167 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -127.69 118.83 24.55 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 -178.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.51 ' HA ' ' O ' ' A' ' 171' ' ' THR . 29.1 tt0 -113.82 111.93 22.56 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 14.5 t -161.86 153.82 19.19 Favored 'General case' 0 C--N 1.359 0.99 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -91.47 3.36 55.16 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 120.26 -0.576 . . . . 0.0 109.893 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 93.2 mtm-85 -133.7 73.78 71.41 Favored Pre-proline 0 C--N 1.355 0.847 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 178.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -94.81 103.47 0.12 Allowed 'Trans proline' 0 N--CA 1.444 -1.426 0 C-N-CA 122.489 2.126 . . . . 0.0 115.67 -177.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -111.15 113.01 25.21 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 176.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.95 -38.75 92.23 Favored 'General case' 0 C--N 1.353 0.748 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.068 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.0 m -64.13 -26.28 68.46 Favored 'General case' 0 C--N 1.353 0.742 0 O-C-N 122.052 -0.405 . . . . 0.0 110.902 -178.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.538 ' HE2' HAA1 ' A' ' 202' ' ' HEM . 85.5 t80 -76.47 -47.41 23.04 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 121.669 -0.645 . . . . 0.0 109.666 -178.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.88 -39.49 93.62 Favored 'General case' 0 C--N 1.357 0.919 0 O-C-N 122.071 -0.393 . . . . 0.0 110.8 -178.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.34 -36.83 85.01 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 122.029 -0.419 . . . . 0.0 109.901 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.44 -43.25 98.93 Favored Glycine 0 C--N 1.348 1.201 0 N-CA-C 109.901 -1.279 . . . . 0.0 109.901 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.0 mt -69.08 -41.08 77.98 Favored 'General case' 0 C--N 1.352 0.694 0 CA-C-N 117.612 0.706 . . . . 0.0 112.415 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 98.2 mt -71.5 -42.49 67.95 Favored 'General case' 0 C--N 1.36 1.042 0 O-C-N 121.3 -0.875 . . . . 0.0 110.714 -177.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.559 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 37.5 t70 -69.38 -32.52 71.61 Favored 'General case' 0 N--CA 1.445 -0.703 0 O-C-N 122.049 -0.407 . . . . 0.0 110.642 -179.231 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.433 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -62.85 -39.57 98.16 Favored Glycine 0 C--N 1.357 1.736 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 47.0 t -60.1 -41.73 93.18 Favored 'General case' 0 C--N 1.351 0.653 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -77.56 0.23 23.81 Favored 'General case' 0 C--N 1.359 0.982 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.559 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 76.8 mm-40 -83.65 -46.77 11.95 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -68.55 -41.46 79.76 Favored 'General case' 0 C--N 1.359 0.991 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.52 ' HZ ' ' SD ' ' A' ' 89' ' ' MET . 9.7 m-30 -69.66 -26.98 64.66 Favored 'General case' 0 C--N 1.36 1.055 0 O-C-N 121.821 -0.549 . . . . 0.0 110.628 -178.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 85.0 tttt 73.59 74.88 0.13 Allowed 'General case' 0 C--N 1.361 1.091 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -142.81 -170.34 3.21 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -148.57 94.37 2.28 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 15.7 m-30 -113.42 156.59 23.22 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 94.5 m -119.23 126.85 52.5 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 119.082 -1.047 . . . . 0.0 108.837 -178.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.491 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.9 mp -104.76 122.61 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 178.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.8 m -120.47 -171.95 2.27 Favored 'General case' 0 C--N 1.355 0.808 0 CA-C-O 121.812 0.815 . . . . 0.0 108.899 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.01 158.64 44.37 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -178.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 50.2 p -98.27 146.59 31.79 Favored Pre-proline 0 C--N 1.357 0.934 0 CA-C-O 122.368 1.08 . . . . 0.0 108.134 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.623 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 72.8 Cg_endo -75.95 -10.98 19.84 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.924 2.416 . . . . 0.0 115.031 -178.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -72.62 -41.17 65.84 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.388 -178.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 39.0 p -116.7 15.32 15.43 Favored 'General case' 0 C--N 1.354 0.795 0 C-N-CA 120.264 -0.575 . . . . 0.0 110.288 -178.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.623 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.2 pp0? -66.67 -12.76 59.67 Favored 'General case' 0 C--N 1.354 0.798 0 O-C-N 121.608 -0.683 . . . . 0.0 110.22 178.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -124.62 38.23 4.24 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 57.7 m -137.21 146.76 45.23 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.617 ' O ' ' HB ' ' A' ' 171' ' ' THR . 61.4 mt-10 -99.85 165.46 11.56 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.617 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 16.4 m 82.28 -59.39 0.19 Allowed 'General case' 0 C--N 1.369 1.453 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.799 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -107.73 117.1 33.24 Favored 'General case' 0 CA--C 1.505 -0.784 0 C-N-CA 119.884 -0.726 . . . . 0.0 109.868 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 88.2 t -131.8 133.66 61.0 Favored 'Isoleucine or valine' 0 C--N 1.358 0.943 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 178.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 49.5 mm -109.59 126.0 66.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.955 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -114.13 147.27 39.1 Favored 'General case' 0 C--N 1.359 0.988 0 CA-C-O 121.942 0.877 . . . . 0.0 108.767 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -128.26 118.19 22.84 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.458 HD11 HD23 ' A' ' 131' ' ' LEU . 4.0 mp -112.58 118.06 56.87 Favored 'Isoleucine or valine' 0 C--N 1.355 0.838 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 -179.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 85.1 m -128.28 144.79 51.16 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 -177.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 81.1 mtm180 -80.82 113.72 19.22 Favored 'General case' 0 C--N 1.37 1.491 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 178.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -71.87 156.65 90.78 Favored Pre-proline 0 CA--C 1.501 -0.923 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -55.98 111.5 0.79 Allowed 'Trans proline' 0 CA--C 1.497 -1.356 0 C-N-CA 122.136 1.891 . . . . 0.0 112.217 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -61.49 -46.14 91.26 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.483 -178.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 174.63 131.99 1.5 Allowed Glycine 0 N--CA 1.434 -1.44 0 N-CA-C 106.215 -2.754 . . . . 0.0 106.215 177.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.662 ' O ' ' HB2' ' A' ' 185' ' ' GLU . . . 64.73 -119.66 0.43 Allowed 'General case' 0 C--N 1.356 0.888 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.662 ' HB2' ' O ' ' A' ' 184' ' ' ALA . 36.8 tt0 151.19 82.17 0.0 OUTLIER 'General case' 0 C--N 1.363 1.179 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -113.48 125.84 54.66 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 15.1 mt -107.67 -78.83 0.58 Allowed 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -139.53 -97.05 0.16 Allowed 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -127.36 147.37 50.26 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 . . . . . 0 C--O 1.265 1.869 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.966 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 201' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 202' ' ' HEM . . . . . 1.123 HBD1 ' HHA' ' A' ' 202' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.788 ' H1 ' ' CMD' ' A' ' 202' ' ' HEM . 54.0 tpp . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.026 0.441 . . . . 0.0 110.333 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.59 -19.14 39.03 Favored 'General case' 0 C--N 1.355 0.833 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.2 -38.98 58.78 Favored Glycine 0 C--N 1.351 1.382 0 N-CA-C 108.563 -1.815 . . . . 0.0 108.563 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.597 ' H ' ' HG3' ' A' ' 1' ' ' MET . 3.2 mtt -70.04 -35.86 74.61 Favored 'General case' 0 C--N 1.356 0.867 0 O-C-N 122.205 -0.585 . . . . 0.0 111.542 -177.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.2 m -69.34 -23.92 27.1 Favored 'Isoleucine or valine' 0 C--N 1.356 0.874 0 O-C-N 121.41 -0.806 . . . . 0.0 109.355 -178.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -71.79 -35.37 69.98 Favored 'General case' 0 C--N 1.357 0.908 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 87.9 m -67.33 -41.67 84.87 Favored 'General case' 0 C--N 1.355 0.84 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.48 -38.35 96.2 Favored Glycine 0 C--N 1.356 1.69 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.589 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -67.18 -38.56 85.61 Favored 'General case' 0 C--N 1.351 0.657 0 CA-C-N 117.311 0.556 . . . . 0.0 110.503 -177.927 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 21.3 mmt -64.26 -40.7 96.53 Favored 'General case' 0 C--N 1.354 0.798 0 O-C-N 121.616 -0.677 . . . . 0.0 110.767 -178.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -66.2 -40.4 90.35 Favored 'General case' 0 C--N 1.349 0.559 0 O-C-N 122.057 -0.402 . . . . 0.0 111.684 -178.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 57.8 tp -65.75 -42.73 90.59 Favored 'General case' 0 C--N 1.35 0.595 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -178.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.589 HG12 ' O ' ' A' ' 9' ' ' LEU . 1.7 mm -75.61 -36.32 34.02 Favored 'Isoleucine or valine' 0 C--N 1.357 0.917 0 O-C-N 121.049 -1.032 . . . . 0.0 110.955 -175.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -67.96 -42.57 80.7 Favored 'General case' 0 C--N 1.351 0.67 0 O-C-N 121.858 -0.526 . . . . 0.0 111.108 -176.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -73.48 -31.28 63.66 Favored 'General case' 0 N--CA 1.447 -0.617 0 O-C-N 122.014 -0.429 . . . . 0.0 111.499 -177.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -72.63 -49.08 34.35 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -175.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -128.56 -20.35 3.63 Favored 'General case' 0 C--N 1.355 0.812 0 C-N-CA 117.566 -1.654 . . . . 0.0 113.02 -176.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 140.8 179.08 17.89 Favored Glycine 0 CA--C 1.496 -1.094 0 C-N-CA 118.104 -1.998 . . . . 0.0 109.657 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -94.26 -11.09 30.89 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -177.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -70.88 -41.52 71.24 Favored 'General case' 0 C--N 1.36 1.046 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 92.8 m -69.91 -38.89 76.4 Favored 'General case' 0 C--N 1.359 0.98 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.508 HD13 ' HB ' ' A' ' 13' ' ' ILE . 56.6 tp -60.5 -37.66 81.81 Favored 'General case' 0 C--N 1.357 0.9 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -64.94 -35.43 81.13 Favored 'General case' 0 C--N 1.357 0.919 0 O-C-N 122.203 -0.311 . . . . 0.0 110.757 -178.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.2 m -64.44 -41.23 96.67 Favored 'General case' 0 C--N 1.354 0.771 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -178.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 93.0 mt -65.23 -37.43 87.23 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 80.3 mt -69.7 -14.38 62.77 Favored 'General case' 0 C--N 1.358 0.971 0 O-C-N 121.445 -0.784 . . . . 0.0 109.604 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -88.07 -25.74 22.9 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 119.621 -0.831 . . . . 0.0 109.287 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 55.9 p -70.27 -23.9 62.96 Favored 'General case' 0 C--N 1.359 1.017 0 C-N-CA 119.65 -0.82 . . . . 0.0 109.22 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.8 p -105.8 -37.19 6.79 Favored 'General case' 0 C--N 1.358 0.967 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 86.09 132.15 0.04 OUTLIER 'General case' 0 C--N 1.36 1.031 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.466 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -90.88 -166.18 1.52 Allowed 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -153.35 -64.81 0.15 Allowed 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.6 t -97.92 -65.19 0.98 Allowed 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -138.11 -45.0 0.51 Allowed 'General case' 0 CA--C 1.503 -0.863 0 C-N-CA 119.567 -0.853 . . . . 0.0 108.752 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 125.88 -35.59 2.97 Favored Glycine 0 C--N 1.352 1.427 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 85.0 mt -107.91 100.26 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.788 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -97.13 -1.47 45.1 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.767 HG22 ' H ' ' A' ' 39' ' ' SER . 2.7 m 77.55 -179.63 0.13 Allowed 'General case' 0 C--N 1.361 1.107 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 -178.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.767 ' H ' HG22 ' A' ' 38' ' ' THR . 21.2 p -85.7 102.71 13.85 Favored 'General case' 0 C--N 1.353 0.729 0 O-C-N 121.116 -0.99 . . . . 0.0 109.261 -178.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.453 HG12 ' O ' ' A' ' 40' ' ' VAL . 97.3 t -153.19 -18.54 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.359 1.013 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -112.58 164.93 12.02 Favored Glycine 0 C--N 1.356 1.668 0 C-N-CA 119.311 -1.423 . . . . 0.0 110.156 -176.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.6 m -128.62 127.76 42.87 Favored 'General case' 0 C--N 1.355 0.816 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -116.42 176.42 5.12 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -79.34 -176.53 5.26 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -91.15 -16.03 28.42 Favored 'General case' 0 CA--C 1.503 -0.858 0 C-N-CA 120.105 -0.638 . . . . 0.0 109.406 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -70.23 -28.15 65.03 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -63.37 -40.85 98.37 Favored 'General case' 0 C--N 1.352 0.68 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.438 ' O ' HG23 ' A' ' 52' ' ' VAL . 63.3 tp -66.82 -38.57 86.71 Favored 'General case' 0 C--N 1.357 0.899 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.308 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.4 ' O ' HG23 ' A' ' 53' ' ' VAL . 58.3 tp -77.31 -26.2 52.0 Favored 'General case' 0 C--N 1.349 0.567 0 O-C-N 122.071 -0.393 . . . . 0.0 110.134 -177.275 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -67.67 -43.9 79.08 Favored 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 121.724 -0.61 . . . . 0.0 110.048 -178.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 81.8 mt -71.93 -34.84 69.38 Favored 'General case' 0 C--N 1.36 1.022 0 C-N-CA 120.164 -0.614 . . . . 0.0 109.467 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 48' ' ' LEU . 40.0 t -63.11 -40.73 90.14 Favored 'Isoleucine or valine' 0 C--N 1.35 0.593 0 O-C-N 122.331 -0.231 . . . . 0.0 110.456 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 49' ' ' LEU . 54.9 t -68.13 -40.29 82.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.662 0 O-C-N 121.672 -0.642 . . . . 0.0 109.929 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.8 tptt -68.39 -23.02 64.61 Favored 'General case' 0 C--N 1.36 1.022 0 O-C-N 121.021 -1.05 . . . . 0.0 108.695 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.406 HD13 HD13 ' A' ' 66' ' ' LEU . 1.9 mt -68.96 -37.48 78.86 Favored 'General case' 0 C--N 1.351 0.674 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.5 p -73.29 -17.11 61.35 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.382 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -100.3 -37.06 9.04 Favored 'General case' 0 C--N 1.354 0.78 0 C-N-CA 119.534 -0.867 . . . . 0.0 111.402 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.9 p -72.67 -36.86 54.38 Favored 'Isoleucine or valine' 0 C--N 1.353 0.725 0 O-C-N 121.56 -0.712 . . . . 0.0 111.525 -177.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.613 ' HB3' HG23 ' A' ' 61' ' ' VAL . 5.3 t -117.89 -3.95 11.14 Favored 'General case' 0 C--N 1.352 0.691 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.143 -178.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 73.2 m 62.9 42.45 7.67 Favored 'General case' 0 C--N 1.355 0.839 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.613 HG23 ' HB3' ' A' ' 59' ' ' SER . 55.1 t -102.37 131.45 22.5 Favored Pre-proline 0 CA--C 1.503 -0.855 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -57.52 147.42 78.74 Favored 'Trans proline' 0 CA--C 1.498 -1.292 0 C-N-CA 122.55 2.167 . . . . 0.0 112.624 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.1 m -75.22 -12.83 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.671 -178.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.451 ' O ' HG12 ' A' ' 67' ' ' VAL . 64.4 p -96.45 -34.07 11.65 Favored 'General case' 0 C--N 1.359 0.996 0 C-N-CA 118.393 -1.323 . . . . 0.0 109.488 -179.1 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -75.59 -23.71 56.49 Favored 'General case' 0 C--N 1.354 0.795 0 O-C-N 121.5 -0.75 . . . . 0.0 109.087 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.406 HD13 HD13 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -79.96 -36.25 36.44 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.007 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.451 HG12 ' O ' ' A' ' 64' ' ' THR . 1.9 p -69.41 -25.45 29.16 Favored 'Isoleucine or valine' 0 C--N 1.354 0.797 0 C-N-CA 120.206 -0.597 . . . . 0.0 110.046 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 5.5 mmm-85 -73.15 -52.48 14.04 Favored 'General case' 0 C--N 1.363 1.162 0 O-C-N 121.548 -0.72 . . . . 0.0 110.12 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.7 mt -63.31 -35.43 80.36 Favored 'General case' 0 C--N 1.357 0.903 0 O-C-N 121.983 -0.448 . . . . 0.0 110.941 -178.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -61.1 -47.67 85.24 Favored 'General case' 0 C--N 1.351 0.638 0 O-C-N 122.117 -0.365 . . . . 0.0 110.624 -178.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.91 -38.51 95.52 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 111.738 -0.545 . . . . 0.0 111.738 -178.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.14 -47.87 80.9 Favored 'General case' 0 C--N 1.349 0.568 0 CA-C-N 118.067 0.934 . . . . 0.0 111.348 -177.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.718 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 9.9 mttm -64.51 -49.21 72.2 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 113.61 0.966 . . . . 0.0 113.61 -177.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.418 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.4 tm? -68.4 -39.81 81.55 Favored 'General case' 0 C--N 1.349 0.585 0 O-C-N 121.082 -1.012 . . . . 0.0 111.86 -175.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -63.41 -45.09 92.6 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 121.091 -1.006 . . . . 0.0 111.258 -177.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.8 p -71.09 -14.92 18.34 Favored 'Isoleucine or valine' 0 C--N 1.359 0.988 0 O-C-N 121.478 -0.763 . . . . 0.0 109.506 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.718 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 74.1 mm-40 -72.74 -38.79 67.3 Favored 'General case' 0 C--N 1.35 0.629 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 78.9 mt -69.09 -35.27 76.3 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 47.7 mm -62.5 -51.49 71.53 Favored 'Isoleucine or valine' 0 C--N 1.356 0.89 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.227 -177.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -75.64 -11.87 60.09 Favored 'General case' 0 C--N 1.353 0.73 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.98 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -94.01 -9.37 59.61 Favored Glycine 0 C--N 1.347 1.166 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.482 -178.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.47 ' O ' HG22 ' A' ' 85' ' ' ILE . 87.5 m-70 -143.93 95.32 5.73 Favored Pre-proline 0 CA--C 1.503 -0.839 0 CA-C-N 118.91 1.355 . . . . 0.0 109.126 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.513 ' O ' ' HB2' ' A' ' 87' ' ' ASN . 38.3 Cg_endo -68.71 -23.8 35.66 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.393 2.062 . . . . 0.0 114.046 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -90.75 -9.11 47.81 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.47 HG22 ' O ' ' A' ' 82' ' ' HIS . 0.6 OUTLIER -89.01 -21.99 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.971 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 -178.792 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -104.38 -14.81 15.61 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.513 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 20.1 t30 -72.88 -40.66 65.42 Favored 'General case' 0 C--N 1.36 1.048 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -67.35 -29.79 69.43 Favored 'General case' 0 C--N 1.353 0.735 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.156 -178.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 28.4 ttp -84.17 146.58 27.77 Favored 'General case' 0 C--N 1.351 0.655 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.75 -21.51 10.15 Favored 'General case' 0 C--N 1.361 1.104 0 O-C-N 121.58 -0.7 . . . . 0.0 110.937 -177.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -164.54 171.39 14.6 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 -177.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.412 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 88.4 p -71.01 -31.7 68.28 Favored 'General case' 0 C--N 1.352 0.682 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.014 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -70.4 -38.46 74.66 Favored 'General case' 0 C--N 1.358 0.942 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -66.67 -24.18 66.24 Favored 'General case' 0 C--N 1.358 0.977 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.412 ' HB3' ' O ' ' A' ' 92' ' ' SER . 61.4 tp -62.92 -46.36 88.16 Favored 'General case' 0 C--N 1.355 0.814 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.3 mp -62.61 -32.89 73.98 Favored 'General case' 0 C--N 1.354 0.765 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 36.3 t -62.41 -45.02 94.99 Favored 'General case' 0 C--N 1.355 0.81 0 O-C-N 121.84 -0.537 . . . . 0.0 111.347 -178.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.08 28.45 8.78 Favored 'General case' 0 C--N 1.361 1.085 0 O-C-N 121.103 -0.998 . . . . 0.0 110.539 -178.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 1.118 HD11 ' C3B' ' A' ' 202' ' ' HEM . 10.6 tt -62.71 -29.91 48.12 Favored 'Isoleucine or valine' 0 C--N 1.354 0.794 0 O-C-N 121.827 -0.546 . . . . 0.0 110.314 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -127.4 -8.8 5.76 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 118.54 -1.264 . . . . 0.0 109.916 -179.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 58.4 m -90.88 -2.93 57.7 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 119.566 -0.854 . . . . 0.0 110.313 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.459 ' O ' HG12 ' A' ' 105' ' ' VAL . 11.9 t80 -146.51 -46.92 0.19 Allowed 'General case' 0 C--N 1.357 0.912 0 C-N-CA 118.264 -1.374 . . . . 0.0 109.754 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.405 ' CG2' ' HAC' ' A' ' 202' ' ' HEM . 96.1 mt -68.57 -48.41 72.18 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 O-C-N 121.788 -0.57 . . . . 0.0 110.948 -178.223 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 44.4 m170 -85.71 -1.52 57.27 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.329 -177.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.459 HG12 ' O ' ' A' ' 102' ' ' PHE . 2.0 p -89.11 -32.72 5.85 Favored 'Isoleucine or valine' 0 C--N 1.354 0.793 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -72.3 -40.14 67.76 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -73.17 -33.97 43.4 Favored 'Isoleucine or valine' 0 C--N 1.355 0.824 0 C-N-CA 119.518 -0.873 . . . . 0.0 109.576 -178.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -60.67 -49.01 79.25 Favored 'General case' 0 C--N 1.363 1.164 0 O-C-N 121.8 -0.563 . . . . 0.0 110.441 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -60.44 -38.99 85.9 Favored 'General case' 0 C--N 1.358 0.96 0 O-C-N 121.579 -0.701 . . . . 0.0 110.096 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.0 mt -57.15 -76.92 0.03 OUTLIER 'General case' 0 C--N 1.354 0.798 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.436 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 92.7 m-85 -115.89 136.11 22.85 Favored Pre-proline 0 N--CA 1.442 -0.855 0 O-C-N 121.067 -1.021 . . . . 0.0 108.817 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 111' ' ' TYR . 68.8 Cg_endo -86.38 -1.72 8.45 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 123.32 2.68 . . . . 0.0 115.585 -178.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -66.73 -36.83 83.4 Favored 'General case' 0 C--N 1.356 0.855 0 O-C-N 121.652 -0.655 . . . . 0.0 110.2 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.46 145.76 54.67 Favored 'General case' 0 C--N 1.352 0.696 0 CA-C-O 121.61 0.719 . . . . 0.0 110.105 -178.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -130.8 134.43 46.84 Favored 'General case' 0 C--N 1.358 0.936 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.478 ' HB3' ' HD2' ' A' ' 117' ' ' PRO . 2.8 mm? -116.36 156.45 47.26 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-O 122.145 0.974 . . . . 0.0 108.855 -178.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' A' ' 116' ' ' LEU . 85.5 Cg_endo -83.88 -151.86 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.123 0 C-N-CA 123.517 2.812 . . . . 0.0 113.147 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -114.53 138.72 50.28 Favored 'General case' 0 C--N 1.362 1.152 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -125.2 126.38 45.12 Favored 'General case' 0 C--N 1.36 1.05 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -178.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.534 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 93.8 m -124.88 127.66 47.47 Favored 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 177.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 77.1 m -121.63 129.99 53.18 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 119.129 -1.029 . . . . 0.0 109.585 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -118.38 148.81 42.14 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 178.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 57.4 ttp180 -120.55 117.21 27.03 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.403 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 95.0 mt -90.55 -16.2 29.24 Favored 'General case' 0 CA--C 1.503 -0.853 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.52 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 175.37 -148.68 9.63 Favored Glycine 0 N--CA 1.437 -1.271 0 N-CA-C 108.891 -1.684 . . . . 0.0 108.891 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -94.35 -37.35 11.52 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -178.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -103.01 3.82 36.62 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.02 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.403 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 66.6 m-20 -119.83 130.81 55.08 Favored 'General case' 0 C--N 1.359 1.003 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.403 HD13 ' HA ' ' A' ' 129' ' ' ILE . 8.4 mm -142.27 136.07 28.49 Favored 'Isoleucine or valine' 0 C--N 1.355 0.819 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 53.2 mtm180 -116.16 139.48 50.28 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 6.3 tp -126.7 118.81 25.5 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.534 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 12.4 m-70 -99.55 133.43 43.88 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -129.94 122.61 28.88 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 -178.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.496 ' HA ' ' O ' ' A' ' 171' ' ' THR . 32.2 tt0 -115.73 113.04 22.93 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.2 t -162.51 154.16 18.25 Favored 'General case' 0 C--N 1.359 1.002 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.406 ' C ' ' HD3' ' A' ' 138' ' ' PRO . 57.7 mtmt -91.41 3.94 53.69 Favored 'General case' 0 C--N 1.357 0.921 0 C-N-CA 120.186 -0.605 . . . . 0.0 109.865 -179.218 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 93.8 mtm-85 -133.01 74.11 74.29 Favored Pre-proline 0 C--N 1.356 0.882 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.406 ' HD3' ' C ' ' A' ' 136' ' ' LYS . 94.1 Cg_endo -96.23 102.7 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.657 2.238 . . . . 0.0 115.759 -177.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -111.47 113.42 25.84 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 176.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.01 -38.16 90.07 Favored 'General case' 0 C--N 1.354 0.778 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.026 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.7 m -63.48 -28.04 69.69 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 122.042 -0.411 . . . . 0.0 110.694 -178.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -75.59 -46.53 31.28 Favored 'General case' 0 C--N 1.352 0.687 0 C-N-CA 120.146 -0.622 . . . . 0.0 109.567 -178.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.68 -39.85 94.38 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 122.258 -0.276 . . . . 0.0 111.187 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.19 -37.2 86.31 Favored 'General case' 0 C--N 1.355 0.81 0 O-C-N 121.987 -0.446 . . . . 0.0 110.184 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.51 -42.88 99.27 Favored Glycine 0 C--N 1.348 1.248 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 -179.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 83.1 mt -70.07 -40.65 74.9 Favored 'General case' 0 C--N 1.351 0.667 0 CA-C-N 117.522 0.661 . . . . 0.0 112.627 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 97.1 mt -71.35 -42.38 68.58 Favored 'General case' 0 C--N 1.361 1.07 0 O-C-N 121.235 -0.916 . . . . 0.0 110.902 -176.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.497 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 36.4 t70 -70.06 -31.07 68.5 Favored 'General case' 0 N--CA 1.445 -0.695 0 O-C-N 121.934 -0.479 . . . . 0.0 110.407 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -63.12 -39.09 97.57 Favored Glycine 0 C--N 1.356 1.672 0 N-CA-C 108.461 -1.856 . . . . 0.0 108.461 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 46.3 t -60.75 -42.2 96.92 Favored 'General case' 0 C--N 1.35 0.622 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 178.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -74.97 -1.25 21.76 Favored 'General case' 0 C--N 1.36 1.046 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.497 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 76.9 mm-40 -83.46 -46.91 11.94 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -65.54 -45.6 82.8 Favored 'General case' 0 C--N 1.36 1.042 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.411 178.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -68.57 -25.95 65.16 Favored 'General case' 0 C--N 1.363 1.191 0 O-C-N 121.798 -0.564 . . . . 0.0 110.896 -178.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 85.1 tttt 73.16 76.43 0.14 Allowed 'General case' 0 C--N 1.36 1.031 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -144.9 -168.56 2.96 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -150.71 93.25 1.93 Allowed 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 14.1 m-30 -111.35 160.08 17.39 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 92.7 m -120.18 127.08 52.13 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 119.289 -0.964 . . . . 0.0 108.819 -178.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.527 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.5 mp -105.55 122.21 58.69 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 178.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.9 m -118.09 -173.01 2.36 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-O 121.851 0.834 . . . . 0.0 109.241 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.19 157.89 43.74 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -178.173 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 52.3 p -99.95 146.43 31.88 Favored Pre-proline 0 C--N 1.358 0.963 0 CA-C-O 122.344 1.069 . . . . 0.0 108.189 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.619 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 72.2 Cg_endo -76.35 -11.14 19.14 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.965 2.443 . . . . 0.0 115.052 -178.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -72.24 -41.29 66.97 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.474 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 36.2 p -117.54 15.82 14.62 Favored 'General case' 0 CA--C 1.505 -0.773 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.355 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.619 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.5 pp0? -65.59 -13.76 59.72 Favored 'General case' 0 C--N 1.355 0.807 0 O-C-N 121.657 -0.652 . . . . 0.0 110.341 178.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 46.6 p30 -125.43 39.76 3.89 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 19.8 t -139.72 144.93 37.75 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.617 ' O ' ' HB ' ' A' ' 171' ' ' THR . 61.9 mt-10 -98.71 164.43 12.23 Favored 'General case' 0 C--N 1.354 0.801 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.617 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 18.4 m 84.35 -60.76 0.1 Allowed 'General case' 0 C--N 1.369 1.44 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -107.2 117.74 34.88 Favored 'General case' 0 CA--C 1.503 -0.855 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.633 -178.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 97.9 t -131.26 132.96 62.9 Favored 'Isoleucine or valine' 0 C--N 1.357 0.923 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 178.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 49.9 mm -107.8 127.43 63.87 Favored 'Isoleucine or valine' 0 C--N 1.357 0.899 0 N-CA-C 107.877 -1.156 . . . . 0.0 107.877 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -115.66 156.14 26.43 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 122.073 0.94 . . . . 0.0 108.593 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -138.84 119.52 14.09 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.7 mp -114.56 118.86 59.88 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 106.395 -1.705 . . . . 0.0 106.395 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 86.1 m -128.2 143.55 51.05 Favored 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -177.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 70.3 mtm180 -85.36 119.26 25.53 Favored 'General case' 0 C--N 1.369 1.431 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.41 ' HA ' ' HD3' ' A' ' 181' ' ' PRO . . . -68.79 148.39 97.98 Favored Pre-proline 0 C--N 1.356 0.861 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 180' ' ' ALA . 52.4 Cg_exo -55.08 126.86 23.98 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.622 2.215 . . . . 0.0 113.915 -178.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' A' ' 182' ' ' ARG . 5.2 mtm105 -113.94 -141.45 0.38 Allowed 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -95.77 58.13 1.55 Allowed Glycine 0 C--N 1.355 1.593 0 N-CA-C 107.477 -2.249 . . . . 0.0 107.477 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -153.6 164.71 37.8 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -154.23 152.31 30.18 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -173.01 67.63 0.03 OUTLIER 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 27.4 tp -97.48 -71.97 0.66 Allowed 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' TYR . . . . . 0.482 ' HB3' ' H ' ' A' ' 189' ' ' PHE . 0.2 OUTLIER -149.78 -124.39 0.05 OUTLIER 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -179.785 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 189' ' ' PHE . . . . . 0.482 ' H ' ' HB3' ' A' ' 188' ' ' TYR . 98.4 m-85 -127.72 148.17 50.41 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 . . . . . 0 C--O 1.264 1.85 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 179.957 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 201' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 202' ' ' HEM . . . . . 1.118 ' C3B' HD11 ' A' ' 99' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.0 mtm . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.532 0.682 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.43 ' HA ' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -82.48 -9.34 59.47 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -178.998 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.33 -42.31 49.96 Favored Glycine 0 C--N 1.352 1.422 0 N-CA-C 108.734 -1.746 . . . . 0.0 108.734 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 61.5 mtt -66.68 -38.78 87.49 Favored 'General case' 0 C--N 1.357 0.893 0 O-C-N 122.13 -0.629 . . . . 0.0 111.21 -178.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.43 HG22 ' HA ' ' A' ' 2' ' ' MET . 34.7 m -69.23 -23.06 26.38 Favored 'Isoleucine or valine' 0 C--N 1.356 0.871 0 C-N-CA 120.178 -0.609 . . . . 0.0 109.91 -178.015 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -70.75 -37.25 73.42 Favored 'General case' 0 C--N 1.355 0.833 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.4 m -67.98 -41.07 82.92 Favored 'General case' 0 C--N 1.354 0.803 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.44 -38.97 97.19 Favored Glycine 0 C--N 1.357 1.702 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.63 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -65.5 -40.12 92.66 Favored 'General case' 0 C--N 1.351 0.652 0 O-C-N 122.384 -0.48 . . . . 0.0 110.733 -178.351 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.408 ' CE ' HD21 ' A' ' 26' ' ' LEU . 24.6 mmt -63.11 -40.42 97.56 Favored 'General case' 0 C--N 1.352 0.676 0 O-C-N 121.611 -0.681 . . . . 0.0 110.935 -178.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -67.33 -40.24 85.91 Favored 'General case' 0 C--N 1.348 0.526 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.438 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 53.7 tp -66.36 -43.07 87.04 Favored 'General case' 0 C--N 1.35 0.588 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -178.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.63 HG12 ' O ' ' A' ' 9' ' ' LEU . 1.1 mm -76.36 -36.05 28.48 Favored 'Isoleucine or valine' 0 C--N 1.36 1.04 0 O-C-N 120.924 -1.11 . . . . 0.0 111.113 -175.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -67.61 -43.18 81.07 Favored 'General case' 0 C--N 1.351 0.642 0 O-C-N 121.683 -0.636 . . . . 0.0 111.134 -176.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -72.32 -33.28 67.23 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 121.956 -0.465 . . . . 0.0 111.76 -177.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -72.49 -48.45 40.61 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -175.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -127.57 -21.12 3.85 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 117.5 -1.68 . . . . 0.0 113.49 -176.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 140.56 179.81 18.45 Favored Glycine 0 CA--C 1.497 -1.041 0 C-N-CA 118.007 -2.044 . . . . 0.0 109.489 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -96.33 -11.96 25.1 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -177.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -70.79 -41.4 71.69 Favored 'General case' 0 C--N 1.36 1.032 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 94.3 m -69.73 -38.89 77.04 Favored 'General case' 0 C--N 1.357 0.896 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.513 HD13 ' HB ' ' A' ' 13' ' ' ILE . 55.5 tp -60.48 -37.12 80.03 Favored 'General case' 0 C--N 1.356 0.873 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -65.09 -35.46 81.22 Favored 'General case' 0 C--N 1.357 0.899 0 O-C-N 122.255 -0.278 . . . . 0.0 110.725 -178.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.7 m -64.49 -40.25 95.32 Favored 'General case' 0 C--N 1.358 0.946 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -178.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.417 HD22 ' HB3' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -65.09 -36.71 85.17 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.563 ' HB3' HD23 ' A' ' 31' ' ' LEU . 83.7 mt -70.88 -14.88 62.55 Favored 'General case' 0 C--N 1.356 0.891 0 O-C-N 121.501 -0.749 . . . . 0.0 109.81 -179.039 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -87.82 -25.79 23.15 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.292 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.4 p -69.22 -24.33 64.01 Favored 'General case' 0 C--N 1.36 1.027 0 C-N-CA 119.7 -0.8 . . . . 0.0 109.085 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.621 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 1.9 p -107.42 -34.88 6.93 Favored 'General case' 0 C--N 1.359 0.992 0 C-N-CA 119.008 -1.077 . . . . 0.0 108.442 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.621 ' HB2' ' O ' ' A' ' 29' ' ' CYS . 12.2 mt-10 83.37 133.58 0.05 Allowed 'General case' 0 C--N 1.359 1.012 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.563 HD23 ' HB3' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -103.2 111.06 23.26 Favored 'General case' 0 C--N 1.359 1.001 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.577 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -73.07 -41.11 64.47 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.425 ' HB3' ' H ' ' A' ' 34' ' ' GLU . 0.6 OUTLIER -113.96 -88.68 0.55 Allowed 'General case' 0 C--N 1.355 0.828 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.074 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.425 ' H ' ' HB3' ' A' ' 33' ' ' SER . 60.5 mt-10 -120.55 -43.15 2.5 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -178.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.91 -34.64 5.11 Favored Glycine 0 C--N 1.351 1.393 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 78.9 mt -106.66 102.67 14.28 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.95 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.47 -136.9 0.06 Allowed 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.455 ' O ' ' HB3' ' A' ' 39' ' ' SER . 52.0 m -113.2 -59.65 1.99 Allowed 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -179.037 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.455 ' HB3' ' O ' ' A' ' 38' ' ' THR . 61.4 p 158.48 10.34 0.0 OUTLIER 'General case' 0 C--N 1.363 1.182 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -178.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.4 p -98.07 6.8 8.65 Favored 'Isoleucine or valine' 0 C--N 1.353 0.733 0 C-N-CA 120.251 -0.579 . . . . 0.0 110.902 -177.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -105.3 154.95 17.13 Favored Glycine 0 C--N 1.353 1.5 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.1 t -134.88 124.99 25.87 Favored 'General case' 0 C--N 1.357 0.901 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -109.46 175.75 5.33 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -72.18 175.33 6.13 Favored 'General case' 0 C--N 1.356 0.879 0 CA-C-O 121.638 0.733 . . . . 0.0 109.443 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 10.7 t60 -82.77 -24.86 33.27 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -178.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -65.81 -28.17 68.8 Favored 'General case' 0 C--N 1.356 0.875 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.2 tp10 -62.58 -39.74 94.68 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -68.15 -38.63 82.35 Favored 'General case' 0 C--N 1.357 0.915 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 59.2 tp -71.28 -32.38 68.62 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -177.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -66.76 -40.96 88.44 Favored 'General case' 0 N--CA 1.441 -0.878 0 O-C-N 122.02 -0.425 . . . . 0.0 110.027 -178.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 80.3 mt -82.47 -17.81 43.93 Favored 'General case' 0 C--N 1.357 0.898 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.191 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -81.56 -36.65 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 54.3 t -68.34 -41.49 83.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.417 ' HB3' HD22 ' A' ' 25' ' ' LEU . 22.6 tptt -69.17 -26.03 64.65 Favored 'General case' 0 C--N 1.365 1.245 0 C-N-CA 119.485 -0.886 . . . . 0.0 109.337 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.451 ' O ' HD23 ' A' ' 55' ' ' LEU . 3.4 tt -67.04 -37.09 83.46 Favored 'General case' 0 C--N 1.353 0.748 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.2 m -76.67 -16.99 59.39 Favored 'General case' 0 C--N 1.352 0.691 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.341 -178.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -97.95 -38.39 9.42 Favored 'General case' 0 C--N 1.353 0.717 0 O-C-N 121.314 -0.867 . . . . 0.0 111.278 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.2 p -73.18 -35.85 48.5 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 O-C-N 121.668 -0.645 . . . . 0.0 111.186 -177.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 61.2 m -111.71 -7.87 14.21 Favored 'General case' 0 CA--C 1.504 -0.821 0 C-N-CA 119.389 -0.924 . . . . 0.0 109.99 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 64.72 52.71 1.63 Allowed 'General case' 0 C--N 1.355 0.831 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.429 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 48.6 t -112.75 135.76 21.59 Favored Pre-proline 0 CA--C 1.504 -0.81 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 61' ' ' VAL . 31.2 Cg_exo -59.93 146.08 96.73 Favored 'Trans proline' 0 C--N 1.316 -1.178 0 C-N-CA 122.144 1.896 . . . . 0.0 112.464 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.2 m -73.55 -16.09 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.91 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.455 ' O ' HG12 ' A' ' 67' ' ' VAL . 67.5 p -96.24 -32.0 12.66 Favored 'General case' 0 C--N 1.359 0.981 0 C-N-CA 118.129 -1.429 . . . . 0.0 110.318 -178.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -80.19 -19.16 47.69 Favored 'General case' 0 C--N 1.353 0.724 0 O-C-N 121.162 -0.961 . . . . 0.0 108.864 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.401 ' HB3' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -80.17 -37.85 32.51 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.845 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.455 HG12 ' O ' ' A' ' 64' ' ' THR . 1.3 p -67.35 -28.38 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 C-N-CA 120.236 -0.586 . . . . 0.0 109.833 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 71.3 mtp180 -71.47 -50.51 30.92 Favored 'General case' 0 C--N 1.364 1.234 0 O-C-N 121.444 -0.785 . . . . 0.0 110.831 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.43 -36.01 82.79 Favored 'General case' 0 C--N 1.357 0.91 0 O-C-N 121.929 -0.482 . . . . 0.0 111.159 -178.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -61.02 -47.31 87.01 Favored 'General case' 0 C--N 1.349 0.577 0 O-C-N 122.154 -0.341 . . . . 0.0 110.388 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.74 -38.45 95.2 Favored Glycine 0 C--N 1.356 1.643 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 -178.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.08 -48.59 77.97 Favored 'General case' 0 C--N 1.35 0.609 0 CA-C-N 118.104 0.952 . . . . 0.0 111.45 -177.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.528 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 10.9 mttm -64.29 -48.0 77.33 Favored 'General case' 0 C--N 1.358 0.947 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -177.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.459 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.1 tm? -68.44 -39.28 81.57 Favored 'General case' 0 C--N 1.349 0.584 0 O-C-N 121.259 -0.9 . . . . 0.0 111.869 -175.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -63.97 -44.38 92.92 Favored 'General case' 0 C--N 1.352 0.69 0 O-C-N 121.248 -0.907 . . . . 0.0 111.06 -177.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.33 -15.27 18.44 Favored 'Isoleucine or valine' 0 C--N 1.359 1.009 0 O-C-N 121.486 -0.759 . . . . 0.0 108.953 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.528 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 14.7 mm-40 -71.67 -39.06 70.52 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 81.8 mt -73.32 -31.22 63.88 Favored 'General case' 0 C--N 1.359 0.984 0 O-C-N 122.301 -0.249 . . . . 0.0 110.505 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.9 mm -64.95 -53.56 40.01 Favored 'Isoleucine or valine' 0 C--N 1.359 1.013 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.956 -177.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -74.69 -15.0 60.81 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 119.693 -0.803 . . . . 0.0 109.36 178.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.65 -36.86 67.62 Favored Glycine 0 C--N 1.35 1.339 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.453 ' O ' HG22 ' A' ' 85' ' ' ILE . 59.5 m80 -132.44 104.97 13.27 Favored Pre-proline 0 N--CA 1.44 -0.941 0 CA-C-N 118.534 1.167 . . . . 0.0 109.499 -177.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.447 ' O ' ' HB2' ' A' ' 87' ' ' ASN . 34.8 Cg_exo -62.07 -29.58 81.53 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 123.018 2.479 . . . . 0.0 113.872 178.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -91.53 -8.37 47.72 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.453 HG22 ' O ' ' A' ' 82' ' ' HIS . 0.9 OUTLIER -86.71 -22.27 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 -178.765 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -104.57 -14.55 15.61 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 49.1 t30 -71.71 -40.85 69.21 Favored 'General case' 0 C--N 1.359 1.001 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -66.92 -30.95 71.23 Favored 'General case' 0 C--N 1.351 0.662 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.284 -178.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 17.5 ttp -83.93 150.16 25.86 Favored 'General case' 0 C--N 1.35 0.63 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.71 -22.31 7.49 Favored 'General case' 0 C--N 1.364 1.21 0 O-C-N 121.608 -0.683 . . . . 0.0 111.436 -177.056 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -165.28 172.03 12.86 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 119.083 -1.047 . . . . 0.0 108.277 -177.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.427 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 40.0 t -64.79 -43.3 93.66 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.056 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -66.13 -39.61 90.01 Favored 'General case' 0 C--N 1.355 0.847 0 O-C-N 121.414 -0.804 . . . . 0.0 109.138 -178.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -65.93 -24.35 66.8 Favored 'General case' 0 C--N 1.355 0.807 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.655 ' O ' HG12 ' A' ' 99' ' ' ILE . 61.7 tp -63.89 -47.16 81.73 Favored 'General case' 0 C--N 1.354 0.777 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.5 mp -60.58 -35.56 76.38 Favored 'General case' 0 C--N 1.36 1.054 0 O-C-N 122.215 -0.303 . . . . 0.0 110.345 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.8 t -68.49 -39.55 81.28 Favored 'General case' 0 C--N 1.348 0.526 0 O-C-N 122.03 -0.419 . . . . 0.0 109.967 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.06 1.26 54.67 Favored 'General case' 0 C--N 1.356 0.855 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -176.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.655 HG12 ' O ' ' A' ' 95' ' ' LEU . 23.4 mm -60.96 -47.16 94.79 Favored 'Isoleucine or valine' 0 C--N 1.359 0.989 0 CA-C-N 118.955 0.798 . . . . 0.0 112.089 -177.298 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -98.77 -20.63 16.79 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 118.273 -1.371 . . . . 0.0 111.282 -177.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.5 t -64.75 -48.48 74.4 Favored 'General case' 0 N--CA 1.445 -0.707 0 O-C-N 121.555 -0.716 . . . . 0.0 112.36 -178.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -136.51 -17.34 1.51 Allowed 'General case' 0 C--N 1.361 1.093 0 C-N-CA 117.174 -1.811 . . . . 0.0 113.536 -176.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.594 HG23 HBC2 ' A' ' 202' ' ' HEM . 96.4 mt -71.56 -50.78 37.42 Favored 'Isoleucine or valine' 0 C--O 1.244 0.771 0 CA-C-N 120.574 1.534 . . . . 0.0 111.215 -177.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 28.8 m170 -89.83 1.5 56.08 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 119.628 -0.829 . . . . 0.0 110.107 -177.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 55.7 t -90.19 -41.73 13.74 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.053 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 54.7 tp10 -68.33 -40.02 81.73 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.5 p -74.05 -35.6 42.07 Favored 'Isoleucine or valine' 0 C--N 1.356 0.867 0 C-N-CA 119.18 -1.008 . . . . 0.0 109.708 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 94.2 t80 -61.26 -48.61 80.63 Favored 'General case' 0 C--N 1.364 1.203 0 O-C-N 121.775 -0.578 . . . . 0.0 110.526 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -61.48 -37.13 82.5 Favored 'General case' 0 C--N 1.358 0.948 0 O-C-N 121.742 -0.599 . . . . 0.0 110.162 -178.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 110' ' ' LEU . 13.6 mt -56.21 -74.47 0.05 OUTLIER 'General case' 0 C--N 1.357 0.922 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.412 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 87.3 m-85 -118.41 133.74 23.49 Favored Pre-proline 0 N--CA 1.439 -0.98 0 C-N-CA 118.978 -1.089 . . . . 0.0 108.538 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 111' ' ' TYR . 96.2 Cg_endo -83.54 -1.48 10.17 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 123.31 2.674 . . . . 0.0 115.52 -178.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -65.73 -37.85 87.55 Favored 'General case' 0 C--N 1.355 0.835 0 O-C-N 121.746 -0.597 . . . . 0.0 110.092 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.38 145.11 56.58 Favored 'General case' 0 C--N 1.354 0.769 0 CA-C-O 121.513 0.673 . . . . 0.0 110.149 -178.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -131.93 135.66 46.79 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.526 ' HB3' ' HD2' ' A' ' 117' ' ' PRO . 93.1 mt -128.96 157.62 75.17 Favored Pre-proline 0 C--N 1.354 0.795 0 CA-C-O 122.098 0.952 . . . . 0.0 109.224 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.526 ' HD2' ' HB3' ' A' ' 116' ' ' LEU . 87.4 Cg_endo -81.35 -150.91 0.04 OUTLIER 'Trans proline' 0 C--N 1.318 -1.059 0 C-N-CA 123.685 2.923 . . . . 0.0 113.933 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -116.7 141.86 47.65 Favored 'General case' 0 C--N 1.364 1.238 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -130.34 133.14 46.2 Favored 'General case' 0 C--N 1.362 1.125 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 94.2 m -127.31 129.16 47.15 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 177.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 77.6 m -119.26 129.29 54.84 Favored 'General case' 0 C--N 1.355 0.808 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.382 -178.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -119.63 133.83 55.48 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -106.63 116.81 32.58 Favored 'General case' 0 C--N 1.352 0.716 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.472 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 94.6 mt -85.54 -23.73 27.56 Favored 'General case' 0 C--N 1.354 0.763 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.203 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -179.59 -144.72 6.0 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -94.02 -40.25 10.19 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 119.993 -0.683 . . . . 0.0 109.254 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -102.51 3.83 37.95 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.985 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.472 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 66.3 m-20 -118.13 129.02 55.28 Favored 'General case' 0 C--N 1.356 0.866 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 10.0 mm -141.25 133.53 29.37 Favored 'Isoleucine or valine' 0 C--N 1.356 0.854 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 58.8 mtm180 -116.57 139.75 50.15 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -127.68 118.11 23.22 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -97.15 132.63 42.74 Favored 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -128.7 120.18 26.0 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -178.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.558 ' HA ' ' O ' ' A' ' 171' ' ' THR . 74.4 mt-30 -115.0 111.77 21.64 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 107.599 -1.259 . . . . 0.0 107.599 178.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.4 t -162.16 153.86 18.61 Favored 'General case' 0 C--N 1.359 0.981 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -90.6 3.08 55.09 Favored 'General case' 0 C--N 1.354 0.782 0 C-N-CA 120.267 -0.573 . . . . 0.0 109.743 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -133.47 74.73 70.83 Favored Pre-proline 0 C--N 1.355 0.806 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -95.36 104.44 0.11 Allowed 'Trans proline' 0 N--CA 1.444 -1.407 0 C-N-CA 122.756 2.304 . . . . 0.0 115.746 -177.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -111.71 110.56 21.0 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 176.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.37 -38.88 92.57 Favored 'General case' 0 C--N 1.354 0.773 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.288 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.1 m -63.28 -26.63 68.86 Favored 'General case' 0 C--N 1.355 0.826 0 O-C-N 121.96 -0.463 . . . . 0.0 110.597 -178.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -75.58 -47.02 28.49 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.554 -178.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.78 -40.08 94.66 Favored 'General case' 0 C--N 1.358 0.96 0 O-C-N 122.154 -0.342 . . . . 0.0 111.226 -178.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.24 -36.91 85.22 Favored 'General case' 0 C--N 1.355 0.812 0 O-C-N 121.852 -0.53 . . . . 0.0 109.985 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.56 -43.71 98.59 Favored Glycine 0 C--N 1.346 1.096 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.3 mt -70.23 -40.34 74.56 Favored 'General case' 0 C--N 1.351 0.671 0 O-C-N 122.126 -0.632 . . . . 0.0 112.639 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 98.2 mt -71.2 -43.24 67.76 Favored 'General case' 0 C--N 1.361 1.068 0 O-C-N 121.21 -0.931 . . . . 0.0 111.115 -176.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.531 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 37.1 t70 -70.54 -29.54 66.03 Favored 'General case' 0 N--CA 1.443 -0.778 0 O-C-N 121.839 -0.538 . . . . 0.0 110.392 -179.172 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.453 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -63.17 -39.47 97.98 Favored Glycine 0 C--N 1.357 1.73 0 N-CA-C 108.464 -1.854 . . . . 0.0 108.464 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 47.9 t -60.38 -41.93 94.81 Favored 'General case' 0 C--N 1.351 0.632 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -75.83 0.17 19.05 Favored 'General case' 0 C--N 1.36 1.029 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.531 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 76.8 mm-40 -85.51 -46.39 10.9 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -66.36 -44.67 82.54 Favored 'General case' 0 C--N 1.36 1.033 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.411 ' O ' ' HB2' ' A' ' 155' ' ' LYS . 52.5 m-85 -69.96 -26.49 64.14 Favored 'General case' 0 C--N 1.36 1.028 0 O-C-N 121.872 -0.517 . . . . 0.0 111.137 -178.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 154' ' ' PHE . 44.1 mttt 71.43 71.78 0.17 Allowed 'General case' 0 C--N 1.363 1.154 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 -178.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.443 ' HB3' ' CE1' ' A' ' 158' ' ' PHE . 3.0 tp10 -141.26 -168.69 2.69 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -140.33 116.34 10.42 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.443 ' CE1' ' HB3' ' A' ' 156' ' ' GLU . 91.2 m-85 -133.65 149.86 51.57 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 92.1 m -120.94 127.59 51.97 Favored 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.529 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.6 mp -103.8 120.89 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 3.1 m -114.5 -177.6 3.17 Favored 'General case' 0 C--N 1.36 1.034 0 CA-C-O 121.708 0.766 . . . . 0.0 109.193 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -146.93 154.6 41.46 Favored 'General case' 0 C--N 1.355 0.847 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -178.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 54.2 p -97.4 146.5 31.48 Favored Pre-proline 0 C--N 1.358 0.961 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.672 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 72.3 Cg_endo -76.19 -11.2 19.4 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.941 2.427 . . . . 0.0 114.918 -178.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -72.63 -41.14 65.83 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.714 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 35.7 p -118.42 15.52 13.84 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.704 -178.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.672 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.1 pp0? -67.06 -13.57 62.06 Favored 'General case' 0 C--N 1.354 0.765 0 O-C-N 121.546 -0.721 . . . . 0.0 110.263 178.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 53.8 p-10 -121.09 35.1 4.99 Favored 'General case' 0 N--CA 1.438 -1.028 0 O-C-N 121.188 -0.945 . . . . 0.0 108.706 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 58.2 m -136.12 148.63 48.32 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.625 ' O ' ' HB ' ' A' ' 171' ' ' THR . 61.4 mt-10 -101.74 166.29 10.75 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.625 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 3.4 m 81.65 -59.04 0.23 Allowed 'General case' 0 C--N 1.37 1.469 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -107.8 117.77 34.98 Favored 'General case' 0 CA--C 1.507 -0.706 0 C-N-CA 119.916 -0.713 . . . . 0.0 109.565 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 90.7 t -132.0 133.44 60.8 Favored 'Isoleucine or valine' 0 C--N 1.357 0.922 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 178.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 50.1 mm -109.95 126.72 67.15 Favored 'Isoleucine or valine' 0 C--N 1.358 0.971 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -113.96 150.36 33.91 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -133.93 83.31 2.03 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.206 -178.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.6 mp -76.94 119.52 25.5 Favored 'Isoleucine or valine' 0 C--N 1.358 0.947 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 92.3 m -118.53 144.4 46.08 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 54.8 ttp180 -87.41 117.77 26.41 Favored 'General case' 0 C--N 1.36 1.027 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 -178.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.582 ' HB1' ' HD2' ' A' ' 181' ' ' PRO . . . -67.18 156.61 87.62 Favored Pre-proline 0 C--N 1.357 0.911 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.582 ' HD2' ' HB1' ' A' ' 180' ' ' ALA . 21.2 Cg_endo -61.68 128.74 25.43 Favored 'Trans proline' 0 CA--C 1.495 -1.439 0 C-N-CA 122.122 1.881 . . . . 0.0 113.709 -178.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.48 31.43 3.45 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 114.688 -1.142 . . . . 0.0 108.672 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.473 ' O ' ' HB3' ' A' ' 184' ' ' ALA . . . 116.89 97.51 1.99 Allowed Glycine 0 N--CA 1.437 -1.247 0 N-CA-C 107.995 -2.042 . . . . 0.0 107.995 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' A' ' 183' ' ' GLY . . . 78.16 149.5 0.1 Allowed 'General case' 0 C--N 1.359 1.005 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -148.84 151.73 35.24 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -114.37 118.51 34.08 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 85.3 mt -89.35 -45.07 9.75 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' TYR . . . . . 0.453 ' HB3' ' H ' ' A' ' 189' ' ' PHE . 3.5 t80 -165.98 -86.52 0.02 OUTLIER 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' PHE . . . . . 0.453 ' H ' ' HB3' ' A' ' 188' ' ' TYR . 87.9 t80 -139.59 129.96 25.47 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 . . . . . 0 C--O 1.264 1.825 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -179.958 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 201' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 202' ' ' HEM . . . . . 0.96 ' HHA' ' CBD' ' A' ' 202' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.883 ' HG2' ' CMD' ' A' ' 202' ' ' HEM . 88.8 mmm . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.041 0.448 . . . . 0.0 110.018 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.463 ' HA ' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -77.18 -17.44 58.55 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 120.586 -0.446 . . . . 0.0 109.969 -178.498 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.76 -44.62 30.96 Favored Glycine 0 C--N 1.35 1.356 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 75.7 mtm -71.43 -33.79 69.7 Favored 'General case' 0 C--N 1.354 0.782 0 O-C-N 122.073 -0.663 . . . . 0.0 111.377 -177.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.463 HG22 ' HA ' ' A' ' 2' ' ' MET . 30.7 m -70.76 -22.89 23.53 Favored 'Isoleucine or valine' 0 C--N 1.357 0.9 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.064 -179.211 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.442 ' HZ ' ' CG ' ' A' ' 47' ' ' GLU . 1.7 m-30 -71.47 -35.31 70.79 Favored 'General case' 0 C--N 1.357 0.917 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 88.9 m -66.41 -39.67 89.13 Favored 'General case' 0 C--N 1.357 0.902 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.23 -37.88 95.28 Favored Glycine 0 C--N 1.357 1.71 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.618 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -66.89 -39.71 87.54 Favored 'General case' 0 C--N 1.354 0.773 0 CA-C-N 117.291 0.545 . . . . 0.0 110.526 -178.282 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 22.6 mmt -63.53 -41.42 98.46 Favored 'General case' 0 C--N 1.355 0.835 0 O-C-N 121.618 -0.676 . . . . 0.0 111.013 -178.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -66.34 -40.4 89.84 Favored 'General case' 0 C--N 1.347 0.493 0 O-C-N 122.148 -0.345 . . . . 0.0 111.702 -177.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 55.8 tp -66.03 -43.06 88.69 Favored 'General case' 0 C--N 1.349 0.583 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 -178.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.618 HG12 ' O ' ' A' ' 9' ' ' LEU . 1.7 mm -74.61 -36.45 40.96 Favored 'Isoleucine or valine' 0 C--N 1.358 0.935 0 O-C-N 121.003 -1.06 . . . . 0.0 111.155 -175.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -66.95 -42.53 85.06 Favored 'General case' 0 C--N 1.351 0.659 0 O-C-N 121.82 -0.55 . . . . 0.0 111.286 -176.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -75.04 -30.89 61.19 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 121.83 -0.544 . . . . 0.0 111.773 -177.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -72.96 -48.67 34.7 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.736 -175.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -127.72 -22.13 3.63 Favored 'General case' 0 CA--C 1.503 -0.849 0 C-N-CA 117.609 -1.636 . . . . 0.0 112.846 -176.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 146.34 178.69 21.94 Favored Glycine 0 N--CA 1.44 -1.077 0 C-N-CA 117.671 -2.204 . . . . 0.0 110.494 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -96.7 -17.5 20.28 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -70.3 -40.17 74.39 Favored 'General case' 0 C--N 1.361 1.089 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 94.5 m -68.28 -38.54 81.81 Favored 'General case' 0 C--N 1.357 0.918 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 178.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 27.1 tp -60.68 -36.49 78.9 Favored 'General case' 0 C--N 1.355 0.839 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -65.15 -37.12 86.39 Favored 'General case' 0 C--N 1.359 0.984 0 O-C-N 121.998 -0.439 . . . . 0.0 110.461 -178.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.7 m -65.67 -37.75 87.38 Favored 'General case' 0 C--N 1.355 0.811 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 23.4 tp -62.39 -40.73 97.44 Favored 'General case' 0 C--N 1.354 0.764 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.484 ' HB3' HD23 ' A' ' 31' ' ' LEU . 6.8 mp -74.94 -11.35 60.1 Favored 'General case' 0 C--N 1.36 1.031 0 O-C-N 121.693 -0.629 . . . . 0.0 110.483 -178.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -85.7 -29.21 24.14 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 119.254 -0.978 . . . . 0.0 108.925 178.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.7 t -67.13 -37.52 83.98 Favored 'General case' 0 C--N 1.357 0.92 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.646 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 1.8 p -89.81 -38.99 13.39 Favored 'General case' 0 C--N 1.359 1.011 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.646 ' HB2' ' O ' ' A' ' 29' ' ' CYS . 10.6 mt-10 85.61 132.39 0.04 OUTLIER 'General case' 0 C--N 1.362 1.119 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.484 HD23 ' HB3' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -108.58 122.18 46.55 Favored 'General case' 0 C--N 1.357 0.898 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.433 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -94.25 -38.03 11.24 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -104.77 -78.16 0.57 Allowed 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.234 -178.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -137.24 -55.56 0.7 Allowed 'General case' 0 CA--C 1.502 -0.888 0 C-N-CA 119.609 -0.836 . . . . 0.0 108.853 -178.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 128.91 -52.11 0.84 Allowed Glycine 0 C--N 1.352 1.458 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 78.4 mt -97.67 95.29 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.755 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.608 ' CD2' HG23 ' A' ' 40' ' ' VAL . 1.2 t80 -65.38 -50.94 63.65 Favored 'General case' 0 C--N 1.36 1.059 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.461 HG22 ' N ' ' A' ' 39' ' ' SER . 1.1 m 143.58 -64.32 0.0 OUTLIER 'General case' 0 C--N 1.368 1.406 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 178.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.461 ' N ' HG22 ' A' ' 38' ' ' THR . 16.5 p 169.59 70.39 0.0 OUTLIER 'General case' 0 C--N 1.364 1.208 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.608 HG23 ' CD2' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -164.52 1.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.938 0 C-N-CA 119.853 -0.739 . . . . 0.0 109.695 -179.811 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.5 146.73 17.35 Favored Glycine 0 C--N 1.353 1.526 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 53.4 m -123.93 124.71 43.2 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -116.45 175.18 5.68 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -82.07 -172.62 4.05 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -92.42 -14.68 28.21 Favored 'General case' 0 N--CA 1.439 -0.975 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.365 -179.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -70.22 -28.44 65.27 Favored 'General case' 0 C--N 1.354 0.764 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.442 ' CG ' ' HZ ' ' A' ' 6' ' ' PHE . 26.0 tp10 -63.2 -40.3 97.09 Favored 'General case' 0 C--N 1.353 0.726 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.412 HD22 ' O ' ' A' ' 48' ' ' LEU . 2.0 tm? -67.68 -38.29 83.52 Favored 'General case' 0 C--N 1.358 0.942 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 58.5 tp -74.17 -29.35 61.73 Favored 'General case' 0 N--CA 1.447 -0.598 0 O-C-N 122.088 -0.382 . . . . 0.0 110.259 -176.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -68.28 -41.02 81.62 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 121.835 -0.54 . . . . 0.0 109.561 -178.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 63.2 mt -83.98 -15.92 45.94 Favored 'General case' 0 C--N 1.361 1.072 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.666 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.4 t -81.85 -35.76 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 52.2 t -70.7 -39.84 76.23 Favored 'Isoleucine or valine' 0 C--N 1.354 0.791 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.0 tptt -67.19 -28.54 68.18 Favored 'General case' 0 C--N 1.36 1.048 0 O-C-N 121.266 -0.896 . . . . 0.0 108.622 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.417 ' O ' HD23 ' A' ' 55' ' ' LEU . 2.5 tt -67.99 -37.79 81.91 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 60.0 p -72.32 -17.65 61.84 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.741 -178.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -101.44 -35.32 9.23 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 119.278 -0.969 . . . . 0.0 111.049 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.8 p -73.61 -36.86 48.44 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 O-C-N 121.797 -0.565 . . . . 0.0 111.081 -177.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 73.0 m -113.17 -6.97 13.62 Favored 'General case' 0 CA--C 1.504 -0.825 0 C-N-CA 119.512 -0.875 . . . . 0.0 110.161 -177.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 64.35 48.63 2.74 Favored 'General case' 0 C--N 1.356 0.858 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.562 HG13 ' HD2' ' A' ' 62' ' ' PRO . 49.8 t -113.6 135.5 21.93 Favored Pre-proline 0 CA--C 1.505 -0.774 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.67 ' HG2' ' HB2' ' A' ' 65' ' ' GLU . 23.4 Cg_endo -62.57 149.12 92.12 Favored 'Trans proline' 0 CA--C 1.5 -1.203 0 C-N-CA 122.276 1.984 . . . . 0.0 112.518 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.2 m -75.98 -13.67 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.319 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.45 ' O ' HG12 ' A' ' 67' ' ' VAL . 72.1 p -95.22 -33.99 12.39 Favored 'General case' 0 C--N 1.356 0.878 0 C-N-CA 118.207 -1.397 . . . . 0.0 109.747 -178.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.67 ' HB2' ' HG2' ' A' ' 62' ' ' PRO . 97.9 mt-10 -78.02 -21.84 50.15 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 121.336 -0.853 . . . . 0.0 108.978 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.52 -37.48 36.54 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 64' ' ' THR . 1.7 p -67.47 -26.9 36.84 Favored 'Isoleucine or valine' 0 C--N 1.355 0.812 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.902 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.9 mmm-85 -71.98 -51.15 23.33 Favored 'General case' 0 C--N 1.363 1.184 0 O-C-N 121.549 -0.719 . . . . 0.0 110.451 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.2 mt -63.24 -36.06 82.41 Favored 'General case' 0 C--N 1.357 0.922 0 O-C-N 121.963 -0.461 . . . . 0.0 110.953 -178.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -60.58 -46.83 88.77 Favored 'General case' 0 C--N 1.348 0.541 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -178.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.39 -38.42 94.71 Favored Glycine 0 C--N 1.352 1.455 0 N-CA-C 111.74 -0.544 . . . . 0.0 111.74 -178.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -63.16 -48.38 78.68 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-N 118.499 1.149 . . . . 0.0 111.547 -177.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.707 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 16.2 mttm -63.76 -49.41 73.08 Favored 'General case' 0 C--N 1.359 1.006 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -176.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.413 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.4 tm? -68.65 -39.71 80.58 Favored 'General case' 0 C--N 1.349 0.559 0 O-C-N 121.125 -0.985 . . . . 0.0 111.973 -175.329 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.537 ' CE1' ' CBB' ' A' ' 202' ' ' HEM . 35.9 t80 -63.86 -44.35 93.39 Favored 'General case' 0 C--N 1.352 0.702 0 O-C-N 121.196 -0.94 . . . . 0.0 111.187 -177.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -70.33 -15.51 19.16 Favored 'Isoleucine or valine' 0 C--N 1.359 0.986 0 O-C-N 121.41 -0.806 . . . . 0.0 109.261 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.707 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 74.5 mm-40 -72.17 -38.33 69.16 Favored 'General case' 0 C--N 1.351 0.651 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 81.4 mt -74.25 -29.11 61.54 Favored 'General case' 0 C--N 1.357 0.9 0 O-C-N 122.311 -0.243 . . . . 0.0 110.543 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.8 mm -67.06 -54.16 27.12 Favored 'Isoleucine or valine' 0 C--N 1.359 1.007 0 C-N-CA 119.993 -0.683 . . . . 0.0 109.897 -177.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -74.63 -14.66 60.79 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 119.686 -0.806 . . . . 0.0 109.285 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.55 -37.25 62.23 Favored Glycine 0 C--N 1.348 1.228 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -134.01 104.16 11.67 Favored Pre-proline 0 N--CA 1.441 -0.88 0 CA-C-O 122.494 1.14 . . . . 0.0 109.026 -177.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.48 ' O ' ' HB2' ' A' ' 87' ' ' ASN . 37.6 Cg_endo -67.98 -23.2 40.85 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.556 2.171 . . . . 0.0 114.004 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -90.01 -8.38 51.72 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.4 tp -89.63 -22.81 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -178.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -102.51 -15.95 16.28 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 49.1 t30 -71.74 -40.92 69.07 Favored 'General case' 0 C--N 1.36 1.061 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -67.1 -29.21 68.9 Favored 'General case' 0 C--N 1.353 0.756 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.209 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 23.7 ttp -84.4 148.1 26.78 Favored 'General case' 0 C--N 1.351 0.652 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.5 -21.96 8.37 Favored 'General case' 0 C--N 1.363 1.193 0 C-N-CA 119.934 -0.707 . . . . 0.0 111.025 -177.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -165.3 171.66 13.28 Favored 'General case' 0 C--N 1.354 0.778 0 C-N-CA 119.045 -1.062 . . . . 0.0 108.338 -177.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 39.6 t -64.62 -42.13 95.71 Favored 'General case' 0 C--N 1.356 0.884 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.864 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -66.46 -39.11 88.63 Favored 'General case' 0 C--N 1.356 0.884 0 O-C-N 121.528 -0.733 . . . . 0.0 109.292 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -65.61 -25.72 67.51 Favored 'General case' 0 C--N 1.357 0.912 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 64.5 tp -62.94 -46.22 88.77 Favored 'General case' 0 C--N 1.355 0.826 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.7 mp -62.5 -32.5 73.43 Favored 'General case' 0 C--N 1.353 0.752 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 37.1 t -62.4 -45.37 93.44 Favored 'General case' 0 C--N 1.356 0.857 0 O-C-N 121.719 -0.613 . . . . 0.0 111.22 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.97 28.88 8.42 Favored 'General case' 0 C--N 1.36 1.049 0 C-N-CA 119.304 -0.958 . . . . 0.0 110.462 -178.126 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.669 HD11 ' C3B' ' A' ' 202' ' ' HEM . 10.4 tt -62.3 -29.17 46.07 Favored 'Isoleucine or valine' 0 C--N 1.356 0.868 0 O-C-N 122.152 -0.343 . . . . 0.0 110.537 -178.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -127.15 -11.43 5.85 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 118.696 -1.202 . . . . 0.0 109.097 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.4 t -68.31 -45.55 72.67 Favored 'General case' 0 N--CA 1.439 -0.977 0 O-C-N 121.879 -0.513 . . . . 0.0 109.901 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.479 ' O ' HG12 ' A' ' 105' ' ' VAL . 19.3 t80 -123.83 -29.53 3.67 Favored 'General case' 0 C--N 1.36 1.049 0 C-N-CA 118.38 -1.328 . . . . 0.0 111.549 -178.122 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 96.2 mt -69.75 -48.4 64.94 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 O-C-N 121.076 -1.015 . . . . 0.0 110.487 -177.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -89.03 3.65 50.97 Favored 'General case' 0 N--CA 1.44 -0.954 0 O-C-N 121.105 -0.997 . . . . 0.0 109.916 -177.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.479 HG12 ' O ' ' A' ' 102' ' ' PHE . 1.9 p -87.68 -33.98 7.04 Favored 'Isoleucine or valine' 0 C--N 1.357 0.899 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 178.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -71.64 -40.12 69.91 Favored 'General case' 0 C--N 1.36 1.049 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 62.2 t -62.82 -47.06 94.63 Favored 'Isoleucine or valine' 0 C--N 1.357 0.909 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.276 -179.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -60.2 -48.61 81.02 Favored 'General case' 0 C--N 1.357 0.931 0 O-C-N 122.115 -0.366 . . . . 0.0 111.466 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -60.61 -38.93 86.33 Favored 'General case' 0 C--N 1.355 0.833 0 O-C-N 121.547 -0.721 . . . . 0.0 110.609 -178.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 19.6 mt -58.26 -75.64 0.05 OUTLIER 'General case' 0 C--N 1.354 0.804 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -115.29 132.97 22.8 Favored Pre-proline 0 N--CA 1.442 -0.874 0 C-N-CA 118.906 -1.117 . . . . 0.0 108.9 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -84.54 -3.4 10.0 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 123.176 2.584 . . . . 0.0 115.056 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -66.42 -36.6 83.21 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 122.001 -0.437 . . . . 0.0 109.948 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.4 146.34 54.13 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 121.714 0.769 . . . . 0.0 110.219 -178.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -130.54 135.18 47.67 Favored 'General case' 0 C--N 1.358 0.949 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.529 ' HB3' ' HD2' ' A' ' 117' ' ' PRO . 87.5 mt -127.03 157.0 73.44 Favored Pre-proline 0 N--CA 1.444 -0.756 0 CA-C-O 122.193 0.997 . . . . 0.0 109.394 -178.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.529 ' HD2' ' HB3' ' A' ' 116' ' ' LEU . 89.6 Cg_endo -80.37 -157.44 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -0.987 0 C-N-CA 123.914 3.076 . . . . 0.0 114.163 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -114.23 142.47 46.23 Favored 'General case' 0 C--N 1.367 1.332 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -124.0 127.85 48.51 Favored 'General case' 0 C--N 1.361 1.067 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -178.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.537 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 94.7 m -124.7 128.51 48.91 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 177.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 78.4 m -122.63 131.17 53.69 Favored 'General case' 0 CA--C 1.504 -0.825 0 C-N-CA 119.061 -1.055 . . . . 0.0 109.929 -177.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -118.15 149.52 40.92 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 177.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -121.2 117.74 27.85 Favored 'General case' 0 C--N 1.353 0.748 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -179.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 97.2 mt -93.37 -13.93 27.46 Favored 'General case' 0 C--N 1.356 0.856 0 C-N-CA 120.431 -0.507 . . . . 0.0 110.603 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 173.29 -149.16 10.88 Favored Glycine 0 C--N 1.348 1.226 0 C-N-CA 118.761 -1.685 . . . . 0.0 109.171 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -94.15 -37.91 11.34 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -103.6 5.79 36.79 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 120.166 -0.614 . . . . 0.0 109.39 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -121.49 127.85 51.48 Favored 'General case' 0 C--N 1.359 0.979 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.3 mm -141.71 135.95 30.59 Favored 'Isoleucine or valine' 0 C--N 1.354 0.787 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 53.2 mtm180 -115.94 140.11 49.57 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 7.5 tp -126.79 118.64 25.07 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.654 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.537 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 12.6 m-70 -99.15 133.11 43.9 Favored 'General case' 0 CA--C 1.497 -1.087 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -127.46 120.54 28.61 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.466 ' HA ' ' O ' ' A' ' 171' ' ' THR . 36.2 tt0 -114.78 111.7 21.65 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 15.9 t -161.7 152.53 17.91 Favored 'General case' 0 C--N 1.359 0.986 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -90.82 1.49 56.89 Favored 'General case' 0 C--N 1.357 0.93 0 C-N-CA 120.245 -0.582 . . . . 0.0 109.95 -178.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -135.35 74.28 61.43 Favored Pre-proline 0 C--N 1.355 0.821 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -96.72 110.51 0.11 Allowed 'Trans proline' 0 N--CA 1.444 -1.429 0 C-N-CA 122.752 2.301 . . . . 0.0 116.03 -177.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -112.85 112.59 24.18 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 176.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.88 -38.59 91.64 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.116 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 74.0 m -63.21 -28.81 70.3 Favored 'General case' 0 C--N 1.354 0.783 0 O-C-N 121.927 -0.483 . . . . 0.0 110.689 -178.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -74.16 -46.82 39.91 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 120.236 -0.586 . . . . 0.0 109.719 -177.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.95 -39.67 93.85 Favored 'General case' 0 C--N 1.357 0.908 0 O-C-N 122.176 -0.327 . . . . 0.0 111.351 -177.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -63.09 -37.47 87.33 Favored 'General case' 0 C--N 1.355 0.83 0 O-C-N 121.872 -0.517 . . . . 0.0 110.164 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.54 -43.26 99.07 Favored Glycine 0 C--N 1.347 1.162 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LEU . . . . . 0.424 ' HB3' HBB2 ' A' ' 202' ' ' HEM . 82.7 mt -70.07 -40.51 74.99 Favored 'General case' 0 C--N 1.351 0.657 0 CA-C-N 117.521 0.66 . . . . 0.0 112.724 -179.39 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 98.0 mt -70.89 -42.39 70.04 Favored 'General case' 0 C--N 1.361 1.103 0 O-C-N 121.146 -0.971 . . . . 0.0 110.829 -176.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -70.4 -30.01 66.79 Favored 'General case' 0 N--CA 1.444 -0.735 0 O-C-N 121.953 -0.467 . . . . 0.0 110.677 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.524 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -63.55 -39.59 97.79 Favored Glycine 0 C--N 1.356 1.688 0 N-CA-C 108.622 -1.791 . . . . 0.0 108.622 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 43.5 t -60.36 -42.99 96.91 Favored 'General case' 0 C--N 1.351 0.64 0 N-CA-C 109.146 -0.686 . . . . 0.0 109.146 178.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -78.83 2.66 19.2 Favored 'General case' 0 C--N 1.359 0.981 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.524 ' HB2' ' O ' ' A' ' 149' ' ' GLY . 24.3 mm-40 -84.56 -48.25 9.73 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -68.67 -40.65 80.05 Favored 'General case' 0 C--N 1.357 0.925 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.504 ' O ' ' HB2' ' A' ' 155' ' ' LYS . 9.1 m-30 -70.46 -26.73 63.77 Favored 'General case' 0 C--N 1.36 1.059 0 O-C-N 121.741 -0.599 . . . . 0.0 111.154 -178.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.504 ' HB2' ' O ' ' A' ' 154' ' ' PHE . 56.8 mtpt 73.2 64.85 0.1 Allowed 'General case' 0 C--N 1.361 1.103 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -178.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -127.16 -179.33 4.81 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -142.3 89.22 2.14 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 17.3 m-30 -115.14 156.7 24.79 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 93.7 m -118.79 127.73 53.8 Favored 'General case' 0 C--N 1.356 0.867 0 C-N-CA 119.462 -0.895 . . . . 0.0 108.831 -178.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.517 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.6 mp -102.88 121.84 54.53 Favored 'Isoleucine or valine' 0 C--N 1.352 0.698 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 178.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -118.05 -173.29 2.42 Favored 'General case' 0 C--N 1.356 0.884 0 CA-C-O 121.801 0.81 . . . . 0.0 109.524 -178.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 26.5 ptt180 -147.54 156.45 42.85 Favored 'General case' 0 C--N 1.357 0.894 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 48.2 p -100.1 146.26 31.62 Favored Pre-proline 0 C--N 1.358 0.967 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.674 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 74.7 Cg_endo -76.83 -11.09 18.32 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.819 2.346 . . . . 0.0 115.234 -178.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -72.66 -41.5 65.33 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.589 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 35.5 p -117.83 16.27 14.36 Favored 'General case' 0 C--N 1.354 0.771 0 C-N-CA 120.069 -0.652 . . . . 0.0 110.443 -178.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.674 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.2 pp0? -66.6 -11.34 52.99 Favored 'General case' 0 C--N 1.353 0.743 0 O-C-N 121.595 -0.69 . . . . 0.0 110.457 178.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -126.56 38.54 4.1 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 58.9 m -137.6 147.11 44.76 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.624 ' O ' ' HB ' ' A' ' 171' ' ' THR . 60.5 mt-10 -101.27 165.23 11.39 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.624 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 19.9 m 84.75 -60.37 0.09 Allowed 'General case' 0 C--N 1.367 1.355 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -109.24 117.38 33.95 Favored 'General case' 0 CA--C 1.502 -0.878 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.43 -178.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 90.8 t -130.73 133.08 63.82 Favored 'Isoleucine or valine' 0 C--N 1.356 0.883 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 49.9 mm -108.53 126.89 65.31 Favored 'Isoleucine or valine' 0 C--N 1.358 0.958 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -115.93 156.62 25.89 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -137.94 118.94 14.33 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.2 mp -114.15 120.16 63.19 Favored 'Isoleucine or valine' 0 C--N 1.352 0.696 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 43.1 p -121.17 159.49 25.75 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-O 121.763 0.792 . . . . 0.0 110.662 -177.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -109.39 110.65 21.85 Favored 'General case' 0 C--N 1.361 1.07 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 177.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.435 ' HA ' ' HD3' ' A' ' 181' ' ' PRO . . . -65.35 144.1 98.9 Favored Pre-proline 0 CA--C 1.503 -0.859 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 180' ' ' ALA . 50.2 Cg_exo -56.66 128.79 31.48 Favored 'Trans proline' 0 CA--C 1.493 -1.563 0 C-N-CA 122.665 2.243 . . . . 0.0 112.627 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -139.47 143.53 37.57 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-O 121.877 0.846 . . . . 0.0 109.164 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.55 ' O ' ' HB2' ' A' ' 184' ' ' ALA . . . 55.25 46.84 77.86 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.55 ' HB2' ' O ' ' A' ' 183' ' ' GLY . . . 153.7 99.45 0.0 OUTLIER 'General case' 0 C--N 1.359 1.006 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 -177.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -115.81 104.64 11.85 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -124.1 126.76 46.76 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 78.0 mt -109.07 -53.98 2.58 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' TYR . . . . . 0.492 ' HB3' ' H ' ' A' ' 189' ' ' PHE . 4.8 t80 -154.58 -87.87 0.05 OUTLIER 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' PHE . . . . . 0.492 ' H ' ' HB3' ' A' ' 188' ' ' TYR . 0.4 OUTLIER -124.64 -60.06 1.41 Allowed 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 179.755 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 . . . . . 0 C--O 1.264 1.819 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 179.891 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 201' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 202' ' ' HEM . . . . . 0.883 ' CMD' ' HG2' ' A' ' 1' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.849 ' H3 ' ' CMD' ' A' ' 202' ' ' HEM . 51.9 tpp . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.038 0.447 . . . . 0.0 110.475 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.44 ' O ' ' HD1' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -82.14 -14.98 54.9 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.383 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -71.93 -41.5 54.99 Favored Glycine 0 C--N 1.351 1.405 0 N-CA-C 108.558 -1.817 . . . . 0.0 108.558 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.767 ' HG3' ' HG2' ' A' ' 1' ' ' MET . 67.8 mtt -66.35 -38.22 87.13 Favored 'General case' 0 C--N 1.356 0.849 0 O-C-N 122.316 -0.52 . . . . 0.0 111.555 -178.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.4 m -69.38 -23.93 27.05 Favored 'Isoleucine or valine' 0 C--N 1.357 0.914 0 C-N-CA 119.996 -0.682 . . . . 0.0 109.847 -177.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.577 ' HZ ' ' HG2' ' A' ' 47' ' ' GLU . 4.6 m-85 -71.36 -35.8 71.25 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 85.3 m -67.77 -41.31 83.47 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.38 -38.98 97.18 Favored Glycine 0 C--N 1.357 1.727 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.611 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -66.05 -39.87 90.49 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-N 117.338 0.569 . . . . 0.0 110.704 -178.336 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.418 ' CE ' HD11 ' A' ' 26' ' ' LEU . 25.6 mmt -64.14 -39.81 94.82 Favored 'General case' 0 C--N 1.351 0.662 0 O-C-N 121.802 -0.561 . . . . 0.0 110.847 -178.291 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.6 -39.83 88.57 Favored 'General case' 0 C--N 1.35 0.604 0 O-C-N 121.974 -0.454 . . . . 0.0 111.148 -178.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 56.0 tp -66.86 -42.83 85.02 Favored 'General case' 0 C--N 1.35 0.593 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.611 HG12 ' O ' ' A' ' 9' ' ' LEU . 2.2 mm -75.32 -36.42 36.23 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 O-C-N 121.053 -1.029 . . . . 0.0 111.074 -175.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -70.01 -42.6 72.81 Favored 'General case' 0 C--N 1.353 0.725 0 O-C-N 121.725 -0.609 . . . . 0.0 111.181 -176.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -71.3 -32.83 69.11 Favored 'General case' 0 N--CA 1.444 -0.735 0 O-C-N 122.002 -0.436 . . . . 0.0 111.219 -177.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -72.61 -50.51 24.82 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -175.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -128.91 -19.32 3.64 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 117.365 -1.734 . . . . 0.0 113.721 -176.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 142.08 179.66 19.25 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 117.594 -2.241 . . . . 0.0 110.134 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -96.06 -11.38 26.45 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -177.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -70.31 -40.23 74.34 Favored 'General case' 0 C--N 1.36 1.062 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 92.6 m -68.74 -39.03 80.54 Favored 'General case' 0 C--N 1.357 0.908 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.0 tt -60.36 -38.73 84.76 Favored 'General case' 0 C--N 1.359 0.99 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -63.98 -37.51 87.66 Favored 'General case' 0 C--N 1.355 0.828 0 O-C-N 122.085 -0.385 . . . . 0.0 111.053 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 90.1 m -65.36 -40.94 94.22 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 121.701 -0.624 . . . . 0.0 109.528 -178.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.442 ' CD2' ' HB3' ' A' ' 54' ' ' LYS . 87.8 mt -64.52 -38.0 89.49 Favored 'General case' 0 C--N 1.354 0.767 0 O-C-N 122.037 -0.414 . . . . 0.0 110.069 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.418 HD11 ' CE ' ' A' ' 10' ' ' MET . 3.9 mp -72.7 -12.8 61.17 Favored 'General case' 0 C--N 1.361 1.072 0 O-C-N 121.51 -0.744 . . . . 0.0 110.145 -178.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -86.99 -28.49 22.62 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 119.298 -0.961 . . . . 0.0 109.047 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.9 t -67.14 -37.67 84.21 Favored 'General case' 0 C--N 1.354 0.801 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.9 p -89.8 -40.88 12.19 Favored 'General case' 0 C--N 1.359 0.996 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 86.18 132.89 0.04 OUTLIER 'General case' 0 C--N 1.36 1.051 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.513 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -83.62 -171.61 3.69 Favored 'General case' 0 C--N 1.357 0.916 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.41 ' H ' ' H ' ' A' ' 33' ' ' SER . 53.5 tt0 -151.2 -27.26 0.2 Allowed 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.41 ' H ' ' H ' ' A' ' 32' ' ' GLN . 2.3 t -144.26 -68.38 0.32 Allowed 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -179.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -129.74 -49.3 1.14 Allowed 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.32 -42.88 1.68 Allowed Glycine 0 C--N 1.352 1.427 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 82.9 mt -110.12 105.48 18.89 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.006 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -87.6 -137.7 0.1 Allowed 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 89.8 m -118.06 -59.0 1.95 Allowed 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.1 p 167.21 25.6 0.0 OUTLIER 'General case' 0 C--N 1.362 1.131 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.0 t -109.49 1.81 9.38 Favored 'Isoleucine or valine' 0 C--N 1.353 0.731 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.476 -178.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -96.78 143.47 16.76 Favored Glycine 0 C--N 1.353 1.502 0 C-N-CA 119.111 -1.518 . . . . 0.0 109.9 -178.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 51.5 m -123.11 127.43 48.7 Favored 'General case' 0 C--N 1.356 0.889 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -120.37 173.4 7.17 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -77.19 -176.63 4.16 Favored 'General case' 0 C--N 1.357 0.924 0 CA-C-O 121.568 0.699 . . . . 0.0 109.287 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 15.3 t60 -88.93 -22.16 23.22 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -66.23 -27.68 68.15 Favored 'General case' 0 C--N 1.356 0.881 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.577 ' HG2' ' HZ ' ' A' ' 6' ' ' PHE . 35.2 tp10 -62.19 -40.8 97.27 Favored 'General case' 0 C--N 1.352 0.704 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.435 HD22 ' O ' ' A' ' 48' ' ' LEU . 1.9 tm? -67.05 -38.64 86.19 Favored 'General case' 0 C--N 1.357 0.899 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 59.0 tp -70.64 -34.25 71.86 Favored 'General case' 0 CA--C 1.51 -0.585 0 O-C-N 122.118 -0.364 . . . . 0.0 110.261 -176.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 71.7 tp60 -66.26 -40.54 90.24 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 121.89 -0.506 . . . . 0.0 109.774 -178.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 85.2 mt -81.99 -17.35 47.19 Favored 'General case' 0 C--N 1.361 1.066 0 C-N-CA 120.086 -0.645 . . . . 0.0 110.593 -178.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.3 t -81.38 -36.65 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 54.7 t -70.05 -39.68 77.56 Favored 'Isoleucine or valine' 0 C--N 1.352 0.682 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.442 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 34.6 tptt -64.81 -28.33 69.49 Favored 'General case' 0 C--N 1.363 1.195 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.498 HD21 HD12 ' A' ' 13' ' ' ILE . 4.5 mt -67.13 -38.48 85.63 Favored 'General case' 0 C--N 1.356 0.866 0 C-N-CA 120.684 -0.407 . . . . 0.0 110.254 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 70.4 p -72.2 -17.65 61.91 Favored 'General case' 0 C--N 1.354 0.789 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.851 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -101.55 -37.4 8.41 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 121.173 -0.954 . . . . 0.0 111.643 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.4 p -72.07 -37.16 59.26 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 121.62 -0.675 . . . . 0.0 111.492 -177.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.627 ' HB3' HG23 ' A' ' 61' ' ' VAL . 3.4 t -115.64 -6.68 12.18 Favored 'General case' 0 C--N 1.351 0.668 0 C-N-CA 119.126 -1.03 . . . . 0.0 110.216 -177.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 65.0 46.91 2.67 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.627 HG23 ' HB3' ' A' ' 59' ' ' SER . 46.5 t -107.49 135.44 19.71 Favored Pre-proline 0 CA--C 1.504 -0.801 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.545 ' HG2' ' HB2' ' A' ' 65' ' ' GLU . 23.9 Cg_endo -62.41 147.84 94.25 Favored 'Trans proline' 0 CA--C 1.5 -1.177 0 C-N-CA 122.078 1.852 . . . . 0.0 112.311 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.4 m -76.68 -12.51 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.545 -177.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.48 ' O ' HG12 ' A' ' 67' ' ' VAL . 70.7 p -95.56 -33.27 12.47 Favored 'General case' 0 C--N 1.356 0.865 0 C-N-CA 118.166 -1.413 . . . . 0.0 109.956 -178.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.545 ' HB2' ' HG2' ' A' ' 62' ' ' PRO . 99.1 mt-10 -81.07 -20.08 42.35 Favored 'General case' 0 C--N 1.354 0.787 0 O-C-N 121.245 -0.909 . . . . 0.0 108.575 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.447 ' HB3' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -78.36 -37.32 44.56 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 179.572 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 64' ' ' THR . 1.8 p -68.84 -29.35 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.278 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -70.81 -48.55 53.54 Favored 'General case' 0 C--N 1.365 1.267 0 O-C-N 121.222 -0.923 . . . . 0.0 110.829 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 83.8 mt -63.76 -36.52 84.16 Favored 'General case' 0 C--N 1.355 0.812 0 O-C-N 122.049 -0.407 . . . . 0.0 110.751 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -61.21 -47.49 85.89 Favored 'General case' 0 C--N 1.348 0.512 0 O-C-N 122.307 -0.246 . . . . 0.0 110.587 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.61 -38.86 96.55 Favored Glycine 0 C--N 1.354 1.542 0 CA-C-O 119.812 -0.438 . . . . 0.0 112.204 -177.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -65.26 -46.05 82.08 Favored 'General case' 0 C--N 1.352 0.693 0 CA-C-N 118.554 1.177 . . . . 0.0 111.318 -176.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.741 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 10.7 mttm -63.74 -49.41 73.13 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -177.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.481 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.2 tm? -68.18 -40.18 82.32 Favored 'General case' 0 C--N 1.35 0.617 0 O-C-N 121.195 -0.941 . . . . 0.0 112.149 -175.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.407 ' CE2' ' HA ' ' A' ' 150' ' ' CYS . 49.3 t80 -62.94 -45.57 91.86 Favored 'General case' 0 C--N 1.353 0.743 0 O-C-N 121.179 -0.951 . . . . 0.0 111.238 -178.043 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.2 p -71.26 -14.79 18.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.888 0 O-C-N 121.523 -0.736 . . . . 0.0 109.588 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.741 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 76.6 mm-40 -73.77 -39.18 64.37 Favored 'General case' 0 C--N 1.35 0.617 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.655 HD13 HBC2 ' A' ' 202' ' ' HEM . 80.1 mt -69.91 -36.71 75.58 Favored 'General case' 0 C--N 1.358 0.977 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.8 mm -62.55 -50.19 80.8 Favored 'Isoleucine or valine' 0 C--N 1.354 0.779 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -178.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -66.17 -24.4 66.63 Favored 'General case' 0 C--N 1.352 0.702 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.345 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.04 -1.18 63.16 Favored Glycine 0 C--N 1.349 1.253 0 C-N-CA 119.793 -1.194 . . . . 0.0 110.656 -177.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.67 ' HB3' ' HB ' ' A' ' 85' ' ' ILE . 84.2 m-70 -138.04 89.87 14.32 Favored Pre-proline 0 CA--C 1.5 -0.95 0 CA-C-N 119.003 1.402 . . . . 0.0 109.201 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 82' ' ' HIS . 34.8 Cg_endo -66.98 -28.52 41.8 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 C-N-CA 122.464 2.109 . . . . 0.0 114.34 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -92.95 -5.11 51.48 Favored 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 119.422 -0.911 . . . . 0.0 108.927 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.67 ' HB ' ' HB3' ' A' ' 82' ' ' HIS . 0.9 OUTLIER -90.04 -19.56 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 -179.973 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.5 -25.85 14.05 Favored 'General case' 0 C--N 1.362 1.127 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -69.84 -35.81 75.05 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -65.53 -36.74 84.69 Favored 'General case' 0 C--N 1.355 0.837 0 O-C-N 122.072 -0.393 . . . . 0.0 110.084 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.615 ' HG2' ' N ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -80.55 156.08 26.65 Favored 'General case' 0 C--N 1.356 0.859 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -178.576 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.615 ' N ' ' HG2' ' A' ' 89' ' ' MET . 4.0 mtpt -119.78 -25.46 5.89 Favored 'General case' 0 C--N 1.363 1.182 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.631 -177.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -166.22 173.75 9.86 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -177.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 61.7 m -66.29 -39.65 89.51 Favored 'General case' 0 C--N 1.354 0.777 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.284 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -67.53 -39.31 85.07 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 119.739 -0.784 . . . . 0.0 109.059 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -65.33 -24.5 67.28 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 57.0 tp -64.76 -44.33 90.4 Favored 'General case' 0 C--N 1.353 0.735 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.9 mp -61.66 -33.92 74.81 Favored 'General case' 0 C--N 1.356 0.879 0 O-C-N 122.139 -0.351 . . . . 0.0 111.025 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 86.3 p -86.56 -7.28 58.5 Favored 'General case' 0 C--N 1.354 0.767 0 C-N-CA 119.294 -0.962 . . . . 0.0 110.805 -178.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.7 tttp -111.36 0.68 16.71 Favored 'General case' 0 C--N 1.356 0.857 0 O-C-N 121.533 -0.729 . . . . 0.0 109.798 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 1.004 HD11 ' C4B' ' A' ' 202' ' ' HEM . 9.5 tp -65.66 -39.9 86.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.808 0 O-C-N 121.867 -0.52 . . . . 0.0 111.818 -177.135 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.412 ' N ' HG23 ' A' ' 99' ' ' ILE . 37.6 t70 -95.51 -27.28 15.45 Favored 'General case' 0 N--CA 1.44 -0.959 0 O-C-N 120.827 -1.171 . . . . 0.0 111.657 -177.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 90.0 p -70.01 -39.87 75.58 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 119.412 -0.915 . . . . 0.0 112.984 -176.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.555 ' HA ' HG12 ' A' ' 105' ' ' VAL . 8.7 t80 -138.47 -19.61 1.07 Allowed 'General case' 0 C--N 1.361 1.08 0 C-N-CA 116.971 -1.891 . . . . 0.0 113.511 -177.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.405 HG21 ' C1C' ' A' ' 202' ' ' HEM . 24.1 mm -68.39 -51.0 51.76 Favored 'Isoleucine or valine' 0 C--O 1.244 0.783 0 CA-C-N 120.424 1.466 . . . . 0.0 110.379 -177.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 54.9 m80 -92.9 4.2 54.35 Favored 'General case' 0 N--CA 1.437 -1.076 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.551 -176.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.555 HG12 ' HA ' ' A' ' 102' ' ' PHE . 3.3 p -87.73 -35.67 8.57 Favored 'Isoleucine or valine' 0 C--N 1.353 0.749 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 178.144 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -72.65 -41.9 64.96 Favored 'General case' 0 C--N 1.358 0.938 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 67.0 t -65.3 -48.39 83.54 Favored 'Isoleucine or valine' 0 C--N 1.358 0.974 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.527 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -60.75 -47.87 84.35 Favored 'General case' 0 C--N 1.359 0.987 0 O-C-N 122.079 -0.388 . . . . 0.0 111.389 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LYS . . . . . 0.477 ' HG2' ' O ' ' A' ' 105' ' ' VAL . 38.3 mmtt -61.14 -39.39 89.88 Favored 'General case' 0 N--CA 1.445 -0.703 0 O-C-N 121.685 -0.634 . . . . 0.0 110.696 -177.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 19.4 mt -56.46 -72.11 0.08 Allowed 'General case' 0 CA--C 1.505 -0.786 0 C-N-CA 120.541 -0.463 . . . . 0.0 109.762 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -123.42 141.33 35.98 Favored Pre-proline 0 N--CA 1.439 -1.005 0 C-N-CA 118.538 -1.265 . . . . 0.0 109.207 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -86.29 -2.15 8.56 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 123.308 2.672 . . . . 0.0 115.402 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -66.31 -37.42 85.36 Favored 'General case' 0 C--N 1.355 0.839 0 O-C-N 121.757 -0.59 . . . . 0.0 109.908 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.618 ' HB1' HAD1 ' A' ' 202' ' ' HEM . . . -65.34 144.92 56.79 Favored 'General case' 0 C--N 1.353 0.73 0 CA-C-O 121.548 0.69 . . . . 0.0 110.174 -178.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.5 ' O ' HD13 ' A' ' 116' ' ' LEU . 47.3 mt-10 -112.05 143.51 42.94 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 179.047 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.5 HD13 ' O ' ' A' ' 115' ' ' GLU . 2.6 mm? -128.37 149.41 71.41 Favored Pre-proline 0 C--N 1.353 0.759 0 CA-C-O 122.164 0.983 . . . . 0.0 108.981 -178.297 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 116' ' ' LEU . 64.8 Cg_endo -91.85 -160.72 0.09 OUTLIER 'Trans proline' 0 C--N 1.316 -1.156 0 C-N-CA 123.857 3.038 . . . . 0.0 112.959 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -121.33 140.68 51.78 Favored 'General case' 0 C--N 1.363 1.18 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.443 ' HE2' ' CD1' ' A' ' 133' ' ' TYR . 65.7 m-85 -127.53 135.2 50.02 Favored 'General case' 0 C--N 1.36 1.06 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.164 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.476 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 93.3 m -124.09 126.31 46.0 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 176.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 80.3 m -117.92 126.96 53.35 Favored 'General case' 0 CA--C 1.502 -0.896 0 C-N-CA 119.17 -1.012 . . . . 0.0 109.372 -177.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -120.47 127.49 52.27 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 178.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -100.05 116.53 32.29 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.447 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 85.9 mt -82.35 -26.86 32.56 Favored 'General case' 0 C--N 1.355 0.836 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -178.74 -144.46 5.69 Favored Glycine 0 N--CA 1.437 -1.244 0 N-CA-C 108.78 -1.728 . . . . 0.0 108.78 -178.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -94.99 -39.62 10.09 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.297 -178.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -98.84 -1.47 40.17 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.758 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.447 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 66.8 m-20 -118.82 133.45 55.83 Favored 'General case' 0 C--N 1.357 0.913 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 9.5 mm -140.78 136.79 35.13 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 179.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 52.7 mtm180 -117.39 136.77 52.93 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 5.7 tp -125.95 118.9 26.36 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.476 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 12.3 m170 -98.53 130.58 45.1 Favored 'General case' 0 CA--C 1.496 -1.133 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.553 ' OH ' HBA1 ' A' ' 202' ' ' HEM . 51.6 t80 -122.59 120.73 34.65 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 -178.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.463 ' HA ' ' O ' ' A' ' 171' ' ' THR . 36.1 tt0 -115.55 109.86 18.41 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.456 ' O ' ' HA ' ' A' ' 171' ' ' THR . 8.8 t -165.07 158.16 16.51 Favored 'General case' 0 C--N 1.359 0.979 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.493 ' C ' ' HD3' ' A' ' 138' ' ' PRO . 63.0 mtpt -91.0 5.85 47.17 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -129.58 72.32 81.97 Favored Pre-proline 0 C--N 1.354 0.804 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.493 ' HD3' ' C ' ' A' ' 136' ' ' LYS . 96.6 Cg_endo -95.21 88.03 0.11 Allowed 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 122.319 2.012 . . . . 0.0 115.446 -178.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -106.51 115.5 30.31 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 177.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.41 -38.27 90.5 Favored 'General case' 0 C--N 1.352 0.687 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.019 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 73.3 m -62.36 -33.57 74.99 Favored 'General case' 0 C--N 1.352 0.713 0 O-C-N 122.115 -0.366 . . . . 0.0 110.784 -178.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -73.15 -47.81 40.82 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.445 -177.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.25 -39.69 93.01 Favored 'General case' 0 C--N 1.355 0.839 0 O-C-N 122.105 -0.372 . . . . 0.0 111.419 -177.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.11 -36.58 84.07 Favored 'General case' 0 C--N 1.354 0.794 0 O-C-N 121.848 -0.532 . . . . 0.0 109.719 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.2 -43.23 98.64 Favored Glycine 0 C--N 1.346 1.091 0 N-CA-C 109.829 -1.309 . . . . 0.0 109.829 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 83.0 mt -70.45 -41.03 73.36 Favored 'General case' 0 C--N 1.353 0.728 0 O-C-N 122.049 -0.677 . . . . 0.0 112.733 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 98.6 mt -71.35 -42.33 68.64 Favored 'General case' 0 C--N 1.36 1.022 0 O-C-N 121.273 -0.892 . . . . 0.0 110.515 -177.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.487 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 21.3 t70 -69.43 -29.81 67.61 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 122.141 -0.349 . . . . 0.0 110.245 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -63.09 -39.46 98.04 Favored Glycine 0 C--N 1.356 1.648 0 N-CA-C 108.276 -1.93 . . . . 0.0 108.276 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' CYS . . . . . 0.407 ' HA ' ' CE2' ' A' ' 75' ' ' PHE . 48.7 t -60.43 -41.95 95.05 Favored 'General case' 0 C--N 1.35 0.598 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -74.42 -1.9 23.11 Favored 'General case' 0 C--N 1.362 1.121 0 O-C-N 121.82 -0.55 . . . . 0.0 109.544 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 76.4 mm-40 -83.74 -46.49 12.19 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -66.06 -44.11 85.48 Favored 'General case' 0 C--N 1.356 0.889 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.472 ' O ' ' HB2' ' A' ' 155' ' ' LYS . 38.0 m-85 -69.09 -25.96 64.69 Favored 'General case' 0 C--N 1.36 1.041 0 O-C-N 121.831 -0.543 . . . . 0.0 111.065 -178.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 154' ' ' PHE . 44.6 mttt 73.88 67.64 0.1 Allowed 'General case' 0 C--N 1.361 1.099 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -138.88 -168.11 2.35 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -148.32 96.64 2.65 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 13.2 m-30 -112.97 156.76 22.45 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 92.2 m -120.1 128.24 53.28 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.505 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.8 mp -107.1 123.14 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.0 m -117.99 -174.66 2.69 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-O 121.835 0.826 . . . . 0.0 109.347 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -146.29 156.12 43.13 Favored 'General case' 0 C--N 1.356 0.865 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 -178.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.2 p -98.72 145.94 30.78 Favored Pre-proline 0 C--N 1.359 0.983 0 CA-C-O 122.443 1.116 . . . . 0.0 108.0 178.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.64 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 72.1 Cg_endo -75.84 -10.93 20.01 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.91 2.407 . . . . 0.0 115.076 -178.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -73.38 -41.26 63.59 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.819 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 38.2 p -117.95 16.15 14.25 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.659 -178.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.64 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.3 pp0? -67.31 -11.47 57.67 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 121.571 -0.706 . . . . 0.0 110.129 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 54.3 p30 -118.51 34.66 5.09 Favored 'General case' 0 N--CA 1.439 -0.996 0 O-C-N 121.199 -0.938 . . . . 0.0 108.893 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 58.5 m -136.15 148.79 48.36 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.752 ' O ' ' HB ' ' A' ' 171' ' ' THR . 97.8 mt-10 -114.51 137.2 52.15 Favored 'General case' 0 C--N 1.354 0.794 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.752 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 1.1 m 115.03 -53.26 0.0 OUTLIER 'General case' 0 C--N 1.377 1.803 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -116.9 111.12 19.21 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 80.1 t -128.5 135.26 62.94 Favored 'Isoleucine or valine' 0 C--N 1.359 1.009 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 50.4 mm -106.74 127.82 61.95 Favored 'Isoleucine or valine' 0 C--N 1.36 1.052 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -116.26 154.98 29.16 Favored 'General case' 0 C--N 1.356 0.875 0 CA-C-O 122.123 0.963 . . . . 0.0 108.849 -178.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -137.14 120.17 16.55 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -178.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.8 mp -115.47 119.84 62.98 Favored 'Isoleucine or valine' 0 C--N 1.354 0.804 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 90.0 m -120.8 141.55 50.42 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -178.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -82.5 124.27 29.94 Favored 'General case' 0 C--N 1.367 1.36 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.428 ' HB1' ' HD2' ' A' ' 181' ' ' PRO . . . -67.66 157.32 86.58 Favored Pre-proline 0 C--N 1.357 0.912 0 N-CA-C 108.156 -1.054 . . . . 0.0 108.156 178.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.428 ' HD2' ' HB1' ' A' ' 180' ' ' ALA . 71.7 Cg_exo -51.44 127.01 20.97 Favored 'Trans proline' 0 CA--C 1.499 -1.253 0 C-N-CA 122.678 2.252 . . . . 0.0 113.819 -178.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.411 ' HD3' HH11 ' A' ' 182' ' ' ARG . 0.3 OUTLIER -96.91 23.31 7.29 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.223 -0.898 . . . . 0.0 108.625 -179.838 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 116.67 -19.58 12.46 Favored Glycine 0 C--N 1.351 1.403 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -123.45 122.25 37.78 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -126.45 118.73 25.57 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -120.11 123.48 43.47 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 82.9 mt -101.15 -51.71 3.45 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' TYR . . . . . 0.464 ' HB3' ' H ' ' A' ' 189' ' ' PHE . 3.4 t80 -161.07 -88.87 0.03 OUTLIER 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' PHE . . . . . 0.464 ' H ' ' HB3' ' A' ' 188' ' ' TYR . 89.0 t80 -139.2 129.59 25.6 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 . . . . . 0 C--O 1.265 1.899 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -179.972 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 201' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 202' ' ' HEM . . . . . 1.004 ' C4B' HD11 ' A' ' 99' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.884 ' N ' HAD1 ' A' ' 202' ' ' HEM . 90.7 mtp . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.185 0.517 . . . . 0.0 110.005 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.452 ' HA ' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -78.63 -16.27 57.54 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.63 -177.908 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.57 -42.27 48.35 Favored Glycine 0 C--N 1.352 1.433 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 62.3 mtt -68.27 -38.19 81.49 Favored 'General case' 0 C--N 1.358 0.942 0 O-C-N 121.893 -0.769 . . . . 0.0 111.464 -178.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.452 HG22 ' HA ' ' A' ' 2' ' ' MET . 27.6 m -68.23 -23.0 28.05 Favored 'Isoleucine or valine' 0 C--N 1.356 0.851 0 C-N-CA 120.031 -0.668 . . . . 0.0 109.749 -178.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -71.08 -37.54 72.46 Favored 'General case' 0 C--N 1.356 0.863 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 89.5 m -68.2 -41.66 81.05 Favored 'General case' 0 C--N 1.357 0.908 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.69 -39.17 97.59 Favored Glycine 0 C--N 1.358 1.757 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.687 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -65.93 -39.84 90.88 Favored 'General case' 0 C--N 1.35 0.614 0 CA-C-N 117.199 0.5 . . . . 0.0 110.618 -178.351 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.3 mmt -63.35 -40.82 98.33 Favored 'General case' 0 C--N 1.352 0.703 0 O-C-N 121.619 -0.675 . . . . 0.0 111.025 -178.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -67.59 -40.14 84.82 Favored 'General case' 0 C--N 1.349 0.563 0 O-C-N 121.896 -0.503 . . . . 0.0 111.504 -177.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 54.8 tp -66.77 -41.93 86.92 Favored 'General case' 0 C--N 1.349 0.558 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -178.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.687 HG12 ' O ' ' A' ' 9' ' ' LEU . 3.7 mm -73.68 -38.22 51.04 Favored 'Isoleucine or valine' 0 C--N 1.357 0.916 0 O-C-N 121.196 -0.94 . . . . 0.0 111.081 -175.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -67.12 -43.32 82.72 Favored 'General case' 0 C--N 1.351 0.646 0 O-C-N 121.914 -0.491 . . . . 0.0 111.573 -176.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -72.11 -33.88 68.17 Favored 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 121.842 -0.536 . . . . 0.0 111.733 -177.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -72.01 -48.5 44.27 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -175.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -127.8 -20.85 3.81 Favored 'General case' 0 C--N 1.354 0.797 0 C-N-CA 117.398 -1.721 . . . . 0.0 113.383 -176.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 141.88 179.72 19.15 Favored Glycine 0 CA--C 1.497 -1.038 0 C-N-CA 117.982 -2.056 . . . . 0.0 109.597 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -97.21 -12.43 23.02 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -177.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -71.44 -40.63 70.26 Favored 'General case' 0 C--N 1.359 1.01 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.7 m -69.21 -38.49 78.61 Favored 'General case' 0 C--N 1.356 0.885 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.578 HD13 ' HB ' ' A' ' 13' ' ' ILE . 59.3 tp -60.32 -38.54 84.06 Favored 'General case' 0 C--N 1.357 0.914 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -64.17 -35.72 81.73 Favored 'General case' 0 C--N 1.357 0.903 0 O-C-N 122.182 -0.324 . . . . 0.0 111.309 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 90.2 m -63.99 -41.39 97.52 Favored 'General case' 0 C--N 1.356 0.89 0 O-C-N 121.566 -0.709 . . . . 0.0 109.189 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.467 ' CD2' ' HB3' ' A' ' 54' ' ' LYS . 89.1 mt -65.02 -38.4 90.78 Favored 'General case' 0 C--N 1.355 0.839 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.27 -11.74 61.11 Favored 'General case' 0 C--N 1.358 0.97 0 O-C-N 121.363 -0.835 . . . . 0.0 109.734 -179.103 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -89.0 -27.25 20.99 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 119.527 -0.869 . . . . 0.0 108.916 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 55.9 p -69.58 -22.7 63.5 Favored 'General case' 0 C--N 1.362 1.109 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.164 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.0 p -106.98 -36.86 6.49 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 119.046 -1.062 . . . . 0.0 108.325 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 86.1 132.37 0.04 OUTLIER 'General case' 0 C--N 1.361 1.067 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.536 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -84.48 -168.04 2.02 Favored 'General case' 0 C--N 1.357 0.902 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.408 ' H ' ' HB2' ' A' ' 31' ' ' LEU . 63.3 tt0 -152.13 -32.57 0.14 Allowed 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.7 t -139.18 -73.37 0.38 Allowed 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -128.32 -33.97 2.1 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.96 -25.75 11.25 Favored Glycine 0 C--N 1.353 1.482 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 84.7 mt -113.71 102.93 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.792 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -99.68 -0.32 40.41 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.793 HG22 ' H ' ' A' ' 39' ' ' SER . 2.7 m 77.62 -179.99 0.13 Allowed 'General case' 0 C--N 1.361 1.096 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 -178.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.793 ' H ' HG22 ' A' ' 38' ' ' THR . 24.9 p -90.9 114.26 26.67 Favored 'General case' 0 N--CA 1.443 -0.779 0 O-C-N 121.214 -0.929 . . . . 0.0 109.44 -178.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.496 HG13 ' O ' ' A' ' 39' ' ' SER . 0.0 OUTLIER -173.48 -8.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.189 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.15 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -117.42 167.56 12.73 Favored Glycine 0 C--N 1.355 1.63 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -178.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 68.6 m -132.24 136.84 47.26 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -124.02 172.57 8.87 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -71.27 174.8 5.96 Favored 'General case' 0 C--N 1.355 0.832 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 76.8 m-70 -86.53 -17.04 35.1 Favored 'General case' 0 CA--C 1.502 -0.884 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.234 -178.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -69.06 -29.33 67.43 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.0 tp10 -63.13 -42.22 99.46 Favored 'General case' 0 C--N 1.351 0.647 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.407 ' O ' HG23 ' A' ' 52' ' ' VAL . 55.0 tp -66.88 -39.4 87.49 Favored 'General case' 0 C--N 1.359 0.985 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 59.0 tp -72.94 -28.98 62.75 Favored 'General case' 0 C--N 1.349 0.569 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -177.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -66.47 -43.22 86.08 Favored 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 121.917 -0.489 . . . . 0.0 110.108 -178.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 80.4 mt -72.36 -34.5 68.04 Favored 'General case' 0 C--N 1.36 1.052 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.278 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 48' ' ' LEU . 39.3 t -63.24 -42.1 95.19 Favored 'Isoleucine or valine' 0 C--N 1.35 0.626 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 54.6 t -66.58 -40.65 86.81 Favored 'Isoleucine or valine' 0 C--N 1.351 0.648 0 O-C-N 121.733 -0.604 . . . . 0.0 109.855 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.467 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 25.9 tptt -66.77 -22.97 66.02 Favored 'General case' 0 C--N 1.361 1.095 0 O-C-N 121.022 -1.049 . . . . 0.0 109.019 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.59 HD21 HD12 ' A' ' 13' ' ' ILE . 6.2 mt -69.78 -38.05 76.56 Favored 'General case' 0 C--N 1.355 0.826 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 57.6 p -71.38 -18.01 62.38 Favored 'General case' 0 C--N 1.353 0.752 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.357 -179.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -100.46 -35.75 9.45 Favored 'General case' 0 C--N 1.355 0.805 0 C-N-CA 119.648 -0.821 . . . . 0.0 111.408 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.6 p -72.27 -40.22 65.01 Favored 'Isoleucine or valine' 0 C--N 1.354 0.766 0 O-C-N 121.664 -0.648 . . . . 0.0 111.507 -177.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 79.7 p -116.02 -2.49 12.26 Favored 'General case' 0 C--N 1.354 0.78 0 C-N-CA 118.89 -1.124 . . . . 0.0 110.914 -178.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 73.6 m 63.74 49.48 2.93 Favored 'General case' 0 C--N 1.357 0.916 0 CA-C-O 120.932 0.396 . . . . 0.0 110.033 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.418 HG13 ' HD2' ' A' ' 62' ' ' PRO . 96.6 t -113.98 134.04 22.22 Favored Pre-proline 0 CA--C 1.504 -0.799 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.418 ' HD2' HG13 ' A' ' 61' ' ' VAL . 41.3 Cg_exo -58.02 149.5 70.65 Favored 'Trans proline' 0 CA--C 1.499 -1.27 0 C-N-CA 122.778 2.319 . . . . 0.0 112.738 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.421 ' HA ' HD23 ' A' ' 66' ' ' LEU . 3.7 m -76.2 -11.64 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.679 -177.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.494 ' O ' HG12 ' A' ' 67' ' ' VAL . 73.0 p -96.51 -33.36 11.87 Favored 'General case' 0 C--N 1.358 0.971 0 C-N-CA 118.433 -1.307 . . . . 0.0 109.504 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -77.65 -21.0 52.85 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 121.474 -0.766 . . . . 0.0 108.968 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -81.19 -34.23 32.46 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 -179.483 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.494 HG12 ' O ' ' A' ' 64' ' ' THR . 1.5 p -70.98 -26.23 27.21 Favored 'Isoleucine or valine' 0 C--N 1.356 0.855 0 C-N-CA 120.169 -0.613 . . . . 0.0 109.799 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 40.7 mtp180 -72.53 -52.87 13.81 Favored 'General case' 0 C--N 1.363 1.181 0 O-C-N 121.477 -0.765 . . . . 0.0 110.427 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.9 mt -63.41 -34.76 78.44 Favored 'General case' 0 C--N 1.357 0.913 0 O-C-N 121.959 -0.463 . . . . 0.0 110.905 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -61.1 -47.23 87.24 Favored 'General case' 0 C--N 1.348 0.502 0 O-C-N 122.248 -0.283 . . . . 0.0 110.239 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.06 -38.8 96.16 Favored Glycine 0 C--N 1.356 1.651 0 N-CA-C 111.729 -0.548 . . . . 0.0 111.729 -178.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -62.6 -49.35 75.58 Favored 'General case' 0 C--N 1.351 0.638 0 CA-C-N 118.31 1.055 . . . . 0.0 111.556 -177.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 12.2 mttm -65.09 -45.93 83.18 Favored 'General case' 0 C--N 1.357 0.926 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -177.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -69.78 -39.04 76.88 Favored 'General case' 0 C--N 1.348 0.52 0 O-C-N 121.161 -0.962 . . . . 0.0 111.841 -175.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -64.61 -44.05 91.8 Favored 'General case' 0 C--N 1.353 0.746 0 O-C-N 121.098 -1.001 . . . . 0.0 110.951 -178.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.83 -13.86 17.08 Favored 'Isoleucine or valine' 0 C--N 1.359 0.985 0 O-C-N 121.45 -0.781 . . . . 0.0 109.0 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -74.37 -37.61 63.42 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.3 mt -74.67 -29.48 61.25 Favored 'General case' 0 C--N 1.357 0.927 0 O-C-N 122.285 -0.259 . . . . 0.0 110.369 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.6 mm -65.86 -52.84 44.77 Favored 'Isoleucine or valine' 0 C--N 1.357 0.895 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.682 -177.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -75.5 -15.35 60.41 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.279 178.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.25 -37.45 63.34 Favored Glycine 0 C--N 1.349 1.276 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -131.75 105.23 14.16 Favored Pre-proline 0 N--CA 1.441 -0.903 0 CA-C-O 122.615 1.198 . . . . 0.0 108.961 -177.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.524 ' O ' ' HB2' ' A' ' 87' ' ' ASN . 37.1 Cg_endo -67.47 -23.08 44.16 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.571 2.181 . . . . 0.0 114.356 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -95.39 -5.19 43.81 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 tp -89.75 -20.1 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -105.7 -18.06 14.19 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.524 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 1.5 t-20 -73.97 -38.0 64.31 Favored 'General case' 0 C--N 1.357 0.931 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -65.49 -33.84 76.86 Favored 'General case' 0 C--N 1.353 0.735 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -178.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 15.8 ttp -83.12 150.37 26.31 Favored 'General case' 0 C--N 1.351 0.654 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.02 -22.59 9.47 Favored 'General case' 0 C--N 1.364 1.199 0 O-C-N 121.691 -0.63 . . . . 0.0 111.14 -177.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -165.55 171.49 13.13 Favored 'General case' 0 C--N 1.354 0.761 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 -177.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.476 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 66.8 m -66.65 -39.54 88.28 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.448 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -68.44 -38.9 81.57 Favored 'General case' 0 C--N 1.355 0.836 0 O-C-N 121.296 -0.877 . . . . 0.0 108.991 -179.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -65.93 -24.09 66.75 Favored 'General case' 0 C--N 1.355 0.823 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.664 ' O ' HG12 ' A' ' 99' ' ' ILE . 59.7 tp -63.64 -47.38 81.54 Favored 'General case' 0 C--N 1.355 0.846 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.4 mp -60.07 -35.7 75.74 Favored 'General case' 0 C--N 1.359 1.013 0 O-C-N 122.256 -0.277 . . . . 0.0 110.521 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 34.0 t -70.14 -39.64 75.28 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.188 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.5 tttp -86.99 0.35 55.31 Favored 'General case' 0 C--N 1.356 0.856 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -176.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.664 HG12 ' O ' ' A' ' 95' ' ' LEU . 22.8 mm -61.01 -46.7 96.15 Favored 'Isoleucine or valine' 0 C--N 1.357 0.896 0 CA-C-N 119.082 0.856 . . . . 0.0 112.014 -177.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -95.64 -22.63 17.46 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 118.402 -1.319 . . . . 0.0 111.329 -177.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 35.2 t -64.29 -48.65 74.87 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 121.565 -0.709 . . . . 0.0 112.491 -177.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -138.08 -16.49 1.25 Allowed 'General case' 0 C--N 1.36 1.06 0 C-N-CA 117.372 -1.731 . . . . 0.0 113.521 -176.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.645 HD12 HD13 ' A' ' 99' ' ' ILE . 96.3 mt -71.83 -50.27 39.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 CA-C-N 120.359 1.436 . . . . 0.0 111.182 -177.143 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -89.98 4.36 50.36 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 119.388 -0.925 . . . . 0.0 109.811 -177.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 57.7 t -86.44 -43.7 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.059 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 54.7 tp10 -67.53 -40.1 85.04 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 65.6 t -62.77 -46.92 95.16 Favored 'Isoleucine or valine' 0 C--N 1.356 0.88 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -60.74 -48.21 82.81 Favored 'General case' 0 C--N 1.36 1.038 0 O-C-N 122.198 -0.314 . . . . 0.0 111.541 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -61.25 -36.59 80.41 Favored 'General case' 0 C--N 1.355 0.821 0 O-C-N 121.534 -0.729 . . . . 0.0 110.503 -178.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 18.0 mt -58.6 -75.5 0.05 Allowed 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -115.58 132.14 23.29 Favored Pre-proline 0 N--CA 1.439 -0.975 0 C-N-CA 118.65 -1.22 . . . . 0.0 108.641 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -83.26 -3.53 10.91 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 123.175 2.583 . . . . 0.0 115.172 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -66.97 -36.36 82.02 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 121.879 -0.513 . . . . 0.0 110.009 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.32 144.86 56.31 Favored 'General case' 0 C--N 1.352 0.683 0 CA-C-O 121.74 0.781 . . . . 0.0 110.142 -178.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -128.86 133.76 48.07 Favored 'General case' 0 C--N 1.357 0.925 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.52 ' HB3' ' HD2' ' A' ' 117' ' ' PRO . 87.8 mt -127.76 156.44 75.71 Favored Pre-proline 0 N--CA 1.443 -0.787 0 CA-C-O 122.262 1.03 . . . . 0.0 109.243 -178.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.52 ' HD2' ' HB3' ' A' ' 116' ' ' LEU . 83.0 Cg_endo -80.46 -158.42 0.09 OUTLIER 'Trans proline' 0 C--N 1.318 -1.074 0 C-N-CA 123.826 3.017 . . . . 0.0 113.922 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -118.86 143.28 47.06 Favored 'General case' 0 C--N 1.364 1.209 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -129.65 135.7 48.84 Favored 'General case' 0 C--N 1.362 1.123 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -178.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 93.8 m -127.64 130.71 49.43 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 177.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -120.6 132.39 55.11 Favored 'General case' 0 CA--C 1.504 -0.804 0 C-N-CA 119.215 -0.994 . . . . 0.0 109.989 -178.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -119.71 138.5 53.26 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 178.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -109.32 117.84 35.13 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 -179.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.574 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 96.5 mt -91.77 -16.02 27.46 Favored 'General case' 0 C--N 1.356 0.856 0 C-N-CA 120.496 -0.481 . . . . 0.0 110.436 -179.336 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 174.04 -148.23 9.87 Favored Glycine 0 C--N 1.349 1.252 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -94.35 -37.55 11.42 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -102.05 4.17 39.48 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.031 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.574 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 8.7 m-20 -121.93 132.09 54.37 Favored 'General case' 0 C--N 1.359 0.984 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -179.336 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.2 mm -143.64 137.8 25.19 Favored 'Isoleucine or valine' 0 C--N 1.356 0.863 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 179.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 53.5 mtm180 -118.49 139.11 51.93 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 5.8 tp -125.53 116.91 22.51 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.52 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -98.29 134.39 41.38 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 107.327 -1.361 . . . . 0.0 107.327 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -129.51 119.55 23.89 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.524 ' HA ' ' O ' ' A' ' 171' ' ' THR . 57.9 mt-30 -115.53 112.17 21.81 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 11.1 t -165.93 155.12 11.75 Favored 'General case' 0 C--N 1.357 0.921 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.434 ' C ' ' HD3' ' A' ' 138' ' ' PRO . 99.6 mttt -90.99 5.49 48.57 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 77.0 mtp180 -132.62 73.25 76.75 Favored Pre-proline 0 C--N 1.354 0.767 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.434 ' HD3' ' C ' ' A' ' 136' ' ' LYS . 92.7 Cg_endo -96.87 99.64 0.08 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.515 0 C-N-CA 122.737 2.291 . . . . 0.0 115.453 -178.06 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -109.4 111.13 22.5 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 177.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.71 -38.05 89.64 Favored 'General case' 0 C--N 1.354 0.787 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.02 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 74.1 m -63.03 -29.33 70.73 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 121.998 -0.439 . . . . 0.0 110.755 -178.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -75.01 -47.1 30.79 Favored 'General case' 0 C--N 1.35 0.612 0 O-C-N 121.698 -0.626 . . . . 0.0 109.763 -177.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.53 -40.06 94.91 Favored 'General case' 0 C--N 1.358 0.976 0 O-C-N 122.095 -0.378 . . . . 0.0 111.212 -178.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.1 -37.0 85.46 Favored 'General case' 0 C--N 1.355 0.809 0 O-C-N 121.938 -0.476 . . . . 0.0 110.212 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.84 -43.15 99.58 Favored Glycine 0 C--N 1.347 1.182 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 -178.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 83.8 mt -70.01 -40.42 75.27 Favored 'General case' 0 C--N 1.351 0.647 0 N-CA-C 112.673 0.619 . . . . 0.0 112.673 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 99.1 mt -71.34 -42.9 67.95 Favored 'General case' 0 C--N 1.361 1.082 0 O-C-N 121.198 -0.939 . . . . 0.0 110.993 -176.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.483 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 21.0 t70 -69.0 -31.72 70.75 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 122.028 -0.42 . . . . 0.0 110.418 -179.324 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -62.96 -39.19 97.76 Favored Glycine 0 C--N 1.356 1.659 0 N-CA-C 108.656 -1.778 . . . . 0.0 108.656 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 49.4 t -60.84 -42.0 96.91 Favored 'General case' 0 C--N 1.351 0.674 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -74.59 -2.19 24.89 Favored 'General case' 0 C--N 1.361 1.082 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.483 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 77.0 mm-40 -83.29 -45.44 13.79 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -68.84 -42.56 76.98 Favored 'General case' 0 C--N 1.358 0.959 0 C-N-CA 120.011 -0.675 . . . . 0.0 109.681 179.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -69.75 -25.68 63.95 Favored 'General case' 0 C--N 1.362 1.132 0 O-C-N 121.659 -0.651 . . . . 0.0 110.619 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 21.2 tttm 73.16 73.39 0.13 Allowed 'General case' 0 C--N 1.36 1.05 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -143.61 -169.44 3.08 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -146.25 96.99 2.87 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 13.3 m-30 -114.9 155.38 26.96 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 93.3 m -120.86 129.12 53.4 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 119.668 -0.813 . . . . 0.0 108.809 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.515 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.7 mp -106.45 122.34 60.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.6 m -119.53 -172.12 2.26 Favored 'General case' 0 C--N 1.357 0.93 0 CA-C-O 121.792 0.806 . . . . 0.0 109.338 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 28.2 ptt-85 -148.42 157.91 43.77 Favored 'General case' 0 C--N 1.356 0.854 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -178.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 56.2 p -98.37 146.77 32.12 Favored Pre-proline 0 C--N 1.359 0.995 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 178.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.666 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 72.7 Cg_endo -75.35 -12.54 20.85 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.903 2.402 . . . . 0.0 115.238 -178.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -72.53 -41.31 66.0 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 120.009 -0.676 . . . . 0.0 109.956 -178.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 35.6 p -118.11 16.06 14.11 Favored 'General case' 0 C--N 1.354 0.797 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.734 -178.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.666 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.4 pp0? -66.97 -12.75 60.68 Favored 'General case' 0 C--N 1.353 0.749 0 O-C-N 121.605 -0.685 . . . . 0.0 110.346 178.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 54.1 p-10 -123.67 38.72 4.13 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 14.6 t -141.65 147.44 37.55 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.63 ' O ' ' HB ' ' A' ' 171' ' ' THR . 46.3 mp0 -101.67 167.4 10.13 Favored 'General case' 0 C--N 1.355 0.847 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.63 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 5.8 m 82.99 -60.01 0.15 Allowed 'General case' 0 C--N 1.37 1.465 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -108.05 116.11 31.37 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 96.1 t -131.64 133.21 61.82 Favored 'Isoleucine or valine' 0 C--N 1.358 0.966 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 50.9 mm -108.16 126.2 64.78 Favored 'Isoleucine or valine' 0 C--N 1.359 1.0 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -114.55 154.53 28.12 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -137.58 118.94 14.68 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 -178.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.7 mp -113.59 120.37 63.29 Favored 'Isoleucine or valine' 0 C--N 1.353 0.742 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 90.6 m -119.91 143.5 47.93 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -177.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.607 ' HD3' ' HE ' ' A' ' 182' ' ' ARG . 37.2 ttm180 -79.59 114.3 18.41 Favored 'General case' 0 C--N 1.363 1.192 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -67.63 154.33 93.48 Favored Pre-proline 0 C--N 1.358 0.939 0 CA-C-O 121.993 0.901 . . . . 0.0 109.278 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.28 119.77 7.18 Favored 'Trans proline' 0 CA--C 1.499 -1.256 0 C-N-CA 122.865 2.377 . . . . 0.0 113.665 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.607 ' HE ' ' HD3' ' A' ' 179' ' ' ARG . 8.8 mtm180 -94.87 28.44 2.72 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.025 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 99.96 108.55 2.98 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 178.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 67.14 74.59 0.32 Allowed 'General case' 0 C--N 1.357 0.933 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 177.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -74.45 152.24 39.48 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -100.57 119.53 38.67 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 60.6 mt -116.03 -69.45 0.85 Allowed 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 179.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -139.65 -89.75 0.19 Allowed 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -129.26 149.15 51.18 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 . . . . . 0 C--O 1.264 1.82 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.887 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 201' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 202' ' ' HEM . . . . . 1.062 ' HHA' HBD2 ' A' ' 202' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.856 ' N ' HBD2 ' A' ' 202' ' ' HEM . 87.7 mmm . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 121.09 0.471 . . . . 0.0 110.031 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.43 ' O ' ' HD1' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -82.04 -15.2 54.4 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 120.516 -0.474 . . . . 0.0 109.963 -178.338 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -71.65 -40.99 57.99 Favored Glycine 0 C--N 1.353 1.482 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.482 ' HG2' ' HB3' ' A' ' 39' ' ' SER . 76.5 mtm -70.15 -35.69 74.22 Favored 'General case' 0 C--N 1.356 0.873 0 O-C-N 121.958 -0.731 . . . . 0.0 111.499 -178.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.414 HG22 ' HA ' ' A' ' 2' ' ' MET . 32.8 m -68.45 -23.77 28.61 Favored 'Isoleucine or valine' 0 C--N 1.357 0.91 0 O-C-N 121.467 -0.77 . . . . 0.0 109.594 -179.101 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.505 ' HZ ' ' CG ' ' A' ' 47' ' ' GLU . 4.5 m-85 -71.38 -36.2 71.33 Favored 'General case' 0 C--N 1.358 0.949 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 90.1 m -66.7 -40.87 88.64 Favored 'General case' 0 C--N 1.357 0.913 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.75 -39.23 97.7 Favored Glycine 0 C--N 1.358 1.753 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.694 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -64.07 -41.47 97.33 Favored 'General case' 0 C--N 1.352 0.679 0 CA-C-N 117.163 0.482 . . . . 0.0 110.835 -178.515 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 17.6 mmt -63.58 -41.02 98.4 Favored 'General case' 0 C--N 1.353 0.746 0 O-C-N 121.438 -0.789 . . . . 0.0 111.079 -178.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -68.34 -40.5 81.55 Favored 'General case' 0 C--N 1.349 0.573 0 O-C-N 121.881 -0.512 . . . . 0.0 111.773 -177.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 56.3 tp -66.3 -43.65 85.69 Favored 'General case' 0 C--N 1.349 0.577 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -177.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.694 HG12 ' O ' ' A' ' 9' ' ' LEU . 1.1 mm -74.3 -34.6 37.5 Favored 'Isoleucine or valine' 0 C--N 1.358 0.956 0 O-C-N 121.127 -0.983 . . . . 0.0 110.96 -175.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -72.73 -42.32 64.25 Favored 'General case' 0 C--N 1.35 0.59 0 O-C-N 121.642 -0.661 . . . . 0.0 111.538 -176.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -71.1 -37.9 72.38 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -175.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -99.42 -25.83 14.33 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 118.924 -1.11 . . . . 0.0 113.659 -174.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -113.62 -35.72 5.12 Favored 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 117.541 -1.664 . . . . 0.0 112.549 -176.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 145.31 177.78 20.35 Favored Glycine 0 C--N 1.349 1.266 0 C-N-CA 118.052 -2.023 . . . . 0.0 110.467 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -99.43 -27.16 13.87 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 -177.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -69.29 -39.22 78.45 Favored 'General case' 0 C--N 1.359 0.992 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 92.7 m -66.75 -39.1 87.78 Favored 'General case' 0 C--N 1.357 0.902 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.3 tt -61.62 -38.44 87.64 Favored 'General case' 0 C--N 1.358 0.938 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -63.74 -37.71 88.38 Favored 'General case' 0 C--N 1.356 0.875 0 O-C-N 122.026 -0.421 . . . . 0.0 110.765 -178.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.9 m -65.73 -38.96 90.58 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -178.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.717 HD13 HD22 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -63.67 -37.41 87.24 Favored 'General case' 0 C--N 1.354 0.765 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -179.043 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.3 mt -74.02 -14.11 60.96 Favored 'General case' 0 C--N 1.359 0.998 0 O-C-N 121.722 -0.612 . . . . 0.0 110.337 -178.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -86.77 -28.23 23.13 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 119.218 -0.993 . . . . 0.0 109.203 179.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.1 t -67.39 -36.58 81.59 Favored 'General case' 0 C--N 1.354 0.761 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.661 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 2.0 p -92.12 -39.65 11.48 Favored 'General case' 0 C--N 1.358 0.963 0 C-N-CA 118.942 -1.103 . . . . 0.0 108.199 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.661 ' HB2' ' O ' ' A' ' 29' ' ' CYS . 14.5 mt-10 86.27 131.53 0.04 OUTLIER 'General case' 0 C--N 1.362 1.109 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.142 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.529 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -86.18 -169.45 2.64 Favored 'General case' 0 C--N 1.357 0.897 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.841 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -152.85 -28.23 0.15 Allowed 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 107.707 -1.219 . . . . 0.0 107.707 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.8 t -141.49 -71.13 0.35 Allowed 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -131.96 -42.97 0.99 Allowed 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.4 -32.71 4.22 Favored Glycine 0 C--N 1.353 1.479 0 N-CA-C 109.261 -1.535 . . . . 0.0 109.261 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 85.1 mt -111.63 101.33 12.38 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -96.41 -1.81 46.8 Favored 'General case' 0 C--N 1.354 0.803 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.747 HG22 ' H ' ' A' ' 39' ' ' SER . 4.0 m 80.1 174.9 0.13 Allowed 'General case' 0 C--N 1.362 1.13 0 N-CA-C 105.952 -1.869 . . . . 0.0 105.952 -178.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.747 ' H ' HG22 ' A' ' 38' ' ' THR . 26.0 p -89.16 113.84 25.07 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 121.033 -1.042 . . . . 0.0 109.78 -178.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 39' ' ' SER . 0.0 OUTLIER -172.71 -8.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.362 1.143 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.762 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.404 ' H ' ' H ' ' A' ' 40' ' ' VAL . . . -113.55 164.75 12.02 Favored Glycine 0 C--N 1.357 1.698 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -178.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 53.5 m -129.11 132.78 47.44 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -117.98 170.62 8.68 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -77.64 -178.13 5.17 Favored 'General case' 0 C--N 1.356 0.866 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -88.32 -15.08 36.66 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -68.18 -29.8 68.75 Favored 'General case' 0 C--N 1.353 0.753 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 178.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.505 ' CG ' ' HZ ' ' A' ' 6' ' ' PHE . 24.1 tp10 -63.07 -41.6 99.47 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.467 HD22 ' O ' ' A' ' 48' ' ' LEU . 1.8 tm? -67.83 -39.99 83.83 Favored 'General case' 0 C--N 1.358 0.965 0 CA-C-O 120.647 0.26 . . . . 0.0 110.531 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 64.6 tp -71.01 -34.71 71.6 Favored 'General case' 0 CA--C 1.509 -0.62 0 O-C-N 122.132 -0.355 . . . . 0.0 110.661 -177.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 73.2 tp60 -65.81 -40.79 92.22 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 121.659 -0.651 . . . . 0.0 110.005 -178.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.717 HD22 HD13 ' A' ' 25' ' ' LEU . 73.4 mt -82.48 -19.22 39.25 Favored 'General case' 0 C--N 1.361 1.091 0 C-N-CA 119.622 -0.831 . . . . 0.0 110.574 -178.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.4 t -79.35 -37.66 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 54.2 t -69.05 -39.99 80.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.73 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 178.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.414 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 32.3 tptt -65.7 -27.86 68.64 Favored 'General case' 0 C--N 1.363 1.191 0 O-C-N 121.214 -0.929 . . . . 0.0 108.754 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.8 tt -67.44 -39.33 85.39 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' A' ' 60' ' ' SER . 81.1 p -72.42 -17.33 61.81 Favored 'General case' 0 C--N 1.358 0.949 0 O-C-N 121.694 -0.628 . . . . 0.0 111.019 -178.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -99.96 -36.78 9.27 Favored 'General case' 0 C--N 1.353 0.736 0 O-C-N 121.153 -0.967 . . . . 0.0 111.346 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.2 p -70.38 -34.35 57.76 Favored 'Isoleucine or valine' 0 C--N 1.352 0.687 0 O-C-N 121.74 -0.6 . . . . 0.0 111.338 -177.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.645 ' HB3' HG23 ' A' ' 61' ' ' VAL . 2.0 t -120.81 -7.15 9.57 Favored 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 119.128 -1.029 . . . . 0.0 109.924 -178.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.473 ' HA ' ' O ' ' A' ' 56' ' ' SER . 0.5 OUTLIER 65.67 47.6 2.12 Favored 'General case' 0 C--N 1.353 0.753 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.792 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.645 HG23 ' HB3' ' A' ' 59' ' ' SER . 52.9 t -106.56 132.44 20.9 Favored Pre-proline 0 N--CA 1.443 -0.785 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -57.2 146.89 79.42 Favored 'Trans proline' 0 CA--C 1.498 -1.301 0 C-N-CA 122.504 2.136 . . . . 0.0 112.845 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.5 m -75.49 -12.12 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.605 -178.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.487 ' O ' HG12 ' A' ' 67' ' ' VAL . 70.2 p -97.65 -32.71 11.63 Favored 'General case' 0 C--N 1.359 0.994 0 C-N-CA 118.258 -1.377 . . . . 0.0 109.26 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -75.43 -23.26 56.94 Favored 'General case' 0 C--N 1.355 0.841 0 O-C-N 121.42 -0.8 . . . . 0.0 109.106 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -82.2 -34.86 28.79 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -179.007 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.487 HG12 ' O ' ' A' ' 64' ' ' THR . 1.6 p -68.21 -27.15 36.0 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.688 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.8 mmm-85 -73.28 -52.12 15.13 Favored 'General case' 0 C--N 1.364 1.198 0 O-C-N 121.609 -0.682 . . . . 0.0 110.284 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.66 -35.6 80.16 Favored 'General case' 0 C--N 1.357 0.92 0 O-C-N 121.973 -0.454 . . . . 0.0 110.954 -178.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -60.95 -47.74 85.05 Favored 'General case' 0 C--N 1.349 0.581 0 O-C-N 122.083 -0.385 . . . . 0.0 110.54 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.99 -38.95 96.35 Favored Glycine 0 C--N 1.355 1.587 0 N-CA-C 111.997 -0.441 . . . . 0.0 111.997 -178.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -63.38 -48.54 77.5 Favored 'General case' 0 C--N 1.35 0.626 0 CA-C-N 118.303 1.052 . . . . 0.0 111.55 -177.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.671 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 11.9 mttm -63.89 -48.6 76.03 Favored 'General case' 0 C--N 1.358 0.961 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -177.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.456 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.3 tm? -68.54 -39.12 81.26 Favored 'General case' 0 C--N 1.35 0.588 0 O-C-N 121.197 -0.94 . . . . 0.0 111.699 -175.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.4 ' CE2' ' HA ' ' A' ' 150' ' ' CYS . 43.8 t80 -62.95 -45.07 94.21 Favored 'General case' 0 C--N 1.352 0.715 0 O-C-N 121.241 -0.912 . . . . 0.0 111.165 -178.002 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.8 p -71.09 -14.66 18.11 Favored 'Isoleucine or valine' 0 C--N 1.359 1.006 0 O-C-N 121.396 -0.815 . . . . 0.0 109.5 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.671 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 73.6 mm-40 -71.43 -39.81 70.8 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 82.9 mt -70.94 -34.96 71.99 Favored 'General case' 0 C--N 1.357 0.911 0 O-C-N 122.188 -0.32 . . . . 0.0 110.599 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.6 mm -63.79 -53.33 45.82 Favored 'Isoleucine or valine' 0 C--N 1.357 0.916 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.615 -176.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -75.15 -10.98 59.96 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.938 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.23 -11.16 60.15 Favored Glycine 0 C--N 1.35 1.345 0 C-N-CA 119.734 -1.222 . . . . 0.0 110.696 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.465 ' HB3' ' HB ' ' A' ' 85' ' ' ILE . 96.3 m-70 -138.34 96.27 9.99 Favored Pre-proline 0 CA--C 1.503 -0.865 0 CA-C-N 118.991 1.396 . . . . 0.0 108.836 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.458 ' O ' ' HB2' ' A' ' 87' ' ' ASN . 37.7 Cg_endo -67.87 -25.74 38.74 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.428 2.085 . . . . 0.0 114.293 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -91.11 -8.39 48.96 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.465 ' HB ' ' HB3' ' A' ' 82' ' ' HIS . 1.5 tp -89.35 -21.73 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 -178.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.81 -16.94 15.26 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 47.1 t30 -70.84 -41.62 71.25 Favored 'General case' 0 C--N 1.36 1.046 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -68.5 -30.36 69.17 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.387 -178.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 29.5 ttp -84.0 148.07 27.08 Favored 'General case' 0 C--N 1.35 0.623 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.04 -21.62 8.2 Favored 'General case' 0 C--N 1.362 1.119 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.865 -177.453 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -164.83 170.64 15.18 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 119.172 -1.011 . . . . 0.0 108.337 -177.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.41 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 41.1 t -64.43 -41.96 96.28 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.806 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -66.17 -38.93 89.24 Favored 'General case' 0 C--N 1.355 0.821 0 O-C-N 121.568 -0.708 . . . . 0.0 109.251 -178.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -65.59 -25.84 67.58 Favored 'General case' 0 C--N 1.357 0.906 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.41 ' HB3' ' O ' ' A' ' 92' ' ' SER . 59.9 tp -62.74 -46.52 87.69 Favored 'General case' 0 C--N 1.355 0.823 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.3 mp -62.71 -32.59 73.73 Favored 'General case' 0 C--N 1.353 0.76 0 O-C-N 122.221 -0.299 . . . . 0.0 110.502 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 37.2 t -62.57 -45.22 93.9 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 121.774 -0.579 . . . . 0.0 111.351 -178.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.403 ' H ' ' HG3' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -111.3 26.28 10.84 Favored 'General case' 0 C--N 1.363 1.185 0 O-C-N 121.07 -1.019 . . . . 0.0 110.491 -178.171 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.799 HD11 ' C3B' ' A' ' 202' ' ' HEM . 10.1 tt -60.6 -29.53 44.97 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.575 -179.005 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -129.3 -7.12 4.78 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 118.444 -1.302 . . . . 0.0 110.039 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 64.5 m -90.75 -3.21 57.61 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.295 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -147.68 -48.7 0.17 Allowed 'General case' 0 C--N 1.357 0.911 0 C-N-CA 118.221 -1.392 . . . . 0.0 109.724 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 96.1 mt -65.75 -47.39 86.07 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 O-C-N 122.038 -0.414 . . . . 0.0 110.922 -177.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 22.7 m170 -83.77 -3.79 58.11 Favored 'General case' 0 C--N 1.354 0.799 0 O-C-N 121.461 -0.774 . . . . 0.0 109.78 -177.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 56.4 t -75.13 -45.24 42.51 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.907 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -70.0 -38.94 76.13 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -178.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 56.7 t -61.65 -46.31 96.82 Favored 'Isoleucine or valine' 0 C--N 1.355 0.822 0 O-C-N 122.196 -0.315 . . . . 0.0 110.48 -178.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -60.04 -47.76 84.5 Favored 'General case' 0 C--N 1.357 0.898 0 O-C-N 122.127 -0.358 . . . . 0.0 111.089 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -61.77 -36.07 79.97 Favored 'General case' 0 C--N 1.355 0.839 0 O-C-N 121.552 -0.718 . . . . 0.0 110.11 -178.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 15.3 mt -59.66 -79.66 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -111.97 140.59 23.59 Favored Pre-proline 0 N--CA 1.442 -0.848 0 C-N-CA 118.877 -1.129 . . . . 0.0 109.242 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -88.84 -6.1 5.82 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 123.286 2.657 . . . . 0.0 114.919 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -69.02 -33.7 74.06 Favored 'General case' 0 C--N 1.353 0.722 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.584 ' HB1' HAD1 ' A' ' 202' ' ' HEM . . . -64.66 145.08 56.72 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 121.697 0.761 . . . . 0.0 110.13 -178.144 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.469 ' O ' HD13 ' A' ' 116' ' ' LEU . 46.5 mt-10 -118.55 143.32 46.84 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 179.118 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.469 HD13 ' O ' ' A' ' 115' ' ' GLU . 2.6 mm? -126.77 149.7 69.31 Favored Pre-proline 0 N--CA 1.445 -0.702 0 CA-C-O 122.074 0.94 . . . . 0.0 108.597 -178.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 116' ' ' LEU . 87.7 Cg_endo -91.28 -155.51 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.265 0 C-N-CA 123.743 2.962 . . . . 0.0 113.197 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -115.98 138.32 51.31 Favored 'General case' 0 C--N 1.362 1.113 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -127.16 129.54 48.08 Favored 'General case' 0 C--N 1.361 1.104 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.548 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 93.2 m -128.58 131.44 48.18 Favored 'General case' 0 C--N 1.356 0.864 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 177.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -125.01 132.44 53.24 Favored 'General case' 0 CA--C 1.503 -0.853 0 C-N-CA 119.316 -0.954 . . . . 0.0 109.769 -178.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -121.28 140.81 51.57 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 178.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 57.7 ttp180 -111.88 117.75 33.62 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -179.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.9 mt -92.91 -16.64 24.95 Favored 'General case' 0 C--N 1.354 0.781 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.193 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 178.19 -150.48 9.83 Favored Glycine 0 C--N 1.347 1.186 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -91.33 -39.69 11.9 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.405 ' HB2' ' HB2' ' A' ' 179' ' ' ARG . 8.2 p30 -104.87 9.3 34.8 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 119.759 -0.777 . . . . 0.0 109.177 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -119.64 124.62 46.76 Favored 'General case' 0 C--N 1.358 0.961 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.403 HD13 ' HA ' ' A' ' 129' ' ' ILE . 9.8 mm -140.13 137.25 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 -116.95 137.65 52.08 Favored 'General case' 0 CA--C 1.492 -1.266 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 6.7 tp -123.23 117.86 26.27 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.023 -0.989 . . . . 0.0 108.486 -178.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.548 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 12.6 m-70 -99.6 131.32 45.68 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -127.95 121.37 29.73 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.541 ' HA ' ' O ' ' A' ' 171' ' ' THR . 75.3 mt-30 -114.5 115.02 26.57 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 179.034 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.2 t -162.86 152.22 15.31 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -90.81 1.14 57.18 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 120.17 -0.612 . . . . 0.0 109.794 -178.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -136.22 74.26 55.79 Favored Pre-proline 0 C--N 1.354 0.789 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -95.42 110.64 0.14 Allowed 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.54 2.16 . . . . 0.0 115.935 -177.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -110.99 112.1 23.69 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 176.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.12 -39.27 93.68 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.424 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.3 m -63.7 -26.96 68.9 Favored 'General case' 0 C--N 1.353 0.758 0 O-C-N 121.894 -0.504 . . . . 0.0 110.729 -178.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -75.78 -47.03 27.5 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 121.731 -0.606 . . . . 0.0 109.692 -177.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.28 -39.83 93.07 Favored 'General case' 0 C--N 1.358 0.94 0 O-C-N 122.074 -0.391 . . . . 0.0 111.323 -178.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -62.97 -36.85 84.87 Favored 'General case' 0 C--N 1.357 0.909 0 O-C-N 121.827 -0.546 . . . . 0.0 109.972 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.6 -43.01 99.42 Favored Glycine 0 C--N 1.346 1.114 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 83.9 mt -70.49 -40.64 73.47 Favored 'General case' 0 C--N 1.351 0.672 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -179.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 98.2 mt -70.92 -42.55 69.75 Favored 'General case' 0 C--N 1.361 1.09 0 O-C-N 121.154 -0.966 . . . . 0.0 110.907 -176.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.55 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 37.2 t70 -70.12 -29.43 66.36 Favored 'General case' 0 N--CA 1.444 -0.737 0 O-C-N 121.995 -0.44 . . . . 0.0 110.373 -179.358 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -63.1 -39.57 98.16 Favored Glycine 0 C--N 1.357 1.701 0 N-CA-C 108.474 -1.85 . . . . 0.0 108.474 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' CYS . . . . . 0.4 ' HA ' ' CE2' ' A' ' 75' ' ' PHE . 45.1 t -61.01 -42.22 98.03 Favored 'General case' 0 C--N 1.351 0.672 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -75.92 0.73 17.29 Favored 'General case' 0 C--N 1.36 1.027 0 O-C-N 121.803 -0.561 . . . . 0.0 109.489 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.55 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 76.8 mm-40 -85.78 -45.96 11.12 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.016 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -66.67 -44.63 81.29 Favored 'General case' 0 C--N 1.358 0.949 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.45 ' O ' ' HB2' ' A' ' 155' ' ' LYS . 51.6 m-85 -70.12 -26.08 63.79 Favored 'General case' 0 C--N 1.361 1.077 0 O-C-N 121.783 -0.573 . . . . 0.0 111.126 -178.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 154' ' ' PHE . 41.1 mttt 73.39 71.32 0.12 Allowed 'General case' 0 C--N 1.361 1.102 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -178.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -137.02 -172.48 3.2 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -148.72 94.0 2.21 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 19.3 m-30 -114.89 158.79 21.49 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 94.0 m -118.32 125.03 49.23 Favored 'General case' 0 C--N 1.356 0.868 0 C-N-CA 119.368 -0.933 . . . . 0.0 108.848 -178.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.509 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.6 mp -101.57 121.8 52.94 Favored 'Isoleucine or valine' 0 C--N 1.353 0.736 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 178.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.2 m -119.2 -173.53 2.53 Favored 'General case' 0 C--N 1.357 0.907 0 CA-C-O 121.787 0.803 . . . . 0.0 109.55 -178.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -147.52 155.95 42.37 Favored 'General case' 0 C--N 1.357 0.918 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -178.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 57.4 p -99.07 146.83 32.36 Favored Pre-proline 0 C--N 1.358 0.966 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.686 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 73.7 Cg_endo -76.02 -10.99 19.72 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.786 2.324 . . . . 0.0 115.082 -178.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -73.17 -41.45 63.85 Favored 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.795 -178.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 37.3 p -117.27 14.96 14.88 Favored 'General case' 0 C--N 1.356 0.872 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.734 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.686 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.1 pp0? -66.52 -12.75 59.08 Favored 'General case' 0 C--N 1.353 0.748 0 O-C-N 121.62 -0.675 . . . . 0.0 110.521 178.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 53.8 p-10 -121.89 34.71 5.09 Favored 'General case' 0 N--CA 1.439 -1.015 0 O-C-N 121.068 -1.02 . . . . 0.0 108.447 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 57.2 m -136.11 148.45 48.26 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.639 ' O ' ' HB ' ' A' ' 171' ' ' THR . 61.1 mt-10 -101.85 166.37 10.69 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.639 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 2.5 m 83.2 -56.94 0.16 Allowed 'General case' 0 C--N 1.368 1.374 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -112.23 117.62 33.05 Favored 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 119.861 -0.735 . . . . 0.0 109.609 -178.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 88.5 t -130.73 132.83 63.99 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 49.8 mm -107.35 125.86 63.58 Favored 'Isoleucine or valine' 0 C--N 1.359 0.982 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -114.92 155.89 26.04 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 122.061 0.934 . . . . 0.0 108.652 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -138.16 119.31 14.52 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -178.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.8 mp -115.09 121.37 66.95 Favored 'Isoleucine or valine' 0 C--N 1.353 0.735 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 42.8 p -126.02 159.86 31.61 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 121.698 0.761 . . . . 0.0 110.854 -177.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.405 ' HB2' ' HB2' ' A' ' 127' ' ' ASN . 0.1 OUTLIER -99.35 113.4 25.7 Favored 'General case' 0 C--N 1.366 1.287 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 177.358 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -60.34 148.86 78.65 Favored Pre-proline 0 C--N 1.358 0.972 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.12 132.05 28.73 Favored 'Trans proline' 0 CA--C 1.495 -1.457 0 C-N-CA 122.225 1.95 . . . . 0.0 113.984 -178.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' A' ' 182' ' ' ARG . 7.0 mtm105 -137.79 -79.99 0.36 Allowed 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -135.02 160.26 24.26 Favored Glycine 0 C--N 1.348 1.237 0 N-CA-C 107.66 -2.176 . . . . 0.0 107.66 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 67.97 63.42 0.39 Allowed 'General case' 0 C--N 1.36 1.024 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -120.08 109.55 15.6 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -117.55 122.5 43.83 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 84.6 mt -117.47 -69.67 0.84 Allowed 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -140.0 -104.36 0.16 Allowed 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -117.47 146.31 43.59 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 . . . . . 0 C--O 1.263 1.812 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 179.966 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 201' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 202' ' ' HEM . . . . . 0.962 HMA2 HBA2 ' A' ' 202' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.896 ' HG2' ' CMD' ' A' ' 202' ' ' HEM . 81.5 mmm . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.068 0.461 . . . . 0.0 110.147 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.27 -19.55 50.29 Favored 'General case' 0 C--N 1.356 0.877 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -178.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.06 -41.13 40.91 Favored Glycine 0 C--N 1.348 1.224 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.92 -34.95 69.49 Favored 'General case' 0 C--N 1.354 0.779 0 O-C-N 122.119 -0.636 . . . . 0.0 111.3 -177.501 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.9 m -71.04 -23.5 23.56 Favored 'Isoleucine or valine' 0 C--N 1.352 0.714 0 C-N-CA 119.915 -0.714 . . . . 0.0 109.122 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.4 m-30 -71.75 -33.44 68.66 Favored 'General case' 0 C--N 1.358 0.969 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 85.0 m -66.98 -40.06 87.32 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.24 -37.79 95.13 Favored Glycine 0 C--N 1.357 1.72 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.611 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -67.77 -38.47 83.46 Favored 'General case' 0 C--N 1.353 0.719 0 CA-C-N 117.346 0.573 . . . . 0.0 110.297 -178.006 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.469 ' CE ' HD21 ' A' ' 26' ' ' LEU . 22.0 mmt -64.01 -41.22 97.54 Favored 'General case' 0 C--N 1.356 0.868 0 O-C-N 121.644 -0.66 . . . . 0.0 111.002 -178.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -66.09 -40.33 90.73 Favored 'General case' 0 C--N 1.348 0.504 0 O-C-N 122.17 -0.331 . . . . 0.0 111.554 -177.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 55.5 tp -65.78 -42.74 90.41 Favored 'General case' 0 C--N 1.349 0.575 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -178.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.611 HG12 ' O ' ' A' ' 9' ' ' LEU . 2.4 mm -73.83 -36.96 47.37 Favored 'Isoleucine or valine' 0 C--N 1.358 0.949 0 O-C-N 121.067 -1.021 . . . . 0.0 111.167 -175.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -67.42 -44.43 78.79 Favored 'General case' 0 C--N 1.353 0.733 0 O-C-N 121.815 -0.553 . . . . 0.0 111.432 -176.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -72.85 -31.14 64.54 Favored 'General case' 0 N--CA 1.447 -0.579 0 O-C-N 122.013 -0.429 . . . . 0.0 111.626 -177.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -72.74 -50.02 27.24 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -175.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -128.47 -20.25 3.68 Favored 'General case' 0 C--N 1.354 0.797 0 C-N-CA 117.328 -1.749 . . . . 0.0 113.328 -176.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 144.44 179.79 21.13 Favored Glycine 0 N--CA 1.44 -1.061 0 C-N-CA 117.575 -2.25 . . . . 0.0 110.537 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -96.55 -16.37 21.11 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 -177.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -70.08 -41.18 74.45 Favored 'General case' 0 C--N 1.36 1.051 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.6 m -69.76 -38.42 76.76 Favored 'General case' 0 C--N 1.358 0.944 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.6 tp -59.64 -37.94 80.03 Favored 'General case' 0 C--N 1.356 0.867 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -65.76 -35.61 81.21 Favored 'General case' 0 C--N 1.356 0.89 0 O-C-N 122.068 -0.395 . . . . 0.0 110.847 -178.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.8 m -65.33 -39.42 92.38 Favored 'General case' 0 C--N 1.355 0.815 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 -178.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.515 HD22 ' HA ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -63.33 -37.96 89.29 Favored 'General case' 0 C--N 1.355 0.807 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.522 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.469 HD21 ' CE ' ' A' ' 10' ' ' MET . 84.5 mt -75.28 -11.85 60.15 Favored 'General case' 0 C--N 1.361 1.079 0 O-C-N 121.652 -0.655 . . . . 0.0 110.457 -178.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -88.48 -27.22 21.63 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 119.115 -1.034 . . . . 0.0 108.982 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.7 t -68.26 -37.64 80.94 Favored 'General case' 0 C--N 1.356 0.883 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.8 p -90.54 -41.07 11.6 Favored 'General case' 0 C--N 1.358 0.935 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 85.02 134.09 0.05 OUTLIER 'General case' 0 C--N 1.36 1.047 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.487 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -84.9 -171.75 3.81 Favored 'General case' 0 C--N 1.356 0.88 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.89 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -151.27 -23.69 0.21 Allowed 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.9 t -148.34 -64.53 0.25 Allowed 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -131.13 -55.97 1.04 Allowed 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 130.76 -44.61 1.2 Allowed Glycine 0 C--N 1.353 1.498 0 N-CA-C 108.749 -1.74 . . . . 0.0 108.749 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 80.3 mt -107.08 100.45 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.758 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.577 ' O ' ' HB ' ' A' ' 38' ' ' THR . 0.9 OUTLIER -71.79 -28.7 63.79 Favored 'General case' 0 C--N 1.357 0.924 0 O-C-N 121.962 -0.461 . . . . 0.0 109.912 -179.844 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.577 ' HB ' ' O ' ' A' ' 37' ' ' TYR . 12.3 m 113.3 -67.36 0.0 OUTLIER 'General case' 0 C--N 1.37 1.47 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.1 p 175.01 64.25 0.0 OUTLIER 'General case' 0 C--N 1.359 0.993 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.439 ' HB ' ' CE2' ' A' ' 37' ' ' TYR . 2.1 t -148.59 -5.97 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.836 0 C-N-CA 119.573 -0.851 . . . . 0.0 109.725 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -98.56 144.32 17.15 Favored Glycine 0 C--N 1.352 1.444 0 C-N-CA 119.162 -1.494 . . . . 0.0 110.23 -177.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.2 m -124.53 122.5 37.75 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -117.63 179.4 4.07 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -83.02 -171.33 3.5 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 73.3 m80 -93.67 -15.13 25.61 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.418 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -70.6 -28.7 65.05 Favored 'General case' 0 C--N 1.354 0.767 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 27.5 tp10 -63.27 -41.12 98.99 Favored 'General case' 0 C--N 1.352 0.688 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.444 ' O ' HG23 ' A' ' 52' ' ' VAL . 60.9 tp -67.7 -37.99 83.04 Favored 'General case' 0 C--N 1.355 0.823 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.295 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 59.8 tp -77.37 -27.74 52.69 Favored 'General case' 0 C--N 1.351 0.633 0 O-C-N 121.983 -0.448 . . . . 0.0 110.496 -176.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 72.7 tp60 -68.48 -42.38 78.78 Favored 'General case' 0 C--N 1.351 0.672 0 O-C-N 121.546 -0.721 . . . . 0.0 109.526 -178.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.423 HD22 HD13 ' A' ' 25' ' ' LEU . 82.4 mt -71.9 -35.16 69.62 Favored 'General case' 0 C--N 1.362 1.14 0 C-N-CA 119.963 -0.695 . . . . 0.0 109.355 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 48' ' ' LEU . 33.6 t -62.02 -40.21 86.51 Favored 'Isoleucine or valine' 0 C--N 1.351 0.632 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.9 t -67.57 -39.33 82.16 Favored 'Isoleucine or valine' 0 C--N 1.351 0.631 0 O-C-N 121.723 -0.611 . . . . 0.0 109.392 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.436 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 33.7 tptt -65.39 -29.17 69.85 Favored 'General case' 0 C--N 1.361 1.07 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -179.068 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.515 HD21 HD12 ' A' ' 13' ' ' ILE . 19.7 mt -66.17 -37.94 86.86 Favored 'General case' 0 C--N 1.355 0.815 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.303 179.178 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 56.3 p -72.16 -17.68 61.93 Favored 'General case' 0 C--N 1.354 0.796 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.704 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -101.8 -37.56 8.24 Favored 'General case' 0 C--N 1.353 0.754 0 O-C-N 121.244 -0.91 . . . . 0.0 111.473 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.1 p -74.22 -38.38 47.88 Favored 'Isoleucine or valine' 0 C--N 1.354 0.779 0 O-C-N 121.599 -0.688 . . . . 0.0 111.143 -177.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.549 ' HB3' HG23 ' A' ' 61' ' ' VAL . 3.4 t -112.21 -7.62 14.02 Favored 'General case' 0 C--N 1.353 0.756 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.309 -177.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 64.25 47.73 3.09 Favored 'General case' 0 C--N 1.354 0.781 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.549 HG23 ' HB3' ' A' ' 59' ' ' SER . 62.0 t -111.5 133.8 21.37 Favored Pre-proline 0 N--CA 1.443 -0.813 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 61' ' ' VAL . 34.1 Cg_exo -58.44 148.35 80.91 Favored 'Trans proline' 0 CA--C 1.498 -1.294 0 C-N-CA 122.565 2.177 . . . . 0.0 112.771 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.9 m -72.73 -15.02 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.687 -178.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.436 ' O ' HG12 ' A' ' 67' ' ' VAL . 70.6 p -96.42 -31.61 12.75 Favored 'General case' 0 C--N 1.359 0.987 0 C-N-CA 118.608 -1.237 . . . . 0.0 109.075 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -71.06 -33.01 69.86 Favored 'General case' 0 C--N 1.353 0.728 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.402 HD13 HD13 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -77.23 -34.88 55.91 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -177.889 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.436 HG12 ' O ' ' A' ' 64' ' ' THR . 1.5 p -70.64 -26.03 27.64 Favored 'Isoleucine or valine' 0 C--N 1.354 0.776 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.523 -178.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 5.3 mmm-85 -74.58 -51.44 14.55 Favored 'General case' 0 C--N 1.36 1.039 0 O-C-N 121.438 -0.789 . . . . 0.0 110.105 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.0 mt -63.2 -35.33 79.97 Favored 'General case' 0 C--N 1.357 0.896 0 O-C-N 122.046 -0.409 . . . . 0.0 110.606 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -60.94 -47.16 87.72 Favored 'General case' 0 C--N 1.35 0.623 0 O-C-N 122.301 -0.25 . . . . 0.0 110.333 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.6 -38.58 95.23 Favored Glycine 0 C--N 1.354 1.547 0 N-CA-C 111.848 -0.501 . . . . 0.0 111.848 -178.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -63.86 -47.65 79.84 Favored 'General case' 0 C--N 1.353 0.726 0 CA-C-N 118.411 1.105 . . . . 0.0 111.457 -177.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.729 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 12.9 mttm -64.15 -49.46 72.02 Favored 'General case' 0 C--N 1.358 0.97 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -176.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.418 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.2 tm? -69.18 -39.38 78.75 Favored 'General case' 0 C--N 1.35 0.609 0 O-C-N 121.214 -0.929 . . . . 0.0 111.882 -175.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -63.47 -44.29 94.86 Favored 'General case' 0 C--N 1.353 0.748 0 O-C-N 121.122 -0.987 . . . . 0.0 110.988 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.29 -14.89 18.19 Favored 'Isoleucine or valine' 0 C--N 1.358 0.954 0 O-C-N 121.496 -0.752 . . . . 0.0 109.194 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.729 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 74.3 mm-40 -71.43 -38.98 71.34 Favored 'General case' 0 C--N 1.352 0.674 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 82.5 mt -72.99 -31.36 64.45 Favored 'General case' 0 C--N 1.356 0.855 0 O-C-N 122.426 -0.171 . . . . 0.0 110.545 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 49.1 mm -65.58 -54.25 30.19 Favored 'Isoleucine or valine' 0 C--N 1.359 0.993 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.286 -177.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -75.38 -14.57 60.48 Favored 'General case' 0 CA--C 1.51 -0.571 0 C-N-CA 119.516 -0.874 . . . . 0.0 109.381 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.35 -37.21 63.01 Favored Glycine 0 C--N 1.349 1.259 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.427 ' O ' HG22 ' A' ' 85' ' ' ILE . 98.7 m-70 -131.38 106.24 14.61 Favored Pre-proline 0 N--CA 1.441 -0.885 0 CA-C-O 122.664 1.221 . . . . 0.0 109.046 -177.057 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.33 -24.87 42.88 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.52 2.147 . . . . 0.0 114.113 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.417 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 44.6 mt-10 -93.11 -4.95 51.39 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.427 HG22 ' O ' ' A' ' 82' ' ' HIS . 1.0 OUTLIER -90.32 -20.08 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.224 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 -179.629 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -101.72 -24.66 14.05 Favored 'General case' 0 C--N 1.36 1.038 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -70.26 -35.65 73.92 Favored 'General case' 0 C--N 1.358 0.955 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.417 ' HG2' ' O ' ' A' ' 84' ' ' GLU . 78.6 mm-40 -65.01 -36.1 83.31 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 122.058 -0.401 . . . . 0.0 110.058 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 21.8 ttp -83.56 149.87 26.31 Favored 'General case' 0 C--N 1.352 0.698 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -178.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.53 -21.95 8.36 Favored 'General case' 0 C--N 1.364 1.222 0 C-N-CA 120.074 -0.651 . . . . 0.0 111.032 -177.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -164.55 170.93 15.19 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 -177.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.415 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 41.0 t -64.4 -42.69 95.97 Favored 'General case' 0 C--N 1.356 0.873 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.955 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -66.86 -38.82 87.09 Favored 'General case' 0 C--N 1.355 0.833 0 O-C-N 121.492 -0.755 . . . . 0.0 109.328 -178.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -65.91 -24.61 66.87 Favored 'General case' 0 C--N 1.357 0.912 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.415 ' HB3' ' O ' ' A' ' 92' ' ' SER . 62.5 tp -63.09 -46.41 87.53 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.7 mp -63.03 -32.35 73.7 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 122.185 -0.322 . . . . 0.0 110.405 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 36.5 t -62.15 -45.08 95.04 Favored 'General case' 0 C--N 1.355 0.847 0 O-C-N 121.783 -0.573 . . . . 0.0 111.304 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.66 26.42 10.39 Favored 'General case' 0 C--N 1.362 1.11 0 O-C-N 121.015 -1.053 . . . . 0.0 110.515 -178.232 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 1.026 HD11 ' C3B' ' A' ' 202' ' ' HEM . 13.0 tt -64.09 -29.57 47.69 Favored 'Isoleucine or valine' 0 C--N 1.352 0.691 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.151 -179.038 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -126.21 -9.46 6.44 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 118.564 -1.254 . . . . 0.0 109.762 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 58.8 m -90.92 -2.54 57.72 Favored 'General case' 0 N--CA 1.441 -0.884 0 O-C-N 121.406 -0.809 . . . . 0.0 110.345 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -147.03 -47.69 0.18 Allowed 'General case' 0 C--N 1.358 0.968 0 C-N-CA 118.28 -1.368 . . . . 0.0 109.913 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 96.2 mt -67.53 -47.84 79.07 Favored 'Isoleucine or valine' 0 C--N 1.354 0.779 0 O-C-N 121.931 -0.481 . . . . 0.0 111.161 -178.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.652 ' HB3' HD21 ' A' ' 116' ' ' LEU . 22.4 m170 -83.55 -1.14 53.09 Favored 'General case' 0 C--N 1.356 0.875 0 O-C-N 121.403 -0.811 . . . . 0.0 110.056 -177.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 70.5 t -83.96 -43.13 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.952 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -67.3 -39.88 85.99 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.323 -178.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.1 p -71.97 -36.5 57.74 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 C-N-CA 119.596 -0.842 . . . . 0.0 110.106 -178.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 93.3 t80 -60.86 -48.6 81.07 Favored 'General case' 0 C--N 1.363 1.171 0 O-C-N 121.744 -0.597 . . . . 0.0 110.71 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -60.25 -38.1 82.45 Favored 'General case' 0 C--N 1.358 0.941 0 O-C-N 121.665 -0.647 . . . . 0.0 110.069 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 16.9 mt -58.05 -76.56 0.04 OUTLIER 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.429 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 91.3 m-85 -115.72 134.3 22.7 Favored Pre-proline 0 N--CA 1.44 -0.954 0 C-N-CA 118.986 -1.086 . . . . 0.0 108.83 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 111' ' ' TYR . 74.3 Cg_endo -86.21 -2.08 8.62 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 123.222 2.615 . . . . 0.0 115.403 -179.012 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -67.39 -36.18 80.8 Favored 'General case' 0 C--N 1.355 0.814 0 O-C-N 121.773 -0.579 . . . . 0.0 109.997 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.519 ' HB1' HBD1 ' A' ' 202' ' ' HEM . . . -61.73 143.99 55.36 Favored 'General case' 0 C--N 1.354 0.775 0 CA-C-O 121.651 0.738 . . . . 0.0 110.018 -178.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -114.26 145.58 41.55 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.652 HD21 ' HB3' ' A' ' 104' ' ' HIS . 5.6 mp -127.48 145.78 55.91 Favored Pre-proline 0 N--CA 1.445 -0.716 0 CA-C-O 122.198 0.999 . . . . 0.0 108.98 -178.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.522 ' HD3' HBA1 ' A' ' 202' ' ' HEM . 73.7 Cg_endo -91.31 -152.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.197 0 C-N-CA 123.909 3.073 . . . . 0.0 113.178 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -115.03 142.46 46.61 Favored 'General case' 0 C--N 1.362 1.125 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.598 ' CE2' ' HD1' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -137.71 125.42 22.37 Favored 'General case' 0 C--N 1.361 1.09 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -177.999 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 94.1 m -124.23 129.99 51.74 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 177.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 74.8 m -118.01 131.35 56.48 Favored 'General case' 0 CA--C 1.504 -0.8 0 C-N-CA 119.277 -0.969 . . . . 0.0 109.852 -177.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -121.02 148.37 44.22 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 58.1 ttp180 -123.32 117.39 25.13 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.451 ' HB2' ' CB ' ' A' ' 128' ' ' ASP . 95.3 mt -92.07 -15.09 28.27 Favored 'General case' 0 C--N 1.354 0.797 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.709 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 178.59 -150.37 9.61 Favored Glycine 0 N--CA 1.439 -1.154 0 N-CA-C 108.886 -1.686 . . . . 0.0 108.886 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -90.4 -38.23 13.45 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -105.99 9.5 32.55 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 119.762 -0.775 . . . . 0.0 109.524 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.451 ' CB ' ' HB2' ' A' ' 124' ' ' LEU . 61.9 m-20 -118.3 123.21 44.8 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 17.8 mm -137.9 133.26 44.57 Favored 'Isoleucine or valine' 0 C--N 1.353 0.729 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 59.9 mtm180 -120.49 139.43 52.9 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.546 ' HG ' ' O ' ' A' ' 131' ' ' LEU . 0.7 OUTLIER -130.04 127.0 39.05 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.917 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -97.34 130.7 44.47 Favored 'General case' 0 CA--C 1.494 -1.188 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 178.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.598 ' HD1' ' CE2' ' A' ' 119' ' ' PHE . 52.5 t80 -124.86 121.43 34.51 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 -178.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.485 ' HA ' ' O ' ' A' ' 171' ' ' THR . 28.2 tt0 -114.42 112.44 23.03 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.8 t -162.28 153.39 17.8 Favored 'General case' 0 C--N 1.358 0.974 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -90.43 5.99 45.2 Favored 'General case' 0 C--N 1.357 0.903 0 C-N-CA 120.199 -0.6 . . . . 0.0 109.912 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 94.7 mtm-85 -131.94 77.35 72.05 Favored Pre-proline 0 C--N 1.356 0.856 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 178.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -91.48 93.07 0.22 Allowed 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.748 2.298 . . . . 0.0 115.709 -177.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -107.43 106.36 16.73 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 177.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.3 -38.88 92.63 Favored 'General case' 0 C--N 1.355 0.835 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.367 -178.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 74.2 m -63.05 -27.1 69.17 Favored 'General case' 0 C--N 1.353 0.755 0 O-C-N 121.981 -0.449 . . . . 0.0 110.554 -178.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -75.58 -47.18 27.78 Favored 'General case' 0 N--CA 1.445 -0.721 0 O-C-N 121.735 -0.603 . . . . 0.0 109.553 -178.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.28 -39.4 92.53 Favored 'General case' 0 C--N 1.358 0.944 0 O-C-N 122.108 -0.37 . . . . 0.0 111.331 -178.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -62.19 -36.94 83.42 Favored 'General case' 0 C--N 1.358 0.947 0 O-C-N 121.777 -0.577 . . . . 0.0 109.764 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.53 -42.2 99.03 Favored Glycine 0 C--N 1.347 1.157 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 83.2 mt -70.19 -41.35 73.82 Favored 'General case' 0 C--N 1.352 0.692 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 96.6 mt -71.27 -42.08 69.22 Favored 'General case' 0 C--N 1.364 1.212 0 O-C-N 121.066 -1.021 . . . . 0.0 110.654 -177.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -70.35 -30.84 67.88 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 121.866 -0.521 . . . . 0.0 110.635 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -63.55 -39.75 97.97 Favored Glycine 0 C--N 1.356 1.654 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 42.7 t -60.43 -43.11 97.12 Favored 'General case' 0 C--N 1.35 0.615 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 178.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -78.91 2.38 20.35 Favored 'General case' 0 C--N 1.355 0.847 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -83.73 -49.09 9.45 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -66.69 -42.93 85.67 Favored 'General case' 0 C--N 1.36 1.061 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 9.6 m-30 -69.01 -27.38 65.62 Favored 'General case' 0 C--N 1.361 1.068 0 O-C-N 121.831 -0.543 . . . . 0.0 110.797 -178.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 85.2 tttt 73.01 75.06 0.14 Allowed 'General case' 0 C--N 1.36 1.058 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -137.65 -177.73 4.92 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -140.27 90.06 2.34 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 16.8 m-30 -116.3 155.11 28.98 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 178.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 93.5 m -119.66 128.83 54.2 Favored 'General case' 0 C--N 1.355 0.808 0 C-N-CA 119.551 -0.859 . . . . 0.0 108.828 -178.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.507 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.5 mp -106.24 123.22 60.83 Favored 'Isoleucine or valine' 0 C--N 1.352 0.704 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.1 m -119.43 -170.77 2.0 Allowed 'General case' 0 C--N 1.356 0.869 0 CA-C-O 121.685 0.755 . . . . 0.0 109.197 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 11.3 ptt85 -147.76 157.0 43.33 Favored 'General case' 0 C--N 1.357 0.931 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -178.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.438 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 32.5 p -97.5 146.37 31.28 Favored Pre-proline 0 C--N 1.36 1.043 0 CA-C-O 122.415 1.103 . . . . 0.0 108.447 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.513 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 16.0 Cg_exo -70.42 -16.7 34.82 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 123.641 2.894 . . . . 0.0 114.486 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -71.95 -40.71 68.49 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.933 -177.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 39.6 p -119.27 15.75 13.09 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.876 -178.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.513 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 12.7 pt20 -67.55 -12.15 59.71 Favored 'General case' 0 C--N 1.352 0.69 0 C-N-CA 119.974 -0.691 . . . . 0.0 110.155 178.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -126.51 37.79 4.24 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 18.2 t -138.94 144.65 39.13 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.622 ' O ' ' HB ' ' A' ' 171' ' ' THR . 61.4 mt-10 -97.87 163.99 12.56 Favored 'General case' 0 C--N 1.354 0.769 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.622 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 18.0 m 83.95 -59.91 0.12 Allowed 'General case' 0 C--N 1.372 1.555 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -105.71 118.0 35.47 Favored 'General case' 0 CA--C 1.503 -0.827 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.596 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 92.8 t -131.48 133.78 61.5 Favored 'Isoleucine or valine' 0 C--N 1.358 0.952 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 178.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 48.4 mm -113.52 126.98 71.06 Favored 'Isoleucine or valine' 0 C--N 1.359 1.021 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.441 ' HB2' ' HG ' ' A' ' 131' ' ' LEU . 97.2 m-85 -116.74 147.2 42.25 Favored 'General case' 0 C--N 1.36 1.054 0 CA-C-O 121.947 0.88 . . . . 0.0 109.105 -179.162 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -125.2 120.16 30.52 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 51.8 mt -116.22 124.79 72.86 Favored 'Isoleucine or valine' 0 C--N 1.353 0.752 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 -178.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 54.9 p -118.55 157.97 26.31 Favored 'General case' 0 CA--C 1.501 -0.92 0 CA-C-O 121.764 0.792 . . . . 0.0 109.581 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -102.87 119.03 38.12 Favored 'General case' 0 C--N 1.356 0.858 0 N-CA-C 106.325 -1.732 . . . . 0.0 106.325 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -60.6 149.65 77.78 Favored Pre-proline 0 C--N 1.357 0.897 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.2 138.11 83.01 Favored 'Trans proline' 0 CA--C 1.494 -1.522 0 C-N-CA 122.167 1.911 . . . . 0.0 113.646 -178.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.469 HH11 ' HD2' ' A' ' 182' ' ' ARG . 6.1 mtm105 -127.47 148.74 50.31 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 -179.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 63.17 -136.58 43.03 Favored Glycine 0 C--N 1.348 1.249 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -95.42 -179.97 4.96 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -128.51 126.81 41.17 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -112.31 123.14 49.62 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 52.6 tp -112.46 -66.95 1.03 Allowed 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -133.3 -82.48 0.47 Allowed 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -131.54 -67.82 0.67 Allowed 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 . . . . . 0 C--O 1.264 1.857 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 179.767 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 201' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 202' ' ' HEM . . . . . 1.026 ' C3B' HD11 ' A' ' 99' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mtm . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 121.287 0.565 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.93 -12.71 54.98 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.172 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.62 -40.2 54.15 Favored Glycine 0 C--N 1.351 1.397 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 7.8 mtm -71.08 -35.4 71.84 Favored 'General case' 0 C--N 1.359 1.0 0 O-C-N 121.875 -0.779 . . . . 0.0 111.299 -177.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.1 m -68.48 -23.98 28.81 Favored 'Isoleucine or valine' 0 C--N 1.356 0.854 0 C-N-CA 119.674 -0.81 . . . . 0.0 109.22 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -71.31 -35.87 71.42 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 178.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 88.6 m -67.35 -41.63 84.85 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.73 -38.95 97.31 Favored Glycine 0 C--N 1.357 1.743 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.633 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -66.73 -39.98 88.2 Favored 'General case' 0 C--N 1.352 0.685 0 O-C-N 122.301 -0.529 . . . . 0.0 110.76 -178.107 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 22.4 mmt -64.25 -41.04 97.15 Favored 'General case' 0 C--N 1.354 0.791 0 O-C-N 121.523 -0.735 . . . . 0.0 111.137 -178.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -67.26 -40.0 86.17 Favored 'General case' 0 C--N 1.35 0.598 0 O-C-N 121.96 -0.463 . . . . 0.0 111.623 -177.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 54.7 tp -66.33 -42.09 88.68 Favored 'General case' 0 C--N 1.348 0.503 0 N-CA-C 112.694 0.628 . . . . 0.0 112.694 -178.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.633 HG12 ' O ' ' A' ' 9' ' ' LEU . 2.1 mm -75.17 -35.77 35.3 Favored 'Isoleucine or valine' 0 C--N 1.36 1.048 0 O-C-N 121.11 -0.994 . . . . 0.0 110.86 -175.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -71.13 -41.89 69.91 Favored 'General case' 0 C--N 1.35 0.587 0 O-C-N 121.558 -0.714 . . . . 0.0 111.405 -176.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -72.04 -38.21 69.56 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -175.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -102.57 -23.22 13.89 Favored 'General case' 0 C--N 1.349 0.584 0 C-N-CA 118.794 -1.162 . . . . 0.0 113.466 -174.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 14.6 m-30 -109.07 -37.76 5.73 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 118.191 -1.404 . . . . 0.0 111.399 -176.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 140.63 178.76 17.48 Favored Glycine 0 N--CA 1.439 -1.144 0 N-CA-C 108.732 -1.747 . . . . 0.0 108.732 -179.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -101.6 -25.61 13.82 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -177.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -70.3 -39.61 74.72 Favored 'General case' 0 C--N 1.361 1.098 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 95.0 m -67.69 -38.38 83.59 Favored 'General case' 0 C--N 1.358 0.96 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.1 tp -59.59 -38.54 81.49 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -66.12 -36.13 82.33 Favored 'General case' 0 C--N 1.356 0.858 0 O-C-N 122.09 -0.381 . . . . 0.0 111.07 -178.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.6 m -64.13 -41.19 97.3 Favored 'General case' 0 C--N 1.355 0.846 0 O-C-N 121.606 -0.684 . . . . 0.0 109.352 -178.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.3 mt -64.28 -36.84 85.42 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.568 ' HB3' HD23 ' A' ' 31' ' ' LEU . 84.3 mt -70.19 -16.2 63.04 Favored 'General case' 0 C--N 1.359 0.982 0 O-C-N 121.782 -0.574 . . . . 0.0 110.105 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -84.89 -28.79 25.72 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 119.524 -0.87 . . . . 0.0 109.167 178.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.4 t -66.52 -36.89 83.82 Favored 'General case' 0 C--N 1.355 0.838 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.8 p -93.07 -37.19 12.29 Favored 'General case' 0 C--N 1.359 1.004 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -179.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 83.66 133.39 0.05 Allowed 'General case' 0 C--N 1.36 1.04 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.568 HD23 ' HB3' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -111.97 132.05 55.02 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 179.246 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -107.88 -21.46 12.83 Favored 'General case' 0 CA--C 1.497 -1.083 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.121 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -114.24 -80.15 0.59 Allowed 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 118.874 -1.131 . . . . 0.0 109.098 -178.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -137.16 -53.17 0.68 Allowed 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 131.4 -44.6 1.19 Allowed Glycine 0 C--N 1.352 1.437 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 82.8 mt -107.87 100.05 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.795 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -98.21 0.07 45.11 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.706 HG22 ' H ' ' A' ' 39' ' ' SER . 3.4 m 78.75 174.22 0.16 Allowed 'General case' 0 C--N 1.362 1.127 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 -178.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.706 ' H ' HG22 ' A' ' 38' ' ' THR . 41.7 p -86.81 119.25 26.84 Favored 'General case' 0 N--CA 1.443 -0.778 0 O-C-N 121.131 -0.981 . . . . 0.0 109.531 -178.483 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.429 ' O ' HG13 ' A' ' 40' ' ' VAL . 0.5 OUTLIER -176.21 -12.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.362 1.117 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.721 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -114.25 168.05 12.47 Favored Glycine 0 C--N 1.358 1.793 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 -178.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 48.9 m -130.95 132.21 44.92 Favored 'General case' 0 C--N 1.355 0.838 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -119.14 173.64 6.8 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -70.19 172.49 8.0 Favored 'General case' 0 C--N 1.357 0.9 0 CA-C-O 121.671 0.748 . . . . 0.0 109.478 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -83.77 -24.05 31.25 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -178.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -65.79 -27.41 68.25 Favored 'General case' 0 C--N 1.355 0.832 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -61.48 -42.11 98.28 Favored 'General case' 0 C--N 1.353 0.734 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.512 ' O ' HG23 ' A' ' 52' ' ' VAL . 61.8 tp -67.4 -38.89 85.34 Favored 'General case' 0 C--N 1.355 0.816 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.296 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 57.9 tp -73.5 -28.05 61.7 Favored 'General case' 0 C--N 1.352 0.697 0 O-C-N 122.081 -0.387 . . . . 0.0 110.278 -177.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 71.7 tp60 -67.42 -42.42 83.22 Favored 'General case' 0 N--CA 1.445 -0.695 0 O-C-N 121.702 -0.624 . . . . 0.0 109.481 -178.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 88.1 mt -76.9 -25.09 52.61 Favored 'General case' 0 C--N 1.36 1.031 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.843 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 48' ' ' LEU . 32.2 t -70.78 -41.7 77.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.1 p -71.82 -30.88 39.25 Favored 'Isoleucine or valine' 0 C--N 1.354 0.797 0 O-C-N 121.514 -0.741 . . . . 0.0 109.766 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 31.1 tptt -71.83 -27.16 62.71 Favored 'General case' 0 C--N 1.364 1.204 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.0 tt -66.58 -41.25 88.81 Favored 'General case' 0 C--N 1.354 0.768 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.498 ' O ' ' HA ' ' A' ' 60' ' ' SER . 46.8 t -65.24 -39.4 92.64 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 121.88 -0.512 . . . . 0.0 110.313 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -76.95 -39.12 51.81 Favored 'General case' 0 C--N 1.352 0.717 0 O-C-N 120.974 -1.078 . . . . 0.0 112.975 -178.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.4 p -70.74 -38.02 71.3 Favored 'Isoleucine or valine' 0 C--N 1.354 0.794 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -175.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.0 t -118.12 -4.44 11.0 Favored 'General case' 0 CA--C 1.505 -0.779 0 C-N-CA 118.975 -1.09 . . . . 0.0 110.085 -177.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' A' ' 56' ' ' SER . 0.3 OUTLIER 69.36 41.23 1.35 Allowed 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.078 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 56' ' ' SER . 61.6 t -110.8 123.86 34.45 Favored Pre-proline 0 CA--C 1.502 -0.891 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 178.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 61' ' ' VAL . 32.5 Cg_exo -57.73 155.03 34.03 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 122.85 2.367 . . . . 0.0 113.689 -178.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.656 ' HA ' HD23 ' A' ' 66' ' ' LEU . 11.4 m -75.3 -9.34 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.457 -177.101 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.504 ' O ' HG12 ' A' ' 67' ' ' VAL . 80.6 p -96.39 -36.13 10.95 Favored 'General case' 0 C--N 1.356 0.882 0 C-N-CA 118.221 -1.392 . . . . 0.0 109.431 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -75.2 -22.3 58.08 Favored 'General case' 0 C--N 1.353 0.733 0 O-C-N 121.407 -0.808 . . . . 0.0 109.337 179.106 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.656 HD23 ' HA ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -82.58 -32.67 28.37 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -178.997 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.504 HG12 ' O ' ' A' ' 64' ' ' THR . 2.3 p -70.98 -25.39 25.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.844 0 C-N-CA 120.077 -0.649 . . . . 0.0 109.864 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.7 mmm-85 -73.29 -53.15 11.55 Favored 'General case' 0 C--N 1.363 1.153 0 O-C-N 121.519 -0.738 . . . . 0.0 109.841 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.54 -34.34 77.58 Favored 'General case' 0 C--N 1.356 0.889 0 O-C-N 122.112 -0.368 . . . . 0.0 110.806 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -61.23 -47.2 87.18 Favored 'General case' 0 C--N 1.35 0.613 0 O-C-N 122.083 -0.385 . . . . 0.0 110.369 -178.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.65 -38.6 95.33 Favored Glycine 0 C--N 1.356 1.663 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 -178.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -63.29 -47.98 80.04 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-N 118.115 0.957 . . . . 0.0 111.644 -177.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 12.8 mttm -65.42 -47.04 77.63 Favored 'General case' 0 C--N 1.359 1.018 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -177.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -70.3 -39.24 74.95 Favored 'General case' 0 C--N 1.349 0.571 0 O-C-N 121.158 -0.964 . . . . 0.0 111.712 -175.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -63.89 -45.55 88.88 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 121.114 -0.991 . . . . 0.0 111.047 -178.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.8 p -71.44 -14.01 17.37 Favored 'Isoleucine or valine' 0 C--N 1.359 0.988 0 O-C-N 121.545 -0.722 . . . . 0.0 109.073 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -71.36 -40.65 70.49 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 79.5 mt -70.32 -34.02 72.2 Favored 'General case' 0 C--N 1.356 0.887 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.337 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 46.4 mm -63.16 -52.95 52.42 Favored 'Isoleucine or valine' 0 C--N 1.358 0.964 0 O-C-N 121.723 -0.611 . . . . 0.0 110.105 -177.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -75.0 -10.7 59.72 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 120.1 -0.64 . . . . 0.0 111.289 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.76 -8.68 58.06 Favored Glycine 0 C--N 1.351 1.401 0 C-N-CA 119.617 -1.277 . . . . 0.0 110.825 -178.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.577 ' HB3' ' HB ' ' A' ' 85' ' ' ILE . 93.3 m-70 -137.22 91.35 14.65 Favored Pre-proline 0 C--N 1.353 0.721 0 CA-C-N 118.994 1.397 . . . . 0.0 108.982 -179.256 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -59.82 -32.96 96.2 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 123.027 2.484 . . . . 0.0 114.408 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -93.24 -2.71 54.82 Favored 'General case' 0 CA--C 1.504 -0.82 0 C-N-CA 119.74 -0.784 . . . . 0.0 109.616 -178.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.577 ' HB ' ' HB3' ' A' ' 82' ' ' HIS . 0.4 OUTLIER -89.07 -19.87 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 -179.832 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -101.64 -23.42 14.26 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -70.27 -36.66 74.57 Favored 'General case' 0 C--N 1.359 0.995 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -65.77 -35.91 82.06 Favored 'General case' 0 C--N 1.355 0.82 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.013 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 23.8 ttp -83.26 149.61 26.69 Favored 'General case' 0 C--N 1.353 0.732 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -178.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.6 -21.91 8.91 Favored 'General case' 0 C--N 1.364 1.233 0 O-C-N 121.698 -0.626 . . . . 0.0 110.556 -177.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -163.91 170.75 16.3 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -177.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.443 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 89.3 p -70.86 -32.32 69.28 Favored 'General case' 0 C--N 1.353 0.736 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.965 -179.238 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -70.3 -38.94 75.09 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -67.06 -23.73 65.9 Favored 'General case' 0 C--N 1.358 0.937 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.443 ' HB3' ' O ' ' A' ' 92' ' ' SER . 61.0 tp -62.67 -46.53 87.73 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.9 mp -63.13 -31.22 72.32 Favored 'General case' 0 C--N 1.355 0.812 0 O-C-N 122.257 -0.277 . . . . 0.0 110.289 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 36.1 t -62.2 -45.98 90.93 Favored 'General case' 0 C--N 1.356 0.868 0 O-C-N 121.69 -0.631 . . . . 0.0 111.237 -178.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.431 ' H ' ' HG3' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -114.89 28.92 8.39 Favored 'General case' 0 C--N 1.36 1.055 0 O-C-N 121.068 -1.02 . . . . 0.0 110.232 -178.338 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 1.386 HD11 ' C3B' ' A' ' 202' ' ' HEM . 12.9 tt -63.45 -27.64 43.41 Favored 'Isoleucine or valine' 0 C--N 1.354 0.79 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.5 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -125.98 -12.29 6.45 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 118.825 -1.15 . . . . 0.0 109.044 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.3 t -69.11 -45.53 69.98 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.057 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -123.85 -28.73 3.77 Favored 'General case' 0 C--N 1.358 0.943 0 C-N-CA 118.636 -1.226 . . . . 0.0 111.47 -177.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.467 HD12 ' HA ' ' A' ' 99' ' ' ILE . 96.2 mt -70.17 -47.8 65.46 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 O-C-N 121.147 -0.971 . . . . 0.0 110.922 -178.014 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 39.3 m170 -87.96 1.71 53.46 Favored 'General case' 0 C--N 1.355 0.834 0 O-C-N 121.224 -0.923 . . . . 0.0 110.028 -177.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.6 p -92.37 -31.71 4.85 Favored 'Isoleucine or valine' 0 C--N 1.354 0.799 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -71.99 -39.8 69.02 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -72.98 -36.6 51.68 Favored 'Isoleucine or valine' 0 C--N 1.354 0.795 0 C-N-CA 119.605 -0.838 . . . . 0.0 109.704 -178.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -61.06 -48.7 80.52 Favored 'General case' 0 C--N 1.364 1.21 0 O-C-N 121.808 -0.557 . . . . 0.0 110.651 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -60.91 -37.9 83.87 Favored 'General case' 0 C--N 1.357 0.903 0 O-C-N 121.709 -0.619 . . . . 0.0 110.226 -179.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.8 mt -57.9 -76.46 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.413 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 79.5 m-85 -116.37 135.04 22.78 Favored Pre-proline 0 N--CA 1.441 -0.899 0 C-N-CA 118.926 -1.109 . . . . 0.0 108.756 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 111' ' ' TYR . 81.2 Cg_endo -85.29 -2.41 9.35 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 123.215 2.61 . . . . 0.0 115.41 -178.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 30.4 mm100 -66.72 -36.42 82.42 Favored 'General case' 0 C--N 1.354 0.79 0 O-C-N 121.779 -0.575 . . . . 0.0 110.029 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.97 146.12 53.82 Favored 'General case' 0 C--N 1.354 0.778 0 CA-C-O 121.695 0.76 . . . . 0.0 110.092 -178.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -117.43 156.77 27.38 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 178.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.824 ' HG ' ' HD2' ' A' ' 117' ' ' PRO . 4.3 tp -142.3 143.47 27.39 Favored Pre-proline 0 N--CA 1.441 -0.893 0 CA-C-O 122.009 0.909 . . . . 0.0 108.646 -178.135 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.824 ' HD2' ' HG ' ' A' ' 116' ' ' LEU . 97.5 Cg_endo -85.73 -152.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.128 0 C-N-CA 123.602 2.868 . . . . 0.0 113.534 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -114.25 145.94 41.08 Favored 'General case' 0 C--N 1.363 1.19 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -145.39 125.28 13.49 Favored 'General case' 0 C--N 1.36 1.052 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -177.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 93.5 m -124.84 132.49 53.32 Favored 'General case' 0 C--N 1.359 0.995 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 179.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 75.2 m -113.68 130.25 56.44 Favored 'General case' 0 C--N 1.356 0.883 0 C-N-CA 119.735 -0.786 . . . . 0.0 109.576 -178.372 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -121.04 126.7 50.55 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 178.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 58.4 ttp180 -102.53 117.4 34.62 Favored 'General case' 0 C--N 1.353 0.755 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.549 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 85.7 mt -83.3 -27.03 30.08 Favored 'General case' 0 CA--C 1.504 -0.818 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.112 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -177.18 -144.96 5.55 Favored Glycine 0 C--N 1.35 1.319 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 -178.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -94.11 -39.06 10.79 Favored 'General case' 0 N--CA 1.438 -1.07 0 O-C-N 121.993 -0.71 . . . . 0.0 109.312 -178.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -101.94 1.89 37.3 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.614 -178.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.549 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 6.6 m-20 -118.97 130.77 55.87 Favored 'General case' 0 C--N 1.359 0.993 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 14.2 mm -139.37 135.81 40.83 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 58.3 mtm180 -122.0 141.01 51.78 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.57 ' HG ' ' HB2' ' A' ' 175' ' ' PHE . 0.9 OUTLIER -131.39 127.01 36.65 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.676 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -97.47 130.77 44.53 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 178.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -125.15 121.04 33.07 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 -178.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.513 ' HA ' ' O ' ' A' ' 171' ' ' THR . 28.7 tt0 -114.9 112.05 22.13 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 14.5 t -161.73 152.65 18.02 Favored 'General case' 0 C--N 1.358 0.976 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.418 ' C ' ' HD3' ' A' ' 138' ' ' PRO . 57.9 mtmt -90.7 3.56 53.92 Favored 'General case' 0 C--N 1.357 0.891 0 C-N-CA 120.269 -0.572 . . . . 0.0 109.576 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -133.49 73.48 72.99 Favored Pre-proline 0 CA--C 1.506 -0.736 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.418 ' HD3' ' C ' ' A' ' 136' ' ' LYS . 89.6 Cg_endo -96.36 104.14 0.09 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.541 0 C-N-CA 122.662 2.241 . . . . 0.0 115.678 -177.339 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -111.87 113.44 25.77 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 176.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.93 -38.12 89.93 Favored 'General case' 0 C--N 1.353 0.75 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.968 -179.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 74.6 m -63.02 -26.17 68.73 Favored 'General case' 0 C--N 1.353 0.741 0 O-C-N 121.971 -0.456 . . . . 0.0 110.55 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -76.57 -46.72 25.1 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 120.13 -0.628 . . . . 0.0 109.375 -178.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.59 -40.24 95.16 Favored 'General case' 0 C--N 1.357 0.915 0 O-C-N 122.187 -0.321 . . . . 0.0 111.087 -178.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.19 -36.79 84.81 Favored 'General case' 0 C--N 1.355 0.834 0 O-C-N 121.961 -0.462 . . . . 0.0 110.112 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.37 -42.94 99.09 Favored Glycine 0 C--N 1.347 1.157 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.5 mt -70.06 -40.92 74.8 Favored 'General case' 0 C--N 1.353 0.719 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 96.7 mt -71.84 -42.2 67.24 Favored 'General case' 0 C--N 1.364 1.2 0 O-C-N 121.059 -1.026 . . . . 0.0 110.801 -176.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.515 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 20.9 t70 -69.15 -33.15 72.97 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 122.097 -0.377 . . . . 0.0 110.57 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.433 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -62.75 -39.28 97.76 Favored Glycine 0 C--N 1.357 1.713 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 45.9 t -60.51 -42.24 95.99 Favored 'General case' 0 C--N 1.35 0.598 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -75.99 -0.13 20.51 Favored 'General case' 0 C--N 1.36 1.043 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.515 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 76.8 mm-40 -84.56 -46.41 11.59 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -66.16 -44.59 83.64 Favored 'General case' 0 C--N 1.359 1.002 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 8.8 m-30 -69.5 -26.28 64.46 Favored 'General case' 0 C--N 1.361 1.086 0 O-C-N 121.87 -0.518 . . . . 0.0 110.81 -178.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 85.0 tttt 73.16 75.95 0.14 Allowed 'General case' 0 C--N 1.36 1.024 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -178.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -141.42 -171.34 3.28 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -148.34 92.65 2.05 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -113.86 158.41 21.09 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 93.3 m -119.9 127.85 53.09 Favored 'General case' 0 C--N 1.355 0.82 0 C-N-CA 119.404 -0.919 . . . . 0.0 108.974 -178.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.498 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.7 mp -105.86 122.82 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 178.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.4 m -116.67 -172.46 2.2 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 121.822 0.82 . . . . 0.0 109.116 -178.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -146.46 155.67 42.72 Favored 'General case' 0 C--N 1.354 0.792 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -178.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 41.7 p -98.68 146.3 31.38 Favored Pre-proline 0 C--N 1.359 0.999 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.689 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 72.6 Cg_endo -76.35 -11.87 19.01 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 123.044 2.496 . . . . 0.0 115.148 -178.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -72.66 -41.07 65.82 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 120.056 -0.657 . . . . 0.0 109.551 -178.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 35.8 p -117.72 15.23 14.47 Favored 'General case' 0 C--N 1.354 0.802 0 C-N-CA 120.129 -0.628 . . . . 0.0 110.48 -178.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.689 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.3 pp0? -67.11 -11.85 58.36 Favored 'General case' 0 C--N 1.354 0.802 0 O-C-N 121.576 -0.703 . . . . 0.0 110.193 178.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -127.0 42.29 3.35 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 15.4 t -142.96 145.4 32.96 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.635 ' O ' ' HB ' ' A' ' 171' ' ' THR . 61.5 mt-10 -98.86 165.0 11.98 Favored 'General case' 0 C--N 1.353 0.751 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.635 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 11.9 m 83.71 -59.12 0.13 Allowed 'General case' 0 C--N 1.37 1.483 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -107.35 117.46 34.13 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 119.889 -0.724 . . . . 0.0 109.654 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 90.4 t -131.85 134.15 60.37 Favored 'Isoleucine or valine' 0 C--N 1.357 0.914 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 178.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 49.2 mm -113.4 126.97 70.92 Favored 'Isoleucine or valine' 0 C--N 1.359 0.987 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.57 ' HB2' ' HG ' ' A' ' 131' ' ' LEU . 97.1 m-85 -116.62 147.13 42.18 Favored 'General case' 0 C--N 1.361 1.081 0 CA-C-O 122.008 0.909 . . . . 0.0 108.778 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -125.68 119.37 27.82 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 51.0 mt -114.67 115.87 50.84 Favored 'Isoleucine or valine' 0 C--N 1.354 0.801 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 -179.177 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 88.4 m -127.55 140.5 52.08 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -178.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -84.3 127.58 34.06 Favored 'General case' 0 C--N 1.366 1.307 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.19 152.52 84.24 Favored Pre-proline 0 C--N 1.358 0.974 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 178.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -50.49 131.12 31.63 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 122.88 2.386 . . . . 0.0 114.023 -178.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.412 ' HD2' HH11 ' A' ' 182' ' ' ARG . 0.6 OUTLIER -125.02 161.94 25.62 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 -179.932 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 101.48 -146.43 17.24 Favored Glycine 0 N--CA 1.437 -1.269 0 N-CA-C 108.439 -1.864 . . . . 0.0 108.439 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -116.82 24.75 11.03 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 68.01 57.14 0.51 Allowed 'General case' 0 C--N 1.36 1.028 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -98.08 119.8 37.36 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 71.6 mt -111.93 -68.45 0.93 Allowed 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -145.13 -87.92 0.11 Allowed 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -127.98 147.81 50.5 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 . . . . . 0 C--O 1.265 1.886 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -179.99 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 201' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 202' ' ' HEM . . . . . 1.386 ' C3B' HD11 ' A' ' 99' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.777 ' HG3' ' CMD' ' A' ' 202' ' ' HEM . 44.9 mtp . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.096 0.474 . . . . 0.0 110.079 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.49 ' HA ' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -79.28 -17.28 54.98 Favored 'General case' 0 C--N 1.354 0.796 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.016 -178.365 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.83 -42.06 32.02 Favored Glycine 0 C--N 1.348 1.245 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.3 tpp -70.73 -37.92 73.52 Favored 'General case' 0 C--N 1.354 0.797 0 O-C-N 122.103 -0.645 . . . . 0.0 110.808 -177.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.49 HG22 ' HA ' ' A' ' 2' ' ' MET . 27.2 m -69.87 -23.16 25.33 Favored 'Isoleucine or valine' 0 C--N 1.357 0.914 0 O-C-N 121.614 -0.679 . . . . 0.0 109.723 -179.081 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.434 ' HZ ' ' CG ' ' A' ' 47' ' ' GLU . 1.5 m-85 -71.22 -34.78 71.13 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.474 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 88.3 m -67.03 -40.29 87.19 Favored 'General case' 0 C--N 1.354 0.795 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.04 -39.21 97.76 Favored Glycine 0 C--N 1.359 1.825 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.566 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -64.7 -40.02 94.66 Favored 'General case' 0 C--N 1.352 0.703 0 O-C-N 122.54 -0.388 . . . . 0.0 110.695 -178.333 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 24.6 mmt -64.18 -40.52 96.29 Favored 'General case' 0 C--N 1.353 0.739 0 O-C-N 121.672 -0.642 . . . . 0.0 111.046 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -65.53 -40.32 92.77 Favored 'General case' 0 C--N 1.349 0.552 0 O-C-N 121.991 -0.443 . . . . 0.0 111.516 -178.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 56.0 tp -66.14 -43.62 86.53 Favored 'General case' 0 C--N 1.348 0.542 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -178.09 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.566 HG12 ' O ' ' A' ' 9' ' ' LEU . 2.4 mm -72.84 -37.28 54.32 Favored 'Isoleucine or valine' 0 C--N 1.361 1.071 0 O-C-N 121.155 -0.966 . . . . 0.0 110.975 -175.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.423 ' HB2' HD13 ' A' ' 22' ' ' LEU . 71.2 tt0 -71.13 -41.49 70.44 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.864 -0.522 . . . . 0.0 111.609 -175.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -72.59 -35.47 67.92 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -175.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -94.54 -30.27 14.47 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 118.901 -1.12 . . . . 0.0 113.966 -174.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -116.04 -30.97 5.87 Favored 'General case' 0 CA--C 1.506 -0.712 0 C-N-CA 117.538 -1.665 . . . . 0.0 112.728 -176.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 139.87 177.71 16.05 Favored Glycine 0 C--N 1.346 1.113 0 C-N-CA 118.346 -1.883 . . . . 0.0 109.523 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -99.11 -18.35 17.75 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -177.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -70.44 -39.59 74.26 Favored 'General case' 0 C--N 1.36 1.049 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 94.3 m -67.92 -39.19 83.55 Favored 'General case' 0 C--N 1.357 0.899 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.423 HD13 ' HB2' ' A' ' 14' ' ' GLU . 1.0 OUTLIER -60.71 -38.16 84.09 Favored 'General case' 0 C--N 1.355 0.847 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.518 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -63.78 -37.17 86.38 Favored 'General case' 0 C--N 1.357 0.916 0 O-C-N 122.154 -0.341 . . . . 0.0 110.787 -178.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.4 m -64.91 -40.49 95.15 Favored 'General case' 0 C--N 1.356 0.884 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -178.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.596 ' CD2' ' HB3' ' A' ' 54' ' ' LYS . 31.4 mt -63.84 -36.75 84.93 Favored 'General case' 0 C--N 1.359 0.982 0 O-C-N 121.946 -0.471 . . . . 0.0 109.957 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.5 mt -71.49 -16.03 62.34 Favored 'General case' 0 C--N 1.358 0.971 0 O-C-N 121.661 -0.65 . . . . 0.0 110.184 -178.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -86.46 -27.73 23.92 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 119.351 -0.939 . . . . 0.0 109.278 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 41.7 t -67.01 -37.1 83.57 Favored 'General case' 0 C--N 1.355 0.845 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.8 p -93.02 -39.0 11.34 Favored 'General case' 0 C--N 1.359 0.988 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -179.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 84.12 133.25 0.05 OUTLIER 'General case' 0 C--N 1.361 1.104 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 179.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.524 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -91.44 -167.05 1.7 Allowed 'General case' 0 C--N 1.357 0.919 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.636 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.414 ' H ' ' HB2' ' A' ' 31' ' ' LEU . 63.3 tt0 -152.99 -66.76 0.16 Allowed 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.7 t -97.57 -66.55 0.89 Allowed 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -130.35 -44.76 1.12 Allowed 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -179.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.21 -33.72 5.42 Favored Glycine 0 C--N 1.353 1.474 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 179.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 83.8 mt -117.22 107.51 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.01 0 CA-C-N 118.413 1.107 . . . . 0.0 108.073 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.503 ' HD1' ' HA ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -84.08 -147.78 0.1 Allowed 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.185 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.524 HG23 ' N ' ' A' ' 39' ' ' SER . 5.0 t -119.46 -53.56 2.22 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.524 ' N ' HG23 ' A' ' 38' ' ' THR . 23.8 p 170.05 65.33 0.0 OUTLIER 'General case' 0 C--N 1.362 1.138 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.5 t -145.49 -11.24 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.957 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.149 -178.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -91.62 142.08 15.93 Favored Glycine 0 C--N 1.352 1.446 0 C-N-CA 119.275 -1.44 . . . . 0.0 110.538 -177.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.1 m -123.61 123.12 39.86 Favored 'General case' 0 C--N 1.354 0.767 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -117.5 175.4 5.65 Favored 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -81.86 -172.49 3.94 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 68.9 m80 -90.64 -15.09 31.07 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.102 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -68.74 -29.39 67.79 Favored 'General case' 0 C--N 1.352 0.678 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.434 ' CG ' ' HZ ' ' A' ' 6' ' ' PHE . 26.5 tp10 -64.38 -39.81 94.59 Favored 'General case' 0 C--N 1.353 0.722 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.419 HD22 ' O ' ' A' ' 48' ' ' LEU . 1.8 tm? -66.66 -38.56 87.11 Favored 'General case' 0 C--N 1.36 1.03 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 61.9 tp -70.32 -35.06 73.4 Favored 'General case' 0 CA--C 1.508 -0.667 0 O-C-N 122.232 -0.292 . . . . 0.0 110.47 -177.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -64.67 -41.2 96.24 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 121.936 -0.478 . . . . 0.0 109.914 -177.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 80.7 mt -83.55 -18.1 39.53 Favored 'General case' 0 C--N 1.359 1.001 0 C-N-CA 119.625 -0.83 . . . . 0.0 110.601 -179.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.4 t -80.33 -38.84 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.0 p -71.76 -30.55 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 O-C-N 121.597 -0.689 . . . . 0.0 109.406 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.596 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 33.5 tptt -70.97 -28.39 64.42 Favored 'General case' 0 C--N 1.368 1.373 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.539 HD13 HD11 ' A' ' 66' ' ' LEU . 1.1 mt -63.85 -42.02 97.66 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 46.7 t -66.21 -39.94 89.98 Favored 'General case' 0 C--N 1.352 0.707 0 O-C-N 121.736 -0.602 . . . . 0.0 110.648 -179.27 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -77.64 -40.31 42.21 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 121.123 -0.985 . . . . 0.0 112.876 -177.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.0 p -75.29 -39.88 42.62 Favored 'Isoleucine or valine' 0 C--N 1.354 0.771 0 O-C-N 121.531 -0.731 . . . . 0.0 112.348 -175.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 63.4 m -105.69 -9.25 17.41 Favored 'General case' 0 CA--C 1.503 -0.845 0 O-C-N 121.173 -0.954 . . . . 0.0 110.316 -177.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.417 ' HA ' ' O ' ' A' ' 56' ' ' SER . 0.4 OUTLIER 68.03 38.16 2.8 Favored 'General case' 0 C--N 1.351 0.656 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.881 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 56' ' ' SER . 58.2 t -115.37 128.05 26.28 Favored Pre-proline 0 N--CA 1.443 -0.81 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 61' ' ' VAL . 37.2 Cg_exo -59.86 154.02 52.9 Favored 'Trans proline' 0 CA--C 1.496 -1.376 0 C-N-CA 122.72 2.28 . . . . 0.0 113.519 -179.029 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.3 m -76.43 -7.71 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.66 -177.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.497 ' O ' HG12 ' A' ' 67' ' ' VAL . 81.4 p -94.71 -36.4 11.75 Favored 'General case' 0 C--N 1.358 0.944 0 C-N-CA 118.315 -1.354 . . . . 0.0 110.113 -178.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -82.48 -23.42 34.72 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.539 HD11 HD13 ' A' ' 55' ' ' LEU . 0.5 OUTLIER -70.29 -43.36 70.57 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.609 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.497 HG12 ' O ' ' A' ' 64' ' ' THR . 4.6 p -67.47 -28.89 43.67 Favored 'Isoleucine or valine' 0 C--N 1.354 0.803 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.678 -179.246 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -65.96 -47.92 73.02 Favored 'General case' 0 C--N 1.366 1.286 0 O-C-N 121.067 -1.021 . . . . 0.0 110.242 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 88.6 mt -64.53 -36.33 83.85 Favored 'General case' 0 C--N 1.353 0.739 0 O-C-N 122.353 -0.217 . . . . 0.0 111.191 -178.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -60.84 -47.4 86.53 Favored 'General case' 0 C--N 1.349 0.582 0 O-C-N 122.115 -0.365 . . . . 0.0 110.44 -178.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.03 -39.24 96.8 Favored Glycine 0 C--N 1.353 1.524 0 N-CA-C 111.882 -0.487 . . . . 0.0 111.882 -178.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.38 -47.86 80.28 Favored 'General case' 0 C--N 1.351 0.656 0 CA-C-N 118.127 0.963 . . . . 0.0 111.615 -177.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.4 mttm -64.38 -49.02 73.26 Favored 'General case' 0 C--N 1.357 0.925 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -177.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.418 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.5 tm? -69.11 -39.8 78.74 Favored 'General case' 0 C--N 1.349 0.566 0 O-C-N 121.194 -0.941 . . . . 0.0 111.865 -175.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -64.16 -45.97 86.1 Favored 'General case' 0 C--N 1.353 0.744 0 O-C-N 121.269 -0.895 . . . . 0.0 111.123 -177.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.11 -12.38 15.79 Favored 'Isoleucine or valine' 0 C--N 1.358 0.941 0 O-C-N 121.586 -0.696 . . . . 0.0 109.463 -179.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -78.52 -36.79 44.39 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 80.2 mt -70.57 -34.61 72.39 Favored 'General case' 0 C--N 1.358 0.94 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.3 mm -62.77 -50.37 79.99 Favored 'Isoleucine or valine' 0 C--N 1.357 0.904 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -178.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -67.89 -22.3 65.1 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.414 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.83 -1.18 61.8 Favored Glycine 0 C--N 1.347 1.19 0 C-N-CA 119.609 -1.281 . . . . 0.0 110.684 -177.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.637 ' HB3' ' HB ' ' A' ' 85' ' ' ILE . 93.2 m-70 -141.21 88.6 10.0 Favored Pre-proline 0 CA--C 1.503 -0.859 0 CA-C-N 118.937 1.368 . . . . 0.0 108.962 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 82' ' ' HIS . 36.8 Cg_endo -67.52 -25.79 40.84 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.425 2.083 . . . . 0.0 114.194 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -92.75 -6.14 49.69 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.637 ' HB ' ' HB3' ' A' ' 82' ' ' HIS . 1.0 OUTLIER -90.44 -22.3 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 -178.81 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -102.05 -21.4 14.46 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -69.85 -39.15 76.56 Favored 'General case' 0 C--N 1.355 0.827 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -65.48 -33.75 76.67 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.636 ' HG2' ' N ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -80.28 155.43 27.29 Favored 'General case' 0 C--N 1.353 0.749 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 -178.908 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.636 ' N ' ' HG2' ' A' ' 89' ' ' MET . 3.4 mtpt -117.15 -27.71 6.41 Favored 'General case' 0 C--N 1.364 1.207 0 C-N-CA 120.058 -0.657 . . . . 0.0 111.319 -177.248 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -167.08 175.47 7.51 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 -177.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 65.1 m -66.62 -40.09 88.63 Favored 'General case' 0 C--N 1.354 0.763 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.415 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -68.03 -39.61 83.09 Favored 'General case' 0 C--N 1.356 0.882 0 C-N-CA 119.587 -0.845 . . . . 0.0 108.805 -178.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -66.57 -23.03 66.15 Favored 'General case' 0 C--N 1.354 0.779 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.4 HD22 ' SG ' ' A' ' 150' ' ' CYS . 60.1 tp -65.25 -45.52 84.26 Favored 'General case' 0 C--N 1.354 0.797 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.5 mp -61.83 -36.5 81.36 Favored 'General case' 0 C--N 1.357 0.901 0 O-C-N 121.993 -0.442 . . . . 0.0 110.165 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 34.0 t -67.49 -39.83 85.2 Favored 'General case' 0 C--N 1.349 0.561 0 O-C-N 121.927 -0.483 . . . . 0.0 110.211 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.4 tttp -93.01 6.37 48.18 Favored 'General case' 0 C--N 1.353 0.76 0 O-C-N 122.241 -0.287 . . . . 0.0 111.567 -176.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 1.276 HD11 ' C3B' ' A' ' 202' ' ' HEM . 9.9 tp -64.4 -38.74 83.36 Favored 'Isoleucine or valine' 0 C--N 1.356 0.859 0 O-C-N 121.391 -0.818 . . . . 0.0 111.671 -177.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -103.44 -21.69 13.76 Favored 'General case' 0 N--CA 1.437 -1.116 0 O-C-N 120.884 -1.135 . . . . 0.0 110.26 -178.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 35.2 t -62.98 -47.0 85.04 Favored 'General case' 0 N--CA 1.445 -0.687 0 O-C-N 121.564 -0.71 . . . . 0.0 111.691 -178.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -137.5 -14.49 1.47 Allowed 'General case' 0 C--N 1.36 1.057 0 C-N-CA 117.369 -1.732 . . . . 0.0 113.036 -177.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.582 HG21 ' C1C' ' A' ' 202' ' ' HEM . 32.3 mm -70.41 -51.37 38.52 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 CA-C-N 120.099 1.318 . . . . 0.0 110.633 -177.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 35.5 m170 -91.9 2.32 56.61 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 119.485 -0.886 . . . . 0.0 110.301 -177.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 52.7 t -83.26 -44.22 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.032 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -68.34 -40.56 81.52 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 69.9 t -63.45 -46.77 94.35 Favored 'Isoleucine or valine' 0 C--N 1.357 0.901 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.363 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -60.75 -48.59 81.09 Favored 'General case' 0 C--N 1.357 0.926 0 O-C-N 122.064 -0.397 . . . . 0.0 111.409 -179.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -61.6 -37.21 83.07 Favored 'General case' 0 C--N 1.356 0.86 0 O-C-N 121.495 -0.753 . . . . 0.0 110.538 -178.274 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.5 mt -56.98 -73.9 0.06 Allowed 'General case' 0 C--N 1.357 0.9 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -119.13 135.47 23.9 Favored Pre-proline 0 N--CA 1.438 -1.047 0 C-N-CA 118.475 -1.29 . . . . 0.0 109.032 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -83.51 -4.61 10.87 Favored 'Trans proline' 0 C--N 1.313 -1.342 0 C-N-CA 123.174 2.583 . . . . 0.0 115.175 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -66.6 -36.84 83.58 Favored 'General case' 0 C--N 1.354 0.79 0 O-C-N 121.88 -0.512 . . . . 0.0 109.842 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.1 145.65 55.09 Favored 'General case' 0 C--N 1.354 0.764 0 CA-C-O 121.554 0.692 . . . . 0.0 109.787 -178.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -130.45 135.44 47.99 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.54 ' HB3' ' HD2' ' A' ' 117' ' ' PRO . 86.4 mt -127.68 157.18 74.09 Favored Pre-proline 0 N--CA 1.443 -0.823 0 CA-C-O 122.173 0.987 . . . . 0.0 109.196 -178.389 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.54 ' HD2' ' HB3' ' A' ' 116' ' ' LEU . 83.6 Cg_endo -81.02 -156.36 0.07 OUTLIER 'Trans proline' 0 C--N 1.316 -1.139 0 C-N-CA 123.797 2.998 . . . . 0.0 114.115 -179.265 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -113.38 140.26 48.2 Favored 'General case' 0 C--N 1.364 1.207 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -123.67 127.02 47.59 Favored 'General case' 0 C--N 1.362 1.144 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -179.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.479 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 94.2 m -126.26 128.98 48.01 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 177.226 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 81.0 m -119.83 130.73 55.03 Favored 'General case' 0 CA--C 1.503 -0.851 0 C-N-CA 119.105 -1.038 . . . . 0.0 109.677 -177.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -119.14 127.13 53.05 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 178.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 66.2 ttp85 -102.18 116.69 33.2 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 92.8 mt -87.42 -21.61 25.49 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.378 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 177.68 -146.59 7.69 Favored Glycine 0 N--CA 1.438 -1.226 0 C-N-CA 118.844 -1.645 . . . . 0.0 109.103 -178.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -94.72 -40.05 9.98 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 120.081 -0.648 . . . . 0.0 109.411 -178.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -101.53 1.45 38.02 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.24 -178.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -119.01 130.43 55.66 Favored 'General case' 0 C--N 1.358 0.968 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 7.6 mm -141.13 136.77 33.68 Favored 'Isoleucine or valine' 0 C--N 1.356 0.861 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 55.6 mtm180 -122.57 139.14 54.24 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.655 ' HG ' ' O ' ' A' ' 131' ' ' LEU . 0.1 OUTLIER -130.16 125.68 35.63 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.078 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.479 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 13.5 m-70 -96.77 134.56 39.89 Favored 'General case' 0 CA--C 1.495 -1.165 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -127.87 119.9 26.59 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 -178.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.534 ' HA ' ' O ' ' A' ' 171' ' ' THR . 76.6 mt-30 -113.51 114.74 26.94 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 179.07 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 12.7 t -162.73 152.55 15.92 Favored 'General case' 0 C--N 1.358 0.96 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -90.62 2.71 55.62 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 120.271 -0.572 . . . . 0.0 109.652 -179.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -136.11 74.54 55.86 Favored Pre-proline 0 CA--C 1.505 -0.752 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -95.88 107.78 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.771 2.314 . . . . 0.0 115.776 -177.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -111.94 113.6 26.02 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 176.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.98 -38.28 90.49 Favored 'General case' 0 C--N 1.353 0.73 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.007 -179.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.0 m -63.27 -27.34 69.27 Favored 'General case' 0 C--N 1.354 0.773 0 O-C-N 122.009 -0.432 . . . . 0.0 110.875 -178.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -76.63 -46.43 25.96 Favored 'General case' 0 C--N 1.351 0.652 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.639 -178.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.63 -40.11 94.9 Favored 'General case' 0 C--N 1.357 0.923 0 O-C-N 122.039 -0.413 . . . . 0.0 111.056 -178.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.64 -37.25 86.61 Favored 'General case' 0 C--N 1.355 0.83 0 O-C-N 121.907 -0.496 . . . . 0.0 110.081 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -59.88 -43.16 98.28 Favored Glycine 0 C--N 1.347 1.176 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 83.5 mt -69.78 -40.78 75.83 Favored 'General case' 0 C--N 1.352 0.694 0 CA-C-N 117.749 0.774 . . . . 0.0 112.503 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 98.0 mt -71.29 -42.41 68.73 Favored 'General case' 0 C--N 1.361 1.083 0 O-C-N 121.206 -0.934 . . . . 0.0 110.961 -176.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.496 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 37.0 t70 -69.93 -31.36 69.08 Favored 'General case' 0 N--CA 1.446 -0.652 0 O-C-N 121.956 -0.465 . . . . 0.0 110.514 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -62.84 -39.38 97.92 Favored Glycine 0 C--N 1.357 1.745 0 N-CA-C 108.46 -1.856 . . . . 0.0 108.46 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' CYS . . . . . 0.4 ' SG ' HD22 ' A' ' 95' ' ' LEU . 49.9 t -60.71 -41.46 95.29 Favored 'General case' 0 C--N 1.35 0.6 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -74.8 -1.48 22.33 Favored 'General case' 0 C--N 1.361 1.077 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 77.7 mm-40 -84.4 -46.07 12.08 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.195 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 92.9 t80 -65.95 -45.06 83.16 Favored 'General case' 0 C--N 1.359 0.989 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.416 ' HZ ' ' SD ' ' A' ' 89' ' ' MET . 38.9 m-85 -69.01 -26.62 65.09 Favored 'General case' 0 C--N 1.36 1.053 0 O-C-N 121.874 -0.516 . . . . 0.0 110.802 -178.473 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 78.9 tttt 72.72 74.35 0.15 Allowed 'General case' 0 C--N 1.36 1.035 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -143.13 -168.12 2.72 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -148.67 94.45 2.28 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -111.88 156.11 22.56 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 178.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 93.9 m -119.47 127.1 52.74 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 119.208 -0.997 . . . . 0.0 108.716 -178.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.497 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.7 mp -103.89 122.2 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 178.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.5 m -115.64 -175.96 2.83 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-O 121.826 0.822 . . . . 0.0 109.134 -179.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 3.5 ptt180 -146.75 153.63 40.46 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 -178.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 44.8 p -97.62 145.93 30.55 Favored Pre-proline 0 C--N 1.361 1.08 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.623 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 76.8 Cg_endo -77.13 -11.24 17.79 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.944 2.429 . . . . 0.0 115.127 -178.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -72.74 -41.29 65.32 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.573 -178.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 36.8 p -116.96 15.3 15.16 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.299 -178.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.623 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.5 pp0? -65.13 -13.65 58.63 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.408 178.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -126.89 43.18 3.17 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 16.8 t -142.57 145.13 33.27 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.631 ' O ' ' HB ' ' A' ' 171' ' ' THR . 61.1 mt-10 -98.98 165.49 11.73 Favored 'General case' 0 C--N 1.354 0.804 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.152 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.631 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 3.0 m 83.42 -57.13 0.15 Allowed 'General case' 0 C--N 1.369 1.423 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.637 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -110.93 117.44 33.38 Favored 'General case' 0 CA--C 1.506 -0.72 0 C-N-CA 119.814 -0.754 . . . . 0.0 109.603 -178.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 98.7 t -131.33 133.39 62.27 Favored 'Isoleucine or valine' 0 C--N 1.356 0.857 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 178.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 48.6 mm -109.36 125.99 66.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.964 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -179.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -115.08 148.38 39.0 Favored 'General case' 0 C--N 1.357 0.922 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -128.58 117.4 21.19 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 -179.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.8 mp -111.94 118.38 57.51 Favored 'Isoleucine or valine' 0 C--N 1.354 0.765 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 89.3 m -124.3 142.84 50.94 Favored 'General case' 0 CA--C 1.502 -0.893 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -177.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 12.2 ttt180 -91.01 113.48 25.75 Favored 'General case' 0 C--N 1.363 1.153 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 178.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -71.55 150.6 93.7 Favored Pre-proline 0 CA--C 1.498 -1.029 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.79 120.96 8.98 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.227 1.951 . . . . 0.0 112.861 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 3.9 ppt_? -135.99 146.48 47.25 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.406 ' O ' ' HB3' ' A' ' 184' ' ' ALA . . . 91.48 78.25 1.37 Allowed Glycine 0 C--N 1.352 1.428 0 N-CA-C 107.839 -2.104 . . . . 0.0 107.839 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' A' ' 183' ' ' GLY . . . 70.77 73.29 0.2 Allowed 'General case' 0 C--N 1.36 1.025 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -58.62 140.94 53.69 Favored 'General case' 0 C--N 1.357 0.922 0 CA-C-O 121.75 0.786 . . . . 0.0 110.076 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -126.39 131.43 51.76 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 50.1 tp -92.26 -65.71 0.98 Allowed 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -156.13 -85.25 0.05 Allowed 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -126.65 146.35 50.22 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 . . . . . 0 C--O 1.263 1.815 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -179.855 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 201' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 202' ' ' HEM . . . . . 1.276 ' C3B' HD11 ' A' ' 99' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.692 ' HG2' ' HB2' ' A' ' 4' ' ' MET . 27.2 tpp . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 120.881 0.372 . . . . 0.0 110.538 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.34 -20.14 41.29 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -77.86 -37.68 29.08 Favored Glycine 0 C--N 1.35 1.331 0 N-CA-C 109.101 -1.599 . . . . 0.0 109.101 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.692 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 3.0 tpp -70.84 -38.21 73.18 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 122.035 -0.685 . . . . 0.0 110.707 -177.385 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.2 m -71.28 -23.14 22.82 Favored 'Isoleucine or valine' 0 C--N 1.357 0.93 0 O-C-N 121.651 -0.656 . . . . 0.0 109.415 -178.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.0 m-30 -71.06 -33.38 70.22 Favored 'General case' 0 C--N 1.357 0.893 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.1 m -67.14 -40.17 86.68 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.93 -38.82 97.22 Favored Glycine 0 C--N 1.36 1.893 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.506 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.1 OUTLIER -66.13 -39.11 89.62 Favored 'General case' 0 C--N 1.353 0.736 0 CA-C-N 117.274 0.537 . . . . 0.0 110.31 -177.952 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.443 ' CE ' HD21 ' A' ' 26' ' ' LEU . 25.5 mmt -64.02 -40.6 96.71 Favored 'General case' 0 C--N 1.355 0.822 0 O-C-N 121.635 -0.666 . . . . 0.0 110.753 -178.606 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -64.77 -40.07 94.66 Favored 'General case' 0 C--N 1.349 0.547 0 O-C-N 122.055 -0.403 . . . . 0.0 111.307 -178.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 58.2 tp -65.0 -42.68 94.26 Favored 'General case' 0 C--N 1.35 0.592 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.659 HD12 HD21 ' A' ' 55' ' ' LEU . 3.3 mm -72.44 -37.58 57.99 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 O-C-N 121.169 -0.957 . . . . 0.0 111.179 -175.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -68.02 -43.75 78.05 Favored 'General case' 0 C--N 1.352 0.679 0 O-C-N 121.821 -0.549 . . . . 0.0 111.653 -175.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -71.9 -32.45 67.42 Favored 'General case' 0 N--CA 1.447 -0.579 0 O-C-N 122.001 -0.437 . . . . 0.0 111.487 -177.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -72.5 -49.96 29.32 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -175.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -127.98 -20.97 3.73 Favored 'General case' 0 C--N 1.357 0.917 0 C-N-CA 117.347 -1.741 . . . . 0.0 113.694 -176.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 143.42 178.88 19.61 Favored Glycine 0 CA--C 1.499 -0.947 0 C-N-CA 117.678 -2.201 . . . . 0.0 110.23 -179.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -96.5 -11.34 25.65 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -177.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -74.64 -36.57 62.88 Favored 'General case' 0 C--N 1.359 0.986 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.2 m -70.11 -38.91 75.74 Favored 'General case' 0 C--N 1.358 0.952 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 178.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.7 tt -59.84 -38.09 81.09 Favored 'General case' 0 C--N 1.359 0.994 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -64.12 -37.09 86.19 Favored 'General case' 0 C--N 1.356 0.87 0 O-C-N 122.097 -0.377 . . . . 0.0 110.788 -178.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.5 m -65.25 -40.63 94.24 Favored 'General case' 0 C--N 1.355 0.836 0 O-C-N 121.698 -0.626 . . . . 0.0 109.62 -178.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.41 HD22 ' HB3' ' A' ' 54' ' ' LYS . 78.7 mt -64.9 -36.82 85.6 Favored 'General case' 0 C--N 1.356 0.868 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 -178.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.443 HD21 ' CE ' ' A' ' 10' ' ' MET . 81.1 mt -70.84 -16.5 62.72 Favored 'General case' 0 C--N 1.36 1.048 0 O-C-N 121.765 -0.584 . . . . 0.0 110.235 -179.22 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -85.07 -27.83 26.06 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.29 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.2 t -66.89 -37.54 84.59 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.8 p -91.61 -39.54 11.82 Favored 'General case' 0 C--N 1.359 0.995 0 C-N-CA 119.064 -1.054 . . . . 0.0 108.18 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 86.15 132.45 0.04 OUTLIER 'General case' 0 C--N 1.36 1.049 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.532 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -91.91 -167.07 1.69 Allowed 'General case' 0 C--N 1.356 0.885 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.841 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.416 ' H ' ' HB2' ' A' ' 31' ' ' LEU . 4.3 mt-30 -153.05 -66.3 0.15 Allowed 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 106.816 -1.549 . . . . 0.0 106.816 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.0 t -97.71 -67.12 0.86 Allowed 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -131.42 -46.53 0.98 Allowed 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.24 -37.37 3.51 Favored Glycine 0 C--N 1.354 1.566 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 179.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 81.9 mt -113.62 106.09 20.02 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.041 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.523 ' HD1' ' HA ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -82.57 -150.78 0.09 Allowed 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.496 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.409 ' H ' ' HB3' ' A' ' 37' ' ' TYR . 86.2 m -112.09 -57.84 2.21 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 11.6 p 169.06 69.8 0.0 OUTLIER 'General case' 0 C--N 1.36 1.029 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.2 t -150.29 -6.69 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.361 1.081 0 C-N-CA 119.707 -0.797 . . . . 0.0 110.047 -178.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -95.26 143.08 16.42 Favored Glycine 0 C--N 1.352 1.447 0 C-N-CA 119.28 -1.438 . . . . 0.0 110.465 -177.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.0 m -123.94 116.77 23.42 Favored 'General case' 0 C--N 1.356 0.871 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 178.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -111.66 177.42 4.66 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -78.66 -175.14 4.23 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 65.4 m80 -94.38 -15.6 24.2 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 119.781 -0.767 . . . . 0.0 109.179 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -68.88 -29.22 67.47 Favored 'General case' 0 C--N 1.353 0.749 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.6 tp10 -62.72 -41.51 99.19 Favored 'General case' 0 C--N 1.353 0.719 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.406 ' O ' HG23 ' A' ' 52' ' ' VAL . 59.9 tp -67.62 -38.74 84.36 Favored 'General case' 0 C--N 1.357 0.893 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.218 -179.181 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 60.5 tp -72.3 -34.69 68.32 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 122.259 -0.276 . . . . 0.0 110.689 -177.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 72.7 tp60 -64.18 -41.81 96.95 Favored 'General case' 0 C--N 1.353 0.721 0 O-C-N 121.589 -0.694 . . . . 0.0 110.004 -177.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 84.2 mt -71.79 -34.64 69.58 Favored 'General case' 0 C--N 1.362 1.113 0 C-N-CA 119.534 -0.867 . . . . 0.0 109.431 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.565 HG13 HD21 ' A' ' 66' ' ' LEU . 29.2 t -62.65 -42.12 94.82 Favored 'Isoleucine or valine' 0 C--N 1.351 0.645 0 CA-C-O 120.705 0.288 . . . . 0.0 110.309 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 53.9 t -65.76 -40.21 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.41 ' HB3' HD22 ' A' ' 25' ' ' LEU . 32.1 tptt -65.22 -29.2 69.98 Favored 'General case' 0 C--N 1.361 1.107 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.659 HD21 HD12 ' A' ' 13' ' ' ILE . 16.0 mt -64.27 -40.26 95.6 Favored 'General case' 0 C--N 1.357 0.902 0 O-C-N 121.968 -0.457 . . . . 0.0 110.395 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.611 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 46.5 t -65.39 -37.44 87.0 Favored 'General case' 0 C--N 1.349 0.573 0 O-C-N 121.775 -0.578 . . . . 0.0 110.324 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -83.74 -38.25 21.61 Favored 'General case' 0 C--N 1.353 0.73 0 O-C-N 121.242 -0.911 . . . . 0.0 112.811 -177.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.6 p -76.03 -41.6 38.4 Favored 'Isoleucine or valine' 0 C--N 1.355 0.83 0 O-C-N 121.354 -0.841 . . . . 0.0 111.897 -176.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 72.8 m -103.66 -5.66 22.38 Favored 'General case' 0 C--N 1.354 0.803 0 O-C-N 121.198 -0.939 . . . . 0.0 110.486 -177.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 74.6 m 65.05 38.95 5.9 Favored 'General case' 0 C--N 1.354 0.769 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.611 ' O ' ' HA ' ' A' ' 56' ' ' SER . 55.4 t -115.53 132.22 23.23 Favored Pre-proline 0 CA--C 1.505 -0.778 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.474 ' HD2' HG13 ' A' ' 61' ' ' VAL . 31.2 Cg_endo -63.99 157.16 54.47 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.258 1.972 . . . . 0.0 114.095 -178.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.839 ' HA ' HD23 ' A' ' 66' ' ' LEU . 15.5 m -75.98 -12.66 14.62 Favored 'Isoleucine or valine' 0 C--N 1.353 0.742 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.031 -177.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.475 ' O ' HG12 ' A' ' 67' ' ' VAL . 81.1 p -94.13 -35.14 12.67 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 118.068 -1.453 . . . . 0.0 110.129 -178.323 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -80.9 -21.22 40.76 Favored 'General case' 0 C--N 1.353 0.737 0 O-C-N 121.167 -0.958 . . . . 0.0 108.892 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.839 HD23 ' HA ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -77.19 -36.67 54.78 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.732 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.515 ' N ' ' HG ' ' A' ' 66' ' ' LEU . 1.8 p -68.83 -28.9 41.59 Favored 'Isoleucine or valine' 0 C--N 1.359 0.981 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.055 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -68.49 -49.1 62.24 Favored 'General case' 0 C--N 1.365 1.265 0 O-C-N 121.234 -0.916 . . . . 0.0 110.656 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.9 mt -63.83 -36.41 83.81 Favored 'General case' 0 C--N 1.357 0.893 0 O-C-N 122.069 -0.395 . . . . 0.0 111.027 -178.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -61.16 -47.07 87.88 Favored 'General case' 0 C--N 1.348 0.536 0 O-C-N 122.134 -0.354 . . . . 0.0 110.495 -178.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.25 -39.29 96.99 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-O 119.787 -0.452 . . . . 0.0 112.17 -177.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -65.7 -45.45 82.75 Favored 'General case' 0 C--N 1.352 0.674 0 CA-C-N 118.513 1.157 . . . . 0.0 111.638 -177.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 12.2 mttm -64.86 -48.24 75.0 Favored 'General case' 0 C--N 1.357 0.921 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -177.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.406 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.2 tm? -70.76 -39.31 73.33 Favored 'General case' 0 C--N 1.349 0.563 0 O-C-N 121.263 -0.898 . . . . 0.0 111.963 -176.024 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -63.56 -46.45 85.85 Favored 'General case' 0 C--N 1.353 0.755 0 O-C-N 121.103 -0.998 . . . . 0.0 111.239 -178.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.8 p -70.89 -14.72 18.26 Favored 'Isoleucine or valine' 0 C--N 1.357 0.931 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -71.11 -39.76 71.88 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 87.7 mt -75.78 -27.19 57.93 Favored 'General case' 0 C--N 1.359 0.986 0 O-C-N 122.258 -0.276 . . . . 0.0 110.569 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.1 mm -65.78 -53.59 36.78 Favored 'Isoleucine or valine' 0 C--N 1.36 1.059 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.432 -178.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -75.26 -14.6 60.52 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 119.611 -0.836 . . . . 0.0 109.259 178.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.7 -37.58 61.47 Favored Glycine 0 C--N 1.35 1.345 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -132.55 102.9 13.69 Favored Pre-proline 0 C--N 1.356 0.887 0 CA-C-O 122.611 1.196 . . . . 0.0 109.104 -177.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.488 ' O ' ' HB2' ' A' ' 87' ' ' ASN . 40.3 Cg_endo -68.74 -22.23 37.49 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.556 2.17 . . . . 0.0 114.039 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -90.69 -9.56 46.36 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -89.84 -21.89 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.967 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 -178.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -102.66 -16.35 16.06 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASN . . . . . 0.488 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 49.2 t30 -70.99 -40.64 71.75 Favored 'General case' 0 C--N 1.36 1.028 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -67.7 -28.38 67.63 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 120.746 -0.381 . . . . 0.0 110.418 -179.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.681 ' SD ' ' HZ ' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -81.59 152.24 27.29 Favored 'General case' 0 C--N 1.352 0.696 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -179.488 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.594 ' N ' ' HG2' ' A' ' 89' ' ' MET . 4.6 mtpt -117.14 -26.76 6.69 Favored 'General case' 0 C--N 1.365 1.246 0 C-N-CA 120.054 -0.659 . . . . 0.0 111.293 -177.094 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -167.74 175.6 6.85 Favored 'General case' 0 C--N 1.354 0.797 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -177.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.417 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 42.2 t -64.75 -43.95 91.67 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.383 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -68.08 -39.54 82.9 Favored 'General case' 0 C--N 1.355 0.836 0 O-C-N 121.365 -0.834 . . . . 0.0 109.418 -178.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -66.23 -22.45 66.33 Favored 'General case' 0 C--N 1.353 0.757 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.417 ' HB3' ' O ' ' A' ' 92' ' ' SER . 60.3 tp -65.08 -46.03 82.85 Favored 'General case' 0 C--N 1.354 0.767 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.9 mp -62.96 -36.13 82.45 Favored 'General case' 0 C--N 1.355 0.839 0 O-C-N 122.2 -0.313 . . . . 0.0 110.744 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 35.9 t -65.09 -41.69 94.74 Favored 'General case' 0 C--N 1.349 0.582 0 O-C-N 121.849 -0.532 . . . . 0.0 111.555 -178.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.786 ' HG2' ' O ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -102.37 9.85 39.5 Favored 'General case' 0 C--N 1.358 0.946 0 O-C-N 121.676 -0.64 . . . . 0.0 110.327 -176.126 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 1.249 HD11 ' C3B' ' A' ' 202' ' ' HEM . 11.7 tt -63.1 -35.14 70.5 Favored 'Isoleucine or valine' 0 C--N 1.354 0.797 0 O-C-N 121.088 -1.008 . . . . 0.0 111.984 -176.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -111.28 -18.52 12.91 Favored 'General case' 0 N--CA 1.438 -1.054 0 O-C-N 120.814 -1.179 . . . . 0.0 109.99 -178.234 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 37.7 t -64.38 -46.9 81.35 Favored 'General case' 0 N--CA 1.443 -0.808 0 O-C-N 121.697 -0.627 . . . . 0.0 111.107 -178.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -130.15 -21.1 2.98 Favored 'General case' 0 C--N 1.359 0.986 0 C-N-CA 118.002 -1.479 . . . . 0.0 112.565 -177.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.661 HD12 ' HA ' ' A' ' 99' ' ' ILE . 96.1 mt -71.15 -49.5 48.25 Favored 'Isoleucine or valine' 0 C--O 1.242 0.693 0 O-C-N 120.771 -1.205 . . . . 0.0 110.976 -177.283 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 29.8 m170 -89.41 3.49 52.1 Favored 'General case' 0 N--CA 1.439 -0.982 0 O-C-N 121.111 -0.993 . . . . 0.0 109.996 -177.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.5 p -88.82 -34.26 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 178.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -72.11 -40.92 67.8 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 76.5 t -63.81 -46.54 94.1 Favored 'Isoleucine or valine' 0 C--N 1.356 0.861 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -60.6 -48.62 80.96 Favored 'General case' 0 C--N 1.359 1.015 0 O-C-N 122.226 -0.296 . . . . 0.0 111.447 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -60.97 -38.11 84.77 Favored 'General case' 0 C--N 1.356 0.857 0 O-C-N 121.567 -0.708 . . . . 0.0 110.651 -178.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 18.5 mt -57.66 -75.66 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -116.22 132.7 23.14 Favored Pre-proline 0 N--CA 1.438 -1.054 0 C-N-CA 118.708 -1.197 . . . . 0.0 108.857 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -83.04 -4.87 11.28 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 123.136 2.557 . . . . 0.0 115.003 -179.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -66.9 -36.76 83.01 Favored 'General case' 0 C--N 1.355 0.806 0 O-C-N 121.964 -0.46 . . . . 0.0 109.826 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.5 147.25 52.27 Favored 'General case' 0 C--N 1.352 0.69 0 CA-C-O 121.585 0.707 . . . . 0.0 109.849 -178.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -132.47 135.56 46.12 Favored 'General case' 0 C--N 1.357 0.898 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 179.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.517 ' HB3' ' HD2' ' A' ' 117' ' ' PRO . 2.7 mm? -124.12 156.45 66.28 Favored Pre-proline 0 C--N 1.354 0.789 0 CA-C-O 122.023 0.916 . . . . 0.0 108.649 -178.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.787 ' HD3' ' CBA' ' A' ' 202' ' ' HEM . 95.0 Cg_endo -79.23 -160.17 0.12 Allowed 'Trans proline' 0 C--N 1.318 -1.047 0 C-N-CA 123.554 2.836 . . . . 0.0 113.22 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -120.73 144.11 48.42 Favored 'General case' 0 C--N 1.364 1.201 0 C-N-CA 118.997 -1.081 . . . . 0.0 108.24 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.56 ' HE2' ' CD1' ' A' ' 133' ' ' TYR . 22.4 m-85 -129.13 137.77 51.4 Favored 'General case' 0 C--N 1.362 1.109 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.35 -178.739 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.401 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 93.8 m -123.87 129.49 51.08 Favored 'General case' 0 C--N 1.356 0.85 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 177.199 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 82.5 m -113.49 127.55 56.14 Favored 'General case' 0 CA--C 1.503 -0.846 0 C-N-CA 119.069 -1.052 . . . . 0.0 109.717 -177.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -120.24 118.9 31.68 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 178.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -96.23 117.85 31.6 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -178.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 92.8 mt -88.98 -20.07 24.91 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.303 -179.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -179.88 -150.08 8.93 Favored Glycine 0 C--N 1.349 1.303 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 -178.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -94.69 -36.06 11.9 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -178.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -103.34 0.12 30.93 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 120.176 -0.61 . . . . 0.0 109.969 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -116.69 134.03 55.3 Favored 'General case' 0 C--N 1.358 0.954 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.411 HD13 ' HA ' ' A' ' 129' ' ' ILE . 8.1 mm -144.85 137.95 22.1 Favored 'Isoleucine or valine' 0 C--N 1.357 0.923 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 26.1 mtm180 -125.42 135.83 52.78 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.726 HD23 HD11 ' A' ' 177' ' ' ILE . 0.2 OUTLIER -129.05 128.03 42.76 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.708 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.401 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 18.5 m170 -95.78 138.29 33.64 Favored 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.56 ' CD1' ' HE2' ' A' ' 119' ' ' PHE . 65.3 t80 -126.3 118.97 26.19 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 -178.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.484 ' HA ' ' O ' ' A' ' 171' ' ' THR . 27.5 tt0 -113.36 114.15 26.23 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 12.7 t -165.11 151.32 10.07 Favored 'General case' 0 C--N 1.358 0.962 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -91.12 4.31 52.51 Favored 'General case' 0 C--N 1.355 0.846 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.638 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' A' ' 137' ' ' ARG . 1.0 OUTLIER -135.68 72.69 62.75 Favored Pre-proline 0 C--N 1.355 0.847 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 179.053 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -96.47 108.23 0.1 Allowed 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 122.749 2.299 . . . . 0.0 115.924 -177.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -111.91 113.27 25.49 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 176.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.21 -38.6 91.8 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.101 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.1 m -63.43 -28.18 69.8 Favored 'General case' 0 C--N 1.353 0.726 0 O-C-N 121.967 -0.458 . . . . 0.0 110.903 -178.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -75.33 -45.94 36.39 Favored 'General case' 0 C--N 1.351 0.641 0 C-N-CA 120.156 -0.617 . . . . 0.0 109.552 -177.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.67 -39.79 91.71 Favored 'General case' 0 C--N 1.356 0.887 0 O-C-N 122.047 -0.408 . . . . 0.0 111.356 -177.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -62.99 -37.26 86.46 Favored 'General case' 0 C--N 1.355 0.843 0 O-C-N 121.78 -0.575 . . . . 0.0 110.057 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.59 -42.94 99.4 Favored Glycine 0 C--N 1.348 1.214 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 82.8 mt -69.54 -41.14 76.34 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 117.437 0.619 . . . . 0.0 112.596 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 97.0 mt -71.29 -42.04 69.18 Favored 'General case' 0 C--N 1.36 1.06 0 O-C-N 121.252 -0.905 . . . . 0.0 110.999 -177.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -69.88 -31.83 69.86 Favored 'General case' 0 C--N 1.349 0.555 0 O-C-N 121.994 -0.441 . . . . 0.0 110.597 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.532 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -62.59 -40.03 98.62 Favored Glycine 0 C--N 1.355 1.632 0 N-CA-C 108.674 -1.771 . . . . 0.0 108.674 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' CYS . . . . . 0.401 ' SG ' HD22 ' A' ' 95' ' ' LEU . 45.1 t -61.05 -42.67 98.91 Favored 'General case' 0 C--N 1.35 0.621 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.456 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.584 ' HB1' ' O ' ' A' ' 156' ' ' GLU . . . -76.05 1.79 14.54 Favored 'General case' 0 C--N 1.357 0.931 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.532 ' HB2' ' O ' ' A' ' 149' ' ' GLY . 7.6 mm-40 -86.57 -47.7 9.0 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -65.11 -45.19 86.14 Favored 'General case' 0 C--N 1.359 0.993 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.681 ' HZ ' ' SD ' ' A' ' 89' ' ' MET . 51.9 m-85 -69.25 -27.99 65.92 Favored 'General case' 0 C--N 1.362 1.132 0 O-C-N 121.897 -0.502 . . . . 0.0 111.013 -178.398 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 85.2 tttt 72.3 73.59 0.16 Allowed 'General case' 0 C--N 1.359 0.998 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -178.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.584 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 2.4 tp10 -156.34 119.21 4.14 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -82.39 106.84 14.6 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 120.086 -0.646 . . . . 0.0 111.069 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 11.9 m-30 -112.38 160.31 17.83 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 176.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 92.3 m -120.47 127.84 52.59 Favored 'General case' 0 CA--C 1.505 -0.772 0 C-N-CA 118.938 -1.105 . . . . 0.0 109.073 -178.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.48 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.9 mp -105.65 122.63 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 178.567 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.7 m -118.87 -171.93 2.19 Favored 'General case' 0 C--N 1.358 0.936 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -178.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -145.36 154.57 42.44 Favored 'General case' 0 C--N 1.356 0.851 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -178.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 28.7 p -96.27 144.84 28.53 Favored Pre-proline 0 C--N 1.36 1.054 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 178.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.702 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 72.9 Cg_endo -75.63 -12.83 20.29 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.79 2.326 . . . . 0.0 115.203 -178.512 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -72.91 -41.77 64.25 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.664 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 41.9 p -115.84 15.14 16.36 Favored 'General case' 0 C--N 1.355 0.807 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.391 -178.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.702 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.3 pp0? -66.6 -12.64 58.9 Favored 'General case' 0 C--N 1.355 0.834 0 O-C-N 121.59 -0.694 . . . . 0.0 110.454 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -128.08 42.53 3.3 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 19.1 t -143.17 145.03 32.44 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.633 ' O ' ' HB ' ' A' ' 171' ' ' THR . 61.7 mt-10 -97.44 165.45 12.0 Favored 'General case' 0 C--N 1.355 0.818 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.456 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.633 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 16.9 m 84.81 -58.62 0.1 Allowed 'General case' 0 C--N 1.369 1.451 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -109.9 114.74 28.53 Favored 'General case' 0 CA--C 1.504 -0.803 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.45 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 95.2 t -133.26 133.09 58.28 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 63.3 mt -117.57 128.48 74.79 Favored 'Isoleucine or valine' 0 C--N 1.358 0.968 0 CA-C-O 122.14 0.971 . . . . 0.0 109.456 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -110.52 145.23 38.1 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 114.838 -1.074 . . . . 0.0 108.336 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -119.61 118.3 30.63 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.726 HD11 HD23 ' A' ' 131' ' ' LEU . 3.7 mp -112.4 119.0 59.23 Favored 'Isoleucine or valine' 0 C--N 1.354 0.793 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 -178.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 90.3 m -124.6 142.05 51.65 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -177.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 13.6 ttt180 -91.68 116.5 28.94 Favored 'General case' 0 C--N 1.36 1.038 0 N-CA-C 106.835 -1.542 . . . . 0.0 106.835 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.605 ' HB1' ' HD2' ' A' ' 181' ' ' PRO . . . -73.41 157.97 87.23 Favored Pre-proline 0 C--N 1.359 0.99 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.605 ' HD2' ' HB1' ' A' ' 180' ' ' ALA . 19.6 Cg_endo -60.05 120.5 8.32 Favored 'Trans proline' 0 CA--C 1.494 -1.507 0 C-N-CA 122.028 1.818 . . . . 0.0 112.864 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 6.9 ppt_? -145.92 159.14 43.65 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.475 ' O ' ' HB3' ' A' ' 184' ' ' ALA . . . 73.07 65.98 2.14 Favored Glycine 0 C--N 1.356 1.656 0 N-CA-C 108.569 -1.813 . . . . 0.0 108.569 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 183' ' ' GLY . . . 76.33 165.35 0.26 Allowed 'General case' 0 C--N 1.361 1.073 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -94.29 -177.6 4.33 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -159.14 100.47 1.54 Allowed 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -178.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.05 -73.79 0.67 Allowed 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' TYR . . . . . 0.572 ' HD2' ' CD1' ' A' ' 189' ' ' PHE . 0.3 OUTLIER -151.92 -94.1 0.05 Allowed 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -179.717 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 189' ' ' PHE . . . . . 0.572 ' CD1' ' HD2' ' A' ' 188' ' ' TYR . 89.9 m-85 -117.03 143.52 45.65 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 . . . . . 0 C--O 1.264 1.817 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -179.607 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 201' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 202' ' ' HEM . . . . . 1.249 ' C3B' HD11 ' A' ' 99' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.5 mtm . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.298 0.57 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.74 -14.11 58.4 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -178.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.22 -41.99 44.62 Favored Glycine 0 C--N 1.351 1.369 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 17.6 ttp -68.15 -39.37 82.67 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 122.119 -0.636 . . . . 0.0 111.564 -177.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.0 m -68.25 -23.5 28.65 Favored 'Isoleucine or valine' 0 C--N 1.356 0.871 0 O-C-N 121.462 -0.773 . . . . 0.0 109.534 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.42 ' HZ ' ' HG3' ' A' ' 47' ' ' GLU . 2.6 m-85 -71.53 -34.05 69.71 Favored 'General case' 0 C--N 1.359 0.994 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 179.181 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.8 m -66.1 -40.37 90.69 Favored 'General case' 0 C--N 1.355 0.826 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -61.83 -38.68 96.38 Favored Glycine 0 C--N 1.358 1.8 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.673 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -64.54 -41.78 96.13 Favored 'General case' 0 C--N 1.352 0.705 0 CA-C-N 117.072 0.436 . . . . 0.0 111.068 -178.552 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 18.5 mmt -63.0 -41.29 99.55 Favored 'General case' 0 C--N 1.353 0.733 0 O-C-N 121.519 -0.738 . . . . 0.0 111.247 -178.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -67.91 -40.27 83.47 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.762 -177.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 55.3 tp -66.7 -43.34 84.63 Favored 'General case' 0 C--N 1.349 0.549 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -177.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.673 HG12 ' O ' ' A' ' 9' ' ' LEU . 1.6 mm -73.84 -37.95 49.44 Favored 'Isoleucine or valine' 0 C--N 1.359 0.979 0 O-C-N 121.06 -1.025 . . . . 0.0 111.057 -175.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -70.19 -42.01 72.96 Favored 'General case' 0 C--N 1.349 0.554 0 O-C-N 121.699 -0.626 . . . . 0.0 111.546 -176.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -71.48 -37.3 71.3 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -175.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -93.37 -32.39 14.28 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -174.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -115.51 -32.22 5.64 Favored 'General case' 0 CA--C 1.506 -0.723 0 C-N-CA 117.424 -1.71 . . . . 0.0 112.828 -176.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 146.58 178.19 21.77 Favored Glycine 0 C--N 1.346 1.085 0 C-N-CA 117.954 -2.069 . . . . 0.0 110.379 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -101.5 -23.75 14.26 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -177.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -69.52 -39.83 77.28 Favored 'General case' 0 C--N 1.36 1.047 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 94.9 m -67.96 -38.33 82.64 Favored 'General case' 0 C--N 1.357 0.915 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.8 tp -59.93 -38.1 81.41 Favored 'General case' 0 C--N 1.355 0.838 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 179.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -65.5 -36.57 84.24 Favored 'General case' 0 C--N 1.358 0.958 0 O-C-N 122.081 -0.387 . . . . 0.0 110.805 -178.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.4 m -65.33 -38.84 91.37 Favored 'General case' 0 C--N 1.354 0.797 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.639 HD13 HD22 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -63.06 -38.23 90.37 Favored 'General case' 0 C--N 1.353 0.732 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -179.13 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 85.0 mt -73.84 -14.11 61.03 Favored 'General case' 0 C--N 1.359 1.009 0 O-C-N 121.749 -0.594 . . . . 0.0 110.415 -178.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -86.61 -28.59 23.16 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 119.185 -1.006 . . . . 0.0 109.374 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.7 t -67.03 -37.04 83.41 Favored 'General case' 0 C--N 1.355 0.827 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.536 ' HB3' HD21 ' A' ' 51' ' ' LEU . 2.0 p -91.51 -39.89 11.68 Favored 'General case' 0 C--N 1.359 1.015 0 C-N-CA 118.849 -1.14 . . . . 0.0 108.153 -179.06 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 85.97 131.45 0.04 OUTLIER 'General case' 0 C--N 1.361 1.091 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.506 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -90.52 -166.83 1.68 Allowed 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.888 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.423 ' H ' ' HB2' ' A' ' 31' ' ' LEU . 60.6 tt0 -154.2 -61.78 0.13 Allowed 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 -179.621 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.8 t -101.53 -68.39 0.82 Allowed 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -137.0 -42.67 0.58 Allowed 'General case' 0 CA--C 1.502 -0.899 0 C-N-CA 119.583 -0.847 . . . . 0.0 108.881 -178.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.16 -33.92 3.86 Favored Glycine 0 C--N 1.352 1.442 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 84.8 mt -112.44 102.03 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.728 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -104.28 11.73 34.5 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.816 HG22 ' H ' ' A' ' 39' ' ' SER . 1.9 m 76.31 -170.53 0.08 Allowed 'General case' 0 C--N 1.358 0.974 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.816 ' H ' HG22 ' A' ' 38' ' ' THR . 21.6 p -97.65 51.45 1.07 Allowed 'General case' 0 C--N 1.354 0.769 0 O-C-N 121.151 -0.968 . . . . 0.0 110.26 -178.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.471 HG12 ' O ' ' A' ' 40' ' ' VAL . 17.9 t -107.95 -10.78 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.685 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -107.09 159.18 14.76 Favored Glycine 0 C--N 1.357 1.743 0 C-N-CA 119.338 -1.411 . . . . 0.0 109.92 -178.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 36.2 m -129.28 134.26 47.87 Favored 'General case' 0 C--N 1.361 1.097 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -122.35 174.37 7.05 Favored 'General case' 0 C--N 1.355 0.815 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -77.31 -176.49 4.16 Favored 'General case' 0 C--N 1.357 0.899 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -92.16 -15.95 26.94 Favored 'General case' 0 C--N 1.356 0.887 0 C-N-CA 120.131 -0.628 . . . . 0.0 109.417 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -67.6 -28.29 67.63 Favored 'General case' 0 C--N 1.351 0.64 0 N-CA-C 107.605 -1.258 . . . . 0.0 107.605 177.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.42 ' HG3' ' HZ ' ' A' ' 6' ' ' PHE . 29.8 tp10 -63.11 -41.52 99.36 Favored 'General case' 0 C--N 1.352 0.687 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -67.88 -39.46 83.7 Favored 'General case' 0 C--N 1.359 1.001 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 60.8 tp -69.64 -36.42 76.1 Favored 'General case' 0 CA--C 1.508 -0.664 0 O-C-N 122.167 -0.333 . . . . 0.0 110.498 -177.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -65.02 -40.22 94.54 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 121.686 -0.634 . . . . 0.0 109.986 -178.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.639 HD22 HD13 ' A' ' 25' ' ' LEU . 77.0 mt -81.37 -19.16 43.28 Favored 'General case' 0 C--N 1.36 1.028 0 C-N-CA 119.644 -0.823 . . . . 0.0 110.661 -178.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.2 t -78.96 -37.22 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.6 t -68.79 -40.41 81.35 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.421 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 32.2 tptt -65.1 -27.15 68.56 Favored 'General case' 0 C--N 1.364 1.235 0 O-C-N 121.126 -0.984 . . . . 0.0 108.827 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.5 tt -68.26 -38.0 81.33 Favored 'General case' 0 C--N 1.354 0.764 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.1 p -72.75 -18.23 61.53 Favored 'General case' 0 C--N 1.357 0.894 0 O-C-N 121.54 -0.725 . . . . 0.0 110.948 -179.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -100.05 -37.7 8.87 Favored 'General case' 0 C--N 1.351 0.674 0 O-C-N 121.168 -0.957 . . . . 0.0 111.668 -179.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.3 p -72.96 -35.96 50.14 Favored 'Isoleucine or valine' 0 C--N 1.351 0.642 0 O-C-N 121.713 -0.617 . . . . 0.0 111.36 -177.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.6 m -111.99 -7.99 14.09 Favored 'General case' 0 CA--C 1.505 -0.754 0 C-N-CA 119.372 -0.931 . . . . 0.0 110.116 -177.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 64.22 49.12 2.69 Favored 'General case' 0 C--N 1.354 0.784 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.583 HG13 ' HD2' ' A' ' 62' ' ' PRO . 52.3 t -113.62 135.51 21.94 Favored Pre-proline 0 CA--C 1.504 -0.802 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.652 ' HG2' ' HB2' ' A' ' 65' ' ' GLU . 20.8 Cg_endo -61.68 149.61 89.18 Favored 'Trans proline' 0 CA--C 1.5 -1.192 0 C-N-CA 122.339 2.026 . . . . 0.0 112.684 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.402 ' HA ' HD23 ' A' ' 66' ' ' LEU . 3.0 m -76.67 -11.78 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.39 -177.419 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.495 ' O ' HG12 ' A' ' 67' ' ' VAL . 72.0 p -96.62 -34.68 11.32 Favored 'General case' 0 C--N 1.357 0.93 0 C-N-CA 118.194 -1.402 . . . . 0.0 109.525 -179.05 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.652 ' HB2' ' HG2' ' A' ' 62' ' ' PRO . 69.1 mt-10 -76.85 -22.3 53.74 Favored 'General case' 0 C--N 1.354 0.792 0 O-C-N 121.437 -0.789 . . . . 0.0 108.893 179.092 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.408 ' HB3' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -79.19 -36.75 39.73 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.408 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.495 HG12 ' O ' ' A' ' 64' ' ' THR . 1.7 p -68.12 -26.82 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 C-N-CA 120.123 -0.631 . . . . 0.0 109.9 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.6 mmm-85 -72.1 -51.66 20.46 Favored 'General case' 0 C--N 1.364 1.216 0 O-C-N 121.549 -0.719 . . . . 0.0 110.453 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.3 mt -62.49 -36.27 81.96 Favored 'General case' 0 C--N 1.357 0.905 0 O-C-N 122.012 -0.43 . . . . 0.0 111.038 -178.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -61.02 -47.5 86.12 Favored 'General case' 0 C--N 1.349 0.556 0 O-C-N 122.23 -0.294 . . . . 0.0 110.639 -178.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.83 -39.21 96.51 Favored Glycine 0 C--N 1.356 1.69 0 N-CA-C 111.888 -0.485 . . . . 0.0 111.888 -177.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -62.76 -49.16 76.11 Favored 'General case' 0 C--N 1.352 0.688 0 CA-C-N 118.303 1.051 . . . . 0.0 111.693 -177.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 10.2 mttm -63.3 -47.67 81.28 Favored 'General case' 0 C--N 1.359 0.985 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -177.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.413 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.4 tm? -69.41 -38.69 78.02 Favored 'General case' 0 C--N 1.348 0.526 0 O-C-N 121.104 -0.997 . . . . 0.0 111.807 -175.682 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -63.71 -46.8 83.8 Favored 'General case' 0 C--N 1.355 0.834 0 O-C-N 121.037 -1.04 . . . . 0.0 111.443 -177.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -70.58 -13.83 17.5 Favored 'Isoleucine or valine' 0 C--N 1.36 1.024 0 O-C-N 121.517 -0.739 . . . . 0.0 109.371 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -73.08 -38.34 66.44 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 85.4 mt -73.97 -30.67 62.62 Favored 'General case' 0 C--N 1.357 0.922 0 O-C-N 122.3 -0.25 . . . . 0.0 110.519 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 47.9 mm -65.1 -53.53 39.96 Favored 'Isoleucine or valine' 0 C--N 1.357 0.921 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.957 -177.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -74.61 -15.52 60.83 Favored 'General case' 0 C--N 1.351 0.634 0 C-N-CA 119.573 -0.851 . . . . 0.0 109.526 178.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.45 -36.43 62.87 Favored Glycine 0 C--N 1.349 1.26 0 N-CA-C 111.001 -0.839 . . . . 0.0 111.001 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.486 ' HA ' ' HD2' ' A' ' 83' ' ' PRO . 99.3 m-70 -130.65 105.57 15.67 Favored Pre-proline 0 N--CA 1.441 -0.88 0 CA-C-O 122.686 1.231 . . . . 0.0 109.263 -176.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.486 ' HD2' ' HA ' ' A' ' 82' ' ' HIS . 37.8 Cg_endo -67.69 -26.0 39.66 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.647 2.231 . . . . 0.0 114.085 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -89.86 -7.66 53.74 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 tp -90.36 -20.97 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 -178.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -101.52 -23.63 14.27 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -70.16 -37.33 75.17 Favored 'General case' 0 C--N 1.359 1.001 0 O-C-N 121.867 -0.521 . . . . 0.0 109.855 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -64.89 -34.98 79.67 Favored 'General case' 0 C--N 1.358 0.975 0 O-C-N 121.836 -0.54 . . . . 0.0 110.545 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 18.4 ttp -82.9 152.51 25.52 Favored 'General case' 0 C--N 1.352 0.704 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 -178.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.43 -21.89 7.84 Favored 'General case' 0 C--N 1.364 1.225 0 O-C-N 121.641 -0.662 . . . . 0.0 111.356 -177.135 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -165.8 171.42 12.83 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -177.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.456 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 62.8 m -66.65 -40.81 88.84 Favored 'General case' 0 C--N 1.355 0.82 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.584 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.492 ' CE1' ' HE2' ' A' ' 158' ' ' PHE . 60.4 m-85 -66.67 -39.65 88.24 Favored 'General case' 0 C--N 1.357 0.915 0 O-C-N 121.188 -0.945 . . . . 0.0 108.836 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -65.79 -23.31 66.68 Favored 'General case' 0 C--N 1.356 0.884 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.694 ' O ' HG13 ' A' ' 99' ' ' ILE . 57.9 tp -63.58 -46.86 83.92 Favored 'General case' 0 C--N 1.355 0.843 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.477 ' HA ' ' CD1' ' A' ' 99' ' ' ILE . 4.2 mp -60.59 -37.34 81.04 Favored 'General case' 0 C--N 1.359 1.016 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.416 -179.539 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 34.3 t -67.88 -39.71 83.66 Favored 'General case' 0 C--N 1.349 0.566 0 O-C-N 121.918 -0.489 . . . . 0.0 110.242 -179.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.72 -0.89 56.44 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -176.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.694 HG13 ' O ' ' A' ' 95' ' ' LEU . 78.8 mt -60.81 -47.09 94.78 Favored 'Isoleucine or valine' 0 C--N 1.357 0.906 0 CA-C-N 118.919 0.782 . . . . 0.0 112.331 -177.223 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -94.44 -23.92 17.54 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 118.55 -1.26 . . . . 0.0 111.522 -176.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.5 t -63.86 -48.07 78.21 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.607 -0.683 . . . . 0.0 112.717 -177.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -137.92 -15.86 1.32 Allowed 'General case' 0 C--N 1.359 0.992 0 C-N-CA 116.946 -1.901 . . . . 0.0 113.763 -176.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.539 HD12 ' HA ' ' A' ' 99' ' ' ILE . 96.4 mt -70.81 -49.7 48.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 CA-C-N 120.54 1.518 . . . . 0.0 111.164 -177.404 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.442 ' HD2' HG22 ' A' ' 103' ' ' ILE . 17.8 m170 -89.04 0.67 56.49 Favored 'General case' 0 N--CA 1.442 -0.858 0 O-C-N 121.176 -0.953 . . . . 0.0 110.171 -177.158 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 72.7 t -83.71 -44.18 18.22 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.996 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 178.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -67.68 -40.55 84.4 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 71.9 t -63.06 -45.22 99.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.826 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.256 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -60.33 -48.38 82.01 Favored 'General case' 0 C--N 1.36 1.055 0 O-C-N 122.016 -0.428 . . . . 0.0 111.34 -178.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -63.5 -35.41 80.37 Favored 'General case' 0 C--N 1.354 0.795 0 O-C-N 121.544 -0.722 . . . . 0.0 110.615 -178.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 110' ' ' LEU . 16.4 mt -57.33 -72.1 0.09 Allowed 'General case' 0 C--N 1.357 0.919 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.104 -179.046 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -122.31 143.7 40.0 Favored Pre-proline 0 N--CA 1.441 -0.899 0 C-N-CA 118.038 -1.465 . . . . 0.0 109.292 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -87.25 -2.46 7.83 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 C-N-CA 123.505 2.803 . . . . 0.0 116.265 -178.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -83.42 -8.11 59.44 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 121.272 -0.892 . . . . 0.0 109.486 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -83.06 144.33 29.98 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.552 ' O ' HD13 ' A' ' 116' ' ' LEU . 46.0 mt-10 -120.33 144.11 48.02 Favored 'General case' 0 C--N 1.359 1.021 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.552 HD13 ' O ' ' A' ' 115' ' ' GLU . 2.6 mm? -129.88 152.52 80.04 Favored Pre-proline 0 C--N 1.358 0.946 0 CA-C-O 121.951 0.882 . . . . 0.0 109.27 -178.463 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 116' ' ' LEU . 87.7 Cg_endo -92.73 -155.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.32 -0.946 0 C-N-CA 123.929 3.086 . . . . 0.0 113.036 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -122.5 141.84 51.22 Favored 'General case' 0 C--N 1.368 1.399 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -132.61 137.04 46.9 Favored 'General case' 0 C--N 1.362 1.132 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.629 -178.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.437 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 93.7 m -127.32 128.52 46.06 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 176.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 78.2 m -118.69 128.89 54.94 Favored 'General case' 0 CA--C 1.503 -0.862 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.436 -178.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -120.85 130.89 54.12 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -103.55 117.23 33.95 Favored 'General case' 0 C--N 1.353 0.738 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -179.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.463 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 88.7 mt -83.27 -27.48 29.83 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 120.668 -0.413 . . . . 0.0 109.968 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 179.49 -143.24 5.59 Favored Glycine 0 C--N 1.351 1.378 0 C-N-CA 118.771 -1.681 . . . . 0.0 109.648 -178.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -91.37 -45.98 8.27 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -178.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -98.67 3.25 47.75 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.699 -177.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.463 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 66.7 m-20 -119.91 133.38 55.59 Favored 'General case' 0 C--N 1.357 0.917 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.533 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.1 mm -142.57 138.45 28.69 Favored 'Isoleucine or valine' 0 C--N 1.357 0.91 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 179.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 52.3 mtm180 -119.79 137.75 53.77 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 6.6 tp -125.5 119.45 28.25 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.76 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.437 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 11.8 m170 -99.92 135.2 41.71 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.325 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -128.06 121.97 30.99 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -178.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.448 ' HA ' ' O ' ' A' ' 171' ' ' THR . 10.2 tt0 -115.55 112.88 22.86 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 178.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.8 t -167.25 156.63 10.45 Favored 'General case' 0 C--N 1.357 0.908 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.439 ' C ' ' HD3' ' A' ' 138' ' ' PRO . 99.5 mttt -91.3 6.86 43.61 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 75.0 mtp180 -130.82 74.04 80.44 Favored Pre-proline 0 C--N 1.355 0.816 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.439 ' HD3' ' C ' ' A' ' 136' ' ' LYS . 80.1 Cg_endo -95.57 89.27 0.1 Allowed 'Trans proline' 0 N--CA 1.445 -1.373 0 C-N-CA 122.821 2.347 . . . . 0.0 115.559 -178.308 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -106.57 112.42 25.41 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 177.333 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.89 -37.74 88.51 Favored 'General case' 0 C--N 1.353 0.735 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.132 -178.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 71.5 m -61.77 -32.46 72.73 Favored 'General case' 0 C--N 1.353 0.741 0 O-C-N 121.967 -0.458 . . . . 0.0 110.693 -178.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -73.11 -46.48 51.04 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 120.25 -0.58 . . . . 0.0 109.988 -177.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.35 -40.17 95.33 Favored 'General case' 0 C--N 1.356 0.88 0 O-C-N 122.127 -0.358 . . . . 0.0 111.461 -177.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -63.27 -36.89 85.16 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 121.85 -0.531 . . . . 0.0 110.273 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.14 -43.52 98.28 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 -178.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 82.7 mt -69.82 -40.57 75.84 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 96.2 mt -71.63 -42.43 67.63 Favored 'General case' 0 C--N 1.362 1.152 0 O-C-N 121.152 -0.968 . . . . 0.0 111.186 -176.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.472 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 36.2 t70 -69.84 -30.55 68.06 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 121.834 -0.541 . . . . 0.0 110.535 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -62.85 -39.1 97.58 Favored Glycine 0 C--N 1.357 1.708 0 N-CA-C 108.303 -1.919 . . . . 0.0 108.303 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 48.9 t -60.55 -42.02 95.71 Favored 'General case' 0 C--N 1.351 0.659 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -74.96 -1.24 21.69 Favored 'General case' 0 C--N 1.361 1.093 0 O-C-N 121.739 -0.601 . . . . 0.0 109.476 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.472 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 76.5 mm-40 -84.38 -46.33 11.83 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.238 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -68.06 -43.19 79.19 Favored 'General case' 0 C--N 1.359 1.017 0 C-N-CA 120.002 -0.679 . . . . 0.0 109.553 179.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -69.19 -27.67 65.71 Favored 'General case' 0 C--N 1.361 1.076 0 O-C-N 121.739 -0.601 . . . . 0.0 110.701 -178.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 86.1 tttt 70.42 72.31 0.21 Allowed 'General case' 0 C--N 1.361 1.07 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -178.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -143.45 -167.26 2.52 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -142.18 116.6 9.61 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' PHE . . . . . 0.492 ' HE2' ' CE1' ' A' ' 93' ' ' PHE . 94.9 m-85 -135.09 150.47 50.24 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 178.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 92.4 m -120.63 127.82 52.44 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.549 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.4 mp -105.9 122.88 60.04 Favored 'Isoleucine or valine' 0 C--N 1.351 0.672 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.9 m -120.12 -173.61 2.59 Favored 'General case' 0 C--N 1.357 0.911 0 CA-C-O 121.86 0.838 . . . . 0.0 109.341 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -147.74 156.96 43.29 Favored 'General case' 0 C--N 1.357 0.932 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -178.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 64.6 p -100.79 146.2 31.68 Favored Pre-proline 0 C--N 1.359 0.988 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.9 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 62.7 Cg_endo -75.75 -9.6 19.77 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.754 2.303 . . . . 0.0 115.424 -178.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -71.97 -41.11 68.1 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 119.771 -0.772 . . . . 0.0 109.101 -179.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 39.2 p -118.05 14.53 14.08 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 120.071 -0.651 . . . . 0.0 110.538 -178.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.9 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 11.6 pt20 -67.03 -10.34 48.73 Favored 'General case' 0 C--N 1.355 0.828 0 O-C-N 121.455 -0.778 . . . . 0.0 110.335 178.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -126.54 38.28 4.15 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.9 m -137.38 146.9 45.02 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.64 ' O ' ' HB ' ' A' ' 171' ' ' THR . 60.5 mt-10 -98.77 164.4 12.23 Favored 'General case' 0 C--N 1.353 0.759 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.64 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 1.7 m 82.05 -56.65 0.23 Allowed 'General case' 0 C--N 1.371 1.532 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.004 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -110.19 117.65 34.26 Favored 'General case' 0 CA--C 1.503 -0.83 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.802 -178.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 67.4 t -131.22 134.0 61.75 Favored 'Isoleucine or valine' 0 C--N 1.357 0.912 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 50.4 mm -108.53 125.44 65.38 Favored 'Isoleucine or valine' 0 C--N 1.357 0.914 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -113.25 153.16 28.84 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 122.136 0.969 . . . . 0.0 108.541 -179.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -136.69 117.56 14.16 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -178.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.3 mp -113.04 118.6 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 -179.161 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 89.4 m -120.28 144.24 47.9 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -177.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.551 ' NE ' ' HD2' ' A' ' 182' ' ' ARG . 5.2 ttt180 -89.08 114.59 25.85 Favored 'General case' 0 C--N 1.363 1.185 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.432 ' HA ' ' HD3' ' A' ' 181' ' ' PRO . . . -60.5 147.78 82.21 Favored Pre-proline 0 C--N 1.359 0.982 0 CA-C-O 121.93 0.872 . . . . 0.0 108.925 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 180' ' ' ALA . 74.3 Cg_exo -51.95 128.56 27.22 Favored 'Trans proline' 0 CA--C 1.494 -1.478 0 C-N-CA 122.932 2.422 . . . . 0.0 113.762 -178.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.551 ' HD2' ' NE ' ' A' ' 179' ' ' ARG . 0.1 OUTLIER -110.73 21.86 16.05 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 179.935 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 148.25 -138.5 7.08 Favored Glycine 0 N--CA 1.436 -1.305 0 N-CA-C 107.591 -2.204 . . . . 0.0 107.591 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -79.45 169.42 18.08 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -117.24 112.34 20.66 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 -179.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -113.41 122.72 48.19 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.91 -81.25 0.45 Allowed 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -141.38 -83.06 0.21 Allowed 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -126.7 147.12 49.98 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 . . . . . 0 C--O 1.263 1.771 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 179.939 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 201' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 202' ' ' HEM . . . . . 0.733 ' HHA' HBD2 ' A' ' 202' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.477 ' HG3' ' CMD' ' A' ' 202' ' ' HEM . 43.6 mtp . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.212 0.53 . . . . 0.0 109.862 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.624 ' HA ' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -82.17 -5.46 58.49 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.046 -177.873 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.52 -46.16 26.47 Favored Glycine 0 C--N 1.35 1.34 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 76.9 mtm -72.15 -34.53 68.57 Favored 'General case' 0 C--N 1.354 0.791 0 O-C-N 121.92 -0.753 . . . . 0.0 111.271 -177.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.624 HG22 ' HA ' ' A' ' 2' ' ' MET . 36.0 m -69.78 -23.44 25.8 Favored 'Isoleucine or valine' 0 C--N 1.356 0.868 0 C-N-CA 119.926 -0.709 . . . . 0.0 109.346 -179.064 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.426 ' HZ ' ' CG ' ' A' ' 47' ' ' GLU . 1.6 m-85 -71.79 -34.45 69.42 Favored 'General case' 0 C--N 1.357 0.908 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.16 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.6 m -66.7 -39.65 88.16 Favored 'General case' 0 C--N 1.354 0.798 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -61.29 -38.81 96.28 Favored Glycine 0 C--N 1.359 1.809 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.617 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -65.33 -40.08 93.24 Favored 'General case' 0 C--N 1.353 0.741 0 O-C-N 122.354 -0.498 . . . . 0.0 110.761 -178.83 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.2 mmt -63.02 -41.02 99.43 Favored 'General case' 0 C--N 1.351 0.665 0 O-C-N 121.632 -0.667 . . . . 0.0 111.099 -178.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -66.81 -40.65 88.14 Favored 'General case' 0 C--N 1.35 0.613 0 O-C-N 121.869 -0.519 . . . . 0.0 111.688 -177.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 53.9 tp -65.8 -42.78 90.25 Favored 'General case' 0 C--N 1.349 0.585 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.617 HG12 ' O ' ' A' ' 9' ' ' LEU . 1.5 mm -75.67 -37.44 36.19 Favored 'Isoleucine or valine' 0 C--N 1.357 0.896 0 O-C-N 121.083 -1.011 . . . . 0.0 111.134 -175.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -68.53 -43.16 77.35 Favored 'General case' 0 C--N 1.352 0.703 0 O-C-N 121.911 -0.493 . . . . 0.0 111.315 -176.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -71.42 -34.36 70.25 Favored 'General case' 0 N--CA 1.446 -0.634 0 O-C-N 122.06 -0.4 . . . . 0.0 111.717 -177.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -71.83 -48.71 44.33 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -175.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -128.22 -19.29 3.93 Favored 'General case' 0 C--N 1.356 0.854 0 C-N-CA 117.352 -1.739 . . . . 0.0 113.747 -176.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 140.56 179.48 18.15 Favored Glycine 0 CA--C 1.497 -1.066 0 C-N-CA 117.773 -2.156 . . . . 0.0 109.97 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -96.42 -12.09 24.75 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -177.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -70.49 -41.41 72.71 Favored 'General case' 0 C--N 1.361 1.073 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.2 m -69.91 -39.08 76.41 Favored 'General case' 0 C--N 1.356 0.859 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.531 HD13 ' HB ' ' A' ' 13' ' ' ILE . 58.3 tp -60.6 -37.93 83.03 Favored 'General case' 0 C--N 1.357 0.918 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -64.59 -36.26 83.66 Favored 'General case' 0 C--N 1.357 0.893 0 O-C-N 122.132 -0.355 . . . . 0.0 110.84 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 93.6 m -63.52 -41.19 98.51 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -178.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.428 ' CD2' ' HB3' ' A' ' 54' ' ' LYS . 88.7 mt -64.17 -37.72 88.47 Favored 'General case' 0 C--N 1.352 0.711 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.09 -13.62 61.63 Favored 'General case' 0 C--N 1.36 1.053 0 O-C-N 121.606 -0.684 . . . . 0.0 110.085 -178.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -86.74 -28.94 22.74 Favored 'General case' 0 CA--C 1.506 -0.712 0 O-C-N 121.262 -0.899 . . . . 0.0 109.12 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.8 t -66.81 -36.29 82.03 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.647 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 2.2 p -92.15 -38.16 12.31 Favored 'General case' 0 C--N 1.359 0.996 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.647 ' HB2' ' O ' ' A' ' 29' ' ' CYS . 15.9 mt-10 85.96 131.73 0.04 OUTLIER 'General case' 0 C--N 1.36 1.041 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.511 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -89.96 -167.49 1.86 Allowed 'General case' 0 C--N 1.356 0.871 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.791 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -153.39 -66.59 0.15 Allowed 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.2 m -96.47 -62.06 1.33 Allowed 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -141.1 -43.2 0.38 Allowed 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -179.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.43 -39.02 2.47 Favored Glycine 0 C--N 1.351 1.398 0 N-CA-C 108.69 -1.764 . . . . 0.0 108.69 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 84.9 mt -109.8 104.68 17.46 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.878 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.425 ' HB3' ' H ' ' A' ' 38' ' ' THR . 4.0 t80 -74.03 -92.31 0.02 OUTLIER 'General case' 0 C--N 1.355 0.833 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.46 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.441 HG22 ' N ' ' A' ' 39' ' ' SER . 1.2 m -166.37 -64.52 0.03 OUTLIER 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 -178.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.441 ' N ' HG22 ' A' ' 38' ' ' THR . 12.3 p 161.87 80.9 0.0 OUTLIER 'General case' 0 C--N 1.362 1.122 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.513 ' O ' HG13 ' A' ' 40' ' ' VAL . 0.4 OUTLIER -172.05 -4.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.972 0 C-N-CA 119.459 -0.896 . . . . 0.0 109.735 -179.18 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -96.3 150.61 19.67 Favored Glycine 0 C--N 1.355 1.6 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 -178.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 59.2 m -125.41 131.5 52.91 Favored 'General case' 0 C--N 1.354 0.77 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -121.05 171.11 8.9 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -76.24 -178.67 4.62 Favored 'General case' 0 C--N 1.355 0.842 0 CA-C-O 121.642 0.734 . . . . 0.0 109.573 -178.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -86.36 -19.65 29.45 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -179.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.709 ' HA ' HD23 ' A' ' 49' ' ' LEU . 0.5 OUTLIER -65.55 -30.65 71.42 Favored 'General case' 0 C--N 1.354 0.764 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 179.08 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.426 ' CG ' ' HZ ' ' A' ' 6' ' ' PHE . 23.6 tp10 -63.97 -40.25 95.97 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -65.52 -39.41 91.79 Favored 'General case' 0 C--N 1.358 0.972 0 O-C-N 122.305 -0.247 . . . . 0.0 111.266 -178.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.709 HD23 ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -81.37 -15.02 56.52 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 119.078 -1.049 . . . . 0.0 110.402 -176.339 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 71.5 tp60 -73.09 -41.44 64.06 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 84.3 mt -84.51 -17.96 37.33 Favored 'General case' 0 C--N 1.362 1.111 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.723 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.6 t -80.52 -37.45 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.9 t -69.73 -39.68 78.3 Favored 'Isoleucine or valine' 0 C--N 1.354 0.78 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.428 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 32.9 tptt -66.15 -27.16 67.81 Favored 'General case' 0 C--N 1.363 1.171 0 O-C-N 121.235 -0.915 . . . . 0.0 108.6 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.496 HD13 HD13 ' A' ' 66' ' ' LEU . 0.3 OUTLIER -68.38 -37.64 80.59 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.704 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 60' ' ' SER . 77.0 p -73.9 -16.93 61.09 Favored 'General case' 0 C--N 1.355 0.847 0 O-C-N 121.693 -0.629 . . . . 0.0 110.885 -178.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -100.46 -36.38 9.23 Favored 'General case' 0 C--N 1.353 0.752 0 C-N-CA 119.377 -0.929 . . . . 0.0 111.434 -179.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.5 p -72.66 -34.44 47.54 Favored 'Isoleucine or valine' 0 C--N 1.351 0.651 0 O-C-N 121.683 -0.636 . . . . 0.0 111.455 -177.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.568 ' HB3' HG23 ' A' ' 61' ' ' VAL . 4.2 t -119.99 -5.58 10.05 Favored 'General case' 0 C--N 1.353 0.725 0 C-N-CA 119.143 -1.023 . . . . 0.0 110.069 -178.146 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.417 ' HA ' ' O ' ' A' ' 56' ' ' SER . 73.3 m 64.3 43.25 4.86 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.568 HG23 ' HB3' ' A' ' 59' ' ' SER . 50.0 t -103.37 132.89 20.65 Favored Pre-proline 0 N--CA 1.443 -0.799 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 179.489 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -57.31 146.68 81.24 Favored 'Trans proline' 0 CA--C 1.497 -1.345 0 C-N-CA 122.397 2.065 . . . . 0.0 112.959 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.1 m -75.15 -14.1 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.788 -178.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.412 ' O ' HG12 ' A' ' 67' ' ' VAL . 52.6 p -96.07 -31.88 12.81 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 118.139 -1.425 . . . . 0.0 109.611 -178.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -78.01 -21.49 50.73 Favored 'General case' 0 C--N 1.356 0.856 0 O-C-N 121.385 -0.822 . . . . 0.0 108.894 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.496 HD13 HD13 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -81.82 -35.73 29.14 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.4 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.421 HG11 ' HB3' ' A' ' 141' ' ' SER . 1.4 p -68.79 -27.17 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 C-N-CA 120.138 -0.625 . . . . 0.0 109.95 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.5 mmm-85 -73.21 -51.2 18.6 Favored 'General case' 0 C--N 1.362 1.131 0 O-C-N 121.521 -0.737 . . . . 0.0 110.435 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.7 mt -63.69 -36.08 82.68 Favored 'General case' 0 C--N 1.357 0.934 0 O-C-N 121.976 -0.452 . . . . 0.0 110.85 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -60.65 -47.36 86.58 Favored 'General case' 0 C--N 1.349 0.577 0 O-C-N 122.208 -0.307 . . . . 0.0 110.297 -178.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.57 -37.87 94.06 Favored Glycine 0 C--N 1.354 1.552 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 -178.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -63.02 -48.64 77.91 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-N 118.261 1.031 . . . . 0.0 111.397 -177.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.701 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 16.0 mttm -64.39 -48.96 73.47 Favored 'General case' 0 C--N 1.359 0.983 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -176.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.431 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.3 tm? -68.29 -39.68 82.03 Favored 'General case' 0 C--N 1.348 0.534 0 O-C-N 121.207 -0.933 . . . . 0.0 112.047 -175.363 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -63.88 -42.83 97.39 Favored 'General case' 0 C--N 1.353 0.719 0 O-C-N 121.115 -0.991 . . . . 0.0 111.22 -177.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.7 p -71.97 -15.48 18.11 Favored 'Isoleucine or valine' 0 C--N 1.36 1.026 0 O-C-N 121.232 -0.917 . . . . 0.0 109.217 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.701 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 74.1 mm-40 -71.52 -38.89 71.07 Favored 'General case' 0 C--N 1.349 0.552 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.219 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 80.7 mt -72.45 -33.3 66.97 Favored 'General case' 0 C--N 1.358 0.967 0 O-C-N 122.334 -0.229 . . . . 0.0 110.754 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 43.5 mm -64.43 -52.97 48.57 Favored 'Isoleucine or valine' 0 C--N 1.357 0.912 0 O-C-N 121.733 -0.604 . . . . 0.0 110.509 -177.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -76.67 -14.75 59.94 Favored 'General case' 0 C--N 1.35 0.591 0 C-N-CA 119.423 -0.911 . . . . 0.0 109.501 178.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.85 -36.32 61.43 Favored Glycine 0 C--N 1.349 1.27 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -179.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -128.46 104.45 19.58 Favored Pre-proline 0 N--CA 1.44 -0.938 0 CA-C-O 122.564 1.173 . . . . 0.0 109.596 -176.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.08 -33.23 91.8 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 123.366 2.711 . . . . 0.0 114.29 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -91.34 -5.67 54.23 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 120.14 -0.624 . . . . 0.0 109.834 -178.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -87.89 -23.15 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -178.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.6 -18.03 14.91 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -72.39 -38.36 68.49 Favored 'General case' 0 C--N 1.358 0.94 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -65.17 -33.51 76.18 Favored 'General case' 0 C--N 1.355 0.816 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.479 ' SD ' ' HB2' ' A' ' 95' ' ' LEU . 17.8 ttp -84.53 152.08 24.15 Favored 'General case' 0 C--N 1.351 0.651 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -178.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.64 -21.4 8.54 Favored 'General case' 0 C--N 1.364 1.21 0 C-N-CA 120.051 -0.659 . . . . 0.0 111.19 -177.405 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -165.96 171.28 12.77 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -177.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 67.3 m -66.63 -39.89 88.49 Favored 'General case' 0 C--N 1.355 0.842 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.68 -179.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -67.48 -39.21 85.25 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 119.616 -0.834 . . . . 0.0 108.83 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -66.26 -23.36 66.39 Favored 'General case' 0 C--N 1.355 0.832 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.681 ' O ' HG13 ' A' ' 99' ' ' ILE . 66.1 tp -65.25 -45.17 85.67 Favored 'General case' 0 C--N 1.357 0.926 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.425 ' HA ' ' CD1' ' A' ' 99' ' ' ILE . 3.3 mp -60.08 -35.94 76.29 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.1 t -70.49 -39.62 74.06 Favored 'General case' 0 C--N 1.35 0.599 0 O-C-N 121.881 -0.512 . . . . 0.0 109.935 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.3 -0.33 52.06 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -176.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.681 HG13 ' O ' ' A' ' 95' ' ' LEU . 81.1 mt -61.6 -47.18 94.56 Favored 'Isoleucine or valine' 0 C--N 1.357 0.894 0 CA-C-N 119.197 0.908 . . . . 0.0 111.704 -177.42 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -93.06 -23.41 18.66 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 118.642 -1.223 . . . . 0.0 111.349 -177.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 33.6 t -63.71 -48.57 76.56 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 121.645 -0.659 . . . . 0.0 112.592 -177.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -139.99 -12.87 1.09 Allowed 'General case' 0 C--N 1.359 0.982 0 C-N-CA 117.083 -1.847 . . . . 0.0 113.685 -177.034 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.735 HG21 ' C1C' ' A' ' 202' ' ' HEM . 24.9 mm -70.12 -51.23 41.05 Favored 'Isoleucine or valine' 0 C--O 1.242 0.706 0 CA-C-N 120.352 1.433 . . . . 0.0 110.564 -177.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.418 ' HD2' HG22 ' A' ' 103' ' ' ILE . 65.5 m170 -91.72 1.15 57.35 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.209 -177.271 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 79.5 t -81.39 -44.54 20.6 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.009 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 178.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 54.8 tp10 -68.09 -40.44 82.65 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 53.8 t -62.13 -46.95 95.29 Favored 'Isoleucine or valine' 0 C--N 1.355 0.824 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.685 -179.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -60.45 -48.13 83.11 Favored 'General case' 0 C--N 1.361 1.078 0 O-C-N 121.998 -0.438 . . . . 0.0 111.546 -179.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -60.66 -36.84 79.7 Favored 'General case' 0 C--N 1.355 0.821 0 O-C-N 121.503 -0.748 . . . . 0.0 110.383 -178.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 18.5 mt -59.49 -77.08 0.04 OUTLIER 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.438 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 79.8 m-85 -119.14 140.32 28.69 Favored Pre-proline 0 N--CA 1.44 -0.958 0 C-N-CA 118.574 -1.251 . . . . 0.0 108.973 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 111' ' ' TYR . 67.3 Cg_endo -87.18 -2.1 7.87 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 123.077 2.518 . . . . 0.0 115.124 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 29.7 mm100 -66.9 -36.51 82.45 Favored 'General case' 0 C--N 1.355 0.824 0 O-C-N 121.819 -0.551 . . . . 0.0 109.888 -179.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.24 144.63 57.04 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 121.56 0.695 . . . . 0.0 110.067 -178.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.453 ' O ' HD13 ' A' ' 116' ' ' LEU . 46.3 mt-10 -115.91 142.78 46.33 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 179.061 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.453 HD13 ' O ' ' A' ' 115' ' ' GLU . 2.6 mm? -127.16 148.8 67.49 Favored Pre-proline 0 N--CA 1.444 -0.737 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -178.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 116' ' ' LEU . 92.1 Cg_endo -91.07 -157.36 0.06 OUTLIER 'Trans proline' 0 C--N 1.315 -1.21 0 C-N-CA 123.797 2.998 . . . . 0.0 113.263 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -118.41 140.4 49.92 Favored 'General case' 0 C--N 1.363 1.186 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.414 ' CZ ' ' HG2' ' A' ' 117' ' ' PRO . 94.2 m-85 -131.51 135.03 46.74 Favored 'General case' 0 C--N 1.359 1.013 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.526 -178.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.453 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 93.6 m -124.05 127.57 48.06 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 176.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 75.2 m -118.06 128.02 54.36 Favored 'General case' 0 CA--C 1.504 -0.794 0 C-N-CA 119.215 -0.994 . . . . 0.0 109.545 -177.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -118.77 151.36 38.18 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 178.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -122.56 117.16 25.23 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.478 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 94.7 mt -86.9 -22.54 25.63 Favored 'General case' 0 C--N 1.354 0.782 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.219 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 177.8 -145.64 7.17 Favored Glycine 0 C--N 1.348 1.248 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 -178.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -94.7 -39.35 10.36 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -178.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -99.46 1.97 44.57 Favored 'General case' 0 C--N 1.353 0.756 0 C-N-CA 120.292 -0.563 . . . . 0.0 109.95 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.478 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 66.1 m-20 -121.12 133.42 55.21 Favored 'General case' 0 C--N 1.357 0.935 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.167 -179.181 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.413 HD13 ' HA ' ' A' ' 129' ' ' ILE . 8.0 mm -142.86 136.42 26.49 Favored 'Isoleucine or valine' 0 C--N 1.356 0.878 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 52.9 mtm180 -116.94 139.06 51.09 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.0 tp -128.02 118.6 23.8 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.453 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 12.0 m170 -97.35 132.92 42.61 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -126.42 121.38 32.27 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -178.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.485 ' HA ' ' O ' ' A' ' 171' ' ' THR . 29.9 tt0 -115.24 112.2 22.09 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.3 t -162.02 151.39 15.96 Favored 'General case' 0 C--N 1.36 1.038 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -90.47 2.31 55.82 Favored 'General case' 0 C--N 1.356 0.867 0 C-N-CA 120.316 -0.554 . . . . 0.0 109.777 -179.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -134.17 74.65 67.24 Favored Pre-proline 0 C--N 1.354 0.786 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -94.82 106.24 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.659 2.239 . . . . 0.0 115.968 -177.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -111.18 109.61 19.74 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 176.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.82 -39.14 93.51 Favored 'General case' 0 C--N 1.354 0.797 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.66 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.421 ' HB3' HG11 ' A' ' 67' ' ' VAL . 73.8 m -62.81 -27.6 69.42 Favored 'General case' 0 C--N 1.354 0.797 0 O-C-N 121.876 -0.515 . . . . 0.0 110.715 -178.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -76.53 -46.49 26.28 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.862 -177.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.83 -39.81 94.17 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 122.05 -0.406 . . . . 0.0 111.176 -177.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -63.17 -36.83 84.92 Favored 'General case' 0 C--N 1.356 0.86 0 O-C-N 121.902 -0.499 . . . . 0.0 109.85 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.01 -42.94 98.58 Favored Glycine 0 C--N 1.348 1.202 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 86.3 mt -70.57 -41.0 73.0 Favored 'General case' 0 C--N 1.354 0.761 0 CA-C-N 117.552 0.676 . . . . 0.0 112.775 -179.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 97.1 mt -71.37 -41.82 69.22 Favored 'General case' 0 C--N 1.361 1.092 0 O-C-N 121.155 -0.966 . . . . 0.0 110.832 -176.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.472 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 36.8 t70 -69.97 -28.61 65.68 Favored 'General case' 0 N--CA 1.442 -0.865 0 O-C-N 121.258 -0.901 . . . . 0.0 109.987 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.447 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -63.72 -40.61 98.7 Favored Glycine 0 C--N 1.355 1.601 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 14.1 p -65.6 -31.49 72.56 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 119.341 -0.943 . . . . 0.0 109.451 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -78.75 -1.16 33.32 Favored 'General case' 0 C--N 1.363 1.184 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 177.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.472 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 76.8 mm-40 -85.33 -45.55 11.81 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.052 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -66.71 -45.72 77.86 Favored 'General case' 0 C--N 1.36 1.062 0 C-N-CA 120.152 -0.619 . . . . 0.0 109.545 178.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -68.98 -26.83 65.24 Favored 'General case' 0 C--N 1.361 1.078 0 O-C-N 121.843 -0.536 . . . . 0.0 110.664 -178.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 84.6 tttt 73.51 71.85 0.12 Allowed 'General case' 0 C--N 1.362 1.109 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -139.38 -171.62 3.17 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -147.28 94.69 2.43 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 16.3 m-30 -114.78 157.17 23.6 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 178.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 93.4 m -120.2 128.8 53.71 Favored 'General case' 0 C--N 1.354 0.791 0 C-N-CA 119.655 -0.818 . . . . 0.0 108.857 -178.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.535 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.5 mp -104.49 122.04 56.98 Favored 'Isoleucine or valine' 0 C--N 1.351 0.66 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 179.024 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.3 m -117.86 -174.05 2.56 Favored 'General case' 0 C--N 1.358 0.948 0 CA-C-O 121.942 0.877 . . . . 0.0 109.462 -178.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 26.6 ptt180 -146.2 155.69 42.88 Favored 'General case' 0 C--N 1.357 0.918 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -178.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.446 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 34.8 p -96.98 145.67 29.98 Favored Pre-proline 0 C--N 1.358 0.971 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.623 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 15.3 Cg_exo -70.82 -16.19 33.09 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 123.439 2.759 . . . . 0.0 114.445 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -71.63 -40.78 69.53 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 120.436 -0.506 . . . . 0.0 110.708 -177.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 40.8 p -119.28 16.38 13.11 Favored 'General case' 0 C--N 1.353 0.739 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.852 -178.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.623 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 9.9 pt20 -66.89 -12.86 60.73 Favored 'General case' 0 C--N 1.353 0.741 0 O-C-N 121.517 -0.739 . . . . 0.0 110.212 178.463 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 54.0 p30 -124.74 38.23 4.24 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 19.9 t -139.42 144.95 38.32 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.599 ' O ' ' HB ' ' A' ' 171' ' ' THR . 62.0 mt-10 -97.9 165.07 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -179.357 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.599 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 18.7 m 82.52 -58.98 0.18 Allowed 'General case' 0 C--N 1.37 1.49 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.771 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -107.75 116.83 32.66 Favored 'General case' 0 CA--C 1.503 -0.829 0 C-N-CA 119.952 -0.699 . . . . 0.0 109.538 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 85.1 t -130.69 132.45 64.24 Favored 'Isoleucine or valine' 0 C--N 1.357 0.904 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 178.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 50.8 mm -107.74 126.31 64.15 Favored 'Isoleucine or valine' 0 C--N 1.356 0.878 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -114.8 154.44 28.57 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-O 122.173 0.987 . . . . 0.0 108.588 -178.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -136.82 119.24 15.79 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.8 mp -113.85 119.83 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 N-CA-C 106.525 -1.658 . . . . 0.0 106.525 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 89.6 m -120.39 143.06 48.64 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -177.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 10.2 ttm180 -83.67 118.58 23.95 Favored 'General case' 0 C--N 1.363 1.184 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.475 ' HB1' ' HD2' ' A' ' 181' ' ' PRO . . . -64.33 157.16 72.9 Favored Pre-proline 0 C--N 1.359 1.004 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.475 ' HD2' ' HB1' ' A' ' 180' ' ' ALA . 86.9 Cg_exo -50.0 126.07 16.11 Favored 'Trans proline' 0 CA--C 1.498 -1.313 0 C-N-CA 122.737 2.291 . . . . 0.0 114.055 -178.3 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -92.64 12.09 24.42 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 103.25 113.46 3.81 Favored Glycine 0 N--CA 1.439 -1.123 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 67.28 69.66 0.38 Allowed 'General case' 0 C--N 1.359 0.981 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -72.79 150.06 43.11 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -109.21 120.9 43.93 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 89.8 mt -106.25 -59.6 1.76 Allowed 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' TYR . . . . . 0.498 ' HB3' ' H ' ' A' ' 189' ' ' PHE . 0.2 OUTLIER -152.12 -101.81 0.05 Allowed 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 179.897 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 189' ' ' PHE . . . . . 0.498 ' H ' ' HB3' ' A' ' 188' ' ' TYR . 71.9 m-85 -114.03 144.47 43.05 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 . . . . . 0 C--O 1.265 1.873 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -179.85 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 201' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 202' ' ' HEM . . . . . 1.018 ' HHA' HBD2 ' A' ' 202' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.956 ' HG2' HMD3 ' A' ' 202' ' ' HEM . 78.2 mmm . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.065 0.459 . . . . 0.0 110.202 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.18 -19.05 47.98 Favored 'General case' 0 C--N 1.356 0.856 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -178.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.73 -40.44 45.6 Favored Glycine 0 C--N 1.35 1.323 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.22 -34.81 68.62 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 121.853 -0.792 . . . . 0.0 111.164 -177.379 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.1 m -69.03 -23.99 27.76 Favored 'Isoleucine or valine' 0 C--N 1.356 0.85 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.453 ' HZ ' ' CG ' ' A' ' 47' ' ' GLU . 2.0 m-85 -70.6 -35.03 72.77 Favored 'General case' 0 C--N 1.356 0.86 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.045 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 89.6 m -67.4 -39.71 85.57 Favored 'General case' 0 C--N 1.356 0.883 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -61.81 -38.45 95.99 Favored Glycine 0 C--N 1.36 1.874 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.675 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -64.72 -41.35 96.05 Favored 'General case' 0 C--N 1.352 0.685 0 O-C-N 122.511 -0.405 . . . . 0.0 110.791 -178.768 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.433 ' CE ' HD21 ' A' ' 26' ' ' LEU . 20.7 mmt -62.71 -40.92 98.68 Favored 'General case' 0 C--N 1.352 0.692 0 O-C-N 121.693 -0.629 . . . . 0.0 110.891 -178.165 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -68.06 -40.66 82.71 Favored 'General case' 0 C--N 1.347 0.481 0 O-C-N 121.952 -0.467 . . . . 0.0 111.738 -177.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 54.0 tp -66.65 -43.79 83.67 Favored 'General case' 0 C--N 1.35 0.599 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -178.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.675 HG12 ' O ' ' A' ' 9' ' ' LEU . 2.0 mm -72.71 -37.36 55.4 Favored 'Isoleucine or valine' 0 C--N 1.36 1.032 0 O-C-N 121.164 -0.96 . . . . 0.0 111.054 -175.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -71.65 -42.85 67.03 Favored 'General case' 0 C--N 1.35 0.619 0 O-C-N 121.662 -0.649 . . . . 0.0 111.835 -176.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -71.26 -37.03 71.95 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -175.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -98.31 -27.95 13.89 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 118.627 -1.229 . . . . 0.0 114.085 -174.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -115.28 -30.55 6.25 Favored 'General case' 0 CA--C 1.506 -0.743 0 C-N-CA 117.162 -1.815 . . . . 0.0 112.7 -176.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 143.17 177.83 18.48 Favored Glycine 0 C--N 1.347 1.155 0 C-N-CA 118.122 -1.99 . . . . 0.0 110.068 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -101.46 -24.4 14.18 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 -177.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -68.98 -39.86 79.16 Favored 'General case' 0 C--N 1.361 1.106 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 96.3 m -68.54 -38.63 81.0 Favored 'General case' 0 C--N 1.357 0.923 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 178.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.9 tp -59.4 -39.16 82.53 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -65.31 -37.21 86.44 Favored 'General case' 0 C--N 1.355 0.828 0 O-C-N 122.144 -0.347 . . . . 0.0 111.241 -178.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 88.6 m -64.61 -40.72 96.0 Favored 'General case' 0 C--N 1.354 0.787 0 O-C-N 121.679 -0.638 . . . . 0.0 109.708 -178.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.499 HD22 ' HB3' ' A' ' 54' ' ' LYS . 10.2 mt -64.81 -37.47 87.71 Favored 'General case' 0 C--N 1.353 0.757 0 C-N-CA 120.566 -0.454 . . . . 0.0 109.777 -178.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.433 HD21 ' CE ' ' A' ' 10' ' ' MET . 83.6 mt -70.0 -17.24 63.27 Favored 'General case' 0 C--N 1.359 0.996 0 O-C-N 121.739 -0.6 . . . . 0.0 110.192 -179.171 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -84.66 -28.27 26.53 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 119.51 -0.876 . . . . 0.0 109.493 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 45.7 t -66.76 -36.89 83.47 Favored 'General case' 0 C--N 1.354 0.781 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.625 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 2.2 p -92.91 -37.98 11.96 Favored 'General case' 0 C--N 1.358 0.957 0 C-N-CA 118.936 -1.106 . . . . 0.0 108.031 -178.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.625 ' HB2' ' O ' ' A' ' 29' ' ' CYS . 14.9 mt-10 84.73 132.61 0.05 OUTLIER 'General case' 0 C--N 1.359 1.005 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.528 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -90.25 -167.67 1.9 Allowed 'General case' 0 C--N 1.356 0.85 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.286 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -154.25 -64.63 0.14 Allowed 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.5 t -97.26 -64.92 1.0 Allowed 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -139.21 -44.02 0.46 Allowed 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 -178.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.74 -35.97 3.0 Favored Glycine 0 C--N 1.352 1.448 0 N-CA-C 109.151 -1.579 . . . . 0.0 109.151 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 82.5 mt -110.84 101.92 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.782 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.613 ' CD2' HG23 ' A' ' 40' ' ' VAL . 0.4 OUTLIER -66.65 -57.27 7.53 Favored 'General case' 0 C--N 1.358 0.964 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 178.947 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.478 HG22 ' N ' ' A' ' 39' ' ' SER . 1.0 OUTLIER 148.65 -64.04 0.0 OUTLIER 'General case' 0 C--N 1.367 1.355 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 178.422 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.478 ' N ' HG22 ' A' ' 38' ' ' THR . 17.7 p 168.73 70.69 0.0 OUTLIER 'General case' 0 C--N 1.362 1.135 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.613 HG23 ' CD2' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -159.21 4.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.869 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.797 -179.438 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.78 -158.11 21.14 Favored Glycine 0 C--N 1.355 1.597 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 -179.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 171.17 85.34 0.0 OUTLIER 'General case' 0 CA--C 1.5 -0.963 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 -178.554 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -95.47 177.08 5.94 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -83.63 -170.82 3.25 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -91.93 -14.95 28.73 Favored 'General case' 0 CA--C 1.499 -0.992 0 C-N-CA 119.994 -0.682 . . . . 0.0 109.3 -179.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -69.85 -30.5 67.99 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.453 ' CG ' ' HZ ' ' A' ' 6' ' ' PHE . 33.0 tp10 -64.02 -40.82 97.18 Favored 'General case' 0 C--N 1.351 0.654 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.655 ' O ' HD23 ' A' ' 48' ' ' LEU . 4.6 tt -71.78 -35.52 70.05 Favored 'General case' 0 C--N 1.357 0.896 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -179.149 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 61.5 tp -69.99 -36.7 75.36 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -177.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 72.9 tp60 -65.0 -41.72 95.14 Favored 'General case' 0 N--CA 1.441 -0.881 0 O-C-N 121.87 -0.519 . . . . 0.0 109.707 -178.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 81.7 mt -73.94 -35.82 64.61 Favored 'General case' 0 C--N 1.364 1.2 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.28 -179.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.4 t -64.03 -39.05 84.07 Favored 'Isoleucine or valine' 0 C--N 1.353 0.76 0 O-C-N 121.904 -0.497 . . . . 0.0 109.759 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.8 t -67.66 -39.6 82.5 Favored 'Isoleucine or valine' 0 C--N 1.352 0.699 0 O-C-N 121.675 -0.641 . . . . 0.0 109.474 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.499 ' HB3' HD22 ' A' ' 25' ' ' LEU . 35.1 tptt -63.51 -28.7 70.13 Favored 'General case' 0 C--N 1.363 1.175 0 O-C-N 121.234 -0.916 . . . . 0.0 108.711 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.583 HD21 HD12 ' A' ' 13' ' ' ILE . 14.1 mt -66.65 -38.3 86.6 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.439 179.097 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.6 p -72.54 -17.79 61.69 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.879 -178.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -101.72 -38.68 7.78 Favored 'General case' 0 C--N 1.353 0.729 0 C-N-CA 119.358 -0.937 . . . . 0.0 111.813 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.6 p -74.38 -37.48 45.05 Favored 'Isoleucine or valine' 0 C--N 1.352 0.704 0 O-C-N 121.515 -0.741 . . . . 0.0 111.255 -176.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.569 ' HB3' HG23 ' A' ' 61' ' ' VAL . 1.9 t -110.57 -9.44 14.55 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 119.249 -0.981 . . . . 0.0 110.281 -178.073 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 65.29 49.26 1.97 Allowed 'General case' 0 C--N 1.354 0.792 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.569 HG23 ' HB3' ' A' ' 59' ' ' SER . 58.2 t -113.92 133.49 22.3 Favored Pre-proline 0 CA--C 1.504 -0.822 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 61' ' ' VAL . 43.2 Cg_exo -57.88 147.44 81.42 Favored 'Trans proline' 0 CA--C 1.499 -1.229 0 C-N-CA 122.581 2.187 . . . . 0.0 112.825 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.2 m -74.51 -13.03 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.912 -178.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.411 ' O ' HG12 ' A' ' 67' ' ' VAL . 68.2 p -95.95 -32.03 12.8 Favored 'General case' 0 C--N 1.357 0.922 0 C-N-CA 118.151 -1.42 . . . . 0.0 109.509 -179.13 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -76.44 -24.43 53.93 Favored 'General case' 0 C--N 1.355 0.819 0 O-C-N 121.452 -0.78 . . . . 0.0 109.201 179.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.435 HD13 HD13 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -80.15 -36.92 34.48 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -179.029 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.411 HG12 ' O ' ' A' ' 64' ' ' THR . 1.5 p -67.97 -26.87 35.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.737 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.036 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 5.2 mmm-85 -73.14 -51.17 18.92 Favored 'General case' 0 C--N 1.362 1.151 0 O-C-N 121.549 -0.719 . . . . 0.0 110.283 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.1 mt -63.64 -36.24 83.16 Favored 'General case' 0 C--N 1.357 0.929 0 O-C-N 121.959 -0.463 . . . . 0.0 111.003 -178.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -60.85 -47.83 84.57 Favored 'General case' 0 C--N 1.349 0.575 0 O-C-N 122.155 -0.341 . . . . 0.0 110.596 -178.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.76 -38.09 94.65 Favored Glycine 0 C--N 1.355 1.592 0 N-CA-C 111.854 -0.498 . . . . 0.0 111.854 -178.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -63.64 -47.94 79.27 Favored 'General case' 0 C--N 1.35 0.588 0 CA-C-N 117.976 0.888 . . . . 0.0 111.508 -177.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.639 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 12.6 mttm -64.65 -48.51 74.55 Favored 'General case' 0 C--N 1.358 0.973 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -177.114 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.413 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.3 tm? -68.71 -39.2 80.56 Favored 'General case' 0 C--N 1.348 0.507 0 O-C-N 121.3 -0.875 . . . . 0.0 111.926 -175.553 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.602 ' HE1' ' CBB' ' A' ' 202' ' ' HEM . 40.7 t80 -63.22 -44.33 95.56 Favored 'General case' 0 C--N 1.354 0.766 0 O-C-N 121.068 -1.02 . . . . 0.0 111.044 -178.193 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.12 -15.23 18.55 Favored 'Isoleucine or valine' 0 C--N 1.359 0.982 0 O-C-N 121.509 -0.744 . . . . 0.0 109.184 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.639 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 69.5 mm-40 -71.8 -38.83 70.18 Favored 'General case' 0 C--N 1.349 0.574 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.2 mt -72.98 -32.37 65.15 Favored 'General case' 0 C--N 1.358 0.946 0 O-C-N 122.309 -0.244 . . . . 0.0 110.471 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.8 mm -64.58 -53.43 42.53 Favored 'Isoleucine or valine' 0 C--N 1.357 0.922 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.372 -177.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -75.39 -15.49 60.45 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 119.624 -0.831 . . . . 0.0 109.337 178.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.11 -37.06 64.0 Favored Glycine 0 C--N 1.35 1.348 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -131.33 105.73 14.69 Favored Pre-proline 0 N--CA 1.441 -0.922 0 CA-C-O 122.643 1.211 . . . . 0.0 109.321 -176.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.99 -25.88 37.91 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.614 2.209 . . . . 0.0 114.146 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -89.0 -8.26 54.41 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.2 tp -90.26 -20.56 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -178.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.41 -23.57 14.71 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -70.06 -37.42 75.51 Favored 'General case' 0 C--N 1.358 0.949 0 C-N-CA 120.264 -0.575 . . . . 0.0 109.527 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -64.9 -36.21 83.63 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.333 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 25.9 ttp -82.75 149.31 27.34 Favored 'General case' 0 C--N 1.351 0.646 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 -178.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.59 -22.27 8.17 Favored 'General case' 0 C--N 1.361 1.093 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.831 -177.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -165.25 171.76 13.23 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -177.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.418 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 41.0 t -64.3 -42.07 96.54 Favored 'General case' 0 C--N 1.357 0.921 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.08 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -66.54 -38.55 87.37 Favored 'General case' 0 C--N 1.355 0.81 0 O-C-N 121.437 -0.789 . . . . 0.0 109.493 -178.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -65.65 -25.31 67.3 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.418 ' HB3' ' O ' ' A' ' 92' ' ' SER . 57.6 tp -63.21 -46.62 86.16 Favored 'General case' 0 C--N 1.357 0.928 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.1 mp -61.78 -32.64 72.93 Favored 'General case' 0 C--N 1.356 0.862 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 36.0 t -62.87 -44.74 95.29 Favored 'General case' 0 C--N 1.354 0.762 0 O-C-N 121.931 -0.481 . . . . 0.0 111.584 -178.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.97 26.88 10.1 Favored 'General case' 0 C--N 1.364 1.225 0 O-C-N 120.939 -1.101 . . . . 0.0 111.132 -177.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 1.035 HD11 ' C3B' ' A' ' 202' ' ' HEM . 8.9 tp -61.31 -30.33 47.72 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 C-N-CA 120.431 -0.507 . . . . 0.0 110.539 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -126.95 -7.78 6.05 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 118.484 -1.287 . . . . 0.0 110.005 -179.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 57.5 m -90.43 -3.36 57.73 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.442 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -149.0 -47.39 0.14 Allowed 'General case' 0 C--N 1.358 0.956 0 C-N-CA 118.132 -1.427 . . . . 0.0 110.043 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.494 HG23 HBC2 ' A' ' 202' ' ' HEM . 96.2 mt -67.41 -47.29 81.35 Favored 'Isoleucine or valine' 0 C--N 1.354 0.802 0 O-C-N 121.926 -0.484 . . . . 0.0 110.979 -177.603 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -84.65 0.33 50.69 Favored 'General case' 0 C--N 1.353 0.754 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.933 -177.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 77.3 t -80.78 -45.01 21.53 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.975 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -67.45 -40.0 85.39 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.959 -179.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.754 HG11 HMD1 ' A' ' 202' ' ' HEM . 64.8 t -62.96 -46.71 95.61 Favored 'Isoleucine or valine' 0 C--N 1.354 0.782 0 O-C-N 122.155 -0.341 . . . . 0.0 110.742 -178.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -60.21 -47.85 84.2 Favored 'General case' 0 C--N 1.358 0.945 0 O-C-N 122.112 -0.367 . . . . 0.0 111.361 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -62.91 -36.18 82.53 Favored 'General case' 0 C--N 1.353 0.753 0 O-C-N 121.545 -0.722 . . . . 0.0 110.502 -178.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.5 mt -59.08 -77.22 0.04 OUTLIER 'General case' 0 C--N 1.357 0.931 0 C-N-CA 120.444 -0.503 . . . . 0.0 109.809 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.403 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 81.1 m-85 -111.13 141.76 24.95 Favored Pre-proline 0 N--CA 1.442 -0.863 0 C-N-CA 118.583 -1.247 . . . . 0.0 109.553 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 111' ' ' TYR . 51.3 Cg_endo -90.73 0.63 5.06 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 123.781 2.988 . . . . 0.0 115.216 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -86.1 4.42 38.29 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 121.63 -0.668 . . . . 0.0 109.851 -178.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -96.1 143.81 26.91 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 119.798 -0.761 . . . . 0.0 109.7 -178.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -119.51 141.43 49.21 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 178.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 95.6 mt -136.53 152.97 75.71 Favored Pre-proline 0 C--N 1.355 0.831 0 CA-C-O 122.198 0.999 . . . . 0.0 109.518 -178.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.421 ' HG3' HBA1 ' A' ' 202' ' ' HEM . 78.3 Cg_endo -87.19 -158.15 0.08 OUTLIER 'Trans proline' 0 C--N 1.32 -0.925 0 C-N-CA 123.96 3.106 . . . . 0.0 113.894 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -114.84 139.2 49.95 Favored 'General case' 0 C--N 1.368 1.38 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -125.32 127.31 46.45 Favored 'General case' 0 C--N 1.362 1.13 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -178.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.51 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 93.9 m -125.47 128.79 48.6 Favored 'General case' 0 C--N 1.357 0.912 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 177.309 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 73.7 m -119.76 128.12 53.45 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 119.323 -0.951 . . . . 0.0 109.506 -178.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -122.18 145.44 48.19 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 178.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.661 ' HG2' ' H ' ' A' ' 124' ' ' LEU . 35.4 ttp180 -100.33 -169.02 1.66 Allowed 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.661 ' H ' ' HG2' ' A' ' 123' ' ' ARG . 21.9 mt -165.12 -36.91 0.03 OUTLIER 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 -178.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -171.03 -150.89 7.27 Favored Glycine 0 C--N 1.353 1.503 0 N-CA-C 108.241 -1.944 . . . . 0.0 108.241 -178.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -94.29 -40.1 10.16 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.331 -179.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -97.64 3.84 50.27 Favored 'General case' 0 C--N 1.352 0.683 0 C-N-CA 120.216 -0.593 . . . . 0.0 110.276 -178.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -122.31 135.22 54.69 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 119.552 -0.859 . . . . 0.0 109.405 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.415 HD13 ' HA ' ' A' ' 129' ' ' ILE . 6.4 mm -142.11 136.9 29.94 Favored 'Isoleucine or valine' 0 C--N 1.356 0.87 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 178.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 52.3 mtm180 -114.88 138.47 50.76 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 8.3 tp -126.28 118.35 24.93 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.51 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 15.7 m-70 -98.27 134.43 41.32 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 179.212 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -130.3 121.43 26.05 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.544 ' HA ' ' O ' ' A' ' 171' ' ' THR . 75.1 mt-30 -114.15 114.69 26.39 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 19.4 t -161.52 150.41 15.95 Favored 'General case' 0 C--N 1.357 0.916 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -90.5 1.69 56.44 Favored 'General case' 0 C--N 1.355 0.805 0 C-N-CA 120.306 -0.557 . . . . 0.0 109.879 -178.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -136.78 74.57 51.37 Favored Pre-proline 0 CA--C 1.506 -0.742 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -94.11 110.6 0.18 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.657 2.238 . . . . 0.0 116.157 -177.272 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -111.56 109.7 19.74 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 176.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.4 -39.65 95.09 Favored 'General case' 0 C--N 1.355 0.811 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.518 -178.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 74.8 m -64.29 -24.93 67.83 Favored 'General case' 0 C--N 1.353 0.738 0 O-C-N 121.849 -0.532 . . . . 0.0 110.831 -178.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -76.51 -47.69 21.95 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 120.192 -0.603 . . . . 0.0 109.611 -178.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.1 -39.21 92.83 Favored 'General case' 0 C--N 1.357 0.93 0 O-C-N 122.115 -0.365 . . . . 0.0 111.123 -178.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -62.65 -37.29 85.77 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 121.801 -0.562 . . . . 0.0 109.77 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.27 -42.53 98.78 Favored Glycine 0 C--N 1.347 1.162 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.2 mt -70.46 -40.72 73.52 Favored 'General case' 0 C--N 1.352 0.687 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 96.3 mt -70.91 -41.97 70.54 Favored 'General case' 0 C--N 1.361 1.096 0 O-C-N 121.32 -0.862 . . . . 0.0 110.891 -177.016 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.551 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 36.8 t70 -70.33 -29.73 66.52 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 121.893 -0.504 . . . . 0.0 110.295 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -63.3 -39.43 97.83 Favored Glycine 0 C--N 1.356 1.656 0 N-CA-C 108.489 -1.844 . . . . 0.0 108.489 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 47.6 t -60.68 -42.25 96.73 Favored 'General case' 0 C--N 1.351 0.635 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -75.99 0.08 19.78 Favored 'General case' 0 C--N 1.36 1.025 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.551 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 76.5 mm-40 -84.6 -46.03 11.95 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.215 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -67.65 -43.77 79.51 Favored 'General case' 0 C--N 1.359 0.999 0 C-N-CA 120.109 -0.636 . . . . 0.0 109.559 179.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.467 ' O ' ' HB2' ' A' ' 155' ' ' LYS . 54.3 m-85 -70.42 -24.94 63.01 Favored 'General case' 0 C--N 1.361 1.087 0 O-C-N 121.734 -0.604 . . . . 0.0 111.311 -178.116 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 154' ' ' PHE . 47.9 mttt 73.62 67.82 0.1 Allowed 'General case' 0 C--N 1.362 1.116 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -178.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -134.16 -176.04 4.06 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -146.76 91.88 2.08 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 16.3 m-30 -113.54 157.73 21.66 Favored 'General case' 0 C--N 1.352 0.678 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 179.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 92.6 m -119.27 127.77 53.54 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 119.548 -0.861 . . . . 0.0 108.832 -178.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.554 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.2 mp -103.97 121.9 56.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.661 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 178.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.9 m -118.38 -173.69 2.52 Favored 'General case' 0 C--N 1.358 0.935 0 CA-C-O 121.661 0.743 . . . . 0.0 109.412 -178.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -146.97 157.0 43.5 Favored 'General case' 0 C--N 1.356 0.858 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 -178.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 49.6 p -99.64 146.37 31.7 Favored Pre-proline 0 C--N 1.358 0.974 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.685 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 73.9 Cg_endo -75.04 -12.0 21.42 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.941 2.427 . . . . 0.0 114.966 -178.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -72.63 -41.67 65.28 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.84 -178.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 37.8 p -117.21 15.5 14.92 Favored 'General case' 0 C--N 1.354 0.789 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.717 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.685 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.1 pp0? -67.59 -11.62 58.52 Favored 'General case' 0 C--N 1.354 0.796 0 O-C-N 121.569 -0.707 . . . . 0.0 110.245 178.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 54.4 p-10 -122.41 33.33 5.48 Favored 'General case' 0 N--CA 1.438 -1.038 0 O-C-N 121.148 -0.97 . . . . 0.0 108.707 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 57.8 m -135.67 148.37 48.9 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.634 ' O ' ' HB ' ' A' ' 171' ' ' THR . 60.8 mt-10 -100.77 166.12 11.03 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.634 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 6.9 m 83.26 -59.66 0.14 Allowed 'General case' 0 C--N 1.369 1.434 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -108.42 118.05 35.76 Favored 'General case' 0 CA--C 1.505 -0.77 0 C-N-CA 119.901 -0.72 . . . . 0.0 109.567 -178.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 97.2 t -131.01 132.78 63.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.916 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 178.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 49.5 mm -106.54 126.06 62.33 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -115.44 156.46 25.57 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 122.141 0.972 . . . . 0.0 108.562 -179.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -138.79 120.77 15.55 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -178.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.8 mp -115.06 121.12 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 89.1 m -117.96 143.26 46.52 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -177.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 30.4 ttm180 -90.85 118.77 30.52 Favored 'General case' 0 C--N 1.364 1.221 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.47 149.41 92.02 Favored Pre-proline 0 C--N 1.356 0.872 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.24 136.86 57.89 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.096 1.864 . . . . 0.0 113.672 -178.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' ARG . . . . . 0.47 HH11 ' HD2' ' A' ' 182' ' ' ARG . 1.7 mtm105 -136.71 153.51 50.86 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -179.328 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 92.18 -44.71 2.64 Favored Glycine 0 C--N 1.347 1.182 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 179.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -160.74 158.07 28.0 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 -179.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -118.82 115.05 23.61 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -122.81 124.45 43.34 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 75.4 mt -104.69 -66.81 0.94 Allowed 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -150.55 -91.5 0.06 Allowed 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -126.84 147.57 50.03 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 . . . . . 0 C--O 1.263 1.799 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 179.941 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 201' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 202' ' ' HEM . . . . . 1.036 HMA2 HBA2 ' A' ' 202' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.86 ' HG2' ' CMD' ' A' ' 202' ' ' HEM . 76.3 mmm . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 120.876 0.37 . . . . 0.0 110.17 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.52 -22.14 44.32 Favored 'General case' 0 C--N 1.356 0.854 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.059 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -76.16 -39.36 32.22 Favored Glycine 0 C--N 1.348 1.238 0 N-CA-C 109.084 -1.607 . . . . 0.0 109.084 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.4 tpp -70.63 -37.03 73.75 Favored 'General case' 0 C--N 1.353 0.725 0 O-C-N 122.297 -0.531 . . . . 0.0 110.593 -177.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.9 m -70.77 -22.46 23.24 Favored 'Isoleucine or valine' 0 C--N 1.358 0.939 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.527 ' HZ ' ' HG2' ' A' ' 47' ' ' GLU . 2.2 m-30 -69.92 -35.32 74.47 Favored 'General case' 0 C--N 1.357 0.912 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 84.9 m -67.06 -40.05 87.01 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.44 -37.86 95.35 Favored Glycine 0 C--N 1.358 1.753 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.637 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -66.96 -39.76 87.31 Favored 'General case' 0 C--N 1.352 0.681 0 CA-C-N 117.29 0.545 . . . . 0.0 110.544 -178.224 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.453 ' CE ' HD21 ' A' ' 26' ' ' LEU . 22.7 mmt -63.71 -41.16 98.14 Favored 'General case' 0 C--N 1.354 0.786 0 O-C-N 121.753 -0.592 . . . . 0.0 110.905 -178.33 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -66.38 -40.14 89.5 Favored 'General case' 0 C--N 1.349 0.572 0 O-C-N 121.989 -0.444 . . . . 0.0 111.381 -178.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 57.7 tp -66.43 -41.95 88.43 Favored 'General case' 0 C--N 1.35 0.608 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.637 HG12 ' O ' ' A' ' 9' ' ' LEU . 3.8 mm -73.78 -37.9 49.69 Favored 'Isoleucine or valine' 0 C--N 1.358 0.941 0 O-C-N 121.186 -0.947 . . . . 0.0 111.187 -176.082 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -69.05 -42.8 75.81 Favored 'General case' 0 C--N 1.352 0.714 0 O-C-N 121.7 -0.625 . . . . 0.0 111.236 -176.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -72.22 -33.24 67.43 Favored 'General case' 0 N--CA 1.446 -0.646 0 O-C-N 121.953 -0.467 . . . . 0.0 111.771 -177.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -73.02 -48.65 34.35 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -175.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -126.61 -20.33 4.36 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 117.718 -1.593 . . . . 0.0 112.367 -176.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 130.25 164.11 11.24 Favored Glycine 0 N--CA 1.437 -1.271 0 C-N-CA 118.102 -1.999 . . . . 0.0 110.809 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -67.08 -24.54 65.97 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 113.828 -1.186 . . . . 0.0 111.266 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -64.06 -44.27 92.95 Favored 'General case' 0 C--N 1.359 1.014 0 O-C-N 121.0 -1.062 . . . . 0.0 109.882 -179.098 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 94.2 m -67.24 -37.58 83.79 Favored 'General case' 0 C--N 1.352 0.717 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.454 HD13 ' HB ' ' A' ' 13' ' ' ILE . 33.3 tp -60.06 -37.59 80.32 Favored 'General case' 0 C--N 1.352 0.685 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.585 -179.267 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -66.14 -36.73 83.9 Favored 'General case' 0 C--N 1.356 0.87 0 O-C-N 122.105 -0.372 . . . . 0.0 110.704 -178.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.5 m -65.02 -40.43 94.87 Favored 'General case' 0 C--N 1.355 0.808 0 O-C-N 121.707 -0.621 . . . . 0.0 109.368 -178.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.443 HD21 HG11 ' A' ' 58' ' ' VAL . 83.2 mt -66.33 -36.32 82.63 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -179.036 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.453 HD21 ' CE ' ' A' ' 10' ' ' MET . 81.9 mt -72.41 -12.91 61.31 Favored 'General case' 0 C--N 1.36 1.042 0 O-C-N 121.819 -0.55 . . . . 0.0 110.106 -178.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -89.11 -26.23 21.45 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 119.098 -1.041 . . . . 0.0 108.971 178.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.9 t -67.76 -36.64 80.87 Favored 'General case' 0 C--N 1.358 0.936 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 178.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.636 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 1.8 p -92.92 -40.72 10.44 Favored 'General case' 0 C--N 1.359 0.985 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -179.107 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.636 ' HB2' ' O ' ' A' ' 29' ' ' CYS . 13.6 mt-10 84.94 134.71 0.05 Allowed 'General case' 0 C--N 1.361 1.089 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.007 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.493 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -85.79 -170.46 3.11 Favored 'General case' 0 C--N 1.358 0.936 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.49 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -150.99 -24.27 0.21 Allowed 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -179.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.3 t -148.84 -65.13 0.23 Allowed 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -178.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -130.73 -55.49 1.07 Allowed 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 -179.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 131.43 -41.21 1.54 Allowed Glycine 0 C--N 1.351 1.407 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 79.7 mt -106.84 101.67 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.57 ' O ' ' HB ' ' A' ' 38' ' ' THR . 0.8 OUTLIER -72.23 -30.05 64.53 Favored 'General case' 0 C--N 1.357 0.906 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.685 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.57 ' HB ' ' O ' ' A' ' 37' ' ' TYR . 8.0 m 114.71 -67.12 0.0 OUTLIER 'General case' 0 C--N 1.37 1.489 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.668 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.2 p 174.13 63.71 0.0 OUTLIER 'General case' 0 C--N 1.36 1.043 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -179.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.1 t -148.43 -5.03 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.831 0 C-N-CA 119.411 -0.916 . . . . 0.0 109.692 -178.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -98.12 143.92 16.96 Favored Glycine 0 C--N 1.352 1.428 0 C-N-CA 119.186 -1.483 . . . . 0.0 110.071 -178.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.0 m -124.07 122.61 38.33 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 178.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -117.14 175.86 5.4 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 -178.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -82.59 -172.04 3.83 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -90.97 -13.81 32.7 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 120.014 -0.674 . . . . 0.0 109.305 -179.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -70.12 -29.32 66.23 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.527 ' HG2' ' HZ ' ' A' ' 6' ' ' PHE . 25.9 tp10 -63.28 -40.33 97.08 Favored 'General case' 0 C--N 1.352 0.693 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.472 HD22 ' O ' ' A' ' 48' ' ' LEU . 1.8 tm? -67.63 -38.08 83.37 Favored 'General case' 0 C--N 1.357 0.9 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.44 ' O ' HG23 ' A' ' 53' ' ' VAL . 58.6 tp -73.9 -29.66 62.18 Favored 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 122.063 -0.398 . . . . 0.0 110.336 -176.704 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 71.6 tp60 -69.0 -40.09 78.95 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -178.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 81.3 mt -83.31 -17.17 43.42 Favored 'General case' 0 C--N 1.36 1.039 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.699 -178.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.1 t -82.25 -35.25 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 49' ' ' LEU . 55.1 t -69.07 -39.38 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.404 ' HB3' HD22 ' A' ' 25' ' ' LEU . 34.0 tptt -66.79 -32.09 73.15 Favored 'General case' 0 C--N 1.364 1.209 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -178.798 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.631 HD21 HD12 ' A' ' 13' ' ' ILE . 18.1 mt -62.78 -39.58 94.65 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.32 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.539 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 39.3 t -65.95 -36.61 83.8 Favored 'General case' 0 C--N 1.35 0.605 0 O-C-N 121.942 -0.474 . . . . 0.0 110.647 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -86.42 -37.65 18.15 Favored 'General case' 0 C--N 1.355 0.834 0 O-C-N 120.961 -1.087 . . . . 0.0 112.766 -177.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.443 HG11 HD21 ' A' ' 25' ' ' LEU . 4.9 p -75.47 -40.01 41.38 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 O-C-N 121.37 -0.831 . . . . 0.0 111.482 -176.414 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.4 t -106.5 -5.84 18.55 Favored 'General case' 0 C--N 1.352 0.69 0 C-N-CA 119.304 -0.958 . . . . 0.0 110.331 -177.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 56' ' ' SER . 72.3 m 65.29 39.91 5.11 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 56' ' ' SER . 59.4 t -114.72 124.77 29.97 Favored Pre-proline 0 CA--C 1.503 -0.831 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.93 155.33 33.73 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 122.803 2.335 . . . . 0.0 113.562 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.675 ' HA ' HD23 ' A' ' 66' ' ' LEU . 13.7 m -74.45 -12.09 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.89 -177.097 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.518 ' O ' HG12 ' A' ' 67' ' ' VAL . 72.9 p -94.2 -34.2 12.99 Favored 'General case' 0 C--N 1.357 0.905 0 C-N-CA 118.067 -1.453 . . . . 0.0 110.154 -178.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -80.21 -20.83 43.77 Favored 'General case' 0 C--N 1.354 0.803 0 O-C-N 121.202 -0.936 . . . . 0.0 109.13 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.675 HD23 ' HA ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -79.88 -34.43 39.19 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -179.757 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.518 HG12 ' O ' ' A' ' 64' ' ' THR . 2.4 p -69.82 -29.54 41.12 Favored 'Isoleucine or valine' 0 C--N 1.357 0.912 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.023 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -69.93 -48.1 59.78 Favored 'General case' 0 C--N 1.364 1.232 0 O-C-N 121.373 -0.83 . . . . 0.0 110.71 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.4 mt -64.36 -36.24 83.48 Favored 'General case' 0 C--N 1.355 0.828 0 O-C-N 121.949 -0.469 . . . . 0.0 110.796 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -61.08 -47.73 85.01 Favored 'General case' 0 C--N 1.35 0.593 0 O-C-N 122.212 -0.305 . . . . 0.0 110.715 -178.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.61 -38.95 96.69 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 119.817 -0.435 . . . . 0.0 112.227 -177.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -66.19 -45.35 81.1 Favored 'General case' 0 C--N 1.352 0.675 0 CA-C-N 118.441 1.121 . . . . 0.0 111.453 -176.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.731 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 6.6 mttm -64.16 -49.52 71.79 Favored 'General case' 0 C--N 1.356 0.886 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -177.284 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.47 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.5 tm? -68.12 -40.74 82.45 Favored 'General case' 0 C--N 1.349 0.568 0 O-C-N 121.358 -0.839 . . . . 0.0 112.219 -175.247 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -64.12 -44.55 91.89 Favored 'General case' 0 C--N 1.354 0.784 0 O-C-N 121.066 -1.021 . . . . 0.0 111.485 -177.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.65 -14.54 17.69 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 O-C-N 121.48 -0.762 . . . . 0.0 109.664 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.731 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 77.1 mm-40 -74.75 -37.82 62.38 Favored 'General case' 0 C--N 1.351 0.636 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 178.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.408 HD13 HBC2 ' A' ' 202' ' ' HEM . 73.9 mt -67.41 -37.41 83.03 Favored 'General case' 0 C--N 1.36 1.063 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.0 mm -63.1 -50.63 78.57 Favored 'Isoleucine or valine' 0 C--N 1.356 0.857 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 -178.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -68.12 -20.94 64.95 Favored 'General case' 0 C--N 1.35 0.595 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.494 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -99.2 -0.97 56.99 Favored Glycine 0 N--CA 1.437 -1.256 0 C-N-CA 119.509 -1.329 . . . . 0.0 110.713 -177.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.669 ' HB3' ' HB ' ' A' ' 85' ' ' ILE . 93.4 m-70 -139.14 88.88 12.83 Favored Pre-proline 0 CA--C 1.502 -0.892 0 CA-C-N 119.113 1.456 . . . . 0.0 109.044 -179.354 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 82' ' ' HIS . 31.9 Cg_endo -65.85 -27.78 51.26 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.504 2.136 . . . . 0.0 114.556 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -95.1 -4.2 46.69 Favored 'General case' 0 CA--C 1.502 -0.895 0 C-N-CA 119.388 -0.925 . . . . 0.0 108.978 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.669 ' HB ' ' HB3' ' A' ' 82' ' ' HIS . 0.1 OUTLIER -89.0 -19.68 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 -179.575 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -104.4 -23.39 13.19 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -68.55 -36.96 79.52 Favored 'General case' 0 C--N 1.362 1.129 0 O-C-N 121.656 -0.652 . . . . 0.0 109.372 178.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -65.42 -35.12 79.99 Favored 'General case' 0 C--N 1.356 0.883 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.416 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.453 ' SD ' ' HB2' ' A' ' 95' ' ' LEU . 18.1 ttp -83.69 151.14 25.42 Favored 'General case' 0 C--N 1.352 0.715 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -178.33 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.79 -22.8 9.49 Favored 'General case' 0 C--N 1.365 1.261 0 O-C-N 121.632 -0.667 . . . . 0.0 111.258 -177.447 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -166.0 172.26 11.65 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -177.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.424 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 63.4 m -66.42 -39.73 89.15 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.506 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -67.82 -39.33 83.92 Favored 'General case' 0 C--N 1.356 0.865 0 O-C-N 121.375 -0.828 . . . . 0.0 109.093 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -65.53 -24.61 67.16 Favored 'General case' 0 C--N 1.355 0.83 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.726 ' O ' HG13 ' A' ' 99' ' ' ILE . 64.9 tp -63.65 -46.92 83.41 Favored 'General case' 0 C--N 1.353 0.732 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.365 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.468 ' HA ' ' CD1' ' A' ' 99' ' ' ILE . 2.0 mp -59.81 -36.65 77.2 Favored 'General case' 0 C--N 1.361 1.081 0 O-C-N 122.143 -0.348 . . . . 0.0 110.28 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.7 t -70.2 -39.81 74.96 Favored 'General case' 0 C--N 1.348 0.519 0 O-C-N 122.003 -0.436 . . . . 0.0 110.238 -179.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -87.43 2.7 49.75 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 122.136 -0.353 . . . . 0.0 111.934 -176.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.726 HG13 ' O ' ' A' ' 95' ' ' LEU . 77.3 mt -61.18 -46.9 95.72 Favored 'Isoleucine or valine' 0 C--N 1.355 0.822 0 CA-C-N 119.156 0.889 . . . . 0.0 111.967 -177.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -94.66 -23.56 17.54 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 118.52 -1.272 . . . . 0.0 111.176 -177.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.0 t -63.63 -50.09 70.72 Favored 'General case' 0 N--CA 1.445 -0.718 0 O-C-N 121.644 -0.66 . . . . 0.0 112.527 -177.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.51 ' HA ' HG12 ' A' ' 105' ' ' VAL . 17.5 t80 -134.68 -15.89 2.06 Favored 'General case' 0 C--N 1.361 1.071 0 C-N-CA 117.352 -1.739 . . . . 0.0 113.578 -176.66 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.624 HG21 ' C1C' ' A' ' 202' ' ' HEM . 29.3 mm -71.15 -51.58 33.6 Favored 'Isoleucine or valine' 0 C--O 1.245 0.847 0 CA-C-N 120.493 1.497 . . . . 0.0 110.683 -177.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.457 ' HB3' HD21 ' A' ' 116' ' ' LEU . 64.7 m170 -91.58 1.49 57.1 Favored 'General case' 0 N--CA 1.439 -1.021 0 O-C-N 121.284 -0.885 . . . . 0.0 110.348 -177.046 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.51 HG12 ' HA ' ' A' ' 102' ' ' PHE . 1.2 p -88.8 -33.45 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 178.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.38 -40.36 67.31 Favored 'General case' 0 CA--C 1.5 -0.957 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.362 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -72.33 -37.05 57.15 Favored 'Isoleucine or valine' 0 C--N 1.355 0.809 0 C-N-CA 119.592 -0.843 . . . . 0.0 109.89 -178.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -61.24 -49.0 78.87 Favored 'General case' 0 C--N 1.362 1.115 0 O-C-N 121.786 -0.571 . . . . 0.0 110.828 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -60.0 -37.43 79.65 Favored 'General case' 0 C--N 1.357 0.908 0 O-C-N 121.639 -0.663 . . . . 0.0 110.057 -179.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 14.7 mt -57.15 -75.47 0.04 OUTLIER 'General case' 0 C--N 1.356 0.866 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.417 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 90.3 m-85 -119.82 136.8 25.08 Favored Pre-proline 0 N--CA 1.441 -0.915 0 C-N-CA 119.026 -1.069 . . . . 0.0 108.733 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 111' ' ' TYR . 76.6 Cg_endo -85.28 -1.96 9.3 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 123.205 2.603 . . . . 0.0 115.345 -178.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -67.52 -36.26 80.69 Favored 'General case' 0 C--N 1.354 0.784 0 O-C-N 121.712 -0.617 . . . . 0.0 110.229 -179.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.34 144.42 56.97 Favored 'General case' 0 C--N 1.354 0.792 0 CA-C-O 121.647 0.737 . . . . 0.0 109.995 -178.218 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -114.54 148.08 38.49 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.462 ' HA ' ' HD3' ' A' ' 117' ' ' PRO . 1.2 mp -128.6 144.11 50.93 Favored Pre-proline 0 N--CA 1.442 -0.841 0 CA-C-O 122.143 0.973 . . . . 0.0 109.099 -178.399 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 116' ' ' LEU . 97.6 Cg_endo -87.68 -155.46 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.215 0 C-N-CA 123.738 2.959 . . . . 0.0 112.959 179.197 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -120.21 140.26 51.42 Favored 'General case' 0 C--N 1.363 1.165 0 C-N-CA 119.142 -1.023 . . . . 0.0 108.316 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -133.03 133.4 43.03 Favored 'General case' 0 C--N 1.362 1.114 0 C-N-CA 120.069 -0.653 . . . . 0.0 109.835 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.427 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 93.6 m -124.22 128.03 48.58 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 176.572 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 74.7 m -118.78 127.68 53.76 Favored 'General case' 0 CA--C 1.503 -0.848 0 C-N-CA 119.162 -1.015 . . . . 0.0 109.52 -177.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -116.9 153.14 33.09 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 178.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 57.4 ttp180 -123.72 117.17 24.34 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 95.9 mt -90.28 -16.69 28.82 Favored 'General case' 0 C--N 1.355 0.831 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.55 -179.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 174.77 -148.9 10.0 Favored Glycine 0 N--CA 1.437 -1.236 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -94.1 -37.18 11.74 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ASN . . . . . 0.455 ' HB2' ' HG2' ' A' ' 179' ' ' ARG . 41.3 p-10 -102.45 1.22 34.96 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 119.886 -0.725 . . . . 0.0 110.315 -178.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -119.8 131.57 55.36 Favored 'General case' 0 C--N 1.358 0.977 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 7.9 mm -141.29 136.25 32.58 Favored 'Isoleucine or valine' 0 C--N 1.354 0.778 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 179.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 53.5 mtm180 -116.04 139.18 50.54 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.3 tp -127.93 117.42 21.72 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.427 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 12.0 m170 -96.78 133.98 40.65 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 179.119 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -129.77 122.44 28.83 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -178.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.553 ' HA ' ' O ' ' A' ' 171' ' ' THR . 76.2 mt-30 -116.21 115.7 26.47 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 12.8 t -163.22 155.19 17.84 Favored 'General case' 0 C--N 1.36 1.023 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -91.66 2.33 56.55 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 121.821 -0.55 . . . . 0.0 109.873 -178.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 93.6 mtm-85 -135.08 74.32 63.09 Favored Pre-proline 0 CA--C 1.505 -0.771 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -95.39 105.64 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.736 2.291 . . . . 0.0 115.7 -177.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -112.41 114.1 26.63 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 176.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.89 -38.82 92.52 Favored 'General case' 0 C--N 1.355 0.805 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.242 -179.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.3 m -63.63 -27.03 68.95 Favored 'General case' 0 C--N 1.354 0.782 0 O-C-N 121.926 -0.484 . . . . 0.0 110.827 -178.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -76.58 -47.87 21.1 Favored 'General case' 0 N--CA 1.446 -0.642 0 O-C-N 121.763 -0.586 . . . . 0.0 109.856 -177.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.49 -39.6 94.1 Favored 'General case' 0 C--N 1.357 0.895 0 O-C-N 122.183 -0.323 . . . . 0.0 111.149 -177.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -63.27 -37.64 88.04 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 121.907 -0.495 . . . . 0.0 109.927 -179.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.03 -42.91 98.6 Favored Glycine 0 C--N 1.348 1.217 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 -179.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 83.6 mt -70.06 -40.84 74.85 Favored 'General case' 0 C--N 1.353 0.747 0 CA-C-N 117.774 0.787 . . . . 0.0 112.549 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 97.7 mt -71.03 -42.07 70.01 Favored 'General case' 0 C--N 1.36 1.061 0 O-C-N 121.271 -0.893 . . . . 0.0 110.551 -176.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.479 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 21.5 t70 -69.17 -32.09 71.17 Favored 'General case' 0 N--CA 1.445 -0.723 0 O-C-N 122.211 -0.306 . . . . 0.0 110.505 -179.213 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -63.04 -39.85 98.55 Favored Glycine 0 C--N 1.357 1.707 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' CYS . . . . . 0.42 ' SG ' HD22 ' A' ' 95' ' ' LEU . 49.5 t -61.14 -42.11 97.95 Favored 'General case' 0 C--N 1.35 0.594 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.665 ' HB1' ' O ' ' A' ' 156' ' ' GLU . . . -73.84 -2.39 23.48 Favored 'General case' 0 C--N 1.359 1.001 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.479 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 74.5 mm-40 -83.17 -45.96 13.29 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.052 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 92.9 t80 -65.89 -45.06 83.4 Favored 'General case' 0 C--N 1.359 1.008 0 C-N-CA 120.154 -0.619 . . . . 0.0 109.609 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -68.88 -26.4 65.1 Favored 'General case' 0 C--N 1.363 1.158 0 O-C-N 121.716 -0.615 . . . . 0.0 111.023 -178.182 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 78.2 tttt 74.39 71.95 0.11 Allowed 'General case' 0 C--N 1.361 1.072 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.665 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 5.4 tp10 -161.34 125.24 3.35 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 178.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -87.25 108.35 18.9 Favored 'General case' 0 C--N 1.354 0.788 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.339 -179.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 9.3 m-30 -107.37 163.89 12.65 Favored 'General case' 0 C--N 1.353 0.734 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 177.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 95.5 m -121.37 129.21 52.92 Favored 'General case' 0 C--N 1.354 0.802 0 C-N-CA 118.972 -1.091 . . . . 0.0 109.41 -178.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.509 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.6 mp -110.5 122.12 64.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 178.349 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.7 m -119.12 -171.87 2.19 Favored 'General case' 0 C--N 1.357 0.916 0 CA-C-O 121.674 0.75 . . . . 0.0 109.245 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.11 159.29 44.53 Favored 'General case' 0 C--N 1.357 0.913 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 -178.371 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 64.6 p -100.72 146.83 32.76 Favored Pre-proline 0 C--N 1.359 1.012 0 CA-C-O 122.471 1.129 . . . . 0.0 108.298 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.641 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 73.5 Cg_endo -76.22 -11.49 19.32 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.957 2.438 . . . . 0.0 115.193 -178.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -72.11 -41.44 67.24 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 119.936 -0.705 . . . . 0.0 109.42 -178.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 31.4 p -116.73 16.5 15.34 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 120.159 -0.616 . . . . 0.0 110.323 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.641 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.2 pp0? -66.73 -10.29 45.49 Favored 'General case' 0 C--N 1.354 0.796 0 O-C-N 121.642 -0.661 . . . . 0.0 110.45 178.75 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -128.02 38.69 3.97 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 74.8 m -136.54 146.34 46.07 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.675 ' O ' ' HB ' ' A' ' 171' ' ' THR . 59.2 mp0 -99.61 162.55 12.95 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.675 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 1.5 m 84.53 -57.72 0.11 Allowed 'General case' 0 C--N 1.369 1.455 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.566 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -109.67 118.38 36.4 Favored 'General case' 0 CA--C 1.505 -0.75 0 C-N-CA 119.798 -0.761 . . . . 0.0 109.789 -178.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 97.5 t -132.4 132.32 60.42 Favored 'Isoleucine or valine' 0 C--N 1.36 1.065 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 178.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 50.3 mm -105.31 127.46 60.03 Favored 'Isoleucine or valine' 0 C--N 1.356 0.89 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -116.31 153.82 31.29 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -136.73 119.36 16.02 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -178.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.0 mp -114.21 119.06 60.29 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 -179.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 88.4 m -126.62 140.76 52.18 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -177.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.455 ' HG2' ' HB2' ' A' ' 127' ' ' ASN . 39.7 ptt180 -80.48 121.4 25.71 Favored 'General case' 0 C--N 1.366 1.285 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 179.073 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -66.07 149.17 97.97 Favored Pre-proline 0 CA--C 1.499 -1.008 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.19 122.63 11.8 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.44 2.093 . . . . 0.0 113.204 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -138.78 148.57 44.0 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.493 ' O ' ' HB3' ' A' ' 184' ' ' ALA . . . 72.51 62.0 3.41 Favored Glycine 0 C--N 1.353 1.504 0 N-CA-C 108.155 -1.978 . . . . 0.0 108.155 -179.5 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' A' ' 183' ' ' GLY . . . 78.24 167.55 0.22 Allowed 'General case' 0 C--N 1.362 1.131 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.26 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -131.4 121.27 24.33 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -123.67 128.88 50.27 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.09 -76.98 0.6 Allowed 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -131.59 -87.82 0.47 Allowed 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -127.89 147.31 50.45 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 . . . . . 0 C--O 1.265 1.874 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -179.964 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 201' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 202' ' ' HEM . . . . . 0.86 ' CMD' ' HG2' ' A' ' 1' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.415 ' HB2' ' HB2' ' A' ' 4' ' ' MET . 2.3 mmm . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 120.943 0.401 . . . . 0.0 110.07 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.426 ' HA ' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -80.63 -18.72 47.25 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 120.161 -0.616 . . . . 0.0 109.353 -179.043 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.11 -40.92 49.35 Favored Glycine 0 C--N 1.353 1.497 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.415 ' HB2' ' HB2' ' A' ' 1' ' ' MET . 4.9 mtm -70.39 -36.33 74.04 Favored 'General case' 0 C--N 1.36 1.044 0 O-C-N 121.836 -0.802 . . . . 0.0 111.335 -178.147 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.426 HG22 ' HA ' ' A' ' 2' ' ' MET . 34.6 m -69.4 -22.95 25.97 Favored 'Isoleucine or valine' 0 C--N 1.356 0.872 0 O-C-N 121.555 -0.715 . . . . 0.0 109.366 -178.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -71.05 -35.85 72.1 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 85.4 m -67.07 -41.37 86.51 Favored 'General case' 0 C--N 1.356 0.881 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.62 -39.01 97.36 Favored Glycine 0 C--N 1.359 1.81 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.712 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -64.99 -40.37 94.86 Favored 'General case' 0 C--N 1.351 0.658 0 CA-C-N 117.3 0.55 . . . . 0.0 110.731 -178.471 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' MET . . . . . 0.46 ' CE ' HD21 ' A' ' 26' ' ' LEU . 21.1 mmt -63.47 -40.68 97.76 Favored 'General case' 0 C--N 1.351 0.665 0 O-C-N 121.606 -0.684 . . . . 0.0 110.981 -178.203 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -67.23 -41.71 85.21 Favored 'General case' 0 C--N 1.35 0.611 0 O-C-N 121.859 -0.526 . . . . 0.0 111.691 -178.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 59.6 tp -65.61 -43.39 89.77 Favored 'General case' 0 C--N 1.35 0.598 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -178.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.712 HG12 ' O ' ' A' ' 9' ' ' LEU . 2.4 mm -72.92 -36.9 52.83 Favored 'Isoleucine or valine' 0 C--N 1.356 0.883 0 O-C-N 121.167 -0.958 . . . . 0.0 111.091 -175.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -65.99 -43.31 88.14 Favored 'General case' 0 C--N 1.352 0.688 0 O-C-N 121.746 -0.596 . . . . 0.0 111.663 -176.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -73.67 -37.27 65.31 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 121.773 -0.579 . . . . 0.0 112.279 -176.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -71.9 -41.64 67.72 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -175.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -129.9 -27.1 2.34 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 117.43 -1.708 . . . . 0.0 113.358 -177.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 148.19 -179.94 24.65 Favored Glycine 0 C--N 1.346 1.115 0 C-N-CA 117.499 -2.286 . . . . 0.0 110.664 -179.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 93.4 t80 -98.05 -20.41 17.39 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -177.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -70.27 -40.16 74.51 Favored 'General case' 0 C--N 1.361 1.085 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.3 m -68.35 -38.15 81.19 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.404 HD13 ' HB ' ' A' ' 13' ' ' ILE . 31.6 tp -59.97 -37.6 80.1 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -66.22 -35.18 79.77 Favored 'General case' 0 C--N 1.359 0.989 0 O-C-N 121.989 -0.444 . . . . 0.0 110.81 -178.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.8 m -64.86 -39.26 93.27 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -178.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.662 HD13 HD22 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -62.83 -38.12 89.48 Favored 'General case' 0 C--N 1.352 0.696 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 -179.266 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.46 HD21 ' CE ' ' A' ' 10' ' ' MET . 80.4 mt -74.52 -12.89 60.59 Favored 'General case' 0 C--N 1.358 0.947 0 O-C-N 121.768 -0.582 . . . . 0.0 110.746 -178.554 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -87.71 -27.11 22.6 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 119.1 -1.04 . . . . 0.0 108.929 178.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.9 t -67.15 -37.36 83.66 Favored 'General case' 0 C--N 1.357 0.905 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.621 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 2.0 p -93.25 -37.72 11.91 Favored 'General case' 0 C--N 1.358 0.935 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.621 ' HB2' ' O ' ' A' ' 29' ' ' CYS . 9.9 mt-10 85.37 133.57 0.05 OUTLIER 'General case' 0 C--N 1.359 0.979 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.491 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -85.37 -169.9 2.87 Favored 'General case' 0 C--N 1.358 0.954 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -150.84 -26.49 0.22 Allowed 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -179.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.7 t -146.65 -66.97 0.28 Allowed 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -178.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -130.33 -50.65 1.09 Allowed 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -178.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 127.86 -40.08 1.8 Allowed Glycine 0 C--N 1.351 1.382 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 86.4 mt -110.01 101.71 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.86 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -100.33 1.63 41.74 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.786 HG22 ' H ' ' A' ' 39' ' ' SER . 1.7 m 74.46 -176.56 0.15 Allowed 'General case' 0 C--N 1.362 1.144 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 -178.447 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.786 ' H ' HG22 ' A' ' 38' ' ' THR . 28.1 p -87.99 104.69 16.87 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 121.184 -0.948 . . . . 0.0 108.788 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.426 HG12 ' O ' ' A' ' 40' ' ' VAL . 61.4 t -152.99 -21.29 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.361 1.1 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.402 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.76 171.59 13.86 Favored Glycine 0 C--N 1.357 1.696 0 C-N-CA 119.049 -1.548 . . . . 0.0 110.162 -176.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 59.2 m -131.29 136.05 47.83 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -121.31 175.42 6.15 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -78.48 -176.17 4.65 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.522 ' CE1' HH12 ' A' ' 137' ' ' ARG . 81.7 m-70 -94.15 -15.13 24.94 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.441 -178.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -68.86 -27.78 66.13 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 177.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.2 tp10 -62.62 -40.32 96.59 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -68.93 -38.65 79.65 Favored 'General case' 0 C--N 1.357 0.933 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 59.2 tp -70.39 -35.05 73.24 Favored 'General case' 0 CA--C 1.506 -0.712 0 O-C-N 122.099 -0.376 . . . . 0.0 110.14 -176.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 71.7 tp60 -66.6 -39.94 88.63 Favored 'General case' 0 N--CA 1.443 -0.781 0 O-C-N 121.873 -0.517 . . . . 0.0 109.779 -178.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.662 HD22 HD13 ' A' ' 25' ' ' LEU . 68.3 mt -80.68 -18.01 49.32 Favored 'General case' 0 C--N 1.363 1.171 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.301 -179.017 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -80.35 -34.81 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 54.3 t -70.17 -40.48 78.22 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.419 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 33.5 tptt -65.75 -27.6 68.42 Favored 'General case' 0 C--N 1.364 1.226 0 O-C-N 121.231 -0.918 . . . . 0.0 108.737 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.422 ' O ' HD23 ' A' ' 55' ' ' LEU . 1.5 tt -68.5 -37.37 80.01 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.7 p -72.07 -18.72 61.91 Favored 'General case' 0 C--N 1.359 0.992 0 O-C-N 121.439 -0.788 . . . . 0.0 110.704 -178.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -99.89 -36.4 9.43 Favored 'General case' 0 C--N 1.353 0.738 0 O-C-N 121.3 -0.875 . . . . 0.0 111.424 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.7 p -72.94 -36.52 51.76 Favored 'Isoleucine or valine' 0 C--N 1.35 0.62 0 O-C-N 121.717 -0.614 . . . . 0.0 111.294 -177.051 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 74.7 m -114.09 -6.68 13.09 Favored 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 119.35 -0.94 . . . . 0.0 109.936 -178.051 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 64.31 50.31 2.35 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.615 HG13 ' HD2' ' A' ' 62' ' ' PRO . 56.1 t -113.81 136.14 22.05 Favored Pre-proline 0 CA--C 1.505 -0.778 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.688 ' HG2' ' HB2' ' A' ' 65' ' ' GLU . 23.3 Cg_endo -62.36 149.22 91.58 Favored 'Trans proline' 0 CA--C 1.5 -1.192 0 C-N-CA 122.226 1.95 . . . . 0.0 112.391 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.5 m -75.83 -14.16 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.344 -177.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.467 ' O ' HG12 ' A' ' 67' ' ' VAL . 68.7 p -94.71 -34.65 12.47 Favored 'General case' 0 C--N 1.358 0.939 0 C-N-CA 118.347 -1.341 . . . . 0.0 109.722 -178.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.688 ' HB2' ' HG2' ' A' ' 62' ' ' PRO . 97.7 mt-10 -78.32 -20.48 51.34 Favored 'General case' 0 C--N 1.354 0.768 0 O-C-N 121.31 -0.869 . . . . 0.0 109.075 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.404 ' HB3' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -79.7 -37.67 35.19 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -179.624 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.467 HG12 ' O ' ' A' ' 64' ' ' THR . 1.8 p -67.92 -25.82 33.25 Favored 'Isoleucine or valine' 0 C--N 1.354 0.8 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.812 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 9.3 mtp180 -72.61 -53.17 12.61 Favored 'General case' 0 C--N 1.364 1.216 0 O-C-N 121.467 -0.771 . . . . 0.0 110.532 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 92.3 mt -63.07 -34.81 78.39 Favored 'General case' 0 C--N 1.357 0.927 0 O-C-N 121.933 -0.479 . . . . 0.0 111.031 -178.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -60.69 -47.34 86.72 Favored 'General case' 0 C--N 1.348 0.519 0 O-C-N 122.138 -0.351 . . . . 0.0 110.244 -178.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.44 -38.31 94.6 Favored Glycine 0 C--N 1.357 1.696 0 N-CA-C 111.766 -0.534 . . . . 0.0 111.766 -178.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.19 -49.04 75.81 Favored 'General case' 0 C--N 1.352 0.696 0 CA-C-N 118.264 1.032 . . . . 0.0 111.821 -177.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.542 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 8.4 mttm -64.26 -47.86 77.96 Favored 'General case' 0 C--N 1.358 0.948 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -177.159 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -68.66 -39.06 80.84 Favored 'General case' 0 C--N 1.35 0.624 0 O-C-N 121.055 -1.028 . . . . 0.0 111.92 -175.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -65.36 -43.23 91.45 Favored 'General case' 0 C--N 1.356 0.855 0 O-C-N 121.126 -0.984 . . . . 0.0 111.46 -177.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -72.16 -12.68 16.05 Favored 'Isoleucine or valine' 0 C--N 1.359 1.004 0 O-C-N 121.149 -0.969 . . . . 0.0 109.266 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.542 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 70.1 mm-40 -81.33 -29.78 34.06 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.183 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 73.3 mt -72.9 -34.69 66.81 Favored 'General case' 0 C--N 1.358 0.946 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.7 mm -64.63 -50.75 74.27 Favored 'Isoleucine or valine' 0 C--N 1.357 0.91 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -178.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -69.42 -28.29 66.01 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -66.68 -34.15 86.56 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -178.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.442 ' HA ' ' HD2' ' A' ' 83' ' ' PRO . 96.7 m-70 -135.7 101.34 10.76 Favored Pre-proline 0 CA--C 1.501 -0.91 0 CA-C-N 118.511 1.155 . . . . 0.0 109.372 -176.648 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' A' ' 82' ' ' HIS . 34.7 Cg_endo -66.85 -22.52 49.03 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.416 2.077 . . . . 0.0 113.607 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.425 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 42.5 mt-10 -91.87 -6.14 52.05 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.403 HG22 ' O ' ' A' ' 82' ' ' HIS . 1.6 tp -90.32 -19.65 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.23 -26.09 14.04 Favored 'General case' 0 C--N 1.361 1.084 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -70.75 -34.73 72.15 Favored 'General case' 0 C--N 1.356 0.875 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.425 ' HG2' ' O ' ' A' ' 84' ' ' GLU . 78.2 mm-40 -65.49 -36.25 83.28 Favored 'General case' 0 C--N 1.357 0.919 0 O-C-N 122.023 -0.423 . . . . 0.0 110.254 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.427 ' SD ' ' HB2' ' A' ' 95' ' ' LEU . 16.6 ttp -83.12 153.04 25.03 Favored 'General case' 0 C--N 1.353 0.743 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -178.509 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.96 -24.13 7.2 Favored 'General case' 0 C--N 1.365 1.253 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.352 -176.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -164.63 170.57 15.54 Favored 'General case' 0 C--N 1.354 0.802 0 C-N-CA 119.098 -1.041 . . . . 0.0 108.344 -177.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 39.7 t -64.01 -43.4 95.76 Favored 'General case' 0 C--N 1.357 0.899 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.489 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -66.33 -39.61 89.36 Favored 'General case' 0 C--N 1.355 0.816 0 O-C-N 121.366 -0.834 . . . . 0.0 109.255 -178.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -65.09 -25.73 67.92 Favored 'General case' 0 C--N 1.353 0.76 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.602 ' O ' HG13 ' A' ' 99' ' ' ILE . 61.8 tp -63.37 -46.46 86.39 Favored 'General case' 0 C--N 1.356 0.867 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.43 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.2 mp -59.54 -34.79 73.1 Favored 'General case' 0 C--N 1.357 0.917 0 O-C-N 122.177 -0.327 . . . . 0.0 110.591 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.4 t -69.88 -39.28 76.4 Favored 'General case' 0 C--N 1.348 0.538 0 O-C-N 121.917 -0.49 . . . . 0.0 109.944 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -90.97 4.11 52.88 Favored 'General case' 0 C--N 1.352 0.712 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -176.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.602 HG13 ' O ' ' A' ' 95' ' ' LEU . 77.6 mt -61.62 -47.29 94.01 Favored 'Isoleucine or valine' 0 C--N 1.358 0.977 0 CA-C-N 119.657 1.117 . . . . 0.0 111.9 -177.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -98.49 -22.46 16.0 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 118.408 -1.317 . . . . 0.0 111.285 -176.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 33.4 t -65.69 -47.01 76.9 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 121.684 -0.635 . . . . 0.0 111.951 -177.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -132.26 -23.04 2.19 Favored 'General case' 0 C--N 1.361 1.079 0 C-N-CA 117.763 -1.575 . . . . 0.0 113.056 -176.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.672 HG21 ' C2C' ' A' ' 202' ' ' HEM . 31.1 mm -69.21 -50.03 56.23 Favored 'Isoleucine or valine' 0 C--N 1.354 0.785 0 CA-C-N 120.001 1.273 . . . . 0.0 110.57 -177.358 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 54.8 m170 -90.12 3.8 52.29 Favored 'General case' 0 N--CA 1.439 -0.976 0 O-C-N 121.311 -0.868 . . . . 0.0 110.444 -177.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.3 p -89.35 -34.01 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 178.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -72.54 -40.03 67.06 Favored 'General case' 0 C--N 1.36 1.065 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.676 HG11 HMD1 ' A' ' 202' ' ' HEM . 73.4 t -63.09 -46.35 96.32 Favored 'Isoleucine or valine' 0 C--N 1.355 0.846 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 93.2 t80 -60.6 -48.76 80.34 Favored 'General case' 0 C--N 1.361 1.089 0 O-C-N 122.064 -0.397 . . . . 0.0 111.428 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -60.9 -37.1 81.07 Favored 'General case' 0 C--N 1.356 0.864 0 O-C-N 121.556 -0.715 . . . . 0.0 110.604 -178.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 110' ' ' LEU . 17.9 mt -58.17 -73.83 0.07 Allowed 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -121.67 134.75 24.71 Favored Pre-proline 0 N--CA 1.439 -1.023 0 C-N-CA 118.37 -1.332 . . . . 0.0 108.773 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -84.51 -1.12 9.59 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 123.25 2.634 . . . . 0.0 115.052 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -66.75 -36.03 81.48 Favored 'General case' 0 C--N 1.354 0.795 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.13 145.39 56.35 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 121.649 0.738 . . . . 0.0 110.146 -178.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -126.95 134.31 50.44 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 179.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.453 ' HB3' ' HD2' ' A' ' 117' ' ' PRO . 84.4 mt -126.81 155.33 75.48 Favored Pre-proline 0 N--CA 1.442 -0.833 0 CA-C-O 122.184 0.992 . . . . 0.0 109.087 -178.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.453 ' HD2' ' HB3' ' A' ' 116' ' ' LEU . 87.7 Cg_endo -85.1 -152.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.125 0 C-N-CA 123.887 3.058 . . . . 0.0 114.543 -178.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -112.64 148.67 34.13 Favored 'General case' 0 C--N 1.368 1.38 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -179.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.642 ' CZ ' HD13 ' A' ' 131' ' ' LEU . 8.3 t80 -142.5 125.06 15.76 Favored 'General case' 0 C--N 1.361 1.066 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -177.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 95.8 m -126.44 133.62 51.19 Favored 'General case' 0 C--N 1.361 1.068 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 85.0 m -117.63 132.16 56.54 Favored 'General case' 0 C--N 1.358 0.946 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.732 -178.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -120.43 125.05 46.97 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 177.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -101.61 117.3 34.61 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.485 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 94.5 mt -84.98 -25.64 27.63 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.502 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -179.1 -142.6 4.98 Favored Glycine 0 C--N 1.349 1.257 0 C-N-CA 118.898 -1.62 . . . . 0.0 109.082 -178.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -94.1 -41.1 9.7 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 119.928 -0.709 . . . . 0.0 109.616 -178.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -102.18 3.49 38.46 Favored 'General case' 0 C--N 1.352 0.712 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.446 -178.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.485 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 67.4 m-20 -118.01 128.95 55.28 Favored 'General case' 0 C--N 1.356 0.885 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 10.6 mm -140.88 133.79 31.33 Favored 'Isoleucine or valine' 0 C--N 1.357 0.935 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 62.3 mtm180 -121.34 140.84 51.58 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.777 HD23 HD11 ' A' ' 177' ' ' ILE . 0.3 OUTLIER -129.79 128.03 41.55 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.679 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -99.08 131.28 45.24 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -126.24 120.99 31.43 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -178.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.468 ' HA ' ' O ' ' A' ' 171' ' ' THR . 27.5 tt0 -114.88 110.23 19.35 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 171' ' ' THR . 11.6 t -162.95 154.37 17.53 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -87.93 9.2 22.94 Favored 'General case' 0 C--N 1.355 0.836 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ARG . . . . . 0.522 HH12 ' CE1' ' A' ' 45' ' ' HIS . 78.3 mtp180 -129.46 78.28 75.92 Favored Pre-proline 0 N--CA 1.443 -0.777 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -91.98 86.61 0.24 Allowed 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.663 2.242 . . . . 0.0 115.556 -178.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -111.7 109.71 19.71 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 177.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -70.4 -30.73 67.69 Favored 'General case' 0 C--N 1.354 0.792 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.3 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.4 m -62.88 -34.22 76.93 Favored 'General case' 0 C--N 1.352 0.697 0 O-C-N 122.001 -0.437 . . . . 0.0 109.95 -179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -74.35 -44.59 51.7 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 120.434 -0.506 . . . . 0.0 109.732 -177.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.55 -40.39 95.49 Favored 'General case' 0 C--N 1.357 0.902 0 O-C-N 122.067 -0.395 . . . . 0.0 111.254 -177.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.87 -37.02 85.84 Favored 'General case' 0 CA--C 1.506 -0.736 0 O-C-N 122.012 -0.43 . . . . 0.0 110.187 -179.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.49 -43.71 98.5 Favored Glycine 0 C--N 1.347 1.161 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -178.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 82.8 mt -69.9 -40.49 75.58 Favored 'General case' 0 C--N 1.35 0.612 0 O-C-N 122.108 -0.642 . . . . 0.0 112.507 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 96.7 mt -71.75 -43.16 66.28 Favored 'General case' 0 C--N 1.361 1.103 0 O-C-N 121.215 -0.928 . . . . 0.0 111.032 -176.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.584 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 37.3 t70 -71.01 -31.46 67.98 Favored 'General case' 0 N--CA 1.447 -0.604 0 O-C-N 122.1 -0.375 . . . . 0.0 110.634 -178.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -62.77 -39.89 98.52 Favored Glycine 0 C--N 1.358 1.76 0 N-CA-C 108.512 -1.835 . . . . 0.0 108.512 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 48.8 t -60.71 -41.61 95.57 Favored 'General case' 0 C--N 1.35 0.591 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -76.83 2.05 15.64 Favored 'General case' 0 C--N 1.361 1.079 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.584 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 77.3 mm-40 -86.0 -46.16 10.78 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -66.16 -45.18 81.82 Favored 'General case' 0 C--N 1.361 1.102 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -69.54 -26.61 64.58 Favored 'General case' 0 C--N 1.362 1.124 0 O-C-N 121.842 -0.536 . . . . 0.0 110.793 -178.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 84.7 tttt 71.65 77.7 0.17 Allowed 'General case' 0 C--N 1.358 0.95 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.28 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -141.38 -170.66 3.13 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 179.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -145.96 93.5 2.34 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 13.5 m-30 -113.52 155.93 24.49 Favored 'General case' 0 CA--C 1.504 -0.802 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 178.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 95.5 m -120.2 127.54 52.54 Favored 'General case' 0 C--N 1.356 0.856 0 C-N-CA 119.392 -0.923 . . . . 0.0 108.979 -178.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.501 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.7 mp -100.99 121.3 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 178.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.12 -176.44 2.9 Favored 'General case' 0 C--N 1.365 1.245 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 28.8 ptt180 -146.95 154.46 41.29 Favored 'General case' 0 C--N 1.359 0.98 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -179.009 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 35.1 p -97.69 146.56 31.64 Favored Pre-proline 0 C--N 1.36 1.06 0 CA-C-O 122.448 1.118 . . . . 0.0 108.046 178.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.659 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 72.1 Cg_endo -75.03 -12.49 21.45 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 123.055 2.504 . . . . 0.0 114.923 -178.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -72.21 -41.21 67.15 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.84 -178.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 26.8 p -118.6 16.45 13.69 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 119.824 -0.75 . . . . 0.0 110.829 -178.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.659 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.2 pp0? -67.15 -14.37 62.84 Favored 'General case' 0 C--N 1.352 0.707 0 O-C-N 121.563 -0.71 . . . . 0.0 110.121 178.448 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -124.28 38.81 4.11 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 22.0 t -138.49 143.37 39.55 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 107.165 -1.421 . . . . 0.0 107.165 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.644 ' O ' ' HB ' ' A' ' 171' ' ' THR . 60.5 mt-10 -96.77 163.63 12.91 Favored 'General case' 0 C--N 1.354 0.776 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.199 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.644 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 2.7 m 81.91 -57.49 0.23 Allowed 'General case' 0 C--N 1.374 1.645 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.906 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -105.63 117.76 34.85 Favored 'General case' 0 CA--C 1.504 -0.813 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.567 -178.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 89.0 t -132.57 134.21 58.98 Favored 'Isoleucine or valine' 0 C--N 1.357 0.928 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.685 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 48.5 mm -115.22 127.73 72.68 Favored 'Isoleucine or valine' 0 C--N 1.361 1.07 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -116.2 146.33 42.4 Favored 'General case' 0 C--N 1.359 1.021 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -125.53 84.05 2.23 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.193 -178.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' ILE . . . . . 0.777 HD11 HD23 ' A' ' 131' ' ' LEU . 3.6 mp -77.1 117.99 22.98 Favored 'Isoleucine or valine' 0 C--N 1.363 1.167 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 90.1 m -128.35 144.41 51.13 Favored 'General case' 0 C--N 1.356 0.885 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -178.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 59.3 mtm180 -79.7 116.59 19.96 Favored 'General case' 0 C--N 1.371 1.539 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -65.9 149.85 97.11 Favored Pre-proline 0 C--N 1.358 0.959 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.9 124.74 12.66 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 121.775 1.65 . . . . 0.0 113.51 -178.666 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 2.9 ppt_? -137.03 152.88 50.6 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.491 ' O ' ' HB3' ' A' ' 184' ' ' ALA . . . 75.82 62.92 2.54 Favored Glycine 0 C--N 1.351 1.373 0 N-CA-C 107.489 -2.244 . . . . 0.0 107.489 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 183' ' ' GLY . . . 80.1 163.83 0.18 Allowed 'General case' 0 C--N 1.361 1.088 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -178.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -146.99 148.84 32.11 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -123.79 126.68 46.9 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 78.5 mt -99.23 -61.39 1.37 Allowed 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' TYR . . . . . 0.417 ' HB3' ' H ' ' A' ' 189' ' ' PHE . 0.2 OUTLIER -151.19 -94.57 0.06 Allowed 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 179.672 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 189' ' ' PHE . . . . . 0.417 ' H ' ' HB3' ' A' ' 188' ' ' TYR . 99.0 m-85 -128.83 147.76 50.83 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 . . . . . 0 C--O 1.264 1.816 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -179.937 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 201' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 202' ' ' HEM . . . . . 0.676 HMD1 HG11 ' A' ' 107' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.4 mtm . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 121.252 0.548 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.401 ' HA ' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -83.99 -13.5 53.14 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -179.442 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.0 -39.32 38.18 Favored Glycine 0 C--N 1.353 1.49 0 N-CA-C 108.641 -1.783 . . . . 0.0 108.641 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.7 tpp -71.6 -36.69 70.9 Favored 'General case' 0 C--N 1.359 0.982 0 O-C-N 121.92 -0.753 . . . . 0.0 110.767 -177.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.401 HG22 ' HA ' ' A' ' 2' ' ' MET . 35.5 m -69.81 -22.76 25.12 Favored 'Isoleucine or valine' 0 C--N 1.357 0.908 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.446 ' HZ ' ' HG2' ' A' ' 47' ' ' GLU . 1.8 m-30 -70.4 -35.57 73.54 Favored 'General case' 0 C--N 1.357 0.922 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.244 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 85.3 m -67.38 -40.61 85.71 Favored 'General case' 0 C--N 1.355 0.847 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.34 -38.81 96.87 Favored Glycine 0 C--N 1.358 1.75 0 N-CA-C 110.541 -1.023 . . . . 0.0 110.541 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.648 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -66.96 -39.42 87.24 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 122.297 -0.531 . . . . 0.0 110.674 -178.198 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 20.9 mmt -63.91 -41.01 97.78 Favored 'General case' 0 C--N 1.354 0.78 0 O-C-N 121.602 -0.686 . . . . 0.0 110.979 -178.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -67.43 -40.76 85.5 Favored 'General case' 0 C--N 1.349 0.554 0 O-C-N 121.929 -0.482 . . . . 0.0 111.857 -177.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 54.7 tp -65.52 -42.83 91.58 Favored 'General case' 0 C--N 1.349 0.571 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -178.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.648 HG12 ' O ' ' A' ' 9' ' ' LEU . 1.2 mm -76.42 -35.74 27.4 Favored 'Isoleucine or valine' 0 C--N 1.358 0.951 0 O-C-N 120.957 -1.09 . . . . 0.0 111.041 -175.385 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -67.98 -43.38 79.1 Favored 'General case' 0 C--N 1.352 0.677 0 O-C-N 121.766 -0.584 . . . . 0.0 111.173 -176.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -72.64 -33.71 66.81 Favored 'General case' 0 N--CA 1.448 -0.566 0 O-C-N 121.98 -0.45 . . . . 0.0 111.658 -177.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -71.57 -47.88 52.02 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -175.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -127.89 -19.18 4.09 Favored 'General case' 0 C--N 1.355 0.834 0 C-N-CA 117.417 -1.713 . . . . 0.0 113.496 -176.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 139.99 178.92 17.32 Favored Glycine 0 N--CA 1.44 -1.053 0 C-N-CA 117.923 -2.084 . . . . 0.0 109.862 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -95.99 -12.4 25.05 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -177.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -70.69 -40.48 72.87 Favored 'General case' 0 C--N 1.359 0.997 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.8 m -69.09 -39.25 79.13 Favored 'General case' 0 C--N 1.357 0.907 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 53.4 tp -62.59 -37.83 87.76 Favored 'General case' 0 C--N 1.357 0.934 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -62.97 -37.42 87.06 Favored 'General case' 0 C--N 1.358 0.955 0 O-C-N 121.968 -0.458 . . . . 0.0 110.997 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.6 m -65.6 -38.22 88.86 Favored 'General case' 0 C--N 1.353 0.735 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.443 ' HG ' HD22 ' A' ' 51' ' ' LEU . 21.8 tp -62.53 -39.49 93.74 Favored 'General case' 0 C--N 1.353 0.735 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.281 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 85.6 mt -72.95 -13.85 61.33 Favored 'General case' 0 C--N 1.359 0.997 0 O-C-N 121.92 -0.488 . . . . 0.0 110.579 -178.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -86.93 -28.77 22.55 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 119.312 -0.955 . . . . 0.0 109.368 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.0 t -67.25 -37.01 82.82 Favored 'General case' 0 C--N 1.355 0.839 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.1 p -91.63 -39.5 11.84 Favored 'General case' 0 C--N 1.357 0.924 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -179.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 86.06 132.85 0.04 OUTLIER 'General case' 0 C--N 1.36 1.052 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.51 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -86.91 -169.55 2.68 Favored 'General case' 0 C--N 1.357 0.9 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -179.884 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.416 ' H ' ' H ' ' A' ' 33' ' ' SER . 62.5 tt0 -152.26 -24.92 0.17 Allowed 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.416 ' H ' ' H ' ' A' ' 32' ' ' GLN . 1.8 t -145.22 -69.51 0.28 Allowed 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -179.063 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -131.05 -50.24 1.02 Allowed 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -178.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 130.41 -37.31 2.15 Favored Glycine 0 C--N 1.353 1.475 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 83.0 mt -110.0 100.75 11.41 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -95.65 -4.78 43.77 Favored 'General case' 0 C--N 1.354 0.801 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.76 HG22 ' H ' ' A' ' 39' ' ' SER . 5.2 m 82.43 174.84 0.09 Allowed 'General case' 0 C--N 1.362 1.118 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 -178.534 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.76 ' H ' HG22 ' A' ' 38' ' ' THR . 41.1 p -89.38 114.89 26.38 Favored 'General case' 0 N--CA 1.443 -0.791 0 O-C-N 121.041 -1.037 . . . . 0.0 109.855 -178.042 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.46 HG13 ' O ' ' A' ' 39' ' ' SER . 0.0 OUTLIER -172.92 -3.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.218 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.795 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -98.26 -136.74 9.38 Favored Glycine 0 C--N 1.357 1.735 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -178.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 164.47 98.97 0.0 OUTLIER 'General case' 0 C--N 1.362 1.132 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 -178.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -98.11 176.87 5.59 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.71 -174.61 4.42 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.566 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -91.1 -15.89 28.72 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 120.011 -0.676 . . . . 0.0 109.29 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -70.31 -29.32 66.03 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.446 ' HG2' ' HZ ' ' A' ' 6' ' ' PHE . 33.1 tp10 -63.69 -41.64 98.1 Favored 'General case' 0 C--N 1.354 0.769 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.494 ' O ' HG23 ' A' ' 52' ' ' VAL . 54.5 tp -67.24 -38.36 85.06 Favored 'General case' 0 C--N 1.354 0.782 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.197 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 60.6 tp -76.49 -28.04 56.3 Favored 'General case' 0 C--N 1.349 0.583 0 O-C-N 122.029 -0.419 . . . . 0.0 110.647 -177.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 71.5 tp60 -68.2 -42.6 79.64 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 121.509 -0.745 . . . . 0.0 109.615 -178.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.443 HD22 ' HG ' ' A' ' 25' ' ' LEU . 57.5 mt -72.8 -33.8 66.47 Favored 'General case' 0 C--N 1.363 1.18 0 C-N-CA 119.679 -0.809 . . . . 0.0 109.48 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 48' ' ' LEU . 38.7 t -62.61 -41.47 92.26 Favored 'Isoleucine or valine' 0 C--N 1.35 0.59 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 51.3 t -68.1 -40.61 83.3 Favored 'Isoleucine or valine' 0 C--N 1.351 0.668 0 O-C-N 121.716 -0.615 . . . . 0.0 109.809 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 31.7 tptt -66.84 -26.08 66.74 Favored 'General case' 0 C--N 1.359 1.007 0 O-C-N 121.131 -0.98 . . . . 0.0 108.768 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.408 ' O ' HD23 ' A' ' 55' ' ' LEU . 2.2 tt -69.09 -37.5 78.46 Favored 'General case' 0 C--N 1.353 0.744 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.402 ' O ' ' HA ' ' A' ' 60' ' ' SER . 71.5 p -72.05 -18.05 61.97 Favored 'General case' 0 C--N 1.356 0.868 0 O-C-N 121.722 -0.611 . . . . 0.0 110.624 -178.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -100.5 -35.04 9.68 Favored 'General case' 0 C--N 1.353 0.743 0 O-C-N 121.143 -0.973 . . . . 0.0 111.389 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.5 p -72.29 -34.8 50.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.719 0 O-C-N 121.755 -0.591 . . . . 0.0 111.375 -177.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.562 ' HB3' HG23 ' A' ' 61' ' ' VAL . 2.5 t -120.29 -7.4 9.79 Favored 'General case' 0 C--N 1.353 0.718 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.094 -177.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 56' ' ' SER . 0.6 OUTLIER 65.71 47.26 2.17 Favored 'General case' 0 C--N 1.353 0.76 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.796 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.562 HG23 ' HB3' ' A' ' 59' ' ' SER . 52.3 t -108.71 131.92 21.48 Favored Pre-proline 0 CA--C 1.503 -0.839 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 179.334 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -57.46 147.24 79.41 Favored 'Trans proline' 0 CA--C 1.497 -1.355 0 C-N-CA 122.439 2.093 . . . . 0.0 112.82 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.9 m -75.51 -12.97 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.685 -178.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.433 ' O ' HG12 ' A' ' 67' ' ' VAL . 71.5 p -96.09 -33.04 12.23 Favored 'General case' 0 C--N 1.358 0.961 0 C-N-CA 118.291 -1.364 . . . . 0.0 109.534 -179.138 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -76.55 -22.58 54.14 Favored 'General case' 0 C--N 1.354 0.799 0 O-C-N 121.449 -0.782 . . . . 0.0 109.033 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -81.7 -34.89 30.37 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.093 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.433 HG12 ' O ' ' A' ' 64' ' ' THR . 1.5 p -69.4 -26.33 31.13 Favored 'Isoleucine or valine' 0 C--N 1.354 0.795 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.916 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.5 mmm-85 -72.96 -51.5 18.13 Favored 'General case' 0 C--N 1.363 1.157 0 O-C-N 121.53 -0.731 . . . . 0.0 110.269 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 83.7 mt -63.76 -36.17 83.01 Favored 'General case' 0 C--N 1.357 0.923 0 O-C-N 122.064 -0.398 . . . . 0.0 110.939 -179.042 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -60.94 -46.9 88.82 Favored 'General case' 0 C--N 1.35 0.609 0 O-C-N 122.233 -0.292 . . . . 0.0 110.238 -178.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.56 -37.97 94.21 Favored Glycine 0 C--N 1.355 1.598 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 -178.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -63.64 -47.84 79.69 Favored 'General case' 0 C--N 1.354 0.782 0 CA-C-N 118.419 1.109 . . . . 0.0 111.486 -177.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.9 mttm -64.38 -47.72 78.2 Favored 'General case' 0 C--N 1.36 1.027 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -176.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.427 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.5 tm? -69.64 -40.21 76.64 Favored 'General case' 0 C--N 1.349 0.581 0 O-C-N 121.051 -1.031 . . . . 0.0 111.828 -175.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -63.76 -45.45 89.74 Favored 'General case' 0 C--N 1.354 0.768 0 O-C-N 121.19 -0.944 . . . . 0.0 111.27 -178.126 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 8.5 p -71.72 -12.83 16.31 Favored 'Isoleucine or valine' 0 C--N 1.357 0.911 0 O-C-N 121.543 -0.723 . . . . 0.0 109.294 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.33 -37.39 60.74 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 82.4 mt -72.53 -32.84 66.44 Favored 'General case' 0 C--N 1.358 0.949 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.7 mm -64.07 -52.99 49.34 Favored 'Isoleucine or valine' 0 C--N 1.36 1.043 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.196 -177.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -75.36 -14.87 60.5 Favored 'General case' 0 CA--C 1.51 -0.593 0 C-N-CA 119.693 -0.803 . . . . 0.0 109.529 178.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.32 -37.05 63.17 Favored Glycine 0 C--N 1.349 1.267 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -179.121 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -133.45 105.78 12.06 Favored Pre-proline 0 N--CA 1.44 -0.97 0 CA-C-O 122.555 1.169 . . . . 0.0 109.199 -176.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.8 -25.03 39.81 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.381 2.054 . . . . 0.0 113.806 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -88.78 -7.69 55.76 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.8 tp -89.31 -22.7 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 -178.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -98.7 -22.12 16.06 Favored 'General case' 0 C--N 1.362 1.113 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -70.03 -37.22 75.54 Favored 'General case' 0 C--N 1.358 0.976 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -64.78 -36.73 85.27 Favored 'General case' 0 C--N 1.358 0.956 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.261 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.565 ' SD ' ' HZ ' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -82.17 151.07 27.08 Favored 'General case' 0 C--N 1.352 0.704 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -178.837 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.552 ' N ' ' HG2' ' A' ' 89' ' ' MET . 0.7 OUTLIER -118.27 -22.63 7.61 Favored 'General case' 0 C--N 1.363 1.18 0 C-N-CA 119.852 -0.739 . . . . 0.0 111.298 -177.472 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -166.71 172.77 10.22 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.425 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 65.1 m -67.12 -40.06 86.76 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.478 -179.38 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -68.68 -39.09 80.75 Favored 'General case' 0 C--N 1.356 0.859 0 O-C-N 121.322 -0.862 . . . . 0.0 109.011 -178.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -66.29 -23.16 66.34 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.519 HD21 ' HAB' ' A' ' 202' ' ' HEM . 58.3 tp -63.99 -46.1 86.07 Favored 'General case' 0 C--N 1.355 0.829 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.2 mp -63.14 -33.13 74.79 Favored 'General case' 0 C--N 1.354 0.797 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 35.6 t -62.34 -44.4 96.58 Favored 'General case' 0 C--N 1.353 0.747 0 O-C-N 121.897 -0.502 . . . . 0.0 110.954 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.63 26.73 10.37 Favored 'General case' 0 C--N 1.359 0.99 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.376 -177.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 1.291 HD11 ' C2B' ' A' ' 202' ' ' HEM . 14.1 tt -62.36 -31.55 52.08 Favored 'Isoleucine or valine' 0 C--N 1.356 0.88 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.625 -179.088 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -119.43 -18.29 8.55 Favored 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 119.218 -0.993 . . . . 0.0 109.113 -178.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 35.6 t -64.25 -46.61 82.99 Favored 'General case' 0 N--CA 1.444 -0.747 0 O-C-N 121.82 -0.55 . . . . 0.0 110.869 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.4 ' HA ' HG12 ' A' ' 105' ' ' VAL . 14.4 t80 -127.59 -26.34 3.01 Favored 'General case' 0 C--N 1.36 1.028 0 C-N-CA 118.103 -1.439 . . . . 0.0 111.828 -177.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 19.0 mm -67.05 -50.23 65.97 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 O-C-N 121.097 -1.002 . . . . 0.0 110.236 -177.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 49.4 m170 -91.08 3.43 54.77 Favored 'General case' 0 N--CA 1.439 -0.985 0 O-C-N 121.462 -0.774 . . . . 0.0 110.408 -177.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.4 HG12 ' HA ' ' A' ' 102' ' ' PHE . 2.4 p -87.64 -35.4 8.26 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -72.88 -39.95 66.01 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.028 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.787 HG11 HMD3 ' A' ' 202' ' ' HEM . 74.4 t -63.48 -46.06 96.17 Favored 'Isoleucine or valine' 0 C--N 1.357 0.909 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.255 -179.115 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -60.3 -48.13 83.06 Favored 'General case' 0 C--N 1.36 1.026 0 O-C-N 122.117 -0.364 . . . . 0.0 111.484 -178.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -61.98 -36.55 81.81 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 121.412 -0.805 . . . . 0.0 110.506 -178.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.9 mt -58.28 -76.33 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 120.665 -0.414 . . . . 0.0 109.951 -179.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.468 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 90.5 m-85 -110.9 141.0 23.26 Favored Pre-proline 0 N--CA 1.443 -0.807 0 C-N-CA 118.745 -1.182 . . . . 0.0 109.169 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 111' ' ' TYR . 54.2 Cg_endo -88.39 -7.53 5.79 Favored 'Trans proline' 0 C--N 1.315 -1.198 0 C-N-CA 123.219 2.613 . . . . 0.0 115.877 -178.457 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -77.96 -23.87 48.31 Favored 'General case' 0 C--N 1.354 0.789 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.22 -178.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.2 142.53 58.29 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 121.512 0.672 . . . . 0.0 109.656 -178.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -118.72 143.63 46.75 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.434 ' HA ' ' HD3' ' A' ' 117' ' ' PRO . 96.3 mt -136.93 152.22 73.66 Favored Pre-proline 0 C--N 1.354 0.802 0 CA-C-O 122.138 0.971 . . . . 0.0 109.604 -178.292 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 116' ' ' LEU . 75.0 Cg_endo -89.85 -155.24 0.05 OUTLIER 'Trans proline' 0 C--N 1.318 -1.03 0 C-N-CA 123.934 3.089 . . . . 0.0 113.484 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -119.63 142.34 48.51 Favored 'General case' 0 C--N 1.367 1.327 0 C-N-CA 119.328 -0.949 . . . . 0.0 108.711 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -126.26 128.66 47.53 Favored 'General case' 0 C--N 1.363 1.157 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -178.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.526 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 93.6 m -124.17 128.26 48.98 Favored 'General case' 0 C--N 1.357 0.893 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 176.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 78.1 m -121.77 130.97 53.81 Favored 'General case' 0 CA--C 1.504 -0.827 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.175 -177.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -118.76 149.81 40.85 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 177.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -121.62 117.61 27.15 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -179.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.0 mt -91.34 -16.27 27.74 Favored 'General case' 0 C--N 1.354 0.796 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.57 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 175.41 -149.5 10.21 Favored Glycine 0 C--N 1.348 1.214 0 C-N-CA 118.859 -1.639 . . . . 0.0 109.076 -179.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -93.87 -37.64 11.63 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -178.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -102.83 4.38 37.73 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.81 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -120.8 129.62 53.65 Favored 'General case' 0 C--N 1.357 0.934 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -179.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.3 mm -141.89 136.57 30.47 Favored 'Isoleucine or valine' 0 C--N 1.355 0.834 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 51.7 mtm180 -116.63 139.67 50.26 Favored 'General case' 0 CA--C 1.495 -1.16 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 8.0 tp -127.61 119.57 26.22 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-N 115.172 -0.922 . . . . 0.0 108.856 -178.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.526 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 12.1 m170 -99.2 134.28 42.27 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 178.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -130.21 122.26 27.77 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -178.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.492 ' HA ' ' O ' ' A' ' 171' ' ' THR . 30.0 tt0 -114.35 113.74 24.96 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 15.6 t -161.88 153.34 18.55 Favored 'General case' 0 C--N 1.358 0.954 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -91.55 3.89 53.91 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.866 -179.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 94.3 mtm-85 -133.42 74.98 70.65 Favored Pre-proline 0 C--N 1.355 0.847 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 178.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -94.88 100.89 0.11 Allowed 'Trans proline' 0 N--CA 1.442 -1.506 0 C-N-CA 122.621 2.214 . . . . 0.0 115.63 -177.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -110.67 113.54 26.22 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 176.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.63 -38.59 91.7 Favored 'General case' 0 C--N 1.354 0.771 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.166 -179.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 73.4 m -63.83 -26.98 68.87 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 121.886 -0.509 . . . . 0.0 110.808 -178.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -76.11 -47.37 24.74 Favored 'General case' 0 C--N 1.352 0.695 0 C-N-CA 120.038 -0.665 . . . . 0.0 109.593 -177.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.46 -39.8 94.5 Favored 'General case' 0 C--N 1.356 0.864 0 O-C-N 122.215 -0.303 . . . . 0.0 111.185 -178.005 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -63.31 -37.37 86.98 Favored 'General case' 0 C--N 1.354 0.797 0 O-C-N 121.879 -0.513 . . . . 0.0 109.908 -179.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.04 -42.94 98.63 Favored Glycine 0 C--N 1.348 1.232 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 -179.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.0 mt -70.82 -41.0 72.14 Favored 'General case' 0 C--N 1.354 0.762 0 CA-C-N 117.586 0.693 . . . . 0.0 112.704 -179.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 98.5 mt -71.08 -42.15 69.74 Favored 'General case' 0 C--N 1.36 1.057 0 O-C-N 121.28 -0.888 . . . . 0.0 110.833 -176.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.447 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 36.3 t70 -70.53 -28.9 65.29 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 121.935 -0.478 . . . . 0.0 110.385 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.426 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -63.08 -39.01 97.51 Favored Glycine 0 C--N 1.358 1.793 0 N-CA-C 108.049 -2.02 . . . . 0.0 108.049 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 48.1 t -60.95 -42.13 97.66 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -74.71 -0.36 17.85 Favored 'General case' 0 C--N 1.361 1.095 0 O-C-N 121.789 -0.57 . . . . 0.0 109.603 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.447 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 75.7 mm-40 -85.79 -45.8 11.26 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.013 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -65.61 -46.06 80.74 Favored 'General case' 0 C--N 1.361 1.082 0 C-N-CA 120.158 -0.617 . . . . 0.0 109.363 178.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' PHE . . . . . 0.565 ' HZ ' ' SD ' ' A' ' 89' ' ' MET . 37.5 m-85 -68.44 -27.85 66.54 Favored 'General case' 0 C--N 1.363 1.189 0 O-C-N 121.859 -0.525 . . . . 0.0 110.917 -178.437 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 85.4 tttt 74.44 73.94 0.11 Allowed 'General case' 0 C--N 1.36 1.041 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -178.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -142.84 -169.28 2.97 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -148.15 96.18 2.59 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 13.1 m-30 -113.24 155.55 24.88 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 178.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 92.2 m -119.32 128.16 53.87 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -178.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.518 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.7 mp -105.47 122.04 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 179.213 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.7 m -117.06 -174.41 2.58 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-O 121.913 0.863 . . . . 0.0 109.352 -178.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -146.08 155.48 42.8 Favored 'General case' 0 C--N 1.356 0.862 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 -177.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 47.3 p -100.28 146.6 32.25 Favored Pre-proline 0 C--N 1.359 0.997 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.638 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 75.0 Cg_endo -76.4 -11.46 19.0 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 123.056 2.504 . . . . 0.0 115.022 -178.686 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -72.34 -41.51 66.4 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 119.932 -0.707 . . . . 0.0 109.591 -178.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 37.9 p -116.76 15.59 15.36 Favored 'General case' 0 CA--C 1.505 -0.785 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.527 -178.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.638 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.3 pp0? -67.03 -12.18 59.15 Favored 'General case' 0 C--N 1.353 0.744 0 O-C-N 121.595 -0.691 . . . . 0.0 110.52 178.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -122.97 34.36 5.15 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 65.4 m -134.91 147.27 49.77 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.61 ' O ' ' HB ' ' A' ' 171' ' ' THR . 37.3 mt-10 -101.12 165.67 11.18 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.61 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 18.6 m 83.15 -60.52 0.14 Allowed 'General case' 0 C--N 1.37 1.467 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -107.37 117.31 33.75 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.623 -178.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 90.1 t -130.69 133.02 63.98 Favored 'Isoleucine or valine' 0 C--N 1.357 0.899 0 N-CA-C 106.924 -1.509 . . . . 0.0 106.924 178.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 49.6 mm -107.25 127.27 63.17 Favored 'Isoleucine or valine' 0 C--N 1.358 0.976 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -115.85 156.8 25.47 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 122.156 0.979 . . . . 0.0 108.513 -179.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -138.54 119.42 14.28 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -178.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.8 mp -113.55 118.54 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 -179.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 91.4 m -122.84 142.38 50.82 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -177.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -101.03 118.94 37.99 Favored 'General case' 0 C--N 1.362 1.147 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.476 ' HB1' ' HD2' ' A' ' 181' ' ' PRO . . . -71.57 155.67 92.27 Favored Pre-proline 0 N--CA 1.442 -0.86 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 178.552 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.476 ' HD2' ' HB1' ' A' ' 180' ' ' ALA . 19.4 Cg_endo -62.86 129.91 27.62 Favored 'Trans proline' 0 CA--C 1.49 -1.706 0 C-N-CA 121.552 1.502 . . . . 0.0 112.787 -179.483 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -143.02 163.75 31.96 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -178.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 102.88 -25.57 26.98 Favored Glycine 0 C--N 1.349 1.286 0 N-CA-C 108.333 -1.907 . . . . 0.0 108.333 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -151.63 -100.86 0.06 Allowed 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 163.81 76.31 0.0 OUTLIER 'General case' 0 C--N 1.362 1.131 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -113.48 113.69 25.5 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 179.35 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.66 -65.97 0.97 Allowed 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -136.16 -83.48 0.38 Allowed 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -137.69 -69.64 0.45 Allowed 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 . . . . . 0 C--O 1.264 1.838 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.732 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 201' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 202' ' ' HEM . . . . . 1.291 ' C2B' HD11 ' A' ' 99' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.636 ' HG2' ' HG3' ' A' ' 4' ' ' MET . 27.7 tpp . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 120.986 0.422 . . . . 0.0 110.402 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' MET . . . . . 0.425 ' HA ' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -81.1 -14.49 57.7 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 -179.471 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.5 -42.96 38.99 Favored Glycine 0 C--N 1.35 1.333 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.636 ' HG3' ' HG2' ' A' ' 1' ' ' MET . 76.0 mtm -70.38 -34.78 72.98 Favored 'General case' 0 C--N 1.355 0.808 0 O-C-N 122.149 -0.618 . . . . 0.0 111.206 -178.15 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.425 HG22 ' HA ' ' A' ' 2' ' ' MET . 35.7 m -68.95 -23.34 27.19 Favored 'Isoleucine or valine' 0 C--N 1.358 0.946 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.314 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.461 ' HZ ' ' CG ' ' A' ' 47' ' ' GLU . 2.6 m-85 -72.22 -33.07 67.3 Favored 'General case' 0 C--N 1.357 0.922 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.1 m -67.01 -40.09 87.21 Favored 'General case' 0 C--N 1.355 0.846 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.54 -39.32 97.7 Favored Glycine 0 C--N 1.359 1.83 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.644 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -64.22 -40.66 96.51 Favored 'General case' 0 C--N 1.351 0.671 0 O-C-N 122.522 -0.399 . . . . 0.0 110.698 -178.795 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 20.5 mmt -63.43 -40.63 97.7 Favored 'General case' 0 C--N 1.352 0.708 0 O-C-N 121.72 -0.612 . . . . 0.0 110.832 -178.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -67.29 -40.5 86.09 Favored 'General case' 0 C--N 1.349 0.563 0 O-C-N 122.012 -0.43 . . . . 0.0 111.692 -178.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 54.9 tp -66.31 -42.93 87.57 Favored 'General case' 0 C--N 1.35 0.606 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -178.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.644 HG12 ' O ' ' A' ' 9' ' ' LEU . 2.6 mm -73.51 -37.1 49.63 Favored 'Isoleucine or valine' 0 C--N 1.36 1.032 0 O-C-N 121.142 -0.974 . . . . 0.0 110.861 -175.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -71.02 -42.35 69.68 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 121.659 -0.65 . . . . 0.0 111.73 -176.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -71.31 -37.57 71.79 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -175.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -100.66 -27.0 13.62 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 118.678 -1.209 . . . . 0.0 113.791 -174.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -111.56 -34.23 6.14 Favored 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 117.579 -1.648 . . . . 0.0 112.146 -176.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 142.11 178.41 18.15 Favored Glycine 0 C--N 1.348 1.216 0 C-N-CA 118.431 -1.842 . . . . 0.0 109.774 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 93.3 t80 -101.08 -26.19 13.78 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 -177.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -69.11 -39.72 78.77 Favored 'General case' 0 C--N 1.36 1.054 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.5 m -67.96 -38.54 82.89 Favored 'General case' 0 C--N 1.357 0.898 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 34.7 tp -59.53 -38.34 80.74 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -65.14 -37.11 86.38 Favored 'General case' 0 C--N 1.357 0.933 0 O-C-N 122.214 -0.304 . . . . 0.0 111.081 -178.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.3 m -64.45 -40.96 96.71 Favored 'General case' 0 C--N 1.355 0.834 0 O-C-N 121.636 -0.665 . . . . 0.0 109.774 -178.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.461 ' CD2' ' HB3' ' A' ' 54' ' ' LYS . 84.8 mt -64.48 -37.49 87.73 Favored 'General case' 0 C--N 1.356 0.861 0 O-C-N 121.892 -0.505 . . . . 0.0 109.744 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 82.5 mt -67.68 -18.77 65.04 Favored 'General case' 0 C--N 1.357 0.922 0 O-C-N 121.426 -0.796 . . . . 0.0 109.629 -179.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -85.74 -25.85 26.19 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.712 179.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.9 p -69.28 -24.45 63.96 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 119.856 -0.738 . . . . 0.0 109.304 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.4 p -106.96 -34.38 7.21 Favored 'General case' 0 C--N 1.357 0.898 0 C-N-CA 119.041 -1.064 . . . . 0.0 108.17 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 82.55 134.0 0.06 Allowed 'General case' 0 C--N 1.359 0.98 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.428 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -84.59 -169.82 2.81 Favored 'General case' 0 C--N 1.357 0.898 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.655 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.421 ' H ' ' H ' ' A' ' 33' ' ' SER . 63.1 tt0 -151.68 -25.25 0.19 Allowed 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.421 ' H ' ' H ' ' A' ' 32' ' ' GLN . 1.5 t -146.12 -73.18 0.23 Allowed 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -179.167 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -126.83 -38.73 2.02 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -179.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.35 -31.74 5.68 Favored Glycine 0 C--N 1.353 1.502 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 82.7 mt -112.5 99.98 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.512 ' O ' ' HB ' ' A' ' 38' ' ' THR . 3.0 t80 -70.84 -33.24 70.47 Favored 'General case' 0 C--N 1.357 0.916 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.512 ' HB ' ' O ' ' A' ' 37' ' ' TYR . 6.0 m 119.45 -70.07 0.0 OUTLIER 'General case' 0 C--N 1.369 1.456 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.6 p 174.4 66.62 0.0 OUTLIER 'General case' 0 C--N 1.359 0.998 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.503 ' HB ' ' CE2' ' A' ' 37' ' ' TYR . 19.0 t -147.53 -11.52 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.878 0 C-N-CA 119.772 -0.771 . . . . 0.0 109.463 -178.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.53 146.01 18.07 Favored Glycine 0 C--N 1.352 1.461 0 C-N-CA 119.314 -1.422 . . . . 0.0 110.53 -177.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 52.7 m -122.25 125.74 46.69 Favored 'General case' 0 C--N 1.354 0.775 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 178.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -117.05 172.04 7.53 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 121.644 0.735 . . . . 0.0 109.058 -178.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -78.3 -176.15 4.54 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-O 121.662 0.744 . . . . 0.0 109.249 -179.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -85.56 -23.25 27.72 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -179.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -65.89 -28.88 69.28 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.461 ' CG ' ' HZ ' ' A' ' 6' ' ' PHE . 24.4 tp10 -62.95 -39.55 94.98 Favored 'General case' 0 C--N 1.352 0.717 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.639 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -67.67 -38.81 84.25 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 61.8 tp -70.44 -34.31 72.31 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -177.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -65.15 -41.36 94.83 Favored 'General case' 0 N--CA 1.443 -0.799 0 O-C-N 122.041 -0.412 . . . . 0.0 110.227 -178.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 78.5 mt -81.86 -19.4 41.04 Favored 'General case' 0 C--N 1.357 0.934 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.384 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.3 t -80.18 -37.23 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -179.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 52.5 t -67.78 -40.85 84.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.461 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 25.0 tptt -66.66 -25.81 66.75 Favored 'General case' 0 C--N 1.364 1.219 0 O-C-N 121.07 -1.019 . . . . 0.0 108.895 -179.421 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.534 HD21 HD12 ' A' ' 13' ' ' ILE . 6.4 mt -67.11 -37.99 84.86 Favored 'General case' 0 C--N 1.355 0.807 0 C-N-CA 120.431 -0.507 . . . . 0.0 109.904 178.614 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.448 ' O ' ' HA ' ' A' ' 60' ' ' SER . 57.4 p -72.86 -17.81 61.5 Favored 'General case' 0 C--N 1.354 0.791 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.477 -179.036 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -99.3 -38.04 9.02 Favored 'General case' 0 C--N 1.354 0.777 0 O-C-N 121.321 -0.862 . . . . 0.0 111.497 -179.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.8 p -72.91 -37.88 55.27 Favored 'Isoleucine or valine' 0 C--N 1.353 0.722 0 O-C-N 121.656 -0.653 . . . . 0.0 111.327 -177.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.552 ' HB3' HG23 ' A' ' 61' ' ' VAL . 5.0 t -115.4 -6.72 12.32 Favored 'General case' 0 C--N 1.352 0.717 0 C-N-CA 119.033 -1.067 . . . . 0.0 110.265 -178.383 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 56' ' ' SER . 74.5 m 64.78 44.16 3.82 Favored 'General case' 0 C--N 1.355 0.829 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.552 HG23 ' HB3' ' A' ' 59' ' ' SER . 53.5 t -105.95 133.59 20.14 Favored Pre-proline 0 N--CA 1.444 -0.764 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -57.59 147.08 81.29 Favored 'Trans proline' 0 CA--C 1.498 -1.28 0 C-N-CA 122.538 2.159 . . . . 0.0 112.815 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.5 m -75.47 -12.13 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.919 -178.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.435 ' O ' HG12 ' A' ' 67' ' ' VAL . 67.3 p -96.48 -32.42 12.31 Favored 'General case' 0 C--N 1.358 0.969 0 C-N-CA 118.289 -1.364 . . . . 0.0 109.489 -179.104 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -77.82 -22.89 49.34 Favored 'General case' 0 C--N 1.355 0.819 0 O-C-N 121.341 -0.849 . . . . 0.0 108.868 179.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.426 HD13 HD13 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -79.97 -37.36 34.52 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.196 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.435 HG12 ' O ' ' A' ' 64' ' ' THR . 1.9 p -67.97 -26.66 35.15 Favored 'Isoleucine or valine' 0 C--N 1.355 0.828 0 C-N-CA 120.089 -0.644 . . . . 0.0 110.002 -179.627 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.2 mmm-85 -72.16 -50.86 24.39 Favored 'General case' 0 C--N 1.363 1.159 0 O-C-N 121.519 -0.738 . . . . 0.0 110.354 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 83.9 mt -63.57 -36.0 82.35 Favored 'General case' 0 C--N 1.357 0.932 0 O-C-N 122.061 -0.399 . . . . 0.0 110.966 -178.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -60.8 -47.69 85.18 Favored 'General case' 0 C--N 1.35 0.608 0 O-C-N 122.221 -0.299 . . . . 0.0 110.64 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.54 95.75 Favored Glycine 0 C--N 1.354 1.554 0 N-CA-C 111.834 -0.506 . . . . 0.0 111.834 -178.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.65 -47.65 80.45 Favored 'General case' 0 C--N 1.349 0.568 0 CA-C-N 118.13 0.965 . . . . 0.0 111.548 -177.115 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 10.2 mttm -65.39 -48.39 73.02 Favored 'General case' 0 C--N 1.359 1.006 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -177.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.444 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.4 tm? -68.93 -39.37 79.63 Favored 'General case' 0 C--N 1.348 0.529 0 O-C-N 121.156 -0.965 . . . . 0.0 111.788 -175.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -63.81 -44.96 91.73 Favored 'General case' 0 C--N 1.354 0.779 0 O-C-N 121.084 -1.01 . . . . 0.0 111.032 -178.003 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.83 -13.86 17.08 Favored 'Isoleucine or valine' 0 C--N 1.359 0.98 0 O-C-N 121.548 -0.72 . . . . 0.0 109.084 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -73.52 -38.06 65.44 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . 0.426 HD13 HBC2 ' A' ' 202' ' ' HEM . 83.6 mt -74.47 -29.78 61.59 Favored 'General case' 0 C--N 1.357 0.928 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 46.5 mm -65.25 -52.94 46.29 Favored 'Isoleucine or valine' 0 C--N 1.358 0.977 0 C-N-CA 120.059 -0.656 . . . . 0.0 109.883 -177.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -75.36 -15.89 60.44 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.425 178.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.85 -37.26 65.72 Favored Glycine 0 C--N 1.349 1.27 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -131.88 106.21 13.97 Favored Pre-proline 0 N--CA 1.441 -0.923 0 CA-C-O 122.58 1.181 . . . . 0.0 109.37 -177.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -68.36 -25.35 36.14 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.581 2.187 . . . . 0.0 113.848 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -88.5 -9.1 53.55 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -89.51 -21.92 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 -178.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.26 -23.25 14.85 Favored 'General case' 0 C--N 1.36 1.049 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -70.2 -37.24 75.04 Favored 'General case' 0 C--N 1.358 0.959 0 O-C-N 121.845 -0.535 . . . . 0.0 109.845 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -64.28 -36.24 83.47 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.322 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.45 ' SD ' ' HB2' ' A' ' 95' ' ' LEU . 17.4 ttp -83.32 153.54 24.56 Favored 'General case' 0 C--N 1.351 0.67 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -178.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.46 -22.65 8.08 Favored 'General case' 0 C--N 1.365 1.276 0 O-C-N 121.627 -0.671 . . . . 0.0 111.138 -177.241 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -164.21 170.14 16.7 Favored 'General case' 0 CA--C 1.504 -0.802 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -177.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.489 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 64.9 m -66.05 -40.56 91.04 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.469 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 1.6 m-30 -68.42 -37.9 80.74 Favored 'General case' 0 C--N 1.354 0.788 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.135 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -66.22 -22.5 66.34 Favored 'General case' 0 C--N 1.357 0.935 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.489 ' HB3' ' O ' ' A' ' 92' ' ' SER . 62.0 tp -64.42 -45.16 88.77 Favored 'General case' 0 C--N 1.357 0.919 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.049 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.5 mp -60.89 -35.76 77.47 Favored 'General case' 0 C--N 1.356 0.874 0 O-C-N 122.139 -0.351 . . . . 0.0 110.17 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.6 t -69.09 -39.9 78.72 Favored 'General case' 0 C--N 1.35 0.613 0 O-C-N 121.871 -0.518 . . . . 0.0 110.067 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.77 8.15 40.62 Favored 'General case' 0 C--N 1.354 0.766 0 O-C-N 122.163 -0.336 . . . . 0.0 111.359 -176.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.818 HD11 ' C2B' ' A' ' 202' ' ' HEM . 19.3 tt -63.32 -38.81 83.13 Favored 'Isoleucine or valine' 0 C--N 1.36 1.024 0 O-C-N 121.44 -0.787 . . . . 0.0 111.876 -176.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -108.51 -14.75 14.59 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 118.103 -1.439 . . . . 0.0 110.156 -178.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.9 t -64.42 -46.09 84.73 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 120.253 -0.579 . . . . 0.0 111.07 -179.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -137.37 -15.09 1.46 Allowed 'General case' 0 C--N 1.359 1.016 0 C-N-CA 117.343 -1.743 . . . . 0.0 112.512 -177.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.641 HG21 ' C1C' ' A' ' 202' ' ' HEM . 26.5 mm -70.56 -51.74 34.83 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 CA-C-N 119.875 1.216 . . . . 0.0 110.468 -177.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 51.8 m170 -92.09 -1.05 57.41 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.203 -177.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 65.6 t -80.04 -44.6 22.71 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.026 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 178.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 54.8 tp10 -68.31 -40.76 81.59 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.1 t -62.66 -46.69 95.75 Favored 'Isoleucine or valine' 0 C--N 1.356 0.856 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.598 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -60.38 -48.24 82.61 Favored 'General case' 0 C--N 1.359 0.993 0 O-C-N 121.967 -0.458 . . . . 0.0 111.472 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -60.61 -36.55 78.87 Favored 'General case' 0 C--N 1.356 0.857 0 O-C-N 121.544 -0.722 . . . . 0.0 110.293 -178.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.4 mt -59.27 -77.16 0.04 OUTLIER 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' TYR . . . . . 0.444 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 82.7 m-85 -118.9 140.73 29.01 Favored Pre-proline 0 N--CA 1.438 -1.027 0 C-N-CA 118.663 -1.215 . . . . 0.0 109.053 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 111' ' ' TYR . 73.7 Cg_endo -87.0 -2.5 8.05 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 C-N-CA 123.129 2.553 . . . . 0.0 114.904 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -66.97 -36.52 82.38 Favored 'General case' 0 C--N 1.355 0.825 0 O-C-N 121.921 -0.487 . . . . 0.0 110.06 -179.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.44 ' CB ' HBD2 ' A' ' 202' ' ' HEM . . . -66.82 147.11 53.68 Favored 'General case' 0 C--N 1.352 0.704 0 CA-C-O 121.525 0.679 . . . . 0.0 109.81 -178.441 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.462 ' O ' HD13 ' A' ' 116' ' ' LEU . 46.5 mt-10 -117.51 142.66 46.9 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 179.308 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.462 HD13 ' O ' ' A' ' 115' ' ' GLU . 2.7 mm? -127.12 149.29 69.06 Favored Pre-proline 0 C--N 1.352 0.695 0 CA-C-O 122.178 0.99 . . . . 0.0 108.73 -178.64 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.464 ' HD3' ' CGA' ' A' ' 202' ' ' HEM . 75.1 Cg_endo -89.65 -158.86 0.08 OUTLIER 'Trans proline' 0 C--N 1.316 -1.18 0 C-N-CA 123.75 2.967 . . . . 0.0 113.029 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -118.33 140.56 49.65 Favored 'General case' 0 C--N 1.362 1.128 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -126.55 129.36 48.44 Favored 'General case' 0 C--N 1.361 1.081 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -178.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' THR . . . . . 0.478 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 95.3 m -125.42 127.53 46.69 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 176.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 80.9 m -120.12 129.51 54.2 Favored 'General case' 0 CA--C 1.503 -0.855 0 C-N-CA 119.087 -1.045 . . . . 0.0 109.693 -177.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -120.74 117.48 27.59 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 178.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.589 ' HG3' ' CD1' ' A' ' 129' ' ' ILE . 12.9 ttm180 -92.8 113.81 26.19 Favored 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -179.113 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.555 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 87.1 mt -75.96 -38.99 56.93 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.074 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -166.21 -139.65 2.7 Favored Glycine 0 C--N 1.351 1.387 0 N-CA-C 109.231 -1.547 . . . . 0.0 109.231 -178.173 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -94.75 -41.09 9.43 Favored 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 120.134 -0.626 . . . . 0.0 109.452 -178.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 51.3 p-10 -101.28 4.48 41.76 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 120.049 -0.661 . . . . 0.0 109.956 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.555 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 67.3 m-20 -118.2 128.36 54.63 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.589 ' CD1' ' HG3' ' A' ' 123' ' ' ARG . 3.4 mm -139.42 132.33 36.92 Favored 'Isoleucine or valine' 0 C--N 1.355 0.823 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 52.9 mtm180 -116.08 137.8 51.8 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 179.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.9 tp -127.5 118.83 24.76 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 115.328 -0.851 . . . . 0.0 108.829 -178.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.478 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 11.9 m170 -97.56 131.54 44.06 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 178.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -127.37 121.14 30.16 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 -178.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.511 ' HA ' ' O ' ' A' ' 171' ' ' THR . 28.6 tt0 -113.75 113.9 25.61 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.7 t -161.06 151.82 18.3 Favored 'General case' 0 C--N 1.359 0.982 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.402 ' C ' ' HD3' ' A' ' 138' ' ' PRO . 99.4 mttt -90.72 2.08 56.29 Favored 'General case' 0 C--N 1.355 0.838 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -179.155 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -132.99 74.54 73.69 Favored Pre-proline 0 CA--C 1.505 -0.787 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' PRO . . . . . 0.402 ' HD3' ' C ' ' A' ' 136' ' ' LYS . 90.2 Cg_endo -96.47 102.2 0.09 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.533 0 C-N-CA 122.743 2.296 . . . . 0.0 115.818 -177.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -110.76 114.07 27.15 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 105.971 -1.862 . . . . 0.0 105.971 176.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.88 -38.41 90.98 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.311 -178.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 74.5 m -64.01 -27.1 68.89 Favored 'General case' 0 C--N 1.354 0.777 0 O-C-N 121.864 -0.522 . . . . 0.0 110.7 -178.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -76.33 -47.08 24.77 Favored 'General case' 0 C--N 1.351 0.646 0 O-C-N 121.743 -0.598 . . . . 0.0 109.765 -177.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.67 -39.77 94.27 Favored 'General case' 0 C--N 1.356 0.885 0 O-C-N 122.183 -0.323 . . . . 0.0 111.256 -178.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.61 -37.71 88.38 Favored 'General case' 0 C--N 1.355 0.836 0 O-C-N 121.867 -0.521 . . . . 0.0 110.024 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.15 -43.17 98.63 Favored Glycine 0 C--N 1.347 1.188 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -179.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 83.6 mt -70.44 -40.38 73.81 Favored 'General case' 0 C--N 1.352 0.682 0 CA-C-N 117.559 0.68 . . . . 0.0 112.649 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 98.4 mt -70.91 -42.47 69.89 Favored 'General case' 0 C--N 1.362 1.11 0 O-C-N 121.215 -0.928 . . . . 0.0 110.86 -176.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.555 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 37.2 t70 -71.5 -28.85 64.19 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 121.894 -0.504 . . . . 0.0 110.336 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -63.03 -39.64 98.31 Favored Glycine 0 C--N 1.357 1.719 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 44.1 t -61.03 -41.06 95.86 Favored 'General case' 0 C--N 1.352 0.681 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -76.22 0.86 17.63 Favored 'General case' 0 C--N 1.361 1.071 0 CA-C-O 121.406 0.622 . . . . 0.0 109.403 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.555 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 76.8 mm-40 -86.37 -45.8 10.86 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.304 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -68.34 -43.67 76.99 Favored 'General case' 0 C--N 1.357 0.912 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.503 179.086 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -69.73 -27.9 65.35 Favored 'General case' 0 C--N 1.361 1.078 0 O-C-N 121.815 -0.553 . . . . 0.0 110.932 -178.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 85.1 tttt 71.56 69.22 0.16 Allowed 'General case' 0 C--N 1.362 1.114 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -177.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -134.57 -176.71 4.31 Favored 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -135.95 110.45 8.54 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -132.9 150.34 52.17 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 95.2 m -120.39 126.57 50.8 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.531 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.5 mp -101.86 121.31 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.7 m -116.32 -176.69 3.01 Favored 'General case' 0 C--N 1.361 1.082 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.734 ' HD2' ' HG3' ' A' ' 167' ' ' GLN . 8.8 ptt180 -148.95 158.17 43.97 Favored 'General case' 0 C--N 1.356 0.858 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 -179.208 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 65.5 p -104.75 145.01 29.89 Favored Pre-proline 0 C--N 1.359 1.017 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 179.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' PRO . . . . . 0.868 ' HA ' ' HB2' ' A' ' 167' ' ' GLN . 57.7 Cg_endo -75.36 -8.24 19.49 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 123.094 2.529 . . . . 0.0 115.521 -178.64 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -71.19 -41.31 70.45 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 34.1 p -117.77 16.12 14.41 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.868 ' HB2' ' HA ' ' A' ' 164' ' ' PRO . 10.0 tt0 -58.96 -38.67 79.6 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.87 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -111.71 48.69 0.94 Allowed 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 19.0 t -139.64 142.95 36.98 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.613 ' O ' ' HB ' ' A' ' 171' ' ' THR . 61.0 mt-10 -97.15 164.77 12.36 Favored 'General case' 0 C--N 1.356 0.86 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.332 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' THR . . . . . 0.613 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 3.1 m 80.81 -57.73 0.3 Allowed 'General case' 0 C--N 1.371 1.542 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -107.96 116.76 32.55 Favored 'General case' 0 CA--C 1.503 -0.83 0 C-N-CA 119.843 -0.743 . . . . 0.0 109.732 -178.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 86.3 t -130.26 131.86 65.35 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 178.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 50.5 mm -108.1 125.75 64.71 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -112.51 151.15 30.31 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-O 122.138 0.97 . . . . 0.0 108.551 -179.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -133.9 82.84 2.0 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.804 -178.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.1 mp -78.23 116.49 21.98 Favored 'Isoleucine or valine' 0 C--N 1.359 1.007 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 90.7 m -118.3 144.2 46.02 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -178.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -87.96 113.78 23.94 Favored 'General case' 0 C--N 1.36 1.035 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 -179.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' A' ' 181' ' ' PRO . . . -62.81 143.86 96.83 Favored Pre-proline 0 CA--C 1.5 -0.979 0 CA-C-O 121.983 0.896 . . . . 0.0 108.85 -179.309 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 180' ' ' ALA . 53.2 Cg_exo -54.97 127.73 27.54 Favored 'Trans proline' 0 CA--C 1.497 -1.353 0 C-N-CA 122.85 2.367 . . . . 0.0 113.397 -179.381 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.37 148.13 51.82 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 73.46 -152.06 45.84 Favored Glycine 0 C--N 1.351 1.376 0 N-CA-C 107.102 -2.399 . . . . 0.0 107.102 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -86.89 -179.74 6.57 Favored 'General case' 0 N--CA 1.433 -1.275 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -75.51 176.65 7.37 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -150.58 161.65 42.16 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 -178.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -153.22 -86.88 0.06 Allowed 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -155.81 -80.1 0.08 Allowed 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -136.24 129.08 31.01 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 -179.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 . . . . . 0 C--O 1.264 1.855 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.968 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 201' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 202' ' ' HEM . . . . . 0.934 ' CMD' HBD1 ' A' ' 202' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.4 mmm . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 120.822 0.344 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.09 -25.39 47.58 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -178.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.45 -39.4 50.6 Favored Glycine 0 C--N 1.351 1.392 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.0 tpp -69.78 -38.07 76.57 Favored 'General case' 0 C--N 1.357 0.914 0 O-C-N 121.911 -0.758 . . . . 0.0 111.081 -177.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.8 m -69.26 -22.63 25.98 Favored 'Isoleucine or valine' 0 C--N 1.356 0.89 0 O-C-N 121.504 -0.748 . . . . 0.0 109.51 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -70.22 -36.76 74.75 Favored 'General case' 0 C--N 1.359 0.989 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 87.8 m -66.56 -40.91 89.26 Favored 'General case' 0 C--N 1.357 0.911 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.64 -38.9 97.18 Favored Glycine 0 C--N 1.357 1.71 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.628 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -65.55 -40.31 92.72 Favored 'General case' 0 C--N 1.351 0.673 0 CA-C-N 117.207 0.503 . . . . 0.0 110.739 -178.205 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 20.7 mmt -63.75 -41.44 98.0 Favored 'General case' 0 C--N 1.355 0.819 0 O-C-N 121.419 -0.801 . . . . 0.0 111.207 -178.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -66.82 -40.36 88.02 Favored 'General case' 0 C--N 1.348 0.518 0 O-C-N 122.011 -0.431 . . . . 0.0 111.691 -177.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 55.7 tp -66.08 -43.29 87.77 Favored 'General case' 0 C--N 1.349 0.573 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -177.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.628 HG12 ' O ' ' A' ' 9' ' ' LEU . 1.7 mm -73.18 -36.57 50.34 Favored 'Isoleucine or valine' 0 C--N 1.36 1.029 0 O-C-N 121.076 -1.015 . . . . 0.0 111.14 -175.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -70.66 -42.57 70.62 Favored 'General case' 0 C--N 1.35 0.612 0 O-C-N 121.505 -0.747 . . . . 0.0 111.746 -176.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -72.01 -38.33 69.62 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -175.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -102.75 -23.97 13.76 Favored 'General case' 0 CA--C 1.509 -0.612 0 C-N-CA 118.524 -1.27 . . . . 0.0 113.655 -174.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 13.8 m-30 -108.2 -37.43 6.03 Favored 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 117.994 -1.482 . . . . 0.0 111.531 -176.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 143.37 178.11 18.89 Favored Glycine 0 C--N 1.347 1.173 0 C-N-CA 118.842 -1.646 . . . . 0.0 109.214 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -102.19 -26.93 13.16 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 -177.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -70.48 -38.92 74.47 Favored 'General case' 0 C--N 1.36 1.061 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.6 m -67.31 -38.48 85.02 Favored 'General case' 0 C--N 1.359 0.995 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 35.2 tp -60.57 -38.81 85.81 Favored 'General case' 0 C--N 1.356 0.859 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -63.77 -37.91 89.15 Favored 'General case' 0 C--N 1.358 0.96 0 O-C-N 122.122 -0.361 . . . . 0.0 111.485 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 87.1 m -65.42 -38.86 91.19 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.699 HD13 HD22 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -62.34 -39.36 92.84 Favored 'General case' 0 C--N 1.354 0.768 0 CA-C-O 120.958 0.408 . . . . 0.0 109.988 -179.046 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 85.7 mt -73.09 -15.27 61.5 Favored 'General case' 0 C--N 1.359 0.987 0 O-C-N 121.7 -0.625 . . . . 0.0 110.518 -178.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -86.13 -27.89 24.35 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 119.2 -1.0 . . . . 0.0 109.429 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.6 t -67.0 -36.47 82.25 Favored 'General case' 0 C--N 1.354 0.804 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.625 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 1.7 p -93.65 -37.97 11.57 Favored 'General case' 0 C--N 1.357 0.931 0 C-N-CA 118.781 -1.168 . . . . 0.0 108.12 -179.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.625 ' HB2' ' O ' ' A' ' 29' ' ' CYS . 13.7 mt-10 84.65 133.18 0.05 OUTLIER 'General case' 0 C--N 1.36 1.026 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.514 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -86.08 -169.12 2.5 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.874 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -152.91 -28.21 0.15 Allowed 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.7 t -141.85 -71.21 0.34 Allowed 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -178.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -130.6 -45.71 1.07 Allowed 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 125.7 -32.65 3.8 Favored Glycine 0 C--N 1.352 1.452 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 84.8 mt -113.3 102.84 14.49 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.806 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -97.23 -2.3 43.05 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.731 HG22 ' H ' ' A' ' 39' ' ' SER . 3.9 m 79.42 174.68 0.14 Allowed 'General case' 0 C--N 1.362 1.135 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 -178.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.731 ' H ' HG22 ' A' ' 38' ' ' THR . 31.8 p -87.96 113.91 24.07 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 121.115 -0.99 . . . . 0.0 109.561 -178.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.481 HG13 ' O ' ' A' ' 39' ' ' SER . 0.0 OUTLIER -173.31 -9.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.362 1.146 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.946 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -115.25 166.17 12.17 Favored Glycine 0 C--N 1.356 1.671 0 N-CA-C 109.211 -1.555 . . . . 0.0 109.211 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.3 m -130.1 130.36 44.74 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -117.3 172.33 7.37 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -70.68 172.91 7.86 Favored 'General case' 0 C--N 1.356 0.879 0 CA-C-O 121.762 0.791 . . . . 0.0 109.58 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -81.4 -25.99 35.79 Favored 'General case' 0 C--N 1.356 0.85 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -64.52 -28.19 69.48 Favored 'General case' 0 C--N 1.354 0.779 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -61.79 -42.34 98.87 Favored 'General case' 0 C--N 1.353 0.725 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.456 ' O ' HG23 ' A' ' 52' ' ' VAL . 62.6 tp -67.04 -40.0 87.06 Favored 'General case' 0 C--N 1.355 0.811 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.439 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 59.0 tp -72.15 -33.51 67.79 Favored 'General case' 0 C--N 1.35 0.611 0 O-C-N 122.14 -0.35 . . . . 0.0 110.68 -177.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -64.73 -42.78 94.97 Favored 'General case' 0 N--CA 1.445 -0.688 0 O-C-N 121.66 -0.65 . . . . 0.0 109.852 -177.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.699 HD22 HD13 ' A' ' 25' ' ' LEU . 77.6 mt -72.76 -33.83 66.6 Favored 'General case' 0 C--N 1.361 1.08 0 C-N-CA 119.762 -0.775 . . . . 0.0 109.753 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 48' ' ' LEU . 35.8 t -63.03 -42.3 96.12 Favored 'Isoleucine or valine' 0 C--N 1.35 0.605 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.7 t -66.1 -39.71 85.19 Favored 'Isoleucine or valine' 0 C--N 1.351 0.663 0 O-C-N 121.795 -0.565 . . . . 0.0 109.515 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.485 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 34.9 tptt -63.54 -28.64 70.08 Favored 'General case' 0 C--N 1.361 1.099 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.523 HD21 HD12 ' A' ' 13' ' ' ILE . 16.8 mt -66.51 -38.77 87.93 Favored 'General case' 0 C--N 1.355 0.847 0 O-C-N 121.996 -0.44 . . . . 0.0 110.459 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.7 p -72.13 -17.47 61.96 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.76 -178.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -101.57 -38.43 7.95 Favored 'General case' 0 C--N 1.354 0.769 0 C-N-CA 119.369 -0.932 . . . . 0.0 111.651 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.7 p -72.3 -38.27 61.09 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 O-C-N 121.616 -0.678 . . . . 0.0 111.24 -177.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.589 ' HB3' HG23 ' A' ' 61' ' ' VAL . 1.9 t -113.21 -7.71 13.57 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 118.948 -1.101 . . . . 0.0 110.406 -178.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 64.86 49.56 2.15 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.589 HG23 ' HB3' ' A' ' 59' ' ' SER . 58.7 t -113.07 133.39 22.04 Favored Pre-proline 0 N--CA 1.443 -0.79 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 61' ' ' VAL . 39.3 Cg_exo -58.14 147.36 83.84 Favored 'Trans proline' 0 CA--C 1.499 -1.259 0 C-N-CA 122.562 2.175 . . . . 0.0 112.631 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.7 m -75.65 -11.52 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.922 -178.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 68.3 p -95.88 -32.97 12.39 Favored 'General case' 0 C--N 1.358 0.96 0 C-N-CA 118.183 -1.407 . . . . 0.0 109.468 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -77.52 -22.72 50.73 Favored 'General case' 0 C--N 1.355 0.814 0 O-C-N 121.488 -0.758 . . . . 0.0 109.138 179.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.76 -35.61 38.46 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -69.93 -28.4 36.46 Favored 'Isoleucine or valine' 0 C--N 1.357 0.9 0 C-N-CA 119.932 -0.707 . . . . 0.0 110.049 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 63.2 mtp180 -70.45 -50.12 41.55 Favored 'General case' 0 C--N 1.362 1.15 0 O-C-N 121.398 -0.814 . . . . 0.0 110.533 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.68 -35.96 81.36 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 122.246 -0.284 . . . . 0.0 110.91 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -61.1 -47.44 86.26 Favored 'General case' 0 C--N 1.348 0.512 0 O-C-N 122.229 -0.294 . . . . 0.0 110.498 -178.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.85 -39.59 97.06 Favored Glycine 0 C--N 1.355 1.616 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 -178.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.0 -48.97 76.53 Favored 'General case' 0 C--N 1.352 0.694 0 CA-C-N 118.363 1.081 . . . . 0.0 111.635 -177.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.698 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 10.0 mttm -63.17 -48.38 78.65 Favored 'General case' 0 C--N 1.359 0.987 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -177.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.414 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.5 tm? -68.77 -39.07 80.42 Favored 'General case' 0 C--N 1.348 0.533 0 O-C-N 121.198 -0.939 . . . . 0.0 111.777 -175.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.413 ' CE2' ' HA ' ' A' ' 150' ' ' CYS . 48.0 t80 -62.84 -45.96 90.13 Favored 'General case' 0 C--N 1.353 0.761 0 O-C-N 121.152 -0.968 . . . . 0.0 111.286 -178.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 8.5 p -70.08 -15.08 18.89 Favored 'Isoleucine or valine' 0 C--N 1.359 0.993 0 O-C-N 121.377 -0.827 . . . . 0.0 109.392 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.698 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 75.2 mm-40 -71.07 -38.93 72.47 Favored 'General case' 0 C--N 1.352 0.702 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 81.7 mt -72.17 -33.12 67.45 Favored 'General case' 0 C--N 1.356 0.873 0 O-C-N 122.432 -0.168 . . . . 0.0 110.739 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 47.3 mm -64.48 -54.05 35.36 Favored 'Isoleucine or valine' 0 C--N 1.358 0.943 0 C-N-CA 120.126 -0.63 . . . . 0.0 110.396 -177.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -75.33 -14.37 60.48 Favored 'General case' 0 C--N 1.351 0.673 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.45 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.09 -36.78 64.11 Favored Glycine 0 C--N 1.347 1.192 0 N-CA-C 110.969 -0.853 . . . . 0.0 110.969 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -134.18 106.81 11.28 Favored Pre-proline 0 C--N 1.357 0.894 0 CA-C-O 122.68 1.229 . . . . 0.0 109.189 -176.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.526 ' O ' ' HB2' ' A' ' 87' ' ' ASN . 39.3 Cg_endo -68.97 -23.3 34.57 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.675 2.25 . . . . 0.0 114.239 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -90.55 -8.71 49.56 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 tp -90.31 -21.25 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 -178.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -104.11 -14.74 15.78 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.526 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 20.1 t30 -73.3 -41.02 64.06 Favored 'General case' 0 C--N 1.359 1.012 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -68.1 -28.4 67.3 Favored 'General case' 0 C--N 1.352 0.716 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.552 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 25.9 ttp -84.86 148.55 26.22 Favored 'General case' 0 C--N 1.351 0.636 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.13 -21.63 8.14 Favored 'General case' 0 C--N 1.364 1.216 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.984 -177.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -164.22 171.18 15.31 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -177.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.443 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 86.6 p -70.22 -34.0 72.37 Favored 'General case' 0 C--N 1.354 0.776 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.197 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -70.04 -38.46 75.84 Favored 'General case' 0 C--N 1.357 0.922 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -66.14 -24.67 66.71 Favored 'General case' 0 C--N 1.358 0.952 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.443 ' HB3' ' O ' ' A' ' 92' ' ' SER . 61.3 tp -62.63 -46.63 87.34 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.2 mp -62.76 -32.6 73.78 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 122.246 -0.284 . . . . 0.0 110.302 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 35.8 t -62.73 -45.58 92.07 Favored 'General case' 0 C--N 1.356 0.864 0 O-C-N 121.688 -0.632 . . . . 0.0 111.597 -178.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.08 25.87 10.99 Favored 'General case' 0 C--N 1.361 1.071 0 O-C-N 121.057 -1.027 . . . . 0.0 110.453 -178.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 12.3 tt -64.26 -29.66 47.94 Favored 'Isoleucine or valine' 0 C--N 1.352 0.689 0 C-N-CA 120.341 -0.543 . . . . 0.0 110.507 -179.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -120.19 -18.59 7.99 Favored 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 119.336 -0.946 . . . . 0.0 109.115 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 35.5 t -66.06 -45.98 79.42 Favored 'General case' 0 N--CA 1.443 -0.785 0 O-C-N 121.841 -0.537 . . . . 0.0 110.85 -178.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.552 ' O ' HG12 ' A' ' 105' ' ' VAL . 30.8 t80 -124.97 -31.21 3.15 Favored 'General case' 0 C--N 1.359 0.99 0 C-N-CA 118.23 -1.388 . . . . 0.0 111.992 -177.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 96.3 mt -67.52 -47.27 81.09 Favored 'Isoleucine or valine' 0 C--N 1.352 0.704 0 O-C-N 121.034 -1.041 . . . . 0.0 110.687 -177.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 17.5 m170 -87.72 3.16 49.06 Favored 'General case' 0 N--CA 1.441 -0.913 0 O-C-N 121.252 -0.905 . . . . 0.0 110.15 -177.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.552 HG12 ' O ' ' A' ' 102' ' ' PHE . 1.8 p -87.39 -34.15 7.26 Favored 'Isoleucine or valine' 0 C--N 1.356 0.872 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 178.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -71.86 -40.26 69.1 Favored 'General case' 0 C--N 1.359 0.997 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 62.4 t -62.81 -47.37 93.19 Favored 'Isoleucine or valine' 0 C--N 1.356 0.87 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.517 -179.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -60.55 -48.25 82.62 Favored 'General case' 0 C--N 1.359 0.979 0 O-C-N 122.115 -0.366 . . . . 0.0 111.364 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -61.96 -37.57 85.27 Favored 'General case' 0 C--N 1.354 0.786 0 O-C-N 121.533 -0.729 . . . . 0.0 110.708 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.8 mt -57.47 -74.96 0.05 OUTLIER 'General case' 0 C--N 1.356 0.851 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -114.54 135.52 22.3 Favored Pre-proline 0 N--CA 1.441 -0.921 0 C-N-CA 118.656 -1.218 . . . . 0.0 109.146 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -84.66 -5.91 9.87 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 123.133 2.555 . . . . 0.0 115.055 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -66.96 -36.58 82.53 Favored 'General case' 0 C--N 1.355 0.808 0 O-C-N 122.009 -0.432 . . . . 0.0 110.073 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.71 145.21 56.29 Favored 'General case' 0 C--N 1.355 0.807 0 CA-C-O 121.683 0.754 . . . . 0.0 110.139 -178.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -131.09 135.64 47.69 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.467 ' HB3' ' HD2' ' A' ' 117' ' ' PRO . 91.6 mt -127.9 155.73 77.11 Favored Pre-proline 0 N--CA 1.443 -0.791 0 CA-C-O 122.173 0.987 . . . . 0.0 109.246 -178.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' A' ' 116' ' ' LEU . 84.6 Cg_endo -81.89 -151.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.081 0 C-N-CA 123.736 2.957 . . . . 0.0 113.895 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -115.52 146.42 41.72 Favored 'General case' 0 C--N 1.362 1.126 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.629 ' CE1' HD13 ' A' ' 131' ' ' LEU . 14.1 t80 -140.6 125.57 18.34 Favored 'General case' 0 C--N 1.362 1.144 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -177.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 93.3 m -125.83 134.06 51.78 Favored 'General case' 0 C--N 1.36 1.038 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 79.0 m -113.36 131.19 56.07 Favored 'General case' 0 C--N 1.356 0.872 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.772 -178.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -117.69 141.77 48.01 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 177.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -117.75 116.57 27.28 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.528 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 87.6 mt -84.49 -25.75 28.63 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 120.686 -0.406 . . . . 0.0 109.994 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 179.2 -144.26 6.11 Favored Glycine 0 C--N 1.349 1.251 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -94.68 -40.88 9.57 Favored 'General case' 0 N--CA 1.436 -1.137 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.567 -178.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -99.17 2.31 45.72 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.614 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.528 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 8.4 m-20 -121.72 131.63 54.18 Favored 'General case' 0 C--N 1.358 0.961 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.5 mm -140.91 137.43 34.7 Favored 'Isoleucine or valine' 0 C--N 1.354 0.797 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 61.9 mtm180 -123.78 140.35 53.08 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 1.038 HD23 HD11 ' A' ' 177' ' ' ILE . 1.1 pp -127.79 129.43 47.01 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -99.49 133.96 43.06 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -129.67 120.32 24.99 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -178.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.578 ' HA ' ' O ' ' A' ' 171' ' ' THR . 74.2 mt-30 -114.25 115.08 26.85 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 18.1 t -161.69 152.01 17.32 Favored 'General case' 0 C--N 1.359 0.991 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -92.02 2.22 56.7 Favored 'General case' 0 C--N 1.358 0.939 0 C-N-CA 120.15 -0.62 . . . . 0.0 109.937 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -134.4 73.03 69.62 Favored Pre-proline 0 C--N 1.355 0.81 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -96.19 110.01 0.12 Allowed 'Trans proline' 0 N--CA 1.445 -1.368 0 C-N-CA 122.714 2.276 . . . . 0.0 116.079 -177.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -113.64 113.93 25.73 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 176.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.08 -38.7 92.0 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.264 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.3 m -62.41 -27.07 68.84 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 121.871 -0.518 . . . . 0.0 110.731 -178.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -76.02 -47.94 22.89 Favored 'General case' 0 C--N 1.351 0.64 0 C-N-CA 120.196 -0.602 . . . . 0.0 109.702 -178.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.68 -40.17 94.93 Favored 'General case' 0 C--N 1.358 0.949 0 O-C-N 122.17 -0.331 . . . . 0.0 111.269 -178.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -62.82 -36.54 83.52 Favored 'General case' 0 C--N 1.355 0.818 0 O-C-N 121.92 -0.487 . . . . 0.0 110.088 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.3 -42.81 98.94 Favored Glycine 0 C--N 1.347 1.171 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.0 mt -69.75 -40.93 75.86 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 96.0 mt -71.69 -42.34 67.55 Favored 'General case' 0 C--N 1.363 1.168 0 O-C-N 121.091 -1.006 . . . . 0.0 111.086 -176.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.506 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 37.2 t70 -69.3 -31.78 70.49 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 121.887 -0.508 . . . . 0.0 110.484 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -62.66 -39.26 97.69 Favored Glycine 0 C--N 1.356 1.658 0 N-CA-C 108.62 -1.792 . . . . 0.0 108.62 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.413 ' HA ' ' CE2' ' A' ' 75' ' ' PHE . 42.8 t -60.42 -42.55 96.27 Favored 'General case' 0 C--N 1.35 0.625 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -74.55 -1.6 22.14 Favored 'General case' 0 C--N 1.36 1.058 0 O-C-N 121.72 -0.612 . . . . 0.0 109.458 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.506 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 77.7 mm-40 -83.56 -46.9 11.89 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -65.87 -45.04 83.59 Favored 'General case' 0 C--N 1.36 1.036 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -68.96 -26.15 64.91 Favored 'General case' 0 C--N 1.362 1.126 0 O-C-N 121.75 -0.594 . . . . 0.0 110.796 -178.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 86.2 tttt 72.73 75.92 0.15 Allowed 'General case' 0 C--N 1.359 0.989 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -143.7 -168.28 2.8 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -152.24 92.99 1.76 Allowed 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 16.3 m-30 -112.38 161.93 16.13 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 93.7 m -118.5 125.95 50.97 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 119.293 -0.963 . . . . 0.0 109.234 -177.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.5 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.6 mp -104.61 122.33 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 178.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.6 m -120.52 -171.3 2.15 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-O 121.665 0.745 . . . . 0.0 109.241 -178.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.49 ' HD2' ' HG3' ' A' ' 167' ' ' GLN . 5.9 ptt85 -152.0 161.6 42.39 Favored 'General case' 0 C--N 1.357 0.897 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 56.8 p -107.95 143.9 28.28 Favored Pre-proline 0 C--N 1.36 1.049 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.878 ' HA ' ' HB2' ' A' ' 167' ' ' GLN . 56.7 Cg_endo -75.15 -7.86 19.4 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 123.204 2.603 . . . . 0.0 115.578 -178.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -71.6 -41.42 68.96 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 36.5 p -116.89 16.03 15.2 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.878 ' HB2' ' HA ' ' A' ' 164' ' ' PRO . 37.6 tt0 -58.38 -39.02 78.5 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.323 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -113.23 49.04 0.98 Allowed 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 20.7 t -139.11 142.24 38.09 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.618 ' O ' ' HB ' ' A' ' 171' ' ' THR . 61.8 mt-10 -96.52 163.7 12.93 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.618 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 18.6 m 84.12 -56.71 0.13 Allowed 'General case' 0 C--N 1.369 1.418 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.657 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -110.79 118.8 37.13 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.924 -178.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 99.6 t -132.01 133.4 60.83 Favored 'Isoleucine or valine' 0 C--N 1.358 0.963 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 49.2 mm -112.03 125.84 69.36 Favored 'Isoleucine or valine' 0 C--N 1.36 1.03 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.576 ' HB2' ' HG ' ' A' ' 131' ' ' LEU . 96.8 m-85 -116.07 148.75 39.91 Favored 'General case' 0 C--N 1.359 0.996 0 CA-C-O 121.901 0.857 . . . . 0.0 109.063 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -126.55 119.87 28.2 Favored 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 1.038 HD11 HD23 ' A' ' 131' ' ' LEU . 4.0 mp -115.42 121.58 67.52 Favored 'Isoleucine or valine' 0 C--N 1.354 0.795 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 38.0 p -126.11 159.55 32.55 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 121.429 0.633 . . . . 0.0 110.811 -178.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 77.3 mtm180 . . . . . 0 C--N 1.367 1.365 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 177.392 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.7 mtp . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.089 0.471 . . . . 0.0 110.228 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.39 -17.86 55.85 Favored 'General case' 0 C--N 1.355 0.839 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -178.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -76.33 -41.12 26.72 Favored Glycine 0 C--N 1.349 1.256 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 14.5 tpp -69.12 -38.68 79.02 Favored 'General case' 0 C--N 1.355 0.827 0 O-C-N 121.946 -0.738 . . . . 0.0 110.612 -177.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.5 m -68.25 -22.83 27.85 Favored 'Isoleucine or valine' 0 C--N 1.357 0.903 0 C-N-CA 120.27 -0.572 . . . . 0.0 109.617 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -70.57 -35.58 73.15 Favored 'General case' 0 C--N 1.356 0.876 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 85.5 m -67.15 -40.85 86.77 Favored 'General case' 0 C--N 1.355 0.814 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.43 -39.39 97.73 Favored Glycine 0 C--N 1.359 1.814 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.583 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -64.62 -39.6 93.99 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-N 117.131 0.465 . . . . 0.0 110.711 -178.481 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.438 ' SD ' HD11 ' A' ' 26' ' ' LEU . 25.8 mmt -63.43 -40.44 97.18 Favored 'General case' 0 C--N 1.352 0.684 0 O-C-N 121.679 -0.638 . . . . 0.0 110.984 -178.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -66.88 -40.22 87.75 Favored 'General case' 0 C--N 1.349 0.571 0 O-C-N 121.956 -0.465 . . . . 0.0 111.362 -177.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 53.7 tp -66.42 -42.83 87.2 Favored 'General case' 0 C--N 1.35 0.588 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -178.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.583 HG12 ' O ' ' A' ' 9' ' ' LEU . 1.4 mm -74.99 -36.76 39.52 Favored 'Isoleucine or valine' 0 C--N 1.359 1.008 0 O-C-N 120.988 -1.07 . . . . 0.0 111.002 -175.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -68.18 -43.66 77.65 Favored 'General case' 0 C--N 1.353 0.729 0 O-C-N 121.723 -0.611 . . . . 0.0 111.555 -176.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -71.22 -35.27 71.43 Favored 'General case' 0 N--CA 1.446 -0.634 0 O-C-N 121.974 -0.454 . . . . 0.0 111.909 -176.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -72.69 -48.56 38.02 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -175.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -126.41 -20.9 4.3 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 117.349 -1.741 . . . . 0.0 113.816 -176.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 141.36 179.6 18.7 Favored Glycine 0 CA--C 1.497 -1.078 0 C-N-CA 117.789 -2.148 . . . . 0.0 109.884 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -97.16 -12.26 23.29 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -177.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -70.64 -41.08 72.65 Favored 'General case' 0 C--N 1.36 1.05 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 94.5 m -69.51 -39.05 77.79 Favored 'General case' 0 C--N 1.357 0.932 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.463 HD13 ' HB ' ' A' ' 13' ' ' ILE . 59.1 tp -61.17 -37.99 84.87 Favored 'General case' 0 C--N 1.357 0.905 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -65.17 -35.71 81.94 Favored 'General case' 0 C--N 1.356 0.851 0 O-C-N 122.177 -0.327 . . . . 0.0 110.802 -178.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.5 m -63.71 -40.74 97.53 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.435 ' CD2' ' HB3' ' A' ' 54' ' ' LYS . 87.6 mt -64.87 -37.97 89.4 Favored 'General case' 0 C--N 1.356 0.874 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.444 HD23 ' CD2' ' A' ' 31' ' ' LEU . 6.7 mp -69.39 -14.8 63.1 Favored 'General case' 0 C--N 1.357 0.922 0 O-C-N 121.415 -0.803 . . . . 0.0 109.802 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -85.84 -28.38 24.47 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.224 178.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 55.0 p -68.18 -23.11 64.82 Favored 'General case' 0 C--N 1.361 1.066 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.3 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.0 p -106.96 -33.6 7.45 Favored 'General case' 0 C--N 1.357 0.912 0 C-N-CA 118.933 -1.107 . . . . 0.0 108.141 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 83.63 132.56 0.05 OUTLIER 'General case' 0 C--N 1.361 1.106 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.457 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -100.53 109.63 21.75 Favored 'General case' 0 C--N 1.357 0.896 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.737 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -72.23 -40.71 67.55 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 178.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.43 ' HB3' ' H ' ' A' ' 34' ' ' GLU . 0.9 OUTLIER -116.09 -86.22 0.62 Allowed 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -179.212 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.43 ' H ' ' HB3' ' A' ' 33' ' ' SER . 57.4 mt-10 -122.14 -40.88 2.46 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -178.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.62 -32.79 6.33 Favored Glycine 0 C--N 1.351 1.365 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 80.4 mt -109.89 104.15 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.005 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.509 ' HD1' ' HA ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -82.89 -143.44 0.06 Allowed 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.337 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 86.2 m -109.82 -56.89 2.26 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.5 p 166.03 16.57 0.0 OUTLIER 'General case' 0 C--N 1.363 1.161 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 23.3 m -109.79 6.48 8.97 Favored 'Isoleucine or valine' 0 C--N 1.353 0.738 0 C-N-CA 119.522 -0.871 . . . . 0.0 111.313 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -91.75 143.67 16.71 Favored Glycine 0 C--N 1.354 1.533 0 C-N-CA 119.223 -1.465 . . . . 0.0 109.505 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 57.0 m -126.61 130.19 50.0 Favored 'General case' 0 C--N 1.356 0.871 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -125.27 174.52 8.06 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -76.07 -179.0 4.69 Favored 'General case' 0 C--N 1.356 0.864 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -86.44 -19.87 28.98 Favored 'General case' 0 C--N 1.356 0.876 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.744 ' HA ' HD23 ' A' ' 49' ' ' LEU . 38.1 tt0 -63.98 -35.5 80.9 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.0 tp10 -61.59 -40.55 95.21 Favored 'General case' 0 C--N 1.349 0.572 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 60.4 tp -65.38 -40.29 93.32 Favored 'General case' 0 C--N 1.357 0.896 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.691 -178.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.744 HD23 ' HA ' ' A' ' 46' ' ' GLN . 0.1 OUTLIER -83.45 -14.57 52.23 Favored 'General case' 0 C--N 1.352 0.71 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.131 -177.226 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -71.62 -43.57 65.95 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.8 mt -73.24 -34.93 66.14 Favored 'General case' 0 C--N 1.361 1.083 0 C-N-CA 120.17 -0.612 . . . . 0.0 109.704 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 50.3 t -63.91 -41.41 92.42 Favored 'Isoleucine or valine' 0 C--N 1.352 0.697 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 49' ' ' LEU . 52.9 t -65.84 -40.74 88.46 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 O-C-N 121.761 -0.587 . . . . 0.0 109.962 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.435 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 24.6 tptt -67.65 -20.29 65.3 Favored 'General case' 0 C--N 1.36 1.054 0 O-C-N 120.939 -1.101 . . . . 0.0 108.863 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.83 -37.47 70.3 Favored 'General case' 0 C--N 1.353 0.745 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.471 ' O ' ' HA ' ' A' ' 60' ' ' SER . 81.2 p -73.04 -17.32 61.45 Favored 'General case' 0 C--N 1.356 0.852 0 O-C-N 121.766 -0.584 . . . . 0.0 110.285 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -99.51 -37.56 9.13 Favored 'General case' 0 C--N 1.355 0.805 0 O-C-N 121.305 -0.872 . . . . 0.0 111.325 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.1 p -71.85 -34.7 52.24 Favored 'Isoleucine or valine' 0 C--N 1.353 0.723 0 O-C-N 121.709 -0.619 . . . . 0.0 111.52 -177.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.559 ' HB3' HG23 ' A' ' 61' ' ' VAL . 4.3 t -119.99 -8.74 9.75 Favored 'General case' 0 CA--C 1.508 -0.671 0 C-N-CA 119.26 -0.976 . . . . 0.0 109.849 -178.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.471 ' HA ' ' O ' ' A' ' 56' ' ' SER . 0.6 OUTLIER 66.65 47.78 1.54 Allowed 'General case' 0 C--N 1.353 0.737 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 179.61 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.559 HG23 ' HB3' ' A' ' 59' ' ' SER . 47.6 t -107.44 133.35 20.41 Favored Pre-proline 0 CA--C 1.505 -0.773 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.408 ' O ' ' HB3' ' A' ' 66' ' ' LEU . 41.9 Cg_exo -57.38 147.21 78.89 Favored 'Trans proline' 0 CA--C 1.498 -1.3 0 C-N-CA 122.505 2.137 . . . . 0.0 112.794 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.4 m -75.9 -13.61 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.826 -178.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.425 ' O ' HG12 ' A' ' 67' ' ' VAL . 69.0 p -97.54 -32.77 11.64 Favored 'General case' 0 C--N 1.36 1.055 0 C-N-CA 118.176 -1.41 . . . . 0.0 109.533 -178.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -76.6 -21.47 55.52 Favored 'General case' 0 C--N 1.354 0.776 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.408 ' HB3' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -82.05 -35.57 28.6 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.139 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.425 HG12 ' O ' ' A' ' 64' ' ' THR . 1.3 p -68.92 -26.43 32.52 Favored 'Isoleucine or valine' 0 C--N 1.354 0.795 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.914 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.5 mmm-85 -73.04 -52.5 14.13 Favored 'General case' 0 C--N 1.36 1.055 0 O-C-N 121.596 -0.69 . . . . 0.0 110.124 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 86.1 mt -63.37 -35.93 82.04 Favored 'General case' 0 C--N 1.357 0.929 0 O-C-N 121.991 -0.443 . . . . 0.0 110.979 -178.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -60.92 -47.27 87.17 Favored 'General case' 0 C--N 1.349 0.555 0 O-C-N 122.258 -0.276 . . . . 0.0 110.494 -178.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.54 -37.94 94.13 Favored Glycine 0 C--N 1.356 1.641 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -62.47 -49.33 75.85 Favored 'General case' 0 C--N 1.35 0.622 0 CA-C-N 118.044 0.922 . . . . 0.0 111.485 -177.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.689 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 11.9 mttm -64.36 -47.72 78.25 Favored 'General case' 0 C--N 1.359 0.996 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -177.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -68.5 -38.84 81.31 Favored 'General case' 0 C--N 1.347 0.5 0 O-C-N 121.265 -0.897 . . . . 0.0 112.004 -175.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -64.84 -42.85 94.59 Favored 'General case' 0 C--N 1.352 0.703 0 O-C-N 121.116 -0.99 . . . . 0.0 111.077 -177.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.7 -15.43 18.28 Favored 'Isoleucine or valine' 0 C--N 1.36 1.057 0 O-C-N 121.324 -0.86 . . . . 0.0 109.114 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.689 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 74.1 mm-40 -71.88 -38.71 69.97 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 84.5 mt -74.32 -29.69 61.72 Favored 'General case' 0 C--N 1.358 0.967 0 O-C-N 122.215 -0.303 . . . . 0.0 110.749 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.4 mm -66.41 -53.28 37.72 Favored 'Isoleucine or valine' 0 C--N 1.357 0.91 0 C-N-CA 119.973 -0.691 . . . . 0.0 109.973 -177.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -76.08 -14.71 60.19 Favored 'General case' 0 C--N 1.351 0.651 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.39 178.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.0 -36.93 64.47 Favored Glycine 0 C--N 1.349 1.267 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.483 ' HA ' ' HD2' ' A' ' 83' ' ' PRO . 98.6 m-70 -131.86 105.52 14.01 Favored Pre-proline 0 N--CA 1.44 -0.968 0 CA-C-O 122.604 1.192 . . . . 0.0 108.911 -177.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.483 ' HD2' ' HA ' ' A' ' 82' ' ' HIS . 41.4 Cg_endo -68.87 -23.29 35.24 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.637 2.225 . . . . 0.0 114.052 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -90.61 -9.64 46.24 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.3 tp -89.52 -21.75 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 -178.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -102.24 -17.4 15.96 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 51.3 t30 -70.84 -41.28 71.68 Favored 'General case' 0 C--N 1.359 0.999 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -66.13 -33.48 75.86 Favored 'General case' 0 C--N 1.352 0.699 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.318 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.538 ' HG2' ' N ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -80.87 149.97 29.28 Favored 'General case' 0 C--N 1.353 0.745 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 -179.029 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.538 ' N ' ' HG2' ' A' ' 89' ' ' MET . 1.4 mtpt -117.56 -24.69 7.2 Favored 'General case' 0 C--N 1.361 1.1 0 C-N-CA 120.07 -0.652 . . . . 0.0 111.183 -177.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -165.83 171.88 12.29 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -177.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.428 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 57.8 m -67.26 -39.44 86.1 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.486 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.648 ' HZ ' ' HG3' ' A' ' 179' ' ' ARG . 64.7 m-85 -67.77 -39.14 84.15 Favored 'General case' 0 C--N 1.358 0.94 0 O-C-N 121.216 -0.928 . . . . 0.0 108.681 -179.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -66.16 -22.79 66.38 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.428 ' HB3' ' O ' ' A' ' 92' ' ' SER . 62.0 tp -65.2 -45.13 85.99 Favored 'General case' 0 C--N 1.357 0.929 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.3 mp -61.44 -36.5 80.54 Favored 'General case' 0 C--N 1.358 0.956 0 O-C-N 122.001 -0.437 . . . . 0.0 110.239 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 34.7 t -67.77 -39.79 84.09 Favored 'General case' 0 C--N 1.349 0.549 0 O-C-N 121.829 -0.545 . . . . 0.0 110.021 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.2 tttp -93.78 8.1 42.38 Favored 'General case' 0 C--N 1.353 0.75 0 O-C-N 122.286 -0.259 . . . . 0.0 111.279 -176.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 15.6 tt -64.29 -38.18 81.85 Favored 'Isoleucine or valine' 0 C--N 1.36 1.033 0 O-C-N 121.464 -0.773 . . . . 0.0 111.694 -176.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -107.87 -15.79 14.46 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 118.181 -1.408 . . . . 0.0 110.195 -178.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.9 t -64.83 -46.6 81.25 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 121.76 -0.588 . . . . 0.0 111.272 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -137.32 -15.12 1.47 Allowed 'General case' 0 C--N 1.36 1.058 0 C-N-CA 117.497 -1.681 . . . . 0.0 112.684 -177.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 31.0 mm -71.0 -51.74 32.99 Favored 'Isoleucine or valine' 0 C--N 1.352 0.682 0 CA-C-N 119.982 1.265 . . . . 0.0 110.715 -177.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -92.03 2.88 56.28 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 119.529 -0.869 . . . . 0.0 110.22 -177.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 49.5 t -85.79 -44.37 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.083 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 178.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 54.7 tp10 -68.1 -40.41 82.62 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 66.6 t -63.84 -46.28 94.75 Favored 'Isoleucine or valine' 0 C--N 1.356 0.889 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.074 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 92.4 t80 -60.94 -48.51 81.5 Favored 'General case' 0 C--N 1.359 1.019 0 O-C-N 122.06 -0.4 . . . . 0.0 111.322 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -61.28 -37.12 82.02 Favored 'General case' 0 C--N 1.357 0.896 0 O-C-N 121.567 -0.708 . . . . 0.0 110.596 -178.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 15.5 mt -56.68 -72.94 0.07 Allowed 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.408 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 88.3 m-85 -121.9 135.16 25.05 Favored Pre-proline 0 N--CA 1.438 -1.061 0 C-N-CA 118.488 -1.285 . . . . 0.0 108.638 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 111' ' ' TYR . 97.7 Cg_endo -83.47 -2.56 10.55 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 123.197 2.598 . . . . 0.0 115.255 -178.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 29.7 mm100 -66.07 -37.16 85.13 Favored 'General case' 0 C--N 1.354 0.778 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.61 145.8 55.2 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-O 121.614 0.721 . . . . 0.0 109.846 -178.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -127.54 134.07 49.76 Favored 'General case' 0 C--N 1.357 0.922 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.485 ' HB3' ' HD2' ' A' ' 117' ' ' PRO . 86.8 mt -128.25 156.43 76.67 Favored Pre-proline 0 C--N 1.354 0.769 0 CA-C-O 122.116 0.96 . . . . 0.0 109.21 -178.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' A' ' 116' ' ' LEU . 95.3 Cg_endo -84.05 -153.67 0.05 OUTLIER 'Trans proline' 0 C--N 1.318 -1.074 0 C-N-CA 123.763 2.975 . . . . 0.0 114.317 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -116.66 143.79 45.21 Favored 'General case' 0 C--N 1.364 1.233 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -126.3 130.78 51.51 Favored 'General case' 0 C--N 1.364 1.203 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -178.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.494 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 94.1 m -127.52 129.18 46.93 Favored 'General case' 0 C--N 1.358 0.951 0 N-CA-C 105.739 -1.949 . . . . 0.0 105.739 177.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 77.2 m -122.88 131.47 53.76 Favored 'General case' 0 CA--C 1.504 -0.794 0 C-N-CA 119.178 -1.009 . . . . 0.0 109.855 -178.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -120.03 132.43 55.46 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 106.325 -1.732 . . . . 0.0 106.325 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -105.28 117.27 33.59 Favored 'General case' 0 C--N 1.353 0.729 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 95.2 mt -88.42 -19.84 26.02 Favored 'General case' 0 C--N 1.354 0.781 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.464 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 176.75 -146.74 8.05 Favored Glycine 0 C--N 1.348 1.229 0 C-N-CA 118.905 -1.617 . . . . 0.0 109.06 -178.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -94.82 -39.31 10.32 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -178.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -101.27 0.69 37.78 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.24 -178.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.412 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 66.2 m-20 -118.49 130.74 56.11 Favored 'General case' 0 C--N 1.358 0.955 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.0 mm -141.9 136.79 30.65 Favored 'Isoleucine or valine' 0 C--N 1.355 0.829 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 52.2 mtm180 -118.21 137.87 52.71 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 5.6 tp -125.0 119.14 27.86 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.494 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 13.7 m-70 -99.68 134.15 42.99 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.456 ' HE2' ' HG ' ' A' ' 135' ' ' SER . 32.0 t80 -129.22 121.58 27.94 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 -178.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.442 ' HA ' ' O ' ' A' ' 171' ' ' THR . 27.7 mt-30 -114.96 111.47 21.2 Favored 'General case' 0 C--N 1.357 0.916 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.54 ' O ' ' HA ' ' A' ' 171' ' ' THR . 87.6 p -160.72 161.99 32.39 Favored 'General case' 0 C--N 1.358 0.964 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -98.8 3.59 47.47 Favored 'General case' 0 C--N 1.354 0.796 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 10.8 mtp180 -133.42 74.08 72.24 Favored Pre-proline 0 C--N 1.353 0.75 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -94.74 102.25 0.12 Allowed 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 122.799 2.332 . . . . 0.0 115.926 -177.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -110.11 109.11 19.53 Favored 'General case' 0 CA--C 1.502 -0.904 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 176.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.88 -39.31 93.9 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.679 -178.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 74.3 m -62.92 -27.24 69.24 Favored 'General case' 0 C--N 1.354 0.763 0 O-C-N 121.813 -0.554 . . . . 0.0 110.762 -178.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -76.03 -46.49 29.06 Favored 'General case' 0 N--CA 1.444 -0.757 0 O-C-N 121.719 -0.613 . . . . 0.0 109.65 -178.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.19 -39.93 95.03 Favored 'General case' 0 C--N 1.359 1.01 0 O-C-N 122.124 -0.36 . . . . 0.0 111.234 -178.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -62.79 -36.95 84.81 Favored 'General case' 0 C--N 1.356 0.864 0 O-C-N 121.904 -0.498 . . . . 0.0 109.919 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.07 -43.05 98.64 Favored Glycine 0 C--N 1.348 1.205 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.8 mt -70.54 -40.84 73.19 Favored 'General case' 0 C--N 1.352 0.681 0 CA-C-N 117.606 0.703 . . . . 0.0 112.887 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 97.8 mt -71.04 -42.69 69.17 Favored 'General case' 0 C--N 1.362 1.142 0 O-C-N 121.118 -0.989 . . . . 0.0 110.945 -176.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -70.43 -29.95 66.68 Favored 'General case' 0 N--CA 1.445 -0.675 0 O-C-N 122.015 -0.428 . . . . 0.0 110.486 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.504 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -63.04 -39.69 98.35 Favored Glycine 0 C--N 1.357 1.735 0 N-CA-C 108.394 -1.882 . . . . 0.0 108.394 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 48.8 t -61.16 -42.56 98.78 Favored 'General case' 0 C--N 1.351 0.639 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -75.8 1.87 13.75 Favored 'General case' 0 C--N 1.361 1.071 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.504 ' HB2' ' O ' ' A' ' 149' ' ' GLY . 15.5 mm-40 -87.12 -45.56 10.58 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -66.45 -44.55 82.51 Favored 'General case' 0 C--N 1.359 0.984 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.439 ' O ' ' HB2' ' A' ' 155' ' ' LYS . 50.6 m-85 -70.15 -25.45 63.46 Favored 'General case' 0 C--N 1.361 1.108 0 O-C-N 121.84 -0.537 . . . . 0.0 111.119 -178.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 154' ' ' PHE . 97.3 mttt 71.6 66.07 0.15 Allowed 'General case' 0 C--N 1.363 1.168 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 -177.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -128.68 -177.44 4.19 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -140.98 95.18 2.8 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -117.27 154.29 31.46 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 93.5 m -119.63 126.47 51.25 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.526 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.5 mp -103.82 122.45 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 179.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 3.0 m -118.15 -174.84 2.73 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-O 121.797 0.808 . . . . 0.0 109.29 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.11 155.38 42.12 Favored 'General case' 0 C--N 1.356 0.874 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -178.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 63.8 p -98.79 146.86 32.36 Favored Pre-proline 0 C--N 1.36 1.062 0 CA-C-O 122.502 1.144 . . . . 0.0 108.359 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.668 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 76.9 Cg_endo -76.9 -11.22 18.16 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 123.006 2.47 . . . . 0.0 114.971 -178.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -72.09 -41.79 66.91 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 120.193 -0.603 . . . . 0.0 109.583 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 39.0 p -116.06 14.57 16.06 Favored 'General case' 0 CA--C 1.505 -0.786 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.381 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.668 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.3 pp0? -68.38 -10.27 53.92 Favored 'General case' 0 C--N 1.351 0.665 0 O-C-N 121.525 -0.734 . . . . 0.0 110.083 178.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 55.6 p30 -121.57 35.16 4.96 Favored 'General case' 0 N--CA 1.435 -1.198 0 O-C-N 121.16 -0.962 . . . . 0.0 109.48 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 94.1 p -145.51 157.83 43.94 Favored 'General case' 0 C--N 1.353 0.736 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.619 ' O ' ' HB ' ' A' ' 171' ' ' THR . 60.0 mt-10 -106.96 170.2 8.09 Favored 'General case' 0 C--N 1.356 0.856 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -179.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.619 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 6.1 m 82.79 -53.96 0.19 Allowed 'General case' 0 C--N 1.37 1.489 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.62 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -115.64 117.59 30.73 Favored 'General case' 0 CA--C 1.505 -0.763 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.655 -178.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 94.9 t -130.38 132.8 64.62 Favored 'Isoleucine or valine' 0 C--N 1.357 0.917 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 49.8 mm -107.23 127.02 63.33 Favored 'Isoleucine or valine' 0 C--N 1.359 1.0 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -115.42 155.28 27.72 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 122.139 0.971 . . . . 0.0 108.688 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -138.21 119.11 14.24 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -178.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.0 mp -114.03 119.22 60.61 Favored 'Isoleucine or valine' 0 C--N 1.355 0.807 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 89.4 m -122.02 144.51 48.85 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -177.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.648 ' HG3' ' HZ ' ' A' ' 93' ' ' PHE . 3.8 mtm180 . . . . . 0 C--N 1.367 1.358 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 179.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.4 mmm . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 120.821 0.343 . . . . 0.0 110.19 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.409 ' HA ' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -78.5 -22.68 47.06 Favored 'General case' 0 C--N 1.356 0.856 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -178.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.66 -40.56 45.82 Favored Glycine 0 C--N 1.35 1.348 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.1 tpp -70.27 -37.0 74.78 Favored 'General case' 0 C--N 1.354 0.792 0 O-C-N 122.132 -0.628 . . . . 0.0 110.865 -177.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.409 HG22 ' HA ' ' A' ' 2' ' ' MET . 27.0 m -71.17 -22.71 22.73 Favored 'Isoleucine or valine' 0 C--N 1.357 0.895 0 O-C-N 121.642 -0.661 . . . . 0.0 109.524 -179.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.445 ' HZ ' ' CG ' ' A' ' 47' ' ' GLU . 2.2 m-85 -70.8 -35.23 72.43 Favored 'General case' 0 C--N 1.357 0.915 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 85.4 m -66.95 -40.63 87.59 Favored 'General case' 0 C--N 1.354 0.795 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.13 -38.76 97.06 Favored Glycine 0 C--N 1.358 1.785 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.518 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -65.94 -39.85 90.85 Favored 'General case' 0 C--N 1.352 0.686 0 CA-C-N 117.241 0.521 . . . . 0.0 110.608 -178.087 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.442 ' CE ' HD21 ' A' ' 26' ' ' LEU . 24.8 mmt -64.73 -40.12 94.79 Favored 'General case' 0 C--N 1.354 0.775 0 O-C-N 121.591 -0.693 . . . . 0.0 110.707 -178.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -65.86 -39.93 91.19 Favored 'General case' 0 C--N 1.349 0.569 0 O-C-N 122.107 -0.37 . . . . 0.0 111.303 -178.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 56.3 tp -65.81 -42.86 90.15 Favored 'General case' 0 C--N 1.349 0.572 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -178.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.518 HG12 ' O ' ' A' ' 9' ' ' LEU . 1.9 mm -74.5 -35.38 38.45 Favored 'Isoleucine or valine' 0 C--N 1.361 1.073 0 O-C-N 121.031 -1.043 . . . . 0.0 110.746 -175.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -72.0 -42.54 66.3 Favored 'General case' 0 C--N 1.349 0.55 0 O-C-N 121.648 -0.657 . . . . 0.0 111.475 -176.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -70.95 -36.68 72.7 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -176.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -101.1 -25.06 14.17 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 118.725 -1.19 . . . . 0.0 113.628 -174.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -114.8 -36.43 4.5 Favored 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 117.606 -1.638 . . . . 0.0 112.288 -176.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 145.03 177.98 20.26 Favored Glycine 0 C--N 1.348 1.227 0 C-N-CA 118.176 -1.964 . . . . 0.0 110.314 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -99.33 -25.89 14.34 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 -177.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -70.14 -39.15 75.56 Favored 'General case' 0 C--N 1.358 0.937 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.1 m -67.64 -39.33 84.62 Favored 'General case' 0 C--N 1.357 0.919 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.7 tt -60.21 -38.66 84.02 Favored 'General case' 0 C--N 1.357 0.933 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -64.16 -36.82 85.28 Favored 'General case' 0 C--N 1.355 0.821 0 O-C-N 122.081 -0.387 . . . . 0.0 110.901 -178.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 88.2 m -65.0 -40.35 94.82 Favored 'General case' 0 C--N 1.354 0.775 0 O-C-N 121.638 -0.664 . . . . 0.0 109.55 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 88.6 mt -63.74 -38.17 90.09 Favored 'General case' 0 C--N 1.355 0.847 0 O-C-N 122.023 -0.423 . . . . 0.0 109.941 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.442 HD21 ' CE ' ' A' ' 10' ' ' MET . 82.5 mt -70.53 -17.35 62.94 Favored 'General case' 0 C--N 1.36 1.028 0 O-C-N 121.532 -0.73 . . . . 0.0 110.373 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -85.56 -27.38 25.58 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.488 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.5 t -66.09 -36.71 83.91 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 99.5 m -96.5 -35.67 11.05 Favored 'General case' 0 C--N 1.357 0.902 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -178.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 83.31 136.12 0.06 Allowed 'General case' 0 C--N 1.358 0.969 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.538 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -84.8 -171.41 3.62 Favored 'General case' 0 C--N 1.356 0.876 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.535 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -151.2 -24.32 0.21 Allowed 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.1 t -147.07 -67.92 0.26 Allowed 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -128.5 -50.64 1.27 Allowed 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.81 -44.5 1.36 Allowed Glycine 0 C--N 1.351 1.377 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 82.3 mt -110.38 105.18 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.971 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.44 ' HD1' ' HA ' ' A' ' 37' ' ' TYR . 0.1 OUTLIER -82.75 -142.09 0.06 Allowed 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.664 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 87.8 m -112.17 -58.77 2.09 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 52.6 p 165.59 16.92 0.0 OUTLIER 'General case' 0 C--N 1.362 1.113 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.5 t -103.26 3.63 10.64 Favored 'Isoleucine or valine' 0 C--N 1.353 0.732 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.209 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -94.34 141.71 15.68 Favored Glycine 0 C--N 1.352 1.461 0 C-N-CA 119.25 -1.452 . . . . 0.0 109.631 -178.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 50.0 m -124.55 124.73 42.89 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 178.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -117.74 174.98 5.87 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -80.83 -173.06 4.0 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -91.97 -14.85 28.82 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -69.48 -28.87 66.45 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.445 ' CG ' ' HZ ' ' A' ' 6' ' ' PHE . 20.3 tp10 -63.71 -41.28 98.11 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.461 HD22 ' O ' ' A' ' 48' ' ' LEU . 1.9 tm? -67.65 -38.74 84.23 Favored 'General case' 0 C--N 1.359 1.017 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 60.4 tp -70.05 -34.05 72.73 Favored 'General case' 0 CA--C 1.508 -0.639 0 O-C-N 122.134 -0.354 . . . . 0.0 110.141 -177.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 70.6 tp60 -65.2 -41.16 94.78 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -178.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 85.1 mt -81.51 -18.71 44.13 Favored 'General case' 0 C--N 1.362 1.121 0 O-C-N 121.558 -0.714 . . . . 0.0 110.846 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.6 t -80.6 -38.53 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 C-N-CA 119.706 -0.798 . . . . 0.0 109.124 -178.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.7 p -74.22 -31.51 29.35 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 C-N-CA 119.756 -0.778 . . . . 0.0 109.417 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.3 tptt -70.22 -26.94 64.1 Favored 'General case' 0 C--N 1.366 1.289 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.7 tt -67.98 -39.04 83.35 Favored 'General case' 0 C--N 1.353 0.735 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.507 ' O ' ' HA ' ' A' ' 60' ' ' SER . 59.9 p -72.8 -17.26 61.59 Favored 'General case' 0 C--N 1.357 0.933 0 O-C-N 121.729 -0.607 . . . . 0.0 110.916 -178.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -98.93 -37.15 9.51 Favored 'General case' 0 C--N 1.353 0.739 0 O-C-N 121.181 -0.949 . . . . 0.0 111.364 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.2 p -70.92 -35.02 57.98 Favored 'Isoleucine or valine' 0 C--N 1.351 0.672 0 O-C-N 121.712 -0.617 . . . . 0.0 111.399 -177.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.505 ' HB3' HG23 ' A' ' 61' ' ' VAL . 3.9 t -120.49 -7.57 9.67 Favored 'General case' 0 C--N 1.352 0.708 0 C-N-CA 119.118 -1.033 . . . . 0.0 110.08 -178.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.507 ' HA ' ' O ' ' A' ' 56' ' ' SER . 1.0 OUTLIER 66.03 46.41 2.18 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.552 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.505 HG23 ' HB3' ' A' ' 59' ' ' SER . 61.3 t -106.23 132.82 20.58 Favored Pre-proline 0 CA--C 1.506 -0.745 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.62 146.02 78.32 Favored 'Trans proline' 0 CA--C 1.497 -1.341 0 C-N-CA 122.59 2.193 . . . . 0.0 113.071 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.404 ' HA ' ' CD2' ' A' ' 66' ' ' LEU . 4.8 m -75.25 -12.89 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.792 -178.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.47 ' O ' HG12 ' A' ' 67' ' ' VAL . 72.2 p -96.36 -32.24 12.47 Favored 'General case' 0 C--N 1.358 0.944 0 C-N-CA 118.273 -1.371 . . . . 0.0 109.761 -178.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -80.26 -20.67 43.98 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 121.394 -0.816 . . . . 0.0 108.912 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.404 ' CD2' ' HA ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -81.0 -36.49 30.57 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -179.901 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.47 HG12 ' O ' ' A' ' 64' ' ' THR . 2.1 p -67.44 -29.86 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.678 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 -70.35 -48.81 54.7 Favored 'General case' 0 C--N 1.366 1.298 0 O-C-N 121.428 -0.795 . . . . 0.0 110.777 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.9 mt -64.14 -35.84 82.08 Favored 'General case' 0 C--N 1.355 0.84 0 O-C-N 122.033 -0.417 . . . . 0.0 110.961 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -60.8 -47.37 86.64 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 122.132 -0.355 . . . . 0.0 110.427 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.19 -39.07 96.64 Favored Glycine 0 C--N 1.354 1.579 0 N-CA-C 111.729 -0.549 . . . . 0.0 111.729 -178.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.44 -47.55 81.43 Favored 'General case' 0 C--N 1.351 0.651 0 CA-C-N 118.227 1.013 . . . . 0.0 111.462 -177.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.73 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 10.6 mttm -63.98 -50.17 69.6 Favored 'General case' 0 C--N 1.357 0.921 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -177.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.417 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.4 tm? -68.67 -38.96 80.77 Favored 'General case' 0 C--N 1.349 0.552 0 O-C-N 121.339 -0.85 . . . . 0.0 111.868 -175.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -63.43 -45.09 92.57 Favored 'General case' 0 C--N 1.352 0.678 0 O-C-N 121.208 -0.932 . . . . 0.0 110.965 -177.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 8.6 p -70.59 -15.71 19.19 Favored 'Isoleucine or valine' 0 C--N 1.358 0.958 0 O-C-N 121.521 -0.737 . . . . 0.0 109.366 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.73 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 75.1 mm-40 -71.28 -38.73 71.81 Favored 'General case' 0 C--N 1.35 0.608 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.7 mt -73.04 -31.66 64.58 Favored 'General case' 0 C--N 1.356 0.865 0 O-C-N 122.426 -0.171 . . . . 0.0 110.685 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.9 mm -65.06 -53.72 37.81 Favored 'Isoleucine or valine' 0 C--N 1.359 0.984 0 C-N-CA 120.081 -0.648 . . . . 0.0 110.099 -177.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -74.99 -14.98 60.68 Favored 'General case' 0 C--N 1.351 0.634 0 C-N-CA 119.554 -0.859 . . . . 0.0 109.37 178.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.58 -37.66 68.26 Favored Glycine 0 C--N 1.349 1.278 0 N-CA-C 110.971 -0.851 . . . . 0.0 110.971 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -132.45 108.3 13.38 Favored Pre-proline 0 N--CA 1.441 -0.917 0 CA-C-O 122.776 1.274 . . . . 0.0 109.232 -177.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.8 -24.58 40.38 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.596 2.197 . . . . 0.0 114.301 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -93.7 -5.05 49.4 Favored 'General case' 0 CA--C 1.5 -0.966 0 C-N-CA 119.448 -0.901 . . . . 0.0 108.776 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -89.64 -19.97 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.78 -25.18 14.21 Favored 'General case' 0 C--N 1.361 1.106 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -70.23 -35.23 73.71 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 120.207 -0.597 . . . . 0.0 109.443 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -65.42 -36.98 85.57 Favored 'General case' 0 C--N 1.355 0.837 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.415 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.558 ' HG2' ' N ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -81.52 155.05 25.96 Favored 'General case' 0 C--N 1.355 0.841 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -178.468 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.558 ' N ' ' HG2' ' A' ' 89' ' ' MET . 0.8 OUTLIER -120.36 -25.41 5.64 Favored 'General case' 0 C--N 1.364 1.199 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.031 -177.655 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -165.12 172.09 13.01 Favored 'General case' 0 C--N 1.354 0.78 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 -177.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 41.1 t -64.62 -43.16 94.61 Favored 'General case' 0 C--N 1.356 0.863 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.208 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -67.11 -39.72 86.72 Favored 'General case' 0 C--N 1.356 0.853 0 O-C-N 121.429 -0.794 . . . . 0.0 109.282 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -66.41 -23.17 66.26 Favored 'General case' 0 C--N 1.355 0.821 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.661 ' O ' HG13 ' A' ' 99' ' ' ILE . 61.2 tp -64.78 -46.28 82.78 Favored 'General case' 0 C--N 1.356 0.888 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.496 ' HA ' ' CD1' ' A' ' 99' ' ' ILE . 3.2 mp -59.94 -35.11 74.23 Favored 'General case' 0 C--N 1.36 1.035 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.5 t -69.61 -39.57 77.15 Favored 'General case' 0 C--N 1.349 0.549 0 O-C-N 121.994 -0.441 . . . . 0.0 109.934 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.1 tttp -87.32 1.37 53.47 Favored 'General case' 0 C--N 1.357 0.905 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -176.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.661 HG13 ' O ' ' A' ' 95' ' ' LEU . 81.4 mt -61.51 -47.06 95.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.868 0 CA-C-N 119.282 0.946 . . . . 0.0 111.408 -177.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -92.88 -25.67 17.98 Favored 'General case' 0 N--CA 1.442 -0.858 0 O-C-N 121.04 -1.037 . . . . 0.0 110.973 -177.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 35.0 t -63.21 -49.0 75.92 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 121.64 -0.662 . . . . 0.0 112.667 -177.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.654 ' HA ' HG12 ' A' ' 105' ' ' VAL . 16.9 t80 -139.42 -14.25 1.12 Allowed 'General case' 0 C--N 1.361 1.066 0 C-N-CA 117.274 -1.77 . . . . 0.0 113.529 -176.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 32.7 mm -71.77 -52.14 27.42 Favored 'Isoleucine or valine' 0 C--O 1.246 0.875 0 CA-C-N 120.659 1.572 . . . . 0.0 110.592 -177.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -91.82 2.3 56.6 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 119.659 -0.817 . . . . 0.0 110.299 -176.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.654 HG12 ' HA ' ' A' ' 102' ' ' PHE . 1.3 p -92.4 -32.47 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -72.93 -40.82 65.12 Favored 'General case' 0 C--N 1.357 0.924 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.6 p -74.99 -35.99 37.07 Favored 'Isoleucine or valine' 0 C--N 1.355 0.847 0 C-N-CA 119.231 -0.988 . . . . 0.0 109.684 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -61.23 -48.61 80.68 Favored 'General case' 0 C--N 1.365 1.245 0 O-C-N 121.727 -0.608 . . . . 0.0 110.428 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -60.35 -37.48 80.82 Favored 'General case' 0 C--N 1.358 0.961 0 O-C-N 121.694 -0.629 . . . . 0.0 110.096 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 13.4 mt -56.5 -75.07 0.04 OUTLIER 'General case' 0 C--N 1.356 0.869 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.433 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 92.6 m-85 -119.05 135.21 23.72 Favored Pre-proline 0 N--CA 1.439 -0.983 0 C-N-CA 118.855 -1.138 . . . . 0.0 108.821 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 111' ' ' TYR . 89.4 Cg_endo -84.16 -1.5 9.86 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 123.315 2.677 . . . . 0.0 115.318 -178.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -65.78 -37.24 85.76 Favored 'General case' 0 C--N 1.354 0.788 0 O-C-N 121.805 -0.56 . . . . 0.0 109.933 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.35 144.9 56.27 Favored 'General case' 0 C--N 1.353 0.734 0 CA-C-O 121.495 0.664 . . . . 0.0 109.742 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -131.45 135.96 47.57 Favored 'General case' 0 C--N 1.356 0.882 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.522 ' HB3' ' HD2' ' A' ' 117' ' ' PRO . 90.7 mt -128.45 157.17 75.61 Favored Pre-proline 0 N--CA 1.443 -0.794 0 CA-C-O 122.189 0.995 . . . . 0.0 109.286 -178.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.522 ' HD2' ' HB3' ' A' ' 116' ' ' LEU . 94.0 Cg_endo -80.29 -153.52 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.122 0 C-N-CA 123.644 2.896 . . . . 0.0 113.472 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -118.21 144.14 45.97 Favored 'General case' 0 C--N 1.362 1.148 0 C-N-CA 119.172 -1.011 . . . . 0.0 108.458 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -129.59 134.36 47.68 Favored 'General case' 0 C--N 1.361 1.081 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.49 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 94.2 m -125.05 129.32 50.03 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 177.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 84.4 m -116.02 127.26 54.77 Favored 'General case' 0 CA--C 1.504 -0.802 0 C-N-CA 119.094 -1.042 . . . . 0.0 109.402 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -120.36 130.77 54.55 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 57.9 ttp180 -105.16 116.98 32.87 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.49 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 90.7 mt -85.81 -24.32 26.84 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 120.709 -0.397 . . . . 0.0 109.997 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -179.6 -146.0 6.61 Favored Glycine 0 C--N 1.349 1.294 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 -178.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -94.12 -40.16 10.2 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 120.007 -0.677 . . . . 0.0 109.274 -178.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -101.69 4.25 40.5 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 119.882 -0.727 . . . . 0.0 110.406 -178.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.49 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 8.4 m-20 -120.74 130.65 54.13 Favored 'General case' 0 C--N 1.36 1.035 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.404 HD13 ' HA ' ' A' ' 129' ' ' ILE . 8.7 mm -141.49 137.71 32.51 Favored 'Isoleucine or valine' 0 C--N 1.356 0.871 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 60.3 mtm180 -124.11 138.83 54.38 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' A' ' 131' ' ' LEU . 0.1 OUTLIER -130.63 127.42 38.93 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.594 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.49 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 12.3 m170 -95.6 135.72 36.9 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 179.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -127.69 118.83 24.55 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 -178.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.51 ' HA ' ' O ' ' A' ' 171' ' ' THR . 29.1 tt0 -113.82 111.93 22.56 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 14.5 t -161.86 153.82 19.19 Favored 'General case' 0 C--N 1.359 0.99 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -91.47 3.36 55.16 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 120.26 -0.576 . . . . 0.0 109.893 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 93.2 mtm-85 -133.7 73.78 71.41 Favored Pre-proline 0 C--N 1.355 0.847 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 178.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -94.81 103.47 0.12 Allowed 'Trans proline' 0 N--CA 1.444 -1.426 0 C-N-CA 122.489 2.126 . . . . 0.0 115.67 -177.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -111.15 113.01 25.21 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 176.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.95 -38.75 92.23 Favored 'General case' 0 C--N 1.353 0.748 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.068 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.0 m -64.13 -26.28 68.46 Favored 'General case' 0 C--N 1.353 0.742 0 O-C-N 122.052 -0.405 . . . . 0.0 110.902 -178.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -76.47 -47.41 23.04 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 121.669 -0.645 . . . . 0.0 109.666 -178.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.88 -39.49 93.62 Favored 'General case' 0 C--N 1.357 0.919 0 O-C-N 122.071 -0.393 . . . . 0.0 110.8 -178.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.34 -36.83 85.01 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 122.029 -0.419 . . . . 0.0 109.901 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.44 -43.25 98.93 Favored Glycine 0 C--N 1.348 1.201 0 N-CA-C 109.901 -1.279 . . . . 0.0 109.901 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.0 mt -69.08 -41.08 77.98 Favored 'General case' 0 C--N 1.352 0.694 0 CA-C-N 117.612 0.706 . . . . 0.0 112.415 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 98.2 mt -71.5 -42.49 67.95 Favored 'General case' 0 C--N 1.36 1.042 0 O-C-N 121.3 -0.875 . . . . 0.0 110.714 -177.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.559 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 37.5 t70 -69.38 -32.52 71.61 Favored 'General case' 0 N--CA 1.445 -0.703 0 O-C-N 122.049 -0.407 . . . . 0.0 110.642 -179.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.433 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -62.85 -39.57 98.16 Favored Glycine 0 C--N 1.357 1.736 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 47.0 t -60.1 -41.73 93.18 Favored 'General case' 0 C--N 1.351 0.653 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -77.56 0.23 23.81 Favored 'General case' 0 C--N 1.359 0.982 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.559 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 76.8 mm-40 -83.65 -46.77 11.95 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -68.55 -41.46 79.76 Favored 'General case' 0 C--N 1.359 0.991 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.52 ' HZ ' ' SD ' ' A' ' 89' ' ' MET . 9.7 m-30 -69.66 -26.98 64.66 Favored 'General case' 0 C--N 1.36 1.055 0 O-C-N 121.821 -0.549 . . . . 0.0 110.628 -178.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 85.0 tttt 73.59 74.88 0.13 Allowed 'General case' 0 C--N 1.361 1.091 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -142.81 -170.34 3.21 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -148.57 94.37 2.28 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 15.7 m-30 -113.42 156.59 23.22 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 94.5 m -119.23 126.85 52.5 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 119.082 -1.047 . . . . 0.0 108.837 -178.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.491 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.9 mp -104.76 122.61 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 178.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.8 m -120.47 -171.95 2.27 Favored 'General case' 0 C--N 1.355 0.808 0 CA-C-O 121.812 0.815 . . . . 0.0 108.899 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.01 158.64 44.37 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -178.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 50.2 p -98.27 146.59 31.79 Favored Pre-proline 0 C--N 1.357 0.934 0 CA-C-O 122.368 1.08 . . . . 0.0 108.134 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.623 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 72.8 Cg_endo -75.95 -10.98 19.84 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.924 2.416 . . . . 0.0 115.031 -178.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -72.62 -41.17 65.84 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.388 -178.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 39.0 p -116.7 15.32 15.43 Favored 'General case' 0 C--N 1.354 0.795 0 C-N-CA 120.264 -0.575 . . . . 0.0 110.288 -178.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.623 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.2 pp0? -66.67 -12.76 59.67 Favored 'General case' 0 C--N 1.354 0.798 0 O-C-N 121.608 -0.683 . . . . 0.0 110.22 178.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -124.62 38.23 4.24 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 57.7 m -137.21 146.76 45.23 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.617 ' O ' ' HB ' ' A' ' 171' ' ' THR . 61.4 mt-10 -99.85 165.46 11.56 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.617 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 16.4 m 82.28 -59.39 0.19 Allowed 'General case' 0 C--N 1.369 1.453 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.799 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -107.73 117.1 33.24 Favored 'General case' 0 CA--C 1.505 -0.784 0 C-N-CA 119.884 -0.726 . . . . 0.0 109.868 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 88.2 t -131.8 133.66 61.0 Favored 'Isoleucine or valine' 0 C--N 1.358 0.943 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 178.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 49.5 mm -109.59 126.0 66.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.955 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -114.13 147.27 39.1 Favored 'General case' 0 C--N 1.359 0.988 0 CA-C-O 121.942 0.877 . . . . 0.0 108.767 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -128.26 118.19 22.84 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.458 HD11 HD23 ' A' ' 131' ' ' LEU . 4.0 mp -112.58 118.06 56.87 Favored 'Isoleucine or valine' 0 C--N 1.355 0.838 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 -179.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 85.1 m -128.28 144.79 51.16 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 -177.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 81.1 mtm180 . . . . . 0 C--N 1.37 1.491 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 178.171 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.597 ' HG3' ' H ' ' A' ' 4' ' ' MET . 54.0 tpp . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.026 0.441 . . . . 0.0 110.333 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.59 -19.14 39.03 Favored 'General case' 0 C--N 1.355 0.833 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.2 -38.98 58.78 Favored Glycine 0 C--N 1.351 1.382 0 N-CA-C 108.563 -1.815 . . . . 0.0 108.563 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . 0.597 ' H ' ' HG3' ' A' ' 1' ' ' MET . 3.2 mtt -70.04 -35.86 74.61 Favored 'General case' 0 C--N 1.356 0.867 0 O-C-N 122.205 -0.585 . . . . 0.0 111.542 -177.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.2 m -69.34 -23.92 27.1 Favored 'Isoleucine or valine' 0 C--N 1.356 0.874 0 O-C-N 121.41 -0.806 . . . . 0.0 109.355 -178.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -71.79 -35.37 69.98 Favored 'General case' 0 C--N 1.357 0.908 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 87.9 m -67.33 -41.67 84.87 Favored 'General case' 0 C--N 1.355 0.84 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.48 -38.35 96.2 Favored Glycine 0 C--N 1.356 1.69 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.589 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -67.18 -38.56 85.61 Favored 'General case' 0 C--N 1.351 0.657 0 CA-C-N 117.311 0.556 . . . . 0.0 110.503 -177.927 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 21.3 mmt -64.26 -40.7 96.53 Favored 'General case' 0 C--N 1.354 0.798 0 O-C-N 121.616 -0.677 . . . . 0.0 110.767 -178.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -66.2 -40.4 90.35 Favored 'General case' 0 C--N 1.349 0.559 0 O-C-N 122.057 -0.402 . . . . 0.0 111.684 -178.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 57.8 tp -65.75 -42.73 90.59 Favored 'General case' 0 C--N 1.35 0.595 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -178.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.589 HG12 ' O ' ' A' ' 9' ' ' LEU . 1.7 mm -75.61 -36.32 34.02 Favored 'Isoleucine or valine' 0 C--N 1.357 0.917 0 O-C-N 121.049 -1.032 . . . . 0.0 110.955 -175.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -67.96 -42.57 80.7 Favored 'General case' 0 C--N 1.351 0.67 0 O-C-N 121.858 -0.526 . . . . 0.0 111.108 -176.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -73.48 -31.28 63.66 Favored 'General case' 0 N--CA 1.447 -0.617 0 O-C-N 122.014 -0.429 . . . . 0.0 111.499 -177.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -72.63 -49.08 34.35 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -175.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -128.56 -20.35 3.63 Favored 'General case' 0 C--N 1.355 0.812 0 C-N-CA 117.566 -1.654 . . . . 0.0 113.02 -176.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 140.8 179.08 17.89 Favored Glycine 0 CA--C 1.496 -1.094 0 C-N-CA 118.104 -1.998 . . . . 0.0 109.657 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -94.26 -11.09 30.89 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -177.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -70.88 -41.52 71.24 Favored 'General case' 0 C--N 1.36 1.046 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 92.8 m -69.91 -38.89 76.4 Favored 'General case' 0 C--N 1.359 0.98 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.508 HD13 ' HB ' ' A' ' 13' ' ' ILE . 56.6 tp -60.5 -37.66 81.81 Favored 'General case' 0 C--N 1.357 0.9 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -64.94 -35.43 81.13 Favored 'General case' 0 C--N 1.357 0.919 0 O-C-N 122.203 -0.311 . . . . 0.0 110.757 -178.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.2 m -64.44 -41.23 96.67 Favored 'General case' 0 C--N 1.354 0.771 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -178.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 93.0 mt -65.23 -37.43 87.23 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 80.3 mt -69.7 -14.38 62.77 Favored 'General case' 0 C--N 1.358 0.971 0 O-C-N 121.445 -0.784 . . . . 0.0 109.604 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -88.07 -25.74 22.9 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 119.621 -0.831 . . . . 0.0 109.287 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 55.9 p -70.27 -23.9 62.96 Favored 'General case' 0 C--N 1.359 1.017 0 C-N-CA 119.65 -0.82 . . . . 0.0 109.22 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.8 p -105.8 -37.19 6.79 Favored 'General case' 0 C--N 1.358 0.967 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 86.09 132.15 0.04 OUTLIER 'General case' 0 C--N 1.36 1.031 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.466 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -90.88 -166.18 1.52 Allowed 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -153.35 -64.81 0.15 Allowed 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.6 t -97.92 -65.19 0.98 Allowed 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -138.11 -45.0 0.51 Allowed 'General case' 0 CA--C 1.503 -0.863 0 C-N-CA 119.567 -0.853 . . . . 0.0 108.752 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 125.88 -35.59 2.97 Favored Glycine 0 C--N 1.352 1.427 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 85.0 mt -107.91 100.26 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.788 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -97.13 -1.47 45.1 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.767 HG22 ' H ' ' A' ' 39' ' ' SER . 2.7 m 77.55 -179.63 0.13 Allowed 'General case' 0 C--N 1.361 1.107 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 -178.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.767 ' H ' HG22 ' A' ' 38' ' ' THR . 21.2 p -85.7 102.71 13.85 Favored 'General case' 0 C--N 1.353 0.729 0 O-C-N 121.116 -0.99 . . . . 0.0 109.261 -178.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.453 HG12 ' O ' ' A' ' 40' ' ' VAL . 97.3 t -153.19 -18.54 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.359 1.013 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -112.58 164.93 12.02 Favored Glycine 0 C--N 1.356 1.668 0 C-N-CA 119.311 -1.423 . . . . 0.0 110.156 -176.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.6 m -128.62 127.76 42.87 Favored 'General case' 0 C--N 1.355 0.816 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -116.42 176.42 5.12 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -79.34 -176.53 5.26 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -91.15 -16.03 28.42 Favored 'General case' 0 CA--C 1.503 -0.858 0 C-N-CA 120.105 -0.638 . . . . 0.0 109.406 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -70.23 -28.15 65.03 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -63.37 -40.85 98.37 Favored 'General case' 0 C--N 1.352 0.68 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.438 ' O ' HG23 ' A' ' 52' ' ' VAL . 63.3 tp -66.82 -38.57 86.71 Favored 'General case' 0 C--N 1.357 0.899 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.308 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.4 ' O ' HG23 ' A' ' 53' ' ' VAL . 58.3 tp -77.31 -26.2 52.0 Favored 'General case' 0 C--N 1.349 0.567 0 O-C-N 122.071 -0.393 . . . . 0.0 110.134 -177.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -67.67 -43.9 79.08 Favored 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 121.724 -0.61 . . . . 0.0 110.048 -178.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 81.8 mt -71.93 -34.84 69.38 Favored 'General case' 0 C--N 1.36 1.022 0 C-N-CA 120.164 -0.614 . . . . 0.0 109.467 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 48' ' ' LEU . 40.0 t -63.11 -40.73 90.14 Favored 'Isoleucine or valine' 0 C--N 1.35 0.593 0 O-C-N 122.331 -0.231 . . . . 0.0 110.456 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 49' ' ' LEU . 54.9 t -68.13 -40.29 82.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.662 0 O-C-N 121.672 -0.642 . . . . 0.0 109.929 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.8 tptt -68.39 -23.02 64.61 Favored 'General case' 0 C--N 1.36 1.022 0 O-C-N 121.021 -1.05 . . . . 0.0 108.695 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.406 HD13 HD13 ' A' ' 66' ' ' LEU . 1.9 mt -68.96 -37.48 78.86 Favored 'General case' 0 C--N 1.351 0.674 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.5 p -73.29 -17.11 61.35 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.382 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -100.3 -37.06 9.04 Favored 'General case' 0 C--N 1.354 0.78 0 C-N-CA 119.534 -0.867 . . . . 0.0 111.402 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.9 p -72.67 -36.86 54.38 Favored 'Isoleucine or valine' 0 C--N 1.353 0.725 0 O-C-N 121.56 -0.712 . . . . 0.0 111.525 -177.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.613 ' HB3' HG23 ' A' ' 61' ' ' VAL . 5.3 t -117.89 -3.95 11.14 Favored 'General case' 0 C--N 1.352 0.691 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.143 -178.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 73.2 m 62.9 42.45 7.67 Favored 'General case' 0 C--N 1.355 0.839 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.613 HG23 ' HB3' ' A' ' 59' ' ' SER . 55.1 t -102.37 131.45 22.5 Favored Pre-proline 0 CA--C 1.503 -0.855 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -57.52 147.42 78.74 Favored 'Trans proline' 0 CA--C 1.498 -1.292 0 C-N-CA 122.55 2.167 . . . . 0.0 112.624 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.1 m -75.22 -12.83 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.671 -178.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.451 ' O ' HG12 ' A' ' 67' ' ' VAL . 64.4 p -96.45 -34.07 11.65 Favored 'General case' 0 C--N 1.359 0.996 0 C-N-CA 118.393 -1.323 . . . . 0.0 109.488 -179.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -75.59 -23.71 56.49 Favored 'General case' 0 C--N 1.354 0.795 0 O-C-N 121.5 -0.75 . . . . 0.0 109.087 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.406 HD13 HD13 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -79.96 -36.25 36.44 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.007 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.451 HG12 ' O ' ' A' ' 64' ' ' THR . 1.9 p -69.41 -25.45 29.16 Favored 'Isoleucine or valine' 0 C--N 1.354 0.797 0 C-N-CA 120.206 -0.597 . . . . 0.0 110.046 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 5.5 mmm-85 -73.15 -52.48 14.04 Favored 'General case' 0 C--N 1.363 1.162 0 O-C-N 121.548 -0.72 . . . . 0.0 110.12 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.7 mt -63.31 -35.43 80.36 Favored 'General case' 0 C--N 1.357 0.903 0 O-C-N 121.983 -0.448 . . . . 0.0 110.941 -178.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -61.1 -47.67 85.24 Favored 'General case' 0 C--N 1.351 0.638 0 O-C-N 122.117 -0.365 . . . . 0.0 110.624 -178.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.91 -38.51 95.52 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 111.738 -0.545 . . . . 0.0 111.738 -178.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.14 -47.87 80.9 Favored 'General case' 0 C--N 1.349 0.568 0 CA-C-N 118.067 0.934 . . . . 0.0 111.348 -177.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.718 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 9.9 mttm -64.51 -49.21 72.2 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 113.61 0.966 . . . . 0.0 113.61 -177.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.418 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.4 tm? -68.4 -39.81 81.55 Favored 'General case' 0 C--N 1.349 0.585 0 O-C-N 121.082 -1.012 . . . . 0.0 111.86 -175.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -63.41 -45.09 92.6 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 121.091 -1.006 . . . . 0.0 111.258 -177.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.8 p -71.09 -14.92 18.34 Favored 'Isoleucine or valine' 0 C--N 1.359 0.988 0 O-C-N 121.478 -0.763 . . . . 0.0 109.506 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.718 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 74.1 mm-40 -72.74 -38.79 67.3 Favored 'General case' 0 C--N 1.35 0.629 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 78.9 mt -69.09 -35.27 76.3 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 47.7 mm -62.5 -51.49 71.53 Favored 'Isoleucine or valine' 0 C--N 1.356 0.89 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.227 -177.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -75.64 -11.87 60.09 Favored 'General case' 0 C--N 1.353 0.73 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.98 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -94.01 -9.37 59.61 Favored Glycine 0 C--N 1.347 1.166 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.482 -178.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.47 ' O ' HG22 ' A' ' 85' ' ' ILE . 87.5 m-70 -143.93 95.32 5.73 Favored Pre-proline 0 CA--C 1.503 -0.839 0 CA-C-N 118.91 1.355 . . . . 0.0 109.126 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.513 ' O ' ' HB2' ' A' ' 87' ' ' ASN . 38.3 Cg_endo -68.71 -23.8 35.66 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.393 2.062 . . . . 0.0 114.046 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -90.75 -9.11 47.81 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.47 HG22 ' O ' ' A' ' 82' ' ' HIS . 0.6 OUTLIER -89.01 -21.99 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.971 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 -178.792 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -104.38 -14.81 15.61 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.513 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 20.1 t30 -72.88 -40.66 65.42 Favored 'General case' 0 C--N 1.36 1.048 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -67.35 -29.79 69.43 Favored 'General case' 0 C--N 1.353 0.735 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.156 -178.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 28.4 ttp -84.17 146.58 27.77 Favored 'General case' 0 C--N 1.351 0.655 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.75 -21.51 10.15 Favored 'General case' 0 C--N 1.361 1.104 0 O-C-N 121.58 -0.7 . . . . 0.0 110.937 -177.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -164.54 171.39 14.6 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 -177.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.412 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 88.4 p -71.01 -31.7 68.28 Favored 'General case' 0 C--N 1.352 0.682 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.014 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -70.4 -38.46 74.66 Favored 'General case' 0 C--N 1.358 0.942 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -66.67 -24.18 66.24 Favored 'General case' 0 C--N 1.358 0.977 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.412 ' HB3' ' O ' ' A' ' 92' ' ' SER . 61.4 tp -62.92 -46.36 88.16 Favored 'General case' 0 C--N 1.355 0.814 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.3 mp -62.61 -32.89 73.98 Favored 'General case' 0 C--N 1.354 0.765 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 36.3 t -62.41 -45.02 94.99 Favored 'General case' 0 C--N 1.355 0.81 0 O-C-N 121.84 -0.537 . . . . 0.0 111.347 -178.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.08 28.45 8.78 Favored 'General case' 0 C--N 1.361 1.085 0 O-C-N 121.103 -0.998 . . . . 0.0 110.539 -178.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.6 tt -62.71 -29.91 48.12 Favored 'Isoleucine or valine' 0 C--N 1.354 0.794 0 O-C-N 121.827 -0.546 . . . . 0.0 110.314 -179.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -127.4 -8.8 5.76 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 118.54 -1.264 . . . . 0.0 109.916 -179.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 58.4 m -90.88 -2.93 57.7 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 119.566 -0.854 . . . . 0.0 110.313 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.459 ' O ' HG12 ' A' ' 105' ' ' VAL . 11.9 t80 -146.51 -46.92 0.19 Allowed 'General case' 0 C--N 1.357 0.912 0 C-N-CA 118.264 -1.374 . . . . 0.0 109.754 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 96.1 mt -68.57 -48.41 72.18 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 O-C-N 121.788 -0.57 . . . . 0.0 110.948 -178.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 44.4 m170 -85.71 -1.52 57.27 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.329 -177.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.459 HG12 ' O ' ' A' ' 102' ' ' PHE . 2.0 p -89.11 -32.72 5.85 Favored 'Isoleucine or valine' 0 C--N 1.354 0.793 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -72.3 -40.14 67.76 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -73.17 -33.97 43.4 Favored 'Isoleucine or valine' 0 C--N 1.355 0.824 0 C-N-CA 119.518 -0.873 . . . . 0.0 109.576 -178.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -60.67 -49.01 79.25 Favored 'General case' 0 C--N 1.363 1.164 0 O-C-N 121.8 -0.563 . . . . 0.0 110.441 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -60.44 -38.99 85.9 Favored 'General case' 0 C--N 1.358 0.96 0 O-C-N 121.579 -0.701 . . . . 0.0 110.096 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.0 mt -57.15 -76.92 0.03 OUTLIER 'General case' 0 C--N 1.354 0.798 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.436 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 92.7 m-85 -115.89 136.11 22.85 Favored Pre-proline 0 N--CA 1.442 -0.855 0 O-C-N 121.067 -1.021 . . . . 0.0 108.817 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 111' ' ' TYR . 68.8 Cg_endo -86.38 -1.72 8.45 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 123.32 2.68 . . . . 0.0 115.585 -178.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -66.73 -36.83 83.4 Favored 'General case' 0 C--N 1.356 0.855 0 O-C-N 121.652 -0.655 . . . . 0.0 110.2 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.46 145.76 54.67 Favored 'General case' 0 C--N 1.352 0.696 0 CA-C-O 121.61 0.719 . . . . 0.0 110.105 -178.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -130.8 134.43 46.84 Favored 'General case' 0 C--N 1.358 0.936 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.478 ' HB3' ' HD2' ' A' ' 117' ' ' PRO . 2.8 mm? -116.36 156.45 47.26 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-O 122.145 0.974 . . . . 0.0 108.855 -178.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' A' ' 116' ' ' LEU . 85.5 Cg_endo -83.88 -151.86 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.123 0 C-N-CA 123.517 2.812 . . . . 0.0 113.147 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -114.53 138.72 50.28 Favored 'General case' 0 C--N 1.362 1.152 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -125.2 126.38 45.12 Favored 'General case' 0 C--N 1.36 1.05 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -178.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.534 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 93.8 m -124.88 127.66 47.47 Favored 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 177.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 77.1 m -121.63 129.99 53.18 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 119.129 -1.029 . . . . 0.0 109.585 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -118.38 148.81 42.14 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 178.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 57.4 ttp180 -120.55 117.21 27.03 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.403 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 95.0 mt -90.55 -16.2 29.24 Favored 'General case' 0 CA--C 1.503 -0.853 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.52 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 175.37 -148.68 9.63 Favored Glycine 0 N--CA 1.437 -1.271 0 N-CA-C 108.891 -1.684 . . . . 0.0 108.891 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -94.35 -37.35 11.52 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -178.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -103.01 3.82 36.62 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.02 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.403 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 66.6 m-20 -119.83 130.81 55.08 Favored 'General case' 0 C--N 1.359 1.003 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.403 HD13 ' HA ' ' A' ' 129' ' ' ILE . 8.4 mm -142.27 136.07 28.49 Favored 'Isoleucine or valine' 0 C--N 1.355 0.819 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 53.2 mtm180 -116.16 139.48 50.28 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 6.3 tp -126.7 118.81 25.5 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.534 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 12.4 m-70 -99.55 133.43 43.88 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -129.94 122.61 28.88 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 -178.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.496 ' HA ' ' O ' ' A' ' 171' ' ' THR . 32.2 tt0 -115.73 113.04 22.93 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.2 t -162.51 154.16 18.25 Favored 'General case' 0 C--N 1.359 1.002 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.406 ' C ' ' HD3' ' A' ' 138' ' ' PRO . 57.7 mtmt -91.41 3.94 53.69 Favored 'General case' 0 C--N 1.357 0.921 0 C-N-CA 120.186 -0.605 . . . . 0.0 109.865 -179.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 93.8 mtm-85 -133.01 74.11 74.29 Favored Pre-proline 0 C--N 1.356 0.882 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.406 ' HD3' ' C ' ' A' ' 136' ' ' LYS . 94.1 Cg_endo -96.23 102.7 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.657 2.238 . . . . 0.0 115.759 -177.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -111.47 113.42 25.84 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 176.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.01 -38.16 90.07 Favored 'General case' 0 C--N 1.354 0.778 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.026 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.7 m -63.48 -28.04 69.69 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 122.042 -0.411 . . . . 0.0 110.694 -178.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -75.59 -46.53 31.28 Favored 'General case' 0 C--N 1.352 0.687 0 C-N-CA 120.146 -0.622 . . . . 0.0 109.567 -178.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.68 -39.85 94.38 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 122.258 -0.276 . . . . 0.0 111.187 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.19 -37.2 86.31 Favored 'General case' 0 C--N 1.355 0.81 0 O-C-N 121.987 -0.446 . . . . 0.0 110.184 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.51 -42.88 99.27 Favored Glycine 0 C--N 1.348 1.248 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 -179.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 83.1 mt -70.07 -40.65 74.9 Favored 'General case' 0 C--N 1.351 0.667 0 CA-C-N 117.522 0.661 . . . . 0.0 112.627 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 97.1 mt -71.35 -42.38 68.58 Favored 'General case' 0 C--N 1.361 1.07 0 O-C-N 121.235 -0.916 . . . . 0.0 110.902 -176.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.497 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 36.4 t70 -70.06 -31.07 68.5 Favored 'General case' 0 N--CA 1.445 -0.695 0 O-C-N 121.934 -0.479 . . . . 0.0 110.407 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -63.12 -39.09 97.57 Favored Glycine 0 C--N 1.356 1.672 0 N-CA-C 108.461 -1.856 . . . . 0.0 108.461 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 46.3 t -60.75 -42.2 96.92 Favored 'General case' 0 C--N 1.35 0.622 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 178.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -74.97 -1.25 21.76 Favored 'General case' 0 C--N 1.36 1.046 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.497 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 76.9 mm-40 -83.46 -46.91 11.94 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -65.54 -45.6 82.8 Favored 'General case' 0 C--N 1.36 1.042 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.411 178.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -68.57 -25.95 65.16 Favored 'General case' 0 C--N 1.363 1.191 0 O-C-N 121.798 -0.564 . . . . 0.0 110.896 -178.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 85.1 tttt 73.16 76.43 0.14 Allowed 'General case' 0 C--N 1.36 1.031 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -144.9 -168.56 2.96 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -150.71 93.25 1.93 Allowed 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 14.1 m-30 -111.35 160.08 17.39 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 92.7 m -120.18 127.08 52.13 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 119.289 -0.964 . . . . 0.0 108.819 -178.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.527 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.5 mp -105.55 122.21 58.69 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 178.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.9 m -118.09 -173.01 2.36 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-O 121.851 0.834 . . . . 0.0 109.241 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.19 157.89 43.74 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -178.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 52.3 p -99.95 146.43 31.88 Favored Pre-proline 0 C--N 1.358 0.963 0 CA-C-O 122.344 1.069 . . . . 0.0 108.189 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.619 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 72.2 Cg_endo -76.35 -11.14 19.14 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.965 2.443 . . . . 0.0 115.052 -178.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -72.24 -41.29 66.97 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.474 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 36.2 p -117.54 15.82 14.62 Favored 'General case' 0 CA--C 1.505 -0.773 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.355 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.619 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.5 pp0? -65.59 -13.76 59.72 Favored 'General case' 0 C--N 1.355 0.807 0 O-C-N 121.657 -0.652 . . . . 0.0 110.341 178.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 46.6 p30 -125.43 39.76 3.89 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 19.8 t -139.72 144.93 37.75 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.617 ' O ' ' HB ' ' A' ' 171' ' ' THR . 61.9 mt-10 -98.71 164.43 12.23 Favored 'General case' 0 C--N 1.354 0.801 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.617 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 18.4 m 84.35 -60.76 0.1 Allowed 'General case' 0 C--N 1.369 1.44 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -107.2 117.74 34.88 Favored 'General case' 0 CA--C 1.503 -0.855 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.633 -178.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 97.9 t -131.26 132.96 62.9 Favored 'Isoleucine or valine' 0 C--N 1.357 0.923 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 178.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 49.9 mm -107.8 127.43 63.87 Favored 'Isoleucine or valine' 0 C--N 1.357 0.899 0 N-CA-C 107.877 -1.156 . . . . 0.0 107.877 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -115.66 156.14 26.43 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 122.073 0.94 . . . . 0.0 108.593 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -138.84 119.52 14.09 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.7 mp -114.56 118.86 59.88 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 106.395 -1.705 . . . . 0.0 106.395 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 86.1 m -128.2 143.55 51.05 Favored 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -177.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 70.3 mtm180 . . . . . 0 C--N 1.369 1.431 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.287 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.0 mtm . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.532 0.682 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.43 ' HA ' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -82.48 -9.34 59.47 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -178.998 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.33 -42.31 49.96 Favored Glycine 0 C--N 1.352 1.422 0 N-CA-C 108.734 -1.746 . . . . 0.0 108.734 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 61.5 mtt -66.68 -38.78 87.49 Favored 'General case' 0 C--N 1.357 0.893 0 O-C-N 122.13 -0.629 . . . . 0.0 111.21 -178.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.43 HG22 ' HA ' ' A' ' 2' ' ' MET . 34.7 m -69.23 -23.06 26.38 Favored 'Isoleucine or valine' 0 C--N 1.356 0.871 0 C-N-CA 120.178 -0.609 . . . . 0.0 109.91 -178.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -70.75 -37.25 73.42 Favored 'General case' 0 C--N 1.355 0.833 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.4 m -67.98 -41.07 82.92 Favored 'General case' 0 C--N 1.354 0.803 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.44 -38.97 97.19 Favored Glycine 0 C--N 1.357 1.702 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.63 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -65.5 -40.12 92.66 Favored 'General case' 0 C--N 1.351 0.652 0 O-C-N 122.384 -0.48 . . . . 0.0 110.733 -178.351 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.408 ' CE ' HD21 ' A' ' 26' ' ' LEU . 24.6 mmt -63.11 -40.42 97.56 Favored 'General case' 0 C--N 1.352 0.676 0 O-C-N 121.611 -0.681 . . . . 0.0 110.935 -178.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -67.33 -40.24 85.91 Favored 'General case' 0 C--N 1.348 0.526 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.438 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 53.7 tp -66.36 -43.07 87.04 Favored 'General case' 0 C--N 1.35 0.588 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -178.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.63 HG12 ' O ' ' A' ' 9' ' ' LEU . 1.1 mm -76.36 -36.05 28.48 Favored 'Isoleucine or valine' 0 C--N 1.36 1.04 0 O-C-N 120.924 -1.11 . . . . 0.0 111.113 -175.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -67.61 -43.18 81.07 Favored 'General case' 0 C--N 1.351 0.642 0 O-C-N 121.683 -0.636 . . . . 0.0 111.134 -176.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -72.32 -33.28 67.23 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 121.956 -0.465 . . . . 0.0 111.76 -177.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -72.49 -48.45 40.61 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -175.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -127.57 -21.12 3.85 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 117.5 -1.68 . . . . 0.0 113.49 -176.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 140.56 179.81 18.45 Favored Glycine 0 CA--C 1.497 -1.041 0 C-N-CA 118.007 -2.044 . . . . 0.0 109.489 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -96.33 -11.96 25.1 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -177.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -70.79 -41.4 71.69 Favored 'General case' 0 C--N 1.36 1.032 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 94.3 m -69.73 -38.89 77.04 Favored 'General case' 0 C--N 1.357 0.896 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.513 HD13 ' HB ' ' A' ' 13' ' ' ILE . 55.5 tp -60.48 -37.12 80.03 Favored 'General case' 0 C--N 1.356 0.873 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -65.09 -35.46 81.22 Favored 'General case' 0 C--N 1.357 0.899 0 O-C-N 122.255 -0.278 . . . . 0.0 110.725 -178.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.7 m -64.49 -40.25 95.32 Favored 'General case' 0 C--N 1.358 0.946 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -178.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.417 HD22 ' HB3' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -65.09 -36.71 85.17 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.563 ' HB3' HD23 ' A' ' 31' ' ' LEU . 83.7 mt -70.88 -14.88 62.55 Favored 'General case' 0 C--N 1.356 0.891 0 O-C-N 121.501 -0.749 . . . . 0.0 109.81 -179.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -87.82 -25.79 23.15 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.292 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.4 p -69.22 -24.33 64.01 Favored 'General case' 0 C--N 1.36 1.027 0 C-N-CA 119.7 -0.8 . . . . 0.0 109.085 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.621 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 1.9 p -107.42 -34.88 6.93 Favored 'General case' 0 C--N 1.359 0.992 0 C-N-CA 119.008 -1.077 . . . . 0.0 108.442 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.621 ' HB2' ' O ' ' A' ' 29' ' ' CYS . 12.2 mt-10 83.37 133.58 0.05 Allowed 'General case' 0 C--N 1.359 1.012 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.563 HD23 ' HB3' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -103.2 111.06 23.26 Favored 'General case' 0 C--N 1.359 1.001 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.577 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -73.07 -41.11 64.47 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.425 ' HB3' ' H ' ' A' ' 34' ' ' GLU . 0.6 OUTLIER -113.96 -88.68 0.55 Allowed 'General case' 0 C--N 1.355 0.828 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.074 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.425 ' H ' ' HB3' ' A' ' 33' ' ' SER . 60.5 mt-10 -120.55 -43.15 2.5 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -178.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.91 -34.64 5.11 Favored Glycine 0 C--N 1.351 1.393 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 78.9 mt -106.66 102.67 14.28 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.95 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.47 -136.9 0.06 Allowed 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.455 ' O ' ' HB3' ' A' ' 39' ' ' SER . 52.0 m -113.2 -59.65 1.99 Allowed 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -179.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.455 ' HB3' ' O ' ' A' ' 38' ' ' THR . 61.4 p 158.48 10.34 0.0 OUTLIER 'General case' 0 C--N 1.363 1.182 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -178.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.4 p -98.07 6.8 8.65 Favored 'Isoleucine or valine' 0 C--N 1.353 0.733 0 C-N-CA 120.251 -0.579 . . . . 0.0 110.902 -177.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -105.3 154.95 17.13 Favored Glycine 0 C--N 1.353 1.5 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.1 t -134.88 124.99 25.87 Favored 'General case' 0 C--N 1.357 0.901 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -109.46 175.75 5.33 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -72.18 175.33 6.13 Favored 'General case' 0 C--N 1.356 0.879 0 CA-C-O 121.638 0.733 . . . . 0.0 109.443 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 10.7 t60 -82.77 -24.86 33.27 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -178.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -65.81 -28.17 68.8 Favored 'General case' 0 C--N 1.356 0.875 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.2 tp10 -62.58 -39.74 94.68 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -68.15 -38.63 82.35 Favored 'General case' 0 C--N 1.357 0.915 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 59.2 tp -71.28 -32.38 68.62 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -177.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -66.76 -40.96 88.44 Favored 'General case' 0 N--CA 1.441 -0.878 0 O-C-N 122.02 -0.425 . . . . 0.0 110.027 -178.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 80.3 mt -82.47 -17.81 43.93 Favored 'General case' 0 C--N 1.357 0.898 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.191 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -81.56 -36.65 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 54.3 t -68.34 -41.49 83.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.417 ' HB3' HD22 ' A' ' 25' ' ' LEU . 22.6 tptt -69.17 -26.03 64.65 Favored 'General case' 0 C--N 1.365 1.245 0 C-N-CA 119.485 -0.886 . . . . 0.0 109.337 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.451 ' O ' HD23 ' A' ' 55' ' ' LEU . 3.4 tt -67.04 -37.09 83.46 Favored 'General case' 0 C--N 1.353 0.748 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.2 m -76.67 -16.99 59.39 Favored 'General case' 0 C--N 1.352 0.691 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.341 -178.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -97.95 -38.39 9.42 Favored 'General case' 0 C--N 1.353 0.717 0 O-C-N 121.314 -0.867 . . . . 0.0 111.278 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.2 p -73.18 -35.85 48.5 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 O-C-N 121.668 -0.645 . . . . 0.0 111.186 -177.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 61.2 m -111.71 -7.87 14.21 Favored 'General case' 0 CA--C 1.504 -0.821 0 C-N-CA 119.389 -0.924 . . . . 0.0 109.99 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 64.72 52.71 1.63 Allowed 'General case' 0 C--N 1.355 0.831 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.429 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 48.6 t -112.75 135.76 21.59 Favored Pre-proline 0 CA--C 1.504 -0.81 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 61' ' ' VAL . 31.2 Cg_exo -59.93 146.08 96.73 Favored 'Trans proline' 0 C--N 1.316 -1.178 0 C-N-CA 122.144 1.896 . . . . 0.0 112.464 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.2 m -73.55 -16.09 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.91 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.455 ' O ' HG12 ' A' ' 67' ' ' VAL . 67.5 p -96.24 -32.0 12.66 Favored 'General case' 0 C--N 1.359 0.981 0 C-N-CA 118.129 -1.429 . . . . 0.0 110.318 -178.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -80.19 -19.16 47.69 Favored 'General case' 0 C--N 1.353 0.724 0 O-C-N 121.162 -0.961 . . . . 0.0 108.864 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.401 ' HB3' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -80.17 -37.85 32.51 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.845 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.455 HG12 ' O ' ' A' ' 64' ' ' THR . 1.3 p -67.35 -28.38 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 C-N-CA 120.236 -0.586 . . . . 0.0 109.833 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 71.3 mtp180 -71.47 -50.51 30.92 Favored 'General case' 0 C--N 1.364 1.234 0 O-C-N 121.444 -0.785 . . . . 0.0 110.831 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.43 -36.01 82.79 Favored 'General case' 0 C--N 1.357 0.91 0 O-C-N 121.929 -0.482 . . . . 0.0 111.159 -178.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -61.02 -47.31 87.01 Favored 'General case' 0 C--N 1.349 0.577 0 O-C-N 122.154 -0.341 . . . . 0.0 110.388 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.74 -38.45 95.2 Favored Glycine 0 C--N 1.356 1.643 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 -178.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.08 -48.59 77.97 Favored 'General case' 0 C--N 1.35 0.609 0 CA-C-N 118.104 0.952 . . . . 0.0 111.45 -177.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.528 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 10.9 mttm -64.29 -48.0 77.33 Favored 'General case' 0 C--N 1.358 0.947 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -177.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.459 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.1 tm? -68.44 -39.28 81.57 Favored 'General case' 0 C--N 1.349 0.584 0 O-C-N 121.259 -0.9 . . . . 0.0 111.869 -175.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -63.97 -44.38 92.92 Favored 'General case' 0 C--N 1.352 0.69 0 O-C-N 121.248 -0.907 . . . . 0.0 111.06 -177.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.33 -15.27 18.44 Favored 'Isoleucine or valine' 0 C--N 1.359 1.009 0 O-C-N 121.486 -0.759 . . . . 0.0 108.953 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.528 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 14.7 mm-40 -71.67 -39.06 70.52 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 81.8 mt -73.32 -31.22 63.88 Favored 'General case' 0 C--N 1.359 0.984 0 O-C-N 122.301 -0.249 . . . . 0.0 110.505 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.9 mm -64.95 -53.56 40.01 Favored 'Isoleucine or valine' 0 C--N 1.359 1.013 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.956 -177.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -74.69 -15.0 60.81 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 119.693 -0.803 . . . . 0.0 109.36 178.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.65 -36.86 67.62 Favored Glycine 0 C--N 1.35 1.339 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.453 ' O ' HG22 ' A' ' 85' ' ' ILE . 59.5 m80 -132.44 104.97 13.27 Favored Pre-proline 0 N--CA 1.44 -0.941 0 CA-C-N 118.534 1.167 . . . . 0.0 109.499 -177.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.447 ' O ' ' HB2' ' A' ' 87' ' ' ASN . 34.8 Cg_exo -62.07 -29.58 81.53 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 123.018 2.479 . . . . 0.0 113.872 178.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -91.53 -8.37 47.72 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.453 HG22 ' O ' ' A' ' 82' ' ' HIS . 0.9 OUTLIER -86.71 -22.27 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 -178.765 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -104.57 -14.55 15.61 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 49.1 t30 -71.71 -40.85 69.21 Favored 'General case' 0 C--N 1.359 1.001 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -66.92 -30.95 71.23 Favored 'General case' 0 C--N 1.351 0.662 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.284 -178.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 17.5 ttp -83.93 150.16 25.86 Favored 'General case' 0 C--N 1.35 0.63 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.71 -22.31 7.49 Favored 'General case' 0 C--N 1.364 1.21 0 O-C-N 121.608 -0.683 . . . . 0.0 111.436 -177.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -165.28 172.03 12.86 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 119.083 -1.047 . . . . 0.0 108.277 -177.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.427 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 40.0 t -64.79 -43.3 93.66 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.056 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -66.13 -39.61 90.01 Favored 'General case' 0 C--N 1.355 0.847 0 O-C-N 121.414 -0.804 . . . . 0.0 109.138 -178.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -65.93 -24.35 66.8 Favored 'General case' 0 C--N 1.355 0.807 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.655 ' O ' HG12 ' A' ' 99' ' ' ILE . 61.7 tp -63.89 -47.16 81.73 Favored 'General case' 0 C--N 1.354 0.777 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.5 mp -60.58 -35.56 76.38 Favored 'General case' 0 C--N 1.36 1.054 0 O-C-N 122.215 -0.303 . . . . 0.0 110.345 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.8 t -68.49 -39.55 81.28 Favored 'General case' 0 C--N 1.348 0.526 0 O-C-N 122.03 -0.419 . . . . 0.0 109.967 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.06 1.26 54.67 Favored 'General case' 0 C--N 1.356 0.855 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -176.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.655 HG12 ' O ' ' A' ' 95' ' ' LEU . 23.4 mm -60.96 -47.16 94.79 Favored 'Isoleucine or valine' 0 C--N 1.359 0.989 0 CA-C-N 118.955 0.798 . . . . 0.0 112.089 -177.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -98.77 -20.63 16.79 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 118.273 -1.371 . . . . 0.0 111.282 -177.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.5 t -64.75 -48.48 74.4 Favored 'General case' 0 N--CA 1.445 -0.707 0 O-C-N 121.555 -0.716 . . . . 0.0 112.36 -178.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -136.51 -17.34 1.51 Allowed 'General case' 0 C--N 1.361 1.093 0 C-N-CA 117.174 -1.811 . . . . 0.0 113.536 -176.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.472 HD12 HD13 ' A' ' 99' ' ' ILE . 96.4 mt -71.56 -50.78 37.42 Favored 'Isoleucine or valine' 0 C--O 1.244 0.771 0 CA-C-N 120.574 1.534 . . . . 0.0 111.215 -177.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 28.8 m170 -89.83 1.5 56.08 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 119.628 -0.829 . . . . 0.0 110.107 -177.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 55.7 t -90.19 -41.73 13.74 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.053 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 54.7 tp10 -68.33 -40.02 81.73 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.5 p -74.05 -35.6 42.07 Favored 'Isoleucine or valine' 0 C--N 1.356 0.867 0 C-N-CA 119.18 -1.008 . . . . 0.0 109.708 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 94.2 t80 -61.26 -48.61 80.63 Favored 'General case' 0 C--N 1.364 1.203 0 O-C-N 121.775 -0.578 . . . . 0.0 110.526 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -61.48 -37.13 82.5 Favored 'General case' 0 C--N 1.358 0.948 0 O-C-N 121.742 -0.599 . . . . 0.0 110.162 -178.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 110' ' ' LEU . 13.6 mt -56.21 -74.47 0.05 OUTLIER 'General case' 0 C--N 1.357 0.922 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.412 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 87.3 m-85 -118.41 133.74 23.49 Favored Pre-proline 0 N--CA 1.439 -0.98 0 C-N-CA 118.978 -1.089 . . . . 0.0 108.538 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 111' ' ' TYR . 96.2 Cg_endo -83.54 -1.48 10.17 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 123.31 2.674 . . . . 0.0 115.52 -178.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -65.73 -37.85 87.55 Favored 'General case' 0 C--N 1.355 0.835 0 O-C-N 121.746 -0.597 . . . . 0.0 110.092 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.38 145.11 56.58 Favored 'General case' 0 C--N 1.354 0.769 0 CA-C-O 121.513 0.673 . . . . 0.0 110.149 -178.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -131.93 135.66 46.79 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.526 ' HB3' ' HD2' ' A' ' 117' ' ' PRO . 93.1 mt -128.96 157.62 75.17 Favored Pre-proline 0 C--N 1.354 0.795 0 CA-C-O 122.098 0.952 . . . . 0.0 109.224 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.526 ' HD2' ' HB3' ' A' ' 116' ' ' LEU . 87.4 Cg_endo -81.35 -150.91 0.04 OUTLIER 'Trans proline' 0 C--N 1.318 -1.059 0 C-N-CA 123.685 2.923 . . . . 0.0 113.933 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -116.7 141.86 47.65 Favored 'General case' 0 C--N 1.364 1.238 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -130.34 133.14 46.2 Favored 'General case' 0 C--N 1.362 1.125 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 94.2 m -127.31 129.16 47.15 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 177.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 77.6 m -119.26 129.29 54.84 Favored 'General case' 0 C--N 1.355 0.808 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.382 -178.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -119.63 133.83 55.48 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -106.63 116.81 32.58 Favored 'General case' 0 C--N 1.352 0.716 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.472 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 94.6 mt -85.54 -23.73 27.56 Favored 'General case' 0 C--N 1.354 0.763 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.203 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -179.59 -144.72 6.0 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -94.02 -40.25 10.19 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 119.993 -0.683 . . . . 0.0 109.254 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -102.51 3.83 37.95 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.985 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.472 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 66.3 m-20 -118.13 129.02 55.28 Favored 'General case' 0 C--N 1.356 0.866 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 10.0 mm -141.25 133.53 29.37 Favored 'Isoleucine or valine' 0 C--N 1.356 0.854 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 58.8 mtm180 -116.57 139.75 50.15 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -127.68 118.11 23.22 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -97.15 132.63 42.74 Favored 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -128.7 120.18 26.0 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -178.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.558 ' HA ' ' O ' ' A' ' 171' ' ' THR . 74.4 mt-30 -115.0 111.77 21.64 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 107.599 -1.259 . . . . 0.0 107.599 178.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.4 t -162.16 153.86 18.61 Favored 'General case' 0 C--N 1.359 0.981 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -90.6 3.08 55.09 Favored 'General case' 0 C--N 1.354 0.782 0 C-N-CA 120.267 -0.573 . . . . 0.0 109.743 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -133.47 74.73 70.83 Favored Pre-proline 0 C--N 1.355 0.806 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -95.36 104.44 0.11 Allowed 'Trans proline' 0 N--CA 1.444 -1.407 0 C-N-CA 122.756 2.304 . . . . 0.0 115.746 -177.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -111.71 110.56 21.0 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 176.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.37 -38.88 92.57 Favored 'General case' 0 C--N 1.354 0.773 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.288 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.1 m -63.28 -26.63 68.86 Favored 'General case' 0 C--N 1.355 0.826 0 O-C-N 121.96 -0.463 . . . . 0.0 110.597 -178.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -75.58 -47.02 28.49 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.554 -178.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.78 -40.08 94.66 Favored 'General case' 0 C--N 1.358 0.96 0 O-C-N 122.154 -0.342 . . . . 0.0 111.226 -178.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.24 -36.91 85.22 Favored 'General case' 0 C--N 1.355 0.812 0 O-C-N 121.852 -0.53 . . . . 0.0 109.985 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.56 -43.71 98.59 Favored Glycine 0 C--N 1.346 1.096 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.3 mt -70.23 -40.34 74.56 Favored 'General case' 0 C--N 1.351 0.671 0 O-C-N 122.126 -0.632 . . . . 0.0 112.639 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 98.2 mt -71.2 -43.24 67.76 Favored 'General case' 0 C--N 1.361 1.068 0 O-C-N 121.21 -0.931 . . . . 0.0 111.115 -176.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.531 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 37.1 t70 -70.54 -29.54 66.03 Favored 'General case' 0 N--CA 1.443 -0.778 0 O-C-N 121.839 -0.538 . . . . 0.0 110.392 -179.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.453 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -63.17 -39.47 97.98 Favored Glycine 0 C--N 1.357 1.73 0 N-CA-C 108.464 -1.854 . . . . 0.0 108.464 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 47.9 t -60.38 -41.93 94.81 Favored 'General case' 0 C--N 1.351 0.632 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -75.83 0.17 19.05 Favored 'General case' 0 C--N 1.36 1.029 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.531 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 76.8 mm-40 -85.51 -46.39 10.9 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -66.36 -44.67 82.54 Favored 'General case' 0 C--N 1.36 1.033 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.411 ' O ' ' HB2' ' A' ' 155' ' ' LYS . 52.5 m-85 -69.96 -26.49 64.14 Favored 'General case' 0 C--N 1.36 1.028 0 O-C-N 121.872 -0.517 . . . . 0.0 111.137 -178.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 154' ' ' PHE . 44.1 mttt 71.43 71.78 0.17 Allowed 'General case' 0 C--N 1.363 1.154 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 -178.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.443 ' HB3' ' CE1' ' A' ' 158' ' ' PHE . 3.0 tp10 -141.26 -168.69 2.69 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -140.33 116.34 10.42 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.443 ' CE1' ' HB3' ' A' ' 156' ' ' GLU . 91.2 m-85 -133.65 149.86 51.57 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 92.1 m -120.94 127.59 51.97 Favored 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.529 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.6 mp -103.8 120.89 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 3.1 m -114.5 -177.6 3.17 Favored 'General case' 0 C--N 1.36 1.034 0 CA-C-O 121.708 0.766 . . . . 0.0 109.193 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -146.93 154.6 41.46 Favored 'General case' 0 C--N 1.355 0.847 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -178.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 54.2 p -97.4 146.5 31.48 Favored Pre-proline 0 C--N 1.358 0.961 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.672 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 72.3 Cg_endo -76.19 -11.2 19.4 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.941 2.427 . . . . 0.0 114.918 -178.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -72.63 -41.14 65.83 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.714 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 35.7 p -118.42 15.52 13.84 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.704 -178.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.672 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.1 pp0? -67.06 -13.57 62.06 Favored 'General case' 0 C--N 1.354 0.765 0 O-C-N 121.546 -0.721 . . . . 0.0 110.263 178.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 53.8 p-10 -121.09 35.1 4.99 Favored 'General case' 0 N--CA 1.438 -1.028 0 O-C-N 121.188 -0.945 . . . . 0.0 108.706 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 58.2 m -136.12 148.63 48.32 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.625 ' O ' ' HB ' ' A' ' 171' ' ' THR . 61.4 mt-10 -101.74 166.29 10.75 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.625 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 3.4 m 81.65 -59.04 0.23 Allowed 'General case' 0 C--N 1.37 1.469 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -107.8 117.77 34.98 Favored 'General case' 0 CA--C 1.507 -0.706 0 C-N-CA 119.916 -0.713 . . . . 0.0 109.565 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 90.7 t -132.0 133.44 60.8 Favored 'Isoleucine or valine' 0 C--N 1.357 0.922 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 178.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 50.1 mm -109.95 126.72 67.15 Favored 'Isoleucine or valine' 0 C--N 1.358 0.971 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -113.96 150.36 33.91 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -133.93 83.31 2.03 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.206 -178.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.6 mp -76.94 119.52 25.5 Favored 'Isoleucine or valine' 0 C--N 1.358 0.947 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 92.3 m -118.53 144.4 46.08 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 54.8 ttp180 . . . . . 0 C--N 1.36 1.027 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 -178.904 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.8 mmm . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.041 0.448 . . . . 0.0 110.018 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.463 ' HA ' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -77.18 -17.44 58.55 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 120.586 -0.446 . . . . 0.0 109.969 -178.498 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.76 -44.62 30.96 Favored Glycine 0 C--N 1.35 1.356 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 75.7 mtm -71.43 -33.79 69.7 Favored 'General case' 0 C--N 1.354 0.782 0 O-C-N 122.073 -0.663 . . . . 0.0 111.377 -177.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.463 HG22 ' HA ' ' A' ' 2' ' ' MET . 30.7 m -70.76 -22.89 23.53 Favored 'Isoleucine or valine' 0 C--N 1.357 0.9 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.064 -179.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.442 ' HZ ' ' CG ' ' A' ' 47' ' ' GLU . 1.7 m-30 -71.47 -35.31 70.79 Favored 'General case' 0 C--N 1.357 0.917 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 88.9 m -66.41 -39.67 89.13 Favored 'General case' 0 C--N 1.357 0.902 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.23 -37.88 95.28 Favored Glycine 0 C--N 1.357 1.71 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.618 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -66.89 -39.71 87.54 Favored 'General case' 0 C--N 1.354 0.773 0 CA-C-N 117.291 0.545 . . . . 0.0 110.526 -178.282 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 22.6 mmt -63.53 -41.42 98.46 Favored 'General case' 0 C--N 1.355 0.835 0 O-C-N 121.618 -0.676 . . . . 0.0 111.013 -178.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -66.34 -40.4 89.84 Favored 'General case' 0 C--N 1.347 0.493 0 O-C-N 122.148 -0.345 . . . . 0.0 111.702 -177.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 55.8 tp -66.03 -43.06 88.69 Favored 'General case' 0 C--N 1.349 0.583 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 -178.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.618 HG12 ' O ' ' A' ' 9' ' ' LEU . 1.7 mm -74.61 -36.45 40.96 Favored 'Isoleucine or valine' 0 C--N 1.358 0.935 0 O-C-N 121.003 -1.06 . . . . 0.0 111.155 -175.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -66.95 -42.53 85.06 Favored 'General case' 0 C--N 1.351 0.659 0 O-C-N 121.82 -0.55 . . . . 0.0 111.286 -176.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -75.04 -30.89 61.19 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 121.83 -0.544 . . . . 0.0 111.773 -177.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -72.96 -48.67 34.7 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.736 -175.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -127.72 -22.13 3.63 Favored 'General case' 0 CA--C 1.503 -0.849 0 C-N-CA 117.609 -1.636 . . . . 0.0 112.846 -176.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 146.34 178.69 21.94 Favored Glycine 0 N--CA 1.44 -1.077 0 C-N-CA 117.671 -2.204 . . . . 0.0 110.494 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -96.7 -17.5 20.28 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -70.3 -40.17 74.39 Favored 'General case' 0 C--N 1.361 1.089 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 94.5 m -68.28 -38.54 81.81 Favored 'General case' 0 C--N 1.357 0.918 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 178.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 27.1 tp -60.68 -36.49 78.9 Favored 'General case' 0 C--N 1.355 0.839 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -65.15 -37.12 86.39 Favored 'General case' 0 C--N 1.359 0.984 0 O-C-N 121.998 -0.439 . . . . 0.0 110.461 -178.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.7 m -65.67 -37.75 87.38 Favored 'General case' 0 C--N 1.355 0.811 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 23.4 tp -62.39 -40.73 97.44 Favored 'General case' 0 C--N 1.354 0.764 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.484 ' HB3' HD23 ' A' ' 31' ' ' LEU . 6.8 mp -74.94 -11.35 60.1 Favored 'General case' 0 C--N 1.36 1.031 0 O-C-N 121.693 -0.629 . . . . 0.0 110.483 -178.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -85.7 -29.21 24.14 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 119.254 -0.978 . . . . 0.0 108.925 178.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.7 t -67.13 -37.52 83.98 Favored 'General case' 0 C--N 1.357 0.92 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.646 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 1.8 p -89.81 -38.99 13.39 Favored 'General case' 0 C--N 1.359 1.011 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.646 ' HB2' ' O ' ' A' ' 29' ' ' CYS . 10.6 mt-10 85.61 132.39 0.04 OUTLIER 'General case' 0 C--N 1.362 1.119 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.484 HD23 ' HB3' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -108.58 122.18 46.55 Favored 'General case' 0 C--N 1.357 0.898 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.433 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -94.25 -38.03 11.24 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -104.77 -78.16 0.57 Allowed 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.234 -178.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -137.24 -55.56 0.7 Allowed 'General case' 0 CA--C 1.502 -0.888 0 C-N-CA 119.609 -0.836 . . . . 0.0 108.853 -178.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 128.91 -52.11 0.84 Allowed Glycine 0 C--N 1.352 1.458 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 78.4 mt -97.67 95.29 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.755 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.608 ' CD2' HG23 ' A' ' 40' ' ' VAL . 1.2 t80 -65.38 -50.94 63.65 Favored 'General case' 0 C--N 1.36 1.059 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.461 HG22 ' N ' ' A' ' 39' ' ' SER . 1.1 m 143.58 -64.32 0.0 OUTLIER 'General case' 0 C--N 1.368 1.406 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 178.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.461 ' N ' HG22 ' A' ' 38' ' ' THR . 16.5 p 169.59 70.39 0.0 OUTLIER 'General case' 0 C--N 1.364 1.208 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.608 HG23 ' CD2' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -164.52 1.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.938 0 C-N-CA 119.853 -0.739 . . . . 0.0 109.695 -179.811 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.5 146.73 17.35 Favored Glycine 0 C--N 1.353 1.526 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 53.4 m -123.93 124.71 43.2 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -116.45 175.18 5.68 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -82.07 -172.62 4.05 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -92.42 -14.68 28.21 Favored 'General case' 0 N--CA 1.439 -0.975 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.365 -179.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -70.22 -28.44 65.27 Favored 'General case' 0 C--N 1.354 0.764 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.442 ' CG ' ' HZ ' ' A' ' 6' ' ' PHE . 26.0 tp10 -63.2 -40.3 97.09 Favored 'General case' 0 C--N 1.353 0.726 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.412 HD22 ' O ' ' A' ' 48' ' ' LEU . 2.0 tm? -67.68 -38.29 83.52 Favored 'General case' 0 C--N 1.358 0.942 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 58.5 tp -74.17 -29.35 61.73 Favored 'General case' 0 N--CA 1.447 -0.598 0 O-C-N 122.088 -0.382 . . . . 0.0 110.259 -176.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -68.28 -41.02 81.62 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 121.835 -0.54 . . . . 0.0 109.561 -178.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 63.2 mt -83.98 -15.92 45.94 Favored 'General case' 0 C--N 1.361 1.072 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.666 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.4 t -81.85 -35.76 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 52.2 t -70.7 -39.84 76.23 Favored 'Isoleucine or valine' 0 C--N 1.354 0.791 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.0 tptt -67.19 -28.54 68.18 Favored 'General case' 0 C--N 1.36 1.048 0 O-C-N 121.266 -0.896 . . . . 0.0 108.622 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.417 ' O ' HD23 ' A' ' 55' ' ' LEU . 2.5 tt -67.99 -37.79 81.91 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 60.0 p -72.32 -17.65 61.84 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.741 -178.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -101.44 -35.32 9.23 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 119.278 -0.969 . . . . 0.0 111.049 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.8 p -73.61 -36.86 48.44 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 O-C-N 121.797 -0.565 . . . . 0.0 111.081 -177.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 73.0 m -113.17 -6.97 13.62 Favored 'General case' 0 CA--C 1.504 -0.825 0 C-N-CA 119.512 -0.875 . . . . 0.0 110.161 -177.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 64.35 48.63 2.74 Favored 'General case' 0 C--N 1.356 0.858 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.562 HG13 ' HD2' ' A' ' 62' ' ' PRO . 49.8 t -113.6 135.5 21.93 Favored Pre-proline 0 CA--C 1.505 -0.774 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.67 ' HG2' ' HB2' ' A' ' 65' ' ' GLU . 23.4 Cg_endo -62.57 149.12 92.12 Favored 'Trans proline' 0 CA--C 1.5 -1.203 0 C-N-CA 122.276 1.984 . . . . 0.0 112.518 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.2 m -75.98 -13.67 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.319 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.45 ' O ' HG12 ' A' ' 67' ' ' VAL . 72.1 p -95.22 -33.99 12.39 Favored 'General case' 0 C--N 1.356 0.878 0 C-N-CA 118.207 -1.397 . . . . 0.0 109.747 -178.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.67 ' HB2' ' HG2' ' A' ' 62' ' ' PRO . 97.9 mt-10 -78.02 -21.84 50.15 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 121.336 -0.853 . . . . 0.0 108.978 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.52 -37.48 36.54 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 64' ' ' THR . 1.7 p -67.47 -26.9 36.84 Favored 'Isoleucine or valine' 0 C--N 1.355 0.812 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.902 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.9 mmm-85 -71.98 -51.15 23.33 Favored 'General case' 0 C--N 1.363 1.184 0 O-C-N 121.549 -0.719 . . . . 0.0 110.451 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.2 mt -63.24 -36.06 82.41 Favored 'General case' 0 C--N 1.357 0.922 0 O-C-N 121.963 -0.461 . . . . 0.0 110.953 -178.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -60.58 -46.83 88.77 Favored 'General case' 0 C--N 1.348 0.541 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -178.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.39 -38.42 94.71 Favored Glycine 0 C--N 1.352 1.455 0 N-CA-C 111.74 -0.544 . . . . 0.0 111.74 -178.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -63.16 -48.38 78.68 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-N 118.499 1.149 . . . . 0.0 111.547 -177.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.707 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 16.2 mttm -63.76 -49.41 73.08 Favored 'General case' 0 C--N 1.359 1.006 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -176.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.413 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.4 tm? -68.65 -39.71 80.58 Favored 'General case' 0 C--N 1.349 0.559 0 O-C-N 121.125 -0.985 . . . . 0.0 111.973 -175.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -63.86 -44.35 93.39 Favored 'General case' 0 C--N 1.352 0.702 0 O-C-N 121.196 -0.94 . . . . 0.0 111.187 -177.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -70.33 -15.51 19.16 Favored 'Isoleucine or valine' 0 C--N 1.359 0.986 0 O-C-N 121.41 -0.806 . . . . 0.0 109.261 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.707 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 74.5 mm-40 -72.17 -38.33 69.16 Favored 'General case' 0 C--N 1.351 0.651 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 81.4 mt -74.25 -29.11 61.54 Favored 'General case' 0 C--N 1.357 0.9 0 O-C-N 122.311 -0.243 . . . . 0.0 110.543 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.8 mm -67.06 -54.16 27.12 Favored 'Isoleucine or valine' 0 C--N 1.359 1.007 0 C-N-CA 119.993 -0.683 . . . . 0.0 109.897 -177.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -74.63 -14.66 60.79 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 119.686 -0.806 . . . . 0.0 109.285 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.55 -37.25 62.23 Favored Glycine 0 C--N 1.348 1.228 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -134.01 104.16 11.67 Favored Pre-proline 0 N--CA 1.441 -0.88 0 CA-C-O 122.494 1.14 . . . . 0.0 109.026 -177.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.48 ' O ' ' HB2' ' A' ' 87' ' ' ASN . 37.6 Cg_endo -67.98 -23.2 40.85 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.556 2.171 . . . . 0.0 114.004 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -90.01 -8.38 51.72 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.4 tp -89.63 -22.81 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -178.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -102.51 -15.95 16.28 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 49.1 t30 -71.74 -40.92 69.07 Favored 'General case' 0 C--N 1.36 1.061 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -67.1 -29.21 68.9 Favored 'General case' 0 C--N 1.353 0.756 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.209 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 23.7 ttp -84.4 148.1 26.78 Favored 'General case' 0 C--N 1.351 0.652 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.5 -21.96 8.37 Favored 'General case' 0 C--N 1.363 1.193 0 C-N-CA 119.934 -0.707 . . . . 0.0 111.025 -177.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -165.3 171.66 13.28 Favored 'General case' 0 C--N 1.354 0.778 0 C-N-CA 119.045 -1.062 . . . . 0.0 108.338 -177.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 39.6 t -64.62 -42.13 95.71 Favored 'General case' 0 C--N 1.356 0.884 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.864 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -66.46 -39.11 88.63 Favored 'General case' 0 C--N 1.356 0.884 0 O-C-N 121.528 -0.733 . . . . 0.0 109.292 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -65.61 -25.72 67.51 Favored 'General case' 0 C--N 1.357 0.912 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 64.5 tp -62.94 -46.22 88.77 Favored 'General case' 0 C--N 1.355 0.826 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.7 mp -62.5 -32.5 73.43 Favored 'General case' 0 C--N 1.353 0.752 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 37.1 t -62.4 -45.37 93.44 Favored 'General case' 0 C--N 1.356 0.857 0 O-C-N 121.719 -0.613 . . . . 0.0 111.22 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.97 28.88 8.42 Favored 'General case' 0 C--N 1.36 1.049 0 C-N-CA 119.304 -0.958 . . . . 0.0 110.462 -178.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.4 tt -62.3 -29.17 46.07 Favored 'Isoleucine or valine' 0 C--N 1.356 0.868 0 O-C-N 122.152 -0.343 . . . . 0.0 110.537 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -127.15 -11.43 5.85 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 118.696 -1.202 . . . . 0.0 109.097 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.4 t -68.31 -45.55 72.67 Favored 'General case' 0 N--CA 1.439 -0.977 0 O-C-N 121.879 -0.513 . . . . 0.0 109.901 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.479 ' O ' HG12 ' A' ' 105' ' ' VAL . 19.3 t80 -123.83 -29.53 3.67 Favored 'General case' 0 C--N 1.36 1.049 0 C-N-CA 118.38 -1.328 . . . . 0.0 111.549 -178.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 96.2 mt -69.75 -48.4 64.94 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 O-C-N 121.076 -1.015 . . . . 0.0 110.487 -177.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -89.03 3.65 50.97 Favored 'General case' 0 N--CA 1.44 -0.954 0 O-C-N 121.105 -0.997 . . . . 0.0 109.916 -177.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.479 HG12 ' O ' ' A' ' 102' ' ' PHE . 1.9 p -87.68 -33.98 7.04 Favored 'Isoleucine or valine' 0 C--N 1.357 0.899 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 178.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -71.64 -40.12 69.91 Favored 'General case' 0 C--N 1.36 1.049 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 62.2 t -62.82 -47.06 94.63 Favored 'Isoleucine or valine' 0 C--N 1.357 0.909 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.276 -179.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -60.2 -48.61 81.02 Favored 'General case' 0 C--N 1.357 0.931 0 O-C-N 122.115 -0.366 . . . . 0.0 111.466 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -60.61 -38.93 86.33 Favored 'General case' 0 C--N 1.355 0.833 0 O-C-N 121.547 -0.721 . . . . 0.0 110.609 -178.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 19.6 mt -58.26 -75.64 0.05 OUTLIER 'General case' 0 C--N 1.354 0.804 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -115.29 132.97 22.8 Favored Pre-proline 0 N--CA 1.442 -0.874 0 C-N-CA 118.906 -1.117 . . . . 0.0 108.9 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -84.54 -3.4 10.0 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 123.176 2.584 . . . . 0.0 115.056 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -66.42 -36.6 83.21 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 122.001 -0.437 . . . . 0.0 109.948 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.4 146.34 54.13 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 121.714 0.769 . . . . 0.0 110.219 -178.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -130.54 135.18 47.67 Favored 'General case' 0 C--N 1.358 0.949 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.529 ' HB3' ' HD2' ' A' ' 117' ' ' PRO . 87.5 mt -127.03 157.0 73.44 Favored Pre-proline 0 N--CA 1.444 -0.756 0 CA-C-O 122.193 0.997 . . . . 0.0 109.394 -178.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.529 ' HD2' ' HB3' ' A' ' 116' ' ' LEU . 89.6 Cg_endo -80.37 -157.44 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -0.987 0 C-N-CA 123.914 3.076 . . . . 0.0 114.163 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -114.23 142.47 46.23 Favored 'General case' 0 C--N 1.367 1.332 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -124.0 127.85 48.51 Favored 'General case' 0 C--N 1.361 1.067 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -178.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.537 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 94.7 m -124.7 128.51 48.91 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 177.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 78.4 m -122.63 131.17 53.69 Favored 'General case' 0 CA--C 1.504 -0.825 0 C-N-CA 119.061 -1.055 . . . . 0.0 109.929 -177.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -118.15 149.52 40.92 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 177.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -121.2 117.74 27.85 Favored 'General case' 0 C--N 1.353 0.748 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -179.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 97.2 mt -93.37 -13.93 27.46 Favored 'General case' 0 C--N 1.356 0.856 0 C-N-CA 120.431 -0.507 . . . . 0.0 110.603 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 173.29 -149.16 10.88 Favored Glycine 0 C--N 1.348 1.226 0 C-N-CA 118.761 -1.685 . . . . 0.0 109.171 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -94.15 -37.91 11.34 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -103.6 5.79 36.79 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 120.166 -0.614 . . . . 0.0 109.39 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -121.49 127.85 51.48 Favored 'General case' 0 C--N 1.359 0.979 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.3 mm -141.71 135.95 30.59 Favored 'Isoleucine or valine' 0 C--N 1.354 0.787 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 53.2 mtm180 -115.94 140.11 49.57 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 7.5 tp -126.79 118.64 25.07 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.654 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.537 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 12.6 m-70 -99.15 133.11 43.9 Favored 'General case' 0 CA--C 1.497 -1.087 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -127.46 120.54 28.61 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.466 ' HA ' ' O ' ' A' ' 171' ' ' THR . 36.2 tt0 -114.78 111.7 21.65 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 15.9 t -161.7 152.53 17.91 Favored 'General case' 0 C--N 1.359 0.986 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -90.82 1.49 56.89 Favored 'General case' 0 C--N 1.357 0.93 0 C-N-CA 120.245 -0.582 . . . . 0.0 109.95 -178.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -135.35 74.28 61.43 Favored Pre-proline 0 C--N 1.355 0.821 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -96.72 110.51 0.11 Allowed 'Trans proline' 0 N--CA 1.444 -1.429 0 C-N-CA 122.752 2.301 . . . . 0.0 116.03 -177.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -112.85 112.59 24.18 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 176.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.88 -38.59 91.64 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.116 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 74.0 m -63.21 -28.81 70.3 Favored 'General case' 0 C--N 1.354 0.783 0 O-C-N 121.927 -0.483 . . . . 0.0 110.689 -178.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -74.16 -46.82 39.91 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 120.236 -0.586 . . . . 0.0 109.719 -177.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.95 -39.67 93.85 Favored 'General case' 0 C--N 1.357 0.908 0 O-C-N 122.176 -0.327 . . . . 0.0 111.351 -177.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -63.09 -37.47 87.33 Favored 'General case' 0 C--N 1.355 0.83 0 O-C-N 121.872 -0.517 . . . . 0.0 110.164 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.54 -43.26 99.07 Favored Glycine 0 C--N 1.347 1.162 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 82.7 mt -70.07 -40.51 74.99 Favored 'General case' 0 C--N 1.351 0.657 0 CA-C-N 117.521 0.66 . . . . 0.0 112.724 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 98.0 mt -70.89 -42.39 70.04 Favored 'General case' 0 C--N 1.361 1.103 0 O-C-N 121.146 -0.971 . . . . 0.0 110.829 -176.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -70.4 -30.01 66.79 Favored 'General case' 0 N--CA 1.444 -0.735 0 O-C-N 121.953 -0.467 . . . . 0.0 110.677 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.524 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -63.55 -39.59 97.79 Favored Glycine 0 C--N 1.356 1.688 0 N-CA-C 108.622 -1.791 . . . . 0.0 108.622 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 43.5 t -60.36 -42.99 96.91 Favored 'General case' 0 C--N 1.351 0.64 0 N-CA-C 109.146 -0.686 . . . . 0.0 109.146 178.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -78.83 2.66 19.2 Favored 'General case' 0 C--N 1.359 0.981 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.524 ' HB2' ' O ' ' A' ' 149' ' ' GLY . 24.3 mm-40 -84.56 -48.25 9.73 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -68.67 -40.65 80.05 Favored 'General case' 0 C--N 1.357 0.925 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.504 ' O ' ' HB2' ' A' ' 155' ' ' LYS . 9.1 m-30 -70.46 -26.73 63.77 Favored 'General case' 0 C--N 1.36 1.059 0 O-C-N 121.741 -0.599 . . . . 0.0 111.154 -178.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.504 ' HB2' ' O ' ' A' ' 154' ' ' PHE . 56.8 mtpt 73.2 64.85 0.1 Allowed 'General case' 0 C--N 1.361 1.103 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -178.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -127.16 -179.33 4.81 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -142.3 89.22 2.14 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 17.3 m-30 -115.14 156.7 24.79 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 93.7 m -118.79 127.73 53.8 Favored 'General case' 0 C--N 1.356 0.867 0 C-N-CA 119.462 -0.895 . . . . 0.0 108.831 -178.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.517 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.6 mp -102.88 121.84 54.53 Favored 'Isoleucine or valine' 0 C--N 1.352 0.698 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 178.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -118.05 -173.29 2.42 Favored 'General case' 0 C--N 1.356 0.884 0 CA-C-O 121.801 0.81 . . . . 0.0 109.524 -178.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 26.5 ptt180 -147.54 156.45 42.85 Favored 'General case' 0 C--N 1.357 0.894 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 48.2 p -100.1 146.26 31.62 Favored Pre-proline 0 C--N 1.358 0.967 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.674 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 74.7 Cg_endo -76.83 -11.09 18.32 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.819 2.346 . . . . 0.0 115.234 -178.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -72.66 -41.5 65.33 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.589 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 35.5 p -117.83 16.27 14.36 Favored 'General case' 0 C--N 1.354 0.771 0 C-N-CA 120.069 -0.652 . . . . 0.0 110.443 -178.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.674 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.2 pp0? -66.6 -11.34 52.99 Favored 'General case' 0 C--N 1.353 0.743 0 O-C-N 121.595 -0.69 . . . . 0.0 110.457 178.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -126.56 38.54 4.1 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 58.9 m -137.6 147.11 44.76 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.624 ' O ' ' HB ' ' A' ' 171' ' ' THR . 60.5 mt-10 -101.27 165.23 11.39 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.624 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 19.9 m 84.75 -60.37 0.09 Allowed 'General case' 0 C--N 1.367 1.355 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -109.24 117.38 33.95 Favored 'General case' 0 CA--C 1.502 -0.878 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.43 -178.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 90.8 t -130.73 133.08 63.82 Favored 'Isoleucine or valine' 0 C--N 1.356 0.883 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 49.9 mm -108.53 126.89 65.31 Favored 'Isoleucine or valine' 0 C--N 1.358 0.958 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -115.93 156.62 25.89 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -137.94 118.94 14.33 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.2 mp -114.15 120.16 63.19 Favored 'Isoleucine or valine' 0 C--N 1.352 0.696 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 43.1 p -121.17 159.49 25.75 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-O 121.763 0.792 . . . . 0.0 110.662 -177.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.361 1.07 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 177.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.767 ' HG2' ' HG3' ' A' ' 4' ' ' MET . 51.9 tpp . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.038 0.447 . . . . 0.0 110.475 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.44 ' O ' ' HD1' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -82.14 -14.98 54.9 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.383 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -71.93 -41.5 54.99 Favored Glycine 0 C--N 1.351 1.405 0 N-CA-C 108.558 -1.817 . . . . 0.0 108.558 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . 0.767 ' HG3' ' HG2' ' A' ' 1' ' ' MET . 67.8 mtt -66.35 -38.22 87.13 Favored 'General case' 0 C--N 1.356 0.849 0 O-C-N 122.316 -0.52 . . . . 0.0 111.555 -178.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.4 m -69.38 -23.93 27.05 Favored 'Isoleucine or valine' 0 C--N 1.357 0.914 0 C-N-CA 119.996 -0.682 . . . . 0.0 109.847 -177.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.577 ' HZ ' ' HG2' ' A' ' 47' ' ' GLU . 4.6 m-85 -71.36 -35.8 71.25 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 85.3 m -67.77 -41.31 83.47 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.38 -38.98 97.18 Favored Glycine 0 C--N 1.357 1.727 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.611 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -66.05 -39.87 90.49 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-N 117.338 0.569 . . . . 0.0 110.704 -178.336 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.418 ' CE ' HD11 ' A' ' 26' ' ' LEU . 25.6 mmt -64.14 -39.81 94.82 Favored 'General case' 0 C--N 1.351 0.662 0 O-C-N 121.802 -0.561 . . . . 0.0 110.847 -178.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.6 -39.83 88.57 Favored 'General case' 0 C--N 1.35 0.604 0 O-C-N 121.974 -0.454 . . . . 0.0 111.148 -178.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 56.0 tp -66.86 -42.83 85.02 Favored 'General case' 0 C--N 1.35 0.593 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.611 HG12 ' O ' ' A' ' 9' ' ' LEU . 2.2 mm -75.32 -36.42 36.23 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 O-C-N 121.053 -1.029 . . . . 0.0 111.074 -175.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -70.01 -42.6 72.81 Favored 'General case' 0 C--N 1.353 0.725 0 O-C-N 121.725 -0.609 . . . . 0.0 111.181 -176.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -71.3 -32.83 69.11 Favored 'General case' 0 N--CA 1.444 -0.735 0 O-C-N 122.002 -0.436 . . . . 0.0 111.219 -177.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -72.61 -50.51 24.82 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -175.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -128.91 -19.32 3.64 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 117.365 -1.734 . . . . 0.0 113.721 -176.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 142.08 179.66 19.25 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 117.594 -2.241 . . . . 0.0 110.134 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -96.06 -11.38 26.45 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -177.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -70.31 -40.23 74.34 Favored 'General case' 0 C--N 1.36 1.062 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 92.6 m -68.74 -39.03 80.54 Favored 'General case' 0 C--N 1.357 0.908 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.0 tt -60.36 -38.73 84.76 Favored 'General case' 0 C--N 1.359 0.99 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -63.98 -37.51 87.66 Favored 'General case' 0 C--N 1.355 0.828 0 O-C-N 122.085 -0.385 . . . . 0.0 111.053 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 90.1 m -65.36 -40.94 94.22 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 121.701 -0.624 . . . . 0.0 109.528 -178.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.442 ' CD2' ' HB3' ' A' ' 54' ' ' LYS . 87.8 mt -64.52 -38.0 89.49 Favored 'General case' 0 C--N 1.354 0.767 0 O-C-N 122.037 -0.414 . . . . 0.0 110.069 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.418 HD11 ' CE ' ' A' ' 10' ' ' MET . 3.9 mp -72.7 -12.8 61.17 Favored 'General case' 0 C--N 1.361 1.072 0 O-C-N 121.51 -0.744 . . . . 0.0 110.145 -178.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -86.99 -28.49 22.62 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 119.298 -0.961 . . . . 0.0 109.047 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.9 t -67.14 -37.67 84.21 Favored 'General case' 0 C--N 1.354 0.801 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.9 p -89.8 -40.88 12.19 Favored 'General case' 0 C--N 1.359 0.996 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 86.18 132.89 0.04 OUTLIER 'General case' 0 C--N 1.36 1.051 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.513 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -83.62 -171.61 3.69 Favored 'General case' 0 C--N 1.357 0.916 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.41 ' H ' ' H ' ' A' ' 33' ' ' SER . 53.5 tt0 -151.2 -27.26 0.2 Allowed 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.41 ' H ' ' H ' ' A' ' 32' ' ' GLN . 2.3 t -144.26 -68.38 0.32 Allowed 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -179.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -129.74 -49.3 1.14 Allowed 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.32 -42.88 1.68 Allowed Glycine 0 C--N 1.352 1.427 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 82.9 mt -110.12 105.48 18.89 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.006 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -87.6 -137.7 0.1 Allowed 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 89.8 m -118.06 -59.0 1.95 Allowed 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.1 p 167.21 25.6 0.0 OUTLIER 'General case' 0 C--N 1.362 1.131 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.0 t -109.49 1.81 9.38 Favored 'Isoleucine or valine' 0 C--N 1.353 0.731 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.476 -178.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -96.78 143.47 16.76 Favored Glycine 0 C--N 1.353 1.502 0 C-N-CA 119.111 -1.518 . . . . 0.0 109.9 -178.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 51.5 m -123.11 127.43 48.7 Favored 'General case' 0 C--N 1.356 0.889 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -120.37 173.4 7.17 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -77.19 -176.63 4.16 Favored 'General case' 0 C--N 1.357 0.924 0 CA-C-O 121.568 0.699 . . . . 0.0 109.287 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 15.3 t60 -88.93 -22.16 23.22 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -66.23 -27.68 68.15 Favored 'General case' 0 C--N 1.356 0.881 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.577 ' HG2' ' HZ ' ' A' ' 6' ' ' PHE . 35.2 tp10 -62.19 -40.8 97.27 Favored 'General case' 0 C--N 1.352 0.704 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.435 HD22 ' O ' ' A' ' 48' ' ' LEU . 1.9 tm? -67.05 -38.64 86.19 Favored 'General case' 0 C--N 1.357 0.899 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 59.0 tp -70.64 -34.25 71.86 Favored 'General case' 0 CA--C 1.51 -0.585 0 O-C-N 122.118 -0.364 . . . . 0.0 110.261 -176.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 71.7 tp60 -66.26 -40.54 90.24 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 121.89 -0.506 . . . . 0.0 109.774 -178.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 85.2 mt -81.99 -17.35 47.19 Favored 'General case' 0 C--N 1.361 1.066 0 C-N-CA 120.086 -0.645 . . . . 0.0 110.593 -178.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.3 t -81.38 -36.65 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 54.7 t -70.05 -39.68 77.56 Favored 'Isoleucine or valine' 0 C--N 1.352 0.682 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.442 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 34.6 tptt -64.81 -28.33 69.49 Favored 'General case' 0 C--N 1.363 1.195 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.498 HD21 HD12 ' A' ' 13' ' ' ILE . 4.5 mt -67.13 -38.48 85.63 Favored 'General case' 0 C--N 1.356 0.866 0 C-N-CA 120.684 -0.407 . . . . 0.0 110.254 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 70.4 p -72.2 -17.65 61.91 Favored 'General case' 0 C--N 1.354 0.789 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.851 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -101.55 -37.4 8.41 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 121.173 -0.954 . . . . 0.0 111.643 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.4 p -72.07 -37.16 59.26 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 121.62 -0.675 . . . . 0.0 111.492 -177.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.627 ' HB3' HG23 ' A' ' 61' ' ' VAL . 3.4 t -115.64 -6.68 12.18 Favored 'General case' 0 C--N 1.351 0.668 0 C-N-CA 119.126 -1.03 . . . . 0.0 110.216 -177.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 65.0 46.91 2.67 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.627 HG23 ' HB3' ' A' ' 59' ' ' SER . 46.5 t -107.49 135.44 19.71 Favored Pre-proline 0 CA--C 1.504 -0.801 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.545 ' HG2' ' HB2' ' A' ' 65' ' ' GLU . 23.9 Cg_endo -62.41 147.84 94.25 Favored 'Trans proline' 0 CA--C 1.5 -1.177 0 C-N-CA 122.078 1.852 . . . . 0.0 112.311 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.4 m -76.68 -12.51 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.545 -177.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.48 ' O ' HG12 ' A' ' 67' ' ' VAL . 70.7 p -95.56 -33.27 12.47 Favored 'General case' 0 C--N 1.356 0.865 0 C-N-CA 118.166 -1.413 . . . . 0.0 109.956 -178.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.545 ' HB2' ' HG2' ' A' ' 62' ' ' PRO . 99.1 mt-10 -81.07 -20.08 42.35 Favored 'General case' 0 C--N 1.354 0.787 0 O-C-N 121.245 -0.909 . . . . 0.0 108.575 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.447 ' HB3' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -78.36 -37.32 44.56 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 179.572 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 64' ' ' THR . 1.8 p -68.84 -29.35 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.278 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -70.81 -48.55 53.54 Favored 'General case' 0 C--N 1.365 1.267 0 O-C-N 121.222 -0.923 . . . . 0.0 110.829 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 83.8 mt -63.76 -36.52 84.16 Favored 'General case' 0 C--N 1.355 0.812 0 O-C-N 122.049 -0.407 . . . . 0.0 110.751 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -61.21 -47.49 85.89 Favored 'General case' 0 C--N 1.348 0.512 0 O-C-N 122.307 -0.246 . . . . 0.0 110.587 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.61 -38.86 96.55 Favored Glycine 0 C--N 1.354 1.542 0 CA-C-O 119.812 -0.438 . . . . 0.0 112.204 -177.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -65.26 -46.05 82.08 Favored 'General case' 0 C--N 1.352 0.693 0 CA-C-N 118.554 1.177 . . . . 0.0 111.318 -176.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.741 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 10.7 mttm -63.74 -49.41 73.13 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -177.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.481 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.2 tm? -68.18 -40.18 82.32 Favored 'General case' 0 C--N 1.35 0.617 0 O-C-N 121.195 -0.941 . . . . 0.0 112.149 -175.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.407 ' CE2' ' HA ' ' A' ' 150' ' ' CYS . 49.3 t80 -62.94 -45.57 91.86 Favored 'General case' 0 C--N 1.353 0.743 0 O-C-N 121.179 -0.951 . . . . 0.0 111.238 -178.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.2 p -71.26 -14.79 18.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.888 0 O-C-N 121.523 -0.736 . . . . 0.0 109.588 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.741 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 76.6 mm-40 -73.77 -39.18 64.37 Favored 'General case' 0 C--N 1.35 0.617 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 80.1 mt -69.91 -36.71 75.58 Favored 'General case' 0 C--N 1.358 0.977 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.8 mm -62.55 -50.19 80.8 Favored 'Isoleucine or valine' 0 C--N 1.354 0.779 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -178.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -66.17 -24.4 66.63 Favored 'General case' 0 C--N 1.352 0.702 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.345 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.04 -1.18 63.16 Favored Glycine 0 C--N 1.349 1.253 0 C-N-CA 119.793 -1.194 . . . . 0.0 110.656 -177.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.67 ' HB3' ' HB ' ' A' ' 85' ' ' ILE . 84.2 m-70 -138.04 89.87 14.32 Favored Pre-proline 0 CA--C 1.5 -0.95 0 CA-C-N 119.003 1.402 . . . . 0.0 109.201 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 82' ' ' HIS . 34.8 Cg_endo -66.98 -28.52 41.8 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 C-N-CA 122.464 2.109 . . . . 0.0 114.34 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -92.95 -5.11 51.48 Favored 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 119.422 -0.911 . . . . 0.0 108.927 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.67 ' HB ' ' HB3' ' A' ' 82' ' ' HIS . 0.9 OUTLIER -90.04 -19.56 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 -179.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.5 -25.85 14.05 Favored 'General case' 0 C--N 1.362 1.127 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -69.84 -35.81 75.05 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -65.53 -36.74 84.69 Favored 'General case' 0 C--N 1.355 0.837 0 O-C-N 122.072 -0.393 . . . . 0.0 110.084 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.615 ' HG2' ' N ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -80.55 156.08 26.65 Favored 'General case' 0 C--N 1.356 0.859 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -178.576 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.615 ' N ' ' HG2' ' A' ' 89' ' ' MET . 4.0 mtpt -119.78 -25.46 5.89 Favored 'General case' 0 C--N 1.363 1.182 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.631 -177.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -166.22 173.75 9.86 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -177.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 61.7 m -66.29 -39.65 89.51 Favored 'General case' 0 C--N 1.354 0.777 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.284 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -67.53 -39.31 85.07 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 119.739 -0.784 . . . . 0.0 109.059 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -65.33 -24.5 67.28 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 57.0 tp -64.76 -44.33 90.4 Favored 'General case' 0 C--N 1.353 0.735 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.9 mp -61.66 -33.92 74.81 Favored 'General case' 0 C--N 1.356 0.879 0 O-C-N 122.139 -0.351 . . . . 0.0 111.025 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 86.3 p -86.56 -7.28 58.5 Favored 'General case' 0 C--N 1.354 0.767 0 C-N-CA 119.294 -0.962 . . . . 0.0 110.805 -178.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.7 tttp -111.36 0.68 16.71 Favored 'General case' 0 C--N 1.356 0.857 0 O-C-N 121.533 -0.729 . . . . 0.0 109.798 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.412 HG23 ' N ' ' A' ' 100' ' ' ASP . 9.5 tp -65.66 -39.9 86.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.808 0 O-C-N 121.867 -0.52 . . . . 0.0 111.818 -177.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.412 ' N ' HG23 ' A' ' 99' ' ' ILE . 37.6 t70 -95.51 -27.28 15.45 Favored 'General case' 0 N--CA 1.44 -0.959 0 O-C-N 120.827 -1.171 . . . . 0.0 111.657 -177.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 90.0 p -70.01 -39.87 75.58 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 119.412 -0.915 . . . . 0.0 112.984 -176.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.555 ' HA ' HG12 ' A' ' 105' ' ' VAL . 8.7 t80 -138.47 -19.61 1.07 Allowed 'General case' 0 C--N 1.361 1.08 0 C-N-CA 116.971 -1.891 . . . . 0.0 113.511 -177.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 24.1 mm -68.39 -51.0 51.76 Favored 'Isoleucine or valine' 0 C--O 1.244 0.783 0 CA-C-N 120.424 1.466 . . . . 0.0 110.379 -177.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 54.9 m80 -92.9 4.2 54.35 Favored 'General case' 0 N--CA 1.437 -1.076 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.551 -176.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.555 HG12 ' HA ' ' A' ' 102' ' ' PHE . 3.3 p -87.73 -35.67 8.57 Favored 'Isoleucine or valine' 0 C--N 1.353 0.749 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 178.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -72.65 -41.9 64.96 Favored 'General case' 0 C--N 1.358 0.938 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 67.0 t -65.3 -48.39 83.54 Favored 'Isoleucine or valine' 0 C--N 1.358 0.974 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.527 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -60.75 -47.87 84.35 Favored 'General case' 0 C--N 1.359 0.987 0 O-C-N 122.079 -0.388 . . . . 0.0 111.389 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . 0.477 ' HG2' ' O ' ' A' ' 105' ' ' VAL . 38.3 mmtt -61.14 -39.39 89.88 Favored 'General case' 0 N--CA 1.445 -0.703 0 O-C-N 121.685 -0.634 . . . . 0.0 110.696 -177.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 19.4 mt -56.46 -72.11 0.08 Allowed 'General case' 0 CA--C 1.505 -0.786 0 C-N-CA 120.541 -0.463 . . . . 0.0 109.762 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -123.42 141.33 35.98 Favored Pre-proline 0 N--CA 1.439 -1.005 0 C-N-CA 118.538 -1.265 . . . . 0.0 109.207 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -86.29 -2.15 8.56 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 123.308 2.672 . . . . 0.0 115.402 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -66.31 -37.42 85.36 Favored 'General case' 0 C--N 1.355 0.839 0 O-C-N 121.757 -0.59 . . . . 0.0 109.908 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.34 144.92 56.79 Favored 'General case' 0 C--N 1.353 0.73 0 CA-C-O 121.548 0.69 . . . . 0.0 110.174 -178.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.5 ' O ' HD13 ' A' ' 116' ' ' LEU . 47.3 mt-10 -112.05 143.51 42.94 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 179.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.5 HD13 ' O ' ' A' ' 115' ' ' GLU . 2.6 mm? -128.37 149.41 71.41 Favored Pre-proline 0 C--N 1.353 0.759 0 CA-C-O 122.164 0.983 . . . . 0.0 108.981 -178.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 116' ' ' LEU . 64.8 Cg_endo -91.85 -160.72 0.09 OUTLIER 'Trans proline' 0 C--N 1.316 -1.156 0 C-N-CA 123.857 3.038 . . . . 0.0 112.959 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -121.33 140.68 51.78 Favored 'General case' 0 C--N 1.363 1.18 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.443 ' HE2' ' CD1' ' A' ' 133' ' ' TYR . 65.7 m-85 -127.53 135.2 50.02 Favored 'General case' 0 C--N 1.36 1.06 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.164 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.476 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 93.3 m -124.09 126.31 46.0 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 176.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 80.3 m -117.92 126.96 53.35 Favored 'General case' 0 CA--C 1.502 -0.896 0 C-N-CA 119.17 -1.012 . . . . 0.0 109.372 -177.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -120.47 127.49 52.27 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 178.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -100.05 116.53 32.29 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.447 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 85.9 mt -82.35 -26.86 32.56 Favored 'General case' 0 C--N 1.355 0.836 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -178.74 -144.46 5.69 Favored Glycine 0 N--CA 1.437 -1.244 0 N-CA-C 108.78 -1.728 . . . . 0.0 108.78 -178.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -94.99 -39.62 10.09 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.297 -178.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -98.84 -1.47 40.17 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.758 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.447 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 66.8 m-20 -118.82 133.45 55.83 Favored 'General case' 0 C--N 1.357 0.913 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 9.5 mm -140.78 136.79 35.13 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 179.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 52.7 mtm180 -117.39 136.77 52.93 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 5.7 tp -125.95 118.9 26.36 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.476 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 12.3 m170 -98.53 130.58 45.1 Favored 'General case' 0 CA--C 1.496 -1.133 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.443 ' CD1' ' HE2' ' A' ' 119' ' ' PHE . 51.6 t80 -122.59 120.73 34.65 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 -178.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.463 ' HA ' ' O ' ' A' ' 171' ' ' THR . 36.1 tt0 -115.55 109.86 18.41 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.456 ' O ' ' HA ' ' A' ' 171' ' ' THR . 8.8 t -165.07 158.16 16.51 Favored 'General case' 0 C--N 1.359 0.979 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.493 ' C ' ' HD3' ' A' ' 138' ' ' PRO . 63.0 mtpt -91.0 5.85 47.17 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -129.58 72.32 81.97 Favored Pre-proline 0 C--N 1.354 0.804 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.493 ' HD3' ' C ' ' A' ' 136' ' ' LYS . 96.6 Cg_endo -95.21 88.03 0.11 Allowed 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 122.319 2.012 . . . . 0.0 115.446 -178.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -106.51 115.5 30.31 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 177.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.41 -38.27 90.5 Favored 'General case' 0 C--N 1.352 0.687 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.019 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 73.3 m -62.36 -33.57 74.99 Favored 'General case' 0 C--N 1.352 0.713 0 O-C-N 122.115 -0.366 . . . . 0.0 110.784 -178.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -73.15 -47.81 40.82 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.445 -177.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.25 -39.69 93.01 Favored 'General case' 0 C--N 1.355 0.839 0 O-C-N 122.105 -0.372 . . . . 0.0 111.419 -177.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.11 -36.58 84.07 Favored 'General case' 0 C--N 1.354 0.794 0 O-C-N 121.848 -0.532 . . . . 0.0 109.719 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.2 -43.23 98.64 Favored Glycine 0 C--N 1.346 1.091 0 N-CA-C 109.829 -1.309 . . . . 0.0 109.829 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 83.0 mt -70.45 -41.03 73.36 Favored 'General case' 0 C--N 1.353 0.728 0 O-C-N 122.049 -0.677 . . . . 0.0 112.733 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 98.6 mt -71.35 -42.33 68.64 Favored 'General case' 0 C--N 1.36 1.022 0 O-C-N 121.273 -0.892 . . . . 0.0 110.515 -177.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.487 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 21.3 t70 -69.43 -29.81 67.61 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 122.141 -0.349 . . . . 0.0 110.245 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -63.09 -39.46 98.04 Favored Glycine 0 C--N 1.356 1.648 0 N-CA-C 108.276 -1.93 . . . . 0.0 108.276 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.407 ' HA ' ' CE2' ' A' ' 75' ' ' PHE . 48.7 t -60.43 -41.95 95.05 Favored 'General case' 0 C--N 1.35 0.598 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -74.42 -1.9 23.11 Favored 'General case' 0 C--N 1.362 1.121 0 O-C-N 121.82 -0.55 . . . . 0.0 109.544 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 76.4 mm-40 -83.74 -46.49 12.19 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -66.06 -44.11 85.48 Favored 'General case' 0 C--N 1.356 0.889 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.472 ' O ' ' HB2' ' A' ' 155' ' ' LYS . 38.0 m-85 -69.09 -25.96 64.69 Favored 'General case' 0 C--N 1.36 1.041 0 O-C-N 121.831 -0.543 . . . . 0.0 111.065 -178.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 154' ' ' PHE . 44.6 mttt 73.88 67.64 0.1 Allowed 'General case' 0 C--N 1.361 1.099 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -138.88 -168.11 2.35 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -148.32 96.64 2.65 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 13.2 m-30 -112.97 156.76 22.45 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 92.2 m -120.1 128.24 53.28 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.505 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.8 mp -107.1 123.14 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.0 m -117.99 -174.66 2.69 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-O 121.835 0.826 . . . . 0.0 109.347 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -146.29 156.12 43.13 Favored 'General case' 0 C--N 1.356 0.865 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 -178.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.2 p -98.72 145.94 30.78 Favored Pre-proline 0 C--N 1.359 0.983 0 CA-C-O 122.443 1.116 . . . . 0.0 108.0 178.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.64 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 72.1 Cg_endo -75.84 -10.93 20.01 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.91 2.407 . . . . 0.0 115.076 -178.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -73.38 -41.26 63.59 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.819 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 38.2 p -117.95 16.15 14.25 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.659 -178.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.64 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.3 pp0? -67.31 -11.47 57.67 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 121.571 -0.706 . . . . 0.0 110.129 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 54.3 p30 -118.51 34.66 5.09 Favored 'General case' 0 N--CA 1.439 -0.996 0 O-C-N 121.199 -0.938 . . . . 0.0 108.893 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 58.5 m -136.15 148.79 48.36 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.752 ' O ' ' HB ' ' A' ' 171' ' ' THR . 97.8 mt-10 -114.51 137.2 52.15 Favored 'General case' 0 C--N 1.354 0.794 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.752 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 1.1 m 115.03 -53.26 0.0 OUTLIER 'General case' 0 C--N 1.377 1.803 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -116.9 111.12 19.21 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 80.1 t -128.5 135.26 62.94 Favored 'Isoleucine or valine' 0 C--N 1.359 1.009 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 50.4 mm -106.74 127.82 61.95 Favored 'Isoleucine or valine' 0 C--N 1.36 1.052 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -116.26 154.98 29.16 Favored 'General case' 0 C--N 1.356 0.875 0 CA-C-O 122.123 0.963 . . . . 0.0 108.849 -178.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -137.14 120.17 16.55 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -178.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.8 mp -115.47 119.84 62.98 Favored 'Isoleucine or valine' 0 C--N 1.354 0.804 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 90.0 m -120.8 141.55 50.42 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -178.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 . . . . . 0 C--N 1.367 1.36 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -179.944 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.7 mtp . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.185 0.517 . . . . 0.0 110.005 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.452 ' HA ' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -78.63 -16.27 57.54 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.63 -177.908 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.57 -42.27 48.35 Favored Glycine 0 C--N 1.352 1.433 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 62.3 mtt -68.27 -38.19 81.49 Favored 'General case' 0 C--N 1.358 0.942 0 O-C-N 121.893 -0.769 . . . . 0.0 111.464 -178.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.452 HG22 ' HA ' ' A' ' 2' ' ' MET . 27.6 m -68.23 -23.0 28.05 Favored 'Isoleucine or valine' 0 C--N 1.356 0.851 0 C-N-CA 120.031 -0.668 . . . . 0.0 109.749 -178.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -71.08 -37.54 72.46 Favored 'General case' 0 C--N 1.356 0.863 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 89.5 m -68.2 -41.66 81.05 Favored 'General case' 0 C--N 1.357 0.908 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.69 -39.17 97.59 Favored Glycine 0 C--N 1.358 1.757 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.687 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -65.93 -39.84 90.88 Favored 'General case' 0 C--N 1.35 0.614 0 CA-C-N 117.199 0.5 . . . . 0.0 110.618 -178.351 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.3 mmt -63.35 -40.82 98.33 Favored 'General case' 0 C--N 1.352 0.703 0 O-C-N 121.619 -0.675 . . . . 0.0 111.025 -178.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -67.59 -40.14 84.82 Favored 'General case' 0 C--N 1.349 0.563 0 O-C-N 121.896 -0.503 . . . . 0.0 111.504 -177.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 54.8 tp -66.77 -41.93 86.92 Favored 'General case' 0 C--N 1.349 0.558 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -178.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.687 HG12 ' O ' ' A' ' 9' ' ' LEU . 3.7 mm -73.68 -38.22 51.04 Favored 'Isoleucine or valine' 0 C--N 1.357 0.916 0 O-C-N 121.196 -0.94 . . . . 0.0 111.081 -175.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -67.12 -43.32 82.72 Favored 'General case' 0 C--N 1.351 0.646 0 O-C-N 121.914 -0.491 . . . . 0.0 111.573 -176.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -72.11 -33.88 68.17 Favored 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 121.842 -0.536 . . . . 0.0 111.733 -177.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -72.01 -48.5 44.27 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -175.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -127.8 -20.85 3.81 Favored 'General case' 0 C--N 1.354 0.797 0 C-N-CA 117.398 -1.721 . . . . 0.0 113.383 -176.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 141.88 179.72 19.15 Favored Glycine 0 CA--C 1.497 -1.038 0 C-N-CA 117.982 -2.056 . . . . 0.0 109.597 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -97.21 -12.43 23.02 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -177.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -71.44 -40.63 70.26 Favored 'General case' 0 C--N 1.359 1.01 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.7 m -69.21 -38.49 78.61 Favored 'General case' 0 C--N 1.356 0.885 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.578 HD13 ' HB ' ' A' ' 13' ' ' ILE . 59.3 tp -60.32 -38.54 84.06 Favored 'General case' 0 C--N 1.357 0.914 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -64.17 -35.72 81.73 Favored 'General case' 0 C--N 1.357 0.903 0 O-C-N 122.182 -0.324 . . . . 0.0 111.309 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 90.2 m -63.99 -41.39 97.52 Favored 'General case' 0 C--N 1.356 0.89 0 O-C-N 121.566 -0.709 . . . . 0.0 109.189 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.467 ' CD2' ' HB3' ' A' ' 54' ' ' LYS . 89.1 mt -65.02 -38.4 90.78 Favored 'General case' 0 C--N 1.355 0.839 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.27 -11.74 61.11 Favored 'General case' 0 C--N 1.358 0.97 0 O-C-N 121.363 -0.835 . . . . 0.0 109.734 -179.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -89.0 -27.25 20.99 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 119.527 -0.869 . . . . 0.0 108.916 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 55.9 p -69.58 -22.7 63.5 Favored 'General case' 0 C--N 1.362 1.109 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.164 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.0 p -106.98 -36.86 6.49 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 119.046 -1.062 . . . . 0.0 108.325 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 86.1 132.37 0.04 OUTLIER 'General case' 0 C--N 1.361 1.067 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.536 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -84.48 -168.04 2.02 Favored 'General case' 0 C--N 1.357 0.902 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.408 ' H ' ' HB2' ' A' ' 31' ' ' LEU . 63.3 tt0 -152.13 -32.57 0.14 Allowed 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.7 t -139.18 -73.37 0.38 Allowed 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -128.32 -33.97 2.1 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.96 -25.75 11.25 Favored Glycine 0 C--N 1.353 1.482 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 84.7 mt -113.71 102.93 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.792 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -99.68 -0.32 40.41 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.793 HG22 ' H ' ' A' ' 39' ' ' SER . 2.7 m 77.62 -179.99 0.13 Allowed 'General case' 0 C--N 1.361 1.096 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 -178.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.793 ' H ' HG22 ' A' ' 38' ' ' THR . 24.9 p -90.9 114.26 26.67 Favored 'General case' 0 N--CA 1.443 -0.779 0 O-C-N 121.214 -0.929 . . . . 0.0 109.44 -178.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.496 HG13 ' O ' ' A' ' 39' ' ' SER . 0.0 OUTLIER -173.48 -8.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.189 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.15 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -117.42 167.56 12.73 Favored Glycine 0 C--N 1.355 1.63 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -178.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 68.6 m -132.24 136.84 47.26 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -124.02 172.57 8.87 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -71.27 174.8 5.96 Favored 'General case' 0 C--N 1.355 0.832 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.511 ' CD2' HH22 ' A' ' 137' ' ' ARG . 70.4 m80 -86.53 -17.04 35.1 Favored 'General case' 0 CA--C 1.502 -0.884 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.234 -178.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -69.06 -29.33 67.43 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.0 tp10 -63.13 -42.22 99.46 Favored 'General case' 0 C--N 1.351 0.647 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.407 ' O ' HG23 ' A' ' 52' ' ' VAL . 55.0 tp -66.88 -39.4 87.49 Favored 'General case' 0 C--N 1.359 0.985 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 59.0 tp -72.94 -28.98 62.75 Favored 'General case' 0 C--N 1.349 0.569 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -177.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -66.47 -43.22 86.08 Favored 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 121.917 -0.489 . . . . 0.0 110.108 -178.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 80.4 mt -72.36 -34.5 68.04 Favored 'General case' 0 C--N 1.36 1.052 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.278 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 48' ' ' LEU . 39.3 t -63.24 -42.1 95.19 Favored 'Isoleucine or valine' 0 C--N 1.35 0.626 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 54.6 t -66.58 -40.65 86.81 Favored 'Isoleucine or valine' 0 C--N 1.351 0.648 0 O-C-N 121.733 -0.604 . . . . 0.0 109.855 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.467 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 25.9 tptt -66.77 -22.97 66.02 Favored 'General case' 0 C--N 1.361 1.095 0 O-C-N 121.022 -1.049 . . . . 0.0 109.019 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.59 HD21 HD12 ' A' ' 13' ' ' ILE . 6.2 mt -69.78 -38.05 76.56 Favored 'General case' 0 C--N 1.355 0.826 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 57.6 p -71.38 -18.01 62.38 Favored 'General case' 0 C--N 1.353 0.752 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.357 -179.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -100.46 -35.75 9.45 Favored 'General case' 0 C--N 1.355 0.805 0 C-N-CA 119.648 -0.821 . . . . 0.0 111.408 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.6 p -72.27 -40.22 65.01 Favored 'Isoleucine or valine' 0 C--N 1.354 0.766 0 O-C-N 121.664 -0.648 . . . . 0.0 111.507 -177.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 79.7 p -116.02 -2.49 12.26 Favored 'General case' 0 C--N 1.354 0.78 0 C-N-CA 118.89 -1.124 . . . . 0.0 110.914 -178.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 73.6 m 63.74 49.48 2.93 Favored 'General case' 0 C--N 1.357 0.916 0 CA-C-O 120.932 0.396 . . . . 0.0 110.033 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.418 HG13 ' HD2' ' A' ' 62' ' ' PRO . 96.6 t -113.98 134.04 22.22 Favored Pre-proline 0 CA--C 1.504 -0.799 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.418 ' HD2' HG13 ' A' ' 61' ' ' VAL . 41.3 Cg_exo -58.02 149.5 70.65 Favored 'Trans proline' 0 CA--C 1.499 -1.27 0 C-N-CA 122.778 2.319 . . . . 0.0 112.738 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.421 ' HA ' HD23 ' A' ' 66' ' ' LEU . 3.7 m -76.2 -11.64 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.679 -177.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.494 ' O ' HG12 ' A' ' 67' ' ' VAL . 73.0 p -96.51 -33.36 11.87 Favored 'General case' 0 C--N 1.358 0.971 0 C-N-CA 118.433 -1.307 . . . . 0.0 109.504 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -77.65 -21.0 52.85 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 121.474 -0.766 . . . . 0.0 108.968 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -81.19 -34.23 32.46 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 -179.483 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.494 HG12 ' O ' ' A' ' 64' ' ' THR . 1.5 p -70.98 -26.23 27.21 Favored 'Isoleucine or valine' 0 C--N 1.356 0.855 0 C-N-CA 120.169 -0.613 . . . . 0.0 109.799 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 40.7 mtp180 -72.53 -52.87 13.81 Favored 'General case' 0 C--N 1.363 1.181 0 O-C-N 121.477 -0.765 . . . . 0.0 110.427 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.9 mt -63.41 -34.76 78.44 Favored 'General case' 0 C--N 1.357 0.913 0 O-C-N 121.959 -0.463 . . . . 0.0 110.905 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -61.1 -47.23 87.24 Favored 'General case' 0 C--N 1.348 0.502 0 O-C-N 122.248 -0.283 . . . . 0.0 110.239 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.06 -38.8 96.16 Favored Glycine 0 C--N 1.356 1.651 0 N-CA-C 111.729 -0.548 . . . . 0.0 111.729 -178.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -62.6 -49.35 75.58 Favored 'General case' 0 C--N 1.351 0.638 0 CA-C-N 118.31 1.055 . . . . 0.0 111.556 -177.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 12.2 mttm -65.09 -45.93 83.18 Favored 'General case' 0 C--N 1.357 0.926 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -177.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -69.78 -39.04 76.88 Favored 'General case' 0 C--N 1.348 0.52 0 O-C-N 121.161 -0.962 . . . . 0.0 111.841 -175.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -64.61 -44.05 91.8 Favored 'General case' 0 C--N 1.353 0.746 0 O-C-N 121.098 -1.001 . . . . 0.0 110.951 -178.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.83 -13.86 17.08 Favored 'Isoleucine or valine' 0 C--N 1.359 0.985 0 O-C-N 121.45 -0.781 . . . . 0.0 109.0 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -74.37 -37.61 63.42 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.3 mt -74.67 -29.48 61.25 Favored 'General case' 0 C--N 1.357 0.927 0 O-C-N 122.285 -0.259 . . . . 0.0 110.369 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.6 mm -65.86 -52.84 44.77 Favored 'Isoleucine or valine' 0 C--N 1.357 0.895 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.682 -177.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -75.5 -15.35 60.41 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.279 178.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.25 -37.45 63.34 Favored Glycine 0 C--N 1.349 1.276 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -131.75 105.23 14.16 Favored Pre-proline 0 N--CA 1.441 -0.903 0 CA-C-O 122.615 1.198 . . . . 0.0 108.961 -177.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.524 ' O ' ' HB2' ' A' ' 87' ' ' ASN . 37.1 Cg_endo -67.47 -23.08 44.16 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.571 2.181 . . . . 0.0 114.356 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -95.39 -5.19 43.81 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 tp -89.75 -20.1 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -105.7 -18.06 14.19 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.524 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 1.5 t-20 -73.97 -38.0 64.31 Favored 'General case' 0 C--N 1.357 0.931 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -65.49 -33.84 76.86 Favored 'General case' 0 C--N 1.353 0.735 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -178.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 15.8 ttp -83.12 150.37 26.31 Favored 'General case' 0 C--N 1.351 0.654 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.02 -22.59 9.47 Favored 'General case' 0 C--N 1.364 1.199 0 O-C-N 121.691 -0.63 . . . . 0.0 111.14 -177.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -165.55 171.49 13.13 Favored 'General case' 0 C--N 1.354 0.761 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 -177.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.476 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 66.8 m -66.65 -39.54 88.28 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.448 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -68.44 -38.9 81.57 Favored 'General case' 0 C--N 1.355 0.836 0 O-C-N 121.296 -0.877 . . . . 0.0 108.991 -179.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -65.93 -24.09 66.75 Favored 'General case' 0 C--N 1.355 0.823 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.664 ' O ' HG12 ' A' ' 99' ' ' ILE . 59.7 tp -63.64 -47.38 81.54 Favored 'General case' 0 C--N 1.355 0.846 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.4 mp -60.07 -35.7 75.74 Favored 'General case' 0 C--N 1.359 1.013 0 O-C-N 122.256 -0.277 . . . . 0.0 110.521 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 34.0 t -70.14 -39.64 75.28 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.188 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.5 tttp -86.99 0.35 55.31 Favored 'General case' 0 C--N 1.356 0.856 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -176.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.664 HG12 ' O ' ' A' ' 95' ' ' LEU . 22.8 mm -61.01 -46.7 96.15 Favored 'Isoleucine or valine' 0 C--N 1.357 0.896 0 CA-C-N 119.082 0.856 . . . . 0.0 112.014 -177.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -95.64 -22.63 17.46 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 118.402 -1.319 . . . . 0.0 111.329 -177.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 35.2 t -64.29 -48.65 74.87 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 121.565 -0.709 . . . . 0.0 112.491 -177.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -138.08 -16.49 1.25 Allowed 'General case' 0 C--N 1.36 1.06 0 C-N-CA 117.372 -1.731 . . . . 0.0 113.521 -176.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.645 HD12 HD13 ' A' ' 99' ' ' ILE . 96.3 mt -71.83 -50.27 39.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 CA-C-N 120.359 1.436 . . . . 0.0 111.182 -177.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -89.98 4.36 50.36 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 119.388 -0.925 . . . . 0.0 109.811 -177.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 57.7 t -86.44 -43.7 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.059 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 54.7 tp10 -67.53 -40.1 85.04 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 65.6 t -62.77 -46.92 95.16 Favored 'Isoleucine or valine' 0 C--N 1.356 0.88 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -60.74 -48.21 82.81 Favored 'General case' 0 C--N 1.36 1.038 0 O-C-N 122.198 -0.314 . . . . 0.0 111.541 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -61.25 -36.59 80.41 Favored 'General case' 0 C--N 1.355 0.821 0 O-C-N 121.534 -0.729 . . . . 0.0 110.503 -178.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 18.0 mt -58.6 -75.5 0.05 Allowed 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -115.58 132.14 23.29 Favored Pre-proline 0 N--CA 1.439 -0.975 0 C-N-CA 118.65 -1.22 . . . . 0.0 108.641 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -83.26 -3.53 10.91 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 123.175 2.583 . . . . 0.0 115.172 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -66.97 -36.36 82.02 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 121.879 -0.513 . . . . 0.0 110.009 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.32 144.86 56.31 Favored 'General case' 0 C--N 1.352 0.683 0 CA-C-O 121.74 0.781 . . . . 0.0 110.142 -178.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -128.86 133.76 48.07 Favored 'General case' 0 C--N 1.357 0.925 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.52 ' HB3' ' HD2' ' A' ' 117' ' ' PRO . 87.8 mt -127.76 156.44 75.71 Favored Pre-proline 0 N--CA 1.443 -0.787 0 CA-C-O 122.262 1.03 . . . . 0.0 109.243 -178.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.52 ' HD2' ' HB3' ' A' ' 116' ' ' LEU . 83.0 Cg_endo -80.46 -158.42 0.09 OUTLIER 'Trans proline' 0 C--N 1.318 -1.074 0 C-N-CA 123.826 3.017 . . . . 0.0 113.922 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -118.86 143.28 47.06 Favored 'General case' 0 C--N 1.364 1.209 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -129.65 135.7 48.84 Favored 'General case' 0 C--N 1.362 1.123 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -178.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 93.8 m -127.64 130.71 49.43 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 177.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -120.6 132.39 55.11 Favored 'General case' 0 CA--C 1.504 -0.804 0 C-N-CA 119.215 -0.994 . . . . 0.0 109.989 -178.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -119.71 138.5 53.26 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 178.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -109.32 117.84 35.13 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 -179.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.574 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 96.5 mt -91.77 -16.02 27.46 Favored 'General case' 0 C--N 1.356 0.856 0 C-N-CA 120.496 -0.481 . . . . 0.0 110.436 -179.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 174.04 -148.23 9.87 Favored Glycine 0 C--N 1.349 1.252 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -94.35 -37.55 11.42 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -102.05 4.17 39.48 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.031 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.574 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 8.7 m-20 -121.93 132.09 54.37 Favored 'General case' 0 C--N 1.359 0.984 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -179.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.2 mm -143.64 137.8 25.19 Favored 'Isoleucine or valine' 0 C--N 1.356 0.863 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 179.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 53.5 mtm180 -118.49 139.11 51.93 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 5.8 tp -125.53 116.91 22.51 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.52 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -98.29 134.39 41.38 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 107.327 -1.361 . . . . 0.0 107.327 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -129.51 119.55 23.89 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.524 ' HA ' ' O ' ' A' ' 171' ' ' THR . 57.9 mt-30 -115.53 112.17 21.81 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 11.1 t -165.93 155.12 11.75 Favored 'General case' 0 C--N 1.357 0.921 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.434 ' C ' ' HD3' ' A' ' 138' ' ' PRO . 99.6 mttt -90.99 5.49 48.57 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.511 HH22 ' CD2' ' A' ' 45' ' ' HIS . 77.0 mtp180 -132.62 73.25 76.75 Favored Pre-proline 0 C--N 1.354 0.767 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.434 ' HD3' ' C ' ' A' ' 136' ' ' LYS . 92.7 Cg_endo -96.87 99.64 0.08 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.515 0 C-N-CA 122.737 2.291 . . . . 0.0 115.453 -178.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -109.4 111.13 22.5 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 177.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.71 -38.05 89.64 Favored 'General case' 0 C--N 1.354 0.787 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.02 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 74.1 m -63.03 -29.33 70.73 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 121.998 -0.439 . . . . 0.0 110.755 -178.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -75.01 -47.1 30.79 Favored 'General case' 0 C--N 1.35 0.612 0 O-C-N 121.698 -0.626 . . . . 0.0 109.763 -177.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.53 -40.06 94.91 Favored 'General case' 0 C--N 1.358 0.976 0 O-C-N 122.095 -0.378 . . . . 0.0 111.212 -178.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.1 -37.0 85.46 Favored 'General case' 0 C--N 1.355 0.809 0 O-C-N 121.938 -0.476 . . . . 0.0 110.212 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.84 -43.15 99.58 Favored Glycine 0 C--N 1.347 1.182 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 -178.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 83.8 mt -70.01 -40.42 75.27 Favored 'General case' 0 C--N 1.351 0.647 0 N-CA-C 112.673 0.619 . . . . 0.0 112.673 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 99.1 mt -71.34 -42.9 67.95 Favored 'General case' 0 C--N 1.361 1.082 0 O-C-N 121.198 -0.939 . . . . 0.0 110.993 -176.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.483 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 21.0 t70 -69.0 -31.72 70.75 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 122.028 -0.42 . . . . 0.0 110.418 -179.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -62.96 -39.19 97.76 Favored Glycine 0 C--N 1.356 1.659 0 N-CA-C 108.656 -1.778 . . . . 0.0 108.656 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 49.4 t -60.84 -42.0 96.91 Favored 'General case' 0 C--N 1.351 0.674 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -74.59 -2.19 24.89 Favored 'General case' 0 C--N 1.361 1.082 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.483 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 77.0 mm-40 -83.29 -45.44 13.79 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -68.84 -42.56 76.98 Favored 'General case' 0 C--N 1.358 0.959 0 C-N-CA 120.011 -0.675 . . . . 0.0 109.681 179.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -69.75 -25.68 63.95 Favored 'General case' 0 C--N 1.362 1.132 0 O-C-N 121.659 -0.651 . . . . 0.0 110.619 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 21.2 tttm 73.16 73.39 0.13 Allowed 'General case' 0 C--N 1.36 1.05 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -143.61 -169.44 3.08 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -146.25 96.99 2.87 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 13.3 m-30 -114.9 155.38 26.96 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 93.3 m -120.86 129.12 53.4 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 119.668 -0.813 . . . . 0.0 108.809 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.515 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.7 mp -106.45 122.34 60.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.6 m -119.53 -172.12 2.26 Favored 'General case' 0 C--N 1.357 0.93 0 CA-C-O 121.792 0.806 . . . . 0.0 109.338 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 28.2 ptt-85 -148.42 157.91 43.77 Favored 'General case' 0 C--N 1.356 0.854 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -178.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 56.2 p -98.37 146.77 32.12 Favored Pre-proline 0 C--N 1.359 0.995 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 178.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.666 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 72.7 Cg_endo -75.35 -12.54 20.85 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.903 2.402 . . . . 0.0 115.238 -178.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -72.53 -41.31 66.0 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 120.009 -0.676 . . . . 0.0 109.956 -178.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 35.6 p -118.11 16.06 14.11 Favored 'General case' 0 C--N 1.354 0.797 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.734 -178.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.666 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.4 pp0? -66.97 -12.75 60.68 Favored 'General case' 0 C--N 1.353 0.749 0 O-C-N 121.605 -0.685 . . . . 0.0 110.346 178.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 54.1 p-10 -123.67 38.72 4.13 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 14.6 t -141.65 147.44 37.55 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.63 ' O ' ' HB ' ' A' ' 171' ' ' THR . 46.3 mp0 -101.67 167.4 10.13 Favored 'General case' 0 C--N 1.355 0.847 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.63 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 5.8 m 82.99 -60.01 0.15 Allowed 'General case' 0 C--N 1.37 1.465 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -108.05 116.11 31.37 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 96.1 t -131.64 133.21 61.82 Favored 'Isoleucine or valine' 0 C--N 1.358 0.966 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 50.9 mm -108.16 126.2 64.78 Favored 'Isoleucine or valine' 0 C--N 1.359 1.0 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -114.55 154.53 28.12 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -137.58 118.94 14.68 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 -178.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.7 mp -113.59 120.37 63.29 Favored 'Isoleucine or valine' 0 C--N 1.353 0.742 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 90.6 m -119.91 143.5 47.93 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -177.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 37.2 ttm180 . . . . . 0 C--N 1.363 1.192 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 179.995 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.42 ' HG3' ' HE2' ' A' ' 4' ' ' MET . 87.7 mmm . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 121.09 0.471 . . . . 0.0 110.031 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.43 ' O ' ' HD1' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -82.04 -15.2 54.4 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 120.516 -0.474 . . . . 0.0 109.963 -178.338 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -71.65 -40.99 57.99 Favored Glycine 0 C--N 1.353 1.482 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . 0.482 ' HG2' ' HB3' ' A' ' 39' ' ' SER . 76.5 mtm -70.15 -35.69 74.22 Favored 'General case' 0 C--N 1.356 0.873 0 O-C-N 121.958 -0.731 . . . . 0.0 111.499 -178.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.414 HG22 ' HA ' ' A' ' 2' ' ' MET . 32.8 m -68.45 -23.77 28.61 Favored 'Isoleucine or valine' 0 C--N 1.357 0.91 0 O-C-N 121.467 -0.77 . . . . 0.0 109.594 -179.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.505 ' HZ ' ' CG ' ' A' ' 47' ' ' GLU . 4.5 m-85 -71.38 -36.2 71.33 Favored 'General case' 0 C--N 1.358 0.949 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 90.1 m -66.7 -40.87 88.64 Favored 'General case' 0 C--N 1.357 0.913 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.75 -39.23 97.7 Favored Glycine 0 C--N 1.358 1.753 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.694 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -64.07 -41.47 97.33 Favored 'General case' 0 C--N 1.352 0.679 0 CA-C-N 117.163 0.482 . . . . 0.0 110.835 -178.515 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 17.6 mmt -63.58 -41.02 98.4 Favored 'General case' 0 C--N 1.353 0.746 0 O-C-N 121.438 -0.789 . . . . 0.0 111.079 -178.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -68.34 -40.5 81.55 Favored 'General case' 0 C--N 1.349 0.573 0 O-C-N 121.881 -0.512 . . . . 0.0 111.773 -177.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 56.3 tp -66.3 -43.65 85.69 Favored 'General case' 0 C--N 1.349 0.577 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -177.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.694 HG12 ' O ' ' A' ' 9' ' ' LEU . 1.1 mm -74.3 -34.6 37.5 Favored 'Isoleucine or valine' 0 C--N 1.358 0.956 0 O-C-N 121.127 -0.983 . . . . 0.0 110.96 -175.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -72.73 -42.32 64.25 Favored 'General case' 0 C--N 1.35 0.59 0 O-C-N 121.642 -0.661 . . . . 0.0 111.538 -176.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -71.1 -37.9 72.38 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -175.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -99.42 -25.83 14.33 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 118.924 -1.11 . . . . 0.0 113.659 -174.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -113.62 -35.72 5.12 Favored 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 117.541 -1.664 . . . . 0.0 112.549 -176.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 145.31 177.78 20.35 Favored Glycine 0 C--N 1.349 1.266 0 C-N-CA 118.052 -2.023 . . . . 0.0 110.467 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -99.43 -27.16 13.87 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 -177.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -69.29 -39.22 78.45 Favored 'General case' 0 C--N 1.359 0.992 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 92.7 m -66.75 -39.1 87.78 Favored 'General case' 0 C--N 1.357 0.902 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.3 tt -61.62 -38.44 87.64 Favored 'General case' 0 C--N 1.358 0.938 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -63.74 -37.71 88.38 Favored 'General case' 0 C--N 1.356 0.875 0 O-C-N 122.026 -0.421 . . . . 0.0 110.765 -178.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.9 m -65.73 -38.96 90.58 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -178.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.717 HD13 HD22 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -63.67 -37.41 87.24 Favored 'General case' 0 C--N 1.354 0.765 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -179.043 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.3 mt -74.02 -14.11 60.96 Favored 'General case' 0 C--N 1.359 0.998 0 O-C-N 121.722 -0.612 . . . . 0.0 110.337 -178.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -86.77 -28.23 23.13 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 119.218 -0.993 . . . . 0.0 109.203 179.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.1 t -67.39 -36.58 81.59 Favored 'General case' 0 C--N 1.354 0.761 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.661 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 2.0 p -92.12 -39.65 11.48 Favored 'General case' 0 C--N 1.358 0.963 0 C-N-CA 118.942 -1.103 . . . . 0.0 108.199 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.661 ' HB2' ' O ' ' A' ' 29' ' ' CYS . 14.5 mt-10 86.27 131.53 0.04 OUTLIER 'General case' 0 C--N 1.362 1.109 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.529 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -86.18 -169.45 2.64 Favored 'General case' 0 C--N 1.357 0.897 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.841 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -152.85 -28.23 0.15 Allowed 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 107.707 -1.219 . . . . 0.0 107.707 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.8 t -141.49 -71.13 0.35 Allowed 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -131.96 -42.97 0.99 Allowed 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.4 -32.71 4.22 Favored Glycine 0 C--N 1.353 1.479 0 N-CA-C 109.261 -1.535 . . . . 0.0 109.261 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 85.1 mt -111.63 101.33 12.38 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -96.41 -1.81 46.8 Favored 'General case' 0 C--N 1.354 0.803 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.747 HG22 ' H ' ' A' ' 39' ' ' SER . 4.0 m 80.1 174.9 0.13 Allowed 'General case' 0 C--N 1.362 1.13 0 N-CA-C 105.952 -1.869 . . . . 0.0 105.952 -178.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.747 ' H ' HG22 ' A' ' 38' ' ' THR . 26.0 p -89.16 113.84 25.07 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 121.033 -1.042 . . . . 0.0 109.78 -178.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 39' ' ' SER . 0.0 OUTLIER -172.71 -8.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.362 1.143 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.762 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.404 ' H ' ' H ' ' A' ' 40' ' ' VAL . . . -113.55 164.75 12.02 Favored Glycine 0 C--N 1.357 1.698 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -178.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 53.5 m -129.11 132.78 47.44 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -117.98 170.62 8.68 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -77.64 -178.13 5.17 Favored 'General case' 0 C--N 1.356 0.866 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -88.32 -15.08 36.66 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -68.18 -29.8 68.75 Favored 'General case' 0 C--N 1.353 0.753 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 178.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.505 ' CG ' ' HZ ' ' A' ' 6' ' ' PHE . 24.1 tp10 -63.07 -41.6 99.47 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.467 HD22 ' O ' ' A' ' 48' ' ' LEU . 1.8 tm? -67.83 -39.99 83.83 Favored 'General case' 0 C--N 1.358 0.965 0 CA-C-O 120.647 0.26 . . . . 0.0 110.531 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 64.6 tp -71.01 -34.71 71.6 Favored 'General case' 0 CA--C 1.509 -0.62 0 O-C-N 122.132 -0.355 . . . . 0.0 110.661 -177.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 73.2 tp60 -65.81 -40.79 92.22 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 121.659 -0.651 . . . . 0.0 110.005 -178.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.717 HD22 HD13 ' A' ' 25' ' ' LEU . 73.4 mt -82.48 -19.22 39.25 Favored 'General case' 0 C--N 1.361 1.091 0 C-N-CA 119.622 -0.831 . . . . 0.0 110.574 -178.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.4 t -79.35 -37.66 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 54.2 t -69.05 -39.99 80.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.73 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 178.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.414 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 32.3 tptt -65.7 -27.86 68.64 Favored 'General case' 0 C--N 1.363 1.191 0 O-C-N 121.214 -0.929 . . . . 0.0 108.754 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.8 tt -67.44 -39.33 85.39 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' A' ' 60' ' ' SER . 81.1 p -72.42 -17.33 61.81 Favored 'General case' 0 C--N 1.358 0.949 0 O-C-N 121.694 -0.628 . . . . 0.0 111.019 -178.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -99.96 -36.78 9.27 Favored 'General case' 0 C--N 1.353 0.736 0 O-C-N 121.153 -0.967 . . . . 0.0 111.346 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.2 p -70.38 -34.35 57.76 Favored 'Isoleucine or valine' 0 C--N 1.352 0.687 0 O-C-N 121.74 -0.6 . . . . 0.0 111.338 -177.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.645 ' HB3' HG23 ' A' ' 61' ' ' VAL . 2.0 t -120.81 -7.15 9.57 Favored 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 119.128 -1.029 . . . . 0.0 109.924 -178.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.473 ' HA ' ' O ' ' A' ' 56' ' ' SER . 0.5 OUTLIER 65.67 47.6 2.12 Favored 'General case' 0 C--N 1.353 0.753 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.792 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.645 HG23 ' HB3' ' A' ' 59' ' ' SER . 52.9 t -106.56 132.44 20.9 Favored Pre-proline 0 N--CA 1.443 -0.785 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -57.2 146.89 79.42 Favored 'Trans proline' 0 CA--C 1.498 -1.301 0 C-N-CA 122.504 2.136 . . . . 0.0 112.845 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.5 m -75.49 -12.12 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.605 -178.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.487 ' O ' HG12 ' A' ' 67' ' ' VAL . 70.2 p -97.65 -32.71 11.63 Favored 'General case' 0 C--N 1.359 0.994 0 C-N-CA 118.258 -1.377 . . . . 0.0 109.26 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -75.43 -23.26 56.94 Favored 'General case' 0 C--N 1.355 0.841 0 O-C-N 121.42 -0.8 . . . . 0.0 109.106 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -82.2 -34.86 28.79 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -179.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.487 HG12 ' O ' ' A' ' 64' ' ' THR . 1.6 p -68.21 -27.15 36.0 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.688 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.8 mmm-85 -73.28 -52.12 15.13 Favored 'General case' 0 C--N 1.364 1.198 0 O-C-N 121.609 -0.682 . . . . 0.0 110.284 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.66 -35.6 80.16 Favored 'General case' 0 C--N 1.357 0.92 0 O-C-N 121.973 -0.454 . . . . 0.0 110.954 -178.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -60.95 -47.74 85.05 Favored 'General case' 0 C--N 1.349 0.581 0 O-C-N 122.083 -0.385 . . . . 0.0 110.54 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.99 -38.95 96.35 Favored Glycine 0 C--N 1.355 1.587 0 N-CA-C 111.997 -0.441 . . . . 0.0 111.997 -178.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -63.38 -48.54 77.5 Favored 'General case' 0 C--N 1.35 0.626 0 CA-C-N 118.303 1.052 . . . . 0.0 111.55 -177.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.671 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 11.9 mttm -63.89 -48.6 76.03 Favored 'General case' 0 C--N 1.358 0.961 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -177.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.456 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.3 tm? -68.54 -39.12 81.26 Favored 'General case' 0 C--N 1.35 0.588 0 O-C-N 121.197 -0.94 . . . . 0.0 111.699 -175.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.4 ' CE2' ' HA ' ' A' ' 150' ' ' CYS . 43.8 t80 -62.95 -45.07 94.21 Favored 'General case' 0 C--N 1.352 0.715 0 O-C-N 121.241 -0.912 . . . . 0.0 111.165 -178.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.8 p -71.09 -14.66 18.11 Favored 'Isoleucine or valine' 0 C--N 1.359 1.006 0 O-C-N 121.396 -0.815 . . . . 0.0 109.5 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.671 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 73.6 mm-40 -71.43 -39.81 70.8 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 82.9 mt -70.94 -34.96 71.99 Favored 'General case' 0 C--N 1.357 0.911 0 O-C-N 122.188 -0.32 . . . . 0.0 110.599 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.6 mm -63.79 -53.33 45.82 Favored 'Isoleucine or valine' 0 C--N 1.357 0.916 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.615 -176.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -75.15 -10.98 59.96 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.938 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.23 -11.16 60.15 Favored Glycine 0 C--N 1.35 1.345 0 C-N-CA 119.734 -1.222 . . . . 0.0 110.696 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.465 ' HB3' ' HB ' ' A' ' 85' ' ' ILE . 96.3 m-70 -138.34 96.27 9.99 Favored Pre-proline 0 CA--C 1.503 -0.865 0 CA-C-N 118.991 1.396 . . . . 0.0 108.836 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.458 ' O ' ' HB2' ' A' ' 87' ' ' ASN . 37.7 Cg_endo -67.87 -25.74 38.74 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.428 2.085 . . . . 0.0 114.293 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -91.11 -8.39 48.96 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.465 ' HB ' ' HB3' ' A' ' 82' ' ' HIS . 1.5 tp -89.35 -21.73 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 -178.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.81 -16.94 15.26 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 47.1 t30 -70.84 -41.62 71.25 Favored 'General case' 0 C--N 1.36 1.046 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -68.5 -30.36 69.17 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.387 -178.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 29.5 ttp -84.0 148.07 27.08 Favored 'General case' 0 C--N 1.35 0.623 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.04 -21.62 8.2 Favored 'General case' 0 C--N 1.362 1.119 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.865 -177.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -164.83 170.64 15.18 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 119.172 -1.011 . . . . 0.0 108.337 -177.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.41 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 41.1 t -64.43 -41.96 96.28 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.806 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -66.17 -38.93 89.24 Favored 'General case' 0 C--N 1.355 0.821 0 O-C-N 121.568 -0.708 . . . . 0.0 109.251 -178.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -65.59 -25.84 67.58 Favored 'General case' 0 C--N 1.357 0.906 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.41 ' HB3' ' O ' ' A' ' 92' ' ' SER . 59.9 tp -62.74 -46.52 87.69 Favored 'General case' 0 C--N 1.355 0.823 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.3 mp -62.71 -32.59 73.73 Favored 'General case' 0 C--N 1.353 0.76 0 O-C-N 122.221 -0.299 . . . . 0.0 110.502 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 37.2 t -62.57 -45.22 93.9 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 121.774 -0.579 . . . . 0.0 111.351 -178.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.403 ' H ' ' HG3' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -111.3 26.28 10.84 Favored 'General case' 0 C--N 1.363 1.185 0 O-C-N 121.07 -1.019 . . . . 0.0 110.491 -178.171 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 10.1 tt -60.6 -29.53 44.97 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.575 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -129.3 -7.12 4.78 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 118.444 -1.302 . . . . 0.0 110.039 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 64.5 m -90.75 -3.21 57.61 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.295 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -147.68 -48.7 0.17 Allowed 'General case' 0 C--N 1.357 0.911 0 C-N-CA 118.221 -1.392 . . . . 0.0 109.724 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 96.1 mt -65.75 -47.39 86.07 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 O-C-N 122.038 -0.414 . . . . 0.0 110.922 -177.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 22.7 m170 -83.77 -3.79 58.11 Favored 'General case' 0 C--N 1.354 0.799 0 O-C-N 121.461 -0.774 . . . . 0.0 109.78 -177.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 56.4 t -75.13 -45.24 42.51 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.907 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -70.0 -38.94 76.13 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -178.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 56.7 t -61.65 -46.31 96.82 Favored 'Isoleucine or valine' 0 C--N 1.355 0.822 0 O-C-N 122.196 -0.315 . . . . 0.0 110.48 -178.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -60.04 -47.76 84.5 Favored 'General case' 0 C--N 1.357 0.898 0 O-C-N 122.127 -0.358 . . . . 0.0 111.089 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -61.77 -36.07 79.97 Favored 'General case' 0 C--N 1.355 0.839 0 O-C-N 121.552 -0.718 . . . . 0.0 110.11 -178.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 15.3 mt -59.66 -79.66 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -111.97 140.59 23.59 Favored Pre-proline 0 N--CA 1.442 -0.848 0 C-N-CA 118.877 -1.129 . . . . 0.0 109.242 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -88.84 -6.1 5.82 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 123.286 2.657 . . . . 0.0 114.919 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -69.02 -33.7 74.06 Favored 'General case' 0 C--N 1.353 0.722 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.66 145.08 56.72 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 121.697 0.761 . . . . 0.0 110.13 -178.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.469 ' O ' HD13 ' A' ' 116' ' ' LEU . 46.5 mt-10 -118.55 143.32 46.84 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 179.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.469 HD13 ' O ' ' A' ' 115' ' ' GLU . 2.6 mm? -126.77 149.7 69.31 Favored Pre-proline 0 N--CA 1.445 -0.702 0 CA-C-O 122.074 0.94 . . . . 0.0 108.597 -178.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 116' ' ' LEU . 87.7 Cg_endo -91.28 -155.51 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.265 0 C-N-CA 123.743 2.962 . . . . 0.0 113.197 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -115.98 138.32 51.31 Favored 'General case' 0 C--N 1.362 1.113 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -127.16 129.54 48.08 Favored 'General case' 0 C--N 1.361 1.104 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.548 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 93.2 m -128.58 131.44 48.18 Favored 'General case' 0 C--N 1.356 0.864 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 177.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -125.01 132.44 53.24 Favored 'General case' 0 CA--C 1.503 -0.853 0 C-N-CA 119.316 -0.954 . . . . 0.0 109.769 -178.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -121.28 140.81 51.57 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 178.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 57.7 ttp180 -111.88 117.75 33.62 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -179.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.9 mt -92.91 -16.64 24.95 Favored 'General case' 0 C--N 1.354 0.781 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.193 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 178.19 -150.48 9.83 Favored Glycine 0 C--N 1.347 1.186 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -91.33 -39.69 11.9 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.405 ' HB2' ' HB2' ' A' ' 179' ' ' ARG . 8.2 p30 -104.87 9.3 34.8 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 119.759 -0.777 . . . . 0.0 109.177 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -119.64 124.62 46.76 Favored 'General case' 0 C--N 1.358 0.961 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.403 HD13 ' HA ' ' A' ' 129' ' ' ILE . 9.8 mm -140.13 137.25 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 -116.95 137.65 52.08 Favored 'General case' 0 CA--C 1.492 -1.266 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 6.7 tp -123.23 117.86 26.27 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.023 -0.989 . . . . 0.0 108.486 -178.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.548 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 12.6 m-70 -99.6 131.32 45.68 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -127.95 121.37 29.73 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.541 ' HA ' ' O ' ' A' ' 171' ' ' THR . 75.3 mt-30 -114.5 115.02 26.57 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 179.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.2 t -162.86 152.22 15.31 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -90.81 1.14 57.18 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 120.17 -0.612 . . . . 0.0 109.794 -178.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -136.22 74.26 55.79 Favored Pre-proline 0 C--N 1.354 0.789 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -95.42 110.64 0.14 Allowed 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.54 2.16 . . . . 0.0 115.935 -177.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -110.99 112.1 23.69 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 176.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.12 -39.27 93.68 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.424 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.3 m -63.7 -26.96 68.9 Favored 'General case' 0 C--N 1.353 0.758 0 O-C-N 121.894 -0.504 . . . . 0.0 110.729 -178.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -75.78 -47.03 27.5 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 121.731 -0.606 . . . . 0.0 109.692 -177.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.28 -39.83 93.07 Favored 'General case' 0 C--N 1.358 0.94 0 O-C-N 122.074 -0.391 . . . . 0.0 111.323 -178.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -62.97 -36.85 84.87 Favored 'General case' 0 C--N 1.357 0.909 0 O-C-N 121.827 -0.546 . . . . 0.0 109.972 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.6 -43.01 99.42 Favored Glycine 0 C--N 1.346 1.114 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 83.9 mt -70.49 -40.64 73.47 Favored 'General case' 0 C--N 1.351 0.672 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -179.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 98.2 mt -70.92 -42.55 69.75 Favored 'General case' 0 C--N 1.361 1.09 0 O-C-N 121.154 -0.966 . . . . 0.0 110.907 -176.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.55 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 37.2 t70 -70.12 -29.43 66.36 Favored 'General case' 0 N--CA 1.444 -0.737 0 O-C-N 121.995 -0.44 . . . . 0.0 110.373 -179.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -63.1 -39.57 98.16 Favored Glycine 0 C--N 1.357 1.701 0 N-CA-C 108.474 -1.85 . . . . 0.0 108.474 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.4 ' HA ' ' CE2' ' A' ' 75' ' ' PHE . 45.1 t -61.01 -42.22 98.03 Favored 'General case' 0 C--N 1.351 0.672 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -75.92 0.73 17.29 Favored 'General case' 0 C--N 1.36 1.027 0 O-C-N 121.803 -0.561 . . . . 0.0 109.489 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.55 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 76.8 mm-40 -85.78 -45.96 11.12 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -66.67 -44.63 81.29 Favored 'General case' 0 C--N 1.358 0.949 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.45 ' O ' ' HB2' ' A' ' 155' ' ' LYS . 51.6 m-85 -70.12 -26.08 63.79 Favored 'General case' 0 C--N 1.361 1.077 0 O-C-N 121.783 -0.573 . . . . 0.0 111.126 -178.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 154' ' ' PHE . 41.1 mttt 73.39 71.32 0.12 Allowed 'General case' 0 C--N 1.361 1.102 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -178.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -137.02 -172.48 3.2 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -148.72 94.0 2.21 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 19.3 m-30 -114.89 158.79 21.49 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 94.0 m -118.32 125.03 49.23 Favored 'General case' 0 C--N 1.356 0.868 0 C-N-CA 119.368 -0.933 . . . . 0.0 108.848 -178.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.509 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.6 mp -101.57 121.8 52.94 Favored 'Isoleucine or valine' 0 C--N 1.353 0.736 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 178.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.2 m -119.2 -173.53 2.53 Favored 'General case' 0 C--N 1.357 0.907 0 CA-C-O 121.787 0.803 . . . . 0.0 109.55 -178.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -147.52 155.95 42.37 Favored 'General case' 0 C--N 1.357 0.918 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -178.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 57.4 p -99.07 146.83 32.36 Favored Pre-proline 0 C--N 1.358 0.966 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.686 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 73.7 Cg_endo -76.02 -10.99 19.72 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.786 2.324 . . . . 0.0 115.082 -178.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -73.17 -41.45 63.85 Favored 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.795 -178.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 37.3 p -117.27 14.96 14.88 Favored 'General case' 0 C--N 1.356 0.872 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.734 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.686 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.1 pp0? -66.52 -12.75 59.08 Favored 'General case' 0 C--N 1.353 0.748 0 O-C-N 121.62 -0.675 . . . . 0.0 110.521 178.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 53.8 p-10 -121.89 34.71 5.09 Favored 'General case' 0 N--CA 1.439 -1.015 0 O-C-N 121.068 -1.02 . . . . 0.0 108.447 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 57.2 m -136.11 148.45 48.26 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.639 ' O ' ' HB ' ' A' ' 171' ' ' THR . 61.1 mt-10 -101.85 166.37 10.69 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.639 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 2.5 m 83.2 -56.94 0.16 Allowed 'General case' 0 C--N 1.368 1.374 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -112.23 117.62 33.05 Favored 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 119.861 -0.735 . . . . 0.0 109.609 -178.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 88.5 t -130.73 132.83 63.99 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 49.8 mm -107.35 125.86 63.58 Favored 'Isoleucine or valine' 0 C--N 1.359 0.982 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -114.92 155.89 26.04 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 122.061 0.934 . . . . 0.0 108.652 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -138.16 119.31 14.52 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -178.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.8 mp -115.09 121.37 66.95 Favored 'Isoleucine or valine' 0 C--N 1.353 0.735 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 42.8 p -126.02 159.86 31.61 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 121.698 0.761 . . . . 0.0 110.854 -177.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.405 ' HB2' ' HB2' ' A' ' 127' ' ' ASN . 0.1 OUTLIER . . . . . 0 C--N 1.366 1.287 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 177.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 81.5 mmm . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.068 0.461 . . . . 0.0 110.147 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.27 -19.55 50.29 Favored 'General case' 0 C--N 1.356 0.877 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -178.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.06 -41.13 40.91 Favored Glycine 0 C--N 1.348 1.224 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.92 -34.95 69.49 Favored 'General case' 0 C--N 1.354 0.779 0 O-C-N 122.119 -0.636 . . . . 0.0 111.3 -177.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.9 m -71.04 -23.5 23.56 Favored 'Isoleucine or valine' 0 C--N 1.352 0.714 0 C-N-CA 119.915 -0.714 . . . . 0.0 109.122 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.4 m-30 -71.75 -33.44 68.66 Favored 'General case' 0 C--N 1.358 0.969 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 85.0 m -66.98 -40.06 87.32 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.24 -37.79 95.13 Favored Glycine 0 C--N 1.357 1.72 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.611 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -67.77 -38.47 83.46 Favored 'General case' 0 C--N 1.353 0.719 0 CA-C-N 117.346 0.573 . . . . 0.0 110.297 -178.006 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.469 ' CE ' HD21 ' A' ' 26' ' ' LEU . 22.0 mmt -64.01 -41.22 97.54 Favored 'General case' 0 C--N 1.356 0.868 0 O-C-N 121.644 -0.66 . . . . 0.0 111.002 -178.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -66.09 -40.33 90.73 Favored 'General case' 0 C--N 1.348 0.504 0 O-C-N 122.17 -0.331 . . . . 0.0 111.554 -177.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 55.5 tp -65.78 -42.74 90.41 Favored 'General case' 0 C--N 1.349 0.575 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -178.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.611 HG12 ' O ' ' A' ' 9' ' ' LEU . 2.4 mm -73.83 -36.96 47.37 Favored 'Isoleucine or valine' 0 C--N 1.358 0.949 0 O-C-N 121.067 -1.021 . . . . 0.0 111.167 -175.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -67.42 -44.43 78.79 Favored 'General case' 0 C--N 1.353 0.733 0 O-C-N 121.815 -0.553 . . . . 0.0 111.432 -176.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -72.85 -31.14 64.54 Favored 'General case' 0 N--CA 1.447 -0.579 0 O-C-N 122.013 -0.429 . . . . 0.0 111.626 -177.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -72.74 -50.02 27.24 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -175.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -128.47 -20.25 3.68 Favored 'General case' 0 C--N 1.354 0.797 0 C-N-CA 117.328 -1.749 . . . . 0.0 113.328 -176.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 144.44 179.79 21.13 Favored Glycine 0 N--CA 1.44 -1.061 0 C-N-CA 117.575 -2.25 . . . . 0.0 110.537 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -96.55 -16.37 21.11 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 -177.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -70.08 -41.18 74.45 Favored 'General case' 0 C--N 1.36 1.051 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.6 m -69.76 -38.42 76.76 Favored 'General case' 0 C--N 1.358 0.944 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.6 tp -59.64 -37.94 80.03 Favored 'General case' 0 C--N 1.356 0.867 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -65.76 -35.61 81.21 Favored 'General case' 0 C--N 1.356 0.89 0 O-C-N 122.068 -0.395 . . . . 0.0 110.847 -178.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.8 m -65.33 -39.42 92.38 Favored 'General case' 0 C--N 1.355 0.815 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 -178.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.515 HD22 ' HA ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -63.33 -37.96 89.29 Favored 'General case' 0 C--N 1.355 0.807 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.522 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.469 HD21 ' CE ' ' A' ' 10' ' ' MET . 84.5 mt -75.28 -11.85 60.15 Favored 'General case' 0 C--N 1.361 1.079 0 O-C-N 121.652 -0.655 . . . . 0.0 110.457 -178.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -88.48 -27.22 21.63 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 119.115 -1.034 . . . . 0.0 108.982 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.7 t -68.26 -37.64 80.94 Favored 'General case' 0 C--N 1.356 0.883 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.8 p -90.54 -41.07 11.6 Favored 'General case' 0 C--N 1.358 0.935 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 85.02 134.09 0.05 OUTLIER 'General case' 0 C--N 1.36 1.047 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.487 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -84.9 -171.75 3.81 Favored 'General case' 0 C--N 1.356 0.88 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.89 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -151.27 -23.69 0.21 Allowed 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.9 t -148.34 -64.53 0.25 Allowed 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -131.13 -55.97 1.04 Allowed 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 130.76 -44.61 1.2 Allowed Glycine 0 C--N 1.353 1.498 0 N-CA-C 108.749 -1.74 . . . . 0.0 108.749 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 80.3 mt -107.08 100.45 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.758 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.577 ' O ' ' HB ' ' A' ' 38' ' ' THR . 0.9 OUTLIER -71.79 -28.7 63.79 Favored 'General case' 0 C--N 1.357 0.924 0 O-C-N 121.962 -0.461 . . . . 0.0 109.912 -179.844 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.577 ' HB ' ' O ' ' A' ' 37' ' ' TYR . 12.3 m 113.3 -67.36 0.0 OUTLIER 'General case' 0 C--N 1.37 1.47 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.1 p 175.01 64.25 0.0 OUTLIER 'General case' 0 C--N 1.359 0.993 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.439 ' HB ' ' CE2' ' A' ' 37' ' ' TYR . 2.1 t -148.59 -5.97 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.836 0 C-N-CA 119.573 -0.851 . . . . 0.0 109.725 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -98.56 144.32 17.15 Favored Glycine 0 C--N 1.352 1.444 0 C-N-CA 119.162 -1.494 . . . . 0.0 110.23 -177.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.2 m -124.53 122.5 37.75 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -117.63 179.4 4.07 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -83.02 -171.33 3.5 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 73.3 m80 -93.67 -15.13 25.61 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.418 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -70.6 -28.7 65.05 Favored 'General case' 0 C--N 1.354 0.767 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 27.5 tp10 -63.27 -41.12 98.99 Favored 'General case' 0 C--N 1.352 0.688 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.444 ' O ' HG23 ' A' ' 52' ' ' VAL . 60.9 tp -67.7 -37.99 83.04 Favored 'General case' 0 C--N 1.355 0.823 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.295 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 59.8 tp -77.37 -27.74 52.69 Favored 'General case' 0 C--N 1.351 0.633 0 O-C-N 121.983 -0.448 . . . . 0.0 110.496 -176.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 72.7 tp60 -68.48 -42.38 78.78 Favored 'General case' 0 C--N 1.351 0.672 0 O-C-N 121.546 -0.721 . . . . 0.0 109.526 -178.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.423 HD22 HD13 ' A' ' 25' ' ' LEU . 82.4 mt -71.9 -35.16 69.62 Favored 'General case' 0 C--N 1.362 1.14 0 C-N-CA 119.963 -0.695 . . . . 0.0 109.355 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 48' ' ' LEU . 33.6 t -62.02 -40.21 86.51 Favored 'Isoleucine or valine' 0 C--N 1.351 0.632 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.9 t -67.57 -39.33 82.16 Favored 'Isoleucine or valine' 0 C--N 1.351 0.631 0 O-C-N 121.723 -0.611 . . . . 0.0 109.392 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.436 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 33.7 tptt -65.39 -29.17 69.85 Favored 'General case' 0 C--N 1.361 1.07 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -179.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.515 HD21 HD12 ' A' ' 13' ' ' ILE . 19.7 mt -66.17 -37.94 86.86 Favored 'General case' 0 C--N 1.355 0.815 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.303 179.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 56.3 p -72.16 -17.68 61.93 Favored 'General case' 0 C--N 1.354 0.796 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.704 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -101.8 -37.56 8.24 Favored 'General case' 0 C--N 1.353 0.754 0 O-C-N 121.244 -0.91 . . . . 0.0 111.473 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.1 p -74.22 -38.38 47.88 Favored 'Isoleucine or valine' 0 C--N 1.354 0.779 0 O-C-N 121.599 -0.688 . . . . 0.0 111.143 -177.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.549 ' HB3' HG23 ' A' ' 61' ' ' VAL . 3.4 t -112.21 -7.62 14.02 Favored 'General case' 0 C--N 1.353 0.756 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.309 -177.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 64.25 47.73 3.09 Favored 'General case' 0 C--N 1.354 0.781 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.549 HG23 ' HB3' ' A' ' 59' ' ' SER . 62.0 t -111.5 133.8 21.37 Favored Pre-proline 0 N--CA 1.443 -0.813 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 61' ' ' VAL . 34.1 Cg_exo -58.44 148.35 80.91 Favored 'Trans proline' 0 CA--C 1.498 -1.294 0 C-N-CA 122.565 2.177 . . . . 0.0 112.771 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.9 m -72.73 -15.02 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.687 -178.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.436 ' O ' HG12 ' A' ' 67' ' ' VAL . 70.6 p -96.42 -31.61 12.75 Favored 'General case' 0 C--N 1.359 0.987 0 C-N-CA 118.608 -1.237 . . . . 0.0 109.075 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -71.06 -33.01 69.86 Favored 'General case' 0 C--N 1.353 0.728 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.402 HD13 HD13 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -77.23 -34.88 55.91 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -177.889 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.436 HG12 ' O ' ' A' ' 64' ' ' THR . 1.5 p -70.64 -26.03 27.64 Favored 'Isoleucine or valine' 0 C--N 1.354 0.776 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.523 -178.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 5.3 mmm-85 -74.58 -51.44 14.55 Favored 'General case' 0 C--N 1.36 1.039 0 O-C-N 121.438 -0.789 . . . . 0.0 110.105 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.0 mt -63.2 -35.33 79.97 Favored 'General case' 0 C--N 1.357 0.896 0 O-C-N 122.046 -0.409 . . . . 0.0 110.606 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -60.94 -47.16 87.72 Favored 'General case' 0 C--N 1.35 0.623 0 O-C-N 122.301 -0.25 . . . . 0.0 110.333 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.6 -38.58 95.23 Favored Glycine 0 C--N 1.354 1.547 0 N-CA-C 111.848 -0.501 . . . . 0.0 111.848 -178.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -63.86 -47.65 79.84 Favored 'General case' 0 C--N 1.353 0.726 0 CA-C-N 118.411 1.105 . . . . 0.0 111.457 -177.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.729 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 12.9 mttm -64.15 -49.46 72.02 Favored 'General case' 0 C--N 1.358 0.97 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -176.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.418 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.2 tm? -69.18 -39.38 78.75 Favored 'General case' 0 C--N 1.35 0.609 0 O-C-N 121.214 -0.929 . . . . 0.0 111.882 -175.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -63.47 -44.29 94.86 Favored 'General case' 0 C--N 1.353 0.748 0 O-C-N 121.122 -0.987 . . . . 0.0 110.988 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.29 -14.89 18.19 Favored 'Isoleucine or valine' 0 C--N 1.358 0.954 0 O-C-N 121.496 -0.752 . . . . 0.0 109.194 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.729 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 74.3 mm-40 -71.43 -38.98 71.34 Favored 'General case' 0 C--N 1.352 0.674 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 82.5 mt -72.99 -31.36 64.45 Favored 'General case' 0 C--N 1.356 0.855 0 O-C-N 122.426 -0.171 . . . . 0.0 110.545 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 49.1 mm -65.58 -54.25 30.19 Favored 'Isoleucine or valine' 0 C--N 1.359 0.993 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.286 -177.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -75.38 -14.57 60.48 Favored 'General case' 0 CA--C 1.51 -0.571 0 C-N-CA 119.516 -0.874 . . . . 0.0 109.381 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.35 -37.21 63.01 Favored Glycine 0 C--N 1.349 1.259 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.427 ' O ' HG22 ' A' ' 85' ' ' ILE . 98.7 m-70 -131.38 106.24 14.61 Favored Pre-proline 0 N--CA 1.441 -0.885 0 CA-C-O 122.664 1.221 . . . . 0.0 109.046 -177.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.33 -24.87 42.88 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.52 2.147 . . . . 0.0 114.113 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.417 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 44.6 mt-10 -93.11 -4.95 51.39 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.427 HG22 ' O ' ' A' ' 82' ' ' HIS . 1.0 OUTLIER -90.32 -20.08 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.224 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 -179.629 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -101.72 -24.66 14.05 Favored 'General case' 0 C--N 1.36 1.038 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -70.26 -35.65 73.92 Favored 'General case' 0 C--N 1.358 0.955 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.417 ' HG2' ' O ' ' A' ' 84' ' ' GLU . 78.6 mm-40 -65.01 -36.1 83.31 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 122.058 -0.401 . . . . 0.0 110.058 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 21.8 ttp -83.56 149.87 26.31 Favored 'General case' 0 C--N 1.352 0.698 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -178.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.53 -21.95 8.36 Favored 'General case' 0 C--N 1.364 1.222 0 C-N-CA 120.074 -0.651 . . . . 0.0 111.032 -177.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -164.55 170.93 15.19 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 -177.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.415 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 41.0 t -64.4 -42.69 95.97 Favored 'General case' 0 C--N 1.356 0.873 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.955 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -66.86 -38.82 87.09 Favored 'General case' 0 C--N 1.355 0.833 0 O-C-N 121.492 -0.755 . . . . 0.0 109.328 -178.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -65.91 -24.61 66.87 Favored 'General case' 0 C--N 1.357 0.912 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.415 ' HB3' ' O ' ' A' ' 92' ' ' SER . 62.5 tp -63.09 -46.41 87.53 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.7 mp -63.03 -32.35 73.7 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 122.185 -0.322 . . . . 0.0 110.405 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 36.5 t -62.15 -45.08 95.04 Favored 'General case' 0 C--N 1.355 0.847 0 O-C-N 121.783 -0.573 . . . . 0.0 111.304 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.66 26.42 10.39 Favored 'General case' 0 C--N 1.362 1.11 0 O-C-N 121.015 -1.053 . . . . 0.0 110.515 -178.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 13.0 tt -64.09 -29.57 47.69 Favored 'Isoleucine or valine' 0 C--N 1.352 0.691 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.151 -179.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -126.21 -9.46 6.44 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 118.564 -1.254 . . . . 0.0 109.762 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 58.8 m -90.92 -2.54 57.72 Favored 'General case' 0 N--CA 1.441 -0.884 0 O-C-N 121.406 -0.809 . . . . 0.0 110.345 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -147.03 -47.69 0.18 Allowed 'General case' 0 C--N 1.358 0.968 0 C-N-CA 118.28 -1.368 . . . . 0.0 109.913 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 96.2 mt -67.53 -47.84 79.07 Favored 'Isoleucine or valine' 0 C--N 1.354 0.779 0 O-C-N 121.931 -0.481 . . . . 0.0 111.161 -178.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.652 ' HB3' HD21 ' A' ' 116' ' ' LEU . 22.4 m170 -83.55 -1.14 53.09 Favored 'General case' 0 C--N 1.356 0.875 0 O-C-N 121.403 -0.811 . . . . 0.0 110.056 -177.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 70.5 t -83.96 -43.13 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.952 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -67.3 -39.88 85.99 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.323 -178.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.1 p -71.97 -36.5 57.74 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 C-N-CA 119.596 -0.842 . . . . 0.0 110.106 -178.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 93.3 t80 -60.86 -48.6 81.07 Favored 'General case' 0 C--N 1.363 1.171 0 O-C-N 121.744 -0.597 . . . . 0.0 110.71 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -60.25 -38.1 82.45 Favored 'General case' 0 C--N 1.358 0.941 0 O-C-N 121.665 -0.647 . . . . 0.0 110.069 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 16.9 mt -58.05 -76.56 0.04 OUTLIER 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.429 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 91.3 m-85 -115.72 134.3 22.7 Favored Pre-proline 0 N--CA 1.44 -0.954 0 C-N-CA 118.986 -1.086 . . . . 0.0 108.83 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 111' ' ' TYR . 74.3 Cg_endo -86.21 -2.08 8.62 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 123.222 2.615 . . . . 0.0 115.403 -179.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -67.39 -36.18 80.8 Favored 'General case' 0 C--N 1.355 0.814 0 O-C-N 121.773 -0.579 . . . . 0.0 109.997 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -61.73 143.99 55.36 Favored 'General case' 0 C--N 1.354 0.775 0 CA-C-O 121.651 0.738 . . . . 0.0 110.018 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -114.26 145.58 41.55 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.652 HD21 ' HB3' ' A' ' 104' ' ' HIS . 5.6 mp -127.48 145.78 55.91 Favored Pre-proline 0 N--CA 1.445 -0.716 0 CA-C-O 122.198 0.999 . . . . 0.0 108.98 -178.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 116' ' ' LEU . 73.7 Cg_endo -91.31 -152.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.197 0 C-N-CA 123.909 3.073 . . . . 0.0 113.178 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -115.03 142.46 46.61 Favored 'General case' 0 C--N 1.362 1.125 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.598 ' CE2' ' HD1' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -137.71 125.42 22.37 Favored 'General case' 0 C--N 1.361 1.09 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -177.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 94.1 m -124.23 129.99 51.74 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 177.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 74.8 m -118.01 131.35 56.48 Favored 'General case' 0 CA--C 1.504 -0.8 0 C-N-CA 119.277 -0.969 . . . . 0.0 109.852 -177.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -121.02 148.37 44.22 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 58.1 ttp180 -123.32 117.39 25.13 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.451 ' HB2' ' CB ' ' A' ' 128' ' ' ASP . 95.3 mt -92.07 -15.09 28.27 Favored 'General case' 0 C--N 1.354 0.797 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.709 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 178.59 -150.37 9.61 Favored Glycine 0 N--CA 1.439 -1.154 0 N-CA-C 108.886 -1.686 . . . . 0.0 108.886 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -90.4 -38.23 13.45 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -105.99 9.5 32.55 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 119.762 -0.775 . . . . 0.0 109.524 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.451 ' CB ' ' HB2' ' A' ' 124' ' ' LEU . 61.9 m-20 -118.3 123.21 44.8 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 17.8 mm -137.9 133.26 44.57 Favored 'Isoleucine or valine' 0 C--N 1.353 0.729 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 59.9 mtm180 -120.49 139.43 52.9 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.546 ' HG ' ' O ' ' A' ' 131' ' ' LEU . 0.7 OUTLIER -130.04 127.0 39.05 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -97.34 130.7 44.47 Favored 'General case' 0 CA--C 1.494 -1.188 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 178.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.598 ' HD1' ' CE2' ' A' ' 119' ' ' PHE . 52.5 t80 -124.86 121.43 34.51 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 -178.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.485 ' HA ' ' O ' ' A' ' 171' ' ' THR . 28.2 tt0 -114.42 112.44 23.03 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.8 t -162.28 153.39 17.8 Favored 'General case' 0 C--N 1.358 0.974 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -90.43 5.99 45.2 Favored 'General case' 0 C--N 1.357 0.903 0 C-N-CA 120.199 -0.6 . . . . 0.0 109.912 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 94.7 mtm-85 -131.94 77.35 72.05 Favored Pre-proline 0 C--N 1.356 0.856 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 178.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -91.48 93.07 0.22 Allowed 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.748 2.298 . . . . 0.0 115.709 -177.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -107.43 106.36 16.73 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 177.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.3 -38.88 92.63 Favored 'General case' 0 C--N 1.355 0.835 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.367 -178.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 74.2 m -63.05 -27.1 69.17 Favored 'General case' 0 C--N 1.353 0.755 0 O-C-N 121.981 -0.449 . . . . 0.0 110.554 -178.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -75.58 -47.18 27.78 Favored 'General case' 0 N--CA 1.445 -0.721 0 O-C-N 121.735 -0.603 . . . . 0.0 109.553 -178.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.28 -39.4 92.53 Favored 'General case' 0 C--N 1.358 0.944 0 O-C-N 122.108 -0.37 . . . . 0.0 111.331 -178.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -62.19 -36.94 83.42 Favored 'General case' 0 C--N 1.358 0.947 0 O-C-N 121.777 -0.577 . . . . 0.0 109.764 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.53 -42.2 99.03 Favored Glycine 0 C--N 1.347 1.157 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 83.2 mt -70.19 -41.35 73.82 Favored 'General case' 0 C--N 1.352 0.692 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 96.6 mt -71.27 -42.08 69.22 Favored 'General case' 0 C--N 1.364 1.212 0 O-C-N 121.066 -1.021 . . . . 0.0 110.654 -177.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -70.35 -30.84 67.88 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 121.866 -0.521 . . . . 0.0 110.635 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -63.55 -39.75 97.97 Favored Glycine 0 C--N 1.356 1.654 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 42.7 t -60.43 -43.11 97.12 Favored 'General case' 0 C--N 1.35 0.615 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 178.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -78.91 2.38 20.35 Favored 'General case' 0 C--N 1.355 0.847 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -83.73 -49.09 9.45 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -66.69 -42.93 85.67 Favored 'General case' 0 C--N 1.36 1.061 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 9.6 m-30 -69.01 -27.38 65.62 Favored 'General case' 0 C--N 1.361 1.068 0 O-C-N 121.831 -0.543 . . . . 0.0 110.797 -178.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 85.2 tttt 73.01 75.06 0.14 Allowed 'General case' 0 C--N 1.36 1.058 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -137.65 -177.73 4.92 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -140.27 90.06 2.34 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 16.8 m-30 -116.3 155.11 28.98 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 178.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 93.5 m -119.66 128.83 54.2 Favored 'General case' 0 C--N 1.355 0.808 0 C-N-CA 119.551 -0.859 . . . . 0.0 108.828 -178.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.507 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.5 mp -106.24 123.22 60.83 Favored 'Isoleucine or valine' 0 C--N 1.352 0.704 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.1 m -119.43 -170.77 2.0 Allowed 'General case' 0 C--N 1.356 0.869 0 CA-C-O 121.685 0.755 . . . . 0.0 109.197 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 11.3 ptt85 -147.76 157.0 43.33 Favored 'General case' 0 C--N 1.357 0.931 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -178.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . 0.438 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 32.5 p -97.5 146.37 31.28 Favored Pre-proline 0 C--N 1.36 1.043 0 CA-C-O 122.415 1.103 . . . . 0.0 108.447 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.513 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 16.0 Cg_exo -70.42 -16.7 34.82 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 123.641 2.894 . . . . 0.0 114.486 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -71.95 -40.71 68.49 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.933 -177.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 39.6 p -119.27 15.75 13.09 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.876 -178.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.513 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 12.7 pt20 -67.55 -12.15 59.71 Favored 'General case' 0 C--N 1.352 0.69 0 C-N-CA 119.974 -0.691 . . . . 0.0 110.155 178.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -126.51 37.79 4.24 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 18.2 t -138.94 144.65 39.13 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.622 ' O ' ' HB ' ' A' ' 171' ' ' THR . 61.4 mt-10 -97.87 163.99 12.56 Favored 'General case' 0 C--N 1.354 0.769 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.622 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 18.0 m 83.95 -59.91 0.12 Allowed 'General case' 0 C--N 1.372 1.555 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -105.71 118.0 35.47 Favored 'General case' 0 CA--C 1.503 -0.827 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.596 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 92.8 t -131.48 133.78 61.5 Favored 'Isoleucine or valine' 0 C--N 1.358 0.952 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 178.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 48.4 mm -113.52 126.98 71.06 Favored 'Isoleucine or valine' 0 C--N 1.359 1.021 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.441 ' HB2' ' HG ' ' A' ' 131' ' ' LEU . 97.2 m-85 -116.74 147.2 42.25 Favored 'General case' 0 C--N 1.36 1.054 0 CA-C-O 121.947 0.88 . . . . 0.0 109.105 -179.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -125.2 120.16 30.52 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 51.8 mt -116.22 124.79 72.86 Favored 'Isoleucine or valine' 0 C--N 1.353 0.752 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 -178.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 54.9 p -118.55 157.97 26.31 Favored 'General case' 0 CA--C 1.501 -0.92 0 CA-C-O 121.764 0.792 . . . . 0.0 109.581 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 . . . . . 0 C--N 1.356 0.858 0 N-CA-C 106.325 -1.732 . . . . 0.0 106.325 178.838 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mtm . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 121.287 0.565 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.93 -12.71 54.98 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.62 -40.2 54.15 Favored Glycine 0 C--N 1.351 1.397 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 7.8 mtm -71.08 -35.4 71.84 Favored 'General case' 0 C--N 1.359 1.0 0 O-C-N 121.875 -0.779 . . . . 0.0 111.299 -177.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.1 m -68.48 -23.98 28.81 Favored 'Isoleucine or valine' 0 C--N 1.356 0.854 0 C-N-CA 119.674 -0.81 . . . . 0.0 109.22 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -71.31 -35.87 71.42 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 178.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 88.6 m -67.35 -41.63 84.85 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.73 -38.95 97.31 Favored Glycine 0 C--N 1.357 1.743 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.633 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -66.73 -39.98 88.2 Favored 'General case' 0 C--N 1.352 0.685 0 O-C-N 122.301 -0.529 . . . . 0.0 110.76 -178.107 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 22.4 mmt -64.25 -41.04 97.15 Favored 'General case' 0 C--N 1.354 0.791 0 O-C-N 121.523 -0.735 . . . . 0.0 111.137 -178.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -67.26 -40.0 86.17 Favored 'General case' 0 C--N 1.35 0.598 0 O-C-N 121.96 -0.463 . . . . 0.0 111.623 -177.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 54.7 tp -66.33 -42.09 88.68 Favored 'General case' 0 C--N 1.348 0.503 0 N-CA-C 112.694 0.628 . . . . 0.0 112.694 -178.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.633 HG12 ' O ' ' A' ' 9' ' ' LEU . 2.1 mm -75.17 -35.77 35.3 Favored 'Isoleucine or valine' 0 C--N 1.36 1.048 0 O-C-N 121.11 -0.994 . . . . 0.0 110.86 -175.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -71.13 -41.89 69.91 Favored 'General case' 0 C--N 1.35 0.587 0 O-C-N 121.558 -0.714 . . . . 0.0 111.405 -176.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -72.04 -38.21 69.56 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -175.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -102.57 -23.22 13.89 Favored 'General case' 0 C--N 1.349 0.584 0 C-N-CA 118.794 -1.162 . . . . 0.0 113.466 -174.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 14.6 m-30 -109.07 -37.76 5.73 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 118.191 -1.404 . . . . 0.0 111.399 -176.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 140.63 178.76 17.48 Favored Glycine 0 N--CA 1.439 -1.144 0 N-CA-C 108.732 -1.747 . . . . 0.0 108.732 -179.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -101.6 -25.61 13.82 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -177.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -70.3 -39.61 74.72 Favored 'General case' 0 C--N 1.361 1.098 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 95.0 m -67.69 -38.38 83.59 Favored 'General case' 0 C--N 1.358 0.96 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.1 tp -59.59 -38.54 81.49 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -66.12 -36.13 82.33 Favored 'General case' 0 C--N 1.356 0.858 0 O-C-N 122.09 -0.381 . . . . 0.0 111.07 -178.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.6 m -64.13 -41.19 97.3 Favored 'General case' 0 C--N 1.355 0.846 0 O-C-N 121.606 -0.684 . . . . 0.0 109.352 -178.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.3 mt -64.28 -36.84 85.42 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.568 ' HB3' HD23 ' A' ' 31' ' ' LEU . 84.3 mt -70.19 -16.2 63.04 Favored 'General case' 0 C--N 1.359 0.982 0 O-C-N 121.782 -0.574 . . . . 0.0 110.105 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -84.89 -28.79 25.72 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 119.524 -0.87 . . . . 0.0 109.167 178.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.4 t -66.52 -36.89 83.82 Favored 'General case' 0 C--N 1.355 0.838 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.8 p -93.07 -37.19 12.29 Favored 'General case' 0 C--N 1.359 1.004 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -179.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 83.66 133.39 0.05 Allowed 'General case' 0 C--N 1.36 1.04 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.568 HD23 ' HB3' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -111.97 132.05 55.02 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 179.246 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -107.88 -21.46 12.83 Favored 'General case' 0 CA--C 1.497 -1.083 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.121 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -114.24 -80.15 0.59 Allowed 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 118.874 -1.131 . . . . 0.0 109.098 -178.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -137.16 -53.17 0.68 Allowed 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 131.4 -44.6 1.19 Allowed Glycine 0 C--N 1.352 1.437 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 82.8 mt -107.87 100.05 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.795 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -98.21 0.07 45.11 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.706 HG22 ' H ' ' A' ' 39' ' ' SER . 3.4 m 78.75 174.22 0.16 Allowed 'General case' 0 C--N 1.362 1.127 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 -178.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.706 ' H ' HG22 ' A' ' 38' ' ' THR . 41.7 p -86.81 119.25 26.84 Favored 'General case' 0 N--CA 1.443 -0.778 0 O-C-N 121.131 -0.981 . . . . 0.0 109.531 -178.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.429 ' O ' HG13 ' A' ' 40' ' ' VAL . 0.5 OUTLIER -176.21 -12.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.362 1.117 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.721 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -114.25 168.05 12.47 Favored Glycine 0 C--N 1.358 1.793 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 -178.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 48.9 m -130.95 132.21 44.92 Favored 'General case' 0 C--N 1.355 0.838 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -119.14 173.64 6.8 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -70.19 172.49 8.0 Favored 'General case' 0 C--N 1.357 0.9 0 CA-C-O 121.671 0.748 . . . . 0.0 109.478 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -83.77 -24.05 31.25 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -178.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -65.79 -27.41 68.25 Favored 'General case' 0 C--N 1.355 0.832 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -61.48 -42.11 98.28 Favored 'General case' 0 C--N 1.353 0.734 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.512 ' O ' HG23 ' A' ' 52' ' ' VAL . 61.8 tp -67.4 -38.89 85.34 Favored 'General case' 0 C--N 1.355 0.816 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.296 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 57.9 tp -73.5 -28.05 61.7 Favored 'General case' 0 C--N 1.352 0.697 0 O-C-N 122.081 -0.387 . . . . 0.0 110.278 -177.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 71.7 tp60 -67.42 -42.42 83.22 Favored 'General case' 0 N--CA 1.445 -0.695 0 O-C-N 121.702 -0.624 . . . . 0.0 109.481 -178.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 88.1 mt -76.9 -25.09 52.61 Favored 'General case' 0 C--N 1.36 1.031 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.843 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 48' ' ' LEU . 32.2 t -70.78 -41.7 77.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.1 p -71.82 -30.88 39.25 Favored 'Isoleucine or valine' 0 C--N 1.354 0.797 0 O-C-N 121.514 -0.741 . . . . 0.0 109.766 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 31.1 tptt -71.83 -27.16 62.71 Favored 'General case' 0 C--N 1.364 1.204 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.0 tt -66.58 -41.25 88.81 Favored 'General case' 0 C--N 1.354 0.768 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.498 ' O ' ' HA ' ' A' ' 60' ' ' SER . 46.8 t -65.24 -39.4 92.64 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 121.88 -0.512 . . . . 0.0 110.313 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -76.95 -39.12 51.81 Favored 'General case' 0 C--N 1.352 0.717 0 O-C-N 120.974 -1.078 . . . . 0.0 112.975 -178.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.4 p -70.74 -38.02 71.3 Favored 'Isoleucine or valine' 0 C--N 1.354 0.794 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -175.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.0 t -118.12 -4.44 11.0 Favored 'General case' 0 CA--C 1.505 -0.779 0 C-N-CA 118.975 -1.09 . . . . 0.0 110.085 -177.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' A' ' 56' ' ' SER . 0.3 OUTLIER 69.36 41.23 1.35 Allowed 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.078 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 56' ' ' SER . 61.6 t -110.8 123.86 34.45 Favored Pre-proline 0 CA--C 1.502 -0.891 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 178.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 61' ' ' VAL . 32.5 Cg_exo -57.73 155.03 34.03 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 122.85 2.367 . . . . 0.0 113.689 -178.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.656 ' HA ' HD23 ' A' ' 66' ' ' LEU . 11.4 m -75.3 -9.34 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.457 -177.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.504 ' O ' HG12 ' A' ' 67' ' ' VAL . 80.6 p -96.39 -36.13 10.95 Favored 'General case' 0 C--N 1.356 0.882 0 C-N-CA 118.221 -1.392 . . . . 0.0 109.431 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -75.2 -22.3 58.08 Favored 'General case' 0 C--N 1.353 0.733 0 O-C-N 121.407 -0.808 . . . . 0.0 109.337 179.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.656 HD23 ' HA ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -82.58 -32.67 28.37 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -178.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.504 HG12 ' O ' ' A' ' 64' ' ' THR . 2.3 p -70.98 -25.39 25.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.844 0 C-N-CA 120.077 -0.649 . . . . 0.0 109.864 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.7 mmm-85 -73.29 -53.15 11.55 Favored 'General case' 0 C--N 1.363 1.153 0 O-C-N 121.519 -0.738 . . . . 0.0 109.841 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.54 -34.34 77.58 Favored 'General case' 0 C--N 1.356 0.889 0 O-C-N 122.112 -0.368 . . . . 0.0 110.806 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -61.23 -47.2 87.18 Favored 'General case' 0 C--N 1.35 0.613 0 O-C-N 122.083 -0.385 . . . . 0.0 110.369 -178.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.65 -38.6 95.33 Favored Glycine 0 C--N 1.356 1.663 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 -178.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -63.29 -47.98 80.04 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-N 118.115 0.957 . . . . 0.0 111.644 -177.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 12.8 mttm -65.42 -47.04 77.63 Favored 'General case' 0 C--N 1.359 1.018 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -177.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -70.3 -39.24 74.95 Favored 'General case' 0 C--N 1.349 0.571 0 O-C-N 121.158 -0.964 . . . . 0.0 111.712 -175.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -63.89 -45.55 88.88 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 121.114 -0.991 . . . . 0.0 111.047 -178.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.8 p -71.44 -14.01 17.37 Favored 'Isoleucine or valine' 0 C--N 1.359 0.988 0 O-C-N 121.545 -0.722 . . . . 0.0 109.073 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -71.36 -40.65 70.49 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 79.5 mt -70.32 -34.02 72.2 Favored 'General case' 0 C--N 1.356 0.887 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.337 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 46.4 mm -63.16 -52.95 52.42 Favored 'Isoleucine or valine' 0 C--N 1.358 0.964 0 O-C-N 121.723 -0.611 . . . . 0.0 110.105 -177.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -75.0 -10.7 59.72 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 120.1 -0.64 . . . . 0.0 111.289 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.76 -8.68 58.06 Favored Glycine 0 C--N 1.351 1.401 0 C-N-CA 119.617 -1.277 . . . . 0.0 110.825 -178.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.577 ' HB3' ' HB ' ' A' ' 85' ' ' ILE . 93.3 m-70 -137.22 91.35 14.65 Favored Pre-proline 0 C--N 1.353 0.721 0 CA-C-N 118.994 1.397 . . . . 0.0 108.982 -179.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -59.82 -32.96 96.2 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 123.027 2.484 . . . . 0.0 114.408 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -93.24 -2.71 54.82 Favored 'General case' 0 CA--C 1.504 -0.82 0 C-N-CA 119.74 -0.784 . . . . 0.0 109.616 -178.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.577 ' HB ' ' HB3' ' A' ' 82' ' ' HIS . 0.4 OUTLIER -89.07 -19.87 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 -179.832 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -101.64 -23.42 14.26 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -70.27 -36.66 74.57 Favored 'General case' 0 C--N 1.359 0.995 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -65.77 -35.91 82.06 Favored 'General case' 0 C--N 1.355 0.82 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.013 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 23.8 ttp -83.26 149.61 26.69 Favored 'General case' 0 C--N 1.353 0.732 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -178.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.6 -21.91 8.91 Favored 'General case' 0 C--N 1.364 1.233 0 O-C-N 121.698 -0.626 . . . . 0.0 110.556 -177.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -163.91 170.75 16.3 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -177.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.443 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 89.3 p -70.86 -32.32 69.28 Favored 'General case' 0 C--N 1.353 0.736 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.965 -179.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -70.3 -38.94 75.09 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -67.06 -23.73 65.9 Favored 'General case' 0 C--N 1.358 0.937 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.443 ' HB3' ' O ' ' A' ' 92' ' ' SER . 61.0 tp -62.67 -46.53 87.73 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.9 mp -63.13 -31.22 72.32 Favored 'General case' 0 C--N 1.355 0.812 0 O-C-N 122.257 -0.277 . . . . 0.0 110.289 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 36.1 t -62.2 -45.98 90.93 Favored 'General case' 0 C--N 1.356 0.868 0 O-C-N 121.69 -0.631 . . . . 0.0 111.237 -178.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.431 ' H ' ' HG3' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -114.89 28.92 8.39 Favored 'General case' 0 C--N 1.36 1.055 0 O-C-N 121.068 -1.02 . . . . 0.0 110.232 -178.338 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.467 ' HA ' HD12 ' A' ' 103' ' ' ILE . 12.9 tt -63.45 -27.64 43.41 Favored 'Isoleucine or valine' 0 C--N 1.354 0.79 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.5 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -125.98 -12.29 6.45 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 118.825 -1.15 . . . . 0.0 109.044 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.3 t -69.11 -45.53 69.98 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.057 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -123.85 -28.73 3.77 Favored 'General case' 0 C--N 1.358 0.943 0 C-N-CA 118.636 -1.226 . . . . 0.0 111.47 -177.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.467 HD12 ' HA ' ' A' ' 99' ' ' ILE . 96.2 mt -70.17 -47.8 65.46 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 O-C-N 121.147 -0.971 . . . . 0.0 110.922 -178.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 39.3 m170 -87.96 1.71 53.46 Favored 'General case' 0 C--N 1.355 0.834 0 O-C-N 121.224 -0.923 . . . . 0.0 110.028 -177.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.6 p -92.37 -31.71 4.85 Favored 'Isoleucine or valine' 0 C--N 1.354 0.799 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -71.99 -39.8 69.02 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -72.98 -36.6 51.68 Favored 'Isoleucine or valine' 0 C--N 1.354 0.795 0 C-N-CA 119.605 -0.838 . . . . 0.0 109.704 -178.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -61.06 -48.7 80.52 Favored 'General case' 0 C--N 1.364 1.21 0 O-C-N 121.808 -0.557 . . . . 0.0 110.651 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -60.91 -37.9 83.87 Favored 'General case' 0 C--N 1.357 0.903 0 O-C-N 121.709 -0.619 . . . . 0.0 110.226 -179.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.8 mt -57.9 -76.46 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.413 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 79.5 m-85 -116.37 135.04 22.78 Favored Pre-proline 0 N--CA 1.441 -0.899 0 C-N-CA 118.926 -1.109 . . . . 0.0 108.756 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 111' ' ' TYR . 81.2 Cg_endo -85.29 -2.41 9.35 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 123.215 2.61 . . . . 0.0 115.41 -178.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 30.4 mm100 -66.72 -36.42 82.42 Favored 'General case' 0 C--N 1.354 0.79 0 O-C-N 121.779 -0.575 . . . . 0.0 110.029 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.97 146.12 53.82 Favored 'General case' 0 C--N 1.354 0.778 0 CA-C-O 121.695 0.76 . . . . 0.0 110.092 -178.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -117.43 156.77 27.38 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 178.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.824 ' HG ' ' HD2' ' A' ' 117' ' ' PRO . 4.3 tp -142.3 143.47 27.39 Favored Pre-proline 0 N--CA 1.441 -0.893 0 CA-C-O 122.009 0.909 . . . . 0.0 108.646 -178.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.824 ' HD2' ' HG ' ' A' ' 116' ' ' LEU . 97.5 Cg_endo -85.73 -152.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.128 0 C-N-CA 123.602 2.868 . . . . 0.0 113.534 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -114.25 145.94 41.08 Favored 'General case' 0 C--N 1.363 1.19 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -145.39 125.28 13.49 Favored 'General case' 0 C--N 1.36 1.052 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -177.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 93.5 m -124.84 132.49 53.32 Favored 'General case' 0 C--N 1.359 0.995 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 179.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 75.2 m -113.68 130.25 56.44 Favored 'General case' 0 C--N 1.356 0.883 0 C-N-CA 119.735 -0.786 . . . . 0.0 109.576 -178.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -121.04 126.7 50.55 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 178.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 58.4 ttp180 -102.53 117.4 34.62 Favored 'General case' 0 C--N 1.353 0.755 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.549 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 85.7 mt -83.3 -27.03 30.08 Favored 'General case' 0 CA--C 1.504 -0.818 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.112 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -177.18 -144.96 5.55 Favored Glycine 0 C--N 1.35 1.319 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 -178.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -94.11 -39.06 10.79 Favored 'General case' 0 N--CA 1.438 -1.07 0 O-C-N 121.993 -0.71 . . . . 0.0 109.312 -178.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -101.94 1.89 37.3 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.614 -178.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.549 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 6.6 m-20 -118.97 130.77 55.87 Favored 'General case' 0 C--N 1.359 0.993 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 14.2 mm -139.37 135.81 40.83 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 58.3 mtm180 -122.0 141.01 51.78 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.57 ' HG ' ' HB2' ' A' ' 175' ' ' PHE . 0.9 OUTLIER -131.39 127.01 36.65 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.676 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -97.47 130.77 44.53 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 178.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -125.15 121.04 33.07 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 -178.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.513 ' HA ' ' O ' ' A' ' 171' ' ' THR . 28.7 tt0 -114.9 112.05 22.13 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 14.5 t -161.73 152.65 18.02 Favored 'General case' 0 C--N 1.358 0.976 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.418 ' C ' ' HD3' ' A' ' 138' ' ' PRO . 57.9 mtmt -90.7 3.56 53.92 Favored 'General case' 0 C--N 1.357 0.891 0 C-N-CA 120.269 -0.572 . . . . 0.0 109.576 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -133.49 73.48 72.99 Favored Pre-proline 0 CA--C 1.506 -0.736 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.418 ' HD3' ' C ' ' A' ' 136' ' ' LYS . 89.6 Cg_endo -96.36 104.14 0.09 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.541 0 C-N-CA 122.662 2.241 . . . . 0.0 115.678 -177.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -111.87 113.44 25.77 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 176.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.93 -38.12 89.93 Favored 'General case' 0 C--N 1.353 0.75 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.968 -179.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 74.6 m -63.02 -26.17 68.73 Favored 'General case' 0 C--N 1.353 0.741 0 O-C-N 121.971 -0.456 . . . . 0.0 110.55 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -76.57 -46.72 25.1 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 120.13 -0.628 . . . . 0.0 109.375 -178.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.59 -40.24 95.16 Favored 'General case' 0 C--N 1.357 0.915 0 O-C-N 122.187 -0.321 . . . . 0.0 111.087 -178.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.19 -36.79 84.81 Favored 'General case' 0 C--N 1.355 0.834 0 O-C-N 121.961 -0.462 . . . . 0.0 110.112 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.37 -42.94 99.09 Favored Glycine 0 C--N 1.347 1.157 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.5 mt -70.06 -40.92 74.8 Favored 'General case' 0 C--N 1.353 0.719 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 96.7 mt -71.84 -42.2 67.24 Favored 'General case' 0 C--N 1.364 1.2 0 O-C-N 121.059 -1.026 . . . . 0.0 110.801 -176.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.515 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 20.9 t70 -69.15 -33.15 72.97 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 122.097 -0.377 . . . . 0.0 110.57 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.433 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -62.75 -39.28 97.76 Favored Glycine 0 C--N 1.357 1.713 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 45.9 t -60.51 -42.24 95.99 Favored 'General case' 0 C--N 1.35 0.598 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -75.99 -0.13 20.51 Favored 'General case' 0 C--N 1.36 1.043 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.515 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 76.8 mm-40 -84.56 -46.41 11.59 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -66.16 -44.59 83.64 Favored 'General case' 0 C--N 1.359 1.002 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 8.8 m-30 -69.5 -26.28 64.46 Favored 'General case' 0 C--N 1.361 1.086 0 O-C-N 121.87 -0.518 . . . . 0.0 110.81 -178.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 85.0 tttt 73.16 75.95 0.14 Allowed 'General case' 0 C--N 1.36 1.024 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -178.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -141.42 -171.34 3.28 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -148.34 92.65 2.05 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -113.86 158.41 21.09 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 93.3 m -119.9 127.85 53.09 Favored 'General case' 0 C--N 1.355 0.82 0 C-N-CA 119.404 -0.919 . . . . 0.0 108.974 -178.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.498 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.7 mp -105.86 122.82 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 178.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.4 m -116.67 -172.46 2.2 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 121.822 0.82 . . . . 0.0 109.116 -178.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -146.46 155.67 42.72 Favored 'General case' 0 C--N 1.354 0.792 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -178.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 41.7 p -98.68 146.3 31.38 Favored Pre-proline 0 C--N 1.359 0.999 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.689 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 72.6 Cg_endo -76.35 -11.87 19.01 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 123.044 2.496 . . . . 0.0 115.148 -178.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -72.66 -41.07 65.82 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 120.056 -0.657 . . . . 0.0 109.551 -178.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 35.8 p -117.72 15.23 14.47 Favored 'General case' 0 C--N 1.354 0.802 0 C-N-CA 120.129 -0.628 . . . . 0.0 110.48 -178.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.689 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.3 pp0? -67.11 -11.85 58.36 Favored 'General case' 0 C--N 1.354 0.802 0 O-C-N 121.576 -0.703 . . . . 0.0 110.193 178.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -127.0 42.29 3.35 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 15.4 t -142.96 145.4 32.96 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.635 ' O ' ' HB ' ' A' ' 171' ' ' THR . 61.5 mt-10 -98.86 165.0 11.98 Favored 'General case' 0 C--N 1.353 0.751 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.635 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 11.9 m 83.71 -59.12 0.13 Allowed 'General case' 0 C--N 1.37 1.483 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -107.35 117.46 34.13 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 119.889 -0.724 . . . . 0.0 109.654 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 90.4 t -131.85 134.15 60.37 Favored 'Isoleucine or valine' 0 C--N 1.357 0.914 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 178.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 49.2 mm -113.4 126.97 70.92 Favored 'Isoleucine or valine' 0 C--N 1.359 0.987 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.57 ' HB2' ' HG ' ' A' ' 131' ' ' LEU . 97.1 m-85 -116.62 147.13 42.18 Favored 'General case' 0 C--N 1.361 1.081 0 CA-C-O 122.008 0.909 . . . . 0.0 108.778 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -125.68 119.37 27.82 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 51.0 mt -114.67 115.87 50.84 Favored 'Isoleucine or valine' 0 C--N 1.354 0.801 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 -179.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 88.4 m -127.55 140.5 52.08 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -178.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 . . . . . 0 C--N 1.366 1.307 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 179.231 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.9 mtp . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.096 0.474 . . . . 0.0 110.079 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.49 ' HA ' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -79.28 -17.28 54.98 Favored 'General case' 0 C--N 1.354 0.796 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.016 -178.365 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.83 -42.06 32.02 Favored Glycine 0 C--N 1.348 1.245 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.3 tpp -70.73 -37.92 73.52 Favored 'General case' 0 C--N 1.354 0.797 0 O-C-N 122.103 -0.645 . . . . 0.0 110.808 -177.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.49 HG22 ' HA ' ' A' ' 2' ' ' MET . 27.2 m -69.87 -23.16 25.33 Favored 'Isoleucine or valine' 0 C--N 1.357 0.914 0 O-C-N 121.614 -0.679 . . . . 0.0 109.723 -179.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.434 ' HZ ' ' CG ' ' A' ' 47' ' ' GLU . 1.5 m-85 -71.22 -34.78 71.13 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 88.3 m -67.03 -40.29 87.19 Favored 'General case' 0 C--N 1.354 0.795 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.04 -39.21 97.76 Favored Glycine 0 C--N 1.359 1.825 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.566 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -64.7 -40.02 94.66 Favored 'General case' 0 C--N 1.352 0.703 0 O-C-N 122.54 -0.388 . . . . 0.0 110.695 -178.333 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 24.6 mmt -64.18 -40.52 96.29 Favored 'General case' 0 C--N 1.353 0.739 0 O-C-N 121.672 -0.642 . . . . 0.0 111.046 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -65.53 -40.32 92.77 Favored 'General case' 0 C--N 1.349 0.552 0 O-C-N 121.991 -0.443 . . . . 0.0 111.516 -178.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 56.0 tp -66.14 -43.62 86.53 Favored 'General case' 0 C--N 1.348 0.542 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -178.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.566 HG12 ' O ' ' A' ' 9' ' ' LEU . 2.4 mm -72.84 -37.28 54.32 Favored 'Isoleucine or valine' 0 C--N 1.361 1.071 0 O-C-N 121.155 -0.966 . . . . 0.0 110.975 -175.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.423 ' HB2' HD13 ' A' ' 22' ' ' LEU . 71.2 tt0 -71.13 -41.49 70.44 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.864 -0.522 . . . . 0.0 111.609 -175.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -72.59 -35.47 67.92 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -175.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -94.54 -30.27 14.47 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 118.901 -1.12 . . . . 0.0 113.966 -174.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -116.04 -30.97 5.87 Favored 'General case' 0 CA--C 1.506 -0.712 0 C-N-CA 117.538 -1.665 . . . . 0.0 112.728 -176.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 139.87 177.71 16.05 Favored Glycine 0 C--N 1.346 1.113 0 C-N-CA 118.346 -1.883 . . . . 0.0 109.523 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -99.11 -18.35 17.75 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -177.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -70.44 -39.59 74.26 Favored 'General case' 0 C--N 1.36 1.049 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 94.3 m -67.92 -39.19 83.55 Favored 'General case' 0 C--N 1.357 0.899 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.423 HD13 ' HB2' ' A' ' 14' ' ' GLU . 1.0 OUTLIER -60.71 -38.16 84.09 Favored 'General case' 0 C--N 1.355 0.847 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.518 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -63.78 -37.17 86.38 Favored 'General case' 0 C--N 1.357 0.916 0 O-C-N 122.154 -0.341 . . . . 0.0 110.787 -178.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.4 m -64.91 -40.49 95.15 Favored 'General case' 0 C--N 1.356 0.884 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -178.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.596 ' CD2' ' HB3' ' A' ' 54' ' ' LYS . 31.4 mt -63.84 -36.75 84.93 Favored 'General case' 0 C--N 1.359 0.982 0 O-C-N 121.946 -0.471 . . . . 0.0 109.957 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.5 mt -71.49 -16.03 62.34 Favored 'General case' 0 C--N 1.358 0.971 0 O-C-N 121.661 -0.65 . . . . 0.0 110.184 -178.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -86.46 -27.73 23.92 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 119.351 -0.939 . . . . 0.0 109.278 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 41.7 t -67.01 -37.1 83.57 Favored 'General case' 0 C--N 1.355 0.845 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.8 p -93.02 -39.0 11.34 Favored 'General case' 0 C--N 1.359 0.988 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -179.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 84.12 133.25 0.05 OUTLIER 'General case' 0 C--N 1.361 1.104 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 179.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.524 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -91.44 -167.05 1.7 Allowed 'General case' 0 C--N 1.357 0.919 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.636 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.414 ' H ' ' HB2' ' A' ' 31' ' ' LEU . 63.3 tt0 -152.99 -66.76 0.16 Allowed 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.7 t -97.57 -66.55 0.89 Allowed 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -130.35 -44.76 1.12 Allowed 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -179.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.21 -33.72 5.42 Favored Glycine 0 C--N 1.353 1.474 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 179.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 83.8 mt -117.22 107.51 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.01 0 CA-C-N 118.413 1.107 . . . . 0.0 108.073 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.503 ' HD1' ' HA ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -84.08 -147.78 0.1 Allowed 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.185 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.524 HG23 ' N ' ' A' ' 39' ' ' SER . 5.0 t -119.46 -53.56 2.22 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.524 ' N ' HG23 ' A' ' 38' ' ' THR . 23.8 p 170.05 65.33 0.0 OUTLIER 'General case' 0 C--N 1.362 1.138 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.5 t -145.49 -11.24 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.957 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.149 -178.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -91.62 142.08 15.93 Favored Glycine 0 C--N 1.352 1.446 0 C-N-CA 119.275 -1.44 . . . . 0.0 110.538 -177.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.1 m -123.61 123.12 39.86 Favored 'General case' 0 C--N 1.354 0.767 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -117.5 175.4 5.65 Favored 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -81.86 -172.49 3.94 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 68.9 m80 -90.64 -15.09 31.07 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -68.74 -29.39 67.79 Favored 'General case' 0 C--N 1.352 0.678 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.434 ' CG ' ' HZ ' ' A' ' 6' ' ' PHE . 26.5 tp10 -64.38 -39.81 94.59 Favored 'General case' 0 C--N 1.353 0.722 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.419 HD22 ' O ' ' A' ' 48' ' ' LEU . 1.8 tm? -66.66 -38.56 87.11 Favored 'General case' 0 C--N 1.36 1.03 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 61.9 tp -70.32 -35.06 73.4 Favored 'General case' 0 CA--C 1.508 -0.667 0 O-C-N 122.232 -0.292 . . . . 0.0 110.47 -177.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -64.67 -41.2 96.24 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 121.936 -0.478 . . . . 0.0 109.914 -177.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 80.7 mt -83.55 -18.1 39.53 Favored 'General case' 0 C--N 1.359 1.001 0 C-N-CA 119.625 -0.83 . . . . 0.0 110.601 -179.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.4 t -80.33 -38.84 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.0 p -71.76 -30.55 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 O-C-N 121.597 -0.689 . . . . 0.0 109.406 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.596 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 33.5 tptt -70.97 -28.39 64.42 Favored 'General case' 0 C--N 1.368 1.373 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.539 HD13 HD11 ' A' ' 66' ' ' LEU . 1.1 mt -63.85 -42.02 97.66 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 46.7 t -66.21 -39.94 89.98 Favored 'General case' 0 C--N 1.352 0.707 0 O-C-N 121.736 -0.602 . . . . 0.0 110.648 -179.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -77.64 -40.31 42.21 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 121.123 -0.985 . . . . 0.0 112.876 -177.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.0 p -75.29 -39.88 42.62 Favored 'Isoleucine or valine' 0 C--N 1.354 0.771 0 O-C-N 121.531 -0.731 . . . . 0.0 112.348 -175.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 63.4 m -105.69 -9.25 17.41 Favored 'General case' 0 CA--C 1.503 -0.845 0 O-C-N 121.173 -0.954 . . . . 0.0 110.316 -177.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.417 ' HA ' ' O ' ' A' ' 56' ' ' SER . 0.4 OUTLIER 68.03 38.16 2.8 Favored 'General case' 0 C--N 1.351 0.656 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.881 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 56' ' ' SER . 58.2 t -115.37 128.05 26.28 Favored Pre-proline 0 N--CA 1.443 -0.81 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 61' ' ' VAL . 37.2 Cg_exo -59.86 154.02 52.9 Favored 'Trans proline' 0 CA--C 1.496 -1.376 0 C-N-CA 122.72 2.28 . . . . 0.0 113.519 -179.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.3 m -76.43 -7.71 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.66 -177.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.497 ' O ' HG12 ' A' ' 67' ' ' VAL . 81.4 p -94.71 -36.4 11.75 Favored 'General case' 0 C--N 1.358 0.944 0 C-N-CA 118.315 -1.354 . . . . 0.0 110.113 -178.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -82.48 -23.42 34.72 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.539 HD11 HD13 ' A' ' 55' ' ' LEU . 0.5 OUTLIER -70.29 -43.36 70.57 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.609 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.497 HG12 ' O ' ' A' ' 64' ' ' THR . 4.6 p -67.47 -28.89 43.67 Favored 'Isoleucine or valine' 0 C--N 1.354 0.803 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.678 -179.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -65.96 -47.92 73.02 Favored 'General case' 0 C--N 1.366 1.286 0 O-C-N 121.067 -1.021 . . . . 0.0 110.242 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 88.6 mt -64.53 -36.33 83.85 Favored 'General case' 0 C--N 1.353 0.739 0 O-C-N 122.353 -0.217 . . . . 0.0 111.191 -178.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -60.84 -47.4 86.53 Favored 'General case' 0 C--N 1.349 0.582 0 O-C-N 122.115 -0.365 . . . . 0.0 110.44 -178.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.03 -39.24 96.8 Favored Glycine 0 C--N 1.353 1.524 0 N-CA-C 111.882 -0.487 . . . . 0.0 111.882 -178.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.38 -47.86 80.28 Favored 'General case' 0 C--N 1.351 0.656 0 CA-C-N 118.127 0.963 . . . . 0.0 111.615 -177.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.4 mttm -64.38 -49.02 73.26 Favored 'General case' 0 C--N 1.357 0.925 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -177.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.418 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.5 tm? -69.11 -39.8 78.74 Favored 'General case' 0 C--N 1.349 0.566 0 O-C-N 121.194 -0.941 . . . . 0.0 111.865 -175.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -64.16 -45.97 86.1 Favored 'General case' 0 C--N 1.353 0.744 0 O-C-N 121.269 -0.895 . . . . 0.0 111.123 -177.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.11 -12.38 15.79 Favored 'Isoleucine or valine' 0 C--N 1.358 0.941 0 O-C-N 121.586 -0.696 . . . . 0.0 109.463 -179.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -78.52 -36.79 44.39 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 80.2 mt -70.57 -34.61 72.39 Favored 'General case' 0 C--N 1.358 0.94 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.3 mm -62.77 -50.37 79.99 Favored 'Isoleucine or valine' 0 C--N 1.357 0.904 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -178.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -67.89 -22.3 65.1 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.414 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.83 -1.18 61.8 Favored Glycine 0 C--N 1.347 1.19 0 C-N-CA 119.609 -1.281 . . . . 0.0 110.684 -177.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.637 ' HB3' ' HB ' ' A' ' 85' ' ' ILE . 93.2 m-70 -141.21 88.6 10.0 Favored Pre-proline 0 CA--C 1.503 -0.859 0 CA-C-N 118.937 1.368 . . . . 0.0 108.962 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 82' ' ' HIS . 36.8 Cg_endo -67.52 -25.79 40.84 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.425 2.083 . . . . 0.0 114.194 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -92.75 -6.14 49.69 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.637 ' HB ' ' HB3' ' A' ' 82' ' ' HIS . 1.0 OUTLIER -90.44 -22.3 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 -178.81 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -102.05 -21.4 14.46 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -69.85 -39.15 76.56 Favored 'General case' 0 C--N 1.355 0.827 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -65.48 -33.75 76.67 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.636 ' HG2' ' N ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -80.28 155.43 27.29 Favored 'General case' 0 C--N 1.353 0.749 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 -178.908 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.636 ' N ' ' HG2' ' A' ' 89' ' ' MET . 3.4 mtpt -117.15 -27.71 6.41 Favored 'General case' 0 C--N 1.364 1.207 0 C-N-CA 120.058 -0.657 . . . . 0.0 111.319 -177.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -167.08 175.47 7.51 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 -177.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 65.1 m -66.62 -40.09 88.63 Favored 'General case' 0 C--N 1.354 0.763 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.415 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -68.03 -39.61 83.09 Favored 'General case' 0 C--N 1.356 0.882 0 C-N-CA 119.587 -0.845 . . . . 0.0 108.805 -178.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -66.57 -23.03 66.15 Favored 'General case' 0 C--N 1.354 0.779 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.4 HD22 ' SG ' ' A' ' 150' ' ' CYS . 60.1 tp -65.25 -45.52 84.26 Favored 'General case' 0 C--N 1.354 0.797 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.5 mp -61.83 -36.5 81.36 Favored 'General case' 0 C--N 1.357 0.901 0 O-C-N 121.993 -0.442 . . . . 0.0 110.165 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 34.0 t -67.49 -39.83 85.2 Favored 'General case' 0 C--N 1.349 0.561 0 O-C-N 121.927 -0.483 . . . . 0.0 110.211 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.4 tttp -93.01 6.37 48.18 Favored 'General case' 0 C--N 1.353 0.76 0 O-C-N 122.241 -0.287 . . . . 0.0 111.567 -176.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 9.9 tp -64.4 -38.74 83.36 Favored 'Isoleucine or valine' 0 C--N 1.356 0.859 0 O-C-N 121.391 -0.818 . . . . 0.0 111.671 -177.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -103.44 -21.69 13.76 Favored 'General case' 0 N--CA 1.437 -1.116 0 O-C-N 120.884 -1.135 . . . . 0.0 110.26 -178.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 35.2 t -62.98 -47.0 85.04 Favored 'General case' 0 N--CA 1.445 -0.687 0 O-C-N 121.564 -0.71 . . . . 0.0 111.691 -178.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -137.5 -14.49 1.47 Allowed 'General case' 0 C--N 1.36 1.057 0 C-N-CA 117.369 -1.732 . . . . 0.0 113.036 -177.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 32.3 mm -70.41 -51.37 38.52 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 CA-C-N 120.099 1.318 . . . . 0.0 110.633 -177.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 35.5 m170 -91.9 2.32 56.61 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 119.485 -0.886 . . . . 0.0 110.301 -177.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 52.7 t -83.26 -44.22 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.032 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -68.34 -40.56 81.52 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 69.9 t -63.45 -46.77 94.35 Favored 'Isoleucine or valine' 0 C--N 1.357 0.901 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.363 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -60.75 -48.59 81.09 Favored 'General case' 0 C--N 1.357 0.926 0 O-C-N 122.064 -0.397 . . . . 0.0 111.409 -179.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -61.6 -37.21 83.07 Favored 'General case' 0 C--N 1.356 0.86 0 O-C-N 121.495 -0.753 . . . . 0.0 110.538 -178.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.5 mt -56.98 -73.9 0.06 Allowed 'General case' 0 C--N 1.357 0.9 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -119.13 135.47 23.9 Favored Pre-proline 0 N--CA 1.438 -1.047 0 C-N-CA 118.475 -1.29 . . . . 0.0 109.032 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -83.51 -4.61 10.87 Favored 'Trans proline' 0 C--N 1.313 -1.342 0 C-N-CA 123.174 2.583 . . . . 0.0 115.175 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -66.6 -36.84 83.58 Favored 'General case' 0 C--N 1.354 0.79 0 O-C-N 121.88 -0.512 . . . . 0.0 109.842 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.1 145.65 55.09 Favored 'General case' 0 C--N 1.354 0.764 0 CA-C-O 121.554 0.692 . . . . 0.0 109.787 -178.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -130.45 135.44 47.99 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.54 ' HB3' ' HD2' ' A' ' 117' ' ' PRO . 86.4 mt -127.68 157.18 74.09 Favored Pre-proline 0 N--CA 1.443 -0.823 0 CA-C-O 122.173 0.987 . . . . 0.0 109.196 -178.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.54 ' HD2' ' HB3' ' A' ' 116' ' ' LEU . 83.6 Cg_endo -81.02 -156.36 0.07 OUTLIER 'Trans proline' 0 C--N 1.316 -1.139 0 C-N-CA 123.797 2.998 . . . . 0.0 114.115 -179.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -113.38 140.26 48.2 Favored 'General case' 0 C--N 1.364 1.207 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -123.67 127.02 47.59 Favored 'General case' 0 C--N 1.362 1.144 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -179.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.479 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 94.2 m -126.26 128.98 48.01 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 177.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 81.0 m -119.83 130.73 55.03 Favored 'General case' 0 CA--C 1.503 -0.851 0 C-N-CA 119.105 -1.038 . . . . 0.0 109.677 -177.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -119.14 127.13 53.05 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 178.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 66.2 ttp85 -102.18 116.69 33.2 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 92.8 mt -87.42 -21.61 25.49 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.378 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 177.68 -146.59 7.69 Favored Glycine 0 N--CA 1.438 -1.226 0 C-N-CA 118.844 -1.645 . . . . 0.0 109.103 -178.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -94.72 -40.05 9.98 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 120.081 -0.648 . . . . 0.0 109.411 -178.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -101.53 1.45 38.02 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.24 -178.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -119.01 130.43 55.66 Favored 'General case' 0 C--N 1.358 0.968 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 7.6 mm -141.13 136.77 33.68 Favored 'Isoleucine or valine' 0 C--N 1.356 0.861 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 55.6 mtm180 -122.57 139.14 54.24 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.655 ' HG ' ' O ' ' A' ' 131' ' ' LEU . 0.1 OUTLIER -130.16 125.68 35.63 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.078 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.479 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 13.5 m-70 -96.77 134.56 39.89 Favored 'General case' 0 CA--C 1.495 -1.165 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -127.87 119.9 26.59 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 -178.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.534 ' HA ' ' O ' ' A' ' 171' ' ' THR . 76.6 mt-30 -113.51 114.74 26.94 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 179.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 12.7 t -162.73 152.55 15.92 Favored 'General case' 0 C--N 1.358 0.96 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -90.62 2.71 55.62 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 120.271 -0.572 . . . . 0.0 109.652 -179.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -136.11 74.54 55.86 Favored Pre-proline 0 CA--C 1.505 -0.752 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -95.88 107.78 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.771 2.314 . . . . 0.0 115.776 -177.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -111.94 113.6 26.02 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 176.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.98 -38.28 90.49 Favored 'General case' 0 C--N 1.353 0.73 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.007 -179.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.0 m -63.27 -27.34 69.27 Favored 'General case' 0 C--N 1.354 0.773 0 O-C-N 122.009 -0.432 . . . . 0.0 110.875 -178.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -76.63 -46.43 25.96 Favored 'General case' 0 C--N 1.351 0.652 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.639 -178.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.63 -40.11 94.9 Favored 'General case' 0 C--N 1.357 0.923 0 O-C-N 122.039 -0.413 . . . . 0.0 111.056 -178.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.64 -37.25 86.61 Favored 'General case' 0 C--N 1.355 0.83 0 O-C-N 121.907 -0.496 . . . . 0.0 110.081 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -59.88 -43.16 98.28 Favored Glycine 0 C--N 1.347 1.176 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 83.5 mt -69.78 -40.78 75.83 Favored 'General case' 0 C--N 1.352 0.694 0 CA-C-N 117.749 0.774 . . . . 0.0 112.503 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 98.0 mt -71.29 -42.41 68.73 Favored 'General case' 0 C--N 1.361 1.083 0 O-C-N 121.206 -0.934 . . . . 0.0 110.961 -176.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.496 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 37.0 t70 -69.93 -31.36 69.08 Favored 'General case' 0 N--CA 1.446 -0.652 0 O-C-N 121.956 -0.465 . . . . 0.0 110.514 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -62.84 -39.38 97.92 Favored Glycine 0 C--N 1.357 1.745 0 N-CA-C 108.46 -1.856 . . . . 0.0 108.46 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.4 ' SG ' HD22 ' A' ' 95' ' ' LEU . 49.9 t -60.71 -41.46 95.29 Favored 'General case' 0 C--N 1.35 0.6 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -74.8 -1.48 22.33 Favored 'General case' 0 C--N 1.361 1.077 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 77.7 mm-40 -84.4 -46.07 12.08 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 92.9 t80 -65.95 -45.06 83.16 Favored 'General case' 0 C--N 1.359 0.989 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.416 ' HZ ' ' SD ' ' A' ' 89' ' ' MET . 38.9 m-85 -69.01 -26.62 65.09 Favored 'General case' 0 C--N 1.36 1.053 0 O-C-N 121.874 -0.516 . . . . 0.0 110.802 -178.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 78.9 tttt 72.72 74.35 0.15 Allowed 'General case' 0 C--N 1.36 1.035 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -143.13 -168.12 2.72 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -148.67 94.45 2.28 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -111.88 156.11 22.56 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 178.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 93.9 m -119.47 127.1 52.74 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 119.208 -0.997 . . . . 0.0 108.716 -178.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.497 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.7 mp -103.89 122.2 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 178.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.5 m -115.64 -175.96 2.83 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-O 121.826 0.822 . . . . 0.0 109.134 -179.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 3.5 ptt180 -146.75 153.63 40.46 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 -178.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 44.8 p -97.62 145.93 30.55 Favored Pre-proline 0 C--N 1.361 1.08 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.623 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 76.8 Cg_endo -77.13 -11.24 17.79 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.944 2.429 . . . . 0.0 115.127 -178.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -72.74 -41.29 65.32 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.573 -178.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 36.8 p -116.96 15.3 15.16 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.299 -178.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.623 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.5 pp0? -65.13 -13.65 58.63 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.408 178.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -126.89 43.18 3.17 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 16.8 t -142.57 145.13 33.27 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.631 ' O ' ' HB ' ' A' ' 171' ' ' THR . 61.1 mt-10 -98.98 165.49 11.73 Favored 'General case' 0 C--N 1.354 0.804 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.631 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 3.0 m 83.42 -57.13 0.15 Allowed 'General case' 0 C--N 1.369 1.423 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.637 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -110.93 117.44 33.38 Favored 'General case' 0 CA--C 1.506 -0.72 0 C-N-CA 119.814 -0.754 . . . . 0.0 109.603 -178.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 98.7 t -131.33 133.39 62.27 Favored 'Isoleucine or valine' 0 C--N 1.356 0.857 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 178.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 48.6 mm -109.36 125.99 66.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.964 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -179.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -115.08 148.38 39.0 Favored 'General case' 0 C--N 1.357 0.922 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -128.58 117.4 21.19 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 -179.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.8 mp -111.94 118.38 57.51 Favored 'Isoleucine or valine' 0 C--N 1.354 0.765 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 89.3 m -124.3 142.84 50.94 Favored 'General case' 0 CA--C 1.502 -0.893 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -177.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 12.2 ttt180 . . . . . 0 C--N 1.363 1.153 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 178.848 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.692 ' HG2' ' HB2' ' A' ' 4' ' ' MET . 27.2 tpp . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 120.881 0.372 . . . . 0.0 110.538 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.34 -20.14 41.29 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -77.86 -37.68 29.08 Favored Glycine 0 C--N 1.35 1.331 0 N-CA-C 109.101 -1.599 . . . . 0.0 109.101 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . 0.692 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 3.0 tpp -70.84 -38.21 73.18 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 122.035 -0.685 . . . . 0.0 110.707 -177.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.2 m -71.28 -23.14 22.82 Favored 'Isoleucine or valine' 0 C--N 1.357 0.93 0 O-C-N 121.651 -0.656 . . . . 0.0 109.415 -178.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.0 m-30 -71.06 -33.38 70.22 Favored 'General case' 0 C--N 1.357 0.893 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.1 m -67.14 -40.17 86.68 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.93 -38.82 97.22 Favored Glycine 0 C--N 1.36 1.893 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.506 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.1 OUTLIER -66.13 -39.11 89.62 Favored 'General case' 0 C--N 1.353 0.736 0 CA-C-N 117.274 0.537 . . . . 0.0 110.31 -177.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.443 ' CE ' HD21 ' A' ' 26' ' ' LEU . 25.5 mmt -64.02 -40.6 96.71 Favored 'General case' 0 C--N 1.355 0.822 0 O-C-N 121.635 -0.666 . . . . 0.0 110.753 -178.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -64.77 -40.07 94.66 Favored 'General case' 0 C--N 1.349 0.547 0 O-C-N 122.055 -0.403 . . . . 0.0 111.307 -178.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 58.2 tp -65.0 -42.68 94.26 Favored 'General case' 0 C--N 1.35 0.592 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.659 HD12 HD21 ' A' ' 55' ' ' LEU . 3.3 mm -72.44 -37.58 57.99 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 O-C-N 121.169 -0.957 . . . . 0.0 111.179 -175.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -68.02 -43.75 78.05 Favored 'General case' 0 C--N 1.352 0.679 0 O-C-N 121.821 -0.549 . . . . 0.0 111.653 -175.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -71.9 -32.45 67.42 Favored 'General case' 0 N--CA 1.447 -0.579 0 O-C-N 122.001 -0.437 . . . . 0.0 111.487 -177.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -72.5 -49.96 29.32 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -175.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -127.98 -20.97 3.73 Favored 'General case' 0 C--N 1.357 0.917 0 C-N-CA 117.347 -1.741 . . . . 0.0 113.694 -176.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 143.42 178.88 19.61 Favored Glycine 0 CA--C 1.499 -0.947 0 C-N-CA 117.678 -2.201 . . . . 0.0 110.23 -179.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -96.5 -11.34 25.65 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -177.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -74.64 -36.57 62.88 Favored 'General case' 0 C--N 1.359 0.986 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.2 m -70.11 -38.91 75.74 Favored 'General case' 0 C--N 1.358 0.952 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 178.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.7 tt -59.84 -38.09 81.09 Favored 'General case' 0 C--N 1.359 0.994 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -64.12 -37.09 86.19 Favored 'General case' 0 C--N 1.356 0.87 0 O-C-N 122.097 -0.377 . . . . 0.0 110.788 -178.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.5 m -65.25 -40.63 94.24 Favored 'General case' 0 C--N 1.355 0.836 0 O-C-N 121.698 -0.626 . . . . 0.0 109.62 -178.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.41 HD22 ' HB3' ' A' ' 54' ' ' LYS . 78.7 mt -64.9 -36.82 85.6 Favored 'General case' 0 C--N 1.356 0.868 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 -178.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.443 HD21 ' CE ' ' A' ' 10' ' ' MET . 81.1 mt -70.84 -16.5 62.72 Favored 'General case' 0 C--N 1.36 1.048 0 O-C-N 121.765 -0.584 . . . . 0.0 110.235 -179.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -85.07 -27.83 26.06 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.29 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.2 t -66.89 -37.54 84.59 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.8 p -91.61 -39.54 11.82 Favored 'General case' 0 C--N 1.359 0.995 0 C-N-CA 119.064 -1.054 . . . . 0.0 108.18 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 86.15 132.45 0.04 OUTLIER 'General case' 0 C--N 1.36 1.049 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.532 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -91.91 -167.07 1.69 Allowed 'General case' 0 C--N 1.356 0.885 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.841 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.416 ' H ' ' HB2' ' A' ' 31' ' ' LEU . 4.3 mt-30 -153.05 -66.3 0.15 Allowed 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 106.816 -1.549 . . . . 0.0 106.816 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.0 t -97.71 -67.12 0.86 Allowed 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -131.42 -46.53 0.98 Allowed 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.24 -37.37 3.51 Favored Glycine 0 C--N 1.354 1.566 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 179.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 81.9 mt -113.62 106.09 20.02 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.041 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.523 ' HD1' ' HA ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -82.57 -150.78 0.09 Allowed 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.496 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.409 ' H ' ' HB3' ' A' ' 37' ' ' TYR . 86.2 m -112.09 -57.84 2.21 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 11.6 p 169.06 69.8 0.0 OUTLIER 'General case' 0 C--N 1.36 1.029 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.2 t -150.29 -6.69 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.361 1.081 0 C-N-CA 119.707 -0.797 . . . . 0.0 110.047 -178.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -95.26 143.08 16.42 Favored Glycine 0 C--N 1.352 1.447 0 C-N-CA 119.28 -1.438 . . . . 0.0 110.465 -177.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.0 m -123.94 116.77 23.42 Favored 'General case' 0 C--N 1.356 0.871 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 178.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -111.66 177.42 4.66 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -78.66 -175.14 4.23 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 65.4 m80 -94.38 -15.6 24.2 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 119.781 -0.767 . . . . 0.0 109.179 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -68.88 -29.22 67.47 Favored 'General case' 0 C--N 1.353 0.749 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.6 tp10 -62.72 -41.51 99.19 Favored 'General case' 0 C--N 1.353 0.719 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.406 ' O ' HG23 ' A' ' 52' ' ' VAL . 59.9 tp -67.62 -38.74 84.36 Favored 'General case' 0 C--N 1.357 0.893 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.218 -179.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 60.5 tp -72.3 -34.69 68.32 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 122.259 -0.276 . . . . 0.0 110.689 -177.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 72.7 tp60 -64.18 -41.81 96.95 Favored 'General case' 0 C--N 1.353 0.721 0 O-C-N 121.589 -0.694 . . . . 0.0 110.004 -177.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 84.2 mt -71.79 -34.64 69.58 Favored 'General case' 0 C--N 1.362 1.113 0 C-N-CA 119.534 -0.867 . . . . 0.0 109.431 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.565 HG13 HD21 ' A' ' 66' ' ' LEU . 29.2 t -62.65 -42.12 94.82 Favored 'Isoleucine or valine' 0 C--N 1.351 0.645 0 CA-C-O 120.705 0.288 . . . . 0.0 110.309 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 53.9 t -65.76 -40.21 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.41 ' HB3' HD22 ' A' ' 25' ' ' LEU . 32.1 tptt -65.22 -29.2 69.98 Favored 'General case' 0 C--N 1.361 1.107 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.659 HD21 HD12 ' A' ' 13' ' ' ILE . 16.0 mt -64.27 -40.26 95.6 Favored 'General case' 0 C--N 1.357 0.902 0 O-C-N 121.968 -0.457 . . . . 0.0 110.395 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.611 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 46.5 t -65.39 -37.44 87.0 Favored 'General case' 0 C--N 1.349 0.573 0 O-C-N 121.775 -0.578 . . . . 0.0 110.324 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -83.74 -38.25 21.61 Favored 'General case' 0 C--N 1.353 0.73 0 O-C-N 121.242 -0.911 . . . . 0.0 112.811 -177.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.6 p -76.03 -41.6 38.4 Favored 'Isoleucine or valine' 0 C--N 1.355 0.83 0 O-C-N 121.354 -0.841 . . . . 0.0 111.897 -176.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 72.8 m -103.66 -5.66 22.38 Favored 'General case' 0 C--N 1.354 0.803 0 O-C-N 121.198 -0.939 . . . . 0.0 110.486 -177.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 74.6 m 65.05 38.95 5.9 Favored 'General case' 0 C--N 1.354 0.769 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.611 ' O ' ' HA ' ' A' ' 56' ' ' SER . 55.4 t -115.53 132.22 23.23 Favored Pre-proline 0 CA--C 1.505 -0.778 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.474 ' HD2' HG13 ' A' ' 61' ' ' VAL . 31.2 Cg_endo -63.99 157.16 54.47 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.258 1.972 . . . . 0.0 114.095 -178.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.839 ' HA ' HD23 ' A' ' 66' ' ' LEU . 15.5 m -75.98 -12.66 14.62 Favored 'Isoleucine or valine' 0 C--N 1.353 0.742 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.031 -177.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.475 ' O ' HG12 ' A' ' 67' ' ' VAL . 81.1 p -94.13 -35.14 12.67 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 118.068 -1.453 . . . . 0.0 110.129 -178.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -80.9 -21.22 40.76 Favored 'General case' 0 C--N 1.353 0.737 0 O-C-N 121.167 -0.958 . . . . 0.0 108.892 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.839 HD23 ' HA ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -77.19 -36.67 54.78 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.732 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.515 ' N ' ' HG ' ' A' ' 66' ' ' LEU . 1.8 p -68.83 -28.9 41.59 Favored 'Isoleucine or valine' 0 C--N 1.359 0.981 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.055 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -68.49 -49.1 62.24 Favored 'General case' 0 C--N 1.365 1.265 0 O-C-N 121.234 -0.916 . . . . 0.0 110.656 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.9 mt -63.83 -36.41 83.81 Favored 'General case' 0 C--N 1.357 0.893 0 O-C-N 122.069 -0.395 . . . . 0.0 111.027 -178.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -61.16 -47.07 87.88 Favored 'General case' 0 C--N 1.348 0.536 0 O-C-N 122.134 -0.354 . . . . 0.0 110.495 -178.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.25 -39.29 96.99 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-O 119.787 -0.452 . . . . 0.0 112.17 -177.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -65.7 -45.45 82.75 Favored 'General case' 0 C--N 1.352 0.674 0 CA-C-N 118.513 1.157 . . . . 0.0 111.638 -177.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 12.2 mttm -64.86 -48.24 75.0 Favored 'General case' 0 C--N 1.357 0.921 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -177.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.406 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.2 tm? -70.76 -39.31 73.33 Favored 'General case' 0 C--N 1.349 0.563 0 O-C-N 121.263 -0.898 . . . . 0.0 111.963 -176.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -63.56 -46.45 85.85 Favored 'General case' 0 C--N 1.353 0.755 0 O-C-N 121.103 -0.998 . . . . 0.0 111.239 -178.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.8 p -70.89 -14.72 18.26 Favored 'Isoleucine or valine' 0 C--N 1.357 0.931 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -71.11 -39.76 71.88 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 87.7 mt -75.78 -27.19 57.93 Favored 'General case' 0 C--N 1.359 0.986 0 O-C-N 122.258 -0.276 . . . . 0.0 110.569 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.1 mm -65.78 -53.59 36.78 Favored 'Isoleucine or valine' 0 C--N 1.36 1.059 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.432 -178.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -75.26 -14.6 60.52 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 119.611 -0.836 . . . . 0.0 109.259 178.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.7 -37.58 61.47 Favored Glycine 0 C--N 1.35 1.345 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -132.55 102.9 13.69 Favored Pre-proline 0 C--N 1.356 0.887 0 CA-C-O 122.611 1.196 . . . . 0.0 109.104 -177.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.488 ' O ' ' HB2' ' A' ' 87' ' ' ASN . 40.3 Cg_endo -68.74 -22.23 37.49 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.556 2.17 . . . . 0.0 114.039 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -90.69 -9.56 46.36 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -89.84 -21.89 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.967 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 -178.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -102.66 -16.35 16.06 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . 0.488 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 49.2 t30 -70.99 -40.64 71.75 Favored 'General case' 0 C--N 1.36 1.028 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -67.7 -28.38 67.63 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 120.746 -0.381 . . . . 0.0 110.418 -179.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.681 ' SD ' ' HZ ' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -81.59 152.24 27.29 Favored 'General case' 0 C--N 1.352 0.696 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -179.488 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.594 ' N ' ' HG2' ' A' ' 89' ' ' MET . 4.6 mtpt -117.14 -26.76 6.69 Favored 'General case' 0 C--N 1.365 1.246 0 C-N-CA 120.054 -0.659 . . . . 0.0 111.293 -177.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -167.74 175.6 6.85 Favored 'General case' 0 C--N 1.354 0.797 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -177.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.417 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 42.2 t -64.75 -43.95 91.67 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.383 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -68.08 -39.54 82.9 Favored 'General case' 0 C--N 1.355 0.836 0 O-C-N 121.365 -0.834 . . . . 0.0 109.418 -178.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -66.23 -22.45 66.33 Favored 'General case' 0 C--N 1.353 0.757 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.417 ' HB3' ' O ' ' A' ' 92' ' ' SER . 60.3 tp -65.08 -46.03 82.85 Favored 'General case' 0 C--N 1.354 0.767 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.9 mp -62.96 -36.13 82.45 Favored 'General case' 0 C--N 1.355 0.839 0 O-C-N 122.2 -0.313 . . . . 0.0 110.744 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 35.9 t -65.09 -41.69 94.74 Favored 'General case' 0 C--N 1.349 0.582 0 O-C-N 121.849 -0.532 . . . . 0.0 111.555 -178.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.786 ' HG2' ' O ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -102.37 9.85 39.5 Favored 'General case' 0 C--N 1.358 0.946 0 O-C-N 121.676 -0.64 . . . . 0.0 110.327 -176.126 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.661 ' HA ' HD12 ' A' ' 103' ' ' ILE . 11.7 tt -63.1 -35.14 70.5 Favored 'Isoleucine or valine' 0 C--N 1.354 0.797 0 O-C-N 121.088 -1.008 . . . . 0.0 111.984 -176.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -111.28 -18.52 12.91 Favored 'General case' 0 N--CA 1.438 -1.054 0 O-C-N 120.814 -1.179 . . . . 0.0 109.99 -178.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 37.7 t -64.38 -46.9 81.35 Favored 'General case' 0 N--CA 1.443 -0.808 0 O-C-N 121.697 -0.627 . . . . 0.0 111.107 -178.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -130.15 -21.1 2.98 Favored 'General case' 0 C--N 1.359 0.986 0 C-N-CA 118.002 -1.479 . . . . 0.0 112.565 -177.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.661 HD12 ' HA ' ' A' ' 99' ' ' ILE . 96.1 mt -71.15 -49.5 48.25 Favored 'Isoleucine or valine' 0 C--O 1.242 0.693 0 O-C-N 120.771 -1.205 . . . . 0.0 110.976 -177.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 29.8 m170 -89.41 3.49 52.1 Favored 'General case' 0 N--CA 1.439 -0.982 0 O-C-N 121.111 -0.993 . . . . 0.0 109.996 -177.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.5 p -88.82 -34.26 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 178.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -72.11 -40.92 67.8 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 76.5 t -63.81 -46.54 94.1 Favored 'Isoleucine or valine' 0 C--N 1.356 0.861 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -60.6 -48.62 80.96 Favored 'General case' 0 C--N 1.359 1.015 0 O-C-N 122.226 -0.296 . . . . 0.0 111.447 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -60.97 -38.11 84.77 Favored 'General case' 0 C--N 1.356 0.857 0 O-C-N 121.567 -0.708 . . . . 0.0 110.651 -178.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 18.5 mt -57.66 -75.66 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -116.22 132.7 23.14 Favored Pre-proline 0 N--CA 1.438 -1.054 0 C-N-CA 118.708 -1.197 . . . . 0.0 108.857 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -83.04 -4.87 11.28 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 123.136 2.557 . . . . 0.0 115.003 -179.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -66.9 -36.76 83.01 Favored 'General case' 0 C--N 1.355 0.806 0 O-C-N 121.964 -0.46 . . . . 0.0 109.826 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.5 147.25 52.27 Favored 'General case' 0 C--N 1.352 0.69 0 CA-C-O 121.585 0.707 . . . . 0.0 109.849 -178.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -132.47 135.56 46.12 Favored 'General case' 0 C--N 1.357 0.898 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 179.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.517 ' HB3' ' HD2' ' A' ' 117' ' ' PRO . 2.7 mm? -124.12 156.45 66.28 Favored Pre-proline 0 C--N 1.354 0.789 0 CA-C-O 122.023 0.916 . . . . 0.0 108.649 -178.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.517 ' HD2' ' HB3' ' A' ' 116' ' ' LEU . 95.0 Cg_endo -79.23 -160.17 0.12 Allowed 'Trans proline' 0 C--N 1.318 -1.047 0 C-N-CA 123.554 2.836 . . . . 0.0 113.22 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -120.73 144.11 48.42 Favored 'General case' 0 C--N 1.364 1.201 0 C-N-CA 118.997 -1.081 . . . . 0.0 108.24 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.56 ' HE2' ' CD1' ' A' ' 133' ' ' TYR . 22.4 m-85 -129.13 137.77 51.4 Favored 'General case' 0 C--N 1.362 1.109 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.35 -178.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.401 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 93.8 m -123.87 129.49 51.08 Favored 'General case' 0 C--N 1.356 0.85 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 177.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 82.5 m -113.49 127.55 56.14 Favored 'General case' 0 CA--C 1.503 -0.846 0 C-N-CA 119.069 -1.052 . . . . 0.0 109.717 -177.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -120.24 118.9 31.68 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 178.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -96.23 117.85 31.6 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -178.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 92.8 mt -88.98 -20.07 24.91 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.303 -179.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -179.88 -150.08 8.93 Favored Glycine 0 C--N 1.349 1.303 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 -178.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -94.69 -36.06 11.9 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -178.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -103.34 0.12 30.93 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 120.176 -0.61 . . . . 0.0 109.969 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -116.69 134.03 55.3 Favored 'General case' 0 C--N 1.358 0.954 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.411 HD13 ' HA ' ' A' ' 129' ' ' ILE . 8.1 mm -144.85 137.95 22.1 Favored 'Isoleucine or valine' 0 C--N 1.357 0.923 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 26.1 mtm180 -125.42 135.83 52.78 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.726 HD23 HD11 ' A' ' 177' ' ' ILE . 0.2 OUTLIER -129.05 128.03 42.76 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.708 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.401 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 18.5 m170 -95.78 138.29 33.64 Favored 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.56 ' CD1' ' HE2' ' A' ' 119' ' ' PHE . 65.3 t80 -126.3 118.97 26.19 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 -178.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.484 ' HA ' ' O ' ' A' ' 171' ' ' THR . 27.5 tt0 -113.36 114.15 26.23 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 12.7 t -165.11 151.32 10.07 Favored 'General case' 0 C--N 1.358 0.962 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -91.12 4.31 52.51 Favored 'General case' 0 C--N 1.355 0.846 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.638 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' A' ' 137' ' ' ARG . 1.0 OUTLIER -135.68 72.69 62.75 Favored Pre-proline 0 C--N 1.355 0.847 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 179.053 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -96.47 108.23 0.1 Allowed 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 122.749 2.299 . . . . 0.0 115.924 -177.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -111.91 113.27 25.49 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 176.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.21 -38.6 91.8 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.101 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.1 m -63.43 -28.18 69.8 Favored 'General case' 0 C--N 1.353 0.726 0 O-C-N 121.967 -0.458 . . . . 0.0 110.903 -178.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -75.33 -45.94 36.39 Favored 'General case' 0 C--N 1.351 0.641 0 C-N-CA 120.156 -0.617 . . . . 0.0 109.552 -177.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.67 -39.79 91.71 Favored 'General case' 0 C--N 1.356 0.887 0 O-C-N 122.047 -0.408 . . . . 0.0 111.356 -177.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -62.99 -37.26 86.46 Favored 'General case' 0 C--N 1.355 0.843 0 O-C-N 121.78 -0.575 . . . . 0.0 110.057 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.59 -42.94 99.4 Favored Glycine 0 C--N 1.348 1.214 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 82.8 mt -69.54 -41.14 76.34 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 117.437 0.619 . . . . 0.0 112.596 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 97.0 mt -71.29 -42.04 69.18 Favored 'General case' 0 C--N 1.36 1.06 0 O-C-N 121.252 -0.905 . . . . 0.0 110.999 -177.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -69.88 -31.83 69.86 Favored 'General case' 0 C--N 1.349 0.555 0 O-C-N 121.994 -0.441 . . . . 0.0 110.597 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.532 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -62.59 -40.03 98.62 Favored Glycine 0 C--N 1.355 1.632 0 N-CA-C 108.674 -1.771 . . . . 0.0 108.674 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.401 ' SG ' HD22 ' A' ' 95' ' ' LEU . 45.1 t -61.05 -42.67 98.91 Favored 'General case' 0 C--N 1.35 0.621 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.584 ' HB1' ' O ' ' A' ' 156' ' ' GLU . . . -76.05 1.79 14.54 Favored 'General case' 0 C--N 1.357 0.931 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.532 ' HB2' ' O ' ' A' ' 149' ' ' GLY . 7.6 mm-40 -86.57 -47.7 9.0 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -65.11 -45.19 86.14 Favored 'General case' 0 C--N 1.359 0.993 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.681 ' HZ ' ' SD ' ' A' ' 89' ' ' MET . 51.9 m-85 -69.25 -27.99 65.92 Favored 'General case' 0 C--N 1.362 1.132 0 O-C-N 121.897 -0.502 . . . . 0.0 111.013 -178.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 85.2 tttt 72.3 73.59 0.16 Allowed 'General case' 0 C--N 1.359 0.998 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -178.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.584 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 2.4 tp10 -156.34 119.21 4.14 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -82.39 106.84 14.6 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 120.086 -0.646 . . . . 0.0 111.069 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 11.9 m-30 -112.38 160.31 17.83 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 176.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 92.3 m -120.47 127.84 52.59 Favored 'General case' 0 CA--C 1.505 -0.772 0 C-N-CA 118.938 -1.105 . . . . 0.0 109.073 -178.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.48 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.9 mp -105.65 122.63 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 178.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.7 m -118.87 -171.93 2.19 Favored 'General case' 0 C--N 1.358 0.936 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -178.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -145.36 154.57 42.44 Favored 'General case' 0 C--N 1.356 0.851 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -178.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 28.7 p -96.27 144.84 28.53 Favored Pre-proline 0 C--N 1.36 1.054 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 178.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.702 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 72.9 Cg_endo -75.63 -12.83 20.29 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.79 2.326 . . . . 0.0 115.203 -178.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -72.91 -41.77 64.25 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.664 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 41.9 p -115.84 15.14 16.36 Favored 'General case' 0 C--N 1.355 0.807 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.391 -178.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.702 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.3 pp0? -66.6 -12.64 58.9 Favored 'General case' 0 C--N 1.355 0.834 0 O-C-N 121.59 -0.694 . . . . 0.0 110.454 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -128.08 42.53 3.3 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 19.1 t -143.17 145.03 32.44 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.633 ' O ' ' HB ' ' A' ' 171' ' ' THR . 61.7 mt-10 -97.44 165.45 12.0 Favored 'General case' 0 C--N 1.355 0.818 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.633 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 16.9 m 84.81 -58.62 0.1 Allowed 'General case' 0 C--N 1.369 1.451 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -109.9 114.74 28.53 Favored 'General case' 0 CA--C 1.504 -0.803 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.45 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 95.2 t -133.26 133.09 58.28 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 63.3 mt -117.57 128.48 74.79 Favored 'Isoleucine or valine' 0 C--N 1.358 0.968 0 CA-C-O 122.14 0.971 . . . . 0.0 109.456 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -110.52 145.23 38.1 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 114.838 -1.074 . . . . 0.0 108.336 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -119.61 118.3 30.63 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.726 HD11 HD23 ' A' ' 131' ' ' LEU . 3.7 mp -112.4 119.0 59.23 Favored 'Isoleucine or valine' 0 C--N 1.354 0.793 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 -178.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 90.3 m -124.6 142.05 51.65 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -177.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 13.6 ttt180 . . . . . 0 C--N 1.36 1.038 0 N-CA-C 106.835 -1.542 . . . . 0.0 106.835 179.127 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.5 mtm . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.298 0.57 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.74 -14.11 58.4 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -178.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.22 -41.99 44.62 Favored Glycine 0 C--N 1.351 1.369 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 17.6 ttp -68.15 -39.37 82.67 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 122.119 -0.636 . . . . 0.0 111.564 -177.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.0 m -68.25 -23.5 28.65 Favored 'Isoleucine or valine' 0 C--N 1.356 0.871 0 O-C-N 121.462 -0.773 . . . . 0.0 109.534 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.42 ' HZ ' ' HG3' ' A' ' 47' ' ' GLU . 2.6 m-85 -71.53 -34.05 69.71 Favored 'General case' 0 C--N 1.359 0.994 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 179.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.8 m -66.1 -40.37 90.69 Favored 'General case' 0 C--N 1.355 0.826 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -61.83 -38.68 96.38 Favored Glycine 0 C--N 1.358 1.8 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.673 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -64.54 -41.78 96.13 Favored 'General case' 0 C--N 1.352 0.705 0 CA-C-N 117.072 0.436 . . . . 0.0 111.068 -178.552 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 18.5 mmt -63.0 -41.29 99.55 Favored 'General case' 0 C--N 1.353 0.733 0 O-C-N 121.519 -0.738 . . . . 0.0 111.247 -178.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -67.91 -40.27 83.47 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.762 -177.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 55.3 tp -66.7 -43.34 84.63 Favored 'General case' 0 C--N 1.349 0.549 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -177.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.673 HG12 ' O ' ' A' ' 9' ' ' LEU . 1.6 mm -73.84 -37.95 49.44 Favored 'Isoleucine or valine' 0 C--N 1.359 0.979 0 O-C-N 121.06 -1.025 . . . . 0.0 111.057 -175.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -70.19 -42.01 72.96 Favored 'General case' 0 C--N 1.349 0.554 0 O-C-N 121.699 -0.626 . . . . 0.0 111.546 -176.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -71.48 -37.3 71.3 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -175.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -93.37 -32.39 14.28 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -174.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -115.51 -32.22 5.64 Favored 'General case' 0 CA--C 1.506 -0.723 0 C-N-CA 117.424 -1.71 . . . . 0.0 112.828 -176.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 146.58 178.19 21.77 Favored Glycine 0 C--N 1.346 1.085 0 C-N-CA 117.954 -2.069 . . . . 0.0 110.379 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -101.5 -23.75 14.26 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -177.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -69.52 -39.83 77.28 Favored 'General case' 0 C--N 1.36 1.047 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 94.9 m -67.96 -38.33 82.64 Favored 'General case' 0 C--N 1.357 0.915 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.8 tp -59.93 -38.1 81.41 Favored 'General case' 0 C--N 1.355 0.838 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 179.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -65.5 -36.57 84.24 Favored 'General case' 0 C--N 1.358 0.958 0 O-C-N 122.081 -0.387 . . . . 0.0 110.805 -178.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.4 m -65.33 -38.84 91.37 Favored 'General case' 0 C--N 1.354 0.797 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.639 HD13 HD22 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -63.06 -38.23 90.37 Favored 'General case' 0 C--N 1.353 0.732 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -179.13 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 85.0 mt -73.84 -14.11 61.03 Favored 'General case' 0 C--N 1.359 1.009 0 O-C-N 121.749 -0.594 . . . . 0.0 110.415 -178.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -86.61 -28.59 23.16 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 119.185 -1.006 . . . . 0.0 109.374 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.7 t -67.03 -37.04 83.41 Favored 'General case' 0 C--N 1.355 0.827 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.536 ' HB3' HD21 ' A' ' 51' ' ' LEU . 2.0 p -91.51 -39.89 11.68 Favored 'General case' 0 C--N 1.359 1.015 0 C-N-CA 118.849 -1.14 . . . . 0.0 108.153 -179.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 85.97 131.45 0.04 OUTLIER 'General case' 0 C--N 1.361 1.091 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.506 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -90.52 -166.83 1.68 Allowed 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.888 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.423 ' H ' ' HB2' ' A' ' 31' ' ' LEU . 60.6 tt0 -154.2 -61.78 0.13 Allowed 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 -179.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.8 t -101.53 -68.39 0.82 Allowed 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -137.0 -42.67 0.58 Allowed 'General case' 0 CA--C 1.502 -0.899 0 C-N-CA 119.583 -0.847 . . . . 0.0 108.881 -178.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.16 -33.92 3.86 Favored Glycine 0 C--N 1.352 1.442 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 84.8 mt -112.44 102.03 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.728 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -104.28 11.73 34.5 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.816 HG22 ' H ' ' A' ' 39' ' ' SER . 1.9 m 76.31 -170.53 0.08 Allowed 'General case' 0 C--N 1.358 0.974 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.816 ' H ' HG22 ' A' ' 38' ' ' THR . 21.6 p -97.65 51.45 1.07 Allowed 'General case' 0 C--N 1.354 0.769 0 O-C-N 121.151 -0.968 . . . . 0.0 110.26 -178.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.471 HG12 ' O ' ' A' ' 40' ' ' VAL . 17.9 t -107.95 -10.78 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.685 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -107.09 159.18 14.76 Favored Glycine 0 C--N 1.357 1.743 0 C-N-CA 119.338 -1.411 . . . . 0.0 109.92 -178.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 36.2 m -129.28 134.26 47.87 Favored 'General case' 0 C--N 1.361 1.097 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -122.35 174.37 7.05 Favored 'General case' 0 C--N 1.355 0.815 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -77.31 -176.49 4.16 Favored 'General case' 0 C--N 1.357 0.899 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.514 ' CD2' HH22 ' A' ' 137' ' ' ARG . 74.8 m80 -92.16 -15.95 26.94 Favored 'General case' 0 C--N 1.356 0.887 0 C-N-CA 120.131 -0.628 . . . . 0.0 109.417 -178.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -67.6 -28.29 67.63 Favored 'General case' 0 C--N 1.351 0.64 0 N-CA-C 107.605 -1.258 . . . . 0.0 107.605 177.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.42 ' HG3' ' HZ ' ' A' ' 6' ' ' PHE . 29.8 tp10 -63.11 -41.52 99.36 Favored 'General case' 0 C--N 1.352 0.687 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -67.88 -39.46 83.7 Favored 'General case' 0 C--N 1.359 1.001 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 60.8 tp -69.64 -36.42 76.1 Favored 'General case' 0 CA--C 1.508 -0.664 0 O-C-N 122.167 -0.333 . . . . 0.0 110.498 -177.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -65.02 -40.22 94.54 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 121.686 -0.634 . . . . 0.0 109.986 -178.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.639 HD22 HD13 ' A' ' 25' ' ' LEU . 77.0 mt -81.37 -19.16 43.28 Favored 'General case' 0 C--N 1.36 1.028 0 C-N-CA 119.644 -0.823 . . . . 0.0 110.661 -178.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.2 t -78.96 -37.22 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.6 t -68.79 -40.41 81.35 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.421 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 32.2 tptt -65.1 -27.15 68.56 Favored 'General case' 0 C--N 1.364 1.235 0 O-C-N 121.126 -0.984 . . . . 0.0 108.827 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.5 tt -68.26 -38.0 81.33 Favored 'General case' 0 C--N 1.354 0.764 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.1 p -72.75 -18.23 61.53 Favored 'General case' 0 C--N 1.357 0.894 0 O-C-N 121.54 -0.725 . . . . 0.0 110.948 -179.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -100.05 -37.7 8.87 Favored 'General case' 0 C--N 1.351 0.674 0 O-C-N 121.168 -0.957 . . . . 0.0 111.668 -179.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.3 p -72.96 -35.96 50.14 Favored 'Isoleucine or valine' 0 C--N 1.351 0.642 0 O-C-N 121.713 -0.617 . . . . 0.0 111.36 -177.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.6 m -111.99 -7.99 14.09 Favored 'General case' 0 CA--C 1.505 -0.754 0 C-N-CA 119.372 -0.931 . . . . 0.0 110.116 -177.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 64.22 49.12 2.69 Favored 'General case' 0 C--N 1.354 0.784 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.583 HG13 ' HD2' ' A' ' 62' ' ' PRO . 52.3 t -113.62 135.51 21.94 Favored Pre-proline 0 CA--C 1.504 -0.802 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.652 ' HG2' ' HB2' ' A' ' 65' ' ' GLU . 20.8 Cg_endo -61.68 149.61 89.18 Favored 'Trans proline' 0 CA--C 1.5 -1.192 0 C-N-CA 122.339 2.026 . . . . 0.0 112.684 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.402 ' HA ' HD23 ' A' ' 66' ' ' LEU . 3.0 m -76.67 -11.78 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.39 -177.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.495 ' O ' HG12 ' A' ' 67' ' ' VAL . 72.0 p -96.62 -34.68 11.32 Favored 'General case' 0 C--N 1.357 0.93 0 C-N-CA 118.194 -1.402 . . . . 0.0 109.525 -179.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.652 ' HB2' ' HG2' ' A' ' 62' ' ' PRO . 69.1 mt-10 -76.85 -22.3 53.74 Favored 'General case' 0 C--N 1.354 0.792 0 O-C-N 121.437 -0.789 . . . . 0.0 108.893 179.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.408 ' HB3' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -79.19 -36.75 39.73 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.408 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.495 HG12 ' O ' ' A' ' 64' ' ' THR . 1.7 p -68.12 -26.82 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 C-N-CA 120.123 -0.631 . . . . 0.0 109.9 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.6 mmm-85 -72.1 -51.66 20.46 Favored 'General case' 0 C--N 1.364 1.216 0 O-C-N 121.549 -0.719 . . . . 0.0 110.453 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.3 mt -62.49 -36.27 81.96 Favored 'General case' 0 C--N 1.357 0.905 0 O-C-N 122.012 -0.43 . . . . 0.0 111.038 -178.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -61.02 -47.5 86.12 Favored 'General case' 0 C--N 1.349 0.556 0 O-C-N 122.23 -0.294 . . . . 0.0 110.639 -178.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.83 -39.21 96.51 Favored Glycine 0 C--N 1.356 1.69 0 N-CA-C 111.888 -0.485 . . . . 0.0 111.888 -177.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -62.76 -49.16 76.11 Favored 'General case' 0 C--N 1.352 0.688 0 CA-C-N 118.303 1.051 . . . . 0.0 111.693 -177.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 10.2 mttm -63.3 -47.67 81.28 Favored 'General case' 0 C--N 1.359 0.985 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -177.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.413 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.4 tm? -69.41 -38.69 78.02 Favored 'General case' 0 C--N 1.348 0.526 0 O-C-N 121.104 -0.997 . . . . 0.0 111.807 -175.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -63.71 -46.8 83.8 Favored 'General case' 0 C--N 1.355 0.834 0 O-C-N 121.037 -1.04 . . . . 0.0 111.443 -177.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -70.58 -13.83 17.5 Favored 'Isoleucine or valine' 0 C--N 1.36 1.024 0 O-C-N 121.517 -0.739 . . . . 0.0 109.371 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -73.08 -38.34 66.44 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 85.4 mt -73.97 -30.67 62.62 Favored 'General case' 0 C--N 1.357 0.922 0 O-C-N 122.3 -0.25 . . . . 0.0 110.519 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 47.9 mm -65.1 -53.53 39.96 Favored 'Isoleucine or valine' 0 C--N 1.357 0.921 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.957 -177.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -74.61 -15.52 60.83 Favored 'General case' 0 C--N 1.351 0.634 0 C-N-CA 119.573 -0.851 . . . . 0.0 109.526 178.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.45 -36.43 62.87 Favored Glycine 0 C--N 1.349 1.26 0 N-CA-C 111.001 -0.839 . . . . 0.0 111.001 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.486 ' HA ' ' HD2' ' A' ' 83' ' ' PRO . 99.3 m-70 -130.65 105.57 15.67 Favored Pre-proline 0 N--CA 1.441 -0.88 0 CA-C-O 122.686 1.231 . . . . 0.0 109.263 -176.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.486 ' HD2' ' HA ' ' A' ' 82' ' ' HIS . 37.8 Cg_endo -67.69 -26.0 39.66 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.647 2.231 . . . . 0.0 114.085 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -89.86 -7.66 53.74 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 tp -90.36 -20.97 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 -178.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -101.52 -23.63 14.27 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -70.16 -37.33 75.17 Favored 'General case' 0 C--N 1.359 1.001 0 O-C-N 121.867 -0.521 . . . . 0.0 109.855 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -64.89 -34.98 79.67 Favored 'General case' 0 C--N 1.358 0.975 0 O-C-N 121.836 -0.54 . . . . 0.0 110.545 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 18.4 ttp -82.9 152.51 25.52 Favored 'General case' 0 C--N 1.352 0.704 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 -178.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.43 -21.89 7.84 Favored 'General case' 0 C--N 1.364 1.225 0 O-C-N 121.641 -0.662 . . . . 0.0 111.356 -177.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -165.8 171.42 12.83 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -177.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.456 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 62.8 m -66.65 -40.81 88.84 Favored 'General case' 0 C--N 1.355 0.82 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.584 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.492 ' CE1' ' HE2' ' A' ' 158' ' ' PHE . 60.4 m-85 -66.67 -39.65 88.24 Favored 'General case' 0 C--N 1.357 0.915 0 O-C-N 121.188 -0.945 . . . . 0.0 108.836 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -65.79 -23.31 66.68 Favored 'General case' 0 C--N 1.356 0.884 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.694 ' O ' HG13 ' A' ' 99' ' ' ILE . 57.9 tp -63.58 -46.86 83.92 Favored 'General case' 0 C--N 1.355 0.843 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.477 ' HA ' ' CD1' ' A' ' 99' ' ' ILE . 4.2 mp -60.59 -37.34 81.04 Favored 'General case' 0 C--N 1.359 1.016 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.416 -179.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 34.3 t -67.88 -39.71 83.66 Favored 'General case' 0 C--N 1.349 0.566 0 O-C-N 121.918 -0.489 . . . . 0.0 110.242 -179.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.72 -0.89 56.44 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -176.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.694 HG13 ' O ' ' A' ' 95' ' ' LEU . 78.8 mt -60.81 -47.09 94.78 Favored 'Isoleucine or valine' 0 C--N 1.357 0.906 0 CA-C-N 118.919 0.782 . . . . 0.0 112.331 -177.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -94.44 -23.92 17.54 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 118.55 -1.26 . . . . 0.0 111.522 -176.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.5 t -63.86 -48.07 78.21 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.607 -0.683 . . . . 0.0 112.717 -177.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -137.92 -15.86 1.32 Allowed 'General case' 0 C--N 1.359 0.992 0 C-N-CA 116.946 -1.901 . . . . 0.0 113.763 -176.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.539 HD12 ' HA ' ' A' ' 99' ' ' ILE . 96.4 mt -70.81 -49.7 48.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 CA-C-N 120.54 1.518 . . . . 0.0 111.164 -177.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.442 ' HD2' HG22 ' A' ' 103' ' ' ILE . 17.8 m170 -89.04 0.67 56.49 Favored 'General case' 0 N--CA 1.442 -0.858 0 O-C-N 121.176 -0.953 . . . . 0.0 110.171 -177.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 72.7 t -83.71 -44.18 18.22 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.996 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 178.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -67.68 -40.55 84.4 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 71.9 t -63.06 -45.22 99.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.826 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.256 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -60.33 -48.38 82.01 Favored 'General case' 0 C--N 1.36 1.055 0 O-C-N 122.016 -0.428 . . . . 0.0 111.34 -178.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -63.5 -35.41 80.37 Favored 'General case' 0 C--N 1.354 0.795 0 O-C-N 121.544 -0.722 . . . . 0.0 110.615 -178.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 110' ' ' LEU . 16.4 mt -57.33 -72.1 0.09 Allowed 'General case' 0 C--N 1.357 0.919 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.104 -179.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -122.31 143.7 40.0 Favored Pre-proline 0 N--CA 1.441 -0.899 0 C-N-CA 118.038 -1.465 . . . . 0.0 109.292 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -87.25 -2.46 7.83 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 C-N-CA 123.505 2.803 . . . . 0.0 116.265 -178.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -83.42 -8.11 59.44 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 121.272 -0.892 . . . . 0.0 109.486 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -83.06 144.33 29.98 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.552 ' O ' HD13 ' A' ' 116' ' ' LEU . 46.0 mt-10 -120.33 144.11 48.02 Favored 'General case' 0 C--N 1.359 1.021 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.552 HD13 ' O ' ' A' ' 115' ' ' GLU . 2.6 mm? -129.88 152.52 80.04 Favored Pre-proline 0 C--N 1.358 0.946 0 CA-C-O 121.951 0.882 . . . . 0.0 109.27 -178.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 116' ' ' LEU . 87.7 Cg_endo -92.73 -155.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.32 -0.946 0 C-N-CA 123.929 3.086 . . . . 0.0 113.036 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -122.5 141.84 51.22 Favored 'General case' 0 C--N 1.368 1.399 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -132.61 137.04 46.9 Favored 'General case' 0 C--N 1.362 1.132 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.629 -178.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.437 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 93.7 m -127.32 128.52 46.06 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 176.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 78.2 m -118.69 128.89 54.94 Favored 'General case' 0 CA--C 1.503 -0.862 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.436 -178.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -120.85 130.89 54.12 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -103.55 117.23 33.95 Favored 'General case' 0 C--N 1.353 0.738 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -179.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.463 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 88.7 mt -83.27 -27.48 29.83 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 120.668 -0.413 . . . . 0.0 109.968 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 179.49 -143.24 5.59 Favored Glycine 0 C--N 1.351 1.378 0 C-N-CA 118.771 -1.681 . . . . 0.0 109.648 -178.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -91.37 -45.98 8.27 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -178.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -98.67 3.25 47.75 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.699 -177.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.463 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 66.7 m-20 -119.91 133.38 55.59 Favored 'General case' 0 C--N 1.357 0.917 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.1 mm -142.57 138.45 28.69 Favored 'Isoleucine or valine' 0 C--N 1.357 0.91 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 179.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 52.3 mtm180 -119.79 137.75 53.77 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 6.6 tp -125.5 119.45 28.25 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.76 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.437 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 11.8 m170 -99.92 135.2 41.71 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -128.06 121.97 30.99 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -178.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.448 ' HA ' ' O ' ' A' ' 171' ' ' THR . 10.2 tt0 -115.55 112.88 22.86 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 178.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.8 t -167.25 156.63 10.45 Favored 'General case' 0 C--N 1.357 0.908 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.439 ' C ' ' HD3' ' A' ' 138' ' ' PRO . 99.5 mttt -91.3 6.86 43.61 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.514 HH22 ' CD2' ' A' ' 45' ' ' HIS . 75.0 mtp180 -130.82 74.04 80.44 Favored Pre-proline 0 C--N 1.355 0.816 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.439 ' HD3' ' C ' ' A' ' 136' ' ' LYS . 80.1 Cg_endo -95.57 89.27 0.1 Allowed 'Trans proline' 0 N--CA 1.445 -1.373 0 C-N-CA 122.821 2.347 . . . . 0.0 115.559 -178.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -106.57 112.42 25.41 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 177.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.89 -37.74 88.51 Favored 'General case' 0 C--N 1.353 0.735 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.132 -178.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 71.5 m -61.77 -32.46 72.73 Favored 'General case' 0 C--N 1.353 0.741 0 O-C-N 121.967 -0.458 . . . . 0.0 110.693 -178.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -73.11 -46.48 51.04 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 120.25 -0.58 . . . . 0.0 109.988 -177.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.35 -40.17 95.33 Favored 'General case' 0 C--N 1.356 0.88 0 O-C-N 122.127 -0.358 . . . . 0.0 111.461 -177.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -63.27 -36.89 85.16 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 121.85 -0.531 . . . . 0.0 110.273 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.14 -43.52 98.28 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 -178.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 82.7 mt -69.82 -40.57 75.84 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 96.2 mt -71.63 -42.43 67.63 Favored 'General case' 0 C--N 1.362 1.152 0 O-C-N 121.152 -0.968 . . . . 0.0 111.186 -176.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.472 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 36.2 t70 -69.84 -30.55 68.06 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 121.834 -0.541 . . . . 0.0 110.535 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -62.85 -39.1 97.58 Favored Glycine 0 C--N 1.357 1.708 0 N-CA-C 108.303 -1.919 . . . . 0.0 108.303 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 48.9 t -60.55 -42.02 95.71 Favored 'General case' 0 C--N 1.351 0.659 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -74.96 -1.24 21.69 Favored 'General case' 0 C--N 1.361 1.093 0 O-C-N 121.739 -0.601 . . . . 0.0 109.476 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.472 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 76.5 mm-40 -84.38 -46.33 11.83 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -68.06 -43.19 79.19 Favored 'General case' 0 C--N 1.359 1.017 0 C-N-CA 120.002 -0.679 . . . . 0.0 109.553 179.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -69.19 -27.67 65.71 Favored 'General case' 0 C--N 1.361 1.076 0 O-C-N 121.739 -0.601 . . . . 0.0 110.701 -178.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 86.1 tttt 70.42 72.31 0.21 Allowed 'General case' 0 C--N 1.361 1.07 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -178.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -143.45 -167.26 2.52 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -142.18 116.6 9.61 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . 0.492 ' HE2' ' CE1' ' A' ' 93' ' ' PHE . 94.9 m-85 -135.09 150.47 50.24 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 178.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 92.4 m -120.63 127.82 52.44 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.549 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.4 mp -105.9 122.88 60.04 Favored 'Isoleucine or valine' 0 C--N 1.351 0.672 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.9 m -120.12 -173.61 2.59 Favored 'General case' 0 C--N 1.357 0.911 0 CA-C-O 121.86 0.838 . . . . 0.0 109.341 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -147.74 156.96 43.29 Favored 'General case' 0 C--N 1.357 0.932 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -178.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 64.6 p -100.79 146.2 31.68 Favored Pre-proline 0 C--N 1.359 0.988 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.9 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 62.7 Cg_endo -75.75 -9.6 19.77 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.754 2.303 . . . . 0.0 115.424 -178.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -71.97 -41.11 68.1 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 119.771 -0.772 . . . . 0.0 109.101 -179.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 39.2 p -118.05 14.53 14.08 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 120.071 -0.651 . . . . 0.0 110.538 -178.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.9 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 11.6 pt20 -67.03 -10.34 48.73 Favored 'General case' 0 C--N 1.355 0.828 0 O-C-N 121.455 -0.778 . . . . 0.0 110.335 178.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -126.54 38.28 4.15 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.9 m -137.38 146.9 45.02 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.64 ' O ' ' HB ' ' A' ' 171' ' ' THR . 60.5 mt-10 -98.77 164.4 12.23 Favored 'General case' 0 C--N 1.353 0.759 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.64 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 1.7 m 82.05 -56.65 0.23 Allowed 'General case' 0 C--N 1.371 1.532 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.004 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -110.19 117.65 34.26 Favored 'General case' 0 CA--C 1.503 -0.83 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.802 -178.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 67.4 t -131.22 134.0 61.75 Favored 'Isoleucine or valine' 0 C--N 1.357 0.912 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 50.4 mm -108.53 125.44 65.38 Favored 'Isoleucine or valine' 0 C--N 1.357 0.914 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -113.25 153.16 28.84 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 122.136 0.969 . . . . 0.0 108.541 -179.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -136.69 117.56 14.16 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -178.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.3 mp -113.04 118.6 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 -179.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 89.4 m -120.28 144.24 47.9 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -177.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 5.2 ttt180 . . . . . 0 C--N 1.363 1.185 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 179.476 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.6 mtp . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.212 0.53 . . . . 0.0 109.862 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.624 ' HA ' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -82.17 -5.46 58.49 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.046 -177.873 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.52 -46.16 26.47 Favored Glycine 0 C--N 1.35 1.34 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 76.9 mtm -72.15 -34.53 68.57 Favored 'General case' 0 C--N 1.354 0.791 0 O-C-N 121.92 -0.753 . . . . 0.0 111.271 -177.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.624 HG22 ' HA ' ' A' ' 2' ' ' MET . 36.0 m -69.78 -23.44 25.8 Favored 'Isoleucine or valine' 0 C--N 1.356 0.868 0 C-N-CA 119.926 -0.709 . . . . 0.0 109.346 -179.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.426 ' HZ ' ' CG ' ' A' ' 47' ' ' GLU . 1.6 m-85 -71.79 -34.45 69.42 Favored 'General case' 0 C--N 1.357 0.908 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.6 m -66.7 -39.65 88.16 Favored 'General case' 0 C--N 1.354 0.798 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -61.29 -38.81 96.28 Favored Glycine 0 C--N 1.359 1.809 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.617 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -65.33 -40.08 93.24 Favored 'General case' 0 C--N 1.353 0.741 0 O-C-N 122.354 -0.498 . . . . 0.0 110.761 -178.83 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.2 mmt -63.02 -41.02 99.43 Favored 'General case' 0 C--N 1.351 0.665 0 O-C-N 121.632 -0.667 . . . . 0.0 111.099 -178.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -66.81 -40.65 88.14 Favored 'General case' 0 C--N 1.35 0.613 0 O-C-N 121.869 -0.519 . . . . 0.0 111.688 -177.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 53.9 tp -65.8 -42.78 90.25 Favored 'General case' 0 C--N 1.349 0.585 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.617 HG12 ' O ' ' A' ' 9' ' ' LEU . 1.5 mm -75.67 -37.44 36.19 Favored 'Isoleucine or valine' 0 C--N 1.357 0.896 0 O-C-N 121.083 -1.011 . . . . 0.0 111.134 -175.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -68.53 -43.16 77.35 Favored 'General case' 0 C--N 1.352 0.703 0 O-C-N 121.911 -0.493 . . . . 0.0 111.315 -176.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -71.42 -34.36 70.25 Favored 'General case' 0 N--CA 1.446 -0.634 0 O-C-N 122.06 -0.4 . . . . 0.0 111.717 -177.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -71.83 -48.71 44.33 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -175.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -128.22 -19.29 3.93 Favored 'General case' 0 C--N 1.356 0.854 0 C-N-CA 117.352 -1.739 . . . . 0.0 113.747 -176.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 140.56 179.48 18.15 Favored Glycine 0 CA--C 1.497 -1.066 0 C-N-CA 117.773 -2.156 . . . . 0.0 109.97 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -96.42 -12.09 24.75 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -177.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -70.49 -41.41 72.71 Favored 'General case' 0 C--N 1.361 1.073 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.2 m -69.91 -39.08 76.41 Favored 'General case' 0 C--N 1.356 0.859 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.531 HD13 ' HB ' ' A' ' 13' ' ' ILE . 58.3 tp -60.6 -37.93 83.03 Favored 'General case' 0 C--N 1.357 0.918 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -64.59 -36.26 83.66 Favored 'General case' 0 C--N 1.357 0.893 0 O-C-N 122.132 -0.355 . . . . 0.0 110.84 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 93.6 m -63.52 -41.19 98.51 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -178.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.428 ' CD2' ' HB3' ' A' ' 54' ' ' LYS . 88.7 mt -64.17 -37.72 88.47 Favored 'General case' 0 C--N 1.352 0.711 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.09 -13.62 61.63 Favored 'General case' 0 C--N 1.36 1.053 0 O-C-N 121.606 -0.684 . . . . 0.0 110.085 -178.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -86.74 -28.94 22.74 Favored 'General case' 0 CA--C 1.506 -0.712 0 O-C-N 121.262 -0.899 . . . . 0.0 109.12 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.8 t -66.81 -36.29 82.03 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.647 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 2.2 p -92.15 -38.16 12.31 Favored 'General case' 0 C--N 1.359 0.996 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.647 ' HB2' ' O ' ' A' ' 29' ' ' CYS . 15.9 mt-10 85.96 131.73 0.04 OUTLIER 'General case' 0 C--N 1.36 1.041 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.511 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -89.96 -167.49 1.86 Allowed 'General case' 0 C--N 1.356 0.871 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.791 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -153.39 -66.59 0.15 Allowed 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.2 m -96.47 -62.06 1.33 Allowed 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -141.1 -43.2 0.38 Allowed 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -179.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.43 -39.02 2.47 Favored Glycine 0 C--N 1.351 1.398 0 N-CA-C 108.69 -1.764 . . . . 0.0 108.69 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 84.9 mt -109.8 104.68 17.46 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.878 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.425 ' HB3' ' H ' ' A' ' 38' ' ' THR . 4.0 t80 -74.03 -92.31 0.02 OUTLIER 'General case' 0 C--N 1.355 0.833 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.441 HG22 ' N ' ' A' ' 39' ' ' SER . 1.2 m -166.37 -64.52 0.03 OUTLIER 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 -178.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.441 ' N ' HG22 ' A' ' 38' ' ' THR . 12.3 p 161.87 80.9 0.0 OUTLIER 'General case' 0 C--N 1.362 1.122 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.513 ' O ' HG13 ' A' ' 40' ' ' VAL . 0.4 OUTLIER -172.05 -4.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.972 0 C-N-CA 119.459 -0.896 . . . . 0.0 109.735 -179.18 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -96.3 150.61 19.67 Favored Glycine 0 C--N 1.355 1.6 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 -178.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 59.2 m -125.41 131.5 52.91 Favored 'General case' 0 C--N 1.354 0.77 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -121.05 171.11 8.9 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -76.24 -178.67 4.62 Favored 'General case' 0 C--N 1.355 0.842 0 CA-C-O 121.642 0.734 . . . . 0.0 109.573 -178.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -86.36 -19.65 29.45 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -179.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.709 ' HA ' HD23 ' A' ' 49' ' ' LEU . 0.5 OUTLIER -65.55 -30.65 71.42 Favored 'General case' 0 C--N 1.354 0.764 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 179.08 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.426 ' CG ' ' HZ ' ' A' ' 6' ' ' PHE . 23.6 tp10 -63.97 -40.25 95.97 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -65.52 -39.41 91.79 Favored 'General case' 0 C--N 1.358 0.972 0 O-C-N 122.305 -0.247 . . . . 0.0 111.266 -178.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.709 HD23 ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -81.37 -15.02 56.52 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 119.078 -1.049 . . . . 0.0 110.402 -176.339 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 71.5 tp60 -73.09 -41.44 64.06 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 84.3 mt -84.51 -17.96 37.33 Favored 'General case' 0 C--N 1.362 1.111 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.723 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.6 t -80.52 -37.45 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.9 t -69.73 -39.68 78.3 Favored 'Isoleucine or valine' 0 C--N 1.354 0.78 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.428 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 32.9 tptt -66.15 -27.16 67.81 Favored 'General case' 0 C--N 1.363 1.171 0 O-C-N 121.235 -0.915 . . . . 0.0 108.6 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.496 HD13 HD13 ' A' ' 66' ' ' LEU . 0.3 OUTLIER -68.38 -37.64 80.59 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.704 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 60' ' ' SER . 77.0 p -73.9 -16.93 61.09 Favored 'General case' 0 C--N 1.355 0.847 0 O-C-N 121.693 -0.629 . . . . 0.0 110.885 -178.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -100.46 -36.38 9.23 Favored 'General case' 0 C--N 1.353 0.752 0 C-N-CA 119.377 -0.929 . . . . 0.0 111.434 -179.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.5 p -72.66 -34.44 47.54 Favored 'Isoleucine or valine' 0 C--N 1.351 0.651 0 O-C-N 121.683 -0.636 . . . . 0.0 111.455 -177.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.568 ' HB3' HG23 ' A' ' 61' ' ' VAL . 4.2 t -119.99 -5.58 10.05 Favored 'General case' 0 C--N 1.353 0.725 0 C-N-CA 119.143 -1.023 . . . . 0.0 110.069 -178.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.417 ' HA ' ' O ' ' A' ' 56' ' ' SER . 73.3 m 64.3 43.25 4.86 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.568 HG23 ' HB3' ' A' ' 59' ' ' SER . 50.0 t -103.37 132.89 20.65 Favored Pre-proline 0 N--CA 1.443 -0.799 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 179.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -57.31 146.68 81.24 Favored 'Trans proline' 0 CA--C 1.497 -1.345 0 C-N-CA 122.397 2.065 . . . . 0.0 112.959 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.1 m -75.15 -14.1 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.788 -178.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.412 ' O ' HG12 ' A' ' 67' ' ' VAL . 52.6 p -96.07 -31.88 12.81 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 118.139 -1.425 . . . . 0.0 109.611 -178.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -78.01 -21.49 50.73 Favored 'General case' 0 C--N 1.356 0.856 0 O-C-N 121.385 -0.822 . . . . 0.0 108.894 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.496 HD13 HD13 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -81.82 -35.73 29.14 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.4 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.421 HG11 ' HB3' ' A' ' 141' ' ' SER . 1.4 p -68.79 -27.17 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 C-N-CA 120.138 -0.625 . . . . 0.0 109.95 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.5 mmm-85 -73.21 -51.2 18.6 Favored 'General case' 0 C--N 1.362 1.131 0 O-C-N 121.521 -0.737 . . . . 0.0 110.435 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.7 mt -63.69 -36.08 82.68 Favored 'General case' 0 C--N 1.357 0.934 0 O-C-N 121.976 -0.452 . . . . 0.0 110.85 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -60.65 -47.36 86.58 Favored 'General case' 0 C--N 1.349 0.577 0 O-C-N 122.208 -0.307 . . . . 0.0 110.297 -178.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.57 -37.87 94.06 Favored Glycine 0 C--N 1.354 1.552 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 -178.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -63.02 -48.64 77.91 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-N 118.261 1.031 . . . . 0.0 111.397 -177.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.701 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 16.0 mttm -64.39 -48.96 73.47 Favored 'General case' 0 C--N 1.359 0.983 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -176.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.431 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.3 tm? -68.29 -39.68 82.03 Favored 'General case' 0 C--N 1.348 0.534 0 O-C-N 121.207 -0.933 . . . . 0.0 112.047 -175.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -63.88 -42.83 97.39 Favored 'General case' 0 C--N 1.353 0.719 0 O-C-N 121.115 -0.991 . . . . 0.0 111.22 -177.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.7 p -71.97 -15.48 18.11 Favored 'Isoleucine or valine' 0 C--N 1.36 1.026 0 O-C-N 121.232 -0.917 . . . . 0.0 109.217 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.701 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 74.1 mm-40 -71.52 -38.89 71.07 Favored 'General case' 0 C--N 1.349 0.552 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 80.7 mt -72.45 -33.3 66.97 Favored 'General case' 0 C--N 1.358 0.967 0 O-C-N 122.334 -0.229 . . . . 0.0 110.754 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 43.5 mm -64.43 -52.97 48.57 Favored 'Isoleucine or valine' 0 C--N 1.357 0.912 0 O-C-N 121.733 -0.604 . . . . 0.0 110.509 -177.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -76.67 -14.75 59.94 Favored 'General case' 0 C--N 1.35 0.591 0 C-N-CA 119.423 -0.911 . . . . 0.0 109.501 178.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.85 -36.32 61.43 Favored Glycine 0 C--N 1.349 1.27 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -179.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -128.46 104.45 19.58 Favored Pre-proline 0 N--CA 1.44 -0.938 0 CA-C-O 122.564 1.173 . . . . 0.0 109.596 -176.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.08 -33.23 91.8 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 123.366 2.711 . . . . 0.0 114.29 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -91.34 -5.67 54.23 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 120.14 -0.624 . . . . 0.0 109.834 -178.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -87.89 -23.15 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -178.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.6 -18.03 14.91 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -72.39 -38.36 68.49 Favored 'General case' 0 C--N 1.358 0.94 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -65.17 -33.51 76.18 Favored 'General case' 0 C--N 1.355 0.816 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.479 ' SD ' ' HB2' ' A' ' 95' ' ' LEU . 17.8 ttp -84.53 152.08 24.15 Favored 'General case' 0 C--N 1.351 0.651 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -178.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.64 -21.4 8.54 Favored 'General case' 0 C--N 1.364 1.21 0 C-N-CA 120.051 -0.659 . . . . 0.0 111.19 -177.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -165.96 171.28 12.77 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -177.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 67.3 m -66.63 -39.89 88.49 Favored 'General case' 0 C--N 1.355 0.842 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.68 -179.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -67.48 -39.21 85.25 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 119.616 -0.834 . . . . 0.0 108.83 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -66.26 -23.36 66.39 Favored 'General case' 0 C--N 1.355 0.832 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.681 ' O ' HG13 ' A' ' 99' ' ' ILE . 66.1 tp -65.25 -45.17 85.67 Favored 'General case' 0 C--N 1.357 0.926 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.425 ' HA ' ' CD1' ' A' ' 99' ' ' ILE . 3.3 mp -60.08 -35.94 76.29 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.1 t -70.49 -39.62 74.06 Favored 'General case' 0 C--N 1.35 0.599 0 O-C-N 121.881 -0.512 . . . . 0.0 109.935 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.3 -0.33 52.06 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -176.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.681 HG13 ' O ' ' A' ' 95' ' ' LEU . 81.1 mt -61.6 -47.18 94.56 Favored 'Isoleucine or valine' 0 C--N 1.357 0.894 0 CA-C-N 119.197 0.908 . . . . 0.0 111.704 -177.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -93.06 -23.41 18.66 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 118.642 -1.223 . . . . 0.0 111.349 -177.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 33.6 t -63.71 -48.57 76.56 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 121.645 -0.659 . . . . 0.0 112.592 -177.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -139.99 -12.87 1.09 Allowed 'General case' 0 C--N 1.359 0.982 0 C-N-CA 117.083 -1.847 . . . . 0.0 113.685 -177.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.418 HG22 ' HD2' ' A' ' 104' ' ' HIS . 24.9 mm -70.12 -51.23 41.05 Favored 'Isoleucine or valine' 0 C--O 1.242 0.706 0 CA-C-N 120.352 1.433 . . . . 0.0 110.564 -177.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.418 ' HD2' HG22 ' A' ' 103' ' ' ILE . 65.5 m170 -91.72 1.15 57.35 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.209 -177.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 79.5 t -81.39 -44.54 20.6 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.009 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 178.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 54.8 tp10 -68.09 -40.44 82.65 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 53.8 t -62.13 -46.95 95.29 Favored 'Isoleucine or valine' 0 C--N 1.355 0.824 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.685 -179.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -60.45 -48.13 83.11 Favored 'General case' 0 C--N 1.361 1.078 0 O-C-N 121.998 -0.438 . . . . 0.0 111.546 -179.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -60.66 -36.84 79.7 Favored 'General case' 0 C--N 1.355 0.821 0 O-C-N 121.503 -0.748 . . . . 0.0 110.383 -178.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 18.5 mt -59.49 -77.08 0.04 OUTLIER 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.438 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 79.8 m-85 -119.14 140.32 28.69 Favored Pre-proline 0 N--CA 1.44 -0.958 0 C-N-CA 118.574 -1.251 . . . . 0.0 108.973 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 111' ' ' TYR . 67.3 Cg_endo -87.18 -2.1 7.87 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 123.077 2.518 . . . . 0.0 115.124 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 29.7 mm100 -66.9 -36.51 82.45 Favored 'General case' 0 C--N 1.355 0.824 0 O-C-N 121.819 -0.551 . . . . 0.0 109.888 -179.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.24 144.63 57.04 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 121.56 0.695 . . . . 0.0 110.067 -178.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.453 ' O ' HD13 ' A' ' 116' ' ' LEU . 46.3 mt-10 -115.91 142.78 46.33 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 179.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.453 HD13 ' O ' ' A' ' 115' ' ' GLU . 2.6 mm? -127.16 148.8 67.49 Favored Pre-proline 0 N--CA 1.444 -0.737 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -178.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 116' ' ' LEU . 92.1 Cg_endo -91.07 -157.36 0.06 OUTLIER 'Trans proline' 0 C--N 1.315 -1.21 0 C-N-CA 123.797 2.998 . . . . 0.0 113.263 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -118.41 140.4 49.92 Favored 'General case' 0 C--N 1.363 1.186 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.414 ' CZ ' ' HG2' ' A' ' 117' ' ' PRO . 94.2 m-85 -131.51 135.03 46.74 Favored 'General case' 0 C--N 1.359 1.013 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.526 -178.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.453 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 93.6 m -124.05 127.57 48.06 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 176.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 75.2 m -118.06 128.02 54.36 Favored 'General case' 0 CA--C 1.504 -0.794 0 C-N-CA 119.215 -0.994 . . . . 0.0 109.545 -177.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -118.77 151.36 38.18 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 178.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -122.56 117.16 25.23 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.478 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 94.7 mt -86.9 -22.54 25.63 Favored 'General case' 0 C--N 1.354 0.782 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.219 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 177.8 -145.64 7.17 Favored Glycine 0 C--N 1.348 1.248 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 -178.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -94.7 -39.35 10.36 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -178.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -99.46 1.97 44.57 Favored 'General case' 0 C--N 1.353 0.756 0 C-N-CA 120.292 -0.563 . . . . 0.0 109.95 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.478 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 66.1 m-20 -121.12 133.42 55.21 Favored 'General case' 0 C--N 1.357 0.935 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.167 -179.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.413 HD13 ' HA ' ' A' ' 129' ' ' ILE . 8.0 mm -142.86 136.42 26.49 Favored 'Isoleucine or valine' 0 C--N 1.356 0.878 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 52.9 mtm180 -116.94 139.06 51.09 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.0 tp -128.02 118.6 23.8 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.453 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 12.0 m170 -97.35 132.92 42.61 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -126.42 121.38 32.27 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -178.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.485 ' HA ' ' O ' ' A' ' 171' ' ' THR . 29.9 tt0 -115.24 112.2 22.09 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.3 t -162.02 151.39 15.96 Favored 'General case' 0 C--N 1.36 1.038 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -90.47 2.31 55.82 Favored 'General case' 0 C--N 1.356 0.867 0 C-N-CA 120.316 -0.554 . . . . 0.0 109.777 -179.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -134.17 74.65 67.24 Favored Pre-proline 0 C--N 1.354 0.786 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -94.82 106.24 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.659 2.239 . . . . 0.0 115.968 -177.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -111.18 109.61 19.74 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 176.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.82 -39.14 93.51 Favored 'General case' 0 C--N 1.354 0.797 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.66 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.421 ' HB3' HG11 ' A' ' 67' ' ' VAL . 73.8 m -62.81 -27.6 69.42 Favored 'General case' 0 C--N 1.354 0.797 0 O-C-N 121.876 -0.515 . . . . 0.0 110.715 -178.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -76.53 -46.49 26.28 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.862 -177.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.83 -39.81 94.17 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 122.05 -0.406 . . . . 0.0 111.176 -177.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -63.17 -36.83 84.92 Favored 'General case' 0 C--N 1.356 0.86 0 O-C-N 121.902 -0.499 . . . . 0.0 109.85 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.01 -42.94 98.58 Favored Glycine 0 C--N 1.348 1.202 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 86.3 mt -70.57 -41.0 73.0 Favored 'General case' 0 C--N 1.354 0.761 0 CA-C-N 117.552 0.676 . . . . 0.0 112.775 -179.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 97.1 mt -71.37 -41.82 69.22 Favored 'General case' 0 C--N 1.361 1.092 0 O-C-N 121.155 -0.966 . . . . 0.0 110.832 -176.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.472 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 36.8 t70 -69.97 -28.61 65.68 Favored 'General case' 0 N--CA 1.442 -0.865 0 O-C-N 121.258 -0.901 . . . . 0.0 109.987 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.447 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -63.72 -40.61 98.7 Favored Glycine 0 C--N 1.355 1.601 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 14.1 p -65.6 -31.49 72.56 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 119.341 -0.943 . . . . 0.0 109.451 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -78.75 -1.16 33.32 Favored 'General case' 0 C--N 1.363 1.184 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 177.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.472 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 76.8 mm-40 -85.33 -45.55 11.81 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -66.71 -45.72 77.86 Favored 'General case' 0 C--N 1.36 1.062 0 C-N-CA 120.152 -0.619 . . . . 0.0 109.545 178.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -68.98 -26.83 65.24 Favored 'General case' 0 C--N 1.361 1.078 0 O-C-N 121.843 -0.536 . . . . 0.0 110.664 -178.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 84.6 tttt 73.51 71.85 0.12 Allowed 'General case' 0 C--N 1.362 1.109 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -139.38 -171.62 3.17 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -147.28 94.69 2.43 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 16.3 m-30 -114.78 157.17 23.6 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 178.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 93.4 m -120.2 128.8 53.71 Favored 'General case' 0 C--N 1.354 0.791 0 C-N-CA 119.655 -0.818 . . . . 0.0 108.857 -178.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.535 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.5 mp -104.49 122.04 56.98 Favored 'Isoleucine or valine' 0 C--N 1.351 0.66 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 179.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.3 m -117.86 -174.05 2.56 Favored 'General case' 0 C--N 1.358 0.948 0 CA-C-O 121.942 0.877 . . . . 0.0 109.462 -178.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 26.6 ptt180 -146.2 155.69 42.88 Favored 'General case' 0 C--N 1.357 0.918 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -178.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . 0.446 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 34.8 p -96.98 145.67 29.98 Favored Pre-proline 0 C--N 1.358 0.971 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.623 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 15.3 Cg_exo -70.82 -16.19 33.09 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 123.439 2.759 . . . . 0.0 114.445 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -71.63 -40.78 69.53 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 120.436 -0.506 . . . . 0.0 110.708 -177.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 40.8 p -119.28 16.38 13.11 Favored 'General case' 0 C--N 1.353 0.739 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.852 -178.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.623 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 9.9 pt20 -66.89 -12.86 60.73 Favored 'General case' 0 C--N 1.353 0.741 0 O-C-N 121.517 -0.739 . . . . 0.0 110.212 178.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 54.0 p30 -124.74 38.23 4.24 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 19.9 t -139.42 144.95 38.32 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.599 ' O ' ' HB ' ' A' ' 171' ' ' THR . 62.0 mt-10 -97.9 165.07 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -179.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.599 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 18.7 m 82.52 -58.98 0.18 Allowed 'General case' 0 C--N 1.37 1.49 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.771 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -107.75 116.83 32.66 Favored 'General case' 0 CA--C 1.503 -0.829 0 C-N-CA 119.952 -0.699 . . . . 0.0 109.538 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 85.1 t -130.69 132.45 64.24 Favored 'Isoleucine or valine' 0 C--N 1.357 0.904 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 178.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 50.8 mm -107.74 126.31 64.15 Favored 'Isoleucine or valine' 0 C--N 1.356 0.878 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -114.8 154.44 28.57 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-O 122.173 0.987 . . . . 0.0 108.588 -178.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -136.82 119.24 15.79 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.8 mp -113.85 119.83 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 N-CA-C 106.525 -1.658 . . . . 0.0 106.525 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 89.6 m -120.39 143.06 48.64 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -177.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 10.2 ttm180 . . . . . 0 C--N 1.363 1.184 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -179.964 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.2 mmm . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.065 0.459 . . . . 0.0 110.202 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.18 -19.05 47.98 Favored 'General case' 0 C--N 1.356 0.856 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -178.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.73 -40.44 45.6 Favored Glycine 0 C--N 1.35 1.323 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.22 -34.81 68.62 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 121.853 -0.792 . . . . 0.0 111.164 -177.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.1 m -69.03 -23.99 27.76 Favored 'Isoleucine or valine' 0 C--N 1.356 0.85 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.453 ' HZ ' ' CG ' ' A' ' 47' ' ' GLU . 2.0 m-85 -70.6 -35.03 72.77 Favored 'General case' 0 C--N 1.356 0.86 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 89.6 m -67.4 -39.71 85.57 Favored 'General case' 0 C--N 1.356 0.883 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -61.81 -38.45 95.99 Favored Glycine 0 C--N 1.36 1.874 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.675 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -64.72 -41.35 96.05 Favored 'General case' 0 C--N 1.352 0.685 0 O-C-N 122.511 -0.405 . . . . 0.0 110.791 -178.768 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.433 ' CE ' HD21 ' A' ' 26' ' ' LEU . 20.7 mmt -62.71 -40.92 98.68 Favored 'General case' 0 C--N 1.352 0.692 0 O-C-N 121.693 -0.629 . . . . 0.0 110.891 -178.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -68.06 -40.66 82.71 Favored 'General case' 0 C--N 1.347 0.481 0 O-C-N 121.952 -0.467 . . . . 0.0 111.738 -177.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 54.0 tp -66.65 -43.79 83.67 Favored 'General case' 0 C--N 1.35 0.599 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -178.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.675 HG12 ' O ' ' A' ' 9' ' ' LEU . 2.0 mm -72.71 -37.36 55.4 Favored 'Isoleucine or valine' 0 C--N 1.36 1.032 0 O-C-N 121.164 -0.96 . . . . 0.0 111.054 -175.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -71.65 -42.85 67.03 Favored 'General case' 0 C--N 1.35 0.619 0 O-C-N 121.662 -0.649 . . . . 0.0 111.835 -176.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -71.26 -37.03 71.95 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -175.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -98.31 -27.95 13.89 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 118.627 -1.229 . . . . 0.0 114.085 -174.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -115.28 -30.55 6.25 Favored 'General case' 0 CA--C 1.506 -0.743 0 C-N-CA 117.162 -1.815 . . . . 0.0 112.7 -176.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 143.17 177.83 18.48 Favored Glycine 0 C--N 1.347 1.155 0 C-N-CA 118.122 -1.99 . . . . 0.0 110.068 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -101.46 -24.4 14.18 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 -177.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -68.98 -39.86 79.16 Favored 'General case' 0 C--N 1.361 1.106 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 96.3 m -68.54 -38.63 81.0 Favored 'General case' 0 C--N 1.357 0.923 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 178.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.9 tp -59.4 -39.16 82.53 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -65.31 -37.21 86.44 Favored 'General case' 0 C--N 1.355 0.828 0 O-C-N 122.144 -0.347 . . . . 0.0 111.241 -178.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 88.6 m -64.61 -40.72 96.0 Favored 'General case' 0 C--N 1.354 0.787 0 O-C-N 121.679 -0.638 . . . . 0.0 109.708 -178.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.499 HD22 ' HB3' ' A' ' 54' ' ' LYS . 10.2 mt -64.81 -37.47 87.71 Favored 'General case' 0 C--N 1.353 0.757 0 C-N-CA 120.566 -0.454 . . . . 0.0 109.777 -178.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.433 HD21 ' CE ' ' A' ' 10' ' ' MET . 83.6 mt -70.0 -17.24 63.27 Favored 'General case' 0 C--N 1.359 0.996 0 O-C-N 121.739 -0.6 . . . . 0.0 110.192 -179.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -84.66 -28.27 26.53 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 119.51 -0.876 . . . . 0.0 109.493 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 45.7 t -66.76 -36.89 83.47 Favored 'General case' 0 C--N 1.354 0.781 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.625 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 2.2 p -92.91 -37.98 11.96 Favored 'General case' 0 C--N 1.358 0.957 0 C-N-CA 118.936 -1.106 . . . . 0.0 108.031 -178.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.625 ' HB2' ' O ' ' A' ' 29' ' ' CYS . 14.9 mt-10 84.73 132.61 0.05 OUTLIER 'General case' 0 C--N 1.359 1.005 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.528 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -90.25 -167.67 1.9 Allowed 'General case' 0 C--N 1.356 0.85 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.286 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -154.25 -64.63 0.14 Allowed 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.5 t -97.26 -64.92 1.0 Allowed 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -139.21 -44.02 0.46 Allowed 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 -178.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.74 -35.97 3.0 Favored Glycine 0 C--N 1.352 1.448 0 N-CA-C 109.151 -1.579 . . . . 0.0 109.151 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 82.5 mt -110.84 101.92 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.782 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.613 ' CD2' HG23 ' A' ' 40' ' ' VAL . 0.4 OUTLIER -66.65 -57.27 7.53 Favored 'General case' 0 C--N 1.358 0.964 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 178.947 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.478 HG22 ' N ' ' A' ' 39' ' ' SER . 1.0 OUTLIER 148.65 -64.04 0.0 OUTLIER 'General case' 0 C--N 1.367 1.355 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 178.422 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.478 ' N ' HG22 ' A' ' 38' ' ' THR . 17.7 p 168.73 70.69 0.0 OUTLIER 'General case' 0 C--N 1.362 1.135 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.613 HG23 ' CD2' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -159.21 4.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.869 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.797 -179.438 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.78 -158.11 21.14 Favored Glycine 0 C--N 1.355 1.597 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 -179.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 171.17 85.34 0.0 OUTLIER 'General case' 0 CA--C 1.5 -0.963 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 -178.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -95.47 177.08 5.94 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -83.63 -170.82 3.25 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -91.93 -14.95 28.73 Favored 'General case' 0 CA--C 1.499 -0.992 0 C-N-CA 119.994 -0.682 . . . . 0.0 109.3 -179.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -69.85 -30.5 67.99 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.453 ' CG ' ' HZ ' ' A' ' 6' ' ' PHE . 33.0 tp10 -64.02 -40.82 97.18 Favored 'General case' 0 C--N 1.351 0.654 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.655 ' O ' HD23 ' A' ' 48' ' ' LEU . 4.6 tt -71.78 -35.52 70.05 Favored 'General case' 0 C--N 1.357 0.896 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -179.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 61.5 tp -69.99 -36.7 75.36 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -177.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 72.9 tp60 -65.0 -41.72 95.14 Favored 'General case' 0 N--CA 1.441 -0.881 0 O-C-N 121.87 -0.519 . . . . 0.0 109.707 -178.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 81.7 mt -73.94 -35.82 64.61 Favored 'General case' 0 C--N 1.364 1.2 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.28 -179.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.4 t -64.03 -39.05 84.07 Favored 'Isoleucine or valine' 0 C--N 1.353 0.76 0 O-C-N 121.904 -0.497 . . . . 0.0 109.759 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.8 t -67.66 -39.6 82.5 Favored 'Isoleucine or valine' 0 C--N 1.352 0.699 0 O-C-N 121.675 -0.641 . . . . 0.0 109.474 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.499 ' HB3' HD22 ' A' ' 25' ' ' LEU . 35.1 tptt -63.51 -28.7 70.13 Favored 'General case' 0 C--N 1.363 1.175 0 O-C-N 121.234 -0.916 . . . . 0.0 108.711 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.583 HD21 HD12 ' A' ' 13' ' ' ILE . 14.1 mt -66.65 -38.3 86.6 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.439 179.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.6 p -72.54 -17.79 61.69 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.879 -178.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -101.72 -38.68 7.78 Favored 'General case' 0 C--N 1.353 0.729 0 C-N-CA 119.358 -0.937 . . . . 0.0 111.813 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.6 p -74.38 -37.48 45.05 Favored 'Isoleucine or valine' 0 C--N 1.352 0.704 0 O-C-N 121.515 -0.741 . . . . 0.0 111.255 -176.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.569 ' HB3' HG23 ' A' ' 61' ' ' VAL . 1.9 t -110.57 -9.44 14.55 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 119.249 -0.981 . . . . 0.0 110.281 -178.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 65.29 49.26 1.97 Allowed 'General case' 0 C--N 1.354 0.792 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.569 HG23 ' HB3' ' A' ' 59' ' ' SER . 58.2 t -113.92 133.49 22.3 Favored Pre-proline 0 CA--C 1.504 -0.822 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 61' ' ' VAL . 43.2 Cg_exo -57.88 147.44 81.42 Favored 'Trans proline' 0 CA--C 1.499 -1.229 0 C-N-CA 122.581 2.187 . . . . 0.0 112.825 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.2 m -74.51 -13.03 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.912 -178.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.411 ' O ' HG12 ' A' ' 67' ' ' VAL . 68.2 p -95.95 -32.03 12.8 Favored 'General case' 0 C--N 1.357 0.922 0 C-N-CA 118.151 -1.42 . . . . 0.0 109.509 -179.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -76.44 -24.43 53.93 Favored 'General case' 0 C--N 1.355 0.819 0 O-C-N 121.452 -0.78 . . . . 0.0 109.201 179.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.435 HD13 HD13 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -80.15 -36.92 34.48 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -179.029 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.411 HG12 ' O ' ' A' ' 64' ' ' THR . 1.5 p -67.97 -26.87 35.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.737 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.036 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 5.2 mmm-85 -73.14 -51.17 18.92 Favored 'General case' 0 C--N 1.362 1.151 0 O-C-N 121.549 -0.719 . . . . 0.0 110.283 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.1 mt -63.64 -36.24 83.16 Favored 'General case' 0 C--N 1.357 0.929 0 O-C-N 121.959 -0.463 . . . . 0.0 111.003 -178.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -60.85 -47.83 84.57 Favored 'General case' 0 C--N 1.349 0.575 0 O-C-N 122.155 -0.341 . . . . 0.0 110.596 -178.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.76 -38.09 94.65 Favored Glycine 0 C--N 1.355 1.592 0 N-CA-C 111.854 -0.498 . . . . 0.0 111.854 -178.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -63.64 -47.94 79.27 Favored 'General case' 0 C--N 1.35 0.588 0 CA-C-N 117.976 0.888 . . . . 0.0 111.508 -177.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.639 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 12.6 mttm -64.65 -48.51 74.55 Favored 'General case' 0 C--N 1.358 0.973 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -177.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.413 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.3 tm? -68.71 -39.2 80.56 Favored 'General case' 0 C--N 1.348 0.507 0 O-C-N 121.3 -0.875 . . . . 0.0 111.926 -175.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 40.7 t80 -63.22 -44.33 95.56 Favored 'General case' 0 C--N 1.354 0.766 0 O-C-N 121.068 -1.02 . . . . 0.0 111.044 -178.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.12 -15.23 18.55 Favored 'Isoleucine or valine' 0 C--N 1.359 0.982 0 O-C-N 121.509 -0.744 . . . . 0.0 109.184 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.639 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 69.5 mm-40 -71.8 -38.83 70.18 Favored 'General case' 0 C--N 1.349 0.574 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.2 mt -72.98 -32.37 65.15 Favored 'General case' 0 C--N 1.358 0.946 0 O-C-N 122.309 -0.244 . . . . 0.0 110.471 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.8 mm -64.58 -53.43 42.53 Favored 'Isoleucine or valine' 0 C--N 1.357 0.922 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.372 -177.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -75.39 -15.49 60.45 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 119.624 -0.831 . . . . 0.0 109.337 178.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.11 -37.06 64.0 Favored Glycine 0 C--N 1.35 1.348 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -131.33 105.73 14.69 Favored Pre-proline 0 N--CA 1.441 -0.922 0 CA-C-O 122.643 1.211 . . . . 0.0 109.321 -176.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.99 -25.88 37.91 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.614 2.209 . . . . 0.0 114.146 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -89.0 -8.26 54.41 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.2 tp -90.26 -20.56 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -178.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.41 -23.57 14.71 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -70.06 -37.42 75.51 Favored 'General case' 0 C--N 1.358 0.949 0 C-N-CA 120.264 -0.575 . . . . 0.0 109.527 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -64.9 -36.21 83.63 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.333 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 25.9 ttp -82.75 149.31 27.34 Favored 'General case' 0 C--N 1.351 0.646 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 -178.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.59 -22.27 8.17 Favored 'General case' 0 C--N 1.361 1.093 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.831 -177.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -165.25 171.76 13.23 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -177.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.418 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 41.0 t -64.3 -42.07 96.54 Favored 'General case' 0 C--N 1.357 0.921 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.08 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -66.54 -38.55 87.37 Favored 'General case' 0 C--N 1.355 0.81 0 O-C-N 121.437 -0.789 . . . . 0.0 109.493 -178.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -65.65 -25.31 67.3 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.418 ' HB3' ' O ' ' A' ' 92' ' ' SER . 57.6 tp -63.21 -46.62 86.16 Favored 'General case' 0 C--N 1.357 0.928 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.1 mp -61.78 -32.64 72.93 Favored 'General case' 0 C--N 1.356 0.862 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 36.0 t -62.87 -44.74 95.29 Favored 'General case' 0 C--N 1.354 0.762 0 O-C-N 121.931 -0.481 . . . . 0.0 111.584 -178.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.97 26.88 10.1 Favored 'General case' 0 C--N 1.364 1.225 0 O-C-N 120.939 -1.101 . . . . 0.0 111.132 -177.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.421 HD12 ' HA ' ' A' ' 99' ' ' ILE . 8.9 tp -61.31 -30.33 47.72 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 C-N-CA 120.431 -0.507 . . . . 0.0 110.539 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -126.95 -7.78 6.05 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 118.484 -1.287 . . . . 0.0 110.005 -179.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 57.5 m -90.43 -3.36 57.73 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.442 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -149.0 -47.39 0.14 Allowed 'General case' 0 C--N 1.358 0.956 0 C-N-CA 118.132 -1.427 . . . . 0.0 110.043 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 96.2 mt -67.41 -47.29 81.35 Favored 'Isoleucine or valine' 0 C--N 1.354 0.802 0 O-C-N 121.926 -0.484 . . . . 0.0 110.979 -177.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -84.65 0.33 50.69 Favored 'General case' 0 C--N 1.353 0.754 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.933 -177.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 77.3 t -80.78 -45.01 21.53 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.975 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -67.45 -40.0 85.39 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.959 -179.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 64.8 t -62.96 -46.71 95.61 Favored 'Isoleucine or valine' 0 C--N 1.354 0.782 0 O-C-N 122.155 -0.341 . . . . 0.0 110.742 -178.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -60.21 -47.85 84.2 Favored 'General case' 0 C--N 1.358 0.945 0 O-C-N 122.112 -0.367 . . . . 0.0 111.361 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -62.91 -36.18 82.53 Favored 'General case' 0 C--N 1.353 0.753 0 O-C-N 121.545 -0.722 . . . . 0.0 110.502 -178.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.5 mt -59.08 -77.22 0.04 OUTLIER 'General case' 0 C--N 1.357 0.931 0 C-N-CA 120.444 -0.503 . . . . 0.0 109.809 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.403 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 81.1 m-85 -111.13 141.76 24.95 Favored Pre-proline 0 N--CA 1.442 -0.863 0 C-N-CA 118.583 -1.247 . . . . 0.0 109.553 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 111' ' ' TYR . 51.3 Cg_endo -90.73 0.63 5.06 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 123.781 2.988 . . . . 0.0 115.216 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -86.1 4.42 38.29 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 121.63 -0.668 . . . . 0.0 109.851 -178.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -96.1 143.81 26.91 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 119.798 -0.761 . . . . 0.0 109.7 -178.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -119.51 141.43 49.21 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 178.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 95.6 mt -136.53 152.97 75.71 Favored Pre-proline 0 C--N 1.355 0.831 0 CA-C-O 122.198 0.999 . . . . 0.0 109.518 -178.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -87.19 -158.15 0.08 OUTLIER 'Trans proline' 0 C--N 1.32 -0.925 0 C-N-CA 123.96 3.106 . . . . 0.0 113.894 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -114.84 139.2 49.95 Favored 'General case' 0 C--N 1.368 1.38 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -125.32 127.31 46.45 Favored 'General case' 0 C--N 1.362 1.13 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -178.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.51 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 93.9 m -125.47 128.79 48.6 Favored 'General case' 0 C--N 1.357 0.912 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 177.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 73.7 m -119.76 128.12 53.45 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 119.323 -0.951 . . . . 0.0 109.506 -178.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -122.18 145.44 48.19 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 178.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.661 ' HG2' ' H ' ' A' ' 124' ' ' LEU . 35.4 ttp180 -100.33 -169.02 1.66 Allowed 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.661 ' H ' ' HG2' ' A' ' 123' ' ' ARG . 21.9 mt -165.12 -36.91 0.03 OUTLIER 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 -178.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -171.03 -150.89 7.27 Favored Glycine 0 C--N 1.353 1.503 0 N-CA-C 108.241 -1.944 . . . . 0.0 108.241 -178.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -94.29 -40.1 10.16 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.331 -179.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -97.64 3.84 50.27 Favored 'General case' 0 C--N 1.352 0.683 0 C-N-CA 120.216 -0.593 . . . . 0.0 110.276 -178.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -122.31 135.22 54.69 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 119.552 -0.859 . . . . 0.0 109.405 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.415 HD13 ' HA ' ' A' ' 129' ' ' ILE . 6.4 mm -142.11 136.9 29.94 Favored 'Isoleucine or valine' 0 C--N 1.356 0.87 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 178.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 52.3 mtm180 -114.88 138.47 50.76 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 8.3 tp -126.28 118.35 24.93 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.51 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 15.7 m-70 -98.27 134.43 41.32 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 179.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -130.3 121.43 26.05 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.544 ' HA ' ' O ' ' A' ' 171' ' ' THR . 75.1 mt-30 -114.15 114.69 26.39 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 19.4 t -161.52 150.41 15.95 Favored 'General case' 0 C--N 1.357 0.916 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -90.5 1.69 56.44 Favored 'General case' 0 C--N 1.355 0.805 0 C-N-CA 120.306 -0.557 . . . . 0.0 109.879 -178.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -136.78 74.57 51.37 Favored Pre-proline 0 CA--C 1.506 -0.742 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -94.11 110.6 0.18 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.657 2.238 . . . . 0.0 116.157 -177.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -111.56 109.7 19.74 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 176.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.4 -39.65 95.09 Favored 'General case' 0 C--N 1.355 0.811 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.518 -178.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 74.8 m -64.29 -24.93 67.83 Favored 'General case' 0 C--N 1.353 0.738 0 O-C-N 121.849 -0.532 . . . . 0.0 110.831 -178.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -76.51 -47.69 21.95 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 120.192 -0.603 . . . . 0.0 109.611 -178.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.1 -39.21 92.83 Favored 'General case' 0 C--N 1.357 0.93 0 O-C-N 122.115 -0.365 . . . . 0.0 111.123 -178.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -62.65 -37.29 85.77 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 121.801 -0.562 . . . . 0.0 109.77 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.27 -42.53 98.78 Favored Glycine 0 C--N 1.347 1.162 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.2 mt -70.46 -40.72 73.52 Favored 'General case' 0 C--N 1.352 0.687 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 96.3 mt -70.91 -41.97 70.54 Favored 'General case' 0 C--N 1.361 1.096 0 O-C-N 121.32 -0.862 . . . . 0.0 110.891 -177.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.551 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 36.8 t70 -70.33 -29.73 66.52 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 121.893 -0.504 . . . . 0.0 110.295 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -63.3 -39.43 97.83 Favored Glycine 0 C--N 1.356 1.656 0 N-CA-C 108.489 -1.844 . . . . 0.0 108.489 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 47.6 t -60.68 -42.25 96.73 Favored 'General case' 0 C--N 1.351 0.635 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -75.99 0.08 19.78 Favored 'General case' 0 C--N 1.36 1.025 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.551 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 76.5 mm-40 -84.6 -46.03 11.95 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -67.65 -43.77 79.51 Favored 'General case' 0 C--N 1.359 0.999 0 C-N-CA 120.109 -0.636 . . . . 0.0 109.559 179.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.467 ' O ' ' HB2' ' A' ' 155' ' ' LYS . 54.3 m-85 -70.42 -24.94 63.01 Favored 'General case' 0 C--N 1.361 1.087 0 O-C-N 121.734 -0.604 . . . . 0.0 111.311 -178.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 154' ' ' PHE . 47.9 mttt 73.62 67.82 0.1 Allowed 'General case' 0 C--N 1.362 1.116 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -178.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -134.16 -176.04 4.06 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -146.76 91.88 2.08 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 16.3 m-30 -113.54 157.73 21.66 Favored 'General case' 0 C--N 1.352 0.678 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 179.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 92.6 m -119.27 127.77 53.54 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 119.548 -0.861 . . . . 0.0 108.832 -178.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.554 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.2 mp -103.97 121.9 56.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.661 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 178.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.9 m -118.38 -173.69 2.52 Favored 'General case' 0 C--N 1.358 0.935 0 CA-C-O 121.661 0.743 . . . . 0.0 109.412 -178.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -146.97 157.0 43.5 Favored 'General case' 0 C--N 1.356 0.858 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 -178.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 49.6 p -99.64 146.37 31.7 Favored Pre-proline 0 C--N 1.358 0.974 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.685 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 73.9 Cg_endo -75.04 -12.0 21.42 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.941 2.427 . . . . 0.0 114.966 -178.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -72.63 -41.67 65.28 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.84 -178.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 37.8 p -117.21 15.5 14.92 Favored 'General case' 0 C--N 1.354 0.789 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.717 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.685 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.1 pp0? -67.59 -11.62 58.52 Favored 'General case' 0 C--N 1.354 0.796 0 O-C-N 121.569 -0.707 . . . . 0.0 110.245 178.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 54.4 p-10 -122.41 33.33 5.48 Favored 'General case' 0 N--CA 1.438 -1.038 0 O-C-N 121.148 -0.97 . . . . 0.0 108.707 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 57.8 m -135.67 148.37 48.9 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.634 ' O ' ' HB ' ' A' ' 171' ' ' THR . 60.8 mt-10 -100.77 166.12 11.03 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.634 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 6.9 m 83.26 -59.66 0.14 Allowed 'General case' 0 C--N 1.369 1.434 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -108.42 118.05 35.76 Favored 'General case' 0 CA--C 1.505 -0.77 0 C-N-CA 119.901 -0.72 . . . . 0.0 109.567 -178.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 97.2 t -131.01 132.78 63.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.916 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 178.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 49.5 mm -106.54 126.06 62.33 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -115.44 156.46 25.57 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 122.141 0.972 . . . . 0.0 108.562 -179.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -138.79 120.77 15.55 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -178.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.8 mp -115.06 121.12 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 89.1 m -117.96 143.26 46.52 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -177.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 30.4 ttm180 . . . . . 0 C--N 1.364 1.221 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 179.725 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.3 mmm . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 120.876 0.37 . . . . 0.0 110.17 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.52 -22.14 44.32 Favored 'General case' 0 C--N 1.356 0.854 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -76.16 -39.36 32.22 Favored Glycine 0 C--N 1.348 1.238 0 N-CA-C 109.084 -1.607 . . . . 0.0 109.084 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.4 tpp -70.63 -37.03 73.75 Favored 'General case' 0 C--N 1.353 0.725 0 O-C-N 122.297 -0.531 . . . . 0.0 110.593 -177.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.9 m -70.77 -22.46 23.24 Favored 'Isoleucine or valine' 0 C--N 1.358 0.939 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.527 ' HZ ' ' HG2' ' A' ' 47' ' ' GLU . 2.2 m-30 -69.92 -35.32 74.47 Favored 'General case' 0 C--N 1.357 0.912 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 84.9 m -67.06 -40.05 87.01 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.44 -37.86 95.35 Favored Glycine 0 C--N 1.358 1.753 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.637 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -66.96 -39.76 87.31 Favored 'General case' 0 C--N 1.352 0.681 0 CA-C-N 117.29 0.545 . . . . 0.0 110.544 -178.224 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.453 ' CE ' HD21 ' A' ' 26' ' ' LEU . 22.7 mmt -63.71 -41.16 98.14 Favored 'General case' 0 C--N 1.354 0.786 0 O-C-N 121.753 -0.592 . . . . 0.0 110.905 -178.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -66.38 -40.14 89.5 Favored 'General case' 0 C--N 1.349 0.572 0 O-C-N 121.989 -0.444 . . . . 0.0 111.381 -178.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 57.7 tp -66.43 -41.95 88.43 Favored 'General case' 0 C--N 1.35 0.608 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.637 HG12 ' O ' ' A' ' 9' ' ' LEU . 3.8 mm -73.78 -37.9 49.69 Favored 'Isoleucine or valine' 0 C--N 1.358 0.941 0 O-C-N 121.186 -0.947 . . . . 0.0 111.187 -176.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -69.05 -42.8 75.81 Favored 'General case' 0 C--N 1.352 0.714 0 O-C-N 121.7 -0.625 . . . . 0.0 111.236 -176.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -72.22 -33.24 67.43 Favored 'General case' 0 N--CA 1.446 -0.646 0 O-C-N 121.953 -0.467 . . . . 0.0 111.771 -177.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -73.02 -48.65 34.35 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -175.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -126.61 -20.33 4.36 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 117.718 -1.593 . . . . 0.0 112.367 -176.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 130.25 164.11 11.24 Favored Glycine 0 N--CA 1.437 -1.271 0 C-N-CA 118.102 -1.999 . . . . 0.0 110.809 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -67.08 -24.54 65.97 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 113.828 -1.186 . . . . 0.0 111.266 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -64.06 -44.27 92.95 Favored 'General case' 0 C--N 1.359 1.014 0 O-C-N 121.0 -1.062 . . . . 0.0 109.882 -179.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 94.2 m -67.24 -37.58 83.79 Favored 'General case' 0 C--N 1.352 0.717 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.454 HD13 ' HB ' ' A' ' 13' ' ' ILE . 33.3 tp -60.06 -37.59 80.32 Favored 'General case' 0 C--N 1.352 0.685 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.585 -179.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -66.14 -36.73 83.9 Favored 'General case' 0 C--N 1.356 0.87 0 O-C-N 122.105 -0.372 . . . . 0.0 110.704 -178.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.5 m -65.02 -40.43 94.87 Favored 'General case' 0 C--N 1.355 0.808 0 O-C-N 121.707 -0.621 . . . . 0.0 109.368 -178.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.443 HD21 HG11 ' A' ' 58' ' ' VAL . 83.2 mt -66.33 -36.32 82.63 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -179.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.453 HD21 ' CE ' ' A' ' 10' ' ' MET . 81.9 mt -72.41 -12.91 61.31 Favored 'General case' 0 C--N 1.36 1.042 0 O-C-N 121.819 -0.55 . . . . 0.0 110.106 -178.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -89.11 -26.23 21.45 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 119.098 -1.041 . . . . 0.0 108.971 178.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.9 t -67.76 -36.64 80.87 Favored 'General case' 0 C--N 1.358 0.936 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 178.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.636 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 1.8 p -92.92 -40.72 10.44 Favored 'General case' 0 C--N 1.359 0.985 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -179.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.636 ' HB2' ' O ' ' A' ' 29' ' ' CYS . 13.6 mt-10 84.94 134.71 0.05 Allowed 'General case' 0 C--N 1.361 1.089 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.493 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -85.79 -170.46 3.11 Favored 'General case' 0 C--N 1.358 0.936 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.49 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -150.99 -24.27 0.21 Allowed 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -179.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.3 t -148.84 -65.13 0.23 Allowed 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -178.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -130.73 -55.49 1.07 Allowed 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 -179.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 131.43 -41.21 1.54 Allowed Glycine 0 C--N 1.351 1.407 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 79.7 mt -106.84 101.67 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.57 ' O ' ' HB ' ' A' ' 38' ' ' THR . 0.8 OUTLIER -72.23 -30.05 64.53 Favored 'General case' 0 C--N 1.357 0.906 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.685 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.57 ' HB ' ' O ' ' A' ' 37' ' ' TYR . 8.0 m 114.71 -67.12 0.0 OUTLIER 'General case' 0 C--N 1.37 1.489 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.2 p 174.13 63.71 0.0 OUTLIER 'General case' 0 C--N 1.36 1.043 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -179.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.1 t -148.43 -5.03 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.831 0 C-N-CA 119.411 -0.916 . . . . 0.0 109.692 -178.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -98.12 143.92 16.96 Favored Glycine 0 C--N 1.352 1.428 0 C-N-CA 119.186 -1.483 . . . . 0.0 110.071 -178.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.0 m -124.07 122.61 38.33 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 178.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -117.14 175.86 5.4 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 -178.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -82.59 -172.04 3.83 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -90.97 -13.81 32.7 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 120.014 -0.674 . . . . 0.0 109.305 -179.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -70.12 -29.32 66.23 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.527 ' HG2' ' HZ ' ' A' ' 6' ' ' PHE . 25.9 tp10 -63.28 -40.33 97.08 Favored 'General case' 0 C--N 1.352 0.693 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.472 HD22 ' O ' ' A' ' 48' ' ' LEU . 1.8 tm? -67.63 -38.08 83.37 Favored 'General case' 0 C--N 1.357 0.9 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.44 ' O ' HG23 ' A' ' 53' ' ' VAL . 58.6 tp -73.9 -29.66 62.18 Favored 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 122.063 -0.398 . . . . 0.0 110.336 -176.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 71.6 tp60 -69.0 -40.09 78.95 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -178.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 81.3 mt -83.31 -17.17 43.42 Favored 'General case' 0 C--N 1.36 1.039 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.699 -178.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.1 t -82.25 -35.25 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 49' ' ' LEU . 55.1 t -69.07 -39.38 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.404 ' HB3' HD22 ' A' ' 25' ' ' LEU . 34.0 tptt -66.79 -32.09 73.15 Favored 'General case' 0 C--N 1.364 1.209 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -178.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.631 HD21 HD12 ' A' ' 13' ' ' ILE . 18.1 mt -62.78 -39.58 94.65 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.32 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.539 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 39.3 t -65.95 -36.61 83.8 Favored 'General case' 0 C--N 1.35 0.605 0 O-C-N 121.942 -0.474 . . . . 0.0 110.647 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -86.42 -37.65 18.15 Favored 'General case' 0 C--N 1.355 0.834 0 O-C-N 120.961 -1.087 . . . . 0.0 112.766 -177.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.443 HG11 HD21 ' A' ' 25' ' ' LEU . 4.9 p -75.47 -40.01 41.38 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 O-C-N 121.37 -0.831 . . . . 0.0 111.482 -176.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.4 t -106.5 -5.84 18.55 Favored 'General case' 0 C--N 1.352 0.69 0 C-N-CA 119.304 -0.958 . . . . 0.0 110.331 -177.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 56' ' ' SER . 72.3 m 65.29 39.91 5.11 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 56' ' ' SER . 59.4 t -114.72 124.77 29.97 Favored Pre-proline 0 CA--C 1.503 -0.831 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.93 155.33 33.73 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 122.803 2.335 . . . . 0.0 113.562 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.675 ' HA ' HD23 ' A' ' 66' ' ' LEU . 13.7 m -74.45 -12.09 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.89 -177.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.518 ' O ' HG12 ' A' ' 67' ' ' VAL . 72.9 p -94.2 -34.2 12.99 Favored 'General case' 0 C--N 1.357 0.905 0 C-N-CA 118.067 -1.453 . . . . 0.0 110.154 -178.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -80.21 -20.83 43.77 Favored 'General case' 0 C--N 1.354 0.803 0 O-C-N 121.202 -0.936 . . . . 0.0 109.13 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.675 HD23 ' HA ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -79.88 -34.43 39.19 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -179.757 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.518 HG12 ' O ' ' A' ' 64' ' ' THR . 2.4 p -69.82 -29.54 41.12 Favored 'Isoleucine or valine' 0 C--N 1.357 0.912 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.023 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -69.93 -48.1 59.78 Favored 'General case' 0 C--N 1.364 1.232 0 O-C-N 121.373 -0.83 . . . . 0.0 110.71 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.4 mt -64.36 -36.24 83.48 Favored 'General case' 0 C--N 1.355 0.828 0 O-C-N 121.949 -0.469 . . . . 0.0 110.796 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -61.08 -47.73 85.01 Favored 'General case' 0 C--N 1.35 0.593 0 O-C-N 122.212 -0.305 . . . . 0.0 110.715 -178.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.61 -38.95 96.69 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 119.817 -0.435 . . . . 0.0 112.227 -177.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -66.19 -45.35 81.1 Favored 'General case' 0 C--N 1.352 0.675 0 CA-C-N 118.441 1.121 . . . . 0.0 111.453 -176.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.731 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 6.6 mttm -64.16 -49.52 71.79 Favored 'General case' 0 C--N 1.356 0.886 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -177.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.47 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.5 tm? -68.12 -40.74 82.45 Favored 'General case' 0 C--N 1.349 0.568 0 O-C-N 121.358 -0.839 . . . . 0.0 112.219 -175.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -64.12 -44.55 91.89 Favored 'General case' 0 C--N 1.354 0.784 0 O-C-N 121.066 -1.021 . . . . 0.0 111.485 -177.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.65 -14.54 17.69 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 O-C-N 121.48 -0.762 . . . . 0.0 109.664 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.731 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 77.1 mm-40 -74.75 -37.82 62.38 Favored 'General case' 0 C--N 1.351 0.636 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 178.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 73.9 mt -67.41 -37.41 83.03 Favored 'General case' 0 C--N 1.36 1.063 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.0 mm -63.1 -50.63 78.57 Favored 'Isoleucine or valine' 0 C--N 1.356 0.857 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 -178.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -68.12 -20.94 64.95 Favored 'General case' 0 C--N 1.35 0.595 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.494 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -99.2 -0.97 56.99 Favored Glycine 0 N--CA 1.437 -1.256 0 C-N-CA 119.509 -1.329 . . . . 0.0 110.713 -177.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.669 ' HB3' ' HB ' ' A' ' 85' ' ' ILE . 93.4 m-70 -139.14 88.88 12.83 Favored Pre-proline 0 CA--C 1.502 -0.892 0 CA-C-N 119.113 1.456 . . . . 0.0 109.044 -179.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 82' ' ' HIS . 31.9 Cg_endo -65.85 -27.78 51.26 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.504 2.136 . . . . 0.0 114.556 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -95.1 -4.2 46.69 Favored 'General case' 0 CA--C 1.502 -0.895 0 C-N-CA 119.388 -0.925 . . . . 0.0 108.978 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.669 ' HB ' ' HB3' ' A' ' 82' ' ' HIS . 0.1 OUTLIER -89.0 -19.68 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 -179.575 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -104.4 -23.39 13.19 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -68.55 -36.96 79.52 Favored 'General case' 0 C--N 1.362 1.129 0 O-C-N 121.656 -0.652 . . . . 0.0 109.372 178.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -65.42 -35.12 79.99 Favored 'General case' 0 C--N 1.356 0.883 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.416 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.453 ' SD ' ' HB2' ' A' ' 95' ' ' LEU . 18.1 ttp -83.69 151.14 25.42 Favored 'General case' 0 C--N 1.352 0.715 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -178.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.79 -22.8 9.49 Favored 'General case' 0 C--N 1.365 1.261 0 O-C-N 121.632 -0.667 . . . . 0.0 111.258 -177.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -166.0 172.26 11.65 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -177.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.424 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 63.4 m -66.42 -39.73 89.15 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.506 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -67.82 -39.33 83.92 Favored 'General case' 0 C--N 1.356 0.865 0 O-C-N 121.375 -0.828 . . . . 0.0 109.093 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -65.53 -24.61 67.16 Favored 'General case' 0 C--N 1.355 0.83 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.726 ' O ' HG13 ' A' ' 99' ' ' ILE . 64.9 tp -63.65 -46.92 83.41 Favored 'General case' 0 C--N 1.353 0.732 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.468 ' HA ' ' CD1' ' A' ' 99' ' ' ILE . 2.0 mp -59.81 -36.65 77.2 Favored 'General case' 0 C--N 1.361 1.081 0 O-C-N 122.143 -0.348 . . . . 0.0 110.28 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.7 t -70.2 -39.81 74.96 Favored 'General case' 0 C--N 1.348 0.519 0 O-C-N 122.003 -0.436 . . . . 0.0 110.238 -179.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -87.43 2.7 49.75 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 122.136 -0.353 . . . . 0.0 111.934 -176.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.726 HG13 ' O ' ' A' ' 95' ' ' LEU . 77.3 mt -61.18 -46.9 95.72 Favored 'Isoleucine or valine' 0 C--N 1.355 0.822 0 CA-C-N 119.156 0.889 . . . . 0.0 111.967 -177.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -94.66 -23.56 17.54 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 118.52 -1.272 . . . . 0.0 111.176 -177.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.0 t -63.63 -50.09 70.72 Favored 'General case' 0 N--CA 1.445 -0.718 0 O-C-N 121.644 -0.66 . . . . 0.0 112.527 -177.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.51 ' HA ' HG12 ' A' ' 105' ' ' VAL . 17.5 t80 -134.68 -15.89 2.06 Favored 'General case' 0 C--N 1.361 1.071 0 C-N-CA 117.352 -1.739 . . . . 0.0 113.578 -176.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 29.3 mm -71.15 -51.58 33.6 Favored 'Isoleucine or valine' 0 C--O 1.245 0.847 0 CA-C-N 120.493 1.497 . . . . 0.0 110.683 -177.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.457 ' HB3' HD21 ' A' ' 116' ' ' LEU . 64.7 m170 -91.58 1.49 57.1 Favored 'General case' 0 N--CA 1.439 -1.021 0 O-C-N 121.284 -0.885 . . . . 0.0 110.348 -177.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.51 HG12 ' HA ' ' A' ' 102' ' ' PHE . 1.2 p -88.8 -33.45 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 178.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.38 -40.36 67.31 Favored 'General case' 0 CA--C 1.5 -0.957 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -72.33 -37.05 57.15 Favored 'Isoleucine or valine' 0 C--N 1.355 0.809 0 C-N-CA 119.592 -0.843 . . . . 0.0 109.89 -178.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -61.24 -49.0 78.87 Favored 'General case' 0 C--N 1.362 1.115 0 O-C-N 121.786 -0.571 . . . . 0.0 110.828 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -60.0 -37.43 79.65 Favored 'General case' 0 C--N 1.357 0.908 0 O-C-N 121.639 -0.663 . . . . 0.0 110.057 -179.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 14.7 mt -57.15 -75.47 0.04 OUTLIER 'General case' 0 C--N 1.356 0.866 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.417 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 90.3 m-85 -119.82 136.8 25.08 Favored Pre-proline 0 N--CA 1.441 -0.915 0 C-N-CA 119.026 -1.069 . . . . 0.0 108.733 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 111' ' ' TYR . 76.6 Cg_endo -85.28 -1.96 9.3 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 123.205 2.603 . . . . 0.0 115.345 -178.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -67.52 -36.26 80.69 Favored 'General case' 0 C--N 1.354 0.784 0 O-C-N 121.712 -0.617 . . . . 0.0 110.229 -179.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.34 144.42 56.97 Favored 'General case' 0 C--N 1.354 0.792 0 CA-C-O 121.647 0.737 . . . . 0.0 109.995 -178.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -114.54 148.08 38.49 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.462 ' HA ' ' HD3' ' A' ' 117' ' ' PRO . 1.2 mp -128.6 144.11 50.93 Favored Pre-proline 0 N--CA 1.442 -0.841 0 CA-C-O 122.143 0.973 . . . . 0.0 109.099 -178.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 116' ' ' LEU . 97.6 Cg_endo -87.68 -155.46 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.215 0 C-N-CA 123.738 2.959 . . . . 0.0 112.959 179.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -120.21 140.26 51.42 Favored 'General case' 0 C--N 1.363 1.165 0 C-N-CA 119.142 -1.023 . . . . 0.0 108.316 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -133.03 133.4 43.03 Favored 'General case' 0 C--N 1.362 1.114 0 C-N-CA 120.069 -0.653 . . . . 0.0 109.835 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.427 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 93.6 m -124.22 128.03 48.58 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 176.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 74.7 m -118.78 127.68 53.76 Favored 'General case' 0 CA--C 1.503 -0.848 0 C-N-CA 119.162 -1.015 . . . . 0.0 109.52 -177.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -116.9 153.14 33.09 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 178.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 57.4 ttp180 -123.72 117.17 24.34 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 95.9 mt -90.28 -16.69 28.82 Favored 'General case' 0 C--N 1.355 0.831 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.55 -179.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 174.77 -148.9 10.0 Favored Glycine 0 N--CA 1.437 -1.236 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -94.1 -37.18 11.74 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . 0.455 ' HB2' ' HG2' ' A' ' 179' ' ' ARG . 41.3 p-10 -102.45 1.22 34.96 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 119.886 -0.725 . . . . 0.0 110.315 -178.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -119.8 131.57 55.36 Favored 'General case' 0 C--N 1.358 0.977 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 7.9 mm -141.29 136.25 32.58 Favored 'Isoleucine or valine' 0 C--N 1.354 0.778 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 179.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 53.5 mtm180 -116.04 139.18 50.54 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.3 tp -127.93 117.42 21.72 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.427 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 12.0 m170 -96.78 133.98 40.65 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 179.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -129.77 122.44 28.83 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -178.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.553 ' HA ' ' O ' ' A' ' 171' ' ' THR . 76.2 mt-30 -116.21 115.7 26.47 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 12.8 t -163.22 155.19 17.84 Favored 'General case' 0 C--N 1.36 1.023 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -91.66 2.33 56.55 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 121.821 -0.55 . . . . 0.0 109.873 -178.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 93.6 mtm-85 -135.08 74.32 63.09 Favored Pre-proline 0 CA--C 1.505 -0.771 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -95.39 105.64 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.736 2.291 . . . . 0.0 115.7 -177.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -112.41 114.1 26.63 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 176.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.89 -38.82 92.52 Favored 'General case' 0 C--N 1.355 0.805 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.242 -179.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.3 m -63.63 -27.03 68.95 Favored 'General case' 0 C--N 1.354 0.782 0 O-C-N 121.926 -0.484 . . . . 0.0 110.827 -178.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -76.58 -47.87 21.1 Favored 'General case' 0 N--CA 1.446 -0.642 0 O-C-N 121.763 -0.586 . . . . 0.0 109.856 -177.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.49 -39.6 94.1 Favored 'General case' 0 C--N 1.357 0.895 0 O-C-N 122.183 -0.323 . . . . 0.0 111.149 -177.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -63.27 -37.64 88.04 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 121.907 -0.495 . . . . 0.0 109.927 -179.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.03 -42.91 98.6 Favored Glycine 0 C--N 1.348 1.217 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 -179.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 83.6 mt -70.06 -40.84 74.85 Favored 'General case' 0 C--N 1.353 0.747 0 CA-C-N 117.774 0.787 . . . . 0.0 112.549 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 97.7 mt -71.03 -42.07 70.01 Favored 'General case' 0 C--N 1.36 1.061 0 O-C-N 121.271 -0.893 . . . . 0.0 110.551 -176.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.479 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 21.5 t70 -69.17 -32.09 71.17 Favored 'General case' 0 N--CA 1.445 -0.723 0 O-C-N 122.211 -0.306 . . . . 0.0 110.505 -179.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -63.04 -39.85 98.55 Favored Glycine 0 C--N 1.357 1.707 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . 0.42 ' SG ' HD22 ' A' ' 95' ' ' LEU . 49.5 t -61.14 -42.11 97.95 Favored 'General case' 0 C--N 1.35 0.594 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.665 ' HB1' ' O ' ' A' ' 156' ' ' GLU . . . -73.84 -2.39 23.48 Favored 'General case' 0 C--N 1.359 1.001 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.479 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 74.5 mm-40 -83.17 -45.96 13.29 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 92.9 t80 -65.89 -45.06 83.4 Favored 'General case' 0 C--N 1.359 1.008 0 C-N-CA 120.154 -0.619 . . . . 0.0 109.609 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -68.88 -26.4 65.1 Favored 'General case' 0 C--N 1.363 1.158 0 O-C-N 121.716 -0.615 . . . . 0.0 111.023 -178.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 78.2 tttt 74.39 71.95 0.11 Allowed 'General case' 0 C--N 1.361 1.072 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.665 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 5.4 tp10 -161.34 125.24 3.35 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 178.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -87.25 108.35 18.9 Favored 'General case' 0 C--N 1.354 0.788 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.339 -179.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 9.3 m-30 -107.37 163.89 12.65 Favored 'General case' 0 C--N 1.353 0.734 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 177.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 95.5 m -121.37 129.21 52.92 Favored 'General case' 0 C--N 1.354 0.802 0 C-N-CA 118.972 -1.091 . . . . 0.0 109.41 -178.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.509 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.6 mp -110.5 122.12 64.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 178.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.7 m -119.12 -171.87 2.19 Favored 'General case' 0 C--N 1.357 0.916 0 CA-C-O 121.674 0.75 . . . . 0.0 109.245 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.11 159.29 44.53 Favored 'General case' 0 C--N 1.357 0.913 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 -178.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 64.6 p -100.72 146.83 32.76 Favored Pre-proline 0 C--N 1.359 1.012 0 CA-C-O 122.471 1.129 . . . . 0.0 108.298 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.641 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 73.5 Cg_endo -76.22 -11.49 19.32 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.957 2.438 . . . . 0.0 115.193 -178.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -72.11 -41.44 67.24 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 119.936 -0.705 . . . . 0.0 109.42 -178.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 31.4 p -116.73 16.5 15.34 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 120.159 -0.616 . . . . 0.0 110.323 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.641 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.2 pp0? -66.73 -10.29 45.49 Favored 'General case' 0 C--N 1.354 0.796 0 O-C-N 121.642 -0.661 . . . . 0.0 110.45 178.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -128.02 38.69 3.97 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 74.8 m -136.54 146.34 46.07 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.675 ' O ' ' HB ' ' A' ' 171' ' ' THR . 59.2 mp0 -99.61 162.55 12.95 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.675 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 1.5 m 84.53 -57.72 0.11 Allowed 'General case' 0 C--N 1.369 1.455 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.566 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -109.67 118.38 36.4 Favored 'General case' 0 CA--C 1.505 -0.75 0 C-N-CA 119.798 -0.761 . . . . 0.0 109.789 -178.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 97.5 t -132.4 132.32 60.42 Favored 'Isoleucine or valine' 0 C--N 1.36 1.065 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 178.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 50.3 mm -105.31 127.46 60.03 Favored 'Isoleucine or valine' 0 C--N 1.356 0.89 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -116.31 153.82 31.29 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -136.73 119.36 16.02 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -178.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.0 mp -114.21 119.06 60.29 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 -179.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 88.4 m -126.62 140.76 52.18 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -177.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.455 ' HG2' ' HB2' ' A' ' 127' ' ' ASN . 39.7 ptt180 . . . . . 0 C--N 1.366 1.285 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 179.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.415 ' HB2' ' HB2' ' A' ' 4' ' ' MET . 2.3 mmm . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 120.943 0.401 . . . . 0.0 110.07 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.426 ' HA ' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -80.63 -18.72 47.25 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 120.161 -0.616 . . . . 0.0 109.353 -179.043 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.11 -40.92 49.35 Favored Glycine 0 C--N 1.353 1.497 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . 0.415 ' HB2' ' HB2' ' A' ' 1' ' ' MET . 4.9 mtm -70.39 -36.33 74.04 Favored 'General case' 0 C--N 1.36 1.044 0 O-C-N 121.836 -0.802 . . . . 0.0 111.335 -178.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.426 HG22 ' HA ' ' A' ' 2' ' ' MET . 34.6 m -69.4 -22.95 25.97 Favored 'Isoleucine or valine' 0 C--N 1.356 0.872 0 O-C-N 121.555 -0.715 . . . . 0.0 109.366 -178.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -71.05 -35.85 72.1 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 85.4 m -67.07 -41.37 86.51 Favored 'General case' 0 C--N 1.356 0.881 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.62 -39.01 97.36 Favored Glycine 0 C--N 1.359 1.81 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.712 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -64.99 -40.37 94.86 Favored 'General case' 0 C--N 1.351 0.658 0 CA-C-N 117.3 0.55 . . . . 0.0 110.731 -178.471 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . 0.46 ' CE ' HD21 ' A' ' 26' ' ' LEU . 21.1 mmt -63.47 -40.68 97.76 Favored 'General case' 0 C--N 1.351 0.665 0 O-C-N 121.606 -0.684 . . . . 0.0 110.981 -178.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -67.23 -41.71 85.21 Favored 'General case' 0 C--N 1.35 0.611 0 O-C-N 121.859 -0.526 . . . . 0.0 111.691 -178.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 59.6 tp -65.61 -43.39 89.77 Favored 'General case' 0 C--N 1.35 0.598 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -178.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.712 HG12 ' O ' ' A' ' 9' ' ' LEU . 2.4 mm -72.92 -36.9 52.83 Favored 'Isoleucine or valine' 0 C--N 1.356 0.883 0 O-C-N 121.167 -0.958 . . . . 0.0 111.091 -175.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -65.99 -43.31 88.14 Favored 'General case' 0 C--N 1.352 0.688 0 O-C-N 121.746 -0.596 . . . . 0.0 111.663 -176.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -73.67 -37.27 65.31 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 121.773 -0.579 . . . . 0.0 112.279 -176.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -71.9 -41.64 67.72 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -175.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -129.9 -27.1 2.34 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 117.43 -1.708 . . . . 0.0 113.358 -177.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 148.19 -179.94 24.65 Favored Glycine 0 C--N 1.346 1.115 0 C-N-CA 117.499 -2.286 . . . . 0.0 110.664 -179.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 93.4 t80 -98.05 -20.41 17.39 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -177.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -70.27 -40.16 74.51 Favored 'General case' 0 C--N 1.361 1.085 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.3 m -68.35 -38.15 81.19 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.404 HD13 ' HB ' ' A' ' 13' ' ' ILE . 31.6 tp -59.97 -37.6 80.1 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -66.22 -35.18 79.77 Favored 'General case' 0 C--N 1.359 0.989 0 O-C-N 121.989 -0.444 . . . . 0.0 110.81 -178.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.8 m -64.86 -39.26 93.27 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -178.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.662 HD13 HD22 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -62.83 -38.12 89.48 Favored 'General case' 0 C--N 1.352 0.696 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 -179.266 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.46 HD21 ' CE ' ' A' ' 10' ' ' MET . 80.4 mt -74.52 -12.89 60.59 Favored 'General case' 0 C--N 1.358 0.947 0 O-C-N 121.768 -0.582 . . . . 0.0 110.746 -178.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -87.71 -27.11 22.6 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 119.1 -1.04 . . . . 0.0 108.929 178.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.9 t -67.15 -37.36 83.66 Favored 'General case' 0 C--N 1.357 0.905 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.621 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 2.0 p -93.25 -37.72 11.91 Favored 'General case' 0 C--N 1.358 0.935 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.621 ' HB2' ' O ' ' A' ' 29' ' ' CYS . 9.9 mt-10 85.37 133.57 0.05 OUTLIER 'General case' 0 C--N 1.359 0.979 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.491 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -85.37 -169.9 2.87 Favored 'General case' 0 C--N 1.358 0.954 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -150.84 -26.49 0.22 Allowed 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -179.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.7 t -146.65 -66.97 0.28 Allowed 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -178.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -130.33 -50.65 1.09 Allowed 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -178.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 127.86 -40.08 1.8 Allowed Glycine 0 C--N 1.351 1.382 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 86.4 mt -110.01 101.71 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.86 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -100.33 1.63 41.74 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.786 HG22 ' H ' ' A' ' 39' ' ' SER . 1.7 m 74.46 -176.56 0.15 Allowed 'General case' 0 C--N 1.362 1.144 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 -178.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.786 ' H ' HG22 ' A' ' 38' ' ' THR . 28.1 p -87.99 104.69 16.87 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 121.184 -0.948 . . . . 0.0 108.788 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.426 HG12 ' O ' ' A' ' 40' ' ' VAL . 61.4 t -152.99 -21.29 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.361 1.1 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.76 171.59 13.86 Favored Glycine 0 C--N 1.357 1.696 0 C-N-CA 119.049 -1.548 . . . . 0.0 110.162 -176.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 59.2 m -131.29 136.05 47.83 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -121.31 175.42 6.15 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -78.48 -176.17 4.65 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.426 ' CD2' HH22 ' A' ' 137' ' ' ARG . 73.5 m80 -94.15 -15.13 24.94 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.441 -178.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -68.86 -27.78 66.13 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 177.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.2 tp10 -62.62 -40.32 96.59 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -68.93 -38.65 79.65 Favored 'General case' 0 C--N 1.357 0.933 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 59.2 tp -70.39 -35.05 73.24 Favored 'General case' 0 CA--C 1.506 -0.712 0 O-C-N 122.099 -0.376 . . . . 0.0 110.14 -176.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 71.7 tp60 -66.6 -39.94 88.63 Favored 'General case' 0 N--CA 1.443 -0.781 0 O-C-N 121.873 -0.517 . . . . 0.0 109.779 -178.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.662 HD22 HD13 ' A' ' 25' ' ' LEU . 68.3 mt -80.68 -18.01 49.32 Favored 'General case' 0 C--N 1.363 1.171 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.301 -179.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -80.35 -34.81 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 54.3 t -70.17 -40.48 78.22 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.419 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 33.5 tptt -65.75 -27.6 68.42 Favored 'General case' 0 C--N 1.364 1.226 0 O-C-N 121.231 -0.918 . . . . 0.0 108.737 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.422 ' O ' HD23 ' A' ' 55' ' ' LEU . 1.5 tt -68.5 -37.37 80.01 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.7 p -72.07 -18.72 61.91 Favored 'General case' 0 C--N 1.359 0.992 0 O-C-N 121.439 -0.788 . . . . 0.0 110.704 -178.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -99.89 -36.4 9.43 Favored 'General case' 0 C--N 1.353 0.738 0 O-C-N 121.3 -0.875 . . . . 0.0 111.424 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.7 p -72.94 -36.52 51.76 Favored 'Isoleucine or valine' 0 C--N 1.35 0.62 0 O-C-N 121.717 -0.614 . . . . 0.0 111.294 -177.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 74.7 m -114.09 -6.68 13.09 Favored 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 119.35 -0.94 . . . . 0.0 109.936 -178.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 64.31 50.31 2.35 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.615 HG13 ' HD2' ' A' ' 62' ' ' PRO . 56.1 t -113.81 136.14 22.05 Favored Pre-proline 0 CA--C 1.505 -0.778 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.688 ' HG2' ' HB2' ' A' ' 65' ' ' GLU . 23.3 Cg_endo -62.36 149.22 91.58 Favored 'Trans proline' 0 CA--C 1.5 -1.192 0 C-N-CA 122.226 1.95 . . . . 0.0 112.391 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.5 m -75.83 -14.16 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.344 -177.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.467 ' O ' HG12 ' A' ' 67' ' ' VAL . 68.7 p -94.71 -34.65 12.47 Favored 'General case' 0 C--N 1.358 0.939 0 C-N-CA 118.347 -1.341 . . . . 0.0 109.722 -178.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.688 ' HB2' ' HG2' ' A' ' 62' ' ' PRO . 97.7 mt-10 -78.32 -20.48 51.34 Favored 'General case' 0 C--N 1.354 0.768 0 O-C-N 121.31 -0.869 . . . . 0.0 109.075 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.404 ' HB3' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -79.7 -37.67 35.19 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -179.624 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.467 HG12 ' O ' ' A' ' 64' ' ' THR . 1.8 p -67.92 -25.82 33.25 Favored 'Isoleucine or valine' 0 C--N 1.354 0.8 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.812 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 9.3 mtp180 -72.61 -53.17 12.61 Favored 'General case' 0 C--N 1.364 1.216 0 O-C-N 121.467 -0.771 . . . . 0.0 110.532 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 92.3 mt -63.07 -34.81 78.39 Favored 'General case' 0 C--N 1.357 0.927 0 O-C-N 121.933 -0.479 . . . . 0.0 111.031 -178.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -60.69 -47.34 86.72 Favored 'General case' 0 C--N 1.348 0.519 0 O-C-N 122.138 -0.351 . . . . 0.0 110.244 -178.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.44 -38.31 94.6 Favored Glycine 0 C--N 1.357 1.696 0 N-CA-C 111.766 -0.534 . . . . 0.0 111.766 -178.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.19 -49.04 75.81 Favored 'General case' 0 C--N 1.352 0.696 0 CA-C-N 118.264 1.032 . . . . 0.0 111.821 -177.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.542 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 8.4 mttm -64.26 -47.86 77.96 Favored 'General case' 0 C--N 1.358 0.948 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -177.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -68.66 -39.06 80.84 Favored 'General case' 0 C--N 1.35 0.624 0 O-C-N 121.055 -1.028 . . . . 0.0 111.92 -175.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -65.36 -43.23 91.45 Favored 'General case' 0 C--N 1.356 0.855 0 O-C-N 121.126 -0.984 . . . . 0.0 111.46 -177.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -72.16 -12.68 16.05 Favored 'Isoleucine or valine' 0 C--N 1.359 1.004 0 O-C-N 121.149 -0.969 . . . . 0.0 109.266 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.542 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 70.1 mm-40 -81.33 -29.78 34.06 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 73.3 mt -72.9 -34.69 66.81 Favored 'General case' 0 C--N 1.358 0.946 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.7 mm -64.63 -50.75 74.27 Favored 'Isoleucine or valine' 0 C--N 1.357 0.91 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -178.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -69.42 -28.29 66.01 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -66.68 -34.15 86.56 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -178.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.442 ' HA ' ' HD2' ' A' ' 83' ' ' PRO . 96.7 m-70 -135.7 101.34 10.76 Favored Pre-proline 0 CA--C 1.501 -0.91 0 CA-C-N 118.511 1.155 . . . . 0.0 109.372 -176.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' A' ' 82' ' ' HIS . 34.7 Cg_endo -66.85 -22.52 49.03 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.416 2.077 . . . . 0.0 113.607 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.425 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 42.5 mt-10 -91.87 -6.14 52.05 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.403 HG22 ' O ' ' A' ' 82' ' ' HIS . 1.6 tp -90.32 -19.65 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.23 -26.09 14.04 Favored 'General case' 0 C--N 1.361 1.084 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -70.75 -34.73 72.15 Favored 'General case' 0 C--N 1.356 0.875 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.425 ' HG2' ' O ' ' A' ' 84' ' ' GLU . 78.2 mm-40 -65.49 -36.25 83.28 Favored 'General case' 0 C--N 1.357 0.919 0 O-C-N 122.023 -0.423 . . . . 0.0 110.254 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.427 ' SD ' ' HB2' ' A' ' 95' ' ' LEU . 16.6 ttp -83.12 153.04 25.03 Favored 'General case' 0 C--N 1.353 0.743 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -178.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.96 -24.13 7.2 Favored 'General case' 0 C--N 1.365 1.253 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.352 -176.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -164.63 170.57 15.54 Favored 'General case' 0 C--N 1.354 0.802 0 C-N-CA 119.098 -1.041 . . . . 0.0 108.344 -177.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 39.7 t -64.01 -43.4 95.76 Favored 'General case' 0 C--N 1.357 0.899 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.489 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -66.33 -39.61 89.36 Favored 'General case' 0 C--N 1.355 0.816 0 O-C-N 121.366 -0.834 . . . . 0.0 109.255 -178.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -65.09 -25.73 67.92 Favored 'General case' 0 C--N 1.353 0.76 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.602 ' O ' HG13 ' A' ' 99' ' ' ILE . 61.8 tp -63.37 -46.46 86.39 Favored 'General case' 0 C--N 1.356 0.867 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.2 mp -59.54 -34.79 73.1 Favored 'General case' 0 C--N 1.357 0.917 0 O-C-N 122.177 -0.327 . . . . 0.0 110.591 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.4 t -69.88 -39.28 76.4 Favored 'General case' 0 C--N 1.348 0.538 0 O-C-N 121.917 -0.49 . . . . 0.0 109.944 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -90.97 4.11 52.88 Favored 'General case' 0 C--N 1.352 0.712 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -176.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.602 HG13 ' O ' ' A' ' 95' ' ' LEU . 77.6 mt -61.62 -47.29 94.01 Favored 'Isoleucine or valine' 0 C--N 1.358 0.977 0 CA-C-N 119.657 1.117 . . . . 0.0 111.9 -177.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -98.49 -22.46 16.0 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 118.408 -1.317 . . . . 0.0 111.285 -176.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 33.4 t -65.69 -47.01 76.9 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 121.684 -0.635 . . . . 0.0 111.951 -177.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -132.26 -23.04 2.19 Favored 'General case' 0 C--N 1.361 1.079 0 C-N-CA 117.763 -1.575 . . . . 0.0 113.056 -176.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 31.1 mm -69.21 -50.03 56.23 Favored 'Isoleucine or valine' 0 C--N 1.354 0.785 0 CA-C-N 120.001 1.273 . . . . 0.0 110.57 -177.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 54.8 m170 -90.12 3.8 52.29 Favored 'General case' 0 N--CA 1.439 -0.976 0 O-C-N 121.311 -0.868 . . . . 0.0 110.444 -177.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.3 p -89.35 -34.01 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 178.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -72.54 -40.03 67.06 Favored 'General case' 0 C--N 1.36 1.065 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 73.4 t -63.09 -46.35 96.32 Favored 'Isoleucine or valine' 0 C--N 1.355 0.846 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 93.2 t80 -60.6 -48.76 80.34 Favored 'General case' 0 C--N 1.361 1.089 0 O-C-N 122.064 -0.397 . . . . 0.0 111.428 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -60.9 -37.1 81.07 Favored 'General case' 0 C--N 1.356 0.864 0 O-C-N 121.556 -0.715 . . . . 0.0 110.604 -178.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 110' ' ' LEU . 17.9 mt -58.17 -73.83 0.07 Allowed 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -121.67 134.75 24.71 Favored Pre-proline 0 N--CA 1.439 -1.023 0 C-N-CA 118.37 -1.332 . . . . 0.0 108.773 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -84.51 -1.12 9.59 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 123.25 2.634 . . . . 0.0 115.052 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -66.75 -36.03 81.48 Favored 'General case' 0 C--N 1.354 0.795 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.13 145.39 56.35 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 121.649 0.738 . . . . 0.0 110.146 -178.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -126.95 134.31 50.44 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 179.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.453 ' HB3' ' HD2' ' A' ' 117' ' ' PRO . 84.4 mt -126.81 155.33 75.48 Favored Pre-proline 0 N--CA 1.442 -0.833 0 CA-C-O 122.184 0.992 . . . . 0.0 109.087 -178.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.453 ' HD2' ' HB3' ' A' ' 116' ' ' LEU . 87.7 Cg_endo -85.1 -152.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.125 0 C-N-CA 123.887 3.058 . . . . 0.0 114.543 -178.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -112.64 148.67 34.13 Favored 'General case' 0 C--N 1.368 1.38 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -179.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.642 ' CZ ' HD13 ' A' ' 131' ' ' LEU . 8.3 t80 -142.5 125.06 15.76 Favored 'General case' 0 C--N 1.361 1.066 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -177.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 95.8 m -126.44 133.62 51.19 Favored 'General case' 0 C--N 1.361 1.068 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 85.0 m -117.63 132.16 56.54 Favored 'General case' 0 C--N 1.358 0.946 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.732 -178.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -120.43 125.05 46.97 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 177.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -101.61 117.3 34.61 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.485 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 94.5 mt -84.98 -25.64 27.63 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.502 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -179.1 -142.6 4.98 Favored Glycine 0 C--N 1.349 1.257 0 C-N-CA 118.898 -1.62 . . . . 0.0 109.082 -178.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -94.1 -41.1 9.7 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 119.928 -0.709 . . . . 0.0 109.616 -178.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -102.18 3.49 38.46 Favored 'General case' 0 C--N 1.352 0.712 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.446 -178.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.485 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 67.4 m-20 -118.01 128.95 55.28 Favored 'General case' 0 C--N 1.356 0.885 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 10.6 mm -140.88 133.79 31.33 Favored 'Isoleucine or valine' 0 C--N 1.357 0.935 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 62.3 mtm180 -121.34 140.84 51.58 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.777 HD23 HD11 ' A' ' 177' ' ' ILE . 0.3 OUTLIER -129.79 128.03 41.55 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.679 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -99.08 131.28 45.24 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -126.24 120.99 31.43 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -178.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.468 ' HA ' ' O ' ' A' ' 171' ' ' THR . 27.5 tt0 -114.88 110.23 19.35 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 171' ' ' THR . 11.6 t -162.95 154.37 17.53 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -87.93 9.2 22.94 Favored 'General case' 0 C--N 1.355 0.836 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . 0.426 HH22 ' CD2' ' A' ' 45' ' ' HIS . 78.3 mtp180 -129.46 78.28 75.92 Favored Pre-proline 0 N--CA 1.443 -0.777 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -91.98 86.61 0.24 Allowed 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.663 2.242 . . . . 0.0 115.556 -178.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -111.7 109.71 19.71 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 177.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -70.4 -30.73 67.69 Favored 'General case' 0 C--N 1.354 0.792 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.3 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.4 m -62.88 -34.22 76.93 Favored 'General case' 0 C--N 1.352 0.697 0 O-C-N 122.001 -0.437 . . . . 0.0 109.95 -179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -74.35 -44.59 51.7 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 120.434 -0.506 . . . . 0.0 109.732 -177.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.55 -40.39 95.49 Favored 'General case' 0 C--N 1.357 0.902 0 O-C-N 122.067 -0.395 . . . . 0.0 111.254 -177.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.87 -37.02 85.84 Favored 'General case' 0 CA--C 1.506 -0.736 0 O-C-N 122.012 -0.43 . . . . 0.0 110.187 -179.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.49 -43.71 98.5 Favored Glycine 0 C--N 1.347 1.161 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -178.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 82.8 mt -69.9 -40.49 75.58 Favored 'General case' 0 C--N 1.35 0.612 0 O-C-N 122.108 -0.642 . . . . 0.0 112.507 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 96.7 mt -71.75 -43.16 66.28 Favored 'General case' 0 C--N 1.361 1.103 0 O-C-N 121.215 -0.928 . . . . 0.0 111.032 -176.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.584 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 37.3 t70 -71.01 -31.46 67.98 Favored 'General case' 0 N--CA 1.447 -0.604 0 O-C-N 122.1 -0.375 . . . . 0.0 110.634 -178.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -62.77 -39.89 98.52 Favored Glycine 0 C--N 1.358 1.76 0 N-CA-C 108.512 -1.835 . . . . 0.0 108.512 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 48.8 t -60.71 -41.61 95.57 Favored 'General case' 0 C--N 1.35 0.591 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -76.83 2.05 15.64 Favored 'General case' 0 C--N 1.361 1.079 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.584 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 77.3 mm-40 -86.0 -46.16 10.78 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -66.16 -45.18 81.82 Favored 'General case' 0 C--N 1.361 1.102 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -69.54 -26.61 64.58 Favored 'General case' 0 C--N 1.362 1.124 0 O-C-N 121.842 -0.536 . . . . 0.0 110.793 -178.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 84.7 tttt 71.65 77.7 0.17 Allowed 'General case' 0 C--N 1.358 0.95 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -141.38 -170.66 3.13 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 179.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -145.96 93.5 2.34 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 13.5 m-30 -113.52 155.93 24.49 Favored 'General case' 0 CA--C 1.504 -0.802 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 178.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 95.5 m -120.2 127.54 52.54 Favored 'General case' 0 C--N 1.356 0.856 0 C-N-CA 119.392 -0.923 . . . . 0.0 108.979 -178.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.501 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.7 mp -100.99 121.3 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 178.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.12 -176.44 2.9 Favored 'General case' 0 C--N 1.365 1.245 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 28.8 ptt180 -146.95 154.46 41.29 Favored 'General case' 0 C--N 1.359 0.98 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -179.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 35.1 p -97.69 146.56 31.64 Favored Pre-proline 0 C--N 1.36 1.06 0 CA-C-O 122.448 1.118 . . . . 0.0 108.046 178.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.659 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 72.1 Cg_endo -75.03 -12.49 21.45 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 123.055 2.504 . . . . 0.0 114.923 -178.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -72.21 -41.21 67.15 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.84 -178.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 26.8 p -118.6 16.45 13.69 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 119.824 -0.75 . . . . 0.0 110.829 -178.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.659 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.2 pp0? -67.15 -14.37 62.84 Favored 'General case' 0 C--N 1.352 0.707 0 O-C-N 121.563 -0.71 . . . . 0.0 110.121 178.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -124.28 38.81 4.11 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 22.0 t -138.49 143.37 39.55 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 107.165 -1.421 . . . . 0.0 107.165 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.644 ' O ' ' HB ' ' A' ' 171' ' ' THR . 60.5 mt-10 -96.77 163.63 12.91 Favored 'General case' 0 C--N 1.354 0.776 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.644 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 2.7 m 81.91 -57.49 0.23 Allowed 'General case' 0 C--N 1.374 1.645 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.906 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -105.63 117.76 34.85 Favored 'General case' 0 CA--C 1.504 -0.813 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.567 -178.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 89.0 t -132.57 134.21 58.98 Favored 'Isoleucine or valine' 0 C--N 1.357 0.928 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 48.5 mm -115.22 127.73 72.68 Favored 'Isoleucine or valine' 0 C--N 1.361 1.07 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -116.2 146.33 42.4 Favored 'General case' 0 C--N 1.359 1.021 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -125.53 84.05 2.23 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.193 -178.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . 0.777 HD11 HD23 ' A' ' 131' ' ' LEU . 3.6 mp -77.1 117.99 22.98 Favored 'Isoleucine or valine' 0 C--N 1.363 1.167 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 90.1 m -128.35 144.41 51.13 Favored 'General case' 0 C--N 1.356 0.885 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -178.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 59.3 mtm180 . . . . . 0 C--N 1.371 1.539 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.499 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.4 mtm . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 121.252 0.548 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.401 ' HA ' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -83.99 -13.5 53.14 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -179.442 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.0 -39.32 38.18 Favored Glycine 0 C--N 1.353 1.49 0 N-CA-C 108.641 -1.783 . . . . 0.0 108.641 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.7 tpp -71.6 -36.69 70.9 Favored 'General case' 0 C--N 1.359 0.982 0 O-C-N 121.92 -0.753 . . . . 0.0 110.767 -177.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.401 HG22 ' HA ' ' A' ' 2' ' ' MET . 35.5 m -69.81 -22.76 25.12 Favored 'Isoleucine or valine' 0 C--N 1.357 0.908 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.446 ' HZ ' ' HG2' ' A' ' 47' ' ' GLU . 1.8 m-30 -70.4 -35.57 73.54 Favored 'General case' 0 C--N 1.357 0.922 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 85.3 m -67.38 -40.61 85.71 Favored 'General case' 0 C--N 1.355 0.847 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.34 -38.81 96.87 Favored Glycine 0 C--N 1.358 1.75 0 N-CA-C 110.541 -1.023 . . . . 0.0 110.541 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.648 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -66.96 -39.42 87.24 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 122.297 -0.531 . . . . 0.0 110.674 -178.198 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 20.9 mmt -63.91 -41.01 97.78 Favored 'General case' 0 C--N 1.354 0.78 0 O-C-N 121.602 -0.686 . . . . 0.0 110.979 -178.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -67.43 -40.76 85.5 Favored 'General case' 0 C--N 1.349 0.554 0 O-C-N 121.929 -0.482 . . . . 0.0 111.857 -177.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 54.7 tp -65.52 -42.83 91.58 Favored 'General case' 0 C--N 1.349 0.571 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -178.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.648 HG12 ' O ' ' A' ' 9' ' ' LEU . 1.2 mm -76.42 -35.74 27.4 Favored 'Isoleucine or valine' 0 C--N 1.358 0.951 0 O-C-N 120.957 -1.09 . . . . 0.0 111.041 -175.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -67.98 -43.38 79.1 Favored 'General case' 0 C--N 1.352 0.677 0 O-C-N 121.766 -0.584 . . . . 0.0 111.173 -176.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -72.64 -33.71 66.81 Favored 'General case' 0 N--CA 1.448 -0.566 0 O-C-N 121.98 -0.45 . . . . 0.0 111.658 -177.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -71.57 -47.88 52.02 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -175.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -127.89 -19.18 4.09 Favored 'General case' 0 C--N 1.355 0.834 0 C-N-CA 117.417 -1.713 . . . . 0.0 113.496 -176.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 139.99 178.92 17.32 Favored Glycine 0 N--CA 1.44 -1.053 0 C-N-CA 117.923 -2.084 . . . . 0.0 109.862 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -95.99 -12.4 25.05 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -177.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -70.69 -40.48 72.87 Favored 'General case' 0 C--N 1.359 0.997 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.8 m -69.09 -39.25 79.13 Favored 'General case' 0 C--N 1.357 0.907 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 53.4 tp -62.59 -37.83 87.76 Favored 'General case' 0 C--N 1.357 0.934 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -62.97 -37.42 87.06 Favored 'General case' 0 C--N 1.358 0.955 0 O-C-N 121.968 -0.458 . . . . 0.0 110.997 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.6 m -65.6 -38.22 88.86 Favored 'General case' 0 C--N 1.353 0.735 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.443 ' HG ' HD22 ' A' ' 51' ' ' LEU . 21.8 tp -62.53 -39.49 93.74 Favored 'General case' 0 C--N 1.353 0.735 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 85.6 mt -72.95 -13.85 61.33 Favored 'General case' 0 C--N 1.359 0.997 0 O-C-N 121.92 -0.488 . . . . 0.0 110.579 -178.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -86.93 -28.77 22.55 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 119.312 -0.955 . . . . 0.0 109.368 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.0 t -67.25 -37.01 82.82 Favored 'General case' 0 C--N 1.355 0.839 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.1 p -91.63 -39.5 11.84 Favored 'General case' 0 C--N 1.357 0.924 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -179.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 86.06 132.85 0.04 OUTLIER 'General case' 0 C--N 1.36 1.052 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.51 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -86.91 -169.55 2.68 Favored 'General case' 0 C--N 1.357 0.9 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -179.884 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.416 ' H ' ' H ' ' A' ' 33' ' ' SER . 62.5 tt0 -152.26 -24.92 0.17 Allowed 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.416 ' H ' ' H ' ' A' ' 32' ' ' GLN . 1.8 t -145.22 -69.51 0.28 Allowed 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -179.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -131.05 -50.24 1.02 Allowed 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -178.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 130.41 -37.31 2.15 Favored Glycine 0 C--N 1.353 1.475 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 83.0 mt -110.0 100.75 11.41 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -95.65 -4.78 43.77 Favored 'General case' 0 C--N 1.354 0.801 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.76 HG22 ' H ' ' A' ' 39' ' ' SER . 5.2 m 82.43 174.84 0.09 Allowed 'General case' 0 C--N 1.362 1.118 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 -178.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.76 ' H ' HG22 ' A' ' 38' ' ' THR . 41.1 p -89.38 114.89 26.38 Favored 'General case' 0 N--CA 1.443 -0.791 0 O-C-N 121.041 -1.037 . . . . 0.0 109.855 -178.042 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.46 HG13 ' O ' ' A' ' 39' ' ' SER . 0.0 OUTLIER -172.92 -3.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.218 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.795 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -98.26 -136.74 9.38 Favored Glycine 0 C--N 1.357 1.735 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -178.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 164.47 98.97 0.0 OUTLIER 'General case' 0 C--N 1.362 1.132 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 -178.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -98.11 176.87 5.59 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.71 -174.61 4.42 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -91.1 -15.89 28.72 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 120.011 -0.676 . . . . 0.0 109.29 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -70.31 -29.32 66.03 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.446 ' HG2' ' HZ ' ' A' ' 6' ' ' PHE . 33.1 tp10 -63.69 -41.64 98.1 Favored 'General case' 0 C--N 1.354 0.769 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.494 ' O ' HG23 ' A' ' 52' ' ' VAL . 54.5 tp -67.24 -38.36 85.06 Favored 'General case' 0 C--N 1.354 0.782 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.197 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 60.6 tp -76.49 -28.04 56.3 Favored 'General case' 0 C--N 1.349 0.583 0 O-C-N 122.029 -0.419 . . . . 0.0 110.647 -177.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 71.5 tp60 -68.2 -42.6 79.64 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 121.509 -0.745 . . . . 0.0 109.615 -178.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.443 HD22 ' HG ' ' A' ' 25' ' ' LEU . 57.5 mt -72.8 -33.8 66.47 Favored 'General case' 0 C--N 1.363 1.18 0 C-N-CA 119.679 -0.809 . . . . 0.0 109.48 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 48' ' ' LEU . 38.7 t -62.61 -41.47 92.26 Favored 'Isoleucine or valine' 0 C--N 1.35 0.59 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 51.3 t -68.1 -40.61 83.3 Favored 'Isoleucine or valine' 0 C--N 1.351 0.668 0 O-C-N 121.716 -0.615 . . . . 0.0 109.809 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 31.7 tptt -66.84 -26.08 66.74 Favored 'General case' 0 C--N 1.359 1.007 0 O-C-N 121.131 -0.98 . . . . 0.0 108.768 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.408 ' O ' HD23 ' A' ' 55' ' ' LEU . 2.2 tt -69.09 -37.5 78.46 Favored 'General case' 0 C--N 1.353 0.744 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.402 ' O ' ' HA ' ' A' ' 60' ' ' SER . 71.5 p -72.05 -18.05 61.97 Favored 'General case' 0 C--N 1.356 0.868 0 O-C-N 121.722 -0.611 . . . . 0.0 110.624 -178.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -100.5 -35.04 9.68 Favored 'General case' 0 C--N 1.353 0.743 0 O-C-N 121.143 -0.973 . . . . 0.0 111.389 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.5 p -72.29 -34.8 50.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.719 0 O-C-N 121.755 -0.591 . . . . 0.0 111.375 -177.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.562 ' HB3' HG23 ' A' ' 61' ' ' VAL . 2.5 t -120.29 -7.4 9.79 Favored 'General case' 0 C--N 1.353 0.718 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.094 -177.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 56' ' ' SER . 0.6 OUTLIER 65.71 47.26 2.17 Favored 'General case' 0 C--N 1.353 0.76 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.796 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.562 HG23 ' HB3' ' A' ' 59' ' ' SER . 52.3 t -108.71 131.92 21.48 Favored Pre-proline 0 CA--C 1.503 -0.839 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 179.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -57.46 147.24 79.41 Favored 'Trans proline' 0 CA--C 1.497 -1.355 0 C-N-CA 122.439 2.093 . . . . 0.0 112.82 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.9 m -75.51 -12.97 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.685 -178.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.433 ' O ' HG12 ' A' ' 67' ' ' VAL . 71.5 p -96.09 -33.04 12.23 Favored 'General case' 0 C--N 1.358 0.961 0 C-N-CA 118.291 -1.364 . . . . 0.0 109.534 -179.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -76.55 -22.58 54.14 Favored 'General case' 0 C--N 1.354 0.799 0 O-C-N 121.449 -0.782 . . . . 0.0 109.033 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -81.7 -34.89 30.37 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.433 HG12 ' O ' ' A' ' 64' ' ' THR . 1.5 p -69.4 -26.33 31.13 Favored 'Isoleucine or valine' 0 C--N 1.354 0.795 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.916 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.5 mmm-85 -72.96 -51.5 18.13 Favored 'General case' 0 C--N 1.363 1.157 0 O-C-N 121.53 -0.731 . . . . 0.0 110.269 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 83.7 mt -63.76 -36.17 83.01 Favored 'General case' 0 C--N 1.357 0.923 0 O-C-N 122.064 -0.398 . . . . 0.0 110.939 -179.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -60.94 -46.9 88.82 Favored 'General case' 0 C--N 1.35 0.609 0 O-C-N 122.233 -0.292 . . . . 0.0 110.238 -178.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.56 -37.97 94.21 Favored Glycine 0 C--N 1.355 1.598 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 -178.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -63.64 -47.84 79.69 Favored 'General case' 0 C--N 1.354 0.782 0 CA-C-N 118.419 1.109 . . . . 0.0 111.486 -177.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.9 mttm -64.38 -47.72 78.2 Favored 'General case' 0 C--N 1.36 1.027 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -176.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.427 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.5 tm? -69.64 -40.21 76.64 Favored 'General case' 0 C--N 1.349 0.581 0 O-C-N 121.051 -1.031 . . . . 0.0 111.828 -175.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -63.76 -45.45 89.74 Favored 'General case' 0 C--N 1.354 0.768 0 O-C-N 121.19 -0.944 . . . . 0.0 111.27 -178.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 8.5 p -71.72 -12.83 16.31 Favored 'Isoleucine or valine' 0 C--N 1.357 0.911 0 O-C-N 121.543 -0.723 . . . . 0.0 109.294 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.33 -37.39 60.74 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 82.4 mt -72.53 -32.84 66.44 Favored 'General case' 0 C--N 1.358 0.949 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.7 mm -64.07 -52.99 49.34 Favored 'Isoleucine or valine' 0 C--N 1.36 1.043 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.196 -177.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -75.36 -14.87 60.5 Favored 'General case' 0 CA--C 1.51 -0.593 0 C-N-CA 119.693 -0.803 . . . . 0.0 109.529 178.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.32 -37.05 63.17 Favored Glycine 0 C--N 1.349 1.267 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -179.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -133.45 105.78 12.06 Favored Pre-proline 0 N--CA 1.44 -0.97 0 CA-C-O 122.555 1.169 . . . . 0.0 109.199 -176.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.8 -25.03 39.81 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.381 2.054 . . . . 0.0 113.806 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -88.78 -7.69 55.76 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.8 tp -89.31 -22.7 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 -178.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -98.7 -22.12 16.06 Favored 'General case' 0 C--N 1.362 1.113 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -70.03 -37.22 75.54 Favored 'General case' 0 C--N 1.358 0.976 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -64.78 -36.73 85.27 Favored 'General case' 0 C--N 1.358 0.956 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.261 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.565 ' SD ' ' HZ ' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -82.17 151.07 27.08 Favored 'General case' 0 C--N 1.352 0.704 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -178.837 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.552 ' N ' ' HG2' ' A' ' 89' ' ' MET . 0.7 OUTLIER -118.27 -22.63 7.61 Favored 'General case' 0 C--N 1.363 1.18 0 C-N-CA 119.852 -0.739 . . . . 0.0 111.298 -177.472 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -166.71 172.77 10.22 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.425 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 65.1 m -67.12 -40.06 86.76 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.478 -179.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -68.68 -39.09 80.75 Favored 'General case' 0 C--N 1.356 0.859 0 O-C-N 121.322 -0.862 . . . . 0.0 109.011 -178.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -66.29 -23.16 66.34 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.425 ' HB3' ' O ' ' A' ' 92' ' ' SER . 58.3 tp -63.99 -46.1 86.07 Favored 'General case' 0 C--N 1.355 0.829 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.2 mp -63.14 -33.13 74.79 Favored 'General case' 0 C--N 1.354 0.797 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 35.6 t -62.34 -44.4 96.58 Favored 'General case' 0 C--N 1.353 0.747 0 O-C-N 121.897 -0.502 . . . . 0.0 110.954 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.63 26.73 10.37 Favored 'General case' 0 C--N 1.359 0.99 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.376 -177.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 14.1 tt -62.36 -31.55 52.08 Favored 'Isoleucine or valine' 0 C--N 1.356 0.88 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.625 -179.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -119.43 -18.29 8.55 Favored 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 119.218 -0.993 . . . . 0.0 109.113 -178.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 35.6 t -64.25 -46.61 82.99 Favored 'General case' 0 N--CA 1.444 -0.747 0 O-C-N 121.82 -0.55 . . . . 0.0 110.869 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.4 ' HA ' HG12 ' A' ' 105' ' ' VAL . 14.4 t80 -127.59 -26.34 3.01 Favored 'General case' 0 C--N 1.36 1.028 0 C-N-CA 118.103 -1.439 . . . . 0.0 111.828 -177.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 19.0 mm -67.05 -50.23 65.97 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 O-C-N 121.097 -1.002 . . . . 0.0 110.236 -177.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 49.4 m170 -91.08 3.43 54.77 Favored 'General case' 0 N--CA 1.439 -0.985 0 O-C-N 121.462 -0.774 . . . . 0.0 110.408 -177.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.4 HG12 ' HA ' ' A' ' 102' ' ' PHE . 2.4 p -87.64 -35.4 8.26 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -72.88 -39.95 66.01 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 74.4 t -63.48 -46.06 96.17 Favored 'Isoleucine or valine' 0 C--N 1.357 0.909 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.255 -179.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -60.3 -48.13 83.06 Favored 'General case' 0 C--N 1.36 1.026 0 O-C-N 122.117 -0.364 . . . . 0.0 111.484 -178.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -61.98 -36.55 81.81 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 121.412 -0.805 . . . . 0.0 110.506 -178.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.9 mt -58.28 -76.33 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 120.665 -0.414 . . . . 0.0 109.951 -179.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.468 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 90.5 m-85 -110.9 141.0 23.26 Favored Pre-proline 0 N--CA 1.443 -0.807 0 C-N-CA 118.745 -1.182 . . . . 0.0 109.169 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 111' ' ' TYR . 54.2 Cg_endo -88.39 -7.53 5.79 Favored 'Trans proline' 0 C--N 1.315 -1.198 0 C-N-CA 123.219 2.613 . . . . 0.0 115.877 -178.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -77.96 -23.87 48.31 Favored 'General case' 0 C--N 1.354 0.789 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.22 -178.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.2 142.53 58.29 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 121.512 0.672 . . . . 0.0 109.656 -178.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -118.72 143.63 46.75 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.434 ' HA ' ' HD3' ' A' ' 117' ' ' PRO . 96.3 mt -136.93 152.22 73.66 Favored Pre-proline 0 C--N 1.354 0.802 0 CA-C-O 122.138 0.971 . . . . 0.0 109.604 -178.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 116' ' ' LEU . 75.0 Cg_endo -89.85 -155.24 0.05 OUTLIER 'Trans proline' 0 C--N 1.318 -1.03 0 C-N-CA 123.934 3.089 . . . . 0.0 113.484 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -119.63 142.34 48.51 Favored 'General case' 0 C--N 1.367 1.327 0 C-N-CA 119.328 -0.949 . . . . 0.0 108.711 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -126.26 128.66 47.53 Favored 'General case' 0 C--N 1.363 1.157 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -178.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.526 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 93.6 m -124.17 128.26 48.98 Favored 'General case' 0 C--N 1.357 0.893 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 176.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 78.1 m -121.77 130.97 53.81 Favored 'General case' 0 CA--C 1.504 -0.827 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.175 -177.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -118.76 149.81 40.85 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 177.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -121.62 117.61 27.15 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -179.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.0 mt -91.34 -16.27 27.74 Favored 'General case' 0 C--N 1.354 0.796 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.57 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 175.41 -149.5 10.21 Favored Glycine 0 C--N 1.348 1.214 0 C-N-CA 118.859 -1.639 . . . . 0.0 109.076 -179.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -93.87 -37.64 11.63 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -178.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -102.83 4.38 37.73 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.81 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -120.8 129.62 53.65 Favored 'General case' 0 C--N 1.357 0.934 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -179.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.3 mm -141.89 136.57 30.47 Favored 'Isoleucine or valine' 0 C--N 1.355 0.834 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 51.7 mtm180 -116.63 139.67 50.26 Favored 'General case' 0 CA--C 1.495 -1.16 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 8.0 tp -127.61 119.57 26.22 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-N 115.172 -0.922 . . . . 0.0 108.856 -178.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.526 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 12.1 m170 -99.2 134.28 42.27 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 178.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -130.21 122.26 27.77 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -178.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.492 ' HA ' ' O ' ' A' ' 171' ' ' THR . 30.0 tt0 -114.35 113.74 24.96 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 15.6 t -161.88 153.34 18.55 Favored 'General case' 0 C--N 1.358 0.954 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -91.55 3.89 53.91 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.866 -179.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 94.3 mtm-85 -133.42 74.98 70.65 Favored Pre-proline 0 C--N 1.355 0.847 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 178.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -94.88 100.89 0.11 Allowed 'Trans proline' 0 N--CA 1.442 -1.506 0 C-N-CA 122.621 2.214 . . . . 0.0 115.63 -177.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -110.67 113.54 26.22 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 176.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.63 -38.59 91.7 Favored 'General case' 0 C--N 1.354 0.771 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.166 -179.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 73.4 m -63.83 -26.98 68.87 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 121.886 -0.509 . . . . 0.0 110.808 -178.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -76.11 -47.37 24.74 Favored 'General case' 0 C--N 1.352 0.695 0 C-N-CA 120.038 -0.665 . . . . 0.0 109.593 -177.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.46 -39.8 94.5 Favored 'General case' 0 C--N 1.356 0.864 0 O-C-N 122.215 -0.303 . . . . 0.0 111.185 -178.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -63.31 -37.37 86.98 Favored 'General case' 0 C--N 1.354 0.797 0 O-C-N 121.879 -0.513 . . . . 0.0 109.908 -179.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.04 -42.94 98.63 Favored Glycine 0 C--N 1.348 1.232 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 -179.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.0 mt -70.82 -41.0 72.14 Favored 'General case' 0 C--N 1.354 0.762 0 CA-C-N 117.586 0.693 . . . . 0.0 112.704 -179.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 98.5 mt -71.08 -42.15 69.74 Favored 'General case' 0 C--N 1.36 1.057 0 O-C-N 121.28 -0.888 . . . . 0.0 110.833 -176.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.447 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 36.3 t70 -70.53 -28.9 65.29 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 121.935 -0.478 . . . . 0.0 110.385 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.426 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -63.08 -39.01 97.51 Favored Glycine 0 C--N 1.358 1.793 0 N-CA-C 108.049 -2.02 . . . . 0.0 108.049 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 48.1 t -60.95 -42.13 97.66 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -74.71 -0.36 17.85 Favored 'General case' 0 C--N 1.361 1.095 0 O-C-N 121.789 -0.57 . . . . 0.0 109.603 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.447 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 75.7 mm-40 -85.79 -45.8 11.26 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -65.61 -46.06 80.74 Favored 'General case' 0 C--N 1.361 1.082 0 C-N-CA 120.158 -0.617 . . . . 0.0 109.363 178.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . 0.565 ' HZ ' ' SD ' ' A' ' 89' ' ' MET . 37.5 m-85 -68.44 -27.85 66.54 Favored 'General case' 0 C--N 1.363 1.189 0 O-C-N 121.859 -0.525 . . . . 0.0 110.917 -178.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 85.4 tttt 74.44 73.94 0.11 Allowed 'General case' 0 C--N 1.36 1.041 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -178.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -142.84 -169.28 2.97 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -148.15 96.18 2.59 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 13.1 m-30 -113.24 155.55 24.88 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 178.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 92.2 m -119.32 128.16 53.87 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -178.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.518 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.7 mp -105.47 122.04 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 179.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.7 m -117.06 -174.41 2.58 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-O 121.913 0.863 . . . . 0.0 109.352 -178.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -146.08 155.48 42.8 Favored 'General case' 0 C--N 1.356 0.862 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 -177.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 47.3 p -100.28 146.6 32.25 Favored Pre-proline 0 C--N 1.359 0.997 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.638 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 75.0 Cg_endo -76.4 -11.46 19.0 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 123.056 2.504 . . . . 0.0 115.022 -178.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -72.34 -41.51 66.4 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 119.932 -0.707 . . . . 0.0 109.591 -178.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 37.9 p -116.76 15.59 15.36 Favored 'General case' 0 CA--C 1.505 -0.785 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.527 -178.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.638 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.3 pp0? -67.03 -12.18 59.15 Favored 'General case' 0 C--N 1.353 0.744 0 O-C-N 121.595 -0.691 . . . . 0.0 110.52 178.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -122.97 34.36 5.15 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 65.4 m -134.91 147.27 49.77 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.61 ' O ' ' HB ' ' A' ' 171' ' ' THR . 37.3 mt-10 -101.12 165.67 11.18 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.61 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 18.6 m 83.15 -60.52 0.14 Allowed 'General case' 0 C--N 1.37 1.467 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -107.37 117.31 33.75 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.623 -178.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 90.1 t -130.69 133.02 63.98 Favored 'Isoleucine or valine' 0 C--N 1.357 0.899 0 N-CA-C 106.924 -1.509 . . . . 0.0 106.924 178.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 49.6 mm -107.25 127.27 63.17 Favored 'Isoleucine or valine' 0 C--N 1.358 0.976 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -115.85 156.8 25.47 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 122.156 0.979 . . . . 0.0 108.513 -179.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -138.54 119.42 14.28 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -178.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.8 mp -113.55 118.54 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 -179.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 91.4 m -122.84 142.38 50.82 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -177.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 . . . . . 0 C--N 1.362 1.147 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 179.394 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.636 ' HG2' ' HG3' ' A' ' 4' ' ' MET . 27.7 tpp . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 120.986 0.422 . . . . 0.0 110.402 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' MET . . . . . 0.425 ' HA ' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -81.1 -14.49 57.7 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 -179.471 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.5 -42.96 38.99 Favored Glycine 0 C--N 1.35 1.333 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' MET . . . . . 0.636 ' HG3' ' HG2' ' A' ' 1' ' ' MET . 76.0 mtm -70.38 -34.78 72.98 Favored 'General case' 0 C--N 1.355 0.808 0 O-C-N 122.149 -0.618 . . . . 0.0 111.206 -178.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.425 HG22 ' HA ' ' A' ' 2' ' ' MET . 35.7 m -68.95 -23.34 27.19 Favored 'Isoleucine or valine' 0 C--N 1.358 0.946 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.314 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.461 ' HZ ' ' CG ' ' A' ' 47' ' ' GLU . 2.6 m-85 -72.22 -33.07 67.3 Favored 'General case' 0 C--N 1.357 0.922 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.1 m -67.01 -40.09 87.21 Favored 'General case' 0 C--N 1.355 0.846 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.54 -39.32 97.7 Favored Glycine 0 C--N 1.359 1.83 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.644 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -64.22 -40.66 96.51 Favored 'General case' 0 C--N 1.351 0.671 0 O-C-N 122.522 -0.399 . . . . 0.0 110.698 -178.795 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 20.5 mmt -63.43 -40.63 97.7 Favored 'General case' 0 C--N 1.352 0.708 0 O-C-N 121.72 -0.612 . . . . 0.0 110.832 -178.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -67.29 -40.5 86.09 Favored 'General case' 0 C--N 1.349 0.563 0 O-C-N 122.012 -0.43 . . . . 0.0 111.692 -178.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 54.9 tp -66.31 -42.93 87.57 Favored 'General case' 0 C--N 1.35 0.606 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -178.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.644 HG12 ' O ' ' A' ' 9' ' ' LEU . 2.6 mm -73.51 -37.1 49.63 Favored 'Isoleucine or valine' 0 C--N 1.36 1.032 0 O-C-N 121.142 -0.974 . . . . 0.0 110.861 -175.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -71.02 -42.35 69.68 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 121.659 -0.65 . . . . 0.0 111.73 -176.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -71.31 -37.57 71.79 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -175.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -100.66 -27.0 13.62 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 118.678 -1.209 . . . . 0.0 113.791 -174.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -111.56 -34.23 6.14 Favored 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 117.579 -1.648 . . . . 0.0 112.146 -176.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 142.11 178.41 18.15 Favored Glycine 0 C--N 1.348 1.216 0 C-N-CA 118.431 -1.842 . . . . 0.0 109.774 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 93.3 t80 -101.08 -26.19 13.78 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 -177.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -69.11 -39.72 78.77 Favored 'General case' 0 C--N 1.36 1.054 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.5 m -67.96 -38.54 82.89 Favored 'General case' 0 C--N 1.357 0.898 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 34.7 tp -59.53 -38.34 80.74 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -65.14 -37.11 86.38 Favored 'General case' 0 C--N 1.357 0.933 0 O-C-N 122.214 -0.304 . . . . 0.0 111.081 -178.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.3 m -64.45 -40.96 96.71 Favored 'General case' 0 C--N 1.355 0.834 0 O-C-N 121.636 -0.665 . . . . 0.0 109.774 -178.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.461 ' CD2' ' HB3' ' A' ' 54' ' ' LYS . 84.8 mt -64.48 -37.49 87.73 Favored 'General case' 0 C--N 1.356 0.861 0 O-C-N 121.892 -0.505 . . . . 0.0 109.744 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 82.5 mt -67.68 -18.77 65.04 Favored 'General case' 0 C--N 1.357 0.922 0 O-C-N 121.426 -0.796 . . . . 0.0 109.629 -179.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -85.74 -25.85 26.19 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.712 179.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.9 p -69.28 -24.45 63.96 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 119.856 -0.738 . . . . 0.0 109.304 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.4 p -106.96 -34.38 7.21 Favored 'General case' 0 C--N 1.357 0.898 0 C-N-CA 119.041 -1.064 . . . . 0.0 108.17 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 82.55 134.0 0.06 Allowed 'General case' 0 C--N 1.359 0.98 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.428 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -84.59 -169.82 2.81 Favored 'General case' 0 C--N 1.357 0.898 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.655 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.421 ' H ' ' H ' ' A' ' 33' ' ' SER . 63.1 tt0 -151.68 -25.25 0.19 Allowed 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.421 ' H ' ' H ' ' A' ' 32' ' ' GLN . 1.5 t -146.12 -73.18 0.23 Allowed 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -179.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -126.83 -38.73 2.02 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -179.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.35 -31.74 5.68 Favored Glycine 0 C--N 1.353 1.502 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 82.7 mt -112.5 99.98 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.512 ' O ' ' HB ' ' A' ' 38' ' ' THR . 3.0 t80 -70.84 -33.24 70.47 Favored 'General case' 0 C--N 1.357 0.916 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.512 ' HB ' ' O ' ' A' ' 37' ' ' TYR . 6.0 m 119.45 -70.07 0.0 OUTLIER 'General case' 0 C--N 1.369 1.456 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.6 p 174.4 66.62 0.0 OUTLIER 'General case' 0 C--N 1.359 0.998 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.503 ' HB ' ' CE2' ' A' ' 37' ' ' TYR . 19.0 t -147.53 -11.52 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.878 0 C-N-CA 119.772 -0.771 . . . . 0.0 109.463 -178.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.53 146.01 18.07 Favored Glycine 0 C--N 1.352 1.461 0 C-N-CA 119.314 -1.422 . . . . 0.0 110.53 -177.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 52.7 m -122.25 125.74 46.69 Favored 'General case' 0 C--N 1.354 0.775 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 178.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -117.05 172.04 7.53 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 121.644 0.735 . . . . 0.0 109.058 -178.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -78.3 -176.15 4.54 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-O 121.662 0.744 . . . . 0.0 109.249 -179.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -85.56 -23.25 27.72 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -179.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -65.89 -28.88 69.28 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.461 ' CG ' ' HZ ' ' A' ' 6' ' ' PHE . 24.4 tp10 -62.95 -39.55 94.98 Favored 'General case' 0 C--N 1.352 0.717 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -67.67 -38.81 84.25 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 61.8 tp -70.44 -34.31 72.31 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -177.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -65.15 -41.36 94.83 Favored 'General case' 0 N--CA 1.443 -0.799 0 O-C-N 122.041 -0.412 . . . . 0.0 110.227 -178.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 78.5 mt -81.86 -19.4 41.04 Favored 'General case' 0 C--N 1.357 0.934 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.384 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.3 t -80.18 -37.23 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -179.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 52.5 t -67.78 -40.85 84.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.461 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 25.0 tptt -66.66 -25.81 66.75 Favored 'General case' 0 C--N 1.364 1.219 0 O-C-N 121.07 -1.019 . . . . 0.0 108.895 -179.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.534 HD21 HD12 ' A' ' 13' ' ' ILE . 6.4 mt -67.11 -37.99 84.86 Favored 'General case' 0 C--N 1.355 0.807 0 C-N-CA 120.431 -0.507 . . . . 0.0 109.904 178.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.448 ' O ' ' HA ' ' A' ' 60' ' ' SER . 57.4 p -72.86 -17.81 61.5 Favored 'General case' 0 C--N 1.354 0.791 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.477 -179.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -99.3 -38.04 9.02 Favored 'General case' 0 C--N 1.354 0.777 0 O-C-N 121.321 -0.862 . . . . 0.0 111.497 -179.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.8 p -72.91 -37.88 55.27 Favored 'Isoleucine or valine' 0 C--N 1.353 0.722 0 O-C-N 121.656 -0.653 . . . . 0.0 111.327 -177.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.552 ' HB3' HG23 ' A' ' 61' ' ' VAL . 5.0 t -115.4 -6.72 12.32 Favored 'General case' 0 C--N 1.352 0.717 0 C-N-CA 119.033 -1.067 . . . . 0.0 110.265 -178.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 56' ' ' SER . 74.5 m 64.78 44.16 3.82 Favored 'General case' 0 C--N 1.355 0.829 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.552 HG23 ' HB3' ' A' ' 59' ' ' SER . 53.5 t -105.95 133.59 20.14 Favored Pre-proline 0 N--CA 1.444 -0.764 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -57.59 147.08 81.29 Favored 'Trans proline' 0 CA--C 1.498 -1.28 0 C-N-CA 122.538 2.159 . . . . 0.0 112.815 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.5 m -75.47 -12.13 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.919 -178.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.435 ' O ' HG12 ' A' ' 67' ' ' VAL . 67.3 p -96.48 -32.42 12.31 Favored 'General case' 0 C--N 1.358 0.969 0 C-N-CA 118.289 -1.364 . . . . 0.0 109.489 -179.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -77.82 -22.89 49.34 Favored 'General case' 0 C--N 1.355 0.819 0 O-C-N 121.341 -0.849 . . . . 0.0 108.868 179.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.426 HD13 HD13 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -79.97 -37.36 34.52 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.196 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.435 HG12 ' O ' ' A' ' 64' ' ' THR . 1.9 p -67.97 -26.66 35.15 Favored 'Isoleucine or valine' 0 C--N 1.355 0.828 0 C-N-CA 120.089 -0.644 . . . . 0.0 110.002 -179.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.2 mmm-85 -72.16 -50.86 24.39 Favored 'General case' 0 C--N 1.363 1.159 0 O-C-N 121.519 -0.738 . . . . 0.0 110.354 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 83.9 mt -63.57 -36.0 82.35 Favored 'General case' 0 C--N 1.357 0.932 0 O-C-N 122.061 -0.399 . . . . 0.0 110.966 -178.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -60.8 -47.69 85.18 Favored 'General case' 0 C--N 1.35 0.608 0 O-C-N 122.221 -0.299 . . . . 0.0 110.64 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.54 95.75 Favored Glycine 0 C--N 1.354 1.554 0 N-CA-C 111.834 -0.506 . . . . 0.0 111.834 -178.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.65 -47.65 80.45 Favored 'General case' 0 C--N 1.349 0.568 0 CA-C-N 118.13 0.965 . . . . 0.0 111.548 -177.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 10.2 mttm -65.39 -48.39 73.02 Favored 'General case' 0 C--N 1.359 1.006 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -177.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . 0.444 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.4 tm? -68.93 -39.37 79.63 Favored 'General case' 0 C--N 1.348 0.529 0 O-C-N 121.156 -0.965 . . . . 0.0 111.788 -175.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -63.81 -44.96 91.73 Favored 'General case' 0 C--N 1.354 0.779 0 O-C-N 121.084 -1.01 . . . . 0.0 111.032 -178.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.83 -13.86 17.08 Favored 'Isoleucine or valine' 0 C--N 1.359 0.98 0 O-C-N 121.548 -0.72 . . . . 0.0 109.084 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -73.52 -38.06 65.44 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.6 mt -74.47 -29.78 61.59 Favored 'General case' 0 C--N 1.357 0.928 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 46.5 mm -65.25 -52.94 46.29 Favored 'Isoleucine or valine' 0 C--N 1.358 0.977 0 C-N-CA 120.059 -0.656 . . . . 0.0 109.883 -177.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -75.36 -15.89 60.44 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.425 178.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.85 -37.26 65.72 Favored Glycine 0 C--N 1.349 1.27 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -131.88 106.21 13.97 Favored Pre-proline 0 N--CA 1.441 -0.923 0 CA-C-O 122.58 1.181 . . . . 0.0 109.37 -177.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -68.36 -25.35 36.14 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.581 2.187 . . . . 0.0 113.848 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -88.5 -9.1 53.55 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -89.51 -21.92 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 -178.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.26 -23.25 14.85 Favored 'General case' 0 C--N 1.36 1.049 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -70.2 -37.24 75.04 Favored 'General case' 0 C--N 1.358 0.959 0 O-C-N 121.845 -0.535 . . . . 0.0 109.845 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -64.28 -36.24 83.47 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.322 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.45 ' SD ' ' HB2' ' A' ' 95' ' ' LEU . 17.4 ttp -83.32 153.54 24.56 Favored 'General case' 0 C--N 1.351 0.67 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -178.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.46 -22.65 8.08 Favored 'General case' 0 C--N 1.365 1.276 0 O-C-N 121.627 -0.671 . . . . 0.0 111.138 -177.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -164.21 170.14 16.7 Favored 'General case' 0 CA--C 1.504 -0.802 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -177.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.489 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 64.9 m -66.05 -40.56 91.04 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.469 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 1.6 m-30 -68.42 -37.9 80.74 Favored 'General case' 0 C--N 1.354 0.788 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.135 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -66.22 -22.5 66.34 Favored 'General case' 0 C--N 1.357 0.935 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LEU . . . . . 0.489 ' HB3' ' O ' ' A' ' 92' ' ' SER . 62.0 tp -64.42 -45.16 88.77 Favored 'General case' 0 C--N 1.357 0.919 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.049 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.5 mp -60.89 -35.76 77.47 Favored 'General case' 0 C--N 1.356 0.874 0 O-C-N 122.139 -0.351 . . . . 0.0 110.17 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.6 t -69.09 -39.9 78.72 Favored 'General case' 0 C--N 1.35 0.613 0 O-C-N 121.871 -0.518 . . . . 0.0 110.067 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.77 8.15 40.62 Favored 'General case' 0 C--N 1.354 0.766 0 O-C-N 122.163 -0.336 . . . . 0.0 111.359 -176.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 19.3 tt -63.32 -38.81 83.13 Favored 'Isoleucine or valine' 0 C--N 1.36 1.024 0 O-C-N 121.44 -0.787 . . . . 0.0 111.876 -176.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -108.51 -14.75 14.59 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 118.103 -1.439 . . . . 0.0 110.156 -178.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.9 t -64.42 -46.09 84.73 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 120.253 -0.579 . . . . 0.0 111.07 -179.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -137.37 -15.09 1.46 Allowed 'General case' 0 C--N 1.359 1.016 0 C-N-CA 117.343 -1.743 . . . . 0.0 112.512 -177.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 26.5 mm -70.56 -51.74 34.83 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 CA-C-N 119.875 1.216 . . . . 0.0 110.468 -177.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 51.8 m170 -92.09 -1.05 57.41 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.203 -177.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 65.6 t -80.04 -44.6 22.71 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.026 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 178.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 54.8 tp10 -68.31 -40.76 81.59 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.1 t -62.66 -46.69 95.75 Favored 'Isoleucine or valine' 0 C--N 1.356 0.856 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.598 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -60.38 -48.24 82.61 Favored 'General case' 0 C--N 1.359 0.993 0 O-C-N 121.967 -0.458 . . . . 0.0 111.472 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -60.61 -36.55 78.87 Favored 'General case' 0 C--N 1.356 0.857 0 O-C-N 121.544 -0.722 . . . . 0.0 110.293 -178.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.4 mt -59.27 -77.16 0.04 OUTLIER 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' TYR . . . . . 0.444 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 82.7 m-85 -118.9 140.73 29.01 Favored Pre-proline 0 N--CA 1.438 -1.027 0 C-N-CA 118.663 -1.215 . . . . 0.0 109.053 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 111' ' ' TYR . 73.7 Cg_endo -87.0 -2.5 8.05 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 C-N-CA 123.129 2.553 . . . . 0.0 114.904 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -66.97 -36.52 82.38 Favored 'General case' 0 C--N 1.355 0.825 0 O-C-N 121.921 -0.487 . . . . 0.0 110.06 -179.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.82 147.11 53.68 Favored 'General case' 0 C--N 1.352 0.704 0 CA-C-O 121.525 0.679 . . . . 0.0 109.81 -178.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.462 ' O ' HD13 ' A' ' 116' ' ' LEU . 46.5 mt-10 -117.51 142.66 46.9 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 179.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.462 HD13 ' O ' ' A' ' 115' ' ' GLU . 2.7 mm? -127.12 149.29 69.06 Favored Pre-proline 0 C--N 1.352 0.695 0 CA-C-O 122.178 0.99 . . . . 0.0 108.73 -178.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -89.65 -158.86 0.08 OUTLIER 'Trans proline' 0 C--N 1.316 -1.18 0 C-N-CA 123.75 2.967 . . . . 0.0 113.029 179.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -118.33 140.56 49.65 Favored 'General case' 0 C--N 1.362 1.128 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -126.55 129.36 48.44 Favored 'General case' 0 C--N 1.361 1.081 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -178.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . 0.478 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 95.3 m -125.42 127.53 46.69 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 176.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 80.9 m -120.12 129.51 54.2 Favored 'General case' 0 CA--C 1.503 -0.855 0 C-N-CA 119.087 -1.045 . . . . 0.0 109.693 -177.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -120.74 117.48 27.59 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 178.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.589 ' HG3' ' CD1' ' A' ' 129' ' ' ILE . 12.9 ttm180 -92.8 113.81 26.19 Favored 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -179.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.555 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 87.1 mt -75.96 -38.99 56.93 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.074 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -166.21 -139.65 2.7 Favored Glycine 0 C--N 1.351 1.387 0 N-CA-C 109.231 -1.547 . . . . 0.0 109.231 -178.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -94.75 -41.09 9.43 Favored 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 120.134 -0.626 . . . . 0.0 109.452 -178.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 51.3 p-10 -101.28 4.48 41.76 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 120.049 -0.661 . . . . 0.0 109.956 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.555 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 67.3 m-20 -118.2 128.36 54.63 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.589 ' CD1' ' HG3' ' A' ' 123' ' ' ARG . 3.4 mm -139.42 132.33 36.92 Favored 'Isoleucine or valine' 0 C--N 1.355 0.823 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 52.9 mtm180 -116.08 137.8 51.8 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 179.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.9 tp -127.5 118.83 24.76 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 115.328 -0.851 . . . . 0.0 108.829 -178.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' HIS . . . . . 0.478 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 11.9 m170 -97.56 131.54 44.06 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 178.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -127.37 121.14 30.16 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 -178.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.511 ' HA ' ' O ' ' A' ' 171' ' ' THR . 28.6 tt0 -113.75 113.9 25.61 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.7 t -161.06 151.82 18.3 Favored 'General case' 0 C--N 1.359 0.982 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.402 ' C ' ' HD3' ' A' ' 138' ' ' PRO . 99.4 mttt -90.72 2.08 56.29 Favored 'General case' 0 C--N 1.355 0.838 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -179.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -132.99 74.54 73.69 Favored Pre-proline 0 CA--C 1.505 -0.787 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' PRO . . . . . 0.402 ' HD3' ' C ' ' A' ' 136' ' ' LYS . 90.2 Cg_endo -96.47 102.2 0.09 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.533 0 C-N-CA 122.743 2.296 . . . . 0.0 115.818 -177.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -110.76 114.07 27.15 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 105.971 -1.862 . . . . 0.0 105.971 176.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.88 -38.41 90.98 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.311 -178.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 74.5 m -64.01 -27.1 68.89 Favored 'General case' 0 C--N 1.354 0.777 0 O-C-N 121.864 -0.522 . . . . 0.0 110.7 -178.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -76.33 -47.08 24.77 Favored 'General case' 0 C--N 1.351 0.646 0 O-C-N 121.743 -0.598 . . . . 0.0 109.765 -177.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.67 -39.77 94.27 Favored 'General case' 0 C--N 1.356 0.885 0 O-C-N 122.183 -0.323 . . . . 0.0 111.256 -178.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.61 -37.71 88.38 Favored 'General case' 0 C--N 1.355 0.836 0 O-C-N 121.867 -0.521 . . . . 0.0 110.024 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.15 -43.17 98.63 Favored Glycine 0 C--N 1.347 1.188 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -179.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 83.6 mt -70.44 -40.38 73.81 Favored 'General case' 0 C--N 1.352 0.682 0 CA-C-N 117.559 0.68 . . . . 0.0 112.649 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 98.4 mt -70.91 -42.47 69.89 Favored 'General case' 0 C--N 1.362 1.11 0 O-C-N 121.215 -0.928 . . . . 0.0 110.86 -176.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.555 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 37.2 t70 -71.5 -28.85 64.19 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 121.894 -0.504 . . . . 0.0 110.336 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -63.03 -39.64 98.31 Favored Glycine 0 C--N 1.357 1.719 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 44.1 t -61.03 -41.06 95.86 Favored 'General case' 0 C--N 1.352 0.681 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -76.22 0.86 17.63 Favored 'General case' 0 C--N 1.361 1.071 0 CA-C-O 121.406 0.622 . . . . 0.0 109.403 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.555 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 76.8 mm-40 -86.37 -45.8 10.86 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -68.34 -43.67 76.99 Favored 'General case' 0 C--N 1.357 0.912 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.503 179.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -69.73 -27.9 65.35 Favored 'General case' 0 C--N 1.361 1.078 0 O-C-N 121.815 -0.553 . . . . 0.0 110.932 -178.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 85.1 tttt 71.56 69.22 0.16 Allowed 'General case' 0 C--N 1.362 1.114 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -177.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -134.57 -176.71 4.31 Favored 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -135.95 110.45 8.54 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -132.9 150.34 52.17 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 95.2 m -120.39 126.57 50.8 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.531 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.5 mp -101.86 121.31 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.7 m -116.32 -176.69 3.01 Favored 'General case' 0 C--N 1.361 1.082 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.734 ' HD2' ' HG3' ' A' ' 167' ' ' GLN . 8.8 ptt180 -148.95 158.17 43.97 Favored 'General case' 0 C--N 1.356 0.858 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 -179.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 65.5 p -104.75 145.01 29.89 Favored Pre-proline 0 C--N 1.359 1.017 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 179.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' PRO . . . . . 0.868 ' HA ' ' HB2' ' A' ' 167' ' ' GLN . 57.7 Cg_endo -75.36 -8.24 19.49 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 123.094 2.529 . . . . 0.0 115.521 -178.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -71.19 -41.31 70.45 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 34.1 p -117.77 16.12 14.41 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.868 ' HB2' ' HA ' ' A' ' 164' ' ' PRO . 45.1 tt0 -58.96 -38.67 79.6 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.87 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -111.71 48.69 0.94 Allowed 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 19.0 t -139.64 142.95 36.98 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.613 ' O ' ' HB ' ' A' ' 171' ' ' THR . 61.0 mt-10 -97.15 164.77 12.36 Favored 'General case' 0 C--N 1.356 0.86 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' THR . . . . . 0.613 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 3.1 m 80.81 -57.73 0.3 Allowed 'General case' 0 C--N 1.371 1.542 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -107.96 116.76 32.55 Favored 'General case' 0 CA--C 1.503 -0.83 0 C-N-CA 119.843 -0.743 . . . . 0.0 109.732 -178.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 86.3 t -130.26 131.86 65.35 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 178.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 50.5 mm -108.1 125.75 64.71 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -112.51 151.15 30.31 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-O 122.138 0.97 . . . . 0.0 108.551 -179.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -133.9 82.84 2.0 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.804 -178.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.1 mp -78.23 116.49 21.98 Favored 'Isoleucine or valine' 0 C--N 1.359 1.007 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 90.7 m -118.3 144.2 46.02 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -178.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 . . . . . 0 C--N 1.36 1.035 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 -179.669 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 1.018 ' HG2' HMD3 ' A' ' 202' ' ' HEM . 93.4 mmm . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 120.822 0.344 . . . . 0.0 110.197 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.09 -25.39 47.58 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -178.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.45 -39.4 50.6 Favored Glycine 0 C--N 1.351 1.392 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.0 tpp -69.78 -38.07 76.57 Favored 'General case' 0 C--N 1.357 0.914 0 O-C-N 121.911 -0.758 . . . . 0.0 111.081 -177.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.8 m -69.26 -22.63 25.98 Favored 'Isoleucine or valine' 0 C--N 1.356 0.89 0 O-C-N 121.504 -0.748 . . . . 0.0 109.51 -179.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -70.22 -36.76 74.75 Favored 'General case' 0 C--N 1.359 0.989 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 87.8 m -66.56 -40.91 89.26 Favored 'General case' 0 C--N 1.357 0.911 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 -179.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.64 -38.9 97.18 Favored Glycine 0 C--N 1.357 1.71 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 -179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.628 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -65.55 -40.31 92.72 Favored 'General case' 0 C--N 1.351 0.673 0 CA-C-N 117.207 0.503 . . . . 0.0 110.739 -178.205 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 20.7 mmt -63.75 -41.44 98.0 Favored 'General case' 0 C--N 1.355 0.819 0 O-C-N 121.419 -0.801 . . . . 0.0 111.207 -178.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -66.82 -40.36 88.02 Favored 'General case' 0 C--N 1.348 0.518 0 O-C-N 122.011 -0.431 . . . . 0.0 111.691 -177.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 55.7 tp -66.08 -43.29 87.77 Favored 'General case' 0 C--N 1.349 0.573 0 N-CA-C 112.966 0.728 . . . . 0.0 112.966 -177.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.628 HG12 ' O ' ' A' ' 9' ' ' LEU . 1.7 mm -73.18 -36.57 50.34 Favored 'Isoleucine or valine' 0 C--N 1.36 1.029 0 O-C-N 121.076 -1.015 . . . . 0.0 111.14 -175.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -70.66 -42.57 70.62 Favored 'General case' 0 C--N 1.35 0.612 0 O-C-N 121.505 -0.747 . . . . 0.0 111.746 -176.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -72.01 -38.33 69.62 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 -175.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -102.75 -23.97 13.76 Favored 'General case' 0 CA--C 1.509 -0.612 0 C-N-CA 118.524 -1.27 . . . . 0.0 113.655 -174.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 13.8 m-30 -108.2 -37.43 6.03 Favored 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 117.994 -1.482 . . . . 0.0 111.531 -176.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 143.37 178.11 18.89 Favored Glycine 0 C--N 1.347 1.173 0 C-N-CA 118.842 -1.646 . . . . 0.0 109.214 -179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -102.19 -26.93 13.16 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 -177.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -70.48 -38.92 74.47 Favored 'General case' 0 C--N 1.36 1.061 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 177.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.6 m -67.31 -38.48 85.02 Favored 'General case' 0 C--N 1.359 0.995 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 178.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 35.2 tp -60.57 -38.81 85.81 Favored 'General case' 0 C--N 1.356 0.859 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -63.77 -37.91 89.15 Favored 'General case' 0 C--N 1.358 0.96 0 O-C-N 122.122 -0.361 . . . . 0.0 111.485 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 87.1 m -65.42 -38.86 91.19 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -178.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.699 HD13 HD22 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -62.34 -39.36 92.84 Favored 'General case' 0 C--N 1.354 0.768 0 CA-C-O 120.958 0.408 . . . . 0.0 109.988 -179.046 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 85.7 mt -73.09 -15.27 61.5 Favored 'General case' 0 C--N 1.359 0.987 0 O-C-N 121.7 -0.625 . . . . 0.0 110.518 -178.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -86.13 -27.89 24.35 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 119.2 -1.0 . . . . 0.0 109.429 179.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.6 t -67.0 -36.47 82.25 Favored 'General case' 0 C--N 1.354 0.804 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.625 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 1.7 p -93.65 -37.97 11.57 Favored 'General case' 0 C--N 1.357 0.931 0 C-N-CA 118.781 -1.168 . . . . 0.0 108.12 -179.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.625 ' HB2' ' O ' ' A' ' 29' ' ' CYS . 13.7 mt-10 84.65 133.18 0.05 OUTLIER 'General case' 0 C--N 1.36 1.026 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.514 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -86.08 -169.12 2.5 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.874 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -152.91 -28.21 0.15 Allowed 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.7 t -141.85 -71.21 0.34 Allowed 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -178.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -130.6 -45.71 1.07 Allowed 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 125.7 -32.65 3.8 Favored Glycine 0 C--N 1.352 1.452 0 N-CA-C 109.374 -1.491 . . . . 0.0 109.374 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 84.8 mt -113.3 102.84 14.49 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.806 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 62.1 t80 -97.23 -2.3 43.05 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.731 HG22 ' H ' ' A' ' 39' ' ' SER . 3.9 m 79.42 174.68 0.14 Allowed 'General case' 0 C--N 1.362 1.135 0 N-CA-C 106.132 -1.803 . . . . 0.0 106.132 -178.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.731 ' H ' HG22 ' A' ' 38' ' ' THR . 31.8 p -87.96 113.91 24.07 Favored 'General case' 0 N--CA 1.443 -0.784 0 O-C-N 121.115 -0.99 . . . . 0.0 109.561 -178.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.481 HG13 ' O ' ' A' ' 39' ' ' SER . 0.0 OUTLIER -173.31 -9.0 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.362 1.146 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.946 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -115.25 166.17 12.17 Favored Glycine 0 C--N 1.356 1.671 0 N-CA-C 109.211 -1.555 . . . . 0.0 109.211 -178.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.3 m -130.1 130.36 44.74 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -117.3 172.33 7.37 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -70.68 172.91 7.86 Favored 'General case' 0 C--N 1.356 0.879 0 CA-C-O 121.762 0.791 . . . . 0.0 109.58 -179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -81.4 -25.99 35.79 Favored 'General case' 0 C--N 1.356 0.85 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -64.52 -28.19 69.48 Favored 'General case' 0 C--N 1.354 0.779 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -61.79 -42.34 98.87 Favored 'General case' 0 C--N 1.353 0.725 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.456 ' O ' HG23 ' A' ' 52' ' ' VAL . 62.6 tp -67.04 -40.0 87.06 Favored 'General case' 0 C--N 1.355 0.811 0 CA-C-N 116.631 -0.259 . . . . 0.0 110.439 -179.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 59.0 tp -72.15 -33.51 67.79 Favored 'General case' 0 C--N 1.35 0.611 0 O-C-N 122.14 -0.35 . . . . 0.0 110.68 -177.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -64.73 -42.78 94.97 Favored 'General case' 0 N--CA 1.445 -0.688 0 O-C-N 121.66 -0.65 . . . . 0.0 109.852 -177.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.699 HD22 HD13 ' A' ' 25' ' ' LEU . 77.6 mt -72.76 -33.83 66.6 Favored 'General case' 0 C--N 1.361 1.08 0 C-N-CA 119.762 -0.775 . . . . 0.0 109.753 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 48' ' ' LEU . 35.8 t -63.03 -42.3 96.12 Favored 'Isoleucine or valine' 0 C--N 1.35 0.605 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.7 t -66.1 -39.71 85.19 Favored 'Isoleucine or valine' 0 C--N 1.351 0.663 0 O-C-N 121.795 -0.565 . . . . 0.0 109.515 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.485 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 34.9 tptt -63.54 -28.64 70.08 Favored 'General case' 0 C--N 1.361 1.099 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.523 HD21 HD12 ' A' ' 13' ' ' ILE . 16.8 mt -66.51 -38.77 87.93 Favored 'General case' 0 C--N 1.355 0.847 0 O-C-N 121.996 -0.44 . . . . 0.0 110.459 179.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.7 p -72.13 -17.47 61.96 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.76 -178.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -101.57 -38.43 7.95 Favored 'General case' 0 C--N 1.354 0.769 0 C-N-CA 119.369 -0.932 . . . . 0.0 111.651 -179.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.7 p -72.3 -38.27 61.09 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 O-C-N 121.616 -0.678 . . . . 0.0 111.24 -177.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.589 ' HB3' HG23 ' A' ' 61' ' ' VAL . 1.9 t -113.21 -7.71 13.57 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 118.948 -1.101 . . . . 0.0 110.406 -178.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 64.86 49.56 2.15 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.589 HG23 ' HB3' ' A' ' 59' ' ' SER . 58.7 t -113.07 133.39 22.04 Favored Pre-proline 0 N--CA 1.443 -0.79 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 61' ' ' VAL . 39.3 Cg_exo -58.14 147.36 83.84 Favored 'Trans proline' 0 CA--C 1.499 -1.259 0 C-N-CA 122.562 2.175 . . . . 0.0 112.631 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.7 m -75.65 -11.52 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.922 -178.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 68.3 p -95.88 -32.97 12.39 Favored 'General case' 0 C--N 1.358 0.96 0 C-N-CA 118.183 -1.407 . . . . 0.0 109.468 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -77.52 -22.72 50.73 Favored 'General case' 0 C--N 1.355 0.814 0 O-C-N 121.488 -0.758 . . . . 0.0 109.138 179.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.76 -35.61 38.46 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 108.539 -0.912 . . . . 0.0 108.539 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -69.93 -28.4 36.46 Favored 'Isoleucine or valine' 0 C--N 1.357 0.9 0 C-N-CA 119.932 -0.707 . . . . 0.0 110.049 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 63.2 mtp180 -70.45 -50.12 41.55 Favored 'General case' 0 C--N 1.362 1.15 0 O-C-N 121.398 -0.814 . . . . 0.0 110.533 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.68 -35.96 81.36 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 122.246 -0.284 . . . . 0.0 110.91 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 92.1 t80 -61.1 -47.44 86.26 Favored 'General case' 0 C--N 1.348 0.512 0 O-C-N 122.229 -0.294 . . . . 0.0 110.498 -178.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.85 -39.59 97.06 Favored Glycine 0 C--N 1.355 1.616 0 N-CA-C 111.972 -0.451 . . . . 0.0 111.972 -178.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.0 -48.97 76.53 Favored 'General case' 0 C--N 1.352 0.694 0 CA-C-N 118.363 1.081 . . . . 0.0 111.635 -177.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.698 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 10.0 mttm -63.17 -48.38 78.65 Favored 'General case' 0 C--N 1.359 0.987 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -177.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.414 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.5 tm? -68.77 -39.07 80.42 Favored 'General case' 0 C--N 1.348 0.533 0 O-C-N 121.198 -0.939 . . . . 0.0 111.777 -175.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.413 ' CE2' ' HA ' ' A' ' 150' ' ' CYS . 48.0 t80 -62.84 -45.96 90.13 Favored 'General case' 0 C--N 1.353 0.761 0 O-C-N 121.152 -0.968 . . . . 0.0 111.286 -178.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 8.5 p -70.08 -15.08 18.89 Favored 'Isoleucine or valine' 0 C--N 1.359 0.993 0 O-C-N 121.377 -0.827 . . . . 0.0 109.392 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.698 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 75.2 mm-40 -71.07 -38.93 72.47 Favored 'General case' 0 C--N 1.352 0.702 0 N-CA-C 108.493 -0.929 . . . . 0.0 108.493 178.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 81.7 mt -72.17 -33.12 67.45 Favored 'General case' 0 C--N 1.356 0.873 0 O-C-N 122.432 -0.168 . . . . 0.0 110.739 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 47.3 mm -64.48 -54.05 35.36 Favored 'Isoleucine or valine' 0 C--N 1.358 0.943 0 C-N-CA 120.126 -0.63 . . . . 0.0 110.396 -177.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -75.33 -14.37 60.48 Favored 'General case' 0 C--N 1.351 0.673 0 C-N-CA 119.327 -0.949 . . . . 0.0 109.45 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.09 -36.78 64.11 Favored Glycine 0 C--N 1.347 1.192 0 N-CA-C 110.969 -0.853 . . . . 0.0 110.969 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -134.18 106.81 11.28 Favored Pre-proline 0 C--N 1.357 0.894 0 CA-C-O 122.68 1.229 . . . . 0.0 109.189 -176.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.526 ' O ' ' HB2' ' A' ' 87' ' ' ASN . 39.3 Cg_endo -68.97 -23.3 34.57 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.675 2.25 . . . . 0.0 114.239 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -90.55 -8.71 49.56 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 tp -90.31 -21.25 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.038 0 N-CA-C 106.679 -1.6 . . . . 0.0 106.679 -178.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -104.11 -14.74 15.78 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.526 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 20.1 t30 -73.3 -41.02 64.06 Favored 'General case' 0 C--N 1.359 1.012 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -68.1 -28.4 67.3 Favored 'General case' 0 C--N 1.352 0.716 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.552 -178.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 25.9 ttp -84.86 148.55 26.22 Favored 'General case' 0 C--N 1.351 0.636 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 -179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.13 -21.63 8.14 Favored 'General case' 0 C--N 1.364 1.216 0 C-N-CA 120.145 -0.622 . . . . 0.0 110.984 -177.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -164.22 171.18 15.31 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -177.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.443 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 86.6 p -70.22 -34.0 72.37 Favored 'General case' 0 C--N 1.354 0.776 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.197 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -70.04 -38.46 75.84 Favored 'General case' 0 C--N 1.357 0.922 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -66.14 -24.67 66.71 Favored 'General case' 0 C--N 1.358 0.952 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 178.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.443 ' HB3' ' O ' ' A' ' 92' ' ' SER . 61.3 tp -62.63 -46.63 87.34 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.2 mp -62.76 -32.6 73.78 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 122.246 -0.284 . . . . 0.0 110.302 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 35.8 t -62.73 -45.58 92.07 Favored 'General case' 0 C--N 1.356 0.864 0 O-C-N 121.688 -0.632 . . . . 0.0 111.597 -178.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.08 25.87 10.99 Favored 'General case' 0 C--N 1.361 1.071 0 O-C-N 121.057 -1.027 . . . . 0.0 110.453 -178.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 1.042 HD11 ' C3B' ' A' ' 202' ' ' HEM . 12.3 tt -64.26 -29.66 47.94 Favored 'Isoleucine or valine' 0 C--N 1.352 0.689 0 C-N-CA 120.341 -0.543 . . . . 0.0 110.507 -179.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -120.19 -18.59 7.99 Favored 'General case' 0 N--CA 1.439 -1.012 0 C-N-CA 119.336 -0.946 . . . . 0.0 109.115 -179.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 35.5 t -66.06 -45.98 79.42 Favored 'General case' 0 N--CA 1.443 -0.785 0 O-C-N 121.841 -0.537 . . . . 0.0 110.85 -178.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.552 ' O ' HG12 ' A' ' 105' ' ' VAL . 30.8 t80 -124.97 -31.21 3.15 Favored 'General case' 0 C--N 1.359 0.99 0 C-N-CA 118.23 -1.388 . . . . 0.0 111.992 -177.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 96.3 mt -67.52 -47.27 81.09 Favored 'Isoleucine or valine' 0 C--N 1.352 0.704 0 O-C-N 121.034 -1.041 . . . . 0.0 110.687 -177.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 17.5 m170 -87.72 3.16 49.06 Favored 'General case' 0 N--CA 1.441 -0.913 0 O-C-N 121.252 -0.905 . . . . 0.0 110.15 -177.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.552 HG12 ' O ' ' A' ' 102' ' ' PHE . 1.8 p -87.39 -34.15 7.26 Favored 'Isoleucine or valine' 0 C--N 1.356 0.872 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 178.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -71.86 -40.26 69.1 Favored 'General case' 0 C--N 1.359 0.997 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.505 HG21 ' HHD' ' A' ' 202' ' ' HEM . 62.4 t -62.81 -47.37 93.19 Favored 'Isoleucine or valine' 0 C--N 1.356 0.87 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.517 -179.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -60.55 -48.25 82.62 Favored 'General case' 0 C--N 1.359 0.979 0 O-C-N 122.115 -0.366 . . . . 0.0 111.364 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -61.96 -37.57 85.27 Favored 'General case' 0 C--N 1.354 0.786 0 O-C-N 121.533 -0.729 . . . . 0.0 110.708 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.8 mt -57.47 -74.96 0.05 OUTLIER 'General case' 0 C--N 1.356 0.851 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -114.54 135.52 22.3 Favored Pre-proline 0 N--CA 1.441 -0.921 0 C-N-CA 118.656 -1.218 . . . . 0.0 109.146 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -84.66 -5.91 9.87 Favored 'Trans proline' 0 C--N 1.313 -1.336 0 C-N-CA 123.133 2.555 . . . . 0.0 115.055 -179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -66.96 -36.58 82.53 Favored 'General case' 0 C--N 1.355 0.808 0 O-C-N 122.009 -0.432 . . . . 0.0 110.073 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.71 145.21 56.29 Favored 'General case' 0 C--N 1.355 0.807 0 CA-C-O 121.683 0.754 . . . . 0.0 110.139 -178.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -131.09 135.64 47.69 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.467 ' HB3' ' HD2' ' A' ' 117' ' ' PRO . 91.6 mt -127.9 155.73 77.11 Favored Pre-proline 0 N--CA 1.443 -0.791 0 CA-C-O 122.173 0.987 . . . . 0.0 109.246 -178.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' A' ' 116' ' ' LEU . 84.6 Cg_endo -81.89 -151.45 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.081 0 C-N-CA 123.736 2.957 . . . . 0.0 113.895 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -115.52 146.42 41.72 Favored 'General case' 0 C--N 1.362 1.126 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.629 ' CE1' HD13 ' A' ' 131' ' ' LEU . 14.1 t80 -140.6 125.57 18.34 Favored 'General case' 0 C--N 1.362 1.144 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 -177.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 93.3 m -125.83 134.06 51.78 Favored 'General case' 0 C--N 1.36 1.038 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 79.0 m -113.36 131.19 56.07 Favored 'General case' 0 C--N 1.356 0.872 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.772 -178.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -117.69 141.77 48.01 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 177.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -117.75 116.57 27.28 Favored 'General case' 0 N--CA 1.444 -0.749 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.528 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 87.6 mt -84.49 -25.75 28.63 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 120.686 -0.406 . . . . 0.0 109.994 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 179.2 -144.26 6.11 Favored Glycine 0 C--N 1.349 1.251 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -94.68 -40.88 9.57 Favored 'General case' 0 N--CA 1.436 -1.137 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.567 -178.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 15.7 p-10 -99.17 2.31 45.72 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 119.762 -0.775 . . . . 0.0 110.614 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.528 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 8.4 m-20 -121.72 131.63 54.18 Favored 'General case' 0 C--N 1.358 0.961 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.5 mm -140.91 137.43 34.7 Favored 'Isoleucine or valine' 0 C--N 1.354 0.797 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 61.9 mtm180 -123.78 140.35 53.08 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 1.038 HD23 HD11 ' A' ' 177' ' ' ILE . 1.1 pp -127.79 129.43 47.01 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -99.49 133.96 43.06 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 107.065 -1.457 . . . . 0.0 107.065 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 55.5 t80 -129.67 120.32 24.99 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -178.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.578 ' HA ' ' O ' ' A' ' 171' ' ' THR . 74.2 mt-30 -114.25 115.08 26.85 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 18.1 t -161.69 152.01 17.32 Favored 'General case' 0 C--N 1.359 0.991 0 N-CA-C 106.917 -1.512 . . . . 0.0 106.917 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -92.02 2.22 56.7 Favored 'General case' 0 C--N 1.358 0.939 0 C-N-CA 120.15 -0.62 . . . . 0.0 109.937 -179.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 87.2 mtm180 -134.4 73.03 69.62 Favored Pre-proline 0 C--N 1.355 0.81 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -96.19 110.01 0.12 Allowed 'Trans proline' 0 N--CA 1.445 -1.368 0 C-N-CA 122.714 2.276 . . . . 0.0 116.079 -177.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -113.64 113.93 25.73 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 176.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.08 -38.7 92.0 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.264 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.3 m -62.41 -27.07 68.84 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 121.871 -0.518 . . . . 0.0 110.731 -178.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -76.02 -47.94 22.89 Favored 'General case' 0 C--N 1.351 0.64 0 C-N-CA 120.196 -0.602 . . . . 0.0 109.702 -178.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.68 -40.17 94.93 Favored 'General case' 0 C--N 1.358 0.949 0 O-C-N 122.17 -0.331 . . . . 0.0 111.269 -178.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -62.82 -36.54 83.52 Favored 'General case' 0 C--N 1.355 0.818 0 O-C-N 121.92 -0.487 . . . . 0.0 110.088 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.3 -42.81 98.94 Favored Glycine 0 C--N 1.347 1.171 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -179.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.0 mt -69.75 -40.93 75.86 Favored 'General case' 0 C--N 1.353 0.72 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 96.0 mt -71.69 -42.34 67.55 Favored 'General case' 0 C--N 1.363 1.168 0 O-C-N 121.091 -1.006 . . . . 0.0 111.086 -176.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.506 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 37.2 t70 -69.3 -31.78 70.49 Favored 'General case' 0 N--CA 1.446 -0.654 0 O-C-N 121.887 -0.508 . . . . 0.0 110.484 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -62.66 -39.26 97.69 Favored Glycine 0 C--N 1.356 1.658 0 N-CA-C 108.62 -1.792 . . . . 0.0 108.62 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . 0.413 ' HA ' ' CE2' ' A' ' 75' ' ' PHE . 42.8 t -60.42 -42.55 96.27 Favored 'General case' 0 C--N 1.35 0.625 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -74.55 -1.6 22.14 Favored 'General case' 0 C--N 1.36 1.058 0 O-C-N 121.72 -0.612 . . . . 0.0 109.458 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.506 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 77.7 mm-40 -83.56 -46.9 11.89 Favored 'General case' 0 N--CA 1.444 -0.75 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -65.87 -45.04 83.59 Favored 'General case' 0 C--N 1.36 1.036 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -68.96 -26.15 64.91 Favored 'General case' 0 C--N 1.362 1.126 0 O-C-N 121.75 -0.594 . . . . 0.0 110.796 -178.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 86.2 tttt 72.73 75.92 0.15 Allowed 'General case' 0 C--N 1.359 0.989 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -143.7 -168.28 2.8 Favored 'General case' 0 N--CA 1.442 -0.842 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -152.24 92.99 1.76 Allowed 'General case' 0 N--CA 1.437 -1.081 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 16.3 m-30 -112.38 161.93 16.13 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 106.665 -1.605 . . . . 0.0 106.665 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 93.7 m -118.5 125.95 50.97 Favored 'General case' 0 C--N 1.356 0.886 0 C-N-CA 119.293 -0.963 . . . . 0.0 109.234 -177.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.5 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.6 mp -104.61 122.33 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 178.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.6 m -120.52 -171.3 2.15 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-O 121.665 0.745 . . . . 0.0 109.241 -178.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.49 ' HD2' ' HG3' ' A' ' 167' ' ' GLN . 5.9 ptt85 -152.0 161.6 42.39 Favored 'General case' 0 C--N 1.357 0.897 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -178.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 56.8 p -107.95 143.9 28.28 Favored Pre-proline 0 C--N 1.36 1.049 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.878 ' HA ' ' HB2' ' A' ' 167' ' ' GLN . 56.7 Cg_endo -75.15 -7.86 19.4 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 123.204 2.603 . . . . 0.0 115.578 -178.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -71.6 -41.42 68.96 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 36.5 p -116.89 16.03 15.2 Favored 'General case' 0 CA--C 1.501 -0.911 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.878 ' HB2' ' HA ' ' A' ' 164' ' ' PRO . 37.6 tt0 -58.38 -39.02 78.5 Favored 'General case' 0 N--CA 1.444 -0.75 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.323 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -113.23 49.04 0.98 Allowed 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 108.046 -1.094 . . . . 0.0 108.046 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 20.7 t -139.11 142.24 38.09 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.618 ' O ' ' HB ' ' A' ' 171' ' ' THR . 61.8 mt-10 -96.52 163.7 12.93 Favored 'General case' 0 N--CA 1.443 -0.788 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.618 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 18.6 m 84.12 -56.71 0.13 Allowed 'General case' 0 C--N 1.369 1.418 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.657 179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -110.79 118.8 37.13 Favored 'General case' 0 CA--C 1.506 -0.744 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.924 -178.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 99.6 t -132.01 133.4 60.83 Favored 'Isoleucine or valine' 0 C--N 1.358 0.963 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 178.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 49.2 mm -112.03 125.84 69.36 Favored 'Isoleucine or valine' 0 C--N 1.36 1.03 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.576 ' HB2' ' HG ' ' A' ' 131' ' ' LEU . 96.8 m-85 -116.07 148.75 39.91 Favored 'General case' 0 C--N 1.359 0.996 0 CA-C-O 121.901 0.857 . . . . 0.0 109.063 -179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -126.55 119.87 28.2 Favored 'General case' 0 C--N 1.354 0.768 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 1.038 HD11 HD23 ' A' ' 131' ' ' LEU . 4.0 mp -115.42 121.58 67.52 Favored 'Isoleucine or valine' 0 C--N 1.354 0.795 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 38.0 p -126.11 159.55 32.55 Favored 'General case' 0 CA--C 1.502 -0.877 0 CA-C-O 121.429 0.633 . . . . 0.0 110.811 -178.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 77.3 mtm180 -95.45 115.41 27.39 Favored 'General case' 0 C--N 1.367 1.365 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 177.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.437 ' HA ' ' HD3' ' A' ' 181' ' ' PRO . . . -67.44 146.56 98.74 Favored Pre-proline 0 C--N 1.357 0.912 0 N-CA-C 107.345 -1.354 . . . . 0.0 107.345 177.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 180' ' ' ALA . 50.1 Cg_exo -55.85 125.54 19.46 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.521 2.148 . . . . 0.0 113.756 -179.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 6.8 ppt_? -151.18 170.68 18.86 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.476 ' O ' ' HB3' ' A' ' 184' ' ' ALA . . . 92.76 82.23 1.49 Allowed Glycine 0 C--N 1.351 1.394 0 N-CA-C 107.898 -2.081 . . . . 0.0 107.898 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.672 ' O ' ' HB2' ' A' ' 185' ' ' GLU . . . 81.62 -93.56 0.01 OUTLIER 'General case' 0 C--N 1.358 0.958 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.672 ' HB2' ' O ' ' A' ' 184' ' ' ALA . 35.1 tt0 150.85 84.21 0.0 OUTLIER 'General case' 0 C--N 1.365 1.263 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -112.71 112.28 23.67 Favored 'General case' 0 CA--C 1.502 -0.901 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 178.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 59.4 tp -74.29 -47.11 36.87 Favored 'General case' 0 C--N 1.356 0.858 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 11.1 t80 -161.71 -80.76 0.04 OUTLIER 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -127.42 -69.24 0.75 Allowed 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 107.174 -1.417 . . . . 0.0 107.174 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 . . . . . 0 C--O 1.264 1.852 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 179.897 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' HEM . . . . . 1.042 ' C3B' HD11 ' A' ' 99' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.894 ' HG3' ' CMD' ' A' ' 202' ' ' HEM . 55.7 mtp . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.089 0.471 . . . . 0.0 110.228 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.39 -17.86 55.85 Favored 'General case' 0 C--N 1.355 0.839 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -178.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -76.33 -41.12 26.72 Favored Glycine 0 C--N 1.349 1.256 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 -179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 14.5 tpp -69.12 -38.68 79.02 Favored 'General case' 0 C--N 1.355 0.827 0 O-C-N 121.946 -0.738 . . . . 0.0 110.612 -177.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.5 m -68.25 -22.83 27.85 Favored 'Isoleucine or valine' 0 C--N 1.357 0.903 0 C-N-CA 120.27 -0.572 . . . . 0.0 109.617 -179.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.3 m-30 -70.57 -35.58 73.15 Favored 'General case' 0 C--N 1.356 0.876 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 85.5 m -67.15 -40.85 86.77 Favored 'General case' 0 C--N 1.355 0.814 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.43 -39.39 97.73 Favored Glycine 0 C--N 1.359 1.814 0 N-CA-C 110.499 -1.04 . . . . 0.0 110.499 -179.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.583 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -64.62 -39.6 93.99 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-N 117.131 0.465 . . . . 0.0 110.711 -178.481 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.438 ' SD ' HD11 ' A' ' 26' ' ' LEU . 25.8 mmt -63.43 -40.44 97.18 Favored 'General case' 0 C--N 1.352 0.684 0 O-C-N 121.679 -0.638 . . . . 0.0 110.984 -178.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -66.88 -40.22 87.75 Favored 'General case' 0 C--N 1.349 0.571 0 O-C-N 121.956 -0.465 . . . . 0.0 111.362 -177.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 53.7 tp -66.42 -42.83 87.2 Favored 'General case' 0 C--N 1.35 0.588 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -178.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.583 HG12 ' O ' ' A' ' 9' ' ' LEU . 1.4 mm -74.99 -36.76 39.52 Favored 'Isoleucine or valine' 0 C--N 1.359 1.008 0 O-C-N 120.988 -1.07 . . . . 0.0 111.002 -175.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -68.18 -43.66 77.65 Favored 'General case' 0 C--N 1.353 0.729 0 O-C-N 121.723 -0.611 . . . . 0.0 111.555 -176.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -71.22 -35.27 71.43 Favored 'General case' 0 N--CA 1.446 -0.634 0 O-C-N 121.974 -0.454 . . . . 0.0 111.909 -176.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -72.69 -48.56 38.02 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -175.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -126.41 -20.9 4.3 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 117.349 -1.741 . . . . 0.0 113.816 -176.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 141.36 179.6 18.7 Favored Glycine 0 CA--C 1.497 -1.078 0 C-N-CA 117.789 -2.148 . . . . 0.0 109.884 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -97.16 -12.26 23.29 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 -177.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -70.64 -41.08 72.65 Favored 'General case' 0 C--N 1.36 1.05 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 94.5 m -69.51 -39.05 77.79 Favored 'General case' 0 C--N 1.357 0.932 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.463 HD13 ' HB ' ' A' ' 13' ' ' ILE . 59.1 tp -61.17 -37.99 84.87 Favored 'General case' 0 C--N 1.357 0.905 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -65.17 -35.71 81.94 Favored 'General case' 0 C--N 1.356 0.851 0 O-C-N 122.177 -0.327 . . . . 0.0 110.802 -178.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.5 m -63.71 -40.74 97.53 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.435 ' CD2' ' HB3' ' A' ' 54' ' ' LYS . 87.6 mt -64.87 -37.97 89.4 Favored 'General case' 0 C--N 1.356 0.874 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.444 HD23 ' CD2' ' A' ' 31' ' ' LEU . 6.7 mp -69.39 -14.8 63.1 Favored 'General case' 0 C--N 1.357 0.922 0 O-C-N 121.415 -0.803 . . . . 0.0 109.802 -179.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -85.84 -28.38 24.47 Favored 'General case' 0 N--CA 1.442 -0.871 0 C-N-CA 119.624 -0.83 . . . . 0.0 109.224 178.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 55.0 p -68.18 -23.11 64.82 Favored 'General case' 0 C--N 1.361 1.066 0 C-N-CA 119.888 -0.725 . . . . 0.0 109.3 179.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.0 p -106.96 -33.6 7.45 Favored 'General case' 0 C--N 1.357 0.912 0 C-N-CA 118.933 -1.107 . . . . 0.0 108.141 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 83.63 132.56 0.05 OUTLIER 'General case' 0 C--N 1.361 1.106 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 178.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.457 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -100.53 109.63 21.75 Favored 'General case' 0 C--N 1.357 0.896 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.737 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 62.5 tt0 -72.23 -40.71 67.55 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 107.907 -1.145 . . . . 0.0 107.907 178.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.43 ' HB3' ' H ' ' A' ' 34' ' ' GLU . 0.9 OUTLIER -116.09 -86.22 0.62 Allowed 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -179.212 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.43 ' H ' ' HB3' ' A' ' 33' ' ' SER . 57.4 mt-10 -122.14 -40.88 2.46 Favored 'General case' 0 CA--C 1.5 -0.956 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -178.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 110.62 -32.79 6.33 Favored Glycine 0 C--N 1.351 1.365 0 N-CA-C 109.629 -1.389 . . . . 0.0 109.629 178.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 80.4 mt -109.89 104.15 16.62 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.005 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 -179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.509 ' HD1' ' HA ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -82.89 -143.44 0.06 Allowed 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.337 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 86.2 m -109.82 -56.89 2.26 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.5 p 166.03 16.57 0.0 OUTLIER 'General case' 0 C--N 1.363 1.161 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 23.3 m -109.79 6.48 8.97 Favored 'Isoleucine or valine' 0 C--N 1.353 0.738 0 C-N-CA 119.522 -0.871 . . . . 0.0 111.313 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -91.75 143.67 16.71 Favored Glycine 0 C--N 1.354 1.533 0 C-N-CA 119.223 -1.465 . . . . 0.0 109.505 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 57.0 m -126.61 130.19 50.0 Favored 'General case' 0 C--N 1.356 0.871 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 73.4 m-85 -125.27 174.52 8.06 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 67.7 m-20 -76.07 -179.0 4.69 Favored 'General case' 0 C--N 1.356 0.864 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 3.3 t60 -86.44 -19.87 28.98 Favored 'General case' 0 C--N 1.356 0.876 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.744 ' HA ' HD23 ' A' ' 49' ' ' LEU . 38.1 tt0 -63.98 -35.5 80.9 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.0 tp10 -61.59 -40.55 95.21 Favored 'General case' 0 C--N 1.349 0.572 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 60.4 tp -65.38 -40.29 93.32 Favored 'General case' 0 C--N 1.357 0.896 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.691 -178.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.744 HD23 ' HA ' ' A' ' 46' ' ' GLN . 0.1 OUTLIER -83.45 -14.57 52.23 Favored 'General case' 0 C--N 1.352 0.71 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.131 -177.226 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -71.62 -43.57 65.95 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.8 mt -73.24 -34.93 66.14 Favored 'General case' 0 C--N 1.361 1.083 0 C-N-CA 120.17 -0.612 . . . . 0.0 109.704 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 50.3 t -63.91 -41.41 92.42 Favored 'Isoleucine or valine' 0 C--N 1.352 0.697 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 49' ' ' LEU . 52.9 t -65.84 -40.74 88.46 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 O-C-N 121.761 -0.587 . . . . 0.0 109.962 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.435 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 24.6 tptt -67.65 -20.29 65.3 Favored 'General case' 0 C--N 1.36 1.054 0 O-C-N 120.939 -1.101 . . . . 0.0 108.863 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.83 -37.47 70.3 Favored 'General case' 0 C--N 1.353 0.745 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.471 ' O ' ' HA ' ' A' ' 60' ' ' SER . 81.2 p -73.04 -17.32 61.45 Favored 'General case' 0 C--N 1.356 0.852 0 O-C-N 121.766 -0.584 . . . . 0.0 110.285 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -99.51 -37.56 9.13 Favored 'General case' 0 C--N 1.355 0.805 0 O-C-N 121.305 -0.872 . . . . 0.0 111.325 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.1 p -71.85 -34.7 52.24 Favored 'Isoleucine or valine' 0 C--N 1.353 0.723 0 O-C-N 121.709 -0.619 . . . . 0.0 111.52 -177.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.559 ' HB3' HG23 ' A' ' 61' ' ' VAL . 4.3 t -119.99 -8.74 9.75 Favored 'General case' 0 CA--C 1.508 -0.671 0 C-N-CA 119.26 -0.976 . . . . 0.0 109.849 -178.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.471 ' HA ' ' O ' ' A' ' 56' ' ' SER . 0.6 OUTLIER 66.65 47.78 1.54 Allowed 'General case' 0 C--N 1.353 0.737 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 179.61 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.559 HG23 ' HB3' ' A' ' 59' ' ' SER . 47.6 t -107.44 133.35 20.41 Favored Pre-proline 0 CA--C 1.505 -0.773 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.408 ' O ' ' HB3' ' A' ' 66' ' ' LEU . 41.9 Cg_exo -57.38 147.21 78.89 Favored 'Trans proline' 0 CA--C 1.498 -1.3 0 C-N-CA 122.505 2.137 . . . . 0.0 112.794 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.4 m -75.9 -13.61 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.826 -178.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.425 ' O ' HG12 ' A' ' 67' ' ' VAL . 69.0 p -97.54 -32.77 11.64 Favored 'General case' 0 C--N 1.36 1.055 0 C-N-CA 118.176 -1.41 . . . . 0.0 109.533 -178.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -76.6 -21.47 55.52 Favored 'General case' 0 C--N 1.354 0.776 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.408 ' HB3' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -82.05 -35.57 28.6 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -179.139 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.425 HG12 ' O ' ' A' ' 64' ' ' THR . 1.3 p -68.92 -26.43 32.52 Favored 'Isoleucine or valine' 0 C--N 1.354 0.795 0 C-N-CA 120.11 -0.636 . . . . 0.0 109.914 -179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.5 mmm-85 -73.04 -52.5 14.13 Favored 'General case' 0 C--N 1.36 1.055 0 O-C-N 121.596 -0.69 . . . . 0.0 110.124 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 86.1 mt -63.37 -35.93 82.04 Favored 'General case' 0 C--N 1.357 0.929 0 O-C-N 121.991 -0.443 . . . . 0.0 110.979 -178.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -60.92 -47.27 87.17 Favored 'General case' 0 C--N 1.349 0.555 0 O-C-N 122.258 -0.276 . . . . 0.0 110.494 -178.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.54 -37.94 94.13 Favored Glycine 0 C--N 1.356 1.641 0 N-CA-C 111.637 -0.585 . . . . 0.0 111.637 -178.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -62.47 -49.33 75.85 Favored 'General case' 0 C--N 1.35 0.622 0 CA-C-N 118.044 0.922 . . . . 0.0 111.485 -177.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.689 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 11.9 mttm -64.36 -47.72 78.25 Favored 'General case' 0 C--N 1.359 0.996 0 N-CA-C 113.566 0.95 . . . . 0.0 113.566 -177.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -68.5 -38.84 81.31 Favored 'General case' 0 C--N 1.347 0.5 0 O-C-N 121.265 -0.897 . . . . 0.0 112.004 -175.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -64.84 -42.85 94.59 Favored 'General case' 0 C--N 1.352 0.703 0 O-C-N 121.116 -0.99 . . . . 0.0 111.077 -177.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.7 -15.43 18.28 Favored 'Isoleucine or valine' 0 C--N 1.36 1.057 0 O-C-N 121.324 -0.86 . . . . 0.0 109.114 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.689 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 74.1 mm-40 -71.88 -38.71 69.97 Favored 'General case' 0 C--N 1.35 0.603 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 179.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 84.5 mt -74.32 -29.69 61.72 Favored 'General case' 0 C--N 1.358 0.967 0 O-C-N 122.215 -0.303 . . . . 0.0 110.749 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.4 mm -66.41 -53.28 37.72 Favored 'Isoleucine or valine' 0 C--N 1.357 0.91 0 C-N-CA 119.973 -0.691 . . . . 0.0 109.973 -177.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -76.08 -14.71 60.19 Favored 'General case' 0 C--N 1.351 0.651 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.39 178.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.0 -36.93 64.47 Favored Glycine 0 C--N 1.349 1.267 0 N-CA-C 110.687 -0.965 . . . . 0.0 110.687 -179.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.483 ' HA ' ' HD2' ' A' ' 83' ' ' PRO . 98.6 m-70 -131.86 105.52 14.01 Favored Pre-proline 0 N--CA 1.44 -0.968 0 CA-C-O 122.604 1.192 . . . . 0.0 108.911 -177.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.483 ' HD2' ' HA ' ' A' ' 82' ' ' HIS . 41.4 Cg_endo -68.87 -23.29 35.24 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.637 2.225 . . . . 0.0 114.052 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -90.61 -9.64 46.24 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.3 tp -89.52 -21.75 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 -178.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -102.24 -17.4 15.96 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 51.3 t30 -70.84 -41.28 71.68 Favored 'General case' 0 C--N 1.359 0.999 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 179.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -66.13 -33.48 75.86 Favored 'General case' 0 C--N 1.352 0.699 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.318 -179.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.538 ' HG2' ' N ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -80.87 149.97 29.28 Favored 'General case' 0 C--N 1.353 0.745 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 -179.029 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.538 ' N ' ' HG2' ' A' ' 89' ' ' MET . 1.4 mtpt -117.56 -24.69 7.2 Favored 'General case' 0 C--N 1.361 1.1 0 C-N-CA 120.07 -0.652 . . . . 0.0 111.183 -177.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -165.83 171.88 12.29 Favored 'General case' 0 CA--C 1.505 -0.783 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 -177.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.428 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 57.8 m -67.26 -39.44 86.1 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.486 -179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.648 ' HZ ' ' HG3' ' A' ' 179' ' ' ARG . 64.7 m-85 -67.77 -39.14 84.15 Favored 'General case' 0 C--N 1.358 0.94 0 O-C-N 121.216 -0.928 . . . . 0.0 108.681 -179.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -66.16 -22.79 66.38 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.428 ' HB3' ' O ' ' A' ' 92' ' ' SER . 62.0 tp -65.2 -45.13 85.99 Favored 'General case' 0 C--N 1.357 0.929 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.3 mp -61.44 -36.5 80.54 Favored 'General case' 0 C--N 1.358 0.956 0 O-C-N 122.001 -0.437 . . . . 0.0 110.239 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 34.7 t -67.77 -39.79 84.09 Favored 'General case' 0 C--N 1.349 0.549 0 O-C-N 121.829 -0.545 . . . . 0.0 110.021 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 8.2 tttp -93.78 8.1 42.38 Favored 'General case' 0 C--N 1.353 0.75 0 O-C-N 122.286 -0.259 . . . . 0.0 111.279 -176.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 1.053 HD11 ' C2B' ' A' ' 202' ' ' HEM . 15.6 tt -64.29 -38.18 81.85 Favored 'Isoleucine or valine' 0 C--N 1.36 1.033 0 O-C-N 121.464 -0.773 . . . . 0.0 111.694 -176.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -107.87 -15.79 14.46 Favored 'General case' 0 N--CA 1.437 -1.095 0 C-N-CA 118.181 -1.408 . . . . 0.0 110.195 -178.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.9 t -64.83 -46.6 81.25 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 121.76 -0.588 . . . . 0.0 111.272 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -137.32 -15.12 1.47 Allowed 'General case' 0 C--N 1.36 1.058 0 C-N-CA 117.497 -1.681 . . . . 0.0 112.684 -177.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.518 HG21 ' C1C' ' A' ' 202' ' ' HEM . 31.0 mm -71.0 -51.74 32.99 Favored 'Isoleucine or valine' 0 C--N 1.352 0.682 0 CA-C-N 119.982 1.265 . . . . 0.0 110.715 -177.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 35.2 m170 -92.03 2.88 56.28 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 119.529 -0.869 . . . . 0.0 110.22 -177.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 49.5 t -85.79 -44.37 16.88 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.083 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 178.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 54.7 tp10 -68.1 -40.41 82.62 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.502 HG11 HMD1 ' A' ' 202' ' ' HEM . 66.6 t -63.84 -46.28 94.75 Favored 'Isoleucine or valine' 0 C--N 1.356 0.889 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.074 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 92.4 t80 -60.94 -48.51 81.5 Favored 'General case' 0 C--N 1.359 1.019 0 O-C-N 122.06 -0.4 . . . . 0.0 111.322 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -61.28 -37.12 82.02 Favored 'General case' 0 C--N 1.357 0.896 0 O-C-N 121.567 -0.708 . . . . 0.0 110.596 -178.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 15.5 mt -56.68 -72.94 0.07 Allowed 'General case' 0 CA--C 1.501 -0.918 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.408 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 88.3 m-85 -121.9 135.16 25.05 Favored Pre-proline 0 N--CA 1.438 -1.061 0 C-N-CA 118.488 -1.285 . . . . 0.0 108.638 179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 111' ' ' TYR . 97.7 Cg_endo -83.47 -2.56 10.55 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 123.197 2.598 . . . . 0.0 115.255 -178.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 29.7 mm100 -66.07 -37.16 85.13 Favored 'General case' 0 C--N 1.354 0.778 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.61 145.8 55.2 Favored 'General case' 0 C--N 1.354 0.796 0 CA-C-O 121.614 0.721 . . . . 0.0 109.846 -178.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -127.54 134.07 49.76 Favored 'General case' 0 C--N 1.357 0.922 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.485 ' HB3' ' HD2' ' A' ' 117' ' ' PRO . 86.8 mt -128.25 156.43 76.67 Favored Pre-proline 0 C--N 1.354 0.769 0 CA-C-O 122.116 0.96 . . . . 0.0 109.21 -178.596 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.485 ' HD2' ' HB3' ' A' ' 116' ' ' LEU . 95.3 Cg_endo -84.05 -153.67 0.05 OUTLIER 'Trans proline' 0 C--N 1.318 -1.074 0 C-N-CA 123.763 2.975 . . . . 0.0 114.317 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -116.66 143.79 45.21 Favored 'General case' 0 C--N 1.364 1.233 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -126.3 130.78 51.51 Favored 'General case' 0 C--N 1.364 1.203 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -178.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.494 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 94.1 m -127.52 129.18 46.93 Favored 'General case' 0 C--N 1.358 0.951 0 N-CA-C 105.739 -1.949 . . . . 0.0 105.739 177.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 77.2 m -122.88 131.47 53.76 Favored 'General case' 0 CA--C 1.504 -0.794 0 C-N-CA 119.178 -1.009 . . . . 0.0 109.855 -178.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -120.03 132.43 55.46 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 106.325 -1.732 . . . . 0.0 106.325 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -105.28 117.27 33.59 Favored 'General case' 0 C--N 1.353 0.729 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 95.2 mt -88.42 -19.84 26.02 Favored 'General case' 0 C--N 1.354 0.781 0 C-N-CA 120.578 -0.449 . . . . 0.0 110.464 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 176.75 -146.74 8.05 Favored Glycine 0 C--N 1.348 1.229 0 C-N-CA 118.905 -1.617 . . . . 0.0 109.06 -178.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -94.82 -39.31 10.32 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -178.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 10.4 p-10 -101.27 0.69 37.78 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 120.085 -0.646 . . . . 0.0 110.24 -178.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.412 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 66.2 m-20 -118.49 130.74 56.11 Favored 'General case' 0 C--N 1.358 0.955 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.0 mm -141.9 136.79 30.65 Favored 'Isoleucine or valine' 0 C--N 1.355 0.829 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 52.2 mtm180 -118.21 137.87 52.71 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 5.6 tp -125.0 119.14 27.86 Favored 'General case' 0 N--CA 1.431 -1.405 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.494 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 13.7 m-70 -99.68 134.15 42.99 Favored 'General case' 0 CA--C 1.495 -1.152 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.456 ' HE2' ' HG ' ' A' ' 135' ' ' SER . 32.0 t80 -129.22 121.58 27.94 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 -178.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.442 ' HA ' ' O ' ' A' ' 171' ' ' THR . 27.7 mt-30 -114.96 111.47 21.2 Favored 'General case' 0 C--N 1.357 0.916 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.54 ' O ' ' HA ' ' A' ' 171' ' ' THR . 87.6 p -160.72 161.99 32.39 Favored 'General case' 0 C--N 1.358 0.964 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -98.8 3.59 47.47 Favored 'General case' 0 C--N 1.354 0.796 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 10.8 mtp180 -133.42 74.08 72.24 Favored Pre-proline 0 C--N 1.353 0.75 0 N-CA-C 107.218 -1.401 . . . . 0.0 107.218 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -94.74 102.25 0.12 Allowed 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 122.799 2.332 . . . . 0.0 115.926 -177.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -110.11 109.11 19.53 Favored 'General case' 0 CA--C 1.502 -0.904 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 176.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.88 -39.31 93.9 Favored 'General case' 0 C--N 1.353 0.76 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.679 -178.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 74.3 m -62.92 -27.24 69.24 Favored 'General case' 0 C--N 1.354 0.763 0 O-C-N 121.813 -0.554 . . . . 0.0 110.762 -178.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -76.03 -46.49 29.06 Favored 'General case' 0 N--CA 1.444 -0.757 0 O-C-N 121.719 -0.613 . . . . 0.0 109.65 -178.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.19 -39.93 95.03 Favored 'General case' 0 C--N 1.359 1.01 0 O-C-N 122.124 -0.36 . . . . 0.0 111.234 -178.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -62.79 -36.95 84.81 Favored 'General case' 0 C--N 1.356 0.864 0 O-C-N 121.904 -0.498 . . . . 0.0 109.919 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.07 -43.05 98.64 Favored Glycine 0 C--N 1.348 1.205 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -179.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.8 mt -70.54 -40.84 73.19 Favored 'General case' 0 C--N 1.352 0.681 0 CA-C-N 117.606 0.703 . . . . 0.0 112.887 -179.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 97.8 mt -71.04 -42.69 69.17 Favored 'General case' 0 C--N 1.362 1.142 0 O-C-N 121.118 -0.989 . . . . 0.0 110.945 -176.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -70.43 -29.95 66.68 Favored 'General case' 0 N--CA 1.445 -0.675 0 O-C-N 122.015 -0.428 . . . . 0.0 110.486 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.504 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -63.04 -39.69 98.35 Favored Glycine 0 C--N 1.357 1.735 0 N-CA-C 108.394 -1.882 . . . . 0.0 108.394 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 48.8 t -61.16 -42.56 98.78 Favored 'General case' 0 C--N 1.351 0.639 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -75.8 1.87 13.75 Favored 'General case' 0 C--N 1.361 1.071 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.504 ' HB2' ' O ' ' A' ' 149' ' ' GLY . 15.5 mm-40 -87.12 -45.56 10.58 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -66.45 -44.55 82.51 Favored 'General case' 0 C--N 1.359 0.984 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.439 ' O ' ' HB2' ' A' ' 155' ' ' LYS . 50.6 m-85 -70.15 -25.45 63.46 Favored 'General case' 0 C--N 1.361 1.108 0 O-C-N 121.84 -0.537 . . . . 0.0 111.119 -178.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.439 ' HB2' ' O ' ' A' ' 154' ' ' PHE . 97.3 mttt 71.6 66.07 0.15 Allowed 'General case' 0 C--N 1.363 1.168 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 -177.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -128.68 -177.44 4.19 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -140.98 95.18 2.8 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -117.27 154.29 31.46 Favored 'General case' 0 CA--C 1.503 -0.857 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 93.5 m -119.63 126.47 51.25 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 -178.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.526 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.5 mp -103.82 122.45 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 179.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 3.0 m -118.15 -174.84 2.73 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-O 121.797 0.808 . . . . 0.0 109.29 -178.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.11 155.38 42.12 Favored 'General case' 0 C--N 1.356 0.874 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 -178.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 63.8 p -98.79 146.86 32.36 Favored Pre-proline 0 C--N 1.36 1.062 0 CA-C-O 122.502 1.144 . . . . 0.0 108.359 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.668 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 76.9 Cg_endo -76.9 -11.22 18.16 Favored 'Trans proline' 0 C--N 1.311 -1.404 0 C-N-CA 123.006 2.47 . . . . 0.0 114.971 -178.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 53.8 tp10 -72.09 -41.79 66.91 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 120.193 -0.603 . . . . 0.0 109.583 -178.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 39.0 p -116.06 14.57 16.06 Favored 'General case' 0 CA--C 1.505 -0.786 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.381 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.668 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.3 pp0? -68.38 -10.27 53.92 Favored 'General case' 0 C--N 1.351 0.665 0 O-C-N 121.525 -0.734 . . . . 0.0 110.083 178.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 55.6 p30 -121.57 35.16 4.96 Favored 'General case' 0 N--CA 1.435 -1.198 0 O-C-N 121.16 -0.962 . . . . 0.0 109.48 -178.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 94.1 p -145.51 157.83 43.94 Favored 'General case' 0 C--N 1.353 0.736 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.619 ' O ' ' HB ' ' A' ' 171' ' ' THR . 60.0 mt-10 -106.96 170.2 8.09 Favored 'General case' 0 C--N 1.356 0.856 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -179.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.619 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 6.1 m 82.79 -53.96 0.19 Allowed 'General case' 0 C--N 1.37 1.489 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.62 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -115.64 117.59 30.73 Favored 'General case' 0 CA--C 1.505 -0.763 0 C-N-CA 119.737 -0.785 . . . . 0.0 109.655 -178.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 94.9 t -130.38 132.8 64.62 Favored 'Isoleucine or valine' 0 C--N 1.357 0.917 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 49.8 mm -107.23 127.02 63.33 Favored 'Isoleucine or valine' 0 C--N 1.359 1.0 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -115.42 155.28 27.72 Favored 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 122.139 0.971 . . . . 0.0 108.688 -179.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -138.21 119.11 14.24 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -178.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.0 mp -114.03 119.22 60.61 Favored 'Isoleucine or valine' 0 C--N 1.355 0.807 0 N-CA-C 106.405 -1.702 . . . . 0.0 106.405 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 89.4 m -122.02 144.51 48.85 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -177.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.648 ' HG3' ' HZ ' ' A' ' 93' ' ' PHE . 3.8 mtm180 -86.8 115.48 24.26 Favored 'General case' 0 C--N 1.367 1.358 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -65.9 150.54 96.38 Favored Pre-proline 0 C--N 1.358 0.945 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 178.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.51 132.06 26.24 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 121.995 1.797 . . . . 0.0 114.173 -178.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.478 HH11 ' HD2' ' A' ' 182' ' ' ARG . 4.9 mtm105 -126.45 66.56 1.23 Allowed 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 179.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 77.0 58.41 3.44 Favored Glycine 0 N--CA 1.441 -0.993 0 N-CA-C 108.019 -2.032 . . . . 0.0 108.019 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 170.13 71.83 0.0 OUTLIER 'General case' 0 CA--C 1.497 -1.068 0 N-CA-C 106.513 -1.662 . . . . 0.0 106.513 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -114.76 99.8 7.77 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -116.02 121.85 43.45 Favored 'General case' 0 N--CA 1.438 -1.028 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 81.4 mt -98.26 -50.33 4.38 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 179.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . 0.466 ' HB3' ' H ' ' A' ' 189' ' ' PHE . 2.7 t80 -160.75 -85.84 0.03 OUTLIER 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . 0.466 ' H ' ' HB3' ' A' ' 188' ' ' TYR . 89.7 t80 -138.79 130.7 27.92 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 107.2 -1.407 . . . . 0.0 107.2 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 64.9 tt0 . . . . . 0 C--O 1.264 1.852 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.974 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' HEM . . . . . 1.053 ' C2B' HD11 ' A' ' 99' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.927 ' HG2' HMD3 ' A' ' 202' ' ' HEM . 81.4 mmm . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 120.821 0.343 . . . . 0.0 110.19 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.409 ' HA ' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -78.5 -22.68 47.06 Favored 'General case' 0 C--N 1.356 0.856 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -178.943 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.66 -40.56 45.82 Favored Glycine 0 C--N 1.35 1.348 0 N-CA-C 109.159 -1.576 . . . . 0.0 109.159 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.1 tpp -70.27 -37.0 74.78 Favored 'General case' 0 C--N 1.354 0.792 0 O-C-N 122.132 -0.628 . . . . 0.0 110.865 -177.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.409 HG22 ' HA ' ' A' ' 2' ' ' MET . 27.0 m -71.17 -22.71 22.73 Favored 'Isoleucine or valine' 0 C--N 1.357 0.895 0 O-C-N 121.642 -0.661 . . . . 0.0 109.524 -179.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.445 ' HZ ' ' CG ' ' A' ' 47' ' ' GLU . 2.2 m-85 -70.8 -35.23 72.43 Favored 'General case' 0 C--N 1.357 0.915 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 85.4 m -66.95 -40.63 87.59 Favored 'General case' 0 C--N 1.354 0.795 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 -179.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.13 -38.76 97.06 Favored Glycine 0 C--N 1.358 1.785 0 N-CA-C 110.508 -1.037 . . . . 0.0 110.508 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.518 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -65.94 -39.85 90.85 Favored 'General case' 0 C--N 1.352 0.686 0 CA-C-N 117.241 0.521 . . . . 0.0 110.608 -178.087 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.442 ' CE ' HD21 ' A' ' 26' ' ' LEU . 24.8 mmt -64.73 -40.12 94.79 Favored 'General case' 0 C--N 1.354 0.775 0 O-C-N 121.591 -0.693 . . . . 0.0 110.707 -178.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -65.86 -39.93 91.19 Favored 'General case' 0 C--N 1.349 0.569 0 O-C-N 122.107 -0.37 . . . . 0.0 111.303 -178.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 56.3 tp -65.81 -42.86 90.15 Favored 'General case' 0 C--N 1.349 0.572 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -178.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.518 HG12 ' O ' ' A' ' 9' ' ' LEU . 1.9 mm -74.5 -35.38 38.45 Favored 'Isoleucine or valine' 0 C--N 1.361 1.073 0 O-C-N 121.031 -1.043 . . . . 0.0 110.746 -175.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -72.0 -42.54 66.3 Favored 'General case' 0 C--N 1.349 0.55 0 O-C-N 121.648 -0.657 . . . . 0.0 111.475 -176.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -70.95 -36.68 72.7 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 113.081 0.771 . . . . 0.0 113.081 -176.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -101.1 -25.06 14.17 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 118.725 -1.19 . . . . 0.0 113.628 -174.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -114.8 -36.43 4.5 Favored 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 117.606 -1.638 . . . . 0.0 112.288 -176.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 145.03 177.98 20.26 Favored Glycine 0 C--N 1.348 1.227 0 C-N-CA 118.176 -1.964 . . . . 0.0 110.314 -179.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -99.33 -25.89 14.34 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 -177.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -70.14 -39.15 75.56 Favored 'General case' 0 C--N 1.358 0.937 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.1 m -67.64 -39.33 84.62 Favored 'General case' 0 C--N 1.357 0.919 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.7 tt -60.21 -38.66 84.02 Favored 'General case' 0 C--N 1.357 0.933 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -64.16 -36.82 85.28 Favored 'General case' 0 C--N 1.355 0.821 0 O-C-N 122.081 -0.387 . . . . 0.0 110.901 -178.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 88.2 m -65.0 -40.35 94.82 Favored 'General case' 0 C--N 1.354 0.775 0 O-C-N 121.638 -0.664 . . . . 0.0 109.55 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 88.6 mt -63.74 -38.17 90.09 Favored 'General case' 0 C--N 1.355 0.847 0 O-C-N 122.023 -0.423 . . . . 0.0 109.941 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.442 HD21 ' CE ' ' A' ' 10' ' ' MET . 82.5 mt -70.53 -17.35 62.94 Favored 'General case' 0 C--N 1.36 1.028 0 O-C-N 121.532 -0.73 . . . . 0.0 110.373 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -85.56 -27.38 25.58 Favored 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 119.422 -0.911 . . . . 0.0 109.488 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 42.5 t -66.09 -36.71 83.91 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 99.5 m -96.5 -35.67 11.05 Favored 'General case' 0 C--N 1.357 0.902 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -178.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 83.31 136.12 0.06 Allowed 'General case' 0 C--N 1.358 0.969 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 178.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.538 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -84.8 -171.41 3.62 Favored 'General case' 0 C--N 1.356 0.876 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 179.535 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -151.2 -24.32 0.21 Allowed 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.1 t -147.07 -67.92 0.26 Allowed 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -179.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -128.5 -50.64 1.27 Allowed 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 -179.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 120.81 -44.5 1.36 Allowed Glycine 0 C--N 1.351 1.377 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 82.3 mt -110.38 105.18 18.32 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.971 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.44 ' HD1' ' HA ' ' A' ' 37' ' ' TYR . 0.1 OUTLIER -82.75 -142.09 0.06 Allowed 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.664 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 87.8 m -112.17 -58.77 2.09 Favored 'General case' 0 N--CA 1.441 -0.912 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 52.6 p 165.59 16.92 0.0 OUTLIER 'General case' 0 C--N 1.362 1.113 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.5 t -103.26 3.63 10.64 Favored 'Isoleucine or valine' 0 C--N 1.353 0.732 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.209 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -94.34 141.71 15.68 Favored Glycine 0 C--N 1.352 1.461 0 C-N-CA 119.25 -1.452 . . . . 0.0 109.631 -178.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 50.0 m -124.55 124.73 42.89 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 178.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -117.74 174.98 5.87 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 -179.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -80.83 -173.06 4.0 Favored 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -91.97 -14.85 28.82 Favored 'General case' 0 CA--C 1.501 -0.932 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -69.48 -28.87 66.45 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 178.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.445 ' CG ' ' HZ ' ' A' ' 6' ' ' PHE . 20.3 tp10 -63.71 -41.28 98.11 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.461 HD22 ' O ' ' A' ' 48' ' ' LEU . 1.9 tm? -67.65 -38.74 84.23 Favored 'General case' 0 C--N 1.359 1.017 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 60.4 tp -70.05 -34.05 72.73 Favored 'General case' 0 CA--C 1.508 -0.639 0 O-C-N 122.134 -0.354 . . . . 0.0 110.141 -177.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 70.6 tp60 -65.2 -41.16 94.78 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -178.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 85.1 mt -81.51 -18.71 44.13 Favored 'General case' 0 C--N 1.362 1.121 0 O-C-N 121.558 -0.714 . . . . 0.0 110.846 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.6 t -80.6 -38.53 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 C-N-CA 119.706 -0.798 . . . . 0.0 109.124 -178.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.7 p -74.22 -31.51 29.35 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 C-N-CA 119.756 -0.778 . . . . 0.0 109.417 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.3 tptt -70.22 -26.94 64.1 Favored 'General case' 0 C--N 1.366 1.289 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.7 tt -67.98 -39.04 83.35 Favored 'General case' 0 C--N 1.353 0.735 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.507 ' O ' ' HA ' ' A' ' 60' ' ' SER . 59.9 p -72.8 -17.26 61.59 Favored 'General case' 0 C--N 1.357 0.933 0 O-C-N 121.729 -0.607 . . . . 0.0 110.916 -178.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -98.93 -37.15 9.51 Favored 'General case' 0 C--N 1.353 0.739 0 O-C-N 121.181 -0.949 . . . . 0.0 111.364 -179.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.2 p -70.92 -35.02 57.98 Favored 'Isoleucine or valine' 0 C--N 1.351 0.672 0 O-C-N 121.712 -0.617 . . . . 0.0 111.399 -177.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.505 ' HB3' HG23 ' A' ' 61' ' ' VAL . 3.9 t -120.49 -7.57 9.67 Favored 'General case' 0 C--N 1.352 0.708 0 C-N-CA 119.118 -1.033 . . . . 0.0 110.08 -178.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.507 ' HA ' ' O ' ' A' ' 56' ' ' SER . 1.0 OUTLIER 66.03 46.41 2.18 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.552 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.505 HG23 ' HB3' ' A' ' 59' ' ' SER . 61.3 t -106.23 132.82 20.58 Favored Pre-proline 0 CA--C 1.506 -0.745 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 179.196 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -56.62 146.02 78.32 Favored 'Trans proline' 0 CA--C 1.497 -1.341 0 C-N-CA 122.59 2.193 . . . . 0.0 113.071 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.404 ' HA ' ' CD2' ' A' ' 66' ' ' LEU . 4.8 m -75.25 -12.89 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.792 -178.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.47 ' O ' HG12 ' A' ' 67' ' ' VAL . 72.2 p -96.36 -32.24 12.47 Favored 'General case' 0 C--N 1.358 0.944 0 C-N-CA 118.273 -1.371 . . . . 0.0 109.761 -178.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -80.26 -20.67 43.98 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 121.394 -0.816 . . . . 0.0 108.912 179.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.404 ' CD2' ' HA ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -81.0 -36.49 30.57 Favored 'General case' 0 N--CA 1.441 -0.876 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 -179.901 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.47 HG12 ' O ' ' A' ' 64' ' ' THR . 2.1 p -67.44 -29.86 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.678 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 76.2 mtp180 -70.35 -48.81 54.7 Favored 'General case' 0 C--N 1.366 1.298 0 O-C-N 121.428 -0.795 . . . . 0.0 110.777 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.9 mt -64.14 -35.84 82.08 Favored 'General case' 0 C--N 1.355 0.84 0 O-C-N 122.033 -0.417 . . . . 0.0 110.961 -178.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 92.8 t80 -60.8 -47.37 86.64 Favored 'General case' 0 C--N 1.348 0.541 0 O-C-N 122.132 -0.355 . . . . 0.0 110.427 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.19 -39.07 96.64 Favored Glycine 0 C--N 1.354 1.579 0 N-CA-C 111.729 -0.549 . . . . 0.0 111.729 -178.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.44 -47.55 81.43 Favored 'General case' 0 C--N 1.351 0.651 0 CA-C-N 118.227 1.013 . . . . 0.0 111.462 -177.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.73 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 10.6 mttm -63.98 -50.17 69.6 Favored 'General case' 0 C--N 1.357 0.921 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -177.121 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.417 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.4 tm? -68.67 -38.96 80.77 Favored 'General case' 0 C--N 1.349 0.552 0 O-C-N 121.339 -0.85 . . . . 0.0 111.868 -175.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -63.43 -45.09 92.57 Favored 'General case' 0 C--N 1.352 0.678 0 O-C-N 121.208 -0.932 . . . . 0.0 110.965 -177.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 8.6 p -70.59 -15.71 19.19 Favored 'Isoleucine or valine' 0 C--N 1.358 0.958 0 O-C-N 121.521 -0.737 . . . . 0.0 109.366 -179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.73 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 75.1 mm-40 -71.28 -38.73 71.81 Favored 'General case' 0 C--N 1.35 0.608 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.7 mt -73.04 -31.66 64.58 Favored 'General case' 0 C--N 1.356 0.865 0 O-C-N 122.426 -0.171 . . . . 0.0 110.685 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 44.9 mm -65.06 -53.72 37.81 Favored 'Isoleucine or valine' 0 C--N 1.359 0.984 0 C-N-CA 120.081 -0.648 . . . . 0.0 110.099 -177.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -74.99 -14.98 60.68 Favored 'General case' 0 C--N 1.351 0.634 0 C-N-CA 119.554 -0.859 . . . . 0.0 109.37 178.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.58 -37.66 68.26 Favored Glycine 0 C--N 1.349 1.278 0 N-CA-C 110.971 -0.851 . . . . 0.0 110.971 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -132.45 108.3 13.38 Favored Pre-proline 0 N--CA 1.441 -0.917 0 CA-C-O 122.776 1.274 . . . . 0.0 109.232 -177.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.8 -24.58 40.38 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 C-N-CA 122.596 2.197 . . . . 0.0 114.301 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -93.7 -5.05 49.4 Favored 'General case' 0 CA--C 1.5 -0.966 0 C-N-CA 119.448 -0.901 . . . . 0.0 108.776 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -89.64 -19.97 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.78 -25.18 14.21 Favored 'General case' 0 C--N 1.361 1.106 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -70.23 -35.23 73.71 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 120.207 -0.597 . . . . 0.0 109.443 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -65.42 -36.98 85.57 Favored 'General case' 0 C--N 1.355 0.837 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.415 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.558 ' HG2' ' N ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -81.52 155.05 25.96 Favored 'General case' 0 C--N 1.355 0.841 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -178.468 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.558 ' N ' ' HG2' ' A' ' 89' ' ' MET . 0.8 OUTLIER -120.36 -25.41 5.64 Favored 'General case' 0 C--N 1.364 1.199 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.031 -177.655 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -165.12 172.09 13.01 Favored 'General case' 0 C--N 1.354 0.78 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 -177.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 41.1 t -64.62 -43.16 94.61 Favored 'General case' 0 C--N 1.356 0.863 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.208 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -67.11 -39.72 86.72 Favored 'General case' 0 C--N 1.356 0.853 0 O-C-N 121.429 -0.794 . . . . 0.0 109.282 -178.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -66.41 -23.17 66.26 Favored 'General case' 0 C--N 1.355 0.821 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.661 ' O ' HG13 ' A' ' 99' ' ' ILE . 61.2 tp -64.78 -46.28 82.78 Favored 'General case' 0 C--N 1.356 0.888 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.496 ' HA ' ' CD1' ' A' ' 99' ' ' ILE . 3.2 mp -59.94 -35.11 74.23 Favored 'General case' 0 C--N 1.36 1.035 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 -179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.5 t -69.61 -39.57 77.15 Favored 'General case' 0 C--N 1.349 0.549 0 O-C-N 121.994 -0.441 . . . . 0.0 109.934 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 15.1 tttp -87.32 1.37 53.47 Favored 'General case' 0 C--N 1.357 0.905 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -176.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.661 HG13 ' O ' ' A' ' 95' ' ' LEU . 81.4 mt -61.51 -47.06 95.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.868 0 CA-C-N 119.282 0.946 . . . . 0.0 111.408 -177.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 15.7 t0 -92.88 -25.67 17.98 Favored 'General case' 0 N--CA 1.442 -0.858 0 O-C-N 121.04 -1.037 . . . . 0.0 110.973 -177.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 35.0 t -63.21 -49.0 75.92 Favored 'General case' 0 N--CA 1.447 -0.591 0 O-C-N 121.64 -0.662 . . . . 0.0 112.667 -177.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.654 ' HA ' HG12 ' A' ' 105' ' ' VAL . 16.9 t80 -139.42 -14.25 1.12 Allowed 'General case' 0 C--N 1.361 1.066 0 C-N-CA 117.274 -1.77 . . . . 0.0 113.529 -176.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.662 HG21 ' C2C' ' A' ' 202' ' ' HEM . 32.7 mm -71.77 -52.14 27.42 Favored 'Isoleucine or valine' 0 C--O 1.246 0.875 0 CA-C-N 120.659 1.572 . . . . 0.0 110.592 -177.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 32.0 m170 -91.82 2.3 56.6 Favored 'General case' 0 N--CA 1.438 -1.059 0 C-N-CA 119.659 -0.817 . . . . 0.0 110.299 -176.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.654 HG12 ' HA ' ' A' ' 102' ' ' PHE . 1.3 p -92.4 -32.47 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -72.93 -40.82 65.12 Favored 'General case' 0 C--N 1.357 0.924 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.6 p -74.99 -35.99 37.07 Favored 'Isoleucine or valine' 0 C--N 1.355 0.847 0 C-N-CA 119.231 -0.988 . . . . 0.0 109.684 -178.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 92.5 t80 -61.23 -48.61 80.68 Favored 'General case' 0 C--N 1.365 1.245 0 O-C-N 121.727 -0.608 . . . . 0.0 110.428 178.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -60.35 -37.48 80.82 Favored 'General case' 0 C--N 1.358 0.961 0 O-C-N 121.694 -0.629 . . . . 0.0 110.096 -179.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 13.4 mt -56.5 -75.07 0.04 OUTLIER 'General case' 0 C--N 1.356 0.869 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.433 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 92.6 m-85 -119.05 135.21 23.72 Favored Pre-proline 0 N--CA 1.439 -0.983 0 C-N-CA 118.855 -1.138 . . . . 0.0 108.821 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 111' ' ' TYR . 89.4 Cg_endo -84.16 -1.5 9.86 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 123.315 2.677 . . . . 0.0 115.318 -178.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -65.78 -37.24 85.76 Favored 'General case' 0 C--N 1.354 0.788 0 O-C-N 121.805 -0.56 . . . . 0.0 109.933 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.35 144.9 56.27 Favored 'General case' 0 C--N 1.353 0.734 0 CA-C-O 121.495 0.664 . . . . 0.0 109.742 -178.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -131.45 135.96 47.57 Favored 'General case' 0 C--N 1.356 0.882 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.522 ' HB3' ' HD2' ' A' ' 117' ' ' PRO . 90.7 mt -128.45 157.17 75.61 Favored Pre-proline 0 N--CA 1.443 -0.794 0 CA-C-O 122.189 0.995 . . . . 0.0 109.286 -178.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.522 ' HD2' ' HB3' ' A' ' 116' ' ' LEU . 94.0 Cg_endo -80.29 -153.52 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.122 0 C-N-CA 123.644 2.896 . . . . 0.0 113.472 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -118.21 144.14 45.97 Favored 'General case' 0 C--N 1.362 1.148 0 C-N-CA 119.172 -1.011 . . . . 0.0 108.458 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -129.59 134.36 47.68 Favored 'General case' 0 C--N 1.361 1.081 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.49 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 94.2 m -125.05 129.32 50.03 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 105.674 -1.973 . . . . 0.0 105.674 177.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 84.4 m -116.02 127.26 54.77 Favored 'General case' 0 CA--C 1.504 -0.802 0 C-N-CA 119.094 -1.042 . . . . 0.0 109.402 -178.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.4 t0 -120.36 130.77 54.55 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 106.425 -1.694 . . . . 0.0 106.425 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 57.9 ttp180 -105.16 116.98 32.87 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -179.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.49 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 90.7 mt -85.81 -24.32 26.84 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 120.709 -0.397 . . . . 0.0 109.997 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -179.6 -146.0 6.61 Favored Glycine 0 C--N 1.349 1.294 0 N-CA-C 108.983 -1.647 . . . . 0.0 108.983 -178.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -94.12 -40.16 10.2 Favored 'General case' 0 N--CA 1.438 -1.071 0 C-N-CA 120.007 -0.677 . . . . 0.0 109.274 -178.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 15.6 p-10 -101.69 4.25 40.5 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 119.882 -0.727 . . . . 0.0 110.406 -178.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.49 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 8.4 m-20 -120.74 130.65 54.13 Favored 'General case' 0 C--N 1.36 1.035 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.404 HD13 ' HA ' ' A' ' 129' ' ' ILE . 8.7 mm -141.49 137.71 32.51 Favored 'Isoleucine or valine' 0 C--N 1.356 0.871 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 60.3 mtm180 -124.11 138.83 54.38 Favored 'General case' 0 CA--C 1.503 -0.865 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.617 ' HG ' ' O ' ' A' ' 131' ' ' LEU . 0.1 OUTLIER -130.63 127.42 38.93 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.594 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.49 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 12.3 m170 -95.6 135.72 36.9 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 179.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -127.69 118.83 24.55 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 -178.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.51 ' HA ' ' O ' ' A' ' 171' ' ' THR . 29.1 tt0 -113.82 111.93 22.56 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 14.5 t -161.86 153.82 19.19 Favored 'General case' 0 C--N 1.359 0.99 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -91.47 3.36 55.16 Favored 'General case' 0 C--N 1.356 0.885 0 C-N-CA 120.26 -0.576 . . . . 0.0 109.893 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 93.2 mtm-85 -133.7 73.78 71.41 Favored Pre-proline 0 C--N 1.355 0.847 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 178.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -94.81 103.47 0.12 Allowed 'Trans proline' 0 N--CA 1.444 -1.426 0 C-N-CA 122.489 2.126 . . . . 0.0 115.67 -177.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -111.15 113.01 25.21 Favored 'General case' 0 CA--C 1.499 -0.994 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 176.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.95 -38.75 92.23 Favored 'General case' 0 C--N 1.353 0.748 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.068 -179.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.0 m -64.13 -26.28 68.46 Favored 'General case' 0 C--N 1.353 0.742 0 O-C-N 122.052 -0.405 . . . . 0.0 110.902 -178.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.538 ' HE2' HAA1 ' A' ' 202' ' ' HEM . 85.5 t80 -76.47 -47.41 23.04 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 121.669 -0.645 . . . . 0.0 109.666 -178.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.88 -39.49 93.62 Favored 'General case' 0 C--N 1.357 0.919 0 O-C-N 122.071 -0.393 . . . . 0.0 110.8 -178.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.34 -36.83 85.01 Favored 'General case' 0 C--N 1.354 0.8 0 O-C-N 122.029 -0.419 . . . . 0.0 109.901 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.44 -43.25 98.93 Favored Glycine 0 C--N 1.348 1.201 0 N-CA-C 109.901 -1.279 . . . . 0.0 109.901 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.0 mt -69.08 -41.08 77.98 Favored 'General case' 0 C--N 1.352 0.694 0 CA-C-N 117.612 0.706 . . . . 0.0 112.415 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 98.2 mt -71.5 -42.49 67.95 Favored 'General case' 0 C--N 1.36 1.042 0 O-C-N 121.3 -0.875 . . . . 0.0 110.714 -177.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.559 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 37.5 t70 -69.38 -32.52 71.61 Favored 'General case' 0 N--CA 1.445 -0.703 0 O-C-N 122.049 -0.407 . . . . 0.0 110.642 -179.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.433 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -62.85 -39.57 98.16 Favored Glycine 0 C--N 1.357 1.736 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 47.0 t -60.1 -41.73 93.18 Favored 'General case' 0 C--N 1.351 0.653 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -77.56 0.23 23.81 Favored 'General case' 0 C--N 1.359 0.982 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.559 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 76.8 mm-40 -83.65 -46.77 11.95 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 84.8 t80 -68.55 -41.46 79.76 Favored 'General case' 0 C--N 1.359 0.991 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 178.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.52 ' HZ ' ' SD ' ' A' ' 89' ' ' MET . 9.7 m-30 -69.66 -26.98 64.66 Favored 'General case' 0 C--N 1.36 1.055 0 O-C-N 121.821 -0.549 . . . . 0.0 110.628 -178.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 85.0 tttt 73.59 74.88 0.13 Allowed 'General case' 0 C--N 1.361 1.091 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -142.81 -170.34 3.21 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -148.57 94.37 2.28 Favored 'General case' 0 N--CA 1.438 -1.068 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 15.7 m-30 -113.42 156.59 23.22 Favored 'General case' 0 CA--C 1.503 -0.864 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 94.5 m -119.23 126.85 52.5 Favored 'General case' 0 N--CA 1.441 -0.886 0 C-N-CA 119.082 -1.047 . . . . 0.0 108.837 -178.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.491 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.9 mp -104.76 122.61 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.884 0 N-CA-C 106.554 -1.647 . . . . 0.0 106.554 178.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.8 m -120.47 -171.95 2.27 Favored 'General case' 0 C--N 1.355 0.808 0 CA-C-O 121.812 0.815 . . . . 0.0 108.899 -178.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.01 158.64 44.37 Favored 'General case' 0 N--CA 1.441 -0.885 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 -178.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 50.2 p -98.27 146.59 31.79 Favored Pre-proline 0 C--N 1.357 0.934 0 CA-C-O 122.368 1.08 . . . . 0.0 108.134 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.623 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 72.8 Cg_endo -75.95 -10.98 19.84 Favored 'Trans proline' 0 C--N 1.311 -1.428 0 C-N-CA 122.924 2.416 . . . . 0.0 115.031 -178.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -72.62 -41.17 65.84 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 119.959 -0.696 . . . . 0.0 109.388 -178.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 39.0 p -116.7 15.32 15.43 Favored 'General case' 0 C--N 1.354 0.795 0 C-N-CA 120.264 -0.575 . . . . 0.0 110.288 -178.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.623 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.2 pp0? -66.67 -12.76 59.67 Favored 'General case' 0 C--N 1.354 0.798 0 O-C-N 121.608 -0.683 . . . . 0.0 110.22 178.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -124.62 38.23 4.24 Favored 'General case' 0 N--CA 1.436 -1.139 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 57.7 m -137.21 146.76 45.23 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.617 ' O ' ' HB ' ' A' ' 171' ' ' THR . 61.4 mt-10 -99.85 165.46 11.56 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.617 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 16.4 m 82.28 -59.39 0.19 Allowed 'General case' 0 C--N 1.369 1.453 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.799 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -107.73 117.1 33.24 Favored 'General case' 0 CA--C 1.505 -0.784 0 C-N-CA 119.884 -0.726 . . . . 0.0 109.868 -178.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 88.2 t -131.8 133.66 61.0 Favored 'Isoleucine or valine' 0 C--N 1.358 0.943 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 178.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 49.5 mm -109.59 126.0 66.73 Favored 'Isoleucine or valine' 0 C--N 1.358 0.955 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -114.13 147.27 39.1 Favored 'General case' 0 C--N 1.359 0.988 0 CA-C-O 121.942 0.877 . . . . 0.0 108.767 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -128.26 118.19 22.84 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.458 HD11 HD23 ' A' ' 131' ' ' LEU . 4.0 mp -112.58 118.06 56.87 Favored 'Isoleucine or valine' 0 C--N 1.355 0.838 0 N-CA-C 105.991 -1.855 . . . . 0.0 105.991 -179.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 85.1 m -128.28 144.79 51.16 Favored 'General case' 0 CA--C 1.504 -0.804 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 -177.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 81.1 mtm180 -80.82 113.72 19.22 Favored 'General case' 0 C--N 1.37 1.491 0 N-CA-C 107.227 -1.398 . . . . 0.0 107.227 178.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -71.87 156.65 90.78 Favored Pre-proline 0 CA--C 1.501 -0.923 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -55.98 111.5 0.79 Allowed 'Trans proline' 0 CA--C 1.497 -1.356 0 C-N-CA 122.136 1.891 . . . . 0.0 112.217 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -61.49 -46.14 91.26 Favored 'General case' 0 N--CA 1.441 -0.918 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.483 -178.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 174.63 131.99 1.5 Allowed Glycine 0 N--CA 1.434 -1.44 0 N-CA-C 106.215 -2.754 . . . . 0.0 106.215 177.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.662 ' O ' ' HB2' ' A' ' 185' ' ' GLU . . . 64.73 -119.66 0.43 Allowed 'General case' 0 C--N 1.356 0.888 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.662 ' HB2' ' O ' ' A' ' 184' ' ' ALA . 36.8 tt0 151.19 82.17 0.0 OUTLIER 'General case' 0 C--N 1.363 1.179 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 33.5 m120 -113.48 125.84 54.66 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 15.1 mt -107.67 -78.83 0.58 Allowed 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -139.53 -97.05 0.16 Allowed 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -127.36 147.37 50.26 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 42.8 tt0 . . . . . 0 C--O 1.265 1.869 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 179.966 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' HEM . . . . . 1.123 HBD1 ' HHA' ' A' ' 202' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.788 ' H1 ' ' CMD' ' A' ' 202' ' ' HEM . 54.0 tpp . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.026 0.441 . . . . 0.0 110.333 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.59 -19.14 39.03 Favored 'General case' 0 C--N 1.355 0.833 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.2 -38.98 58.78 Favored Glycine 0 C--N 1.351 1.382 0 N-CA-C 108.563 -1.815 . . . . 0.0 108.563 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.597 ' H ' ' HG3' ' A' ' 1' ' ' MET . 3.2 mtt -70.04 -35.86 74.61 Favored 'General case' 0 C--N 1.356 0.867 0 O-C-N 122.205 -0.585 . . . . 0.0 111.542 -177.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.2 m -69.34 -23.92 27.1 Favored 'Isoleucine or valine' 0 C--N 1.356 0.874 0 O-C-N 121.41 -0.806 . . . . 0.0 109.355 -178.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -71.79 -35.37 69.98 Favored 'General case' 0 C--N 1.357 0.908 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 87.9 m -67.33 -41.67 84.87 Favored 'General case' 0 C--N 1.355 0.84 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.48 -38.35 96.2 Favored Glycine 0 C--N 1.356 1.69 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -179.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.589 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -67.18 -38.56 85.61 Favored 'General case' 0 C--N 1.351 0.657 0 CA-C-N 117.311 0.556 . . . . 0.0 110.503 -177.927 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 21.3 mmt -64.26 -40.7 96.53 Favored 'General case' 0 C--N 1.354 0.798 0 O-C-N 121.616 -0.677 . . . . 0.0 110.767 -178.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -66.2 -40.4 90.35 Favored 'General case' 0 C--N 1.349 0.559 0 O-C-N 122.057 -0.402 . . . . 0.0 111.684 -178.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 57.8 tp -65.75 -42.73 90.59 Favored 'General case' 0 C--N 1.35 0.595 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 -178.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.589 HG12 ' O ' ' A' ' 9' ' ' LEU . 1.7 mm -75.61 -36.32 34.02 Favored 'Isoleucine or valine' 0 C--N 1.357 0.917 0 O-C-N 121.049 -1.032 . . . . 0.0 110.955 -175.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 -67.96 -42.57 80.7 Favored 'General case' 0 C--N 1.351 0.67 0 O-C-N 121.858 -0.526 . . . . 0.0 111.108 -176.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -73.48 -31.28 63.66 Favored 'General case' 0 N--CA 1.447 -0.617 0 O-C-N 122.014 -0.429 . . . . 0.0 111.499 -177.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -72.63 -49.08 34.35 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -175.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -128.56 -20.35 3.63 Favored 'General case' 0 C--N 1.355 0.812 0 C-N-CA 117.566 -1.654 . . . . 0.0 113.02 -176.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 140.8 179.08 17.89 Favored Glycine 0 CA--C 1.496 -1.094 0 C-N-CA 118.104 -1.998 . . . . 0.0 109.657 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -94.26 -11.09 30.89 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 -177.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -70.88 -41.52 71.24 Favored 'General case' 0 C--N 1.36 1.046 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 92.8 m -69.91 -38.89 76.4 Favored 'General case' 0 C--N 1.359 0.98 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.508 HD13 ' HB ' ' A' ' 13' ' ' ILE . 56.6 tp -60.5 -37.66 81.81 Favored 'General case' 0 C--N 1.357 0.9 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -64.94 -35.43 81.13 Favored 'General case' 0 C--N 1.357 0.919 0 O-C-N 122.203 -0.311 . . . . 0.0 110.757 -178.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.2 m -64.44 -41.23 96.67 Favored 'General case' 0 C--N 1.354 0.771 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 -178.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 93.0 mt -65.23 -37.43 87.23 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 80.3 mt -69.7 -14.38 62.77 Favored 'General case' 0 C--N 1.358 0.971 0 O-C-N 121.445 -0.784 . . . . 0.0 109.604 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -88.07 -25.74 22.9 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 119.621 -0.831 . . . . 0.0 109.287 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 55.9 p -70.27 -23.9 62.96 Favored 'General case' 0 C--N 1.359 1.017 0 C-N-CA 119.65 -0.82 . . . . 0.0 109.22 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.8 p -105.8 -37.19 6.79 Favored 'General case' 0 C--N 1.358 0.967 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 86.09 132.15 0.04 OUTLIER 'General case' 0 C--N 1.36 1.031 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.466 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -90.88 -166.18 1.52 Allowed 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 179.804 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -153.35 -64.81 0.15 Allowed 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.6 t -97.92 -65.19 0.98 Allowed 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -138.11 -45.0 0.51 Allowed 'General case' 0 CA--C 1.503 -0.863 0 C-N-CA 119.567 -0.853 . . . . 0.0 108.752 -178.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 125.88 -35.59 2.97 Favored Glycine 0 C--N 1.352 1.427 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 85.0 mt -107.91 100.26 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.788 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -97.13 -1.47 45.1 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.767 HG22 ' H ' ' A' ' 39' ' ' SER . 2.7 m 77.55 -179.63 0.13 Allowed 'General case' 0 C--N 1.361 1.107 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 -178.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.767 ' H ' HG22 ' A' ' 38' ' ' THR . 21.2 p -85.7 102.71 13.85 Favored 'General case' 0 C--N 1.353 0.729 0 O-C-N 121.116 -0.99 . . . . 0.0 109.261 -178.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.453 HG12 ' O ' ' A' ' 40' ' ' VAL . 97.3 t -153.19 -18.54 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.359 1.013 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -112.58 164.93 12.02 Favored Glycine 0 C--N 1.356 1.668 0 C-N-CA 119.311 -1.423 . . . . 0.0 110.156 -176.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.6 m -128.62 127.76 42.87 Favored 'General case' 0 C--N 1.355 0.816 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -116.42 176.42 5.12 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -79.34 -176.53 5.26 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 73.1 m80 -91.15 -16.03 28.42 Favored 'General case' 0 CA--C 1.503 -0.858 0 C-N-CA 120.105 -0.638 . . . . 0.0 109.406 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -70.23 -28.15 65.03 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -63.37 -40.85 98.37 Favored 'General case' 0 C--N 1.352 0.68 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.438 ' O ' HG23 ' A' ' 52' ' ' VAL . 63.3 tp -66.82 -38.57 86.71 Favored 'General case' 0 C--N 1.357 0.899 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.308 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.4 ' O ' HG23 ' A' ' 53' ' ' VAL . 58.3 tp -77.31 -26.2 52.0 Favored 'General case' 0 C--N 1.349 0.567 0 O-C-N 122.071 -0.393 . . . . 0.0 110.134 -177.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 43.6 tt0 -67.67 -43.9 79.08 Favored 'General case' 0 N--CA 1.446 -0.638 0 O-C-N 121.724 -0.61 . . . . 0.0 110.048 -178.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 81.8 mt -71.93 -34.84 69.38 Favored 'General case' 0 C--N 1.36 1.022 0 C-N-CA 120.164 -0.614 . . . . 0.0 109.467 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 48' ' ' LEU . 40.0 t -63.11 -40.73 90.14 Favored 'Isoleucine or valine' 0 C--N 1.35 0.593 0 O-C-N 122.331 -0.231 . . . . 0.0 110.456 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 49' ' ' LEU . 54.9 t -68.13 -40.29 82.71 Favored 'Isoleucine or valine' 0 C--N 1.351 0.662 0 O-C-N 121.672 -0.642 . . . . 0.0 109.929 -179.291 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.8 tptt -68.39 -23.02 64.61 Favored 'General case' 0 C--N 1.36 1.022 0 O-C-N 121.021 -1.05 . . . . 0.0 108.695 -179.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.406 HD13 HD13 ' A' ' 66' ' ' LEU . 1.9 mt -68.96 -37.48 78.86 Favored 'General case' 0 C--N 1.351 0.674 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.5 p -73.29 -17.11 61.35 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 120.247 -0.581 . . . . 0.0 110.382 -179.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -100.3 -37.06 9.04 Favored 'General case' 0 C--N 1.354 0.78 0 C-N-CA 119.534 -0.867 . . . . 0.0 111.402 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.9 p -72.67 -36.86 54.38 Favored 'Isoleucine or valine' 0 C--N 1.353 0.725 0 O-C-N 121.56 -0.712 . . . . 0.0 111.525 -177.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.613 ' HB3' HG23 ' A' ' 61' ' ' VAL . 5.3 t -117.89 -3.95 11.14 Favored 'General case' 0 C--N 1.352 0.691 0 C-N-CA 119.095 -1.042 . . . . 0.0 110.143 -178.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 73.2 m 62.9 42.45 7.67 Favored 'General case' 0 C--N 1.355 0.839 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.613 HG23 ' HB3' ' A' ' 59' ' ' SER . 55.1 t -102.37 131.45 22.5 Favored Pre-proline 0 CA--C 1.503 -0.855 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_exo -57.52 147.42 78.74 Favored 'Trans proline' 0 CA--C 1.498 -1.292 0 C-N-CA 122.55 2.167 . . . . 0.0 112.624 179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.1 m -75.22 -12.83 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.671 -178.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.451 ' O ' HG12 ' A' ' 67' ' ' VAL . 64.4 p -96.45 -34.07 11.65 Favored 'General case' 0 C--N 1.359 0.996 0 C-N-CA 118.393 -1.323 . . . . 0.0 109.488 -179.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -75.59 -23.71 56.49 Favored 'General case' 0 C--N 1.354 0.795 0 O-C-N 121.5 -0.75 . . . . 0.0 109.087 179.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.406 HD13 HD13 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -79.96 -36.25 36.44 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.007 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.451 HG12 ' O ' ' A' ' 64' ' ' THR . 1.9 p -69.41 -25.45 29.16 Favored 'Isoleucine or valine' 0 C--N 1.354 0.797 0 C-N-CA 120.206 -0.597 . . . . 0.0 110.046 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 5.5 mmm-85 -73.15 -52.48 14.04 Favored 'General case' 0 C--N 1.363 1.162 0 O-C-N 121.548 -0.72 . . . . 0.0 110.12 -179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.7 mt -63.31 -35.43 80.36 Favored 'General case' 0 C--N 1.357 0.903 0 O-C-N 121.983 -0.448 . . . . 0.0 110.941 -178.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -61.1 -47.67 85.24 Favored 'General case' 0 C--N 1.351 0.638 0 O-C-N 122.117 -0.365 . . . . 0.0 110.624 -178.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.91 -38.51 95.52 Favored Glycine 0 C--N 1.355 1.608 0 N-CA-C 111.738 -0.545 . . . . 0.0 111.738 -178.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.14 -47.87 80.9 Favored 'General case' 0 C--N 1.349 0.568 0 CA-C-N 118.067 0.934 . . . . 0.0 111.348 -177.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.718 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 9.9 mttm -64.51 -49.21 72.2 Favored 'General case' 0 C--N 1.357 0.895 0 N-CA-C 113.61 0.966 . . . . 0.0 113.61 -177.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.418 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.4 tm? -68.4 -39.81 81.55 Favored 'General case' 0 C--N 1.349 0.585 0 O-C-N 121.082 -1.012 . . . . 0.0 111.86 -175.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 42.8 t80 -63.41 -45.09 92.6 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 121.091 -1.006 . . . . 0.0 111.258 -177.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.8 p -71.09 -14.92 18.34 Favored 'Isoleucine or valine' 0 C--N 1.359 0.988 0 O-C-N 121.478 -0.763 . . . . 0.0 109.506 -179.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.718 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 74.1 mm-40 -72.74 -38.79 67.3 Favored 'General case' 0 C--N 1.35 0.629 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.244 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 78.9 mt -69.09 -35.27 76.3 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 47.7 mm -62.5 -51.49 71.53 Favored 'Isoleucine or valine' 0 C--N 1.356 0.89 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.227 -177.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -75.64 -11.87 60.09 Favored 'General case' 0 C--N 1.353 0.73 0 C-N-CA 119.947 -0.701 . . . . 0.0 110.98 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -94.01 -9.37 59.61 Favored Glycine 0 C--N 1.347 1.166 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.482 -178.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.47 ' O ' HG22 ' A' ' 85' ' ' ILE . 87.5 m-70 -143.93 95.32 5.73 Favored Pre-proline 0 CA--C 1.503 -0.839 0 CA-C-N 118.91 1.355 . . . . 0.0 109.126 -179.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.513 ' O ' ' HB2' ' A' ' 87' ' ' ASN . 38.3 Cg_endo -68.71 -23.8 35.66 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.393 2.062 . . . . 0.0 114.046 179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -90.75 -9.11 47.81 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.47 HG22 ' O ' ' A' ' 82' ' ' HIS . 0.6 OUTLIER -89.01 -21.99 6.71 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.971 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 -178.792 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -104.38 -14.81 15.61 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.513 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 20.1 t30 -72.88 -40.66 65.42 Favored 'General case' 0 C--N 1.36 1.048 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -67.35 -29.79 69.43 Favored 'General case' 0 C--N 1.353 0.735 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.156 -178.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 28.4 ttp -84.17 146.58 27.77 Favored 'General case' 0 C--N 1.351 0.655 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.75 -21.51 10.15 Favored 'General case' 0 C--N 1.361 1.104 0 O-C-N 121.58 -0.7 . . . . 0.0 110.937 -177.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -164.54 171.39 14.6 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 -177.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.412 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 88.4 p -71.01 -31.7 68.28 Favored 'General case' 0 C--N 1.352 0.682 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.014 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -70.4 -38.46 74.66 Favored 'General case' 0 C--N 1.358 0.942 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -66.67 -24.18 66.24 Favored 'General case' 0 C--N 1.358 0.977 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 178.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.412 ' HB3' ' O ' ' A' ' 92' ' ' SER . 61.4 tp -62.92 -46.36 88.16 Favored 'General case' 0 C--N 1.355 0.814 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 179.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.3 mp -62.61 -32.89 73.98 Favored 'General case' 0 C--N 1.354 0.765 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 36.3 t -62.41 -45.02 94.99 Favored 'General case' 0 C--N 1.355 0.81 0 O-C-N 121.84 -0.537 . . . . 0.0 111.347 -178.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.08 28.45 8.78 Favored 'General case' 0 C--N 1.361 1.085 0 O-C-N 121.103 -0.998 . . . . 0.0 110.539 -178.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 1.118 HD11 ' C3B' ' A' ' 202' ' ' HEM . 10.6 tt -62.71 -29.91 48.12 Favored 'Isoleucine or valine' 0 C--N 1.354 0.794 0 O-C-N 121.827 -0.546 . . . . 0.0 110.314 -179.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -127.4 -8.8 5.76 Favored 'General case' 0 N--CA 1.437 -1.089 0 C-N-CA 118.54 -1.264 . . . . 0.0 109.916 -179.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 58.4 m -90.88 -2.93 57.7 Favored 'General case' 0 N--CA 1.441 -0.889 0 C-N-CA 119.566 -0.854 . . . . 0.0 110.313 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.459 ' O ' HG12 ' A' ' 105' ' ' VAL . 11.9 t80 -146.51 -46.92 0.19 Allowed 'General case' 0 C--N 1.357 0.912 0 C-N-CA 118.264 -1.374 . . . . 0.0 109.754 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.405 ' CG2' ' HAC' ' A' ' 202' ' ' HEM . 96.1 mt -68.57 -48.41 72.18 Favored 'Isoleucine or valine' 0 C--O 1.243 0.74 0 O-C-N 121.788 -0.57 . . . . 0.0 110.948 -178.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 44.4 m170 -85.71 -1.52 57.27 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 119.825 -0.75 . . . . 0.0 110.329 -177.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.459 HG12 ' O ' ' A' ' 102' ' ' PHE . 2.0 p -89.11 -32.72 5.85 Favored 'Isoleucine or valine' 0 C--N 1.354 0.793 0 N-CA-C 107.778 -1.193 . . . . 0.0 107.778 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 45.0 tt0 -72.3 -40.14 67.76 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -73.17 -33.97 43.4 Favored 'Isoleucine or valine' 0 C--N 1.355 0.824 0 C-N-CA 119.518 -0.873 . . . . 0.0 109.576 -178.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -60.67 -49.01 79.25 Favored 'General case' 0 C--N 1.363 1.164 0 O-C-N 121.8 -0.563 . . . . 0.0 110.441 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.1 mptp? -60.44 -38.99 85.9 Favored 'General case' 0 C--N 1.358 0.96 0 O-C-N 121.579 -0.701 . . . . 0.0 110.096 -179.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.0 mt -57.15 -76.92 0.03 OUTLIER 'General case' 0 C--N 1.354 0.798 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.436 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 92.7 m-85 -115.89 136.11 22.85 Favored Pre-proline 0 N--CA 1.442 -0.855 0 O-C-N 121.067 -1.021 . . . . 0.0 108.817 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 111' ' ' TYR . 68.8 Cg_endo -86.38 -1.72 8.45 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 123.32 2.68 . . . . 0.0 115.585 -178.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -66.73 -36.83 83.4 Favored 'General case' 0 C--N 1.356 0.855 0 O-C-N 121.652 -0.655 . . . . 0.0 110.2 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.46 145.76 54.67 Favored 'General case' 0 C--N 1.352 0.696 0 CA-C-O 121.61 0.719 . . . . 0.0 110.105 -178.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -130.8 134.43 46.84 Favored 'General case' 0 C--N 1.358 0.936 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.478 ' HB3' ' HD2' ' A' ' 117' ' ' PRO . 2.8 mm? -116.36 156.45 47.26 Favored Pre-proline 0 C--N 1.354 0.803 0 CA-C-O 122.145 0.974 . . . . 0.0 108.855 -178.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' A' ' 116' ' ' LEU . 85.5 Cg_endo -83.88 -151.86 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.123 0 C-N-CA 123.517 2.812 . . . . 0.0 113.147 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -114.53 138.72 50.28 Favored 'General case' 0 C--N 1.362 1.152 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 -179.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -125.2 126.38 45.12 Favored 'General case' 0 C--N 1.36 1.05 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 -178.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.534 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 93.8 m -124.88 127.66 47.47 Favored 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 105.639 -1.986 . . . . 0.0 105.639 177.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 77.1 m -121.63 129.99 53.18 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 119.129 -1.029 . . . . 0.0 109.585 -178.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.3 t0 -118.38 148.81 42.14 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 178.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 57.4 ttp180 -120.55 117.21 27.03 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.403 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 95.0 mt -90.55 -16.2 29.24 Favored 'General case' 0 CA--C 1.503 -0.853 0 C-N-CA 120.495 -0.482 . . . . 0.0 110.52 -179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 175.37 -148.68 9.63 Favored Glycine 0 N--CA 1.437 -1.271 0 N-CA-C 108.891 -1.684 . . . . 0.0 108.891 -179.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -94.35 -37.35 11.52 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -178.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -103.01 3.82 36.62 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 119.794 -0.762 . . . . 0.0 110.02 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.403 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 66.6 m-20 -119.83 130.81 55.08 Favored 'General case' 0 C--N 1.359 1.003 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.403 HD13 ' HA ' ' A' ' 129' ' ' ILE . 8.4 mm -142.27 136.07 28.49 Favored 'Isoleucine or valine' 0 C--N 1.355 0.819 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 179.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 53.2 mtm180 -116.16 139.48 50.28 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 179.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 6.3 tp -126.7 118.81 25.5 Favored 'General case' 0 N--CA 1.432 -1.375 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.534 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 12.4 m-70 -99.55 133.43 43.88 Favored 'General case' 0 CA--C 1.497 -1.085 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -129.94 122.61 28.88 Favored 'General case' 0 N--CA 1.436 -1.141 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 -178.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.496 ' HA ' ' O ' ' A' ' 171' ' ' THR . 32.2 tt0 -115.73 113.04 22.93 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.2 t -162.51 154.16 18.25 Favored 'General case' 0 C--N 1.359 1.002 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.406 ' C ' ' HD3' ' A' ' 138' ' ' PRO . 57.7 mtmt -91.41 3.94 53.69 Favored 'General case' 0 C--N 1.357 0.921 0 C-N-CA 120.186 -0.605 . . . . 0.0 109.865 -179.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 93.8 mtm-85 -133.01 74.11 74.29 Favored Pre-proline 0 C--N 1.356 0.882 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.406 ' HD3' ' C ' ' A' ' 136' ' ' LYS . 94.1 Cg_endo -96.23 102.7 0.09 OUTLIER 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.657 2.238 . . . . 0.0 115.759 -177.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -111.47 113.42 25.84 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 106.507 -1.664 . . . . 0.0 106.507 176.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.01 -38.16 90.07 Favored 'General case' 0 C--N 1.354 0.778 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.026 -179.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.7 m -63.48 -28.04 69.69 Favored 'General case' 0 C--N 1.352 0.71 0 O-C-N 122.042 -0.411 . . . . 0.0 110.694 -178.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -75.59 -46.53 31.28 Favored 'General case' 0 C--N 1.352 0.687 0 C-N-CA 120.146 -0.622 . . . . 0.0 109.567 -178.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.68 -39.85 94.38 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 122.258 -0.276 . . . . 0.0 111.187 -178.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.19 -37.2 86.31 Favored 'General case' 0 C--N 1.355 0.81 0 O-C-N 121.987 -0.446 . . . . 0.0 110.184 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.51 -42.88 99.27 Favored Glycine 0 C--N 1.348 1.248 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 -179.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 83.1 mt -70.07 -40.65 74.9 Favored 'General case' 0 C--N 1.351 0.667 0 CA-C-N 117.522 0.661 . . . . 0.0 112.627 -179.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 97.1 mt -71.35 -42.38 68.58 Favored 'General case' 0 C--N 1.361 1.07 0 O-C-N 121.235 -0.916 . . . . 0.0 110.902 -176.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.497 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 36.4 t70 -70.06 -31.07 68.5 Favored 'General case' 0 N--CA 1.445 -0.695 0 O-C-N 121.934 -0.479 . . . . 0.0 110.407 -179.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -63.12 -39.09 97.57 Favored Glycine 0 C--N 1.356 1.672 0 N-CA-C 108.461 -1.856 . . . . 0.0 108.461 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 46.3 t -60.75 -42.2 96.92 Favored 'General case' 0 C--N 1.35 0.622 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 178.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -74.97 -1.25 21.76 Favored 'General case' 0 C--N 1.36 1.046 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.497 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 76.9 mm-40 -83.46 -46.91 11.94 Favored 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -65.54 -45.6 82.8 Favored 'General case' 0 C--N 1.36 1.042 0 C-N-CA 120.175 -0.61 . . . . 0.0 109.411 178.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -68.57 -25.95 65.16 Favored 'General case' 0 C--N 1.363 1.191 0 O-C-N 121.798 -0.564 . . . . 0.0 110.896 -178.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 85.1 tttt 73.16 76.43 0.14 Allowed 'General case' 0 C--N 1.36 1.031 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -144.9 -168.56 2.96 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 107.699 -1.222 . . . . 0.0 107.699 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -150.71 93.25 1.93 Allowed 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 14.1 m-30 -111.35 160.08 17.39 Favored 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 92.7 m -120.18 127.08 52.13 Favored 'General case' 0 N--CA 1.442 -0.836 0 C-N-CA 119.289 -0.964 . . . . 0.0 108.819 -178.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.527 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.5 mp -105.55 122.21 58.69 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 178.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.9 m -118.09 -173.01 2.36 Favored 'General case' 0 C--N 1.356 0.857 0 CA-C-O 121.851 0.834 . . . . 0.0 109.241 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.19 157.89 43.74 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 -178.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 52.3 p -99.95 146.43 31.88 Favored Pre-proline 0 C--N 1.358 0.963 0 CA-C-O 122.344 1.069 . . . . 0.0 108.189 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.619 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 72.2 Cg_endo -76.35 -11.14 19.14 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.965 2.443 . . . . 0.0 115.052 -178.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -72.24 -41.29 66.97 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 119.97 -0.692 . . . . 0.0 109.474 -178.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 36.2 p -117.54 15.82 14.62 Favored 'General case' 0 CA--C 1.505 -0.773 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.355 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.619 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.5 pp0? -65.59 -13.76 59.72 Favored 'General case' 0 C--N 1.355 0.807 0 O-C-N 121.657 -0.652 . . . . 0.0 110.341 178.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 46.6 p30 -125.43 39.76 3.89 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 19.8 t -139.72 144.93 37.75 Favored 'General case' 0 N--CA 1.444 -0.755 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.617 ' O ' ' HB ' ' A' ' 171' ' ' THR . 61.9 mt-10 -98.71 164.43 12.23 Favored 'General case' 0 C--N 1.354 0.801 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.617 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 18.4 m 84.35 -60.76 0.1 Allowed 'General case' 0 C--N 1.369 1.44 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -107.2 117.74 34.88 Favored 'General case' 0 CA--C 1.503 -0.855 0 C-N-CA 119.865 -0.734 . . . . 0.0 109.633 -178.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 97.9 t -131.26 132.96 62.9 Favored 'Isoleucine or valine' 0 C--N 1.357 0.923 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 178.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 49.9 mm -107.8 127.43 63.87 Favored 'Isoleucine or valine' 0 C--N 1.357 0.899 0 N-CA-C 107.877 -1.156 . . . . 0.0 107.877 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -115.66 156.14 26.43 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 122.073 0.94 . . . . 0.0 108.593 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.8 t30 -138.84 119.52 14.09 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.7 mp -114.56 118.86 59.88 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 N-CA-C 106.395 -1.705 . . . . 0.0 106.395 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 86.1 m -128.2 143.55 51.05 Favored 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 -177.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 70.3 mtm180 -85.36 119.26 25.53 Favored 'General case' 0 C--N 1.369 1.431 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.41 ' HA ' ' HD3' ' A' ' 181' ' ' PRO . . . -68.79 148.39 97.98 Favored Pre-proline 0 C--N 1.356 0.861 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 180' ' ' ALA . 52.4 Cg_exo -55.08 126.86 23.98 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.622 2.215 . . . . 0.0 113.915 -178.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' A' ' 182' ' ' ARG . 5.2 mtm105 -113.94 -141.45 0.38 Allowed 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 107.799 -1.185 . . . . 0.0 107.799 179.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -95.77 58.13 1.55 Allowed Glycine 0 C--N 1.355 1.593 0 N-CA-C 107.477 -2.249 . . . . 0.0 107.477 179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -153.6 164.71 37.8 Favored 'General case' 0 N--CA 1.432 -1.327 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -154.23 152.31 30.18 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 -179.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -173.01 67.63 0.03 OUTLIER 'General case' 0 N--CA 1.439 -0.987 0 N-CA-C 106.672 -1.603 . . . . 0.0 106.672 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 27.4 tp -97.48 -71.97 0.66 Allowed 'General case' 0 N--CA 1.441 -0.918 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . 0.482 ' HB3' ' H ' ' A' ' 189' ' ' PHE . 0.2 OUTLIER -149.78 -124.39 0.05 OUTLIER 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -179.785 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . 0.482 ' H ' ' HB3' ' A' ' 188' ' ' TYR . 98.4 m-85 -127.72 148.17 50.41 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 . . . . . 0 C--O 1.264 1.85 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 179.957 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' HEM . . . . . 1.118 ' C3B' HD11 ' A' ' 99' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.0 mtm . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.532 0.682 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.43 ' HA ' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -82.48 -9.34 59.47 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 -178.998 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.33 -42.31 49.96 Favored Glycine 0 C--N 1.352 1.422 0 N-CA-C 108.734 -1.746 . . . . 0.0 108.734 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 61.5 mtt -66.68 -38.78 87.49 Favored 'General case' 0 C--N 1.357 0.893 0 O-C-N 122.13 -0.629 . . . . 0.0 111.21 -178.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.43 HG22 ' HA ' ' A' ' 2' ' ' MET . 34.7 m -69.23 -23.06 26.38 Favored 'Isoleucine or valine' 0 C--N 1.356 0.871 0 C-N-CA 120.178 -0.609 . . . . 0.0 109.91 -178.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.2 m-30 -70.75 -37.25 73.42 Favored 'General case' 0 C--N 1.355 0.833 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.4 m -67.98 -41.07 82.92 Favored 'General case' 0 C--N 1.354 0.803 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.44 -38.97 97.19 Favored Glycine 0 C--N 1.357 1.702 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 -179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.63 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -65.5 -40.12 92.66 Favored 'General case' 0 C--N 1.351 0.652 0 O-C-N 122.384 -0.48 . . . . 0.0 110.733 -178.351 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.408 ' CE ' HD21 ' A' ' 26' ' ' LEU . 24.6 mmt -63.11 -40.42 97.56 Favored 'General case' 0 C--N 1.352 0.676 0 O-C-N 121.611 -0.681 . . . . 0.0 110.935 -178.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -67.33 -40.24 85.91 Favored 'General case' 0 C--N 1.348 0.526 0 C-N-CA 120.612 -0.435 . . . . 0.0 111.438 -178.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 53.7 tp -66.36 -43.07 87.04 Favored 'General case' 0 C--N 1.35 0.588 0 N-CA-C 113.025 0.75 . . . . 0.0 113.025 -178.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.63 HG12 ' O ' ' A' ' 9' ' ' LEU . 1.1 mm -76.36 -36.05 28.48 Favored 'Isoleucine or valine' 0 C--N 1.36 1.04 0 O-C-N 120.924 -1.11 . . . . 0.0 111.113 -175.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -67.61 -43.18 81.07 Favored 'General case' 0 C--N 1.351 0.642 0 O-C-N 121.683 -0.636 . . . . 0.0 111.134 -176.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -72.32 -33.28 67.23 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 121.956 -0.465 . . . . 0.0 111.76 -177.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.9 mm-40 -72.49 -48.45 40.61 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -175.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 58.1 m-85 -127.57 -21.12 3.85 Favored 'General case' 0 C--N 1.354 0.798 0 C-N-CA 117.5 -1.68 . . . . 0.0 113.49 -176.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 140.56 179.81 18.45 Favored Glycine 0 CA--C 1.497 -1.041 0 C-N-CA 118.007 -2.044 . . . . 0.0 109.489 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -96.33 -11.96 25.1 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -177.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -70.79 -41.4 71.69 Favored 'General case' 0 C--N 1.36 1.032 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 94.3 m -69.73 -38.89 77.04 Favored 'General case' 0 C--N 1.357 0.896 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 178.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.513 HD13 ' HB ' ' A' ' 13' ' ' ILE . 55.5 tp -60.48 -37.12 80.03 Favored 'General case' 0 C--N 1.356 0.873 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -65.09 -35.46 81.22 Favored 'General case' 0 C--N 1.357 0.899 0 O-C-N 122.255 -0.278 . . . . 0.0 110.725 -178.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.7 m -64.49 -40.25 95.32 Favored 'General case' 0 C--N 1.358 0.946 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 -178.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.417 HD22 ' HB3' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -65.09 -36.71 85.17 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.563 ' HB3' HD23 ' A' ' 31' ' ' LEU . 83.7 mt -70.88 -14.88 62.55 Favored 'General case' 0 C--N 1.356 0.891 0 O-C-N 121.501 -0.749 . . . . 0.0 109.81 -179.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -87.82 -25.79 23.15 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.292 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.4 p -69.22 -24.33 64.01 Favored 'General case' 0 C--N 1.36 1.027 0 C-N-CA 119.7 -0.8 . . . . 0.0 109.085 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.621 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 1.9 p -107.42 -34.88 6.93 Favored 'General case' 0 C--N 1.359 0.992 0 C-N-CA 119.008 -1.077 . . . . 0.0 108.442 179.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.621 ' HB2' ' O ' ' A' ' 29' ' ' CYS . 12.2 mt-10 83.37 133.58 0.05 Allowed 'General case' 0 C--N 1.359 1.012 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.563 HD23 ' HB3' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -103.2 111.06 23.26 Favored 'General case' 0 C--N 1.359 1.001 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.577 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -73.07 -41.11 64.47 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.425 ' HB3' ' H ' ' A' ' 34' ' ' GLU . 0.6 OUTLIER -113.96 -88.68 0.55 Allowed 'General case' 0 C--N 1.355 0.828 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 -179.074 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.425 ' H ' ' HB3' ' A' ' 33' ' ' SER . 60.5 mt-10 -120.55 -43.15 2.5 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -178.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 111.91 -34.64 5.11 Favored Glycine 0 C--N 1.351 1.393 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 178.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 78.9 mt -106.66 102.67 14.28 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.95 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.47 -136.9 0.06 Allowed 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.455 ' O ' ' HB3' ' A' ' 39' ' ' SER . 52.0 m -113.2 -59.65 1.99 Allowed 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -179.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.455 ' HB3' ' O ' ' A' ' 38' ' ' THR . 61.4 p 158.48 10.34 0.0 OUTLIER 'General case' 0 C--N 1.363 1.182 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 -178.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.4 p -98.07 6.8 8.65 Favored 'Isoleucine or valine' 0 C--N 1.353 0.733 0 C-N-CA 120.251 -0.579 . . . . 0.0 110.902 -177.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -105.3 154.95 17.13 Favored Glycine 0 C--N 1.353 1.5 0 N-CA-C 109.376 -1.489 . . . . 0.0 109.376 -178.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 35.1 t -134.88 124.99 25.87 Favored 'General case' 0 C--N 1.357 0.901 0 N-CA-C 106.469 -1.678 . . . . 0.0 106.469 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -109.46 175.75 5.33 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -72.18 175.33 6.13 Favored 'General case' 0 C--N 1.356 0.879 0 CA-C-O 121.638 0.733 . . . . 0.0 109.443 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 10.7 t60 -82.77 -24.86 33.27 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -178.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 46.3 tt0 -65.81 -28.17 68.8 Favored 'General case' 0 C--N 1.356 0.875 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.2 tp10 -62.58 -39.74 94.68 Favored 'General case' 0 C--N 1.351 0.673 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -68.15 -38.63 82.35 Favored 'General case' 0 C--N 1.357 0.915 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 59.2 tp -71.28 -32.38 68.62 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -177.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -66.76 -40.96 88.44 Favored 'General case' 0 N--CA 1.441 -0.878 0 O-C-N 122.02 -0.425 . . . . 0.0 110.027 -178.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 80.3 mt -82.47 -17.81 43.93 Favored 'General case' 0 C--N 1.357 0.898 0 C-N-CA 120.005 -0.678 . . . . 0.0 110.191 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -81.56 -36.65 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -179.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 54.3 t -68.34 -41.49 83.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.417 ' HB3' HD22 ' A' ' 25' ' ' LEU . 22.6 tptt -69.17 -26.03 64.65 Favored 'General case' 0 C--N 1.365 1.245 0 C-N-CA 119.485 -0.886 . . . . 0.0 109.337 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.451 ' O ' HD23 ' A' ' 55' ' ' LEU . 3.4 tt -67.04 -37.09 83.46 Favored 'General case' 0 C--N 1.353 0.748 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 68.2 m -76.67 -16.99 59.39 Favored 'General case' 0 C--N 1.352 0.691 0 C-N-CA 120.232 -0.587 . . . . 0.0 110.341 -178.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -97.95 -38.39 9.42 Favored 'General case' 0 C--N 1.353 0.717 0 O-C-N 121.314 -0.867 . . . . 0.0 111.278 -179.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.2 p -73.18 -35.85 48.5 Favored 'Isoleucine or valine' 0 C--N 1.353 0.759 0 O-C-N 121.668 -0.645 . . . . 0.0 111.186 -177.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 61.2 m -111.71 -7.87 14.21 Favored 'General case' 0 CA--C 1.504 -0.821 0 C-N-CA 119.389 -0.924 . . . . 0.0 109.99 -177.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 64.72 52.71 1.63 Allowed 'General case' 0 C--N 1.355 0.831 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.429 ' HA ' ' HD3' ' A' ' 62' ' ' PRO . 48.6 t -112.75 135.76 21.59 Favored Pre-proline 0 CA--C 1.504 -0.81 0 N-CA-C 107.507 -1.294 . . . . 0.0 107.507 -179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 61' ' ' VAL . 31.2 Cg_exo -59.93 146.08 96.73 Favored 'Trans proline' 0 C--N 1.316 -1.178 0 C-N-CA 122.144 1.896 . . . . 0.0 112.464 178.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.2 m -73.55 -16.09 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 C-N-CA 120.888 -0.325 . . . . 0.0 110.91 -178.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.455 ' O ' HG12 ' A' ' 67' ' ' VAL . 67.5 p -96.24 -32.0 12.66 Favored 'General case' 0 C--N 1.359 0.981 0 C-N-CA 118.129 -1.429 . . . . 0.0 110.318 -178.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -80.19 -19.16 47.69 Favored 'General case' 0 C--N 1.353 0.724 0 O-C-N 121.162 -0.961 . . . . 0.0 108.864 179.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.401 ' HB3' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -80.17 -37.85 32.51 Favored 'General case' 0 N--CA 1.442 -0.869 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.845 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.455 HG12 ' O ' ' A' ' 64' ' ' THR . 1.3 p -67.35 -28.38 42.11 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.927 0 C-N-CA 120.236 -0.586 . . . . 0.0 109.833 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 71.3 mtp180 -71.47 -50.51 30.92 Favored 'General case' 0 C--N 1.364 1.234 0 O-C-N 121.444 -0.785 . . . . 0.0 110.831 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.7 mt -64.43 -36.01 82.79 Favored 'General case' 0 C--N 1.357 0.91 0 O-C-N 121.929 -0.482 . . . . 0.0 111.159 -178.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -61.02 -47.31 87.01 Favored 'General case' 0 C--N 1.349 0.577 0 O-C-N 122.154 -0.341 . . . . 0.0 110.388 -178.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.74 -38.45 95.2 Favored Glycine 0 C--N 1.356 1.643 0 N-CA-C 111.639 -0.584 . . . . 0.0 111.639 -178.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.08 -48.59 77.97 Favored 'General case' 0 C--N 1.35 0.609 0 CA-C-N 118.104 0.952 . . . . 0.0 111.45 -177.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.528 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 10.9 mttm -64.29 -48.0 77.33 Favored 'General case' 0 C--N 1.358 0.947 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -177.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.459 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.1 tm? -68.44 -39.28 81.57 Favored 'General case' 0 C--N 1.349 0.584 0 O-C-N 121.259 -0.9 . . . . 0.0 111.869 -175.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -63.97 -44.38 92.92 Favored 'General case' 0 C--N 1.352 0.69 0 O-C-N 121.248 -0.907 . . . . 0.0 111.06 -177.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.33 -15.27 18.44 Favored 'Isoleucine or valine' 0 C--N 1.359 1.009 0 O-C-N 121.486 -0.759 . . . . 0.0 108.953 -179.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.528 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 14.7 mm-40 -71.67 -39.06 70.52 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 81.8 mt -73.32 -31.22 63.88 Favored 'General case' 0 C--N 1.359 0.984 0 O-C-N 122.301 -0.249 . . . . 0.0 110.505 -179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.9 mm -64.95 -53.56 40.01 Favored 'Isoleucine or valine' 0 C--N 1.359 1.013 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.956 -177.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -74.69 -15.0 60.81 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 119.693 -0.803 . . . . 0.0 109.36 178.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.65 -36.86 67.62 Favored Glycine 0 C--N 1.35 1.339 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 -179.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.453 ' O ' HG22 ' A' ' 85' ' ' ILE . 59.5 m80 -132.44 104.97 13.27 Favored Pre-proline 0 N--CA 1.44 -0.941 0 CA-C-N 118.534 1.167 . . . . 0.0 109.499 -177.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.447 ' O ' ' HB2' ' A' ' 87' ' ' ASN . 34.8 Cg_exo -62.07 -29.58 81.53 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 123.018 2.479 . . . . 0.0 113.872 178.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -91.53 -8.37 47.72 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -178.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.453 HG22 ' O ' ' A' ' 82' ' ' HIS . 0.9 OUTLIER -86.71 -22.27 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.856 0 N-CA-C 106.911 -1.514 . . . . 0.0 106.911 -178.765 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -104.57 -14.55 15.61 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 178.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 49.1 t30 -71.71 -40.85 69.21 Favored 'General case' 0 C--N 1.359 1.001 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -66.92 -30.95 71.23 Favored 'General case' 0 C--N 1.351 0.662 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.284 -178.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 17.5 ttp -83.93 150.16 25.86 Favored 'General case' 0 C--N 1.35 0.63 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -179.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.71 -22.31 7.49 Favored 'General case' 0 C--N 1.364 1.21 0 O-C-N 121.608 -0.683 . . . . 0.0 111.436 -177.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -165.28 172.03 12.86 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 119.083 -1.047 . . . . 0.0 108.277 -177.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.427 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 40.0 t -64.79 -43.3 93.66 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.056 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -66.13 -39.61 90.01 Favored 'General case' 0 C--N 1.355 0.847 0 O-C-N 121.414 -0.804 . . . . 0.0 109.138 -178.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -65.93 -24.35 66.8 Favored 'General case' 0 C--N 1.355 0.807 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.655 ' O ' HG12 ' A' ' 99' ' ' ILE . 61.7 tp -63.89 -47.16 81.73 Favored 'General case' 0 C--N 1.354 0.777 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.5 mp -60.58 -35.56 76.38 Favored 'General case' 0 C--N 1.36 1.054 0 O-C-N 122.215 -0.303 . . . . 0.0 110.345 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.8 t -68.49 -39.55 81.28 Favored 'General case' 0 C--N 1.348 0.526 0 O-C-N 122.03 -0.419 . . . . 0.0 109.967 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.06 1.26 54.67 Favored 'General case' 0 C--N 1.356 0.855 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -176.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.655 HG12 ' O ' ' A' ' 95' ' ' LEU . 23.4 mm -60.96 -47.16 94.79 Favored 'Isoleucine or valine' 0 C--N 1.359 0.989 0 CA-C-N 118.955 0.798 . . . . 0.0 112.089 -177.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -98.77 -20.63 16.79 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 118.273 -1.371 . . . . 0.0 111.282 -177.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.5 t -64.75 -48.48 74.4 Favored 'General case' 0 N--CA 1.445 -0.707 0 O-C-N 121.555 -0.716 . . . . 0.0 112.36 -178.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 23.5 t80 -136.51 -17.34 1.51 Allowed 'General case' 0 C--N 1.361 1.093 0 C-N-CA 117.174 -1.811 . . . . 0.0 113.536 -176.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.594 HG23 HBC2 ' A' ' 202' ' ' HEM . 96.4 mt -71.56 -50.78 37.42 Favored 'Isoleucine or valine' 0 C--O 1.244 0.771 0 CA-C-N 120.574 1.534 . . . . 0.0 111.215 -177.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 28.8 m170 -89.83 1.5 56.08 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 119.628 -0.829 . . . . 0.0 110.107 -177.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 55.7 t -90.19 -41.73 13.74 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.053 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 178.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 54.7 tp10 -68.33 -40.02 81.73 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 -179.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 2.5 p -74.05 -35.6 42.07 Favored 'Isoleucine or valine' 0 C--N 1.356 0.867 0 C-N-CA 119.18 -1.008 . . . . 0.0 109.708 -178.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 94.2 t80 -61.26 -48.61 80.63 Favored 'General case' 0 C--N 1.364 1.203 0 O-C-N 121.775 -0.578 . . . . 0.0 110.526 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -61.48 -37.13 82.5 Favored 'General case' 0 C--N 1.358 0.948 0 O-C-N 121.742 -0.599 . . . . 0.0 110.162 -178.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 110' ' ' LEU . 13.6 mt -56.21 -74.47 0.05 OUTLIER 'General case' 0 C--N 1.357 0.922 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.412 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 87.3 m-85 -118.41 133.74 23.49 Favored Pre-proline 0 N--CA 1.439 -0.98 0 C-N-CA 118.978 -1.089 . . . . 0.0 108.538 179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 111' ' ' TYR . 96.2 Cg_endo -83.54 -1.48 10.17 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 123.31 2.674 . . . . 0.0 115.52 -178.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -65.73 -37.85 87.55 Favored 'General case' 0 C--N 1.355 0.835 0 O-C-N 121.746 -0.597 . . . . 0.0 110.092 -179.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.38 145.11 56.58 Favored 'General case' 0 C--N 1.354 0.769 0 CA-C-O 121.513 0.673 . . . . 0.0 110.149 -178.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -131.93 135.66 46.79 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.526 ' HB3' ' HD2' ' A' ' 117' ' ' PRO . 93.1 mt -128.96 157.62 75.17 Favored Pre-proline 0 C--N 1.354 0.795 0 CA-C-O 122.098 0.952 . . . . 0.0 109.224 -178.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.526 ' HD2' ' HB3' ' A' ' 116' ' ' LEU . 87.4 Cg_endo -81.35 -150.91 0.04 OUTLIER 'Trans proline' 0 C--N 1.318 -1.059 0 C-N-CA 123.685 2.923 . . . . 0.0 113.933 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -116.7 141.86 47.65 Favored 'General case' 0 C--N 1.364 1.238 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -130.34 133.14 46.2 Favored 'General case' 0 C--N 1.362 1.125 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 94.2 m -127.31 129.16 47.15 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 177.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 77.6 m -119.26 129.29 54.84 Favored 'General case' 0 C--N 1.355 0.808 0 C-N-CA 119.382 -0.927 . . . . 0.0 109.382 -178.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 12.2 t0 -119.63 133.83 55.48 Favored 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 178.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 58.8 ttp180 -106.63 116.81 32.58 Favored 'General case' 0 C--N 1.352 0.716 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.472 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 94.6 mt -85.54 -23.73 27.56 Favored 'General case' 0 C--N 1.354 0.763 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.203 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -179.59 -144.72 6.0 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -94.02 -40.25 10.19 Favored 'General case' 0 N--CA 1.437 -1.086 0 C-N-CA 119.993 -0.683 . . . . 0.0 109.254 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.0 p-10 -102.51 3.83 37.95 Favored 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.985 -178.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.472 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 66.3 m-20 -118.13 129.02 55.28 Favored 'General case' 0 C--N 1.356 0.866 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 10.0 mm -141.25 133.53 29.37 Favored 'Isoleucine or valine' 0 C--N 1.356 0.854 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 58.8 mtm180 -116.57 139.75 50.15 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -127.68 118.11 23.22 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 -179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 12.4 m-70 -97.15 132.63 42.74 Favored 'General case' 0 CA--C 1.497 -1.09 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 179.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -128.7 120.18 26.0 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 -178.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.558 ' HA ' ' O ' ' A' ' 171' ' ' THR . 74.4 mt-30 -115.0 111.77 21.64 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 107.599 -1.259 . . . . 0.0 107.599 178.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.4 t -162.16 153.86 18.61 Favored 'General case' 0 C--N 1.359 0.981 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -90.6 3.08 55.09 Favored 'General case' 0 C--N 1.354 0.782 0 C-N-CA 120.267 -0.573 . . . . 0.0 109.743 -179.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -133.47 74.73 70.83 Favored Pre-proline 0 C--N 1.355 0.806 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -95.36 104.44 0.11 Allowed 'Trans proline' 0 N--CA 1.444 -1.407 0 C-N-CA 122.756 2.304 . . . . 0.0 115.746 -177.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -111.71 110.56 21.0 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 106.864 -1.532 . . . . 0.0 106.864 176.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.37 -38.88 92.57 Favored 'General case' 0 C--N 1.354 0.773 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.288 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.1 m -63.28 -26.63 68.86 Favored 'General case' 0 C--N 1.355 0.826 0 O-C-N 121.96 -0.463 . . . . 0.0 110.597 -178.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -75.58 -47.02 28.49 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.554 -178.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.78 -40.08 94.66 Favored 'General case' 0 C--N 1.358 0.96 0 O-C-N 122.154 -0.342 . . . . 0.0 111.226 -178.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.24 -36.91 85.22 Favored 'General case' 0 C--N 1.355 0.812 0 O-C-N 121.852 -0.53 . . . . 0.0 109.985 -179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.56 -43.71 98.59 Favored Glycine 0 C--N 1.346 1.096 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -178.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.3 mt -70.23 -40.34 74.56 Favored 'General case' 0 C--N 1.351 0.671 0 O-C-N 122.126 -0.632 . . . . 0.0 112.639 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 98.2 mt -71.2 -43.24 67.76 Favored 'General case' 0 C--N 1.361 1.068 0 O-C-N 121.21 -0.931 . . . . 0.0 111.115 -176.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.531 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 37.1 t70 -70.54 -29.54 66.03 Favored 'General case' 0 N--CA 1.443 -0.778 0 O-C-N 121.839 -0.538 . . . . 0.0 110.392 -179.172 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.453 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -63.17 -39.47 97.98 Favored Glycine 0 C--N 1.357 1.73 0 N-CA-C 108.464 -1.854 . . . . 0.0 108.464 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 47.9 t -60.38 -41.93 94.81 Favored 'General case' 0 C--N 1.351 0.632 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -75.83 0.17 19.05 Favored 'General case' 0 C--N 1.36 1.029 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.531 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 76.8 mm-40 -85.51 -46.39 10.9 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -66.36 -44.67 82.54 Favored 'General case' 0 C--N 1.36 1.033 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.411 ' O ' ' HB2' ' A' ' 155' ' ' LYS . 52.5 m-85 -69.96 -26.49 64.14 Favored 'General case' 0 C--N 1.36 1.028 0 O-C-N 121.872 -0.517 . . . . 0.0 111.137 -178.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.411 ' HB2' ' O ' ' A' ' 154' ' ' PHE . 44.1 mttt 71.43 71.78 0.17 Allowed 'General case' 0 C--N 1.363 1.154 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 -178.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.443 ' HB3' ' CE1' ' A' ' 158' ' ' PHE . 3.0 tp10 -141.26 -168.69 2.69 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -140.33 116.34 10.42 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.443 ' CE1' ' HB3' ' A' ' 156' ' ' GLU . 91.2 m-85 -133.65 149.86 51.57 Favored 'General case' 0 CA--C 1.505 -0.771 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 92.1 m -120.94 127.59 51.97 Favored 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.529 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.6 mp -103.8 120.89 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 179.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 3.1 m -114.5 -177.6 3.17 Favored 'General case' 0 C--N 1.36 1.034 0 CA-C-O 121.708 0.766 . . . . 0.0 109.193 -179.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 28.2 ptt180 -146.93 154.6 41.46 Favored 'General case' 0 C--N 1.355 0.847 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 -178.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 54.2 p -97.4 146.5 31.48 Favored Pre-proline 0 C--N 1.358 0.961 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.672 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 72.3 Cg_endo -76.19 -11.2 19.4 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.941 2.427 . . . . 0.0 114.918 -178.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -72.63 -41.14 65.83 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 120.128 -0.629 . . . . 0.0 109.714 -178.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 35.7 p -118.42 15.52 13.84 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 120.04 -0.664 . . . . 0.0 110.704 -178.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.672 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.1 pp0? -67.06 -13.57 62.06 Favored 'General case' 0 C--N 1.354 0.765 0 O-C-N 121.546 -0.721 . . . . 0.0 110.263 178.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 53.8 p-10 -121.09 35.1 4.99 Favored 'General case' 0 N--CA 1.438 -1.028 0 O-C-N 121.188 -0.945 . . . . 0.0 108.706 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 58.2 m -136.12 148.63 48.32 Favored 'General case' 0 CA--C 1.503 -0.833 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.625 ' O ' ' HB ' ' A' ' 171' ' ' THR . 61.4 mt-10 -101.74 166.29 10.75 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.625 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 3.4 m 81.65 -59.04 0.23 Allowed 'General case' 0 C--N 1.37 1.469 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -107.8 117.77 34.98 Favored 'General case' 0 CA--C 1.507 -0.706 0 C-N-CA 119.916 -0.713 . . . . 0.0 109.565 -178.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 90.7 t -132.0 133.44 60.8 Favored 'Isoleucine or valine' 0 C--N 1.357 0.922 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 178.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 50.1 mm -109.95 126.72 67.15 Favored 'Isoleucine or valine' 0 C--N 1.358 0.971 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -113.96 150.36 33.91 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -179.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -133.93 83.31 2.03 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.206 -178.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.6 mp -76.94 119.52 25.5 Favored 'Isoleucine or valine' 0 C--N 1.358 0.947 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 178.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 92.3 m -118.53 144.4 46.08 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -179.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 54.8 ttp180 -87.41 117.77 26.41 Favored 'General case' 0 C--N 1.36 1.027 0 N-CA-C 107.594 -1.261 . . . . 0.0 107.594 -178.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.582 ' HB1' ' HD2' ' A' ' 181' ' ' PRO . . . -67.18 156.61 87.62 Favored Pre-proline 0 C--N 1.357 0.911 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.582 ' HD2' ' HB1' ' A' ' 180' ' ' ALA . 21.2 Cg_endo -61.68 128.74 25.43 Favored 'Trans proline' 0 CA--C 1.495 -1.439 0 C-N-CA 122.122 1.881 . . . . 0.0 113.709 -178.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.48 31.43 3.45 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 114.688 -1.142 . . . . 0.0 108.672 -179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.473 ' O ' ' HB3' ' A' ' 184' ' ' ALA . . . 116.89 97.51 1.99 Allowed Glycine 0 N--CA 1.437 -1.247 0 N-CA-C 107.995 -2.042 . . . . 0.0 107.995 179.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' A' ' 183' ' ' GLY . . . 78.16 149.5 0.1 Allowed 'General case' 0 C--N 1.359 1.005 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -148.84 151.73 35.24 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -114.37 118.51 34.08 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 85.3 mt -89.35 -45.07 9.75 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . 0.453 ' HB3' ' H ' ' A' ' 189' ' ' PHE . 3.5 t80 -165.98 -86.52 0.02 OUTLIER 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . 0.453 ' H ' ' HB3' ' A' ' 188' ' ' TYR . 87.9 t80 -139.59 129.96 25.47 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 107.054 -1.461 . . . . 0.0 107.054 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 . . . . . 0 C--O 1.264 1.825 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 -179.958 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' HEM . . . . . 0.96 ' HHA' ' CBD' ' A' ' 202' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.883 ' HG2' ' CMD' ' A' ' 202' ' ' HEM . 88.8 mmm . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 121.041 0.448 . . . . 0.0 110.018 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.463 ' HA ' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -77.18 -17.44 58.55 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 120.586 -0.446 . . . . 0.0 109.969 -178.498 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.76 -44.62 30.96 Favored Glycine 0 C--N 1.35 1.356 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 -179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 75.7 mtm -71.43 -33.79 69.7 Favored 'General case' 0 C--N 1.354 0.782 0 O-C-N 122.073 -0.663 . . . . 0.0 111.377 -177.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.463 HG22 ' HA ' ' A' ' 2' ' ' MET . 30.7 m -70.76 -22.89 23.53 Favored 'Isoleucine or valine' 0 C--N 1.357 0.9 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.064 -179.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.442 ' HZ ' ' CG ' ' A' ' 47' ' ' GLU . 1.7 m-30 -71.47 -35.31 70.79 Favored 'General case' 0 C--N 1.357 0.917 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 88.9 m -66.41 -39.67 89.13 Favored 'General case' 0 C--N 1.357 0.902 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.23 -37.88 95.28 Favored Glycine 0 C--N 1.357 1.71 0 N-CA-C 110.295 -1.122 . . . . 0.0 110.295 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.618 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -66.89 -39.71 87.54 Favored 'General case' 0 C--N 1.354 0.773 0 CA-C-N 117.291 0.545 . . . . 0.0 110.526 -178.282 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 22.6 mmt -63.53 -41.42 98.46 Favored 'General case' 0 C--N 1.355 0.835 0 O-C-N 121.618 -0.676 . . . . 0.0 111.013 -178.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -66.34 -40.4 89.84 Favored 'General case' 0 C--N 1.347 0.493 0 O-C-N 122.148 -0.345 . . . . 0.0 111.702 -177.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 55.8 tp -66.03 -43.06 88.69 Favored 'General case' 0 C--N 1.349 0.583 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 -178.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.618 HG12 ' O ' ' A' ' 9' ' ' LEU . 1.7 mm -74.61 -36.45 40.96 Favored 'Isoleucine or valine' 0 C--N 1.358 0.935 0 O-C-N 121.003 -1.06 . . . . 0.0 111.155 -175.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 75.5 tt0 -66.95 -42.53 85.06 Favored 'General case' 0 C--N 1.351 0.659 0 O-C-N 121.82 -0.55 . . . . 0.0 111.286 -176.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -75.04 -30.89 61.19 Favored 'General case' 0 N--CA 1.446 -0.653 0 O-C-N 121.83 -0.544 . . . . 0.0 111.773 -177.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -72.96 -48.67 34.7 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 120.065 -0.654 . . . . 0.0 112.736 -175.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -127.72 -22.13 3.63 Favored 'General case' 0 CA--C 1.503 -0.849 0 C-N-CA 117.609 -1.636 . . . . 0.0 112.846 -176.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 146.34 178.69 21.94 Favored Glycine 0 N--CA 1.44 -1.077 0 C-N-CA 117.671 -2.204 . . . . 0.0 110.494 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -96.7 -17.5 20.28 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -70.3 -40.17 74.39 Favored 'General case' 0 C--N 1.361 1.089 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 94.5 m -68.28 -38.54 81.81 Favored 'General case' 0 C--N 1.357 0.918 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 178.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 27.1 tp -60.68 -36.49 78.9 Favored 'General case' 0 C--N 1.355 0.839 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -65.15 -37.12 86.39 Favored 'General case' 0 C--N 1.359 0.984 0 O-C-N 121.998 -0.439 . . . . 0.0 110.461 -178.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.7 m -65.67 -37.75 87.38 Favored 'General case' 0 C--N 1.355 0.811 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 23.4 tp -62.39 -40.73 97.44 Favored 'General case' 0 C--N 1.354 0.764 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.484 ' HB3' HD23 ' A' ' 31' ' ' LEU . 6.8 mp -74.94 -11.35 60.1 Favored 'General case' 0 C--N 1.36 1.031 0 O-C-N 121.693 -0.629 . . . . 0.0 110.483 -178.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -85.7 -29.21 24.14 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 119.254 -0.978 . . . . 0.0 108.925 178.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.7 t -67.13 -37.52 83.98 Favored 'General case' 0 C--N 1.357 0.92 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.646 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 1.8 p -89.81 -38.99 13.39 Favored 'General case' 0 C--N 1.359 1.011 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 -179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.646 ' HB2' ' O ' ' A' ' 29' ' ' CYS . 10.6 mt-10 85.61 132.39 0.04 OUTLIER 'General case' 0 C--N 1.362 1.119 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 178.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.484 HD23 ' HB3' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -108.58 122.18 46.55 Favored 'General case' 0 C--N 1.357 0.898 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.433 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -94.25 -38.03 11.24 Favored 'General case' 0 N--CA 1.436 -1.125 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 178.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -104.77 -78.16 0.57 Allowed 'General case' 0 N--CA 1.441 -0.915 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.234 -178.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -137.24 -55.56 0.7 Allowed 'General case' 0 CA--C 1.502 -0.888 0 C-N-CA 119.609 -0.836 . . . . 0.0 108.853 -178.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 128.91 -52.11 0.84 Allowed Glycine 0 C--N 1.352 1.458 0 N-CA-C 108.788 -1.725 . . . . 0.0 108.788 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 78.4 mt -97.67 95.29 4.4 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.755 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 -179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.608 ' CD2' HG23 ' A' ' 40' ' ' VAL . 1.2 t80 -65.38 -50.94 63.65 Favored 'General case' 0 C--N 1.36 1.059 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.461 HG22 ' N ' ' A' ' 39' ' ' SER . 1.1 m 143.58 -64.32 0.0 OUTLIER 'General case' 0 C--N 1.368 1.406 0 N-CA-C 107.28 -1.378 . . . . 0.0 107.28 178.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.461 ' N ' HG22 ' A' ' 38' ' ' THR . 16.5 p 169.59 70.39 0.0 OUTLIER 'General case' 0 C--N 1.364 1.208 0 N-CA-C 108.126 -1.065 . . . . 0.0 108.126 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.608 HG23 ' CD2' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -164.52 1.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.938 0 C-N-CA 119.853 -0.739 . . . . 0.0 109.695 -179.811 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.5 146.73 17.35 Favored Glycine 0 C--N 1.353 1.526 0 N-CA-C 109.207 -1.557 . . . . 0.0 109.207 -179.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 53.4 m -123.93 124.71 43.2 Favored 'General case' 0 N--CA 1.443 -0.78 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -116.45 175.18 5.68 Favored 'General case' 0 N--CA 1.441 -0.886 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -82.07 -172.62 4.05 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 65.9 m80 -92.42 -14.68 28.21 Favored 'General case' 0 N--CA 1.439 -0.975 0 C-N-CA 120.117 -0.633 . . . . 0.0 109.365 -179.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -70.22 -28.44 65.27 Favored 'General case' 0 C--N 1.354 0.764 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 178.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.442 ' CG ' ' HZ ' ' A' ' 6' ' ' PHE . 26.0 tp10 -63.2 -40.3 97.09 Favored 'General case' 0 C--N 1.353 0.726 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.412 HD22 ' O ' ' A' ' 48' ' ' LEU . 2.0 tm? -67.68 -38.29 83.52 Favored 'General case' 0 C--N 1.358 0.942 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 58.5 tp -74.17 -29.35 61.73 Favored 'General case' 0 N--CA 1.447 -0.598 0 O-C-N 122.088 -0.382 . . . . 0.0 110.259 -176.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.3 tp-100 -68.28 -41.02 81.62 Favored 'General case' 0 N--CA 1.444 -0.774 0 O-C-N 121.835 -0.54 . . . . 0.0 109.561 -178.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 63.2 mt -83.98 -15.92 45.94 Favored 'General case' 0 C--N 1.361 1.072 0 C-N-CA 119.745 -0.782 . . . . 0.0 110.666 -179.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.4 t -81.85 -35.76 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 52.2 t -70.7 -39.84 76.23 Favored 'Isoleucine or valine' 0 C--N 1.354 0.791 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.0 tptt -67.19 -28.54 68.18 Favored 'General case' 0 C--N 1.36 1.048 0 O-C-N 121.266 -0.896 . . . . 0.0 108.622 -179.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.417 ' O ' HD23 ' A' ' 55' ' ' LEU . 2.5 tt -67.99 -37.79 81.91 Favored 'General case' 0 C--N 1.353 0.747 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 60.0 p -72.32 -17.65 61.84 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 120.11 -0.636 . . . . 0.0 110.741 -178.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -101.44 -35.32 9.23 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 119.278 -0.969 . . . . 0.0 111.049 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.8 p -73.61 -36.86 48.44 Favored 'Isoleucine or valine' 0 C--N 1.353 0.74 0 O-C-N 121.797 -0.565 . . . . 0.0 111.081 -177.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 73.0 m -113.17 -6.97 13.62 Favored 'General case' 0 CA--C 1.504 -0.825 0 C-N-CA 119.512 -0.875 . . . . 0.0 110.161 -177.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 64.35 48.63 2.74 Favored 'General case' 0 C--N 1.356 0.858 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.562 HG13 ' HD2' ' A' ' 62' ' ' PRO . 49.8 t -113.6 135.5 21.93 Favored Pre-proline 0 CA--C 1.505 -0.774 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.67 ' HG2' ' HB2' ' A' ' 65' ' ' GLU . 23.4 Cg_endo -62.57 149.12 92.12 Favored 'Trans proline' 0 CA--C 1.5 -1.203 0 C-N-CA 122.276 1.984 . . . . 0.0 112.518 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.2 m -75.98 -13.67 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.655 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.319 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.45 ' O ' HG12 ' A' ' 67' ' ' VAL . 72.1 p -95.22 -33.99 12.39 Favored 'General case' 0 C--N 1.356 0.878 0 C-N-CA 118.207 -1.397 . . . . 0.0 109.747 -178.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.67 ' HB2' ' HG2' ' A' ' 62' ' ' PRO . 97.9 mt-10 -78.02 -21.84 50.15 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 121.336 -0.853 . . . . 0.0 108.978 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.52 -37.48 36.54 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 -179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 64' ' ' THR . 1.7 p -67.47 -26.9 36.84 Favored 'Isoleucine or valine' 0 C--N 1.355 0.812 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.902 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.9 mmm-85 -71.98 -51.15 23.33 Favored 'General case' 0 C--N 1.363 1.184 0 O-C-N 121.549 -0.719 . . . . 0.0 110.451 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.2 mt -63.24 -36.06 82.41 Favored 'General case' 0 C--N 1.357 0.922 0 O-C-N 121.963 -0.461 . . . . 0.0 110.953 -178.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -60.58 -46.83 88.77 Favored 'General case' 0 C--N 1.348 0.541 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 -178.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.39 -38.42 94.71 Favored Glycine 0 C--N 1.352 1.455 0 N-CA-C 111.74 -0.544 . . . . 0.0 111.74 -178.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -63.16 -48.38 78.68 Favored 'General case' 0 C--N 1.353 0.731 0 CA-C-N 118.499 1.149 . . . . 0.0 111.547 -177.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.707 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 16.2 mttm -63.76 -49.41 73.08 Favored 'General case' 0 C--N 1.359 1.006 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -176.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.413 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.4 tm? -68.65 -39.71 80.58 Favored 'General case' 0 C--N 1.349 0.559 0 O-C-N 121.125 -0.985 . . . . 0.0 111.973 -175.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.537 ' CE1' ' CBB' ' A' ' 202' ' ' HEM . 35.9 t80 -63.86 -44.35 93.39 Favored 'General case' 0 C--N 1.352 0.702 0 O-C-N 121.196 -0.94 . . . . 0.0 111.187 -177.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -70.33 -15.51 19.16 Favored 'Isoleucine or valine' 0 C--N 1.359 0.986 0 O-C-N 121.41 -0.806 . . . . 0.0 109.261 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.707 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 74.5 mm-40 -72.17 -38.33 69.16 Favored 'General case' 0 C--N 1.351 0.651 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 81.4 mt -74.25 -29.11 61.54 Favored 'General case' 0 C--N 1.357 0.9 0 O-C-N 122.311 -0.243 . . . . 0.0 110.543 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.8 mm -67.06 -54.16 27.12 Favored 'Isoleucine or valine' 0 C--N 1.359 1.007 0 C-N-CA 119.993 -0.683 . . . . 0.0 109.897 -177.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -74.63 -14.66 60.79 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 119.686 -0.806 . . . . 0.0 109.285 178.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.55 -37.25 62.23 Favored Glycine 0 C--N 1.348 1.228 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -134.01 104.16 11.67 Favored Pre-proline 0 N--CA 1.441 -0.88 0 CA-C-O 122.494 1.14 . . . . 0.0 109.026 -177.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.48 ' O ' ' HB2' ' A' ' 87' ' ' ASN . 37.6 Cg_endo -67.98 -23.2 40.85 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.556 2.171 . . . . 0.0 114.004 179.697 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -90.01 -8.38 51.72 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.4 tp -89.63 -22.81 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -178.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -102.51 -15.95 16.28 Favored 'General case' 0 N--CA 1.436 -1.149 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 179.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.48 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 49.1 t30 -71.74 -40.92 69.07 Favored 'General case' 0 C--N 1.36 1.061 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -67.1 -29.21 68.9 Favored 'General case' 0 C--N 1.353 0.756 0 C-N-CA 120.841 -0.344 . . . . 0.0 110.209 -178.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 23.7 ttp -84.4 148.1 26.78 Favored 'General case' 0 C--N 1.351 0.652 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.5 -21.96 8.37 Favored 'General case' 0 C--N 1.363 1.193 0 C-N-CA 119.934 -0.707 . . . . 0.0 111.025 -177.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -165.3 171.66 13.28 Favored 'General case' 0 C--N 1.354 0.778 0 C-N-CA 119.045 -1.062 . . . . 0.0 108.338 -177.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 39.6 t -64.62 -42.13 95.71 Favored 'General case' 0 C--N 1.356 0.884 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.864 -179.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -66.46 -39.11 88.63 Favored 'General case' 0 C--N 1.356 0.884 0 O-C-N 121.528 -0.733 . . . . 0.0 109.292 -178.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -65.61 -25.72 67.51 Favored 'General case' 0 C--N 1.357 0.912 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 64.5 tp -62.94 -46.22 88.77 Favored 'General case' 0 C--N 1.355 0.826 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.7 mp -62.5 -32.5 73.43 Favored 'General case' 0 C--N 1.353 0.752 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 37.1 t -62.4 -45.37 93.44 Favored 'General case' 0 C--N 1.356 0.857 0 O-C-N 121.719 -0.613 . . . . 0.0 111.22 -178.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.97 28.88 8.42 Favored 'General case' 0 C--N 1.36 1.049 0 C-N-CA 119.304 -0.958 . . . . 0.0 110.462 -178.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.669 HD11 ' C3B' ' A' ' 202' ' ' HEM . 10.4 tt -62.3 -29.17 46.07 Favored 'Isoleucine or valine' 0 C--N 1.356 0.868 0 O-C-N 122.152 -0.343 . . . . 0.0 110.537 -178.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -127.15 -11.43 5.85 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 118.696 -1.202 . . . . 0.0 109.097 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.4 t -68.31 -45.55 72.67 Favored 'General case' 0 N--CA 1.439 -0.977 0 O-C-N 121.879 -0.513 . . . . 0.0 109.901 -179.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.479 ' O ' HG12 ' A' ' 105' ' ' VAL . 19.3 t80 -123.83 -29.53 3.67 Favored 'General case' 0 C--N 1.36 1.049 0 C-N-CA 118.38 -1.328 . . . . 0.0 111.549 -178.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 96.2 mt -69.75 -48.4 64.94 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 O-C-N 121.076 -1.015 . . . . 0.0 110.487 -177.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -89.03 3.65 50.97 Favored 'General case' 0 N--CA 1.44 -0.954 0 O-C-N 121.105 -0.997 . . . . 0.0 109.916 -177.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.479 HG12 ' O ' ' A' ' 102' ' ' PHE . 1.9 p -87.68 -33.98 7.04 Favored 'Isoleucine or valine' 0 C--N 1.357 0.899 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 178.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -71.64 -40.12 69.91 Favored 'General case' 0 C--N 1.36 1.049 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 62.2 t -62.82 -47.06 94.63 Favored 'Isoleucine or valine' 0 C--N 1.357 0.909 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.276 -179.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -60.2 -48.61 81.02 Favored 'General case' 0 C--N 1.357 0.931 0 O-C-N 122.115 -0.366 . . . . 0.0 111.466 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -60.61 -38.93 86.33 Favored 'General case' 0 C--N 1.355 0.833 0 O-C-N 121.547 -0.721 . . . . 0.0 110.609 -178.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 19.6 mt -58.26 -75.64 0.05 OUTLIER 'General case' 0 C--N 1.354 0.804 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -115.29 132.97 22.8 Favored Pre-proline 0 N--CA 1.442 -0.874 0 C-N-CA 118.906 -1.117 . . . . 0.0 108.9 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -84.54 -3.4 10.0 Favored 'Trans proline' 0 C--N 1.313 -1.324 0 C-N-CA 123.176 2.584 . . . . 0.0 115.056 -179.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -66.42 -36.6 83.21 Favored 'General case' 0 C--N 1.354 0.778 0 O-C-N 122.001 -0.437 . . . . 0.0 109.948 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.4 146.34 54.13 Favored 'General case' 0 C--N 1.354 0.766 0 CA-C-O 121.714 0.769 . . . . 0.0 110.219 -178.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -130.54 135.18 47.67 Favored 'General case' 0 C--N 1.358 0.949 0 N-CA-C 106.121 -1.807 . . . . 0.0 106.121 179.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.529 ' HB3' ' HD2' ' A' ' 117' ' ' PRO . 87.5 mt -127.03 157.0 73.44 Favored Pre-proline 0 N--CA 1.444 -0.756 0 CA-C-O 122.193 0.997 . . . . 0.0 109.394 -178.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.529 ' HD2' ' HB3' ' A' ' 116' ' ' LEU . 89.6 Cg_endo -80.37 -157.44 0.08 OUTLIER 'Trans proline' 0 C--N 1.319 -0.987 0 C-N-CA 123.914 3.076 . . . . 0.0 114.163 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -114.23 142.47 46.23 Favored 'General case' 0 C--N 1.367 1.332 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -124.0 127.85 48.51 Favored 'General case' 0 C--N 1.361 1.067 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -178.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.537 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 94.7 m -124.7 128.51 48.91 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 105.654 -1.98 . . . . 0.0 105.654 177.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 78.4 m -122.63 131.17 53.69 Favored 'General case' 0 CA--C 1.504 -0.825 0 C-N-CA 119.061 -1.055 . . . . 0.0 109.929 -177.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -118.15 149.52 40.92 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 177.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 57.8 ttp180 -121.2 117.74 27.85 Favored 'General case' 0 C--N 1.353 0.748 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -179.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 97.2 mt -93.37 -13.93 27.46 Favored 'General case' 0 C--N 1.356 0.856 0 C-N-CA 120.431 -0.507 . . . . 0.0 110.603 -179.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 173.29 -149.16 10.88 Favored Glycine 0 C--N 1.348 1.226 0 C-N-CA 118.761 -1.685 . . . . 0.0 109.171 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -94.15 -37.91 11.34 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 -178.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -103.6 5.79 36.79 Favored 'General case' 0 N--CA 1.444 -0.761 0 C-N-CA 120.166 -0.614 . . . . 0.0 109.39 -179.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -121.49 127.85 51.48 Favored 'General case' 0 C--N 1.359 0.979 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.3 mm -141.71 135.95 30.59 Favored 'Isoleucine or valine' 0 C--N 1.354 0.787 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 53.2 mtm180 -115.94 140.11 49.57 Favored 'General case' 0 CA--C 1.495 -1.144 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 7.5 tp -126.79 118.64 25.07 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-N 115.233 -0.894 . . . . 0.0 108.654 -178.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.537 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 12.6 m-70 -99.15 133.11 43.9 Favored 'General case' 0 CA--C 1.497 -1.087 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 179.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -127.46 120.54 28.61 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.466 ' HA ' ' O ' ' A' ' 171' ' ' THR . 36.2 tt0 -114.78 111.7 21.65 Favored 'General case' 0 N--CA 1.437 -1.083 0 N-CA-C 107.411 -1.329 . . . . 0.0 107.411 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 15.9 t -161.7 152.53 17.91 Favored 'General case' 0 C--N 1.359 0.986 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 58.1 mtmt -90.82 1.49 56.89 Favored 'General case' 0 C--N 1.357 0.93 0 C-N-CA 120.245 -0.582 . . . . 0.0 109.95 -178.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 87.9 mtm180 -135.35 74.28 61.43 Favored Pre-proline 0 C--N 1.355 0.821 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -96.72 110.51 0.11 Allowed 'Trans proline' 0 N--CA 1.444 -1.429 0 C-N-CA 122.752 2.301 . . . . 0.0 116.03 -177.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -112.85 112.59 24.18 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 176.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.88 -38.59 91.64 Favored 'General case' 0 C--N 1.354 0.77 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.116 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 74.0 m -63.21 -28.81 70.3 Favored 'General case' 0 C--N 1.354 0.783 0 O-C-N 121.927 -0.483 . . . . 0.0 110.689 -178.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -74.16 -46.82 39.91 Favored 'General case' 0 C--N 1.351 0.633 0 C-N-CA 120.236 -0.586 . . . . 0.0 109.719 -177.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.95 -39.67 93.85 Favored 'General case' 0 C--N 1.357 0.908 0 O-C-N 122.176 -0.327 . . . . 0.0 111.351 -177.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -63.09 -37.47 87.33 Favored 'General case' 0 C--N 1.355 0.83 0 O-C-N 121.872 -0.517 . . . . 0.0 110.164 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.54 -43.26 99.07 Favored Glycine 0 C--N 1.347 1.162 0 N-CA-C 109.911 -1.276 . . . . 0.0 109.911 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . 0.424 ' HB3' HBB2 ' A' ' 202' ' ' HEM . 82.7 mt -70.07 -40.51 74.99 Favored 'General case' 0 C--N 1.351 0.657 0 CA-C-N 117.521 0.66 . . . . 0.0 112.724 -179.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 98.0 mt -70.89 -42.39 70.04 Favored 'General case' 0 C--N 1.361 1.103 0 O-C-N 121.146 -0.971 . . . . 0.0 110.829 -176.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -70.4 -30.01 66.79 Favored 'General case' 0 N--CA 1.444 -0.735 0 O-C-N 121.953 -0.467 . . . . 0.0 110.677 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.524 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -63.55 -39.59 97.79 Favored Glycine 0 C--N 1.356 1.688 0 N-CA-C 108.622 -1.791 . . . . 0.0 108.622 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 43.5 t -60.36 -42.99 96.91 Favored 'General case' 0 C--N 1.351 0.64 0 N-CA-C 109.146 -0.686 . . . . 0.0 109.146 178.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -78.83 2.66 19.2 Favored 'General case' 0 C--N 1.359 0.981 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.524 ' HB2' ' O ' ' A' ' 149' ' ' GLY . 24.3 mm-40 -84.56 -48.25 9.73 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 74.4 t80 -68.67 -40.65 80.05 Favored 'General case' 0 C--N 1.357 0.925 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.504 ' O ' ' HB2' ' A' ' 155' ' ' LYS . 9.1 m-30 -70.46 -26.73 63.77 Favored 'General case' 0 C--N 1.36 1.059 0 O-C-N 121.741 -0.599 . . . . 0.0 111.154 -178.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.504 ' HB2' ' O ' ' A' ' 154' ' ' PHE . 56.8 mtpt 73.2 64.85 0.1 Allowed 'General case' 0 C--N 1.361 1.103 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -178.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -127.16 -179.33 4.81 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -142.3 89.22 2.14 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 17.3 m-30 -115.14 156.7 24.79 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 179.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 93.7 m -118.79 127.73 53.8 Favored 'General case' 0 C--N 1.356 0.867 0 C-N-CA 119.462 -0.895 . . . . 0.0 108.831 -178.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.517 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.6 mp -102.88 121.84 54.53 Favored 'Isoleucine or valine' 0 C--N 1.352 0.698 0 N-CA-C 106.728 -1.582 . . . . 0.0 106.728 178.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -118.05 -173.29 2.42 Favored 'General case' 0 C--N 1.356 0.884 0 CA-C-O 121.801 0.81 . . . . 0.0 109.524 -178.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 26.5 ptt180 -147.54 156.45 42.85 Favored 'General case' 0 C--N 1.357 0.894 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 48.2 p -100.1 146.26 31.62 Favored Pre-proline 0 C--N 1.358 0.967 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.674 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 74.7 Cg_endo -76.83 -11.09 18.32 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.819 2.346 . . . . 0.0 115.234 -178.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -72.66 -41.5 65.33 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 119.93 -0.708 . . . . 0.0 109.589 -178.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 35.5 p -117.83 16.27 14.36 Favored 'General case' 0 C--N 1.354 0.771 0 C-N-CA 120.069 -0.652 . . . . 0.0 110.443 -178.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.674 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.2 pp0? -66.6 -11.34 52.99 Favored 'General case' 0 C--N 1.353 0.743 0 O-C-N 121.595 -0.69 . . . . 0.0 110.457 178.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -126.56 38.54 4.1 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 58.9 m -137.6 147.11 44.76 Favored 'General case' 0 CA--C 1.502 -0.895 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.624 ' O ' ' HB ' ' A' ' 171' ' ' THR . 60.5 mt-10 -101.27 165.23 11.39 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.624 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 19.9 m 84.75 -60.37 0.09 Allowed 'General case' 0 C--N 1.367 1.355 0 N-CA-C 109.311 -0.625 . . . . 0.0 109.311 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -109.24 117.38 33.95 Favored 'General case' 0 CA--C 1.502 -0.878 0 C-N-CA 119.872 -0.731 . . . . 0.0 109.43 -178.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 90.8 t -130.73 133.08 63.82 Favored 'Isoleucine or valine' 0 C--N 1.356 0.883 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 178.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 49.9 mm -108.53 126.89 65.31 Favored 'Isoleucine or valine' 0 C--N 1.358 0.958 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -115.93 156.62 25.89 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -179.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -137.94 118.94 14.33 Favored 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.2 mp -114.15 120.16 63.19 Favored 'Isoleucine or valine' 0 C--N 1.352 0.696 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 43.1 p -121.17 159.49 25.75 Favored 'General case' 0 CA--C 1.5 -0.951 0 CA-C-O 121.763 0.792 . . . . 0.0 110.662 -177.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -109.39 110.65 21.85 Favored 'General case' 0 C--N 1.361 1.07 0 N-CA-C 105.344 -2.095 . . . . 0.0 105.344 177.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.435 ' HA ' ' HD3' ' A' ' 181' ' ' PRO . . . -65.35 144.1 98.9 Favored Pre-proline 0 CA--C 1.503 -0.859 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 180' ' ' ALA . 50.2 Cg_exo -56.66 128.79 31.48 Favored 'Trans proline' 0 CA--C 1.493 -1.563 0 C-N-CA 122.665 2.243 . . . . 0.0 112.627 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -139.47 143.53 37.57 Favored 'General case' 0 N--CA 1.433 -1.295 0 CA-C-O 121.877 0.846 . . . . 0.0 109.164 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.55 ' O ' ' HB2' ' A' ' 184' ' ' ALA . . . 55.25 46.84 77.86 Favored Glycine 0 C--N 1.351 1.37 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.55 ' HB2' ' O ' ' A' ' 183' ' ' GLY . . . 153.7 99.45 0.0 OUTLIER 'General case' 0 C--N 1.359 1.006 0 N-CA-C 106.884 -1.524 . . . . 0.0 106.884 -177.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -115.81 104.64 11.85 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -124.1 126.76 46.76 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 78.0 mt -109.07 -53.98 2.58 Favored 'General case' 0 N--CA 1.44 -0.964 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . 0.492 ' HB3' ' H ' ' A' ' 189' ' ' PHE . 4.8 t80 -154.58 -87.87 0.05 OUTLIER 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 107.071 -1.455 . . . . 0.0 107.071 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . 0.492 ' H ' ' HB3' ' A' ' 188' ' ' TYR . 0.4 OUTLIER -124.64 -60.06 1.41 Allowed 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 179.755 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 . . . . . 0 C--O 1.264 1.819 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 179.891 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' HEM . . . . . 0.883 ' CMD' ' HG2' ' A' ' 1' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.849 ' H3 ' ' CMD' ' A' ' 202' ' ' HEM . 51.9 tpp . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.038 0.447 . . . . 0.0 110.475 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.44 ' O ' ' HD1' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -82.14 -14.98 54.9 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.383 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -71.93 -41.5 54.99 Favored Glycine 0 C--N 1.351 1.405 0 N-CA-C 108.558 -1.817 . . . . 0.0 108.558 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.767 ' HG3' ' HG2' ' A' ' 1' ' ' MET . 67.8 mtt -66.35 -38.22 87.13 Favored 'General case' 0 C--N 1.356 0.849 0 O-C-N 122.316 -0.52 . . . . 0.0 111.555 -178.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.4 m -69.38 -23.93 27.05 Favored 'Isoleucine or valine' 0 C--N 1.357 0.914 0 C-N-CA 119.996 -0.682 . . . . 0.0 109.847 -177.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.577 ' HZ ' ' HG2' ' A' ' 47' ' ' GLU . 4.6 m-85 -71.36 -35.8 71.25 Favored 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 85.3 m -67.77 -41.31 83.47 Favored 'General case' 0 C--N 1.354 0.772 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.38 -38.98 97.18 Favored Glycine 0 C--N 1.357 1.727 0 N-CA-C 110.749 -0.94 . . . . 0.0 110.749 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.611 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -66.05 -39.87 90.49 Favored 'General case' 0 C--N 1.351 0.635 0 CA-C-N 117.338 0.569 . . . . 0.0 110.704 -178.336 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.418 ' CE ' HD11 ' A' ' 26' ' ' LEU . 25.6 mmt -64.14 -39.81 94.82 Favored 'General case' 0 C--N 1.351 0.662 0 O-C-N 121.802 -0.561 . . . . 0.0 110.847 -178.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -66.6 -39.83 88.57 Favored 'General case' 0 C--N 1.35 0.604 0 O-C-N 121.974 -0.454 . . . . 0.0 111.148 -178.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 56.0 tp -66.86 -42.83 85.02 Favored 'General case' 0 C--N 1.35 0.593 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.611 HG12 ' O ' ' A' ' 9' ' ' LEU . 2.2 mm -75.32 -36.42 36.23 Favored 'Isoleucine or valine' 0 C--N 1.357 0.929 0 O-C-N 121.053 -1.029 . . . . 0.0 111.074 -175.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -70.01 -42.6 72.81 Favored 'General case' 0 C--N 1.353 0.725 0 O-C-N 121.725 -0.609 . . . . 0.0 111.181 -176.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -71.3 -32.83 69.11 Favored 'General case' 0 N--CA 1.444 -0.735 0 O-C-N 122.002 -0.436 . . . . 0.0 111.219 -177.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -72.61 -50.51 24.82 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 113.187 0.81 . . . . 0.0 113.187 -175.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -128.91 -19.32 3.64 Favored 'General case' 0 C--N 1.357 0.897 0 C-N-CA 117.365 -1.734 . . . . 0.0 113.721 -176.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 142.08 179.66 19.25 Favored Glycine 0 N--CA 1.441 -1.017 0 C-N-CA 117.594 -2.241 . . . . 0.0 110.134 -179.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -96.06 -11.38 26.45 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 -177.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -70.31 -40.23 74.34 Favored 'General case' 0 C--N 1.36 1.062 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 92.6 m -68.74 -39.03 80.54 Favored 'General case' 0 C--N 1.357 0.908 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 4.0 tt -60.36 -38.73 84.76 Favored 'General case' 0 C--N 1.359 0.99 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 179.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -63.98 -37.51 87.66 Favored 'General case' 0 C--N 1.355 0.828 0 O-C-N 122.085 -0.385 . . . . 0.0 111.053 -178.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 90.1 m -65.36 -40.94 94.22 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 121.701 -0.624 . . . . 0.0 109.528 -178.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.442 ' CD2' ' HB3' ' A' ' 54' ' ' LYS . 87.8 mt -64.52 -38.0 89.49 Favored 'General case' 0 C--N 1.354 0.767 0 O-C-N 122.037 -0.414 . . . . 0.0 110.069 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.418 HD11 ' CE ' ' A' ' 10' ' ' MET . 3.9 mp -72.7 -12.8 61.17 Favored 'General case' 0 C--N 1.361 1.072 0 O-C-N 121.51 -0.744 . . . . 0.0 110.145 -178.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -86.99 -28.49 22.62 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 119.298 -0.961 . . . . 0.0 109.047 178.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.9 t -67.14 -37.67 84.21 Favored 'General case' 0 C--N 1.354 0.801 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 3.9 p -89.8 -40.88 12.19 Favored 'General case' 0 C--N 1.359 0.996 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 86.18 132.89 0.04 OUTLIER 'General case' 0 C--N 1.36 1.051 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.513 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -83.62 -171.61 3.69 Favored 'General case' 0 C--N 1.357 0.916 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.41 ' H ' ' H ' ' A' ' 33' ' ' SER . 53.5 tt0 -151.2 -27.26 0.2 Allowed 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -179.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.41 ' H ' ' H ' ' A' ' 32' ' ' GLN . 2.3 t -144.26 -68.38 0.32 Allowed 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 -179.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -129.74 -49.3 1.14 Allowed 'General case' 0 CA--C 1.5 -0.954 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 119.32 -42.88 1.68 Allowed Glycine 0 C--N 1.352 1.427 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 82.9 mt -110.12 105.48 18.89 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.006 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -87.6 -137.7 0.1 Allowed 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 89.8 m -118.06 -59.0 1.95 Allowed 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 40.1 p 167.21 25.6 0.0 OUTLIER 'General case' 0 C--N 1.362 1.131 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.0 t -109.49 1.81 9.38 Favored 'Isoleucine or valine' 0 C--N 1.353 0.731 0 C-N-CA 119.79 -0.764 . . . . 0.0 110.476 -178.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -96.78 143.47 16.76 Favored Glycine 0 C--N 1.353 1.502 0 C-N-CA 119.111 -1.518 . . . . 0.0 109.9 -178.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 51.5 m -123.11 127.43 48.7 Favored 'General case' 0 C--N 1.356 0.889 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 178.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -120.37 173.4 7.17 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -77.19 -176.63 4.16 Favored 'General case' 0 C--N 1.357 0.924 0 CA-C-O 121.568 0.699 . . . . 0.0 109.287 -179.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 15.3 t60 -88.93 -22.16 23.22 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -66.23 -27.68 68.15 Favored 'General case' 0 C--N 1.356 0.881 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.577 ' HG2' ' HZ ' ' A' ' 6' ' ' PHE . 35.2 tp10 -62.19 -40.8 97.27 Favored 'General case' 0 C--N 1.352 0.704 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.435 HD22 ' O ' ' A' ' 48' ' ' LEU . 1.9 tm? -67.05 -38.64 86.19 Favored 'General case' 0 C--N 1.357 0.899 0 N-CA-C 109.997 -0.371 . . . . 0.0 109.997 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 59.0 tp -70.64 -34.25 71.86 Favored 'General case' 0 CA--C 1.51 -0.585 0 O-C-N 122.118 -0.364 . . . . 0.0 110.261 -176.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 71.7 tp60 -66.26 -40.54 90.24 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 121.89 -0.506 . . . . 0.0 109.774 -178.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 85.2 mt -81.99 -17.35 47.19 Favored 'General case' 0 C--N 1.361 1.066 0 C-N-CA 120.086 -0.645 . . . . 0.0 110.593 -178.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.3 t -81.38 -36.65 14.94 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 54.7 t -70.05 -39.68 77.56 Favored 'Isoleucine or valine' 0 C--N 1.352 0.682 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.442 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 34.6 tptt -64.81 -28.33 69.49 Favored 'General case' 0 C--N 1.363 1.195 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.498 HD21 HD12 ' A' ' 13' ' ' ILE . 4.5 mt -67.13 -38.48 85.63 Favored 'General case' 0 C--N 1.356 0.866 0 C-N-CA 120.684 -0.407 . . . . 0.0 110.254 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 70.4 p -72.2 -17.65 61.91 Favored 'General case' 0 C--N 1.354 0.789 0 C-N-CA 119.983 -0.687 . . . . 0.0 110.851 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -101.55 -37.4 8.41 Favored 'General case' 0 C--N 1.353 0.752 0 O-C-N 121.173 -0.954 . . . . 0.0 111.643 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.4 p -72.07 -37.16 59.26 Favored 'Isoleucine or valine' 0 C--N 1.353 0.726 0 O-C-N 121.62 -0.675 . . . . 0.0 111.492 -177.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.627 ' HB3' HG23 ' A' ' 61' ' ' VAL . 3.4 t -115.64 -6.68 12.18 Favored 'General case' 0 C--N 1.351 0.668 0 C-N-CA 119.126 -1.03 . . . . 0.0 110.216 -177.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 65.0 46.91 2.67 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.627 HG23 ' HB3' ' A' ' 59' ' ' SER . 46.5 t -107.49 135.44 19.71 Favored Pre-proline 0 CA--C 1.504 -0.801 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.545 ' HG2' ' HB2' ' A' ' 65' ' ' GLU . 23.9 Cg_endo -62.41 147.84 94.25 Favored 'Trans proline' 0 CA--C 1.5 -1.177 0 C-N-CA 122.078 1.852 . . . . 0.0 112.311 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.4 m -76.68 -12.51 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.545 -177.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.48 ' O ' HG12 ' A' ' 67' ' ' VAL . 70.7 p -95.56 -33.27 12.47 Favored 'General case' 0 C--N 1.356 0.865 0 C-N-CA 118.166 -1.413 . . . . 0.0 109.956 -178.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.545 ' HB2' ' HG2' ' A' ' 62' ' ' PRO . 99.1 mt-10 -81.07 -20.08 42.35 Favored 'General case' 0 C--N 1.354 0.787 0 O-C-N 121.245 -0.909 . . . . 0.0 108.575 179.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.447 ' HB3' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -78.36 -37.32 44.56 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 179.572 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.48 HG12 ' O ' ' A' ' 64' ' ' THR . 1.8 p -68.84 -29.35 43.18 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.278 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 80.4 mtp180 -70.81 -48.55 53.54 Favored 'General case' 0 C--N 1.365 1.267 0 O-C-N 121.222 -0.923 . . . . 0.0 110.829 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 83.8 mt -63.76 -36.52 84.16 Favored 'General case' 0 C--N 1.355 0.812 0 O-C-N 122.049 -0.407 . . . . 0.0 110.751 -178.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -61.21 -47.49 85.89 Favored 'General case' 0 C--N 1.348 0.512 0 O-C-N 122.307 -0.246 . . . . 0.0 110.587 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.61 -38.86 96.55 Favored Glycine 0 C--N 1.354 1.542 0 CA-C-O 119.812 -0.438 . . . . 0.0 112.204 -177.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 39.2 ttpt -65.26 -46.05 82.08 Favored 'General case' 0 C--N 1.352 0.693 0 CA-C-N 118.554 1.177 . . . . 0.0 111.318 -176.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.741 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 10.7 mttm -63.74 -49.41 73.13 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -177.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.481 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.2 tm? -68.18 -40.18 82.32 Favored 'General case' 0 C--N 1.35 0.617 0 O-C-N 121.195 -0.941 . . . . 0.0 112.149 -175.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.407 ' CE2' ' HA ' ' A' ' 150' ' ' CYS . 49.3 t80 -62.94 -45.57 91.86 Favored 'General case' 0 C--N 1.353 0.743 0 O-C-N 121.179 -0.951 . . . . 0.0 111.238 -178.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.2 p -71.26 -14.79 18.12 Favored 'Isoleucine or valine' 0 C--N 1.356 0.888 0 O-C-N 121.523 -0.736 . . . . 0.0 109.588 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.741 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 76.6 mm-40 -73.77 -39.18 64.37 Favored 'General case' 0 C--N 1.35 0.617 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.655 HD13 HBC2 ' A' ' 202' ' ' HEM . 80.1 mt -69.91 -36.71 75.58 Favored 'General case' 0 C--N 1.358 0.977 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.8 mm -62.55 -50.19 80.8 Favored 'Isoleucine or valine' 0 C--N 1.354 0.779 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 -178.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -66.17 -24.4 66.63 Favored 'General case' 0 C--N 1.352 0.702 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.345 179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.04 -1.18 63.16 Favored Glycine 0 C--N 1.349 1.253 0 C-N-CA 119.793 -1.194 . . . . 0.0 110.656 -177.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.67 ' HB3' ' HB ' ' A' ' 85' ' ' ILE . 84.2 m-70 -138.04 89.87 14.32 Favored Pre-proline 0 CA--C 1.5 -0.95 0 CA-C-N 119.003 1.402 . . . . 0.0 109.201 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 82' ' ' HIS . 34.8 Cg_endo -66.98 -28.52 41.8 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 C-N-CA 122.464 2.109 . . . . 0.0 114.34 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -92.95 -5.11 51.48 Favored 'General case' 0 CA--C 1.5 -0.958 0 C-N-CA 119.422 -0.911 . . . . 0.0 108.927 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.67 ' HB ' ' HB3' ' A' ' 82' ' ' HIS . 0.9 OUTLIER -90.04 -19.56 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 N-CA-C 105.979 -1.86 . . . . 0.0 105.979 -179.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.5 -25.85 14.05 Favored 'General case' 0 C--N 1.362 1.127 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -69.84 -35.81 75.05 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -65.53 -36.74 84.69 Favored 'General case' 0 C--N 1.355 0.837 0 O-C-N 122.072 -0.393 . . . . 0.0 110.084 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.615 ' HG2' ' N ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -80.55 156.08 26.65 Favored 'General case' 0 C--N 1.356 0.859 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 -178.576 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.615 ' N ' ' HG2' ' A' ' 89' ' ' MET . 4.0 mtpt -119.78 -25.46 5.89 Favored 'General case' 0 C--N 1.363 1.182 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.631 -177.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -166.22 173.75 9.86 Favored 'General case' 0 N--CA 1.442 -0.836 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 -177.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 61.7 m -66.29 -39.65 89.51 Favored 'General case' 0 C--N 1.354 0.777 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.284 -179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -67.53 -39.31 85.07 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 119.739 -0.784 . . . . 0.0 109.059 -178.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 95.4 m-20 -65.33 -24.5 67.28 Favored 'General case' 0 C--N 1.355 0.813 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 57.0 tp -64.76 -44.33 90.4 Favored 'General case' 0 C--N 1.353 0.735 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.9 mp -61.66 -33.92 74.81 Favored 'General case' 0 C--N 1.356 0.879 0 O-C-N 122.139 -0.351 . . . . 0.0 111.025 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 86.3 p -86.56 -7.28 58.5 Favored 'General case' 0 C--N 1.354 0.767 0 C-N-CA 119.294 -0.962 . . . . 0.0 110.805 -178.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 20.7 tttp -111.36 0.68 16.71 Favored 'General case' 0 C--N 1.356 0.857 0 O-C-N 121.533 -0.729 . . . . 0.0 109.798 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 1.004 HD11 ' C4B' ' A' ' 202' ' ' HEM . 9.5 tp -65.66 -39.9 86.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.808 0 O-C-N 121.867 -0.52 . . . . 0.0 111.818 -177.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.412 ' N ' HG23 ' A' ' 99' ' ' ILE . 37.6 t70 -95.51 -27.28 15.45 Favored 'General case' 0 N--CA 1.44 -0.959 0 O-C-N 120.827 -1.171 . . . . 0.0 111.657 -177.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 90.0 p -70.01 -39.87 75.58 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 119.412 -0.915 . . . . 0.0 112.984 -176.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.555 ' HA ' HG12 ' A' ' 105' ' ' VAL . 8.7 t80 -138.47 -19.61 1.07 Allowed 'General case' 0 C--N 1.361 1.08 0 C-N-CA 116.971 -1.891 . . . . 0.0 113.511 -177.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.405 HG21 ' C1C' ' A' ' 202' ' ' HEM . 24.1 mm -68.39 -51.0 51.76 Favored 'Isoleucine or valine' 0 C--O 1.244 0.783 0 CA-C-N 120.424 1.466 . . . . 0.0 110.379 -177.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 54.9 m80 -92.9 4.2 54.35 Favored 'General case' 0 N--CA 1.437 -1.076 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.551 -176.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.555 HG12 ' HA ' ' A' ' 102' ' ' PHE . 3.3 p -87.73 -35.67 8.57 Favored 'Isoleucine or valine' 0 C--N 1.353 0.749 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 178.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -72.65 -41.9 64.96 Favored 'General case' 0 C--N 1.358 0.938 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 67.0 t -65.3 -48.39 83.54 Favored 'Isoleucine or valine' 0 C--N 1.358 0.974 0 C-N-CA 120.594 -0.442 . . . . 0.0 110.527 -179.442 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 89.1 t80 -60.75 -47.87 84.35 Favored 'General case' 0 C--N 1.359 0.987 0 O-C-N 122.079 -0.388 . . . . 0.0 111.389 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . 0.477 ' HG2' ' O ' ' A' ' 105' ' ' VAL . 38.3 mmtt -61.14 -39.39 89.88 Favored 'General case' 0 N--CA 1.445 -0.703 0 O-C-N 121.685 -0.634 . . . . 0.0 110.696 -177.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 19.4 mt -56.46 -72.11 0.08 Allowed 'General case' 0 CA--C 1.505 -0.786 0 C-N-CA 120.541 -0.463 . . . . 0.0 109.762 -179.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -123.42 141.33 35.98 Favored Pre-proline 0 N--CA 1.439 -1.005 0 C-N-CA 118.538 -1.265 . . . . 0.0 109.207 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -86.29 -2.15 8.56 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 C-N-CA 123.308 2.672 . . . . 0.0 115.402 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -66.31 -37.42 85.36 Favored 'General case' 0 C--N 1.355 0.839 0 O-C-N 121.757 -0.59 . . . . 0.0 109.908 -179.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.618 ' HB1' HAD1 ' A' ' 202' ' ' HEM . . . -65.34 144.92 56.79 Favored 'General case' 0 C--N 1.353 0.73 0 CA-C-O 121.548 0.69 . . . . 0.0 110.174 -178.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.5 ' O ' HD13 ' A' ' 116' ' ' LEU . 47.3 mt-10 -112.05 143.51 42.94 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 179.047 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.5 HD13 ' O ' ' A' ' 115' ' ' GLU . 2.6 mm? -128.37 149.41 71.41 Favored Pre-proline 0 C--N 1.353 0.759 0 CA-C-O 122.164 0.983 . . . . 0.0 108.981 -178.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 116' ' ' LEU . 64.8 Cg_endo -91.85 -160.72 0.09 OUTLIER 'Trans proline' 0 C--N 1.316 -1.156 0 C-N-CA 123.857 3.038 . . . . 0.0 112.959 179.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -121.33 140.68 51.78 Favored 'General case' 0 C--N 1.363 1.18 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.443 ' HE2' ' CD1' ' A' ' 133' ' ' TYR . 65.7 m-85 -127.53 135.2 50.02 Favored 'General case' 0 C--N 1.36 1.06 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.164 -179.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.476 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 93.3 m -124.09 126.31 46.0 Favored 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 105.147 -2.168 . . . . 0.0 105.147 176.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 80.3 m -117.92 126.96 53.35 Favored 'General case' 0 CA--C 1.502 -0.896 0 C-N-CA 119.17 -1.012 . . . . 0.0 109.372 -177.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -120.47 127.49 52.27 Favored 'General case' 0 N--CA 1.439 -0.983 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 178.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -100.05 116.53 32.29 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -179.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.447 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 85.9 mt -82.35 -26.86 32.56 Favored 'General case' 0 C--N 1.355 0.836 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -178.74 -144.46 5.69 Favored Glycine 0 N--CA 1.437 -1.244 0 N-CA-C 108.78 -1.728 . . . . 0.0 108.78 -178.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -94.99 -39.62 10.09 Favored 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.297 -178.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -98.84 -1.47 40.17 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 119.923 -0.711 . . . . 0.0 110.758 -178.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.447 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 66.8 m-20 -118.82 133.45 55.83 Favored 'General case' 0 C--N 1.357 0.913 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 -179.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 9.5 mm -140.78 136.79 35.13 Favored 'Isoleucine or valine' 0 C--N 1.355 0.82 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 179.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 52.7 mtm180 -117.39 136.77 52.93 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 5.7 tp -125.95 118.9 26.36 Favored 'General case' 0 N--CA 1.431 -1.417 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.476 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 12.3 m170 -98.53 130.58 45.1 Favored 'General case' 0 CA--C 1.496 -1.133 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 179.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.553 ' OH ' HBA1 ' A' ' 202' ' ' HEM . 51.6 t80 -122.59 120.73 34.65 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 -178.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.463 ' HA ' ' O ' ' A' ' 171' ' ' THR . 36.1 tt0 -115.55 109.86 18.41 Favored 'General case' 0 N--CA 1.435 -1.212 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.456 ' O ' ' HA ' ' A' ' 171' ' ' THR . 8.8 t -165.07 158.16 16.51 Favored 'General case' 0 C--N 1.359 0.979 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.493 ' C ' ' HD3' ' A' ' 138' ' ' PRO . 63.0 mtpt -91.0 5.85 47.17 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 74.6 mtt180 -129.58 72.32 81.97 Favored Pre-proline 0 C--N 1.354 0.804 0 N-CA-C 106.411 -1.7 . . . . 0.0 106.411 179.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.493 ' HD3' ' C ' ' A' ' 136' ' ' LYS . 96.6 Cg_endo -95.21 88.03 0.11 Allowed 'Trans proline' 0 N--CA 1.443 -1.479 0 C-N-CA 122.319 2.012 . . . . 0.0 115.446 -178.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -106.51 115.5 30.31 Favored 'General case' 0 N--CA 1.438 -1.046 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 177.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.41 -38.27 90.5 Favored 'General case' 0 C--N 1.352 0.687 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.019 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 73.3 m -62.36 -33.57 74.99 Favored 'General case' 0 C--N 1.352 0.713 0 O-C-N 122.115 -0.366 . . . . 0.0 110.784 -178.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -73.15 -47.81 40.82 Favored 'General case' 0 C--N 1.352 0.693 0 C-N-CA 120.269 -0.572 . . . . 0.0 110.445 -177.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.25 -39.69 93.01 Favored 'General case' 0 C--N 1.355 0.839 0 O-C-N 122.105 -0.372 . . . . 0.0 111.419 -177.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.11 -36.58 84.07 Favored 'General case' 0 C--N 1.354 0.794 0 O-C-N 121.848 -0.532 . . . . 0.0 109.719 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.2 -43.23 98.64 Favored Glycine 0 C--N 1.346 1.091 0 N-CA-C 109.829 -1.309 . . . . 0.0 109.829 -179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 83.0 mt -70.45 -41.03 73.36 Favored 'General case' 0 C--N 1.353 0.728 0 O-C-N 122.049 -0.677 . . . . 0.0 112.733 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 98.6 mt -71.35 -42.33 68.64 Favored 'General case' 0 C--N 1.36 1.022 0 O-C-N 121.273 -0.892 . . . . 0.0 110.515 -177.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.487 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 21.3 t70 -69.43 -29.81 67.61 Favored 'General case' 0 N--CA 1.445 -0.678 0 O-C-N 122.141 -0.349 . . . . 0.0 110.245 -179.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -63.09 -39.46 98.04 Favored Glycine 0 C--N 1.356 1.648 0 N-CA-C 108.276 -1.93 . . . . 0.0 108.276 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . 0.407 ' HA ' ' CE2' ' A' ' 75' ' ' PHE . 48.7 t -60.43 -41.95 95.05 Favored 'General case' 0 C--N 1.35 0.598 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 178.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -74.42 -1.9 23.11 Favored 'General case' 0 C--N 1.362 1.121 0 O-C-N 121.82 -0.55 . . . . 0.0 109.544 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 76.4 mm-40 -83.74 -46.49 12.19 Favored 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -66.06 -44.11 85.48 Favored 'General case' 0 C--N 1.356 0.889 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.472 ' O ' ' HB2' ' A' ' 155' ' ' LYS . 38.0 m-85 -69.09 -25.96 64.69 Favored 'General case' 0 C--N 1.36 1.041 0 O-C-N 121.831 -0.543 . . . . 0.0 111.065 -178.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 154' ' ' PHE . 44.6 mttt 73.88 67.64 0.1 Allowed 'General case' 0 C--N 1.361 1.099 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 -138.88 -168.11 2.35 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -148.32 96.64 2.65 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 13.2 m-30 -112.97 156.76 22.45 Favored 'General case' 0 CA--C 1.506 -0.735 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 92.2 m -120.1 128.24 53.28 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.505 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.8 mp -107.1 123.14 62.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 106.838 -1.541 . . . . 0.0 106.838 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.0 m -117.99 -174.66 2.69 Favored 'General case' 0 C--N 1.357 0.934 0 CA-C-O 121.835 0.826 . . . . 0.0 109.347 -178.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -146.29 156.12 43.13 Favored 'General case' 0 C--N 1.356 0.865 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 -178.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 51.2 p -98.72 145.94 30.78 Favored Pre-proline 0 C--N 1.359 0.983 0 CA-C-O 122.443 1.116 . . . . 0.0 108.0 178.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.64 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 72.1 Cg_endo -75.84 -10.93 20.01 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.91 2.407 . . . . 0.0 115.076 -178.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -73.38 -41.26 63.59 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 120.027 -0.669 . . . . 0.0 109.819 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 38.2 p -117.95 16.15 14.25 Favored 'General case' 0 C--N 1.355 0.814 0 C-N-CA 120.046 -0.662 . . . . 0.0 110.659 -178.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.64 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.3 pp0? -67.31 -11.47 57.67 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 121.571 -0.706 . . . . 0.0 110.129 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 54.3 p30 -118.51 34.66 5.09 Favored 'General case' 0 N--CA 1.439 -0.996 0 O-C-N 121.199 -0.938 . . . . 0.0 108.893 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 58.5 m -136.15 148.79 48.36 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.752 ' O ' ' HB ' ' A' ' 171' ' ' THR . 97.8 mt-10 -114.51 137.2 52.15 Favored 'General case' 0 C--N 1.354 0.794 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.752 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 1.1 m 115.03 -53.26 0.0 OUTLIER 'General case' 0 C--N 1.377 1.803 0 N-CA-C 106.572 -1.64 . . . . 0.0 106.572 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -116.9 111.12 19.21 Favored 'General case' 0 CA--C 1.508 -0.636 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 80.1 t -128.5 135.26 62.94 Favored 'Isoleucine or valine' 0 C--N 1.359 1.009 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 50.4 mm -106.74 127.82 61.95 Favored 'Isoleucine or valine' 0 C--N 1.36 1.052 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -116.26 154.98 29.16 Favored 'General case' 0 C--N 1.356 0.875 0 CA-C-O 122.123 0.963 . . . . 0.0 108.849 -178.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -137.14 120.17 16.55 Favored 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 -178.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.8 mp -115.47 119.84 62.98 Favored 'Isoleucine or valine' 0 C--N 1.354 0.804 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -179.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 90.0 m -120.8 141.55 50.42 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 -178.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 40.5 ptt180 -82.5 124.27 29.94 Favored 'General case' 0 C--N 1.367 1.36 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.428 ' HB1' ' HD2' ' A' ' 181' ' ' PRO . . . -67.66 157.32 86.58 Favored Pre-proline 0 C--N 1.357 0.912 0 N-CA-C 108.156 -1.054 . . . . 0.0 108.156 178.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.428 ' HD2' ' HB1' ' A' ' 180' ' ' ALA . 71.7 Cg_exo -51.44 127.01 20.97 Favored 'Trans proline' 0 CA--C 1.499 -1.253 0 C-N-CA 122.678 2.252 . . . . 0.0 113.819 -178.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.411 ' HD3' HH11 ' A' ' 182' ' ' ARG . 0.3 OUTLIER -96.91 23.31 7.29 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.223 -0.898 . . . . 0.0 108.625 -179.838 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 116.67 -19.58 12.46 Favored Glycine 0 C--N 1.351 1.403 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -123.45 122.25 37.78 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -126.45 118.73 25.57 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -120.11 123.48 43.47 Favored 'General case' 0 N--CA 1.438 -1.041 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 179.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 82.9 mt -101.15 -51.71 3.45 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . 0.464 ' HB3' ' H ' ' A' ' 189' ' ' PHE . 3.4 t80 -161.07 -88.87 0.03 OUTLIER 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . 0.464 ' H ' ' HB3' ' A' ' 188' ' ' TYR . 89.0 t80 -139.2 129.59 25.6 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 . . . . . 0 C--O 1.265 1.899 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -179.972 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' HEM . . . . . 1.004 ' C4B' HD11 ' A' ' 99' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.884 ' N ' HAD1 ' A' ' 202' ' ' HEM . 90.7 mtp . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.185 0.517 . . . . 0.0 110.005 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.452 ' HA ' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -78.63 -16.27 57.54 Favored 'General case' 0 C--N 1.356 0.851 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.63 -177.908 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.57 -42.27 48.35 Favored Glycine 0 C--N 1.352 1.433 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 62.3 mtt -68.27 -38.19 81.49 Favored 'General case' 0 C--N 1.358 0.942 0 O-C-N 121.893 -0.769 . . . . 0.0 111.464 -178.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.452 HG22 ' HA ' ' A' ' 2' ' ' MET . 27.6 m -68.23 -23.0 28.05 Favored 'Isoleucine or valine' 0 C--N 1.356 0.851 0 C-N-CA 120.031 -0.668 . . . . 0.0 109.749 -178.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -71.08 -37.54 72.46 Favored 'General case' 0 C--N 1.356 0.863 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 89.5 m -68.2 -41.66 81.05 Favored 'General case' 0 C--N 1.357 0.908 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 -179.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.69 -39.17 97.59 Favored Glycine 0 C--N 1.358 1.757 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.687 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -65.93 -39.84 90.88 Favored 'General case' 0 C--N 1.35 0.614 0 CA-C-N 117.199 0.5 . . . . 0.0 110.618 -178.351 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.3 mmt -63.35 -40.82 98.33 Favored 'General case' 0 C--N 1.352 0.703 0 O-C-N 121.619 -0.675 . . . . 0.0 111.025 -178.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -67.59 -40.14 84.82 Favored 'General case' 0 C--N 1.349 0.563 0 O-C-N 121.896 -0.503 . . . . 0.0 111.504 -177.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 54.8 tp -66.77 -41.93 86.92 Favored 'General case' 0 C--N 1.349 0.558 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -178.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.687 HG12 ' O ' ' A' ' 9' ' ' LEU . 3.7 mm -73.68 -38.22 51.04 Favored 'Isoleucine or valine' 0 C--N 1.357 0.916 0 O-C-N 121.196 -0.94 . . . . 0.0 111.081 -175.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -67.12 -43.32 82.72 Favored 'General case' 0 C--N 1.351 0.646 0 O-C-N 121.914 -0.491 . . . . 0.0 111.573 -176.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -72.11 -33.88 68.17 Favored 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 121.842 -0.536 . . . . 0.0 111.733 -177.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -72.01 -48.5 44.27 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 -175.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -127.8 -20.85 3.81 Favored 'General case' 0 C--N 1.354 0.797 0 C-N-CA 117.398 -1.721 . . . . 0.0 113.383 -176.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 141.88 179.72 19.15 Favored Glycine 0 CA--C 1.497 -1.038 0 C-N-CA 117.982 -2.056 . . . . 0.0 109.597 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -97.21 -12.43 23.02 Favored 'General case' 0 N--CA 1.431 -1.42 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -177.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -71.44 -40.63 70.26 Favored 'General case' 0 C--N 1.359 1.01 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.7 m -69.21 -38.49 78.61 Favored 'General case' 0 C--N 1.356 0.885 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.578 HD13 ' HB ' ' A' ' 13' ' ' ILE . 59.3 tp -60.32 -38.54 84.06 Favored 'General case' 0 C--N 1.357 0.914 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -64.17 -35.72 81.73 Favored 'General case' 0 C--N 1.357 0.903 0 O-C-N 122.182 -0.324 . . . . 0.0 111.309 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 90.2 m -63.99 -41.39 97.52 Favored 'General case' 0 C--N 1.356 0.89 0 O-C-N 121.566 -0.709 . . . . 0.0 109.189 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.467 ' CD2' ' HB3' ' A' ' 54' ' ' LYS . 89.1 mt -65.02 -38.4 90.78 Favored 'General case' 0 C--N 1.355 0.839 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 -179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.27 -11.74 61.11 Favored 'General case' 0 C--N 1.358 0.97 0 O-C-N 121.363 -0.835 . . . . 0.0 109.734 -179.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -89.0 -27.25 20.99 Favored 'General case' 0 N--CA 1.44 -0.956 0 C-N-CA 119.527 -0.869 . . . . 0.0 108.916 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 55.9 p -69.58 -22.7 63.5 Favored 'General case' 0 C--N 1.362 1.109 0 C-N-CA 119.88 -0.728 . . . . 0.0 109.164 179.057 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.0 p -106.98 -36.86 6.49 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 119.046 -1.062 . . . . 0.0 108.325 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 86.1 132.37 0.04 OUTLIER 'General case' 0 C--N 1.361 1.067 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.536 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -84.48 -168.04 2.02 Favored 'General case' 0 C--N 1.357 0.902 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 -179.937 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.408 ' H ' ' HB2' ' A' ' 31' ' ' LEU . 63.3 tt0 -152.13 -32.57 0.14 Allowed 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.7 t -139.18 -73.37 0.38 Allowed 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -128.32 -33.97 2.1 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 112.96 -25.75 11.25 Favored Glycine 0 C--N 1.353 1.482 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 84.7 mt -113.71 102.93 14.6 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.792 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 179.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 53.8 t80 -99.68 -0.32 40.41 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.793 HG22 ' H ' ' A' ' 39' ' ' SER . 2.7 m 77.62 -179.99 0.13 Allowed 'General case' 0 C--N 1.361 1.096 0 N-CA-C 106.367 -1.716 . . . . 0.0 106.367 -178.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.793 ' H ' HG22 ' A' ' 38' ' ' THR . 24.9 p -90.9 114.26 26.67 Favored 'General case' 0 N--CA 1.443 -0.779 0 O-C-N 121.214 -0.929 . . . . 0.0 109.44 -178.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.496 HG13 ' O ' ' A' ' 39' ' ' SER . 0.0 OUTLIER -173.48 -8.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.363 1.189 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.15 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -117.42 167.56 12.73 Favored Glycine 0 C--N 1.355 1.63 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -178.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 68.6 m -132.24 136.84 47.26 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 -179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -124.02 172.57 8.87 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -71.27 174.8 5.96 Favored 'General case' 0 C--N 1.355 0.832 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.511 ' CD2' HH22 ' A' ' 137' ' ' ARG . 70.4 m80 -86.53 -17.04 35.1 Favored 'General case' 0 CA--C 1.502 -0.884 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.234 -178.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -69.06 -29.33 67.43 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.0 tp10 -63.13 -42.22 99.46 Favored 'General case' 0 C--N 1.351 0.647 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.407 ' O ' HG23 ' A' ' 52' ' ' VAL . 55.0 tp -66.88 -39.4 87.49 Favored 'General case' 0 C--N 1.359 0.985 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 -179.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 59.0 tp -72.94 -28.98 62.75 Favored 'General case' 0 C--N 1.349 0.569 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -177.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 41.7 tt0 -66.47 -43.22 86.08 Favored 'General case' 0 N--CA 1.443 -0.806 0 O-C-N 121.917 -0.489 . . . . 0.0 110.108 -178.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 80.4 mt -72.36 -34.5 68.04 Favored 'General case' 0 C--N 1.36 1.052 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.278 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 48' ' ' LEU . 39.3 t -63.24 -42.1 95.19 Favored 'Isoleucine or valine' 0 C--N 1.35 0.626 0 N-CA-C 110.326 -0.25 . . . . 0.0 110.326 -179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 54.6 t -66.58 -40.65 86.81 Favored 'Isoleucine or valine' 0 C--N 1.351 0.648 0 O-C-N 121.733 -0.604 . . . . 0.0 109.855 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.467 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 25.9 tptt -66.77 -22.97 66.02 Favored 'General case' 0 C--N 1.361 1.095 0 O-C-N 121.022 -1.049 . . . . 0.0 109.019 -179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.59 HD21 HD12 ' A' ' 13' ' ' ILE . 6.2 mt -69.78 -38.05 76.56 Favored 'General case' 0 C--N 1.355 0.826 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 57.6 p -71.38 -18.01 62.38 Favored 'General case' 0 C--N 1.353 0.752 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.357 -179.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -100.46 -35.75 9.45 Favored 'General case' 0 C--N 1.355 0.805 0 C-N-CA 119.648 -0.821 . . . . 0.0 111.408 -179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.6 p -72.27 -40.22 65.01 Favored 'Isoleucine or valine' 0 C--N 1.354 0.766 0 O-C-N 121.664 -0.648 . . . . 0.0 111.507 -177.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 79.7 p -116.02 -2.49 12.26 Favored 'General case' 0 C--N 1.354 0.78 0 C-N-CA 118.89 -1.124 . . . . 0.0 110.914 -178.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 73.6 m 63.74 49.48 2.93 Favored 'General case' 0 C--N 1.357 0.916 0 CA-C-O 120.932 0.396 . . . . 0.0 110.033 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.418 HG13 ' HD2' ' A' ' 62' ' ' PRO . 96.6 t -113.98 134.04 22.22 Favored Pre-proline 0 CA--C 1.504 -0.799 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.418 ' HD2' HG13 ' A' ' 61' ' ' VAL . 41.3 Cg_exo -58.02 149.5 70.65 Favored 'Trans proline' 0 CA--C 1.499 -1.27 0 C-N-CA 122.778 2.319 . . . . 0.0 112.738 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.421 ' HA ' HD23 ' A' ' 66' ' ' LEU . 3.7 m -76.2 -11.64 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.679 -177.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.494 ' O ' HG12 ' A' ' 67' ' ' VAL . 73.0 p -96.51 -33.36 11.87 Favored 'General case' 0 C--N 1.358 0.971 0 C-N-CA 118.433 -1.307 . . . . 0.0 109.504 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -77.65 -21.0 52.85 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 121.474 -0.766 . . . . 0.0 108.968 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -81.19 -34.23 32.46 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 -179.483 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.494 HG12 ' O ' ' A' ' 64' ' ' THR . 1.5 p -70.98 -26.23 27.21 Favored 'Isoleucine or valine' 0 C--N 1.356 0.855 0 C-N-CA 120.169 -0.613 . . . . 0.0 109.799 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 40.7 mtp180 -72.53 -52.87 13.81 Favored 'General case' 0 C--N 1.363 1.181 0 O-C-N 121.477 -0.765 . . . . 0.0 110.427 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.9 mt -63.41 -34.76 78.44 Favored 'General case' 0 C--N 1.357 0.913 0 O-C-N 121.959 -0.463 . . . . 0.0 110.905 -178.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -61.1 -47.23 87.24 Favored 'General case' 0 C--N 1.348 0.502 0 O-C-N 122.248 -0.283 . . . . 0.0 110.239 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.06 -38.8 96.16 Favored Glycine 0 C--N 1.356 1.651 0 N-CA-C 111.729 -0.548 . . . . 0.0 111.729 -178.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -62.6 -49.35 75.58 Favored 'General case' 0 C--N 1.351 0.638 0 CA-C-N 118.31 1.055 . . . . 0.0 111.556 -177.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 12.2 mttm -65.09 -45.93 83.18 Favored 'General case' 0 C--N 1.357 0.926 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 -177.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -69.78 -39.04 76.88 Favored 'General case' 0 C--N 1.348 0.52 0 O-C-N 121.161 -0.962 . . . . 0.0 111.841 -175.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -64.61 -44.05 91.8 Favored 'General case' 0 C--N 1.353 0.746 0 O-C-N 121.098 -1.001 . . . . 0.0 110.951 -178.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.83 -13.86 17.08 Favored 'Isoleucine or valine' 0 C--N 1.359 0.985 0 O-C-N 121.45 -0.781 . . . . 0.0 109.0 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -74.37 -37.61 63.42 Favored 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.3 mt -74.67 -29.48 61.25 Favored 'General case' 0 C--N 1.357 0.927 0 O-C-N 122.285 -0.259 . . . . 0.0 110.369 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.6 mm -65.86 -52.84 44.77 Favored 'Isoleucine or valine' 0 C--N 1.357 0.895 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.682 -177.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -75.5 -15.35 60.41 Favored 'General case' 0 C--N 1.351 0.632 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.279 178.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.25 -37.45 63.34 Favored Glycine 0 C--N 1.349 1.276 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -131.75 105.23 14.16 Favored Pre-proline 0 N--CA 1.441 -0.903 0 CA-C-O 122.615 1.198 . . . . 0.0 108.961 -177.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.524 ' O ' ' HB2' ' A' ' 87' ' ' ASN . 37.1 Cg_endo -67.47 -23.08 44.16 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.571 2.181 . . . . 0.0 114.356 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -95.39 -5.19 43.81 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 tp -89.75 -20.1 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.1 0 N-CA-C 106.112 -1.81 . . . . 0.0 106.112 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -105.7 -18.06 14.19 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.524 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 1.5 t-20 -73.97 -38.0 64.31 Favored 'General case' 0 C--N 1.357 0.931 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -65.49 -33.84 76.86 Favored 'General case' 0 C--N 1.353 0.735 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -178.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 15.8 ttp -83.12 150.37 26.31 Favored 'General case' 0 C--N 1.351 0.654 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -179.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.02 -22.59 9.47 Favored 'General case' 0 C--N 1.364 1.199 0 O-C-N 121.691 -0.63 . . . . 0.0 111.14 -177.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -165.55 171.49 13.13 Favored 'General case' 0 C--N 1.354 0.761 0 N-CA-C 108.007 -1.108 . . . . 0.0 108.007 -177.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.476 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 66.8 m -66.65 -39.54 88.28 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.448 -179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -68.44 -38.9 81.57 Favored 'General case' 0 C--N 1.355 0.836 0 O-C-N 121.296 -0.877 . . . . 0.0 108.991 -179.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -65.93 -24.09 66.75 Favored 'General case' 0 C--N 1.355 0.823 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 178.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.664 ' O ' HG12 ' A' ' 99' ' ' ILE . 59.7 tp -63.64 -47.38 81.54 Favored 'General case' 0 C--N 1.355 0.846 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.4 mp -60.07 -35.7 75.74 Favored 'General case' 0 C--N 1.359 1.013 0 O-C-N 122.256 -0.277 . . . . 0.0 110.521 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 34.0 t -70.14 -39.64 75.28 Favored 'General case' 0 C--N 1.349 0.549 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.188 -179.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.5 tttp -86.99 0.35 55.31 Favored 'General case' 0 C--N 1.356 0.856 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -176.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.664 HG12 ' O ' ' A' ' 95' ' ' LEU . 22.8 mm -61.01 -46.7 96.15 Favored 'Isoleucine or valine' 0 C--N 1.357 0.896 0 CA-C-N 119.082 0.856 . . . . 0.0 112.014 -177.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -95.64 -22.63 17.46 Favored 'General case' 0 N--CA 1.442 -0.835 0 C-N-CA 118.402 -1.319 . . . . 0.0 111.329 -177.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 35.2 t -64.29 -48.65 74.87 Favored 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 121.565 -0.709 . . . . 0.0 112.491 -177.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -138.08 -16.49 1.25 Allowed 'General case' 0 C--N 1.36 1.06 0 C-N-CA 117.372 -1.731 . . . . 0.0 113.521 -176.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.645 HD12 HD13 ' A' ' 99' ' ' ILE . 96.3 mt -71.83 -50.27 39.44 Favored 'Isoleucine or valine' 0 C--O 1.241 0.638 0 CA-C-N 120.359 1.436 . . . . 0.0 111.182 -177.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -89.98 4.36 50.36 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 119.388 -0.925 . . . . 0.0 109.811 -177.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 57.7 t -86.44 -43.7 16.29 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.059 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 54.7 tp10 -67.53 -40.1 85.04 Favored 'General case' 0 N--CA 1.439 -0.977 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 65.6 t -62.77 -46.92 95.16 Favored 'Isoleucine or valine' 0 C--N 1.356 0.88 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -60.74 -48.21 82.81 Favored 'General case' 0 C--N 1.36 1.038 0 O-C-N 122.198 -0.314 . . . . 0.0 111.541 -179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -61.25 -36.59 80.41 Favored 'General case' 0 C--N 1.355 0.821 0 O-C-N 121.534 -0.729 . . . . 0.0 110.503 -178.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 18.0 mt -58.6 -75.5 0.05 Allowed 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -115.58 132.14 23.29 Favored Pre-proline 0 N--CA 1.439 -0.975 0 C-N-CA 118.65 -1.22 . . . . 0.0 108.641 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -83.26 -3.53 10.91 Favored 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 123.175 2.583 . . . . 0.0 115.172 -179.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 98.9 mm-40 -66.97 -36.36 82.02 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 121.879 -0.513 . . . . 0.0 110.009 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.32 144.86 56.31 Favored 'General case' 0 C--N 1.352 0.683 0 CA-C-O 121.74 0.781 . . . . 0.0 110.142 -178.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -128.86 133.76 48.07 Favored 'General case' 0 C--N 1.357 0.925 0 N-CA-C 106.152 -1.796 . . . . 0.0 106.152 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.52 ' HB3' ' HD2' ' A' ' 117' ' ' PRO . 87.8 mt -127.76 156.44 75.71 Favored Pre-proline 0 N--CA 1.443 -0.787 0 CA-C-O 122.262 1.03 . . . . 0.0 109.243 -178.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.52 ' HD2' ' HB3' ' A' ' 116' ' ' LEU . 83.0 Cg_endo -80.46 -158.42 0.09 OUTLIER 'Trans proline' 0 C--N 1.318 -1.074 0 C-N-CA 123.826 3.017 . . . . 0.0 113.922 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -118.86 143.28 47.06 Favored 'General case' 0 C--N 1.364 1.209 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -179.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 -129.65 135.7 48.84 Favored 'General case' 0 C--N 1.362 1.123 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -178.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 93.8 m -127.64 130.71 49.43 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 177.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -120.6 132.39 55.11 Favored 'General case' 0 CA--C 1.504 -0.804 0 C-N-CA 119.215 -0.994 . . . . 0.0 109.989 -178.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -119.71 138.5 53.26 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 106.22 -1.77 . . . . 0.0 106.22 178.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 56.8 ttp180 -109.32 117.84 35.13 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 -179.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.574 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 96.5 mt -91.77 -16.02 27.46 Favored 'General case' 0 C--N 1.356 0.856 0 C-N-CA 120.496 -0.481 . . . . 0.0 110.436 -179.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 174.04 -148.23 9.87 Favored Glycine 0 C--N 1.349 1.252 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -179.069 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -94.35 -37.55 11.42 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 -178.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -102.05 4.17 39.48 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 120.221 -0.592 . . . . 0.0 110.031 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.574 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 8.7 m-20 -121.93 132.09 54.37 Favored 'General case' 0 C--N 1.359 0.984 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -179.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.2 mm -143.64 137.8 25.19 Favored 'Isoleucine or valine' 0 C--N 1.356 0.863 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 179.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 53.5 mtm180 -118.49 139.11 51.93 Favored 'General case' 0 CA--C 1.494 -1.178 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 5.8 tp -125.53 116.91 22.51 Favored 'General case' 0 N--CA 1.431 -1.407 0 CA-C-N 115.05 -0.977 . . . . 0.0 108.52 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -98.29 134.39 41.38 Favored 'General case' 0 CA--C 1.495 -1.138 0 N-CA-C 107.327 -1.361 . . . . 0.0 107.327 179.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -129.51 119.55 23.89 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 107.665 -1.235 . . . . 0.0 107.665 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.524 ' HA ' ' O ' ' A' ' 171' ' ' THR . 57.9 mt-30 -115.53 112.17 21.81 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 11.1 t -165.93 155.12 11.75 Favored 'General case' 0 C--N 1.357 0.921 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.434 ' C ' ' HD3' ' A' ' 138' ' ' PRO . 99.6 mttt -90.99 5.49 48.57 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.511 HH22 ' CD2' ' A' ' 45' ' ' HIS . 77.0 mtp180 -132.62 73.25 76.75 Favored Pre-proline 0 C--N 1.354 0.767 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.434 ' HD3' ' C ' ' A' ' 136' ' ' LYS . 92.7 Cg_endo -96.87 99.64 0.08 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.515 0 C-N-CA 122.737 2.291 . . . . 0.0 115.453 -178.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -109.4 111.13 22.5 Favored 'General case' 0 CA--C 1.5 -0.962 0 N-CA-C 106.556 -1.646 . . . . 0.0 106.556 177.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.71 -38.05 89.64 Favored 'General case' 0 C--N 1.354 0.787 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.02 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 74.1 m -63.03 -29.33 70.73 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 121.998 -0.439 . . . . 0.0 110.755 -178.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -75.01 -47.1 30.79 Favored 'General case' 0 C--N 1.35 0.612 0 O-C-N 121.698 -0.626 . . . . 0.0 109.763 -177.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.53 -40.06 94.91 Favored 'General case' 0 C--N 1.358 0.976 0 O-C-N 122.095 -0.378 . . . . 0.0 111.212 -178.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.1 -37.0 85.46 Favored 'General case' 0 C--N 1.355 0.809 0 O-C-N 121.938 -0.476 . . . . 0.0 110.212 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.84 -43.15 99.58 Favored Glycine 0 C--N 1.347 1.182 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 -178.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 83.8 mt -70.01 -40.42 75.27 Favored 'General case' 0 C--N 1.351 0.647 0 N-CA-C 112.673 0.619 . . . . 0.0 112.673 -179.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 99.1 mt -71.34 -42.9 67.95 Favored 'General case' 0 C--N 1.361 1.082 0 O-C-N 121.198 -0.939 . . . . 0.0 110.993 -176.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.483 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 21.0 t70 -69.0 -31.72 70.75 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 122.028 -0.42 . . . . 0.0 110.418 -179.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -62.96 -39.19 97.76 Favored Glycine 0 C--N 1.356 1.659 0 N-CA-C 108.656 -1.778 . . . . 0.0 108.656 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 49.4 t -60.84 -42.0 96.91 Favored 'General case' 0 C--N 1.351 0.674 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -74.59 -2.19 24.89 Favored 'General case' 0 C--N 1.361 1.082 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.483 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 77.0 mm-40 -83.29 -45.44 13.79 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -68.84 -42.56 76.98 Favored 'General case' 0 C--N 1.358 0.959 0 C-N-CA 120.011 -0.675 . . . . 0.0 109.681 179.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -69.75 -25.68 63.95 Favored 'General case' 0 C--N 1.362 1.132 0 O-C-N 121.659 -0.651 . . . . 0.0 110.619 -178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 21.2 tttm 73.16 73.39 0.13 Allowed 'General case' 0 C--N 1.36 1.05 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -143.61 -169.44 3.08 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -146.25 96.99 2.87 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 13.3 m-30 -114.9 155.38 26.96 Favored 'General case' 0 CA--C 1.506 -0.726 0 N-CA-C 106.448 -1.686 . . . . 0.0 106.448 179.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 93.3 m -120.86 129.12 53.4 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 119.668 -0.813 . . . . 0.0 108.809 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.515 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.7 mp -106.45 122.34 60.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 179.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.6 m -119.53 -172.12 2.26 Favored 'General case' 0 C--N 1.357 0.93 0 CA-C-O 121.792 0.806 . . . . 0.0 109.338 -178.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 28.2 ptt-85 -148.42 157.91 43.77 Favored 'General case' 0 C--N 1.356 0.854 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -178.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 56.2 p -98.37 146.77 32.12 Favored Pre-proline 0 C--N 1.359 0.995 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 178.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.666 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 72.7 Cg_endo -75.35 -12.54 20.85 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.903 2.402 . . . . 0.0 115.238 -178.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -72.53 -41.31 66.0 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 120.009 -0.676 . . . . 0.0 109.956 -178.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 35.6 p -118.11 16.06 14.11 Favored 'General case' 0 C--N 1.354 0.797 0 C-N-CA 119.978 -0.689 . . . . 0.0 110.734 -178.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.666 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.4 pp0? -66.97 -12.75 60.68 Favored 'General case' 0 C--N 1.353 0.749 0 O-C-N 121.605 -0.685 . . . . 0.0 110.346 178.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 54.1 p-10 -123.67 38.72 4.13 Favored 'General case' 0 N--CA 1.437 -1.079 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 14.6 t -141.65 147.44 37.55 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.63 ' O ' ' HB ' ' A' ' 171' ' ' THR . 46.3 mp0 -101.67 167.4 10.13 Favored 'General case' 0 C--N 1.355 0.847 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.63 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 5.8 m 82.99 -60.01 0.15 Allowed 'General case' 0 C--N 1.37 1.465 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -108.05 116.11 31.37 Favored 'General case' 0 CA--C 1.506 -0.741 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -178.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 96.1 t -131.64 133.21 61.82 Favored 'Isoleucine or valine' 0 C--N 1.358 0.966 0 N-CA-C 107.212 -1.403 . . . . 0.0 107.212 178.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 50.9 mm -108.16 126.2 64.78 Favored 'Isoleucine or valine' 0 C--N 1.359 1.0 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -114.55 154.53 28.12 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -137.58 118.94 14.68 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 -178.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.7 mp -113.59 120.37 63.29 Favored 'Isoleucine or valine' 0 C--N 1.353 0.742 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 90.6 m -119.91 143.5 47.93 Favored 'General case' 0 CA--C 1.505 -0.758 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -177.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.607 ' HD3' ' HE ' ' A' ' 182' ' ' ARG . 37.2 ttm180 -79.59 114.3 18.41 Favored 'General case' 0 C--N 1.363 1.192 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -67.63 154.33 93.48 Favored Pre-proline 0 C--N 1.358 0.939 0 CA-C-O 121.993 0.901 . . . . 0.0 109.278 -179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.28 119.77 7.18 Favored 'Trans proline' 0 CA--C 1.499 -1.256 0 C-N-CA 122.865 2.377 . . . . 0.0 113.665 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.607 ' HE ' ' HD3' ' A' ' 179' ' ' ARG . 8.8 mtm180 -94.87 28.44 2.72 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.025 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 99.96 108.55 2.98 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 178.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 67.14 74.59 0.32 Allowed 'General case' 0 C--N 1.357 0.933 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 177.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 21.0 pt-20 -74.45 152.24 39.48 Favored 'General case' 0 N--CA 1.442 -0.831 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -100.57 119.53 38.67 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 60.6 mt -116.03 -69.45 0.85 Allowed 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 179.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -139.65 -89.75 0.19 Allowed 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -129.26 149.15 51.18 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 . . . . . 0 C--O 1.264 1.82 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.887 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' HEM . . . . . 1.062 ' HHA' HBD2 ' A' ' 202' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.856 ' N ' HBD2 ' A' ' 202' ' ' HEM . 87.7 mmm . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 121.09 0.471 . . . . 0.0 110.031 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.43 ' O ' ' HD1' ' A' ' 6' ' ' PHE . 0.0 OUTLIER -82.04 -15.2 54.4 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 120.516 -0.474 . . . . 0.0 109.963 -178.338 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -71.65 -40.99 57.99 Favored Glycine 0 C--N 1.353 1.482 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.482 ' HG2' ' HB3' ' A' ' 39' ' ' SER . 76.5 mtm -70.15 -35.69 74.22 Favored 'General case' 0 C--N 1.356 0.873 0 O-C-N 121.958 -0.731 . . . . 0.0 111.499 -178.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.414 HG22 ' HA ' ' A' ' 2' ' ' MET . 32.8 m -68.45 -23.77 28.61 Favored 'Isoleucine or valine' 0 C--N 1.357 0.91 0 O-C-N 121.467 -0.77 . . . . 0.0 109.594 -179.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.505 ' HZ ' ' CG ' ' A' ' 47' ' ' GLU . 4.5 m-85 -71.38 -36.2 71.33 Favored 'General case' 0 C--N 1.358 0.949 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 90.1 m -66.7 -40.87 88.64 Favored 'General case' 0 C--N 1.357 0.913 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.75 -39.23 97.7 Favored Glycine 0 C--N 1.358 1.753 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.694 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -64.07 -41.47 97.33 Favored 'General case' 0 C--N 1.352 0.679 0 CA-C-N 117.163 0.482 . . . . 0.0 110.835 -178.515 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 17.6 mmt -63.58 -41.02 98.4 Favored 'General case' 0 C--N 1.353 0.746 0 O-C-N 121.438 -0.789 . . . . 0.0 111.079 -178.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -68.34 -40.5 81.55 Favored 'General case' 0 C--N 1.349 0.573 0 O-C-N 121.881 -0.512 . . . . 0.0 111.773 -177.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 56.3 tp -66.3 -43.65 85.69 Favored 'General case' 0 C--N 1.349 0.577 0 N-CA-C 113.076 0.769 . . . . 0.0 113.076 -177.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.694 HG12 ' O ' ' A' ' 9' ' ' LEU . 1.1 mm -74.3 -34.6 37.5 Favored 'Isoleucine or valine' 0 C--N 1.358 0.956 0 O-C-N 121.127 -0.983 . . . . 0.0 110.96 -175.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -72.73 -42.32 64.25 Favored 'General case' 0 C--N 1.35 0.59 0 O-C-N 121.642 -0.661 . . . . 0.0 111.538 -176.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -71.1 -37.9 72.38 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 -175.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -99.42 -25.83 14.33 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 118.924 -1.11 . . . . 0.0 113.659 -174.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 90.1 m-85 -113.62 -35.72 5.12 Favored 'General case' 0 CA--C 1.507 -0.693 0 C-N-CA 117.541 -1.664 . . . . 0.0 112.549 -176.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 145.31 177.78 20.35 Favored Glycine 0 C--N 1.349 1.266 0 C-N-CA 118.052 -2.023 . . . . 0.0 110.467 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -99.43 -27.16 13.87 Favored 'General case' 0 N--CA 1.436 -1.169 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 -177.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -69.29 -39.22 78.45 Favored 'General case' 0 C--N 1.359 0.992 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 92.7 m -66.75 -39.1 87.78 Favored 'General case' 0 C--N 1.357 0.902 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.3 tt -61.62 -38.44 87.64 Favored 'General case' 0 C--N 1.358 0.938 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -63.74 -37.71 88.38 Favored 'General case' 0 C--N 1.356 0.875 0 O-C-N 122.026 -0.421 . . . . 0.0 110.765 -178.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.9 m -65.73 -38.96 90.58 Favored 'General case' 0 C--N 1.354 0.762 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -178.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.717 HD13 HD22 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -63.67 -37.41 87.24 Favored 'General case' 0 C--N 1.354 0.765 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -179.043 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.3 mt -74.02 -14.11 60.96 Favored 'General case' 0 C--N 1.359 0.998 0 O-C-N 121.722 -0.612 . . . . 0.0 110.337 -178.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -86.77 -28.23 23.13 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 119.218 -0.993 . . . . 0.0 109.203 179.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 43.1 t -67.39 -36.58 81.59 Favored 'General case' 0 C--N 1.354 0.761 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.661 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 2.0 p -92.12 -39.65 11.48 Favored 'General case' 0 C--N 1.358 0.963 0 C-N-CA 118.942 -1.103 . . . . 0.0 108.199 -179.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.661 ' HB2' ' O ' ' A' ' 29' ' ' CYS . 14.5 mt-10 86.27 131.53 0.04 OUTLIER 'General case' 0 C--N 1.362 1.109 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 179.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.529 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -86.18 -169.45 2.64 Favored 'General case' 0 C--N 1.357 0.897 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 179.841 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -152.85 -28.23 0.15 Allowed 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 107.707 -1.219 . . . . 0.0 107.707 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.8 t -141.49 -71.13 0.35 Allowed 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -131.96 -42.97 0.99 Allowed 'General case' 0 CA--C 1.501 -0.939 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 -178.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.4 -32.71 4.22 Favored Glycine 0 C--N 1.353 1.479 0 N-CA-C 109.261 -1.535 . . . . 0.0 109.261 179.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 85.1 mt -111.63 101.33 12.38 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.743 0 N-CA-C 106.731 -1.581 . . . . 0.0 106.731 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 64.3 t80 -96.41 -1.81 46.8 Favored 'General case' 0 C--N 1.354 0.803 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -179.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.747 HG22 ' H ' ' A' ' 39' ' ' SER . 4.0 m 80.1 174.9 0.13 Allowed 'General case' 0 C--N 1.362 1.13 0 N-CA-C 105.952 -1.869 . . . . 0.0 105.952 -178.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.747 ' H ' HG22 ' A' ' 38' ' ' THR . 26.0 p -89.16 113.84 25.07 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 121.033 -1.042 . . . . 0.0 109.78 -178.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 39' ' ' SER . 0.0 OUTLIER -172.71 -8.7 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.362 1.143 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.762 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.404 ' H ' ' H ' ' A' ' 40' ' ' VAL . . . -113.55 164.75 12.02 Favored Glycine 0 C--N 1.357 1.698 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -178.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 53.5 m -129.11 132.78 47.44 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -117.98 170.62 8.68 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -77.64 -178.13 5.17 Favored 'General case' 0 C--N 1.356 0.866 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 74.1 m80 -88.32 -15.08 36.66 Favored 'General case' 0 CA--C 1.502 -0.891 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -179.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -68.18 -29.8 68.75 Favored 'General case' 0 C--N 1.353 0.753 0 N-CA-C 107.705 -1.221 . . . . 0.0 107.705 178.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.505 ' CG ' ' HZ ' ' A' ' 6' ' ' PHE . 24.1 tp10 -63.07 -41.6 99.47 Favored 'General case' 0 C--N 1.352 0.707 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.467 HD22 ' O ' ' A' ' 48' ' ' LEU . 1.8 tm? -67.83 -39.99 83.83 Favored 'General case' 0 C--N 1.358 0.965 0 CA-C-O 120.647 0.26 . . . . 0.0 110.531 -179.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 64.6 tp -71.01 -34.71 71.6 Favored 'General case' 0 CA--C 1.509 -0.62 0 O-C-N 122.132 -0.355 . . . . 0.0 110.661 -177.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 73.2 tp60 -65.81 -40.79 92.22 Favored 'General case' 0 N--CA 1.445 -0.722 0 O-C-N 121.659 -0.651 . . . . 0.0 110.005 -178.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.717 HD22 HD13 ' A' ' 25' ' ' LEU . 73.4 mt -82.48 -19.22 39.25 Favored 'General case' 0 C--N 1.361 1.091 0 C-N-CA 119.622 -0.831 . . . . 0.0 110.574 -178.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.4 t -79.35 -37.66 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 -179.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 54.2 t -69.05 -39.99 80.25 Favored 'Isoleucine or valine' 0 C--N 1.353 0.73 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 178.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.414 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 32.3 tptt -65.7 -27.86 68.64 Favored 'General case' 0 C--N 1.363 1.191 0 O-C-N 121.214 -0.929 . . . . 0.0 108.754 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.8 tt -67.44 -39.33 85.39 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' A' ' 60' ' ' SER . 81.1 p -72.42 -17.33 61.81 Favored 'General case' 0 C--N 1.358 0.949 0 O-C-N 121.694 -0.628 . . . . 0.0 111.019 -178.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -99.96 -36.78 9.27 Favored 'General case' 0 C--N 1.353 0.736 0 O-C-N 121.153 -0.967 . . . . 0.0 111.346 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.2 p -70.38 -34.35 57.76 Favored 'Isoleucine or valine' 0 C--N 1.352 0.687 0 O-C-N 121.74 -0.6 . . . . 0.0 111.338 -177.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.645 ' HB3' HG23 ' A' ' 61' ' ' VAL . 2.0 t -120.81 -7.15 9.57 Favored 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 119.128 -1.029 . . . . 0.0 109.924 -178.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.473 ' HA ' ' O ' ' A' ' 56' ' ' SER . 0.5 OUTLIER 65.67 47.6 2.12 Favored 'General case' 0 C--N 1.353 0.753 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.792 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.645 HG23 ' HB3' ' A' ' 59' ' ' SER . 52.9 t -106.56 132.44 20.9 Favored Pre-proline 0 N--CA 1.443 -0.785 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -57.2 146.89 79.42 Favored 'Trans proline' 0 CA--C 1.498 -1.301 0 C-N-CA 122.504 2.136 . . . . 0.0 112.845 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.5 m -75.49 -12.12 14.54 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.605 -178.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.487 ' O ' HG12 ' A' ' 67' ' ' VAL . 70.2 p -97.65 -32.71 11.63 Favored 'General case' 0 C--N 1.359 0.994 0 C-N-CA 118.258 -1.377 . . . . 0.0 109.26 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -75.43 -23.26 56.94 Favored 'General case' 0 C--N 1.355 0.841 0 O-C-N 121.42 -0.8 . . . . 0.0 109.106 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -82.2 -34.86 28.79 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -179.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.487 HG12 ' O ' ' A' ' 64' ' ' THR . 1.6 p -68.21 -27.15 36.0 Favored 'Isoleucine or valine' 0 C--N 1.355 0.811 0 C-N-CA 120.098 -0.641 . . . . 0.0 109.688 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.8 mmm-85 -73.28 -52.12 15.13 Favored 'General case' 0 C--N 1.364 1.198 0 O-C-N 121.609 -0.682 . . . . 0.0 110.284 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.7 mt -62.66 -35.6 80.16 Favored 'General case' 0 C--N 1.357 0.92 0 O-C-N 121.973 -0.454 . . . . 0.0 110.954 -178.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -60.95 -47.74 85.05 Favored 'General case' 0 C--N 1.349 0.581 0 O-C-N 122.083 -0.385 . . . . 0.0 110.54 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.99 -38.95 96.35 Favored Glycine 0 C--N 1.355 1.587 0 N-CA-C 111.997 -0.441 . . . . 0.0 111.997 -178.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -63.38 -48.54 77.5 Favored 'General case' 0 C--N 1.35 0.626 0 CA-C-N 118.303 1.052 . . . . 0.0 111.55 -177.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.671 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 11.9 mttm -63.89 -48.6 76.03 Favored 'General case' 0 C--N 1.358 0.961 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -177.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.456 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.3 tm? -68.54 -39.12 81.26 Favored 'General case' 0 C--N 1.35 0.588 0 O-C-N 121.197 -0.94 . . . . 0.0 111.699 -175.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.4 ' CE2' ' HA ' ' A' ' 150' ' ' CYS . 43.8 t80 -62.95 -45.07 94.21 Favored 'General case' 0 C--N 1.352 0.715 0 O-C-N 121.241 -0.912 . . . . 0.0 111.165 -178.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.8 p -71.09 -14.66 18.11 Favored 'Isoleucine or valine' 0 C--N 1.359 1.006 0 O-C-N 121.396 -0.815 . . . . 0.0 109.5 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.671 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 73.6 mm-40 -71.43 -39.81 70.8 Favored 'General case' 0 C--N 1.35 0.616 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 178.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 82.9 mt -70.94 -34.96 71.99 Favored 'General case' 0 C--N 1.357 0.911 0 O-C-N 122.188 -0.32 . . . . 0.0 110.599 -179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.6 mm -63.79 -53.33 45.82 Favored 'Isoleucine or valine' 0 C--N 1.357 0.916 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.615 -176.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -75.15 -10.98 59.96 Favored 'General case' 0 N--CA 1.448 -0.563 0 C-N-CA 119.655 -0.818 . . . . 0.0 110.938 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -92.23 -11.16 60.15 Favored Glycine 0 C--N 1.35 1.345 0 C-N-CA 119.734 -1.222 . . . . 0.0 110.696 -178.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.465 ' HB3' ' HB ' ' A' ' 85' ' ' ILE . 96.3 m-70 -138.34 96.27 9.99 Favored Pre-proline 0 CA--C 1.503 -0.865 0 CA-C-N 118.991 1.396 . . . . 0.0 108.836 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.458 ' O ' ' HB2' ' A' ' 87' ' ' ASN . 37.7 Cg_endo -67.87 -25.74 38.74 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.428 2.085 . . . . 0.0 114.293 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -91.11 -8.39 48.96 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.465 ' HB ' ' HB3' ' A' ' 82' ' ' HIS . 1.5 tp -89.35 -21.73 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 -178.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.81 -16.94 15.26 Favored 'General case' 0 N--CA 1.435 -1.214 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 47.1 t30 -70.84 -41.62 71.25 Favored 'General case' 0 C--N 1.36 1.046 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -68.5 -30.36 69.17 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.387 -178.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 29.5 ttp -84.0 148.07 27.08 Favored 'General case' 0 C--N 1.35 0.623 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.04 -21.62 8.2 Favored 'General case' 0 C--N 1.362 1.119 0 C-N-CA 119.955 -0.698 . . . . 0.0 110.865 -177.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.6 t0 -164.83 170.64 15.18 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 119.172 -1.011 . . . . 0.0 108.337 -177.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.41 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 41.1 t -64.43 -41.96 96.28 Favored 'General case' 0 C--N 1.355 0.812 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.806 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -66.17 -38.93 89.24 Favored 'General case' 0 C--N 1.355 0.821 0 O-C-N 121.568 -0.708 . . . . 0.0 109.251 -178.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -65.59 -25.84 67.58 Favored 'General case' 0 C--N 1.357 0.906 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.41 ' HB3' ' O ' ' A' ' 92' ' ' SER . 59.9 tp -62.74 -46.52 87.69 Favored 'General case' 0 C--N 1.355 0.823 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.3 mp -62.71 -32.59 73.73 Favored 'General case' 0 C--N 1.353 0.76 0 O-C-N 122.221 -0.299 . . . . 0.0 110.502 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 37.2 t -62.57 -45.22 93.9 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 121.774 -0.579 . . . . 0.0 111.351 -178.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.403 ' H ' ' HG3' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -111.3 26.28 10.84 Favored 'General case' 0 C--N 1.363 1.185 0 O-C-N 121.07 -1.019 . . . . 0.0 110.491 -178.171 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.799 HD11 ' C3B' ' A' ' 202' ' ' HEM . 10.1 tt -60.6 -29.53 44.97 Favored 'Isoleucine or valine' 0 C--N 1.353 0.751 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.575 -179.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 10.6 p-10 -129.3 -7.12 4.78 Favored 'General case' 0 N--CA 1.438 -1.041 0 C-N-CA 118.444 -1.302 . . . . 0.0 110.039 -179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 64.5 m -90.75 -3.21 57.61 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.295 -179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -147.68 -48.7 0.17 Allowed 'General case' 0 C--N 1.357 0.911 0 C-N-CA 118.221 -1.392 . . . . 0.0 109.724 179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 96.1 mt -65.75 -47.39 86.07 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 O-C-N 122.038 -0.414 . . . . 0.0 110.922 -177.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 22.7 m170 -83.77 -3.79 58.11 Favored 'General case' 0 C--N 1.354 0.799 0 O-C-N 121.461 -0.774 . . . . 0.0 109.78 -177.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 56.4 t -75.13 -45.24 42.51 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.907 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -70.0 -38.94 76.13 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -178.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 56.7 t -61.65 -46.31 96.82 Favored 'Isoleucine or valine' 0 C--N 1.355 0.822 0 O-C-N 122.196 -0.315 . . . . 0.0 110.48 -178.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -60.04 -47.76 84.5 Favored 'General case' 0 C--N 1.357 0.898 0 O-C-N 122.127 -0.358 . . . . 0.0 111.089 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -61.77 -36.07 79.97 Favored 'General case' 0 C--N 1.355 0.839 0 O-C-N 121.552 -0.718 . . . . 0.0 110.11 -178.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 15.3 mt -59.66 -79.66 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -111.97 140.59 23.59 Favored Pre-proline 0 N--CA 1.442 -0.848 0 C-N-CA 118.877 -1.129 . . . . 0.0 109.242 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -88.84 -6.1 5.82 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 C-N-CA 123.286 2.657 . . . . 0.0 114.919 -179.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -69.02 -33.7 74.06 Favored 'General case' 0 C--N 1.353 0.722 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.584 ' HB1' HAD1 ' A' ' 202' ' ' HEM . . . -64.66 145.08 56.72 Favored 'General case' 0 C--N 1.354 0.784 0 CA-C-O 121.697 0.761 . . . . 0.0 110.13 -178.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.469 ' O ' HD13 ' A' ' 116' ' ' LEU . 46.5 mt-10 -118.55 143.32 46.84 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 179.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.469 HD13 ' O ' ' A' ' 115' ' ' GLU . 2.6 mm? -126.77 149.7 69.31 Favored Pre-proline 0 N--CA 1.445 -0.702 0 CA-C-O 122.074 0.94 . . . . 0.0 108.597 -178.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 116' ' ' LEU . 87.7 Cg_endo -91.28 -155.51 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.265 0 C-N-CA 123.743 2.962 . . . . 0.0 113.197 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -115.98 138.32 51.31 Favored 'General case' 0 C--N 1.362 1.113 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -127.16 129.54 48.08 Favored 'General case' 0 C--N 1.361 1.104 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.548 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 93.2 m -128.58 131.44 48.18 Favored 'General case' 0 C--N 1.356 0.864 0 N-CA-C 106.156 -1.794 . . . . 0.0 106.156 177.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -125.01 132.44 53.24 Favored 'General case' 0 CA--C 1.503 -0.853 0 C-N-CA 119.316 -0.954 . . . . 0.0 109.769 -178.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -121.28 140.81 51.57 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 106.279 -1.749 . . . . 0.0 106.279 178.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 57.7 ttp180 -111.88 117.75 33.62 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 -179.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 94.9 mt -92.91 -16.64 24.95 Favored 'General case' 0 C--N 1.354 0.781 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.193 -179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 178.19 -150.48 9.83 Favored Glycine 0 C--N 1.347 1.186 0 N-CA-C 109.047 -1.621 . . . . 0.0 109.047 -178.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -91.33 -39.69 11.9 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -178.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.405 ' HB2' ' HB2' ' A' ' 179' ' ' ARG . 8.2 p30 -104.87 9.3 34.8 Favored 'General case' 0 N--CA 1.444 -0.742 0 C-N-CA 119.759 -0.777 . . . . 0.0 109.177 -179.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 64.4 m-20 -119.64 124.62 46.76 Favored 'General case' 0 C--N 1.358 0.961 0 N-CA-C 108.285 -1.005 . . . . 0.0 108.285 -179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.403 HD13 ' HA ' ' A' ' 129' ' ' ILE . 9.8 mm -140.13 137.25 37.9 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 50.9 mtm180 -116.95 137.65 52.08 Favored 'General case' 0 CA--C 1.492 -1.266 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 6.7 tp -123.23 117.86 26.27 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.023 -0.989 . . . . 0.0 108.486 -178.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.548 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 12.6 m-70 -99.6 131.32 45.68 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 106.723 -1.584 . . . . 0.0 106.723 178.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -127.95 121.37 29.73 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 -178.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.541 ' HA ' ' O ' ' A' ' 171' ' ' THR . 75.3 mt-30 -114.5 115.02 26.57 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 179.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.2 t -162.86 152.22 15.31 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 106.722 -1.585 . . . . 0.0 106.722 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -90.81 1.14 57.18 Favored 'General case' 0 C--N 1.355 0.806 0 C-N-CA 120.17 -0.612 . . . . 0.0 109.794 -178.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -136.22 74.26 55.79 Favored Pre-proline 0 C--N 1.354 0.789 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -95.42 110.64 0.14 Allowed 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.54 2.16 . . . . 0.0 115.935 -177.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -110.99 112.1 23.69 Favored 'General case' 0 CA--C 1.5 -0.97 0 N-CA-C 106.562 -1.644 . . . . 0.0 106.562 176.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.12 -39.27 93.68 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.424 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.3 m -63.7 -26.96 68.9 Favored 'General case' 0 C--N 1.353 0.758 0 O-C-N 121.894 -0.504 . . . . 0.0 110.729 -178.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -75.78 -47.03 27.5 Favored 'General case' 0 N--CA 1.444 -0.727 0 O-C-N 121.731 -0.606 . . . . 0.0 109.692 -177.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.28 -39.83 93.07 Favored 'General case' 0 C--N 1.358 0.94 0 O-C-N 122.074 -0.391 . . . . 0.0 111.323 -178.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -62.97 -36.85 84.87 Favored 'General case' 0 C--N 1.357 0.909 0 O-C-N 121.827 -0.546 . . . . 0.0 109.972 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.6 -43.01 99.42 Favored Glycine 0 C--N 1.346 1.114 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 83.9 mt -70.49 -40.64 73.47 Favored 'General case' 0 C--N 1.351 0.672 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -179.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 98.2 mt -70.92 -42.55 69.75 Favored 'General case' 0 C--N 1.361 1.09 0 O-C-N 121.154 -0.966 . . . . 0.0 110.907 -176.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.55 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 37.2 t70 -70.12 -29.43 66.36 Favored 'General case' 0 N--CA 1.444 -0.737 0 O-C-N 121.995 -0.44 . . . . 0.0 110.373 -179.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -63.1 -39.57 98.16 Favored Glycine 0 C--N 1.357 1.701 0 N-CA-C 108.474 -1.85 . . . . 0.0 108.474 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . 0.4 ' HA ' ' CE2' ' A' ' 75' ' ' PHE . 45.1 t -61.01 -42.22 98.03 Favored 'General case' 0 C--N 1.351 0.672 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -75.92 0.73 17.29 Favored 'General case' 0 C--N 1.36 1.027 0 O-C-N 121.803 -0.561 . . . . 0.0 109.489 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.55 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 76.8 mm-40 -85.78 -45.96 11.12 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.016 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -66.67 -44.63 81.29 Favored 'General case' 0 C--N 1.358 0.949 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.45 ' O ' ' HB2' ' A' ' 155' ' ' LYS . 51.6 m-85 -70.12 -26.08 63.79 Favored 'General case' 0 C--N 1.361 1.077 0 O-C-N 121.783 -0.573 . . . . 0.0 111.126 -178.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 154' ' ' PHE . 41.1 mttt 73.39 71.32 0.12 Allowed 'General case' 0 C--N 1.361 1.102 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -178.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -137.02 -172.48 3.2 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -148.72 94.0 2.21 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 19.3 m-30 -114.89 158.79 21.49 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 94.0 m -118.32 125.03 49.23 Favored 'General case' 0 C--N 1.356 0.868 0 C-N-CA 119.368 -0.933 . . . . 0.0 108.848 -178.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.509 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.6 mp -101.57 121.8 52.94 Favored 'Isoleucine or valine' 0 C--N 1.353 0.736 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 178.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.2 m -119.2 -173.53 2.53 Favored 'General case' 0 C--N 1.357 0.907 0 CA-C-O 121.787 0.803 . . . . 0.0 109.55 -178.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 29.6 ptt180 -147.52 155.95 42.37 Favored 'General case' 0 C--N 1.357 0.918 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -178.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 57.4 p -99.07 146.83 32.36 Favored Pre-proline 0 C--N 1.358 0.966 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.686 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 73.7 Cg_endo -76.02 -10.99 19.72 Favored 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.786 2.324 . . . . 0.0 115.082 -178.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -73.17 -41.45 63.85 Favored 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 120.012 -0.675 . . . . 0.0 109.795 -178.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 37.3 p -117.27 14.96 14.88 Favored 'General case' 0 C--N 1.356 0.872 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.734 -178.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.686 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.1 pp0? -66.52 -12.75 59.08 Favored 'General case' 0 C--N 1.353 0.748 0 O-C-N 121.62 -0.675 . . . . 0.0 110.521 178.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 53.8 p-10 -121.89 34.71 5.09 Favored 'General case' 0 N--CA 1.439 -1.015 0 O-C-N 121.068 -1.02 . . . . 0.0 108.447 -179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 57.2 m -136.11 148.45 48.26 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.639 ' O ' ' HB ' ' A' ' 171' ' ' THR . 61.1 mt-10 -101.85 166.37 10.69 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.639 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 2.5 m 83.2 -56.94 0.16 Allowed 'General case' 0 C--N 1.368 1.374 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -112.23 117.62 33.05 Favored 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 119.861 -0.735 . . . . 0.0 109.609 -178.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 88.5 t -130.73 132.83 63.99 Favored 'Isoleucine or valine' 0 C--N 1.356 0.864 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 178.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 49.8 mm -107.35 125.86 63.58 Favored 'Isoleucine or valine' 0 C--N 1.359 0.982 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -114.92 155.89 26.04 Favored 'General case' 0 CA--C 1.503 -0.846 0 CA-C-O 122.061 0.934 . . . . 0.0 108.652 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -138.16 119.31 14.52 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -178.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.8 mp -115.09 121.37 66.95 Favored 'Isoleucine or valine' 0 C--N 1.353 0.735 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 42.8 p -126.02 159.86 31.61 Favored 'General case' 0 CA--C 1.502 -0.879 0 CA-C-O 121.698 0.761 . . . . 0.0 110.854 -177.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.405 ' HB2' ' HB2' ' A' ' 127' ' ' ASN . 0.1 OUTLIER -99.35 113.4 25.7 Favored 'General case' 0 C--N 1.366 1.287 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 177.358 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -60.34 148.86 78.65 Favored Pre-proline 0 C--N 1.358 0.972 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 178.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.12 132.05 28.73 Favored 'Trans proline' 0 CA--C 1.495 -1.457 0 C-N-CA 122.225 1.95 . . . . 0.0 113.984 -178.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.439 HH11 ' HD2' ' A' ' 182' ' ' ARG . 7.0 mtm105 -137.79 -79.99 0.36 Allowed 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . -135.02 160.26 24.26 Favored Glycine 0 C--N 1.348 1.237 0 N-CA-C 107.66 -2.176 . . . . 0.0 107.66 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 67.97 63.42 0.39 Allowed 'General case' 0 C--N 1.36 1.024 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -120.08 109.55 15.6 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -117.55 122.5 43.83 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 106.992 -1.485 . . . . 0.0 106.992 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 84.6 mt -117.47 -69.67 0.84 Allowed 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 107.915 -1.143 . . . . 0.0 107.915 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -140.0 -104.36 0.16 Allowed 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -117.47 146.31 43.59 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 . . . . . 0 C--O 1.263 1.812 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 179.966 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' HEM . . . . . 0.962 HMA2 HBA2 ' A' ' 202' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.896 ' HG2' ' CMD' ' A' ' 202' ' ' HEM . 81.5 mmm . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 121.068 0.461 . . . . 0.0 110.147 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.27 -19.55 50.29 Favored 'General case' 0 C--N 1.356 0.877 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -178.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.06 -41.13 40.91 Favored Glycine 0 C--N 1.348 1.224 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.92 -34.95 69.49 Favored 'General case' 0 C--N 1.354 0.779 0 O-C-N 122.119 -0.636 . . . . 0.0 111.3 -177.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.9 m -71.04 -23.5 23.56 Favored 'Isoleucine or valine' 0 C--N 1.352 0.714 0 C-N-CA 119.915 -0.714 . . . . 0.0 109.122 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.4 m-30 -71.75 -33.44 68.66 Favored 'General case' 0 C--N 1.358 0.969 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 85.0 m -66.98 -40.06 87.32 Favored 'General case' 0 C--N 1.355 0.819 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.24 -37.79 95.13 Favored Glycine 0 C--N 1.357 1.72 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.611 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -67.77 -38.47 83.46 Favored 'General case' 0 C--N 1.353 0.719 0 CA-C-N 117.346 0.573 . . . . 0.0 110.297 -178.006 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.469 ' CE ' HD21 ' A' ' 26' ' ' LEU . 22.0 mmt -64.01 -41.22 97.54 Favored 'General case' 0 C--N 1.356 0.868 0 O-C-N 121.644 -0.66 . . . . 0.0 111.002 -178.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -66.09 -40.33 90.73 Favored 'General case' 0 C--N 1.348 0.504 0 O-C-N 122.17 -0.331 . . . . 0.0 111.554 -177.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 55.5 tp -65.78 -42.74 90.41 Favored 'General case' 0 C--N 1.349 0.575 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -178.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.611 HG12 ' O ' ' A' ' 9' ' ' LEU . 2.4 mm -73.83 -36.96 47.37 Favored 'Isoleucine or valine' 0 C--N 1.358 0.949 0 O-C-N 121.067 -1.021 . . . . 0.0 111.167 -175.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -67.42 -44.43 78.79 Favored 'General case' 0 C--N 1.353 0.733 0 O-C-N 121.815 -0.553 . . . . 0.0 111.432 -176.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -72.85 -31.14 64.54 Favored 'General case' 0 N--CA 1.447 -0.579 0 O-C-N 122.013 -0.429 . . . . 0.0 111.626 -177.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.0 mm-40 -72.74 -50.02 27.24 Favored 'General case' 0 N--CA 1.443 -0.79 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 -175.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -128.47 -20.25 3.68 Favored 'General case' 0 C--N 1.354 0.797 0 C-N-CA 117.328 -1.749 . . . . 0.0 113.328 -176.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 144.44 179.79 21.13 Favored Glycine 0 N--CA 1.44 -1.061 0 C-N-CA 117.575 -2.25 . . . . 0.0 110.537 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -96.55 -16.37 21.11 Favored 'General case' 0 N--CA 1.432 -1.337 0 N-CA-C 107.586 -1.265 . . . . 0.0 107.586 -177.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -70.08 -41.18 74.45 Favored 'General case' 0 C--N 1.36 1.051 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 178.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.6 m -69.76 -38.42 76.76 Favored 'General case' 0 C--N 1.358 0.944 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 178.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.6 tp -59.64 -37.94 80.03 Favored 'General case' 0 C--N 1.356 0.867 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.5 t0 -65.76 -35.61 81.21 Favored 'General case' 0 C--N 1.356 0.89 0 O-C-N 122.068 -0.395 . . . . 0.0 110.847 -178.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.8 m -65.33 -39.42 92.38 Favored 'General case' 0 C--N 1.355 0.815 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 -178.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.515 HD22 ' HA ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -63.33 -37.96 89.29 Favored 'General case' 0 C--N 1.355 0.807 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 -179.522 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.469 HD21 ' CE ' ' A' ' 10' ' ' MET . 84.5 mt -75.28 -11.85 60.15 Favored 'General case' 0 C--N 1.361 1.079 0 O-C-N 121.652 -0.655 . . . . 0.0 110.457 -178.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -88.48 -27.22 21.63 Favored 'General case' 0 N--CA 1.442 -0.842 0 C-N-CA 119.115 -1.034 . . . . 0.0 108.982 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.7 t -68.26 -37.64 80.94 Favored 'General case' 0 C--N 1.356 0.883 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.8 p -90.54 -41.07 11.6 Favored 'General case' 0 C--N 1.358 0.935 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 85.02 134.09 0.05 OUTLIER 'General case' 0 C--N 1.36 1.047 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.487 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -84.9 -171.75 3.81 Favored 'General case' 0 C--N 1.356 0.88 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.89 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -151.27 -23.69 0.21 Allowed 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.9 t -148.34 -64.53 0.25 Allowed 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -131.13 -55.97 1.04 Allowed 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 130.76 -44.61 1.2 Allowed Glycine 0 C--N 1.353 1.498 0 N-CA-C 108.749 -1.74 . . . . 0.0 108.749 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 80.3 mt -107.08 100.45 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.758 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 -179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.577 ' O ' ' HB ' ' A' ' 38' ' ' THR . 0.9 OUTLIER -71.79 -28.7 63.79 Favored 'General case' 0 C--N 1.357 0.924 0 O-C-N 121.962 -0.461 . . . . 0.0 109.912 -179.844 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.577 ' HB ' ' O ' ' A' ' 37' ' ' TYR . 12.3 m 113.3 -67.36 0.0 OUTLIER 'General case' 0 C--N 1.37 1.47 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 14.1 p 175.01 64.25 0.0 OUTLIER 'General case' 0 C--N 1.359 0.993 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.439 ' HB ' ' CE2' ' A' ' 37' ' ' TYR . 2.1 t -148.59 -5.97 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.355 0.836 0 C-N-CA 119.573 -0.851 . . . . 0.0 109.725 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -98.56 144.32 17.15 Favored Glycine 0 C--N 1.352 1.444 0 C-N-CA 119.162 -1.494 . . . . 0.0 110.23 -177.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.2 m -124.53 122.5 37.75 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 105.699 -1.963 . . . . 0.0 105.699 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 70.3 m-85 -117.63 179.4 4.07 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -178.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -83.02 -171.33 3.5 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 73.3 m80 -93.67 -15.13 25.61 Favored 'General case' 0 CA--C 1.501 -0.939 0 C-N-CA 119.988 -0.685 . . . . 0.0 109.418 -179.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -70.6 -28.7 65.05 Favored 'General case' 0 C--N 1.354 0.767 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 27.5 tp10 -63.27 -41.12 98.99 Favored 'General case' 0 C--N 1.352 0.688 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.444 ' O ' HG23 ' A' ' 52' ' ' VAL . 60.9 tp -67.7 -37.99 83.04 Favored 'General case' 0 C--N 1.355 0.823 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.295 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 59.8 tp -77.37 -27.74 52.69 Favored 'General case' 0 C--N 1.351 0.633 0 O-C-N 121.983 -0.448 . . . . 0.0 110.496 -176.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 72.7 tp60 -68.48 -42.38 78.78 Favored 'General case' 0 C--N 1.351 0.672 0 O-C-N 121.546 -0.721 . . . . 0.0 109.526 -178.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.423 HD22 HD13 ' A' ' 25' ' ' LEU . 82.4 mt -71.9 -35.16 69.62 Favored 'General case' 0 C--N 1.362 1.14 0 C-N-CA 119.963 -0.695 . . . . 0.0 109.355 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 48' ' ' LEU . 33.6 t -62.02 -40.21 86.51 Favored 'Isoleucine or valine' 0 C--N 1.351 0.632 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.9 t -67.57 -39.33 82.16 Favored 'Isoleucine or valine' 0 C--N 1.351 0.631 0 O-C-N 121.723 -0.611 . . . . 0.0 109.392 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.436 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 33.7 tptt -65.39 -29.17 69.85 Favored 'General case' 0 C--N 1.361 1.07 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -179.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.515 HD21 HD12 ' A' ' 13' ' ' ILE . 19.7 mt -66.17 -37.94 86.86 Favored 'General case' 0 C--N 1.355 0.815 0 C-N-CA 120.773 -0.371 . . . . 0.0 110.303 179.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 56.3 p -72.16 -17.68 61.93 Favored 'General case' 0 C--N 1.354 0.796 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.704 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -101.8 -37.56 8.24 Favored 'General case' 0 C--N 1.353 0.754 0 O-C-N 121.244 -0.91 . . . . 0.0 111.473 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.1 p -74.22 -38.38 47.88 Favored 'Isoleucine or valine' 0 C--N 1.354 0.779 0 O-C-N 121.599 -0.688 . . . . 0.0 111.143 -177.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.549 ' HB3' HG23 ' A' ' 61' ' ' VAL . 3.4 t -112.21 -7.62 14.02 Favored 'General case' 0 C--N 1.353 0.756 0 C-N-CA 119.29 -0.964 . . . . 0.0 110.309 -177.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 64.25 47.73 3.09 Favored 'General case' 0 C--N 1.354 0.781 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.549 HG23 ' HB3' ' A' ' 59' ' ' SER . 62.0 t -111.5 133.8 21.37 Favored Pre-proline 0 N--CA 1.443 -0.813 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 61' ' ' VAL . 34.1 Cg_exo -58.44 148.35 80.91 Favored 'Trans proline' 0 CA--C 1.498 -1.294 0 C-N-CA 122.565 2.177 . . . . 0.0 112.771 179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.9 m -72.73 -15.02 17.36 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.738 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.687 -178.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.436 ' O ' HG12 ' A' ' 67' ' ' VAL . 70.6 p -96.42 -31.61 12.75 Favored 'General case' 0 C--N 1.359 0.987 0 C-N-CA 118.608 -1.237 . . . . 0.0 109.075 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -71.06 -33.01 69.86 Favored 'General case' 0 C--N 1.353 0.728 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 178.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.402 HD13 HD13 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -77.23 -34.88 55.91 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -177.889 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.436 HG12 ' O ' ' A' ' 64' ' ' THR . 1.5 p -70.64 -26.03 27.64 Favored 'Isoleucine or valine' 0 C--N 1.354 0.776 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.523 -178.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 5.3 mmm-85 -74.58 -51.44 14.55 Favored 'General case' 0 C--N 1.36 1.039 0 O-C-N 121.438 -0.789 . . . . 0.0 110.105 -179.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.0 mt -63.2 -35.33 79.97 Favored 'General case' 0 C--N 1.357 0.896 0 O-C-N 122.046 -0.409 . . . . 0.0 110.606 -179.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -60.94 -47.16 87.72 Favored 'General case' 0 C--N 1.35 0.623 0 O-C-N 122.301 -0.25 . . . . 0.0 110.333 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.6 -38.58 95.23 Favored Glycine 0 C--N 1.354 1.547 0 N-CA-C 111.848 -0.501 . . . . 0.0 111.848 -178.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -63.86 -47.65 79.84 Favored 'General case' 0 C--N 1.353 0.726 0 CA-C-N 118.411 1.105 . . . . 0.0 111.457 -177.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.729 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 12.9 mttm -64.15 -49.46 72.02 Favored 'General case' 0 C--N 1.358 0.97 0 N-CA-C 113.776 1.028 . . . . 0.0 113.776 -176.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.418 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.2 tm? -69.18 -39.38 78.75 Favored 'General case' 0 C--N 1.35 0.609 0 O-C-N 121.214 -0.929 . . . . 0.0 111.882 -175.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -63.47 -44.29 94.86 Favored 'General case' 0 C--N 1.353 0.748 0 O-C-N 121.122 -0.987 . . . . 0.0 110.988 -178.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.29 -14.89 18.19 Favored 'Isoleucine or valine' 0 C--N 1.358 0.954 0 O-C-N 121.496 -0.752 . . . . 0.0 109.194 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.729 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 74.3 mm-40 -71.43 -38.98 71.34 Favored 'General case' 0 C--N 1.352 0.674 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 82.5 mt -72.99 -31.36 64.45 Favored 'General case' 0 C--N 1.356 0.855 0 O-C-N 122.426 -0.171 . . . . 0.0 110.545 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 49.1 mm -65.58 -54.25 30.19 Favored 'Isoleucine or valine' 0 C--N 1.359 0.993 0 C-N-CA 120.122 -0.631 . . . . 0.0 110.286 -177.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -75.38 -14.57 60.48 Favored 'General case' 0 CA--C 1.51 -0.571 0 C-N-CA 119.516 -0.874 . . . . 0.0 109.381 178.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.35 -37.21 63.01 Favored Glycine 0 C--N 1.349 1.259 0 N-CA-C 110.773 -0.931 . . . . 0.0 110.773 -179.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.427 ' O ' HG22 ' A' ' 85' ' ' ILE . 98.7 m-70 -131.38 106.24 14.61 Favored Pre-proline 0 N--CA 1.441 -0.885 0 CA-C-O 122.664 1.221 . . . . 0.0 109.046 -177.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.33 -24.87 42.88 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.52 2.147 . . . . 0.0 114.113 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.417 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 44.6 mt-10 -93.11 -4.95 51.39 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.427 HG22 ' O ' ' A' ' 82' ' ' HIS . 1.0 OUTLIER -90.32 -20.08 7.07 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.224 0 N-CA-C 106.17 -1.789 . . . . 0.0 106.17 -179.629 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -101.72 -24.66 14.05 Favored 'General case' 0 C--N 1.36 1.038 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -70.26 -35.65 73.92 Favored 'General case' 0 C--N 1.358 0.955 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.417 ' HG2' ' O ' ' A' ' 84' ' ' GLU . 78.6 mm-40 -65.01 -36.1 83.31 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 122.058 -0.401 . . . . 0.0 110.058 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 21.8 ttp -83.56 149.87 26.31 Favored 'General case' 0 C--N 1.352 0.698 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 -178.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.53 -21.95 8.36 Favored 'General case' 0 C--N 1.364 1.222 0 C-N-CA 120.074 -0.651 . . . . 0.0 111.032 -177.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -164.55 170.93 15.19 Favored 'General case' 0 C--N 1.355 0.806 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 -177.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.415 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 41.0 t -64.4 -42.69 95.97 Favored 'General case' 0 C--N 1.356 0.873 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.955 -179.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -66.86 -38.82 87.09 Favored 'General case' 0 C--N 1.355 0.833 0 O-C-N 121.492 -0.755 . . . . 0.0 109.328 -178.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -65.91 -24.61 66.87 Favored 'General case' 0 C--N 1.357 0.912 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.415 ' HB3' ' O ' ' A' ' 92' ' ' SER . 62.5 tp -63.09 -46.41 87.53 Favored 'General case' 0 C--N 1.355 0.824 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.7 mp -63.03 -32.35 73.7 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 122.185 -0.322 . . . . 0.0 110.405 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 36.5 t -62.15 -45.08 95.04 Favored 'General case' 0 C--N 1.355 0.847 0 O-C-N 121.783 -0.573 . . . . 0.0 111.304 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.66 26.42 10.39 Favored 'General case' 0 C--N 1.362 1.11 0 O-C-N 121.015 -1.053 . . . . 0.0 110.515 -178.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 1.026 HD11 ' C3B' ' A' ' 202' ' ' HEM . 13.0 tt -64.09 -29.57 47.69 Favored 'Isoleucine or valine' 0 C--N 1.352 0.691 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.151 -179.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -126.21 -9.46 6.44 Favored 'General case' 0 N--CA 1.436 -1.146 0 C-N-CA 118.564 -1.254 . . . . 0.0 109.762 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 58.8 m -90.92 -2.54 57.72 Favored 'General case' 0 N--CA 1.441 -0.884 0 O-C-N 121.406 -0.809 . . . . 0.0 110.345 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 14.5 t80 -147.03 -47.69 0.18 Allowed 'General case' 0 C--N 1.358 0.968 0 C-N-CA 118.28 -1.368 . . . . 0.0 109.913 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 96.2 mt -67.53 -47.84 79.07 Favored 'Isoleucine or valine' 0 C--N 1.354 0.779 0 O-C-N 121.931 -0.481 . . . . 0.0 111.161 -178.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.652 ' HB3' HD21 ' A' ' 116' ' ' LEU . 22.4 m170 -83.55 -1.14 53.09 Favored 'General case' 0 C--N 1.356 0.875 0 O-C-N 121.403 -0.811 . . . . 0.0 110.056 -177.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 70.5 t -83.96 -43.13 17.65 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.952 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 178.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -67.3 -39.88 85.99 Favored 'General case' 0 N--CA 1.44 -0.975 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.323 -178.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 1.1 p -71.97 -36.5 57.74 Favored 'Isoleucine or valine' 0 C--N 1.353 0.728 0 C-N-CA 119.596 -0.842 . . . . 0.0 110.106 -178.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 93.3 t80 -60.86 -48.6 81.07 Favored 'General case' 0 C--N 1.363 1.171 0 O-C-N 121.744 -0.597 . . . . 0.0 110.71 179.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -60.25 -38.1 82.45 Favored 'General case' 0 C--N 1.358 0.941 0 O-C-N 121.665 -0.647 . . . . 0.0 110.069 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 16.9 mt -58.05 -76.56 0.04 OUTLIER 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.429 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 91.3 m-85 -115.72 134.3 22.7 Favored Pre-proline 0 N--CA 1.44 -0.954 0 C-N-CA 118.986 -1.086 . . . . 0.0 108.83 179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 111' ' ' TYR . 74.3 Cg_endo -86.21 -2.08 8.62 Favored 'Trans proline' 0 C--N 1.313 -1.333 0 C-N-CA 123.222 2.615 . . . . 0.0 115.403 -179.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -67.39 -36.18 80.8 Favored 'General case' 0 C--N 1.355 0.814 0 O-C-N 121.773 -0.579 . . . . 0.0 109.997 -179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.519 ' HB1' HBD1 ' A' ' 202' ' ' HEM . . . -61.73 143.99 55.36 Favored 'General case' 0 C--N 1.354 0.775 0 CA-C-O 121.651 0.738 . . . . 0.0 110.018 -178.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -114.26 145.58 41.55 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 107.678 -1.23 . . . . 0.0 107.678 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.652 HD21 ' HB3' ' A' ' 104' ' ' HIS . 5.6 mp -127.48 145.78 55.91 Favored Pre-proline 0 N--CA 1.445 -0.716 0 CA-C-O 122.198 0.999 . . . . 0.0 108.98 -178.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.522 ' HD3' HBA1 ' A' ' 202' ' ' HEM . 73.7 Cg_endo -91.31 -152.22 0.04 OUTLIER 'Trans proline' 0 C--N 1.315 -1.197 0 C-N-CA 123.909 3.073 . . . . 0.0 113.178 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -115.03 142.46 46.61 Favored 'General case' 0 C--N 1.362 1.125 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.598 ' CE2' ' HD1' ' A' ' 133' ' ' TYR . 0.0 OUTLIER -137.71 125.42 22.37 Favored 'General case' 0 C--N 1.361 1.09 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -177.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 94.1 m -124.23 129.99 51.74 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 105.85 -1.907 . . . . 0.0 105.85 177.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 74.8 m -118.01 131.35 56.48 Favored 'General case' 0 CA--C 1.504 -0.8 0 C-N-CA 119.277 -0.969 . . . . 0.0 109.852 -177.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -121.02 148.37 44.22 Favored 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 106.597 -1.631 . . . . 0.0 106.597 178.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 58.1 ttp180 -123.32 117.39 25.13 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.451 ' HB2' ' CB ' ' A' ' 128' ' ' ASP . 95.3 mt -92.07 -15.09 28.27 Favored 'General case' 0 C--N 1.354 0.797 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.709 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 178.59 -150.37 9.61 Favored Glycine 0 N--CA 1.439 -1.154 0 N-CA-C 108.886 -1.686 . . . . 0.0 108.886 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -90.4 -38.23 13.45 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -105.99 9.5 32.55 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 119.762 -0.775 . . . . 0.0 109.524 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.451 ' CB ' ' HB2' ' A' ' 124' ' ' LEU . 61.9 m-20 -118.3 123.21 44.8 Favored 'General case' 0 C--N 1.358 0.978 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 17.8 mm -137.9 133.26 44.57 Favored 'Isoleucine or valine' 0 C--N 1.353 0.729 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 59.9 mtm180 -120.49 139.43 52.9 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.546 ' HG ' ' O ' ' A' ' 131' ' ' LEU . 0.7 OUTLIER -130.04 127.0 39.05 Favored 'General case' 0 N--CA 1.438 -1.056 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 178.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -97.34 130.7 44.47 Favored 'General case' 0 CA--C 1.494 -1.188 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 178.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.598 ' HD1' ' CE2' ' A' ' 119' ' ' PHE . 52.5 t80 -124.86 121.43 34.51 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 -178.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.485 ' HA ' ' O ' ' A' ' 171' ' ' THR . 28.2 tt0 -114.42 112.44 23.03 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.8 t -162.28 153.39 17.8 Favored 'General case' 0 C--N 1.358 0.974 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 57.6 mtmt -90.43 5.99 45.2 Favored 'General case' 0 C--N 1.357 0.903 0 C-N-CA 120.199 -0.6 . . . . 0.0 109.912 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 94.7 mtm-85 -131.94 77.35 72.05 Favored Pre-proline 0 C--N 1.356 0.856 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 178.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -91.48 93.07 0.22 Allowed 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.748 2.298 . . . . 0.0 115.709 -177.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -107.43 106.36 16.73 Favored 'General case' 0 CA--C 1.5 -0.946 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 177.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -64.3 -38.88 92.63 Favored 'General case' 0 C--N 1.355 0.835 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.367 -178.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 74.2 m -63.05 -27.1 69.17 Favored 'General case' 0 C--N 1.353 0.755 0 O-C-N 121.981 -0.449 . . . . 0.0 110.554 -178.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -75.58 -47.18 27.78 Favored 'General case' 0 N--CA 1.445 -0.721 0 O-C-N 121.735 -0.603 . . . . 0.0 109.553 -178.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.28 -39.4 92.53 Favored 'General case' 0 C--N 1.358 0.944 0 O-C-N 122.108 -0.37 . . . . 0.0 111.331 -178.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -62.19 -36.94 83.42 Favored 'General case' 0 C--N 1.358 0.947 0 O-C-N 121.777 -0.577 . . . . 0.0 109.764 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.53 -42.2 99.03 Favored Glycine 0 C--N 1.347 1.157 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 83.2 mt -70.19 -41.35 73.82 Favored 'General case' 0 C--N 1.352 0.692 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -179.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 96.6 mt -71.27 -42.08 69.22 Favored 'General case' 0 C--N 1.364 1.212 0 O-C-N 121.066 -1.021 . . . . 0.0 110.654 -177.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -70.35 -30.84 67.88 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 121.866 -0.521 . . . . 0.0 110.635 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -63.55 -39.75 97.97 Favored Glycine 0 C--N 1.356 1.654 0 N-CA-C 108.985 -1.646 . . . . 0.0 108.985 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 42.7 t -60.43 -43.11 97.12 Favored 'General case' 0 C--N 1.35 0.615 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 178.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -78.91 2.38 20.35 Favored 'General case' 0 C--N 1.355 0.847 0 N-CA-C 109.138 -0.689 . . . . 0.0 109.138 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.4 tm-20 -83.73 -49.09 9.45 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 179.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -66.69 -42.93 85.67 Favored 'General case' 0 C--N 1.36 1.061 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 9.6 m-30 -69.01 -27.38 65.62 Favored 'General case' 0 C--N 1.361 1.068 0 O-C-N 121.831 -0.543 . . . . 0.0 110.797 -178.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 85.2 tttt 73.01 75.06 0.14 Allowed 'General case' 0 C--N 1.36 1.058 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -137.65 -177.73 4.92 Favored 'General case' 0 N--CA 1.442 -0.847 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -140.27 90.06 2.34 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 16.8 m-30 -116.3 155.11 28.98 Favored 'General case' 0 CA--C 1.507 -0.683 0 N-CA-C 106.095 -1.817 . . . . 0.0 106.095 178.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 93.5 m -119.66 128.83 54.2 Favored 'General case' 0 C--N 1.355 0.808 0 C-N-CA 119.551 -0.859 . . . . 0.0 108.828 -178.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.507 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.5 mp -106.24 123.22 60.83 Favored 'Isoleucine or valine' 0 C--N 1.352 0.704 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.1 m -119.43 -170.77 2.0 Allowed 'General case' 0 C--N 1.356 0.869 0 CA-C-O 121.685 0.755 . . . . 0.0 109.197 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 11.3 ptt85 -147.76 157.0 43.33 Favored 'General case' 0 C--N 1.357 0.931 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -178.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.438 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 32.5 p -97.5 146.37 31.28 Favored Pre-proline 0 C--N 1.36 1.043 0 CA-C-O 122.415 1.103 . . . . 0.0 108.447 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.513 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 16.0 Cg_exo -70.42 -16.7 34.82 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 123.641 2.894 . . . . 0.0 114.486 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -71.95 -40.71 68.49 Favored 'General case' 0 N--CA 1.443 -0.801 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.933 -177.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 39.6 p -119.27 15.75 13.09 Favored 'General case' 0 C--N 1.353 0.724 0 C-N-CA 119.746 -0.782 . . . . 0.0 110.876 -178.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.513 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 12.7 pt20 -67.55 -12.15 59.71 Favored 'General case' 0 C--N 1.352 0.69 0 C-N-CA 119.974 -0.691 . . . . 0.0 110.155 178.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 54.2 p-10 -126.51 37.79 4.24 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 18.2 t -138.94 144.65 39.13 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 -179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.622 ' O ' ' HB ' ' A' ' 171' ' ' THR . 61.4 mt-10 -97.87 163.99 12.56 Favored 'General case' 0 C--N 1.354 0.769 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.622 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 18.0 m 83.95 -59.91 0.12 Allowed 'General case' 0 C--N 1.372 1.555 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -105.71 118.0 35.47 Favored 'General case' 0 CA--C 1.503 -0.827 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.596 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 92.8 t -131.48 133.78 61.5 Favored 'Isoleucine or valine' 0 C--N 1.358 0.952 0 N-CA-C 107.295 -1.372 . . . . 0.0 107.295 178.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 48.4 mm -113.52 126.98 71.06 Favored 'Isoleucine or valine' 0 C--N 1.359 1.021 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.441 ' HB2' ' HG ' ' A' ' 131' ' ' LEU . 97.2 m-85 -116.74 147.2 42.25 Favored 'General case' 0 C--N 1.36 1.054 0 CA-C-O 121.947 0.88 . . . . 0.0 109.105 -179.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -125.2 120.16 30.52 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 -179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 51.8 mt -116.22 124.79 72.86 Favored 'Isoleucine or valine' 0 C--N 1.353 0.752 0 N-CA-C 107.277 -1.379 . . . . 0.0 107.277 -178.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 54.9 p -118.55 157.97 26.31 Favored 'General case' 0 CA--C 1.501 -0.92 0 CA-C-O 121.764 0.792 . . . . 0.0 109.581 -178.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 57.5 ttp180 -102.87 119.03 38.12 Favored 'General case' 0 C--N 1.356 0.858 0 N-CA-C 106.325 -1.732 . . . . 0.0 106.325 178.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -60.6 149.65 77.78 Favored Pre-proline 0 C--N 1.357 0.897 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 178.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.2 138.11 83.01 Favored 'Trans proline' 0 CA--C 1.494 -1.522 0 C-N-CA 122.167 1.911 . . . . 0.0 113.646 -178.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.469 HH11 ' HD2' ' A' ' 182' ' ' ARG . 6.1 mtm105 -127.47 148.74 50.31 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 -179.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 63.17 -136.58 43.03 Favored Glycine 0 C--N 1.348 1.249 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 -179.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -95.42 -179.97 4.96 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -128.51 126.81 41.17 Favored 'General case' 0 N--CA 1.438 -1.039 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -112.31 123.14 49.62 Favored 'General case' 0 N--CA 1.438 -1.026 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 52.6 tp -112.46 -66.95 1.03 Allowed 'General case' 0 N--CA 1.439 -1.001 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -133.3 -82.48 0.47 Allowed 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 -179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -131.54 -67.82 0.67 Allowed 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 54.7 tt0 . . . . . 0 C--O 1.264 1.857 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 179.767 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' HEM . . . . . 1.026 ' C3B' HD11 ' A' ' 99' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mtm . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 121.287 0.565 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.93 -12.71 54.98 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.62 -40.2 54.15 Favored Glycine 0 C--N 1.351 1.397 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 7.8 mtm -71.08 -35.4 71.84 Favored 'General case' 0 C--N 1.359 1.0 0 O-C-N 121.875 -0.779 . . . . 0.0 111.299 -177.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.1 m -68.48 -23.98 28.81 Favored 'Isoleucine or valine' 0 C--N 1.356 0.854 0 C-N-CA 119.674 -0.81 . . . . 0.0 109.22 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -71.31 -35.87 71.42 Favored 'General case' 0 C--N 1.36 1.031 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 178.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 88.6 m -67.35 -41.63 84.85 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.73 -38.95 97.31 Favored Glycine 0 C--N 1.357 1.743 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 -179.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.633 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -66.73 -39.98 88.2 Favored 'General case' 0 C--N 1.352 0.685 0 O-C-N 122.301 -0.529 . . . . 0.0 110.76 -178.107 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 22.4 mmt -64.25 -41.04 97.15 Favored 'General case' 0 C--N 1.354 0.791 0 O-C-N 121.523 -0.735 . . . . 0.0 111.137 -178.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -67.26 -40.0 86.17 Favored 'General case' 0 C--N 1.35 0.598 0 O-C-N 121.96 -0.463 . . . . 0.0 111.623 -177.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 54.7 tp -66.33 -42.09 88.68 Favored 'General case' 0 C--N 1.348 0.503 0 N-CA-C 112.694 0.628 . . . . 0.0 112.694 -178.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.633 HG12 ' O ' ' A' ' 9' ' ' LEU . 2.1 mm -75.17 -35.77 35.3 Favored 'Isoleucine or valine' 0 C--N 1.36 1.048 0 O-C-N 121.11 -0.994 . . . . 0.0 110.86 -175.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -71.13 -41.89 69.91 Favored 'General case' 0 C--N 1.35 0.587 0 O-C-N 121.558 -0.714 . . . . 0.0 111.405 -176.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -72.04 -38.21 69.56 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 113.275 0.843 . . . . 0.0 113.275 -175.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 76.1 mm-40 -102.57 -23.22 13.89 Favored 'General case' 0 C--N 1.349 0.584 0 C-N-CA 118.794 -1.162 . . . . 0.0 113.466 -174.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 14.6 m-30 -109.07 -37.76 5.73 Favored 'General case' 0 CA--C 1.505 -0.753 0 C-N-CA 118.191 -1.404 . . . . 0.0 111.399 -176.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 140.63 178.76 17.48 Favored Glycine 0 N--CA 1.439 -1.144 0 N-CA-C 108.732 -1.747 . . . . 0.0 108.732 -179.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -101.6 -25.61 13.82 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -177.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -70.3 -39.61 74.72 Favored 'General case' 0 C--N 1.361 1.098 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 95.0 m -67.69 -38.38 83.59 Favored 'General case' 0 C--N 1.358 0.96 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 178.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.1 tp -59.59 -38.54 81.49 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -66.12 -36.13 82.33 Favored 'General case' 0 C--N 1.356 0.858 0 O-C-N 122.09 -0.381 . . . . 0.0 111.07 -178.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.6 m -64.13 -41.19 97.3 Favored 'General case' 0 C--N 1.355 0.846 0 O-C-N 121.606 -0.684 . . . . 0.0 109.352 -178.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 86.3 mt -64.28 -36.84 85.42 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 109.554 -0.535 . . . . 0.0 109.554 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.568 ' HB3' HD23 ' A' ' 31' ' ' LEU . 84.3 mt -70.19 -16.2 63.04 Favored 'General case' 0 C--N 1.359 0.982 0 O-C-N 121.782 -0.574 . . . . 0.0 110.105 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -84.89 -28.79 25.72 Favored 'General case' 0 N--CA 1.444 -0.744 0 C-N-CA 119.524 -0.87 . . . . 0.0 109.167 178.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.4 t -66.52 -36.89 83.82 Favored 'General case' 0 C--N 1.355 0.838 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.8 p -93.07 -37.19 12.29 Favored 'General case' 0 C--N 1.359 1.004 0 N-CA-C 107.604 -1.258 . . . . 0.0 107.604 -179.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 83.66 133.39 0.05 Allowed 'General case' 0 C--N 1.36 1.04 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.568 HD23 ' HB3' ' A' ' 26' ' ' LEU . 0.4 OUTLIER -111.97 132.05 55.02 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 179.246 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -107.88 -21.46 12.83 Favored 'General case' 0 CA--C 1.497 -1.083 0 C-N-CA 119.816 -0.754 . . . . 0.0 109.121 179.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -114.24 -80.15 0.59 Allowed 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 118.874 -1.131 . . . . 0.0 109.098 -178.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -137.16 -53.17 0.68 Allowed 'General case' 0 CA--C 1.501 -0.908 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 -178.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 131.4 -44.6 1.19 Allowed Glycine 0 C--N 1.352 1.437 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 82.8 mt -107.87 100.05 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.795 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 73.7 t80 -98.21 0.07 45.11 Favored 'General case' 0 C--N 1.355 0.831 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.706 HG22 ' H ' ' A' ' 39' ' ' SER . 3.4 m 78.75 174.22 0.16 Allowed 'General case' 0 C--N 1.362 1.127 0 N-CA-C 106.037 -1.838 . . . . 0.0 106.037 -178.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.706 ' H ' HG22 ' A' ' 38' ' ' THR . 41.7 p -86.81 119.25 26.84 Favored 'General case' 0 N--CA 1.443 -0.778 0 O-C-N 121.131 -0.981 . . . . 0.0 109.531 -178.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.429 ' O ' HG13 ' A' ' 40' ' ' VAL . 0.5 OUTLIER -176.21 -12.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.362 1.117 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 178.721 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -114.25 168.05 12.47 Favored Glycine 0 C--N 1.358 1.793 0 N-CA-C 109.155 -1.578 . . . . 0.0 109.155 -178.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 48.9 m -130.95 132.21 44.92 Favored 'General case' 0 C--N 1.355 0.838 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -119.14 173.64 6.8 Favored 'General case' 0 N--CA 1.443 -0.825 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -70.19 172.49 8.0 Favored 'General case' 0 C--N 1.357 0.9 0 CA-C-O 121.671 0.748 . . . . 0.0 109.478 -179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -83.77 -24.05 31.25 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -178.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 45.6 tt0 -65.79 -27.41 68.25 Favored 'General case' 0 C--N 1.355 0.832 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -61.48 -42.11 98.28 Favored 'General case' 0 C--N 1.353 0.734 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.512 ' O ' HG23 ' A' ' 52' ' ' VAL . 61.8 tp -67.4 -38.89 85.34 Favored 'General case' 0 C--N 1.355 0.816 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.296 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 57.9 tp -73.5 -28.05 61.7 Favored 'General case' 0 C--N 1.352 0.697 0 O-C-N 122.081 -0.387 . . . . 0.0 110.278 -177.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 71.7 tp60 -67.42 -42.42 83.22 Favored 'General case' 0 N--CA 1.445 -0.695 0 O-C-N 121.702 -0.624 . . . . 0.0 109.481 -178.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 88.1 mt -76.9 -25.09 52.61 Favored 'General case' 0 C--N 1.36 1.031 0 C-N-CA 119.9 -0.72 . . . . 0.0 109.843 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 48' ' ' LEU . 32.2 t -70.78 -41.7 77.47 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.1 p -71.82 -30.88 39.25 Favored 'Isoleucine or valine' 0 C--N 1.354 0.797 0 O-C-N 121.514 -0.741 . . . . 0.0 109.766 -179.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 31.1 tptt -71.83 -27.16 62.71 Favored 'General case' 0 C--N 1.364 1.204 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.0 tt -66.58 -41.25 88.81 Favored 'General case' 0 C--N 1.354 0.768 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.498 ' O ' ' HA ' ' A' ' 60' ' ' SER . 46.8 t -65.24 -39.4 92.64 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 121.88 -0.512 . . . . 0.0 110.313 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -76.95 -39.12 51.81 Favored 'General case' 0 C--N 1.352 0.717 0 O-C-N 120.974 -1.078 . . . . 0.0 112.975 -178.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.4 p -70.74 -38.02 71.3 Favored 'Isoleucine or valine' 0 C--N 1.354 0.794 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -175.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.0 t -118.12 -4.44 11.0 Favored 'General case' 0 CA--C 1.505 -0.779 0 C-N-CA 118.975 -1.09 . . . . 0.0 110.085 -177.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' A' ' 56' ' ' SER . 0.3 OUTLIER 69.36 41.23 1.35 Allowed 'General case' 0 CA--C 1.508 -0.645 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.078 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.416 ' O ' ' HA ' ' A' ' 56' ' ' SER . 61.6 t -110.8 123.86 34.45 Favored Pre-proline 0 CA--C 1.502 -0.891 0 N-CA-C 106.5 -1.667 . . . . 0.0 106.5 178.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 61' ' ' VAL . 32.5 Cg_exo -57.73 155.03 34.03 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 122.85 2.367 . . . . 0.0 113.689 -178.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.656 ' HA ' HD23 ' A' ' 66' ' ' LEU . 11.4 m -75.3 -9.34 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 CA-C-N 115.597 -0.729 . . . . 0.0 111.457 -177.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.504 ' O ' HG12 ' A' ' 67' ' ' VAL . 80.6 p -96.39 -36.13 10.95 Favored 'General case' 0 C--N 1.356 0.882 0 C-N-CA 118.221 -1.392 . . . . 0.0 109.431 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -75.2 -22.3 58.08 Favored 'General case' 0 C--N 1.353 0.733 0 O-C-N 121.407 -0.808 . . . . 0.0 109.337 179.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.656 HD23 ' HA ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -82.58 -32.67 28.37 Favored 'General case' 0 N--CA 1.44 -0.967 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -178.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.504 HG12 ' O ' ' A' ' 64' ' ' THR . 2.3 p -70.98 -25.39 25.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.844 0 C-N-CA 120.077 -0.649 . . . . 0.0 109.864 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 4.7 mmm-85 -73.29 -53.15 11.55 Favored 'General case' 0 C--N 1.363 1.153 0 O-C-N 121.519 -0.738 . . . . 0.0 109.841 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 88.9 mt -63.54 -34.34 77.58 Favored 'General case' 0 C--N 1.356 0.889 0 O-C-N 122.112 -0.368 . . . . 0.0 110.806 -178.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 92.4 t80 -61.23 -47.2 87.18 Favored 'General case' 0 C--N 1.35 0.613 0 O-C-N 122.083 -0.385 . . . . 0.0 110.369 -178.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.65 -38.6 95.33 Favored Glycine 0 C--N 1.356 1.663 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 -178.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -63.29 -47.98 80.04 Favored 'General case' 0 C--N 1.35 0.623 0 CA-C-N 118.115 0.957 . . . . 0.0 111.644 -177.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 12.8 mttm -65.42 -47.04 77.63 Favored 'General case' 0 C--N 1.359 1.018 0 N-CA-C 113.616 0.969 . . . . 0.0 113.616 -177.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -70.3 -39.24 74.95 Favored 'General case' 0 C--N 1.349 0.571 0 O-C-N 121.158 -0.964 . . . . 0.0 111.712 -175.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -63.89 -45.55 88.88 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 121.114 -0.991 . . . . 0.0 111.047 -178.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.8 p -71.44 -14.01 17.37 Favored 'Isoleucine or valine' 0 C--N 1.359 0.988 0 O-C-N 121.545 -0.722 . . . . 0.0 109.073 -179.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -71.36 -40.65 70.49 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.746 -1.205 . . . . 0.0 107.746 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 79.5 mt -70.32 -34.02 72.2 Favored 'General case' 0 C--N 1.356 0.887 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.337 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 46.4 mm -63.16 -52.95 52.42 Favored 'Isoleucine or valine' 0 C--N 1.358 0.964 0 O-C-N 121.723 -0.611 . . . . 0.0 110.105 -177.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -75.0 -10.7 59.72 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 120.1 -0.64 . . . . 0.0 111.289 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.76 -8.68 58.06 Favored Glycine 0 C--N 1.351 1.401 0 C-N-CA 119.617 -1.277 . . . . 0.0 110.825 -178.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.577 ' HB3' ' HB ' ' A' ' 85' ' ' ILE . 93.3 m-70 -137.22 91.35 14.65 Favored Pre-proline 0 C--N 1.353 0.721 0 CA-C-N 118.994 1.397 . . . . 0.0 108.982 -179.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -59.82 -32.96 96.2 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 123.027 2.484 . . . . 0.0 114.408 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -93.24 -2.71 54.82 Favored 'General case' 0 CA--C 1.504 -0.82 0 C-N-CA 119.74 -0.784 . . . . 0.0 109.616 -178.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.577 ' HB ' ' HB3' ' A' ' 82' ' ' HIS . 0.4 OUTLIER -89.07 -19.87 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.062 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 -179.832 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -101.64 -23.42 14.26 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -70.27 -36.66 74.57 Favored 'General case' 0 C--N 1.359 0.995 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -65.77 -35.91 82.06 Favored 'General case' 0 C--N 1.355 0.82 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.013 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 23.8 ttp -83.26 149.61 26.69 Favored 'General case' 0 C--N 1.353 0.732 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 -178.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -116.6 -21.91 8.91 Favored 'General case' 0 C--N 1.364 1.233 0 O-C-N 121.698 -0.626 . . . . 0.0 110.556 -177.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -163.91 170.75 16.3 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 -177.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.443 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 89.3 p -70.86 -32.32 69.28 Favored 'General case' 0 C--N 1.353 0.736 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.965 -179.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -70.3 -38.94 75.09 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -67.06 -23.73 65.9 Favored 'General case' 0 C--N 1.358 0.937 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.443 ' HB3' ' O ' ' A' ' 92' ' ' SER . 61.0 tp -62.67 -46.53 87.73 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.9 mp -63.13 -31.22 72.32 Favored 'General case' 0 C--N 1.355 0.812 0 O-C-N 122.257 -0.277 . . . . 0.0 110.289 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 36.1 t -62.2 -45.98 90.93 Favored 'General case' 0 C--N 1.356 0.868 0 O-C-N 121.69 -0.631 . . . . 0.0 111.237 -178.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.431 ' H ' ' HG3' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -114.89 28.92 8.39 Favored 'General case' 0 C--N 1.36 1.055 0 O-C-N 121.068 -1.02 . . . . 0.0 110.232 -178.338 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 1.386 HD11 ' C3B' ' A' ' 202' ' ' HEM . 12.9 tt -63.45 -27.64 43.41 Favored 'Isoleucine or valine' 0 C--N 1.354 0.79 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.5 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -125.98 -12.29 6.45 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 118.825 -1.15 . . . . 0.0 109.044 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.3 t -69.11 -45.53 69.98 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.057 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 29.7 t80 -123.85 -28.73 3.77 Favored 'General case' 0 C--N 1.358 0.943 0 C-N-CA 118.636 -1.226 . . . . 0.0 111.47 -177.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.467 HD12 ' HA ' ' A' ' 99' ' ' ILE . 96.2 mt -70.17 -47.8 65.46 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 O-C-N 121.147 -0.971 . . . . 0.0 110.922 -178.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 39.3 m170 -87.96 1.71 53.46 Favored 'General case' 0 C--N 1.355 0.834 0 O-C-N 121.224 -0.923 . . . . 0.0 110.028 -177.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.6 p -92.37 -31.71 4.85 Favored 'Isoleucine or valine' 0 C--N 1.354 0.799 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 179.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -71.99 -39.8 69.02 Favored 'General case' 0 CA--C 1.501 -0.935 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -72.98 -36.6 51.68 Favored 'Isoleucine or valine' 0 C--N 1.354 0.795 0 C-N-CA 119.605 -0.838 . . . . 0.0 109.704 -178.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 91.6 t80 -61.06 -48.7 80.52 Favored 'General case' 0 C--N 1.364 1.21 0 O-C-N 121.808 -0.557 . . . . 0.0 110.651 179.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -60.91 -37.9 83.87 Favored 'General case' 0 C--N 1.357 0.903 0 O-C-N 121.709 -0.619 . . . . 0.0 110.226 -179.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.8 mt -57.9 -76.46 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.413 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 79.5 m-85 -116.37 135.04 22.78 Favored Pre-proline 0 N--CA 1.441 -0.899 0 C-N-CA 118.926 -1.109 . . . . 0.0 108.756 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 111' ' ' TYR . 81.2 Cg_endo -85.29 -2.41 9.35 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 123.215 2.61 . . . . 0.0 115.41 -178.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 30.4 mm100 -66.72 -36.42 82.42 Favored 'General case' 0 C--N 1.354 0.79 0 O-C-N 121.779 -0.575 . . . . 0.0 110.029 -179.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.97 146.12 53.82 Favored 'General case' 0 C--N 1.354 0.778 0 CA-C-O 121.695 0.76 . . . . 0.0 110.092 -178.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -117.43 156.77 27.38 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 178.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.824 ' HG ' ' HD2' ' A' ' 117' ' ' PRO . 4.3 tp -142.3 143.47 27.39 Favored Pre-proline 0 N--CA 1.441 -0.893 0 CA-C-O 122.009 0.909 . . . . 0.0 108.646 -178.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.824 ' HD2' ' HG ' ' A' ' 116' ' ' LEU . 97.5 Cg_endo -85.73 -152.23 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.128 0 C-N-CA 123.602 2.868 . . . . 0.0 113.534 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -114.25 145.94 41.08 Favored 'General case' 0 C--N 1.363 1.19 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -145.39 125.28 13.49 Favored 'General case' 0 C--N 1.36 1.052 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 -177.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 93.5 m -124.84 132.49 53.32 Favored 'General case' 0 C--N 1.359 0.995 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 179.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 75.2 m -113.68 130.25 56.44 Favored 'General case' 0 C--N 1.356 0.883 0 C-N-CA 119.735 -0.786 . . . . 0.0 109.576 -178.372 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -121.04 126.7 50.55 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 178.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 58.4 ttp180 -102.53 117.4 34.62 Favored 'General case' 0 C--N 1.353 0.755 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.549 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 85.7 mt -83.3 -27.03 30.08 Favored 'General case' 0 CA--C 1.504 -0.818 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.112 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -177.18 -144.96 5.55 Favored Glycine 0 C--N 1.35 1.319 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 -178.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -94.11 -39.06 10.79 Favored 'General case' 0 N--CA 1.438 -1.07 0 O-C-N 121.993 -0.71 . . . . 0.0 109.312 -178.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -101.94 1.89 37.3 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 119.835 -0.746 . . . . 0.0 110.614 -178.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.549 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 6.6 m-20 -118.97 130.77 55.87 Favored 'General case' 0 C--N 1.359 0.993 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 14.2 mm -139.37 135.81 40.83 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 58.3 mtm180 -122.0 141.01 51.78 Favored 'General case' 0 CA--C 1.502 -0.882 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.57 ' HG ' ' HB2' ' A' ' 175' ' ' PHE . 0.9 OUTLIER -131.39 127.01 36.65 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.676 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -97.47 130.77 44.53 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 178.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 47.0 t80 -125.15 121.04 33.07 Favored 'General case' 0 N--CA 1.435 -1.194 0 N-CA-C 107.04 -1.467 . . . . 0.0 107.04 -178.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.513 ' HA ' ' O ' ' A' ' 171' ' ' THR . 28.7 tt0 -114.9 112.05 22.13 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 14.5 t -161.73 152.65 18.02 Favored 'General case' 0 C--N 1.358 0.976 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.418 ' C ' ' HD3' ' A' ' 138' ' ' PRO . 57.9 mtmt -90.7 3.56 53.92 Favored 'General case' 0 C--N 1.357 0.891 0 C-N-CA 120.269 -0.572 . . . . 0.0 109.576 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -133.49 73.48 72.99 Favored Pre-proline 0 CA--C 1.506 -0.736 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 179.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.418 ' HD3' ' C ' ' A' ' 136' ' ' LYS . 89.6 Cg_endo -96.36 104.14 0.09 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.541 0 C-N-CA 122.662 2.241 . . . . 0.0 115.678 -177.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -111.87 113.44 25.77 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 106.376 -1.713 . . . . 0.0 106.376 176.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.93 -38.12 89.93 Favored 'General case' 0 C--N 1.353 0.75 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.968 -179.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 74.6 m -63.02 -26.17 68.73 Favored 'General case' 0 C--N 1.353 0.741 0 O-C-N 121.971 -0.456 . . . . 0.0 110.55 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -76.57 -46.72 25.1 Favored 'General case' 0 C--N 1.352 0.698 0 C-N-CA 120.13 -0.628 . . . . 0.0 109.375 -178.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.59 -40.24 95.16 Favored 'General case' 0 C--N 1.357 0.915 0 O-C-N 122.187 -0.321 . . . . 0.0 111.087 -178.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.19 -36.79 84.81 Favored 'General case' 0 C--N 1.355 0.834 0 O-C-N 121.961 -0.462 . . . . 0.0 110.112 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.37 -42.94 99.09 Favored Glycine 0 C--N 1.347 1.157 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.5 mt -70.06 -40.92 74.8 Favored 'General case' 0 C--N 1.353 0.719 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -179.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 96.7 mt -71.84 -42.2 67.24 Favored 'General case' 0 C--N 1.364 1.2 0 O-C-N 121.059 -1.026 . . . . 0.0 110.801 -176.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.515 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 20.9 t70 -69.15 -33.15 72.97 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 122.097 -0.377 . . . . 0.0 110.57 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.433 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -62.75 -39.28 97.76 Favored Glycine 0 C--N 1.357 1.713 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -179.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 45.9 t -60.51 -42.24 95.99 Favored 'General case' 0 C--N 1.35 0.598 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -75.99 -0.13 20.51 Favored 'General case' 0 C--N 1.36 1.043 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.515 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 76.8 mm-40 -84.56 -46.41 11.59 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -66.16 -44.59 83.64 Favored 'General case' 0 C--N 1.359 1.002 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 178.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 8.8 m-30 -69.5 -26.28 64.46 Favored 'General case' 0 C--N 1.361 1.086 0 O-C-N 121.87 -0.518 . . . . 0.0 110.81 -178.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 85.0 tttt 73.16 75.95 0.14 Allowed 'General case' 0 C--N 1.36 1.024 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 -178.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -141.42 -171.34 3.28 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 179.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -148.34 92.65 2.05 Favored 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -113.86 158.41 21.09 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 106.844 -1.539 . . . . 0.0 106.844 179.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 93.3 m -119.9 127.85 53.09 Favored 'General case' 0 C--N 1.355 0.82 0 C-N-CA 119.404 -0.919 . . . . 0.0 108.974 -178.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.498 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.7 mp -105.86 122.82 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.739 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 178.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.4 m -116.67 -172.46 2.2 Favored 'General case' 0 C--N 1.354 0.791 0 CA-C-O 121.822 0.82 . . . . 0.0 109.116 -178.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 23.9 ptt180 -146.46 155.67 42.72 Favored 'General case' 0 C--N 1.354 0.792 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 -178.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 41.7 p -98.68 146.3 31.38 Favored Pre-proline 0 C--N 1.359 0.999 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.689 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 72.6 Cg_endo -76.35 -11.87 19.01 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 123.044 2.496 . . . . 0.0 115.148 -178.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -72.66 -41.07 65.82 Favored 'General case' 0 N--CA 1.442 -0.855 0 C-N-CA 120.056 -0.657 . . . . 0.0 109.551 -178.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 35.8 p -117.72 15.23 14.47 Favored 'General case' 0 C--N 1.354 0.802 0 C-N-CA 120.129 -0.628 . . . . 0.0 110.48 -178.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.689 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.3 pp0? -67.11 -11.85 58.36 Favored 'General case' 0 C--N 1.354 0.802 0 O-C-N 121.576 -0.703 . . . . 0.0 110.193 178.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -127.0 42.29 3.35 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 15.4 t -142.96 145.4 32.96 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.635 ' O ' ' HB ' ' A' ' 171' ' ' THR . 61.5 mt-10 -98.86 165.0 11.98 Favored 'General case' 0 C--N 1.353 0.751 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -179.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.635 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 11.9 m 83.71 -59.12 0.13 Allowed 'General case' 0 C--N 1.37 1.483 0 N-CA-C 109.487 -0.561 . . . . 0.0 109.487 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -107.35 117.46 34.13 Favored 'General case' 0 CA--C 1.504 -0.801 0 C-N-CA 119.889 -0.724 . . . . 0.0 109.654 -178.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 90.4 t -131.85 134.15 60.37 Favored 'Isoleucine or valine' 0 C--N 1.357 0.914 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 178.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 49.2 mm -113.4 126.97 70.92 Favored 'Isoleucine or valine' 0 C--N 1.359 0.987 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -179.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.57 ' HB2' ' HG ' ' A' ' 131' ' ' LEU . 97.1 m-85 -116.62 147.13 42.18 Favored 'General case' 0 C--N 1.361 1.081 0 CA-C-O 122.008 0.909 . . . . 0.0 108.778 -179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -125.68 119.37 27.82 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 107.439 -1.319 . . . . 0.0 107.439 -179.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 51.0 mt -114.67 115.87 50.84 Favored 'Isoleucine or valine' 0 C--N 1.354 0.801 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 -179.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 88.4 m -127.55 140.5 52.08 Favored 'General case' 0 CA--C 1.501 -0.919 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -178.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 40.4 ptt180 -84.3 127.58 34.06 Favored 'General case' 0 C--N 1.366 1.307 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 179.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.19 152.52 84.24 Favored Pre-proline 0 C--N 1.358 0.974 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 178.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -50.49 131.12 31.63 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 122.88 2.386 . . . . 0.0 114.023 -178.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.412 ' HD2' HH11 ' A' ' 182' ' ' ARG . 0.6 OUTLIER -125.02 161.94 25.62 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 -179.932 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 101.48 -146.43 17.24 Favored Glycine 0 N--CA 1.437 -1.269 0 N-CA-C 108.439 -1.864 . . . . 0.0 108.439 179.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -116.82 24.75 11.03 Favored 'General case' 0 N--CA 1.437 -1.091 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 -179.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 68.01 57.14 0.51 Allowed 'General case' 0 C--N 1.36 1.028 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -98.08 119.8 37.36 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 106.86 -1.533 . . . . 0.0 106.86 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 71.6 mt -111.93 -68.45 0.93 Allowed 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -145.13 -87.92 0.11 Allowed 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -127.98 147.81 50.5 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 . . . . . 0 C--O 1.265 1.886 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 -179.99 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' HEM . . . . . 1.386 ' C3B' HD11 ' A' ' 99' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.777 ' HG3' ' CMD' ' A' ' 202' ' ' HEM . 44.9 mtp . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.096 0.474 . . . . 0.0 110.079 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.49 ' HA ' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -79.28 -17.28 54.98 Favored 'General case' 0 C--N 1.354 0.796 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.016 -178.365 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -74.83 -42.06 32.02 Favored Glycine 0 C--N 1.348 1.245 0 N-CA-C 109.258 -1.537 . . . . 0.0 109.258 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.3 tpp -70.73 -37.92 73.52 Favored 'General case' 0 C--N 1.354 0.797 0 O-C-N 122.103 -0.645 . . . . 0.0 110.808 -177.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.49 HG22 ' HA ' ' A' ' 2' ' ' MET . 27.2 m -69.87 -23.16 25.33 Favored 'Isoleucine or valine' 0 C--N 1.357 0.914 0 O-C-N 121.614 -0.679 . . . . 0.0 109.723 -179.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.434 ' HZ ' ' CG ' ' A' ' 47' ' ' GLU . 1.5 m-85 -71.22 -34.78 71.13 Favored 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 88.3 m -67.03 -40.29 87.19 Favored 'General case' 0 C--N 1.354 0.795 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 -179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -63.04 -39.21 97.76 Favored Glycine 0 C--N 1.359 1.825 0 N-CA-C 110.387 -1.085 . . . . 0.0 110.387 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.566 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -64.7 -40.02 94.66 Favored 'General case' 0 C--N 1.352 0.703 0 O-C-N 122.54 -0.388 . . . . 0.0 110.695 -178.333 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 24.6 mmt -64.18 -40.52 96.29 Favored 'General case' 0 C--N 1.353 0.739 0 O-C-N 121.672 -0.642 . . . . 0.0 111.046 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -65.53 -40.32 92.77 Favored 'General case' 0 C--N 1.349 0.552 0 O-C-N 121.991 -0.443 . . . . 0.0 111.516 -178.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 56.0 tp -66.14 -43.62 86.53 Favored 'General case' 0 C--N 1.348 0.542 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -178.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.566 HG12 ' O ' ' A' ' 9' ' ' LEU . 2.4 mm -72.84 -37.28 54.32 Favored 'Isoleucine or valine' 0 C--N 1.361 1.071 0 O-C-N 121.155 -0.966 . . . . 0.0 110.975 -175.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.423 ' HB2' HD13 ' A' ' 22' ' ' LEU . 71.2 tt0 -71.13 -41.49 70.44 Favored 'General case' 0 N--CA 1.449 -0.509 0 O-C-N 121.864 -0.522 . . . . 0.0 111.609 -175.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -72.59 -35.47 67.92 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -175.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -94.54 -30.27 14.47 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 118.901 -1.12 . . . . 0.0 113.966 -174.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -116.04 -30.97 5.87 Favored 'General case' 0 CA--C 1.506 -0.712 0 C-N-CA 117.538 -1.665 . . . . 0.0 112.728 -176.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 139.87 177.71 16.05 Favored Glycine 0 C--N 1.346 1.113 0 C-N-CA 118.346 -1.883 . . . . 0.0 109.523 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -99.11 -18.35 17.75 Favored 'General case' 0 N--CA 1.433 -1.315 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -177.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -70.44 -39.59 74.26 Favored 'General case' 0 C--N 1.36 1.049 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 94.3 m -67.92 -39.19 83.55 Favored 'General case' 0 C--N 1.357 0.899 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 179.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.423 HD13 ' HB2' ' A' ' 14' ' ' GLU . 1.0 OUTLIER -60.71 -38.16 84.09 Favored 'General case' 0 C--N 1.355 0.847 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 179.518 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -63.78 -37.17 86.38 Favored 'General case' 0 C--N 1.357 0.916 0 O-C-N 122.154 -0.341 . . . . 0.0 110.787 -178.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.4 m -64.91 -40.49 95.15 Favored 'General case' 0 C--N 1.356 0.884 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -178.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.596 ' CD2' ' HB3' ' A' ' 54' ' ' LYS . 31.4 mt -63.84 -36.75 84.93 Favored 'General case' 0 C--N 1.359 0.982 0 O-C-N 121.946 -0.471 . . . . 0.0 109.957 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.5 mt -71.49 -16.03 62.34 Favored 'General case' 0 C--N 1.358 0.971 0 O-C-N 121.661 -0.65 . . . . 0.0 110.184 -178.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -86.46 -27.73 23.92 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 119.351 -0.939 . . . . 0.0 109.278 179.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 41.7 t -67.01 -37.1 83.57 Favored 'General case' 0 C--N 1.355 0.845 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 178.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.8 p -93.02 -39.0 11.34 Favored 'General case' 0 C--N 1.359 0.988 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 -179.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 84.12 133.25 0.05 OUTLIER 'General case' 0 C--N 1.361 1.104 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 179.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.524 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -91.44 -167.05 1.7 Allowed 'General case' 0 C--N 1.357 0.919 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.636 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.414 ' H ' ' HB2' ' A' ' 31' ' ' LEU . 63.3 tt0 -152.99 -66.76 0.16 Allowed 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 106.676 -1.601 . . . . 0.0 106.676 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.7 t -97.57 -66.55 0.89 Allowed 'General case' 0 N--CA 1.441 -0.9 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -130.35 -44.76 1.12 Allowed 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 -179.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 113.21 -33.72 5.42 Favored Glycine 0 C--N 1.353 1.474 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 179.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 83.8 mt -117.22 107.51 22.48 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.01 0 CA-C-N 118.413 1.107 . . . . 0.0 108.073 -179.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.503 ' HD1' ' HA ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -84.08 -147.78 0.1 Allowed 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 178.185 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.524 HG23 ' N ' ' A' ' 39' ' ' SER . 5.0 t -119.46 -53.56 2.22 Favored 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.524 ' N ' HG23 ' A' ' 38' ' ' THR . 23.8 p 170.05 65.33 0.0 OUTLIER 'General case' 0 C--N 1.362 1.138 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.5 t -145.49 -11.24 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.957 0 C-N-CA 119.525 -0.87 . . . . 0.0 110.149 -178.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -91.62 142.08 15.93 Favored Glycine 0 C--N 1.352 1.446 0 C-N-CA 119.275 -1.44 . . . . 0.0 110.538 -177.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.1 m -123.61 123.12 39.86 Favored 'General case' 0 C--N 1.354 0.767 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 178.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -117.5 175.4 5.65 Favored 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -179.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -81.86 -172.49 3.94 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 -179.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 68.9 m80 -90.64 -15.09 31.07 Favored 'General case' 0 N--CA 1.441 -0.896 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -179.102 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -68.74 -29.39 67.79 Favored 'General case' 0 C--N 1.352 0.678 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.434 ' CG ' ' HZ ' ' A' ' 6' ' ' PHE . 26.5 tp10 -64.38 -39.81 94.59 Favored 'General case' 0 C--N 1.353 0.722 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.419 HD22 ' O ' ' A' ' 48' ' ' LEU . 1.8 tm? -66.66 -38.56 87.11 Favored 'General case' 0 C--N 1.36 1.03 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 61.9 tp -70.32 -35.06 73.4 Favored 'General case' 0 CA--C 1.508 -0.667 0 O-C-N 122.232 -0.292 . . . . 0.0 110.47 -177.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -64.67 -41.2 96.24 Favored 'General case' 0 N--CA 1.444 -0.77 0 O-C-N 121.936 -0.478 . . . . 0.0 109.914 -177.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 80.7 mt -83.55 -18.1 39.53 Favored 'General case' 0 C--N 1.359 1.001 0 C-N-CA 119.625 -0.83 . . . . 0.0 110.601 -179.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.4 t -80.33 -38.84 18.42 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.0 p -71.76 -30.55 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 O-C-N 121.597 -0.689 . . . . 0.0 109.406 179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.596 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 33.5 tptt -70.97 -28.39 64.42 Favored 'General case' 0 C--N 1.368 1.373 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.539 HD13 HD11 ' A' ' 66' ' ' LEU . 1.1 mt -63.85 -42.02 97.66 Favored 'General case' 0 C--N 1.355 0.837 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 46.7 t -66.21 -39.94 89.98 Favored 'General case' 0 C--N 1.352 0.707 0 O-C-N 121.736 -0.602 . . . . 0.0 110.648 -179.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -77.64 -40.31 42.21 Favored 'General case' 0 C--N 1.352 0.716 0 O-C-N 121.123 -0.985 . . . . 0.0 112.876 -177.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.0 p -75.29 -39.88 42.62 Favored 'Isoleucine or valine' 0 C--N 1.354 0.771 0 O-C-N 121.531 -0.731 . . . . 0.0 112.348 -175.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 63.4 m -105.69 -9.25 17.41 Favored 'General case' 0 CA--C 1.503 -0.845 0 O-C-N 121.173 -0.954 . . . . 0.0 110.316 -177.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.417 ' HA ' ' O ' ' A' ' 56' ' ' SER . 0.4 OUTLIER 68.03 38.16 2.8 Favored 'General case' 0 C--N 1.351 0.656 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 -179.881 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 56' ' ' SER . 58.2 t -115.37 128.05 26.28 Favored Pre-proline 0 N--CA 1.443 -0.81 0 N-CA-C 106.939 -1.504 . . . . 0.0 106.939 179.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 61' ' ' VAL . 37.2 Cg_exo -59.86 154.02 52.9 Favored 'Trans proline' 0 CA--C 1.496 -1.376 0 C-N-CA 122.72 2.28 . . . . 0.0 113.519 -179.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 15.3 m -76.43 -7.71 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.66 -177.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.497 ' O ' HG12 ' A' ' 67' ' ' VAL . 81.4 p -94.71 -36.4 11.75 Favored 'General case' 0 C--N 1.358 0.944 0 C-N-CA 118.315 -1.354 . . . . 0.0 110.113 -178.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -82.48 -23.42 34.72 Favored 'General case' 0 CA--C 1.501 -0.909 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.539 HD11 HD13 ' A' ' 55' ' ' LEU . 0.5 OUTLIER -70.29 -43.36 70.57 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.609 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.497 HG12 ' O ' ' A' ' 64' ' ' THR . 4.6 p -67.47 -28.89 43.67 Favored 'Isoleucine or valine' 0 C--N 1.354 0.803 0 C-N-CA 120.491 -0.484 . . . . 0.0 110.678 -179.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -65.96 -47.92 73.02 Favored 'General case' 0 C--N 1.366 1.286 0 O-C-N 121.067 -1.021 . . . . 0.0 110.242 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 88.6 mt -64.53 -36.33 83.85 Favored 'General case' 0 C--N 1.353 0.739 0 O-C-N 122.353 -0.217 . . . . 0.0 111.191 -178.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -60.84 -47.4 86.53 Favored 'General case' 0 C--N 1.349 0.582 0 O-C-N 122.115 -0.365 . . . . 0.0 110.44 -178.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.03 -39.24 96.8 Favored Glycine 0 C--N 1.353 1.524 0 N-CA-C 111.882 -0.487 . . . . 0.0 111.882 -178.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -63.38 -47.86 80.28 Favored 'General case' 0 C--N 1.351 0.656 0 CA-C-N 118.127 0.963 . . . . 0.0 111.615 -177.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 9.4 mttm -64.38 -49.02 73.26 Favored 'General case' 0 C--N 1.357 0.925 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -177.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.418 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.5 tm? -69.11 -39.8 78.74 Favored 'General case' 0 C--N 1.349 0.566 0 O-C-N 121.194 -0.941 . . . . 0.0 111.865 -175.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -64.16 -45.97 86.1 Favored 'General case' 0 C--N 1.353 0.744 0 O-C-N 121.269 -0.895 . . . . 0.0 111.123 -177.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.7 p -72.11 -12.38 15.79 Favored 'Isoleucine or valine' 0 C--N 1.358 0.941 0 O-C-N 121.586 -0.696 . . . . 0.0 109.463 -179.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -78.52 -36.79 44.39 Favored 'General case' 0 N--CA 1.447 -0.611 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 80.2 mt -70.57 -34.61 72.39 Favored 'General case' 0 C--N 1.358 0.94 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.3 mm -62.77 -50.37 79.99 Favored 'Isoleucine or valine' 0 C--N 1.357 0.904 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -178.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -67.89 -22.3 65.1 Favored 'General case' 0 C--N 1.351 0.66 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.414 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -95.83 -1.18 61.8 Favored Glycine 0 C--N 1.347 1.19 0 C-N-CA 119.609 -1.281 . . . . 0.0 110.684 -177.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.637 ' HB3' ' HB ' ' A' ' 85' ' ' ILE . 93.2 m-70 -141.21 88.6 10.0 Favored Pre-proline 0 CA--C 1.503 -0.859 0 CA-C-N 118.937 1.368 . . . . 0.0 108.962 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 82' ' ' HIS . 36.8 Cg_endo -67.52 -25.79 40.84 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.425 2.083 . . . . 0.0 114.194 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -92.75 -6.14 49.69 Favored 'General case' 0 N--CA 1.442 -0.85 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.637 ' HB ' ' HB3' ' A' ' 82' ' ' HIS . 1.0 OUTLIER -90.44 -22.3 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 -178.81 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -102.05 -21.4 14.46 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -69.85 -39.15 76.56 Favored 'General case' 0 C--N 1.355 0.827 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -65.48 -33.75 76.67 Favored 'General case' 0 C--N 1.356 0.861 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -179.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.636 ' HG2' ' N ' ' A' ' 90' ' ' LYS . 0.0 OUTLIER -80.28 155.43 27.29 Favored 'General case' 0 C--N 1.353 0.749 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 -178.908 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.636 ' N ' ' HG2' ' A' ' 89' ' ' MET . 3.4 mtpt -117.15 -27.71 6.41 Favored 'General case' 0 C--N 1.364 1.207 0 C-N-CA 120.058 -0.657 . . . . 0.0 111.319 -177.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -167.08 175.47 7.51 Favored 'General case' 0 CA--C 1.505 -0.765 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 -177.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 65.1 m -66.62 -40.09 88.63 Favored 'General case' 0 C--N 1.354 0.763 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.415 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 74.0 m-85 -68.03 -39.61 83.09 Favored 'General case' 0 C--N 1.356 0.882 0 C-N-CA 119.587 -0.845 . . . . 0.0 108.805 -178.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -66.57 -23.03 66.15 Favored 'General case' 0 C--N 1.354 0.779 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.4 HD22 ' SG ' ' A' ' 150' ' ' CYS . 60.1 tp -65.25 -45.52 84.26 Favored 'General case' 0 C--N 1.354 0.797 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.5 mp -61.83 -36.5 81.36 Favored 'General case' 0 C--N 1.357 0.901 0 O-C-N 121.993 -0.442 . . . . 0.0 110.165 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 34.0 t -67.49 -39.83 85.2 Favored 'General case' 0 C--N 1.349 0.561 0 O-C-N 121.927 -0.483 . . . . 0.0 110.211 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 11.4 tttp -93.01 6.37 48.18 Favored 'General case' 0 C--N 1.353 0.76 0 O-C-N 122.241 -0.287 . . . . 0.0 111.567 -176.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 1.276 HD11 ' C3B' ' A' ' 202' ' ' HEM . 9.9 tp -64.4 -38.74 83.36 Favored 'Isoleucine or valine' 0 C--N 1.356 0.859 0 O-C-N 121.391 -0.818 . . . . 0.0 111.671 -177.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -103.44 -21.69 13.76 Favored 'General case' 0 N--CA 1.437 -1.116 0 O-C-N 120.884 -1.135 . . . . 0.0 110.26 -178.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 35.2 t -62.98 -47.0 85.04 Favored 'General case' 0 N--CA 1.445 -0.687 0 O-C-N 121.564 -0.71 . . . . 0.0 111.691 -178.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 11.9 t80 -137.5 -14.49 1.47 Allowed 'General case' 0 C--N 1.36 1.057 0 C-N-CA 117.369 -1.732 . . . . 0.0 113.036 -177.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.582 HG21 ' C1C' ' A' ' 202' ' ' HEM . 32.3 mm -70.41 -51.37 38.52 Favored 'Isoleucine or valine' 0 C--O 1.242 0.694 0 CA-C-N 120.099 1.318 . . . . 0.0 110.633 -177.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 35.5 m170 -91.9 2.32 56.61 Favored 'General case' 0 N--CA 1.439 -1.02 0 C-N-CA 119.485 -0.886 . . . . 0.0 110.301 -177.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 52.7 t -83.26 -44.22 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.032 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -68.34 -40.56 81.52 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 69.9 t -63.45 -46.77 94.35 Favored 'Isoleucine or valine' 0 C--N 1.357 0.901 0 C-N-CA 120.591 -0.444 . . . . 0.0 110.363 -179.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -60.75 -48.59 81.09 Favored 'General case' 0 C--N 1.357 0.926 0 O-C-N 122.064 -0.397 . . . . 0.0 111.409 -179.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -61.6 -37.21 83.07 Favored 'General case' 0 C--N 1.356 0.86 0 O-C-N 121.495 -0.753 . . . . 0.0 110.538 -178.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.5 mt -56.98 -73.9 0.06 Allowed 'General case' 0 C--N 1.357 0.9 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -119.13 135.47 23.9 Favored Pre-proline 0 N--CA 1.438 -1.047 0 C-N-CA 118.475 -1.29 . . . . 0.0 109.032 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -83.51 -4.61 10.87 Favored 'Trans proline' 0 C--N 1.313 -1.342 0 C-N-CA 123.174 2.583 . . . . 0.0 115.175 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -66.6 -36.84 83.58 Favored 'General case' 0 C--N 1.354 0.79 0 O-C-N 121.88 -0.512 . . . . 0.0 109.842 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.1 145.65 55.09 Favored 'General case' 0 C--N 1.354 0.764 0 CA-C-O 121.554 0.692 . . . . 0.0 109.787 -178.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 -130.45 135.44 47.99 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 179.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.54 ' HB3' ' HD2' ' A' ' 117' ' ' PRO . 86.4 mt -127.68 157.18 74.09 Favored Pre-proline 0 N--CA 1.443 -0.823 0 CA-C-O 122.173 0.987 . . . . 0.0 109.196 -178.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.54 ' HD2' ' HB3' ' A' ' 116' ' ' LEU . 83.6 Cg_endo -81.02 -156.36 0.07 OUTLIER 'Trans proline' 0 C--N 1.316 -1.139 0 C-N-CA 123.797 2.998 . . . . 0.0 114.115 -179.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -113.38 140.26 48.2 Favored 'General case' 0 C--N 1.364 1.207 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 -179.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -123.67 127.02 47.59 Favored 'General case' 0 C--N 1.362 1.144 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -179.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.479 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 94.2 m -126.26 128.98 48.01 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 105.583 -2.006 . . . . 0.0 105.583 177.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 81.0 m -119.83 130.73 55.03 Favored 'General case' 0 CA--C 1.503 -0.851 0 C-N-CA 119.105 -1.038 . . . . 0.0 109.677 -177.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -119.14 127.13 53.05 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 178.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 66.2 ttp85 -102.18 116.69 33.2 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 92.8 mt -87.42 -21.61 25.49 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.378 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 177.68 -146.59 7.69 Favored Glycine 0 N--CA 1.438 -1.226 0 C-N-CA 118.844 -1.645 . . . . 0.0 109.103 -178.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -94.72 -40.05 9.98 Favored 'General case' 0 N--CA 1.437 -1.097 0 C-N-CA 120.081 -0.648 . . . . 0.0 109.411 -178.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -101.53 1.45 38.02 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 119.772 -0.771 . . . . 0.0 110.24 -178.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -119.01 130.43 55.66 Favored 'General case' 0 C--N 1.358 0.968 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 7.6 mm -141.13 136.77 33.68 Favored 'Isoleucine or valine' 0 C--N 1.356 0.861 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 55.6 mtm180 -122.57 139.14 54.24 Favored 'General case' 0 CA--C 1.502 -0.881 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.655 ' HG ' ' O ' ' A' ' 131' ' ' LEU . 0.1 OUTLIER -130.16 125.68 35.63 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.078 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.479 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 13.5 m-70 -96.77 134.56 39.89 Favored 'General case' 0 CA--C 1.495 -1.165 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 179.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -127.87 119.9 26.59 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 107.154 -1.424 . . . . 0.0 107.154 -178.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.534 ' HA ' ' O ' ' A' ' 171' ' ' THR . 76.6 mt-30 -113.51 114.74 26.94 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 179.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 12.7 t -162.73 152.55 15.92 Favored 'General case' 0 C--N 1.358 0.96 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 179.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -90.62 2.71 55.62 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 120.271 -0.572 . . . . 0.0 109.652 -179.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -136.11 74.54 55.86 Favored Pre-proline 0 CA--C 1.505 -0.752 0 N-CA-C 106.754 -1.573 . . . . 0.0 106.754 179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -95.88 107.78 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.771 2.314 . . . . 0.0 115.776 -177.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -111.94 113.6 26.02 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 176.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.98 -38.28 90.49 Favored 'General case' 0 C--N 1.353 0.73 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.007 -179.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.0 m -63.27 -27.34 69.27 Favored 'General case' 0 C--N 1.354 0.773 0 O-C-N 122.009 -0.432 . . . . 0.0 110.875 -178.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 82.6 t80 -76.63 -46.43 25.96 Favored 'General case' 0 C--N 1.351 0.652 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.639 -178.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.63 -40.11 94.9 Favored 'General case' 0 C--N 1.357 0.923 0 O-C-N 122.039 -0.413 . . . . 0.0 111.056 -178.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.64 -37.25 86.61 Favored 'General case' 0 C--N 1.355 0.83 0 O-C-N 121.907 -0.496 . . . . 0.0 110.081 -179.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -59.88 -43.16 98.28 Favored Glycine 0 C--N 1.347 1.176 0 N-CA-C 110.02 -1.232 . . . . 0.0 110.02 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 83.5 mt -69.78 -40.78 75.83 Favored 'General case' 0 C--N 1.352 0.694 0 CA-C-N 117.749 0.774 . . . . 0.0 112.503 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 98.0 mt -71.29 -42.41 68.73 Favored 'General case' 0 C--N 1.361 1.083 0 O-C-N 121.206 -0.934 . . . . 0.0 110.961 -176.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.496 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 37.0 t70 -69.93 -31.36 69.08 Favored 'General case' 0 N--CA 1.446 -0.652 0 O-C-N 121.956 -0.465 . . . . 0.0 110.514 -179.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -62.84 -39.38 97.92 Favored Glycine 0 C--N 1.357 1.745 0 N-CA-C 108.46 -1.856 . . . . 0.0 108.46 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . 0.4 ' SG ' HD22 ' A' ' 95' ' ' LEU . 49.9 t -60.71 -41.46 95.29 Favored 'General case' 0 C--N 1.35 0.6 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 178.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -74.8 -1.48 22.33 Favored 'General case' 0 C--N 1.361 1.077 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 77.7 mm-40 -84.4 -46.07 12.08 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 179.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 92.9 t80 -65.95 -45.06 83.16 Favored 'General case' 0 C--N 1.359 0.989 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.416 ' HZ ' ' SD ' ' A' ' 89' ' ' MET . 38.9 m-85 -69.01 -26.62 65.09 Favored 'General case' 0 C--N 1.36 1.053 0 O-C-N 121.874 -0.516 . . . . 0.0 110.802 -178.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 78.9 tttt 72.72 74.35 0.15 Allowed 'General case' 0 C--N 1.36 1.035 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -178.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -143.13 -168.12 2.72 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -148.67 94.45 2.28 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -111.88 156.11 22.56 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 106.14 -1.8 . . . . 0.0 106.14 178.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 93.9 m -119.47 127.1 52.74 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 119.208 -0.997 . . . . 0.0 108.716 -178.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.497 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.7 mp -103.89 122.2 56.33 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 178.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.5 m -115.64 -175.96 2.83 Favored 'General case' 0 C--N 1.354 0.794 0 CA-C-O 121.826 0.822 . . . . 0.0 109.134 -179.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 3.5 ptt180 -146.75 153.63 40.46 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 -178.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 44.8 p -97.62 145.93 30.55 Favored Pre-proline 0 C--N 1.361 1.08 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.623 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 76.8 Cg_endo -77.13 -11.24 17.79 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.944 2.429 . . . . 0.0 115.127 -178.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -72.74 -41.29 65.32 Favored 'General case' 0 N--CA 1.442 -0.845 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.573 -178.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 36.8 p -116.96 15.3 15.16 Favored 'General case' 0 C--N 1.354 0.783 0 C-N-CA 120.16 -0.616 . . . . 0.0 110.299 -178.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.623 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.5 pp0? -65.13 -13.65 58.63 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.408 178.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -126.89 43.18 3.17 Favored 'General case' 0 N--CA 1.435 -1.213 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 16.8 t -142.57 145.13 33.27 Favored 'General case' 0 C--N 1.353 0.75 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.631 ' O ' ' HB ' ' A' ' 171' ' ' THR . 61.1 mt-10 -98.98 165.49 11.73 Favored 'General case' 0 C--N 1.354 0.804 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 -179.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.631 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 3.0 m 83.42 -57.13 0.15 Allowed 'General case' 0 C--N 1.369 1.423 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.637 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -110.93 117.44 33.38 Favored 'General case' 0 CA--C 1.506 -0.72 0 C-N-CA 119.814 -0.754 . . . . 0.0 109.603 -178.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 98.7 t -131.33 133.39 62.27 Favored 'Isoleucine or valine' 0 C--N 1.356 0.857 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 178.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 48.6 mm -109.36 125.99 66.47 Favored 'Isoleucine or valine' 0 C--N 1.358 0.964 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -179.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -115.08 148.38 39.0 Favored 'General case' 0 C--N 1.357 0.922 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 -179.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -128.58 117.4 21.19 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 -179.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.8 mp -111.94 118.38 57.51 Favored 'Isoleucine or valine' 0 C--N 1.354 0.765 0 N-CA-C 106.145 -1.798 . . . . 0.0 106.145 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 89.3 m -124.3 142.84 50.94 Favored 'General case' 0 CA--C 1.502 -0.893 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -177.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 12.2 ttt180 -91.01 113.48 25.75 Favored 'General case' 0 C--N 1.363 1.153 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 178.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -71.55 150.6 93.7 Favored Pre-proline 0 CA--C 1.498 -1.029 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.79 120.96 8.98 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.227 1.951 . . . . 0.0 112.861 -179.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 3.9 ppt_? -135.99 146.48 47.25 Favored 'General case' 0 N--CA 1.431 -1.382 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.406 ' O ' ' HB3' ' A' ' 184' ' ' ALA . . . 91.48 78.25 1.37 Allowed Glycine 0 C--N 1.352 1.428 0 N-CA-C 107.839 -2.104 . . . . 0.0 107.839 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' A' ' 183' ' ' GLY . . . 70.77 73.29 0.2 Allowed 'General case' 0 C--N 1.36 1.025 0 N-CA-C 108.339 -0.985 . . . . 0.0 108.339 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -58.62 140.94 53.69 Favored 'General case' 0 C--N 1.357 0.922 0 CA-C-O 121.75 0.786 . . . . 0.0 110.076 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -126.39 131.43 51.76 Favored 'General case' 0 N--CA 1.441 -0.921 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 50.1 tp -92.26 -65.71 0.98 Allowed 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -156.13 -85.25 0.05 Allowed 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -126.65 146.35 50.22 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 . . . . . 0 C--O 1.263 1.815 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -179.855 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' HEM . . . . . 1.276 ' C3B' HD11 ' A' ' 99' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.692 ' HG2' ' HB2' ' A' ' 4' ' ' MET . 27.2 tpp . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 120.881 0.372 . . . . 0.0 110.538 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.34 -20.14 41.29 Favored 'General case' 0 CA--C 1.505 -0.785 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -179.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -77.86 -37.68 29.08 Favored Glycine 0 C--N 1.35 1.331 0 N-CA-C 109.101 -1.599 . . . . 0.0 109.101 -179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.692 ' HB2' ' HG2' ' A' ' 1' ' ' MET . 3.0 tpp -70.84 -38.21 73.18 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 122.035 -0.685 . . . . 0.0 110.707 -177.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 27.2 m -71.28 -23.14 22.82 Favored 'Isoleucine or valine' 0 C--N 1.357 0.93 0 O-C-N 121.651 -0.656 . . . . 0.0 109.415 -178.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.0 m-30 -71.06 -33.38 70.22 Favored 'General case' 0 C--N 1.357 0.893 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.1 m -67.14 -40.17 86.68 Favored 'General case' 0 C--N 1.355 0.809 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.93 -38.82 97.22 Favored Glycine 0 C--N 1.36 1.893 0 N-CA-C 110.581 -1.008 . . . . 0.0 110.581 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.506 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.1 OUTLIER -66.13 -39.11 89.62 Favored 'General case' 0 C--N 1.353 0.736 0 CA-C-N 117.274 0.537 . . . . 0.0 110.31 -177.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.443 ' CE ' HD21 ' A' ' 26' ' ' LEU . 25.5 mmt -64.02 -40.6 96.71 Favored 'General case' 0 C--N 1.355 0.822 0 O-C-N 121.635 -0.666 . . . . 0.0 110.753 -178.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -64.77 -40.07 94.66 Favored 'General case' 0 C--N 1.349 0.547 0 O-C-N 122.055 -0.403 . . . . 0.0 111.307 -178.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 58.2 tp -65.0 -42.68 94.26 Favored 'General case' 0 C--N 1.35 0.592 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.659 HD12 HD21 ' A' ' 55' ' ' LEU . 3.3 mm -72.44 -37.58 57.99 Favored 'Isoleucine or valine' 0 C--N 1.358 0.96 0 O-C-N 121.169 -0.957 . . . . 0.0 111.179 -175.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -68.02 -43.75 78.05 Favored 'General case' 0 C--N 1.352 0.679 0 O-C-N 121.821 -0.549 . . . . 0.0 111.653 -175.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -71.9 -32.45 67.42 Favored 'General case' 0 N--CA 1.447 -0.579 0 O-C-N 122.001 -0.437 . . . . 0.0 111.487 -177.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -72.5 -49.96 29.32 Favored 'General case' 0 N--CA 1.443 -0.802 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -175.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -127.98 -20.97 3.73 Favored 'General case' 0 C--N 1.357 0.917 0 C-N-CA 117.347 -1.741 . . . . 0.0 113.694 -176.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 143.42 178.88 19.61 Favored Glycine 0 CA--C 1.499 -0.947 0 C-N-CA 117.678 -2.201 . . . . 0.0 110.23 -179.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -96.5 -11.34 25.65 Favored 'General case' 0 N--CA 1.429 -1.5 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -177.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -74.64 -36.57 62.88 Favored 'General case' 0 C--N 1.359 0.986 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.2 m -70.11 -38.91 75.74 Favored 'General case' 0 C--N 1.358 0.952 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 178.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.7 tt -59.84 -38.09 81.09 Favored 'General case' 0 C--N 1.359 0.994 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -64.12 -37.09 86.19 Favored 'General case' 0 C--N 1.356 0.87 0 O-C-N 122.097 -0.377 . . . . 0.0 110.788 -178.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.5 m -65.25 -40.63 94.24 Favored 'General case' 0 C--N 1.355 0.836 0 O-C-N 121.698 -0.626 . . . . 0.0 109.62 -178.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.41 HD22 ' HB3' ' A' ' 54' ' ' LYS . 78.7 mt -64.9 -36.82 85.6 Favored 'General case' 0 C--N 1.356 0.868 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 -178.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.443 HD21 ' CE ' ' A' ' 10' ' ' MET . 81.1 mt -70.84 -16.5 62.72 Favored 'General case' 0 C--N 1.36 1.048 0 O-C-N 121.765 -0.584 . . . . 0.0 110.235 -179.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -85.07 -27.83 26.06 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 119.449 -0.9 . . . . 0.0 109.29 179.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.2 t -66.89 -37.54 84.59 Favored 'General case' 0 C--N 1.355 0.825 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.8 p -91.61 -39.54 11.82 Favored 'General case' 0 C--N 1.359 0.995 0 C-N-CA 119.064 -1.054 . . . . 0.0 108.18 -179.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 86.15 132.45 0.04 OUTLIER 'General case' 0 C--N 1.36 1.049 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.532 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -91.91 -167.07 1.69 Allowed 'General case' 0 C--N 1.356 0.885 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.841 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.416 ' H ' ' HB2' ' A' ' 31' ' ' LEU . 4.3 mt-30 -153.05 -66.3 0.15 Allowed 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 106.816 -1.549 . . . . 0.0 106.816 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.0 t -97.71 -67.12 0.86 Allowed 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -131.42 -46.53 0.98 Allowed 'General case' 0 N--CA 1.441 -0.923 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 115.24 -37.37 3.51 Favored Glycine 0 C--N 1.354 1.566 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 179.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 81.9 mt -113.62 106.09 20.02 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.041 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 -179.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.523 ' HD1' ' HA ' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -82.57 -150.78 0.09 Allowed 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 178.496 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.409 ' H ' ' HB3' ' A' ' 37' ' ' TYR . 86.2 m -112.09 -57.84 2.21 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 11.6 p 169.06 69.8 0.0 OUTLIER 'General case' 0 C--N 1.36 1.029 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 -179.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 2.2 t -150.29 -6.69 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.361 1.081 0 C-N-CA 119.707 -0.797 . . . . 0.0 110.047 -178.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -95.26 143.08 16.42 Favored Glycine 0 C--N 1.352 1.447 0 C-N-CA 119.28 -1.438 . . . . 0.0 110.465 -177.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 46.0 m -123.94 116.77 23.42 Favored 'General case' 0 C--N 1.356 0.871 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 178.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -111.66 177.42 4.66 Favored 'General case' 0 CA--C 1.502 -0.898 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -78.66 -175.14 4.23 Favored 'General case' 0 N--CA 1.441 -0.905 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 65.4 m80 -94.38 -15.6 24.2 Favored 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 119.781 -0.767 . . . . 0.0 109.179 -179.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -68.88 -29.22 67.47 Favored 'General case' 0 C--N 1.353 0.749 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 178.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.6 tp10 -62.72 -41.51 99.19 Favored 'General case' 0 C--N 1.353 0.719 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.406 ' O ' HG23 ' A' ' 52' ' ' VAL . 59.9 tp -67.62 -38.74 84.36 Favored 'General case' 0 C--N 1.357 0.893 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.218 -179.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 60.5 tp -72.3 -34.69 68.32 Favored 'General case' 0 N--CA 1.446 -0.647 0 O-C-N 122.259 -0.276 . . . . 0.0 110.689 -177.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 72.7 tp60 -64.18 -41.81 96.95 Favored 'General case' 0 C--N 1.353 0.721 0 O-C-N 121.589 -0.694 . . . . 0.0 110.004 -177.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 84.2 mt -71.79 -34.64 69.58 Favored 'General case' 0 C--N 1.362 1.113 0 C-N-CA 119.534 -0.867 . . . . 0.0 109.431 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.565 HG13 HD21 ' A' ' 66' ' ' LEU . 29.2 t -62.65 -42.12 94.82 Favored 'Isoleucine or valine' 0 C--N 1.351 0.645 0 CA-C-O 120.705 0.288 . . . . 0.0 110.309 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 53.9 t -65.76 -40.21 87.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 -179.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.41 ' HB3' HD22 ' A' ' 25' ' ' LEU . 32.1 tptt -65.22 -29.2 69.98 Favored 'General case' 0 C--N 1.361 1.107 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.659 HD21 HD12 ' A' ' 13' ' ' ILE . 16.0 mt -64.27 -40.26 95.6 Favored 'General case' 0 C--N 1.357 0.902 0 O-C-N 121.968 -0.457 . . . . 0.0 110.395 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.611 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 46.5 t -65.39 -37.44 87.0 Favored 'General case' 0 C--N 1.349 0.573 0 O-C-N 121.775 -0.578 . . . . 0.0 110.324 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -83.74 -38.25 21.61 Favored 'General case' 0 C--N 1.353 0.73 0 O-C-N 121.242 -0.911 . . . . 0.0 112.811 -177.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.6 p -76.03 -41.6 38.4 Favored 'Isoleucine or valine' 0 C--N 1.355 0.83 0 O-C-N 121.354 -0.841 . . . . 0.0 111.897 -176.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 72.8 m -103.66 -5.66 22.38 Favored 'General case' 0 C--N 1.354 0.803 0 O-C-N 121.198 -0.939 . . . . 0.0 110.486 -177.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 74.6 m 65.05 38.95 5.9 Favored 'General case' 0 C--N 1.354 0.769 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.611 ' O ' ' HA ' ' A' ' 56' ' ' SER . 55.4 t -115.53 132.22 23.23 Favored Pre-proline 0 CA--C 1.505 -0.778 0 N-CA-C 106.767 -1.568 . . . . 0.0 106.767 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.474 ' HD2' HG13 ' A' ' 61' ' ' VAL . 31.2 Cg_endo -63.99 157.16 54.47 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.258 1.972 . . . . 0.0 114.095 -178.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.839 ' HA ' HD23 ' A' ' 66' ' ' LEU . 15.5 m -75.98 -12.66 14.62 Favored 'Isoleucine or valine' 0 C--N 1.353 0.742 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.031 -177.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.475 ' O ' HG12 ' A' ' 67' ' ' VAL . 81.1 p -94.13 -35.14 12.67 Favored 'General case' 0 C--N 1.356 0.888 0 C-N-CA 118.068 -1.453 . . . . 0.0 110.129 -178.323 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -80.9 -21.22 40.76 Favored 'General case' 0 C--N 1.353 0.737 0 O-C-N 121.167 -0.958 . . . . 0.0 108.892 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.839 HD23 ' HA ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -77.19 -36.67 54.78 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.732 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.515 ' N ' ' HG ' ' A' ' 66' ' ' LEU . 1.8 p -68.83 -28.9 41.59 Favored 'Isoleucine or valine' 0 C--N 1.359 0.981 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.055 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -68.49 -49.1 62.24 Favored 'General case' 0 C--N 1.365 1.265 0 O-C-N 121.234 -0.916 . . . . 0.0 110.656 179.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.9 mt -63.83 -36.41 83.81 Favored 'General case' 0 C--N 1.357 0.893 0 O-C-N 122.069 -0.395 . . . . 0.0 111.027 -178.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -61.16 -47.07 87.88 Favored 'General case' 0 C--N 1.348 0.536 0 O-C-N 122.134 -0.354 . . . . 0.0 110.495 -178.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.25 -39.29 96.99 Favored Glycine 0 C--N 1.354 1.537 0 CA-C-O 119.787 -0.452 . . . . 0.0 112.17 -177.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -65.7 -45.45 82.75 Favored 'General case' 0 C--N 1.352 0.674 0 CA-C-N 118.513 1.157 . . . . 0.0 111.638 -177.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 12.2 mttm -64.86 -48.24 75.0 Favored 'General case' 0 C--N 1.357 0.921 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -177.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.406 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.2 tm? -70.76 -39.31 73.33 Favored 'General case' 0 C--N 1.349 0.563 0 O-C-N 121.263 -0.898 . . . . 0.0 111.963 -176.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -63.56 -46.45 85.85 Favored 'General case' 0 C--N 1.353 0.755 0 O-C-N 121.103 -0.998 . . . . 0.0 111.239 -178.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.8 p -70.89 -14.72 18.26 Favored 'Isoleucine or valine' 0 C--N 1.357 0.931 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -71.11 -39.76 71.88 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 179.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 87.7 mt -75.78 -27.19 57.93 Favored 'General case' 0 C--N 1.359 0.986 0 O-C-N 122.258 -0.276 . . . . 0.0 110.569 -179.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.1 mm -65.78 -53.59 36.78 Favored 'Isoleucine or valine' 0 C--N 1.36 1.059 0 C-N-CA 119.755 -0.778 . . . . 0.0 109.432 -178.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -75.26 -14.6 60.52 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 119.611 -0.836 . . . . 0.0 109.259 178.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.7 -37.58 61.47 Favored Glycine 0 C--N 1.35 1.345 0 N-CA-C 110.723 -0.951 . . . . 0.0 110.723 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -132.55 102.9 13.69 Favored Pre-proline 0 C--N 1.356 0.887 0 CA-C-O 122.611 1.196 . . . . 0.0 109.104 -177.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.488 ' O ' ' HB2' ' A' ' 87' ' ' ASN . 40.3 Cg_endo -68.74 -22.23 37.49 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.556 2.17 . . . . 0.0 114.039 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -90.69 -9.56 46.36 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -89.84 -21.89 6.6 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.967 0 N-CA-C 106.838 -1.542 . . . . 0.0 106.838 -178.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -102.66 -16.35 16.06 Favored 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 179.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . 0.488 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 49.2 t30 -70.99 -40.64 71.75 Favored 'General case' 0 C--N 1.36 1.028 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -67.7 -28.38 67.63 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 120.746 -0.381 . . . . 0.0 110.418 -179.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.681 ' SD ' ' HZ ' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -81.59 152.24 27.29 Favored 'General case' 0 C--N 1.352 0.696 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -179.488 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.594 ' N ' ' HG2' ' A' ' 89' ' ' MET . 4.6 mtpt -117.14 -26.76 6.69 Favored 'General case' 0 C--N 1.365 1.246 0 C-N-CA 120.054 -0.659 . . . . 0.0 111.293 -177.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -167.74 175.6 6.85 Favored 'General case' 0 C--N 1.354 0.797 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -177.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.417 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 42.2 t -64.75 -43.95 91.67 Favored 'General case' 0 C--N 1.356 0.881 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.383 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -68.08 -39.54 82.9 Favored 'General case' 0 C--N 1.355 0.836 0 O-C-N 121.365 -0.834 . . . . 0.0 109.418 -178.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -66.23 -22.45 66.33 Favored 'General case' 0 C--N 1.353 0.757 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.417 ' HB3' ' O ' ' A' ' 92' ' ' SER . 60.3 tp -65.08 -46.03 82.85 Favored 'General case' 0 C--N 1.354 0.767 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.9 mp -62.96 -36.13 82.45 Favored 'General case' 0 C--N 1.355 0.839 0 O-C-N 122.2 -0.313 . . . . 0.0 110.744 -179.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 35.9 t -65.09 -41.69 94.74 Favored 'General case' 0 C--N 1.349 0.582 0 O-C-N 121.849 -0.532 . . . . 0.0 111.555 -178.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.786 ' HG2' ' O ' ' A' ' 98' ' ' LYS . 0.0 OUTLIER -102.37 9.85 39.5 Favored 'General case' 0 C--N 1.358 0.946 0 O-C-N 121.676 -0.64 . . . . 0.0 110.327 -176.126 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 1.249 HD11 ' C3B' ' A' ' 202' ' ' HEM . 11.7 tt -63.1 -35.14 70.5 Favored 'Isoleucine or valine' 0 C--N 1.354 0.797 0 O-C-N 121.088 -1.008 . . . . 0.0 111.984 -176.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -111.28 -18.52 12.91 Favored 'General case' 0 N--CA 1.438 -1.054 0 O-C-N 120.814 -1.179 . . . . 0.0 109.99 -178.234 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 37.7 t -64.38 -46.9 81.35 Favored 'General case' 0 N--CA 1.443 -0.808 0 O-C-N 121.697 -0.627 . . . . 0.0 111.107 -178.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -130.15 -21.1 2.98 Favored 'General case' 0 C--N 1.359 0.986 0 C-N-CA 118.002 -1.479 . . . . 0.0 112.565 -177.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.661 HD12 ' HA ' ' A' ' 99' ' ' ILE . 96.1 mt -71.15 -49.5 48.25 Favored 'Isoleucine or valine' 0 C--O 1.242 0.693 0 O-C-N 120.771 -1.205 . . . . 0.0 110.976 -177.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 29.8 m170 -89.41 3.49 52.1 Favored 'General case' 0 N--CA 1.439 -0.982 0 O-C-N 121.111 -0.993 . . . . 0.0 109.996 -177.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 2.5 p -88.82 -34.26 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 178.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -72.11 -40.92 67.8 Favored 'General case' 0 C--N 1.359 1.009 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 76.5 t -63.81 -46.54 94.1 Favored 'Isoleucine or valine' 0 C--N 1.356 0.861 0 N-CA-C 110.155 -0.313 . . . . 0.0 110.155 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 91.3 t80 -60.6 -48.62 80.96 Favored 'General case' 0 C--N 1.359 1.015 0 O-C-N 122.226 -0.296 . . . . 0.0 111.447 -179.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -60.97 -38.11 84.77 Favored 'General case' 0 C--N 1.356 0.857 0 O-C-N 121.567 -0.708 . . . . 0.0 110.651 -178.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 18.5 mt -57.66 -75.66 0.04 OUTLIER 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -116.22 132.7 23.14 Favored Pre-proline 0 N--CA 1.438 -1.054 0 C-N-CA 118.708 -1.197 . . . . 0.0 108.857 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -83.04 -4.87 11.28 Favored 'Trans proline' 0 C--N 1.312 -1.35 0 C-N-CA 123.136 2.557 . . . . 0.0 115.003 -179.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -66.9 -36.76 83.01 Favored 'General case' 0 C--N 1.355 0.806 0 O-C-N 121.964 -0.46 . . . . 0.0 109.826 -179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.5 147.25 52.27 Favored 'General case' 0 C--N 1.352 0.69 0 CA-C-O 121.585 0.707 . . . . 0.0 109.849 -178.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 60.1 mt-10 -132.47 135.56 46.12 Favored 'General case' 0 C--N 1.357 0.898 0 N-CA-C 106.699 -1.593 . . . . 0.0 106.699 179.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.517 ' HB3' ' HD2' ' A' ' 117' ' ' PRO . 2.7 mm? -124.12 156.45 66.28 Favored Pre-proline 0 C--N 1.354 0.789 0 CA-C-O 122.023 0.916 . . . . 0.0 108.649 -178.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.787 ' HD3' ' CBA' ' A' ' 202' ' ' HEM . 95.0 Cg_endo -79.23 -160.17 0.12 Allowed 'Trans proline' 0 C--N 1.318 -1.047 0 C-N-CA 123.554 2.836 . . . . 0.0 113.22 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -120.73 144.11 48.42 Favored 'General case' 0 C--N 1.364 1.201 0 C-N-CA 118.997 -1.081 . . . . 0.0 108.24 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.56 ' HE2' ' CD1' ' A' ' 133' ' ' TYR . 22.4 m-85 -129.13 137.77 51.4 Favored 'General case' 0 C--N 1.362 1.109 0 C-N-CA 119.847 -0.741 . . . . 0.0 109.35 -178.739 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.401 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 93.8 m -123.87 129.49 51.08 Favored 'General case' 0 C--N 1.356 0.85 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 177.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 82.5 m -113.49 127.55 56.14 Favored 'General case' 0 CA--C 1.503 -0.846 0 C-N-CA 119.069 -1.052 . . . . 0.0 109.717 -177.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -120.24 118.9 31.68 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 106.045 -1.835 . . . . 0.0 106.045 178.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -96.23 117.85 31.6 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -178.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 92.8 mt -88.98 -20.07 24.91 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 120.751 -0.38 . . . . 0.0 110.303 -179.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -179.88 -150.08 8.93 Favored Glycine 0 C--N 1.349 1.303 0 N-CA-C 108.88 -1.688 . . . . 0.0 108.88 -178.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -94.69 -36.06 11.9 Favored 'General case' 0 N--CA 1.437 -1.085 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 -178.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -103.34 0.12 30.93 Favored 'General case' 0 N--CA 1.444 -0.766 0 C-N-CA 120.176 -0.61 . . . . 0.0 109.969 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -116.69 134.03 55.3 Favored 'General case' 0 C--N 1.358 0.954 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.411 HD13 ' HA ' ' A' ' 129' ' ' ILE . 8.1 mm -144.85 137.95 22.1 Favored 'Isoleucine or valine' 0 C--N 1.357 0.923 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 26.1 mtm180 -125.42 135.83 52.78 Favored 'General case' 0 CA--C 1.503 -0.855 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.726 HD23 HD11 ' A' ' 177' ' ' ILE . 0.2 OUTLIER -129.05 128.03 42.76 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 178.708 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.401 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 18.5 m170 -95.78 138.29 33.64 Favored 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.56 ' CD1' ' HE2' ' A' ' 119' ' ' PHE . 65.3 t80 -126.3 118.97 26.19 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 -178.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.484 ' HA ' ' O ' ' A' ' 171' ' ' THR . 27.5 tt0 -113.36 114.15 26.23 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 12.7 t -165.11 151.32 10.07 Favored 'General case' 0 C--N 1.358 0.962 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 58.2 mtmt -91.12 4.31 52.51 Favored 'General case' 0 C--N 1.355 0.846 0 C-N-CA 120.253 -0.579 . . . . 0.0 109.638 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' A' ' 137' ' ' ARG . 1.0 OUTLIER -135.68 72.69 62.75 Favored Pre-proline 0 C--N 1.355 0.847 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 179.053 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -96.47 108.23 0.1 Allowed 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 122.749 2.299 . . . . 0.0 115.924 -177.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -111.91 113.27 25.49 Favored 'General case' 0 CA--C 1.5 -0.951 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 176.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.21 -38.6 91.8 Favored 'General case' 0 C--N 1.353 0.759 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.101 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.1 m -63.43 -28.18 69.8 Favored 'General case' 0 C--N 1.353 0.726 0 O-C-N 121.967 -0.458 . . . . 0.0 110.903 -178.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -75.33 -45.94 36.39 Favored 'General case' 0 C--N 1.351 0.641 0 C-N-CA 120.156 -0.617 . . . . 0.0 109.552 -177.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.67 -39.79 91.71 Favored 'General case' 0 C--N 1.356 0.887 0 O-C-N 122.047 -0.408 . . . . 0.0 111.356 -177.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 86.8 tt0 -62.99 -37.26 86.46 Favored 'General case' 0 C--N 1.355 0.843 0 O-C-N 121.78 -0.575 . . . . 0.0 110.057 -179.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.59 -42.94 99.4 Favored Glycine 0 C--N 1.348 1.214 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 -179.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 82.8 mt -69.54 -41.14 76.34 Favored 'General case' 0 C--N 1.352 0.709 0 CA-C-N 117.437 0.619 . . . . 0.0 112.596 -179.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 97.0 mt -71.29 -42.04 69.18 Favored 'General case' 0 C--N 1.36 1.06 0 O-C-N 121.252 -0.905 . . . . 0.0 110.999 -177.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -69.88 -31.83 69.86 Favored 'General case' 0 C--N 1.349 0.555 0 O-C-N 121.994 -0.441 . . . . 0.0 110.597 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.532 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -62.59 -40.03 98.62 Favored Glycine 0 C--N 1.355 1.632 0 N-CA-C 108.674 -1.771 . . . . 0.0 108.674 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . 0.401 ' SG ' HD22 ' A' ' 95' ' ' LEU . 45.1 t -61.05 -42.67 98.91 Favored 'General case' 0 C--N 1.35 0.621 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.584 ' HB1' ' O ' ' A' ' 156' ' ' GLU . . . -76.05 1.79 14.54 Favored 'General case' 0 C--N 1.357 0.931 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.532 ' HB2' ' O ' ' A' ' 149' ' ' GLY . 7.6 mm-40 -86.57 -47.7 9.0 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 87.8 t80 -65.11 -45.19 86.14 Favored 'General case' 0 C--N 1.359 0.993 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.681 ' HZ ' ' SD ' ' A' ' 89' ' ' MET . 51.9 m-85 -69.25 -27.99 65.92 Favored 'General case' 0 C--N 1.362 1.132 0 O-C-N 121.897 -0.502 . . . . 0.0 111.013 -178.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 85.2 tttt 72.3 73.59 0.16 Allowed 'General case' 0 C--N 1.359 0.998 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 -178.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.584 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 2.4 tp10 -156.34 119.21 4.14 Favored 'General case' 0 CA--C 1.502 -0.9 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -82.39 106.84 14.6 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 120.086 -0.646 . . . . 0.0 111.069 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 11.9 m-30 -112.38 160.31 17.83 Favored 'General case' 0 CA--C 1.506 -0.742 0 N-CA-C 105.216 -2.142 . . . . 0.0 105.216 176.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 92.3 m -120.47 127.84 52.59 Favored 'General case' 0 CA--C 1.505 -0.772 0 C-N-CA 118.938 -1.105 . . . . 0.0 109.073 -178.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.48 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.9 mp -105.65 122.63 59.35 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 N-CA-C 106.752 -1.573 . . . . 0.0 106.752 178.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.7 m -118.87 -171.93 2.19 Favored 'General case' 0 C--N 1.358 0.936 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 -178.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 30.6 ptt180 -145.36 154.57 42.44 Favored 'General case' 0 C--N 1.356 0.851 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -178.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 28.7 p -96.27 144.84 28.53 Favored Pre-proline 0 C--N 1.36 1.054 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 178.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.702 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 72.9 Cg_endo -75.63 -12.83 20.29 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.79 2.326 . . . . 0.0 115.203 -178.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -72.91 -41.77 64.25 Favored 'General case' 0 N--CA 1.443 -0.785 0 C-N-CA 120.075 -0.65 . . . . 0.0 109.664 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 41.9 p -115.84 15.14 16.36 Favored 'General case' 0 C--N 1.355 0.807 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.391 -178.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.702 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.3 pp0? -66.6 -12.64 58.9 Favored 'General case' 0 C--N 1.355 0.834 0 O-C-N 121.59 -0.694 . . . . 0.0 110.454 179.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -128.08 42.53 3.3 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 107.667 -1.235 . . . . 0.0 107.667 -179.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 19.1 t -143.17 145.03 32.44 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 179.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.633 ' O ' ' HB ' ' A' ' 171' ' ' THR . 61.7 mt-10 -97.44 165.45 12.0 Favored 'General case' 0 C--N 1.355 0.818 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.633 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 16.9 m 84.81 -58.62 0.1 Allowed 'General case' 0 C--N 1.369 1.451 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -109.9 114.74 28.53 Favored 'General case' 0 CA--C 1.504 -0.803 0 C-N-CA 119.968 -0.693 . . . . 0.0 109.45 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 95.2 t -133.26 133.09 58.28 Favored 'Isoleucine or valine' 0 C--N 1.357 0.893 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 178.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 63.3 mt -117.57 128.48 74.79 Favored 'Isoleucine or valine' 0 C--N 1.358 0.968 0 CA-C-O 122.14 0.971 . . . . 0.0 109.456 179.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -110.52 145.23 38.1 Favored 'General case' 0 N--CA 1.439 -1.005 0 CA-C-N 114.838 -1.074 . . . . 0.0 108.336 -179.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -119.61 118.3 30.63 Favored 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.726 HD11 HD23 ' A' ' 131' ' ' LEU . 3.7 mp -112.4 119.0 59.23 Favored 'Isoleucine or valine' 0 C--N 1.354 0.793 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 -178.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 90.3 m -124.6 142.05 51.65 Favored 'General case' 0 CA--C 1.502 -0.872 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -177.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 13.6 ttt180 -91.68 116.5 28.94 Favored 'General case' 0 C--N 1.36 1.038 0 N-CA-C 106.835 -1.542 . . . . 0.0 106.835 179.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.605 ' HB1' ' HD2' ' A' ' 181' ' ' PRO . . . -73.41 157.97 87.23 Favored Pre-proline 0 C--N 1.359 0.99 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.605 ' HD2' ' HB1' ' A' ' 180' ' ' ALA . 19.6 Cg_endo -60.05 120.5 8.32 Favored 'Trans proline' 0 CA--C 1.494 -1.507 0 C-N-CA 122.028 1.818 . . . . 0.0 112.864 -179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 6.9 ppt_? -145.92 159.14 43.65 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -178.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.475 ' O ' ' HB3' ' A' ' 184' ' ' ALA . . . 73.07 65.98 2.14 Favored Glycine 0 C--N 1.356 1.656 0 N-CA-C 108.569 -1.813 . . . . 0.0 108.569 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 183' ' ' GLY . . . 76.33 165.35 0.26 Allowed 'General case' 0 C--N 1.361 1.073 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -179.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -94.29 -177.6 4.33 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 179.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -159.14 100.47 1.54 Allowed 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 -178.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.05 -73.79 0.67 Allowed 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . 0.572 ' HD2' ' CD1' ' A' ' 189' ' ' PHE . 0.3 OUTLIER -151.92 -94.1 0.05 Allowed 'General case' 0 N--CA 1.44 -0.971 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 -179.717 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . 0.572 ' CD1' ' HD2' ' A' ' 188' ' ' TYR . 89.9 m-85 -117.03 143.52 45.65 Favored 'General case' 0 CA--C 1.5 -0.971 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 . . . . . 0 C--O 1.264 1.817 0 N-CA-C 108.155 -1.054 . . . . 0.0 108.155 -179.607 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' HEM . . . . . 1.249 ' C3B' HD11 ' A' ' 99' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.5 mtm . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.298 0.57 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.74 -14.11 58.4 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -178.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.22 -41.99 44.62 Favored Glycine 0 C--N 1.351 1.369 0 N-CA-C 108.936 -1.666 . . . . 0.0 108.936 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 17.6 ttp -68.15 -39.37 82.67 Favored 'General case' 0 C--N 1.355 0.829 0 O-C-N 122.119 -0.636 . . . . 0.0 111.564 -177.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.0 m -68.25 -23.5 28.65 Favored 'Isoleucine or valine' 0 C--N 1.356 0.871 0 O-C-N 121.462 -0.773 . . . . 0.0 109.534 -179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.42 ' HZ ' ' HG3' ' A' ' 47' ' ' GLU . 2.6 m-85 -71.53 -34.05 69.71 Favored 'General case' 0 C--N 1.359 0.994 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 179.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.8 m -66.1 -40.37 90.69 Favored 'General case' 0 C--N 1.355 0.826 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 -179.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -61.83 -38.68 96.38 Favored Glycine 0 C--N 1.358 1.8 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.673 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -64.54 -41.78 96.13 Favored 'General case' 0 C--N 1.352 0.705 0 CA-C-N 117.072 0.436 . . . . 0.0 111.068 -178.552 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 18.5 mmt -63.0 -41.29 99.55 Favored 'General case' 0 C--N 1.353 0.733 0 O-C-N 121.519 -0.738 . . . . 0.0 111.247 -178.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -67.91 -40.27 83.47 Favored 'General case' 0 C--N 1.348 0.528 0 C-N-CA 120.638 -0.425 . . . . 0.0 111.762 -177.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 55.3 tp -66.7 -43.34 84.63 Favored 'General case' 0 C--N 1.349 0.549 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -177.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.673 HG12 ' O ' ' A' ' 9' ' ' LEU . 1.6 mm -73.84 -37.95 49.44 Favored 'Isoleucine or valine' 0 C--N 1.359 0.979 0 O-C-N 121.06 -1.025 . . . . 0.0 111.057 -175.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -70.19 -42.01 72.96 Favored 'General case' 0 C--N 1.349 0.554 0 O-C-N 121.699 -0.626 . . . . 0.0 111.546 -176.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -71.48 -37.3 71.3 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 -175.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -93.37 -32.39 14.28 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 -174.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -115.51 -32.22 5.64 Favored 'General case' 0 CA--C 1.506 -0.723 0 C-N-CA 117.424 -1.71 . . . . 0.0 112.828 -176.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 146.58 178.19 21.77 Favored Glycine 0 C--N 1.346 1.085 0 C-N-CA 117.954 -2.069 . . . . 0.0 110.379 -179.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 78.5 t80 -101.5 -23.75 14.26 Favored 'General case' 0 N--CA 1.434 -1.251 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -177.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -69.52 -39.83 77.28 Favored 'General case' 0 C--N 1.36 1.047 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 94.9 m -67.96 -38.33 82.64 Favored 'General case' 0 C--N 1.357 0.915 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 178.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 42.8 tp -59.93 -38.1 81.41 Favored 'General case' 0 C--N 1.355 0.838 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 179.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -65.5 -36.57 84.24 Favored 'General case' 0 C--N 1.358 0.958 0 O-C-N 122.081 -0.387 . . . . 0.0 110.805 -178.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.4 m -65.33 -38.84 91.37 Favored 'General case' 0 C--N 1.354 0.797 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 -178.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.639 HD13 HD22 ' A' ' 51' ' ' LEU . 0.1 OUTLIER -63.06 -38.23 90.37 Favored 'General case' 0 C--N 1.353 0.732 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -179.13 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 85.0 mt -73.84 -14.11 61.03 Favored 'General case' 0 C--N 1.359 1.009 0 O-C-N 121.749 -0.594 . . . . 0.0 110.415 -178.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -86.61 -28.59 23.16 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 119.185 -1.006 . . . . 0.0 109.374 179.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.7 t -67.03 -37.04 83.41 Favored 'General case' 0 C--N 1.355 0.827 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.536 ' HB3' HD21 ' A' ' 51' ' ' LEU . 2.0 p -91.51 -39.89 11.68 Favored 'General case' 0 C--N 1.359 1.015 0 C-N-CA 118.849 -1.14 . . . . 0.0 108.153 -179.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 85.97 131.45 0.04 OUTLIER 'General case' 0 C--N 1.361 1.091 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.506 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -90.52 -166.83 1.68 Allowed 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.888 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.423 ' H ' ' HB2' ' A' ' 31' ' ' LEU . 60.6 tt0 -154.2 -61.78 0.13 Allowed 'General case' 0 N--CA 1.433 -1.285 0 N-CA-C 106.636 -1.616 . . . . 0.0 106.636 -179.621 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.8 t -101.53 -68.39 0.82 Allowed 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -137.0 -42.67 0.58 Allowed 'General case' 0 CA--C 1.502 -0.899 0 C-N-CA 119.583 -0.847 . . . . 0.0 108.881 -178.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 123.16 -33.92 3.86 Favored Glycine 0 C--N 1.352 1.442 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 84.8 mt -112.44 102.03 13.36 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.728 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -104.28 11.73 34.5 Favored 'General case' 0 C--N 1.355 0.834 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.816 HG22 ' H ' ' A' ' 39' ' ' SER . 1.9 m 76.31 -170.53 0.08 Allowed 'General case' 0 C--N 1.358 0.974 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 -179.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.816 ' H ' HG22 ' A' ' 38' ' ' THR . 21.6 p -97.65 51.45 1.07 Allowed 'General case' 0 C--N 1.354 0.769 0 O-C-N 121.151 -0.968 . . . . 0.0 110.26 -178.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.471 HG12 ' O ' ' A' ' 40' ' ' VAL . 17.9 t -107.95 -10.78 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 119.858 -0.737 . . . . 0.0 109.685 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -107.09 159.18 14.76 Favored Glycine 0 C--N 1.357 1.743 0 C-N-CA 119.338 -1.411 . . . . 0.0 109.92 -178.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 36.2 m -129.28 134.26 47.87 Favored 'General case' 0 C--N 1.361 1.097 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 179.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -122.35 174.37 7.05 Favored 'General case' 0 C--N 1.355 0.815 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -77.31 -176.49 4.16 Favored 'General case' 0 C--N 1.357 0.899 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.514 ' CD2' HH22 ' A' ' 137' ' ' ARG . 74.8 m80 -92.16 -15.95 26.94 Favored 'General case' 0 C--N 1.356 0.887 0 C-N-CA 120.131 -0.628 . . . . 0.0 109.417 -178.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -67.6 -28.29 67.63 Favored 'General case' 0 C--N 1.351 0.64 0 N-CA-C 107.605 -1.258 . . . . 0.0 107.605 177.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.42 ' HG3' ' HZ ' ' A' ' 6' ' ' PHE . 29.8 tp10 -63.11 -41.52 99.36 Favored 'General case' 0 C--N 1.352 0.687 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -67.88 -39.46 83.7 Favored 'General case' 0 C--N 1.359 1.001 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 60.8 tp -69.64 -36.42 76.1 Favored 'General case' 0 CA--C 1.508 -0.664 0 O-C-N 122.167 -0.333 . . . . 0.0 110.498 -177.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -65.02 -40.22 94.54 Favored 'General case' 0 N--CA 1.446 -0.671 0 O-C-N 121.686 -0.634 . . . . 0.0 109.986 -178.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.639 HD22 HD13 ' A' ' 25' ' ' LEU . 77.0 mt -81.37 -19.16 43.28 Favored 'General case' 0 C--N 1.36 1.028 0 C-N-CA 119.644 -0.823 . . . . 0.0 110.661 -178.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.2 t -78.96 -37.22 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 -179.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.6 t -68.79 -40.41 81.35 Favored 'Isoleucine or valine' 0 C--N 1.353 0.727 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 178.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.421 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 32.2 tptt -65.1 -27.15 68.56 Favored 'General case' 0 C--N 1.364 1.235 0 O-C-N 121.126 -0.984 . . . . 0.0 108.827 -179.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.5 tt -68.26 -38.0 81.33 Favored 'General case' 0 C--N 1.354 0.764 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 73.1 p -72.75 -18.23 61.53 Favored 'General case' 0 C--N 1.357 0.894 0 O-C-N 121.54 -0.725 . . . . 0.0 110.948 -179.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -100.05 -37.7 8.87 Favored 'General case' 0 C--N 1.351 0.674 0 O-C-N 121.168 -0.957 . . . . 0.0 111.668 -179.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.3 p -72.96 -35.96 50.14 Favored 'Isoleucine or valine' 0 C--N 1.351 0.642 0 O-C-N 121.713 -0.617 . . . . 0.0 111.36 -177.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.6 m -111.99 -7.99 14.09 Favored 'General case' 0 CA--C 1.505 -0.754 0 C-N-CA 119.372 -0.931 . . . . 0.0 110.116 -177.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 64.22 49.12 2.69 Favored 'General case' 0 C--N 1.354 0.784 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.583 HG13 ' HD2' ' A' ' 62' ' ' PRO . 52.3 t -113.62 135.51 21.94 Favored Pre-proline 0 CA--C 1.504 -0.802 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.652 ' HG2' ' HB2' ' A' ' 65' ' ' GLU . 20.8 Cg_endo -61.68 149.61 89.18 Favored 'Trans proline' 0 CA--C 1.5 -1.192 0 C-N-CA 122.339 2.026 . . . . 0.0 112.684 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.402 ' HA ' HD23 ' A' ' 66' ' ' LEU . 3.0 m -76.67 -11.78 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.39 -177.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.495 ' O ' HG12 ' A' ' 67' ' ' VAL . 72.0 p -96.62 -34.68 11.32 Favored 'General case' 0 C--N 1.357 0.93 0 C-N-CA 118.194 -1.402 . . . . 0.0 109.525 -179.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.652 ' HB2' ' HG2' ' A' ' 62' ' ' PRO . 69.1 mt-10 -76.85 -22.3 53.74 Favored 'General case' 0 C--N 1.354 0.792 0 O-C-N 121.437 -0.789 . . . . 0.0 108.893 179.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.408 ' HB3' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -79.19 -36.75 39.73 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -179.408 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.495 HG12 ' O ' ' A' ' 64' ' ' THR . 1.7 p -68.12 -26.82 35.21 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 C-N-CA 120.123 -0.631 . . . . 0.0 109.9 -179.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.6 mmm-85 -72.1 -51.66 20.46 Favored 'General case' 0 C--N 1.364 1.216 0 O-C-N 121.549 -0.719 . . . . 0.0 110.453 -179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.3 mt -62.49 -36.27 81.96 Favored 'General case' 0 C--N 1.357 0.905 0 O-C-N 122.012 -0.43 . . . . 0.0 111.038 -178.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -61.02 -47.5 86.12 Favored 'General case' 0 C--N 1.349 0.556 0 O-C-N 122.23 -0.294 . . . . 0.0 110.639 -178.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.83 -39.21 96.51 Favored Glycine 0 C--N 1.356 1.69 0 N-CA-C 111.888 -0.485 . . . . 0.0 111.888 -177.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -62.76 -49.16 76.11 Favored 'General case' 0 C--N 1.352 0.688 0 CA-C-N 118.303 1.051 . . . . 0.0 111.693 -177.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 10.2 mttm -63.3 -47.67 81.28 Favored 'General case' 0 C--N 1.359 0.985 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -177.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.413 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.4 tm? -69.41 -38.69 78.02 Favored 'General case' 0 C--N 1.348 0.526 0 O-C-N 121.104 -0.997 . . . . 0.0 111.807 -175.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -63.71 -46.8 83.8 Favored 'General case' 0 C--N 1.355 0.834 0 O-C-N 121.037 -1.04 . . . . 0.0 111.443 -177.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -70.58 -13.83 17.5 Favored 'Isoleucine or valine' 0 C--N 1.36 1.024 0 O-C-N 121.517 -0.739 . . . . 0.0 109.371 -179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -73.08 -38.34 66.44 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 85.4 mt -73.97 -30.67 62.62 Favored 'General case' 0 C--N 1.357 0.922 0 O-C-N 122.3 -0.25 . . . . 0.0 110.519 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 47.9 mm -65.1 -53.53 39.96 Favored 'Isoleucine or valine' 0 C--N 1.357 0.921 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.957 -177.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -74.61 -15.52 60.83 Favored 'General case' 0 C--N 1.351 0.634 0 C-N-CA 119.573 -0.851 . . . . 0.0 109.526 178.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.45 -36.43 62.87 Favored Glycine 0 C--N 1.349 1.26 0 N-CA-C 111.001 -0.839 . . . . 0.0 111.001 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.486 ' HA ' ' HD2' ' A' ' 83' ' ' PRO . 99.3 m-70 -130.65 105.57 15.67 Favored Pre-proline 0 N--CA 1.441 -0.88 0 CA-C-O 122.686 1.231 . . . . 0.0 109.263 -176.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.486 ' HD2' ' HA ' ' A' ' 82' ' ' HIS . 37.8 Cg_endo -67.69 -26.0 39.66 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 122.647 2.231 . . . . 0.0 114.085 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -89.86 -7.66 53.74 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 -179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.1 tp -90.36 -20.97 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.969 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 -178.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -101.52 -23.63 14.27 Favored 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -70.16 -37.33 75.17 Favored 'General case' 0 C--N 1.359 1.001 0 O-C-N 121.867 -0.521 . . . . 0.0 109.855 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -64.89 -34.98 79.67 Favored 'General case' 0 C--N 1.358 0.975 0 O-C-N 121.836 -0.54 . . . . 0.0 110.545 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 18.4 ttp -82.9 152.51 25.52 Favored 'General case' 0 C--N 1.352 0.704 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 -178.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.43 -21.89 7.84 Favored 'General case' 0 C--N 1.364 1.225 0 O-C-N 121.641 -0.662 . . . . 0.0 111.356 -177.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -165.8 171.42 12.83 Favored 'General case' 0 C--N 1.354 0.8 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -177.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.456 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 62.8 m -66.65 -40.81 88.84 Favored 'General case' 0 C--N 1.355 0.82 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.584 -179.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.492 ' CE1' ' HE2' ' A' ' 158' ' ' PHE . 60.4 m-85 -66.67 -39.65 88.24 Favored 'General case' 0 C--N 1.357 0.915 0 O-C-N 121.188 -0.945 . . . . 0.0 108.836 -179.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -65.79 -23.31 66.68 Favored 'General case' 0 C--N 1.356 0.884 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.694 ' O ' HG13 ' A' ' 99' ' ' ILE . 57.9 tp -63.58 -46.86 83.92 Favored 'General case' 0 C--N 1.355 0.843 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.477 ' HA ' ' CD1' ' A' ' 99' ' ' ILE . 4.2 mp -60.59 -37.34 81.04 Favored 'General case' 0 C--N 1.359 1.016 0 C-N-CA 120.936 -0.306 . . . . 0.0 110.416 -179.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 34.3 t -67.88 -39.71 83.66 Favored 'General case' 0 C--N 1.349 0.566 0 O-C-N 121.918 -0.489 . . . . 0.0 110.242 -179.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.72 -0.89 56.44 Favored 'General case' 0 C--N 1.356 0.869 0 N-CA-C 112.147 0.425 . . . . 0.0 112.147 -176.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.694 HG13 ' O ' ' A' ' 95' ' ' LEU . 78.8 mt -60.81 -47.09 94.78 Favored 'Isoleucine or valine' 0 C--N 1.357 0.906 0 CA-C-N 118.919 0.782 . . . . 0.0 112.331 -177.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -94.44 -23.92 17.54 Favored 'General case' 0 N--CA 1.443 -0.784 0 C-N-CA 118.55 -1.26 . . . . 0.0 111.522 -176.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.5 t -63.86 -48.07 78.21 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 121.607 -0.683 . . . . 0.0 112.717 -177.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -137.92 -15.86 1.32 Allowed 'General case' 0 C--N 1.359 0.992 0 C-N-CA 116.946 -1.901 . . . . 0.0 113.763 -176.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.539 HD12 ' HA ' ' A' ' 99' ' ' ILE . 96.4 mt -70.81 -49.7 48.86 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 CA-C-N 120.54 1.518 . . . . 0.0 111.164 -177.404 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.442 ' HD2' HG22 ' A' ' 103' ' ' ILE . 17.8 m170 -89.04 0.67 56.49 Favored 'General case' 0 N--CA 1.442 -0.858 0 O-C-N 121.176 -0.953 . . . . 0.0 110.171 -177.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 72.7 t -83.71 -44.18 18.22 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.996 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 178.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -67.68 -40.55 84.4 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 -179.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 71.9 t -63.06 -45.22 99.31 Favored 'Isoleucine or valine' 0 C--N 1.355 0.826 0 C-N-CA 120.897 -0.321 . . . . 0.0 110.256 -179.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -60.33 -48.38 82.01 Favored 'General case' 0 C--N 1.36 1.055 0 O-C-N 122.016 -0.428 . . . . 0.0 111.34 -178.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.8 mptp? -63.5 -35.41 80.37 Favored 'General case' 0 C--N 1.354 0.795 0 O-C-N 121.544 -0.722 . . . . 0.0 110.615 -178.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 110' ' ' LEU . 16.4 mt -57.33 -72.1 0.09 Allowed 'General case' 0 C--N 1.357 0.919 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.104 -179.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -122.31 143.7 40.0 Favored Pre-proline 0 N--CA 1.441 -0.899 0 C-N-CA 118.038 -1.465 . . . . 0.0 109.292 -179.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -87.25 -2.46 7.83 Favored 'Trans proline' 0 C--N 1.315 -1.22 0 C-N-CA 123.505 2.803 . . . . 0.0 116.265 -178.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -83.42 -8.11 59.44 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 121.272 -0.892 . . . . 0.0 109.486 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -83.06 144.33 29.98 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 -179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.552 ' O ' HD13 ' A' ' 116' ' ' LEU . 46.0 mt-10 -120.33 144.11 48.02 Favored 'General case' 0 C--N 1.359 1.021 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 179.166 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.552 HD13 ' O ' ' A' ' 115' ' ' GLU . 2.6 mm? -129.88 152.52 80.04 Favored Pre-proline 0 C--N 1.358 0.946 0 CA-C-O 121.951 0.882 . . . . 0.0 109.27 -178.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 116' ' ' LEU . 87.7 Cg_endo -92.73 -155.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.32 -0.946 0 C-N-CA 123.929 3.086 . . . . 0.0 113.036 179.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -122.5 141.84 51.22 Favored 'General case' 0 C--N 1.368 1.399 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -132.61 137.04 46.9 Favored 'General case' 0 C--N 1.362 1.132 0 C-N-CA 119.943 -0.703 . . . . 0.0 109.629 -178.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.437 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 93.7 m -127.32 128.52 46.06 Favored 'General case' 0 C--N 1.357 0.904 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 176.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 78.2 m -118.69 128.89 54.94 Favored 'General case' 0 CA--C 1.503 -0.862 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.436 -178.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -120.85 130.89 54.12 Favored 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 106.478 -1.675 . . . . 0.0 106.478 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 58.9 ttp180 -103.55 117.23 33.95 Favored 'General case' 0 C--N 1.353 0.738 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -179.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.463 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 88.7 mt -83.27 -27.48 29.83 Favored 'General case' 0 C--N 1.354 0.79 0 C-N-CA 120.668 -0.413 . . . . 0.0 109.968 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 179.49 -143.24 5.59 Favored Glycine 0 C--N 1.351 1.378 0 C-N-CA 118.771 -1.681 . . . . 0.0 109.648 -178.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -91.37 -45.98 8.27 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -178.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -98.67 3.25 47.75 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 119.927 -0.709 . . . . 0.0 110.699 -177.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.463 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 66.7 m-20 -119.91 133.38 55.59 Favored 'General case' 0 C--N 1.357 0.917 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -179.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.1 mm -142.57 138.45 28.69 Favored 'Isoleucine or valine' 0 C--N 1.357 0.91 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 179.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 52.3 mtm180 -119.79 137.75 53.77 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 6.6 tp -125.5 119.45 28.25 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 115.104 -0.953 . . . . 0.0 108.76 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.437 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 11.8 m170 -99.92 135.2 41.71 Favored 'General case' 0 CA--C 1.497 -1.065 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 179.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -128.06 121.97 30.99 Favored 'General case' 0 N--CA 1.438 -1.062 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -178.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.448 ' HA ' ' O ' ' A' ' 171' ' ' THR . 10.2 tt0 -115.55 112.88 22.86 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 107.096 -1.446 . . . . 0.0 107.096 178.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.8 t -167.25 156.63 10.45 Favored 'General case' 0 C--N 1.357 0.908 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.439 ' C ' ' HD3' ' A' ' 138' ' ' PRO . 99.5 mttt -91.3 6.86 43.61 Favored 'General case' 0 C--N 1.354 0.789 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.514 HH22 ' CD2' ' A' ' 45' ' ' HIS . 75.0 mtp180 -130.82 74.04 80.44 Favored Pre-proline 0 C--N 1.355 0.816 0 N-CA-C 107.281 -1.377 . . . . 0.0 107.281 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.439 ' HD3' ' C ' ' A' ' 136' ' ' LYS . 80.1 Cg_endo -95.57 89.27 0.1 Allowed 'Trans proline' 0 N--CA 1.445 -1.373 0 C-N-CA 122.821 2.347 . . . . 0.0 115.559 -178.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -106.57 112.42 25.41 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 177.333 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.89 -37.74 88.51 Favored 'General case' 0 C--N 1.353 0.735 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.132 -178.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 71.5 m -61.77 -32.46 72.73 Favored 'General case' 0 C--N 1.353 0.741 0 O-C-N 121.967 -0.458 . . . . 0.0 110.693 -178.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -73.11 -46.48 51.04 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 120.25 -0.58 . . . . 0.0 109.988 -177.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.35 -40.17 95.33 Favored 'General case' 0 C--N 1.356 0.88 0 O-C-N 122.127 -0.358 . . . . 0.0 111.461 -177.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -63.27 -36.89 85.16 Favored 'General case' 0 C--N 1.354 0.801 0 O-C-N 121.85 -0.531 . . . . 0.0 110.273 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.14 -43.52 98.28 Favored Glycine 0 C--N 1.348 1.216 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 -178.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 82.7 mt -69.82 -40.57 75.84 Favored 'General case' 0 C--N 1.352 0.705 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 96.2 mt -71.63 -42.43 67.63 Favored 'General case' 0 C--N 1.362 1.152 0 O-C-N 121.152 -0.968 . . . . 0.0 111.186 -176.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.472 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 36.2 t70 -69.84 -30.55 68.06 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 121.834 -0.541 . . . . 0.0 110.535 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.464 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -62.85 -39.1 97.58 Favored Glycine 0 C--N 1.357 1.708 0 N-CA-C 108.303 -1.919 . . . . 0.0 108.303 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 48.9 t -60.55 -42.02 95.71 Favored 'General case' 0 C--N 1.351 0.659 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -74.96 -1.24 21.69 Favored 'General case' 0 C--N 1.361 1.093 0 O-C-N 121.739 -0.601 . . . . 0.0 109.476 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.472 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 76.5 mm-40 -84.38 -46.33 11.83 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -68.06 -43.19 79.19 Favored 'General case' 0 C--N 1.359 1.017 0 C-N-CA 120.002 -0.679 . . . . 0.0 109.553 179.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -69.19 -27.67 65.71 Favored 'General case' 0 C--N 1.361 1.076 0 O-C-N 121.739 -0.601 . . . . 0.0 110.701 -178.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 86.1 tttt 70.42 72.31 0.21 Allowed 'General case' 0 C--N 1.361 1.07 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 -178.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -143.45 -167.26 2.52 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -142.18 116.6 9.61 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . 0.492 ' HE2' ' CE1' ' A' ' 93' ' ' PHE . 94.9 m-85 -135.09 150.47 50.24 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 105.91 -1.885 . . . . 0.0 105.91 178.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 92.4 m -120.63 127.82 52.44 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 -179.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.549 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.4 mp -105.9 122.88 60.04 Favored 'Isoleucine or valine' 0 C--N 1.351 0.672 0 N-CA-C 107.226 -1.398 . . . . 0.0 107.226 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.9 m -120.12 -173.61 2.59 Favored 'General case' 0 C--N 1.357 0.911 0 CA-C-O 121.86 0.838 . . . . 0.0 109.341 -179.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 27.7 ptt180 -147.74 156.96 43.29 Favored 'General case' 0 C--N 1.357 0.932 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -178.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 64.6 p -100.79 146.2 31.68 Favored Pre-proline 0 C--N 1.359 0.988 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 178.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.9 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 62.7 Cg_endo -75.75 -9.6 19.77 Favored 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.754 2.303 . . . . 0.0 115.424 -178.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -71.97 -41.11 68.1 Favored 'General case' 0 N--CA 1.441 -0.893 0 C-N-CA 119.771 -0.772 . . . . 0.0 109.101 -179.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 39.2 p -118.05 14.53 14.08 Favored 'General case' 0 C--N 1.354 0.772 0 C-N-CA 120.071 -0.651 . . . . 0.0 110.538 -178.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.9 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 11.6 pt20 -67.03 -10.34 48.73 Favored 'General case' 0 C--N 1.355 0.828 0 O-C-N 121.455 -0.778 . . . . 0.0 110.335 178.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -126.54 38.28 4.15 Favored 'General case' 0 N--CA 1.437 -1.117 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 60.9 m -137.38 146.9 45.02 Favored 'General case' 0 CA--C 1.504 -0.807 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.64 ' O ' ' HB ' ' A' ' 171' ' ' THR . 60.5 mt-10 -98.77 164.4 12.23 Favored 'General case' 0 C--N 1.353 0.759 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.64 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 1.7 m 82.05 -56.65 0.23 Allowed 'General case' 0 C--N 1.371 1.532 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.004 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.4 m-20 -110.19 117.65 34.26 Favored 'General case' 0 CA--C 1.503 -0.83 0 C-N-CA 119.738 -0.785 . . . . 0.0 109.802 -178.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 67.4 t -131.22 134.0 61.75 Favored 'Isoleucine or valine' 0 C--N 1.357 0.912 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 50.4 mm -108.53 125.44 65.38 Favored 'Isoleucine or valine' 0 C--N 1.357 0.914 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -113.25 153.16 28.84 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-O 122.136 0.969 . . . . 0.0 108.541 -179.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -136.69 117.56 14.16 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -178.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.3 mp -113.04 118.6 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 N-CA-C 106.251 -1.759 . . . . 0.0 106.251 -179.161 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 89.4 m -120.28 144.24 47.9 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 -177.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.551 ' NE ' ' HD2' ' A' ' 182' ' ' ARG . 5.2 ttt180 -89.08 114.59 25.85 Favored 'General case' 0 C--N 1.363 1.185 0 N-CA-C 106.455 -1.683 . . . . 0.0 106.455 179.476 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.432 ' HA ' ' HD3' ' A' ' 181' ' ' PRO . . . -60.5 147.78 82.21 Favored Pre-proline 0 C--N 1.359 0.982 0 CA-C-O 121.93 0.872 . . . . 0.0 108.925 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 180' ' ' ALA . 74.3 Cg_exo -51.95 128.56 27.22 Favored 'Trans proline' 0 CA--C 1.494 -1.478 0 C-N-CA 122.932 2.422 . . . . 0.0 113.762 -178.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.551 ' HD2' ' NE ' ' A' ' 179' ' ' ARG . 0.1 OUTLIER -110.73 21.86 16.05 Favored 'General case' 0 N--CA 1.435 -1.216 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 179.935 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 148.25 -138.5 7.08 Favored Glycine 0 N--CA 1.436 -1.305 0 N-CA-C 107.591 -2.204 . . . . 0.0 107.591 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -79.45 169.42 18.08 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 179.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 59.6 mt-10 -117.24 112.34 20.66 Favored 'General case' 0 N--CA 1.436 -1.142 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 -179.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -113.41 122.72 48.19 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -98.91 -81.25 0.45 Allowed 'General case' 0 N--CA 1.439 -1.008 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -141.38 -83.06 0.21 Allowed 'General case' 0 N--CA 1.437 -1.08 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -126.7 147.12 49.98 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 -179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 . . . . . 0 C--O 1.263 1.771 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 179.939 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' HEM . . . . . 0.733 ' HHA' HBD2 ' A' ' 202' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.477 ' HG3' ' CMD' ' A' ' 202' ' ' HEM . 43.6 mtp . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.212 0.53 . . . . 0.0 109.862 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.624 ' HA ' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -82.17 -5.46 58.49 Favored 'General case' 0 C--N 1.355 0.814 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.046 -177.873 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.52 -46.16 26.47 Favored Glycine 0 C--N 1.35 1.34 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 76.9 mtm -72.15 -34.53 68.57 Favored 'General case' 0 C--N 1.354 0.791 0 O-C-N 121.92 -0.753 . . . . 0.0 111.271 -177.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.624 HG22 ' HA ' ' A' ' 2' ' ' MET . 36.0 m -69.78 -23.44 25.8 Favored 'Isoleucine or valine' 0 C--N 1.356 0.868 0 C-N-CA 119.926 -0.709 . . . . 0.0 109.346 -179.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.426 ' HZ ' ' CG ' ' A' ' 47' ' ' GLU . 1.6 m-85 -71.79 -34.45 69.42 Favored 'General case' 0 C--N 1.357 0.908 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 179.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.6 m -66.7 -39.65 88.16 Favored 'General case' 0 C--N 1.354 0.798 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -61.29 -38.81 96.28 Favored Glycine 0 C--N 1.359 1.809 0 N-CA-C 110.289 -1.124 . . . . 0.0 110.289 -179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.617 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -65.33 -40.08 93.24 Favored 'General case' 0 C--N 1.353 0.741 0 O-C-N 122.354 -0.498 . . . . 0.0 110.761 -178.83 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 23.2 mmt -63.02 -41.02 99.43 Favored 'General case' 0 C--N 1.351 0.665 0 O-C-N 121.632 -0.667 . . . . 0.0 111.099 -178.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -66.81 -40.65 88.14 Favored 'General case' 0 C--N 1.35 0.613 0 O-C-N 121.869 -0.519 . . . . 0.0 111.688 -177.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 53.9 tp -65.8 -42.78 90.25 Favored 'General case' 0 C--N 1.349 0.585 0 N-CA-C 113.013 0.746 . . . . 0.0 113.013 -178.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.617 HG12 ' O ' ' A' ' 9' ' ' LEU . 1.5 mm -75.67 -37.44 36.19 Favored 'Isoleucine or valine' 0 C--N 1.357 0.896 0 O-C-N 121.083 -1.011 . . . . 0.0 111.134 -175.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -68.53 -43.16 77.35 Favored 'General case' 0 C--N 1.352 0.703 0 O-C-N 121.911 -0.493 . . . . 0.0 111.315 -176.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -71.42 -34.36 70.25 Favored 'General case' 0 N--CA 1.446 -0.634 0 O-C-N 122.06 -0.4 . . . . 0.0 111.717 -177.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -71.83 -48.71 44.33 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -175.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -128.22 -19.29 3.93 Favored 'General case' 0 C--N 1.356 0.854 0 C-N-CA 117.352 -1.739 . . . . 0.0 113.747 -176.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 140.56 179.48 18.15 Favored Glycine 0 CA--C 1.497 -1.066 0 C-N-CA 117.773 -2.156 . . . . 0.0 109.97 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 50.1 p90 -96.42 -12.09 24.75 Favored 'General case' 0 N--CA 1.429 -1.494 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 -177.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -70.49 -41.41 72.71 Favored 'General case' 0 C--N 1.361 1.073 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.2 m -69.91 -39.08 76.41 Favored 'General case' 0 C--N 1.356 0.859 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.531 HD13 ' HB ' ' A' ' 13' ' ' ILE . 58.3 tp -60.6 -37.93 83.03 Favored 'General case' 0 C--N 1.357 0.918 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -64.59 -36.26 83.66 Favored 'General case' 0 C--N 1.357 0.893 0 O-C-N 122.132 -0.355 . . . . 0.0 110.84 -178.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 93.6 m -63.52 -41.19 98.51 Favored 'General case' 0 C--N 1.356 0.857 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -178.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.428 ' CD2' ' HB3' ' A' ' 54' ' ' LYS . 88.7 mt -64.17 -37.72 88.47 Favored 'General case' 0 C--N 1.352 0.711 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.09 -13.62 61.63 Favored 'General case' 0 C--N 1.36 1.053 0 O-C-N 121.606 -0.684 . . . . 0.0 110.085 -178.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -86.74 -28.94 22.74 Favored 'General case' 0 CA--C 1.506 -0.712 0 O-C-N 121.262 -0.899 . . . . 0.0 109.12 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.8 t -66.81 -36.29 82.03 Favored 'General case' 0 C--N 1.353 0.742 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.647 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 2.2 p -92.15 -38.16 12.31 Favored 'General case' 0 C--N 1.359 0.996 0 N-CA-C 107.912 -1.144 . . . . 0.0 107.912 -179.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.647 ' HB2' ' O ' ' A' ' 29' ' ' CYS . 15.9 mt-10 85.96 131.73 0.04 OUTLIER 'General case' 0 C--N 1.36 1.041 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 178.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.511 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -89.96 -167.49 1.86 Allowed 'General case' 0 C--N 1.356 0.871 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.791 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -153.39 -66.59 0.15 Allowed 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.2 m -96.47 -62.06 1.33 Allowed 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 -179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -141.1 -43.2 0.38 Allowed 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 -179.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 121.43 -39.02 2.47 Favored Glycine 0 C--N 1.351 1.398 0 N-CA-C 108.69 -1.764 . . . . 0.0 108.69 179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 84.9 mt -109.8 104.68 17.46 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.878 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.425 ' HB3' ' H ' ' A' ' 38' ' ' THR . 4.0 t80 -74.03 -92.31 0.02 OUTLIER 'General case' 0 C--N 1.355 0.833 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.441 HG22 ' N ' ' A' ' 39' ' ' SER . 1.2 m -166.37 -64.52 0.03 OUTLIER 'General case' 0 CA--C 1.503 -0.852 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 -178.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.441 ' N ' HG22 ' A' ' 38' ' ' THR . 12.3 p 161.87 80.9 0.0 OUTLIER 'General case' 0 C--N 1.362 1.122 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.513 ' O ' HG13 ' A' ' 40' ' ' VAL . 0.4 OUTLIER -172.05 -4.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.972 0 C-N-CA 119.459 -0.896 . . . . 0.0 109.735 -179.18 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -96.3 150.61 19.67 Favored Glycine 0 C--N 1.355 1.6 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 -178.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 59.2 m -125.41 131.5 52.91 Favored 'General case' 0 C--N 1.354 0.77 0 N-CA-C 106.617 -1.623 . . . . 0.0 106.617 179.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -121.05 171.11 8.9 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -76.24 -178.67 4.62 Favored 'General case' 0 C--N 1.355 0.842 0 CA-C-O 121.642 0.734 . . . . 0.0 109.573 -178.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -86.36 -19.65 29.45 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 -179.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.709 ' HA ' HD23 ' A' ' 49' ' ' LEU . 0.5 OUTLIER -65.55 -30.65 71.42 Favored 'General case' 0 C--N 1.354 0.764 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 179.08 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.426 ' CG ' ' HZ ' ' A' ' 6' ' ' PHE . 23.6 tp10 -63.97 -40.25 95.97 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -65.52 -39.41 91.79 Favored 'General case' 0 C--N 1.358 0.972 0 O-C-N 122.305 -0.247 . . . . 0.0 111.266 -178.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.709 HD23 ' HA ' ' A' ' 46' ' ' GLN . 0.2 OUTLIER -81.37 -15.02 56.52 Favored 'General case' 0 C--N 1.353 0.733 0 C-N-CA 119.078 -1.049 . . . . 0.0 110.402 -176.339 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 71.5 tp60 -73.09 -41.44 64.06 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 84.3 mt -84.51 -17.96 37.33 Favored 'General case' 0 C--N 1.362 1.111 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.723 -178.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.6 t -80.52 -37.45 16.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.751 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 -179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.9 t -69.73 -39.68 78.3 Favored 'Isoleucine or valine' 0 C--N 1.354 0.78 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.428 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 32.9 tptt -66.15 -27.16 67.81 Favored 'General case' 0 C--N 1.363 1.171 0 O-C-N 121.235 -0.915 . . . . 0.0 108.6 -179.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.496 HD13 HD13 ' A' ' 66' ' ' LEU . 0.3 OUTLIER -68.38 -37.64 80.59 Favored 'General case' 0 C--N 1.353 0.756 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.704 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.417 ' O ' ' HA ' ' A' ' 60' ' ' SER . 77.0 p -73.9 -16.93 61.09 Favored 'General case' 0 C--N 1.355 0.847 0 O-C-N 121.693 -0.629 . . . . 0.0 110.885 -178.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -100.46 -36.38 9.23 Favored 'General case' 0 C--N 1.353 0.752 0 C-N-CA 119.377 -0.929 . . . . 0.0 111.434 -179.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.5 p -72.66 -34.44 47.54 Favored 'Isoleucine or valine' 0 C--N 1.351 0.651 0 O-C-N 121.683 -0.636 . . . . 0.0 111.455 -177.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.568 ' HB3' HG23 ' A' ' 61' ' ' VAL . 4.2 t -119.99 -5.58 10.05 Favored 'General case' 0 C--N 1.353 0.725 0 C-N-CA 119.143 -1.023 . . . . 0.0 110.069 -178.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.417 ' HA ' ' O ' ' A' ' 56' ' ' SER . 73.3 m 64.3 43.25 4.86 Favored 'General case' 0 C--N 1.354 0.783 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.443 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.568 HG23 ' HB3' ' A' ' 59' ' ' SER . 50.0 t -103.37 132.89 20.65 Favored Pre-proline 0 N--CA 1.443 -0.799 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 179.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -57.31 146.68 81.24 Favored 'Trans proline' 0 CA--C 1.497 -1.345 0 C-N-CA 122.397 2.065 . . . . 0.0 112.959 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.1 m -75.15 -14.1 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.788 -178.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.412 ' O ' HG12 ' A' ' 67' ' ' VAL . 52.6 p -96.07 -31.88 12.81 Favored 'General case' 0 C--N 1.357 0.9 0 C-N-CA 118.139 -1.425 . . . . 0.0 109.611 -178.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -78.01 -21.49 50.73 Favored 'General case' 0 C--N 1.356 0.856 0 O-C-N 121.385 -0.822 . . . . 0.0 108.894 179.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.496 HD13 HD13 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -81.82 -35.73 29.14 Favored 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 -179.4 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.421 HG11 ' HB3' ' A' ' 141' ' ' SER . 1.4 p -68.79 -27.17 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.787 0 C-N-CA 120.138 -0.625 . . . . 0.0 109.95 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 6.5 mmm-85 -73.21 -51.2 18.6 Favored 'General case' 0 C--N 1.362 1.131 0 O-C-N 121.521 -0.737 . . . . 0.0 110.435 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.7 mt -63.69 -36.08 82.68 Favored 'General case' 0 C--N 1.357 0.934 0 O-C-N 121.976 -0.452 . . . . 0.0 110.85 -178.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -60.65 -47.36 86.58 Favored 'General case' 0 C--N 1.349 0.577 0 O-C-N 122.208 -0.307 . . . . 0.0 110.297 -178.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.57 -37.87 94.06 Favored Glycine 0 C--N 1.354 1.552 0 N-CA-C 111.661 -0.576 . . . . 0.0 111.661 -178.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -63.02 -48.64 77.91 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-N 118.261 1.031 . . . . 0.0 111.397 -177.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.701 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 16.0 mttm -64.39 -48.96 73.47 Favored 'General case' 0 C--N 1.359 0.983 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -176.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.431 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.3 tm? -68.29 -39.68 82.03 Favored 'General case' 0 C--N 1.348 0.534 0 O-C-N 121.207 -0.933 . . . . 0.0 112.047 -175.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -63.88 -42.83 97.39 Favored 'General case' 0 C--N 1.353 0.719 0 O-C-N 121.115 -0.991 . . . . 0.0 111.22 -177.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.7 p -71.97 -15.48 18.11 Favored 'Isoleucine or valine' 0 C--N 1.36 1.026 0 O-C-N 121.232 -0.917 . . . . 0.0 109.217 -179.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.701 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 74.1 mm-40 -71.52 -38.89 71.07 Favored 'General case' 0 C--N 1.349 0.552 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 179.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 80.7 mt -72.45 -33.3 66.97 Favored 'General case' 0 C--N 1.358 0.967 0 O-C-N 122.334 -0.229 . . . . 0.0 110.754 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 43.5 mm -64.43 -52.97 48.57 Favored 'Isoleucine or valine' 0 C--N 1.357 0.912 0 O-C-N 121.733 -0.604 . . . . 0.0 110.509 -177.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -76.67 -14.75 59.94 Favored 'General case' 0 C--N 1.35 0.591 0 C-N-CA 119.423 -0.911 . . . . 0.0 109.501 178.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.85 -36.32 61.43 Favored Glycine 0 C--N 1.349 1.27 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -179.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -128.46 104.45 19.58 Favored Pre-proline 0 N--CA 1.44 -0.938 0 CA-C-O 122.564 1.173 . . . . 0.0 109.596 -176.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.08 -33.23 91.8 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 123.366 2.711 . . . . 0.0 114.29 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -91.34 -5.67 54.23 Favored 'General case' 0 C--N 1.355 0.811 0 C-N-CA 120.14 -0.624 . . . . 0.0 109.834 -178.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -87.89 -23.15 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.911 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -178.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -103.6 -18.03 14.91 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -72.39 -38.36 68.49 Favored 'General case' 0 C--N 1.358 0.94 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -65.17 -33.51 76.18 Favored 'General case' 0 C--N 1.355 0.816 0 N-CA-C 109.85 -0.426 . . . . 0.0 109.85 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.479 ' SD ' ' HB2' ' A' ' 95' ' ' LEU . 17.8 ttp -84.53 152.08 24.15 Favored 'General case' 0 C--N 1.351 0.651 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -178.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.64 -21.4 8.54 Favored 'General case' 0 C--N 1.364 1.21 0 C-N-CA 120.051 -0.659 . . . . 0.0 111.19 -177.405 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -165.96 171.28 12.77 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 -177.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 67.3 m -66.63 -39.89 88.49 Favored 'General case' 0 C--N 1.355 0.842 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.68 -179.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 -67.48 -39.21 85.25 Favored 'General case' 0 C--N 1.355 0.838 0 C-N-CA 119.616 -0.834 . . . . 0.0 108.83 -179.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -66.26 -23.36 66.39 Favored 'General case' 0 C--N 1.355 0.832 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 178.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.681 ' O ' HG13 ' A' ' 99' ' ' ILE . 66.1 tp -65.25 -45.17 85.67 Favored 'General case' 0 C--N 1.357 0.926 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.425 ' HA ' ' CD1' ' A' ' 99' ' ' ILE . 3.3 mp -60.08 -35.94 76.29 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.1 t -70.49 -39.62 74.06 Favored 'General case' 0 C--N 1.35 0.599 0 O-C-N 121.881 -0.512 . . . . 0.0 109.935 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.3 -0.33 52.06 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -176.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.681 HG13 ' O ' ' A' ' 95' ' ' LEU . 81.1 mt -61.6 -47.18 94.56 Favored 'Isoleucine or valine' 0 C--N 1.357 0.894 0 CA-C-N 119.197 0.908 . . . . 0.0 111.704 -177.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -93.06 -23.41 18.66 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 118.642 -1.223 . . . . 0.0 111.349 -177.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 33.6 t -63.71 -48.57 76.56 Favored 'General case' 0 N--CA 1.446 -0.625 0 O-C-N 121.645 -0.659 . . . . 0.0 112.592 -177.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -139.99 -12.87 1.09 Allowed 'General case' 0 C--N 1.359 0.982 0 C-N-CA 117.083 -1.847 . . . . 0.0 113.685 -177.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.735 HG21 ' C1C' ' A' ' 202' ' ' HEM . 24.9 mm -70.12 -51.23 41.05 Favored 'Isoleucine or valine' 0 C--O 1.242 0.706 0 CA-C-N 120.352 1.433 . . . . 0.0 110.564 -177.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.418 ' HD2' HG22 ' A' ' 103' ' ' ILE . 65.5 m170 -91.72 1.15 57.35 Favored 'General case' 0 N--CA 1.439 -0.983 0 C-N-CA 119.476 -0.89 . . . . 0.0 110.209 -177.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 79.5 t -81.39 -44.54 20.6 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.009 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 178.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 54.8 tp10 -68.09 -40.44 82.65 Favored 'General case' 0 N--CA 1.44 -0.951 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 53.8 t -62.13 -46.95 95.29 Favored 'Isoleucine or valine' 0 C--N 1.355 0.824 0 C-N-CA 120.821 -0.352 . . . . 0.0 110.685 -179.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -60.45 -48.13 83.11 Favored 'General case' 0 C--N 1.361 1.078 0 O-C-N 121.998 -0.438 . . . . 0.0 111.546 -179.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -60.66 -36.84 79.7 Favored 'General case' 0 C--N 1.355 0.821 0 O-C-N 121.503 -0.748 . . . . 0.0 110.383 -178.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 18.5 mt -59.49 -77.08 0.04 OUTLIER 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.438 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 79.8 m-85 -119.14 140.32 28.69 Favored Pre-proline 0 N--CA 1.44 -0.958 0 C-N-CA 118.574 -1.251 . . . . 0.0 108.973 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 111' ' ' TYR . 67.3 Cg_endo -87.18 -2.1 7.87 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 123.077 2.518 . . . . 0.0 115.124 -179.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 29.7 mm100 -66.9 -36.51 82.45 Favored 'General case' 0 C--N 1.355 0.824 0 O-C-N 121.819 -0.551 . . . . 0.0 109.888 -179.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.24 144.63 57.04 Favored 'General case' 0 C--N 1.354 0.802 0 CA-C-O 121.56 0.695 . . . . 0.0 110.067 -178.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.453 ' O ' HD13 ' A' ' 116' ' ' LEU . 46.3 mt-10 -115.91 142.78 46.33 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 107.314 -1.365 . . . . 0.0 107.314 179.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.453 HD13 ' O ' ' A' ' 115' ' ' GLU . 2.6 mm? -127.16 148.8 67.49 Favored Pre-proline 0 N--CA 1.444 -0.737 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -178.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 116' ' ' LEU . 92.1 Cg_endo -91.07 -157.36 0.06 OUTLIER 'Trans proline' 0 C--N 1.315 -1.21 0 C-N-CA 123.797 2.998 . . . . 0.0 113.263 179.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -118.41 140.4 49.92 Favored 'General case' 0 C--N 1.363 1.186 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.414 ' CZ ' ' HG2' ' A' ' 117' ' ' PRO . 94.2 m-85 -131.51 135.03 46.74 Favored 'General case' 0 C--N 1.359 1.013 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.526 -178.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.453 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 93.6 m -124.05 127.57 48.06 Favored 'General case' 0 CA--C 1.502 -0.875 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 176.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 75.2 m -118.06 128.02 54.36 Favored 'General case' 0 CA--C 1.504 -0.794 0 C-N-CA 119.215 -0.994 . . . . 0.0 109.545 -177.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -118.77 151.36 38.18 Favored 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 106.296 -1.742 . . . . 0.0 106.296 178.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -122.56 117.16 25.23 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.478 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 94.7 mt -86.9 -22.54 25.63 Favored 'General case' 0 C--N 1.354 0.782 0 C-N-CA 120.485 -0.486 . . . . 0.0 110.219 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 177.8 -145.64 7.17 Favored Glycine 0 C--N 1.348 1.248 0 N-CA-C 109.003 -1.639 . . . . 0.0 109.003 -178.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -94.7 -39.35 10.36 Favored 'General case' 0 N--CA 1.439 -1.014 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 -178.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 15.2 p-10 -99.46 1.97 44.57 Favored 'General case' 0 C--N 1.353 0.756 0 C-N-CA 120.292 -0.563 . . . . 0.0 109.95 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.478 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 66.1 m-20 -121.12 133.42 55.21 Favored 'General case' 0 C--N 1.357 0.935 0 C-N-CA 119.873 -0.731 . . . . 0.0 109.167 -179.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.413 HD13 ' HA ' ' A' ' 129' ' ' ILE . 8.0 mm -142.86 136.42 26.49 Favored 'Isoleucine or valine' 0 C--N 1.356 0.878 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 52.9 mtm180 -116.94 139.06 51.09 Favored 'General case' 0 CA--C 1.497 -1.077 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.0 tp -128.02 118.6 23.8 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 -179.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.453 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 12.0 m170 -97.35 132.92 42.61 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 179.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 61.4 t80 -126.42 121.38 32.27 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -178.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.485 ' HA ' ' O ' ' A' ' 171' ' ' THR . 29.9 tt0 -115.24 112.2 22.09 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.3 t -162.02 151.39 15.96 Favored 'General case' 0 C--N 1.36 1.038 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -90.47 2.31 55.82 Favored 'General case' 0 C--N 1.356 0.867 0 C-N-CA 120.316 -0.554 . . . . 0.0 109.777 -179.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 88.8 mtm180 -134.17 74.65 67.24 Favored Pre-proline 0 C--N 1.354 0.786 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -94.82 106.24 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.659 2.239 . . . . 0.0 115.968 -177.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -111.18 109.61 19.74 Favored 'General case' 0 N--CA 1.441 -0.911 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 176.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.82 -39.14 93.51 Favored 'General case' 0 C--N 1.354 0.797 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.66 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.421 ' HB3' HG11 ' A' ' 67' ' ' VAL . 73.8 m -62.81 -27.6 69.42 Favored 'General case' 0 C--N 1.354 0.797 0 O-C-N 121.876 -0.515 . . . . 0.0 110.715 -178.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -76.53 -46.49 26.28 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 120.189 -0.604 . . . . 0.0 109.862 -177.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.83 -39.81 94.17 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 122.05 -0.406 . . . . 0.0 111.176 -177.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -63.17 -36.83 84.92 Favored 'General case' 0 C--N 1.356 0.86 0 O-C-N 121.902 -0.499 . . . . 0.0 109.85 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.01 -42.94 98.58 Favored Glycine 0 C--N 1.348 1.202 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 -179.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 86.3 mt -70.57 -41.0 73.0 Favored 'General case' 0 C--N 1.354 0.761 0 CA-C-N 117.552 0.676 . . . . 0.0 112.775 -179.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 97.1 mt -71.37 -41.82 69.22 Favored 'General case' 0 C--N 1.361 1.092 0 O-C-N 121.155 -0.966 . . . . 0.0 110.832 -176.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.472 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 36.8 t70 -69.97 -28.61 65.68 Favored 'General case' 0 N--CA 1.442 -0.865 0 O-C-N 121.258 -0.901 . . . . 0.0 109.987 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.447 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -63.72 -40.61 98.7 Favored Glycine 0 C--N 1.355 1.601 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 14.1 p -65.6 -31.49 72.56 Favored 'General case' 0 C--N 1.357 0.918 0 C-N-CA 119.341 -0.943 . . . . 0.0 109.451 179.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -78.75 -1.16 33.32 Favored 'General case' 0 C--N 1.363 1.184 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 177.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.472 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 76.8 mm-40 -85.33 -45.55 11.81 Favored 'General case' 0 N--CA 1.442 -0.87 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 91.4 t80 -66.71 -45.72 77.86 Favored 'General case' 0 C--N 1.36 1.062 0 C-N-CA 120.152 -0.619 . . . . 0.0 109.545 178.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -68.98 -26.83 65.24 Favored 'General case' 0 C--N 1.361 1.078 0 O-C-N 121.843 -0.536 . . . . 0.0 110.664 -178.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 84.6 tttt 73.51 71.85 0.12 Allowed 'General case' 0 C--N 1.362 1.109 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -139.38 -171.62 3.17 Favored 'General case' 0 CA--C 1.504 -0.81 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -147.28 94.69 2.43 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 16.3 m-30 -114.78 157.17 23.6 Favored 'General case' 0 CA--C 1.506 -0.73 0 N-CA-C 106.358 -1.719 . . . . 0.0 106.358 178.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 93.4 m -120.2 128.8 53.71 Favored 'General case' 0 C--N 1.354 0.791 0 C-N-CA 119.655 -0.818 . . . . 0.0 108.857 -178.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.535 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.5 mp -104.49 122.04 56.98 Favored 'Isoleucine or valine' 0 C--N 1.351 0.66 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 179.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.3 m -117.86 -174.05 2.56 Favored 'General case' 0 C--N 1.358 0.948 0 CA-C-O 121.942 0.877 . . . . 0.0 109.462 -178.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 26.6 ptt180 -146.2 155.69 42.88 Favored 'General case' 0 C--N 1.357 0.918 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 -178.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.446 ' HA ' ' HD3' ' A' ' 164' ' ' PRO . 34.8 p -96.98 145.67 29.98 Favored Pre-proline 0 C--N 1.358 0.971 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.623 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 15.3 Cg_exo -70.82 -16.19 33.09 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 123.439 2.759 . . . . 0.0 114.445 -179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -71.63 -40.78 69.53 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 120.436 -0.506 . . . . 0.0 110.708 -177.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 40.8 p -119.28 16.38 13.11 Favored 'General case' 0 C--N 1.353 0.739 0 C-N-CA 119.778 -0.769 . . . . 0.0 110.852 -178.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.623 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 9.9 pt20 -66.89 -12.86 60.73 Favored 'General case' 0 C--N 1.353 0.741 0 O-C-N 121.517 -0.739 . . . . 0.0 110.212 178.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 54.0 p30 -124.74 38.23 4.24 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 19.9 t -139.42 144.95 38.32 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.599 ' O ' ' HB ' ' A' ' 171' ' ' THR . 62.0 mt-10 -97.9 165.07 12.1 Favored 'General case' 0 C--N 1.355 0.829 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -179.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.599 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 18.7 m 82.52 -58.98 0.18 Allowed 'General case' 0 C--N 1.37 1.49 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.771 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -107.75 116.83 32.66 Favored 'General case' 0 CA--C 1.503 -0.829 0 C-N-CA 119.952 -0.699 . . . . 0.0 109.538 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 85.1 t -130.69 132.45 64.24 Favored 'Isoleucine or valine' 0 C--N 1.357 0.904 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 178.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 50.8 mm -107.74 126.31 64.15 Favored 'Isoleucine or valine' 0 C--N 1.356 0.878 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -114.8 154.44 28.57 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-O 122.173 0.987 . . . . 0.0 108.588 -178.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -136.82 119.24 15.79 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.8 mp -113.85 119.83 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 N-CA-C 106.525 -1.658 . . . . 0.0 106.525 -179.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 89.6 m -120.39 143.06 48.64 Favored 'General case' 0 CA--C 1.505 -0.788 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -177.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 10.2 ttm180 -83.67 118.58 23.95 Favored 'General case' 0 C--N 1.363 1.184 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.475 ' HB1' ' HD2' ' A' ' 181' ' ' PRO . . . -64.33 157.16 72.9 Favored Pre-proline 0 C--N 1.359 1.004 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.475 ' HD2' ' HB1' ' A' ' 180' ' ' ALA . 86.9 Cg_exo -50.0 126.07 16.11 Favored 'Trans proline' 0 CA--C 1.498 -1.313 0 C-N-CA 122.737 2.291 . . . . 0.0 114.055 -178.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -92.64 12.09 24.42 Favored 'General case' 0 N--CA 1.435 -1.184 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 179.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 103.25 113.46 3.81 Favored Glycine 0 N--CA 1.439 -1.123 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . 67.28 69.66 0.38 Allowed 'General case' 0 C--N 1.359 0.981 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -72.79 150.06 43.11 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -109.21 120.9 43.93 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 107.437 -1.32 . . . . 0.0 107.437 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 89.8 mt -106.25 -59.6 1.76 Allowed 'General case' 0 N--CA 1.438 -1.055 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . 0.498 ' HB3' ' H ' ' A' ' 189' ' ' PHE . 0.2 OUTLIER -152.12 -101.81 0.05 Allowed 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 179.897 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . 0.498 ' H ' ' HB3' ' A' ' 188' ' ' TYR . 71.9 m-85 -114.03 144.47 43.05 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 64.4 tt0 . . . . . 0 C--O 1.265 1.873 0 N-CA-C 107.716 -1.216 . . . . 0.0 107.716 -179.85 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' HEM . . . . . 1.018 ' HHA' HBD2 ' A' ' 202' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.956 ' HG2' HMD3 ' A' ' 202' ' ' HEM . 78.2 mmm . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.065 0.459 . . . . 0.0 110.202 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -80.18 -19.05 47.98 Favored 'General case' 0 C--N 1.356 0.856 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -178.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.73 -40.44 45.6 Favored Glycine 0 C--N 1.35 1.323 0 N-CA-C 109.415 -1.474 . . . . 0.0 109.415 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.22 -34.81 68.62 Favored 'General case' 0 C--N 1.354 0.793 0 O-C-N 121.853 -0.792 . . . . 0.0 111.164 -177.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 28.1 m -69.03 -23.99 27.76 Favored 'Isoleucine or valine' 0 C--N 1.356 0.85 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 -179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.453 ' HZ ' ' CG ' ' A' ' 47' ' ' GLU . 2.0 m-85 -70.6 -35.03 72.77 Favored 'General case' 0 C--N 1.356 0.86 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 179.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 89.6 m -67.4 -39.71 85.57 Favored 'General case' 0 C--N 1.356 0.883 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -61.81 -38.45 95.99 Favored Glycine 0 C--N 1.36 1.874 0 N-CA-C 109.901 -1.28 . . . . 0.0 109.901 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.675 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -64.72 -41.35 96.05 Favored 'General case' 0 C--N 1.352 0.685 0 O-C-N 122.511 -0.405 . . . . 0.0 110.791 -178.768 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.433 ' CE ' HD21 ' A' ' 26' ' ' LEU . 20.7 mmt -62.71 -40.92 98.68 Favored 'General case' 0 C--N 1.352 0.692 0 O-C-N 121.693 -0.629 . . . . 0.0 110.891 -178.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -68.06 -40.66 82.71 Favored 'General case' 0 C--N 1.347 0.481 0 O-C-N 121.952 -0.467 . . . . 0.0 111.738 -177.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 54.0 tp -66.65 -43.79 83.67 Favored 'General case' 0 C--N 1.35 0.599 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -178.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.675 HG12 ' O ' ' A' ' 9' ' ' LEU . 2.0 mm -72.71 -37.36 55.4 Favored 'Isoleucine or valine' 0 C--N 1.36 1.032 0 O-C-N 121.164 -0.96 . . . . 0.0 111.054 -175.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -71.65 -42.85 67.03 Favored 'General case' 0 C--N 1.35 0.619 0 O-C-N 121.662 -0.649 . . . . 0.0 111.835 -176.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -71.26 -37.03 71.95 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 -175.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -98.31 -27.95 13.89 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 118.627 -1.229 . . . . 0.0 114.085 -174.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -115.28 -30.55 6.25 Favored 'General case' 0 CA--C 1.506 -0.743 0 C-N-CA 117.162 -1.815 . . . . 0.0 112.7 -176.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 143.17 177.83 18.48 Favored Glycine 0 C--N 1.347 1.155 0 C-N-CA 118.122 -1.99 . . . . 0.0 110.068 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -101.46 -24.4 14.18 Favored 'General case' 0 N--CA 1.434 -1.258 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 -177.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -68.98 -39.86 79.16 Favored 'General case' 0 C--N 1.361 1.106 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 178.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 96.3 m -68.54 -38.63 81.0 Favored 'General case' 0 C--N 1.357 0.923 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 178.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 41.9 tp -59.4 -39.16 82.53 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -65.31 -37.21 86.44 Favored 'General case' 0 C--N 1.355 0.828 0 O-C-N 122.144 -0.347 . . . . 0.0 111.241 -178.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 88.6 m -64.61 -40.72 96.0 Favored 'General case' 0 C--N 1.354 0.787 0 O-C-N 121.679 -0.638 . . . . 0.0 109.708 -178.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.499 HD22 ' HB3' ' A' ' 54' ' ' LYS . 10.2 mt -64.81 -37.47 87.71 Favored 'General case' 0 C--N 1.353 0.757 0 C-N-CA 120.566 -0.454 . . . . 0.0 109.777 -178.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.433 HD21 ' CE ' ' A' ' 10' ' ' MET . 83.6 mt -70.0 -17.24 63.27 Favored 'General case' 0 C--N 1.359 0.996 0 O-C-N 121.739 -0.6 . . . . 0.0 110.192 -179.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -84.66 -28.27 26.53 Favored 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 119.51 -0.876 . . . . 0.0 109.493 179.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 45.7 t -66.76 -36.89 83.47 Favored 'General case' 0 C--N 1.354 0.781 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 178.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.625 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 2.2 p -92.91 -37.98 11.96 Favored 'General case' 0 C--N 1.358 0.957 0 C-N-CA 118.936 -1.106 . . . . 0.0 108.031 -178.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.625 ' HB2' ' O ' ' A' ' 29' ' ' CYS . 14.9 mt-10 84.73 132.61 0.05 OUTLIER 'General case' 0 C--N 1.359 1.005 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.528 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -90.25 -167.67 1.9 Allowed 'General case' 0 C--N 1.356 0.85 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 179.286 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -154.25 -64.63 0.14 Allowed 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.5 t -97.26 -64.92 1.0 Allowed 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -179.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -139.21 -44.02 0.46 Allowed 'General case' 0 CA--C 1.501 -0.91 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 -178.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 124.74 -35.97 3.0 Favored Glycine 0 C--N 1.352 1.448 0 N-CA-C 109.151 -1.579 . . . . 0.0 109.151 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 82.5 mt -110.84 101.92 13.25 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.782 0 N-CA-C 106.929 -1.508 . . . . 0.0 106.929 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.613 ' CD2' HG23 ' A' ' 40' ' ' VAL . 0.4 OUTLIER -66.65 -57.27 7.53 Favored 'General case' 0 C--N 1.358 0.964 0 N-CA-C 108.299 -1.001 . . . . 0.0 108.299 178.947 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.478 HG22 ' N ' ' A' ' 39' ' ' SER . 1.0 OUTLIER 148.65 -64.04 0.0 OUTLIER 'General case' 0 C--N 1.367 1.355 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 178.422 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.478 ' N ' HG22 ' A' ' 38' ' ' THR . 17.7 p 168.73 70.69 0.0 OUTLIER 'General case' 0 C--N 1.362 1.135 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 -179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.613 HG23 ' CD2' ' A' ' 37' ' ' TYR . 0.0 OUTLIER -159.21 4.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.356 0.869 0 C-N-CA 119.785 -0.766 . . . . 0.0 109.797 -179.438 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -81.78 -158.11 21.14 Favored Glycine 0 C--N 1.355 1.597 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 -179.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 171.17 85.34 0.0 OUTLIER 'General case' 0 CA--C 1.5 -0.963 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 -178.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -95.47 177.08 5.94 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -83.63 -170.82 3.25 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 67.0 m80 -91.93 -14.95 28.73 Favored 'General case' 0 CA--C 1.499 -0.992 0 C-N-CA 119.994 -0.682 . . . . 0.0 109.3 -179.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -69.85 -30.5 67.99 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.453 ' CG ' ' HZ ' ' A' ' 6' ' ' PHE . 33.0 tp10 -64.02 -40.82 97.18 Favored 'General case' 0 C--N 1.351 0.654 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.655 ' O ' HD23 ' A' ' 48' ' ' LEU . 4.6 tt -71.78 -35.52 70.05 Favored 'General case' 0 C--N 1.357 0.896 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -179.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 61.5 tp -69.99 -36.7 75.36 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 -177.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 72.9 tp60 -65.0 -41.72 95.14 Favored 'General case' 0 N--CA 1.441 -0.881 0 O-C-N 121.87 -0.519 . . . . 0.0 109.707 -178.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 81.7 mt -73.94 -35.82 64.61 Favored 'General case' 0 C--N 1.364 1.2 0 C-N-CA 119.76 -0.776 . . . . 0.0 110.28 -179.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.4 t -64.03 -39.05 84.07 Favored 'Isoleucine or valine' 0 C--N 1.353 0.76 0 O-C-N 121.904 -0.497 . . . . 0.0 109.759 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 55.8 t -67.66 -39.6 82.5 Favored 'Isoleucine or valine' 0 C--N 1.352 0.699 0 O-C-N 121.675 -0.641 . . . . 0.0 109.474 179.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.499 ' HB3' HD22 ' A' ' 25' ' ' LEU . 35.1 tptt -63.51 -28.7 70.13 Favored 'General case' 0 C--N 1.363 1.175 0 O-C-N 121.234 -0.916 . . . . 0.0 108.711 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.583 HD21 HD12 ' A' ' 13' ' ' ILE . 14.1 mt -66.65 -38.3 86.6 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.439 179.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.6 p -72.54 -17.79 61.69 Favored 'General case' 0 C--N 1.353 0.727 0 C-N-CA 119.93 -0.708 . . . . 0.0 110.879 -178.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -101.72 -38.68 7.78 Favored 'General case' 0 C--N 1.353 0.729 0 C-N-CA 119.358 -0.937 . . . . 0.0 111.813 -178.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 3.6 p -74.38 -37.48 45.05 Favored 'Isoleucine or valine' 0 C--N 1.352 0.704 0 O-C-N 121.515 -0.741 . . . . 0.0 111.255 -176.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.569 ' HB3' HG23 ' A' ' 61' ' ' VAL . 1.9 t -110.57 -9.44 14.55 Favored 'General case' 0 C--N 1.352 0.713 0 C-N-CA 119.249 -0.981 . . . . 0.0 110.281 -178.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 65.29 49.26 1.97 Allowed 'General case' 0 C--N 1.354 0.792 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.569 HG23 ' HB3' ' A' ' 59' ' ' SER . 58.2 t -113.92 133.49 22.3 Favored Pre-proline 0 CA--C 1.504 -0.822 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 61' ' ' VAL . 43.2 Cg_exo -57.88 147.44 81.42 Favored 'Trans proline' 0 CA--C 1.499 -1.229 0 C-N-CA 122.581 2.187 . . . . 0.0 112.825 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.2 m -74.51 -13.03 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.912 -178.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.411 ' O ' HG12 ' A' ' 67' ' ' VAL . 68.2 p -95.95 -32.03 12.8 Favored 'General case' 0 C--N 1.357 0.922 0 C-N-CA 118.151 -1.42 . . . . 0.0 109.509 -179.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -76.44 -24.43 53.93 Favored 'General case' 0 C--N 1.355 0.819 0 O-C-N 121.452 -0.78 . . . . 0.0 109.201 179.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.435 HD13 HD13 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -80.15 -36.92 34.48 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 -179.029 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.411 HG12 ' O ' ' A' ' 64' ' ' THR . 1.5 p -67.97 -26.87 35.66 Favored 'Isoleucine or valine' 0 C--N 1.353 0.737 0 C-N-CA 120.241 -0.584 . . . . 0.0 110.036 -179.489 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 5.2 mmm-85 -73.14 -51.17 18.92 Favored 'General case' 0 C--N 1.362 1.151 0 O-C-N 121.549 -0.719 . . . . 0.0 110.283 -179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 84.1 mt -63.64 -36.24 83.16 Favored 'General case' 0 C--N 1.357 0.929 0 O-C-N 121.959 -0.463 . . . . 0.0 111.003 -178.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.8 t80 -60.85 -47.83 84.57 Favored 'General case' 0 C--N 1.349 0.575 0 O-C-N 122.155 -0.341 . . . . 0.0 110.596 -178.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.76 -38.09 94.65 Favored Glycine 0 C--N 1.355 1.592 0 N-CA-C 111.854 -0.498 . . . . 0.0 111.854 -178.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -63.64 -47.94 79.27 Favored 'General case' 0 C--N 1.35 0.588 0 CA-C-N 117.976 0.888 . . . . 0.0 111.508 -177.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.639 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 12.6 mttm -64.65 -48.51 74.55 Favored 'General case' 0 C--N 1.358 0.973 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -177.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.413 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.3 tm? -68.71 -39.2 80.56 Favored 'General case' 0 C--N 1.348 0.507 0 O-C-N 121.3 -0.875 . . . . 0.0 111.926 -175.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.602 ' HE1' ' CBB' ' A' ' 202' ' ' HEM . 40.7 t80 -63.22 -44.33 95.56 Favored 'General case' 0 C--N 1.354 0.766 0 O-C-N 121.068 -1.02 . . . . 0.0 111.044 -178.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.12 -15.23 18.55 Favored 'Isoleucine or valine' 0 C--N 1.359 0.982 0 O-C-N 121.509 -0.744 . . . . 0.0 109.184 -179.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.639 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 69.5 mm-40 -71.8 -38.83 70.18 Favored 'General case' 0 C--N 1.349 0.574 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 83.2 mt -72.98 -32.37 65.15 Favored 'General case' 0 C--N 1.358 0.946 0 O-C-N 122.309 -0.244 . . . . 0.0 110.471 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.8 mm -64.58 -53.43 42.53 Favored 'Isoleucine or valine' 0 C--N 1.357 0.922 0 C-N-CA 120.303 -0.559 . . . . 0.0 110.372 -177.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -75.39 -15.49 60.45 Favored 'General case' 0 C--N 1.35 0.621 0 C-N-CA 119.624 -0.831 . . . . 0.0 109.337 178.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.11 -37.06 64.0 Favored Glycine 0 C--N 1.35 1.348 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -131.33 105.73 14.69 Favored Pre-proline 0 N--CA 1.441 -0.922 0 CA-C-O 122.643 1.211 . . . . 0.0 109.321 -176.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -67.99 -25.88 37.91 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.614 2.209 . . . . 0.0 114.146 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -89.0 -8.26 54.41 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.2 tp -90.26 -20.56 6.93 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 -178.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.41 -23.57 14.71 Favored 'General case' 0 N--CA 1.439 -1.006 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -70.06 -37.42 75.51 Favored 'General case' 0 C--N 1.358 0.949 0 C-N-CA 120.264 -0.575 . . . . 0.0 109.527 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -64.9 -36.21 83.63 Favored 'General case' 0 C--N 1.356 0.874 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.333 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 25.9 ttp -82.75 149.31 27.34 Favored 'General case' 0 C--N 1.351 0.646 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 -178.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.59 -22.27 8.17 Favored 'General case' 0 C--N 1.361 1.093 0 C-N-CA 119.972 -0.691 . . . . 0.0 110.831 -177.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -165.25 171.76 13.23 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -177.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.418 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 41.0 t -64.3 -42.07 96.54 Favored 'General case' 0 C--N 1.357 0.921 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.08 -179.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -66.54 -38.55 87.37 Favored 'General case' 0 C--N 1.355 0.81 0 O-C-N 121.437 -0.789 . . . . 0.0 109.493 -178.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -65.65 -25.31 67.3 Favored 'General case' 0 C--N 1.355 0.805 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.418 ' HB3' ' O ' ' A' ' 92' ' ' SER . 57.6 tp -63.21 -46.62 86.16 Favored 'General case' 0 C--N 1.357 0.928 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.1 mp -61.78 -32.64 72.93 Favored 'General case' 0 C--N 1.356 0.862 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 36.0 t -62.87 -44.74 95.29 Favored 'General case' 0 C--N 1.354 0.762 0 O-C-N 121.931 -0.481 . . . . 0.0 111.584 -178.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.97 26.88 10.1 Favored 'General case' 0 C--N 1.364 1.225 0 O-C-N 120.939 -1.101 . . . . 0.0 111.132 -177.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 1.035 HD11 ' C3B' ' A' ' 202' ' ' HEM . 8.9 tp -61.31 -30.33 47.72 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 C-N-CA 120.431 -0.507 . . . . 0.0 110.539 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -126.95 -7.78 6.05 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 118.484 -1.287 . . . . 0.0 110.005 -179.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 57.5 m -90.43 -3.36 57.73 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 119.498 -0.881 . . . . 0.0 110.442 -179.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -149.0 -47.39 0.14 Allowed 'General case' 0 C--N 1.358 0.956 0 C-N-CA 118.132 -1.427 . . . . 0.0 110.043 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.494 HG23 HBC2 ' A' ' 202' ' ' HEM . 96.2 mt -67.41 -47.29 81.35 Favored 'Isoleucine or valine' 0 C--N 1.354 0.802 0 O-C-N 121.926 -0.484 . . . . 0.0 110.979 -177.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 23.0 m170 -84.65 0.33 50.69 Favored 'General case' 0 C--N 1.353 0.754 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.933 -177.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 77.3 t -80.78 -45.01 21.53 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.975 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 178.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -67.45 -40.0 85.39 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.959 -179.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.754 HG11 HMD1 ' A' ' 202' ' ' HEM . 64.8 t -62.96 -46.71 95.61 Favored 'Isoleucine or valine' 0 C--N 1.354 0.782 0 O-C-N 122.155 -0.341 . . . . 0.0 110.742 -178.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -60.21 -47.85 84.2 Favored 'General case' 0 C--N 1.358 0.945 0 O-C-N 122.112 -0.367 . . . . 0.0 111.361 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -62.91 -36.18 82.53 Favored 'General case' 0 C--N 1.353 0.753 0 O-C-N 121.545 -0.722 . . . . 0.0 110.502 -178.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.5 mt -59.08 -77.22 0.04 OUTLIER 'General case' 0 C--N 1.357 0.931 0 C-N-CA 120.444 -0.503 . . . . 0.0 109.809 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.403 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 81.1 m-85 -111.13 141.76 24.95 Favored Pre-proline 0 N--CA 1.442 -0.863 0 C-N-CA 118.583 -1.247 . . . . 0.0 109.553 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 111' ' ' TYR . 51.3 Cg_endo -90.73 0.63 5.06 Favored 'Trans proline' 0 C--N 1.313 -1.321 0 C-N-CA 123.781 2.988 . . . . 0.0 115.216 -179.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 78.7 mm-40 -86.1 4.42 38.29 Favored 'General case' 0 C--N 1.355 0.813 0 O-C-N 121.63 -0.668 . . . . 0.0 109.851 -178.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -96.1 143.81 26.91 Favored 'General case' 0 N--CA 1.444 -0.762 0 C-N-CA 119.798 -0.761 . . . . 0.0 109.7 -178.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -119.51 141.43 49.21 Favored 'General case' 0 C--N 1.358 0.963 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 178.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 95.6 mt -136.53 152.97 75.71 Favored Pre-proline 0 C--N 1.355 0.831 0 CA-C-O 122.198 0.999 . . . . 0.0 109.518 -178.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.421 ' HG3' HBA1 ' A' ' 202' ' ' HEM . 78.3 Cg_endo -87.19 -158.15 0.08 OUTLIER 'Trans proline' 0 C--N 1.32 -0.925 0 C-N-CA 123.96 3.106 . . . . 0.0 113.894 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -114.84 139.2 49.95 Favored 'General case' 0 C--N 1.368 1.38 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 -179.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -125.32 127.31 46.45 Favored 'General case' 0 C--N 1.362 1.13 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 -178.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.51 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 93.9 m -125.47 128.79 48.6 Favored 'General case' 0 C--N 1.357 0.912 0 N-CA-C 105.841 -1.911 . . . . 0.0 105.841 177.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 73.7 m -119.76 128.12 53.45 Favored 'General case' 0 CA--C 1.503 -0.836 0 C-N-CA 119.323 -0.951 . . . . 0.0 109.506 -178.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -122.18 145.44 48.19 Favored 'General case' 0 N--CA 1.44 -0.972 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 178.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.661 ' HG2' ' H ' ' A' ' 124' ' ' LEU . 35.4 ttp180 -100.33 -169.02 1.66 Allowed 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 179.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.661 ' H ' ' HG2' ' A' ' 123' ' ' ARG . 21.9 mt -165.12 -36.91 0.03 OUTLIER 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 106.66 -1.607 . . . . 0.0 106.66 -178.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -171.03 -150.89 7.27 Favored Glycine 0 C--N 1.353 1.503 0 N-CA-C 108.241 -1.944 . . . . 0.0 108.241 -178.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -94.29 -40.1 10.16 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.331 -179.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -97.64 3.84 50.27 Favored 'General case' 0 C--N 1.352 0.683 0 C-N-CA 120.216 -0.593 . . . . 0.0 110.276 -178.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -122.31 135.22 54.69 Favored 'General case' 0 C--N 1.356 0.881 0 C-N-CA 119.552 -0.859 . . . . 0.0 109.405 -179.428 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.415 HD13 ' HA ' ' A' ' 129' ' ' ILE . 6.4 mm -142.11 136.9 29.94 Favored 'Isoleucine or valine' 0 C--N 1.356 0.87 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 178.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 52.3 mtm180 -114.88 138.47 50.76 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 8.3 tp -126.28 118.35 24.93 Favored 'General case' 0 N--CA 1.429 -1.509 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.51 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 15.7 m-70 -98.27 134.43 41.32 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 179.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -130.3 121.43 26.05 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.544 ' HA ' ' O ' ' A' ' 171' ' ' THR . 75.1 mt-30 -114.15 114.69 26.39 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 19.4 t -161.52 150.41 15.95 Favored 'General case' 0 C--N 1.357 0.916 0 N-CA-C 106.892 -1.522 . . . . 0.0 106.892 179.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -90.5 1.69 56.44 Favored 'General case' 0 C--N 1.355 0.805 0 C-N-CA 120.306 -0.557 . . . . 0.0 109.879 -178.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -136.78 74.57 51.37 Favored Pre-proline 0 CA--C 1.506 -0.742 0 N-CA-C 106.558 -1.645 . . . . 0.0 106.558 179.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -94.11 110.6 0.18 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.657 2.238 . . . . 0.0 116.157 -177.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -111.56 109.7 19.74 Favored 'General case' 0 N--CA 1.44 -0.97 0 N-CA-C 106.371 -1.715 . . . . 0.0 106.371 176.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.4 -39.65 95.09 Favored 'General case' 0 C--N 1.355 0.811 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.518 -178.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 74.8 m -64.29 -24.93 67.83 Favored 'General case' 0 C--N 1.353 0.738 0 O-C-N 121.849 -0.532 . . . . 0.0 110.831 -178.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 88.4 t80 -76.51 -47.69 21.95 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 120.192 -0.603 . . . . 0.0 109.611 -178.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -65.1 -39.21 92.83 Favored 'General case' 0 C--N 1.357 0.93 0 O-C-N 122.115 -0.365 . . . . 0.0 111.123 -178.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -62.65 -37.29 85.77 Favored 'General case' 0 C--N 1.358 0.966 0 O-C-N 121.801 -0.562 . . . . 0.0 109.77 -179.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.27 -42.53 98.78 Favored Glycine 0 C--N 1.347 1.162 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.2 mt -70.46 -40.72 73.52 Favored 'General case' 0 C--N 1.352 0.687 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -179.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 96.3 mt -70.91 -41.97 70.54 Favored 'General case' 0 C--N 1.361 1.096 0 O-C-N 121.32 -0.862 . . . . 0.0 110.891 -177.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.551 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 36.8 t70 -70.33 -29.73 66.52 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 121.893 -0.504 . . . . 0.0 110.295 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -63.3 -39.43 97.83 Favored Glycine 0 C--N 1.356 1.656 0 N-CA-C 108.489 -1.844 . . . . 0.0 108.489 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 47.6 t -60.68 -42.25 96.73 Favored 'General case' 0 C--N 1.351 0.635 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -75.99 0.08 19.78 Favored 'General case' 0 C--N 1.36 1.025 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.551 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 76.5 mm-40 -84.6 -46.03 11.95 Favored 'General case' 0 N--CA 1.442 -0.857 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -67.65 -43.77 79.51 Favored 'General case' 0 C--N 1.359 0.999 0 C-N-CA 120.109 -0.636 . . . . 0.0 109.559 179.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.467 ' O ' ' HB2' ' A' ' 155' ' ' LYS . 54.3 m-85 -70.42 -24.94 63.01 Favored 'General case' 0 C--N 1.361 1.087 0 O-C-N 121.734 -0.604 . . . . 0.0 111.311 -178.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 154' ' ' PHE . 47.9 mttt 73.62 67.82 0.1 Allowed 'General case' 0 C--N 1.362 1.116 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 -178.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -134.16 -176.04 4.06 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -146.76 91.88 2.08 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 16.3 m-30 -113.54 157.73 21.66 Favored 'General case' 0 C--N 1.352 0.678 0 N-CA-C 106.148 -1.797 . . . . 0.0 106.148 179.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 92.6 m -119.27 127.77 53.54 Favored 'General case' 0 C--N 1.353 0.723 0 C-N-CA 119.548 -0.861 . . . . 0.0 108.832 -178.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.554 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.2 mp -103.97 121.9 56.09 Favored 'Isoleucine or valine' 0 C--N 1.351 0.661 0 N-CA-C 106.744 -1.576 . . . . 0.0 106.744 178.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.9 m -118.38 -173.69 2.52 Favored 'General case' 0 C--N 1.358 0.935 0 CA-C-O 121.661 0.743 . . . . 0.0 109.412 -178.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 32.5 ptt180 -146.97 157.0 43.5 Favored 'General case' 0 C--N 1.356 0.858 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 -178.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 49.6 p -99.64 146.37 31.7 Favored Pre-proline 0 C--N 1.358 0.974 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.685 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 73.9 Cg_endo -75.04 -12.0 21.42 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.941 2.427 . . . . 0.0 114.966 -178.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -72.63 -41.67 65.28 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 119.918 -0.713 . . . . 0.0 109.84 -178.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 37.8 p -117.21 15.5 14.92 Favored 'General case' 0 C--N 1.354 0.789 0 C-N-CA 119.968 -0.693 . . . . 0.0 110.717 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.685 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.1 pp0? -67.59 -11.62 58.52 Favored 'General case' 0 C--N 1.354 0.796 0 O-C-N 121.569 -0.707 . . . . 0.0 110.245 178.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 54.4 p-10 -122.41 33.33 5.48 Favored 'General case' 0 N--CA 1.438 -1.038 0 O-C-N 121.148 -0.97 . . . . 0.0 108.707 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 57.8 m -135.67 148.37 48.9 Favored 'General case' 0 CA--C 1.503 -0.839 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.634 ' O ' ' HB ' ' A' ' 171' ' ' THR . 60.8 mt-10 -100.77 166.12 11.03 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.634 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 6.9 m 83.26 -59.66 0.14 Allowed 'General case' 0 C--N 1.369 1.434 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -108.42 118.05 35.76 Favored 'General case' 0 CA--C 1.505 -0.77 0 C-N-CA 119.901 -0.72 . . . . 0.0 109.567 -178.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 97.2 t -131.01 132.78 63.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.916 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 178.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 49.5 mm -106.54 126.06 62.33 Favored 'Isoleucine or valine' 0 C--N 1.358 0.962 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -115.44 156.46 25.57 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 122.141 0.972 . . . . 0.0 108.562 -179.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -138.79 120.77 15.55 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 -178.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.8 mp -115.06 121.12 66.44 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 -179.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 89.1 m -117.96 143.26 46.52 Favored 'General case' 0 CA--C 1.506 -0.743 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 -177.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 30.4 ttm180 -90.85 118.77 30.52 Favored 'General case' 0 C--N 1.364 1.221 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -63.47 149.41 92.02 Favored Pre-proline 0 C--N 1.356 0.872 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 178.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.24 136.86 57.89 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.096 1.864 . . . . 0.0 113.672 -178.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . 0.47 HH11 ' HD2' ' A' ' 182' ' ' ARG . 1.7 mtm105 -136.71 153.51 50.86 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -179.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 92.18 -44.71 2.64 Favored Glycine 0 C--N 1.347 1.182 0 N-CA-C 108.834 -1.706 . . . . 0.0 108.834 179.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -160.74 158.07 28.0 Favored 'General case' 0 N--CA 1.434 -1.26 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 -179.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 60.6 mt-10 -118.82 115.05 23.61 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -122.81 124.45 43.34 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 179.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 75.4 mt -104.69 -66.81 0.94 Allowed 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 179.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -150.55 -91.5 0.06 Allowed 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -126.84 147.57 50.03 Favored 'General case' 0 CA--C 1.499 -0.987 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 -179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 . . . . . 0 C--O 1.263 1.799 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 179.941 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' HEM . . . . . 1.036 HMA2 HBA2 ' A' ' 202' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.86 ' HG2' ' CMD' ' A' ' 202' ' ' HEM . 76.3 mmm . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 120.876 0.37 . . . . 0.0 110.17 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.52 -22.14 44.32 Favored 'General case' 0 C--N 1.356 0.854 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 -179.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -76.16 -39.36 32.22 Favored Glycine 0 C--N 1.348 1.238 0 N-CA-C 109.084 -1.607 . . . . 0.0 109.084 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.4 tpp -70.63 -37.03 73.75 Favored 'General case' 0 C--N 1.353 0.725 0 O-C-N 122.297 -0.531 . . . . 0.0 110.593 -177.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.9 m -70.77 -22.46 23.24 Favored 'Isoleucine or valine' 0 C--N 1.358 0.939 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -179.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.527 ' HZ ' ' HG2' ' A' ' 47' ' ' GLU . 2.2 m-30 -69.92 -35.32 74.47 Favored 'General case' 0 C--N 1.357 0.912 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 84.9 m -67.06 -40.05 87.01 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.44 -37.86 95.35 Favored Glycine 0 C--N 1.358 1.753 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.637 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -66.96 -39.76 87.31 Favored 'General case' 0 C--N 1.352 0.681 0 CA-C-N 117.29 0.545 . . . . 0.0 110.544 -178.224 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.453 ' CE ' HD21 ' A' ' 26' ' ' LEU . 22.7 mmt -63.71 -41.16 98.14 Favored 'General case' 0 C--N 1.354 0.786 0 O-C-N 121.753 -0.592 . . . . 0.0 110.905 -178.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -66.38 -40.14 89.5 Favored 'General case' 0 C--N 1.349 0.572 0 O-C-N 121.989 -0.444 . . . . 0.0 111.381 -178.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 57.7 tp -66.43 -41.95 88.43 Favored 'General case' 0 C--N 1.35 0.608 0 N-CA-C 112.459 0.54 . . . . 0.0 112.459 -178.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.637 HG12 ' O ' ' A' ' 9' ' ' LEU . 3.8 mm -73.78 -37.9 49.69 Favored 'Isoleucine or valine' 0 C--N 1.358 0.941 0 O-C-N 121.186 -0.947 . . . . 0.0 111.187 -176.082 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -69.05 -42.8 75.81 Favored 'General case' 0 C--N 1.352 0.714 0 O-C-N 121.7 -0.625 . . . . 0.0 111.236 -176.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -72.22 -33.24 67.43 Favored 'General case' 0 N--CA 1.446 -0.646 0 O-C-N 121.953 -0.467 . . . . 0.0 111.771 -177.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -73.02 -48.65 34.35 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 112.802 0.667 . . . . 0.0 112.802 -175.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -126.61 -20.33 4.36 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 117.718 -1.593 . . . . 0.0 112.367 -176.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 130.25 164.11 11.24 Favored Glycine 0 N--CA 1.437 -1.271 0 C-N-CA 118.102 -1.999 . . . . 0.0 110.809 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 63.9 t80 -67.08 -24.54 65.97 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 113.828 -1.186 . . . . 0.0 111.266 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -64.06 -44.27 92.95 Favored 'General case' 0 C--N 1.359 1.014 0 O-C-N 121.0 -1.062 . . . . 0.0 109.882 -179.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 94.2 m -67.24 -37.58 83.79 Favored 'General case' 0 C--N 1.352 0.717 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.454 HD13 ' HB ' ' A' ' 13' ' ' ILE . 33.3 tp -60.06 -37.59 80.32 Favored 'General case' 0 C--N 1.352 0.685 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.585 -179.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -66.14 -36.73 83.9 Favored 'General case' 0 C--N 1.356 0.87 0 O-C-N 122.105 -0.372 . . . . 0.0 110.704 -178.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.5 m -65.02 -40.43 94.87 Favored 'General case' 0 C--N 1.355 0.808 0 O-C-N 121.707 -0.621 . . . . 0.0 109.368 -178.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.443 HD21 HG11 ' A' ' 58' ' ' VAL . 83.2 mt -66.33 -36.32 82.63 Favored 'General case' 0 C--N 1.355 0.842 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -179.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.453 HD21 ' CE ' ' A' ' 10' ' ' MET . 81.9 mt -72.41 -12.91 61.31 Favored 'General case' 0 C--N 1.36 1.042 0 O-C-N 121.819 -0.55 . . . . 0.0 110.106 -178.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -89.11 -26.23 21.45 Favored 'General case' 0 N--CA 1.443 -0.81 0 C-N-CA 119.098 -1.041 . . . . 0.0 108.971 178.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 44.9 t -67.76 -36.64 80.87 Favored 'General case' 0 C--N 1.358 0.936 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 178.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.636 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 1.8 p -92.92 -40.72 10.44 Favored 'General case' 0 C--N 1.359 0.985 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -179.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.636 ' HB2' ' O ' ' A' ' 29' ' ' CYS . 13.6 mt-10 84.94 134.71 0.05 Allowed 'General case' 0 C--N 1.361 1.089 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 179.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.493 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -85.79 -170.46 3.11 Favored 'General case' 0 C--N 1.358 0.936 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.49 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 63.0 tt0 -150.99 -24.27 0.21 Allowed 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 -179.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.3 t -148.84 -65.13 0.23 Allowed 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -178.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -130.73 -55.49 1.07 Allowed 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 -179.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 131.43 -41.21 1.54 Allowed Glycine 0 C--N 1.351 1.407 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 79.7 mt -106.84 101.67 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.727 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.57 ' O ' ' HB ' ' A' ' 38' ' ' THR . 0.8 OUTLIER -72.23 -30.05 64.53 Favored 'General case' 0 C--N 1.357 0.906 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 179.685 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.57 ' HB ' ' O ' ' A' ' 37' ' ' TYR . 8.0 m 114.71 -67.12 0.0 OUTLIER 'General case' 0 C--N 1.37 1.489 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 179.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 13.2 p 174.13 63.71 0.0 OUTLIER 'General case' 0 C--N 1.36 1.043 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 -179.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 1.1 t -148.43 -5.03 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.355 0.831 0 C-N-CA 119.411 -0.916 . . . . 0.0 109.692 -178.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -98.12 143.92 16.96 Favored Glycine 0 C--N 1.352 1.428 0 C-N-CA 119.186 -1.483 . . . . 0.0 110.071 -178.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 49.0 m -124.07 122.61 38.33 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 178.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -117.14 175.86 5.4 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 108.952 -0.758 . . . . 0.0 108.952 -178.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -82.59 -172.04 3.83 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 72.8 m80 -90.97 -13.81 32.7 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 120.014 -0.674 . . . . 0.0 109.305 -179.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -70.12 -29.32 66.23 Favored 'General case' 0 CA--C 1.505 -0.751 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.527 ' HG2' ' HZ ' ' A' ' 6' ' ' PHE . 25.9 tp10 -63.28 -40.33 97.08 Favored 'General case' 0 C--N 1.352 0.693 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.472 HD22 ' O ' ' A' ' 48' ' ' LEU . 1.8 tm? -67.63 -38.08 83.37 Favored 'General case' 0 C--N 1.357 0.9 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.878 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.44 ' O ' HG23 ' A' ' 53' ' ' VAL . 58.6 tp -73.9 -29.66 62.18 Favored 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 122.063 -0.398 . . . . 0.0 110.336 -176.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 71.6 tp60 -69.0 -40.09 78.95 Favored 'General case' 0 N--CA 1.445 -0.701 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -178.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 81.3 mt -83.31 -17.17 43.42 Favored 'General case' 0 C--N 1.36 1.039 0 C-N-CA 120.025 -0.67 . . . . 0.0 110.699 -178.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.1 t -82.25 -35.25 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.78 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 49' ' ' LEU . 55.1 t -69.07 -39.38 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.404 ' HB3' HD22 ' A' ' 25' ' ' LEU . 34.0 tptt -66.79 -32.09 73.15 Favored 'General case' 0 C--N 1.364 1.209 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 -178.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.631 HD21 HD12 ' A' ' 13' ' ' ILE . 18.1 mt -62.78 -39.58 94.65 Favored 'General case' 0 C--N 1.357 0.932 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.32 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.539 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 39.3 t -65.95 -36.61 83.8 Favored 'General case' 0 C--N 1.35 0.605 0 O-C-N 121.942 -0.474 . . . . 0.0 110.647 -179.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -86.42 -37.65 18.15 Favored 'General case' 0 C--N 1.355 0.834 0 O-C-N 120.961 -1.087 . . . . 0.0 112.766 -177.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.443 HG11 HD21 ' A' ' 25' ' ' LEU . 4.9 p -75.47 -40.01 41.38 Favored 'Isoleucine or valine' 0 C--N 1.351 0.673 0 O-C-N 121.37 -0.831 . . . . 0.0 111.482 -176.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 7.4 t -106.5 -5.84 18.55 Favored 'General case' 0 C--N 1.352 0.69 0 C-N-CA 119.304 -0.958 . . . . 0.0 110.331 -177.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.414 ' HA ' ' O ' ' A' ' 56' ' ' SER . 72.3 m 65.29 39.91 5.11 Favored 'General case' 0 C--N 1.353 0.727 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 56' ' ' SER . 59.4 t -114.72 124.77 29.97 Favored Pre-proline 0 CA--C 1.503 -0.831 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.93 155.33 33.73 Favored 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 122.803 2.335 . . . . 0.0 113.562 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.675 ' HA ' HD23 ' A' ' 66' ' ' LEU . 13.7 m -74.45 -12.09 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.89 -177.097 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.518 ' O ' HG12 ' A' ' 67' ' ' VAL . 72.9 p -94.2 -34.2 12.99 Favored 'General case' 0 C--N 1.357 0.905 0 C-N-CA 118.067 -1.453 . . . . 0.0 110.154 -178.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -80.21 -20.83 43.77 Favored 'General case' 0 C--N 1.354 0.803 0 O-C-N 121.202 -0.936 . . . . 0.0 109.13 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.675 HD23 ' HA ' ' A' ' 63' ' ' VAL . 0.0 OUTLIER -79.88 -34.43 39.19 Favored 'General case' 0 N--CA 1.44 -0.947 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -179.757 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.518 HG12 ' O ' ' A' ' 64' ' ' THR . 2.4 p -69.82 -29.54 41.12 Favored 'Isoleucine or valine' 0 C--N 1.357 0.912 0 C-N-CA 120.103 -0.639 . . . . 0.0 110.023 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -69.93 -48.1 59.78 Favored 'General case' 0 C--N 1.364 1.232 0 O-C-N 121.373 -0.83 . . . . 0.0 110.71 179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 85.4 mt -64.36 -36.24 83.48 Favored 'General case' 0 C--N 1.355 0.828 0 O-C-N 121.949 -0.469 . . . . 0.0 110.796 -179.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -61.08 -47.73 85.01 Favored 'General case' 0 C--N 1.35 0.593 0 O-C-N 122.212 -0.305 . . . . 0.0 110.715 -178.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.61 -38.95 96.69 Favored Glycine 0 C--N 1.354 1.544 0 CA-C-O 119.817 -0.435 . . . . 0.0 112.227 -177.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -66.19 -45.35 81.1 Favored 'General case' 0 C--N 1.352 0.675 0 CA-C-N 118.441 1.121 . . . . 0.0 111.453 -176.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.731 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 6.6 mttm -64.16 -49.52 71.79 Favored 'General case' 0 C--N 1.356 0.886 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -177.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.47 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.5 tm? -68.12 -40.74 82.45 Favored 'General case' 0 C--N 1.349 0.568 0 O-C-N 121.358 -0.839 . . . . 0.0 112.219 -175.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 41.4 t80 -64.12 -44.55 91.89 Favored 'General case' 0 C--N 1.354 0.784 0 O-C-N 121.066 -1.021 . . . . 0.0 111.485 -177.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.65 -14.54 17.69 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 O-C-N 121.48 -0.762 . . . . 0.0 109.664 -179.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.731 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 77.1 mm-40 -74.75 -37.82 62.38 Favored 'General case' 0 C--N 1.351 0.636 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 178.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.408 HD13 HBC2 ' A' ' 202' ' ' HEM . 73.9 mt -67.41 -37.41 83.03 Favored 'General case' 0 C--N 1.36 1.063 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.0 mm -63.1 -50.63 78.57 Favored 'Isoleucine or valine' 0 C--N 1.356 0.857 0 N-CA-C 109.649 -0.501 . . . . 0.0 109.649 -178.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -68.12 -20.94 64.95 Favored 'General case' 0 C--N 1.35 0.595 0 CA-C-N 116.607 -0.27 . . . . 0.0 111.494 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -99.2 -0.97 56.99 Favored Glycine 0 N--CA 1.437 -1.256 0 C-N-CA 119.509 -1.329 . . . . 0.0 110.713 -177.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.669 ' HB3' ' HB ' ' A' ' 85' ' ' ILE . 93.4 m-70 -139.14 88.88 12.83 Favored Pre-proline 0 CA--C 1.502 -0.892 0 CA-C-N 119.113 1.456 . . . . 0.0 109.044 -179.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 82' ' ' HIS . 31.9 Cg_endo -65.85 -27.78 51.26 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 C-N-CA 122.504 2.136 . . . . 0.0 114.556 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -95.1 -4.2 46.69 Favored 'General case' 0 CA--C 1.502 -0.895 0 C-N-CA 119.388 -0.925 . . . . 0.0 108.978 -179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.669 ' HB ' ' HB3' ' A' ' 82' ' ' HIS . 0.1 OUTLIER -89.0 -19.68 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.116 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 -179.575 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -104.4 -23.39 13.19 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 179.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -68.55 -36.96 79.52 Favored 'General case' 0 C--N 1.362 1.129 0 O-C-N 121.656 -0.652 . . . . 0.0 109.372 178.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -65.42 -35.12 79.99 Favored 'General case' 0 C--N 1.356 0.883 0 C-N-CA 120.709 -0.396 . . . . 0.0 110.416 -179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.453 ' SD ' ' HB2' ' A' ' 95' ' ' LEU . 18.1 ttp -83.69 151.14 25.42 Favored 'General case' 0 C--N 1.352 0.715 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -178.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.79 -22.8 9.49 Favored 'General case' 0 C--N 1.365 1.261 0 O-C-N 121.632 -0.667 . . . . 0.0 111.258 -177.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.2 t0 -166.0 172.26 11.65 Favored 'General case' 0 C--N 1.354 0.799 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 -177.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.424 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 63.4 m -66.42 -39.73 89.15 Favored 'General case' 0 C--N 1.354 0.781 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.506 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 78.5 m-85 -67.82 -39.33 83.92 Favored 'General case' 0 C--N 1.356 0.865 0 O-C-N 121.375 -0.828 . . . . 0.0 109.093 -178.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -65.53 -24.61 67.16 Favored 'General case' 0 C--N 1.355 0.83 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 178.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.726 ' O ' HG13 ' A' ' 99' ' ' ILE . 64.9 tp -63.65 -46.92 83.41 Favored 'General case' 0 C--N 1.353 0.732 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 179.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.468 ' HA ' ' CD1' ' A' ' 99' ' ' ILE . 2.0 mp -59.81 -36.65 77.2 Favored 'General case' 0 C--N 1.361 1.081 0 O-C-N 122.143 -0.348 . . . . 0.0 110.28 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.7 t -70.2 -39.81 74.96 Favored 'General case' 0 C--N 1.348 0.519 0 O-C-N 122.003 -0.436 . . . . 0.0 110.238 -179.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.8 tttp -87.43 2.7 49.75 Favored 'General case' 0 C--N 1.356 0.85 0 O-C-N 122.136 -0.353 . . . . 0.0 111.934 -176.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.726 HG13 ' O ' ' A' ' 95' ' ' LEU . 77.3 mt -61.18 -46.9 95.72 Favored 'Isoleucine or valine' 0 C--N 1.355 0.822 0 CA-C-N 119.156 0.889 . . . . 0.0 111.967 -177.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -94.66 -23.56 17.54 Favored 'General case' 0 N--CA 1.441 -0.888 0 C-N-CA 118.52 -1.272 . . . . 0.0 111.176 -177.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.0 t -63.63 -50.09 70.72 Favored 'General case' 0 N--CA 1.445 -0.718 0 O-C-N 121.644 -0.66 . . . . 0.0 112.527 -177.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.51 ' HA ' HG12 ' A' ' 105' ' ' VAL . 17.5 t80 -134.68 -15.89 2.06 Favored 'General case' 0 C--N 1.361 1.071 0 C-N-CA 117.352 -1.739 . . . . 0.0 113.578 -176.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.624 HG21 ' C1C' ' A' ' 202' ' ' HEM . 29.3 mm -71.15 -51.58 33.6 Favored 'Isoleucine or valine' 0 C--O 1.245 0.847 0 CA-C-N 120.493 1.497 . . . . 0.0 110.683 -177.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.457 ' HB3' HD21 ' A' ' 116' ' ' LEU . 64.7 m170 -91.58 1.49 57.1 Favored 'General case' 0 N--CA 1.439 -1.021 0 O-C-N 121.284 -0.885 . . . . 0.0 110.348 -177.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.51 HG12 ' HA ' ' A' ' 102' ' ' PHE . 1.2 p -88.8 -33.45 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.803 0 N-CA-C 107.063 -1.458 . . . . 0.0 107.063 178.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -72.38 -40.36 67.31 Favored 'General case' 0 CA--C 1.5 -0.957 0 N-CA-C 109.196 -0.668 . . . . 0.0 109.196 179.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -72.33 -37.05 57.15 Favored 'Isoleucine or valine' 0 C--N 1.355 0.809 0 C-N-CA 119.592 -0.843 . . . . 0.0 109.89 -178.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -61.24 -49.0 78.87 Favored 'General case' 0 C--N 1.362 1.115 0 O-C-N 121.786 -0.571 . . . . 0.0 110.828 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -60.0 -37.43 79.65 Favored 'General case' 0 C--N 1.357 0.908 0 O-C-N 121.639 -0.663 . . . . 0.0 110.057 -179.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 14.7 mt -57.15 -75.47 0.04 OUTLIER 'General case' 0 C--N 1.356 0.866 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.417 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 90.3 m-85 -119.82 136.8 25.08 Favored Pre-proline 0 N--CA 1.441 -0.915 0 C-N-CA 119.026 -1.069 . . . . 0.0 108.733 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 111' ' ' TYR . 76.6 Cg_endo -85.28 -1.96 9.3 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 123.205 2.603 . . . . 0.0 115.345 -178.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -67.52 -36.26 80.69 Favored 'General case' 0 C--N 1.354 0.784 0 O-C-N 121.712 -0.617 . . . . 0.0 110.229 -179.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.34 144.42 56.97 Favored 'General case' 0 C--N 1.354 0.792 0 CA-C-O 121.647 0.737 . . . . 0.0 109.995 -178.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 60.5 mt-10 -114.54 148.08 38.49 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.462 ' HA ' ' HD3' ' A' ' 117' ' ' PRO . 1.2 mp -128.6 144.11 50.93 Favored Pre-proline 0 N--CA 1.442 -0.841 0 CA-C-O 122.143 0.973 . . . . 0.0 109.099 -178.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.462 ' HD3' ' HA ' ' A' ' 116' ' ' LEU . 97.6 Cg_endo -87.68 -155.46 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.215 0 C-N-CA 123.738 2.959 . . . . 0.0 112.959 179.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -120.21 140.26 51.42 Favored 'General case' 0 C--N 1.363 1.165 0 C-N-CA 119.142 -1.023 . . . . 0.0 108.316 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -133.03 133.4 43.03 Favored 'General case' 0 C--N 1.362 1.114 0 C-N-CA 120.069 -0.653 . . . . 0.0 109.835 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.427 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 93.6 m -124.22 128.03 48.58 Favored 'General case' 0 CA--C 1.504 -0.806 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 176.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 74.7 m -118.78 127.68 53.76 Favored 'General case' 0 CA--C 1.503 -0.848 0 C-N-CA 119.162 -1.015 . . . . 0.0 109.52 -177.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -116.9 153.14 33.09 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 178.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 57.4 ttp180 -123.72 117.17 24.34 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.036 -1.468 . . . . 0.0 107.036 -179.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 95.9 mt -90.28 -16.69 28.82 Favored 'General case' 0 C--N 1.355 0.831 0 C-N-CA 120.519 -0.472 . . . . 0.0 110.55 -179.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 174.77 -148.9 10.0 Favored Glycine 0 N--CA 1.437 -1.236 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 -178.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -94.1 -37.18 11.74 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 -178.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . 0.455 ' HB2' ' HG2' ' A' ' 179' ' ' ARG . 41.3 p-10 -102.45 1.22 34.96 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 119.886 -0.725 . . . . 0.0 110.315 -178.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 67.8 m-20 -119.8 131.57 55.36 Favored 'General case' 0 C--N 1.358 0.977 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 -179.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 7.9 mm -141.29 136.25 32.58 Favored 'Isoleucine or valine' 0 C--N 1.354 0.778 0 N-CA-C 107.359 -1.348 . . . . 0.0 107.359 179.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 53.5 mtm180 -116.04 139.18 50.54 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.3 tp -127.93 117.42 21.72 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.427 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 12.0 m170 -96.78 133.98 40.65 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 179.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 72.8 t80 -129.77 122.44 28.83 Favored 'General case' 0 N--CA 1.437 -1.086 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -178.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.553 ' HA ' ' O ' ' A' ' 171' ' ' THR . 76.2 mt-30 -116.21 115.7 26.47 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 12.8 t -163.22 155.19 17.84 Favored 'General case' 0 C--N 1.36 1.023 0 N-CA-C 106.972 -1.492 . . . . 0.0 106.972 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -91.66 2.33 56.55 Favored 'General case' 0 C--N 1.355 0.815 0 O-C-N 121.821 -0.55 . . . . 0.0 109.873 -178.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 93.6 mtm-85 -135.08 74.32 63.09 Favored Pre-proline 0 CA--C 1.505 -0.771 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -95.39 105.64 0.11 Allowed 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.736 2.291 . . . . 0.0 115.7 -177.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 39.1 m-85 -112.41 114.1 26.63 Favored 'General case' 0 CA--C 1.502 -0.894 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 176.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.89 -38.82 92.52 Favored 'General case' 0 C--N 1.355 0.805 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.242 -179.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.3 m -63.63 -27.03 68.95 Favored 'General case' 0 C--N 1.354 0.782 0 O-C-N 121.926 -0.484 . . . . 0.0 110.827 -178.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -76.58 -47.87 21.1 Favored 'General case' 0 N--CA 1.446 -0.642 0 O-C-N 121.763 -0.586 . . . . 0.0 109.856 -177.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.49 -39.6 94.1 Favored 'General case' 0 C--N 1.357 0.895 0 O-C-N 122.183 -0.323 . . . . 0.0 111.149 -177.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -63.27 -37.64 88.04 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 121.907 -0.495 . . . . 0.0 109.927 -179.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.03 -42.91 98.6 Favored Glycine 0 C--N 1.348 1.217 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 -179.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 83.6 mt -70.06 -40.84 74.85 Favored 'General case' 0 C--N 1.353 0.747 0 CA-C-N 117.774 0.787 . . . . 0.0 112.549 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 97.7 mt -71.03 -42.07 70.01 Favored 'General case' 0 C--N 1.36 1.061 0 O-C-N 121.271 -0.893 . . . . 0.0 110.551 -176.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.479 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 21.5 t70 -69.17 -32.09 71.17 Favored 'General case' 0 N--CA 1.445 -0.723 0 O-C-N 122.211 -0.306 . . . . 0.0 110.505 -179.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -63.04 -39.85 98.55 Favored Glycine 0 C--N 1.357 1.707 0 N-CA-C 108.848 -1.701 . . . . 0.0 108.848 -179.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . 0.42 ' SG ' HD22 ' A' ' 95' ' ' LEU . 49.5 t -61.14 -42.11 97.95 Favored 'General case' 0 C--N 1.35 0.594 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 178.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.665 ' HB1' ' O ' ' A' ' 156' ' ' GLU . . . -73.84 -2.39 23.48 Favored 'General case' 0 C--N 1.359 1.001 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.479 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 74.5 mm-40 -83.17 -45.96 13.29 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 179.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 92.9 t80 -65.89 -45.06 83.4 Favored 'General case' 0 C--N 1.359 1.008 0 C-N-CA 120.154 -0.619 . . . . 0.0 109.609 178.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -68.88 -26.4 65.1 Favored 'General case' 0 C--N 1.363 1.158 0 O-C-N 121.716 -0.615 . . . . 0.0 111.023 -178.182 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 78.2 tttt 74.39 71.95 0.11 Allowed 'General case' 0 C--N 1.361 1.072 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.665 ' O ' ' HB1' ' A' ' 151' ' ' ALA . 5.4 tp10 -161.34 125.24 3.35 Favored 'General case' 0 CA--C 1.503 -0.846 0 N-CA-C 107.194 -1.41 . . . . 0.0 107.194 178.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -87.25 108.35 18.9 Favored 'General case' 0 C--N 1.354 0.788 0 C-N-CA 119.82 -0.752 . . . . 0.0 110.339 -179.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 9.3 m-30 -107.37 163.89 12.65 Favored 'General case' 0 C--N 1.353 0.734 0 N-CA-C 105.733 -1.951 . . . . 0.0 105.733 177.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 95.5 m -121.37 129.21 52.92 Favored 'General case' 0 C--N 1.354 0.802 0 C-N-CA 118.972 -1.091 . . . . 0.0 109.41 -178.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.509 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.6 mp -110.5 122.12 64.47 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 178.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.7 m -119.12 -171.87 2.19 Favored 'General case' 0 C--N 1.357 0.916 0 CA-C-O 121.674 0.75 . . . . 0.0 109.245 -178.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.11 159.29 44.53 Favored 'General case' 0 C--N 1.357 0.913 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 -178.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 64.6 p -100.72 146.83 32.76 Favored Pre-proline 0 C--N 1.359 1.012 0 CA-C-O 122.471 1.129 . . . . 0.0 108.298 179.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.641 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 73.5 Cg_endo -76.22 -11.49 19.32 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.957 2.438 . . . . 0.0 115.193 -178.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -72.11 -41.44 67.24 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 119.936 -0.705 . . . . 0.0 109.42 -178.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 31.4 p -116.73 16.5 15.34 Favored 'General case' 0 C--N 1.355 0.833 0 C-N-CA 120.159 -0.616 . . . . 0.0 110.323 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.641 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.2 pp0? -66.73 -10.29 45.49 Favored 'General case' 0 C--N 1.354 0.796 0 O-C-N 121.642 -0.661 . . . . 0.0 110.45 178.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -128.02 38.69 3.97 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 74.8 m -136.54 146.34 46.07 Favored 'General case' 0 CA--C 1.505 -0.787 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 179.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.675 ' O ' ' HB ' ' A' ' 171' ' ' THR . 59.2 mp0 -99.61 162.55 12.95 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.675 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 1.5 m 84.53 -57.72 0.11 Allowed 'General case' 0 C--N 1.369 1.455 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.566 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -109.67 118.38 36.4 Favored 'General case' 0 CA--C 1.505 -0.75 0 C-N-CA 119.798 -0.761 . . . . 0.0 109.789 -178.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 97.5 t -132.4 132.32 60.42 Favored 'Isoleucine or valine' 0 C--N 1.36 1.065 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 178.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 50.3 mm -105.31 127.46 60.03 Favored 'Isoleucine or valine' 0 C--N 1.356 0.89 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -116.31 153.82 31.29 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -136.73 119.36 16.02 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -178.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.0 mp -114.21 119.06 60.29 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 -179.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 88.4 m -126.62 140.76 52.18 Favored 'General case' 0 CA--C 1.502 -0.88 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -177.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.455 ' HG2' ' HB2' ' A' ' 127' ' ' ASN . 39.7 ptt180 -80.48 121.4 25.71 Favored 'General case' 0 C--N 1.366 1.285 0 N-CA-C 107.341 -1.355 . . . . 0.0 107.341 179.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -66.07 149.17 97.97 Favored Pre-proline 0 CA--C 1.499 -1.008 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.19 122.63 11.8 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 C-N-CA 122.44 2.093 . . . . 0.0 113.204 -179.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -138.78 148.57 44.0 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 179.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.493 ' O ' ' HB3' ' A' ' 184' ' ' ALA . . . 72.51 62.0 3.41 Favored Glycine 0 C--N 1.353 1.504 0 N-CA-C 108.155 -1.978 . . . . 0.0 108.155 -179.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.493 ' HB3' ' O ' ' A' ' 183' ' ' GLY . . . 78.24 167.55 0.22 Allowed 'General case' 0 C--N 1.362 1.131 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -131.4 121.27 24.33 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -123.67 128.88 50.27 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.09 -76.98 0.6 Allowed 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -131.59 -87.82 0.47 Allowed 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -127.89 147.31 50.45 Favored 'General case' 0 CA--C 1.498 -1.024 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 . . . . . 0 C--O 1.265 1.874 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -179.964 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' HEM . . . . . 0.86 ' CMD' ' HG2' ' A' ' 1' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.415 ' HB2' ' HB2' ' A' ' 4' ' ' MET . 2.3 mmm . . . . . 0 N--CA 1.492 1.672 0 CA-C-O 120.943 0.401 . . . . 0.0 110.07 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.426 ' HA ' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -80.63 -18.72 47.25 Favored 'General case' 0 N--CA 1.441 -0.877 0 C-N-CA 120.161 -0.616 . . . . 0.0 109.353 -179.043 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.11 -40.92 49.35 Favored Glycine 0 C--N 1.353 1.497 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.415 ' HB2' ' HB2' ' A' ' 1' ' ' MET . 4.9 mtm -70.39 -36.33 74.04 Favored 'General case' 0 C--N 1.36 1.044 0 O-C-N 121.836 -0.802 . . . . 0.0 111.335 -178.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.426 HG22 ' HA ' ' A' ' 2' ' ' MET . 34.6 m -69.4 -22.95 25.97 Favored 'Isoleucine or valine' 0 C--N 1.356 0.872 0 O-C-N 121.555 -0.715 . . . . 0.0 109.366 -178.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -71.05 -35.85 72.1 Favored 'General case' 0 C--N 1.359 1.0 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 85.4 m -67.07 -41.37 86.51 Favored 'General case' 0 C--N 1.356 0.881 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 -179.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.62 -39.01 97.36 Favored Glycine 0 C--N 1.359 1.81 0 N-CA-C 110.631 -0.988 . . . . 0.0 110.631 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.712 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -64.99 -40.37 94.86 Favored 'General case' 0 C--N 1.351 0.658 0 CA-C-N 117.3 0.55 . . . . 0.0 110.731 -178.471 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . 0.46 ' CE ' HD21 ' A' ' 26' ' ' LEU . 21.1 mmt -63.47 -40.68 97.76 Favored 'General case' 0 C--N 1.351 0.665 0 O-C-N 121.606 -0.684 . . . . 0.0 110.981 -178.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -67.23 -41.71 85.21 Favored 'General case' 0 C--N 1.35 0.611 0 O-C-N 121.859 -0.526 . . . . 0.0 111.691 -178.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 59.6 tp -65.61 -43.39 89.77 Favored 'General case' 0 C--N 1.35 0.598 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -178.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.712 HG12 ' O ' ' A' ' 9' ' ' LEU . 2.4 mm -72.92 -36.9 52.83 Favored 'Isoleucine or valine' 0 C--N 1.356 0.883 0 O-C-N 121.167 -0.958 . . . . 0.0 111.091 -175.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -65.99 -43.31 88.14 Favored 'General case' 0 C--N 1.352 0.688 0 O-C-N 121.746 -0.596 . . . . 0.0 111.663 -176.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -73.67 -37.27 65.31 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 121.773 -0.579 . . . . 0.0 112.279 -176.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -71.9 -41.64 67.72 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -175.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 29.2 m-85 -129.9 -27.1 2.34 Favored 'General case' 0 C--N 1.354 0.786 0 C-N-CA 117.43 -1.708 . . . . 0.0 113.358 -177.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 148.19 -179.94 24.65 Favored Glycine 0 C--N 1.346 1.115 0 C-N-CA 117.499 -2.286 . . . . 0.0 110.664 -179.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 93.4 t80 -98.05 -20.41 17.39 Favored 'General case' 0 N--CA 1.433 -1.312 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 -177.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -70.27 -40.16 74.51 Favored 'General case' 0 C--N 1.361 1.085 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.3 m -68.35 -38.15 81.19 Favored 'General case' 0 C--N 1.358 0.965 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 178.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.404 HD13 ' HB ' ' A' ' 13' ' ' ILE . 31.6 tp -59.97 -37.6 80.1 Favored 'General case' 0 C--N 1.356 0.849 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -66.22 -35.18 79.77 Favored 'General case' 0 C--N 1.359 0.989 0 O-C-N 121.989 -0.444 . . . . 0.0 110.81 -178.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.8 m -64.86 -39.26 93.27 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 -178.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.662 HD13 HD22 ' A' ' 51' ' ' LEU . 0.2 OUTLIER -62.83 -38.12 89.48 Favored 'General case' 0 C--N 1.352 0.696 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 -179.266 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.46 HD21 ' CE ' ' A' ' 10' ' ' MET . 80.4 mt -74.52 -12.89 60.59 Favored 'General case' 0 C--N 1.358 0.947 0 O-C-N 121.768 -0.582 . . . . 0.0 110.746 -178.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -87.71 -27.11 22.6 Favored 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 119.1 -1.04 . . . . 0.0 108.929 178.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 46.9 t -67.15 -37.36 83.66 Favored 'General case' 0 C--N 1.357 0.905 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.621 ' O ' ' HB2' ' A' ' 30' ' ' GLU . 2.0 p -93.25 -37.72 11.91 Favored 'General case' 0 C--N 1.358 0.935 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.621 ' HB2' ' O ' ' A' ' 29' ' ' CYS . 9.9 mt-10 85.37 133.57 0.05 OUTLIER 'General case' 0 C--N 1.359 0.979 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.491 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -85.37 -169.9 2.87 Favored 'General case' 0 C--N 1.358 0.954 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 -179.938 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -150.84 -26.49 0.22 Allowed 'General case' 0 N--CA 1.436 -1.158 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -179.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.7 t -146.65 -66.97 0.28 Allowed 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -178.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -130.33 -50.65 1.09 Allowed 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -178.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 127.86 -40.08 1.8 Allowed Glycine 0 C--N 1.351 1.382 0 N-CA-C 108.948 -1.661 . . . . 0.0 108.948 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 86.4 mt -110.01 101.71 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.86 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -100.33 1.63 41.74 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.786 HG22 ' H ' ' A' ' 39' ' ' SER . 1.7 m 74.46 -176.56 0.15 Allowed 'General case' 0 C--N 1.362 1.144 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 -178.447 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.786 ' H ' HG22 ' A' ' 38' ' ' THR . 28.1 p -87.99 104.69 16.87 Favored 'General case' 0 C--N 1.353 0.74 0 O-C-N 121.184 -0.948 . . . . 0.0 108.788 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.426 HG12 ' O ' ' A' ' 40' ' ' VAL . 61.4 t -152.99 -21.29 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.361 1.1 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 -179.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.76 171.59 13.86 Favored Glycine 0 C--N 1.357 1.696 0 C-N-CA 119.049 -1.548 . . . . 0.0 110.162 -176.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 59.2 m -131.29 136.05 47.83 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -121.31 175.42 6.15 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 179.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -78.48 -176.17 4.65 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.426 ' CD2' HH22 ' A' ' 137' ' ' ARG . 73.5 m80 -94.15 -15.13 24.94 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 119.898 -0.721 . . . . 0.0 109.441 -178.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -68.86 -27.78 66.13 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 177.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.2 tp10 -62.62 -40.32 96.59 Favored 'General case' 0 C--N 1.353 0.746 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -68.93 -38.65 79.65 Favored 'General case' 0 C--N 1.357 0.933 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 59.2 tp -70.39 -35.05 73.24 Favored 'General case' 0 CA--C 1.506 -0.712 0 O-C-N 122.099 -0.376 . . . . 0.0 110.14 -176.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 71.7 tp60 -66.6 -39.94 88.63 Favored 'General case' 0 N--CA 1.443 -0.781 0 O-C-N 121.873 -0.517 . . . . 0.0 109.779 -178.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.662 HD22 HD13 ' A' ' 25' ' ' LEU . 68.3 mt -80.68 -18.01 49.32 Favored 'General case' 0 C--N 1.363 1.171 0 C-N-CA 119.63 -0.828 . . . . 0.0 110.301 -179.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -80.35 -34.81 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.868 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 54.3 t -70.17 -40.48 78.22 Favored 'Isoleucine or valine' 0 C--N 1.354 0.768 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 178.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.419 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 33.5 tptt -65.75 -27.6 68.42 Favored 'General case' 0 C--N 1.364 1.226 0 O-C-N 121.231 -0.918 . . . . 0.0 108.737 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.422 ' O ' HD23 ' A' ' 55' ' ' LEU . 1.5 tt -68.5 -37.37 80.01 Favored 'General case' 0 C--N 1.353 0.754 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 59.7 p -72.07 -18.72 61.91 Favored 'General case' 0 C--N 1.359 0.992 0 O-C-N 121.439 -0.788 . . . . 0.0 110.704 -178.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -99.89 -36.4 9.43 Favored 'General case' 0 C--N 1.353 0.738 0 O-C-N 121.3 -0.875 . . . . 0.0 111.424 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.7 p -72.94 -36.52 51.76 Favored 'Isoleucine or valine' 0 C--N 1.35 0.62 0 O-C-N 121.717 -0.614 . . . . 0.0 111.294 -177.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 74.7 m -114.09 -6.68 13.09 Favored 'General case' 0 CA--C 1.505 -0.771 0 C-N-CA 119.35 -0.94 . . . . 0.0 109.936 -178.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 64.31 50.31 2.35 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 179.565 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.615 HG13 ' HD2' ' A' ' 62' ' ' PRO . 56.1 t -113.81 136.14 22.05 Favored Pre-proline 0 CA--C 1.505 -0.778 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.688 ' HG2' ' HB2' ' A' ' 65' ' ' GLU . 23.3 Cg_endo -62.36 149.22 91.58 Favored 'Trans proline' 0 CA--C 1.5 -1.192 0 C-N-CA 122.226 1.95 . . . . 0.0 112.391 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.5 m -75.83 -14.16 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.717 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.344 -177.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.467 ' O ' HG12 ' A' ' 67' ' ' VAL . 68.7 p -94.71 -34.65 12.47 Favored 'General case' 0 C--N 1.358 0.939 0 C-N-CA 118.347 -1.341 . . . . 0.0 109.722 -178.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.688 ' HB2' ' HG2' ' A' ' 62' ' ' PRO . 97.7 mt-10 -78.32 -20.48 51.34 Favored 'General case' 0 C--N 1.354 0.768 0 O-C-N 121.31 -0.869 . . . . 0.0 109.075 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.404 ' HB3' ' O ' ' A' ' 62' ' ' PRO . 0.0 OUTLIER -79.7 -37.67 35.19 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 -179.624 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.467 HG12 ' O ' ' A' ' 64' ' ' THR . 1.8 p -67.92 -25.82 33.25 Favored 'Isoleucine or valine' 0 C--N 1.354 0.8 0 C-N-CA 120.32 -0.552 . . . . 0.0 109.812 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 9.3 mtp180 -72.61 -53.17 12.61 Favored 'General case' 0 C--N 1.364 1.216 0 O-C-N 121.467 -0.771 . . . . 0.0 110.532 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 92.3 mt -63.07 -34.81 78.39 Favored 'General case' 0 C--N 1.357 0.927 0 O-C-N 121.933 -0.479 . . . . 0.0 111.031 -178.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -60.69 -47.34 86.72 Favored 'General case' 0 C--N 1.348 0.519 0 O-C-N 122.138 -0.351 . . . . 0.0 110.244 -178.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.44 -38.31 94.6 Favored Glycine 0 C--N 1.357 1.696 0 N-CA-C 111.766 -0.534 . . . . 0.0 111.766 -178.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.19 -49.04 75.81 Favored 'General case' 0 C--N 1.352 0.696 0 CA-C-N 118.264 1.032 . . . . 0.0 111.821 -177.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.542 ' O ' ' HG2' ' A' ' 77' ' ' GLU . 8.4 mttm -64.26 -47.86 77.96 Favored 'General case' 0 C--N 1.358 0.948 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -177.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -68.66 -39.06 80.84 Favored 'General case' 0 C--N 1.35 0.624 0 O-C-N 121.055 -1.028 . . . . 0.0 111.92 -175.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 21.0 t80 -65.36 -43.23 91.45 Favored 'General case' 0 C--N 1.356 0.855 0 O-C-N 121.126 -0.984 . . . . 0.0 111.46 -177.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -72.16 -12.68 16.05 Favored 'Isoleucine or valine' 0 C--N 1.359 1.004 0 O-C-N 121.149 -0.969 . . . . 0.0 109.266 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.542 ' HG2' ' O ' ' A' ' 73' ' ' LYS . 70.1 mm-40 -81.33 -29.78 34.06 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 73.3 mt -72.9 -34.69 66.81 Favored 'General case' 0 C--N 1.358 0.946 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 48.7 mm -64.63 -50.75 74.27 Favored 'Isoleucine or valine' 0 C--N 1.357 0.91 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -178.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -69.42 -28.29 66.01 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -66.68 -34.15 86.56 Favored Glycine 0 N--CA 1.439 -1.103 0 N-CA-C 111.025 -0.83 . . . . 0.0 111.025 -178.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.442 ' HA ' ' HD2' ' A' ' 83' ' ' PRO . 96.7 m-70 -135.7 101.34 10.76 Favored Pre-proline 0 CA--C 1.501 -0.91 0 CA-C-N 118.511 1.155 . . . . 0.0 109.372 -176.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.442 ' HD2' ' HA ' ' A' ' 82' ' ' HIS . 34.7 Cg_endo -66.85 -22.52 49.03 Favored 'Trans proline' 0 C--N 1.307 -1.655 0 C-N-CA 122.416 2.077 . . . . 0.0 113.607 179.302 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.425 ' O ' ' HG2' ' A' ' 88' ' ' GLU . 42.5 mt-10 -91.87 -6.14 52.05 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.403 HG22 ' O ' ' A' ' 82' ' ' HIS . 1.6 tp -90.32 -19.65 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 -179.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.23 -26.09 14.04 Favored 'General case' 0 C--N 1.361 1.084 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -70.75 -34.73 72.15 Favored 'General case' 0 C--N 1.356 0.875 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.425 ' HG2' ' O ' ' A' ' 84' ' ' GLU . 78.2 mm-40 -65.49 -36.25 83.28 Favored 'General case' 0 C--N 1.357 0.919 0 O-C-N 122.023 -0.423 . . . . 0.0 110.254 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.427 ' SD ' ' HB2' ' A' ' 95' ' ' LEU . 16.6 ttp -83.12 153.04 25.03 Favored 'General case' 0 C--N 1.353 0.743 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -178.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -117.96 -24.13 7.2 Favored 'General case' 0 C--N 1.365 1.253 0 C-N-CA 120.068 -0.653 . . . . 0.0 111.352 -176.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -164.63 170.57 15.54 Favored 'General case' 0 C--N 1.354 0.802 0 C-N-CA 119.098 -1.041 . . . . 0.0 108.344 -177.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 39.7 t -64.01 -43.4 95.76 Favored 'General case' 0 C--N 1.357 0.899 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.489 -179.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -66.33 -39.61 89.36 Favored 'General case' 0 C--N 1.355 0.816 0 O-C-N 121.366 -0.834 . . . . 0.0 109.255 -178.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -65.09 -25.73 67.92 Favored 'General case' 0 C--N 1.353 0.76 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.602 ' O ' HG13 ' A' ' 99' ' ' ILE . 61.8 tp -63.37 -46.46 86.39 Favored 'General case' 0 C--N 1.356 0.867 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.2 mp -59.54 -34.79 73.1 Favored 'General case' 0 C--N 1.357 0.917 0 O-C-N 122.177 -0.327 . . . . 0.0 110.591 -179.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.4 t -69.88 -39.28 76.4 Favored 'General case' 0 C--N 1.348 0.538 0 O-C-N 121.917 -0.49 . . . . 0.0 109.944 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.4 tttp -90.97 4.11 52.88 Favored 'General case' 0 C--N 1.352 0.712 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -176.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.602 HG13 ' O ' ' A' ' 95' ' ' LEU . 77.6 mt -61.62 -47.29 94.01 Favored 'Isoleucine or valine' 0 C--N 1.358 0.977 0 CA-C-N 119.657 1.117 . . . . 0.0 111.9 -177.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -98.49 -22.46 16.0 Favored 'General case' 0 N--CA 1.44 -0.974 0 C-N-CA 118.408 -1.317 . . . . 0.0 111.285 -176.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 33.4 t -65.69 -47.01 76.9 Favored 'General case' 0 N--CA 1.442 -0.833 0 O-C-N 121.684 -0.635 . . . . 0.0 111.951 -177.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -132.26 -23.04 2.19 Favored 'General case' 0 C--N 1.361 1.079 0 C-N-CA 117.763 -1.575 . . . . 0.0 113.056 -176.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.672 HG21 ' C2C' ' A' ' 202' ' ' HEM . 31.1 mm -69.21 -50.03 56.23 Favored 'Isoleucine or valine' 0 C--N 1.354 0.785 0 CA-C-N 120.001 1.273 . . . . 0.0 110.57 -177.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 54.8 m170 -90.12 3.8 52.29 Favored 'General case' 0 N--CA 1.439 -0.976 0 O-C-N 121.311 -0.868 . . . . 0.0 110.444 -177.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 1.3 p -89.35 -34.01 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.87 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 178.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -72.54 -40.03 67.06 Favored 'General case' 0 C--N 1.36 1.065 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 178.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.676 HG11 HMD1 ' A' ' 202' ' ' HEM . 73.4 t -63.09 -46.35 96.32 Favored 'Isoleucine or valine' 0 C--N 1.355 0.846 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 93.2 t80 -60.6 -48.76 80.34 Favored 'General case' 0 C--N 1.361 1.089 0 O-C-N 122.064 -0.397 . . . . 0.0 111.428 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -60.9 -37.1 81.07 Favored 'General case' 0 C--N 1.356 0.864 0 O-C-N 121.556 -0.715 . . . . 0.0 110.604 -178.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 110' ' ' LEU . 17.9 mt -58.17 -73.83 0.07 Allowed 'General case' 0 N--CA 1.441 -0.897 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -121.67 134.75 24.71 Favored Pre-proline 0 N--CA 1.439 -1.023 0 C-N-CA 118.37 -1.332 . . . . 0.0 108.773 179.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -84.51 -1.12 9.59 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 123.25 2.634 . . . . 0.0 115.052 -179.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 96.2 mm-40 -66.75 -36.03 81.48 Favored 'General case' 0 C--N 1.354 0.795 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.13 145.39 56.35 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-O 121.649 0.738 . . . . 0.0 110.146 -178.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -126.95 134.31 50.44 Favored 'General case' 0 CA--C 1.502 -0.903 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 179.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.453 ' HB3' ' HD2' ' A' ' 117' ' ' PRO . 84.4 mt -126.81 155.33 75.48 Favored Pre-proline 0 N--CA 1.442 -0.833 0 CA-C-O 122.184 0.992 . . . . 0.0 109.087 -178.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.453 ' HD2' ' HB3' ' A' ' 116' ' ' LEU . 87.7 Cg_endo -85.1 -152.06 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.125 0 C-N-CA 123.887 3.058 . . . . 0.0 114.543 -178.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -112.64 148.67 34.13 Favored 'General case' 0 C--N 1.368 1.38 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 -179.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.642 ' CZ ' HD13 ' A' ' 131' ' ' LEU . 8.3 t80 -142.5 125.06 15.76 Favored 'General case' 0 C--N 1.361 1.066 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 -177.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 95.8 m -126.44 133.62 51.19 Favored 'General case' 0 C--N 1.361 1.068 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 179.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 85.0 m -117.63 132.16 56.54 Favored 'General case' 0 C--N 1.358 0.946 0 C-N-CA 119.566 -0.854 . . . . 0.0 109.732 -178.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.7 t0 -120.43 125.05 46.97 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 177.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 58.7 ttp180 -101.61 117.3 34.61 Favored 'General case' 0 C--N 1.353 0.718 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 -179.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.485 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 94.5 mt -84.98 -25.64 27.63 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 120.692 -0.403 . . . . 0.0 110.502 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -179.1 -142.6 4.98 Favored Glycine 0 C--N 1.349 1.257 0 C-N-CA 118.898 -1.62 . . . . 0.0 109.082 -178.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -94.1 -41.1 9.7 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 119.928 -0.709 . . . . 0.0 109.616 -178.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -102.18 3.49 38.46 Favored 'General case' 0 C--N 1.352 0.712 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.446 -178.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.485 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 67.4 m-20 -118.01 128.95 55.28 Favored 'General case' 0 C--N 1.356 0.885 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 10.6 mm -140.88 133.79 31.33 Favored 'Isoleucine or valine' 0 C--N 1.357 0.935 0 N-CA-C 107.758 -1.201 . . . . 0.0 107.758 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 62.3 mtm180 -121.34 140.84 51.58 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.777 HD23 HD11 ' A' ' 177' ' ' ILE . 0.3 OUTLIER -129.79 128.03 41.55 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 178.679 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -99.08 131.28 45.24 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 178.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -126.24 120.99 31.43 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 -178.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.468 ' HA ' ' O ' ' A' ' 171' ' ' THR . 27.5 tt0 -114.88 110.23 19.35 Favored 'General case' 0 N--CA 1.439 -0.995 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.474 ' O ' ' HA ' ' A' ' 171' ' ' THR . 11.6 t -162.95 154.37 17.53 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -87.93 9.2 22.94 Favored 'General case' 0 C--N 1.355 0.836 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . 0.426 HH22 ' CD2' ' A' ' 45' ' ' HIS . 78.3 mtp180 -129.46 78.28 75.92 Favored Pre-proline 0 N--CA 1.443 -0.777 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -91.98 86.61 0.24 Allowed 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.663 2.242 . . . . 0.0 115.556 -178.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -111.7 109.71 19.71 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 106.957 -1.498 . . . . 0.0 106.957 177.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -70.4 -30.73 67.69 Favored 'General case' 0 C--N 1.354 0.792 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.3 -179.094 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 75.4 m -62.88 -34.22 76.93 Favored 'General case' 0 C--N 1.352 0.697 0 O-C-N 122.001 -0.437 . . . . 0.0 109.95 -179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -74.35 -44.59 51.7 Favored 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 120.434 -0.506 . . . . 0.0 109.732 -177.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.55 -40.39 95.49 Favored 'General case' 0 C--N 1.357 0.902 0 O-C-N 122.067 -0.395 . . . . 0.0 111.254 -177.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.87 -37.02 85.84 Favored 'General case' 0 CA--C 1.506 -0.736 0 O-C-N 122.012 -0.43 . . . . 0.0 110.187 -179.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.49 -43.71 98.5 Favored Glycine 0 C--N 1.347 1.161 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -178.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 82.8 mt -69.9 -40.49 75.58 Favored 'General case' 0 C--N 1.35 0.612 0 O-C-N 122.108 -0.642 . . . . 0.0 112.507 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 96.7 mt -71.75 -43.16 66.28 Favored 'General case' 0 C--N 1.361 1.103 0 O-C-N 121.215 -0.928 . . . . 0.0 111.032 -176.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.584 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 37.3 t70 -71.01 -31.46 67.98 Favored 'General case' 0 N--CA 1.447 -0.604 0 O-C-N 122.1 -0.375 . . . . 0.0 110.634 -178.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -62.77 -39.89 98.52 Favored Glycine 0 C--N 1.358 1.76 0 N-CA-C 108.512 -1.835 . . . . 0.0 108.512 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 48.8 t -60.71 -41.61 95.57 Favored 'General case' 0 C--N 1.35 0.591 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -76.83 2.05 15.64 Favored 'General case' 0 C--N 1.361 1.079 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.584 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 77.3 mm-40 -86.0 -46.16 10.78 Favored 'General case' 0 N--CA 1.441 -0.894 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -66.16 -45.18 81.82 Favored 'General case' 0 C--N 1.361 1.102 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 178.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -69.54 -26.61 64.58 Favored 'General case' 0 C--N 1.362 1.124 0 O-C-N 121.842 -0.536 . . . . 0.0 110.793 -178.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 84.7 tttt 71.65 77.7 0.17 Allowed 'General case' 0 C--N 1.358 0.95 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.28 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -141.38 -170.66 3.13 Favored 'General case' 0 N--CA 1.441 -0.899 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 179.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -145.96 93.5 2.34 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 13.5 m-30 -113.52 155.93 24.49 Favored 'General case' 0 CA--C 1.504 -0.802 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 178.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 95.5 m -120.2 127.54 52.54 Favored 'General case' 0 C--N 1.356 0.856 0 C-N-CA 119.392 -0.923 . . . . 0.0 108.979 -178.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.501 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.7 mp -100.99 121.3 51.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 N-CA-C 106.988 -1.486 . . . . 0.0 106.988 178.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -114.12 -176.44 2.9 Favored 'General case' 0 C--N 1.365 1.245 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 28.8 ptt180 -146.95 154.46 41.29 Favored 'General case' 0 C--N 1.359 0.98 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 -179.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 35.1 p -97.69 146.56 31.64 Favored Pre-proline 0 C--N 1.36 1.06 0 CA-C-O 122.448 1.118 . . . . 0.0 108.046 178.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.659 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 72.1 Cg_endo -75.03 -12.49 21.45 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 123.055 2.504 . . . . 0.0 114.923 -178.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -72.21 -41.21 67.15 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 120.107 -0.637 . . . . 0.0 109.84 -178.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 26.8 p -118.6 16.45 13.69 Favored 'General case' 0 C--N 1.354 0.768 0 C-N-CA 119.824 -0.75 . . . . 0.0 110.829 -178.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.659 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.2 pp0? -67.15 -14.37 62.84 Favored 'General case' 0 C--N 1.352 0.707 0 O-C-N 121.563 -0.71 . . . . 0.0 110.121 178.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -124.28 38.81 4.11 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 22.0 t -138.49 143.37 39.55 Favored 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 107.165 -1.421 . . . . 0.0 107.165 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.644 ' O ' ' HB ' ' A' ' 171' ' ' THR . 60.5 mt-10 -96.77 163.63 12.91 Favored 'General case' 0 C--N 1.354 0.776 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -179.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.644 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 2.7 m 81.91 -57.49 0.23 Allowed 'General case' 0 C--N 1.374 1.645 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.906 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -105.63 117.76 34.85 Favored 'General case' 0 CA--C 1.504 -0.813 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.567 -178.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 89.0 t -132.57 134.21 58.98 Favored 'Isoleucine or valine' 0 C--N 1.357 0.928 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 178.685 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 48.5 mm -115.22 127.73 72.68 Favored 'Isoleucine or valine' 0 C--N 1.361 1.07 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 -179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -116.2 146.33 42.4 Favored 'General case' 0 C--N 1.359 1.021 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -179.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -125.53 84.05 2.23 Favored 'General case' 0 C--N 1.355 0.824 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.193 -178.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . 0.777 HD11 HD23 ' A' ' 131' ' ' LEU . 3.6 mp -77.1 117.99 22.98 Favored 'Isoleucine or valine' 0 C--N 1.363 1.167 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 177.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 90.1 m -128.35 144.41 51.13 Favored 'General case' 0 C--N 1.356 0.885 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 -178.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 59.3 mtm180 -79.7 116.59 19.96 Favored 'General case' 0 C--N 1.371 1.539 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -65.9 149.85 97.11 Favored Pre-proline 0 C--N 1.358 0.959 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 178.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.9 124.74 12.66 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 121.775 1.65 . . . . 0.0 113.51 -178.666 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 2.9 ppt_? -137.03 152.88 50.6 Favored 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.491 ' O ' ' HB3' ' A' ' 184' ' ' ALA . . . 75.82 62.92 2.54 Favored Glycine 0 C--N 1.351 1.373 0 N-CA-C 107.489 -2.244 . . . . 0.0 107.489 -179.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.491 ' HB3' ' O ' ' A' ' 183' ' ' GLY . . . 80.1 163.83 0.18 Allowed 'General case' 0 C--N 1.361 1.088 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 -178.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -146.99 148.84 32.11 Favored 'General case' 0 N--CA 1.437 -1.115 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -123.79 126.68 46.9 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 78.5 mt -99.23 -61.39 1.37 Allowed 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 179.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . 0.417 ' HB3' ' H ' ' A' ' 189' ' ' PHE . 0.2 OUTLIER -151.19 -94.57 0.06 Allowed 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 179.672 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . 0.417 ' H ' ' HB3' ' A' ' 188' ' ' TYR . 99.0 m-85 -128.83 147.76 50.83 Favored 'General case' 0 N--CA 1.438 -1.054 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 179.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 54.0 tt0 . . . . . 0 C--O 1.264 1.816 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -179.937 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' HEM . . . . . 0.676 HMD1 HG11 ' A' ' 107' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.4 mtm . . . . . 0 N--CA 1.493 1.675 0 CA-C-O 121.252 0.548 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.401 ' HA ' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -83.99 -13.5 53.14 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -179.442 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.0 -39.32 38.18 Favored Glycine 0 C--N 1.353 1.49 0 N-CA-C 108.641 -1.783 . . . . 0.0 108.641 179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.7 tpp -71.6 -36.69 70.9 Favored 'General case' 0 C--N 1.359 0.982 0 O-C-N 121.92 -0.753 . . . . 0.0 110.767 -177.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.401 HG22 ' HA ' ' A' ' 2' ' ' MET . 35.5 m -69.81 -22.76 25.12 Favored 'Isoleucine or valine' 0 C--N 1.357 0.908 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.446 ' HZ ' ' HG2' ' A' ' 47' ' ' GLU . 1.8 m-30 -70.4 -35.57 73.54 Favored 'General case' 0 C--N 1.357 0.922 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 179.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 85.3 m -67.38 -40.61 85.71 Favored 'General case' 0 C--N 1.355 0.847 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.34 -38.81 96.87 Favored Glycine 0 C--N 1.358 1.75 0 N-CA-C 110.541 -1.023 . . . . 0.0 110.541 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.648 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -66.96 -39.42 87.24 Favored 'General case' 0 C--N 1.352 0.687 0 O-C-N 122.297 -0.531 . . . . 0.0 110.674 -178.198 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 20.9 mmt -63.91 -41.01 97.78 Favored 'General case' 0 C--N 1.354 0.78 0 O-C-N 121.602 -0.686 . . . . 0.0 110.979 -178.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -67.43 -40.76 85.5 Favored 'General case' 0 C--N 1.349 0.554 0 O-C-N 121.929 -0.482 . . . . 0.0 111.857 -177.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 54.7 tp -65.52 -42.83 91.58 Favored 'General case' 0 C--N 1.349 0.571 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -178.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.648 HG12 ' O ' ' A' ' 9' ' ' LEU . 1.2 mm -76.42 -35.74 27.4 Favored 'Isoleucine or valine' 0 C--N 1.358 0.951 0 O-C-N 120.957 -1.09 . . . . 0.0 111.041 -175.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -67.98 -43.38 79.1 Favored 'General case' 0 C--N 1.352 0.677 0 O-C-N 121.766 -0.584 . . . . 0.0 111.173 -176.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -72.64 -33.71 66.81 Favored 'General case' 0 N--CA 1.448 -0.566 0 O-C-N 121.98 -0.45 . . . . 0.0 111.658 -177.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.3 mm-40 -71.57 -47.88 52.02 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -175.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -127.89 -19.18 4.09 Favored 'General case' 0 C--N 1.355 0.834 0 C-N-CA 117.417 -1.713 . . . . 0.0 113.496 -176.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 139.99 178.92 17.32 Favored Glycine 0 N--CA 1.44 -1.053 0 C-N-CA 117.923 -2.084 . . . . 0.0 109.862 -179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 44.8 p90 -95.99 -12.4 25.05 Favored 'General case' 0 N--CA 1.429 -1.523 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -177.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -70.69 -40.48 72.87 Favored 'General case' 0 C--N 1.359 0.997 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.8 m -69.09 -39.25 79.13 Favored 'General case' 0 C--N 1.357 0.907 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 179.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 53.4 tp -62.59 -37.83 87.76 Favored 'General case' 0 C--N 1.357 0.934 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -62.97 -37.42 87.06 Favored 'General case' 0 C--N 1.358 0.955 0 O-C-N 121.968 -0.458 . . . . 0.0 110.997 -179.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.6 m -65.6 -38.22 88.86 Favored 'General case' 0 C--N 1.353 0.735 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 -179.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.443 ' HG ' HD22 ' A' ' 51' ' ' LEU . 21.8 tp -62.53 -39.49 93.74 Favored 'General case' 0 C--N 1.353 0.735 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -179.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 85.6 mt -72.95 -13.85 61.33 Favored 'General case' 0 C--N 1.359 0.997 0 O-C-N 121.92 -0.488 . . . . 0.0 110.579 -178.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -86.93 -28.77 22.55 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 119.312 -0.955 . . . . 0.0 109.368 179.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 47.0 t -67.25 -37.01 82.82 Favored 'General case' 0 C--N 1.355 0.839 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 178.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.1 p -91.63 -39.5 11.84 Favored 'General case' 0 C--N 1.357 0.924 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 -179.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 86.06 132.85 0.04 OUTLIER 'General case' 0 C--N 1.36 1.052 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.51 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.2 OUTLIER -86.91 -169.55 2.68 Favored 'General case' 0 C--N 1.357 0.9 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 -179.884 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.416 ' H ' ' H ' ' A' ' 33' ' ' SER . 62.5 tt0 -152.26 -24.92 0.17 Allowed 'General case' 0 N--CA 1.438 -1.071 0 N-CA-C 107.91 -1.145 . . . . 0.0 107.91 -179.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.416 ' H ' ' H ' ' A' ' 32' ' ' GLN . 1.8 t -145.22 -69.51 0.28 Allowed 'General case' 0 N--CA 1.44 -0.952 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 -179.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -131.05 -50.24 1.02 Allowed 'General case' 0 N--CA 1.44 -0.929 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 -178.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 130.41 -37.31 2.15 Favored Glycine 0 C--N 1.353 1.475 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 83.0 mt -110.0 100.75 11.41 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.714 0 N-CA-C 106.724 -1.584 . . . . 0.0 106.724 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -95.65 -4.78 43.77 Favored 'General case' 0 C--N 1.354 0.801 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.76 HG22 ' H ' ' A' ' 39' ' ' SER . 5.2 m 82.43 174.84 0.09 Allowed 'General case' 0 C--N 1.362 1.118 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 -178.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.76 ' H ' HG22 ' A' ' 38' ' ' THR . 41.1 p -89.38 114.89 26.38 Favored 'General case' 0 N--CA 1.443 -0.791 0 O-C-N 121.041 -1.037 . . . . 0.0 109.855 -178.042 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.46 HG13 ' O ' ' A' ' 39' ' ' SER . 0.0 OUTLIER -172.92 -3.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.364 1.218 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 178.795 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -98.26 -136.74 9.38 Favored Glycine 0 C--N 1.357 1.735 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 -178.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 164.47 98.97 0.0 OUTLIER 'General case' 0 C--N 1.362 1.132 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 -178.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -98.11 176.87 5.59 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.71 -174.61 4.42 Favored 'General case' 0 N--CA 1.442 -0.851 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 -179.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 72.7 m80 -91.1 -15.89 28.72 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 120.011 -0.676 . . . . 0.0 109.29 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -70.31 -29.32 66.03 Favored 'General case' 0 N--CA 1.443 -0.779 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 178.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.446 ' HG2' ' HZ ' ' A' ' 6' ' ' PHE . 33.1 tp10 -63.69 -41.64 98.1 Favored 'General case' 0 C--N 1.354 0.769 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 179.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.494 ' O ' HG23 ' A' ' 52' ' ' VAL . 54.5 tp -67.24 -38.36 85.06 Favored 'General case' 0 C--N 1.354 0.782 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.197 -179.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 60.6 tp -76.49 -28.04 56.3 Favored 'General case' 0 C--N 1.349 0.583 0 O-C-N 122.029 -0.419 . . . . 0.0 110.647 -177.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 71.5 tp60 -68.2 -42.6 79.64 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 121.509 -0.745 . . . . 0.0 109.615 -178.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.443 HD22 ' HG ' ' A' ' 25' ' ' LEU . 57.5 mt -72.8 -33.8 66.47 Favored 'General case' 0 C--N 1.363 1.18 0 C-N-CA 119.679 -0.809 . . . . 0.0 109.48 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 48' ' ' LEU . 38.7 t -62.61 -41.47 92.26 Favored 'Isoleucine or valine' 0 C--N 1.35 0.59 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 51.3 t -68.1 -40.61 83.3 Favored 'Isoleucine or valine' 0 C--N 1.351 0.668 0 O-C-N 121.716 -0.615 . . . . 0.0 109.809 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 31.7 tptt -66.84 -26.08 66.74 Favored 'General case' 0 C--N 1.359 1.007 0 O-C-N 121.131 -0.98 . . . . 0.0 108.768 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.408 ' O ' HD23 ' A' ' 55' ' ' LEU . 2.2 tt -69.09 -37.5 78.46 Favored 'General case' 0 C--N 1.353 0.744 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.402 ' O ' ' HA ' ' A' ' 60' ' ' SER . 71.5 p -72.05 -18.05 61.97 Favored 'General case' 0 C--N 1.356 0.868 0 O-C-N 121.722 -0.611 . . . . 0.0 110.624 -178.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -100.5 -35.04 9.68 Favored 'General case' 0 C--N 1.353 0.743 0 O-C-N 121.143 -0.973 . . . . 0.0 111.389 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 5.5 p -72.29 -34.8 50.41 Favored 'Isoleucine or valine' 0 C--N 1.353 0.719 0 O-C-N 121.755 -0.591 . . . . 0.0 111.375 -177.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.562 ' HB3' HG23 ' A' ' 61' ' ' VAL . 2.5 t -120.29 -7.4 9.79 Favored 'General case' 0 C--N 1.353 0.718 0 C-N-CA 119.337 -0.945 . . . . 0.0 110.094 -177.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 56' ' ' SER . 0.6 OUTLIER 65.71 47.26 2.17 Favored 'General case' 0 C--N 1.353 0.76 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.796 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.562 HG23 ' HB3' ' A' ' 59' ' ' SER . 52.3 t -108.71 131.92 21.48 Favored Pre-proline 0 CA--C 1.503 -0.839 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 179.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -57.46 147.24 79.41 Favored 'Trans proline' 0 CA--C 1.497 -1.355 0 C-N-CA 122.439 2.093 . . . . 0.0 112.82 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.9 m -75.51 -12.97 14.98 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.811 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.685 -178.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.433 ' O ' HG12 ' A' ' 67' ' ' VAL . 71.5 p -96.09 -33.04 12.23 Favored 'General case' 0 C--N 1.358 0.961 0 C-N-CA 118.291 -1.364 . . . . 0.0 109.534 -179.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -76.55 -22.58 54.14 Favored 'General case' 0 C--N 1.354 0.799 0 O-C-N 121.449 -0.782 . . . . 0.0 109.033 179.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -81.7 -34.89 30.37 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.433 HG12 ' O ' ' A' ' 64' ' ' THR . 1.5 p -69.4 -26.33 31.13 Favored 'Isoleucine or valine' 0 C--N 1.354 0.795 0 C-N-CA 120.032 -0.667 . . . . 0.0 109.916 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.5 mmm-85 -72.96 -51.5 18.13 Favored 'General case' 0 C--N 1.363 1.157 0 O-C-N 121.53 -0.731 . . . . 0.0 110.269 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 83.7 mt -63.76 -36.17 83.01 Favored 'General case' 0 C--N 1.357 0.923 0 O-C-N 122.064 -0.398 . . . . 0.0 110.939 -179.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -60.94 -46.9 88.82 Favored 'General case' 0 C--N 1.35 0.609 0 O-C-N 122.233 -0.292 . . . . 0.0 110.238 -178.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -60.56 -37.97 94.21 Favored Glycine 0 C--N 1.355 1.598 0 N-CA-C 111.685 -0.566 . . . . 0.0 111.685 -178.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -63.64 -47.84 79.69 Favored 'General case' 0 C--N 1.354 0.782 0 CA-C-N 118.419 1.109 . . . . 0.0 111.486 -177.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.9 mttm -64.38 -47.72 78.2 Favored 'General case' 0 C--N 1.36 1.027 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -176.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.427 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.5 tm? -69.64 -40.21 76.64 Favored 'General case' 0 C--N 1.349 0.581 0 O-C-N 121.051 -1.031 . . . . 0.0 111.828 -175.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -63.76 -45.45 89.74 Favored 'General case' 0 C--N 1.354 0.768 0 O-C-N 121.19 -0.944 . . . . 0.0 111.27 -178.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 8.5 p -71.72 -12.83 16.31 Favored 'Isoleucine or valine' 0 C--N 1.357 0.911 0 O-C-N 121.543 -0.723 . . . . 0.0 109.294 -179.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -75.33 -37.39 60.74 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 82.4 mt -72.53 -32.84 66.44 Favored 'General case' 0 C--N 1.358 0.949 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.7 mm -64.07 -52.99 49.34 Favored 'Isoleucine or valine' 0 C--N 1.36 1.043 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.196 -177.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -75.36 -14.87 60.5 Favored 'General case' 0 CA--C 1.51 -0.593 0 C-N-CA 119.693 -0.803 . . . . 0.0 109.529 178.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -71.32 -37.05 63.17 Favored Glycine 0 C--N 1.349 1.267 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -179.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -133.45 105.78 12.06 Favored Pre-proline 0 N--CA 1.44 -0.97 0 CA-C-O 122.555 1.169 . . . . 0.0 109.199 -176.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -67.8 -25.03 39.81 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.381 2.054 . . . . 0.0 113.806 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -88.78 -7.69 55.76 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.8 tp -89.31 -22.7 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.057 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 -178.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -98.7 -22.12 16.06 Favored 'General case' 0 C--N 1.362 1.113 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 179.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -70.03 -37.22 75.54 Favored 'General case' 0 C--N 1.358 0.976 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 16.5 mm-40 -64.78 -36.73 85.27 Favored 'General case' 0 C--N 1.358 0.956 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.261 179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.565 ' SD ' ' HZ ' ' A' ' 154' ' ' PHE . 0.0 OUTLIER -82.17 151.07 27.08 Favored 'General case' 0 C--N 1.352 0.704 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -178.837 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.552 ' N ' ' HG2' ' A' ' 89' ' ' MET . 0.7 OUTLIER -118.27 -22.63 7.61 Favored 'General case' 0 C--N 1.363 1.18 0 C-N-CA 119.852 -0.739 . . . . 0.0 111.298 -177.472 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -166.71 172.77 10.22 Favored 'General case' 0 N--CA 1.443 -0.813 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.425 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 65.1 m -67.12 -40.06 86.76 Favored 'General case' 0 C--N 1.354 0.774 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.478 -179.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -68.68 -39.09 80.75 Favored 'General case' 0 C--N 1.356 0.859 0 O-C-N 121.322 -0.862 . . . . 0.0 109.011 -178.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -66.29 -23.16 66.34 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.519 HD21 ' HAB' ' A' ' 202' ' ' HEM . 58.3 tp -63.99 -46.1 86.07 Favored 'General case' 0 C--N 1.355 0.829 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.2 mp -63.14 -33.13 74.79 Favored 'General case' 0 C--N 1.354 0.797 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 35.6 t -62.34 -44.4 96.58 Favored 'General case' 0 C--N 1.353 0.747 0 O-C-N 121.897 -0.502 . . . . 0.0 110.954 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.63 26.73 10.37 Favored 'General case' 0 C--N 1.359 0.99 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.376 -177.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 1.291 HD11 ' C2B' ' A' ' 202' ' ' HEM . 14.1 tt -62.36 -31.55 52.08 Favored 'Isoleucine or valine' 0 C--N 1.356 0.88 0 C-N-CA 120.424 -0.51 . . . . 0.0 110.625 -179.088 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -119.43 -18.29 8.55 Favored 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 119.218 -0.993 . . . . 0.0 109.113 -178.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 35.6 t -64.25 -46.61 82.99 Favored 'General case' 0 N--CA 1.444 -0.747 0 O-C-N 121.82 -0.55 . . . . 0.0 110.869 -178.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.4 ' HA ' HG12 ' A' ' 105' ' ' VAL . 14.4 t80 -127.59 -26.34 3.01 Favored 'General case' 0 C--N 1.36 1.028 0 C-N-CA 118.103 -1.439 . . . . 0.0 111.828 -177.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 19.0 mm -67.05 -50.23 65.97 Favored 'Isoleucine or valine' 0 C--O 1.244 0.794 0 O-C-N 121.097 -1.002 . . . . 0.0 110.236 -177.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 49.4 m170 -91.08 3.43 54.77 Favored 'General case' 0 N--CA 1.439 -0.985 0 O-C-N 121.462 -0.774 . . . . 0.0 110.408 -177.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.4 HG12 ' HA ' ' A' ' 102' ' ' PHE . 2.4 p -87.64 -35.4 8.26 Favored 'Isoleucine or valine' 0 C--N 1.356 0.862 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 178.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -72.88 -39.95 66.01 Favored 'General case' 0 N--CA 1.441 -0.903 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.787 HG11 HMD3 ' A' ' 202' ' ' HEM . 74.4 t -63.48 -46.06 96.17 Favored 'Isoleucine or valine' 0 C--N 1.357 0.909 0 C-N-CA 120.794 -0.362 . . . . 0.0 110.255 -179.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -60.3 -48.13 83.06 Favored 'General case' 0 C--N 1.36 1.026 0 O-C-N 122.117 -0.364 . . . . 0.0 111.484 -178.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 2.0 mptp? -61.98 -36.55 81.81 Favored 'General case' 0 C--N 1.355 0.811 0 O-C-N 121.412 -0.805 . . . . 0.0 110.506 -178.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.9 mt -58.28 -76.33 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.795 0 C-N-CA 120.665 -0.414 . . . . 0.0 109.951 -179.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.468 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 90.5 m-85 -110.9 141.0 23.26 Favored Pre-proline 0 N--CA 1.443 -0.807 0 C-N-CA 118.745 -1.182 . . . . 0.0 109.169 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 111' ' ' TYR . 54.2 Cg_endo -88.39 -7.53 5.79 Favored 'Trans proline' 0 C--N 1.315 -1.198 0 C-N-CA 123.219 2.613 . . . . 0.0 115.877 -178.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -77.96 -23.87 48.31 Favored 'General case' 0 C--N 1.354 0.789 0 C-N-CA 119.998 -0.681 . . . . 0.0 110.22 -178.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.2 142.53 58.29 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 121.512 0.672 . . . . 0.0 109.656 -178.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -118.72 143.63 46.75 Favored 'General case' 0 N--CA 1.438 -1.053 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 179.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.434 ' HA ' ' HD3' ' A' ' 117' ' ' PRO . 96.3 mt -136.93 152.22 73.66 Favored Pre-proline 0 C--N 1.354 0.802 0 CA-C-O 122.138 0.971 . . . . 0.0 109.604 -178.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 116' ' ' LEU . 75.0 Cg_endo -89.85 -155.24 0.05 OUTLIER 'Trans proline' 0 C--N 1.318 -1.03 0 C-N-CA 123.934 3.089 . . . . 0.0 113.484 179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -119.63 142.34 48.51 Favored 'General case' 0 C--N 1.367 1.327 0 C-N-CA 119.328 -0.949 . . . . 0.0 108.711 -179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -126.26 128.66 47.53 Favored 'General case' 0 C--N 1.363 1.157 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 -178.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.526 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 93.6 m -124.17 128.26 48.98 Favored 'General case' 0 C--N 1.357 0.893 0 N-CA-C 105.323 -2.103 . . . . 0.0 105.323 176.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 78.1 m -121.77 130.97 53.81 Favored 'General case' 0 CA--C 1.504 -0.827 0 C-N-CA 118.972 -1.091 . . . . 0.0 110.175 -177.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -118.76 149.81 40.85 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 106.178 -1.786 . . . . 0.0 106.178 177.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 58.0 ttp180 -121.62 117.61 27.15 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 -179.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 96.0 mt -91.34 -16.27 27.74 Favored 'General case' 0 C--N 1.354 0.796 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.57 -179.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 175.41 -149.5 10.21 Favored Glycine 0 C--N 1.348 1.214 0 C-N-CA 118.859 -1.639 . . . . 0.0 109.076 -179.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -93.87 -37.64 11.63 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 -178.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 29.9 p-10 -102.83 4.38 37.73 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.81 -179.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -120.8 129.62 53.65 Favored 'General case' 0 C--N 1.357 0.934 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 -179.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 8.3 mm -141.89 136.57 30.47 Favored 'Isoleucine or valine' 0 C--N 1.355 0.834 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 51.7 mtm180 -116.63 139.67 50.26 Favored 'General case' 0 CA--C 1.495 -1.16 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 179.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 8.0 tp -127.61 119.57 26.22 Favored 'General case' 0 N--CA 1.431 -1.385 0 CA-C-N 115.172 -0.922 . . . . 0.0 108.856 -178.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.526 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 12.1 m170 -99.2 134.28 42.27 Favored 'General case' 0 CA--C 1.498 -1.031 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 178.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 52.2 t80 -130.21 122.26 27.77 Favored 'General case' 0 N--CA 1.437 -1.075 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 -178.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.492 ' HA ' ' O ' ' A' ' 171' ' ' THR . 30.0 tt0 -114.35 113.74 24.96 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 15.6 t -161.88 153.34 18.55 Favored 'General case' 0 C--N 1.358 0.954 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 57.4 mtmt -91.55 3.89 53.91 Favored 'General case' 0 C--N 1.357 0.902 0 C-N-CA 120.168 -0.613 . . . . 0.0 109.866 -179.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 94.3 mtm-85 -133.42 74.98 70.65 Favored Pre-proline 0 C--N 1.355 0.847 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 178.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -94.88 100.89 0.11 Allowed 'Trans proline' 0 N--CA 1.442 -1.506 0 C-N-CA 122.621 2.214 . . . . 0.0 115.63 -177.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -110.67 113.54 26.22 Favored 'General case' 0 N--CA 1.439 -1.02 0 N-CA-C 106.136 -1.802 . . . . 0.0 106.136 176.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.63 -38.59 91.7 Favored 'General case' 0 C--N 1.354 0.771 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.166 -179.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 73.4 m -63.83 -26.98 68.87 Favored 'General case' 0 C--N 1.353 0.759 0 O-C-N 121.886 -0.509 . . . . 0.0 110.808 -178.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -76.11 -47.37 24.74 Favored 'General case' 0 C--N 1.352 0.695 0 C-N-CA 120.038 -0.665 . . . . 0.0 109.593 -177.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.46 -39.8 94.5 Favored 'General case' 0 C--N 1.356 0.864 0 O-C-N 122.215 -0.303 . . . . 0.0 111.185 -178.005 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -63.31 -37.37 86.98 Favored 'General case' 0 C--N 1.354 0.797 0 O-C-N 121.879 -0.513 . . . . 0.0 109.908 -179.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.04 -42.94 98.63 Favored Glycine 0 C--N 1.348 1.232 0 N-CA-C 110.019 -1.232 . . . . 0.0 110.019 -179.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 84.0 mt -70.82 -41.0 72.14 Favored 'General case' 0 C--N 1.354 0.762 0 CA-C-N 117.586 0.693 . . . . 0.0 112.704 -179.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 98.5 mt -71.08 -42.15 69.74 Favored 'General case' 0 C--N 1.36 1.057 0 O-C-N 121.28 -0.888 . . . . 0.0 110.833 -176.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.447 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 36.3 t70 -70.53 -28.9 65.29 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 121.935 -0.478 . . . . 0.0 110.385 -179.276 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.426 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -63.08 -39.01 97.51 Favored Glycine 0 C--N 1.358 1.793 0 N-CA-C 108.049 -2.02 . . . . 0.0 108.049 179.648 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 48.1 t -60.95 -42.13 97.66 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 178.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -74.71 -0.36 17.85 Favored 'General case' 0 C--N 1.361 1.095 0 O-C-N 121.789 -0.57 . . . . 0.0 109.603 179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.447 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 75.7 mm-40 -85.79 -45.8 11.26 Favored 'General case' 0 N--CA 1.445 -0.694 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 90.5 t80 -65.61 -46.06 80.74 Favored 'General case' 0 C--N 1.361 1.082 0 C-N-CA 120.158 -0.617 . . . . 0.0 109.363 178.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . 0.565 ' HZ ' ' SD ' ' A' ' 89' ' ' MET . 37.5 m-85 -68.44 -27.85 66.54 Favored 'General case' 0 C--N 1.363 1.189 0 O-C-N 121.859 -0.525 . . . . 0.0 110.917 -178.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 85.4 tttt 74.44 73.94 0.11 Allowed 'General case' 0 C--N 1.36 1.041 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 -178.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -142.84 -169.28 2.97 Favored 'General case' 0 N--CA 1.441 -0.907 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 179.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -148.15 96.18 2.59 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 13.1 m-30 -113.24 155.55 24.88 Favored 'General case' 0 CA--C 1.503 -0.828 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 178.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 92.2 m -119.32 128.16 53.87 Favored 'General case' 0 N--CA 1.443 -0.81 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 -178.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.518 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.7 mp -105.47 122.04 58.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 179.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 2.7 m -117.06 -174.41 2.58 Favored 'General case' 0 C--N 1.357 0.906 0 CA-C-O 121.913 0.863 . . . . 0.0 109.352 -178.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -146.08 155.48 42.8 Favored 'General case' 0 C--N 1.356 0.862 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 -177.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 47.3 p -100.28 146.6 32.25 Favored Pre-proline 0 C--N 1.359 0.997 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.638 ' HA ' ' HG2' ' A' ' 167' ' ' GLN . 75.0 Cg_endo -76.4 -11.46 19.0 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 123.056 2.504 . . . . 0.0 115.022 -178.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -72.34 -41.51 66.4 Favored 'General case' 0 N--CA 1.442 -0.837 0 C-N-CA 119.932 -0.707 . . . . 0.0 109.591 -178.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 37.9 p -116.76 15.59 15.36 Favored 'General case' 0 CA--C 1.505 -0.785 0 C-N-CA 120.172 -0.611 . . . . 0.0 110.527 -178.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.638 ' HG2' ' HA ' ' A' ' 164' ' ' PRO . 3.3 pp0? -67.03 -12.18 59.15 Favored 'General case' 0 C--N 1.353 0.744 0 O-C-N 121.595 -0.691 . . . . 0.0 110.52 178.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -122.97 34.36 5.15 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -179.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 65.4 m -134.91 147.27 49.77 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.61 ' O ' ' HB ' ' A' ' 171' ' ' THR . 37.3 mt-10 -101.12 165.67 11.18 Favored 'General case' 0 N--CA 1.443 -0.793 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.61 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 18.6 m 83.15 -60.52 0.14 Allowed 'General case' 0 C--N 1.37 1.467 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -107.37 117.31 33.75 Favored 'General case' 0 CA--C 1.502 -0.887 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.623 -178.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 90.1 t -130.69 133.02 63.98 Favored 'Isoleucine or valine' 0 C--N 1.357 0.899 0 N-CA-C 106.924 -1.509 . . . . 0.0 106.924 178.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 49.6 mm -107.25 127.27 63.17 Favored 'Isoleucine or valine' 0 C--N 1.358 0.976 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -115.85 156.8 25.47 Favored 'General case' 0 N--CA 1.44 -0.949 0 CA-C-O 122.156 0.979 . . . . 0.0 108.513 -179.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -138.54 119.42 14.28 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -178.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 3.8 mp -113.55 118.54 58.47 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 N-CA-C 106.263 -1.755 . . . . 0.0 106.263 -179.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 91.4 m -122.84 142.38 50.82 Favored 'General case' 0 CA--C 1.502 -0.869 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 -177.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -101.03 118.94 37.99 Favored 'General case' 0 C--N 1.362 1.147 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 179.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.476 ' HB1' ' HD2' ' A' ' 181' ' ' PRO . . . -71.57 155.67 92.27 Favored Pre-proline 0 N--CA 1.442 -0.86 0 N-CA-C 106.74 -1.578 . . . . 0.0 106.74 178.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.476 ' HD2' ' HB1' ' A' ' 180' ' ' ALA . 19.4 Cg_endo -62.86 129.91 27.62 Favored 'Trans proline' 0 CA--C 1.49 -1.706 0 C-N-CA 121.552 1.502 . . . . 0.0 112.787 -179.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -143.02 163.75 31.96 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 -178.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 102.88 -25.57 26.98 Favored Glycine 0 C--N 1.349 1.286 0 N-CA-C 108.333 -1.907 . . . . 0.0 108.333 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -151.63 -100.86 0.06 Allowed 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 163.81 76.31 0.0 OUTLIER 'General case' 0 C--N 1.362 1.131 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -113.48 113.69 25.5 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 179.35 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.66 -65.97 0.97 Allowed 'General case' 0 N--CA 1.44 -0.974 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -136.16 -83.48 0.38 Allowed 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -137.69 -69.64 0.45 Allowed 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 107.097 -1.446 . . . . 0.0 107.097 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 . . . . . 0 C--O 1.264 1.838 0 N-CA-C 107.399 -1.334 . . . . 0.0 107.399 179.732 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' HEM . . . . . 1.291 ' C2B' HD11 ' A' ' 99' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.636 ' HG2' ' HG3' ' A' ' 4' ' ' MET . 27.7 tpp . . . . . 0 N--CA 1.492 1.646 0 CA-C-O 120.986 0.422 . . . . 0.0 110.402 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' MET . . . . . 0.425 ' HA ' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -81.1 -14.49 57.7 Favored 'General case' 0 N--CA 1.44 -0.925 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 -179.471 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -73.5 -42.96 38.99 Favored Glycine 0 C--N 1.35 1.333 0 N-CA-C 109.226 -1.55 . . . . 0.0 109.226 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.636 ' HG3' ' HG2' ' A' ' 1' ' ' MET . 76.0 mtm -70.38 -34.78 72.98 Favored 'General case' 0 C--N 1.355 0.808 0 O-C-N 122.149 -0.618 . . . . 0.0 111.206 -178.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.425 HG22 ' HA ' ' A' ' 2' ' ' MET . 35.7 m -68.95 -23.34 27.19 Favored 'Isoleucine or valine' 0 C--N 1.358 0.946 0 C-N-CA 119.75 -0.78 . . . . 0.0 109.314 -179.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.461 ' HZ ' ' CG ' ' A' ' 47' ' ' GLU . 2.6 m-85 -72.22 -33.07 67.3 Favored 'General case' 0 C--N 1.357 0.922 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 178.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 86.1 m -67.01 -40.09 87.21 Favored 'General case' 0 C--N 1.355 0.846 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -62.54 -39.32 97.7 Favored Glycine 0 C--N 1.359 1.83 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 -179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.644 ' O ' HG12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -64.22 -40.66 96.51 Favored 'General case' 0 C--N 1.351 0.671 0 O-C-N 122.522 -0.399 . . . . 0.0 110.698 -178.795 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' MET . . . . . . . . . . . . . 20.5 mmt -63.43 -40.63 97.7 Favored 'General case' 0 C--N 1.352 0.708 0 O-C-N 121.72 -0.612 . . . . 0.0 110.832 -178.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -67.29 -40.5 86.09 Favored 'General case' 0 C--N 1.349 0.563 0 O-C-N 122.012 -0.43 . . . . 0.0 111.692 -178.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 54.9 tp -66.31 -42.93 87.57 Favored 'General case' 0 C--N 1.35 0.606 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -178.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.644 HG12 ' O ' ' A' ' 9' ' ' LEU . 2.6 mm -73.51 -37.1 49.63 Favored 'Isoleucine or valine' 0 C--N 1.36 1.032 0 O-C-N 121.142 -0.974 . . . . 0.0 110.861 -175.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -71.02 -42.35 69.68 Favored 'General case' 0 C--N 1.351 0.644 0 O-C-N 121.659 -0.65 . . . . 0.0 111.73 -176.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -71.31 -37.57 71.79 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -175.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -100.66 -27.0 13.62 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 118.678 -1.209 . . . . 0.0 113.791 -174.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -111.56 -34.23 6.14 Favored 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 117.579 -1.648 . . . . 0.0 112.146 -176.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 142.11 178.41 18.15 Favored Glycine 0 C--N 1.348 1.216 0 C-N-CA 118.431 -1.842 . . . . 0.0 109.774 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 93.3 t80 -101.08 -26.19 13.78 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 -177.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -69.11 -39.72 78.77 Favored 'General case' 0 C--N 1.36 1.054 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.5 m -67.96 -38.54 82.89 Favored 'General case' 0 C--N 1.357 0.898 0 N-CA-C 107.613 -1.254 . . . . 0.0 107.613 178.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 34.7 tp -59.53 -38.34 80.74 Favored 'General case' 0 C--N 1.355 0.844 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 179.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -65.14 -37.11 86.38 Favored 'General case' 0 C--N 1.357 0.933 0 O-C-N 122.214 -0.304 . . . . 0.0 111.081 -178.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.3 m -64.45 -40.96 96.71 Favored 'General case' 0 C--N 1.355 0.834 0 O-C-N 121.636 -0.665 . . . . 0.0 109.774 -178.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.461 ' CD2' ' HB3' ' A' ' 54' ' ' LYS . 84.8 mt -64.48 -37.49 87.73 Favored 'General case' 0 C--N 1.356 0.861 0 O-C-N 121.892 -0.505 . . . . 0.0 109.744 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 82.5 mt -67.68 -18.77 65.04 Favored 'General case' 0 C--N 1.357 0.922 0 O-C-N 121.426 -0.796 . . . . 0.0 109.629 -179.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -85.74 -25.85 26.19 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 119.598 -0.841 . . . . 0.0 109.712 179.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.9 p -69.28 -24.45 63.96 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 119.856 -0.738 . . . . 0.0 109.304 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.4 p -106.96 -34.38 7.21 Favored 'General case' 0 C--N 1.357 0.898 0 C-N-CA 119.041 -1.064 . . . . 0.0 108.17 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 24.0 tt0 82.55 134.0 0.06 Allowed 'General case' 0 C--N 1.359 0.98 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.428 ' H ' ' HG ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -84.59 -169.82 2.81 Favored 'General case' 0 C--N 1.357 0.898 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.655 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.421 ' H ' ' H ' ' A' ' 33' ' ' SER . 63.1 tt0 -151.68 -25.25 0.19 Allowed 'General case' 0 N--CA 1.439 -1.015 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.421 ' H ' ' H ' ' A' ' 32' ' ' GLN . 1.5 t -146.12 -73.18 0.23 Allowed 'General case' 0 N--CA 1.438 -1.031 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 -179.167 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -126.83 -38.73 2.02 Favored 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -179.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 117.35 -31.74 5.68 Favored Glycine 0 C--N 1.353 1.502 0 N-CA-C 109.197 -1.561 . . . . 0.0 109.197 179.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 82.7 mt -112.5 99.98 9.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.512 ' O ' ' HB ' ' A' ' 38' ' ' THR . 3.0 t80 -70.84 -33.24 70.47 Favored 'General case' 0 C--N 1.357 0.916 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.512 ' HB ' ' O ' ' A' ' 37' ' ' TYR . 6.0 m 119.45 -70.07 0.0 OUTLIER 'General case' 0 C--N 1.369 1.456 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.6 p 174.4 66.62 0.0 OUTLIER 'General case' 0 C--N 1.359 0.998 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 -179.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.503 ' HB ' ' CE2' ' A' ' 37' ' ' TYR . 19.0 t -147.53 -11.52 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.356 0.878 0 C-N-CA 119.772 -0.771 . . . . 0.0 109.463 -178.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.53 146.01 18.07 Favored Glycine 0 C--N 1.352 1.461 0 C-N-CA 119.314 -1.422 . . . . 0.0 110.53 -177.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 52.7 m -122.25 125.74 46.69 Favored 'General case' 0 C--N 1.354 0.775 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 178.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -117.05 172.04 7.53 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-O 121.644 0.735 . . . . 0.0 109.058 -178.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -78.3 -176.15 4.54 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-O 121.662 0.744 . . . . 0.0 109.249 -179.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -85.56 -23.25 27.72 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -179.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -65.89 -28.88 69.28 Favored 'General case' 0 C--N 1.356 0.87 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.461 ' CG ' ' HZ ' ' A' ' 6' ' ' PHE . 24.4 tp10 -62.95 -39.55 94.98 Favored 'General case' 0 C--N 1.352 0.717 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -67.67 -38.81 84.25 Favored 'General case' 0 C--N 1.356 0.878 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 61.8 tp -70.44 -34.31 72.31 Favored 'General case' 0 CA--C 1.508 -0.671 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -177.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -65.15 -41.36 94.83 Favored 'General case' 0 N--CA 1.443 -0.799 0 O-C-N 122.041 -0.412 . . . . 0.0 110.227 -178.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 78.5 mt -81.86 -19.4 41.04 Favored 'General case' 0 C--N 1.357 0.934 0 C-N-CA 119.883 -0.727 . . . . 0.0 110.384 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 1.3 t -80.18 -37.23 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -179.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 52.5 t -67.78 -40.85 84.49 Favored 'Isoleucine or valine' 0 C--N 1.353 0.755 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 178.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.461 ' HB3' ' CD2' ' A' ' 25' ' ' LEU . 25.0 tptt -66.66 -25.81 66.75 Favored 'General case' 0 C--N 1.364 1.219 0 O-C-N 121.07 -1.019 . . . . 0.0 108.895 -179.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.534 HD21 HD12 ' A' ' 13' ' ' ILE . 6.4 mt -67.11 -37.99 84.86 Favored 'General case' 0 C--N 1.355 0.807 0 C-N-CA 120.431 -0.507 . . . . 0.0 109.904 178.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.448 ' O ' ' HA ' ' A' ' 60' ' ' SER . 57.4 p -72.86 -17.81 61.5 Favored 'General case' 0 C--N 1.354 0.791 0 C-N-CA 120.123 -0.631 . . . . 0.0 110.477 -179.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -99.3 -38.04 9.02 Favored 'General case' 0 C--N 1.354 0.777 0 O-C-N 121.321 -0.862 . . . . 0.0 111.497 -179.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.8 p -72.91 -37.88 55.27 Favored 'Isoleucine or valine' 0 C--N 1.353 0.722 0 O-C-N 121.656 -0.653 . . . . 0.0 111.327 -177.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.552 ' HB3' HG23 ' A' ' 61' ' ' VAL . 5.0 t -115.4 -6.72 12.32 Favored 'General case' 0 C--N 1.352 0.717 0 C-N-CA 119.033 -1.067 . . . . 0.0 110.265 -178.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 56' ' ' SER . 74.5 m 64.78 44.16 3.82 Favored 'General case' 0 C--N 1.355 0.829 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.552 HG23 ' HB3' ' A' ' 59' ' ' SER . 53.5 t -105.95 133.59 20.14 Favored Pre-proline 0 N--CA 1.444 -0.764 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -57.59 147.08 81.29 Favored 'Trans proline' 0 CA--C 1.498 -1.28 0 C-N-CA 122.538 2.159 . . . . 0.0 112.815 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.5 m -75.47 -12.13 14.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.919 -178.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.435 ' O ' HG12 ' A' ' 67' ' ' VAL . 67.3 p -96.48 -32.42 12.31 Favored 'General case' 0 C--N 1.358 0.969 0 C-N-CA 118.289 -1.364 . . . . 0.0 109.489 -179.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -77.82 -22.89 49.34 Favored 'General case' 0 C--N 1.355 0.819 0 O-C-N 121.341 -0.849 . . . . 0.0 108.868 179.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.426 HD13 HD13 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -79.97 -37.36 34.52 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.196 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.435 HG12 ' O ' ' A' ' 64' ' ' THR . 1.9 p -67.97 -26.66 35.15 Favored 'Isoleucine or valine' 0 C--N 1.355 0.828 0 C-N-CA 120.089 -0.644 . . . . 0.0 110.002 -179.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.2 mmm-85 -72.16 -50.86 24.39 Favored 'General case' 0 C--N 1.363 1.159 0 O-C-N 121.519 -0.738 . . . . 0.0 110.354 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 83.9 mt -63.57 -36.0 82.35 Favored 'General case' 0 C--N 1.357 0.932 0 O-C-N 122.061 -0.399 . . . . 0.0 110.966 -178.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -60.8 -47.69 85.18 Favored 'General case' 0 C--N 1.35 0.608 0 O-C-N 122.221 -0.299 . . . . 0.0 110.64 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -61.12 -38.54 95.75 Favored Glycine 0 C--N 1.354 1.554 0 N-CA-C 111.834 -0.506 . . . . 0.0 111.834 -178.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.65 -47.65 80.45 Favored 'General case' 0 C--N 1.349 0.568 0 CA-C-N 118.13 0.965 . . . . 0.0 111.548 -177.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 10.2 mttm -65.39 -48.39 73.02 Favored 'General case' 0 C--N 1.359 1.006 0 N-CA-C 113.506 0.928 . . . . 0.0 113.506 -177.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.444 ' O ' HD22 ' A' ' 74' ' ' LEU . 2.4 tm? -68.93 -39.37 79.63 Favored 'General case' 0 C--N 1.348 0.529 0 O-C-N 121.156 -0.965 . . . . 0.0 111.788 -175.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -63.81 -44.96 91.73 Favored 'General case' 0 C--N 1.354 0.779 0 O-C-N 121.084 -1.01 . . . . 0.0 111.032 -178.003 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 9.9 p -71.83 -13.86 17.08 Favored 'Isoleucine or valine' 0 C--N 1.359 0.98 0 O-C-N 121.548 -0.72 . . . . 0.0 109.084 -179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -73.52 -38.06 65.44 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 179.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . 0.426 HD13 HBC2 ' A' ' 202' ' ' HEM . 83.6 mt -74.47 -29.78 61.59 Favored 'General case' 0 C--N 1.357 0.928 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 46.5 mm -65.25 -52.94 46.29 Favored 'Isoleucine or valine' 0 C--N 1.358 0.977 0 C-N-CA 120.059 -0.656 . . . . 0.0 109.883 -177.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -75.36 -15.89 60.44 Favored 'General case' 0 C--N 1.351 0.645 0 C-N-CA 119.692 -0.803 . . . . 0.0 109.425 178.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -70.85 -37.26 65.72 Favored Glycine 0 C--N 1.349 1.27 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -179.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -131.88 106.21 13.97 Favored Pre-proline 0 N--CA 1.441 -0.923 0 CA-C-O 122.58 1.181 . . . . 0.0 109.37 -177.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -68.36 -25.35 36.14 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.581 2.187 . . . . 0.0 113.848 179.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -88.5 -9.1 53.55 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 -179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -89.51 -21.92 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.076 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 -178.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -100.26 -23.25 14.85 Favored 'General case' 0 C--N 1.36 1.049 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -70.2 -37.24 75.04 Favored 'General case' 0 C--N 1.358 0.959 0 O-C-N 121.845 -0.535 . . . . 0.0 109.845 179.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -64.28 -36.24 83.47 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.322 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.45 ' SD ' ' HB2' ' A' ' 95' ' ' LEU . 17.4 ttp -83.32 153.54 24.56 Favored 'General case' 0 C--N 1.351 0.67 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -178.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.46 -22.65 8.08 Favored 'General case' 0 C--N 1.365 1.276 0 O-C-N 121.627 -0.671 . . . . 0.0 111.138 -177.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.6 t0 -164.21 170.14 16.7 Favored 'General case' 0 CA--C 1.504 -0.802 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -177.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.489 ' O ' ' HB3' ' A' ' 95' ' ' LEU . 64.9 m -66.05 -40.56 91.04 Favored 'General case' 0 C--N 1.355 0.809 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.469 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 1.6 m-30 -68.42 -37.9 80.74 Favored 'General case' 0 C--N 1.354 0.788 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.135 -179.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -66.22 -22.5 66.34 Favored 'General case' 0 C--N 1.357 0.935 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.489 ' HB3' ' O ' ' A' ' 92' ' ' SER . 62.0 tp -64.42 -45.16 88.77 Favored 'General case' 0 C--N 1.357 0.919 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.049 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.5 mp -60.89 -35.76 77.47 Favored 'General case' 0 C--N 1.356 0.874 0 O-C-N 122.139 -0.351 . . . . 0.0 110.17 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 33.6 t -69.09 -39.9 78.72 Favored 'General case' 0 C--N 1.35 0.613 0 O-C-N 121.871 -0.518 . . . . 0.0 110.067 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.77 8.15 40.62 Favored 'General case' 0 C--N 1.354 0.766 0 O-C-N 122.163 -0.336 . . . . 0.0 111.359 -176.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.818 HD11 ' C2B' ' A' ' 202' ' ' HEM . 19.3 tt -63.32 -38.81 83.13 Favored 'Isoleucine or valine' 0 C--N 1.36 1.024 0 O-C-N 121.44 -0.787 . . . . 0.0 111.876 -176.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -108.51 -14.75 14.59 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 118.103 -1.439 . . . . 0.0 110.156 -178.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 34.9 t -64.42 -46.09 84.73 Favored 'General case' 0 N--CA 1.444 -0.748 0 C-N-CA 120.253 -0.579 . . . . 0.0 111.07 -179.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 10.8 t80 -137.37 -15.09 1.46 Allowed 'General case' 0 C--N 1.359 1.016 0 C-N-CA 117.343 -1.743 . . . . 0.0 112.512 -177.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.641 HG21 ' C1C' ' A' ' 202' ' ' HEM . 26.5 mm -70.56 -51.74 34.83 Favored 'Isoleucine or valine' 0 C--O 1.243 0.735 0 CA-C-N 119.875 1.216 . . . . 0.0 110.468 -177.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 51.8 m170 -92.09 -1.05 57.41 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 119.5 -0.88 . . . . 0.0 110.203 -177.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 65.6 t -80.04 -44.6 22.71 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.026 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 178.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 54.8 tp10 -68.31 -40.76 81.59 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -179.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 59.1 t -62.66 -46.69 95.75 Favored 'Isoleucine or valine' 0 C--N 1.356 0.856 0 C-N-CA 120.706 -0.397 . . . . 0.0 110.598 -179.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -60.38 -48.24 82.61 Favored 'General case' 0 C--N 1.359 0.993 0 O-C-N 121.967 -0.458 . . . . 0.0 111.472 -178.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -60.61 -36.55 78.87 Favored 'General case' 0 C--N 1.356 0.857 0 O-C-N 121.544 -0.722 . . . . 0.0 110.293 -178.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 17.4 mt -59.27 -77.16 0.04 OUTLIER 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' TYR . . . . . 0.444 ' HA ' ' HD3' ' A' ' 112' ' ' PRO . 82.7 m-85 -118.9 140.73 29.01 Favored Pre-proline 0 N--CA 1.438 -1.027 0 C-N-CA 118.663 -1.215 . . . . 0.0 109.053 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 111' ' ' TYR . 73.7 Cg_endo -87.0 -2.5 8.05 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 C-N-CA 123.129 2.553 . . . . 0.0 114.904 -179.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -66.97 -36.52 82.38 Favored 'General case' 0 C--N 1.355 0.825 0 O-C-N 121.921 -0.487 . . . . 0.0 110.06 -179.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.44 ' CB ' HBD2 ' A' ' 202' ' ' HEM . . . -66.82 147.11 53.68 Favored 'General case' 0 C--N 1.352 0.704 0 CA-C-O 121.525 0.679 . . . . 0.0 109.81 -178.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.462 ' O ' HD13 ' A' ' 116' ' ' LEU . 46.5 mt-10 -117.51 142.66 46.9 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 179.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.462 HD13 ' O ' ' A' ' 115' ' ' GLU . 2.7 mm? -127.12 149.29 69.06 Favored Pre-proline 0 C--N 1.352 0.695 0 CA-C-O 122.178 0.99 . . . . 0.0 108.73 -178.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.464 ' HD3' ' CGA' ' A' ' 202' ' ' HEM . 75.1 Cg_endo -89.65 -158.86 0.08 OUTLIER 'Trans proline' 0 C--N 1.316 -1.18 0 C-N-CA 123.75 2.967 . . . . 0.0 113.029 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -118.33 140.56 49.65 Favored 'General case' 0 C--N 1.362 1.128 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -126.55 129.36 48.44 Favored 'General case' 0 C--N 1.361 1.081 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -178.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . 0.478 ' HB ' ' HB2' ' A' ' 132' ' ' HIS . 95.3 m -125.42 127.53 46.69 Favored 'General case' 0 CA--C 1.503 -0.86 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 176.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 80.9 m -120.12 129.51 54.2 Favored 'General case' 0 CA--C 1.503 -0.855 0 C-N-CA 119.087 -1.045 . . . . 0.0 109.693 -177.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -120.74 117.48 27.59 Favored 'General case' 0 N--CA 1.44 -0.958 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 178.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.589 ' HG3' ' CD1' ' A' ' 129' ' ' ILE . 12.9 ttm180 -92.8 113.81 26.19 Favored 'General case' 0 CA--C 1.504 -0.791 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -179.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.555 ' HB2' ' HB2' ' A' ' 128' ' ' ASP . 87.1 mt -75.96 -38.99 56.93 Favored 'General case' 0 N--CA 1.443 -0.82 0 C-N-CA 120.563 -0.455 . . . . 0.0 110.074 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -166.21 -139.65 2.7 Favored Glycine 0 C--N 1.351 1.387 0 N-CA-C 109.231 -1.547 . . . . 0.0 109.231 -178.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -94.75 -41.09 9.43 Favored 'General case' 0 N--CA 1.439 -0.982 0 C-N-CA 120.134 -0.626 . . . . 0.0 109.452 -178.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 51.3 p-10 -101.28 4.48 41.76 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 120.049 -0.661 . . . . 0.0 109.956 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.555 ' HB2' ' HB2' ' A' ' 124' ' ' LEU . 67.3 m-20 -118.2 128.36 54.63 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.589 ' CD1' ' HG3' ' A' ' 123' ' ' ARG . 3.4 mm -139.42 132.33 36.92 Favored 'Isoleucine or valine' 0 C--N 1.355 0.823 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 52.9 mtm180 -116.08 137.8 51.8 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 179.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 1.9 tp -127.5 118.83 24.76 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 115.328 -0.851 . . . . 0.0 108.829 -178.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.478 ' HB2' ' HB ' ' A' ' 120' ' ' THR . 11.9 m170 -97.56 131.54 44.06 Favored 'General case' 0 CA--C 1.497 -1.075 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 178.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -127.37 121.14 30.16 Favored 'General case' 0 N--CA 1.435 -1.178 0 N-CA-C 107.394 -1.336 . . . . 0.0 107.394 -178.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.511 ' HA ' ' O ' ' A' ' 171' ' ' THR . 28.6 tt0 -113.75 113.9 25.61 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.7 t -161.06 151.82 18.3 Favored 'General case' 0 C--N 1.359 0.982 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.402 ' C ' ' HD3' ' A' ' 138' ' ' PRO . 99.4 mttt -90.72 2.08 56.29 Favored 'General case' 0 C--N 1.355 0.838 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 -179.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -132.99 74.54 73.69 Favored Pre-proline 0 CA--C 1.505 -0.787 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' PRO . . . . . 0.402 ' HD3' ' C ' ' A' ' 136' ' ' LYS . 90.2 Cg_endo -96.47 102.2 0.09 OUTLIER 'Trans proline' 0 N--CA 1.442 -1.533 0 C-N-CA 122.743 2.296 . . . . 0.0 115.818 -177.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 52.5 m-85 -110.76 114.07 27.15 Favored 'General case' 0 N--CA 1.437 -1.096 0 N-CA-C 105.971 -1.862 . . . . 0.0 105.971 176.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -63.88 -38.41 90.98 Favored 'General case' 0 C--N 1.353 0.745 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.311 -178.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 74.5 m -64.01 -27.1 68.89 Favored 'General case' 0 C--N 1.354 0.777 0 O-C-N 121.864 -0.522 . . . . 0.0 110.7 -178.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -76.33 -47.08 24.77 Favored 'General case' 0 C--N 1.351 0.646 0 O-C-N 121.743 -0.598 . . . . 0.0 109.765 -177.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -64.67 -39.77 94.27 Favored 'General case' 0 C--N 1.356 0.885 0 O-C-N 122.183 -0.323 . . . . 0.0 111.256 -178.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.61 -37.71 88.38 Favored 'General case' 0 C--N 1.355 0.836 0 O-C-N 121.867 -0.521 . . . . 0.0 110.024 -179.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -60.15 -43.17 98.63 Favored Glycine 0 C--N 1.347 1.188 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 -179.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' LEU . . . . . . . . . . . . . 83.6 mt -70.44 -40.38 73.81 Favored 'General case' 0 C--N 1.352 0.682 0 CA-C-N 117.559 0.68 . . . . 0.0 112.649 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 98.4 mt -70.91 -42.47 69.89 Favored 'General case' 0 C--N 1.362 1.11 0 O-C-N 121.215 -0.928 . . . . 0.0 110.86 -176.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.555 ' O ' ' HG2' ' A' ' 152' ' ' GLU . 37.2 t70 -71.5 -28.85 64.19 Favored 'General case' 0 N--CA 1.444 -0.744 0 O-C-N 121.894 -0.504 . . . . 0.0 110.336 -179.197 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 152' ' ' GLU . . . -63.03 -39.64 98.31 Favored Glycine 0 C--N 1.357 1.719 0 N-CA-C 108.282 -1.927 . . . . 0.0 108.282 179.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' CYS . . . . . . . . . . . . . 44.1 t -61.03 -41.06 95.86 Favored 'General case' 0 C--N 1.352 0.681 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 178.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -76.22 0.86 17.63 Favored 'General case' 0 C--N 1.361 1.071 0 CA-C-O 121.406 0.622 . . . . 0.0 109.403 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.555 ' HG2' ' O ' ' A' ' 148' ' ' ASP . 76.8 mm-40 -86.37 -45.8 10.86 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -68.34 -43.67 76.99 Favored 'General case' 0 C--N 1.357 0.912 0 C-N-CA 120.097 -0.641 . . . . 0.0 109.503 179.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' PHE . . . . . . . . . . . . . 36.3 m-85 -69.73 -27.9 65.35 Favored 'General case' 0 C--N 1.361 1.078 0 O-C-N 121.815 -0.553 . . . . 0.0 110.932 -178.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 85.1 tttt 71.56 69.22 0.16 Allowed 'General case' 0 C--N 1.362 1.114 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 -177.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -134.57 -176.71 4.31 Favored 'General case' 0 CA--C 1.503 -0.849 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -179.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -135.95 110.45 8.54 Favored 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -179.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -132.9 150.34 52.17 Favored 'General case' 0 CA--C 1.505 -0.754 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . . . . . . . . . 95.2 m -120.39 126.57 50.8 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.531 HD12 ' N ' ' A' ' 160' ' ' ILE . 3.5 mp -101.86 121.31 52.68 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 179.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 1.7 m -116.32 -176.69 3.01 Favored 'General case' 0 C--N 1.361 1.082 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.734 ' HD2' ' HG3' ' A' ' 167' ' ' GLN . 8.8 ptt180 -148.95 158.17 43.97 Favored 'General case' 0 C--N 1.356 0.858 0 N-CA-C 107.548 -1.279 . . . . 0.0 107.548 -179.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 65.5 p -104.75 145.01 29.89 Favored Pre-proline 0 C--N 1.359 1.017 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 179.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . 0.868 ' HA ' ' HB2' ' A' ' 167' ' ' GLN . 57.7 Cg_endo -75.36 -8.24 19.49 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 123.094 2.529 . . . . 0.0 115.521 -178.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -71.19 -41.31 70.45 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 34.1 p -117.77 16.12 14.41 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.868 ' HB2' ' HA ' ' A' ' 164' ' ' PRO . 45.1 tt0 -58.96 -38.67 79.6 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.87 179.091 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 26.4 t0 -111.71 48.69 0.94 Allowed 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -179.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 19.0 t -139.64 142.95 36.98 Favored 'General case' 0 C--N 1.352 0.7 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.613 ' O ' ' HB ' ' A' ' 171' ' ' THR . 61.0 mt-10 -97.15 164.77 12.36 Favored 'General case' 0 C--N 1.356 0.86 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -179.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' THR . . . . . 0.613 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 3.1 m 80.81 -57.73 0.3 Allowed 'General case' 0 C--N 1.371 1.542 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -107.96 116.76 32.55 Favored 'General case' 0 CA--C 1.503 -0.83 0 C-N-CA 119.843 -0.743 . . . . 0.0 109.732 -178.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 86.3 t -130.26 131.86 65.35 Favored 'Isoleucine or valine' 0 C--N 1.356 0.875 0 N-CA-C 106.922 -1.51 . . . . 0.0 106.922 178.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ILE . . . . . . . . . . . . . 50.5 mm -108.1 125.75 64.71 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -112.51 151.15 30.31 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-O 122.138 0.97 . . . . 0.0 108.551 -179.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -133.9 82.84 2.0 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-N 114.64 -1.164 . . . . 0.0 108.804 -178.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' ILE . . . . . . . . . . . . . 4.1 mp -78.23 116.49 21.98 Favored 'Isoleucine or valine' 0 C--N 1.359 1.007 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 90.7 m -118.3 144.2 46.02 Favored 'General case' 0 CA--C 1.503 -0.835 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 -178.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 56.5 ttp180 -87.96 113.78 23.94 Favored 'General case' 0 C--N 1.36 1.035 0 N-CA-C 106.297 -1.742 . . . . 0.0 106.297 -179.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' A' ' 181' ' ' PRO . . . -62.81 143.86 96.83 Favored Pre-proline 0 CA--C 1.5 -0.979 0 CA-C-O 121.983 0.896 . . . . 0.0 108.85 -179.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 180' ' ' ALA . 53.2 Cg_exo -54.97 127.73 27.54 Favored 'Trans proline' 0 CA--C 1.497 -1.353 0 C-N-CA 122.85 2.367 . . . . 0.0 113.397 -179.381 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.37 148.13 51.82 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . . . . . . . . . . . 73.46 -152.06 45.84 Favored Glycine 0 C--N 1.351 1.376 0 N-CA-C 107.102 -2.399 . . . . 0.0 107.102 -178.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -86.89 -179.74 6.57 Favored 'General case' 0 N--CA 1.433 -1.275 0 N-CA-C 107.303 -1.369 . . . . 0.0 107.303 178.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -75.51 176.65 7.37 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -150.58 161.65 42.16 Favored 'General case' 0 N--CA 1.439 -1.01 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 -178.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -153.22 -86.88 0.06 Allowed 'General case' 0 N--CA 1.439 -1.025 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -155.81 -80.1 0.08 Allowed 'General case' 0 N--CA 1.438 -1.045 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 89.4 t80 -136.24 129.08 31.01 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 -179.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 . . . . . 0 C--O 1.264 1.855 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -179.968 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' CMO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' HEM . . . . . 0.934 ' CMD' HBD1 ' A' ' 202' ' ' HEM . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_